Citrus Sinensis ID: 017909

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360----
Protein Sequence
MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHPEAR
Secondary Structure (PSIPRED)
ccccccccccccccccEEEEEccEEEEEccccccccccccccccEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEEEcccccHHHHHcccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccEEEEEEccEEEEEccEEEEEEEEEEccEEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccHcccEEEEHHHHHHcHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccccccccccHHHcccHHHHcEcccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHHHHcccHHHHHHHHHccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHcccccccccccccccccHHHHHHHHHHHHHHHccccc
Coil and Loop (DISEMBL)
matlveppngmksrgkhYYTMWQTLFEIdtkyvpikpigrgaYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIalkdvmmpthrisfkdVYLVYELMDTDLHQIIKSsqslsndhCKYFVFQLLRGLKylhsanilhrdlkpgnllvnancdlKICDfglartsrgneqfMTEYVVTrwyrapelllccdnygtsidVWSVGCIFAeilgrkpifpgtecLNQLKLIISVFGtqqeadlefidnpkarrfikslpysrgthisslypqadPLALDLLQKMLvfepskritvtealqhpyisglydpqcnppaqvplsldiDENIGEQMIRQMMWNetlhyhpear
Flexible Loop (DISEMBL)
matlveppngmksrgkHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHdnvialkdvmmpthRISFKDVYLVYELMDTDLHQIIkssqslsndHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGlartsrgneqFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADlefidnpkarRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETlhyhpear
Low Complexity Region (SEG)
MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHPEAR
Disordered region (IsUnstruct)
***************KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH******
Disordered Region (DISOPRED)
*******************TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPY*R*THISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHP***
Disordered Region (DISEMBL)
MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHPEAR
Disordered Region (DISPRO)
*****EPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHP***
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHPEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	364	2.2.26 [Sep-21-2011]
Q39027	368	Mitogen-activated protein	yes	no	0.997	0.986	0.865	0.0
Q40517	372	Mitogen-activated protein	N/A	no	0.997	0.975	0.834	0.0
Q5Z859	369	Mitogen-activated protein	yes	no	0.997	0.983	0.831	0.0
Q40884	384	Mitogen-activated protein	N/A	no	0.997	0.945	0.829	0.0
Q6Z437	370	Mitogen-activated protein	no	no	0.997	0.981	0.820	0.0
Q39021	370	Mitogen-activated protein	no	no	0.997	0.981	0.812	0.0
O23236	361	Mitogen-activated protein	no	no	0.989	0.997	0.815	1e-180
Q39022	376	Mitogen-activated protein	no	no	0.997	0.965	0.8	1e-178
Q9LQQ9	363	Mitogen-activated protein	no	no	0.934	0.936	0.568	1e-117
Q40531	371	Mitogen-activated protein	N/A	no	0.939	0.921	0.562	1e-116

>sp|Q39027|MPK7_ARATH Mitogen-activated protein kinase 7 OS=Arabidopsis thaliana GN=MPK7 PE=2 SV=2

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/363 (86%), Positives = 349/363 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++H+NVIALKDVM+P +R SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLPYSRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VT+AL HPY++GL+DP  NPPA VP+SLDIDEN+ E +IR+MMWNE L+YH
Sbjct: 301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q40517|NTF3_TOBAC Mitogen-activated protein kinase homolog NTF3 OS=Nicotiana tabacum GN=NTF3 PE=1 SV=1

 Score =  659 bits (1699), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 303/363 (83%), Positives = 340/363 (93%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MAT VEPPNG+++ GKHYY+MWQ+LFEIDTKYVPIKPIGRGAYG+VCSS+NRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINN FENRIDALRTLREL LLRH++H+NVIALKDVMMP HR SFKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ+LSNDHC+YF+FQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS G +QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII++ G+Q+E D+EFIDNPKAR++IKSLPYS GT  S LYP A PLA+DLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKARKYIKSLPYSPGTPFSRLYPHAHPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRI+V EALQHPY+S LYDP  +PPAQVP++LDIDE++GE+ IR+MMW+E L YH
Sbjct: 301 VFDPSKRISVIEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLGEETIREMMWSEILEYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q5Z859|MPK4_ORYSJ Mitogen-activated protein kinase 4 OS=Oryza sativa subsp. japonica GN=MPK4 PE=2 SV=1

 Score =  655 bits (1689), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 302/363 (83%), Positives = 335/363 (92%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA +V+PPNGM ++GKHYYTMWQTLFEIDTKYVPIKPIGRGAYG+VCSSINR TNEKVAI
Sbjct: 1   MAMMVDPPNGMGNQGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGIVCSSINRATNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINNVF+NR+DALRTLREL LLRH++H+NVIALKD+MMP HR SFKDVYLVYELMDTDL
Sbjct: 61  KKINNVFDNRVDALRTLRELKLLRHLRHENVIALKDIMMPVHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LSNDHC+YF+FQLLRGLKYLHSA ILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQPLSNDHCQYFLFQLLRGLKYLHSAGILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RT+    QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIFPGTECL
Sbjct: 181 RTNNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLI++V GT  EAD+EFIDNPKAR++IK+LPY+ G  ++S+YPQA PLA+DLLQKML
Sbjct: 241 NQLKLIVNVLGTMSEADIEFIDNPKARKYIKTLPYTPGIPLTSMYPQAHPLAIDLLQKML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRI+VTEAL+HPY+S LYDP  NPPAQVP+ LDIDEN+G  MIR+MMW E LHYH
Sbjct: 301 VFDPSKRISVTEALEHPYMSPLYDPSANPPAQVPIDLDIDENLGVDMIREMMWQEMLHYH 360

Query: 361 PEA 363
           PE 
Sbjct: 361 PEV 363

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40884|MAPK_PETHY Mitogen-activated protein kinase homolog 1 OS=Petunia hybrida GN=MEK1 PE=2 SV=1

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 301/363 (82%), Positives = 338/363 (93%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MAT VEPPNG+++ GKHYY+MWQ+LFEIDTKYVPIKPIGRGAYG+VCSS+NRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINN FENRIDALRTLREL LLRH++H+NVIALKDVMMP  R SFKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRIDALRTLRELKLLRHLRHENVIALKDVMMPIQRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ+LSNDHC+YF+FQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS G +QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA++LGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFADVLGRKPVFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII++ G+Q+E D+EFIDNPKAR++IKSLPYS GT  S LYP A PLA+DLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKARKYIKSLPYSPGTPFSRLYPNAHPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRI+V EALQHPY+S LYDP  +PPAQVP++LDIDE++ E+ IR+MMW E LHYH
Sbjct: 301 VFDPSKRISVMEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLVEETIREMMWEEILHYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Petunia hybrida (taxid: 4102)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q6Z437|MPK3_ORYSJ Mitogen-activated protein kinase 3 OS=Oryza sativa subsp. japonica GN=MPK3 PE=2 SV=1

 Score =  648 bits (1672), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 298/363 (82%), Positives = 334/363 (92%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA +V+PPNGM ++GK+YY+MWQTLFEIDTKYVPIKPIGRGAYG+VCSSINRETNEKVAI
Sbjct: 1   MAIMVDPPNGMGNQGKYYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSINRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVF+NR+DALRTLREL LLRH++H+NVIALKD+MMP HR SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFDNRVDALRTLRELKLLRHLRHENVIALKDIMMPVHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKS Q LSNDHC+YF+FQLLRGLKYLHSA ILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSPQGLSNDHCQYFLFQLLRGLKYLHSAEILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RT+    QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIFPGTECL
Sbjct: 181 RTNSSKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLI++V GT  E+DLEFIDNPKARR+IKSLPY+ G  ++S+YP A PLA+DLLQKML
Sbjct: 241 NQLKLIVNVLGTMSESDLEFIDNPKARRYIKSLPYTPGVPLASMYPHAHPLAIDLLQKML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           +F+P+KRI+VTEAL+HPY+S LYDP  NPPAQVP+ LDIDENI   MIR+MMW+E LHYH
Sbjct: 301 IFDPTKRISVTEALEHPYMSPLYDPSANPPAQVPIDLDIDENISADMIREMMWHEMLHYH 360

Query: 361 PEA 363
           PE 
Sbjct: 361 PEV 363

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39021|MPK1_ARATH Mitogen-activated protein kinase 1 OS=Arabidopsis thaliana GN=MPK1 PE=1 SV=2

 Score =  644 bits (1661), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 295/363 (81%), Positives = 337/363 (92%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MATLV+PPNG+++ GKHY++MWQTLFEIDTKY+PIKPIGRGAYGVVCSS+N +TNEKVAI
Sbjct: 1   MATLVDPPNGIRNEGKHYFSMWQTLFEIDTKYMPIKPIGRGAYGVVCSSVNSDTNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NV+ENRIDALRTLREL LLRH++H+NVIALKDVMMP H++SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVYENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LSNDHC+YF+FQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           R S    QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIF GTECL
Sbjct: 181 RASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLI+++ G+Q+E DLEFIDNPKA+R+I+SLPYS G  +S LYP A  LA+DLLQKML
Sbjct: 241 NQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDLLQKML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRI+V+EALQHPY++ LYDP  NPPAQVP+ LD+DE++ E+MIR+MMWNE LHYH
Sbjct: 301 VFDPSKRISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDEDLREEMIREMMWNEMLHYH 360

Query: 361 PEA 363
           P+A
Sbjct: 361 PQA 363

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|O23236|MPK14_ARATH Mitogen-activated protein kinase 14 OS=Arabidopsis thaliana GN=MPK14 PE=2 SV=1

 Score =  629 bits (1623), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 297/364 (81%), Positives = 334/364 (91%), Gaps = 4/364 (1%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LV+PPNG++  GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSIN ETNE+VAI
Sbjct: 1   MAMLVDPPNGIRQEGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINSETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENRIDALRTLREL LLRH++H+NVI+LKDVM+PTHR SF+DVYLVYELMD+DL
Sbjct: 61  KKIHNVFENRIDALRTLRELKLLRHVRHENVISLKDVMLPTHRYSFRDVYLVYELMDSDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           +QIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 NQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RT    EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTY---EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 237

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQ+ DL+FIDN KARRFIKSLP+S+GTH S +YP A+PLA+DLLQ+ML
Sbjct: 238 NQLKLIINVVGSQQDWDLQFIDNQKARRFIKSLPFSKGTHFSHIYPHANPLAIDLLQRML 297

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPL-SLDIDENIGEQMIRQMMWNETLHY 359
           VF+P+KRI+V++AL HPY+ GL +P+CNP   VP+ SL+IDEN+   MIR+MMW E LHY
Sbjct: 298 VFDPTKRISVSDALLHPYMEGLLEPECNPSENVPVSSLEIDENMEGDMIREMMWEEMLHY 357

Query: 360 HPEA 363
            P A
Sbjct: 358 LPRA 361

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39022|MPK2_ARATH Mitogen-activated protein kinase 2 OS=Arabidopsis thaliana GN=MPK2 PE=1 SV=2

 Score =  623 bits (1606), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 292/365 (80%), Positives = 335/365 (91%), Gaps = 2/365 (0%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MAT V+PPNG++++GKHY++MWQTLFEIDTKYVPIKPIGRGAYGVVCSS+NRE+NE+VAI
Sbjct: 1   MATPVDPPNGIRNQGKHYFSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSVNRESNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENRIDALRTLREL LLRH++H+NV+ALKDVMM  H+ SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRIDALRTLRELKLLRHLRHENVVALKDVMMANHKRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LSNDHC+YF+FQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS    QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKP+FPGTECL
Sbjct: 181 RTSNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQ+KLII++ G+Q+E DLEFIDNPKA+R+I+SLPYS G   S LYP A+ LA+DLLQKML
Sbjct: 241 NQIKLIINILGSQREEDLEFIDNPKAKRYIESLPYSPGISFSRLYPGANVLAIDLLQKML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPL--SLDIDENIGEQMIRQMMWNETLH 358
           V +PSKRI+VTEALQHPY++ LYDP  NPPAQVP+   +D DE++G +MIR++MW E +H
Sbjct: 301 VLDPSKRISVTEALQHPYMAPLYDPSANPPAQVPIDLDVDEDEDLGAEMIRELMWKEMIH 360

Query: 359 YHPEA 363
           YHPEA
Sbjct: 361 YHPEA 365

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LQQ9|MPK13_ARATH Mitogen-activated protein kinase 13 OS=Arabidopsis thaliana GN=MPK13 PE=1 SV=1

 Score =  423 bits (1087), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 195/343 (56%), Positives = 262/343 (76%), Gaps = 3/343 (0%)

Query: 19  YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL 77
           Y +   +FE+ +KY+P I+PIGRGAYG+VC + N ETNE+VAIKKI N F+NR+DA RTL
Sbjct: 19  YNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANAFDNRVDAKRTL 78

Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKY 137
           RE+ LL H+ HDNVI +KD++    +  F+DVY+VYELMDTDLHQII+S+Q+L++DHC+Y
Sbjct: 79  REIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQY 138

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           F++Q+LRGLKY+HSAN+LHRDLKP NL++N NCDLKICDFGLARTS   E  MTEYVVTR
Sbjct: 139 FLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETE-IMTEYVVTR 197

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           WYRAPELLL    Y  +ID+WSVGCIF EIL R+ +FPG + + QLKLI  + G+  ++D
Sbjct: 198 WYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSD 257

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           L+F+ +  AR+++K LP+ +       +P   P+ALDL +KMLVF+PSKRITV EAL+ P
Sbjct: 258 LDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQP 317

Query: 318 YISGLYDPQCNPPAQVPLSLDIDEN-IGEQMIRQMMWNETLHY 359
           Y++ L++    P    P S D +E  + EQ I++++W E+LH+
Sbjct: 318 YLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  419 bits (1078), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 194/345 (56%), Positives = 260/345 (75%), Gaps = 3/345 (0%)

Query: 19  YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL 77
           Y +    FE+ +KY+P I+P+GRGAYG+VC + N ET E+VAIKKI N FENRIDA RTL
Sbjct: 24  YNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSETKEEVAIKKIGNAFENRIDAKRTL 83

Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKY 137
           RE+ LL H+ H+N+I +KD++ P  R  F DVY+VYELMDTDLHQII+SSQ+L++DHC+Y
Sbjct: 84  REIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYELMDTDLHQIIRSSQALTDDHCQY 143

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           F++QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLART+     FMTEYVVTR
Sbjct: 144 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEADFMTEYVVTR 202

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           WYRAPELLL C  Y  +ID+WSVGCI  E++ R+P+FPG +   QL LII++ G+ +++D
Sbjct: 203 WYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFPGRDYAQQLGLIIALLGSPEDSD 262

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           L F+ +  AR+++K LP       S  +P   PLALDL ++MLVF+P+KRITV +AL HP
Sbjct: 263 LGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDLAERMLVFDPAKRITVEDALNHP 322

Query: 318 YISGLYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHP 361
           ++  L++    P    P + D ++ ++ E  I++++WNE L + P
Sbjct: 323 FLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWNEALKFDP 367

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	364
255561020	368	big map kinase/bmk, putative [Ricinus co	0.991	0.980	0.891	0.0
297748111	368	mitogen-activated protein kinase 7 [Goss	0.997	0.986	0.887	0.0
4887127	368	putative mitogen-activated protein kinas	0.997	0.986	0.873	0.0
312283529	368	unnamed protein product [Thellungiella h	0.997	0.986	0.867	0.0
413966400	368	MAPK7-1 [Brassica napus] gi|413966402|gb	0.997	0.986	0.867	0.0
224134210	368	predicted protein [Populus trichocarpa]	0.997	0.986	0.870	0.0
457406	368	MAP kinase [Arabidopsis thaliana]	0.997	0.986	0.865	0.0
15224120	368	mitogen-activated protein kinase 7 [Arab	0.997	0.986	0.865	0.0
297836542	368	ATMPK7 [Arabidopsis lyrata subsp. lyrata	0.997	0.986	0.865	0.0
110180198	389	double HA-tagged mitogen activated prote	0.997	0.933	0.865	0.0

>gi|255561020|ref|XP_002521522.1| big map kinase/bmk, putative [Ricinus communis] gi|223539200|gb|EEF40793.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  696 bits (1795), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/361 (89%), Positives = 347/361 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MATLVEPPNG++ +GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI
Sbjct: 1   MATLVEPPNGIRQQGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINNVFEN+IDALRTLREL LLRHI+H+NVIALKDVMMP HR SFKDVY+VYELMDTDL
Sbjct: 61  KKINNVFENKIDALRTLRELKLLRHIRHENVIALKDVMMPIHRTSFKDVYMVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LSNDHCKYF+FQLLRGL YLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQPLSNDHCKYFLFQLLRGLNYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSID+WSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDIWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQ+AD+EFIDNPKARR+IK+LPYSRGTH S LYPQADPLA+DLLQ+ML
Sbjct: 241 NQLKLIINVLGSQQDADIEFIDNPKARRYIKTLPYSRGTHFSHLYPQADPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRITVTEAL HPY+ GLYDP+CNPPAQ P+++DIDEN+GE MIR+MMWNE LHYH
Sbjct: 301 VFDPSKRITVTEALLHPYMKGLYDPRCNPPAQFPINIDIDENLGEHMIREMMWNEMLHYH 360

Query: 361 P 361
           P
Sbjct: 361 P 361

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297748111|gb|ADI52622.1| mitogen-activated protein kinase 7 [Gossypium hirsutum] gi|297748123|gb|ADI52628.1| mitogen-activated protein kinase 7 [Gossypium hirsutum]

 Score =  691 bits (1784), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/363 (88%), Positives = 347/363 (95%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MATLVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYG+VCS+INRETNEKVAI
Sbjct: 1   MATLVEPPNGVKPKGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSAINRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINNVFENR+DALRTLREL LLRHI+H+NVIALKDVMMP  RI FKDVYLVYELMDTDL
Sbjct: 61  KKINNVFENRVDALRTLRELKLLRHIRHENVIALKDVMMPIQRIGFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKS Q LSNDHCKYF+FQLLRGLKYLHSANIL RDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSPQPLSNDHCKYFIFQLLRGLKYLHSANILLRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQEA+++FIDNPKARR+IKSLPYSRGTH S LYPQADPLA+DLLQ+ML
Sbjct: 241 NQLKLIINVLGSQQEANIQFIDNPKARRYIKSLPYSRGTHFSLLYPQADPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRITVTEAL HPY+ GLYDP+CNPPAQVP+ L+IDEN+GE MIR+MMW+E LHYH
Sbjct: 301 VFDPSKRITVTEALLHPYLLGLYDPRCNPPAQVPIDLEIDENMGESMIREMMWSEMLHYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|4887127|gb|AAD32204.1|AF134730_1 putative mitogen-activated protein kinase MAPK [Prunus armeniaca]

 Score =  684 bits (1765), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/363 (87%), Positives = 344/363 (94%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MATLVEPP+G++ RGKHYY+MWQTLFE+DTKYVPIKPIGRGAYG+VCSSINR TNEKVAI
Sbjct: 1   MATLVEPPDGIRQRGKHYYSMWQTLFEVDTKYVPIKPIGRGAYGIVCSSINRATNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINNVFENRIDALRTLREL LLRHI+H+NVIALKDVMMP HR SFKDVY VYELMDTDL
Sbjct: 61  KKINNVFENRIDALRTLRELKLLRHIRHENVIALKDVMMPIHRTSFKDVYFVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQPLSSDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS G  QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSGGTGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+Q E DL FIDNPKAR++IKSLPYSRGTH S LYPQADPLA+DLLQ+ML
Sbjct: 241 NQLKLIINVLGSQHEPDLAFIDNPKARKYIKSLPYSRGTHFSRLYPQADPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VTEALQHPY+SGLYDP+CNPPAQVP++LDIDEN+ E MIR+MMW+E LHYH
Sbjct: 301 VFDPTKRISVTEALQHPYMSGLYDPRCNPPAQVPINLDIDENLAEPMIREMMWHEMLHYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Prunus armeniaca

Species: Prunus armeniaca

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|312283529|dbj|BAJ34630.1| unnamed protein product [Thellungiella halophila]

 Score =  681 bits (1758), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/363 (86%), Positives = 350/363 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++HDNVIAL DVM+P++R SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHDNVIALNDVMLPSNRSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ+LS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLP+SRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPFSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VT+AL HPY++GL+DP  NPPA VP+SLDIDEN+ E+MIR+MMWNE L+YH
Sbjct: 301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEERMIREMMWNEMLYYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Thellungiella halophila

Species: Eutrema halophilum

Genus: Eutrema

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|413966400|gb|AFW90259.1| MAPK7-1 [Brassica napus] gi|413966402|gb|AFW90260.1| MAPK7-2 [Brassica napus]

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/363 (86%), Positives = 350/363 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++HDNVIALKDVM+PT++ SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHDNVIALKDVMLPTNKSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLPYSRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VT+AL HPY++GL+DP  NPPA VP+SLDIDEN+ E+MIR+MMW+E L+YH
Sbjct: 301 VFDPTKRISVTDALSHPYMAGLFDPGSNPPAHVPISLDIDENMEERMIREMMWDEMLYYH 360

Query: 361 PEA 363
           P A
Sbjct: 361 PGA 363

Source: Brassica napus

Species: Brassica napus

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224134210|ref|XP_002327783.1| predicted protein [Populus trichocarpa] gi|222836868|gb|EEE75261.1| predicted protein [Populus trichocarpa]

 Score =  679 bits (1753), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/363 (87%), Positives = 345/363 (95%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MATLVEPPNG++  GK YY+MW T+FE+D+KYVPIKPIG+GAYGVVCSSINRETNEKVAI
Sbjct: 1   MATLVEPPNGIRPSGKQYYSMWHTVFELDSKYVPIKPIGKGAYGVVCSSINRETNEKVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKINNVFEN+IDALRTLREL LLRHI+H+NVIALKDV+MP HR SFKDVYLVYELMDTDL
Sbjct: 61  KKINNVFENKIDALRTLRELKLLRHIRHENVIALKDVLMPIHRTSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LS+DHCKYF+FQLLRGL YLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQPLSSDHCKYFIFQLLRGLNYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLIISV G+Q + DLEFIDNPKARR+IK+LPY+RGTH+S LYP ADPLALDLLQ+ML
Sbjct: 241 NQLKLIISVLGSQNDTDLEFIDNPKARRYIKTLPYTRGTHLSHLYPHADPLALDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+PSKRITVTEAL HPYISGLYDP+ +PPAQVP++LDIDEN+GE MIR+M+W+E LHYH
Sbjct: 301 VFDPSKRITVTEALLHPYISGLYDPRRDPPAQVPINLDIDENLGEHMIREMIWDEMLHYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|457406|dbj|BAA04870.1| MAP kinase [Arabidopsis thaliana]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/363 (86%), Positives = 349/363 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++H+NVIALKDVM+P +R SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRTSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLPYSRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VFEP+KRI+VT+AL HPY++GL++P  NPPA VP+SLDIDEN+ E +IR+MMWNE L+YH
Sbjct: 301 VFEPTKRISVTDALLHPYMAGLFEPGTNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15224120|ref|NP_179409.1| mitogen-activated protein kinase 7 [Arabidopsis thaliana] gi|21431797|sp|Q39027.2|MPK7_ARATH RecName: Full=Mitogen-activated protein kinase 7; Short=AtMPK7; Short=MAP kinase 7 gi|4874286|gb|AAD31349.1| MAP kinase (ATMPK7) [Arabidopsis thaliana] gi|110739420|dbj|BAF01620.1| MAP kinase [Arabidopsis thaliana] gi|330251640|gb|AEC06734.1| mitogen-activated protein kinase 7 [Arabidopsis thaliana]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/363 (86%), Positives = 349/363 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++H+NVIALKDVM+P +R SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLPYSRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VT+AL HPY++GL+DP  NPPA VP+SLDIDEN+ E +IR+MMWNE L+YH
Sbjct: 301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297836542|ref|XP_002886153.1| ATMPK7 [Arabidopsis lyrata subsp. lyrata] gi|297331993|gb|EFH62412.1| ATMPK7 [Arabidopsis lyrata subsp. lyrata]

 Score =  677 bits (1746), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/363 (86%), Positives = 348/363 (95%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++H+NVIALKDVM+P +R SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLP+SRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPFSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VT+AL HPY++GL DP  NPPA VP+SLDIDEN+ E MIR+MMWNE L+YH
Sbjct: 301 VFDPTKRISVTDALLHPYMAGLLDPGSNPPAHVPISLDIDENMEEPMIREMMWNEMLYYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110180198|gb|ABG54334.1| double HA-tagged mitogen activated protein kinase 7 [synthetic construct]

 Score =  677 bits (1746), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/363 (86%), Positives = 349/363 (96%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           KKI+NVFENR+DALRTLREL LLRH++H+NVIALKDVM+P +R SFKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLPYSRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
           VF+P+KRI+VT+AL HPY++GL+DP  NPPA VP+SLDIDEN+ E +IR+MMWNE L+YH
Sbjct: 301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query: 361 PEA 363
           PEA
Sbjct: 361 PEA 363

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	364
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.997	0.986	0.865	8.3e-177
TAIR|locus:2012808	370	MPK1 "mitogen-activated protei	0.997	0.981	0.812	1.1e-167
TAIR|locus:2202892	376	MPK2 "mitogen-activated protei	0.997	0.965	0.802	1.1e-165
TAIR|locus:2115445	361	MPK14 "mitogen-activated prote	0.989	0.997	0.815	2.1e-164
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.936	0.863	0.556	1.9e-108
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.934	0.936	0.568	2.4e-108
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.967	0.936	0.537	1.4e-105
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.950	0.920	0.548	1.7e-105
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.939	0.924	0.556	2.8e-105
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.964	0.951	0.525	3.4e-100

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1717 (609.5 bits), Expect = 8.3e-177, P = 8.3e-177
 Identities = 314/363 (86%), Positives = 349/363 (96%)

Query:     1 MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
             MA LVEPPNG+K +GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE+VAI
Sbjct:     1 MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query:    61 KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
             KKI+NVFENR+DALRTLREL LLRH++H+NVIALKDVM+P +R SFKDVYLVYELMDTDL
Sbjct:    61 KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query:   121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             HQIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
             RTS+GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct:   181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query:   241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
             NQLKLII+V G+QQE+D+ FIDNPKARRFIKSLPYSRGTH+S+LYPQA+PLA+DLLQ+ML
Sbjct:   241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query:   301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
             VF+P+KRI+VT+AL HPY++GL+DP  NPPA VP+SLDIDEN+ E +IR+MMWNE L+YH
Sbjct:   301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query:   361 PEA 363
             PEA
Sbjct:   361 PEA 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
 Identities = 295/363 (81%), Positives = 337/363 (92%)

Query:     1 MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
             MATLV+PPNG+++ GKHY++MWQTLFEIDTKY+PIKPIGRGAYGVVCSS+N +TNEKVAI
Sbjct:     1 MATLVDPPNGIRNEGKHYFSMWQTLFEIDTKYMPIKPIGRGAYGVVCSSVNSDTNEKVAI 60

Query:    61 KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
             KKI+NV+ENRIDALRTLREL LLRH++H+NVIALKDVMMP H++SFKDVYLVYELMDTDL
Sbjct:    61 KKIHNVYENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDVYLVYELMDTDL 120

Query:   121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             HQIIKSSQ LSNDHC+YF+FQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
             R S    QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIF GTECL
Sbjct:   181 RASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQGTECL 240

Query:   241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
             NQLKLI+++ G+Q+E DLEFIDNPKA+R+I+SLPYS G  +S LYP A  LA+DLLQKML
Sbjct:   241 NQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDLLQKML 300

Query:   301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYH 360
             VF+PSKRI+V+EALQHPY++ LYDP  NPPAQVP+ LD+DE++ E+MIR+MMWNE LHYH
Sbjct:   301 VFDPSKRISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDEDLREEMIREMMWNEMLHYH 360

Query:   361 PEA 363
             P+A
Sbjct:   361 PQA 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006635 "fatty acid beta-oxidation" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0016558 "protein import into peroxisome matrix" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0009734 "auxin mediated signaling pathway" evidence=TAS

TAIR|locus:2202892 MPK2 "mitogen-activated protein kinase homolog 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1612 (572.5 bits), Expect = 1.1e-165, P = 1.1e-165
 Identities = 293/365 (80%), Positives = 336/365 (92%)

Query:     1 MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
             MAT V+PPNG++++GKHY++MWQTLFEIDTKYVPIKPIGRGAYGVVCSS+NRE+NE+VAI
Sbjct:     1 MATPVDPPNGIRNQGKHYFSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSVNRESNERVAI 60

Query:    61 KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
             KKI+NVFENRIDALRTLREL LLRH++H+NV+ALKDVMM  H+ SFKDVYLVYELMDTDL
Sbjct:    61 KKIHNVFENRIDALRTLRELKLLRHLRHENVVALKDVMMANHKRSFKDVYLVYELMDTDL 120

Query:   121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             HQIIKSSQ LSNDHC+YF+FQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
             RTS    QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKP+FPGTECL
Sbjct:   181 RTSNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query:   241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
             NQ+KLII++ G+Q+E DLEFIDNPKA+R+I+SLPYS G   S LYP A+ LA+DLLQKML
Sbjct:   241 NQIKLIINILGSQREEDLEFIDNPKAKRYIESLPYSPGISFSRLYPGANVLAIDLLQKML 300

Query:   301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDEN--IGEQMIRQMMWNETLH 358
             V +PSKRI+VTEALQHPY++ LYDP  NPPAQVP+ LD+DE+  +G +MIR++MW E +H
Sbjct:   301 VLDPSKRISVTEALQHPYMAPLYDPSANPPAQVPIDLDVDEDEDLGAEMIRELMWKEMIH 360

Query:   359 YHPEA 363
             YHPEA
Sbjct:   361 YHPEA 365

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

TAIR|locus:2115445 MPK14 "mitogen-activated protein kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 1600 (568.3 bits), Expect = 2.1e-164, P = 2.1e-164
 Identities = 297/364 (81%), Positives = 334/364 (91%)

Query:     1 MATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
             MA LV+PPNG++  GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSIN ETNE+VAI
Sbjct:     1 MAMLVDPPNGIRQEGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINSETNERVAI 60

Query:    61 KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
             KKI+NVFENRIDALRTLREL LLRH++H+NVI+LKDVM+PTHR SF+DVYLVYELMD+DL
Sbjct:    61 KKIHNVFENRIDALRTLRELKLLRHVRHENVISLKDVMLPTHRYSFRDVYLVYELMDSDL 120

Query:   121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             +QIIKSSQSLS+DHCKYF+FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 NQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
             RT    EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL
Sbjct:   181 RTY---EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 237

Query:   241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
             NQLKLII+V G+QQ+ DL+FIDN KARRFIKSLP+S+GTH S +YP A+PLA+DLLQ+ML
Sbjct:   238 NQLKLIINVVGSQQDWDLQFIDNQKARRFIKSLPFSKGTHFSHIYPHANPLAIDLLQRML 297

Query:   301 VFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS-LDIDENIGEQMIRQMMWNETLHY 359
             VF+P+KRI+V++AL HPY+ GL +P+CNP   VP+S L+IDEN+   MIR+MMW E LHY
Sbjct:   298 VFDPTKRISVSDALLHPYMEGLLEPECNPSENVPVSSLEIDENMEGDMIREMMWEEMLHY 357

Query:   360 HPEA 363
              P A
Sbjct:   358 LPRA 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1072 (382.4 bits), Expect = 1.9e-108, P = 1.9e-108
 Identities = 193/347 (55%), Positives = 271/347 (78%)

Query:    19 YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL 77
             Y ++  +FE+  KY P I PIG+GAYG+VCS++N ETNE VAIKKI N F+N+IDA RTL
Sbjct:    49 YNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAMNSETNESVAIKKIANAFDNKIDAKRTL 108

Query:    78 RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKY 137
             RE+ LLRH+ H+N++A++D++ P  R +F DVY+ YELMDTDLHQII+S+Q+LS +HC+Y
Sbjct:   109 REIKLLRHMDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY 168

Query:   138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
             F++Q+LRGLKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLAR +  ++ FMTEYVVTR
Sbjct:   169 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESD-FMTEYVVTR 227

Query:   198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
             WYRAPELLL   +Y  +IDVWSVGCIF E++ RKP+FPG + ++QL+L++ + GT  E +
Sbjct:   228 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEE 287

Query:   258 LEFIDNPKARRFIKSLP-YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
             LEF+ N  A+R+I+ LP Y R + I+  +P   PLA+DL++KML F+P +RITV +AL H
Sbjct:   288 LEFL-NENAKRYIRQLPPYPRQS-ITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAH 345

Query:   317 PYISGLYDPQCNPPAQVPLSLDIDEN-IGEQMIRQMMWNETLHYHPE 362
             PY++ L+D    P   +P + D + + + E+ ++++++ E L ++PE
Sbjct:   346 PYLNSLHDISDEPECTIPFNFDFENHALSEEQMKELIYREALAFNPE 392

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
 Identities = 195/343 (56%), Positives = 262/343 (76%)

Query:    19 YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL 77
             Y +   +FE+ +KY+P I+PIGRGAYG+VC + N ETNE+VAIKKI N F+NR+DA RTL
Sbjct:    19 YNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANAFDNRVDAKRTL 78

Query:    78 RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKY 137
             RE+ LL H+ HDNVI +KD++    +  F+DVY+VYELMDTDLHQII+S+Q+L++DHC+Y
Sbjct:    79 REIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQY 138

Query:   138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
             F++Q+LRGLKY+HSAN+LHRDLKP NL++N NCDLKICDFGLARTS   E  MTEYVVTR
Sbjct:   139 FLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETE-IMTEYVVTR 197

Query:   198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
             WYRAPELLL    Y  +ID+WSVGCIF EIL R+ +FPG + + QLKLI  + G+  ++D
Sbjct:   198 WYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSD 257

Query:   258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
             L+F+ +  AR+++K LP+ +       +P   P+ALDL +KMLVF+PSKRITV EAL+ P
Sbjct:   258 LDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQP 317

Query:   318 YISGLYDPQCNPPAQVPLSLDIDEN-IGEQMIRQMMWNETLHY 359
             Y++ L++    P    P S D +E  + EQ I++++W E+LH+
Sbjct:   318 YLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 192/357 (53%), Positives = 269/357 (75%)

Query:    10 GMKSRGKHY--YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
             G+ + G  Y  Y ++  LFE+  KYVP ++PIGRGAYG+VC++ N ET E+VAIKKI N 
Sbjct:    18 GVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGNA 77

Query:    67 FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS 126
             F+N IDA RTLRE+ LL+H+ H+NVIA+KD++ P  R +F DVY+VYELMDTDLHQII+S
Sbjct:    78 FDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRS 137

Query:   127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
             +Q L++DHC++F++QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLK+ DFGLART +  
Sbjct:   138 NQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLART-KSE 196

Query:   187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
               FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  E + R+P+FPG + ++QL+LI
Sbjct:   197 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256

Query:   247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
               + G+  ++ L F+ +  ARR+++ LP     + ++ +P     A+DLL+KMLVF+PS+
Sbjct:   257 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSR 316

Query:   307 RITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHPE 362
             RITV EAL HPY++ L+D    P    P + D ++  + E+ I+++++ ET+ ++P+
Sbjct:   317 RITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1044 (372.6 bits), Expect = 1.7e-105, P = 1.7e-105
 Identities = 192/350 (54%), Positives = 269/350 (76%)

Query:    15 GKHY-YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRID 72
             G+++ Y ++  LFE+  KYVP I+PIGRGAYG VC++++ ET+E++AIKKI   F+N++D
Sbjct:    24 GRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIGKAFDNKVD 83

Query:    73 ALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
             A RTLRE+ LLRH++H+NV+ +KD++ P  +  F DVY+V+ELMDTDLHQII+S+QSL++
Sbjct:    84 AKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLND 143

Query:   133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
             DHC+YF++Q+LRGLKY+HSAN+LHRDLKP NLL+N+NCDLKI DFGLART+   E +MTE
Sbjct:   144 DHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSETE-YMTE 202

Query:   193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
             YVVTRWYRAPELLL    Y ++IDVWSVGCIFAEI+ R+P+FPG + ++QLKLI  + G+
Sbjct:   203 YVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGS 262

Query:   253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                A LEF+ +  AR+++K LP     + S+ +P  +  A+DLL+KMLVF+P KRITV E
Sbjct:   263 PDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEE 322

Query:   313 ALQHPYISGLYDPQCNPPAQVPLSLDI-DENIGEQMIRQMMWNETLHYHP 361
             AL +PY+S L+D    P      S    D +  E+ I++++W E++ ++P
Sbjct:   323 ALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNP 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1042 (371.9 bits), Expect = 2.8e-105, P = 2.8e-105
 Identities = 192/345 (55%), Positives = 263/345 (76%)

Query:    19 YTMWQTLFEIDTKY-VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL 77
             Y ++ +LFEI +KY  PI PIGRGAYG+VCS ++ ETNE VA+KKI N F+N +DA RTL
Sbjct:    24 YDIFGSLFEITSKYRPPIIPIGRGAYGIVCSVLDTETNELVAMKKIANAFDNHMDAKRTL 83

Query:    78 RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKY 137
             RE+ LLRH+ H+N+IA++DV+ P  R  F DVY+  ELMDTDLHQII+S+QSLS +HC+Y
Sbjct:    84 REIKLLRHLDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQY 143

Query:   138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
             F++QLLRGLKY+HSANI+HRDLKP NLL+NANCDLKICDFGLAR +  N+ FMTEYVVTR
Sbjct:   144 FLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSEND-FMTEYVVTR 202

Query:   198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
             WYRAPELLL   +Y  +IDVWSVGCIF E++ RKP+FPG + ++Q++L+  + GT  E+D
Sbjct:   203 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESD 262

Query:   258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
             L F  N  A+R+I+ LP      ++ L+   +P+A+DL+ +ML F+P++RITV +AL H 
Sbjct:   263 LGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQ 322

Query:   318 YISGLYDPQCNPPAQVPLSLDIDEN-IGEQMIRQMMWNETLHYHP 361
             Y++ L+DP   P  Q P S + ++  + E+ I++M++ E +  +P
Sbjct:   323 YLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIKEMIYQEAIALNP 367

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
 Identities = 187/356 (52%), Positives = 261/356 (73%)

Query:    10 GMKSRGKHY--YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
             G+   G  Y  Y ++  LFE+  KYVP ++PIGRGA G+VC++ N ET E+VAIKKI N 
Sbjct:    15 GVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGNA 74

Query:    67 FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS 126
             F N IDA RTLRE+ LL+H+ HDNVIA+ D++ P    +F DV++VYELMDTDLH II+S
Sbjct:    75 FGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRS 134

Query:   127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
             +Q L++DH ++F++QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLKI DFGLART +  
Sbjct:   135 NQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-KSE 193

Query:   187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
               FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  EI+ R+P+FPG + + QL+LI
Sbjct:   194 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLI 253

Query:   247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
               + G+  ++ L F+ +  ARR+++ LP     + ++ +P     A+DLLQKMLVF+P++
Sbjct:   254 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNR 313

Query:   307 RITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHP 361
             RITV EAL HPY++ L++    P    P   D ++ ++ E+ I+++++ E++ ++P
Sbjct:   314 RITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5623	0.9395	0.9218	N/A	no
Q40884	MAPK_PETHY	2, ., 7, ., 1, 1, ., 2, 4	0.8292	0.9972	0.9453	N/A	no
Q6Z437	MPK3_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8209	0.9972	0.9810	no	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.5434	0.9670	0.9487	N/A	no
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.5520	0.9395	0.8680	N/A	no
O23236	MPK14_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8159	0.9890	0.9972	no	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.5378	0.9615	0.9485	N/A	no
P42525	ERK1_DICDI	2, ., 7, ., 1, 1, ., 2, 4	0.5260	0.9450	0.6502	yes	no
O42781	MAPK2_PNECA	2, ., 7, ., 1, 1, ., 2, 4	0.5125	0.8598	0.8917	N/A	no
Q5Z859	MPK4_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8319	0.9972	0.9837	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5491	0.9395	0.8702	N/A	no
Q40517	NTF3_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.8347	0.9972	0.9758	N/A	no
P16892	FUS3_YEAST	2, ., 7, ., 1, 1, ., 2, 4	0.4702	0.8736	0.9008	yes	no
Q39027	MPK7_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8650	0.9972	0.9864	yes	no
Q39022	MPK2_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8	0.9972	0.9654	no	no
Q39021	MPK1_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8126	0.9972	0.9810	no	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.4953	0.8653	0.8467	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.5549	0.9395	0.8837	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.994
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_scaffold_57000068 hypothetical protein (368 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	364
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.0
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-159
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-149
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-141
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-135
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-131
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-125
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-115
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-115
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-110
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-108
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-107
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-107
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-106
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-105
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-102
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-99
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-93
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-91
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-89
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-89
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-86
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-86
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-85
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-81
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-81
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-81
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-81
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-80
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-79
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-76
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-76
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-76
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-75
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-73
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-71
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-71
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-70
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-70
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-68
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-67
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-66
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-65
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-64
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-63
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-62
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-59
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-59
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-57
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-57
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-57
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-55
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-53
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-52
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-52
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-46
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-45
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-44
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-42
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-40
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-35
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-31
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-27
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-27
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-26
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-25
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-24
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-23
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-23
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-23
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-20
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-18
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-17
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-17
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-15
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-06
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	1e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	7e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.004
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.004

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  659 bits (1701), Expect = 0.0
 Identities = 231/337 (68%), Positives = 281/337 (83%), Gaps = 1/337 (0%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           FE+DTKYVPIKPIGRGAYG+VCS+ N ETNEKVAIKKI N F+NRIDA RTLRE+ LLRH
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           + H+NVIA+KD+M P HR +F DVY+VYELMDTDLHQII+SSQ+LS+DHC+YF++QLLRG
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           LKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLART+     FMTEYVVTRWYRAPELL
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L C  Y T+IDVWSVGCIFAE+LGRKP+FPG + ++QLKLI  + G+  E DL FI N K
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
           ARR+I+SLPY+     + L+P A+PLA+DLL+KMLVF+PSKRITV EAL HPY++ L+DP
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300

Query: 326 QCNPPAQVPLSLDIDEN-IGEQMIRQMMWNETLHYHP 361
              P  Q P S D +E+ + E+ I+++++NE L YHP
Sbjct: 301 SDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  532 bits (1374), Expect = 0.0
 Identities = 187/330 (56%), Positives = 251/330 (76%), Gaps = 5/330 (1%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +KPIG GAYGVVCS++++ T  KVAIKKI+NVF++ IDA R LRE+ LLRH++H+N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +I L D++ P     F DVY+V ELM+TDLH++IKS Q L++DH +YF++Q+LRGLKYLH
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---QFMTEYVVTRWYRAPELLLC 207
           SAN++HRDLKP N+LVN+NCDLKICDFGLAR    +E    F+TEYVVTRWYRAPELLL 
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              Y  +ID+WSVGCIFAE+L RKP+FPG + ++QL LI+ V GT  E DL+FI + KAR
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC 327
            ++KSLP      +S L+P A P A+DLL+KMLVF+P KRIT  EAL HPY++ L+DP+ 
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300

Query: 328 NPPAQVPLSLDIDEN--IGEQMIRQMMWNE 355
            P A+ P   D  ++  + E+ ++++++ E
Sbjct: 301 EPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  449 bits (1157), Expect = e-159
 Identities = 172/337 (51%), Positives = 239/337 (70%), Gaps = 7/337 (2%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F++  +Y  +  IG GAYG+VCS+ ++ T  KVAIKKI+  FE++    RTLRE+ +LR 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRR 59

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            KH+N+I + D++ P    SF DVY+V ELM+TDL+++IK+ Q LSNDH +YF++Q+LRG
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRG 118

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAP 202
           LKY+HSAN+LHRDLKP NLL+N NCDLKICDFGLAR +     +  F+TEYV TRWYRAP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  +ID+WSVGCI AE+L  +P+FPG + L+QL LI+ V GT  + DL  I 
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
           + +AR +IKSLP+      + L+P ADP ALDLL KML F P KRITV EAL HPY+   
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298

Query: 323 YDPQCNPPAQVPLSLDID--ENIGEQMIRQMMWNETL 357
           +DP   P A+ P   D +  +++ ++ ++++++ E +
Sbjct: 299 HDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  425 bits (1094), Expect = e-149
 Identities = 169/324 (52%), Positives = 233/324 (71%), Gaps = 5/324 (1%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F++ ++Y PI+ IG GAYGVVCS+I+  + +KVAIKKI + F+    A RTLREL +LRH
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH 60

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            KHDN+IA++D++ P     FKDVY+V +LM++DLH II S Q L+ +H +YF++QLLRG
Sbjct: 61  FKHDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSRGNEQFMTEYVVTRWYRA 201
           LKY+HSAN++HRDLKP NLLVN +C+L+I DFG+AR    +   ++ FMTEYV TRWYRA
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PELLL    Y T+ID+WSVGCIFAE+LGR+ +FPG   ++QLKLI+SV G+  E  L  I
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            + + R++I++LP  +    S ++P+A P ALDLL +ML F+P +RITV +ALQHP+++ 
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Query: 322 LYDPQCNPPAQVPLSLDIDENIGE 345
            +DP   P    P   D +     
Sbjct: 300 YHDPDDEPTCPPPFDFDFEAIELS 323

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  403 bits (1037), Expect = e-141
 Identities = 157/340 (46%), Positives = 228/340 (67%), Gaps = 5/340 (1%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VCS+ + +T  KVAIKK++  F++ I A RT REL L
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 83  LRHIKHDNVIALKDVMMP-THRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+ H+NVI L DV  P +    F+DVYLV  LM  DL+ I+K  Q LS+DH ++ V+Q
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQ 126

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA I+HRDLKP N+ VN +C+LKI DFGLAR     +  MT YV TRWYRA
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRA 183

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +FPG++ ++QLK I+++ GT  E  L+ I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SLP         ++  A+PLA+DLL+KMLV +P KRIT  EAL HPY++ 
Sbjct: 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 322 LYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHP 361
            +DP+  P A          ++     +++++ E +++ P
Sbjct: 304 YHDPEDEPVAPPYDQSFESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  387 bits (996), Expect = e-135
 Identities = 176/330 (53%), Positives = 234/330 (70%), Gaps = 12/330 (3%)

Query: 35  IKPIGRGAYGVVCSSINRETN--EKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNV 91
           IK +G+GAYG+VCS+ N ET+  E VAIKKI NVF  +I A R LREL LLRH + H N+
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
             L D+ +     +F ++YL  ELM+ DLHQII+S Q L++ H + F++Q+L GLKY+HS
Sbjct: 65  TCLYDMDIVFPG-NFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLART-SRG---NEQFMTEYVVTRWYRAPELLLC 207
           AN+LHRDLKPGNLLVNA+C+LKICDFGLAR  S     N  FMTEYV TRWYRAPE++L 
Sbjct: 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
             +Y  +IDVWSVGCI AE+LGRKP+F G + ++QL  I+ V GT  E  L  I +PKA+
Sbjct: 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ 243

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC 327
            +I+SLP        S++P A+PLALDLL+K+L F+P+KRI+V EAL+HPY++  +DP  
Sbjct: 244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD 303

Query: 328 NPPAQVPL--SLDIDENIGEQMIRQMMWNE 355
            P  Q P   S + ++++ E  +R M+  E
Sbjct: 304 EPVCQKPFDFSFESEDSMEE--LRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  377 bits (970), Expect = e-131
 Identities = 159/331 (48%), Positives = 225/331 (67%), Gaps = 7/331 (2%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG+G+YGVVCS+I+  T EKVAIKKIN+VFE+  DA R LRE+ LLR ++H +++ +K +
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
           M+P  R  FKD+Y+V+ELM++DLHQ+IK++  L+ +H ++F++QLLR LKY+H+AN+ HR
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127

Query: 158 DLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELLLCC-DNYGT 213
           DLKP N+L NA+C LKICDFGLAR +        F T+YV TRWYRAPEL       Y  
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 187

Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
           +ID+WS+GCIFAE+L  KP+FPG   ++QL LI  + GT     +  + N KARR++ S+
Sbjct: 188 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSM 247

Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQV 333
              +    S  +P ADPLAL LL+++L F+P  R T  EAL  PY  GL   +  P AQ 
Sbjct: 248 RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQP 307

Query: 334 PLSLDID---ENIGEQMIRQMMWNETLHYHP 361
              L+ +     + ++ +R++++ E L YHP
Sbjct: 308 ITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  361 bits (930), Expect = e-125
 Identities = 145/324 (44%), Positives = 214/324 (66%), Gaps = 12/324 (3%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
            I  KY  ++ +G+GAYG+V  +I+R T E VA+KKI + F N  DA RT RE++ L+ +
Sbjct: 4   HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL 63

Query: 87  K-HDNVIALKDVMMPTHR-ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             H N++ L +V     +  + KD+YLV+E M+TDLH +I+++  L + H +Y ++QLL+
Sbjct: 64  GDHPNIVKLLNV----IKAENDKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLK 118

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART---SRGNEQF--MTEYVVTRWY 199
            LKY+HS N++HRDLKP N+L+N++C +K+ DFGLAR+      N +   +T+YV TRWY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPE+LL    Y   +D+WSVGCI  E+L  KP+FPGT  LNQL+ II V G     D+E
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            I +P A   + SLP      +  L P+A   ALDLL+K+LVF P+KR+T  EAL+HPY+
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Query: 320 SGLYDPQCNPPAQVPLSLDIDENI 343
           +  ++P   P    P+++ +D+N+
Sbjct: 299 AQFHNPSDEPVLPYPITIPLDDNV 322

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  336 bits (864), Expect = e-115
 Identities = 136/290 (46%), Positives = 176/290 (60%), Gaps = 9/290 (3%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +  IG G YGVV  + ++ T E VAIKKI   FE+       LRE+ LL+ + H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLH 150
           I L DV    H+    D+YLV+E MDTDL+++IK  Q  L     K +++QLL+GL + H
Sbjct: 61  IKLLDVF--RHK---GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ILHRDLKP NLL+N    LK+ DFGLAR+     +  T YVVTRWYRAPELLL    
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDNPKARRF 269
           Y T +D+WSVGCIFAE+L R+P+FPG   ++QL  I    GT       +F    +  +F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             S P   G  +  L+P A P ALDLL +ML ++P KRIT  +AL HPY 
Sbjct: 236 --SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  336 bits (863), Expect = e-115
 Identities = 150/333 (45%), Positives = 218/333 (65%), Gaps = 9/333 (2%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           T+FEI  +YV ++P+G GA+G+VCS+ ++ T + VAIKKI   F   + A RT REL LL
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63

Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
           +H++H+N+I+L D+ +       +D+Y V EL+ TDLH+++ S + L     +YF++Q+L
Sbjct: 64  KHLRHENIISLSDIFIS----PLEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQIL 118

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           RGLKY+HSA ++HRDLKP N+L+N NCDLKICDFGLAR     +  MT YV TR+YRAPE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPE 175

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++L    Y   +D+WS GCIFAE+L  KP+FPG + +NQ  +I  + GT  +  +  I +
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
               RF++SLP       S  +  ADP A+DLL+KMLVF+P KRI+  EAL HPY++  +
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295

Query: 324 DPQCNPPAQVPLSLDIDEN-IGEQMIRQMMWNE 355
           DP   P A+       ++  +     + MM++E
Sbjct: 296 DPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  325 bits (835), Expect = e-110
 Identities = 141/292 (48%), Positives = 194/292 (66%), Gaps = 6/292 (2%)

Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           P +PIG GA+GVV S  +    ++VA+KK+ NVF+N +   R  REL +L   KHDNV++
Sbjct: 4   PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 94  LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             D++ P H   F+++Y+V ELM +DLH+II S Q LS+DH K F++Q+LRGLKYLHSA 
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-QFMTEYVVTRWYRAPELLLCCDNYG 212
           ILHRD+KPGNLLVN+NC LKICDFGLAR    +E + MT+ VVT++YRAPE+L+   +Y 
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183

Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           +++D+WSVGCIFAE+LGR+ +F     + QL LI  + GT     +       AR  I  
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM-RSACEGARAHILR 242

Query: 273 LPYSRGTHISSLYPQADPL---ALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            P  +   +  LY  +      A+ LL +MLVF+P KRI+  +AL HPY+  
Sbjct: 243 GP-HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  321 bits (824), Expect = e-108
 Identities = 151/311 (48%), Positives = 217/311 (69%), Gaps = 5/311 (1%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VCS+ +    +KVA+KK++  F++ I A RT REL L
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67

Query: 83  LRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   I +F +VYLV  LM  DL+ I+K  Q LS++H ++ ++Q
Sbjct: 68  LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQ 126

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN +C+L+I DFGLAR +   +  MT YV TRWYRA
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA---DDEMTGYVATRWYRA 183

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +FPG + ++QLK I+ V GT     L+ I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR++I+SLP+     +  ++  A+PLA+DLL+KMLV +  KRI+ +EAL HPY S 
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Query: 322 LYDPQCNPPAQ 332
            +DP+  P A+
Sbjct: 304 YHDPEDEPEAE 314

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  314 bits (808), Expect = e-107
 Identities = 120/291 (41%), Positives = 173/291 (59%), Gaps = 12/291 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL--RTLRELVLLRHIKHD 89
           Y  ++ +G G YGVV  + +++T E VA+KKI    +N  + +    LRE+ LL+ +KH 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKY 148
           N++ L DV+      + + +YLV+E  D DL + +      LS +  K  ++QLLRGL Y
Sbjct: 59  NIVKLLDVI-----HTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
            HS  ILHRDLKP N+L+N +  LK+ DFGLAR      +  T  VVT WYRAPE+LL  
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
            +Y T++D+WSVGCIFAE++  KP+FPG   ++QL  I  + GT  E     +   K   
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT--KLPD 231

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +  + P      +  + P+ DP  +DLL KML + P+KRI+  EAL+HPY 
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  316 bits (812), Expect = e-107
 Identities = 153/341 (44%), Positives = 221/341 (64%), Gaps = 7/341 (2%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  +K +G GAYG VCS+++R T  KVAIKK+   F++ + A R  REL L
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F D YLV   M TDL +++K  + LS D  ++ V+Q
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQ 126

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +L+GLKY+H+A I+HRDLKPGNL VN +C+LKI DFGLAR +   +  MT YVVTRWYRA
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVVTRWYRA 183

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  KP+F G + L+QL  I+ V GT  +  ++ +
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  A+ ++K LP  R     SL P A+PLA+++L+KMLV +   RIT  EAL HPY   
Sbjct: 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Query: 322 LYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHP 361
            +DP+    A  P     DE +   +  +++ + E L + P
Sbjct: 304 FHDPEDETEAP-PYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  315 bits (809), Expect = e-106
 Identities = 153/327 (46%), Positives = 220/327 (67%), Gaps = 13/327 (3%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 83  LRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 128

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 185

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Query: 322 LYDPQCNPPAQVPL-------SLDIDE 341
            +DP   P A  P         L IDE
Sbjct: 306 YHDPDDEPVAD-PYDQSFESRDLLIDE 331

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  312 bits (802), Expect = e-105
 Identities = 154/342 (45%), Positives = 217/342 (63%), Gaps = 10/342 (2%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  +K +G GAYG VCS+I++ T EKVAIKK++  F++ I A R  REL L
Sbjct: 8   KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67

Query: 83  LRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H++H+NVI L DV         F+D YLV   M TDL +I+     LS D  +Y V+Q
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQ 125

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +L GLKY+HSA I+HRDLKPGNL VN +C+LKI DFGLAR +      MT YVVTRWYRA
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRA 182

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ V G      ++ +
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
           ++  A+ +IKSLP       S+L+P+A P A+DLL+KML  +  KR+T TEAL+HPY   
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Query: 322 LYDPQCNPPAQVPL--SLDIDENIGEQMIRQMMWNETLHYHP 361
             D       Q P   SL+ +E +     ++ ++ E   + P
Sbjct: 303 FRDADEETEQQ-PYDDSLE-NEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  304 bits (780), Expect = e-102
 Identities = 144/335 (42%), Positives = 203/335 (60%), Gaps = 24/335 (7%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +  T + VAIKK++  F+N   A R  RELVL+
Sbjct: 10  STFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM 69

Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 70  KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQM 127

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 186

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   II   GT      EF+ 
Sbjct: 187 EVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT---PSDEFMS 242

Query: 263 --NPKARRFIKSLPYSRGTHISSLYP---------QADPL----ALDLLQKMLVFEPSKR 307
              P  R ++++ P   G     L+P           + L    A DLL KMLV +P KR
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 308 ITVTEALQHPYISGLYDP-QCNPPAQVPLSLDIDE 341
           I+V +ALQHPYI+  YDP +   P   P    IDE
Sbjct: 303 ISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDE 337

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  296 bits (760), Expect = 2e-99
 Identities = 136/314 (43%), Positives = 180/314 (57%), Gaps = 26/314 (8%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDAL-RT-LRELVLLRHIK 87
           +Y   K +G G Y VV  + ++ET   VAIKKI     +   D +  T LRE+ LL+ +K
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGL 146
           H N+I L DV          ++ LV+E M+TDL ++IK  S  L+    K ++   LRGL
Sbjct: 61  HPNIIGLLDVFG-----HKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +YLHS  ILHRDLKP NLL+ ++  LK+ DFGLAR+     + MT  VVTRWYRAPELL 
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF 175

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
              +YG  +D+WSVGCIFAE+L R P  PG   ++QL  I    GT  E      + P  
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE-----NWPGV 230

Query: 267 RRFIKSLPY------SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                SLP          T +  ++P A   ALDLLQ++L   P+KRIT  +AL+HPY S
Sbjct: 231 ----TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Query: 321 GLYDPQCNPPAQVP 334
              DP   PP+Q+P
Sbjct: 287 N--DPAPTPPSQLP 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  280 bits (718), Expect = 2e-93
 Identities = 117/298 (39%), Positives = 168/298 (56%), Gaps = 21/298 (7%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  I  IG G YG V  + N++T E VA+KKI    E     +  +RE+ LL+ ++H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLH 150
           + LK+++  T +     +Y+V+E MD DL  ++ S +   +    K ++ QLL GL+YLH
Sbjct: 61  VRLKEIV--TSKGK-GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
           S  ILHRD+K  N+L+N +  LK+ DFGLAR  ++ N    T  V+T WYR PELLL   
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA------DLEFIDN 263
            YG  +D+WSVGCI AE+   KPIF G+  L QL+ I  + G+  +        L + +N
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237

Query: 264 PKARRFIKSLPYSR--GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            K ++     PY R        L   +   ALDLL K+L  +P KRI+  +ALQH Y 
Sbjct: 238 LKPKK-----PYKRRLREFFKHLIDPS---ALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  274 bits (703), Expect = 2e-91
 Identities = 99/289 (34%), Positives = 150/289 (51%), Gaps = 36/289 (12%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +G G++G V  + +++T + VAIK I      +    R LRE+ +L+ +KH N+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE-RILREIKILKKLKHPNI 59

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L DV           +YLV E  +  DL  ++K    LS D  ++++ Q+L  L+YLH
Sbjct: 60  VRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  I+HRDLKP N+L++ +  +K+ DFGLAR     E  +T +V T  Y APE+LL    
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGTPEYMAPEVLL-GKG 172

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG ++D+WS+G I  E+L  KP FPG    +QL  +                     + I
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPG---DDQLLELF--------------------KKI 209

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                              P A DL++K+LV +P KR+T  EALQHP+ 
Sbjct: 210 GKPKPP----FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  270 bits (692), Expect = 2e-89
 Identities = 114/291 (39%), Positives = 166/291 (57%), Gaps = 10/291 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +  IG GA+G+V  + +RET E VA+KK+           + LRE+  L+  +H  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIK-SSQSLSNDHCKYFVFQLLRGLKYL 149
           V+ L DV    H   F    LV E M +DL ++++   + L     K ++  LL+G+ Y+
Sbjct: 61  VVKLLDVF--PHGSGF---VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSRGNEQFMTEYVVTRWYRAPELLLCC 208
           H+  I+HRDLKP NLL++A+  LKI DFGLAR  S    +  +  V TRWYRAPELL   
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD-LEFIDNPKAR 267
             Y   +D+W+VGCIFAE+L   P+FPG   + QL ++    GT  E         P   
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           +   + P S+   +  ++P A P ALDLL+ +LV++PSKR++  EAL+HPY
Sbjct: 236 KI--TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  268 bits (688), Expect = 6e-89
 Identities = 115/291 (39%), Positives = 173/291 (59%), Gaps = 13/291 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDN 90
           Y  IK +G G +G V  + N+ET E VAIKK+   F +  + +  LRE+  LR +  H N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKY 148
           ++ LK+V          ++Y V+E M+ +L+Q++K    +  S    +  ++Q+L+GL +
Sbjct: 60  IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           +H     HRDLKP NLLV+    +KI DFGLAR  R    + T+YV TRWYRAPE+LL  
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYVSTRWYRAPEILLRS 173

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK-AR 267
            +Y + +D+W++GCI AE+   +P+FPG+  ++QL  I SV GT  + D  + +  K A 
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD--WPEGYKLAS 231

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           +     P    T +  L P A P A+DL++ ML ++P KR T ++ALQHPY
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  261 bits (669), Expect = 2e-86
 Identities = 101/289 (34%), Positives = 144/289 (49%), Gaps = 30/289 (10%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +G G++G V  + ++ T + VA+K +    E         RE+ +LR + H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 92  IALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L D            +YLV E  +  DL   +     LS D  K    Q+LRGL+YLH
Sbjct: 61  VRLIDAFE-----DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  I+HRDLKP N+L++ N  +KI DFGLA+    +   +T +V T WY APE+LL  + 
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +DVWS+G I  E+L  KP F G   L+QL+LI  + G   E D     +       
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG------ 229

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                                A DL++K L  +PSKR T  E LQHP+ 
Sbjct: 230 ------------------SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  262 bits (672), Expect = 2e-86
 Identities = 115/292 (39%), Positives = 168/292 (57%), Gaps = 10/292 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  +  +G GAYGVV    N+ T E VAIKK     ++       LRE+ +LR ++H+N
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           ++ LK+      R+     YLV+E ++  L +++++S   L  D  + +++QLL+ + Y 
Sbjct: 62  IVNLKEAFRRKGRL-----YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN-EQFMTEYVVTRWYRAPELLLCC 208
           HS NI+HRD+KP N+LV+ +  LK+CDFG AR  R      +T+YV TRWYRAPELL+  
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE-FIDNPKAR 267
            NYG  +DVW++GCI AE+L  +P+FPG   ++QL LI    G    +  E F  NP+  
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 268 RFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 P    + +   YP      ALD L+  L  +P +R+T  E LQHPY
Sbjct: 237 GVAFPEPSQPES-LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  261 bits (668), Expect = 4e-85
 Identities = 124/346 (35%), Positives = 202/346 (58%), Gaps = 19/346 (5%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F++ ++Y+ ++P+G G+ G+V S+++ + +++VA+KKI  V  +       LRE+ ++R 
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRR 58

Query: 86  IKHDNVIALKDVMMPTHR---------ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCK 136
           + HDN++ + +V+ P+                VY+V E M+TDL  +++    LS +H +
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEEHAR 117

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLAR---TSRGNEQFMTE 192
            F++QLLRGLKY+HSAN+LHRDLKP N+ +N  +  LKI DFGLAR       ++ +++E
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
            +VT+WYR+P LLL  +NY  +ID+W+ GCIFAE+L  KP+F G   L Q++LI+     
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
            +E D   + N             R   +  L P  +P ALD L+++L F P  R+T  E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 313 ALQHPYISGLYDPQCNPPAQVPLSL--DIDENIGEQMIRQMMWNET 356
           AL HPY+S    P   P +  P  +  ++D+ +    I  +++N  
Sbjct: 297 ALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNWD 342

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  252 bits (645), Expect = 1e-81
 Identities = 144/352 (40%), Positives = 213/352 (60%), Gaps = 26/352 (7%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +      VA+KK++  F+N+  A R  RELVLL
Sbjct: 15  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL 74

Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I     L ++   Y ++Q+
Sbjct: 75  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQM 132

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+  N   MT YVVTR+YRAP
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAP 191

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++    IF GT+ ++Q   +I   GT      EF++
Sbjct: 192 EVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT---PSAEFMN 247

Query: 263 --NPKARRFIKSLPYSRGTHISSLYP--------QADPL----ALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P        + D L    A DLL KMLV +P KRI
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307

Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETL 357
           +V EAL+HPYI+  YDP   +  PP      L+  E+  E+  +++++ E +
Sbjct: 308 SVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEW-KELIYKEVM 358

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  250 bits (640), Expect = 1e-81
 Identities = 119/295 (40%), Positives = 159/295 (53%), Gaps = 17/295 (5%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA--LRTLRELVLLRHIK-- 87
           Y  +  IG GAYG V  + +  T   VA+KK+        +   L TLRE+ LL+ ++  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALLKQLESF 58

Query: 88  -HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIK--SSQSLSNDHCKYFVFQLLR 144
            H N++ L DV           + LV+E +D DL   +       L  +  K  + QLLR
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           G+ +LHS  I+HRDLKP N+LV ++  +KI DFGLAR     E  +T  VVT WYRAPE+
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVTLWYRAPEV 177

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           LL   +Y T +D+WSVGCIFAE+  R+P+F GT   +QL  I  V G   E +      P
Sbjct: 178 LLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW-----P 231

Query: 265 KARRFIK-SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           +     + S P        S  P+     LDLL+KML F P KRI+  EALQHPY
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  252 bits (645), Expect = 1e-81
 Identities = 144/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70

Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 128

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 243

Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V EALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 304 SVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 355

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  252 bits (645), Expect = 2e-81
 Identities = 146/352 (41%), Positives = 214/352 (60%), Gaps = 26/352 (7%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77

Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 135

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP---EFMK 250

Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P     AD          A DLL KMLV + SKRI
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310

Query: 309 TVTEALQHPYISGLYDP--QCNPPAQVP-LSLDIDENIGEQMIRQMMWNETL 357
           +V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++ E +
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIYKEVM 361

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 3e-80
 Identities = 118/298 (39%), Positives = 168/298 (56%), Gaps = 27/298 (9%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR------TLRELVLLRH 85
           Y  ++ IG G YGVV  + ++ T E VA+KKI      R++          +RE+ LL+ 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKE 54

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH--CKYFVFQLL 143
           + H N++ L DV+   +++     YLV+E +D DL + + SS     D    K +++QLL
Sbjct: 55  LNHPNIVRLLDVVHSENKL-----YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           +G+ Y HS  +LHRDLKP NLL++    LK+ DFGLAR      +  T  VVT WYRAPE
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +LL    Y T +D+WS+GCIFAE++ R+P+FPG   ++QL  I    GT  E        
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW----- 224

Query: 264 PKARR---FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           P       +  + P      +S + P  D   LDLL KMLV++P+KRI+   ALQHPY
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  244 bits (625), Expect = 3e-79
 Identities = 112/289 (38%), Positives = 170/289 (58%), Gaps = 15/289 (5%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRID--ALRTLRELVLLRHIKHDNVIALK 95
           I  G YGVV  + +++T E VA+KK+    E   +   + +LRE+ +L  ++H N++ +K
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
           +V++ ++      +Y+V E ++ DL  ++++  Q       K  + QLL G+ +LH   I
Sbjct: 71  EVVVGSN---LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           LHRDLK  NLL+N    LKICDFGLAR      +  T+ VVT WYRAPELLL    Y T+
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187

Query: 215 IDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDNPKARRFI-KS 272
           ID+WSVGCIFAE+L +KP+FPG   ++QL  I  + GT  E     F + P A++     
Sbjct: 188 IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTK 247

Query: 273 LPYSRGTHISSLYPQA--DPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            PY++   +   +P         DLL ++L ++P+KRI+  +AL+HPY 
Sbjct: 248 YPYNQ---LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  236 bits (605), Expect = 4e-76
 Identities = 119/286 (41%), Positives = 164/286 (57%), Gaps = 13/286 (4%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL--RTLRELVLLRHIKHDNVIALK 95
           IG G YG+V  + +  + E VA+KK+    +N  D +   +LRE+ LL +++H N++ LK
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
           +V++  H  S   ++LV E  + DL  ++ +     S    K  + QLLRGL+YLH   I
Sbjct: 73  EVVVGKHLDS---IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRDLK  NLL+     LKI DFGLART     + MT  VVT WYRAPELLL C  Y T+
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189

Query: 215 IDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE-FIDNPKARRFI-KS 272
           ID+W+VGCI AE+L  KP+ PG   + QL LII + GT  E+    F D P   +F    
Sbjct: 190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK 249

Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            PY+   H      +A    L LL  +L+++P KR T  EAL+  Y
Sbjct: 250 QPYNNLKHKFPWLSEA---GLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  235 bits (602), Expect = 5e-76
 Identities = 117/291 (40%), Positives = 167/291 (57%), Gaps = 11/291 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ +KH N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFVFQLLRGLKYL 149
           ++ L DV+    +++     LV+E  D DL +   S     +    K F+FQLL+GL + 
Sbjct: 61  IVRLYDVLHSDKKLT-----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS N+LHRDLKP NLL+N N +LK+ DFGLAR      +  +  VVT WYR P++L    
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 210 NYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN-PKAR 267
            Y TSID+WS GCIFAE+    +P+FPG +  +QLK I  + GT  E     +   P  +
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            +     Y   T + ++ P+ +    DLLQ +LV  P +RI+  EALQHPY
Sbjct: 236 PYP---MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  235 bits (601), Expect = 9e-76
 Identities = 116/292 (39%), Positives = 175/292 (59%), Gaps = 12/292 (4%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  ++ IG G YGVV  + +R TNE +A+KKI    E+       +RE+ LL+ ++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH--CKYFVFQLLRGLKY 148
           ++ L+DV+    R+     YLV+E +D DL + + SS   + +    K +++Q+LRG+ Y
Sbjct: 63  IVRLQDVVHSEKRL-----YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 149 LHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
            HS  +LHRDLKP NLL++   + LK+ DFGLAR      +  T  VVT WYRAPE+LL 
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN-PKA 266
             +Y T +D+WSVGCIFAE++ +KP+FPG   +++L  I  + GT  E     + + P  
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD- 236

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
             +  + P      ++++ P  +P  +DLL KML  +PSKRIT   AL+H Y
Sbjct: 237 --YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  234 bits (599), Expect = 4e-75
 Identities = 113/310 (36%), Positives = 163/310 (52%), Gaps = 32/310 (10%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +  +G G +G V  +   +T   VA+KKI    E     +  LRE+ +L+ +KH NV
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 92  IALKDVMM---PTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLK 147
           + L D+ +      +     VY+V   MD DL  ++++ S  L+    K ++ QLL G+ 
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN-EQFM----------TEYVVT 196
           YLH  +ILHRD+K  N+L++    LKI DFGLAR   G                T  VVT
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
           RWYR PELLL    Y T++D+W +GC+FAE+  R+PI  G   ++QL LI  + GT  E 
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE 249

Query: 257 DLEFIDNPKARRFIKSLP-----YSRGTHISSL---YPQADPLALDLLQKMLVFEPSKRI 308
                  P  R    SLP     +S   +  +L   + +  P  LDLL K+L  +P KR+
Sbjct: 250 TW-----PGWR----SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300

Query: 309 TVTEALQHPY 318
           T ++AL+HPY
Sbjct: 301 TASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  228 bits (584), Expect = 3e-73
 Identities = 112/296 (37%), Positives = 168/296 (56%), Gaps = 23/296 (7%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-----TLRELVLLRHI 86
           +  ++ +G G Y  V    NR T E VA+K+I+      +DA        +RE+ L++ +
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKEL 55

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS---SQSLSNDHCKYFVFQLL 143
           KH+N++ L DV+   +++      LV+E MD DL + + +     +L  +  K F +QLL
Sbjct: 56  KHENIVRLHDVIHTENKLM-----LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           +G+ + H   +LHRDLKP NLL+N   +LK+ DFGLAR         +  VVT WYRAP+
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD 170

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +LL    Y TSID+WSVGCI AE++  +P+FPGT   +QL  I  + GT  E+    I  
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230

Query: 264 -PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            P+ +    + P      +  L+P ADPL +DLL ++L   P  RI+  +ALQHP+
Sbjct: 231 LPEYKP---TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  223 bits (569), Expect = 5e-71
 Identities = 111/286 (38%), Positives = 161/286 (56%), Gaps = 9/286 (3%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+      +   +YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 65  LDVIH-----TENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--DYKPS 237

Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            P       S + P  D    DLL +ML ++P+KRI+   AL HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  222 bits (568), Expect = 7e-71
 Identities = 109/291 (37%), Positives = 165/291 (56%), Gaps = 14/291 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDN 90
           Y  +  IG G +  V  + +R+T +  AIK +   F++ ++ +  LRE+  LR +  H N
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPN 59

Query: 91  VIALKDVMM--PTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLK 147
           ++ L +V+    T R++     LV+ELMD +L+++IK   + L     K +++QLL+ L 
Sbjct: 60  ILRLIEVLFDRKTGRLA-----LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           ++H   I HRD+KP N+L+  +  LK+ DFG  R       + TEY+ TRWYRAPE LL 
Sbjct: 115 HMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY-TEYISTRWYRAPECLLT 172

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              YG  +D+W+VGC+F EIL   P+FPGT  L+Q+  I  V GT     L+        
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF-RKSRH 231

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 P  +GT +  L P A    LDLL+K+L ++P +RIT  +AL+HPY
Sbjct: 232 MNYNF-PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  221 bits (566), Expect = 1e-70
 Identities = 108/293 (36%), Positives = 169/293 (57%), Gaps = 14/293 (4%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKH 88
            Y  I+ IG G YGVV    N++T + VA+KKI    E+  + + +  +RE+ LL+ ++H
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQH 58

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQLLRG 145
            N++ L+DV+M   R+     YL++E +  DL +    +   Q +  +  K +++Q+L+G
Sbjct: 59  PNIVCLQDVLMQESRL-----YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           + + HS  +LHRDLKP NLL++    +K+ DFGLAR      +  T  VVT WYRAPE+L
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L    Y T +D+WS+G IFAE+  +KP+F G   ++QL  I  + GT  E    +     
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE--DVWPGVTS 231

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
              +  + P  +   + S     D   LDLL+KML+++P+KRI+  +AL HPY
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  222 bits (568), Expect = 3e-70
 Identities = 118/340 (34%), Positives = 175/340 (51%), Gaps = 43/340 (12%)

Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALR-------- 75
           F I  +Y+     +G G YG V  + +  T + VAIKK+      N +   R        
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 76  ---TLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
              TLREL ++  IKH+N++ L DV +    I+     LV ++M +DL +++     L+ 
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-----LVMDIMASDLKKVVDRKIRLTE 118

Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------- 181
              K  + Q+L GL  LH    +HRDL P N+ +N+    KI DFGLAR           
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 182 ----TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT 237
               T +  E+ MT  VVT WYRAPELL+  + Y  ++D+WSVGCIFAE+L  KP+FPG 
Sbjct: 179 SKDETMQRREE-MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRG--THISSLYPQADPLALDL 295
             ++QL  I  + GT  E +      P+A++      ++      + +++P A   A+DL
Sbjct: 238 NEIDQLGRIFELLGTPNEDNW-----PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL 292

Query: 296 LQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPL 335
           LQ +L   P +RI+  EAL+H Y     DP    P+Q+P 
Sbjct: 293 LQSLLKLNPLERISAKEALKHEYFKS--DPLPCDPSQLPF 330

Length = 335

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  216 bits (551), Expect = 3e-68
 Identities = 104/298 (34%), Positives = 164/298 (55%), Gaps = 24/298 (8%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  +  IG G+YGVV    NRET + VAIKK     ++ +     LRE+ +L+ +KH N
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L +V     ++     +LV+E  D T L+++ K+ + +     K  ++Q L+ + + 
Sbjct: 62  LVNLIEVFRRKRKL-----HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H  N +HRD+KP N+L+     +K+CDFG AR   G     T+YV TRWYRAPELL+   
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            YG  +DVW++GC+FAE+L  +P++PG   ++QL LI    G     DL     P+ ++ 
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG-----DLI----PRHQQI 227

Query: 270 IKSLPYSRGTHI---------SSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
             +  + +G  I          S +P     AL  L+  L  +P++R++  E L+HPY
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  214 bits (546), Expect = 4e-67
 Identities = 119/315 (37%), Positives = 165/315 (52%), Gaps = 41/315 (13%)

Query: 38  IGRGAYGVV--CSSINRETNEKVAIKKINNVFENRID-ALRTLRELVLLRHIKHDNVIAL 94
           IGRG YG V      N +  ++ AIKK     E     +    RE+ LLR +KH+NV++L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIK-----SSQSLSNDHCKYFVFQLLRGLKYL 149
            +V +  H  + K VYL+++  + DL QIIK        S+     K  ++Q+L G+ YL
Sbjct: 68  VEVFL-EH--ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 150 HSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTE---YVVTRWYRAP 202
           HS  +LHRDLKP N+LV         +KI D GLAR      + + +    VVT WYRAP
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC---------LNQLKLIISVFGTQ 253
           ELLL   +Y  +ID+W++GCIFAE+L  +PIF G E           +QL+ I  V GT 
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTP 244

Query: 254 QEADLEFIDN----PKARRFIKSLPYSRGTHISSLYP------QADPLALDLLQKMLVFE 303
            E D   I          +  K+  Y      +SL        + D    DLL+K+L ++
Sbjct: 245 TEKDWPDIKKMPEYDTLMKDFKTKTYPS----NSLAKWMEKHKKPDSQGFDLLRKLLEYD 300

Query: 304 PSKRITVTEALQHPY 318
           P+KRIT  EAL+HPY
Sbjct: 301 PTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  210 bits (537), Expect = 4e-66
 Identities = 109/297 (36%), Positives = 155/297 (52%), Gaps = 23/297 (7%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-----LRTLRELVLLRHI 86
           Y  +  +G G+Y  V    ++ T + VA+K+I      R++         +RE  LL+ +
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDL 60

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRG 145
           KH N++ L D++        K + LV+E +DTDL Q +      LS  + + F+FQLLRG
Sbjct: 61  KHANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRG 115

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L Y H   +LHRDLKP NLL++   +LK+ DFGLAR      +  +  VVT WYR P++L
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL 175

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPG-TECLNQLKLIISVFGTQQEAD---LEFI 261
           L    Y TS+D+W VGCIF E+   +P+FPG T+  +QL  I  V GT  E     +   
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
              K   F    P     H   L         +L  K L +EP KRI+  EA++HPY
Sbjct: 236 PEFKPYSFPFYPPRPLINHAPRLDRIPH--GEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  209 bits (533), Expect = 1e-65
 Identities = 104/293 (35%), Positives = 166/293 (56%), Gaps = 14/293 (4%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  +  +G G+YG+V    ++ET + VAIKK     ++++     +RE+ +L+ ++H+N
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L +V     R+     YLV+E +D T L  + K    L     + ++FQ+LRG+++ 
Sbjct: 62  LVNLIEVFRRKKRL-----YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS NI+HRD+KP N+LV+ +  +K+CDFG ART     +  T+YV TRWYRAPELL+   
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            YG ++D+W+VGC+  E+L  +P+FPG   ++QL  II   G       E     K   F
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ--KNPLF 234

Query: 270 -IKSLPYSRGTHISSL---YPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
               LP  +   I  L   +P+   L LDL ++ L  +P  R + ++ L H +
Sbjct: 235 AGMRLPEVK--EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  205 bits (524), Expect = 3e-64
 Identities = 108/295 (36%), Positives = 155/295 (52%), Gaps = 10/295 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y  ++ IG G YG V  + ++ T + VA+KK     +        LRE+ LL+ +    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 91  -VIALKDVMMPTHRISFKDVYLVYELMDTDLHQII-----KSSQSLSNDHCKYFVFQLLR 144
            ++ L DV     +     +YLV+E +D+DL + +        + L     K F++QLL+
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           G+ + H   ++HRDLKP NLLV+     LKI D GL R      +  T  +VT WYRAPE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +LL   +Y T +D+WSVGCIFAE+  ++P+FPG   L QL  I  + GT  E   +    
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE---QVWPG 238

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
               R     P  +   +S   P   P  LDLLQKML ++P+KRI+   AL HPY
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  203 bits (519), Expect = 3e-63
 Identities = 116/298 (38%), Positives = 159/298 (53%), Gaps = 10/298 (3%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
            K+  I  IG G YG V  + +++T E VA+KK+    E     +  +RE+ +LR + H 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 90  NVIALKDVMM-PTHRISFK----DVYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLL 143
           N++ LK+++      + FK      YLV+E MD DL  +++S     S DH K F+ QLL
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ-FMTEYVVTRWYRAP 202
            GL Y H  N LHRD+K  N+L+N    +K+ DFGLAR     E    T  V+T WYR P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFI 261
           ELLL  + YG +IDVWS GCI  E+  +KPIF   + L QL+LI  + G+   A   + I
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             P          Y R   +   +      ALDLL  ML  +PSKR T  EAL  P++
Sbjct: 247 KLPYFNTMKPKKQYRR--RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  201 bits (513), Expect = 2e-62
 Identities = 105/314 (33%), Positives = 156/314 (49%), Gaps = 35/314 (11%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL--RTLRELVLLR 84
           +  +KY  +  IG+G +G V  + +++T + VA+KK+  + EN  +      LRE+ +L+
Sbjct: 9   DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQ 66

Query: 85  HIKHDNVIALKDV--MMPTHRISFK-DVYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVF 140
            +KH+NV+ L ++     T    +K   YLV+E  + DL  ++ +     +    K  + 
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----SRGNEQFMTEYVVT 196
            LL GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR             T  VVT
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
            WYR PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+    
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246

Query: 257 ------------DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEP 304
                        +E     K +   +  PY +           DP ALDL+ K+LV +P
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVK-----------DPHALDLIDKLLVLDP 295

Query: 305 SKRITVTEALQHPY 318
           +KRI    AL H +
Sbjct: 296 AKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  192 bits (490), Expect = 4e-59
 Identities = 113/294 (38%), Positives = 164/294 (55%), Gaps = 12/294 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDN 90
           Y+ +  +G G Y  V    ++ T+  VA+K+I    E+   A  T +RE+ LL+ +KH N
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFVFQLLRGLKYL 149
           ++ L D++      + K + LV+E +D DL Q +    +  N H  K F+FQLLRGL Y 
Sbjct: 66  IVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LK+ DFGLAR      +  +  VVT WYR P++LL   
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI-DNPKARR 268
           +Y T ID+W VGCIF E+   +P+FPG+    QL  I  + GT  E     I  N + + 
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
           +  + P  R   + +  P+ D    +LL K+L FE  KRI+  EA++HPY   L
Sbjct: 241 Y--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  192 bits (488), Expect = 6e-59
 Identities = 104/287 (36%), Positives = 162/287 (56%), Gaps = 17/287 (5%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GAYGVV    ++ET E VAIKK  +  EN      TLREL +LR +K +N++ LK+ 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
                ++     YLV+E ++ ++ ++++     +  +  + +++QL++ + + H  +I+H
Sbjct: 69  FRRRGKL-----YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 157 RDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           RD+KP NLL++ N  LK+CDFG AR  S G+    TEYV TRWYR+PELLL    YG ++
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAV 182

Query: 216 DVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE-FIDNPKARRFIKSLP 274
           D+WSVGCI  E+   +P+FPG   ++QL  I  V G      ++ F  NP+       L 
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR----FHGLR 238

Query: 275 YSRGTHISSLYPQ----ADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           +    H  SL  +       + LDL++ +L   P+ R    + L HP
Sbjct: 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  187 bits (476), Expect = 3e-57
 Identities = 106/296 (35%), Positives = 158/296 (53%), Gaps = 9/296 (3%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F   T Y+ ++ +G G+Y  V   I+R   + VA+K I+   E  +     +RE  LL+ 
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKG 59

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQ-IIKSSQSLSNDHCKYFVFQLLR 144
           +KH N++ L D++     ++F     V+E M TDL Q +I+    L   + + F+FQLLR
Sbjct: 60  LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           GL Y+H  +ILHRDLKP NLL++   +LK+ DFGLAR      Q  +  VVT WYR P++
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT-ECLNQLKLIISVFGTQQEADLEFI-D 262
           LL   +Y +++D+W  GCIF E+L  +P FPG  +   QL+ I +V G   E     +  
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            P  +         +   +        P A DL  +ML+  P  RI+  +AL HPY
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  187 bits (475), Expect = 5e-57
 Identities = 110/290 (37%), Positives = 161/290 (55%), Gaps = 12/290 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDN 90
           YV +  +G G Y  V    ++ T   VA+K+I    E+   A  T +RE+ LL+++KH N
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFVFQLLRGLKYL 149
           ++ L D++     ++     LV+E +D+DL Q + +  +L + H  K F+FQLLRGL Y 
Sbjct: 65  IVTLHDIIHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   ILHRDLKP NLL+N   +LK+ DFGLAR      +  +  VVT WYR P++LL   
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI-DNPKARR 268
            Y T ID+W VGCI  E+   +P+FPG+    +L LI  + GT  E     I  N + R 
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           +    P  R   + +  P+ D   +DLL  +L++E   RI+   AL+H Y
Sbjct: 240 Y--LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  187 bits (476), Expect = 7e-57
 Identities = 110/296 (37%), Positives = 162/296 (54%), Gaps = 16/296 (5%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDN 90
           Y+ ++ +G G Y  V    ++ T   VA+K+I    E+   A  T +RE+ LL+ +KH N
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFVFQLLRGLKYL 149
           ++ L D++      + K + LV+E +D DL Q +    ++ + H  K F++Q+LRGL Y 
Sbjct: 66  IVTLHDIVH-----TDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LK+ DFGLAR      +  +  VVT WYR P++LL   
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD---LEFIDNPKA 266
            Y T ID+W VGCIF E+   +P+FPG+   ++L LI  + GT  E     +   D  K 
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
             F K  P     H     P+ D   ++LL K L +E  KRI+  EA++H Y   L
Sbjct: 241 YNFPKYKPQPLINHA----PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  184 bits (469), Expect = 4e-56
 Identities = 110/295 (37%), Positives = 153/295 (51%), Gaps = 13/295 (4%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR---HIK 87
           +Y P+  IG GAYG V  + +  +   VA+K +          L T+RE+ LL+      
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQLLRG 145
           H N++ L DV   +       V LV+E +D DL   +       L  +  K  + Q LRG
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L +LH+  I+HRDLKP N+LV +   +K+ DFGLAR     +  +T  VVT WYRAPE+L
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRAPEVL 179

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I  + G   E D      P+
Sbjct: 180 L-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW-----PR 233

Query: 266 ARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                +     RG   + S+ P+ +     LL +ML F P KRI+   ALQHP+ 
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (455), Expect = 7e-55
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 9/193 (4%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V  + +++T +KVAIK I     + +     LRE+ +L+ + H N++ L  V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL-LEELLREIEILKKLNHPNIVKLYGV 59

Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
                      +YLV E  +   L  ++K     LS D     + Q+L GL+YLHS  I+
Sbjct: 60  F-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 156 HRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           HRDLKP N+L++++   +K+ DFGL++    ++  +   V T  Y APE+LL    Y   
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 215 IDVWSVGCIFAEI 227
            D+WS+G I  E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  176 bits (448), Expect = 5e-53
 Identities = 113/295 (38%), Positives = 162/295 (54%), Gaps = 14/295 (4%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHIK-- 87
           +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRH++  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 88  -HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS--LSNDHCKYFVFQLLR 144
            H NV+ L DV   +       + LV+E +D DL   +       +  +  K  +FQLLR
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           GL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR     +  +T  VVT WYRAPE+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEV 180

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I+ V G   E D      P
Sbjct: 181 LL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-----P 234

Query: 265 KARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           +     +   +S+    I       D L  DLL K L F P+KRI+   AL HPY
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  179 bits (456), Expect = 2e-52
 Identities = 110/297 (37%), Positives = 169/297 (56%), Gaps = 19/297 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G++GVV  +I  +T+EKVAIKK+        D     REL++++++ H N+I LKD 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 98  M-MPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLH 150
                 + + K+++L  V E +   +H+ +K    ++ +L     K + +QL R L Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 151 SANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           S  I HRDLKP NLL++ N   LK+CDFG A+     ++ ++ Y+ +R+YRAPEL+L   
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRFYRAPELMLGAT 246

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           NY T ID+WS+GCI AE++   PIF G   ++QL  II V GT  E  L+   NP     
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK-EMNPNYADI 305

Query: 270 IKSLPYSRGTHISSLYPQADP-LALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
               P  +   +  ++P+  P  A++ + + L +EP KR+   EAL  P+   L DP
Sbjct: 306 --KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360

Length = 440

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  172 bits (439), Expect = 8e-52
 Identities = 81/295 (27%), Positives = 142/295 (48%), Gaps = 41/295 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
           ++   + +GRG++G V  +++++T E +A+K +      E  ++AL   RE+ +L  ++H
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE--REIRILSSLQH 58

Query: 89  DNVIALKDVMMPTHRISFKDVYLVY-ELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
            N++        + R   K+   ++ E +    L  ++K    L     + +  Q+L GL
Sbjct: 59  PNIVRYYG----SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGL 114

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPEL 204
            YLHS  I+HRD+K  N+LV+++  +K+ DFG A+     E       V  T ++ APE+
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           +   + YG + D+WS+GC   E+   KP +   E  N +  +  + G+  E         
Sbjct: 175 IR-GEEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKI-GSSGEPP------- 223

Query: 265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                   +P     H+S         A D L+K L  +P KR T  E LQHP++
Sbjct: 224 -------EIP----EHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  158 bits (401), Expect = 7e-46
 Identities = 104/296 (35%), Positives = 153/296 (51%), Gaps = 13/296 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +G G+Y  V    ++   + VA+K I  + E        +RE  LL+ +KH N+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKGLKHANI 65

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQII-KSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L D++     ++     LV+E + TDL Q + K    L  ++ K F+FQLLRGL Y+H
Sbjct: 66  VLLHDIIHTKETLT-----LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
              ILHRDLKP NLL++   +LK+ DFGLAR         +  VVT WYR P++LL    
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQE---ADLEFIDNPKA 266
           Y T +D+W VGCIF E++     FPG + + +QL+ I  V GT  E     +  + + K 
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
            RF  +L   +    +         A DL  K+L   P  R++   AL H Y S L
Sbjct: 241 ERF--TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  154 bits (392), Expect = 7e-45
 Identities = 84/301 (27%), Positives = 132/301 (43%), Gaps = 55/301 (18%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  IK IG+G++G V     +   +   +K+I+    +  +    L E+ +L+ + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDH------CKYFVF 140
           +I   +        SF++   +  +M+     DL Q IK  Q              +FV 
Sbjct: 61  IIKYYE--------SFEEKGKLCIVMEYADGGDLSQKIKK-QKKEGKPFPEEQILDWFV- 110

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           QL   LKYLHS  ILHRD+KP N+ + +N  +K+ DFG+++            V T +Y 
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170

Query: 201 APELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           +PEL   C N  Y    D+WS+GC+  E+   K  F G    N L+L +           
Sbjct: 171 SPEL---CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALK---------- 214

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                      I    Y     I S Y     L  +L+  +L  +P +R ++ + LQ P+
Sbjct: 215 -----------ILKGQYPP---IPSQYSSE--LR-NLVSSLLQKDPEERPSIAQILQSPF 257

Query: 319 I 319
           I
Sbjct: 258 I 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  156 bits (394), Expect = 3e-44
 Identities = 79/315 (25%), Positives = 136/315 (43%), Gaps = 41/315 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKH- 88
            Y  ++ +G G++G V  + +    + VA+K +    E++   + R LRE+ +L  + H 
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLR 144
            N++ L D            +YLV E +D   L  ++K       LS     + + Q+L 
Sbjct: 58  PNIVKLYDFFQ-----DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 145 GLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLAR------TSRGNEQFMTEYVVTR 197
            L+YLHS  I+HRD+KP N+L++ +   +K+ DFGLA+      ++       +  V T 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 198 WYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
            Y APE+LL        +S D+WS+G    E+L   P F G +  +     + +      
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL---- 228

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
                             P        S        A DLL+K+L  +P  R++ +  L 
Sbjct: 229 --------------ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Query: 316 HPYISGLYDPQCNPP 330
           H  ++ L   + +  
Sbjct: 275 HDLLAHLKLKESDLS 289

Length = 384

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  152 bits (386), Expect = 1e-43
 Identities = 110/315 (34%), Positives = 166/315 (52%), Gaps = 41/315 (13%)

Query: 38  IGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +GRG YG V  +  ++  ++   A+K+I    E    ++   RE+ LLR +KH NVIAL+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS---------LSNDHCKYFVFQLLRGL 146
            V + +H  S + V+L+++  + DL  IIK  ++         L     K  ++Q+L G+
Sbjct: 65  KVFL-SH--SDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR      + + +    VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE---------CLNQLKLIISVF 250
           RAPELLL   +Y  +ID+W++GCIFAE+L  +PIF   +           +QL  I SV 
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 251 GTQQEADLEFI----DNPKARRFIKSLPYSRGTHISSLYP---QADPLALDLLQKMLVFE 303
           G   + D E I    + P  ++  +   Y+  + I  +     + D     LLQK+L  +
Sbjct: 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301

Query: 304 PSKRITVTEALQHPY 318
           P+KRIT  +ALQ PY
Sbjct: 302 PTKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  148 bits (375), Expect = 3e-42
 Identities = 87/292 (29%), Positives = 139/292 (47%), Gaps = 45/292 (15%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G+G+ GVV    ++ T +  A+KKI+ V  +     + LREL  LR  +   V+  
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 95  KDVMMPTHRISFKD--VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                  +   +K+  + +V E MD   L  ++K    +      Y   Q+L+GL YLH+
Sbjct: 65  -------YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 152 -ANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
             +I+HRD+KP NLL+N+  ++KI DFG+++      +Q  T +V T  Y +PE +   +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQ-GE 175

Query: 210 NYGTSIDVWSVGCIFAE-ILGRKP-IFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
           +Y  + D+WS+G    E  LG+ P + PG     +L   I   G       E   +P+ R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEF-SPEFR 233

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            FI +                       LQK    +P KR +  E LQHP+I
Sbjct: 234 DFISA----------------------CLQK----DPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  147 bits (373), Expect = 1e-41
 Identities = 109/318 (34%), Positives = 164/318 (51%), Gaps = 47/318 (14%)

Query: 38  IGRGAYGVVCSSINRE--TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +GRG YG V  +  ++   +   A+K+I    E    ++   RE+ LLR +KH NVI+L+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS---------LSNDHCKYFVFQLLRGL 146
            V + +H  + + V+L+++  + DL  IIK  ++         L     K  ++Q+L G+
Sbjct: 65  KVFL-SH--ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR      + + +    VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL------------NQLKLII 247
           RAPELLL   +Y  +ID+W++GCIFAE+L  +PIF    C             +QL  I 
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF---HCRQEDIKTSNPYHHDQLDRIF 238

Query: 248 SVFGTQQEADLEFIDN-PKARRFIKSLPYSRGTHISSL------YPQADPLALDLLQKML 300
           +V G   + D E I   P+    +K    +  T+ S +        + D  A  LLQK+L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 301 VFEPSKRITVTEALQHPY 318
             +P KRIT  +A+Q PY
Sbjct: 299 TMDPIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (359), Expect = 3e-40
 Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 41/291 (14%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            +  ++ IG+G +G V  + ++ T ++VAIK I    + + + +  + E+ +L+  KH N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPN 58

Query: 91  VIALKDVMMPTHRISFKD-VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLK 147
           ++              KD +++V E      L  ++KS+ Q+L+     Y   +LL+GL+
Sbjct: 59  IVKYYG------SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS  I+HRD+K  N+L+ ++ ++K+ DFGL+     + +     V T ++ APE++  
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTMVGTPYWMAPEVIN- 170

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              Y    D+WS+G    E+   KP +     +  L  I                     
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------------------- 210

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 P  R     S   +      D L+K L   P KR T  + L+HP+
Sbjct: 211 --TNGPPGLRNPEKWSDEFK------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  139 bits (352), Expect = 8e-39
 Identities = 85/303 (28%), Positives = 145/303 (47%), Gaps = 57/303 (18%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
              Y  ++ IG GA G V  + +R T ++VAIKK+  + +   + +  + E+++++  KH
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELI--INEILIMKDCKH 74

Query: 89  DNVIALKDVMMPTHRISF---KDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQ 141
            N++   D        S+    ++++V E MD    TD+  I ++   ++     Y   +
Sbjct: 75  PNIVDYYD--------SYLVGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCRE 124

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYR 200
           +L+GL+YLHS N++HRD+K  N+L++ +  +K+ DFG A      E+     VV T ++ 
Sbjct: 125 VLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWM 183

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPI--FPGTECLNQLKLIISVFGTQQEAD 257
           APE++    +YG  +D+WS+G +  E+  G  P    P    L  L LI +         
Sbjct: 184 APEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITT--------- 230

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                        K +P  +     S      P   D L K LV +P KR +  E LQHP
Sbjct: 231 -------------KGIPPLKNPEKWS------PEFKDFLNKCLVKDPEKRPSAEELLQHP 271

Query: 318 YIS 320
           ++ 
Sbjct: 272 FLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 9e-37
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 51/290 (17%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIALKD 96
           IGRGA+GVV   +N ET + VAIK+I+   + + +AL+++  E+ LL+++KH N++    
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 97  VMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   S +    +Y++ E  +   L QIIK            +V+Q+L+GL YLH  
Sbjct: 67  --------SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+K  N+L   +  +K+ DFG+A       +     V T ++ APE++       
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE-MSGAS 177

Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI---DNPKARRF 269
           T+ D+WS+GC   E+L   P +               +     A L  I   D+P     
Sbjct: 178 TASDIWSLGCTVIELLTGNPPY---------------YDLNPMAALFRIVQDDHPP---- 218

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              LP      IS       P   D L +    +P+ R T  + L+HP+I
Sbjct: 219 ---LP----EGIS-------PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  129 bits (327), Expect = 4e-35
 Identities = 88/319 (27%), Positives = 138/319 (43%), Gaps = 74/319 (23%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF---ENRIDALRTLRELVLLRHIKH 88
           +   K IG G++  V  +  +ETN++ AIK ++      E ++  ++  +E VL R   H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE-VLTRLNGH 61

Query: 89  DNVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +I L          +F+D   +Y V E   + +L Q I+   SL     +++  ++L 
Sbjct: 62  PGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------------------TSR 184
            L+YLHS  I+HRDLKP N+L++ +  +KI DFG A+                       
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG-TECLNQL 243
            N +    +V T  Y +PELL      G S D+W++GCI  ++L  KP F G  E L   
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--- 229

Query: 244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFE 303
                 F    + +  F  N                          P A DL++K+LV +
Sbjct: 230 -----TFQKILKLEYSFPPNF------------------------PPDAKDLIEKLLVLD 260

Query: 304 PSKRITV----TEALQHPY 318
           P  R+ V     E   HP+
Sbjct: 261 PQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  127 bits (322), Expect = 1e-34
 Identities = 86/303 (28%), Positives = 142/303 (46%), Gaps = 58/303 (19%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I +GAYG V  +  + T +  AIK I     + +N++D + T R++  L   +   V+ L
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58

Query: 95  KDVMMPTHRISF---KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
                     SF   K++YLV E +   DL  ++++  SL  D  + ++ +++  L+YLH
Sbjct: 59  --------YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH 110

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM--------TEYVVTRWYRAP 202
           S  I+HRDLKP N+L+++N  LK+ DFGL++      Q             V T  Y AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    +  ++D WS+GCI  E L   P F G E   +      +F       +E+ +
Sbjct: 171 EVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEE------IFQNILNGKIEWPE 222

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI---TVTEALQHPYI 319
                                   +    A+DL+ K+LV +P KR+   ++ E   HP+ 
Sbjct: 223 ----------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Query: 320 SGL 322
            G+
Sbjct: 261 KGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 1e-34
 Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 52/291 (17%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G+G++G V     ++T +  A+K +    + + + +   TL E  +L  I H  ++ L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNILSRINHPFIVKLH 59

Query: 96  DVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                    +F+    +YLV E     +L   +      S +  +++  +++  L+YLHS
Sbjct: 60  --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLKP N+L++A+  +K+ DFGLA+           +  T  Y APE+LL    Y
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-Y 170

Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D WS+G +  E+L G+ P +              ++    +  L F +        
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--------IYEKILKDPLRFPEF------- 215

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPY 318
                              P A DL+  +L  +P+KR+      E   HP+
Sbjct: 216 -----------------LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (314), Expect = 1e-33
 Identities = 73/288 (25%), Positives = 138/288 (47%), Gaps = 43/288 (14%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRI--DALRTL-RELVLLRHIKHDNVIAL 94
           +G G++G V   +N +  +  A+K+++   + +   +A++ L +E+ LL  ++H N++  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                    +    ++L      + L +++K   S      + +  Q+L GL+YLH  N 
Sbjct: 68  LGTEREEDNLY---IFLELVPGGS-LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRD+K  N+LV+ N  +K+ DFG+A+       F   +  + ++ APE++     YG +
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLA 182

Query: 215 IDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN---PKARRFIK 271
            D+WS+GC   E+   KP +      +QL+ + +VF   +  +L  I +    +A+ FI 
Sbjct: 183 ADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI- 235

Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                                L  LQ+    +PS R T  E L+HP++
Sbjct: 236 ---------------------LKCLQR----DPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (312), Expect = 3e-33
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 32/215 (14%)

Query: 35  IKPIGRGAYGVVCSSINRETN----EKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHD 89
            K +G GA+G V     +        +VA+K +  +  E +I+    LRE  ++R + H 
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHP 61

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS-LSNDHCKYFVFQLLRGLK 147
           NV+ L  V      +     Y+V E M+  DL   ++ ++  LS      F  Q+ RG++
Sbjct: 62  NVVKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYR 200
           YL S N +HRDL   N LV  N  +KI DFGL+R     + +  +Y          RW  
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSR-----DLYDDDYYRKRGGKLPIRWM- 170

Query: 201 APE-LLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
           APE L      + +  DVWS G +  EI  LG +P
Sbjct: 171 APESLKEGK--FTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (311), Expect = 5e-33
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 35  IKPIGRGAYGVVCS----SINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHD 89
            K +G GA+G V              +VA+K +  +  E +I+    LRE  ++R + H 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHP 61

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS--LSNDHCKYFVFQLLRGL 146
           N++ L  V      +      +V E M   DL   ++ ++   LS      F  Q+ RG+
Sbjct: 62  NIVKLLGVCTEEEPL-----MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT--EYVVTRWYRAPE- 203
           +YL S N +HRDL   N LV  N  +KI DFGL+R    ++ +      +  RW  APE 
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APES 175

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
           L      + +  DVWS G +  EI  LG +P
Sbjct: 176 LKEGK--FTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  122 bits (308), Expect = 1e-32
 Identities = 85/304 (27%), Positives = 136/304 (44%), Gaps = 54/304 (17%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
            Y  ++ IG+G++G V     +   + +  K+I+  N+ E     L  + E+ +LR +KH
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL--VSEVNILRELKH 58

Query: 89  DNVIALKDVMMPTHRI---SFKDVYLVYELMDT-DLHQIIKSS----QSLSNDHCKYFVF 140
            N++   D      RI   S + +Y+V E  +  DL Q+I+      + +  +     + 
Sbjct: 59  PNIVRYYD------RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112

Query: 141 QLLRGLKYLH-----SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           QLL  L   H        +LHRDLKP N+ ++AN ++K+ DFGLA+    +  F   YV 
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           T +Y +PE L    +Y    D+WS+GC+  E+    P F      NQL+L          
Sbjct: 173 TPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTAR---NQLQLA--------- 219

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
                         IK   + R  +  S       L   +++ ML  +P KR +  E LQ
Sbjct: 220 ------------SKIKEGKFRRIPYRYS-----SELNE-VIKSMLNVDPDKRPSTEELLQ 261

Query: 316 HPYI 319
            P I
Sbjct: 262 LPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (296), Expect = 7e-31
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 47/293 (16%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G +G V +++N +T E +A+K+I     +         E+ +L  +KH N++    V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
            +  HR   + VY+  E      L ++++  + L     + +  QLL GL YLHS  I+H
Sbjct: 68  EV--HR---EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 157 RDLKPGNLLVNANCDLKICDFG----LARTSRGNEQFMTEYVVTRWYRAPELLL--CCDN 210
           RD+KP N+ ++ N  +K+ DFG    L   +    + +     T  Y APE++       
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 211 YGTSIDVWSVGCIFAE-ILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +G + D+WS+GC+  E   G++P                      E D EF         
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRP--------------------WSELDNEF--------- 213

Query: 270 IKSLPYSRGTHISSLYP---QADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              + +  G       P   Q  P   D L + L  +P KR T +E LQHP++
Sbjct: 214 --QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  114 bits (288), Expect = 7e-30
 Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 49/291 (16%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDNVIALKD 96
           IG+GA+G VC    R+T +  A+K +N        ++R  L E  +L+ + H  ++ L  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL-- 65

Query: 97  VMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   SF+D   +YLV +L+   DL   +      S +  K+++ +++  L+YLHS 
Sbjct: 66  ------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            I+HRD+KP N+L++    + I DF +A     +    T    T  Y APE +LC   Y 
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-TTSTSGTPGYMAPE-VLCRQGYS 177

Query: 213 TSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
            ++D WS+G    E L G++P + G                             +R    
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP-YRG----------------------------HSRTIRD 208

Query: 272 SLPYSRGTHISSLYPQADPL-ALDLLQKMLVFEPSKRI--TVTEALQHPYI 319
            +   + T    LYP      A+D + K+L  +P KR+   + +   HPY 
Sbjct: 209 QIRAKQETA-DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (271), Expect = 2e-27
 Identities = 74/311 (23%), Positives = 136/311 (43%), Gaps = 70/311 (22%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           + +F+I  K      +G G+YG V  +I++ET + VAIK +    E  +  +  ++E+ +
Sbjct: 2   EEVFDILEK------LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEI--IKEISI 51

Query: 83  LRHIKHDNVIA-----LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSND 133
           L+      ++       K+           D+++V E       +D+ +I   +  L+ +
Sbjct: 52  LKQCDSPYIVKYYGSYFKN----------TDLWIVMEYCGAGSVSDIMKITNKT--LTEE 99

Query: 134 HCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
                ++Q L+GL+YLHS   +HRD+K GN+L+N     K+ DFG++     +       
Sbjct: 100 EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNT 158

Query: 194 VV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS---- 248
           V+ T ++ APE++     Y    D+WS+G    E+   KP +     +  + +I +    
Sbjct: 159 VIGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP 217

Query: 249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI 308
                ++   EF D      F+K                          K LV +P +R 
Sbjct: 218 TLSDPEKWSPEFND------FVK--------------------------KCLVKDPEERP 245

Query: 309 TVTEALQHPYI 319
           +  + LQHP+I
Sbjct: 246 SAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  107 bits (271), Expect = 2e-27
 Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 39/232 (16%)

Query: 35  IKPIGRGAYGVVCS----SINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKH 88
            K +G GA+G V           T  KVA+K +    E   +  R   L E  +++ + H
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSH 60

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS-QSLSNDHCKYFVFQLLRGL 146
            N++ L  V      +     Y+V E M   DL   ++   + L+         Q+ +G+
Sbjct: 61  PNIVRLLGVCTQGEPL-----YIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWY 199
           +YL S N +HRDL   N LV  N  +KI DFGL+R    ++     Y          +W 
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWM 171

Query: 200 RAPELLLCCDNYGTSI--DVWSVGCIFAEI--LGRKPIFPG---TECLNQLK 244
            APE L    +   +   DVWS G +  EI  LG +P +PG    E L  L+
Sbjct: 172 -APESL---KDGKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEEVLELLE 218

Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 47/294 (15%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +KPI +GA+G V  +  R T +  AIK   K + + +N++  ++  R +++++      V
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES-PYV 59

Query: 92  IALKDVMMPTHRISFKD-VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
             L       +    KD +YLV E ++  D   +IK+   L  D  K ++ +++ G++ L
Sbjct: 60  AKL------YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDL 113

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   I+HRD+KP NLL++    LK+ DFGL+R    N++F    V T  Y APE +L   
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----VGTPDYLAPETILGVG 169

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +   S D WS+GC+  E L   P F                    E      DN  +RR 
Sbjct: 170 DDKMS-DWWSLGCVIFEFLFGYPPF------------------HAETPDAVFDNILSRRI 210

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI---TVTEALQHPYIS 320
             + P       S       P A+DL+ ++L  +P+KR+      E   HP+  
Sbjct: 211 --NWPEEVKEFCS-------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (270), Expect = 3e-27
 Identities = 85/309 (27%), Positives = 133/309 (43%), Gaps = 72/309 (23%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKI-------NNVFENRIDALRTLR-ELVLLRHIKHD 89
           IG+G YG V  ++N  T E +A+K++             + D ++ LR E+  L+ + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLH------------QIIKSSQSLSNDHCKY 137
           N++                 YL +E  +  L               +++         ++
Sbjct: 69  NIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR---GNEQFMTEYV 194
           F  Q+L GL YLHS  ILHRDLK  NLLV+A+   KI DFG+++ S     N+Q M+   
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 195 VTRWYRAPELL-LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVF-- 250
              W  APE++      Y   +D+WS+GC+  E+  GR+P        +  + I ++F  
Sbjct: 173 SVFWM-APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-------WSDEEAIAAMFKL 224

Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
           G ++ A                +P         +     P+ALD L       P  R T 
Sbjct: 225 GNKRSA--------------PPIP-------PDVSMNLSPVALDFLNACFTINPDNRPTA 263

Query: 311 TEALQHPYI 319
            E LQHP+I
Sbjct: 264 RELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  107 bits (269), Expect = 4e-27
 Identities = 84/299 (28%), Positives = 135/299 (45%), Gaps = 55/299 (18%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFEN-RIDALRTLRELVLLRHIKH 88
           Y+PI+ +G+GA+G        E +  V  K++N   + E  R DAL    E+V+L  ++H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQH 58

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTD---LHQII--KSSQSLSNDHCKYFVFQLL 143
            N+IA  +  M        D  L+ E+   +   L+  I  +  Q    +   +++FQ++
Sbjct: 59  PNIIAYYNHFM-------DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAP 202
             + Y+H A ILHRD+K  N+ +     +K+ DFG+++   G+E  M E VV T +Y +P
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSP 170

Query: 203 ELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           EL   C    Y    D+W++GC+  E+L  K  F  T   N L L++ +        +  
Sbjct: 171 EL---CQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTPVVS- 223

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                         YS              L   LLQ+    +P KR T  E L  P +
Sbjct: 224 -------------VYSSELI---------SLVHSLLQQ----DPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 1e-26
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 40/235 (17%)

Query: 36  KPIGRGAYGVVCS---SINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G GA+G V             +VA+K +     +  +    L+E  +++ + H NV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE-DASEEERKDFLKEARVMKKLGHPNVV 59

Query: 93  ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCK---------YFVFQL 142
            L  V         + +YLV E M+  DL   ++ S+ +     K          F  Q+
Sbjct: 60  RLLGVC-----TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------ 196
            +G++YL S   +HRDL   N LV  +  +KI DFGL+R    ++     Y         
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKKTGGKLP 170

Query: 197 -RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLNQLK 244
            RW  APE L   D  + +  DVWS G +  EI  LG  P +PG    E L  L+
Sbjct: 171 IRWM-APESLK--DGIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLR 221

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G G +G V     +  N   A+K +   ++ E          E  +L    H  ++ L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE-HIFSEKEILEECNHPFIVKL- 58

Query: 96  DVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                 +R +FKD   +Y LM+     +L  I++          ++++  ++   +YLH+
Sbjct: 59  ------YR-TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLKP NLL+++N  +K+ DFG A+  +  ++  T +  T  Y APE++L    Y
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIIL-NKGY 169

Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTE 238
             S+D WS+G +  E+L  +P F   +
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 7e-26
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 14/198 (7%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIA 93
           ++ IG G YG V  + +++T + VAIK I ++ E+  + ++   E  +LR    H N+  
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKE--EYNILRKYSNHPNIAT 67

Query: 94  LKDVMM-PTHRISFKDVYLVYELMD----TDLHQ-IIKSSQSLSNDHCKYFVFQLLRGLK 147
                +      +   ++LV EL      TDL + + K  + L  +   Y + + LRGL 
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLH   ++HRD+K  N+L+  N ++K+ DFG++            ++ T ++ APE++ C
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187

Query: 208 CDN----YGTSIDVWSVG 221
            +     Y    DVWS+G
Sbjct: 188 DEQPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  103 bits (259), Expect = 2e-25
 Identities = 75/306 (24%), Positives = 148/306 (48%), Gaps = 56/306 (18%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC + ++ T  +VA+KK++   + R + L    E+V++R  +H N++     
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL--FNEVVIMRDYQHPNIVE---- 80

Query: 98  MMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
           M  ++ +   ++++V E ++    TD    I +   ++ +        +L+ L +LH+  
Sbjct: 81  MYSSYLVG-DELWVVMEFLEGGALTD----IVTHTRMNEEQIATVCLAVLKALSFLHAQG 135

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGL-ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++HRD+K  ++L+ ++  +K+ DFG  A+ S+   +     V T ++ APE ++    YG
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPE-VISRLPYG 193

Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP-KARRFIK 271
           T +D+WS+G +  E++  +P +                         F + P +A + I+
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPY-------------------------FNEPPLQAMKRIR 228

Query: 272 SL--PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNP 329
               P  +  H      +  P     L +MLV +P++R T  E L HP+++        P
Sbjct: 229 DNLPPKLKNLH------KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA----KAGPP 278

Query: 330 PAQVPL 335
            + VPL
Sbjct: 279 SSIVPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (255), Expect = 4e-25
 Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 53/293 (18%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G+G+YG V        N+  A+K+++    ++ +    + E+ +L  + H N+I+ 
Sbjct: 5   LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 95  KDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSN-----DHCKYFVFQLLRGLKY 148
           K+  +  +++      +V E     DL + I   +         +  + F+ QLLRGL+ 
Sbjct: 65  KEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPELLLC 207
           LH   ILHRDLK  N+L+ AN  +KI D G+++  + N   M +  + T  Y APE+   
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWK- 174

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              Y    D+WS+GC+  E+    P F                  +   DL        R
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEA----------------RSMQDL--------R 210

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQ---KMLVFEPSKRITVTEALQHP 317
             ++   Y     I  +Y Q      DL      ML  +P  R    + L  P
Sbjct: 211 YKVQRGKYPP---IPPIYSQ------DLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  101 bits (254), Expect = 6e-25
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL---RTLRELVLLRHIKHDNVI 92
           K IG+G + VV  +I       VA+KK+  +FE  +DA      L+E+ LL+ + H NVI
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFE-MMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSN-----DHCKYFVFQLLRGL 146
                      I   ++ +V EL D  DL ++IK  +            KYFV QL   L
Sbjct: 66  KYLASF-----IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV-QLCSAL 119

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +++HS  I+HRD+KP N+ + A   +K+ D GL R            V T +Y +PE + 
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
             + Y    D+WS+GC+  E+   +  F G +
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  101 bits (254), Expect = 6e-25
 Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 50/294 (17%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---NVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           +G GA+     + + +T   +A+K++    N    + + +  LR E+ L+  + H ++I 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 94  LKDVMMPTHRISFKDVYLVYELM-----DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +   +  T   S  ++++  E M        L +     +++  ++ +    QLLRGL Y
Sbjct: 68  M---LGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGLSY 118

Query: 149 LHSANILHRDLKPGNLLVNANC-DLKICDFG----LARTSRGNEQFMTEYVVTRWYRAPE 203
           LH   I+HRD+K  NLL+++    L+I DFG    LA    G  +F  + + T  + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +L   + YG S DVWSVGC+  E+   KP +   +  N L LI  +        +    +
Sbjct: 179 VLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           P  R                          D+  + L  +P  R    E L+HP
Sbjct: 238 PGLR--------------------------DVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 1e-24
 Identities = 57/210 (27%), Positives = 110/210 (52%), Gaps = 25/210 (11%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKI-----NNVFENRIDALRTLRELVLLRHIKHDN 90
           K +G+GA+G V    + +T  ++A+K++     +   +  ++AL    E+ LL++++H+ 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC--EIQLLKNLQHER 65

Query: 91  VI----ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           ++     L+D            + +  E M    +   +K+  +L+    + +  Q+L G
Sbjct: 66  IVQYYGCLRD---DET------LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSRGNEQFMTEYVVTRWYRAP 202
           ++YLHS  I+HRD+K  N+L ++  ++K+ DFG ++   T   +   M     T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKP 232
           E++   + YG   DVWSVGC   E+L  KP
Sbjct: 177 EVIS-GEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  101 bits (253), Expect = 1e-24
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 38/294 (12%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  + T ++VA+KK++   + R + L    E+V++R   H+NV     V
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHENV-----V 82

Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +   ++++V E ++      I +   ++ +        +LR L YLH+  ++HR
Sbjct: 83  DMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+ ++  +K+ DFG               V T ++ APE++     YGT +D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDI 201

Query: 218 WSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYS 276
           WS+G +  E++ G  P F                    E  L+ +     RR   +LP  
Sbjct: 202 WSLGIMVIEMIDGEPPYF-------------------NEPPLQAM-----RRIRDNLP-- 235

Query: 277 RGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
               +   +  +  L    L  MLV EPS+R T  E LQHP++     P C  P
Sbjct: 236 --PRVKDSHKVSSVLR-GFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (250), Expect = 2e-24
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 22/220 (10%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG+G++GVV   + +      A+K+I+    NR +    + E  +L  +    +I   + 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE- 66

Query: 98  MMPTHRISFKDVYLVYELMD----TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHS 151
                  SF D   +  +M+     DLH+++K    + L  D    F  Q+L GL +LHS
Sbjct: 67  -------SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN- 210
             ILHRD+K  NL ++A  ++KI D G+A+    N  F    V T +Y +PE  LC D  
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE--LCEDKP 177

Query: 211 YGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISV 249
           Y    DVW++G +  E   G+ P     +  NQ  LI+ +
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKI 213

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 3e-24
 Identities = 76/295 (25%), Positives = 136/295 (46%), Gaps = 53/295 (17%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GA+G V  + ++ET    A K I    E  ++      E+ +L   KH N++ L + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV--EIDILSECKHPNIVGLYEA 70

Query: 98  --------MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
                   ++    I F D   +  +M        +  + L+    +Y   Q+L  L +L
Sbjct: 71  YFYENKLWIL----IEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEALNFL 119

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC-- 207
           HS  ++HRDLK GN+L+  + D+K+ DFG++  ++   Q    ++ T ++ APE++ C  
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 208 -CDN-YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             DN Y    D+WS+G    E+   +P  P  E LN +++++ +     +++   +D P 
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLKI----LKSEPPTLDQP- 231

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
             ++  S                     D L+  LV +P  R T  E L+HP++S
Sbjct: 232 -SKWSSSFN-------------------DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 98.9 bits (246), Expect = 9e-24
 Identities = 73/295 (24%), Positives = 136/295 (46%), Gaps = 40/295 (13%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  + + + VA+KK++   + R + L    E+V++R  +H+NV     V
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENV-----V 80

Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +   ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 81  EMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDI 199

Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  PK +   K  P 
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPKLKNLHKVSPS 245

Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
            +G                 L ++LV +P++R T  E L+HP+++    P C  P
Sbjct: 246 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 71/289 (24%), Positives = 129/289 (44%), Gaps = 70/289 (24%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR----TLRELVLLRHIKHDN 90
           IK +G G++G V    ++ + +  A+K ++   + +I  L+     L E  +L+ I+H  
Sbjct: 6   IKTLGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           ++ L          SF+D   +Y +M+     +L   ++ S        +++  Q++  L
Sbjct: 63  LVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-W------- 198
           +YLHS +I++RDLKP NLL++++  +KI DFG A+            V  R +       
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK-----------RVKGRTYTLCGTPE 163

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           Y APE++L    YG ++D W++G +  E+L   P F     +   + I+       E  +
Sbjct: 164 YLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-------EGKV 215

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
            F   P                         P A DL++ +L  + +KR
Sbjct: 216 RF---PSFF---------------------SPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 38/294 (12%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  + +  +VA+K ++   + R + L    E+V++R  +H NV     V
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHQNV-----V 81

Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +  ++++++ E +       I S   L+ +        +L+ L YLHS  ++HR
Sbjct: 82  EMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG       +       V T ++ APE++     YGT +D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYGTEVDI 200

Query: 218 WSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYS 276
           WS+G +  E++ G  P F  +               Q    L     PK +   K  P  
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSP-------------VQAMKRLRDSPPPKLKNAHKISPVL 247

Query: 277 RGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
           R                D L++ML  EP +R T  E L HP++     P+C  P
Sbjct: 248 R----------------DFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 87/355 (24%), Positives = 142/355 (40%), Gaps = 91/355 (25%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR-HIKHDN 90
           +  IK IGRGA+G V    +++T +  A+K +              +  ++ R  I H  
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR-------------KSDMIKRNQIAH-- 47

Query: 91  VIALKDVMMPTHR-------ISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
           V A +D++             SF+D   +YLV E M   DL  ++        +  ++++
Sbjct: 48  VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYI 107

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA------------RTSRGNE 187
            +L+  L  +H    +HRD+KP N+L++A+  +K+ DFGL                  N 
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 188 QFMTEYVVTRW-----------------YRAPELLLCCDNYGTSIDVWSVGCIFAEIL-G 229
            F    +V R                  Y APE +L    YG   D WS+G I  E+L G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226

Query: 230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD 289
             P +  T      K+I                      + +SL +     +S       
Sbjct: 227 FPPFYSDTLQETYNKII---------------------NWKESLRFPPDPPVS------- 258

Query: 290 PLALDLLQKMLVFEPSKRIT-VTEALQHPYISGL--YDPQCNPPAQVP-LSLDID 340
           P A+DL+ + L+ +P  R+    E   HP+  G+   + +   P  VP LS  +D
Sbjct: 259 PEAIDLICR-LLCDPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLD 312

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.2 bits (240), Expect = 5e-23
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 29/215 (13%)

Query: 33  VPIKPIGRGAYGVVCSSINRETNEKVAIKKI----NNVFENRIDALRTLRELVLLRHIKH 88
             +  +G G  GVV   ++R T + +A+K I    N   + +I     LREL +L     
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKCNS 58

Query: 89  DNVI----ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFV-FQL 142
             ++    A           +  D+ +  E MD   L +I+K  Q    +     +   +
Sbjct: 59  PYIVGFYGAF---------YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAV 109

Query: 143 LRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           L+GL YLH    I+HRD+KP N+LVN+   +K+CDFG++     N    T +V T  Y A
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS-GQLVNSLAKT-FVGTSSYMA 167

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFP 235
           PE +   D Y    D+WS+G    E+  GR P  P
Sbjct: 168 PERIQGND-YSVKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.1 bits (240), Expect = 6e-23
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 56/299 (18%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKHD 89
            +  ++ IG+G++G V  +I++ TN+ VAIK I+   E   D +  + +E+  L   +  
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSP 59

Query: 90  NVI-----ALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVF 140
            +       LK   +          +++ E        DL +  K    L   +  + + 
Sbjct: 60  YITKYYGSFLKGSKL----------WIIMEYCGGGSCLDLLKPGK----LDETYIAFILR 105

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           ++L GL+YLH    +HRD+K  N+L++   D+K+ DFG++            +V T ++ 
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE ++    Y    D+WS+G    E+   +P       +  L LI              
Sbjct: 166 APE-VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------------- 210

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              PK      SL    G   S           D +   L  +P +R +  E L+H +I
Sbjct: 211 ---PK--NNPPSLE---GNKFS-------KPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 8e-23
 Identities = 83/309 (26%), Positives = 135/309 (43%), Gaps = 65/309 (21%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR---IDALRTLRELVLLRHIKH 88
           Y  I+ IG GA  VV ++I    NEKVAIK+I+   E     +D LR  +E+  +    H
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELR--KEVQAMSQCNH 58

Query: 89  DNVIALKDVMMPTHRISF---KDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVF-Q 141
            NV+         +  SF    +++LV   +    L  I+KSS  +   ++     V  +
Sbjct: 59  PNVV--------KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE 110

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA--------RTSRGNEQFMTEY 193
           +L+GL+YLHS   +HRD+K GN+L+  +  +KI DFG++        RT +  + F    
Sbjct: 111 VLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF---- 166

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE-ILGRKPI--FPGTECLNQLKLIISVF 250
           V T  + APE++     Y    D+WS G    E   G  P   +P  + L  +  + +  
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQNDP 224

Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
            + +            +++ KS                      ++   L  +PSKR T 
Sbjct: 225 PSLET-------GADYKKYSKSFR-------------------KMISLCLQKDPSKRPTA 258

Query: 311 TEALQHPYI 319
            E L+H + 
Sbjct: 259 EELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 95.8 bits (238), Expect = 9e-23
 Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 15/223 (6%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  IK IG G++G +  +  +  +E   IK+I+       +   + +E++LL  +KH N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSL--SNDHCKYFVFQLLRGLK 147
           ++          R+     ++V E  D  DL + I   + +  S D    +  Q+  GLK
Sbjct: 61  IVTFFASFQENGRL-----FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDL-KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           ++H   ILHRD+K  N+ ++ N  + K+ DFG+AR    + +     V T +Y +PE+  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-- 173

Query: 207 CCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII 247
            C N  Y    D+WS+GC+  E+   K  F G   L+QL L I
Sbjct: 174 -CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           +V +  IG G++G V  + N  TNE VA+KK++   +   +  +  ++E+  L+ +KH N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 91  VIALKDVMMPTHRISFKDVYLVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            I  K   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 83  TIEYKGCYLKEH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLA 135

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L+     +K+ DFG A  S     F    V T ++ APE++L 
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF----VGTPYWMAPEVILA 191

Query: 208 CD--NYGTSIDVWSVGCIFAEILGRKP 232
            D   Y   +DVWS+G    E+  RKP
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 9/213 (4%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD---NVIAL 94
           IGRGAYG V    +  T   VA+K IN    +  D     RE+ LL  ++     N+   
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD-DVSDIQREVALLSQLRQSQPPNITKY 67

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
               +   R     ++++ E  +    + +  +  ++  +    + ++L  LKY+H   +
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGV 122

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRD+K  N+LV    ++K+CDFG+A     N    + +V T ++ APE++     Y T 
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182

Query: 215 IDVWSVGCIFAEILGRKPIFPGTECLNQLKLII 247
            D+WS+G    E+    P +   +    + LI 
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 6e-22
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 41/215 (19%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           Q  +E+      I+ IG G YG V  + +  T E VAIK I     +  + ++  +E+ +
Sbjct: 2   QEDYEL------IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISM 53

Query: 83  LRHIKHDNVIALKDVMMPTHRI----------SFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           L+  +H N++A     +   ++          S +D+Y V             +   LS 
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV-------------TRGPLSE 100

Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA----RTSRGNEQ 188
               Y   + L+GL YLH    +HRD+K  N+L+  + D+K+ DFG++     T    + 
Sbjct: 101 LQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160

Query: 189 FMTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVG 221
           F    + T ++ APE+        Y    D+W++G
Sbjct: 161 F----IGTPYWMAPEVAAVERKGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 93.0 bits (231), Expect = 7e-22
 Identities = 61/226 (26%), Positives = 113/226 (50%), Gaps = 19/226 (8%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KYV +K IG G++G      ++E  ++  IK+IN    +  +   + +E+ +L ++KH N
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSL--SNDHCKYFVFQLLR 144
           ++         ++ SF++   +Y +MD     DL++ I + + +    D    +  Q+  
Sbjct: 61  IV--------QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
            LK++H   ILHRD+K  N+ +  +  +K+ DFG+AR      +     + T +Y +PE+
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 205 LLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
              C+N  Y    D+W++GC+  E+   K  F      N +  II 
Sbjct: 173 ---CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 80/297 (26%), Positives = 138/297 (46%), Gaps = 52/297 (17%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKK-----INNVFENR----IDALRTLRELVLLRHIKH 88
           IG G++G V   +N  + E +A+K+     ++   ++R    +DAL   RE+ LL+ ++H
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQH 65

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +N++      +    ++    Y+    +   L+      ++L     + FV Q+L+GL Y
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNY 121

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR------TSRGNEQFMTEYVVTRWYRAP 202
           LH+  I+HRD+K  N+LV+    +KI DFG+++       S            + ++ AP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++    +Y    D+WS+GC+  E+L  K  FP      QL+ I   F   + A  E   
Sbjct: 182 EVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAI---FKIGENASPEIPS 234

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           N                 ISS   +A     D L+K    + +KR T  E L+HP++
Sbjct: 235 N-----------------ISS---EAI----DFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 93.0 bits (231), Expect = 3e-21
 Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 29/260 (11%)

Query: 76  TLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQII-KSSQSLSNDH 134
           TL E +LL+++ H +VI +KD +     +S     +V     +DL+  + K S+ L  D 
Sbjct: 104 TLIEAMLLQNVNHPSVIRMKDTL-----VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
                 Q+L GL+YLH+  I+HRD+K  N+ +N    + I D G A+       F+    
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LA 217

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIF---------PGTECLNQLK 244
            T    APE +L  D Y +  D+WS G +  E+L     IF             C + L 
Sbjct: 218 GTVETNAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHIS--SLYPQADPLALD-----LLQ 297
            IIS      E   EF  +P +R     + Y+        + YP    + L      L+ 
Sbjct: 277 KIISTLKVHPE---EFPRDPGSRLVRGFIEYA-SLERQPYTRYPCFQRVNLPIDGEFLVH 332

Query: 298 KMLVFEPSKRITVTEALQHP 317
           KML F+ + R +  E L +P
Sbjct: 333 KMLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.0 bits (226), Expect = 8e-21
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           +  ++ IG G++G V  + +  TNE VAIKK++   +   +  +  ++E+  L+ ++H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 91  VIALKDVMMPTHRISFKDVYLVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            I  K   +  H       +LV E      +D+ ++ K  + L            L+GL 
Sbjct: 77  TIEYKGCYLREH-----TAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLA 129

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS   +HRD+K GN+L+     +K+ DFG A        F    V T ++ APE++L 
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF----VGTPYWMAPEVILA 185

Query: 208 CD--NYGTSIDVWSVGCIFAEILGRKP 232
            D   Y   +DVWS+G    E+  RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           +  ++ IG G++G V  + +  TNE VAIKK++   +   +  +  ++E+  L+ IKH N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 91  VIALKDVMMPTHRISFKDVYLVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            I  K   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 87  SIEYKGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLA 139

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L+     +K+ DFG A  +     F    V T ++ APE++L 
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF----VGTPYWMAPEVILA 195

Query: 208 CD--NYGTSIDVWSVGCIFAEILGRKP 232
            D   Y   +DVWS+G    E+  RKP
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 35/222 (15%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F+I T+      +G+G YG V  +  ++T E VA+K++             L +L  +RH
Sbjct: 3   FQILTQ------VGQGGYGQVFLAKKKDTGEIVALKRMKK---------SLLFKLNEVRH 47

Query: 86  IKHDNVIALKDVMMPTHR-------ISFKDVYLVYELMD----TDLHQIIKSSQSLSNDH 134
           +  +     +D++  T          +F+D   +Y  M+     D   ++ +   LS DH
Sbjct: 48  VLTE-----RDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH 102

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            ++++ ++   +  LH    +HRDLKP N L++A+  +K+ DFGL   S+G   +    V
Sbjct: 103 ARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL---SKGIVTYANSVV 159

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
            +  Y APE+L     Y  ++D WS+GC+  E L   P F G
Sbjct: 160 GSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  ++ +G G++G      +  +++K A+K+I  + ++      + +E VLL  +KH N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 91  VIALKDVMMPTHRISFK---DVYLVYELMDT-DLHQIIKSSQS--LSNDHCKYFVFQLLR 144
           ++A K+        SF+    +Y+V E  D  DL Q IK  +      D    +  Q+  
Sbjct: 60  IVAFKE--------SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           G++++H   +LHRD+K  N+ +  N  +K+ DFG AR       +   YV T +Y  PE+
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Query: 205 LLCCDN--YGTSIDVWSVGCIFAEI 227
               +N  Y    D+WS+GCI  E+
Sbjct: 172 W---ENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKHDNVIA 93
           K IGRG +  V  +      + VA+KK+  +FE      R   ++E+ LL+ + H NVI 
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQII---KSSQSLSNDHC--KYFVFQLLRGLK 147
             D  +  + ++     +V EL D  DL Q+I   K  + L  +    KYFV QL   ++
Sbjct: 67  YLDSFIEDNELN-----IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLCSAVE 120

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           ++HS  ++HRD+KP N+ + A   +K+ D GL R            V T +Y +PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
            + Y    D+WS+GC+  E+   +  F G
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 40/292 (13%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +G+G+YG V    +R   ++  IKK+N    +R +     +E  LL  +KH N+
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS---LSNDHCKYFVFQLLRGLK 147
           +A ++       +    +Y+V    +  DL+  +K  +      N   ++FV Q+   L+
Sbjct: 62  VAYRESWEGEDGL----LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMALQ 116

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLH  +ILHRDLK  N+ +     +K+ D G+AR         +  + T +Y +PE L  
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFS 175

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              Y    DVW++GC   E+   K  F   +  + +  II       E  L     P  +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-------EGKLP----PMPK 224

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            +                    P   +L+  ML   P KR +V   L+ PYI
Sbjct: 225 DY-------------------SPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.4 bits (214), Expect = 1e-19
 Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 41/291 (14%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  I+ +GRGA+G+V     +   + V IK+I      + + L    E  +L+ + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           +I   +  +    +    + + Y    T    I K   S L  D   +F  Q+L  L ++
Sbjct: 61  IIEYYENFLEDKALM---IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 150 HSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           H+  ILHRDLK  N+L++ +   +KI DFG+++      +  T  V T  Y +PEL   C
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPEL---C 173

Query: 209 DN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
           +   Y    D+W++GC+  E+   K  F   E  N   L++ +              P +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAF---EAANLPALVLKIMSGTF--------APIS 222

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            R+   L                     L+  ML  +PSKR  +++ +  P
Sbjct: 223 DRYSPDLRQ-------------------LILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 37/293 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR---ELVLLRHIK 87
           +Y+  + +G+G++G V    +++   +  +K +  +    ++   T++   E  LL  + 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLS-NDHCKYFVFQLLRGL 146
           H  ++      +          Y     +D  L ++  + ++LS N  C++F+ QLL G+
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI-QLLLGV 119

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            Y+H   ILHRDLK  N+ +  N  LKI DFG++R   G+    T +  T +Y +PE  L
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE-AL 177

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
               Y +  D+WS+GCI  E+      F G    N L +++ +     E           
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIV----EGP--------- 221

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                SLP +    ++S           ++Q ML  +PS R +  E L++P+I
Sbjct: 222 ---TPSLPETYSRQLNS-----------IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 56/198 (28%), Positives = 105/198 (53%), Gaps = 16/198 (8%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLREL-VLLRHIKHDN--VIA 93
           IG+G +G V     ++T    A+K ++      + +   T+ E  +L+R +  ++  ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 94  LKDVMMPTHRISFK---DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           LK         SF+   D+YLV + M   +L   ++     S D  K+++ +L+  L++L
Sbjct: 61  LK--------FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H  +I++RDLKP N+L++A   + +CDFGL++ +  + +    +  T  Y APE+LL   
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 210 NYGTSIDVWSVGCIFAEI 227
            Y   +D WS+G +  E+
Sbjct: 173 GYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 72/299 (24%), Positives = 133/299 (44%), Gaps = 52/299 (17%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
             KY   + IG+GA G V ++I+  T ++VAIK++N   + +      + E++++R  KH
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKH 75

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYE--------LMDTDLHQIIKSSQSLSNDHCKYFVF 140
            N++            ++ D YLV +        L    L  ++  +  +          
Sbjct: 76  PNIV------------NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCR 122

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           + L+ L++LHS  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE ++    YG  +D+WS+G +  E++  +P +     L  L LI     T    +L+ 
Sbjct: 183 APE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNGTPELQ- 236

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                     +   +  D L + L  +  KR +  E LQHP++
Sbjct: 237 --NPE---------------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 75/296 (25%), Positives = 122/296 (41%), Gaps = 35/296 (11%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           K V +  +G GA G V     + T    A+K I     N     + LREL + +  K   
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPY 60

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFV----FQLLRG 145
           ++      +     S   + +  E  +   L  I K  +       +  +      +L+G
Sbjct: 61  IVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L YLHS  I+HRD+KP N+L+     +K+CDFG++     N    T +  T +Y APE +
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS-GELVNSLAGT-FTGTSFYMAPERI 175

Query: 206 LCCDNYGTSIDVWSVGCIFAEI-LGRKPIFP-GTECLNQLKLIISVFGTQQEADLEFIDN 263
                Y  + DVWS+G    E+   R P  P G   L  ++L+  +       + E  D 
Sbjct: 176 Q-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---NMPNPELKDE 231

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           P          +S                 D +++ L  +P++R T  + L+HP+I
Sbjct: 232 PGNGIK-----WSEEFK-------------DFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 44/307 (14%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKHDNVI 92
           +  +G G  GVV   ++R +   +A K I+   E +  A+R   +REL +L       ++
Sbjct: 6   LGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIK-PAIRNQIIRELKVLHECNSPYIV 62

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL-- 149
                      IS     +  E MD   L Q++K +  +  +        +LRGL YL  
Sbjct: 63  GFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 150 -HSANILHRDLKPGNLLVNANCDLKICDFGLART---SRGNEQFMTEYVVTRWYRAPELL 205
            H   I+HRD+KP N+LVN+  ++K+CDFG++     S  N      +V TR Y +PE L
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFVGTRSYMSPERL 170

Query: 206 LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLE----- 259
               +Y    D+WS+G    E+  GR PI P        K + ++FG             
Sbjct: 171 Q-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHR 224

Query: 260 -----FIDNPKARRFIKSLPYSRGTHISSLYPQA--DPLALDLLQKMLVFEPSKRITVTE 312
                  D+P+     + L Y        L P         D + K L   P +R  + E
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKE 283

Query: 313 ALQHPYI 319
             +HP+I
Sbjct: 284 LTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 85.5 bits (211), Expect = 6e-19
 Identities = 68/289 (23%), Positives = 135/289 (46%), Gaps = 36/289 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++I+  T ++VAIK+IN   + +      + E+++++ +K+ N
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 78  IVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           +  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKA 191

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 239

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                           +  P+  D L + L  +  KR +  E LQHP++
Sbjct: 240 ----------------KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 87/315 (27%), Positives = 143/315 (45%), Gaps = 68/315 (21%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIKHDNV 91
           IK I  GAYG V    ++ET ++ A+KKIN    +  N+I  +   R++  L   ++  V
Sbjct: 6   IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFV 63

Query: 92  IALKDVMMPTHRISF---KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
           +++          SF   + + +V E ++  D   ++K+  +L  D  + +  + +  L+
Sbjct: 64  VSM--------FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLART--------------SRGNEQFMTEY 193
           YLH+  I+HRDLKP NLL+ +   +K+ DFGL++                +   +F+ + 
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 194 VV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGT-ECLNQLKLIISVF 250
           V  T  Y APE++L    YG  +D W++G I  E L G  P F  T E L         F
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---------F 225

Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
           G     D+E+ +  +A                     AD  A DL+ ++L   P +R+  
Sbjct: 226 GQVISDDIEWPEGDEA-------------------LPAD--AQDLISRLLRQNPLERLGT 264

Query: 311 TEAL---QHPYISGL 322
             A    QH +  GL
Sbjct: 265 GGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.5 bits (209), Expect = 9e-19
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA-LKD 96
           +G+G YG+V ++ +  T  ++AIK+I       +  L    E+ L  ++KH N++  L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIVQYLGS 73

Query: 97  VMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH---CKYFVFQLLRGLKYLHSAN 153
                    F +     ++    L  +++S      D+     ++  Q+L GLKYLH   
Sbjct: 74  DSENGFFKIFME-----QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 154 ILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN-- 210
           I+HRD+K  N+LVN     +KI DFG ++   G       +  T  Y APE++   D   
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI---DKGP 185

Query: 211 --YGTSIDVWSVGCIFAEILGRKPIF 234
             YG   D+WS+GC   E+   KP F
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 88/305 (28%), Positives = 129/305 (42%), Gaps = 68/305 (22%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR--TLRELVLLRHIKHDNVI 92
           +  IG GA G V   I+R T    A+K I   + N  D +R    RE+ +LR + H NV+
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVV 135

Query: 93  ALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
              D  M  H     ++ ++ E MD       H  I   Q L++        Q+L G+ Y
Sbjct: 136 KCHD--MFDHN---GEIQVLLEFMDGGSLEGTH--IADEQFLAD-----VARQILSGIAY 183

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LH  +I+HRD+KP NLL+N+  ++KI DFG++R            V T  Y +PE +   
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTD 243

Query: 209 DNYGT----SIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD------ 257
            N+G     + D+WS+G    E  LGR   FP              FG  ++ D      
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR---FP--------------FGVGRQGDWASLMC 286

Query: 258 -LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
            +     P+A       P             A       +   L  EP+KR +  + LQH
Sbjct: 287 AICMSQPPEA-------P-----------ATASREFRHFISCCLQREPAKRWSAMQLLQH 328

Query: 317 PYISG 321
           P+I  
Sbjct: 329 PFILR 333

Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           +  ++ IG G++G V  + +   +E VAIKK++   +   +  +  ++E+  L+ ++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 91  VIALKDVMMPTHRISFKDVYLVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            I  +   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 77  TIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L++    +K+ DFG A        F    V T ++ APE++L 
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILA 185

Query: 208 CD--NYGTSIDVWSVGCIFAEILGRKP 232
            D   Y   +DVWS+G    E+  RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 84.8 bits (209), Expect = 1e-18
 Identities = 68/289 (23%), Positives = 135/289 (46%), Gaps = 36/289 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++I+  T ++VAIK++N   + +      + E++++R  K+ N
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L +LH
Sbjct: 78  IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE++     
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKA 191

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L LI +  GT +      + NP+     
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPE------LQNPE----- 239

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  +R +  E LQHP++
Sbjct: 240 ---------RLSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 41/292 (14%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I  +G GA+G V  + N+ET    A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 10  IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 67

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
            D     + +     +     +D  + ++    + L+    +    Q L  L YLH   I
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    DVWS+G    E+   +P  P  E LN +++++ +                     
Sbjct: 185 YDYKADVWSLGITLIEMAQIEP--PHHE-LNPMRVLLKI--------------------A 221

Query: 271 KSLP--YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           KS P   ++ +  SS +        D L+K L      R T T+ LQHP+++
Sbjct: 222 KSEPPTLAQPSRWSSEFK-------DFLKKCLEKNVDARWTTTQLLQHPFVT 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.4 bits (208), Expect = 2e-18
 Identities = 66/289 (22%), Positives = 135/289 (46%), Gaps = 36/289 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKA 192

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 240

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  KR +  E LQH ++
Sbjct: 241 ---------KLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 38/217 (17%)

Query: 35  IKPIGRGAYGVV---CSSINRE-TNEKVAIKKIN--------NVFENRIDALRTLRELVL 82
           IK +G G +G V         + T E+VA+K +N        + FE  I+ LRTL     
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL----- 63

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF 140
                H+N++  K V       S + +  YL    +   L    +    ++      F  
Sbjct: 64  ----DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSS 116

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV----- 195
           Q+ +G+ YL S   +HRDL   N+LV +   +KI DFGLA+    ++ +   Y V     
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY---YYVKEPGE 173

Query: 196 --TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR 230
               WY APE L        S DVWS G    E+   
Sbjct: 174 SPIFWY-APECLRTSKFSSAS-DVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 83.6 bits (206), Expect = 5e-18
 Identities = 79/318 (24%), Positives = 145/318 (45%), Gaps = 51/318 (16%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G+G +G V     + + +  A+K +   V   + +   TL E  +L++ +H  + +L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
           K       R+ F     V E ++  +L   +   +  S D  +++  +++  L YLHS  
Sbjct: 61  KYSFQTKDRLCF-----VMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGR 174

Query: 214 SIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           ++D W +G +  E++ GR P +      NQ            E   E I        ++ 
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LMED 211

Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISG-----L 322
           + + R     +L   A      LL  +L+ +P+KR+        E ++H + +G     +
Sbjct: 212 IKFPR-----TLSADAK----SLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262

Query: 323 YDPQCNPPAQVPLSLDID 340
           YD +  PP +  ++ + D
Sbjct: 263 YDKKLVPPFKPQVTSETD 280

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 67/290 (23%), Positives = 127/290 (43%), Gaps = 37/290 (12%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I  +G GA+G V  + N+ET    A K I    E  ++    + E+ +L    H  ++ L
Sbjct: 17  IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--MVEIEILATCNHPYIVKL 74

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                   ++     +     +D  + ++    + L+    +    Q+L  L+YLHS  I
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC----CDN 210
           +HRDLK GN+L+  + D+K+ DFG++  +    Q    ++ T ++ APE+++C       
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    D+WS+G    E+   +P  P  E LN +++++ +     +++   +  P      
Sbjct: 192 YDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKI----AKSEPPTLSQPS----- 239

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                           +      D L+  L   P  R +  + L+HP++S
Sbjct: 240 ----------------KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)

Query: 33  VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRHIKHDNV 91
             I+ +GRGAYGVV    +  T   +A+K+I     ++ +  R L +L + +R +     
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYT 62

Query: 92  IALKDVMMPTHRISFK--DVYLVYELMDTDLH----QIIKSSQSLSNDHCKYFVFQLLRG 145
           +     +       F+  DV++  E+MDT L     ++     ++  D        +++ 
Sbjct: 63  VTFYGAL-------FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115

Query: 146 LKYLHSA-NILHRDLKPGNLLVNANCDLKICDFG--------LARTSR-GNEQFMTEYVV 195
           L+YLHS  +++HRD+KP N+L+N N  +K+CDFG        +A+T   G + +M     
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYM----- 170

Query: 196 TRWYRAPELL---LCCDNYGTSIDVWSVGCIFAEI-LGRKP 232
                APE +   L    Y    DVWS+G    E+  GR P
Sbjct: 171 -----APERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 86/325 (26%), Positives = 135/325 (41%), Gaps = 56/325 (17%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  ++    GA G   + I+ +T E V IK              T  E  +LR I H ++
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG--------GTATEAHILRAINHPSI 145

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ--LLRGLKYL 149
           I LK           K   L+     TDL+  + + ++++   C     +  +LR ++YL
Sbjct: 146 IQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNIAI--CDILAIERSVLRAIQYL 198

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY--------RA 201
           H   I+HRD+K  N+ +N   D+ + DFG A        F  +    ++Y         A
Sbjct: 199 HENRIIHRDIKAENIFINHPGDVCLGDFGAA-------CFPVDINANKYYGWAGTIATNA 251

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFP------GTECLNQLKLIISVFGTQQ 254
           PE LL  D YG ++D+WS G +  E+      +F         +   Q+KLII   GT  
Sbjct: 252 PE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310

Query: 255 EADLEFIDNPKA---RRFIKSL------PYSRGTHISSLYPQADPLALD-LLQKMLVFEP 304
               EF  + +A     +I         P SR    ++LY    P+ L+ L+ KML F+ 
Sbjct: 311 N---EFPIDAQANLDEIYIGLAKKSSRKPGSRPLW-TNLYEL--PIDLEYLICKMLAFDA 364

Query: 305 SKRITVTEALQHPYISGLYDPQCNP 329
             R +    L       + DP  NP
Sbjct: 365 HHRPSAEALLDFAAFQDIPDPYPNP 389

Length = 391

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 84/328 (25%), Positives = 139/328 (42%), Gaps = 54/328 (16%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVF-ENRIDALRTLRELVLLRHIKHDNVIALKD 96
           IG+G++G V     R+T    A+K I      +R +   TL E  +L  +    ++ LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 97  VMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   SF+    +YLV   ++  +L   ++          +++  +LL  L+ LH  
Sbjct: 60  -------FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF 112

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           N+++RDLKP N+L++    + +CDFGL + +  ++     +  T  Y APELLL    Y 
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYT 171

Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
            ++D W++G +  E+L   P F         + I+      QE  L F D          
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL------QEP-LRFPDG--------- 215

Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ---HPYISG-----LYD 324
                           D  A DLL  +L  +P++R+    A +   HP+ S      L  
Sbjct: 216 ---------------FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLM 260

Query: 325 PQCNPPAQVPLSLDID-ENIGEQMIRQM 351
               PP +  +S  ID  N  E+  R+ 
Sbjct: 261 KGIQPPFKPAVSSAIDTSNFDEEFTREK 288

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 78/320 (24%), Positives = 142/320 (44%), Gaps = 55/320 (17%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G+G +G V     + T +  A+K +   V   + +   TL E  +L++ +H  + AL
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
           K       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS +
Sbjct: 61  KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN-YG 212
           +++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   DN YG
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE--DNDYG 173

Query: 213 TSIDVWSVGCIFAEIL-GRKPIFPGT-ECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
            ++D W +G +  E++ GR P +    E L +L L+  +                  RF 
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------RFP 215

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISG---- 321
           ++L                P A  LL  +L  +P +R+        E ++H + +     
Sbjct: 216 RTL---------------SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260

Query: 322 -LYDPQCNPPAQVPLSLDID 340
            +   +  PP +  ++ + D
Sbjct: 261 DVVQKKLEPPFKPQVTSETD 280

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 67/285 (23%), Positives = 125/285 (43%), Gaps = 60/285 (21%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IK +G G +G V    +R +    A+K +             + E++ L+  +H  V   
Sbjct: 6   IKTVGTGTFGRVHLVRDRISEHYYALKVMA------------IPEVIRLKQEQH--VHNE 51

Query: 95  KDVMMP-THRI------SFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLL 143
           K V+   +H        +  D   +Y LM+     +L   +++S   SN    ++  +++
Sbjct: 52  KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
             L+YLHS  I++RDLKP N+L++    +K+ DFG A+  R     +     T  Y APE
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG---TPEYLAPE 168

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++     +  ++D W++G +  E+L   P F             + FG  ++     ++ 
Sbjct: 169 VIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDD----------NPFGIYEKILAGKLEF 217

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI 308
           P+              H+       D  A DL++K+LV + ++R+
Sbjct: 218 PR--------------HL-------DLYAKDLIKKLLVVDRTRRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 59/211 (27%), Positives = 111/211 (52%), Gaps = 25/211 (11%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKI-----NNVFENRIDALRTLRELVLLRHIKHDN 90
           K +GRGA+G V    + +T  ++A+K++     +      ++AL    E+ LL++++HD 
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC--EIQLLKNLRHDR 65

Query: 91  VI----ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           ++     L+D   P  +   K    V  +    +   +K+  +L+ +  + +  Q+L+G+
Sbjct: 66  IVQYYGCLRD---PEEK---KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV 119

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-----TRWYRA 201
            YLHS  I+HRD+K  N+L ++  ++K+ DFG ++  R     M+   +     T ++ +
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--RIQTICMSGTGIKSVTGTPYWMS 177

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKP 232
           PE ++  + YG   DVWSV C   E+L  KP
Sbjct: 178 PE-VISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 4   DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLH 58

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K ++ +  +        +L
Sbjct: 59  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 113

Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           RGL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 171

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 172 ERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 11/203 (5%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + AL
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
           K       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS +
Sbjct: 61  KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN-YG 212
           +++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   DN YG
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE--DNDYG 173

Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 33/288 (11%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 4   DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLH 58

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113

Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 171

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           E L    +Y    D+WS+G    E+ +GR PI P      +L+L+   FG   E D    
Sbjct: 172 ERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELM---FGCPVEGDPAES 225

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRI 308
           +           P   G  +SS  P +  P+A+  L   +V EP  ++
Sbjct: 226 ETSPR-------PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL 266

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 90/333 (27%), Positives = 149/333 (44%), Gaps = 59/333 (17%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + AL
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA- 152
           K       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS  
Sbjct: 61  KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN-Y 211
           N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   DN Y
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE--DNDY 173

Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D W +G +  E++ GR P +      NQ            E   E I        +
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LM 210

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGL--- 322
           + + + R     +L P+A  L   LL+K    +P +R+        E +QH + +G+   
Sbjct: 211 EEIRFPR-----TLSPEAKSLLSGLLKK----DPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261

Query: 323 --YDPQCNPP--AQVPLSLD---IDENIGEQMI 348
             Y+ +  PP   QV    D    DE    QMI
Sbjct: 262 DVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMI 294

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.9 bits (194), Expect = 8e-17
 Identities = 60/210 (28%), Positives = 110/210 (52%), Gaps = 23/210 (10%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-----RIDALRTLRELVLLRHIKHDN 90
           K +G+GA+G V    + +T  ++A+K++    E+      ++AL    E+ LL+++ H+ 
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKNLLHER 65

Query: 91  VIA----LKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           ++     L+D M  T  I         E M    +   +KS  +L+ +  + +  Q+L G
Sbjct: 66  IVQYYGCLRDPMERTLSI-------FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG---NEQFMTEYVVTRWYRAP 202
           + YLHS  I+HRD+K  N+L ++  ++K+ DFG ++  +    +   M     T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKP 232
           E ++  + YG   D+WSVGC   E+L  KP
Sbjct: 179 E-VISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKHDNVIA 93
           K IGRG +  V  +        VA+KK+  +F+      R   ++E+ LL+ + H NVI 
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQII---KSSQSLSNDHC--KYFVFQLLRGLK 147
                +  + ++     +V EL D  DL ++I   K  + L  +    KYFV QL   L+
Sbjct: 67  YYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-QLCSALE 120

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           ++HS  ++HRD+KP N+ + A   +K+ D GL R            V T +Y +PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
            + Y    D+WS+GC+  E+   +  F G
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 41/92 (44%), Positives = 55/92 (59%), Gaps = 4/92 (4%)

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +++GL YL S  ILHRD+KP N+LVN    +K+CDFG++     +      YV T  Y A
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMA 161

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEI-LGRKP 232
           PE +   + YG   DVWS+G  F E+ LGR P
Sbjct: 162 PERIS-GEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 28/212 (13%)

Query: 36  KPIGRGAYGVV-CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       +     L E  +++ ++HD ++ L
Sbjct: 12  KKLGAGQFGEVWMATYNKHT--KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVF--QLLRGLKYLHS 151
             V      ++ + +Y++ E M    L   +KS +       K   F  Q+  G+ ++  
Sbjct: 67  HAV------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCD 209
            N +HRDL+  N+LV+A+   KI DFGLAR    NE    E      +W  APE +    
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 175

Query: 210 NYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           N+G+     DVWS G +  EI+  GR P +PG
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNV--FENRIDALRTLRELVLLRHI-KHDNV 91
           I+ IG+G YG V    N++     A+K ++ +   +  I+A     E  +L+ +  H NV
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA-----EYNILQSLPNHPNV 81

Query: 92  IALKDVMMPTHRISFKDVYLVYELMD----TDLHQ-IIKSSQSLSNDHCKYFVFQLLRGL 146
           +    +     ++    ++LV EL +    T+L + ++   Q L      Y ++  L GL
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           ++LH+  I+HRD+K  N+L+     +K+ DFG++             V T ++ APE++ 
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 207 CCDNYGTS----IDVWSVGCIFAEIL-GRKPIF 234
           C   Y  S     DVWS+G    E+  G  P+F
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 72/230 (31%), Positives = 104/230 (45%), Gaps = 47/230 (20%)

Query: 28  IDTKYVPI-KPIGRGAYGVVCS---SINRETNEKVAIK--KINNVFENRIDALRTLRELV 81
           ID  YV I K IG G +G VC     +  +    VAIK  K  +  + R+D    L E  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEAS 57

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVF 140
           ++    H N+I L+ V+  +     + V ++ E M+   L +       L  +  K+ V 
Sbjct: 58  IMGQFDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKF------LRENDGKFTVG 106

Query: 141 QLLR-------GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
           QL+        G+KYL   N +HRDL   N+LVN+N   K+ DFGL   SR  E     Y
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL---SRRLEDSEATY 163

Query: 194 VVT------RWYRAPELLLCCDNYG---TSIDVWSVGCIFAEIL--GRKP 232
                    RW  APE +     Y    ++ DVWS G +  E++  G +P
Sbjct: 164 TTKGGKIPIRW-TAPEAI----AYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 4e-16
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 38  IGRGAYGVV-CSSINRETNEKVAIKKI----NNVFENRIDALRTLRELVLLRHIKHDNVI 92
           +G+GAYG V C   N    + +A+K++    +NV     +  +   E+ LL+ +KH N++
Sbjct: 8   LGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSND-HCKYFVFQLLRGLKYLHS 151
                 +  + IS   +++ + +    +  I+     L     CKY   Q+L G+ YLH+
Sbjct: 66  QYLGTCLDDNTIS---IFMEF-VPGGSISSILNRFGPLPEPVFCKY-TKQILDGVAYLHN 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLAR-----TSRGNEQFMTEYVV-TRWYRAPELL 205
             ++HRD+K  N+++  N  +K+ DFG AR        G    M + +  T ++ APE++
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKP 232
                YG   D+WS+GC   E+   KP
Sbjct: 181 N-ESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V   + +    +VAIK + +    +    +   E+  L+ ++H ++I+L  V
Sbjct: 14  LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQDFQK--EVQALKRLRHKHLISLFAV 70

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANI 154
                    + VY++ ELM+   L   ++S   Q L          Q+  G+ YL   N 
Sbjct: 71  CS-----VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY---VVTRWYRAPELLLCCDNY 211
           +HRDL   N+LV  +   K+ DFGLAR  +  E         +  +W  APE      ++
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKW-TAPEAA----SH 178

Query: 212 GT---SIDVWSVGCIFAEILGRKPI-FPG 236
           GT     DVWS G +  E+     + +PG
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.8 bits (189), Expect = 6e-16
 Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 33/230 (14%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEK-VAIKKIN--------------NVFENRIDALRT 76
           Y  ++ +G GA+G V     +   +  +A+K+IN                  + +  +  
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS----SQSLS 131
           ++E      ++H N++      +   R+     Y+V +L++   L +   S     Q  +
Sbjct: 62  IKE-----QLRHPNIVRYYKTFLENDRL-----YIVMDLIEGAPLGEHFNSLKEKKQRFT 111

Query: 132 NDHCKYFVFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            +       Q++  L+YLH    I+HRDL P N+++  +  + I DFGLA+  +  E  +
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL 170

Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           T  V T  Y  PE++   + YG   DVW+ GCI  ++   +P F  T  L
Sbjct: 171 TSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 65/232 (28%), Positives = 111/232 (47%), Gaps = 41/232 (17%)

Query: 107 KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL 165
           ++++ V E ++  DL   I+S          ++  +++ GL++LHS  I++RDLK  N+L
Sbjct: 69  ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128

Query: 166 VNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
           ++ +  +KI DFG+ + +   +     +  T  Y APE+LL    Y TS+D WS G +  
Sbjct: 129 LDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLY 187

Query: 226 EIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSL 284
           E+L G+ P F G    ++ +L  S+           +DNP   R++              
Sbjct: 188 EMLIGQSP-FHG---HDEEELFQSI----------RMDNPCYPRWLTR------------ 221

Query: 285 YPQADPLALDLLQKMLVFEPSKRITVTEAL-QHPYI-----SGLYDPQCNPP 330
                  A D+L K+ V EP +R+ V   + QHP+      S L + +  PP
Sbjct: 222 ------EAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPP 267

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 29/227 (12%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRHIKHDNVIALKD 96
           IGRGA+G V   +++ +   +A+K+I +  + + +  R L +L V++R      ++    
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-EQKRLLMDLDVVMRSSDCPYIVKF-- 68

Query: 97  VMMPTHRISFK--DVYLVYELMDTDLHQIIKSSQSLSNDHCK-----YFVFQLLRGLKYL 149
                +   F+  D ++  ELMD  L +  K    +                 ++ L YL
Sbjct: 69  -----YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 150 HSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRG---NEQFMTEYVVTRWYRAPELL 205
                I+HRD+KP N+L++ N ++K+CDFG++    G   +    T     R Y APE +
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERI 179

Query: 206 L--CCDNYGTSIDVWSVGCIFAEI-LGRKPIFPG-TECLNQLKLIIS 248
                D Y    DVWS+G    E+  G+ P +P      +QL  ++ 
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFP-YPKWNSVFDQLTQVVK 225

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 74/308 (24%), Positives = 130/308 (42%), Gaps = 59/308 (19%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G GAYG V             ++K+      ++ A++ L++  L++  K       
Sbjct: 5   LKVLGTGAYGKV-----------FLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT 53

Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIK------------SSQSLSNDHCKYFVFQ 141
           +  ++   R S   V L Y    +  LH I+                + S D  +++  +
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT-EYVVTRWYR 200
           ++  L++LH   I++RD+K  N+L+++   + + DFGL++     E+  T  +  T  Y 
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           APE++     +G ++D WS+G +  E+L G  P     E             TQ E    
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE-----------RNTQSEV--- 219

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEAL 314
                 +RR +K  P               P A DLL K+L  +P KR+       +E  
Sbjct: 220 ------SRRILKCDP--------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265

Query: 315 QHPYISGL 322
           +HP+  GL
Sbjct: 266 EHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 76/295 (25%), Positives = 138/295 (46%), Gaps = 51/295 (17%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-----RIDALRTLRELVLLRHIKHDN 90
           K +G+GA+G V    + +T  ++A K++    E+      + AL    E+ LL++++H+ 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHER 65

Query: 91  VI----ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           ++     L+D            +++ Y +    +   +K+  +L+    + +  Q+L G+
Sbjct: 66  IVQYYGCLRD-----RAEKTLTIFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEGM 119

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSRGNEQFMTEYVVTRWYRAPE 203
            YLHS  I+HRD+K  N+L ++  ++K+ DFG ++   T   +   +     T ++ +PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
            ++  + YG   DVWS+GC   E+L  KP +   E +  +  I     TQ         N
Sbjct: 180 -VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI----ATQPT-------N 227

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           P+       LP    +HIS         A D L  + V E   R +  E L+HP+
Sbjct: 228 PQ-------LP----SHISE-------HARDFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLREL-VLLRHIKHDNVIA 93
           K IG+G++G V  +  +   +  A+K +   +  NR +    + E  VLL+++KH  ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           L      T ++     Y V + ++  +L   ++  +S      +++  ++   L YLHS 
Sbjct: 61  LHYSFQTTEKL-----YFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           NI++RDLKP N+L+++   + + DFGL +         T +  T  Y APE++     Y 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR-KQPYD 174

Query: 213 TSIDVWSVGCIFAEILGRKPIF 234
            ++D W +G +  E+L   P F
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 74.7 bits (183), Expect = 2e-15
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  I+ +G G YG V  + N  T E  A+K I    E   D     +E+ +++  KH N+
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 92  IALKDVMMPTHRI----------SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           +A     +   ++          S +D+Y V              +  LS     Y   +
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHV--------------TGPLSELQIAYVCRE 114

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
            L+GL YLHS   +HRD+K  N+L+  N D+K+ DFG+A            ++ T ++ A
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174

Query: 202 PELLLCCDN--YGTSIDVWSVGCIFAEILGRKP 232
           PE+     N  Y    D+W+VG    E+   +P
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 62/220 (28%), Positives = 88/220 (40%), Gaps = 45/220 (20%)

Query: 36  KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRT--LRELVLLRHIKHDN 90
           K +G G +G V   +    + K   VA+K +       I A +   LRE  ++  + H  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ---EHIAAGKKEFLREASVMAQLDHPC 57

Query: 91  VIALKDV-----MMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLR 144
           ++ L  V     +M           LV EL     L + +K  + +     K    Q+  
Sbjct: 58  IVRLIGVCKGEPLM-----------LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAM 106

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------R 197
           G+ YL S + +HRDL   N+L+      KI DFG++R           Y  T       +
Sbjct: 107 GMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS---DYYRATTAGRWPLK 163

Query: 198 WYRAPELLLCCDNYGT---SIDVWSVGCIFAEI--LGRKP 232
           WY APE    C NYG      DVWS G    E    G KP
Sbjct: 164 WY-APE----CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +G V        + KVAIK +    +  +     L E  L++ ++H  ++ L
Sbjct: 11  VKKLGAGQFGEVWMGYYN-GHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRL 66

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKY--FVFQLLRGLKYLHS 151
             V      ++ + +Y++ E M+   L   +K+ + +     K      Q+  G+ ++  
Sbjct: 67  YAV------VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCD 209
            N +HRDL+  N+LV+     KI DFGLAR    NE    E      +W  APE +    
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEAI---- 175

Query: 210 NYGT-SI--DVWSVGCIFAEIL--GRKPIFPG 236
           NYGT +I  DVWS G +  EI+  GR P +PG
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 79/325 (24%), Positives = 137/325 (42%), Gaps = 72/325 (22%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G++G V  + ++ T E  AIK               L++  +L+  +  +V   K +
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIK--------------CLKKREILKMKQVQHVAQEKSI 71

Query: 98  MMP-------THRISFKD---VYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           +M            SF+D   VY + E ++  +L   ++ +    ND  K++  +L+   
Sbjct: 72  LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +YLHS +I++RDLKP NLL++    +K+ DFG A+  +  ++  T    T  Y APE++ 
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCGTPEYLAPEVIQ 188

Query: 207 CCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
               +G ++D W++G +  E + G  P F  T      K++           L+F   P 
Sbjct: 189 -SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--------AGRLKF---PN 236

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYIS 320
                                  D  A DL++ +L  + +KR+      V +   HPY  
Sbjct: 237 ---------------------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275

Query: 321 G-----LYDPQCNPPAQVPLSLDID 340
           G     LY      P  V +    D
Sbjct: 276 GANWDKLYARYYPAPIPVRVKSPGD 300

Length = 329

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 89/361 (24%), Positives = 148/361 (40%), Gaps = 60/361 (16%)

Query: 8   PNGMKSRGKHYYTMWQTLFEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
           PN  +  G H+Y +     ++ T+   I   +G G +G V  + +R+  E  A+K + NV
Sbjct: 107 PNQSREEG-HFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV 165

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDTDLHQI 123
            +   DA   ++ +  +R     +   L    M   R    +   + +V       L   
Sbjct: 166 PKYTRDAKIEIQFMEKVRQADPADRFPL----MKIQRYFQNETGHMCIVMPKYGPCLLDW 221

Query: 124 IKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNAN------------- 169
           I      S+ H    +FQ    L Y H+  +++H DLKP N+L+  +             
Sbjct: 222 IMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281

Query: 170 ---CDLKICDFGLA---RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCI 223
              C ++ICD G     R SR      T  V TR YR+PE++L    +  S D+WS+GCI
Sbjct: 282 PDPCRVRICDLGGCCDERHSR------TAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCI 334

Query: 224 FAEILGRKPIFPGTECLNQLKLIISVFGT----------QQEADLEFIDNPKARRFIKSL 273
             E+   K ++   + L  L L+    G            +EA L +    + R      
Sbjct: 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR------ 388

Query: 274 PYSRGTHISSLYPQ-------ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
           P +   H++ +           D L  DL+  +L ++  KR+   +   HPY+   Y P+
Sbjct: 389 PCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY-PE 447

Query: 327 C 327
           C
Sbjct: 448 C 448

Length = 467

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 73.7 bits (182), Expect = 5e-15
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 15/162 (9%)

Query: 117 DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKIC 175
           D DL  ++K    LS    K  + QL+  L  LH  NI+H D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 176 DFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFP 235
           D+GL +   G        +    Y +PE +    NY  S D W+VG +  E+L  K  F 
Sbjct: 153 DYGLCK-IIGTPSCYDGTLD---YFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFK 207

Query: 236 GT--ECLNQLKLIISVFGTQQEADLEFI--DNPKARRFIKSL 273
               E L+     +     +Q+  L FI   +  A  F++S+
Sbjct: 208 EDEDEELD-----LESLLKRQQKKLPFIKNVSKNANDFVQSM 244

Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 6e-15
 Identities = 79/304 (25%), Positives = 127/304 (41%), Gaps = 69/304 (22%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G YG V   ++R T   +A+K+I   + E++ + +  + EL +L       ++    
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQI--IMELDILHKAVSPYIVDFYG 66

Query: 97  VMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                       VY+  E MD      L+    +++ +  D  +   + +++GLK+L   
Sbjct: 67  AFFIE-----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 153 -NILHRDLKPGNLLVNANCDLKICDFG--------LARTSRGNEQFMTEYVVTRWYRAPE 203
            NI+HRD+KP N+LVN N  +K+CDFG        LA+T+ G + +M          APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYM----------APE 171

Query: 204 LLLCCD-----NYGTSIDVWSVGCIFAEI-LGRKPIFPGT--ECLNQLKLIISVFGTQQE 255
            +          Y    DVWS+G    E+ LGR P  P T      QL  I         
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI--------- 222

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
                +D          LP                 A D + K L   P++R T  + L+
Sbjct: 223 -----VDGDPPT-----LP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261

Query: 316 HPYI 319
           HP++
Sbjct: 262 HPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 49/293 (16%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G+G++G V  +  + T+E  A+K +     + ++ ++   T + ++ L   KH  + 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLT 59

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
            L        R+ F     V E ++  DL   I+ S        +++  +++ GL++LH 
Sbjct: 60  QLHSCFQTKDRLFF-----VMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+L+++   +KI DFG+ +         + +  T  Y APE+L     Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS-YQPY 173

Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDNPKARRFI 270
           G ++D W++G +  E+L  +  F G                  E +L + I   + R   
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEG----------------DDEDELFQSILEDEVR--- 214

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA-----LQHPY 318
               Y R              A  +L+  L   P KR+            HP+
Sbjct: 215 ----YPRWLSKE---------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 22/214 (10%)

Query: 35  IKPIGRGAYG-VVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIKHDN 90
           I+ +G G++G V+ ++   E    VAIK+      + + ++D + + R++  L +I H  
Sbjct: 35  IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI--LNYINHPF 92

Query: 91  VIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
            + L          SFKD   +YLV E ++  +    ++ ++   ND   ++  Q++   
Sbjct: 93  CVNLYG--------SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +YL S NI++RDLKP NLL++ +  +K+ DFG A+     +        T  Y APE+LL
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILL 201

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
               +G + D W++G    EIL   P F   E L
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 32/215 (14%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++    Q ++     Y   Q+   ++YL   N 
Sbjct: 71  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT---------RWYRAPELL 205
           +HRDL   N LV  N  +K+ DFGL+R        MT    T         +W  APE  
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSR-------LMTGDTYTAHAGAKFPIKW-TAPE-S 176

Query: 206 LCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           L  + +    DVW+ G +  EI   G  P +PG +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGID 210

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 70/230 (30%), Positives = 99/230 (43%), Gaps = 44/230 (19%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
            + +G G +G V       T  KVA+K +       +     L+E  +++ ++HD ++ L
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTT-KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKY--------FVFQLLR 144
             V      I     Y+V E M        K S    L +   K            Q+  
Sbjct: 67  YAVCSEEEPI-----YIVTEYM-------SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRA 201
           G+ YL S N +HRDL   N+LV  N   KI DFGLAR    +E   T     ++   + A
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTA 172

Query: 202 PELLLCCDNYGT-SI--DVWSVGCIFAEIL--GRKPIFPG---TECLNQL 243
           PE      NYG  +I  DVWS G +  EI+  GR P +PG    E L Q+
Sbjct: 173 PEAA----NYGRFTIKSDVWSFGILLTEIVTYGRVP-YPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 38  IGRGAYGVVCSS--INRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IG+G +G V     I+ +  +   A+K +N + +   +  + L+E ++++   H NV++L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-EVEQFLKEGIIMKDFSHPNVLSL 61

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCK---YFVFQLLRGLKYLHS 151
             + +P+       V L Y +   DL   I+S     N   K    F  Q+ +G++YL S
Sbjct: 62  LGICLPSEGSPL--VVLPY-MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS 116

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL------- 204
              +HRDL   N +++ +  +K+ DFGLAR     + +  EY     +   +L       
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR-----DIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 205 -LLCCDNYGTSIDVWSVGCIFAEILGR 230
             L    + T  DVWS G +  E++ R
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNV--FENRIDALRTLRELVLLRHIK-HDNV 91
           I+ IG+G YG V   +N++   K A+K ++ +   +  I+A     E  +L+ +  H NV
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-----EYNILKALSDHPNV 77

Query: 92  IALKDVMMPTHRISFKDVYLVYELMD----TDLHQ-IIKSSQSLSNDHCKYFVFQLLRGL 146
           +    +       +   ++LV EL +    TDL +  +K  + +      Y + + L GL
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           ++LH    +HRD+K  N+L+     +K+ DFG++             V T ++ APE++ 
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 207 CCD----NYGTSIDVWSVGCIFAEI 227
           C       Y    DVWS+G    E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 15/205 (7%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLREL-VLLRHIKHDNVIA 93
           K IG+G++G V  + ++   +  A+K +       + +    + E  VLL+++KH  ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L          SF+    +Y ++D     +L   ++  +S      +++  ++   L YL
Sbjct: 61  L--------HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYL 112

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS NI++RDLKP N+L+++   + + DFGL +    + +  + +  T  Y APE+L    
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIF 234
            Y  ++D W +G +  E+L   P F
Sbjct: 173 -YDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 19/200 (9%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG+G +G V     R   +KVA+K + +       A   L E  ++  ++H N++ L  V
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDD-STAAQAF--LAEASVMTTLRHPNLVQLLGV 68

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
           ++         +Y+V E M    L   ++S     ++      F   +  G++YL   N 
Sbjct: 69  VLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRDL   N+LV+ +   K+ DFGLA+ +   +   +  +  +W  APE L     + T 
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKW-TAPEALR-EKKFSTK 179

Query: 215 IDVWSVGCIFAEI--LGRKP 232
            DVWS G +  EI   GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 36/287 (12%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I+ IG G YG V  + N  T E  AIK I    E   D     +E+++++  KH N++A 
Sbjct: 14  IQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
               +   ++     ++  E      L  I   +  LS     Y   + L+GL YLHS  
Sbjct: 72  FGSYLRRDKL-----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC--CDNY 211
            +HRD+K  N+L+  N  +K+ DFG++            ++ T ++ APE+        Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
               D+W+VG    E+   +P       +  L L+                 PK +  +K
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK----------SNFQPPKLKDKMK 236

Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
              +S   H               ++  L   P KR T  + LQHP+
Sbjct: 237 ---WSNSFH-------------HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 47/295 (15%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I  +G G  G V    +  T   +A KK+ ++        + LREL ++   +   +++ 
Sbjct: 10  ISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68

Query: 95  KDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
                    ++  ++ +  E MD   L +I K    +  +        ++ GL YL++ +
Sbjct: 69  YGAF-----LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 154 -ILHRDLKPGNLLVNANCDLKICDFG--------LARTSRGNEQFMTEYVVTRWYRAPEL 204
            I+HRD+KP N+LVN+   +K+CDFG        +A T          +V T  Y +PE 
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT----------FVGTSTYMSPER 173

Query: 205 LLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +     Y    DVWS+G    E+ LG+ P        +     + +    Q    + +  
Sbjct: 174 IQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQE 228

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           P  R     LP       SS +P       D +   L+ +P++R T  +    P 
Sbjct: 229 PPPR-----LP-------SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 14/201 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G VC+   R T +  A KK+     + R      L E  +L  +    V++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 65

Query: 97  VMMPTHRISFKDVY-LVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                +    KD   LV  LM   D   H     +     +   ++  ++  GL+ LH  
Sbjct: 66  ----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++    ++I D GLA      E      V T  Y APE++   + Y 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR-VGTVGYMAPEVVK-NERYT 179

Query: 213 TSIDVWSVGCIFAE-ILGRKP 232
            S D W +GC+  E I G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 74/312 (23%), Positives = 134/312 (42%), Gaps = 54/312 (17%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G VC+   + T +  A KK++   + R+   R   ++ L      + V +   V
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLD---KKRLK-KRKGEQMALNEKKILEKVSSRFIV 56

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
            +     +  D+ LV  LM+  DL   I +            ++  Q++ GL++LH   I
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RDLKP N+L++ + +++I D GLA   +G ++ +     T  Y APE+L   + Y  S
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRAGTPGYMAPEVLQ-GEVYDFS 174

Query: 215 IDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
           +D +++GC ++  I GR P                          E ++  + +R    +
Sbjct: 175 VDWFALGCTLYEMIAGRSPF---------------------RQRKEKVEKEELKRRTLEM 213

Query: 274 PYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRI-----TVTEALQHPYI-------- 319
                      YP    P A DL + +L  +P KR+     +  E  +HP          
Sbjct: 214 AVE--------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265

Query: 320 -SGLYDPQCNPP 330
            +G+ +P   P 
Sbjct: 266 EAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 35/213 (16%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +GVV     R     VAIK I    E  +     + E  ++  + H N++ L
Sbjct: 9   LKELGSGQFGVVHLGKWR-GKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQL 64

Query: 95  KDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSN-----DHCKYFVFQLLRGLKY 148
             V         + +++V E M    L   ++  +         D C      +   ++Y
Sbjct: 65  YGVC-----TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEY 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRA 201
           L S   +HRDL   N LV  +  +K+ DFGLAR       TS    +F       +W   
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-----PVKW-AP 169

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
           PE+      + +  DVWS G +  E+   G+ P
Sbjct: 170 PEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 66/239 (27%), Positives = 98/239 (41%), Gaps = 57/239 (23%)

Query: 36  KPIGRGAYGVVCSS-----INRETNEKVAIKKINNVFENRI--DALRTLRELVLLRHI-K 87
           KP+G GA+G V  +      N      VA+K +    ++    D    + E+ +++ I K
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 74

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYEL-----------------MDTDLHQIIKSSQSL 130
           H N+I L  V      +     Y+V E                              ++L
Sbjct: 75  HKNIINLLGVCTQEGPL-----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------- 181
           +      F +Q+ RG+++L S   +HRDL   N+LV  +  +KI DFGLAR         
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189

Query: 182 -TSRGNEQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
            T+ G        +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG
Sbjct: 190 KTTNGR-------LPVKWM-APEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 69/310 (22%), Positives = 134/310 (43%), Gaps = 64/310 (20%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIA 93
           ++ +G GAYG V             ++K+      ++ A++ L++  +++  K  ++   
Sbjct: 5   LRVLGTGAYGKV-----------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT 53

Query: 94  LKDVMMPTHRISFKDVYLVYELM-DTDLHQIIK------------SSQSLSNDHCKYFVF 140
            + V+    R  F  V L Y    DT LH I+               +  +    + ++ 
Sbjct: 54  ERQVLEAVRRCPFL-VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWY 199
           +++  L +LH   I++RD+K  N+L+++   + + DFGL++      E+    +  T  Y
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 200 RAPELLLC-CDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQ-QEA 256
            APE++      +  ++D WS+G +  E+L G  P               +V G Q  ++
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--------------FTVDGEQNSQS 218

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRI---TVTE 312
           ++       +RR +KS P          +P+     A D +QK+L  +P KR+      E
Sbjct: 219 EI-------SRRILKSKP---------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262

Query: 313 ALQHPYISGL 322
              HP+  G+
Sbjct: 263 IKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 12/207 (5%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ +G G YG V    + +T +  AIK + +V E+  + ++ L   +L ++  H N+   
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIK-LEINMLKKYSHHRNIATY 78

Query: 95  KDVMMPTHRISFKD-VYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
               +        D ++LV E       TDL +  K + +L  D   Y   ++LRGL +L
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHL 137

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H+  ++HRD+K  N+L+  N ++K+ DFG++            ++ T ++ APE++ C +
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 210 N----YGTSIDVWSVGCIFAEILGRKP 232
           N    Y    D+WS+G    E+    P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVF------ENRIDALRTLRELVLLRHIKHD 89
           K IG+G++G V  +  +      A+K +          +N I A R     VLL+++KH 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN----VLLKNLKHP 56

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            ++ L          SF+    +Y ++D     +L   ++  +       +++  ++   
Sbjct: 57  FLVGL--------HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           + YLHS NI++RDLKP N+L+++   + + DFGL +     E+  + +  T  Y APE+L
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
              + Y  ++D W +G +  E+L   P F
Sbjct: 169 R-KEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 55/298 (18%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           K +G+G++G V  +  + TNE  AIK  K + V E+  D   T+ E       +    +A
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD-DVECTMVE-------RRVLALA 52

Query: 94  LKDVMMPTHRISFK---DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
            +   +     +F+    ++ V E ++  DL   I+SS        +++  +++ GL++L
Sbjct: 53  WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   I++RDLK  N+L++ +  +KI DFG+ + +   E   + +  T  Y APE+L    
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK-GQ 171

Query: 210 NYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADL-EFI--DNPK 265
            Y  S+D WS G +  E+L G+ P                 F  + E +L + I  D P 
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP-----------------FHGEDEDELFDSILNDRPH 214

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL-QHPYISGL 322
             R+I                     A D L K+   +P+KR+ V   + QHP+  G+
Sbjct: 215 FPRWISK------------------EAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 35  IKPIGRGAYGVV--CSSINR--ETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
           I+ +G G +G V  C        T E+VA+K +      N I  L+  +E+ +LR++ H+
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHE 66

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSN--DHCKYFVFQLLRGL 146
           N++  K +         K   L+ E + +  L + +  +++  N     KY V Q+ +G+
Sbjct: 67  NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV-QICKGM 122

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------WY 199
            YL S   +HRDL   N+LV +   +KI DFGL +    ++++   Y V         WY
Sbjct: 123 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY---YTVKDDLDSPVFWY 179

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
            APE L+    Y  S DVWS G    E+L
Sbjct: 180 -APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 67/293 (22%), Positives = 128/293 (43%), Gaps = 39/293 (13%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ +G G YG V    + +T +  AIK ++   +   +  + +   +L ++  H N+   
Sbjct: 11  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN--MLKKYSHHRNIATY 68

Query: 95  KDVMMPTHRISFKD-VYLVYELMDT-DLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLH 150
               +  +     D ++LV E      +  +IK+++  +L  +   Y   ++LRGL +LH
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
              ++HRD+K  N+L+  N ++K+ DFG++            ++ T ++ APE++ C +N
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188

Query: 211 ----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
               Y    D+WS+G    E+    P       +  L LI                NP  
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--------------NPAP 234

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           R  +KS  +S+                  ++  LV   S+R T  + ++HP+I
Sbjct: 235 R--LKSKKWSKKFQ-------------SFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 27/211 (12%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           IG+G +G V   + +  N +VA+K  +     + +    + L+E  +L+   H N++ L 
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKLI 58

Query: 96  DVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            V +    I     Y+V EL+     L  + K    L+             G++YL S N
Sbjct: 59  GVCVQKQPI-----YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---QFMTEYVVTRWYRAPELLLCCDN 210
            +HRDL   N LV  N  LKI DFG++R   G         + +  +W  APE L    N
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEAL----N 168

Query: 211 YG---TSIDVWSVGCIFAEI--LGRKPIFPG 236
           YG   +  DVWS G +  E   LG  P +PG
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTP-YPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 81/327 (24%), Positives = 135/327 (41%), Gaps = 46/327 (14%)

Query: 27  EIDTKYVPIKPIGRGAYG--VVCSSINRETNEKVAIKKINNVFENRIDALRTL------- 77
           E    +  I  +  GA+G   +C+ +   T E  A + +N+  + +    R +       
Sbjct: 145 EFLAHFRVIDDLPAGAFGKIFICA-LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG 203

Query: 78  --------RELVLLRHIKHDNVIALKDVMMP---THRISFKDVYLVYELM-DTDLHQIIK 125
                    E++ L  + H+N++ +++++     T+ I+ K  + +Y  M D       K
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW--K 261

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SR 184
               L     +  + QLL  ++Y+H   ++HRD+K  N+ +N +  + + DFG A    +
Sbjct: 262 DRPLLK--QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRK--PIFPGTECLNQ 242
             E F   +V T    +PE +L  D Y    D+WS G I  ++L     PI  G      
Sbjct: 320 EREAFDYGWVGTVATNSPE-ILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG--KP 376

Query: 243 LKLIISVFGTQQEADLEFIDNP-KARRFIKSLPYSRGTH-----ISSLYPQAD---PLAL 293
            K ++ +  +    D EF D P K   +I S       H     I +L   AD   PL  
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV- 435

Query: 294 DLLQKMLVFEPSKRITVTEALQHPYIS 320
               KML F+   R    E L  P  S
Sbjct: 436 ----KMLTFDWHLRPGAAELLALPLFS 458

Length = 501

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 10/199 (5%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENR---IDALRTLRELVLLRHIKHDNVIAL 94
           IGRG+Y  V     ++T    A+K +     N    ID ++T +  V  +   H  ++ L
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKH-VFEQASNHPFLVGL 61

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                   R+ F    ++  +   DL   ++  + L  +H +++  ++   L YLH   I
Sbjct: 62  HSCFQTESRLFF----VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   ++YG S
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-GEDYGFS 176

Query: 215 IDVWSVGCIFAEIL-GRKP 232
           +D W++G +  E++ GR P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 11/203 (5%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G+G++G V  +  + T+E  AIK +     + ++ +D   T + ++ L   KH  + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLT 59

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           AL        R+ F     V E ++  DL   I+ S+       +++  ++   L +LH 
Sbjct: 60  ALHCCFQTKDRLFF-----VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             +++RDLK  N+L++A    K+ DFG+ +    N    T +  T  Y APE+L   + Y
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-Y 173

Query: 212 GTSIDVWSVGCIFAEILGRKPIF 234
           G S+D W++G +  E++  +P F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 53/199 (26%), Positives = 100/199 (50%), Gaps = 10/199 (5%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G VC+   + T +  A KK++   + R+   ++  ++ LL     + V +   V
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLD---KKRLKK-KSGEKMALLEKEILEKVNSPFIV 56

Query: 98  MMPTHRISFKDVYLVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
            +     S   + LV  LM   D   H      + L  +   ++  Q+  G+ +LHS +I
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RD+KP N+L++   + ++ D GLA   +  +  +T+   T  Y APE+L   + Y   
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRAGTNGYMAPEILK-EEPYSYP 174

Query: 215 IDVWSVGC-IFAEILGRKP 232
           +D +++GC I+  + GR P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 81/344 (23%), Positives = 132/344 (38%), Gaps = 103/344 (29%)

Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
            IK IGRGA+G V     ++T    A+KK              LR+  +L   +  +V A
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKK--------------LRKSEMLEKEQVAHVRA 50

Query: 94  LKDVMMPTHR-------ISFKD---VYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
            +D++             SF+D   +YL+ E L   D+  ++    + + +  ++++ + 
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET 110

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL----------------------- 179
           +  +  +H    +HRD+KP NLL++A   +K+ DFGL                       
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 180 --------------ARTSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIF 224
                         A T + N + +    V T  Y APE+ L    Y    D WS+G I 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIM 229

Query: 225 AEILGRKPIF----PGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTH 280
            E+L   P F    P        K+I                N K     ++L +     
Sbjct: 230 YEMLVGYPPFCSDNPQETY---RKII----------------NWK-----ETLQFPDEVP 265

Query: 281 ISSLYPQADPLALDLLQKMLVFEPSKRI---TVTEALQHPYISG 321
           +S       P A DL+++ L  E  +R+    V E   HP+  G
Sbjct: 266 LS-------PEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFFKG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 16/236 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G VC+   R T +  A K++     + R      L E  +L  +    V+ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-- 65

Query: 97  VMMPTHRISFKDVY-LVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                +    KD   LV  +M   D   H     +     +   ++  ++L GL+ LH  
Sbjct: 66  ----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLA-RTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
           N ++RDLKP N+L++    ++I D GLA +   G  + +   V T  Y APE +L    Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPE-VLNNQRY 178

Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             S D W +GC+  E++ G+ P     E + + ++   V  T++    +F +  K+
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 31/210 (14%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG +G V S   R  N  VA+K         + A + L+E  +L+   H N++ L  V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 61

Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR-------GLKYLH 150
                 I     Y+V EL+             L  +  +  V +L++       G++YL 
Sbjct: 62  CTQKQPI-----YIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEYLE 111

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT---EYVVTRWYRAPELLLC 207
           S + +HRDL   N LV     LKI DFG++R         T   + +  +W  APE L  
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL-- 168

Query: 208 CDNYG---TSIDVWSVGCIFAEI--LGRKP 232
             NYG   +  DVWS G +  E   LG  P
Sbjct: 169 --NYGRYSSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 78/326 (23%), Positives = 137/326 (42%), Gaps = 65/326 (19%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG +G V     + T +              I A++ +++ VLL           +D+
Sbjct: 9   VGRGHFGEVQVVREKATGD--------------IYAMKVMKKSVLLAQETVSFFEEERDI 54

Query: 98  M-------MPTHRISFKD---VYLVYELM-DTDLHQII-KSSQSLSNDHCKYFVFQLLRG 145
           +       +P  + +F+D   +YLV E     DL  ++ +       D  ++++ +L+  
Sbjct: 55  LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFG-LARTSRGNEQFMTEYVVTRWYRAPEL 204
           +  +H    +HRD+KP N+L++    +K+ DFG  AR +          V T  Y APE+
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 205 LLCCDN-----YGTSIDVWSVGCIFAE-ILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           L   +      YG   D WS+G I  E I GR P   GT       ++        +  L
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------NFQRFL 228

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
           +F ++PK               +SS +       LDL+Q +L     +R+       HP+
Sbjct: 229 KFPEDPK---------------VSSDF-------LDLIQSLLC-GQKERLGYEGLCCHPF 265

Query: 319 ISGL--YDPQCNPPAQVPLSLDIDEN 342
            S +   + + + P  VP +L  D++
Sbjct: 266 FSKIDWNNIRNSLPPFVP-TLKSDDD 290

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)

Query: 36  KPIGRGAYGVVCSSINRETNEK---VAIKKINNVF--ENRIDALRTLRELVLLRHIKHDN 90
           K IG G +G V   I +    K   VAIK +   +  + R D    L E  ++    H N
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHN 67

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL---LRG-- 145
           +I L+ V+       FK   ++ E M+          + L +   ++  +QL   LRG  
Sbjct: 68  IIRLEGVVT-----KFKPAMIITEYMENG-----ALDKYLRDHDGEFSSYQLVGMLRGIA 117

Query: 146 --LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------R 197
             +KYL   N +HRDL   N+LVN+N + K+ DFGL+R    + +    Y  +      R
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE--GTYTTSGGKIPIR 175

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           W  APE  +    + ++ DVWS G +  E++  G +P
Sbjct: 176 W-TAPE-AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 53/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVF---ENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG+Y  V     ++ ++  A+K +       +  ID ++T +  V  +   +  ++ L
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKH-VFEQASSNPFLVGL 61

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
                 T R+     +LV E ++  DL   ++  + L  +H +++  ++   L +LH   
Sbjct: 62  HSCFQTTSRL-----FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L++A+  +K+ D+G+ +   G     + +  T  Y APE+L   + YG 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR-GEEYGF 175

Query: 214 SIDVWSVGCIFAEIL-GRKP 232
           S+D W++G +  E++ GR P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 73/231 (31%), Positives = 105/231 (45%), Gaps = 48/231 (20%)

Query: 28  IDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLRELV 81
           ID   + I K IG G +G VCS   +   ++   VAIK  K     + R D    L E  
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD---FLSEAS 57

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYF-VF 140
           ++    H N+I L+ V+  +     K V +V E M+        S  +    H   F V 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENG------SLDAFLRKHDGQFTVI 106

Query: 141 QL---LRG----LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TS 183
           QL   LRG    +KYL     +HRDL   N+LVN+N   K+ DFGL+R          T+
Sbjct: 107 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166

Query: 184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           RG +      +  RW  APE  +    + ++ DVWS G +  E++  G +P
Sbjct: 167 RGGK------IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 27/209 (12%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +GVV     R    KVAIK IN   E  +     + E  ++  + H  ++ L
Sbjct: 9   MKELGSGQFGVVHLGKWR-AQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 95  KDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
             V         K +Y+V E M+    L+ + +    LS D        +  G++YL   
Sbjct: 65  YGVC-----TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELL 205
           + +HRDL   N LV++   +K+ DFG+ R       TS    +F       +W   PE+ 
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-----PVKW-SPPEVF 173

Query: 206 LCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                Y +  DVWS G +  E+   G+ P
Sbjct: 174 N-FSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 80/336 (23%), Positives = 151/336 (44%), Gaps = 65/336 (19%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IK IGRGA+G V + +  +  E++   KI N +E    A     E    R  +  NV+  
Sbjct: 6   IKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRA-----ETACFR--EERNVLVN 57

Query: 95  KDVM-MPTHRISFKDVYLVYELMD----TDLHQII-KSSQSLSNDHCKYFVFQLLRGLKY 148
            D   + T   +F+D   +Y +MD     DL  ++ K    L  D  ++++ +++  +  
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +H  + +HRD+KP N+L++ N  +++ DFG  L     G  Q  +  V T  Y +PE+L 
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAVGTPDYISPEILQ 176

Query: 207 CCDN----YGTSIDVWSVG-CIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
             ++    YG   D WS+G C++  + G  P +  +        ++  +G         I
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGK--------I 220

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI---TVTEALQHPY 318
            N + R       +   +HI+ +  +A     DL+Q+ L+    +R+    + +  +H +
Sbjct: 221 MNHEER-------FQFPSHITDVSEEAK----DLIQR-LICSRERRLGQNGIEDFKKHAF 268

Query: 319 ISGL-----------YDPQCNPPAQVPLSLDIDENI 343
             G+           Y P  + P+    + D+D+++
Sbjct: 269 FEGIDWENIRNLEAPYIPDVSSPSDTS-NFDVDDDV 303

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +G V       +  KVA+K +       +     L E  L++ ++HD ++ L
Sbjct: 11  VKKLGAGQFGEVWMGYYNNST-KVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRL 66

Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKYLHS 151
             V+     I     Y++ E M    L   +KS +       K   F  Q+  G+ Y+  
Sbjct: 67  YAVVTKEEPI-----YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCD 209
            N +HRDL+  N+LV+ +   KI DFGLAR    NE    E      +W  APE +    
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 176

Query: 210 NYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           N+G+     DVWS G +  EI+  G+ P +PG
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIP-YPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 12/200 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVF---ENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG+Y  V     ++T    A+K I       +  ID ++T +  V      H  ++ L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKH-VFETASNHPFLVGL 61

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
                   R+     + V E +   DL   ++  + L  +H +++  ++   L +LH   
Sbjct: 62  HSCFQTESRL-----FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L++A   +K+ D+G+ +         + +  T  Y APE+L   ++YG 
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR-GEDYGF 175

Query: 214 SIDVWSVGCIFAEIL-GRKP 232
           S+D W++G +  E++ GR P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G +G V       T +KVA+K I    +  + A   L E  ++  + H N++ L  V
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANI 154
           ++         +Y+V ELM   +L   +++     +S      F   +  G++YL S  +
Sbjct: 68  IL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           +HRDL   N+LV+ +   K+ DFGLAR  S G +      +  +W  APE L     + +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKW-TAPEALK-HKKFSS 176

Query: 214 SIDVWSVGCIFAEIL--GRKPIFPG------TECLNQ 242
             DVWS G +  E+   GR P +P        EC+ +
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAP-YPKMSLKEVKECVEK 212

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 72/294 (24%), Positives = 133/294 (45%), Gaps = 49/294 (16%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDN 90
           +  ++ IG+G++G V   I+  T + VAIK I+    E+ I+ ++  +E+ +L       
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63

Query: 91  VIA-----LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           V       LKD  +          +++ E +       +     L        + ++L+G
Sbjct: 64  VTKYYGSYLKDTKL----------WIIMEYLGGGSALDLLEPGPLDETQIATILREILKG 113

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L YLHS   +HRD+K  N+L++ + ++K+ DFG+A      +     +V T ++ APE++
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
                Y +  D+WS+G    E+   +P  P +E L+ +K++  +              PK
Sbjct: 174 K-QSAYDSKADIWSLGITAIELAKGEP--PHSE-LHPMKVLFLI--------------PK 215

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                 + P   G +       + PL  + ++  L  EPS R T  E L+H +I
Sbjct: 216 -----NNPPTLEGNY-------SKPLK-EFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 65/255 (25%), Positives = 117/255 (45%), Gaps = 25/255 (9%)

Query: 35  IKPIGRGAYGVVC---SSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHD 89
           +K +G+G YG V         +T +  A+K  K   +  N+ D   T  E  +L  +KH 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 90  NVIALKDVMMPTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            ++ L        ++     YL+ E L   +L   ++       D   +++ ++   L++
Sbjct: 61  FIVDLIYAFQTGGKL-----YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLKP N+L++A   +K+ DFGL + S         +  T  Y APE+L+  
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPG------TECLNQLKLIISVFGTQQEADLEFID 262
             +G ++D WS+G +  ++L   P F         + + + KL +  + T +  DL    
Sbjct: 176 -GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL---- 230

Query: 263 NPKARRFIKSLPYSR 277
               ++ +K  P SR
Sbjct: 231 ---LKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 23/220 (10%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IK +G G +G V        N KVA+K +       +     L E  +++ ++HD ++ L
Sbjct: 11  IKKLGNGQFGEVWMGT-WNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQL 66

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHS 151
             V      +S + +Y+V E M    L   +K    ++L   +      Q+  G+ Y+  
Sbjct: 67  YAV------VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCD 209
            N +HRDL+  N+LV      KI DFGLAR    NE    +      +W  APE  L   
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YG 178

Query: 210 NYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
            +    DVWS G +  E++  GR P +PG    E L Q++
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP-YPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 31/210 (14%)

Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           I+ +G+G +G V  C    +   T E VA+KK+ +     +      RE+ +L+ ++HDN
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSLQHDN 66

Query: 91  VIALKDVMMPTHRISFKDV--YLVY-ELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRG 145
           ++  K V     R + + V  YL Y  L D     + K  + L  DH K  ++  Q+ +G
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRD----YLQKHRERL--DHRKLLLYASQICKG 120

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------W 198
           ++YL S   +HRDL   N+LV +   +KI DFGL +    ++++   Y V         W
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY---YKVREPGESPIFW 177

Query: 199 YRAPELLLCCDN-YGTSIDVWSVGCIFAEI 227
           Y APE L   ++ +  + DVWS G +  E+
Sbjct: 178 Y-APESL--TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 49/202 (24%), Positives = 100/202 (49%), Gaps = 9/202 (4%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINN--VFENRIDALRTLRELVLLRHIKHDNVIA 93
           K IG+G++G V  + ++   +  A+K +    + + + +        VLL+++KH  ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           L        ++     Y V + ++  +L   ++  +       +++  ++   L YLHS 
Sbjct: 61  LHFSFQTADKL-----YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           NI++RDLKP N+L+++   + + DFGL + +  +    + +  T  Y APE+L     Y 
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-KQPYD 174

Query: 213 TSIDVWSVGCIFAEILGRKPIF 234
            ++D W +G +  E+L   P F
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIK--KINNVFEN-RIDALRT-LRELVLLRHIKHDNVIA 93
           +GRG +G V  +  ++T E  AIK  K  ++     +++L    R        +H  ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 94  LKDVMMPTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           L              V  V E     DL   I +    S     ++   ++ GL+YLH  
Sbjct: 67  LFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHEN 120

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLK  NLL++    +KI DFGL +   G     + +  T  + APE+L    +Y 
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT-ETSYT 179

Query: 213 TSIDVWSVGC-IFAEILGRKPIFPG 236
            ++D W +G  I+  ++G  P FPG
Sbjct: 180 RAVDWWGLGVLIYEMLVGESP-FPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)

Query: 35  IKPIGRGAYG---VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +K +G+G++G   +V      +  +  A+K +        D +RT  E  +L  + H  +
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 92  IALKDVMMPTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L        +     +YL+ + L   DL   +      + +  K+++ +L   L +LH
Sbjct: 61  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLKP N+L++    +K+ DFGL++ S  +E+    +  T  Y APE++    N
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV----N 171

Query: 211 ---YGTSIDVWSVGCIFAEIL 228
              +  S D WS G +  E+L
Sbjct: 172 RRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 14  LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 70  ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 181

Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 27/206 (13%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G +G+V      E   KVAIK I     +  D    + E  ++  + H  ++ L  V
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEED---FIEEAQVMMKLSHPKLVQLYGV 67

Query: 98  MMPTHRISFKDVYLVYELMDTD-LHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANIL 155
                 I      LV+E M+   L   +++ +   S +        +  G+ YL S+N++
Sbjct: 68  CTERSPI-----CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122

Query: 156 HRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLCC 208
           HRDL   N LV  N  +K+ DFG+ R       TS    +F       +W  +PE +   
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-----PVKW-SSPE-VFSF 175

Query: 209 DNYGTSIDVWSVGCIFAEIL--GRKP 232
             Y +  DVWS G +  E+   G+ P
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 42/229 (18%)

Query: 28  IDTKYVPIKP-IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLL 83
           ID   V I+  IG G +G VC    +   ++   VAIK + + +  +      L E  ++
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIM 59

Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-----DTDLHQIIKSSQSLSNDHCKYF 138
               H N+I L+ V+  +     + V ++ E M     D+ L Q         ND  ++ 
Sbjct: 60  GQFDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQ---------NDG-QFT 104

Query: 139 VFQL---LRG----LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT 191
           V QL   LRG    +KYL   N +HRDL   N+LVN+N   K+ DFGL+R    +    T
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164

Query: 192 EY------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                   +  RW  APE  +    + ++ DVWS G +  E++  G +P
Sbjct: 165 YTSSLGGKIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 11/206 (5%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRE-LVLLRHIKHDNV 91
           +  +G+G++G V  +  + T+E  AIK  K + + ++  D   T+ E  VL    K   +
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFL 63

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
             L        R+     Y V E ++  DL   I+        H  ++  ++  GL +LH
Sbjct: 64  TQLHSCFQTMDRL-----YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLK  N++++A   +KI DFG+ + +    +    +  T  Y APE++     
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA-YQP 177

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPG 236
           YG S+D W+ G +  E+L  +P F G
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 37/236 (15%)

Query: 34  PIKPIGRGAYGVV----CSSINRETNEK-VAIKKINNVFENRI-DALRTLRELVLLRHIK 87
            I  +GRG +G V       I  E  E  V +K +    +  +    R  REL + R + 
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR--RELDMFRKLS 66

Query: 88  HDNVIALKDVMMPT--HRISFKDVYLVYELMD-TDLHQIIKSSQS---------LSNDHC 135
           H NV+ L  +      H       Y++ E  D  DL Q +++++S         LS    
Sbjct: 67  HKNVVRLLGLCREAEPH-------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEY 193
                Q+  G+ +L +A  +HRDL   N LV++  ++K+    L++    +E  +     
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLNQLK 244
           +  RW  APE +   D++ T  DVWS G +  E+   G  P F G    E LN+L+
Sbjct: 180 IPLRWL-APEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELP-FYGLSDEEVLNRLQ 232

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHDNVI 92
           IK IGRGA+G V    ++ + +  A+K ++  FE   R D+     E  ++ H   + ++
Sbjct: 48  IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSEWIV 106

Query: 93  ALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            L          +F+D   +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 107 QL--------HYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPELLLC 207
           +HS   +HRD+KP N+L++ +  LK+ DFG       N     +  V T  Y +PE+L  
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 208 --CDN-YGTSIDVWSVGCIFAEIL-GRKPIF 234
              D  YG   D WSVG    E+L G  P +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 51/234 (21%)

Query: 35  IKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKH 88
            + +G GA+G V              E VA+K +     N  DA +   RE  LL + +H
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQH 67

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS--------------SQSLSND 133
           +N++    V             +V+E M+  DL++ ++S                 L+  
Sbjct: 68  ENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 134 HCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
                  Q+  G+ YL S + +HRDL   N LV  +  +KI DFG++R     + + T+Y
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDY 177

Query: 194 --------VVTRWYRAPELLLCCDNYG---TSIDVWSVGCIFAEIL--GRKPIF 234
                   +  RW   PE ++    Y    T  DVWS G +  EI   G++P +
Sbjct: 178 YRVGGHTMLPIRWM-PPESIM----YRKFTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID   +  ++ +G G +G V   +   T   VA+K +       +D    L E  +++
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMK 56

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKY-----FV 139
            ++H  +I L  V      I     Y+V ELM      +++  Q  +    K        
Sbjct: 57  KLRHPKLIQLYAVCTLEEPI-----YIVTELMKYG--SLLEYLQGGAGRALKLPQLIDMA 109

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
            Q+  G+ YL + N +HRDL   N+LV  N   K+ DFGLAR  + +     E      +
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPG 236
           W  APE  L  + +    DVWS G +  EI+  GR P +PG
Sbjct: 170 W-TAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 77/312 (24%), Positives = 123/312 (39%), Gaps = 88/312 (28%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKI---NNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IG G  G V     ++T   +A+K++    N  EN+    R L +L              
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK----RILMDL-------------- 64

Query: 95  KDVMMPTHR-----------ISFKDVYLVYELMDTDLHQIIKSSQSLSND----HCKYFV 139
            DV++ +H            I+  DV++  ELM T L +++K  Q    +         +
Sbjct: 65  -DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAI 123

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL--------ART-SRGNEQFM 190
            + L  LK  H   ++HRD+KP N+L++A+ ++K+CDFG+        A+T S G   +M
Sbjct: 124 VKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM 181

Query: 191 TEYVVTRWYRAPELL---LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII 247
                     APE +        Y    DVWS+G    E+      FP   C  + +++ 
Sbjct: 182 ----------APERIDPPDPNPKYDIRADVWSLGISLVELA--TGQFPYKNCKTEFEVLT 229

Query: 248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
            +            + P       SLP + G           P     +   L  +  KR
Sbjct: 230 KILQ----------EEP------PSLPPNEGF---------SPDFCSFVDLCLTKDHRKR 264

Query: 308 ITVTEALQHPYI 319
               E LQHP+I
Sbjct: 265 PKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 39/290 (13%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDN 90
           +  ++ IG+G++G V   I+  T E VAIK I+    E+ I+ ++  +E+ +L       
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +       +   ++     +++ E +       +     L   +    + ++L+GL YLH
Sbjct: 64  ITRYYGSYLKGTKL-----WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S   +HRD+K  N+L++   D+K+ DFG+A      +     +V T ++ APE++     
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-QSA 177

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    D+WS+G    E+   +P       +  L LI                 PK     
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-----------------PK----- 215

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            S P   G +       + P   + ++  L  +P  R T  E L+H +I+
Sbjct: 216 NSPPTLEGQY-------SKPFK-EFVEACLNKDPRFRPTAKELLKHKFIT 257

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 12/203 (5%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G V +   R T +  A KK+N    + R      + E  +L  +    +++L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 97  VMMPTHRISFKDVYLVYELMDT-DL----HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                   +  D+ LV  +M+  DL    + + + +         ++  Q++ GL++LH 
Sbjct: 61  AFQ-----TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLKP N+L++ + +++I D GLA   +  +     Y  T  + APELL   + Y
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ-GEEY 174

Query: 212 GTSIDVWSVGCIFAEILGRKPIF 234
             S+D +++G    E++  +  F
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  ++H N++ L
Sbjct: 11  LQTIGKGEFGDVMLGDYRGN--KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL +
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + +   +   T  +  +W  APE L     +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 176

Query: 212 GTSIDVWSVGCIFAEI--LGRKP 232
            T  DVWS G +  EI   GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 23/219 (10%)

Query: 38  IGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +G+G +G V  +  +  +   +KVA+K +     +  D    LRE   ++   H NVI L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 95  KDVMM---PTHRISFKDVYLVYELMDTDLHQIIKSSQ------SLSNDHCKYFVFQLLRG 145
             V +      R+    V L + +   DLH  +  S+      +L       F+  +  G
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPF-MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---QFMTEYVVTRWYRAP 202
           ++YL S N +HRDL   N ++N N  + + DFGL++     +   Q     +  +W    
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185

Query: 203 ELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
            L    DN Y T  DVW+ G    EI   G+ P + G E
Sbjct: 186 SL---ADNVYTTHSDVWAFGVTMWEIMTRGQTP-YAGVE 220

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 36  KPIGRGAYGVVCSS-----INRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K +      +  +AL  + EL ++ H+  H
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL--MSELKIMSHLGNH 98

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +N++ L         I     Y  Y  +   L +  K    L+ +    F +Q+ +G+ +
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAF 156

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSRGNEQFMTEYVVTRWYR 200
           L S N +HRDL   N+L+     +KICDFGLAR          +GN       +  +W  
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN-----ARLPVKWM- 210

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 211 APESIFNC-VYTFESDVWSYGILLWEIFSLGSNP-YPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 34/219 (15%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K IGRGA+G            +VA+ K+ N   +++ A++ L +  +L+  +       
Sbjct: 6   LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 51

Query: 95  KDVM-------MPTHRISFKDVYLVYELMD----TDLHQII-KSSQSLSNDHCKYFVFQL 142
           +DV+       + T   +F+D   +Y +MD     DL  ++ K    L  D  ++++ ++
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSRGNEQFMTEYVVTRWYR 200
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG  L     G  Q  +  V T  Y 
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 170

Query: 201 APELLLCCDN----YGTSIDVWSVG-CIFAEILGRKPIF 234
           +PE+L   ++    YG   D WS+G C++  + G  P +
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 34/243 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  IK IG G +G V    ++ T E    K I+       +  + + E+ ++R +KH N
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVF----QLLRG 145
           ++   D  +     + + +Y++ E  D  DL + I+    +     ++ +     QLL  
Sbjct: 74  IVRYIDRFLNK---ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 146 LKYLHS-------ANILHRDLKPGNLLV-----------------NANCDLKICDFGLAR 181
           L Y H+         +LHRDLKP N+ +                 N     KI DFGL++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 182 TSRGNEQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
            + G E      V T +Y +PELLL    +Y    D+W++GCI  E+   K  F      
Sbjct: 191 -NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 241 NQL 243
           +QL
Sbjct: 250 SQL 252

Length = 1021

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 20/219 (9%)

Query: 36  KPIGRGAYGVVCSS-INRETN-EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           K +G G +G V    +N++ +  KVA+K +      R +    L E V ++   H NV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 94  LKDV-MMPTHRISFKDVYLVYELMD-TDLHQIIKSS------QSLSNDHCKYFVFQLLRG 145
           L  V +       +    ++   M   DLH  +  S      Q L       F+  +  G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV---TRWYRAP 202
           ++YL S + +HRDL   N ++N N ++ + DFGL++     + +    +     +W    
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184

Query: 203 ELLLCCDN-YGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
            L    D  Y T  DVWS G    EI   G+ P +PG E
Sbjct: 185 SL---ADRVYTTKSDVWSFGVTMWEIATRGQTP-YPGVE 219

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 71/311 (22%), Positives = 138/311 (44%), Gaps = 64/311 (20%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G GAYG V             ++K++     ++ A++ L++  +++  K       
Sbjct: 5   LKVLGTGAYGKV-----------FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT 53

Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIK------------SSQSLSNDHCKYFVFQ 141
           +  ++   R S   V L Y    DT LH I+               +       + +  +
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-QFMTEYVVTRWYR 200
           ++  L++LH   I++RD+K  N+L+++N  + + DFGL++    +E +    +  T  Y 
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ-EAD 257
           AP+++   D  +  ++D WS+G +  E+L G  P               +V G +  +A+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP--------------FTVDGEKNSQAE 219

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRI-----TVT 311
           +       +RR +KS P          YPQ    LA D++Q++L+ +P KR+        
Sbjct: 220 I-------SRRILKSEP---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDAD 263

Query: 312 EALQHPYISGL 322
           E  +HP+   +
Sbjct: 264 EIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 45/128 (35%), Positives = 72/128 (56%), Gaps = 12/128 (9%)

Query: 117 DTDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
           D+++  ++    S+ L+      F +Q+ RG+++L S N +HRDL   N+L+     +KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278

Query: 175 CDFGLARTSRGNEQFMTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--L 228
           CDFGLAR    +  ++++   ++  +W  APE +   DN Y T  DVWS G +  EI  L
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIF--DNLYTTLSDVWSYGILLWEIFSL 335

Query: 229 GRKPIFPG 236
           G  P +PG
Sbjct: 336 GGTP-YPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 34/214 (15%)

Query: 38  IGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G V   ++  +T   VA+K         +  ++ L E  +L+   H N++ L  
Sbjct: 3   LGKGNFGEVFKGTLKDKT--PVAVKTCKEDLPQELK-IKFLSEARILKQYDHPNIVKLIG 59

Query: 97  VMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
           V   T R   + +Y+V EL+     L  + K    L       F      G+ YL S N 
Sbjct: 60  VC--TQR---QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL   N LV  N  LKI DFG++R       +S G +Q     +  +W  APE L  
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIKW-TAPEAL-- 166

Query: 208 CDNYG---TSIDVWSVGCIFAEI--LGRKPIFPG 236
             NYG   +  DVWS G +  E   LG  P +PG
Sbjct: 167 --NYGRYSSESDVWSYGILLWETFSLGVCP-YPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 9/207 (4%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           +  +G+G++G V  +  + T+E  AIK  K + V ++       + + VL    K   + 
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
            L        R+     Y V E ++  DL   I+        H  ++  ++  GL +LHS
Sbjct: 65  QLHSCFQTMDRL-----YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+++++   +KI DFG+ + +  +      +  T  Y APE ++    Y
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIAYQPY 178

Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTE 238
           G S+D W+ G +  E+L  +  F G +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 85/352 (24%), Positives = 147/352 (41%), Gaps = 84/352 (23%)

Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVI 92
            IK +G+G  G V     + T +  A+K ++      R    R L E  +L  + H    
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP--- 61

Query: 93  ALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQS---LSNDHCKYFVFQLLRG 145
                 +PT   SF+    +  +MD     +L ++++  Q    LS +  +++  ++L  
Sbjct: 62  -----FLPTLYASFQTETYLCLVMDYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLA 115

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA----------------RTSRGN--- 186
           L+YLH   I++RDLKP N+L++ +  + + DF L+                 + R +   
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 187 ---EQFMTE-------YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFP 235
              E F  E       +V T  Y APE ++  D +G+++D W++G +  E+L G  P F 
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTP-FK 233

Query: 236 GTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDL 295
           G             F    + ++ F  +P                +SS        A DL
Sbjct: 234 G-------SNRDETFSNILKKEVTFPGSPP---------------VSS-------SARDL 264

Query: 296 LQKMLVFEPSKRI----TVTEALQHPYISGLYDP--QCNPPAQVPLSLDIDE 341
           ++K+LV +PSKR+       E  QHP+  G+     +   P  +P   D  +
Sbjct: 265 IRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDDGID 316

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 45/227 (19%)

Query: 35  IKPIGRGAYGVV-------CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           I+ +G+G++G+V             ET  +VAIK   N   +  + +  L E  +++   
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPET--RVAIK-TVNENASMRERIEFLNEASVMKEFN 67

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKY--------- 137
             +V+ L  V+            +V ELM   DL   ++S +  + ++            
Sbjct: 68  CHHVVRLLGVVSTGQP-----TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 138 -FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY--- 193
               ++  G+ YL +   +HRDL   N +V  +  +KI DFG+ R     + + T+Y   
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRK 177

Query: 194 -----VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKP 232
                +  RW  APE L   D  + T  DVWS G +  E+  L  +P
Sbjct: 178 GGKGLLPVRWM-APESLK--DGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 70/270 (25%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +V IK IG GA+G VC     +TN   A+K              TLR+  +L   +  +V
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMK--------------TLRKADVLMRNQAAHV 48

Query: 92  IALKDVMMPTHR-------ISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVF 140
            A +D++             SF+D   +Y +MD     D+  ++        D  ++++ 
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA 108

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------------------- 180
           +L   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                     
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168

Query: 181 ----------------------RTSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDV 217
                                 R  R +++ +   +V T  Y APE+LL    Y    D 
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDW 227

Query: 218 WSVGCIFAEIL-GRKPIFPGTECLNQLKLI 246
           WSVG I  E+L G+ P    T    QLK+I
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKVI 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 25/162 (15%)

Query: 76  TLRELVLLRHIKHDNVIALKDV---------MMPTHRISFKDVYLVYELMDTDLHQIIKS 126
           ++ E  LLR + H  V+AL DV         ++P +R      YL   L    L Q+   
Sbjct: 207 SVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLY-TYLGARLRPLGLAQVTAV 265

Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
           ++            QLL  + Y+H   I+HRD+K  N+LVN   D+ + DFG A  +RG+
Sbjct: 266 AR------------QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 187 EQFMTEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAE 226
                 Y +  T    APE +L  D Y  S+D+WS G +  E
Sbjct: 314 WSTPFHYGIAGTVDTNAPE-VLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 45/130 (34%), Positives = 67/130 (51%), Gaps = 7/130 (5%)

Query: 108 DVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           D YL      T    +I  S +LS      F +Q+  G+++L S N +HRDL   N+L+ 
Sbjct: 214 DQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273

Query: 168 ANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF 224
               +KICDFGLAR    +  ++++   ++  +W  APE +   + Y T  DVWS G + 
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIF-NNLYTTLSDVWSFGILL 331

Query: 225 AEI--LGRKP 232
            EI  LG  P
Sbjct: 332 WEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 7e-12
 Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 36/217 (16%)

Query: 35  IKPIGRGAYGVVCSSINRETNEK----VAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           IK +G GA+G V   +     EK    VAIK +     +       L E  ++  + H +
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPH 70

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-------TDLHQIIKSSQSLSNDHCKYFVFQLL 143
           V+ L  + +         V L+ +LM           H+    SQ L N     +  Q+ 
Sbjct: 71  VVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN-----WCVQIA 119

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------R 197
           +G+ YL    ++HRDL   N+LV     +KI DFGLA+    +E    EY         +
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE---KEYHAEGGKVPIK 176

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           W  A E +L    Y    DVWS G    E++  G KP
Sbjct: 177 WM-ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 14/201 (6%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G VC+   R T +  A KK+     + R      L E  +L  +    V++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-- 65

Query: 97  VMMPTHRISFKDVY-LVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                +    KD   LV  LM   D   H               ++  ++  GL+ LH  
Sbjct: 66  ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ +  ++I D GLA       Q +   V T  Y APE++   + Y 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVK-NERYT 179

Query: 213 TSIDVWSVGCIFAEIL-GRKP 232
            S D W++GC+  E++ G+ P
Sbjct: 180 FSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 44/119 (36%), Positives = 59/119 (49%), Gaps = 16/119 (13%)

Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
           S  L  D    F  Q+ +G+ +L S N +HRD+   N+L+      KICDFGLAR    +
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 187 EQFMTEYVV-------TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
               + YVV        +W  APE +  C  Y    DVWS G +  EI  LG+ P +PG
Sbjct: 266 ----SNYVVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 49/150 (32%), Positives = 70/150 (46%), Gaps = 23/150 (15%)

Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
           D        S+ D  +  E+++ D         +L  +    F +Q+ +G+ +L S N +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCI 236

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-------TRWYRAPELLLCC 208
           HRDL   N+L+      KICDFGLAR  R +    + YVV        +W  APE +  C
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRND----SNYVVKGNARLPVKWM-APESIFNC 291

Query: 209 DNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             Y    DVWS G +  EI  LG  P +PG
Sbjct: 292 -VYTFESDVWSYGILLWEIFSLGSSP-YPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  KVAIK +       +     L+E  +++ ++HD ++ L  V
Sbjct: 14  LGQGCFGEVWMGTWNGTT-KVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 70  ------VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   KI DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 181

Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E++  GR P +PG    E L Q++
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP-YPGMVNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 9/202 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDN 90
           +  ++ IG+G++G V   I+  T + VAIK I+    E+ I+ ++  +E+ +L       
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           V       +   ++     +++ E +       +  +           + ++L+GL YLH
Sbjct: 64  VTKYYGSYLKGTKL-----WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S   +HRD+K  N+L++   D+K+ DFG+A      +     +V T ++ APE++     
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ-QSA 177

Query: 211 YGTSIDVWSVGCIFAEILGRKP 232
           Y +  D+WS+G    E+   +P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 22/167 (13%)

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ------- 128
           L+E+ ++  +K  N+I L  V + +  +      ++ E M+  DL+Q +   +       
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLC-----MITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 129 ----SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-S 183
               ++S     +   Q+  G+KYL S N +HRDL   N LV  N  +KI DFG++R   
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 184 RGNEQFMTEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
            G+   +    V   RW     +LL    + T+ DVW+ G    EIL
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 70/310 (22%), Positives = 128/310 (41%), Gaps = 57/310 (18%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +G+G++G V  +  +E+    A+K +     + ++ ++   T + ++ L    H  +  L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
                   R+ F     V E ++  DL   I+ S+       +++  ++   L +LH   
Sbjct: 62  YCCFQTPDRLFF-----VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L++     K+ DFG+ +    N +  + +  T  Y APE+L     YG 
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGP 175

Query: 214 SIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDNPKARRFIK 271
           S+D W++G +  E+L G  P                 F  + E DL E I N +      
Sbjct: 176 SVDWWAMGVLLYEMLCGHAP-----------------FEAENEDDLFEAILNDEV----- 213

Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE------ALQHPYISG---- 321
                    +   +   D  A+D+L+  +   P+ R+           L+HP+       
Sbjct: 214 ---------VYPTWLSQD--AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262

Query: 322 -LYDPQCNPP 330
            L   Q  PP
Sbjct: 263 KLNRRQIEPP 272

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 37/217 (17%)

Query: 36  KPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           K +G G++GVV      +S  +     V   K + + +   D    L+E  ++  + H+N
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHEN 57

Query: 91  VIALKDVMMPTHRISFKDVYLVYE------LMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           +I L  V++ TH +      +V E      L+D  L +       +S   C Y V Q+  
Sbjct: 58  LIRLYGVVL-THPLM-----MVTELAPLGSLLDR-LRKDALGHFLIST-LCDYAV-QIAN 108

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEY--VVTRWYR 200
           G++YL S   +HRDL   N+L+ ++  +KI DFGL R    NE    M E+  V   W  
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC- 167

Query: 201 APELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKP 232
           APE L       T   + DVW  G    E+   G +P
Sbjct: 168 APESL----RTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 41/107 (38%), Positives = 61/107 (57%), Gaps = 10/107 (9%)

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM---TEYV 194
           + FQ+ RG+++L S   +HRDL   N+L++ N  +KICDFGLAR    +  ++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
             +W  APE +   D  Y T  DVWS G +  EI  LG  P +PG +
Sbjct: 239 PLKWM-APESIF--DKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQ 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 39/186 (20%)

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT 196
           ++  +++ GL++LHS  I++RDLK  N++++ +  +KI DFG+ + +   +   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQE 255
             Y APE+L     Y  S+D WS G +  E+L G+ P                  G  ++
Sbjct: 160 PDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPF----------------HGDDED 202

Query: 256 ADLEFI--DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
              E I  D P   R+I     S+                D+L+K+   +P++R+ V   
Sbjct: 203 ELFESIRVDTPHYPRWI--TKESK----------------DILEKLFERDPTRRLGVVGN 244

Query: 314 LQ-HPY 318
           ++ HP+
Sbjct: 245 IRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR----TLRELVLLRHIKHDN--- 90
           IGRG +G V      +T +  A+K ++   + RI   +     L E ++L  +   +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ +        ++ F     + +LM+  DLH  +      S    +++  +++ GL+++
Sbjct: 59  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHM 113

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H+  +++RDLKP N+L++ +  ++I D GLA      +   +  V T  Y APE+L    
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGT 171

Query: 210 NYGTSIDVWSVGCIFAEIL-GRKP 232
            Y +S D +S+GC+  ++L G  P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 75/310 (24%), Positives = 119/310 (38%), Gaps = 37/310 (11%)

Query: 28  IDTKYVPIKPIGRGAYG--VVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLR 84
           +  +Y  +  +  G+ G   VC+    E  +KV +K +           +T  RE+ +L+
Sbjct: 90  VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILK 141

Query: 85  HIKHDNVIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
            I H  +I L       H   +K  V +V      DL   +  S  L  +       +LL
Sbjct: 142 TISHRAIINL------IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLL 195

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA--RTSRGNEQFMTEYVVTRWYRA 201
             L YLH   I+HRD+K  N+ ++   +  + DFG A    +  +      +  T    +
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE---CLNQLKLIISVFGTQQEADL 258
           PE LL  D Y    D+WS G +  E+  +     G +     +QL+ II      Q   L
Sbjct: 256 PE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM---QVHPL 311

Query: 259 EFIDNPKAR--------RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
           EF  N              +   PY+    I       D     L+ KML F+   R + 
Sbjct: 312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD--VEYLIAKMLTFDQEFRPSA 369

Query: 311 TEALQHPYIS 320
            + L  P  +
Sbjct: 370 QDILSLPLFT 379

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNV 91
            +  +G+G++G V  +  + T+E  AIK  K + V ++       + + VL    K   +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
             L        R+     Y V E ++  DL   I+           ++  ++  GL +LH
Sbjct: 64  TQLHSCFQTVDRL-----YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW------YRAPEL 204
              I++RDLK  N+++++   +KI DFG+ +        M + V TR       Y APE 
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH------MVDGVTTRTFCGTPDYIAPE- 171

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
           ++    YG S+D W+ G +  E+L  +P F G +
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 45/196 (22%)

Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
           L+ +    + FQ+ +G+++L S   +HRDL   N+L++ N  +KICDFGLAR    +  +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQL 243
           + +    +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +     
Sbjct: 236 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK----- 286

Query: 244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVF- 302
                            ID    RR         GT + +     D    ++ Q ML   
Sbjct: 287 -----------------IDEEFCRRL------KEGTRMRA----PDYTTPEMYQTMLDCW 319

Query: 303 --EPSKRITVTEALQH 316
             EPS+R T +E ++H
Sbjct: 320 HGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 41/105 (39%), Positives = 60/105 (57%), Gaps = 10/105 (9%)

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           + FQ+ RG+++L S   +HRDL   N+L++ N  +KICDFGLAR    +  ++ +    +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +   D  Y T  DVWS G +  EI  LG  P +PG
Sbjct: 238 PLKWM-APESIF--DKVYTTQSDVWSFGVLLWEIFSLGASP-YPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 65/270 (24%), Positives = 115/270 (42%), Gaps = 66/270 (24%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKH 88
           +V IK +G GA+G VC +   +T    A+K   K + +  N++  ++  R++  L    +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI--LAEADN 60

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           + V+ L          SF+D   +Y +MD     D+  ++        D  ++++ +L  
Sbjct: 61  EWVVRL--------YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC 112

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA------------------------ 180
            ++ +H    +HRD+KP N+L++ +  +K+ DFGL                         
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172

Query: 181 ----------------------RTSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDV 217
                                 R +R +++ +   +V T  Y APE+LL    Y    D 
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDW 231

Query: 218 WSVGCIFAEIL-GRKPIFPGTECLNQLKLI 246
           WSVG I  E+L G+ P    T    Q+K+I
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 26/207 (12%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G VC+   R T +  A KK+     + R      L E  +L  +    V++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-- 65

Query: 97  VMMPTHRISFKDVY-LVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                +    KD   LV  +M   D   H     +         ++  +L  GL+ L   
Sbjct: 66  ----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLA------RTSRGNEQFMTEYVVTRWYRAPELLL 206
            I++RDLKP N+L++    ++I D GLA       T RG        V T  Y APE++ 
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-------VGTVGYMAPEVIN 174

Query: 207 CCDNYGTSIDVWSVGCIFAEIL-GRKP 232
             + Y  S D W +GC+  E++ G+ P
Sbjct: 175 -NEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 74/274 (27%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +V IK +G GA+G VC +   +T+               + A++TLR+  +L   +  +V
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHA--------------LYAMKTLRKKDVLNRNQVAHV 48

Query: 92  IALKDVMMPTHR-------ISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVF 140
            A +D++             SF+D   +Y +MD     D+  ++   +       ++++ 
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------------------- 180
           +L   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                     
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168

Query: 181 --------------------------RTSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGT 213
                                     R ++ +++ +   +V T  Y APE+LL    Y  
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQ 227

Query: 214 SIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLI 246
             D WSVG I  E+L G+ P    T    QLK+I
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKH 88
           I+ +G G +G V        N  T E VA+K  K     +N        +E+ +L+ + H
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG---WKKEINILKTLYH 65

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYEL--MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           +N++  K           K + L+ E   + +    + K   +L+      F  Q+  G+
Sbjct: 66  ENIVKYKGCCSEQGG---KGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQICEGM 120

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------WY 199
            YLHS + +HRDL   N+L++ +  +KI DFGLA+      ++   Y V         WY
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWY 177

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGR 230
            A E L        S DVWS G    E+L  
Sbjct: 178 -AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHD 89
           Y  +K IGRGA+G V   +  ++++KV   K+ + FE   R D+     E  ++      
Sbjct: 45  YDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            V+ L          +F+D   +Y+V E M   DL  ++ S+  +     K++  +++  
Sbjct: 104 WVVQL--------FCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLA 154

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPEL 204
           L  +HS  ++HRD+KP N+L++ +  LK+ DFG             +  V T  Y +PE+
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 205 LLCCDN---YGTSIDVWSVGCIFAEIL-GRKPIF 234
           L        YG   D WSVG    E+L G  P +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 19/204 (9%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR----TLRELVLLRHIKHDN--- 90
           IGRG +G V      +T +  A+K ++   + RI   +     L E ++L  +   +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ +        ++SF     + +LM+  DLH  +      S    +++  +++ GL+++
Sbjct: 59  IVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H+  +++RDLKP N+L++ +  ++I D GLA      +   +  V T  Y APE+L    
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGV 171

Query: 210 NYGTSIDVWSVGCIFAEIL-GRKP 232
            Y +S D +S+GC+  ++L G  P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 34/192 (17%)

Query: 58  VAIKKINNVFENRIDALRT-----LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV 112
           VA+K +      R D  +T     L+E+ ++  +K+ N+I L  V      +S   + ++
Sbjct: 47  VAVKML------RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC-----VSDDPLCMI 95

Query: 113 YELMDT-DLHQIIKSSQ------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDL 159
            E M+  DL+Q +   +            S+S  +  Y   Q+  G+KYL S N +HRDL
Sbjct: 96  TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL 155

Query: 160 KPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAPELLLCCDNYGTSID 216
              N LV  +  +KI DFG++R     + +  +    +  RW     +LL    + T+ D
Sbjct: 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASD 213

Query: 217 VWSVGCIFAEIL 228
           VW+ G    E+ 
Sbjct: 214 VWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 21/198 (10%)

Query: 53  ETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV-MMPTHRISFKDV 109
            T  +VAIK  + +   E    A R  RE  L   + H N++AL D    P        +
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRA-RFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54

Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           + V+E +    L +++ +  +L        + Q+L  L   H+  I+HRDLKP N++V+ 
Sbjct: 55  FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 169 NCD---LKICDFGLARTSRGNEQFM-------TEYVVTRWYRAPELLLCCDNYGTSIDVW 218
                  K+ DFG+     G            TE + T  Y APE L        S D++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLY 173

Query: 219 SVGCIFAEILGRKPIFPG 236
           + G IF E L  + +  G
Sbjct: 174 AWGLIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 13/131 (9%)

Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV EL +   L++ ++ ++ ++  +    V Q+  G+KYL   N +HRDL   N+L+   
Sbjct: 72  LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131

Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++    +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE----CMNYYKFSSKSDVWSFGVL 187

Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 188 MWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)

Query: 36  KPIGRGAYGVVC-SSINRE--TNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDN 90
           K +G G +G V    ++++  +  KVA+K  K++    + I+    L E   ++   H N
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF--LSEAACMKDFDHPN 62

Query: 91  VIALKDV---MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLL---- 143
           V+ L  V        +I    V L + +   DLH  +  S+       +    Q L    
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPF-MKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFM 119

Query: 144 ----RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV---T 196
                G++YL + N +HRDL   N ++  +  + + DFGL++     + +    +     
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           +W  A E L   D  Y +  DVW+ G    EI   G+ P +PG E
Sbjct: 180 KWI-AIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTP-YPGVE 220

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHD 89
           Y  +K IGRGA+G V   +  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 45  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            V+ L          +F+D   +Y+V E M   DL  ++ S+  +     +++  +++  
Sbjct: 104 WVVQL--------FYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLA 154

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAP 202
           L  +HS   +HRD+KP N+L++ +  LK+ DFG     + N++ M      V T  Y +P
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISP 212

Query: 203 ELLLCCDN---YGTSIDVWSVGCIFAEIL-GRKPIF 234
           E+L        YG   D WSVG    E+L G  P +
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 67/244 (27%)

Query: 31  KYVPIKPIGRG-------AYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVL 82
           +Y  I+ IG+G       AY  VCS        +VA+KKI  ++ EN +   R LRE  +
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCS-------RRVALKKIREDLSENPLLKKRFLREAKI 55

Query: 83  LRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELM----DTDLHQIIKS---SQSLSNDH 134
              + H  +       +P + I S  D   VY  M       L  ++KS    +SLS + 
Sbjct: 56  AADLIHPGI-------VPVYSICSDGDP--VYYTMPYIEGYTLKSLLKSVWQKESLSKEL 106

Query: 135 C-KYFVFQLLR-------GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
             K  V   L         ++Y+HS  +LHRDLKP N+L+    ++ I D+G A   +  
Sbjct: 107 AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166

Query: 187 EQF---------------MT---EYVVTRWYRAPELLLCCDNYGT----SIDVWSVGCIF 224
           E+                MT   + V T  Y APE LL     G     S D++++G I 
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-----GVPASESTDIYALGVIL 221

Query: 225 AEIL 228
            ++L
Sbjct: 222 YQML 225

Length = 932

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 59/240 (24%), Positives = 111/240 (46%), Gaps = 38/240 (15%)

Query: 36  KPIGRGAYGVV----CSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           + +G GA+G V    C ++  E ++  VA+K + +  +N        RE  LL +++H++
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQHEH 68

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-------------SQSLSNDHCK 136
           ++    V      +    + +V+E M   DL++ +++                L+     
Sbjct: 69  IVKFYGVC-----VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT---EY 193
           +   Q+  G+ YL S + +HRDL   N LV  N  +KI DFG++R     + +       
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT-----ECLNQLKLI 246
           +  RW   PE ++    + T  DVWS+G +  EI   G++P +  +     EC+ Q +++
Sbjct: 184 LPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 61/246 (24%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K IGRGA+G V           V  K   +V+     A++ LR+  +L   +  ++ A 
Sbjct: 6   LKVIGRGAFGEV---------RLVQKKDTGHVY-----AMKILRKADMLEKEQVGHIRAE 51

Query: 95  KDVMMPTHRI-------SFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLL 143
           +D+++    +       SF+D   +YL+ E +   D+  ++    +L+ +  ++++ + +
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------RTS------------- 183
             +  +H    +HRD+KP NLL+++   +K+ DFGL        RT              
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 184 ---------------RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
                          R   Q     V T  Y APE+ +    Y    D WS+G I  E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEML 230

Query: 229 GRKPIF 234
              P F
Sbjct: 231 IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +GVV     R   + VAIK I    E  +     + E  ++  + H+ ++ L
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN-DHCKYFVFQLLRGLKYLHSAN 153
             V      I     Y+    +   L +  K  Q     + CK     +  G+ YL S  
Sbjct: 65  YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK----DVCEGMAYLESKQ 120

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---QFMTEYVVTRWYRAPELLLCCDN 210
            +HRDL   N LV+    +K+ DFGL+R    +E      +++ V RW   PE+LL    
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RW-SPPEVLLYS-K 177

Query: 211 YGTSIDVWSVGCIFAEI--LGRKP 232
           + +  DVW+ G +  E+  LG+ P
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 55/237 (23%)

Query: 35  IKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK 87
           ++ +G GA+G V          R +   VAIK +    EN    ++    +E  L+  ++
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK---ENAEPKVQQEFRQEAELMSDLQ 66

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N++ L  V         +   +++E +   DLH+ +                    SL
Sbjct: 67  HPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
                 +   Q+  G++YL S + +HRDL   N LV     +KI DFGL+R     + + 
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR-----DIYS 176

Query: 191 TEY--------VVTRWYRAPELLLCCDNYG---TSIDVWSVGCIFAEIL--GRKPIF 234
            +Y        +  RW   PE +L    YG   T  D+WS G +  EI   G +P +
Sbjct: 177 ADYYRVQSKSLLPVRWM-PPEAIL----YGKFTTESDIWSFGVVLWEIFSYGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)

Query: 36  KPIGRGAYGVV----CSSINRETNEK--VAIKKINN-VFENRIDALRTLRELVLLRHIKH 88
           + +G GA+G V    C +++  T +K  VA+K + +     R D     RE  LL +++H
Sbjct: 11  RELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPTLAARKD---FQREAELLTNLQH 66

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIK----------------SSQSLS 131
           ++++    V           + +V+E M   DL++ ++                +   L 
Sbjct: 67  EHIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT 191
                +   Q+  G+ YL S + +HRDL   N LV AN  +KI DFG++R     + +  
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 192 ---EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT-----ECLN 241
                +  RW   PE ++    + T  DVWS G I  EI   G++P F  +     EC+ 
Sbjct: 182 GGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239

Query: 242 QLKLI 246
           Q +++
Sbjct: 240 QGRVL 244

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 42/120 (35%), Positives = 58/120 (48%), Gaps = 11/120 (9%)

Query: 125 KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR 184
            ++ +LS+    +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL   SR
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL---SR 172

Query: 185 GNEQFMTEY---VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTEC 239
           G E ++ +    +  RW     L      Y T+ DVWS G +  EI  LG  P + G  C
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 229

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 43/113 (38%), Positives = 57/113 (50%), Gaps = 10/113 (8%)

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY---VVT 196
           +Q+ RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +       +  
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
           +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 204 KWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 53/242 (21%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +K IGRGA+G V     ++T    A+K   K + + + ++  +R  R+++    ++ D  
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDIL----VEADGA 61

Query: 92  IALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
             +K         SF+D   +YL+ E +   D+  ++    +LS +  ++++ + +  + 
Sbjct: 62  WVVKMFY------SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGL---------------------------- 179
            +H    +HRD+KP NLL++A   +K+ DFGL                            
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 180 ------ARTSRGN-EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP 232
                 A T + N  Q     V T  Y APE+ +    Y    D WS+G I  E+L   P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYP 234

Query: 233 IF 234
            F
Sbjct: 235 PF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 71/252 (28%), Positives = 110/252 (43%), Gaps = 61/252 (24%)

Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G G +G V  +    I++   ++   VA+K + +   ++ D    + E+ L++ I K
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEMELMKLIGK 76

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDH------------ 134
           H N+I L  V           +Y++ E     +L + +++ +    D+            
Sbjct: 77  HKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 135 -------CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------ 181
                  C Y   Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR      
Sbjct: 132 SFKDLVSCAY---QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 182 ----TSRGNEQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIF 234
               TS G        +  +W  APE L   D  Y    DVWS G +  EI  LG  P +
Sbjct: 189 YYKKTSNGR-------LPVKWM-APEALF--DRVYTHQSDVWSFGILMWEIFTLGGSP-Y 237

Query: 235 PGTECLNQLKLI 246
           PG       KL+
Sbjct: 238 PGIPVEELFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           FEI      +K IGRGA+G V     + T +  A+K +N     + + L+   E    R 
Sbjct: 3   FEI------LKVIGRGAFGEVAVVKMKNTGQVYAMKILN-----KWEMLKR-AETACFR- 49

Query: 86  IKHDNVIALKDVMMPTH-RISFKDVYLVYELMD----TDLHQII-KSSQSLSNDHCKYFV 139
            +  +V+   D    T+   +F+D   +Y +MD     DL  ++ K    L  D  ++++
Sbjct: 50  -EERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRW 198
            +++  +  +H    +HRD+KP N+L++ N  +++ DFG       +    +   V T  
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168

Query: 199 YRAPELLLCCDN----YGTSIDVWSVG-CIFAEILGRKPIF 234
           Y +PE+L   ++    YG   D WS+G C++  + G  P +
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 19/173 (10%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKH 88
           +V +KPI RGA+G V     +  ++  A+K   K + + +N +  ++  R          
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER---------- 55

Query: 89  DNVIALKDVMMPTHRI----SFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
            + +AL       H      S  +VYLV E L+  D+  ++        +    ++ ++ 
Sbjct: 56  -DALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT 196
             L YLH   I+HRDLKP N+L++    +K+ DFGL++ +   E  M + + T
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)

Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G G +G V  +    I+++   K   VA+K + +   ++ D    + E+ +++ I K
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVSEMEMMKMIGK 76

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDH------------ 134
           H N+I L              +Y++ E     +L + +++ +    D+            
Sbjct: 77  HKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131

Query: 135 -CKYFV---FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
             K  V   +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 191 TEY---VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 192 KTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPGIPVEELFK 247

Query: 245 LI 246
           L+
Sbjct: 248 LL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 27/188 (14%)

Query: 58  VAIKKINNVFENRIDALRT--LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYEL 115
           VA+K +     +  D  R   L+E+ +L  +   N+  L  V           + ++ E 
Sbjct: 49  VAVKVLR---PDASDNAREDFLKEVKILSRLSDPNIARLLGVC-----TVDPPLCMIMEY 100

Query: 116 MDT-DLHQIIKSSQSLSNDHC-----------KYFVFQLLRGLKYLHSANILHRDLKPGN 163
           M+  DL+Q ++   + ++               Y   Q+  G++YL S N +HRDL   N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160

Query: 164 LLVNANCDLKICDFGLARTSRGNEQFMTEYVVT---RWYRAPELLLCCDNYGTSIDVWSV 220
            LV  N  +KI DFG++R    ++ +  +       RW     +LL    + T  DVW+ 
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAF 218

Query: 221 GCIFAEIL 228
           G    EIL
Sbjct: 219 GVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY---V 194
           F +Q+ RG++YL    ++HRDL   N+LV     +KI DFGL+R     + ++      +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  A E L   D+ Y T  DVWS G +  EI  LG  P +PG
Sbjct: 192 PVKWM-AIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 31/225 (13%)

Query: 26  FEIDTKYVPIKP-IGRGAYGVVCSSI-NRETNEK--VAIK--KINNVFENRIDALRTLRE 79
           +EI  + + +   IG G +G V   +     NEK  VA+K  K       R    + L+E
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR---EKFLQE 57

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII-KSSQSLSNDHCKY 137
             ++R   H +++ L  V      I+   V++V EL    +L   +  +  SL       
Sbjct: 58  AYIMRQFDHPHIVKLIGV------ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL 111

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
           + +QL   L YL S   +HRD+   N+LV++   +K+ DFGL+R    +E +        
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKL 170

Query: 196 -TRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEIL--GRKPIF 234
             +W  APE +    N+    ++ DVW  G    EIL  G KP  
Sbjct: 171 PIKWM-APESI----NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 63/242 (26%), Positives = 105/242 (43%), Gaps = 52/242 (21%)

Query: 38  IGRGAYGVV----CSSINRETNEK-VAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNV 91
           +G GA+G V    C ++  E ++  VA+K +    E+ R D     RE  LL  ++H ++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---FQREAELLTVLQHQHI 69

Query: 92  IALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQ---------------SLSNDHC 135
           +    V         + + +V+E M   DL++ ++S                  L+    
Sbjct: 70  VRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY-- 193
                Q+  G+ YL S + +HRDL   N LV     +KI DFG++R     + + T+Y  
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYR 179

Query: 194 ------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF-----PGTECL 240
                 +  RW   PE +L    + T  D+WS G +  EI   G++P +        EC+
Sbjct: 180 VGGRTMLPIRWM-PPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Query: 241 NQ 242
            Q
Sbjct: 238 TQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 28/232 (12%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEK----VAIKKINNVFENRIDALRTLRELVLLR 84
           +T++  IK +G GA+G V   +     EK    VAIK++      + +    L E  ++ 
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 64

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQL 142
            + + +V  L  + + +       V L+ +LM     L  + +   ++ + +   +  Q+
Sbjct: 65  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------VVT 196
            +G+ YL    ++HRDL   N+LV     +KI DFGLA+    +E+   EY      V  
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK---EYHAEGGKVPI 175

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPI--FPGTECLNQLK 244
           +W     +L     Y    DVWS G    E++  G KP    P +E  + L+
Sbjct: 176 KWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)

Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G G +G  V+  +I  +  +     KVA+K + +    + D    + E+ +++ I K
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 82

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHC----------- 135
           H N+I L              +Y++ E     +L + +++ +    ++C           
Sbjct: 83  HKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 136 --KYFV---FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
             K  V   +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 191 TEY---VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 198 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 253

Query: 245 LI 246
           L+
Sbjct: 254 LL 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 26/216 (12%)

Query: 36  KPIGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K IG G +G V+   +N        + K   V  +  + ++ L E    R ++H N+  L
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL--L 58

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLR-----GLKY 148
           + +   T    +    LV E     DL   ++S +            Q +      GL +
Sbjct: 59  QCLGQCTEVTPY---LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAPEL- 204
           LH  N +H DL   N L+ A+  +KI D+GL+      + ++T    +V  RW  APEL 
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELV 174

Query: 205 ------LLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
                 LL  D    S +VWS+G    E+  LG +P
Sbjct: 175 DEVHGNLLVVDQTKES-NVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRTLRELVLLR 84
           +T+   +K +G GA+G V   I     E V    AIK +N     + + +  + E +++ 
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMA 64

Query: 85  HIKHDNVIALKDVMM-PTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQ 141
            + H +++ L  V + PT       + LV +LM     L  + +   ++ +     +  Q
Sbjct: 65  SMDHPHLVRLLGVCLSPT-------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------VV 195
           + +G+ YL    ++HRDL   N+LV +   +KI DFGLAR   G+E+   EY      + 
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK---EYNADGGKMP 174

Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKP 232
            +W     + L C +Y       DVWS G    E++  G KP
Sbjct: 175 IKW-----MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 38/190 (20%)

Query: 54  TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF---KDVY 110
           TN  VA+KKIN    ++ D     +E++  R ++H N++         +  SF    ++Y
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELY 75

Query: 111 LVYELMDTDLHQIIKSSQSLSNDHCKY--------FVFQ-LLRGLKYLHSANILHRDLKP 161
           +V  LM         S + L   H           F+ + +L  L Y+HS   +HR +K 
Sbjct: 76  VVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129

Query: 162 GNLLVNANCDLKICDFGLART--SRGNEQ-----FMTEYVVTRWYRAPELLLCCDN---Y 211
            ++L++ +  + +     + +    G  Q     F    V    + +PE+L    N   Y
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ--QNLQGY 187

Query: 212 GTSIDVWSVG 221
               D++SVG
Sbjct: 188 NEKSDIYSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 35/224 (15%)

Query: 38  IGRGAYGVV----CSSINRETNE--KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +G GA+G V     + I    +   +VA+K +     ++ +    L+E  L+ +  H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL------- 143
           + L  V +       +  Y++ ELM+  DL   ++ ++          + +LL       
Sbjct: 62  VKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCD--LKICDFGLARTSRGNEQFMTE---YVV 195
           +G  YL   + +HRDL   N LV+    + D  +KI DFGLAR    ++ +  E    + 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 196 TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEIL--GRKPIFPG 236
            RW  APE LL  D  + T  DVWS G +  EIL  G++P +P 
Sbjct: 177 VRWM-APESLL--DGKFTTQSDVWSFGVLMWEILTLGQQP-YPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 30/175 (17%)

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ------- 128
           L+E+ +L  +K  N+I L  V      +    + ++ E M+  DL+Q + S         
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 129 ---SLSNDHCK---------YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD 176
              ++   HC          +   Q+  G+KYL S N +HRDL   N LV  N  +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 177 FGLARTSRGNEQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           FG++R     + +  +    +  RW  A E +L    + T+ DVW+ G    EIL
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECIL-MGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 40/119 (33%), Positives = 56/119 (47%), Gaps = 11/119 (9%)

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
           ++ +L++     F   +  G++YL     +HRDL   N+LV  N   KI DFGL   SRG
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGL---SRG 168

Query: 186 NEQFMTEY---VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTEC 239
            E ++ +    +  RW     L      Y T  DVWS G +  EI  LG  P + G  C
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTP-YCGMTC 224

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 58/258 (22%), Positives = 102/258 (39%), Gaps = 73/258 (28%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K IG+GA+G V              + +      +I A++TL +  + +  +  +V A 
Sbjct: 6   VKVIGKGAFGEV--------------RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 95  KDVMMPTHR-------ISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLL 143
           +DV+  +          SF+D   +Y +M+     DL  ++    + S D  ++++ + +
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA----------------------- 180
             ++ +H    +HRD+KP N+L++    +K+ DFGL+                       
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171

Query: 181 -----------------------RTSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSID 216
                                   T + N + M    V T  Y APE+ L    YG   D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECD 230

Query: 217 VWSVGCIFAEILGRKPIF 234
            WS+G I  E L   P F
Sbjct: 231 WWSLGAIMFECLIGWPPF 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 42/119 (35%), Positives = 58/119 (48%), Gaps = 11/119 (9%)

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
           ++ +LS+    +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL   SRG
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL---SRG 161

Query: 186 NEQFMTEY---VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTEC 239
            E ++ +    +  RW     L      Y T+ DVWS G +  EI  LG  P + G  C
Sbjct: 162 QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 217

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 13/102 (12%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART------SRGNEQFMTEYV 194
           Q+  G+ YL     +HRDL   N LV  N  +KI DFGL+R        + +E    + +
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE---NDAI 194

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
             RW   PE +   + Y T  DVW+ G +  EI   G +P +
Sbjct: 195 PIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYY 234

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 12/100 (12%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW-- 198
           Q+  G+KYL   N +HRDL   N+L+      KI DFGL++    ++ +       +W  
Sbjct: 103 QVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPL 162

Query: 199 -YRAPELLLCCDNY---GTSIDVWSVGCIFAEIL--GRKP 232
            + APE    C N+    +  DVWS G    E    G+KP
Sbjct: 163 KWYAPE----CINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 42/238 (17%)

Query: 119 DLHQIIKSSQSLSN---DHCKYFVF-QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
           DL Q IKS    +    +H    +F Q+L  + ++HS +++HRD+K  N+L+ +N  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 175 CDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP 232
            DFG ++   +  ++     +  T +Y APE+      Y    D++S+G +  E+L  K 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKR 243

Query: 233 IFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLA 292
            F G                  E   E +    A R+   LP           P   P  
Sbjct: 244 PFDG------------------ENMEEVMHKTLAGRY-DPLP-----------PSISPEM 273

Query: 293 LDLLQKMLVFEPSKRITVTEALQHP----YISGLYD-PQCNPPAQVPLSLDIDENIGE 345
            +++  +L  +P +R + ++ L  P    +ISGL +  Q  P    PL   I   I +
Sbjct: 274 QEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQ 331

Length = 496

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 30/180 (16%)

Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQ--IIKSSQS----- 129
           +E  L+  + H N++ L  V+        + V +++E ++  DLH+  I++S  S     
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 130 --------LSNDHCKYF--VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
                    S DH  +     Q+  G++YL S   +H+DL   N+L+     +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 180 ARTSRGNEQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIF 234
           +R     + +  +    +  RW   PE ++    + +  D+WS G +  EI   G +P +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 22/40 (55%), Positives = 28/40 (70%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           Q+L GL+ LH   I+HRD+KP NLLV  +  +KI DFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 36/215 (16%)

Query: 36  KPIGRGAYG-VVCSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
             IG G +G V+    +R  ++ +V +K++        + L  L+E+   R + H NV+ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVL- 58

Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQ-----LLRGLK 147
                     I      LV E     DL   ++S++ +     +  V Q     +  GL 
Sbjct: 59  ----QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT--------RWY 199
           +LH A+ +H DL   N  + A+  +KI D+GLA      EQ+  +Y +T        RW 
Sbjct: 115 WLHQADFIHSDLALRNCQLTADLSVKIGDYGLA-----LEQYPEDYYITKDCHAVPLRWL 169

Query: 200 RAPEL-------LLCCDNYGTSIDVWSVGCIFAEI 227
            APEL       LL  D    S ++WS+G    E+
Sbjct: 170 -APELVEIRGQDLLPKDQTKKS-NIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 47/227 (20%)

Query: 36  KPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           + +G+G++G+V   I +     E   +VAIK +N     R + +  L E  +++     +
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 70

Query: 91  VIALKDVM---MPTHRISFKDVYLVYELMDT-DLHQIIKS-------SQSLSNDHCKYFV 139
           V+ L  V+    PT         ++ ELM   DL   ++S       +   +    K  +
Sbjct: 71  VVRLLGVVSQGQPT--------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 140 ---FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY--- 193
               ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y   
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRK 177

Query: 194 -----VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKP 232
                +  RW  +PE L   D  + T  DVWS G +  EI  L  +P
Sbjct: 178 GGKGLLPVRWM-SPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 13/100 (13%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------V 194
           Q+ +G+ YL    ++HRDL   N+LV +   +KI DFGLAR    +E   TEY      V
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---TEYHADGGKV 173

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
             +W     +L     +    DVWS G    E++  G KP
Sbjct: 174 PIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 32/118 (27%), Positives = 54/118 (45%), Gaps = 15/118 (12%)

Query: 124 IKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART- 182
             + Q+LS     +   Q+  G+ YLH   ++H+D+   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 183 ------SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
                   G+     E    +W  A E L+    Y ++ DVWS G +  E+  LG+ P
Sbjct: 168 FPMDYHCLGD----NENRPVKWM-ALESLV-NKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 3/99 (3%)

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTR 197
           +Q++  L  +HS  ++HRDLK  N+ +     +K+ DFG ++  +   +    + +  T 
Sbjct: 176 YQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           +Y APEL      Y    D+WS+G I  E+L     F G
Sbjct: 236 YYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 47/228 (20%)

Query: 35  IKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           ++ +G+G++G+V     R     E   +VA+K +N     R + +  L E  +++     
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH 69

Query: 90  NVIALKDVM---MPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSND-------HCKYF 138
           +V+ L  V+    PT         +V ELM   DL   ++S +  + +         +  
Sbjct: 70  HVVRLLGVVSKGQPT--------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 139 V---FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY-- 193
           +    ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y  
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYR 176

Query: 194 ------VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKP 232
                 +  RW  APE L   D  + TS D+WS G +  EI  L  +P
Sbjct: 177 KGGKGLLPVRWM-APESLK--DGVFTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 8e-06
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 30/197 (15%)

Query: 53  ETNEKVAIKKINNVFENRIDALRT-LRELVLLR-HIKHDNVIALKDVMMPTHRISFKDVY 110
           E  + VAIK + +  E     LR   +   ++R  ++H N++ L  V+     +S    Y
Sbjct: 33  EQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89

Query: 111 LVYELMDTDLHQ--IIKSSQSL--SNDHCK------------YFVFQLLRGLKYLHSANI 154
             +    +DLH+  +++S  S   S D  K            + V Q+  G+++L S ++
Sbjct: 90  CSH----SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV 145

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM---TEYVVTRWYRAPELLLCCDNY 211
           +H+DL   N+LV    ++KI D GL R     + +       +  RW  +PE ++    +
Sbjct: 146 VHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIM-YGKF 203

Query: 212 GTSIDVWSVGCIFAEIL 228
               D+WS G +  E+ 
Sbjct: 204 SIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 25/160 (15%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKK------INNVFENRIDALRTLRELVLLRHIKH 88
           +K I RGA   +   +      K  IK        +   + RI   RT RE  ++   + 
Sbjct: 1   MKLIKRGAEAEI--YLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK 58

Query: 89  DNVIALKDVMMPTHRISFKDVY---LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             V            + F D     +V E ++   L  +I S+     +  +     + +
Sbjct: 59  AGV--------NVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK 110

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR 184
               LHSA I+H DL   N++++    + + DFGLA  S+
Sbjct: 111 ----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAEFSK 145

Length = 211

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 56/241 (23%)

Query: 35  IKPIGRGAYGVV----CSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           ++ +G GA+G V        + +  E +VA+K +     +  D    L E +++    H 
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQ 69

Query: 90  NVIALKDVMMPTHRISFKDV--YLVYELMDT-DLHQIIKSSQ-------SLSNDHCKYFV 139
           N++ L  V       SF+ +  +++ ELM   DL   ++ ++       SL+     +  
Sbjct: 70  NIVRLIGV-------SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVT 196
             + +G KYL   + +HRD+   N L+         KI DFG+AR     + +   Y   
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASY--- 174

Query: 197 RWYR------------APELLLCCDNYGTS-IDVWSVGCIFAEI--LGRKPIFPGTECLN 241
             YR             PE  L  D   TS  DVWS G +  EI  LG  P +PG    N
Sbjct: 175 --YRKGGRAMLPIKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMP-YPG--RTN 227

Query: 242 Q 242
           Q
Sbjct: 228 Q 228

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 14/214 (6%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           E+D K + I + +G G +G +C    +  +++   VAI  +     ++      L E + 
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-QRRGFLAEALT 59

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           L    H N++ L+ V+   + +     Y+    +D+ L    K    L        +  L
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGL 116

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYR 200
             G+KYL     +H+ L    +LVN++   KI  F   +  +    +  M+      W  
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-A 175

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           APE +    ++ ++ DVWS G +  E++  G +P
Sbjct: 176 APEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 55/218 (25%), Positives = 80/218 (36%), Gaps = 62/218 (28%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSR-GNEQFMTEYVVTRW 198
           Q+L  L  LHS  I+HRD+KP N++ +      KI D G A   R G      E+++   
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPR 322

Query: 199 YRAPEL---------------------LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT 237
           Y APE                      +L   N     D++S G IF ++          
Sbjct: 323 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM---------- 372

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP------- 290
                L+           +D   I   +  R +K   Y        + P+A P       
Sbjct: 373 -AFPNLR-----------SDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFE 417

Query: 291 -LALD------LLQKMLVFEPSKRITVTEALQHPYISG 321
            L LD      LL+ M+ F+  +RI+   AL HPY   
Sbjct: 418 VLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455

Length = 566

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 27/159 (16%)

Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIKKI-------NNVFENRIDALRTLRELVLLRHI 86
           P   IG+GA   +      E   + A+ K        +   + R+   RT  E  LL   
Sbjct: 337 PDHLIGKGAEADI---KKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA 393

Query: 87  KHDNVIA--LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           +   V    + DV      I  +       +   DL  +++ +  L           +  
Sbjct: 394 RRAGVPTPVIYDVDPEEKTIVME------YIGGKDLKDVLEGNPELVRK--------VGE 439

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS 183
            +  LH A I+H DL   N +V  +  L + DFGL + S
Sbjct: 440 IVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYS 477

Length = 535

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 16/39 (41%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE 187
           LH A I+H DL   N++V  +  L + DFGL + S   E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIE 143

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.4 bits (92), Expect = 0.001
 Identities = 51/230 (22%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 98  MMPTHR--ISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
           M+  H+  +S   V+LV +  +   L   I    ++  +  K +  +++  L  LH   I
Sbjct: 47  MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGI 106

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           + RDL P N+L++    +++  F   R S   +    E  V   Y APE+    +    +
Sbjct: 107 VCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGE-AVENMYCAPEVGGISEE-TEA 162

Query: 215 IDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLP 274
            D WS+G I  E+L  K +                                    ++  P
Sbjct: 163 CDWWSLGAILFELLTGKTL------------------------------------VECHP 186

Query: 275 YSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRI-----TVTEALQHPY 318
               TH +   P+     A  LLQ++L F P++R+      V +   HP+
Sbjct: 187 SGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 30/133 (22%), Positives = 51/133 (38%), Gaps = 16/133 (12%)

Query: 52  RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL 111
              +E   +K   +    R       RE+ +L+ +    +   K +       S    YL
Sbjct: 18  GTKDEDYVLKINPS----REKGADREREVAILQLLARKGLPVPKVL---ASGESDGWSYL 70

Query: 112 VYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL---HRDLKPGNLLVNA 168
           + E ++       ++   +S +  +    QL   L  LH   +L   H DL PGN+LV+ 
Sbjct: 71  LMEWIE------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124

Query: 169 NCDLKICDFGLAR 181
              L I D+  A 
Sbjct: 125 GKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 37.6 bits (88), Expect = 0.004
 Identities = 12/28 (42%), Positives = 17/28 (60%)

Query: 290 PLALDLLQKMLVFEPSKRITVTEALQHP 317
           P   DL++KML  +P KR +  E L+H 
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 32/133 (24%), Positives = 57/133 (42%), Gaps = 17/133 (12%)

Query: 111 LVYELMDT-DLHQIIKSSQSLSND----HCKYFVFQLLRGLKYLHSANILHRDLKPGNLL 165
           LV+E  +  DL   +   Q    +      +    ++  G+ ++H  N LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 166 VNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAPEL-------LLCCDNYGTSI 215
           + ++  +K+ D+G+  +    +   TE    V  RW  APEL       L+  +    S 
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPS- 189

Query: 216 DVWSVGCIFAEIL 228
           +VW++G    E+ 
Sbjct: 190 NVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	364
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
smart00090	237	RIO RIO-like kinase.	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
KOG1243	690	consensus Protein kinase [General function predict	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.41
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
COG4248	637	Uncharacterized protein with protein kinase and he	99.24
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.21
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.09
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.06
PRK09902	216	hypothetical protein; Provisional	99.02
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.0
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.73
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.97
PLN02876	822	acyl-CoA dehydrogenase	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.96
KOG2270	520	consensus Serine/threonine protein kinase involved	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.92
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.84
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.8
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.69
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.6
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.56
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.51
PRK05231	319	homoserine kinase; Provisional	97.48
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.43
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.28
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.2
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.16
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.04
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.0
PLN02236	344	choline kinase	97.0
PLN02756	418	S-methyl-5-thioribose kinase	96.94
PRK12396	409	5-methylribose kinase; Reviewed	96.92
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.68
PTZ00384	383	choline kinase; Provisional	96.66
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.5
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.36
PRK10593	297	hypothetical protein; Provisional	96.28
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.1
PTZ00296	442	choline kinase; Provisional	95.91
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.64
PRK11768	325	serine/threonine protein kinase; Provisional	95.55
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.48
COG2334	331	Putative homoserine kinase type II (protein kinase	95.2
PRK06148	1013	hypothetical protein; Provisional	94.55
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.48
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.41

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-60  Score=408.33  Aligned_cols=348  Identities=57%  Similarity=0.986  Sum_probs=325.2

Q ss_pred             ceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceee
Q 017909           16 KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      +...+.+...+.+..+|...+.||.|+||.|+.|.++.+|+.||||++...........+.++|+.+|+.++|+||+.+.
T Consensus         8 ~~~~~~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~   87 (359)
T KOG0660|consen    8 YYDYEVFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLL   87 (359)
T ss_pred             ceEEEeeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEE
Confidence            56678889999999999999999999999999999999999999999998888888999999999999999999999999


Q ss_pred             eeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909           96 DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      +++..+....+..+|+|+|+|+.+|...++.++.+++..+..++.||+.||+|+|+.|++|||+||+|++++.+..+|++
T Consensus        88 di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   88 DIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             eecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEec
Confidence            99988666667899999999999999999998899999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCC--CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          176 DFGLARTSRG--NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       176 Dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |||+++....  ....++....|.+|.|||.+.+...|+.+.||||.|||+.||++|++.|+|.+...++..|...+|.+
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            9999987743  34445677779999999999998899999999999999999999999999999999999999999999


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQV  333 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~  333 (364)
                      .++....+.+...+.++...+...+..+....++.++...+|+.+||..||.+|+|++|+|+||||.+++++..+|..++
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~  327 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP  327 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998888


Q ss_pred             CCCcccchhhhHHHHHHHHHHHHHhhCCCCC
Q 017909          334 PLSLDIDENIGEQMIRQMMWNETLHYHPEAR  364 (364)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (364)
                      +....-.. ....+++...|.+.+.++|..+
T Consensus       328 ~~~~~~~~-~~~~~~r~~i~~e~~~~~~~~~  357 (359)
T KOG0660|consen  328 IFDSFEHE-LTEEELRELIYKEILDFHPDVS  357 (359)
T ss_pred             CCcccccc-ccHHHHHHHHHHHHHhhCcccc
Confidence            77753333 7788999999999999999863

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-55  Score=399.45  Aligned_cols=269  Identities=30%  Similarity=0.502  Sum_probs=243.1

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+|+.+++||+|||+.+|++++..+|+.||+|++.+... ......+..+|+++.+.++|||||+++++|++.     .+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----Cc
Confidence            589999999999999999999999999999999976433 455667788999999999999999999999999     99


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|||.|+|. ++|..++++++.+++.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||++.......
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999998 8999999999999999999999999999999999999999999999999999999999999999887666


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ..-...|||+.|+|||++.. ...+..+||||+||++|-|+.|++||+..+-.+.+..|...                  
T Consensus       173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------------  233 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------------  233 (592)
T ss_pred             cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------------
Confidence            66778899999999999987 68999999999999999999999999998888888877542                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPL  335 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~  335 (364)
                                   ....+..++..+++||.+||+.||.+|||+++||.|+||+..+-+++.|..-.+.
T Consensus       234 -------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~  288 (592)
T KOG0575|consen  234 -------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTM  288 (592)
T ss_pred             -------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCcccccc
Confidence                         1233457899999999999999999999999999999998888777776643333

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-55  Score=390.61  Aligned_cols=291  Identities=36%  Similarity=0.646  Sum_probs=257.7

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHR  103 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  103 (364)
                      ...+.+||.++++||.|.||.||+|+.+.+|+.||||.++...... +..--++|+..|++++ ||||+++.+++.+.. 
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~-   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDND-   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccC-
Confidence            4567899999999999999999999999999999999998765553 3334468999999998 999999999998883 


Q ss_pred             cccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ..+++|||||+.+|.++++.+ +.+++..++.|+.||++||+|+|.+|++|||+||+|||+..+..+||+|||+|+.
T Consensus        83 ---~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   83 ---RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             ---ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence               389999999999999999754 6799999999999999999999999999999999999999888999999999987


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      . .+....+.+..|.+|.|||++.....|+.+.|+|++|||++|+.+-++.|+|.+..+++-+|.+.+|.+....+... 
T Consensus       160 v-~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-  237 (538)
T KOG0661|consen  160 V-RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-  237 (538)
T ss_pred             c-ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-
Confidence            7 44445677788999999999998889999999999999999999999999999999999999999999988776543 


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ........=.++.-.+..+..+.+..+.++.++|.+|+.+||.+||||.|+|+||||+..
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            223333334556666777777888899999999999999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-53  Score=355.05  Aligned_cols=298  Identities=42%  Similarity=0.689  Sum_probs=261.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|...+++|+|.||+||+|++..+|+.||||+++.....+.-....++|++.|+.++|+||+.++++|...     ..+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence            589999999999999999999999999999999987655555566778999999999999999999999888     889


Q ss_pred             EEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      .||+||++.+|...++.. ..++...++.++.+++.||+|||++.|.||||||.|+|++.+|.+||+|||+++...+...
T Consensus        77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            999999999999999765 5699999999999999999999999999999999999999999999999999998877666


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch-hHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP-KAR  267 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  267 (364)
                      ......-|.+|.|||.+++...|+...|+||.|||+.||+.|.+.|++.++-+++..|...+|.+.+..|.....- .+-
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            5555567899999999999999999999999999999999999999999999999999999999999888766432 222


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS  336 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~  336 (364)
                      .+. ..+..   ....+.+..+.++.+|+.+||..||.+|+|+.|+|+|+||+....|..-...|.|++
T Consensus       237 ~~~-~~P~~---~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  237 KIQ-QFPKP---PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             HHh-cCCCC---ccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence            222 22222   223377889999999999999999999999999999999998655555555555555

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.3e-54  Score=366.60  Aligned_cols=291  Identities=34%  Similarity=0.664  Sum_probs=252.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +.|+...++|+|+||+||+++++.+|+.||||+|..+..+..-..-.++|+.+|++++|+|+|.++++|...     ...
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----cee
Confidence            579999999999999999999999999999999998777776666778999999999999999999999988     889


Q ss_pred             EEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|||||+.++++.++.. ..++...++.++.|++.|+.|||+++++||||||+|||++.+|.+||+|||+++.......
T Consensus        77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            999999999999999876 4699999999999999999999999999999999999999999999999999998876777


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc-CchhHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI-DNPKAR  267 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~  267 (364)
                      ..+.+..|.+|.|||.+.+...|+...|||++||++.||++|.+.|++.++.+++-.|...+|...+.-..-. .++.+.
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            7788888999999999999888999999999999999999999999999999999999999998777543322 222222


Q ss_pred             HH-HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          268 RF-IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       268 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                      .. +++.+.  ......-.+..+..+.+|+++||+.||.+|++.+|+|.||+|.++-....
T Consensus       237 Gv~lP~~~~--~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~  295 (396)
T KOG0593|consen  237 GVRLPEPEH--PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIEREL  295 (396)
T ss_pred             eeecCCCCC--ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHH
Confidence            22 111111  11122345678888999999999999999999999999999987755433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-55  Score=383.07  Aligned_cols=263  Identities=33%  Similarity=0.537  Sum_probs=226.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH-----HHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-----DALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      +.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++......     ......+|+++|++++|||||+++++|... 
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence            68999999999999999999999999999999999976433221     222346899999999999999999999988 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC---CcEEEeecC
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFG  178 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~---~~~~L~Dfg  178 (364)
                          ...|+||||++ |.|.+.+-.++.+.+...+.++.||+.|+.|||++||+||||||+|||++.+   ..+||+|||
T Consensus       249 ----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  249 ----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence                77899999998 6999999999999999999999999999999999999999999999999876   679999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCch
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN-QLKLIISVFGTQQE  255 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  255 (364)
                      +++..+ ....+...|||+.|.|||++.+.  ..+..+.|+|||||++|-+++|.+||.+..... ..+.|...      
T Consensus       325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G------  397 (475)
T KOG0615|consen  325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG------  397 (475)
T ss_pred             hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC------
Confidence            999886 56678889999999999999763  224568899999999999999999998775444 33333221      


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                           +....+..|..+++...+||.+||..||++|||++|+|+||||+-.-
T Consensus       398 ---------------------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 ---------------------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---------------------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                                 22233455677899999999999999999999999999999998643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-53  Score=368.34  Aligned_cols=261  Identities=27%  Similarity=0.438  Sum_probs=225.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc-
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK-  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~-  107 (364)
                      .++.+.++.||+|..|+|++++|+.+++.+|+|++.. ..+.....++.+|+++++..+||+||+++++|..+     + 
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~  151 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GE  151 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----Cc
Confidence            3478899999999999999999999999999999943 35566777889999999999999999999999988     6 


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...|+||||+ |+|.+++...+++++.....++.+++.||.|||+ ++|+||||||+|||++..|.|||+|||.+.....
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            5999999998 6999999988999999999999999999999996 8999999999999999999999999999987654


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT--ECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .  ......||..|||||.+.+ ..|+.++||||||+.++|+++|+.||...  ........+..+...++         
T Consensus       232 S--~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp---------  299 (364)
T KOG0581|consen  232 S--IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP---------  299 (364)
T ss_pred             h--hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC---------
Confidence            4  5677889999999999998 68999999999999999999999999875  11222222222222222         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCC-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                        +..+.+ +|+++++||..||+.||.+|||+.|+|+|||+++....
T Consensus       300 ------------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  300 ------------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             ------------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence                              222333 89999999999999999999999999999999986543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-51  Score=380.06  Aligned_cols=331  Identities=48%  Similarity=0.907  Sum_probs=267.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|+||.||+|+++.+|..||+|.++...........+.+|+.+++.++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            69999999999999999999999999999999875444444556678999999999999999999998765443345689


Q ss_pred             EEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC---
Q 017909          111 LVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---  187 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~---  187 (364)
                      +||||++++|.+.+.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......   
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  160 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA  160 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999986542221   


Q ss_pred             cccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          188 QFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.........+....+.++............
T Consensus       161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  240 (338)
T cd07859         161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA  240 (338)
T ss_pred             ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence            122345678999999998652 4688999999999999999999999999888888888888777777665555544444


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccc---hhh
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID---ENI  343 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~---~~~  343 (364)
                      ..+................+..++.+.++|.+||+.||.+|||++++|+||||++.......+..++.+..+..   ...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (338)
T cd07859         241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL  320 (338)
T ss_pred             HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence            44444433333333444456788999999999999999999999999999999998776666555544443332   222


Q ss_pred             hHHHHHHHHHHHHHhhCC
Q 017909          344 GEQMIRQMMWNETLHYHP  361 (364)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~  361 (364)
                      ....++.-..++.++|||
T Consensus       321 ~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         321 TKEDVRELIYREILEYHP  338 (338)
T ss_pred             CHHHHHHHHHHHHHhcCC
Confidence            255566778899999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-52  Score=361.92  Aligned_cols=285  Identities=25%  Similarity=0.412  Sum_probs=251.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -.++|++++.||.|+||+||.++.+.+++.||+|++++...- ..+......|.++|..++||+||+++-.|++.     
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-----   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-----   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----
Confidence            467999999999999999999999999999999999876443 34667778999999999999999999999999     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..+|+|++|+. |.|...+++.+.+++..++.++.+|+.||.|||++||+|||+||+|||++.+|+++|+|||+|+..-.
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            89999999998 59999999999999999999999999999999999999999999999999999999999999986656


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........+||+-|+|||++.. ..++.++|+||||+++|+|++|.+||.+.+.....++|...-               
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------------  241 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------------  241 (357)
T ss_pred             CCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------------
Confidence            6566667899999999999998 689999999999999999999999999999888888876521               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC----CHHHHhcCCCccCCCC-CCCCCCCCCCCCcccc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI----TVTEALQHPYISGLYD-PQCNPPAQVPLSLDID  340 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~elL~hp~f~~~~~-~~~~~~~~~~~~~~~~  340 (364)
                                     ....+..++...+++|+++|..||.+|.    ++++|-+||||....+ .-.+...++|..+++-
T Consensus       242 ---------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~  306 (357)
T KOG0598|consen  242 ---------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVT  306 (357)
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCC
Confidence                           1222334889999999999999999995    7999999999999844 4455666668888888


Q ss_pred             hhhhHHHH
Q 017909          341 ENIGEQMI  348 (364)
Q Consensus       341 ~~~~~~~~  348 (364)
                      ...+.+..
T Consensus       307 ~~~~~~~F  314 (357)
T KOG0598|consen  307 GLEDTSNF  314 (357)
T ss_pred             Cccccccc
Confidence            77776643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-51  Score=369.99  Aligned_cols=290  Identities=37%  Similarity=0.602  Sum_probs=252.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.+.|+.+++||+|.||.||+|++..+|+.||+|++..+...........+|+.+|+++.||||+++.++..+...   +
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~---~  191 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS---G  191 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC---c
Confidence            4678999999999999999999999999999999998876666677777899999999999999999999887633   6


Q ss_pred             eEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .+|+|||||+.+|.-++... -.|++.+++-++.||+.||.|||++|+.|||||.+||||+.+|.+||+|||++.+....
T Consensus       192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            78999999999998888764 37999999999999999999999999999999999999999999999999999865443


Q ss_pred             -CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          187 -EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       187 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                       ....+...-|.+|.|||.+.+...|+.+.|+||.||||.||+.|++.|++....+++.+|.+.-|.+.+..|....-+.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence             3335666679999999999999999999999999999999999999999999999999999999999999887333332


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ...+...  ..-...+.+....++....+|+..||..||.+|.||.++|+|+||+.-
T Consensus       352 ~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  352 ATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             ccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            2222221  222344455577899999999999999999999999999999999543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-51  Score=370.36  Aligned_cols=266  Identities=28%  Similarity=0.446  Sum_probs=234.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHH-HHHHHHHHhc-CCCCcceeeeeeccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHI-KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (364)
                      ..-..+|.+++.||.|+|++|++|+++.+++.||||++.+...-....... ..|-++|..| .||.|++++..|+++  
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence            334679999999999999999999999999999999998765544443333 3577888888 899999999999999  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ..+|+|+||++ |.|++++...+.+++..++.++.+|+.||.|||++||+||||||+|||++++++++|+|||.++.
T Consensus       147 ---~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  147 ---ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ---cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence               88999999998 89999999999999999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCcc-------------cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017909          183 SRGNEQF-------------MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       183 ~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  249 (364)
                      .......             .....||..|.+||++.. ...++.+|||+|||++|+|+.|.+||.+.+.....++|++.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            5432111             134678999999999988 68999999999999999999999999999999999998874


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      -                               ..+++++++.+.+||+++|..||.+|+|+.||.+||||.++.+..-.
T Consensus       303 ~-------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  303 D-------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             c-------------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence            2                               23446889999999999999999999999999999999998766544

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-51  Score=348.58  Aligned_cols=290  Identities=37%  Similarity=0.611  Sum_probs=251.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      -+.|+.+..|++|.||.||+|+++.+++.||+|.++.+.....-....++|+++|..++|||||.+.++.+-...   ..
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ce
Confidence            468999999999999999999999999999999998765444444456799999999999999999999876654   66


Q ss_pred             EEEEeccccccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|+|||||+.+|..++..-+ ++...+++-++.|++.|++|||++.|+|||+|++|+|++..|.+|++|||+++...++.
T Consensus       152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999999999999998764 89999999999999999999999999999999999999999999999999999888887


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ...+...-|.+|.|||.+.+...|+.+.|+||+|||+.||+++++.|++....+++.+|...+|.+.+..|.........
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            77788888999999999999999999999999999999999999999999999999999999999999888766554433


Q ss_pred             HHHhhCCCCCCCcccccCCC--CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQ--ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ..... .....+........  +++...+|++.+|..||.+|.||+|.|+|+||...
T Consensus       312 k~~~f-~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  312 KKMTF-SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hcccc-CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            21111 11111122222222  56899999999999999999999999999999984

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-49  Score=366.08  Aligned_cols=335  Identities=69%  Similarity=1.187  Sum_probs=284.8

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++.+.||.|++|+||+|++..+++.|++|.+............+.+|+.+++.++|+|++++++++........
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            46789999999999999999999999999999999987654444445566789999999999999999998876644344


Q ss_pred             ceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ...++|+||++++|.+.+...+++++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            56899999999999999988888999999999999999999999999999999999999999999999999998765443


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.....++.++|+||||+++|+|++|..||.+.+.......+....+.+....+........
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence            33344456788899999987645689999999999999999999999999888888888888888877777766666666


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccchhh-hH
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENI-GE  345 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~-~~  345 (364)
                      ..+................+.+++.+.+||++||+.||.+|||++++|+||||..+..+...+..+++...|+.+.. ..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTE  321 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCH
Confidence            66655544444444444556789999999999999999999999999999999999999888888888888877654 46


Q ss_pred             HHHHHHHHHHHHhhCC
Q 017909          346 QMIRQMMWNETLHYHP  361 (364)
Q Consensus       346 ~~~~~~~~~~~~~~~~  361 (364)
                      .++-+-..+++|.|||
T Consensus       322 ~~~~~~~~~~~~~~~~  337 (337)
T cd07858         322 EDIKELIYNEMLAYHP  337 (337)
T ss_pred             HHHHHHHHHHHhhcCC
Confidence            6788888999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-50  Score=348.78  Aligned_cols=301  Identities=38%  Similarity=0.649  Sum_probs=250.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      =.|+-.+++|+|+||.||.|....+++.||||..-.+..-.      -.|+.+|+.+.|||||++.-+|........-+.
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            36899999999999999999999999999999874321111      258999999999999999999987654423467


Q ss_pred             EEEeccccccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecCccccCC
Q 017909          110 YLVYELMDTDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSR  184 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg~~~~~~  184 (364)
                      .+||||++.+|...+..    +..++.-.++-+..||+.||+|||+.|||||||||.|+|+|.+ |.+||+|||+++...
T Consensus        98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            89999999999998874    5789999999999999999999999999999999999999986 899999999998774


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .+. ......-+..|.|||.+.+...|+.+.||||.||++.||+-|++.|+|.+..+++.+|.+.+|.+..+....++.+
T Consensus       178 ~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            433 3466667889999999999999999999999999999999999999999999999999999999999887766544


Q ss_pred             hHHHHHhhCCCCCCCcccc-cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC--CCCCCcccc
Q 017909          265 KARRFIKSLPYSRGTHISS-LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA--QVPLSLDID  340 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~--~~~~~~~~~  340 (364)
                      -...-   .+.-....+.. .....++++.+|+.++|..+|.+|.++.|+|.||||..+.++.+.-|.  +.|.-.|-.
T Consensus       257 y~~~~---~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~  332 (364)
T KOG0658|consen  257 YTEFK---FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFK  332 (364)
T ss_pred             ccccc---CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCch
Confidence            22111   11112222222 567789999999999999999999999999999999999888665332  344444433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=334.55  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=231.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -++|++++.||.|+||.|.+++++.+|..||+|++++... .........+|..+|+.+.||+++++.+.+.+.     .
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----S  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----C
Confidence            4689999999999999999999999999999999986533 344556667899999999999999999999998     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .+++||||++ |.|..++++.+++++..++.++.||+.||.|||+++|++||+||+|||++.+|.+||+|||+++.....
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999998 699999999999999999999999999999999999999999999999999999999999999877332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                         ....|||+-|+|||.+.. +.++.++|+|+||+++|||+.|.+||.+.+....+.+|.+.-                
T Consensus       198 ---T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~----------------  257 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK----------------  257 (355)
T ss_pred             ---EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc----------------
Confidence               456799999999999988 789999999999999999999999999999888888887632                


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDP  325 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~  325 (364)
                                     -..++.+++++++||+++|+.|-.+|.     ..++|.+||||.++.+.
T Consensus       258 ---------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  258 ---------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             ---------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence                           233467899999999999999999993     67899999999988543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-49  Score=359.87  Aligned_cols=260  Identities=33%  Similarity=0.497  Sum_probs=226.9

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc---hHHHHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN---RIDALRTLRELVLLRHIK-HDNVIALKDVMMPT  101 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  101 (364)
                      ....+.|++++.||+|+||+|+.|.+..++..||+|++......   ......+.+|+.+++.+. ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            34678999999999999999999999999999999987664221   123344457999999998 99999999999988


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecCc
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGL  179 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg~  179 (364)
                           ...++||||+. |.|.+.+...+++++.+++.+++||+.|+.|||++||+||||||+||+++.+ +++||+|||+
T Consensus        93 -----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   93 -----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             -----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence                 77999999998 5999999998999999999999999999999999999999999999999999 9999999999


Q ss_pred             cccCCCCCcccccccccccccCCccccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      +.............+|++.|+|||++.+.. ..+.++||||+|++||.|++|..||.+.+.......|.+.         
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~---------  238 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG---------  238 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC---------
Confidence            987754556677889999999999999865 5579999999999999999999999997766666654331         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCC-ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                            ...++..+ ++.+++||.+||..||.+|+|+.++++||||+.
T Consensus       239 ----------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ----------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                  12223445 899999999999999999999999999999997

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=346.88  Aligned_cols=262  Identities=29%  Similarity=0.475  Sum_probs=229.4

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ....++|.+.+.||+|+|++||+|+++.++..||||.+.+..........+..|+.+|+.++|||||.++++++..    
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~----   81 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD----   81 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC----
Confidence            3456899999999999999999999999999999999988766777777788999999999999999999999988    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC------CcEEEeecC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN------CDLKICDFG  178 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~------~~~~L~Dfg  178 (364)
                       +.+++|||||+ |+|.+++++.+.+++..++.++.||+.||++||+++|+||||||.|||++..      -.+||+|||
T Consensus        82 -~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   82 -DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             -CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence             89999999998 7999999999999999999999999999999999999999999999999875      459999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      +++... ........+|++.|||||++.. ..|+.|+|+||+|+++|++++|++||+.....+....+.+.         
T Consensus       161 fAR~L~-~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~---------  229 (429)
T KOG0595|consen  161 FARFLQ-PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG---------  229 (429)
T ss_pred             hhhhCC-chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc---------
Confidence            999885 4555677899999999999987 68999999999999999999999999987766655533221         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                         ...........++.+.+|+...++.+|..|.+..+-+.|+++..-
T Consensus       230 -------------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  230 -------------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             -------------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence                               111122233466677799999999999999999999999999764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-48  Score=351.13  Aligned_cols=282  Identities=38%  Similarity=0.691  Sum_probs=233.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||.|+||+||+|.++.++..||+|+++...... ....+.+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-cchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeE
Confidence            57999999999999999999999999999999987543221 233556899999999999999999999877     788


Q ss_pred             EEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++||||++++|.+.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        79 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            999999999999988764 4589999999999999999999999999999999999999999999999999876543333


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch-hHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP-KAR  267 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  267 (364)
                      ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+....+....+....+.+....+...... ...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            3444567889999999877567899999999999999999999999999888888888888888777666544322 111


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .+.  .+...........+..++++++||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            111  11111222233445788999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-50  Score=339.41  Aligned_cols=247  Identities=28%  Similarity=0.440  Sum_probs=219.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeee-eccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV-MMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~~~  107 (364)
                      -..|+|.++||+|+||.||++++..+|+.+|.|.++....+.........|+.+|++++|||||++++. |.++.    .
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~----e   93 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN----E   93 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc----h
Confidence            357999999999999999999999999999999999777788888888999999999999999999994 44431    3


Q ss_pred             eEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCCeEEccCCcEEEeecC
Q 017909          108 DVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHS--AN--ILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~--~~--i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      -++||||+|+ |+|...++.    .+.+++..+|.++.|++.||.+||+  .+  +.||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            4899999998 899988863    4579999999999999999999999  44  8999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      +++...+.........||+.||+||.+.. ..|+.+||||||||++|||+..++||.+.+-.+...+|.+.         
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg---------  243 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG---------  243 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC---------
Confidence            99998888888888999999999999988 68999999999999999999999999999777777766431         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccC-CCCChHHHHHHHHhcccCCCCCCCH
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLY-PQADPLALDLLQKMLVFEPSKRITV  310 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~  310 (364)
                                           ..++++ ..+|.++..||..|+..||..||+.
T Consensus       244 ---------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  244 ---------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ---------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence                                 223333 4688999999999999999999985

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-48  Score=358.16  Aligned_cols=328  Identities=46%  Similarity=0.835  Sum_probs=257.7

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ....++.++|++.+.||+|+||+||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878           8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             HHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            34556789999999999999999999999999999999999765444445556778999999999999999999886543


Q ss_pred             cc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          103 RI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       103 ~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      .. .....++++++++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          88 SIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             cccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence            21 2245799999999899887754 569999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .....   .....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+..........
T Consensus       167 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         167 QADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             ecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            65332   234467889999999977567899999999999999999999999998888888888877777666555444


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccch
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDE  341 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~  341 (364)
                      .......+....+..............++.+.+||.+||+.||.+|||+.|+|+||||.....+...+..+.......+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~  323 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPENK  323 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCccccchhhh
Confidence            44444444444433333334444556788899999999999999999999999999999987776554433322222223


Q ss_pred             hhhHHHHHHHHHH
Q 017909          342 NIGEQMIRQMMWN  354 (364)
Q Consensus       342 ~~~~~~~~~~~~~  354 (364)
                      .-...+....+|.
T Consensus       324 ~~~~~~~~~~~~~  336 (343)
T cd07878         324 ERTIEEWKELTYE  336 (343)
T ss_pred             hccHHHHHHHHHH
Confidence            3334444445543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-49  Score=341.87  Aligned_cols=304  Identities=40%  Similarity=0.671  Sum_probs=257.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC-cceeeeeeccccc-ccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN-VIALKDVMMPTHR-ISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~-~~~  106 (364)
                      ...|+.+++||+|.||+||+|+.+.+|+.||+|++..+....--.....+|+.+++.++|+| |+.+++++...+. ...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45688899999999999999999999999999999866443223345578999999999999 9999999987742 222


Q ss_pred             ceEEEEeccccccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQ----SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ...++||||+.-+|..++....    .++...++.+++||+.||.|||+++|+||||||.||+++++|.+||+|||++..
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            4789999999999999997654    588899999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..-+....+....|.+|.|||++.+...|+...||||+|||++||+++++.|++..+.++...|...++.+....|....
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            65555557777889999999999998889999999999999999999999999999999999999999999887776543


Q ss_pred             chhHHHHHhhCCCCC-CCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCC
Q 017909          263 NPKARRFIKSLPYSR-GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVP  334 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~  334 (364)
                      ..  .++....+... ...+....+..+++..+++.+||+.+|.+|.|++.+|.||||.....+.+....+.+
T Consensus       250 ~~--~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~~~~~~  320 (323)
T KOG0594|consen  250 SL--PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQLLLQAS  320 (323)
T ss_pred             cc--ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhhhcccc
Confidence            21  11211222222 455555666777899999999999999999999999999999998777776655443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.2e-48  Score=357.86  Aligned_cols=313  Identities=42%  Similarity=0.725  Sum_probs=244.6

Q ss_pred             ceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceee
Q 017909           16 KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      ++...+.+....+.++|++.+.||+|+||+||++.+..+|..||+|++............+.+|+.+++.++||||++++
T Consensus         7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   86 (359)
T cd07876           7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL   86 (359)
T ss_pred             cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeee
Confidence            44555666666788999999999999999999999999999999999976555555566778899999999999999999


Q ss_pred             eeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909           96 DVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus        96 ~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      +++...... .....++||||+++++.+.+..  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             eeeccCCCccccceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEE
Confidence            998755321 2246899999999988877643  5899999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      +|||++..... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+..+.+.
T Consensus       165 ~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  242 (359)
T cd07876         165 LDFGLARTACT-NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS  242 (359)
T ss_pred             ecCCCcccccc-CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            99999865422 222334567889999999987 5789999999999999999999999999888888777777766655


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCC------------cccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGT------------HISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ......... ....+....+.....            .........++.+.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         243 AEFMNRLQP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHHHH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            433222111 111111111111110            1111223356789999999999999999999999999999998


Q ss_pred             CCCCCCCCCCC
Q 017909          323 YDPQCNPPAQV  333 (364)
Q Consensus       323 ~~~~~~~~~~~  333 (364)
                      .++..+...++
T Consensus       322 ~~~~~~~~~~~  332 (359)
T cd07876         322 YDPAEAEAPPP  332 (359)
T ss_pred             cCcccccCCCc
Confidence            87765544333

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-48  Score=353.45  Aligned_cols=282  Identities=24%  Similarity=0.406  Sum_probs=237.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -.++|++++.||+|+||.||+|+-+.+|..+|+|++++... ........+.|-.+|.....|.+|+++-.|++.     
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-----  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-----  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----
Confidence            46799999999999999999999999999999999987644 344555667899999998999999999999999     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||||++ |++..++...+.+++..++.++.+++.|+..+|+.|++|+||||+|+||+..|++||+|||+|.....
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999998 69999999999999999999999999999999999999999999999999999999999999842111


Q ss_pred             -----------------------CCc------------------------ccccccccccccCCcccccccCCCChhhHH
Q 017909          186 -----------------------NEQ------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVW  218 (364)
Q Consensus       186 -----------------------~~~------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~  218 (364)
                                             ...                        ......||+.|+|||++.+ ..|+...|+|
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwW  372 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWW  372 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHH
Confidence                                   000                        0112367899999999999 6799999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHH
Q 017909          219 SVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQK  298 (364)
Q Consensus       219 slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  298 (364)
                      |||||+|||+.|.+||.+....+.+++|+........                           +-...+++++.|||.+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------------------P~~~~~s~eA~DLI~r  425 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------------------PEEVDLSDEAKDLITR  425 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------------------CCcCcccHHHHHHHHH
Confidence            9999999999999999999999999999875322111                           1113466889999999


Q ss_pred             hcccCCCCCC---CHHHHhcCCCccCCCCCCCCCCCCCCCCcccchhhh
Q 017909          299 MLVFEPSKRI---TVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIG  344 (364)
Q Consensus       299 ~l~~dP~~Rp---s~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  344 (364)
                      ||. ||.+|.   .++||.+||||+++.+...-... .|..+.+++..|
T Consensus       426 ll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~-apfvP~v~~~~D  472 (550)
T KOG0605|consen  426 LLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP-APFVPQVNSELD  472 (550)
T ss_pred             Hhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC-CCCCCCCCCccc
Confidence            999 999998   59999999999999665543222 555555655555

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-47  Score=353.47  Aligned_cols=312  Identities=42%  Similarity=0.722  Sum_probs=245.4

Q ss_pred             ceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceee
Q 017909           16 KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      ............+.++|++.+.||+|+||+||++.+..+++.||+|++............+.+|+.+++.++||||++++
T Consensus        10 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~   89 (364)
T cd07875          10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL   89 (364)
T ss_pred             ceeeecCcchhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            44455555666678999999999999999999999999999999999976555555566778899999999999999999


Q ss_pred             eeeccccc-cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909           96 DVMMPTHR-ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus        96 ~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      +++..... ......++||||+++++.+.+..  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|
T Consensus        90 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL  167 (364)
T cd07875          90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  167 (364)
T ss_pred             eeecccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEE
Confidence            98865432 12246899999999998888754  5889999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      +|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....+.+.
T Consensus       168 ~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         168 LDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             EeCCCccccCCC-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998765332 22334567889999999987 5789999999999999999999999999998888888888777765


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCC------------CcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRG------------THISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      +........ ....+....+....            ..........+..+++||.+||+.||.+|||++++|+||||..+
T Consensus       246 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         246 PEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhhH-HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            543332211 11111111111000            00111122345678999999999999999999999999999988


Q ss_pred             CCCCCCCCCC
Q 017909          323 YDPQCNPPAQ  332 (364)
Q Consensus       323 ~~~~~~~~~~  332 (364)
                      .++...++.+
T Consensus       325 ~~~~~~~~~~  334 (364)
T cd07875         325 YDPSEAEAPP  334 (364)
T ss_pred             cCcccCCCCC
Confidence            7776654433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-48  Score=361.08  Aligned_cols=263  Identities=31%  Similarity=0.445  Sum_probs=235.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccch-hhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .+-|++++-||.|+.|.|-+|++..+|+..|||++.+. .........+.+|+.+|+.+.|||++.+++++...     .
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----Q   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----c
Confidence            46899999999999999999999999999999999765 34444555667899999999999999999999988     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++|+|.||++ |.|.+++...+++++.++..++.||+.|+.|||..+|||+|+||+|+|++.++++||+|||++..... 
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999997 79999999999999999999999999999999999999999999999999999999999999976644 


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......||++.|.+||++.+.++.+.++||||.|+|||.|++|+.||++.+-...+.++...                 
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-----------------  227 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-----------------  227 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----------------
Confidence            445667799999999999999888999999999999999999999999987776666665432                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                    ..+.+..+++++++||++||..||.+|+|.+||++|||+.+.......
T Consensus       228 --------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  228 --------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             --------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                          234456799999999999999999999999999999999998766655

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-48  Score=358.71  Aligned_cols=297  Identities=32%  Similarity=0.553  Sum_probs=238.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-C-----CCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-H-----DNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~  102 (364)
                      ..+|+|.+.||+|.||+|.+|.+..+++.||||+++..   ..-..+...|+.+|..++ |     -|+|+++++|... 
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-  260 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-  260 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-
Confidence            44999999999999999999999999999999999863   233344557888888885 3     3899999999988 


Q ss_pred             ccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC--cEEEeecC
Q 017909          103 RISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC--DLKICDFG  178 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~--~~~L~Dfg  178 (364)
                          +++|||+|.++-+|.++++.+  ..++...++.++.||+.||.+||+.||+|+||||+||||..-+  .|||+|||
T Consensus       261 ----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  261 ----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence                899999999999999999876  4699999999999999999999999999999999999997643  69999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      +++.......   ....+..|.|||++.+ ..|+.+.||||||||++||++|.+.|++.+..+++..|++.+|.++..-.
T Consensus       337 SSc~~~q~vy---tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  337 SSCFESQRVY---TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccccCCcce---eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9987633222   6677889999999999 68999999999999999999999999999999999999999998887544


Q ss_pred             hccCchhHHHHHhh-----------------------------CCC---C-CCCcccccCC-CCChHHHHHHHHhcccCC
Q 017909          259 EFIDNPKARRFIKS-----------------------------LPY---S-RGTHISSLYP-QADPLALDLLQKMLVFEP  304 (364)
Q Consensus       259 ~~~~~~~~~~~~~~-----------------------------~~~---~-~~~~~~~~~~-~~~~~l~~li~~~l~~dP  304 (364)
                      +.....  ..|+..                             ...   . ....+..... .....+.+||++||.+||
T Consensus       413 ~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP  490 (586)
T KOG0667|consen  413 DTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP  490 (586)
T ss_pred             Hhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence            432211  111111                             000   0 1111112222 345567899999999999


Q ss_pred             CCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccc
Q 017909          305 SKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID  340 (364)
Q Consensus       305 ~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~  340 (364)
                      .+|+|+.|+|+||||++........+.. .+....+
T Consensus       491 ~~R~tp~qal~Hpfl~~~~~~~~~~~~~-~~~~~~~  525 (586)
T KOG0667|consen  491 AERITPAQALNHPFLTGTSLERRNQSPL-DSSVSAS  525 (586)
T ss_pred             hhcCCHHHHhcCcccccccccccCCCCc-ccccccc
Confidence            9999999999999999776655544443 3333333

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.5e-47  Score=352.04  Aligned_cols=310  Identities=43%  Similarity=0.751  Sum_probs=245.9

Q ss_pred             CceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCccee
Q 017909           15 GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        15 ~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      +++.++.++....+.++|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+.+++.++||||+++
T Consensus         2 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   81 (355)
T cd07874           2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL   81 (355)
T ss_pred             cceeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhce
Confidence            45677777877778899999999999999999999999999999999997655555556677789999999999999999


Q ss_pred             eeeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEE
Q 017909           95 KDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus        95 ~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~  173 (364)
                      ++++...... .....++||||+++++.+.+..  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~k  159 (355)
T cd07874          82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_pred             eeeeeccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEE
Confidence            9998654321 2246899999999988887754  589999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...++.+
T Consensus       160 l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         160 ILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             EeeCcccccCCCc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998765332 22344567899999999977 578999999999999999999999999988888888777777665


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCC------------CcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRG------------THISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ......... +....+....+....            ..........+..+.+||.+||+.||.+|||+.|+|+||||..
T Consensus       238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         238 CPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             CHHHHHhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence            544332221 122222211111100            0011122335677899999999999999999999999999998


Q ss_pred             CCCCCCCC
Q 017909          322 LYDPQCNP  329 (364)
Q Consensus       322 ~~~~~~~~  329 (364)
                      ++++....
T Consensus       317 ~~~~~~~~  324 (355)
T cd07874         317 WYDPAEVE  324 (355)
T ss_pred             ccChhhcc
Confidence            87765444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-48  Score=352.99  Aligned_cols=259  Identities=31%  Similarity=0.521  Sum_probs=235.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|.+.++||+|+||.||+|+.+.+.+.||+|.+.+......+...+.+|+++++.++||||+.+++.|+..     .+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceE
Confidence            589999999999999999999999999999999998877888888889999999999999999999999988     899


Q ss_pred             EEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          110 YLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      ++|.||+.|+|..++...+.++++.+..++.++..||.|||+.+|.|+|+||.||++.++|.+|++|||+++........
T Consensus        77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988777777


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .+...||+.|||||.+.+ ..++..+|+|||||++||++.|++||.........+.|..   .+.               
T Consensus       157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---d~v---------------  217 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---DPV---------------  217 (808)
T ss_pred             eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---CCC---------------
Confidence            888899999999999987 7899999999999999999999999977655555544433   111               


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                   .-+...+..+++|++.+|..||.+|.|..+++.|||.++...-
T Consensus       218 -------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  218 -------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             -------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence                         1123678889999999999999999999999999999886443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.9e-47  Score=342.11  Aligned_cols=284  Identities=35%  Similarity=0.650  Sum_probs=224.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|+||+|+++.++..+|+|+++...........+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEE
Confidence            479999999999999999999999999999999976544444556677899999999999999999999877     789


Q ss_pred             EEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC-
Q 017909          110 YLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-  187 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~-  187 (364)
                      ++||||+++++.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99999999766665543 4579999999999999999999999999999999999999999999999999987653322 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC-chhH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID-NPKA  266 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~  266 (364)
                      .......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||++.........+....+..+........ .+..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            12234567889999999977 568999999999999999999999999887777776666665555443322111 1111


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .....................+++.+.+||++||+.||++|||++++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00000000000011112234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=337.58  Aligned_cols=291  Identities=23%  Similarity=0.314  Sum_probs=238.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.+.|++...||.|..++||+|+....++.||||++..+..+.. ...+.+|+..++.++||||++++..|..+     .
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~   97 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD-----S   97 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec-----c
Confidence            46799999999999999999999999999999999998766665 67788999999999999999999999998     8


Q ss_pred             eEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .+|+||++|. |++.+++...  ..+++..+..++++++.||.|||.+|.+|||||+.|||++.+|.|+|+|||.+....
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999998 7999999865  359999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccc----ccccccccccCCcc-cccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh-
Q 017909          185 GNEQFM----TEYVVTRWYRAPEL-LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-  258 (364)
Q Consensus       185 ~~~~~~----~~~~~~~~~~aPE~-~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-  258 (364)
                      ......    ....|+++|+|||+ ......|+.|+||||||+...||++|+.||........   ++..+...++... 
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~tLqn~pp~~~t  254 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---LLLTLQNDPPTLLT  254 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---HHHHhcCCCCCccc
Confidence            332221    44578999999999 55556799999999999999999999999977654333   2222333332111 


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLD  338 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~  338 (364)
                      ...+..+                   ...++..+.++|..||+.||.+|||+.++|+|+||+........+..--....+
T Consensus       255 ~~~~~d~-------------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~  315 (516)
T KOG0582|consen  255 SGLDKDE-------------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPP  315 (516)
T ss_pred             ccCChHH-------------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCc
Confidence            1111111                   123555799999999999999999999999999999998888877766666665


Q ss_pred             cchhhhHH
Q 017909          339 IDENIGEQ  346 (364)
Q Consensus       339 ~~~~~~~~  346 (364)
                      +-.+...+
T Consensus       316 l~~r~~~~  323 (516)
T KOG0582|consen  316 LGTRFKKS  323 (516)
T ss_pred             HHHHHHHH
Confidence            55555443

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-46  Score=342.72  Aligned_cols=288  Identities=36%  Similarity=0.661  Sum_probs=235.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|+||+||+|+++.++..+|+|.++...... ....+.+|+.+++.++|||++++++++..+     ..
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~   78 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTD-----KS   78 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeC-----Ce
Confidence            368999999999999999999999999999999987543222 233456899999999999999999999877     78


Q ss_pred             EEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++++|.+.+... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            8999999999998888654 458999999999999999999999999999999999999999999999999987554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+....+.........
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            33334466889999999877567899999999999999999999999999888888888888887777665544322111


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ... ..+...........+.+++.+.+||++||+.||.+|||+.|+|+||||+.+.
T Consensus       239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            111 1111111122233456889999999999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.2e-47  Score=344.06  Aligned_cols=288  Identities=35%  Similarity=0.580  Sum_probs=222.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|+||+||+|.++.+++.||+|++....... ....+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~   76 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTK-----E   76 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecC-----C
Confidence            3578999999999999999999999999999999987543222 233456899999999999999999999877     7


Q ss_pred             eEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++++|.+.+... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          77 TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             eEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            89999999999998888654 56999999999999999999999999999999999999999999999999998654333


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhhhccCchh
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-LNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........++..|+|||++.+...++.++|||||||++|+|++|..||.+..+ ......+....+.+....+.....  
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS--  234 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh--
Confidence            33334456788999999987756689999999999999999999999987643 344455555444443322221110  


Q ss_pred             HHHHHhh-CCCCCCCcccc--cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          266 ARRFIKS-LPYSRGTHISS--LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~-~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ...+... ...........  .....++.+.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0000000 00000000000  0113567899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-46  Score=347.47  Aligned_cols=321  Identities=43%  Similarity=0.747  Sum_probs=250.5

Q ss_pred             CceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCccee
Q 017909           15 GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        15 ~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      |++.++.++....+.++|++.+.||+|++|+||+|.+..+|+.+++|.+............+.+|+.+++.++|+|++++
T Consensus         1 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   80 (353)
T cd07850           1 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL   80 (353)
T ss_pred             CceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcce
Confidence            57788888888889999999999999999999999999999999999987654444455667789999999999999999


Q ss_pred             eeeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEE
Q 017909           95 KDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus        95 ~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~  173 (364)
                      ++++...... .....++||||+.++|.+.+...  ++...+..++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             eeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence            9998755321 22468999999999999888653  89999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||.+....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+.+
T Consensus       159 L~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         159 ILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             EccCccceeCCCCC-CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999987653322 2333456788999999987 578999999999999999999999999988888888887777766


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCc-------------ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTH-------------ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      .......... ....+...........             ........+..+.++|++||+.||.+|||+.|+|.||||.
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         237 SDEFMSRLQP-TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             CHHHHHHhhh-hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence            5533222111 1111111111100000             0011224566789999999999999999999999999999


Q ss_pred             CCCCCCC-CCCCCCCCCcccc
Q 017909          321 GLYDPQC-NPPAQVPLSLDID  340 (364)
Q Consensus       321 ~~~~~~~-~~~~~~~~~~~~~  340 (364)
                      +|+.+.. ..+.+.++...++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~  336 (353)
T cd07850         316 VWYDPSEVEAPPPAPYDHSID  336 (353)
T ss_pred             hccCCccCCCCCCCccccccc
Confidence            8876544 3444444444443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-49  Score=324.08  Aligned_cols=263  Identities=30%  Similarity=0.457  Sum_probs=230.9

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .-+.++|++.+.||+|.|+.|+++.+..+|..+++|+++.......+..++.+|+.+.+.++||||+++.+.+.+.    
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~----   82 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE----   82 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc----
Confidence            4478999999999999999999999999999999999976655555777888999999999999999999999888    


Q ss_pred             cceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC---CcEEEeecCccc
Q 017909          106 FKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~---~~~~L~Dfg~~~  181 (364)
                       ...++|||++.| .|-.-+-.+.-+++..+...++||++||.|||++||+|||+||+|+++-..   --+||+|||.+.
T Consensus        83 -~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   83 -SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             -ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence             889999999985 676655555678999999999999999999999999999999999999543   359999999998


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ... +.....+..|++.|+|||++.. ..++..+|||+.|++||-|+.|.+||.+.+....++.|+...-          
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y----------  229 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY----------  229 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc----------
Confidence            886 5666777889999999999988 7899999999999999999999999999877777777755321          


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       ....+.|+.+++..++|+++||..||.+|+|+.|.|+|||+...
T Consensus       230 -----------------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  230 -----------------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             -----------------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                             12244568899999999999999999999999999999999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-46  Score=349.95  Aligned_cols=291  Identities=48%  Similarity=0.814  Sum_probs=236.5

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|+||+||++.+..+|+.||+|.+...........++.+|+.+++.++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            47899999999999999999999999999999876544444556778999999999999999999999876433334789


Q ss_pred             EEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC-Ccc
Q 017909          111 LVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN-EQF  189 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~-~~~  189 (364)
                      +|+||+.++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~  160 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH  160 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998754322 222


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+.+..+.+.......... .....
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~  239 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAH  239 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HHHHH
Confidence            33345688899999998756689999999999999999999999999998888888888877766644332221 11112


Q ss_pred             HhhCCCCCC--CcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          270 IKSLPYSRG--THISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       270 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      .........  ..........++.+.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            111111111  11112345678899999999999999999999999999999884

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-47  Score=340.89  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=217.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.     ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----Ce
Confidence            4799999999999999999999999999999999754332 23445567899999999999999999998877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+. |+|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999997 699999988889999999999999999999999999999999999999999999999999998765332 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                        .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....                 
T Consensus       155 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-----------------  214 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-----------------  214 (291)
T ss_pred             --cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence              223467889999999877 578999999999999999999999998876655555443210                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYD  324 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~  324 (364)
                                    ...+..+++.+.+||++||+.||.+||+     ++++++||||+....
T Consensus       215 --------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         215 --------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             --------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence                          1123456888999999999999999995     999999999987543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-46  Score=342.65  Aligned_cols=314  Identities=54%  Similarity=0.944  Sum_probs=255.6

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++.+.||+|++|.||+|++..+|+.|++|.+.... .......+.+|+.+++.++|+|++++++++........
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            35789999999999999999999999999999999986422 22344556789999999999999999998776544334


Q ss_pred             ceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ...++|+|++++++.+.+.. +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            57899999999998887754 57999999999999999999999999999999999999999999999999988654322


Q ss_pred             Cc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          187 EQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       187 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ..   ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+...++.+..........
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            11   122346688899999876655789999999999999999999999998888788888877777766665554444


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccchh
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDEN  342 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~  342 (364)
                      .....+....+......+....+..++.+.++|.+||+.||.+|||+.++++||||..+.++..++..+.|.-.|...-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~  318 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF  318 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence            4444444433333333333344567889999999999999999999999999999999999988888877777666554

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-46  Score=342.29  Aligned_cols=308  Identities=50%  Similarity=0.898  Sum_probs=253.6

Q ss_pred             EEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeee
Q 017909           19 YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVM   98 (364)
Q Consensus        19 ~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (364)
                      .++.+...++.++|++.+.||+|++|+||+|.+..++..|++|++............+.+|+.+++.++|+|++++++++
T Consensus         4 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851           4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             hhhccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            45566677789999999999999999999999999999999999875443444455667899999999999999999988


Q ss_pred             ccccc-cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeec
Q 017909           99 MPTHR-ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (364)
Q Consensus        99 ~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Df  177 (364)
                      ..... ......++|+++++++|.+++.. .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             hccccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence            66532 22245899999999999988875 57999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |.+......   .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.........+....+.+.+..
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            998765332   23345678899999987645688999999999999999999999999888888888877776666655


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP  330 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~  330 (364)
                      ...........+....+.............+++.+.++|.+||+.||.+|||+.+|++||||..+..+...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~  312 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV  312 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc
Confidence            5555544455555544444444444555667999999999999999999999999999999999988876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.5e-46  Score=337.37  Aligned_cols=284  Identities=39%  Similarity=0.632  Sum_probs=221.8

Q ss_pred             cceeeeeeeccCCceeEEEEEecc-CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRE-TNEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~  105 (364)
                      ++|++.+.||+|+||+||+|++.. ++..+|+|.++.............+|+.+++.+   +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 467899998875433332333444566666655   6999999999986443323


Q ss_pred             cceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ....++|||+++++|.+.+...  ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            3678999999999999988753  45899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+....+.+.+..+.....
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            332 23344567899999999977 5789999999999999999999999999988888888887766554443322111


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ....    ..............+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       239 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccch----hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            0000    001111112223445688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=353.52  Aligned_cols=282  Identities=22%  Similarity=0.348  Sum_probs=245.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      --++|++.++||+|+||+|+++..+.+++.||||++++... ...+......|..++... +||.++.++..|+..    
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~----  441 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK----  441 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC----
Confidence            35799999999999999999999999999999999987643 344556667788888887 599999999999999    


Q ss_pred             cceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                       .++|+||||+.|.-.-.++..+.+++..++.++..++.||.|||++||+|||||.+|||+|.+|.+||+|||+|+..-.
T Consensus       442 -~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  442 -EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             -CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence             8999999999853233345557899999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .....+..+||+-|+|||++.+ ..|+.+.|+|||||+||||+.|..||++.+..+....|...                
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------------  583 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------------  583 (694)
T ss_pred             CCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Confidence            5667788899999999999998 78999999999999999999999999999998888887641                


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCCCCC-CCCCCCCCccc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDPQCN-PPAQVPLSLDI  339 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~~~~-~~~~~~~~~~~  339 (364)
                                     ...++..++.+..++++++|..+|++|..     +++|..||||+.+.+.+.. ...++|..+.+
T Consensus       584 ---------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i  648 (694)
T KOG0694|consen  584 ---------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI  648 (694)
T ss_pred             ---------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence                           13344568889999999999999999994     6899999999999665544 67788888888


Q ss_pred             chhhhHH
Q 017909          340 DENIGEQ  346 (364)
Q Consensus       340 ~~~~~~~  346 (364)
                      .+..|.+
T Consensus       649 ~~~~D~s  655 (694)
T KOG0694|consen  649 KGPEDVS  655 (694)
T ss_pred             CChhhhc
Confidence            8777754

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.7e-46  Score=343.95  Aligned_cols=314  Identities=54%  Similarity=0.968  Sum_probs=263.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +.++|++.+.||.|++|.||+|.++.+|..|++|++............+.+|+.+++.++||||+++++++..... ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA-DFK   81 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC-CCc
Confidence            5689999999999999999999999999999999987654444455566789999999999999999998865432 225


Q ss_pred             eEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ..++||||++++|.+.+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            78999999999999999888889999999999999999999999999999999999999999999999999886543221


Q ss_pred             ----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          188 ----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       188 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                          .......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+....+.++.........
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence                1122346788899999987655689999999999999999999999999888888888888888777766655555


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccchh
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDEN  342 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~  342 (364)
                      ..........+......+....+..++.+.++|++||+.||.+|||+.+++.||||.++..+...+....|...+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAI  320 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhh
Confidence            5555554444444444445556678999999999999999999999999999999999999999888778887777655

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=349.25  Aligned_cols=259  Identities=27%  Similarity=0.486  Sum_probs=225.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -...|...++||+|+.|.||.|....+++.||+|.+....  .....-+++|+.+|+..+|+|||.+++.|...     .
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----d  343 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----D  343 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence            4568999999999999999999999999999999997642  33444567999999999999999999999988     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .+++||||++ |+|.|++.. ..+++..+..+++++++||+|||.+||+|+|||.+|||++.+|.+||+|||+|......
T Consensus       344 eLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            8999999998 588887766 44999999999999999999999999999999999999999999999999999887666


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........||++|||||++.. ..|+++.||||||+++.||+-|.+||-..+....+.+|... +               
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g---------------  485 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G---------------  485 (550)
T ss_pred             cCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-C---------------
Confidence            666778899999999999977 78999999999999999999999999876655555555331 1               


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                  .-....+..+|+.+++||.+||+.|+.+|+++.|||+||||+...
T Consensus       486 ------------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  486 ------------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             ------------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence                        111223457899999999999999999999999999999995433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=335.54  Aligned_cols=263  Identities=27%  Similarity=0.436  Sum_probs=216.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ..+|+.++.||+|+||.||++.+..+|...|+|.....  .......+.+|+.+|++++|||||++++.......   ..
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---ee
Confidence            45789999999999999999999999999999998765  22225567789999999999999999997544421   36


Q ss_pred             EEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~~~  185 (364)
                      ++|.|||+. |+|.+++...+ .+++..++.+.+|+++||.|||++|++|+||||+|||++. ++.+||+|||.+.....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            899999998 69999999876 7999999999999999999999999999999999999999 79999999998876642


Q ss_pred             ---CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 ---NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                         .........||+.|||||++.+.....+++|||||||++.||+||+.||...  .+....+....            
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig------------  236 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIG------------  236 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHh------------
Confidence               1222445788999999999986333446999999999999999999999763  11112121111            


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                    .....+.++..+++.+.+||++|+..||.+||||+++|+|||.+.-..
T Consensus       237 --------------~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  237 --------------REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             --------------ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                          011223556779999999999999999999999999999999987544

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-45  Score=353.57  Aligned_cols=312  Identities=23%  Similarity=0.370  Sum_probs=232.6

Q ss_pred             CCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC------
Q 017909           14 RGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK------   87 (364)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~------   87 (364)
                      .+.......+.+....++|++.+.||+|+||+||+|.+..+++.||+|+++....   .......|+.+++.+.      
T Consensus       113 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~  189 (467)
T PTZ00284        113 EGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPAD  189 (467)
T ss_pred             CCceeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCccc
Confidence            3444555555555567899999999999999999999999999999999864211   1222334555655554      


Q ss_pred             CCCcceeeeeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEE
Q 017909           88 HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLV  166 (364)
Q Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll  166 (364)
                      |.+++++++++....    .+.++||++++++|.+++...+.+++..++.++.||+.||.|||+ .||+|+||||+|||+
T Consensus       190 ~~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl  265 (467)
T PTZ00284        190 RFPLMKIQRYFQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM  265 (467)
T ss_pred             CcceeeeEEEEEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence            455888888886542    578999999999999999888889999999999999999999998 599999999999999


Q ss_pred             ccCC----------------cEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC
Q 017909          167 NANC----------------DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR  230 (364)
Q Consensus       167 ~~~~----------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  230 (364)
                      +.++                .+||+|||.+....   .......|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             ecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhC
Confidence            8765                49999999875432   12334578999999999987 5799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCc-----------ccccCCCCChHHHHHHHHh
Q 017909          231 KPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTH-----------ISSLYPQADPLALDLLQKM  299 (364)
Q Consensus       231 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~  299 (364)
                      +.||.+.+..+....+...++..+..............+...........           ........++.+.+||.+|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            99999998888888888887776554322211111111111111000000           0000011256788999999


Q ss_pred             cccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCC
Q 017909          300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS  336 (364)
Q Consensus       300 l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~  336 (364)
                      |+.||.+|||++|+|+||||..........|.-+..+
T Consensus       422 L~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~  458 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNR  458 (467)
T ss_pred             CCcChhhCCCHHHHhcCccccccCCccccCCCCCCcc
Confidence            9999999999999999999999776555544444333

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-46  Score=345.01  Aligned_cols=251  Identities=25%  Similarity=0.440  Sum_probs=213.5

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEec
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      +.||+|+||+||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++.+...     ...++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence            468999999999999999999999999976433 233445667899999999999999999999877     78999999


Q ss_pred             ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccc
Q 017909          115 LMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY  193 (364)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~  193 (364)
                      |++ ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            998 6999999888899999999999999999999999999999999999999999999999999987543333334455


Q ss_pred             cccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhC
Q 017909          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL  273 (364)
Q Consensus       194 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
                      .|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                        
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------------------------  210 (323)
T cd05571         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------------  210 (323)
T ss_pred             ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------------------------
Confidence            78999999999977 57899999999999999999999999876654444333210                        


Q ss_pred             CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                             ....+..+++.+.+||++||+.||.+||     ++.++++||||.+..
T Consensus       211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         211 -------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                   0122346788999999999999999999     899999999998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-46  Score=340.83  Aligned_cols=316  Identities=59%  Similarity=1.044  Sum_probs=268.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||+|++..+++.+++|.+............+.+|+.+++.++|+|++++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            68999999999999999999998899999999976544444556778899999999999999999998877433345789


Q ss_pred             EEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC---
Q 017909          111 LVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---  187 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~---  187 (364)
                      +||+|++++|.+.+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~  160 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK  160 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence            99999999999999887889999999999999999999999999999999999999999999999999987654432   


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+....+....+....+.+....+.........
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (330)
T cd07834         161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR  240 (330)
T ss_pred             ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence            12334566888999999988547899999999999999999999999999988888888888888877766655666666


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCc--ccchhhhH
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSL--DIDENIGE  345 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~--~~~~~~~~  345 (364)
                      .+...........+....+.+++.+.++|++||+.||.+|||++++++||||+++..+...++...+...  ..+..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (330)
T cd07834         241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTE  320 (330)
T ss_pred             hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCH
Confidence            6665555555555566667789999999999999999999999999999999999999999888888877  44444443


Q ss_pred             H
Q 017909          346 Q  346 (364)
Q Consensus       346 ~  346 (364)
                      .
T Consensus       321 ~  321 (330)
T cd07834         321 E  321 (330)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9e-46  Score=335.63  Aligned_cols=290  Identities=38%  Similarity=0.664  Sum_probs=232.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      -++|++.+.||.|++|.||+|.++.+++.|++|.+....... ....+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~   78 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTE-----KS   78 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecC-----Ce
Confidence            358999999999999999999999999999999986543222 233456899999999999999999999877     78


Q ss_pred             EEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          79 LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9999999999999888754 568999999999999999999999999999999999999999999999999987554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||++.+...++.++||||||+++|+|++|+.||.+.+..+....+...++.+....+.........
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            33334456888999999877566889999999999999999999999998888777777777776665544332211100


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      .. ...+.............+++.+.+||.+||+.||.+|||++|+|+||||+.+...
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         239 KS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            00 0001111111223345688899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.8e-46  Score=333.78  Aligned_cols=283  Identities=38%  Similarity=0.616  Sum_probs=221.9

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +|++.+.||+|++|+||+|.++.+++.+|+|.++.............+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999999875432222222334555555554   799999999998765433336


Q ss_pred             eEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++|||++.++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            78999999999999988764  3589999999999999999999999999999999999999999999999999875532


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      . .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+....+......+.......
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             c-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            2 22234466888999999977 578999999999999999999999999888888888877766655443332111000


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .    ...............+.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       239 ~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 R----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             c----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0    0011112222334456788899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-45  Score=331.51  Aligned_cols=282  Identities=38%  Similarity=0.677  Sum_probs=229.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++++.||+|++|.||+|+++.++..|++|.++...........+.+|+.+++.++|||++++++++..+     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence            58999999999999999999999999999999876544443445667899999999999999999999877     7889


Q ss_pred             EEeccccccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMDTDLHQIIKSS---QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +||||++++|.+.+...   ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            99999999998888643   468999999999999999999999999999999999999999999999999987554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+....+......+....  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT--SLP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch--hhH
Confidence            333344567889999998775567899999999999999999999999887776666666655554443332211  222


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .+....+.............+++.+.++|++||+.||.+|||+.+|++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            2333333333333344456689999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-46  Score=341.58  Aligned_cols=263  Identities=24%  Similarity=0.404  Sum_probs=220.4

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++..... ......+.+|+.++..++||||+++++++...     ..
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CE
Confidence            4799999999999999999999999999999999765332 22445667899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.....  
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999997 69999998888899999999999999999999999999999999999999999999999999875533  


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                       ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+..........           
T Consensus       154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----------  220 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP-----------  220 (333)
T ss_pred             -ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC-----------
Confidence             2345568899999999987 488999999999999999999999998877655555443211110000           


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                  ........+++.+.+||.+||..+|.+||+++++++||||.....
T Consensus       221 ------------~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         221 ------------VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ------------CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                        000001356889999999999999999999999999999998633

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.2e-46  Score=340.24  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=217.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -++|++.+.||+|+||+||+|+++.+++.||+|+++.... .......+.+|+.+++.++||||+++++.+...     .
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence            4689999999999999999999999999999999975432 223445667899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            8999999997 699999988888999999999999999999999999999999999999999999999999998765332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .   ....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...                 
T Consensus       172 ~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-----------------  230 (329)
T PTZ00263        172 T---FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-----------------  230 (329)
T ss_pred             c---ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2   23467899999999987 56899999999999999999999999877655444433221                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL  322 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~  322 (364)
                                    ....+..++..+.+||++||+.||.+||+     ++++++||||.+.
T Consensus       231 --------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        231 --------------RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             --------------CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                          01122347788999999999999999997     7999999999875

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-45  Score=350.77  Aligned_cols=291  Identities=36%  Similarity=0.574  Sum_probs=226.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc---c
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR---I  104 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~  104 (364)
                      ..++|++++.||+|+||+||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3568999999999999999999999999999999885421      122369999999999999999988754321   1


Q ss_pred             ccceEEEEeccccccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCc
Q 017909          105 SFKDVYLVYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGL  179 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~  179 (364)
                      ....+++||||+++++.+.+.    ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||+
T Consensus       138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            113578999999998887764    346799999999999999999999999999999999999998765 699999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +....... ......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+...++.+......
T Consensus       218 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        218 AKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             chhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            97653322 23345678899999998775678999999999999999999999999998888888888877766554332


Q ss_pred             ccCchhHHHHHhhCCCCC-CCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          260 FIDNPKARRFIKSLPYSR-GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      .... .....  ..+... ......++...++.+.+||.+||+.||.+|||+.|+|+||||..+.++...
T Consensus       297 ~~~~-~~~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~  363 (440)
T PTZ00036        297 EMNP-NYADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIK  363 (440)
T ss_pred             Hhch-hhhcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhccccc
Confidence            2111 00000  000000 001112334578899999999999999999999999999999988665443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-45  Score=344.03  Aligned_cols=283  Identities=26%  Similarity=0.302  Sum_probs=219.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||.||+|.+..+++.||+|....        ..+.+|+.+++.++||||+++++++...     ..
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~  157 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYN-----KF  157 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEEC-----Ce
Confidence            4689999999999999999999999999999997532        2356799999999999999999999776     78


Q ss_pred             EEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC-C
Q 017909          109 VYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN-E  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~-~  187 (364)
                      .++|+|++.++|.+.+.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... .
T Consensus       158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            899999999999999988888999999999999999999999999999999999999999999999999998643221 2


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCchhhhhc
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT-------ECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||-..       ........+....+..+......
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            22334578999999999977 57899999999999999999999776432       23345555666555544322111


Q ss_pred             cCchhHHHHHhhCCCC-CCCcc---cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          261 IDNPKARRFIKSLPYS-RGTHI---SSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ........+....... .....   .......+..+.+||++||+.||.+|||++|+|+||||+.+..+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            1111111111100000 00000   00112356789999999999999999999999999999886544

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.1e-46  Score=340.37  Aligned_cols=251  Identities=24%  Similarity=0.430  Sum_probs=212.8

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEec
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      +.||+|+||.||++.++.+|..||+|+++.... .......+.+|+.+++.++||||+++++.+...     ...++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence            468999999999999999999999999976433 223445667899999999999999999999877     78999999


Q ss_pred             ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccc
Q 017909          115 LMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY  193 (364)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~  193 (364)
                      |++ |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            998 6998888888889999999999999999999999999999999999999999999999999887543333333445


Q ss_pred             cccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhC
Q 017909          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL  273 (364)
Q Consensus       194 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
                      .|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                        
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------------------------  210 (323)
T cd05595         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------------  210 (323)
T ss_pred             cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------------
Confidence            68899999999977 57899999999999999999999999877655444433210                        


Q ss_pred             CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                             ....+..+++.+.+||.+||+.||.+||     ++.++++||||.+..
T Consensus       211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         211 -------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                   0112346788999999999999999998     999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=335.13  Aligned_cols=266  Identities=27%  Similarity=0.426  Sum_probs=221.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH------------HHHHHHHHHHHHHhcCCCCcceee
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI------------DALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      .-++|++.+.||+|.||+|.+|++..+++.||||++.+......            ...+..+|+.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            45699999999999999999999999999999999965322211            223567899999999999999999


Q ss_pred             eeeccccccccceEEEEecccc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEE
Q 017909           96 DVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~  173 (364)
                      ++.-+...   ..+|+|+|||. |.+. +....++ +++.+++.+++++..||.|||.+||+||||||+|+|++.+|.+|
T Consensus       175 EvLDDP~s---~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  175 EVLDDPES---DKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EeecCccc---CceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            99866644   78999999998 4443 3334455 99999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCC-----CCCcccccccccccccCCccccc---ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017909          174 ICDFGLARTSR-----GNEQFMTEYVVTRWYRAPELLLC---CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL  245 (364)
Q Consensus       174 L~Dfg~~~~~~-----~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  245 (364)
                      |+|||.+....     ..........||+.|+|||....   ....+.+.||||+|+.||+|+.|+.||-+....+...+
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            99999987552     22333455789999999999877   33467899999999999999999999999888888888


Q ss_pred             HHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      |++.--..+.                             .+.+.+.+++||.+||++||++|.++.+|..|||.....+-
T Consensus       331 Ivn~pL~fP~-----------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  331 IVNDPLEFPE-----------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             HhcCcccCCC-----------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            8663222221                             23567889999999999999999999999999999887444


Q ss_pred             C
Q 017909          326 Q  326 (364)
Q Consensus       326 ~  326 (364)
                      +
T Consensus       382 ~  382 (576)
T KOG0585|consen  382 P  382 (576)
T ss_pred             C
Confidence            3

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-47  Score=317.73  Aligned_cols=297  Identities=32%  Similarity=0.487  Sum_probs=239.9

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-----chH-HHHHHHHHHHHHHhc-CCCCcceeeeeec
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-----NRI-DALRTLRELVLLRHI-KHDNVIALKDVMM   99 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   99 (364)
                      .+...|.-.+.||+|..++|-++.++.+|+.+++|++.....     +.. -...-.+|+.+|+++ .||+|+++.+.|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            456789999999999999999999999999999999853211     111 122335899999999 6999999999999


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      .+     ...++|+|.|+ |.|.|++.+.-.+++...+.+++|+++++.|||.++|+|+|+||+|||++++.+++|+|||
T Consensus        94 s~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             Cc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence            88     88999999998 8999999998899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCCccccc-----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      +++.... .......|||++|+|||.+..     .+.|+...|+|++|+|+|.|+.|.+||-.....-.+..|++..-.+
T Consensus       169 Fa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  169 FACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             eeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            9988744 445677899999999999864     3558899999999999999999999997665555555555432222


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC---CCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY---DPQCNPP  330 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~---~~~~~~~  330 (364)
                                                 .++-|.+++...++||.+||+.||.+|.|++|+|.||||....   .+.-+|-
T Consensus       248 ---------------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~  300 (411)
T KOG0599|consen  248 ---------------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPV  300 (411)
T ss_pred             ---------------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCC
Confidence                                       2344567889999999999999999999999999999995542   3333444


Q ss_pred             CCCCCCcccchhhh-------------HHHHHHHHHHHH
Q 017909          331 AQVPLSLDIDENIG-------------EQMIRQMMWNET  356 (364)
Q Consensus       331 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~  356 (364)
                      +++..-.++.+.-+             .++++...+..|
T Consensus       301 ~~~~~~k~qt~~~aRkrFk~ail~vra~~Ria~~~~~~~  339 (411)
T KOG0599|consen  301 VEVELVKDQTSERARKRFKVAILTVRAFQRIAKYKYRVT  339 (411)
T ss_pred             cchhhhhhhhhHHhhhheeeeeehHHHHHHHHHHhhccc
Confidence            44444444444332             566666665544

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-46  Score=325.94  Aligned_cols=261  Identities=28%  Similarity=0.410  Sum_probs=224.7

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      +.|++++.||.|.-|+||++..+.++..+|+|++.+.... .....+...|.+||..++||.+++++..|..+     ..
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----KY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----ce
Confidence            5799999999999999999999999999999999876554 44556667899999999999999999999988     89


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .|+|||||+ |+|..+.++.  +.+++..++.++.+++.||.|||-.||++|||||+||||.++|++.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999998 5888888654  5799999999999999999999999999999999999999999999999987632110


Q ss_pred             ---------------------------------C-C----------------------cccccccccccccCCccccccc
Q 017909          186 ---------------------------------N-E----------------------QFMTEYVVTRWYRAPELLLCCD  209 (364)
Q Consensus       186 ---------------------------------~-~----------------------~~~~~~~~~~~~~aPE~~~~~~  209 (364)
                                                       . .                      .......||.-|+|||++.+ .
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~  310 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-E  310 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-C
Confidence                                             0 0                      00112355777999999998 6


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCC
Q 017909          210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD  289 (364)
Q Consensus       210 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (364)
                      ..+.+.|+|+||+++|||+.|..||.+.+..+...+|+..-..++.                             .+.++
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~-----------------------------~~~vs  361 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE-----------------------------EPEVS  361 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-----------------------------CCcch
Confidence            8999999999999999999999999999999999888764333222                             13567


Q ss_pred             hHHHHHHHHhcccCCCCCCC----HHHHhcCCCccCCCCC
Q 017909          290 PLALDLLQKMLVFEPSKRIT----VTEALQHPYISGLYDP  325 (364)
Q Consensus       290 ~~l~~li~~~l~~dP~~Rps----~~elL~hp~f~~~~~~  325 (364)
                      ..++|||+++|.+||++|..    +.||.+||||+++.+.
T Consensus       362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence            88999999999999999998    9999999999999776

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-46  Score=343.45  Aligned_cols=261  Identities=27%  Similarity=0.426  Sum_probs=219.7

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|++..+|+.||+|+++...... .....+..|+.++..++|+||+++++++...     ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----Ce
Confidence            47999999999999999999999999999999997654332 3445667899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999987554332


Q ss_pred             -----------------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 017909          188 -----------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE  238 (364)
Q Consensus       188 -----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  238 (364)
                                                   .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                         12334567899999999988 588999999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-HHHHhcCC
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-VTEALQHP  317 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~elL~hp  317 (364)
                      .......+......                           ........+++.+.+||++||. ||.+||+ ++++|+||
T Consensus       235 ~~~~~~~i~~~~~~---------------------------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         235 LQETYNKIINWKES---------------------------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HHHHHHHHhccCCc---------------------------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            65555544331100                           0011112368899999999998 9999999 99999999


Q ss_pred             CccCCCC
Q 017909          318 YISGLYD  324 (364)
Q Consensus       318 ~f~~~~~  324 (364)
                      ||++...
T Consensus       287 ~~~~~~~  293 (350)
T cd05573         287 FFKGIDW  293 (350)
T ss_pred             CcCCCCH
Confidence            9988633

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=334.63  Aligned_cols=340  Identities=44%  Similarity=0.797  Sum_probs=266.7

Q ss_pred             eEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeee
Q 017909           18 YYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV   97 (364)
Q Consensus        18 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (364)
                      ..++...+..+.++|++.+.||+|++|.||++.+..+++.||+|++............+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            34455566778899999999999999999999999999999999997654444445567789999999999999999998


Q ss_pred             ecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909           98 MMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus        98 ~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      +...... .....++++++++++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             eeecccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence            8654321 1245789999998899887765 4699999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA  256 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (364)
                      ||.+......   .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+..+..
T Consensus       164 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T cd07877         164 FGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  240 (345)
T ss_pred             cccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9998654322   2334567889999998765568899999999999999999999999888777777777777666666


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCC
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS  336 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~  336 (364)
                      ..........+.+...................++.+.++|.+||+.||.+||++.++++||||+++..+...+.+...-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~~~~  320 (345)
T cd07877         241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ  320 (345)
T ss_pred             HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCCccC
Confidence            55555544444444433333333333344467889999999999999999999999999999999988887765554444


Q ss_pred             cccchhhhHHHHHHHHHHHHHhhCC
Q 017909          337 LDIDENIGEQMIRQMMWNETLHYHP  361 (364)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~  361 (364)
                      ...-+.+..+|--...|-+.+.|-|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         321 SFESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             cchhcccCHHHHHHHHHHHHHhcCC
Confidence            4444444456656666666666544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-44  Score=334.52  Aligned_cols=336  Identities=46%  Similarity=0.819  Sum_probs=259.8

Q ss_pred             eeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           21 MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        21 ~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      +..+++.+.++|++++.||+|++|.||++.+..+|..||+|.+............+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880           6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            34556678999999999999999999999999999999999986544444444567789999999999999999999876


Q ss_pred             cccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          101 THRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       101 ~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                      .... .....++|+++++++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          86 DLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             CccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            5321 1235689999998888887764 5799999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +......   .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+..+.....
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         165 ARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8754322   2233557889999998764568899999999999999999999999888777777777665555554444


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCccc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDI  339 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~  339 (364)
                      .........+....+...........+.+++.+.++|.+||+.||.+|||+.+++.||||+....+...+..+ |.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~  320 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP-PYDDSF  320 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC-CccccH
Confidence            4444444444444444444444455677899999999999999999999999999999999987765554333 232222


Q ss_pred             chhhh-HHHHHHHHHHHHHhhCC
Q 017909          340 DENIG-EQMIRQMMWNETLHYHP  361 (364)
Q Consensus       340 ~~~~~-~~~~~~~~~~~~~~~~~  361 (364)
                      +.... -.+-++.++.+.|++.|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         321 DEVDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             HhhccchHHHHHHHHHHHHhcCC
Confidence            21111 22225667777777765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-45  Score=330.28  Aligned_cols=282  Identities=41%  Similarity=0.679  Sum_probs=222.2

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||+|++..+|+.+++|.++...........+.+|+.+++.++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence            58999999999999999999999999999999875433333334566799999999999999999999877     7889


Q ss_pred             EEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      +|+||++++|.+.+.. .+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            9999999999888865 467999999999999999999999999999999999999999999999999998755433333


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI-FPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|..| |.+.+.......+....+......+.....  ...
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK--LPD  233 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh--ccc
Confidence            33445678899999987755679999999999999999988777 555555666666666555544332221110  000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      +...........+....+.+++.+.+||++||+.||.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000001111122234456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.5e-46  Score=339.57  Aligned_cols=250  Identities=25%  Similarity=0.455  Sum_probs=211.7

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEec
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      +.||+|+||.||++.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++.+...     ...++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence            468999999999999999999999999976433 233445667899999999999999999999877     78999999


Q ss_pred             ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccc
Q 017909          115 LMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY  193 (364)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~  193 (364)
                      |++ |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            997 6898888888889999999999999999999999999999999999999999999999999986543333333445


Q ss_pred             cccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhC
Q 017909          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL  273 (364)
Q Consensus       194 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
                      .|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..                         
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-------------------------  209 (328)
T cd05593         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------------  209 (328)
T ss_pred             cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-------------------------
Confidence            78999999999977 5789999999999999999999999987655444333211                         


Q ss_pred             CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 017909          274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGL  322 (364)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~  322 (364)
                            .....+..+++.+.+||++||+.||.+|+     ++.++++||||.+.
T Consensus       210 ------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         210 ------EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             ------CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                  00123356788999999999999999997     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-45  Score=338.38  Aligned_cols=256  Identities=26%  Similarity=0.380  Sum_probs=217.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCC-cEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETN-EKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~-~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      -.++|++.+.||+|+||.||+|.++.++ ..||+|++..... .......+.+|+.+++.++||||+++++++...    
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----  103 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----  103 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC----
Confidence            3568999999999999999999876554 6899999865432 233445667899999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||+. |+|.+.+...+.+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++....
T Consensus       104 -~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        104 -SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence             78999999997 6999999988899999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..   .....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....              
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------------  244 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------------  244 (340)
T ss_pred             CC---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            22   234567899999999977 578999999999999999999999998876655554443210              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                       ...+..+++.+.++|++||+.||.+|+     +++++++||||.+..
T Consensus       245 -----------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        245 -----------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                             112345788899999999999999995     999999999998764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-45  Score=334.35  Aligned_cols=248  Identities=28%  Similarity=0.488  Sum_probs=210.9

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||+|+||+||+|.+..+++.||+|+++.... .......+..|+.+++.++||||+++++.+...     ...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence            6999999999999999999999999975432 233445667899999999999999999999877     7899999999


Q ss_pred             c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccc
Q 017909          117 D-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV  195 (364)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  195 (364)
                      + |+|.+.+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..............|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            8 699999988888999999999999999999999999999999999999999999999999998754333333445578


Q ss_pred             cccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCC
Q 017909          196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPY  275 (364)
Q Consensus       196 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (364)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...                          
T Consensus       156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--------------------------  208 (312)
T cd05585         156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--------------------------  208 (312)
T ss_pred             CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------------
Confidence            999999999987 57899999999999999999999999876654444333210                          


Q ss_pred             CCCCcccccCCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCC
Q 017909          276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRI---TVTEALQHPYISGL  322 (364)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~elL~hp~f~~~  322 (364)
                           ....+..+++.+.+||.+||+.||.+||   ++.++|+||||...
T Consensus       209 -----~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         209 -----PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence                 1123356788999999999999999997   58999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-45  Score=340.92  Aligned_cols=261  Identities=26%  Similarity=0.387  Sum_probs=212.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .|++++.||+|+||+||+|+++.++..||+|++..... .......+.+|+.+++.++||||+++++++.+.     ...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEE
Confidence            68999999999999999999999999999999975432 333455677899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC-
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~-  187 (364)
                      ++||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999997 6999999888889999999999999999999999999999999999999999999999999874321000 


Q ss_pred             ----------------------------------------------cccccccccccccCCcccccccCCCChhhHHHHH
Q 017909          188 ----------------------------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVG  221 (364)
Q Consensus       188 ----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG  221 (364)
                                                                    .......|+..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVG  235 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehh
Confidence                                                          00123468899999999977 5789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcc
Q 017909          222 CIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLV  301 (364)
Q Consensus       222 ~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  301 (364)
                      |++|+|++|..||...........+......                           ........+++.+.+||.+|+.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~dli~~ll~  288 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENT---------------------------LHIPPQVKLSPEAVDLITKLCC  288 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------------------cCCCCCCCCCHHHHHHHHHHcc
Confidence            9999999999999887654444333211000                           0011123578899999999664


Q ss_pred             --cCCCCCCCHHHHhcCCCccCCCC
Q 017909          302 --FEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       302 --~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                        .++..|++++++++||||++...
T Consensus       289 ~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         289 SAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             CcccccCCCCHHHHhcCcccCCCCh
Confidence              45555999999999999988644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-45  Score=330.69  Aligned_cols=293  Identities=39%  Similarity=0.641  Sum_probs=231.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||.|++|.||+|.++.+|+.||+|.++.............+|+.+++.++|+|++++++++.....   ..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL---DS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC---Ce
Confidence            568999999999999999999999999999999987543333223345679999999999999999999865432   46


Q ss_pred             EEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            7999999999998888753 679999999999999999999999999999999999999999999999999987664433


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.+....+.........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            33334445778999999877567899999999999999999999999999888888888877666554433222111100


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      .... ........+.......++.+.+||++||+.||++|||++++|+||||++...+
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         243 GKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            0000 00000111122233468889999999999999999999999999999987666

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.6e-45  Score=328.38  Aligned_cols=264  Identities=23%  Similarity=0.349  Sum_probs=215.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .|++.+.||+|+||+||++.+..+|+.||+|.+...... ......+.+|+.+++.++|++++++.+.+...     ...
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeE
Confidence            378999999999999999999999999999998754332 22334567899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||++ |+|.+.+..  ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999998 688877754  246899999999999999999999999999999999999999999999999998765322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                       .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......              
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------  219 (285)
T cd05631         156 -ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--------------  219 (285)
T ss_pred             -CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--------------
Confidence             22334567899999999987 57899999999999999999999999876543333222221111              


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~~~~  328 (364)
                                   ........+++.+.+||++||+.||.+||+     ++++++||||.+.......
T Consensus       220 -------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05631         220 -------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE  273 (285)
T ss_pred             -------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence                         011233467889999999999999999997     8999999999987544433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.3e-45  Score=333.82  Aligned_cols=252  Identities=23%  Similarity=0.375  Sum_probs=212.2

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.++.+++.||+|+++.... .......+..|..++..+ +||||+++++++...     ...++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence            468999999999999999999999999975432 223445556788888776 699999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|.+.+...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9998 699999988889999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------------  211 (320)
T cd05590         156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------------  211 (320)
T ss_pred             cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence            578999999999877 57899999999999999999999999887765555444221                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV------TEALQHPYISGLYD  324 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~elL~hp~f~~~~~  324 (364)
                              ....+..+++.+.+||++||+.||.+||++      +++++||||..+..
T Consensus       212 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         212 --------EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence                    011224578899999999999999999998      99999999988643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-45  Score=331.13  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=215.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcE-EEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ......+.+.+|+|+||+||++.++  |+. ||+|++............+.+|+.+|++++|||||++++++..+.    
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----  112 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----  112 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----
Confidence            3556677788999999999999887  666 999999876666555778899999999999999999999998772    


Q ss_pred             ceEEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCeEEccCC-cEEEeecCccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANC-DLKICDFGLAR  181 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~di~~~NIll~~~~-~~~L~Dfg~~~  181 (364)
                      ...+|||||++ |+|.+++..  .+.++...+..++.+|+.|+.|||+++ |+|+||||+|||++.++ ++||+|||+++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            26899999998 799999987  578999999999999999999999999 99999999999999997 99999999997


Q ss_pred             cCCCCCcccccccccccccCCccccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .............||..|||||++.+ ...++.++||||||+++|||+||..||.+.........+...           
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~-----------  261 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG-----------  261 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----------
Confidence            66544344555788999999999985 267999999999999999999999999998875444444321           


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        .....++..+++.+.+||..||+.||.+||++.+++.
T Consensus       262 ------------------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  262 ------------------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ------------------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                              1223334458899999999999999999999999874

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-44  Score=324.59  Aligned_cols=282  Identities=39%  Similarity=0.680  Sum_probs=227.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++++.||.|++|.||+|+++.+|+.+++|.++...........+.+|+.++++++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence            48999999999999999999999999999999876544444445677899999999999999999998776     7789


Q ss_pred             EEeccccccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          111 LVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      +||||++++|.+.+..  ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            9999999889888865  35689999999999999999999999999999999999999999999999999875543333


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+....+.+....+....  ....
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  233 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT--SLPD  233 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh--HHHH
Confidence            33334557789999998775557899999999999999999999999888777777776666655443222111  1111


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      +....+...........+.+++.+.++|.+||+.||.+|||++++|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            112222222222333445688899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.9e-45  Score=332.14  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=215.2

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCC-Ccceeeeeeccccccccce
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHD-NVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~  108 (364)
                      +|++.+.||+|+||.||+|.++.+++.||+|++..... .......+..|..++..+.|+ +++++++++...     ..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence            58999999999999999999999999999999976432 233445667888999988765 578888888776     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ |+|.+.+.....+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999986543333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+....+....+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------  217 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------  217 (324)
T ss_pred             CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            33445578999999999987 578999999999999999999999998877655555443210                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV-----TEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~elL~hp~f~~~~  323 (364)
                                    ...+..+++.+.++|++||+.||.+|++.     +++++||||....
T Consensus       218 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         218 --------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                          12234578899999999999999999976     8999999998753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-45  Score=338.70  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=215.7

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.++..++||||+++++.+...     ..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----Ce
Confidence            479999999999999999999999999999999975432 223344566899999999999999999999887     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+. |+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999886432111


Q ss_pred             c--------------------------------------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh
Q 017909          188 Q--------------------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG  229 (364)
Q Consensus       188 ~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  229 (364)
                      .                                      ......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhc
Confidence            0                                      0112358999999999877 578999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC
Q 017909          230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT  309 (364)
Q Consensus       230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  309 (364)
                      |..||.+.........+......                           ........+++.+.+||++|+. +|.+|++
T Consensus       235 G~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         235 GYPPFCSDNPQETYRKIINWKET---------------------------LQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCc---------------------------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            99999887665554444321000                           0001112468899999999997 9999998


Q ss_pred             ---HHHHhcCCCccCCCC
Q 017909          310 ---VTEALQHPYISGLYD  324 (364)
Q Consensus       310 ---~~elL~hp~f~~~~~  324 (364)
                         ++++++||||++...
T Consensus       287 ~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         287 NNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCHHHHhcCCCcCCCCH
Confidence               999999999988643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=323.69  Aligned_cols=268  Identities=25%  Similarity=0.447  Sum_probs=234.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +..||++.+.||.|.||+|-+|+.+..|..||||.++++.. ...+...+.+|++++..++||||++++++|...     
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----  125 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----  125 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----
Confidence            57899999999999999999999999999999999987644 455777888999999999999999999999888     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..+.|||||.. |.|+|++.+.+.+++.+++.+++||..|+.|||.++++|+|+|.+|||++.|+++||+|||++... .
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly-~  204 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY-A  204 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh-c
Confidence            88999999997 799999999999999999999999999999999999999999999999999999999999999877 4


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ...+....||++.|.+||...+..+-++..|.||||++||.|+.|..||++.+.....+.|....-.             
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------------  271 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------------  271 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-------------
Confidence            4556778899999999999999877899999999999999999999999999877766666432111             


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc-CCCCCCCCCCCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCNPPAQV  333 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~-~~~~~~~~~~~~~  333 (364)
                                         .+..+.+..-||++||..||.+|.|+++|.+|=|+. +..-+.+.-.+++
T Consensus       272 -------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V~~~ea~h  321 (668)
T KOG0611|consen  272 -------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPVIQEEAQH  321 (668)
T ss_pred             -------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecccccccccccccc
Confidence                               134555678999999999999999999999998884 3344444444443

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.3e-44  Score=325.85  Aligned_cols=288  Identities=43%  Similarity=0.695  Sum_probs=229.5

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc---hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN---RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+......   ......+..|+.+++.++|+|++++++++...     .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----S   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----C
Confidence            588999999999999999999999999999999754333   22334556799999999999999999999886     7


Q ss_pred             eEEEEeccccccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||+.++|.+++.... .+++..++.++.||++||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            899999999889999998766 7999999999999999999999999999999999999999999999999998766544


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+...++.++|+|||||++|+|++|.++|.+.........+....+.+....+......  
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  233 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL--  233 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc--
Confidence            333344456778999999876566899999999999999999999999888777766666665554443332211110  


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                      ..+... ...............+..+.++|.+||+.||++|||+.++|+||||++...+.
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         234 PDYVEF-KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccc-cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            000000 00111112223456688899999999999999999999999999999966555

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-44  Score=332.77  Aligned_cols=313  Identities=46%  Similarity=0.856  Sum_probs=251.7

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+.++|++.+.||+|++|.||+|.+..+++.+++|++............+.+|+.+++.+ +||||+++++++.....  
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~--   81 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND--   81 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC--
Confidence            357899999999999999999999998999999998865433444445667899999999 99999999999865432  


Q ss_pred             cceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                       ...++|||+++++|.+.+... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 -~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 -KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             -ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence             468999999999999888775 789999999999999999999999999999999999999999999999998875533


Q ss_pred             CC-----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          186 NE-----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       186 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..     .......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.........+....+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            22     1223345688899999987656688999999999999999999999999888888888877777666655544


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID  340 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~  340 (364)
                      ...+.....................+.++..+.++|.+||+.||.+|||+.++++||||+.+..+...+..+++.+.-++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD  319 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence            44444444444333333333444455689999999999999999999999999999999998776666555555555444


Q ss_pred             hhh
Q 017909          341 ENI  343 (364)
Q Consensus       341 ~~~  343 (364)
                      ++.
T Consensus       320 ~~~  322 (337)
T cd07852         320 DNV  322 (337)
T ss_pred             ccc
Confidence            443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-45  Score=337.54  Aligned_cols=253  Identities=26%  Similarity=0.436  Sum_probs=212.5

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEec
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      +.||+|+||+||++.++.+|..||+|+++..... ......+.+|+.++..++||||++++..+...     ...++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence            4689999999999999999999999999765332 23445667899999999999999999999877     78999999


Q ss_pred             ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          115 LMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      |++ |+|.+.+...+.+++..++.++.||+.||.|||+ +|++|+||||+||+++.++.++|+|||++............
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            998 6898888888889999999999999999999998 79999999999999999999999999998654333333344


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------------  211 (325)
T cd05594         156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------------  211 (325)
T ss_pred             ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence            568999999999977 57899999999999999999999999876654444333210                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDP  325 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~  325 (364)
                              ....+..+++.+.+||++||+.||.+|+     ++.++++||||.+....
T Consensus       212 --------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         212 --------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence                    0112345788999999999999999997     99999999999986433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-44  Score=335.80  Aligned_cols=263  Identities=23%  Similarity=0.331  Sum_probs=214.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|.++.+++.||+|++...... ......+..|+.++..++|++|+++++.+.+.     ..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Ce
Confidence            4799999999999999999999999999999999754322 23344567899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ |+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999997 6999999888899999999999999999999999999999999999999999999999999986432110


Q ss_pred             -----------------------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCC
Q 017909          188 -----------------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP  232 (364)
Q Consensus       188 -----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~  232 (364)
                                                         .......|++.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCC
Confidence                                               00123468999999999987 578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCC---CCCC
Q 017909          233 IFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPS---KRIT  309 (364)
Q Consensus       233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rps  309 (364)
                      ||.+....+....+.......                          . ..-...+++.+.++|.+|+. +|.   .||+
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~--------------------------~-~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~  286 (363)
T cd05628         235 PFCSETPQETYKKVMNWKETL--------------------------I-FPPEVPISEKAKDLILRFCC-EWEHRIGAPG  286 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCcc--------------------------c-CCCcCCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence            998877666555554311000                          0 00012467889999999776 444   4689


Q ss_pred             HHHHhcCCCccCCCCCC
Q 017909          310 VTEALQHPYISGLYDPQ  326 (364)
Q Consensus       310 ~~elL~hp~f~~~~~~~  326 (364)
                      ++||++||||++.....
T Consensus       287 ~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         287 VEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             HHHHhCCCCCCCCCHHH
Confidence            99999999999874433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.1e-45  Score=340.50  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=213.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++|+||+++++.+...     ..
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~   75 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DN   75 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CE
Confidence            369999999999999999999999999999999975432 233445667899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC-
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN-  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~-  186 (364)
                      .++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... 
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999997 699999988888999999999999999999999999999999999999999999999999986422100 


Q ss_pred             ----------------------------------------------CcccccccccccccCCcccccccCCCChhhHHHH
Q 017909          187 ----------------------------------------------EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV  220 (364)
Q Consensus       187 ----------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  220 (364)
                                                                    ........|++.|+|||++.+ ..++.++|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSl  234 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV  234 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEec
Confidence                                                          000112357899999999977 578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhc
Q 017909          221 GCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML  300 (364)
Q Consensus       221 G~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  300 (364)
                      ||++|+|++|..||.+.+..+....+.......                           .......+++.+.++|.+|+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~s~~~~~li~~l~  287 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------------------HIPPQAKLSPEASDLIIKLC  287 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------------------CCCCcccCCHHHHHHHHHHc
Confidence            999999999999998876554444433210000                           01112357889999999986


Q ss_pred             ccCCCCCCC---HHHHhcCCCccCCCC
Q 017909          301 VFEPSKRIT---VTEALQHPYISGLYD  324 (364)
Q Consensus       301 ~~dP~~Rps---~~elL~hp~f~~~~~  324 (364)
                       .+|.+|++   ++++++||||++...
T Consensus       288 -~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         288 -RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             -cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence             59999997   999999999988643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-44  Score=323.34  Aligned_cols=285  Identities=34%  Similarity=0.639  Sum_probs=220.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|.||+|.++.+|+.|++|++............+.+|+.+++.++|+|++++++++...     ...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence            579999999999999999999999999999999875433333334567899999999999999999999877     788


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++||||+++ ++..+......+++..++.++.||+.+|.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999999996 4555555556799999999999999999999999999999999999999999999999999876644332


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+....+....+....+.................
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            33344567889999998765568899999999999999999999999887776666665554443322111110000000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .................+.++..+.+||.+||+.||++||++.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000000000001112234678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-44  Score=333.19  Aligned_cols=283  Identities=22%  Similarity=0.338  Sum_probs=219.8

Q ss_pred             ceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      +|++++.||+|+||+||++++.   .++..||+|++.....  .......+..|+.+++.+ +|++|+++++++...   
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE---   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence            5899999999999999999864   4688999999975432  222344566899999999 599999999998877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++...
T Consensus        78 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          78 --AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence              78899999998 699999988888999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          184 RGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       184 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... .......|+..|+|||++.+...++.++|||||||++|+|++|..||...........+...+..          
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------  225 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----------  225 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----------
Confidence            3222 22234568999999999987556889999999999999999999999754322111111111000          


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCCCC-CCCCCCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQCN-PPAQVPLS  336 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~~~-~~~~~~~~  336 (364)
                                       .....+..+++.+.++|.+||+.||++||     +++++++||||+........ ...+++..
T Consensus       226 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~  288 (332)
T cd05614         226 -----------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFR  288 (332)
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcC
Confidence                             01223356788999999999999999999     88999999999876332222 23344444


Q ss_pred             cccchhhhH
Q 017909          337 LDIDENIGE  345 (364)
Q Consensus       337 ~~~~~~~~~  345 (364)
                      .+.....+.
T Consensus       289 ~~~~~~~~~  297 (332)
T cd05614         289 PSIRNELDV  297 (332)
T ss_pred             CCCCCcchh
Confidence            444444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.8e-45  Score=334.24  Aligned_cols=256  Identities=22%  Similarity=0.390  Sum_probs=208.3

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.++.+++.||+|+++..... ......+..|..++..+ +||||+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence            4689999999999999999999999999865333 23344566889999888 799999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|.+.+...+++++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9998 599988888889999999999999999999999999999999999999999999999999998653333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCchhhhhccCchhHH
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN-----QLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.......     ....+.                   .
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~-------------------~  215 (329)
T cd05588         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF-------------------Q  215 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH-------------------H
Confidence            678999999999987 578999999999999999999999996432110     000000                   0


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT------VTEALQHPYISGLYD  324 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~elL~hp~f~~~~~  324 (364)
                      ...        ......+..++..+.++|++||+.||.+|++      ++++++||||.....
T Consensus       216 ~~~--------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         216 VIL--------EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHH--------cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            000        0112234567889999999999999999997      789999999987533

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-44  Score=330.69  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=210.1

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHH---HhcCCCCcceeeeeeccccccccc
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLL---RHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      |++.+.||+|++|.||+|.++.+++.||+|+++..... ......+..|..++   +.++||||+++++++...     .
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence            78999999999999999999999999999999754322 22333444555544   566899999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||+. ++|...+.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            8999999998 588776654 57999999999999999999999999999999999999999999999999988654333


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+....                
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------  217 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------------  217 (324)
T ss_pred             CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            333445678999999999977 578999999999999999999999998876655544443210                


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYD  324 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~  324 (364)
                                     ...+..+++.+.++|++||+.||.+||     ++.++++||||.....
T Consensus       218 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         218 ---------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                           112345788999999999999999999     7999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-44  Score=321.24  Aligned_cols=259  Identities=30%  Similarity=0.525  Sum_probs=218.5

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |++++.||+|+||+||++.+..+++.+|+|++..............+|+.+++.++||||+++++++...     ...++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----ccccc
Confidence            8999999999999999999999999999999987766655555556799999999999999999999886     88899


Q ss_pred             Eeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc
Q 017909          112 VYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM  190 (364)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~  190 (364)
                      |||++.+ +|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999996 999999977889999999999999999999999999999999999999999999999999987643444445


Q ss_pred             ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       191 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ....++..|+|||++......+.++|+||||+++++|++|..||...........+..............          
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  225 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ----------  225 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----------
Confidence            5667788999999988336899999999999999999999999998754444444443322221111100          


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                    ....++.+.++|.+||+.||++|||+.++++||||
T Consensus       226 --------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  226 --------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             --------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             --------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                          01122689999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=330.75  Aligned_cols=264  Identities=34%  Similarity=0.512  Sum_probs=232.0

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIK-HDNVIALKDVMMPT  101 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  101 (364)
                      ....+.+.|++.+.||+|.||+||+++++.+|+.+|+|++.+..... .......+|+.+|+.++ |||++.+.+.|...
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            34557889999999999999999999999999999999997664433 34566779999999998 99999999999988


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC----CcEEEee
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN----CDLKICD  176 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~----~~~~L~D  176 (364)
                           ..+++|||+|. |.|.+.+... .+++..+..++.|++.++.|||+.|++|+|+||+|+|+...    +.++++|
T Consensus       109 -----~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 -----DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             -----CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence                 78999999998 6999998776 49999999999999999999999999999999999999543    4799999


Q ss_pred             cCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA  256 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (364)
                      ||++..... .......+|++.|+|||++.. ..++...||||+|+++|.|++|.+||.+.........+...-.     
T Consensus       183 FGla~~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-----  255 (382)
T KOG0032|consen  183 FGLAKFIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-----  255 (382)
T ss_pred             CCCceEccC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-----
Confidence            999988866 666778899999999999987 6899999999999999999999999999887766665543211     


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                            ......|+.++..+.++|+.||..||.+|+|+.++|+|||+++.
T Consensus       256 ----------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 ----------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ----------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                                  22345667899999999999999999999999999999998875

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-44  Score=330.76  Aligned_cols=252  Identities=28%  Similarity=0.465  Sum_probs=211.2

Q ss_pred             eeeeccCCceeEEEEEec---cCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           35 IKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++.||+|+||.||++.+.   .+++.||+|+++....  .......+..|+.+++.++||||+++++.+..+     ...
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence            368999999999999864   4688999999975432  223344566899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++||||++ ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999998 59999998888899999999999999999999999999999999999999999999999999865433333


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+...                   
T Consensus       156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------------  215 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------------  215 (323)
T ss_pred             cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence            3344568999999999977 56889999999999999999999999887655444443221                   


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                  ....++.+++.+.+||++||+.||.+||     +++++++||||....
T Consensus       216 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         216 ------------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence                        0123356788999999999999999999     899999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=288.97  Aligned_cols=286  Identities=41%  Similarity=0.687  Sum_probs=252.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      .|.-.++||+|.||+||+|+.+.+++.||+|.++.+.....-....++|+-+|+.++|.|||++++....+     ..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence            56677899999999999999999999999999987766666667788999999999999999999998777     8899


Q ss_pred             EEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      +|+|+|...|..++.+ ++.++.+.++.++.|++.+|.++|++++.|+|+||.|.+++.+|.+||+|||+++.++-.-..
T Consensus        78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            9999999999998865 578999999999999999999999999999999999999999999999999999887666666


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .+...-|.+|.+|.++++.+-|+.+.|+||.|||+.|+. .|.+.|++.+..+++.+|...++.+....|.....  +.+
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~--lpd  235 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK--LPD  235 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc--CCC
Confidence            667777999999999999888999999999999999998 88999999999999999999999998887765432  233


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      +.....+.....|..+-+..+...++|++++|..+|.+|+++++.|+||||....
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            3333334455566667777888889999999999999999999999999998754

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-43  Score=325.46  Aligned_cols=315  Identities=54%  Similarity=0.939  Sum_probs=248.5

Q ss_pred             ceeeeeeeccCCceeEEEEEeccC--CcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRET--NEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+............+.+|+.+++.+ +||||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            589999999999999999999887  89999999875433443455667899999999 5999999998754331 1125


Q ss_pred             eEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ..++++++++++|.+.+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            68899999999999999888889999999999999999999999999999999999999999999999999987543221


Q ss_pred             c----ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          188 Q----FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       188 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .    ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.++.........
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence            1    122346788899999887655689999999999999999999999999888888888888888777665555544


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccchhh
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENI  343 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  343 (364)
                      +....+................+..+..+.+|+.+||+.||.+|||+.+++.||||+.+..+.-.+--..|...+.-++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED  319 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccc
Confidence            44433333333333333444556678899999999999999999999999999999887765444434444444444444


Q ss_pred             hHH
Q 017909          344 GEQ  346 (364)
Q Consensus       344 ~~~  346 (364)
                      .-+
T Consensus       320 ~~~  322 (332)
T cd07857         320 SME  322 (332)
T ss_pred             cHH
Confidence            333

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-44  Score=330.39  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=210.7

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.++.++..||+|+++.... .......+..|..++..+ +||||+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            469999999999999999999999999986532 223344556788888877 699999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|.+.+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9997 699999888888999999999999999999999999999999999999999999999999988653333333344


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------------  211 (318)
T cd05570         156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------------  211 (318)
T ss_pred             eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            568899999999987 57899999999999999999999999877654444333210                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV-----TEALQHPYISGLY  323 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~elL~hp~f~~~~  323 (364)
                              ....+..++..+.+||++||+.||.+|||+     .++++||||....
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         212 --------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             --------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                    011224578899999999999999999999     9999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-45  Score=302.51  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=227.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH-HHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-DALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -++|++++.||.|.||.||+|+.+.++--||+|++-++..... ...++.+|+++...++||||++.+++|.+.     .
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----K   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----c
Confidence            4699999999999999999999999999999999976654433 334556899999999999999999999988     8


Q ss_pred             eEEEEecccc-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..|+++||.. |++...++  ..+.+++..++.++.|++.|+.|||.++++||||||+|+|++.++.++++|||-+...+
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            8999999997 89999998  56789999999999999999999999999999999999999999999999999986654


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                        .......|||..|.+||+..+ ...+...|+|++|++.||++.|.+||......+.+++|.+.-              
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--------------  238 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--------------  238 (281)
T ss_pred             --CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc--------------
Confidence              334566799999999999988 688999999999999999999999999988888888876532              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       ..+++.++..+.|||.+|+..+|.+|.+..|++.|||+...
T Consensus       239 -----------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  239 -----------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -----------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                             22335788999999999999999999999999999999764

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6e-44  Score=327.87  Aligned_cols=284  Identities=22%  Similarity=0.349  Sum_probs=217.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|+||.||++++..++..+++|.+.... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence            589999999999999999999999999999999987542 233455678999999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||++ ++|.+++...+.+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999998 59999998888899999999999999999999986 5999999999999999999999999998655322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh-------
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE-------  259 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------  259 (364)
                        ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.............       
T Consensus       158 --~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence              2234467889999999987 578999999999999999999999998766544322211100000000000       


Q ss_pred             ------------ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          260 ------------FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       260 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                  ...................  .......+++++.+||.+||+.||++|||+++||+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                        0000000000000000000  0011124788999999999999999999999999999998743

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=327.01  Aligned_cols=286  Identities=26%  Similarity=0.410  Sum_probs=252.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      |.+=|.+.+.||+|.|.+|.+|++-.+|+.||+|++.+..........+++|+..++..+|||||++|++.-..     .
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----T   90 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----T   90 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----c
Confidence            67789999999999999999999999999999999998888888888999999999999999999999998777     7


Q ss_pred             eEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE-ccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV-NANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll-~~~~~~~L~Dfg~~~~~~  184 (364)
                      .+|+|+|.=. |+|.|++... ..+++..+++++.||+.|+.|||...++|+|+||+||.+ .+-|-|||.|||++..+.
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            8999999987 6999998765 579999999999999999999999999999999999866 567899999999998774


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      . .......||+..|.|||.+.+..+.-++.||||||+|||-|+.|++||+..++.+.+..|+.                
T Consensus       171 P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD----------------  233 (864)
T KOG4717|consen  171 P-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD----------------  233 (864)
T ss_pred             C-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc----------------
Confidence            4 44466779999999999999976778899999999999999999999999988888877764                


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccchhhh
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIG  344 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  344 (364)
                                     +-..++..++.++++||..||..||++|.+.++|.+|+|++..-....-. -|.-+++++.++.-
T Consensus       234 ---------------CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~-iPLvsr~~L~ee~H  297 (864)
T KOG4717|consen  234 ---------------CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA-IPLVSRHHLPEEAH  297 (864)
T ss_pred             ---------------ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc-CceeehhhCChHHH
Confidence                           22345567899999999999999999999999999999999985555443 67778888888877


Q ss_pred             HHHHHHH
Q 017909          345 EQMIRQM  351 (364)
Q Consensus       345 ~~~~~~~  351 (364)
                      +.-|.||
T Consensus       298 a~IIq~M  304 (864)
T KOG4717|consen  298 ATIIQQM  304 (864)
T ss_pred             HHHHHHH
Confidence            6655554

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.9e-44  Score=320.26  Aligned_cols=284  Identities=39%  Similarity=0.691  Sum_probs=229.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++++.||.|++|.||+|.+..+|+.+++|++............+.+|+.+++.++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeE
Confidence            68999999999999999999999999999999976554444556778899999999999999999999876     7889


Q ss_pred             EEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC-c
Q 017909          111 LVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-Q  188 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~-~  188 (364)
                      +|+||++++|.+.+.. .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9999997799998864 4679999999999999999999999999999999999999999999999999887654332 1


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+...++.++||||||+++|+|++|.++|.+.........+....+.+....+..........
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            23345678889999998775567999999999999999999999998888877777777766665554333221110000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      .. .........+....+..+..+.++|++||+.||.+|||++++|+||||.
T Consensus       236 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KI-TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cc-cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            00 0011111112234456778999999999999999999999999999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-43  Score=327.55  Aligned_cols=300  Identities=49%  Similarity=0.862  Sum_probs=239.7

Q ss_pred             eeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           21 MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        21 ~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ....+..+.++|.+.+.||+|++|.||+|++..+|+.||+|++............+.+|+.+++.++|||++++++++..
T Consensus         6 ~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879           6 VNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             hhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            33445567789999999999999999999999999999999987644333334456789999999999999999999875


Q ss_pred             cccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          101 THRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       101 ~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                      .... .....++|++++..++....  ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             cccCCCCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            5321 12457999999988877665  34689999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +......   .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+....+.+.+....
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8654221   2234567789999998764568899999999999999999999999888777777777776666655544


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      .........+....+...........+..++.+.+||.+||+.||.+||++.++|.||||..+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            444433333333333333333444456788899999999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-44  Score=331.91  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=216.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|+||+||++.++.+|+.||+|+++.... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----Ce
Confidence            479999999999999999999999999999999986543 223444566889999999999999999998877     78


Q ss_pred             EEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||++ |+|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999997 6999999876 67999999999999999999999999999999999999999999999999998765433


Q ss_pred             Cc-ccccccccccccCCccccc-----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          187 EQ-FMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       187 ~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .. ......++..|+|||++..     ...++.++|||||||++|+|++|..||...........+......        
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------  227 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF--------  227 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc--------
Confidence            22 2233467899999999863     245789999999999999999999999887665555544331000        


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                         ......+.+++.+.+||++||+ ||.+|||++++++||||.+...
T Consensus       228 -------------------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         228 -------------------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             -------------------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence                               0011123578899999999998 9999999999999999987643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-44  Score=319.94  Aligned_cols=281  Identities=42%  Similarity=0.717  Sum_probs=226.6

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |++.+.||.|++|.||+|.++.+|..|++|++............+.+|+.+++.++|||++++++++...     ...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence            6789999999999999999999999999999875543333344567899999999999999999999877     78999


Q ss_pred             EeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          112 VYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       112 v~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      ++||++++|.+++....  .+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+.........
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            99999989999987765  7999999999999999999999999999999999999999999999999998654332222


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .....++..|+|||++.+...++.++|+||||+++|+|++|..||...........+....+.+....+...  .....+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV--TSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh--hhchhh
Confidence            233345778999998876556789999999999999999999999988877777776666555544333221  111122


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ....+...........+.+++.+.++|.+||+.||.+|||+++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            22222222223334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-44  Score=337.54  Aligned_cols=259  Identities=26%  Similarity=0.407  Sum_probs=212.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++|+||+++++.+...     ..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CE
Confidence            479999999999999999999999999999999875432 222345566899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC-
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN-  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~-  186 (364)
                      .++||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999997 699999988888999999999999999999999999999999999999999999999999987422100 


Q ss_pred             ------------------------------------------CcccccccccccccCCcccccccCCCChhhHHHHHHHH
Q 017909          187 ------------------------------------------EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF  224 (364)
Q Consensus       187 ------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll  224 (364)
                                                                ........|++.|+|||++.+ ..++.++|||||||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil  234 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL  234 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeecccee
Confidence                                                      000112468899999999977 5789999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCC
Q 017909          225 AEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEP  304 (364)
Q Consensus       225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  304 (364)
                      |+|++|..||.+....+....+......                           ........+++.+.++|.+|+ .+|
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~~li~~l~-~~p  286 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKVINWETT---------------------------LHIPSQAKLSREASDLILRLC-CGA  286 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHHhccCcc---------------------------ccCCCCCCCCHHHHHHHHHHh-cCH
Confidence            9999999999887655444333211000                           001112357889999999977 599


Q ss_pred             CCCC---CHHHHhcCCCccCC
Q 017909          305 SKRI---TVTEALQHPYISGL  322 (364)
Q Consensus       305 ~~Rp---s~~elL~hp~f~~~  322 (364)
                      .+|+   ++.++++||||++.
T Consensus       287 ~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         287 EDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhcCCCCCHHHHhCCCCcCCC
Confidence            9999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-44  Score=328.50  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=211.4

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|+++.+++.||+|+++.... .......+..|..++..+ +||+|+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence            468999999999999999999999999976432 233444566788888766 799999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9998 699999988888999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------------  212 (321)
T cd05591         156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------------  212 (321)
T ss_pred             cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            568999999999877 578999999999999999999999998877665555443210                      


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-------CHHHHhcCCCccCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-------TVTEALQHPYISGL  322 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~elL~hp~f~~~  322 (364)
                               ...+..++..+.++|++||+.||.+||       +++++++||||..+
T Consensus       213 ---------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         213 ---------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                     112234678899999999999999999       99999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=336.29  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=212.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||++.++.+++.||+|++..... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Ce
Confidence            479999999999999999999999999999999865432 222345567899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ |+|.+.+...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999885321100


Q ss_pred             c-----------------------------------------------ccccccccccccCCcccccccCCCChhhHHHH
Q 017909          188 Q-----------------------------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV  220 (364)
Q Consensus       188 ~-----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  220 (364)
                      .                                               ......|++.|+|||++.+ ..++.++|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  234 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL  234 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEec
Confidence            0                                               0012358899999999977 578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhc
Q 017909          221 GCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML  300 (364)
Q Consensus       221 G~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  300 (364)
                      ||++|+|++|..||.+....+....+.......                           .......++..+.+||.+||
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~s~~~~dli~~lL  287 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRETL---------------------------YFPDDIHLSVEAEDLIRRLI  287 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---------------------------CCCCCCCCCHHHHHHHHHHh
Confidence            999999999999998876655554443210000                           00111246888999999999


Q ss_pred             ccCCCCC---CCHHHHhcCCCccCCC
Q 017909          301 VFEPSKR---ITVTEALQHPYISGLY  323 (364)
Q Consensus       301 ~~dP~~R---ps~~elL~hp~f~~~~  323 (364)
                      . +|.+|   +++.++++||||++..
T Consensus       288 ~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         288 T-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             c-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            8 66665   5999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-43  Score=320.87  Aligned_cols=287  Identities=40%  Similarity=0.706  Sum_probs=228.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||.|++|+||+|.++.+|+.|++|.+............+.+|+.+++.++|||++++++++...     ...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence            579999999999999999999999999999999875443333445667899999999999999999999877     789


Q ss_pred             EEEeccccccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCccccCCCC
Q 017909          110 YLVYELMDTDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||++++|.+.+.....  +++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||.+......
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            99999999999888865443  588899999999999999999999999999999999985 557999999998755433


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+...++.++|+||||+++|+|++|..||......+...++....+.+....+.....  .
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  234 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--L  234 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc--c
Confidence            33333445678899999987755688999999999999999999999998877777777666665554443332111  1


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ..+....+...........+.+++.+.++|.+||+.||++||++.++|+||||..+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            111111121122222233467889999999999999999999999999999998864

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8e-44  Score=320.29  Aligned_cols=285  Identities=34%  Similarity=0.656  Sum_probs=221.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|.||+|.++.+++.+++|.+............+.+|+.+++.++|||++++++++...     ...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeE
Confidence            479999999999999999999998999999999876544443445567899999999999999999999776     789


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+||+++ ++.+.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999999996 5555555556799999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||......+....+....+.................
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            33445678889999998765567899999999999999999999998877666666666554443322111110000000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .................+.++..+.+|+.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            000000000111122345788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-44  Score=331.93  Aligned_cols=255  Identities=22%  Similarity=0.403  Sum_probs=206.9

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.++.+++.+|+|+++..... ......+..|+.++..+ +||||+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence            4699999999999999999999999999865433 23344556788888776 799999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|...+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9998 689888888888999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-----NQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||......     .....+.+.                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------  216 (329)
T cd05618         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------------------  216 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH------------------
Confidence            578999999999987 57899999999999999999999999532110     000000000                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT------VTEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~elL~hp~f~~~~  323 (364)
                       .        ......++..++..+.+||++||+.||.+||+      +.++++||||+...
T Consensus       217 -i--------~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         217 -I--------LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             -H--------hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence             0        00112244567889999999999999999998      58999999998763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.6e-44  Score=320.08  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||+|+||+||++.++.+++.+|+|.+...... ......+..|+.+++.++|+|++++.+++...     ...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence            69999999999999999999999998754332 22334567899999999999999999998877     7789999999


Q ss_pred             c-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccc
Q 017909          117 D-TDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT  191 (364)
Q Consensus       117 ~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~  191 (364)
                      + |+|.+.+.    ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            7 58887763    235699999999999999999999999999999999999999999999999999876544433344


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+......                   
T Consensus       156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  215 (280)
T cd05608         156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-------------------  215 (280)
T ss_pred             ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-------------------
Confidence            4577889999999987 57889999999999999999999999765432222222111000                   


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCC
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~  326 (364)
                              .....+..+++.+.+++.+||+.||.+||     +++++++||||++.....
T Consensus       216 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         216 --------DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             --------cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence                    01122346888999999999999999999     889999999999875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.9e-44  Score=328.94  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=209.2

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHH-HHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELV-LLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|+++.+|+.||+|++...... ......+..|.. +++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence            4689999999999999999999999999754322 223334445544 45778999999999999877     7889999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9998 599999988889999999999999999999999999999999999999999999999999998654333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------------  211 (323)
T cd05575         156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----------------------  211 (323)
T ss_pred             ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            578999999999977 57899999999999999999999999887655544443221                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV----TEALQHPYISGLYD  324 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~elL~hp~f~~~~~  324 (364)
                              .....+.+++.+.++|++||+.||.+||++    .++++||||.....
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         212 --------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                    012235678899999999999999999988    69999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.2e-44  Score=322.29  Aligned_cols=286  Identities=38%  Similarity=0.667  Sum_probs=227.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.++...........+.+|+.+++.++|||++++++++.....   ...
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL---DKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcE
Confidence            58999999999999999999999999999999997554433333455689999999999999999998865532   678


Q ss_pred             EEEeccccccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+||++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999999999999887644 599999999999999999999999999999999999999999999999999876654433


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+....+.+....+.....-....
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            34445667889999998775567899999999999999999999999988888777777766665554443221110000


Q ss_pred             HHhhCCCCCCCcccccCCC--CChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQ--ADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      . ...............+.  +++.+.++|++||+.||++|||+.|+|+||||
T Consensus       242 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 K-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             c-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0 00000011111112222  58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.4e-44  Score=327.73  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=215.2

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccce
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      +|++.+.||+|+||+||+|.++.+++.||+|+++..... .........|..++..+ .|++++++++++...     ..
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence            589999999999999999999999999999999764322 22334456677777777 588999999998877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ |+|.+.+...+.+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999987543333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------------  217 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------------  217 (323)
T ss_pred             CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            33445678999999999987 578999999999999999999999998877665555443210                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~  323 (364)
                                    ...+..++..+.+++.+||+.||.+|++     ..++++||||....
T Consensus       218 --------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         218 --------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             --------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                          1123457889999999999999999998     48999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.7e-44  Score=326.42  Aligned_cols=251  Identities=28%  Similarity=0.430  Sum_probs=208.1

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.+..+++.||+|+++..... .........|..++... +||||+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            4699999999999999999999999999764322 22333445566666654 899999999998877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9997 699999988888999999999999999999999999999999999999999999999999998755333334445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------------  211 (316)
T cd05592         156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------------  211 (316)
T ss_pred             ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            678999999999987 57899999999999999999999999887655444433210                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH-HHHhcCCCccCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV-TEALQHPYISGLY  323 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~elL~hp~f~~~~  323 (364)
                              ....+..++..+.+||.+||+.||.+||++ .++++||||....
T Consensus       212 --------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         212 --------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                    112234578889999999999999999986 5889999998763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.7e-44  Score=325.38  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=208.4

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||.||+|.++.+|+.||+|+++..... .........|..++... +||+++++++++...     ...++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence            4699999999999999999999999999764321 22334455677777654 899999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||+. |+|.+.+.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9998 599999988888999999999999999999999999999999999999999999999999988654333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-----------------------  211 (316)
T cd05620         156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-----------------------  211 (316)
T ss_pred             cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence            678999999999987 57899999999999999999999999877655444333210                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH-HHHhcCCCccCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV-TEALQHPYISGLY  323 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~elL~hp~f~~~~  323 (364)
                              ....+..++..+.+||++||+.||.+||++ +++++||||....
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         212 --------TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                    011223478889999999999999999998 5899999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-45  Score=330.99  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=235.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|+.++.+|+|+||.+++++++.+++.|++|.+..............+|+.+++++.|||||.+.+.|..+     +.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-----~~   77 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-----GQ   77 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-----Cc
Confidence            4689999999999999999999999999999999988777777777888999999999999999999999998     55


Q ss_pred             -EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          109 -VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       109 -~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ++|||+||+ |++.+.+.+.  ..++++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.|+|+|||+++...
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence             999999998 5999988754  469999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..........||+.|+.||.+.+ .+|+.++|||||||++|||++-+++|.+.+......+|....              
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--------------  222 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--------------  222 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--------------
Confidence            77767888999999999999988 789999999999999999999999999998888877776532              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                      ..+++..++..+..+|..||..+|..||++.+||.+|.+...
T Consensus       223 ----------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  223 ----------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             ----------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                            244557889999999999999999999999999999998743

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.5e-43  Score=321.53  Aligned_cols=298  Identities=49%  Similarity=0.917  Sum_probs=239.5

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .+..+.++|++++.||.|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|||++++.+++.... 
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-   82 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-   82 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence            3456889999999999999999999999999999999988654444444456678999999999999999999986532 


Q ss_pred             cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          104 ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                         ...++|+|+++++|.+.+.. .++++..+..++.|+++||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        83 ---~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          83 ---EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             ---CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence               56889999999898887764 56899999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...   .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+.+.++..+.........
T Consensus       159 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         159 DPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            221   12335577899999886645789999999999999999999999998887777777777777766554443333


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNP  329 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~  329 (364)
                      .....+................+.+++.+.++|++||+.+|.+|||+++++.||||..+..+...+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence            322333222222222223334456789999999999999999999999999999999887776663

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.5e-44  Score=319.49  Aligned_cols=281  Identities=39%  Similarity=0.720  Sum_probs=225.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|+||+|++..+|..|++|+++..... .....+.+|+.+++.++|+|++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEE
Confidence            589999999999999999999999999999998754322 2234556899999999999999999999877     7789


Q ss_pred             EEeccccccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMDTDLHQIIKSS---QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +||||++++|.+++...   ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            99999999999888654   358999999999999999999999999999999999999999999999999987554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|++||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+......+....+....  ...
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLP  232 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCc
Confidence            333344567889999998775567899999999999999999999999988887777777665555444333222  111


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .+....+...........+..++.+.++|.+||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1111111111112223334578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-43  Score=325.86  Aligned_cols=301  Identities=39%  Similarity=0.726  Sum_probs=228.1

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc-
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~-  105 (364)
                      ++.++|++.+.||.|++|.||+|.++.+|+.|++|.+.....  .....+.+|+.+++.++|||++++++.+....... 
T Consensus         2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            467899999999999999999999999999999999865432  33455678999999999999999998876543211 


Q ss_pred             --------cceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEee
Q 017909          106 --------FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICD  176 (364)
Q Consensus       106 --------~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~D  176 (364)
                              ....++|+||++++|.+.+.. ..+++..++.++.||++||.+||++|++|+||+|+||+++. ++.++|+|
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    135799999999998887754 46999999999999999999999999999999999999974 55789999


Q ss_pred             cCccccCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          177 FGLARTSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       177 fg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      ||.+........   ......++..|+|||.+.....++.++|||||||++|+|++|..||.+.........+.+..+..
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            998865422111   11233567789999987665568899999999999999999999999888777766666554433


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA  331 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~  331 (364)
                      ........... ....................+..+..+.+||++||+.||.+|||+.++|+||||+.+.++...+..
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~  315 (342)
T cd07854         239 REEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS  315 (342)
T ss_pred             ChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC
Confidence            33221111110 011111001111111222345688899999999999999999999999999999988766544444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-43  Score=330.76  Aligned_cols=262  Identities=25%  Similarity=0.353  Sum_probs=215.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -.++|++.+.||+|+||+||++.++.+++.||+|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-----  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-----  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence            356899999999999999999999999999999999754322 23334456899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||.+.....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            78999999997 689888765 4689999999999999999999999999999999999999999999999999876533


Q ss_pred             CCc-ccccccccccccCCcccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NEQ-FMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ... ......|++.|+|||++.+.   ..++.++|+|||||++|+|++|..||.+.........+.......        
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------  266 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL--------  266 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC--------
Confidence            221 22345689999999998652   247899999999999999999999998876655555443210000        


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGL  322 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~  322 (364)
                                         .......++..+.+||++||+.+|.+  |+|++++++||||+..
T Consensus       267 -------------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         267 -------------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             -------------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence                               00112357889999999999999998  9999999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-44  Score=329.97  Aligned_cols=251  Identities=26%  Similarity=0.438  Sum_probs=212.3

Q ss_pred             eeeeccCCceeEEEEEe---ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           35 IKPIGRGAYGVVCSSIN---RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      ++.||+|+||.||++.+   ..+|+.+|+|++..............+|+.+++.++||||+++++++...     ...++
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEE
Confidence            36799999999999876   35789999999986554444555667899999999999999999999877     78999


Q ss_pred             Eecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc
Q 017909          112 VYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM  190 (364)
Q Consensus       112 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~  190 (364)
                      ||||++ ++|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999997 6999999888889999999999999999999999999999999999999999999999999987654443334


Q ss_pred             ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       191 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...                     
T Consensus       156 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~---------------------  213 (318)
T cd05582         156 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---------------------  213 (318)
T ss_pred             ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC---------------------
Confidence            45578899999999877 57889999999999999999999999877655444433221                     


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL  322 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~  322 (364)
                                ....+..+++.+.+||++||+.||.+||+     ++++++||||...
T Consensus       214 ----------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         214 ----------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence                      01123457889999999999999999999     7889999999875

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-43  Score=330.19  Aligned_cols=263  Identities=25%  Similarity=0.338  Sum_probs=214.7

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ...++|++.+.||+|+||.||++.++.+++.+|+|++..... .......+.+|+.+++.++||||+++++.+..+    
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~----  115 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD----  115 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence            346799999999999999999999999999999999875322 223344566899999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus       116 -~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         116 -KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             -CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence             78999999997 699998865 468999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCc-ccccccccccccCCccccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 GNEQ-FMTEYVVTRWYRAPELLLCCD---NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .... ......|++.|+|||++....   .++.++|+|||||++|+|++|..||.+.........+........      
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------  267 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN------  267 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC------
Confidence            3222 223557899999999987532   378899999999999999999999988776555555433111000      


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGL  322 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~  322 (364)
                                           ......++..+.++|.+||..++.+  |+++.++++||||+..
T Consensus       268 ---------------------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         268 ---------------------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ---------------------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                                 0111346888999999999866654  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-46  Score=328.41  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=225.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -...|+..++||+|+||.||+|.+..+++.||+|++..+.... ....+.+|+.+|..++++||.++++.+...     .
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g-----~   84 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKG-----T   84 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeec-----c
Confidence            3557888899999999999999999999999999998654433 556778999999999999999999999988     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++++||||+ |++.+.++....+++..+..++++++.|+.|||+++.+|+|||+.||++..+|.++|+|||.+......
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            8999999998 699999999888899999999999999999999999999999999999999999999999999877666


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........||+.|||||++.. ..|+.++||||||+..+||++|.+|+........+..|                    
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------------------  223 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------------------  223 (467)
T ss_pred             hhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--------------------
Confidence            666678899999999999986 68999999999999999999999999776542222111                    


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                .+...+.+...+++.+++|+..||+.||+.||+|.++|+|+|++.
T Consensus       224 ----------pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  224 ----------PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             ----------cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence                      111223333478999999999999999999999999999999988

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.4e-44  Score=329.46  Aligned_cols=261  Identities=27%  Similarity=0.356  Sum_probs=208.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  146 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GE  146 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----Ce
Confidence            468999999999999999999999999999999986432 233445677999999999999999999999877     78


Q ss_pred             EEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+.+ +|.+    ....++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus       147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            8999999984 6643    2346788889999999999999999999999999999999999999999999987654333


Q ss_pred             cccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          188 QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .......|+..|+|||++..    ....+.++|||||||++|+|++|+.||......+....+.....            
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~------------  290 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM------------  290 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc------------
Confidence            33344578899999998743    12356799999999999999999999974432222221111100            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                     .........++..+.+||.+||+.||.+|||+.|||+||||.+-..+.
T Consensus       291 ---------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~  338 (353)
T PLN00034        291 ---------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ  338 (353)
T ss_pred             ---------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCccc
Confidence                           011223346788999999999999999999999999999999975553

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.7e-43  Score=317.48  Aligned_cols=288  Identities=38%  Similarity=0.639  Sum_probs=223.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.+. |+|++++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999999999999998764433333445678999999995 699999999987764323245


Q ss_pred             EEEEeccccccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCcccc
Q 017909          109 VYLVYELMDTDLHQIIKSS-----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLART  182 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~  182 (364)
                      .++||||++++|.+++...     ..+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            8999999999998887542     35899999999999999999999999999999999999998 88999999998875


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ............+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+....+.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            43332223334557789999998765568999999999999999999999999887777777666655443332221110


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      .  ...+. ..+...........+.+++.+.+||.+||+.||.+||++.++|.||||+
T Consensus       241 ~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 K--LRDWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             h--ccchh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            0  00000 0001111112233356889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-43  Score=321.53  Aligned_cols=278  Identities=37%  Similarity=0.628  Sum_probs=208.6

Q ss_pred             eeeeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           35 IKPIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.+||+|+||+||+|+++  .++..+|+|.+.....    .....+|+.+++.++||||+++++.+.....   ...+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEE
Confidence            468999999999999965  4678899999864322    2235679999999999999999999865432   568999


Q ss_pred             eccccccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE----ccCCcEEEeecCc
Q 017909          113 YELMDTDLHQIIKSS---------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGL  179 (364)
Q Consensus       113 ~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll----~~~~~~~L~Dfg~  179 (364)
                      |||++++|.+++...         ..+++..++.++.||+.||.|||++|++|+||||+|||+    +.++.++|+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999998887532         258999999999999999999999999999999999999    4567899999999


Q ss_pred             cccCCCCC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 017909          180 ARTSRGNE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC---------LNQLKLII  247 (364)
Q Consensus       180 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~i~  247 (364)
                      +.......   .......++..|+|||++.+...++.++|||||||++|+|++|.+||.+...         ......+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            87653322   1223456788999999998756789999999999999999999999975542         34555666


Q ss_pred             HHhCCCchhhhhccCch-hHHHHHhhCCCCC------CCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          248 SVFGTQQEADLEFIDNP-KARRFIKSLPYSR------GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...+.+....+...... .............      ...........+..+.+||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            66666655544432110 0000110000000      000011112345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=317.51  Aligned_cols=261  Identities=24%  Similarity=0.369  Sum_probs=213.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .|++.+.||+|+||+||++.+..+++.||+|++...... ......+.+|+.+++.++|||++++++.+...     ...
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence            489999999999999999999999999999998754322 22334556899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||+. |+|.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999997 6888877543  46999999999999999999999999999999999999999999999999998765322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      . ......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.........+...+...             
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  220 (285)
T cd05605         156 E-TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED-------------  220 (285)
T ss_pred             C-ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc-------------
Confidence            2 2234467889999999977 578999999999999999999999998765443333332211110             


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDP  325 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~  325 (364)
                                    ....+..+++.+.+||.+||+.||.+||     +++++++||||......
T Consensus       221 --------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         221 --------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             --------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                          0122345788899999999999999999     99999999999875433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-43  Score=322.00  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=214.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccce
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      +|++.+.||+|+||+||+|.++.+|+.||+|++..... .......+..|..++..+. |++++++++++...     ..
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence            47899999999999999999999999999999976433 2233445667888888885 57788888888777     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999987543333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------  217 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------  217 (323)
T ss_pred             ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            33344568899999999877 578999999999999999999999998876655554443210                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~  323 (364)
                                    ...+..++..+.+++.+||+.||.+|++     .+++++||||.+..
T Consensus       218 --------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         218 --------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             --------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                          1123457888999999999999999997     57999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-43  Score=321.79  Aligned_cols=252  Identities=28%  Similarity=0.410  Sum_probs=208.2

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|+++.+++.||+|+++..... .........|..++... +||||+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence            4689999999999999999999999999765321 22333445677777754 899999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9997 699999988788999999999999999999999999999999999999999999999999998654333333345


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------------  212 (316)
T cd05619         156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN----------------------  212 (316)
T ss_pred             ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Confidence            568899999999977 578999999999999999999999998776544443332100                      


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT-EALQHPYISGLYD  324 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-elL~hp~f~~~~~  324 (364)
                               ...+..++..+.++|.+||+.||.+||++. ++++||||.....
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         213 ---------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             ---------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence                     112234678899999999999999999996 8999999988643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=316.75  Aligned_cols=283  Identities=39%  Similarity=0.693  Sum_probs=218.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      -++|++.+.||+|++|+||+|.++.+++.|++|.+....... ....+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~   77 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTK-----KT   77 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecC-----Ce
Confidence            478999999999999999999999999999999986533221 223456799999999999999999999877     78


Q ss_pred             EEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          78 LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9999999999999988754 468999999999999999999999999999999999999999999999999886543222


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE-CLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.. ..+....+.+..+.+....+......  
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN--  235 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc--
Confidence            222233457789999998765568899999999999999999999997765 45555555555555443332211100  


Q ss_pred             HHHHh-hCCCCCCCcccccCCCCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIK-SLPYSRGTHISSLYPQAD--PLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~-~~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ..+.. ..............+..+  ..+.++|.+||+.||.+|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000 000000111112222344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.4e-44  Score=330.66  Aligned_cols=261  Identities=24%  Similarity=0.387  Sum_probs=214.4

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||++.++.+++.||+|+++.... .......+..|+.++..++||+++++++.+...     ..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence            479999999999999999999999999999999975432 233445667899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ |+|.+.+...+.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999997 6999999888889999999999999999999999999999999999999999999999999876432110


Q ss_pred             -----------------------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCC
Q 017909          188 -----------------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP  232 (364)
Q Consensus       188 -----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~  232 (364)
                                                         .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCC
Confidence                                               00113468899999999987 578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC---C
Q 017909          233 IFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI---T  309 (364)
Q Consensus       233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s  309 (364)
                      ||.+.........+......                           ........+++.+.+||.+|+. ||.+|+   +
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~  286 (360)
T cd05627         235 PFCSETPQETYRKVMNWKET---------------------------LVFPPEVPISEKAKDLILRFCT-DSENRIGSNG  286 (360)
T ss_pred             CCCCCCHHHHHHHHHcCCCc---------------------------eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence            99887765555544321000                           0000112368889999999874 999998   5


Q ss_pred             HHHHhcCCCccCCCC
Q 017909          310 VTEALQHPYISGLYD  324 (364)
Q Consensus       310 ~~elL~hp~f~~~~~  324 (364)
                      ++++++||||.+...
T Consensus       287 ~~ei~~hp~f~~~~~  301 (360)
T cd05627         287 VEEIKSHPFFEGVDW  301 (360)
T ss_pred             HHHHhcCCCCCCCCH
Confidence            899999999998743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-44  Score=329.33  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=206.5

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccccccceEEEEe
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      ||+|+||+||+|+++.+++.||+|++..... ..........|..++...   .||+|++++..+...     ...++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence            6999999999999999999999999965432 222334445666666655   699999999999887     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9997 699999988888999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+...++.++|||||||++|+|++|..||.+.........+.....                     
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------  214 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV---------------------  214 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            67899999999997655689999999999999999999999988765544443321100                     


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC----CHHHHhcCCCccCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI----TVTEALQHPYISGLY  323 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~elL~hp~f~~~~  323 (364)
                               ......+++.+.+||++||+.||.+||    ++.++++||||....
T Consensus       215 ---------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         215 ---------RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence                     000123678899999999999999998    799999999998753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.4e-44  Score=326.13  Aligned_cols=250  Identities=26%  Similarity=0.466  Sum_probs=207.7

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHH-HHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELV-LLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.++.+|+.+|+|++..... .......+..|.. +++.++||||+++++.+...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence            468999999999999999999999999975432 2223344445554 46778999999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||+. |+|...+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9998 589888888889999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------------  211 (325)
T cd05604         156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------------  211 (325)
T ss_pred             ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            678999999999977 57899999999999999999999999887655544443220                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV----TEALQHPYISGL  322 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~elL~hp~f~~~  322 (364)
                              .....+..+..+.++|++||+.||.+||++    .++++||||...
T Consensus       212 --------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         212 --------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             --------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence                    012234678889999999999999999977    599999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=323.00  Aligned_cols=263  Identities=22%  Similarity=0.356  Sum_probs=213.4

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||++.+..+++.||+|++..... .......+.+|..++..++|+||+++++.+...     .+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----Ce
Confidence            579999999999999999999999999999999975322 233444567899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||+. |+|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999997 699999876 467999999999999999999999999999999999999999999999999998654332


Q ss_pred             Cc-ccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          187 EQ-FMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       187 ~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .. ......|++.|+|||++..    ...++.++|||||||++|+|++|..||.+....+....+.....          
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~----------  225 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----------  225 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            22 2223468999999999863    24578899999999999999999999988765555544432100          


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGLY  323 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~~  323 (364)
                                      ..........+++.+.++|++||..++++  |++++++++||||.+..
T Consensus       226 ----------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         226 ----------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             ----------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence                            00111222457889999999999765554  88999999999998763

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.8e-43  Score=322.02  Aligned_cols=294  Identities=36%  Similarity=0.621  Sum_probs=231.5

Q ss_pred             eecccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHH------------HHHHHHHHHHHHhcCCCCcc
Q 017909           26 FEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRID------------ALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        26 ~~~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv   92 (364)
                      ..+.++|..+ +.||.|++|+||+|.+..+++.||+|+++........            ...+.+|+.+++.++|+|++
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            4567889754 7799999999999999999999999998654222100            11356899999999999999


Q ss_pred             eeeeeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcE
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~  172 (364)
                      ++++++...     ...++|||+++|+|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.+
T Consensus        84 ~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         84 GLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            999999877     788999999999999999888889999999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCC--------------CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 017909          173 KICDFGLARTSRG--------------NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE  238 (364)
Q Consensus       173 ~L~Dfg~~~~~~~--------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  238 (364)
                      +|+|||.+.....              .........++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999998865431              11112233457789999998775567999999999999999999999999998


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                      ..+....+....+.+....+.....  ..... .................++.+.++|++||+.||.+|||++++|.|||
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKK--LPLYT-EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhh--ccccc-ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            8888887777766655433221110  00000 00011111222233467888999999999999999999999999999


Q ss_pred             ccCCCCCCC
Q 017909          319 ISGLYDPQC  327 (364)
Q Consensus       319 f~~~~~~~~  327 (364)
                      |+....+..
T Consensus       316 ~~~~~~~~~  324 (335)
T PTZ00024        316 FKSDPLPCD  324 (335)
T ss_pred             cCCCCCCCC
Confidence            998755533

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-43  Score=324.31  Aligned_cols=279  Identities=27%  Similarity=0.351  Sum_probs=210.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ...|++++.||+|+||+||+|++..++..||+|+....        ....|+.+++.++|+||+++++++...     ..
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  131 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI  131 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence            45799999999999999999999999999999986432        124588999999999999999999877     77


Q ss_pred             EEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++|++++.++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...... 
T Consensus       132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            899999999999988865 467999999999999999999999999999999999999999999999999998654222 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHHhCCCchhh
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTEC---------LNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~  257 (364)
                      .......|+..|+|||++.+ ..++.++|||||||++|+|+++ ..+|.....         ...+..+....+..+...
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence            22334567899999999987 5789999999999999999975 444544321         122223333333332222


Q ss_pred             hhccCchhHHHHHhhCCCCCCC--c-ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGT--H-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ...........+..........  . .......++.++.+||++||+.||.+|||+.|||+||||+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            1111122222222211111000  0 001122567788899999999999999999999999999863

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-43  Score=322.43  Aligned_cols=284  Identities=22%  Similarity=0.351  Sum_probs=216.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||.|+||.||++.+..++..+++|.+.... .......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~   76 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----G   76 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----C
Confidence            3689999999999999999999999999999999887542 233445678999999999999999999999887     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||+. ++|.+++...+.+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            8999999997 69999998888899999999999999999999985 799999999999999999999999998865422


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh-cc---
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE-FI---  261 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~---  261 (364)
                      .  ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+............. ..   
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             h--ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            2  1233467889999999977 578999999999999999999999998765433322111100000000000 00   


Q ss_pred             -----------Cch--hHHHHHhhCCCCCCCccccc-CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          262 -----------DNP--KARRFIKSLPYSRGTHISSL-YPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       262 -----------~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                 ..+  ............   ..... ...++..+.+||.+||+.||.+|||+.|++.||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNE---PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcC---CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                       000  000000000000   00011 123678899999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.3e-43  Score=316.91  Aligned_cols=292  Identities=34%  Similarity=0.534  Sum_probs=220.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc---
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI---  104 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---  104 (364)
                      .-++|++.+.||+|++|.||+|.++.+++.||+|.+..............+|+.+++.++|||++++++++......   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            45689999999999999999999999999999999865433333334456799999999999999999988665321   


Q ss_pred             ccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .....++||||+++++.+.+... ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            12457999999999998888664 36999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCc----ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQ----FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .....    ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+..+.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            32221    11233457789999998765557889999999999999999999999887777766666665554443322


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccc-cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISS-LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ........................ .....+..+.+||.+||+.||.+|||++++|+||||
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            221111100000000000000000 111246778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-43  Score=327.52  Aligned_cols=284  Identities=23%  Similarity=0.280  Sum_probs=217.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +..+|++++.||.|++|.||++...  .++..+++|.+....       ...+|+.+++.++||||+++++.+...    
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~----  158 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWK----  158 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeC----
Confidence            4678999999999999999999754  346789999886421       234699999999999999999998877    


Q ss_pred             cceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                       ...++||+++.++|.+++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus       159 -~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        159 -STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             -CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence             7899999999999999997778899999999999999999999999999999999999999999999999999865533


Q ss_pred             CCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhhhc
Q 017909          186 NEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC---LNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       186 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...  ......|+..|+|||++.. ..++.++|||||||++|+|++|..||.+...   ...+..+.+.++..+......
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            221  1224568899999999977 5789999999999999999999999976543   344455555444433221111


Q ss_pred             cCchhHHHHHhhCCCCCCC-cccc--cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGT-HISS--LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ........+.......... ....  ....++.++.++|++||..||.+|||+.++|+||||++...
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            1111111111111000000 0000  11246778999999999999999999999999999987433

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.1e-43  Score=314.25  Aligned_cols=277  Identities=25%  Similarity=0.430  Sum_probs=227.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|++|.||++.+..+++.+++|++..... .......+.+|++++++++||||+++++.+...     ..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence            479999999999999999999999999999999875433 223445677899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ ++|.+.+...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999995 799999988889999999999999999999999999999999999999999999999999998765433 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                        .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+...                  
T Consensus       155 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  213 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------------------  213 (290)
T ss_pred             --CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Confidence              233457888999999876 56889999999999999999999999876643333333210                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCCC-CCCCCCCCCcccch
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQC-NPPAQVPLSLDIDE  341 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~~-~~~~~~~~~~~~~~  341 (364)
                                   ....+..++..+.++|++||..||.+|+     +++++++||||..+-.... ....+.|......+
T Consensus       214 -------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (290)
T cd05580         214 -------------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKG  280 (290)
T ss_pred             -------------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCC
Confidence                         0122345688999999999999999999     9999999999987643322 23445555555555


Q ss_pred             hhhHH
Q 017909          342 NIGEQ  346 (364)
Q Consensus       342 ~~~~~  346 (364)
                      .++++
T Consensus       281 ~~~~~  285 (290)
T cd05580         281 PGDTS  285 (290)
T ss_pred             ccccc
Confidence            55544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.7e-44  Score=304.26  Aligned_cols=293  Identities=40%  Similarity=0.656  Sum_probs=240.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      -..|++++.||+|.||.||+|..+.++.    .+|||.++.+...+.-....-+|+..++.++|||++.+..+|...+  
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d--  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD--  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC--
Confidence            4589999999999999999997665443    6899999876555445556678999999999999999999998842  


Q ss_pred             ccceEEEEeccccccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC----CcEEEe
Q 017909          105 SFKDVYLVYELMDTDLHQIIKS-----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN----CDLKIC  175 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~----~~~~L~  175 (364)
                        ..+++++||.+.+|+.++.-     .+.++...++.++.||+.|+.|||++-+.|||+||.|||+..+    |.|||+
T Consensus       101 --~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  101 --KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             --ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence              78999999999999999852     3469999999999999999999999999999999999999887    899999


Q ss_pred             ecCccccCCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 017909          176 DFGLARTSRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE---------CLNQL  243 (364)
Q Consensus       176 Dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~---------~~~~~  243 (364)
                      |+|+++...+.-..   .....-|.+|.|||.+.+...|+.+.|+|+.|||+.||++..+.|.+..         ..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999877554322   2344558899999999999999999999999999999999999996653         45778


Q ss_pred             HHHHHHhCCCchhhhhccC-chhHHHHHhhCCCCC-----CCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          244 KLIISVFGTQQEADLEFID-NPKARRFIKSLPYSR-----GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                      .+|++.+|.+....|.... -+.....+..++...     -..+-+....-++...+|+.+||..||.+|+|++++|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            8999999999998887664 333333333322111     1223344455677788999999999999999999999999


Q ss_pred             CccCCCCC
Q 017909          318 YISGLYDP  325 (364)
Q Consensus       318 ~f~~~~~~  325 (364)
                      ||+.-..+
T Consensus       339 yF~~d~lp  346 (438)
T KOG0666|consen  339 YFTEDPLP  346 (438)
T ss_pred             ccccCCCC
Confidence            99985444

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-42  Score=305.60  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=212.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      .|++.+.||.|++|.||++.++.+++.+++|.+............+.+|+.+++.++|+|++++++.+....    ..++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEE
Confidence            589999999999999999999999999999999765555555666788999999999999999998875432    5689


Q ss_pred             EEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +++|+++ ++|.+.+...  ..+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999998 5898888753  468999999999999999999999999999999999999999999999999987654443


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......+++.|+|||++.+ ..++.++|+||||+++++|++|..||...+.......+...                  
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------------------  217 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG------------------  217 (257)
T ss_pred             CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------------
Confidence            33445567889999999877 57889999999999999999999999876544333322210                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  ........+++.+.++|.+||+.||.+|||+.++++||||
T Consensus       218 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         218 ------------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                        0012234577889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-43  Score=335.59  Aligned_cols=269  Identities=23%  Similarity=0.344  Sum_probs=221.4

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      +.....++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.++..++|+|+++++..+.....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33445789999999999999999999999999999999997665555566677889999999999999999887764422


Q ss_pred             c---ccceEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909          104 I---SFKDVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       104 ~---~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      .   .....++||||++ |+|.+.+..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence            1   1124789999998 699998864    3469999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCC--CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          176 DFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       176 Dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |||++......  ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+...    
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~----  260 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG----  260 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----
Confidence            99998754322  222334568999999999987 57899999999999999999999999877654444333210    


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                                .....++.+++.+.++|.+||+.||.+||++.++|+|||++...
T Consensus       261 --------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        261 --------------------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             --------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                      11223456889999999999999999999999999999987653

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-42  Score=323.95  Aligned_cols=262  Identities=24%  Similarity=0.324  Sum_probs=213.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++.+.||+|+||.||++.++.+++.+|+|++..... .......+.+|..+++.++||||+++++.+...     
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----
Confidence            35899999999999999999999999999999999865322 223344556899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            78999999997 689888765 4589999999999999999999999999999999999999999999999999876533


Q ss_pred             CCc-ccccccccccccCCccccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NEQ-FMTEYVVTRWYRAPELLLCCD---NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ... ......|++.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+.......        
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------  266 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--------  266 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc--------
Confidence            221 223456899999999987532   37889999999999999999999998877655555543311100        


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGL  322 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~  322 (364)
                                         .......++..+.++|.+||..++.+  |++++++++||||++.
T Consensus       267 -------------------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         267 -------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             -------------------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence                               01112467889999999999854443  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-42  Score=305.82  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=215.6

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|++|.||+|+++.+++.+++|.+............+.+|+.+++.++|||++++++.+...     ...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence            48899999999999999999999999999999876555566667788999999999999999999999877     7899


Q ss_pred             EEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +||||+. ++|.+++...  ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999997 5999988764  579999999999999999999999999999999999999999999999999987665444


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||++.+ ..++.++|+||||+++++|++|..||...........+...                  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08529         156 NFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG------------------  216 (256)
T ss_pred             chhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------------
Confidence            44445567889999999987 56889999999999999999999999877644333332210                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  ........+++.+.++|.+||+.+|++||++.++++|||+
T Consensus       217 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         217 ------------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                        0112223577889999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=307.63  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=212.1

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc---hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN---RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +.|++.+.||+|++|.||.+.+..++..+++|.+......   ......+.+|+.++++++||||+++++++...     
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence            5799999999999999999999999999999998654322   22334567899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++|+|+++ ++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            78999999997 59999998888899999999999999999999999999999999999999999999999999865432


Q ss_pred             CCccc---ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 NEQFM---TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .....   ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+...             
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  222 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-------------  222 (263)
T ss_pred             cccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-------------
Confidence            21111   23456788999999987 56899999999999999999999999765443333222110             


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                      ......+..++..+.++|++||..+|.+|||+.++|+||||
T Consensus       223 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         223 ----------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ----------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                            01122335678899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.9e-43  Score=321.19  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=207.0

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHH-HHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELV-LLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|++..+++.||+|++..... .......+..|.. +++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence            468999999999999999999999999975432 2223334445544 57888999999999998777     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ ++|...+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9998 589888888888999999999999999999999999999999999999999999999999998654333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------------  211 (321)
T cd05603         156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----------------------  211 (321)
T ss_pred             ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence            568899999999877 57899999999999999999999999887654444333210                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV----TEALQHPYISGLYD  324 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~elL~hp~f~~~~~  324 (364)
                              ....++..+..+.++|.+||+.||.+||++    .++++|+||..+..
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 --------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                    112335678889999999999999999976    59999999986543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=313.32  Aligned_cols=284  Identities=39%  Similarity=0.696  Sum_probs=222.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|.||+|.++.+++.|++|.++...........+.+|+.+++.++|+|++++++.+...     ...
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEE
Confidence            479999999999999999999999999999999976544444556778899999999999999999999876     789


Q ss_pred             EEEeccccccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQII-KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+||+++++.+.+ .....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            999999997655544 4456799999999999999999999999999999999999999999999999999876544332


Q ss_pred             -ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC-chhH
Q 017909          189 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID-NPKA  266 (364)
Q Consensus       189 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~  266 (364)
                       ......++..|+|||++.+...++.++|+||||+++|+|++|..||.+....+....+....+...+....... ....
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             23345667889999999874478999999999999999999999999887776666666655554443222111 0000


Q ss_pred             HHHHhhCCCCCCCc-ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ... .......... .......++..+.+||++||..+|++|||++++++||||
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGV-AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccc-ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000 0000000000 011223458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=312.20  Aligned_cols=281  Identities=42%  Similarity=0.721  Sum_probs=230.2

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |++.+.||+|++|.||+|+...+++.+++|++............+..|+.+++.++|+|++++++++...     ...++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            6788999999999999999999999999999986543343445567899999999999999999999877     78999


Q ss_pred             EeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc
Q 017909          112 VYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM  190 (364)
Q Consensus       112 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~  190 (364)
                      |+|+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            9999999999999876 579999999999999999999999999999999999999999999999999987654433333


Q ss_pred             ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       191 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ....++..|+|||.+.+...++.++|+||||+++++|++|..||.+.........+....+.+....+.......  .+.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYK  233 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--ccc
Confidence            444557789999998775578999999999999999999999999988888888887777666555443332211  111


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...+...........+..+..+.++|++||..||.+||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1112222222233345568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-42  Score=310.76  Aligned_cols=280  Identities=38%  Similarity=0.708  Sum_probs=218.4

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      |++++.||+|++|.||+|.+..++..+++|.++...... ......+|+.+++++. |+|++++++++.+...   ...+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEE
Confidence            788999999999999999999999999999987643332 2233457888888885 9999999999876532   5679


Q ss_pred             EEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      +|+||+++++.+.+... +.+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+........ 
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            99999999999888764 57899999999999999999999999999999999999999 9999999999876533222 


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .....++..|+|||.+.....++.++|+|||||++|+|++|..||.+.+..+....+....+.................+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            23345678899999876645678999999999999999999999999887777777766665544422111100000000


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                        ..+...........+.++..+.++|.+||+.||.+||+++++|+||||
T Consensus       235 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 --NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             --cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              011111111222334678999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=311.72  Aligned_cols=282  Identities=48%  Similarity=0.787  Sum_probs=229.3

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |++.+.||+|++|.||++.+..+++.+++|.++...........+.+|+.+++.++|++++++++++...     ...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence            6788999999999999999999999999999876555544556777899999999999999999999877     78999


Q ss_pred             EeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc
Q 017909          112 VYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM  190 (364)
Q Consensus       112 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~  190 (364)
                      |+||+++++.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            9999999999888764 579999999999999999999999999999999999999999999999999887664433233


Q ss_pred             ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       191 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+....+.+....+...... .....
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-ARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-hhhhh
Confidence            33456778999999987547899999999999999999999999998888777777776666544433322210 00111


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...............+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1111112222233445678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.9e-43  Score=320.53  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=207.4

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHH-HHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLREL-VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|+++.+++.||+|++...... ......+..|. .+++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence            4699999999999999999999999999754322 22223344444 456778999999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9998 599999988888999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------------  211 (325)
T cd05602         156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------------  211 (325)
T ss_pred             ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence            578999999999987 57899999999999999999999999887665554444321                       


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH----HHhcCCCccCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT----EALQHPYISGL  322 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----elL~hp~f~~~  322 (364)
                              .....+.+++.+.++|.+||+.||.+||++.    ++++|+||...
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         212 --------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             --------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence                    0122356888999999999999999999876    89999999765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-42  Score=317.46  Aligned_cols=263  Identities=22%  Similarity=0.365  Sum_probs=213.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|+||+||++.++.+++.+|+|++..... .......+.+|..++..++|++++++++.+...     ..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CE
Confidence            479999999999999999999999999999999865322 222334466788999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||+. |+|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999997 699999976 467999999999999999999999999999999999999999999999999998654322


Q ss_pred             Cc-ccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          187 EQ-FMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       187 ~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .. ......|++.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+.......+.....          
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------  225 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----------  225 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc----------
Confidence            22 2234568999999999863    24578999999999999999999999988766555554432100          


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGLY  323 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~~  323 (364)
                                      ..........+++.+.+||++||..++.+  |++++++++||||++..
T Consensus       226 ----------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         226 ----------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             ----------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence                            00112223457899999999999765555  78999999999998763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-42  Score=318.63  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.+..+++.||+|+++..... ......+.+|+.++..+ .||+|+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence            4799999999999999999999999999865333 23445567888888888 699999999999877     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ |+|...+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9997 699988888888999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN---QLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      ..|+..|+|||++.+ ..++.++|+||||+++|+|++|..||.......   ....+.....                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  216 (327)
T cd05617         156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------------  216 (327)
T ss_pred             ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------------
Confidence            678999999999977 578999999999999999999999996432110   0000111000                  


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCC
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT------VTEALQHPYISGLY  323 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~elL~hp~f~~~~  323 (364)
                               ......+..++..+.++|++||+.||.+|++      ++++++||||.+..
T Consensus       217 ---------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         217 ---------EKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             ---------hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                     0011234467888999999999999999998      57999999998874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-42  Score=310.39  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||+|+||+||++.++.+|+.|++|.+....... ........|+++++.++||||+++++.+...     ...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence            699999999999999999999999987543322 2233445699999999999999999999877     7899999999


Q ss_pred             c-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccc
Q 017909          117 D-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY  193 (364)
Q Consensus       117 ~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~  193 (364)
                      . ++|.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~  154 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQR  154 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeecc
Confidence            7 5898877543  358999999999999999999999999999999999999999999999999987653322 23345


Q ss_pred             cccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhC
Q 017909          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL  273 (364)
Q Consensus       194 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
                      .++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+......                     
T Consensus       155 ~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  212 (277)
T cd05607         155 AGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE---------------------  212 (277)
T ss_pred             CCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc---------------------
Confidence            67889999999987 46899999999999999999999999765432221111110000                     


Q ss_pred             CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCCCCCCC
Q 017909          274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV----TEALQHPYISGLYDPQCN  328 (364)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~elL~hp~f~~~~~~~~~  328 (364)
                           .........+++.+.+||++||+.||.+||++    ++++.||||+++..+..+
T Consensus       213 -----~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~  266 (277)
T cd05607         213 -----DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE  266 (277)
T ss_pred             -----cccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHh
Confidence                 00011123578899999999999999999999    778899999997655544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=298.92  Aligned_cols=261  Identities=29%  Similarity=0.438  Sum_probs=215.3

Q ss_pred             ecccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      .+-++|++. ++||-|-.|+|..+.++.+|+++|+|++..       ..+..+|++..... .|||||.++++|......
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            367788887 589999999999999999999999999853       23445788887776 699999999999755332


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC---CcEEEeecC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFG  178 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~---~~~~L~Dfg  178 (364)
                       ...+.+|||.++ |.|.+.++..+.  +++.++..++.||+.|+.|||+.+|.||||||+|+|...+   -.+||+|||
T Consensus       131 -rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  131 -RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             -ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             367899999998 699999987754  9999999999999999999999999999999999999654   469999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHHHhCCCc
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK----LIISVFGTQQ  254 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~  254 (364)
                      +++....+.. ....+-|+.|.|||++.. ..|....|+||||+++|-|+.|.+||.+........    +|....-.++
T Consensus       210 FAK~t~~~~~-L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  210 FAKETQEPGD-LMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             cccccCCCcc-ccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            9987755444 445566999999999866 679999999999999999999999998775433222    2222111122


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                                 .+-|..+|.+.+++|+.+|..+|.+|.|++++++|||+.+..-
T Consensus       288 ---------------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  288 ---------------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             ---------------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                                       3344678999999999999999999999999999999988543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4e-42  Score=310.37  Aligned_cols=266  Identities=24%  Similarity=0.411  Sum_probs=215.2

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ...++.|++++.||.|++|.||+|.+..++..+++|.+...  .......+.+|+.+++.++|+|++++++.+..+    
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   81 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD----   81 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC----
Confidence            34678899999999999999999999999999999998653  333455677899999999999999999999877    


Q ss_pred             cceEEEEeccccc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMDT-DLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||+++ +|...+.+ ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        82 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          82 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             -CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence             789999999985 77776654 456899999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ...........++..|+|||.+.+    ...++.++|+||||+++|+|++|..||...........+..   ....    
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~----  233 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPP----  233 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCc----
Confidence            333333344567888999999853    23468899999999999999999999976553332222211   0000    


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                           .......++..+.++|++||..||.+||+++++++||||..+....
T Consensus       234 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         234 ---------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             ---------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence                                 0112245678899999999999999999999999999998765544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-42  Score=326.69  Aligned_cols=279  Identities=25%  Similarity=0.317  Sum_probs=209.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ....|.+.+.||+|+||.||++.+..++..|++|....        ....+|+.++++++|+||+++++++...     .
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~  233 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG-----G  233 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----C
Confidence            35689999999999999999999999999999996432        2345799999999999999999998777     7


Q ss_pred             eEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||+++.++|.+.+... +.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus       234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            88999999999999988764 56999999999999999999999999999999999999999999999999998754322


Q ss_pred             Cc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCC-CCCC------hHHHHHHHHHHhCCCchhh
Q 017909          187 EQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF-PGTE------CLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       187 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~------~~~~~~~i~~~~~~~~~~~  257 (364)
                      ..  ......|+..|+|||++.+ ..++.++|||||||++|+|++|..++ ....      .......+...........
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            11  1223568999999999987 57899999999999999999877544 3221      1223333333322211111


Q ss_pred             hhccCchhHHHHHhh-----CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          258 LEFIDNPKARRFIKS-----LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ...........+...     ........|.. ....++.+.+||++||+.||.+|||+.|||+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            100001111111110     00111111111 1246778999999999999999999999999999975

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-42  Score=314.08  Aligned_cols=278  Identities=39%  Similarity=0.650  Sum_probs=205.0

Q ss_pred             eeeeccCCceeEEEEEecc--CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           35 IKPIGRGAYGVVCSSINRE--TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.+||+|+||+||+|+++.  ++..||+|.+.....    ...+.+|+.+++.++|||++++++++.....   ...++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEE
Confidence            4689999999999999654  567899998864322    2345679999999999999999999865432   678999


Q ss_pred             eccccccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE----ccCCcEEEeecCc
Q 017909          113 YELMDTDLHQIIKSS---------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGL  179 (364)
Q Consensus       113 ~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll----~~~~~~~L~Dfg~  179 (364)
                      +||++++|.+.+...         ..+++..++.++.||+.||.|||++|++|+||||+||++    +.++.++|+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            999999998887521         248899999999999999999999999999999999999    4567899999999


Q ss_pred             cccCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 017909          180 ARTSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC---------LNQLKLII  247 (364)
Q Consensus       180 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~i~  247 (364)
                      +........   ......++..|+|||++.+...++.++|||||||++|+|++|.+||.....         ......+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            876533221   223446788999999997756689999999999999999999999975432         23344455


Q ss_pred             HHhCCCchhhhhccCc-hhHHHHHhhC---CC---CCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          248 SVFGTQQEADLEFIDN-PKARRFIKSL---PY---SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...+.+....+..... +.........   ..   .............+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            5555444433322110 0000000000   00   00001111223456778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=313.19  Aligned_cols=265  Identities=26%  Similarity=0.409  Sum_probs=216.7

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|++|+||+|.+..+++.+++|.+....... .....+..|+++++.++|+||+++++.+...     ..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CE
Confidence            47999999999999999999999999999999997653332 3445677899999999999999999998776     78


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||+. ++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            899999997 5999988754  5699999999999999999999999999999999999999999999999998764322


Q ss_pred             CCc-----------------------------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 017909          186 NEQ-----------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG  236 (364)
Q Consensus       186 ~~~-----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  236 (364)
                      ...                             ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            111                             1112356778999999977 5689999999999999999999999987


Q ss_pred             CChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC----HHH
Q 017909          237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT----VTE  312 (364)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~e  312 (364)
                      .+.......+...   ..                         . .......++.+.++|++||+.||.+|||    +++
T Consensus       235 ~~~~~~~~~~~~~---~~-------------------------~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~  285 (316)
T cd05574         235 SNRDETFSNILKK---EV-------------------------T-FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE  285 (316)
T ss_pred             CchHHHHHHHhcC---Cc-------------------------c-CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence            7655444433210   00                         0 0011226888999999999999999999    999


Q ss_pred             HhcCCCccCCCCCCCCC
Q 017909          313 ALQHPYISGLYDPQCNP  329 (364)
Q Consensus       313 lL~hp~f~~~~~~~~~~  329 (364)
                      +|+||||++...+....
T Consensus       286 ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         286 IKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHcCchhhcCChhhccc
Confidence            99999999976555543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.7e-42  Score=303.29  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=213.6

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|++|.||++.+..+|+.+++|.+............+.+|+.+++.++|||++++++.+...     ...+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEE
Confidence            68999999999999999999999999999999876544444556778999999999999999999999777     7899


Q ss_pred             EEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|+||+. ++|.+.+....  .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999997 59999887543  58999999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+..+....+...                  
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08218         156 ELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG------------------  216 (256)
T ss_pred             hhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC------------------
Confidence            33334457788999999877 56889999999999999999999999876554444333210                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  ........++..+.++|.+||+.+|.+||++.+||+||||
T Consensus       217 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         217 ------------SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ------------CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                        0112234578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=309.34  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=214.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||.|++|+||++.+..++..+++|.+...  .......+..|+.+++.++|+|++++++.+...     ..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----Ce
Confidence            46899999999999999999999889999999998643  333445677899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||++ ++|.+++... +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            899999998 5888888664 57999999999999999999999999999999999999999999999999987655443


Q ss_pred             CcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          187 EQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ........++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+.......+..   ...        
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--------  225 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEP--------  225 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCC--------
Confidence            333344567888999999752    23467899999999999999999999987654433322211   000        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                       ........++..+.++|.+||+.||.+||+++++|+||||....
T Consensus       226 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 -----------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             -----------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                             00111245778899999999999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.1e-42  Score=307.85  Aligned_cols=283  Identities=36%  Similarity=0.647  Sum_probs=213.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|++|.||+|.++.+|..+++|.+....... ....+.+|+.+++.++|+|++++++++...     ..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDIIHTK-----ET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-CcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----Ce
Confidence            468999999999999999999999999999999986543222 223456799999999999999999998776     78


Q ss_pred             EEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++|+||+++++.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          78 LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            8999999998888877543 568899999999999999999999999999999999999999999999999886543333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhhhccCchhH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.... +....+....+.+.........  ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  235 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS--KL  235 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh--hc
Confidence            22334456888999999876556889999999999999999999999866432 3333343333433222111110  00


Q ss_pred             HHHHhhC-CCCCCCcccccCC--CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSL-PYSRGTHISSLYP--QADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~-~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ..+.... ...........+.  ..++.+.+++.+||+.||.+|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0000000 0000001111111  236788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.7e-42  Score=311.28  Aligned_cols=290  Identities=38%  Similarity=0.612  Sum_probs=225.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc----
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR----  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  103 (364)
                      ..++|++.+.||.|++|.||+|+++.+|+.|++|.++...........+.+|+.+++.++|||++++++++.....    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4678999999999999999999999999999999997654333334456689999999999999999999876531    


Q ss_pred             -cccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 -ISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 -~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                       ......++|+||+++++.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence             111378999999999888887754 469999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          182 TSRGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       182 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...... .......++..|+|||.+.+....+.++||||||+++++|++|++||...+.......+....+......+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD  244 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            553322 1122234567899999987655678999999999999999999999998888887777777666555443322


Q ss_pred             cCchhHHHHHhhC-CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          261 IDNPKARRFIKSL-PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       261 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ......  +.... ..............++..+.++|.+||+.||.+||+++++++||||
T Consensus       245 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         245 VIKLPY--FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccc--ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            211000  00000 0000011122334578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.6e-42  Score=316.90  Aligned_cols=262  Identities=23%  Similarity=0.361  Sum_probs=212.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|+||+||++.++.+++.||+|++..... .......+.+|..++..++|++|+++++++...     ..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence            589999999999999999999999999999999875322 223344466788999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999997 699999976 467999999999999999999999999999999999999999999999999998765332


Q ss_pred             Cc-ccccccccccccCCcccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          187 EQ-FMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       187 ~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .. ......|+..|+|||++.+.    ..++.++|+||||+++|+|++|+.||...+..+....+.....          
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------  225 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE----------  225 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC----------
Confidence            22 22235689999999998642    3578899999999999999999999987765555544432100          


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGL  322 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~  322 (364)
                                      ..........++..+.++|.+||+.++.+  |++++++++||||...
T Consensus       226 ----------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         226 ----------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             ----------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence                            00011222457889999999999976655  5799999999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=307.23  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=213.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.++|+|++++++++...     ...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence            57999999999999999999999999999999987543 233445667899999999999999999998877     789


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+|+++ ++|.+.+... ++++..++.++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus        75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999998 5899888765 899999999999999999999999999999999999999999999999999876644433


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...                   
T Consensus       154 ~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------------  213 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-------------------  213 (274)
T ss_pred             ccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-------------------
Confidence            3444567788999999987 46899999999999999999999999766533322222110                   


Q ss_pred             HHhhCCCCCCCcccccCCC-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                 ........ ++..+.+++.+||..||.+|||++++++||||+...
T Consensus       214 -----------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         214 -----------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -----------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                       00111112 678899999999999999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-42  Score=312.91  Aligned_cols=290  Identities=37%  Similarity=0.606  Sum_probs=222.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc---c
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI---S  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~  105 (364)
                      .++|++.+.||+|++|.||+|.++.+++.+++|.+..............+|+++++.++||||+++++.+......   .
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4799999999999999999999999999999998865433332233456799999999999999999987654321   1


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ....++|++|+.+++...+.. ...+++..++.++.|+++||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            246799999999988887765 3579999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCcc-----------cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          185 GNEQF-----------MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       185 ~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      .....           .....++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.........+....+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            22211           1223457789999998765568999999999999999999999999888887777777765554


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .+..+........... ..................++.+.++|++||+.||.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         247 TEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             Chhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            4433221110000000 0000001111112234566889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=307.32  Aligned_cols=284  Identities=39%  Similarity=0.671  Sum_probs=223.0

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            78999999999999999999999999999999865433444456778999999999999999999987652   257899


Q ss_pred             EeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc-c
Q 017909          112 VYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ-F  189 (364)
Q Consensus       112 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~-~  189 (364)
                      |+||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            9999999999888765 5799999999999999999999999999999999999999999999999999876543321 1


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+....+......+...........
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23335577899999887655689999999999999999999999998887777777766655554443332221100000


Q ss_pred             HhhCCCCCCCcccccCCC-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          270 IKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ... .............. +++.+.++|++||+.||.+||++.++++||||
T Consensus       238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            000 00000011111222 48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.3e-42  Score=339.88  Aligned_cols=264  Identities=26%  Similarity=0.386  Sum_probs=214.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||.|+||+||+|.+..++..+++|++............+..|+.+++.++||||++++++|.....   .
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN---Q   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---C
Confidence            4579999999999999999999999999999999997655555566778899999999999999999999865432   5


Q ss_pred             eEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCCeEEcc-------
Q 017909          108 DVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSA-------NILHRDLKPGNLLVNA-------  168 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-------~i~H~di~~~NIll~~-------  168 (364)
                      .++|||||+. ++|.+++..    ...+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            7899999998 699988864    35799999999999999999999985       4999999999999964       


Q ss_pred             ----------CCcEEEeecCccccCCCCCcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 017909          169 ----------NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGT  237 (364)
Q Consensus       169 ----------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~  237 (364)
                                .+.++|+|||++...... .......+++.|+|||++.+. ..++.++|||||||++|+|++|..||...
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                      234899999998765332 223445789999999998642 45889999999999999999999999766


Q ss_pred             ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                      ...........   ..+                           .......+..+.+||..||+.+|.+||++.|+|.||
T Consensus       247 ~~~~qli~~lk---~~p---------------------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~  296 (1021)
T PTZ00266        247 NNFSQLISELK---RGP---------------------------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ  296 (1021)
T ss_pred             CcHHHHHHHHh---cCC---------------------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence            54333222211   100                           001134678899999999999999999999999999


Q ss_pred             CccCCCCC
Q 017909          318 YISGLYDP  325 (364)
Q Consensus       318 ~f~~~~~~  325 (364)
                      ||.....+
T Consensus       297 ~ik~i~~p  304 (1021)
T PTZ00266        297 IIKNVGPP  304 (1021)
T ss_pred             HHhhcCCC
Confidence            99877655

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.6e-42  Score=309.54  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=210.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++|++++++++.+...     ...
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence            4788999999999999999999999999999986543322 2234556899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||+. ++|.+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999997 5898887543  35999999999999999999999999999999999999999999999999988654322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      . ......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||..................              
T Consensus       156 ~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~--------------  219 (285)
T cd05630         156 Q-TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--------------  219 (285)
T ss_pred             c-cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh--------------
Confidence            2 2234467889999999977 57899999999999999999999999865432211111110000              


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDP  325 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~  325 (364)
                            .       .......+++.+.+||++||+.||.+|||     ++|+++||||.++...
T Consensus       220 ------~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         220 ------V-------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             ------h-------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                  0       01123457888999999999999999999     9999999999876333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-41  Score=301.53  Aligned_cols=255  Identities=28%  Similarity=0.484  Sum_probs=214.5

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||++.+..++..+++|.++...........+.+|+.+++.++|+|++++++.+.....   ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEE
Confidence            5899999999999999999999999999999987655555566677889999999999999999998765422   5689


Q ss_pred             EEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          111 LVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLH-----SANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-----~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      +++||++ ++|.+++..    ..++++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999997 599988865    357999999999999999999999     889999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..............++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+..            
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  224 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE------------  224 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc------------
Confidence            876554433444567889999999877 5688999999999999999999999987764333322211            


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                        .........++..+.+++.+||+.+|.+||++.+||+|||+
T Consensus       225 ------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         225 ------------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                              01122334678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.2e-42  Score=314.56  Aligned_cols=284  Identities=18%  Similarity=0.265  Sum_probs=208.5

Q ss_pred             eeeeeeccC--CceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           33 VPIKPIGRG--AYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        33 ~i~~~lg~g--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +++++||+|  ++++||++.++.+|+.||+|.++...........+.+|+.+++.++||||+++++++..+     ...+
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~   75 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELW   75 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEE
Confidence            356789999  678999999999999999999976554444455666799999999999999999999877     7889


Q ss_pred             EEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +||||++ |+|.+++...  +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++++||+.........
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999998 6999988653  458999999999999999999999999999999999999999999999998654321111


Q ss_pred             c-------ccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch----
Q 017909          188 Q-------FMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE----  255 (364)
Q Consensus       188 ~-------~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----  255 (364)
                      .       ......++..|+|||++.+. ..++.++|||||||++|+|++|..||..............  +..+.    
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~  233 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccc
Confidence            1       11122446679999998753 3588999999999999999999999987654333222211  11000    


Q ss_pred             -----hhhhccC-----chhHHHHHh---hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          256 -----ADLEFID-----NPKARRFIK---SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       256 -----~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                           .......     .........   ................+++.+.+||++||+.||.+|||+++||+||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                 0000000     000000000   000001111122334568899999999999999999999999999999875


Q ss_pred             C
Q 017909          323 Y  323 (364)
Q Consensus       323 ~  323 (364)
                      .
T Consensus       314 ~  314 (327)
T cd08227         314 K  314 (327)
T ss_pred             c
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-42  Score=305.84  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||.||+|++..+++.+++|++.....  .....+.+|+.+++.++|||++++++.+...     .
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~   79 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----E   79 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----C
Confidence            35689999999999999999999999999999999864322  2334566899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            8899999998 599999888788999999999999999999999999999999999999999999999999998765433


Q ss_pred             CcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ........++..|+|||.+..  ...++.++|+||||+++|+|++|..||...........+....              
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~--------------  225 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN--------------  225 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC--------------
Confidence            322334567888999998753  2447789999999999999999999986543221111110000              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                                  ...........++..+.+||++||+.||.+|||+++||+|+|
T Consensus       226 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         226 ------------FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ------------CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                        000000112346788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.8e-41  Score=306.62  Aligned_cols=259  Identities=26%  Similarity=0.469  Sum_probs=213.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ...+|++++.||.|++|.||++.+..+++.+++|.+.....  .....+.+|+.+++.++|||++++++.+...     .
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   89 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVG-----D   89 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecC-----c
Confidence            34679999999999999999999999999999999865322  2345667899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|+||+. ++|.+.+.. ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            8999999998 588877754 46999999999999999999999999999999999999999999999999988765433


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+... ..              
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~--------------  232 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT--------------  232 (296)
T ss_pred             cccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC--------------
Confidence            333334567888999999876 56889999999999999999999999877654333222110 00              


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                   .....+..+++.+.++|++||..||.+||++.+++.||||+...
T Consensus       233 -------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         233 -------------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             -------------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                         00112345788899999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-41  Score=307.82  Aligned_cols=262  Identities=24%  Similarity=0.441  Sum_probs=214.9

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      +......+|++.+.||+|++|.||++++..++..+++|.+......  ....+.+|+.+++.+.|+|++++++.+...  
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--   89 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--   89 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--
Confidence            3455678999999999999999999999999999999998754332  345567899999999999999999998876  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...++||||+. ++|.+++.. ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        90 ---~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654          90 ---DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             ---CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence               78999999997 589888754 4689999999999999999999999999999999999999999999999998865


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.. .+.          
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~----------  233 (296)
T cd06654         166 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGT----------  233 (296)
T ss_pred             ccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCC----------
Confidence            4333322334467889999999876 5688999999999999999999999977654322221110 000          


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       ........+++.+.++|.+||..||.+|||+.++++||||...
T Consensus       234 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         234 -----------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             -----------------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                             0011234577889999999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=327.11  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=211.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC-CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET-NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ...|.+.+.||+|++|.||+|.+..+ +..+++|.+...  .......+..|+.+++.++||||+++++++...     .
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~  138 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----D  138 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----C
Confidence            34599999999999999999998877 778899877543  223344566799999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          108 DVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ..++||||+. |+|.+.+..    ..++++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus       139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            8999999997 699887643    35689999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .....  .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+...           
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-----------  286 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-----------  286 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            53322  12334568999999999877 57899999999999999999999999877655544443221           


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                         .....+..+++.+.++|.+||+.||.+||+++++|.|+|++.
T Consensus       287 -------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        287 -------------------KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             -------------------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                               011223457889999999999999999999999999999864

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-41  Score=309.21  Aligned_cols=282  Identities=23%  Similarity=0.366  Sum_probs=214.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|+||.||++.+..++..+++|.++... ......++.+|+++++.++||||+++++.+..+     ..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEE
Confidence            47999999999999999999999999999999987532 233445677899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++||||++ ++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999997 5999999888889999999999999999999998 58999999999999999999999999987654222 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh------hcc
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL------EFI  261 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------~~~  261 (364)
                       ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+............      ...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence             1234467889999999876 56889999999999999999999999766533222211110000000000      000


Q ss_pred             Cc---hhHHHHHhhCCCCCCCccccc-CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          262 DN---PKARRFIKSLPYSRGTHISSL-YPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       262 ~~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ..   .............   ..... ...++..+.+||.+||..||++|||+.+|++||||..+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         232 DSPRPMAIFELLDYIVNE---PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CccchhhHHHHHHHHhcC---CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            00   0000000000000   00111 123788899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-41  Score=304.65  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=211.1

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +-|++.+.||.|++|.||++.+..++..+++|.+...  .......+.+|+.+++.++|||++++++.+...     ...
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~   77 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNL   77 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEE
Confidence            4578999999999999999999999999999998643  233445677899999999999999999999877     788


Q ss_pred             EEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++|+||++ ++|...+.. ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            99999998 577776654 4679999999999999999999999999999999999999999999999999986554333


Q ss_pred             cccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          188 QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .......++..|+|||++..    ...++.++|+|||||++|+|++|..||...........+......           
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-----------  226 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-----------
Confidence            33344567889999999842    245778999999999999999999999876544433333221000           


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       ....+..++..+.+||++||+.||.+||+++++++||||+..
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 -----------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             -----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                             011223567889999999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.6e-42  Score=309.27  Aligned_cols=266  Identities=25%  Similarity=0.440  Sum_probs=216.2

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ......+|++++.||+|++|.||++.+..++..|++|.+......  ....+.+|+.+++.++|+|++++++++...   
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---   88 (297)
T cd06656          14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG---   88 (297)
T ss_pred             cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence            345678999999999999999999999999999999998653222  334567899999999999999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||++ ++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        89 --~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          89 --DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             --CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence              78899999997 588888755 56899999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+.......+..               
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---------------  229 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------  229 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc---------------
Confidence            433333334567888999999877 5789999999999999999999999976543221111100               


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                                   ........+..+++.+.+||.+||..||.+||+++++++||||+.......
T Consensus       230 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         230 -------------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             -------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence                         000001122457788999999999999999999999999999987554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.2e-42  Score=304.59  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=209.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|.||+|.+..+++.+++|+++...  ......+.+|+.+++.++|||++++++.+...     ..
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~   80 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DK   80 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CE
Confidence            568999999999999999999999999999999987542  22334567899999999999999999998877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++|+||++ ++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            899999998 5999999888899999999999999999999999999999999999999999999999999986554333


Q ss_pred             cccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 QFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .......++..|+|||++..  ...++.++|+|||||++|+|++|..||...............  ....          
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~----------  228 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP----------  228 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCC----------
Confidence            33345567889999998742  245788999999999999999999998655432222111100  0000          


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                                   . .......++..+.++|++||+.||.+||++++|++|||
T Consensus       229 -------------~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         229 -------------P-KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -------------C-cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                         0 00011246778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-41  Score=301.04  Aligned_cols=253  Identities=26%  Similarity=0.467  Sum_probs=210.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|.||+++++.++..+++|.+.....    ...+.+|+.+++.++|+|++++++.+...     ..
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~   72 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TD   72 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----Cc
Confidence            4689999999999999999999998899999999865422    55677899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++++|+++ ++|.+++.. ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            899999998 599998865 457899999999999999999999999999999999999999999999999998766443


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..    .             
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~-------------  214 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----K-------------  214 (256)
T ss_pred             ccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----C-------------
Confidence            333344456788999999877 5789999999999999999999999976543322211100    0             


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                 ..........++..+.++|.+||+.||.+|||+.+||.||||
T Consensus       215 -----------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 -----------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -----------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                       000011123467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-41  Score=302.68  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=212.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||.|++|+||+|.+..++..+++|++....... ....+.+|+.+++.++|+|++++++.+...     ...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEE
Confidence            57999999999999999999998899999999987543333 556778899999999999999999998777     788


Q ss_pred             EEEecccc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS---QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ++|+|+++ ++|.+.+...   ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999997 5899988764   4589999999999999999999999999999999999999999999999998865543


Q ss_pred             CCcc----cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NEQF----MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ....    .....++..|+|||.+.....++.++|+||||+++++|++|+.||..............   ..+..     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~-----  226 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDPPS-----  226 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCCCC-----
Confidence            3222    23345688899999987754789999999999999999999999977654433332221   11100     


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                       .........+++.+.+++.+||+.||.+||++.+|++||||
T Consensus       227 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         227 -----------------LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -----------------cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                             00001124678889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-41  Score=302.63  Aligned_cols=253  Identities=26%  Similarity=0.483  Sum_probs=209.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-------HHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-------IDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      +|.++..||.|++|.||+|.+..++..+++|.+.......       .....+.+|+.+++.++|||++++++++...  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence            5888999999999999999999899999999886543221       1224556899999999999999999998877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...++|+||++ ++|.+++...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          79 ---DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             ---CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence               78899999997 59999998888899999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCCc------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Q 017909          183 SRGNEQ------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA  256 (364)
Q Consensus       183 ~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (364)
                      ......      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE--------  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc--------
Confidence            532111      1122346788999999877 5688999999999999999999999987654333222211        


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                            .........++..+.++|++||+.||.+||++.+|++||||
T Consensus       227 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 ----------------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------------------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                  01122334578889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=301.03  Aligned_cols=280  Identities=24%  Similarity=0.388  Sum_probs=246.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .-++|...++||.|.||+|-+++.+.+++.||+|+++++..- ......-+.|-.+|...+||.+..+.-.|+..     
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----
Confidence            457899999999999999999999999999999999876543 34556667899999999999999988888888     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..+|+||||.+ |.|.-.+++.+.+++..++.+..+|..||.|||+++|+++|+|.+|.|++++|++||+|||+|+..-.
T Consensus       241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            88999999998 58888888888899999999999999999999999999999999999999999999999999987766


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........|||+-|+|||++.. ..|+.+.|+|.+|+++|||+.|+.||.+.+......+|.-                 
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----------------  382 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----------------  382 (516)
T ss_pred             ccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------------
Confidence            7777888999999999999988 5899999999999999999999999999887776666542                 


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCCC-CCCCCCCCCccc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQC-NPPAQVPLSLDI  339 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~~-~~~~~~~~~~~~  339 (364)
                                    ....++..++++.+.|+..+|..||++|.     .+.||.+|+||.++.+.+. ..-..+|.++++
T Consensus       383 --------------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV  448 (516)
T KOG0690|consen  383 --------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV  448 (516)
T ss_pred             --------------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence                          11334567899999999999999999998     7899999999999866554 356677788887


Q ss_pred             chhhh
Q 017909          340 DENIG  344 (364)
Q Consensus       340 ~~~~~  344 (364)
                      .++.|
T Consensus       449 tSetD  453 (516)
T KOG0690|consen  449 TSETD  453 (516)
T ss_pred             ccccc
Confidence            77766

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=303.34  Aligned_cols=282  Identities=41%  Similarity=0.652  Sum_probs=218.7

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccccccce
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      |++++.||.|++|.||+|+++.+++.+++|.++...........+.+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7889999999999999999998899999999975444333334455677766655   6999999999998764322235


Q ss_pred             EEEEeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .+++||+++++|.+.+....  .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            89999999999998887643  5899999999999999999999999999999999999999999999999988665332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      . ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+....+....+...........+........
T Consensus       161 ~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         161 M-ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             c-ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            2 2223346778999999987 5789999999999999999999999999888877777776555433322211111000


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ..+    +...........+..++.+.++|++||+.||.+||+++++++||||
T Consensus       239 ~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSF----PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhc----ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000    1111111223334567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=315.02  Aligned_cols=246  Identities=26%  Similarity=0.375  Sum_probs=210.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ...+++++.||+|.||.||+|.++.+ ..|++|.++..   ......+++|++++++++|++||+++++|..+     ..
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~p  275 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EP  275 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----Cc
Confidence            45677889999999999999988743 47999999753   33345667999999999999999999999887     67


Q ss_pred             EEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ++|||||+. |+|+++++.  ...++......++.|||+|++||++++++||||-..||||+.+..+||+|||+++...+
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence            899999998 899999987  46799999999999999999999999999999999999999999999999999995544


Q ss_pred             CCccc-ccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFM-TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      +.... ....-..-|.|||.+.. ..++.+|||||||++|+||+ .|+.||++....+....+.+.              
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G--------------  420 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG--------------  420 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------------
Confidence            33222 22223456999999987 58999999999999999998 689999999988888877542              


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                                      ...+.+..+|+.+-++++.||+.+|++|||++.+.
T Consensus       421 ----------------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 ----------------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ----------------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                            23445578999999999999999999999999765

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.3e-41  Score=304.17  Aligned_cols=267  Identities=24%  Similarity=0.383  Sum_probs=211.7

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT  101 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (364)
                      ..+....++|++.+.||+|++|.||++.++.+++.+++|++....   .....+.+|+.+++++ +|||++++++++...
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            344456889999999999999999999999999999999986432   1233455788889888 799999999998765


Q ss_pred             cccccceEEEEecccc-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      ........++|+||++ ++|.+++.    ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence            4333356899999997 58888775    345789999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccCCccccccc----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      ||.+..............++..|+|||.+....    .++.++|+||||+++|+|++|..||...........+..   .
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~  248 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---N  248 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---C
Confidence            999876543333333456788899999986422    368899999999999999999999977654333322211   0


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      ...                         ........+..+.++|.+||+.||.+||++.++++||||+
T Consensus       249 ~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         249 PPP-------------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCC-------------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            000                         0011234567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.1e-41  Score=297.76  Aligned_cols=253  Identities=27%  Similarity=0.475  Sum_probs=215.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||.+.+..++..+++|.+...........++.+|+.++++++|+|++++++++...     ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence            69999999999999999999999999999999876555555666778999999999999999999999887     7899


Q ss_pred             EEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++|||++ ++|.+.+...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999997 6999998764  468999999999999999999999999999999999999999999999999987654443


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|.|||.+.+ ..++.++|+||||+++|+|++|..||......+....+...                  
T Consensus       156 ~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG------------------  216 (256)
T ss_pred             ccccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------------
Confidence            33445567889999999877 46889999999999999999999999876654444433210                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  ........++..+.++|.+||+.+|.+||++.++|+|||+
T Consensus       217 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         217 ------------NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                        0111224578889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-41  Score=313.58  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=199.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.++..+ +||||+++++++....
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            57999999999999999999975     234567999998743 2233445678999999999 8999999999886542


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC------------------------------------------------------
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (364)
                          ...++||||++ |+|.+++...                                                      
T Consensus        85 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          85 ----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence                46899999998 6999888642                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc--ccccccccc
Q 017909          128 --------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTR  197 (364)
Q Consensus       128 --------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~  197 (364)
                              .++++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  ......++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2477888999999999999999999999999999999999999999999999875432221  112233456


Q ss_pred             cccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCC
Q 017909          198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYS  276 (364)
Q Consensus       198 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (364)
                      .|+|||++.+ ..++.++||||||+++|+|++ |..||.+............   ..                       
T Consensus       241 ~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~-----------------------  293 (338)
T cd05102         241 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---DG-----------------------  293 (338)
T ss_pred             cccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---cC-----------------------
Confidence            7999999977 578999999999999999996 9999987653322221111   00                       


Q ss_pred             CCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          277 RGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                         .....+..+++.+.++|.+||+.||.+|||+.+|++
T Consensus       294 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         294 ---TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               001123457888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=303.85  Aligned_cols=280  Identities=41%  Similarity=0.709  Sum_probs=222.3

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      |++.+.||+|++|+||+|+...+++.+++|.+...... .......+|+..++++. |+|++++++++...     ...+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEE
Confidence            78899999999999999999988999999998754332 23334457899999998 99999999999886     7889


Q ss_pred             EEeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          111 LVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       111 lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      +||||++++|.+.+....  .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence            999999989999887754  78999999999999999999999999999999999999999999999999987653322 


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||++.....++.++|+||||+++++|++|++||+.....+....+...++.+....+..... ....
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  232 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LASK  232 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh-hhcc
Confidence            223445678899999987656689999999999999999999999999988888887777766655443221100 0000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .....+...........+..+..+.++|++||+.||.+|||++|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            000111111111122233457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.3e-42  Score=308.63  Aligned_cols=268  Identities=25%  Similarity=0.471  Sum_probs=218.8

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .....+.|.....||.|++|.||++.+..++..+++|.+...  .......+.+|+.+++.++|+|++++++.+...   
T Consensus        17 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~---   91 (292)
T cd06658          17 PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG---   91 (292)
T ss_pred             cCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC---
Confidence            345667888889999999999999999999999999998643  233445567899999999999999999998877   


Q ss_pred             ccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||+++ +|.+++.. +.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        92 --~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          92 --DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             --CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence              788999999985 77776644 56899999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.......          
T Consensus       169 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------  237 (292)
T cd06658         169 SKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------  237 (292)
T ss_pred             ccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc----------
Confidence            333333334567889999999876 578899999999999999999999998765544433322111000          


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNP  329 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~  329 (364)
                                        .......+..+.++|.+||..||.+|||++++++||||.....+.+-+
T Consensus       238 ------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~  285 (292)
T cd06658         238 ------------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIV  285 (292)
T ss_pred             ------------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccccc
Confidence                              011124677899999999999999999999999999999988877643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-41  Score=303.03  Aligned_cols=261  Identities=23%  Similarity=0.391  Sum_probs=209.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      ...++|++.+.||.|+||.||+|.+..+++.+++|.+....   .....+.+|+.+++.+ +|+|++++++++.......
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            34678999999999999999999999999999999986532   2234566888999988 6999999999987643221


Q ss_pred             -cceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          106 -FKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       106 -~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                       ....++||||++ ++|.+++...  ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence             246899999998 5999988763  468999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .............++..|+|||++.+    ...++.++|+|||||++|+|++|..||...........+..         
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---------  230 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------  230 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---------
Confidence            55333333344567889999999863    23578899999999999999999999976543322221110         


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                          ..........++..+.+||.+||..||.+|||+.++++||||
T Consensus       231 --------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 --------------------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             --------------------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                                000011223567889999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=299.41  Aligned_cols=257  Identities=28%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++......  ....+.+|+.+++.++|||++++++.+...     ..
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CE
Confidence            46899999999999999999999989999999999754332  455677899999999999999999998776     78


Q ss_pred             EEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .+++|||++ ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            999999998 5888888766 78999999999999999999999999999999999999999999999999988765433


Q ss_pred             CcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ........++..|+|||.+.+.  ..++.++|+||||+++|+|++|..||...........+...  ....         
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~--~~~~---------  223 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS--NFPP---------  223 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCC---------
Confidence            3233345677889999998662  26788999999999999999999999876544333222110  0000         


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                                     ........++..+.++|++||..||.+|||+.+|+.|+|
T Consensus       224 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         224 ---------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                           000111345678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-41  Score=303.82  Aligned_cols=261  Identities=24%  Similarity=0.386  Sum_probs=213.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .|++.+.||.|+||+||++.+..+++.+|+|.+...... ......+.+|+.+++.++|++++++.+.+...     ...
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEE
Confidence            478889999999999999999999999999998654332 22334456899999999999999999998877     789


Q ss_pred             EEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||+. ++|.+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            99999998 5888777543  46999999999999999999999999999999999999999999999999988654322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      . ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+........            
T Consensus       156 ~-~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------------  221 (285)
T cd05632         156 E-SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------------  221 (285)
T ss_pred             C-cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------------
Confidence            2 2234567899999999977 5789999999999999999999999987665444433332211111            


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDP  325 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~  325 (364)
                                     ......+++.+.+|+..||+.||.+||+     +.++++|+||......
T Consensus       222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         222 ---------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             ---------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                           1123457888999999999999999999     8999999999887443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-41  Score=301.34  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=212.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+....... .....+.+|+.++++++|||++++++.+...     ...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeE
Confidence            5899999999999999999999999999999997654333 3456778899999999999999999998777     789


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+||+. ++|.+.+....++++..+..++.||++||.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999997 5999998887789999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ...+......                
T Consensus       155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------------  216 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQET----------------  216 (258)
T ss_pred             cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHHHhcc----------------
Confidence            2334567788999999877 568999999999999999999999998765421 1111111000                


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH--HHHhcCCCc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV--TEALQHPYI  319 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~elL~hp~f  319 (364)
                                 .....+...+..+.++|.+||+.||.+||++  .|+++||||
T Consensus       217 -----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 -----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                       1122334567899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=301.76  Aligned_cols=261  Identities=25%  Similarity=0.423  Sum_probs=210.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccc-cc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHR-IS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~  105 (364)
                      -.++|++.+.||+|++|.||+|.++.++..+++|++.....   ....+.+|+.+++++ .|+|++++++.+..... ..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            46899999999999999999999998999999999875322   335667899999999 69999999999976542 22


Q ss_pred             cceEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      ....++||||++ ++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            256899999998 588888764    357999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccCCcccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA  256 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (364)
                      ..............++..|+|||.+...    ..++.++|+||||+++|+|++|..||...........+..   .... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-  236 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPP-  236 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCC-
Confidence            7654433334455678889999987542    3467899999999999999999999976543333322211   0000 


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                              .......+++.+.+||++||..||++|||+.+|++|||+
T Consensus       237 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 ------------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ------------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                    001112367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-41  Score=299.87  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=206.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh---chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE---NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..|++++.||+|++|.||+|.+..++..+++|.+.....   .......+.+|+.+++.++|||++++++.+.....   
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---
Confidence            368999999999999999999999999999998864322   22334456789999999999999999998865422   


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++++||++ ++|.+.+...+.+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            56889999997 59999998878899999999999999999999999999999999999999999999999998865422


Q ss_pred             CC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 NE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..   .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..   ..         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~---------  225 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP---------  225 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC---------
Confidence            11   11123456788999999877 5789999999999999999999999976543332222111   00         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                                       .....+..+++.+.++| .||..+|++||+++||++||||+
T Consensus       226 -----------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         226 -----------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             -----------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                             01122345677888998 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=308.23  Aligned_cols=286  Identities=41%  Similarity=0.651  Sum_probs=214.5

Q ss_pred             ceeeeeeeccCCceeEEEEEecc--CCcEEEEEeccchh-hchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRE--TNEKVAIKKINNVF-ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~--~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +|++.+.||+|++|.||+|.+..  ++..||+|.+.... ..........+|+.+++.++|||++++++++.....   .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---K   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---c
Confidence            58999999999999999999988  88999999997632 112223445679999999999999999999976532   5


Q ss_pred             eEEEEeccccccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc----CCcEEEeecC
Q 017909          108 DVYLVYELMDTDLHQIIKSS-----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA----NCDLKICDFG  178 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~----~~~~~L~Dfg  178 (364)
                      ..++|||++++++.+.+...     ..+++..++.++.|++.||.|||+++++|+||+|+||+++.    ++.++|+|||
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            68999999998888877532     26899999999999999999999999999999999999999    8999999999


Q ss_pred             ccccCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHH
Q 017909          179 LARTSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL---------NQLKLI  246 (364)
Q Consensus       179 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---------~~~~~i  246 (364)
                      ++........   ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+....         ..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            8875533222   2233456788999999877566899999999999999999999999766433         234445


Q ss_pred             HHHhCCCchhhhhccC-chhHHHHHhhCCCCCC-----CcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          247 ISVFGTQQEADLEFID-NPKARRFIKSLPYSRG-----THISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...++......+.... .+..............     ..+.......+..+.++|.+||+.||++|||+.|+++||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            5544443332221110 0111110000000000     00111112677889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-41  Score=303.94  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=212.7

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|.||++.+..++..+++|.++.. ........+.+|+.+++.++|+|++++++.+...     ...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeE
Confidence            4799999999999999999999999999999988653 2333456778999999999999999999998877     789


Q ss_pred             EEEeccccc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          110 YLVYELMDT-DLHQIIKSS---QSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ++||||+++ +|..++...   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999999985 888777653   379999999999999999999997 599999999999999999999999999886543


Q ss_pred             CCCcccccccccccccCCccccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ...  .....++..|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+......       
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------  225 (286)
T cd06622         155 ASL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-------  225 (286)
T ss_pred             CCc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-------
Confidence            221  22335677899999985422     3588999999999999999999999765443333222221111       


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                          .....++.++..+.++|.+||+.+|.+||+++++++||||.....+
T Consensus       226 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         226 --------------------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             --------------------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                                1122345588899999999999999999999999999999887655

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.1e-41  Score=298.75  Aligned_cols=254  Identities=23%  Similarity=0.404  Sum_probs=208.5

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh----chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE----NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +|++++.||.|+||+||+|.+. ++..+++|.+.....    .......+.+|+.+++.++|+|++++++++...     
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence            5889999999999999999864 678999998864322    122334567899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++++||+. ++|.+++.+..++++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            78999999997 59999998878899999999999999999999999999999999999999999999999998865421


Q ss_pred             C------CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          186 N------EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       186 ~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .      ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR---------  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc---------
Confidence            1      112233457888999999877 568899999999999999999999997665433332221110         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                         .........++..+.++|++||+.+|.+||++.++|+||||
T Consensus       225 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         225 -------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                               01122345678899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-41  Score=300.61  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=210.3

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc----hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN----RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +|+..+.||+|++|.||++.+..+++.+++|++......    ......+.+|+.+++.++|+|++++++++...     
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence            488899999999999999999999999999998643321    12345677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~  184 (364)
                      ...++|+||+. ++|.+++...+++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            78899999998 59999998888899999999999999999999999999999999999998776 59999999986553


Q ss_pred             CCC----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 GNE----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...    .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+......        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc--------
Confidence            321    11223456788999999876 57889999999999999999999999765433333222211000        


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                                        ......+..+++.+.+++.+||..+|.+||++.++++||||+
T Consensus       227 ------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                              011223345788899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-41  Score=298.67  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=216.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||.|++|.||+|++..+++.+++|.+...... .....+.+|+..+..++|+|++++++.+...     ...
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence            4789999999999999999999999999999998764332 4456678899999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++|+||++ ++|.+++.....+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999998 6999999888889999999999999999999999 999999999999999999999999999987664444


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...........+......               
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------------  218 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---------------  218 (264)
T ss_pred             CcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---------------
Confidence            33334567888999999877 57899999999999999999999999776421111111111100               


Q ss_pred             HHHhhCCCCCCCcccccCCC-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                  ........ ++..+.++|++||..+|++||++.++++||||+..
T Consensus       219 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         219 ------------PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             ------------CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence                        00112233 78889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-41  Score=303.94  Aligned_cols=258  Identities=23%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|+||+|.+..++..+++|++.... .......+.+|++++++++|||++++++.+...     ...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   74 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRI   74 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEE
Confidence            47899999999999999999999999999999986542 233445677899999999999999999999887     778


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+||+++ +|...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            999999985 55432    357899999999999999999999999999999999999999999999999987543222 


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..............                ....
T Consensus       150 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~----------------~~~~  211 (279)
T cd06619         150 -AKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ----------------LLQC  211 (279)
T ss_pred             -ccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH----------------HHHH
Confidence             233467889999999987 5789999999999999999999999965321110000000                0000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      .....      .........++.+.++|.+||+.||.+||+++++++||||+..
T Consensus       212 ~~~~~------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         212 IVDED------PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HhccC------CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            00000      0001123467889999999999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.3e-41  Score=302.11  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=204.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHH-HHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|+||.||+++++.+|+.||+|.++...... ...++..|+.. ++.++|||++++++++...     ..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----Cc
Confidence            47999999999999999999999999999999987643332 23344455554 5666899999999999876     77


Q ss_pred             EEEEeccccccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          109 VYLVYELMDTDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .+++|||++++|.+++..    ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            899999999998887754    24689999999999999999999997 9999999999999999999999999998755


Q ss_pred             CCCCcccccccccccccCCcccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-LNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ... .......++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||..... .+....+..   ....    
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~----  226 (283)
T cd06617         155 VDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPSP----  226 (283)
T ss_pred             ccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---cCCC----
Confidence            322 122234567889999988642   3468899999999999999999999965321 122222111   0000    


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                            ......++..+.++|.+||..+|.+||++.++++||||....
T Consensus       227 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         227 ----------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ----------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                                  000124678899999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.6e-41  Score=295.92  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=210.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|++|.||++.+..+++.+++|.+............+.+|+.+++.++|||++++++.+...     ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence            58999999999999999999999999999999876554555566778999999999999999999998766     7889


Q ss_pred             EEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCCCC
Q 017909          111 LVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGN  186 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~~~  186 (364)
                      +|||+++ ++|.+++...  ..+++..++.++.+++.++.+||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999997 5999998763  4589999999999999999999999999999999999998654 5899999998765433


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      . ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...                 
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----------------  216 (256)
T cd08220         156 S-KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----------------  216 (256)
T ss_pred             c-cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----------------
Confidence            2 2233456788999999877 56889999999999999999999999876544433332210                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                   ........+++.+.+++.+||+.||.+|||+.|+++||||
T Consensus       217 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         217 -------------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -------------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                         0111224578889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.1e-41  Score=296.67  Aligned_cols=253  Identities=26%  Similarity=0.464  Sum_probs=211.1

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||++.++.+|..+++|.+............+.+|+.+++.++|+|++++++.+...     ...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence            58999999999999999999999999999999876544444555677899999999999999999998777     7899


Q ss_pred             EEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCCCC
Q 017909          111 LVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGN  186 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~~~  186 (364)
                      +|+||+. ++|.+.+....  .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999997 59999887643  479999999999999999999999999999999999999886 4699999988766444


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||++.+ ..++.++|+||||+++++|++|..||...........+..                  
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------  216 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ------------------  216 (257)
T ss_pred             cccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------------------
Confidence            433344567888999999876 4688999999999999999999999976543332222111                  


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  .......+.++..+.++|.+||+.+|.+|||+.++++||||
T Consensus       217 ------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         217 ------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                        01122335678889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-41  Score=301.88  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=211.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|.||++.++.+++.+++|.+..... .....++.+|+++++.++|||++++++.+...     ...
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence            478999999999999999999999999999999876433 24456678899999999999999999999887     789


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++++|+++ ++|.+++... ..+++..++.++.|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999998 6999999876 789999999999999999999999 99999999999999999999999999987654322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC--LNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..  ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....  ......+.......           
T Consensus       155 ~~--~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------  220 (265)
T cd06605         155 LA--KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-----------  220 (265)
T ss_pred             Hh--hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-----------
Confidence            11  11566788999999877 5789999999999999999999999976521  11111111110000           


Q ss_pred             hHHHHHhhCCCCCCCcccccCCC-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                      ....... ++..+.++|.+||..||.+|||+.+++.||||+.+.
T Consensus       221 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         221 ----------------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ----------------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                            0111122 788899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=284.38  Aligned_cols=272  Identities=24%  Similarity=0.304  Sum_probs=214.8

Q ss_pred             ceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceee
Q 017909           16 KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      .-+++-..++.+-++||+|.+.||.|||+.|+++..-.++..||+|++....  ..+....++|+...++++|||+++++
T Consensus         7 ~l~~c~~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~   84 (302)
T KOG2345|consen    7 NLCVCRRGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLV   84 (302)
T ss_pred             ceeEeCCCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHH
Confidence            4445557788889999999999999999999999999999999999997643  45667778999999999999999999


Q ss_pred             eeeccccccccceEEEEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEcc
Q 017909           96 DVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNA  168 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~  168 (364)
                      ++...+........||+++|.. |+|.+.+...    ..+++..+..|+.+++.||.+||+..  ++|+||||.||++++
T Consensus        85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~  164 (302)
T KOG2345|consen   85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD  164 (302)
T ss_pred             HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence            9988775544467999999997 8999988653    36999999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCcc---------cccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 017909          169 NCDLKICDFGLARTSRGNEQF---------MTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGT  237 (364)
Q Consensus       169 ~~~~~L~Dfg~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  237 (364)
                      .+.++|.|||++....-.-..         ......+..|.|||.+.-  ....+.++|||||||++|.|+.|..||+..
T Consensus       165 ~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~  244 (302)
T KOG2345|consen  165 SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI  244 (302)
T ss_pred             CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence            999999999998644211110         011233778999999864  234788999999999999999999999532


Q ss_pred             ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      -         +. |.  .--.             ... ...-.++.. ..++..+.+||++||+.||.+||++.+++++
T Consensus       245 ~---------~~-Gg--SlaL-------------Av~-n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  245 Y---------QQ-GG--SLAL-------------AVQ-NAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             h---------hc-CC--eEEE-------------eee-ccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1         00 00  0000             000 001111111 3389999999999999999999999999864

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-40  Score=295.19  Aligned_cols=257  Identities=29%  Similarity=0.482  Sum_probs=211.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      ||++.+.||+|++|.||++.+..++..+++|.++...........+..|+.+++.++|+||+++++.+...     ...+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence            69999999999999999999998999999999986655545667788999999999999999999998766     7889


Q ss_pred             EEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      +|+||+. ++|.+++...+.+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999998 699999988778999999999999999999999999999999999999999999999999998765433222


Q ss_pred             c----ccccccccccCCccccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          190 M----TEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       190 ~----~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .    ....++..|+|||.+.+..  ..+.++|+||||++++++++|..||...+........... +..+         
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------  225 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---------  225 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---------
Confidence            1    1245678899999987632  2789999999999999999999999765422221111110 0000         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                       .......+++.+.++|++||+.||.+|||+.+++.|||+
T Consensus       226 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                             011112458889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-40  Score=295.36  Aligned_cols=254  Identities=26%  Similarity=0.478  Sum_probs=210.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh---chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE---NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +|+..+.||+|++|+||+|.+..++..|++|.+.....   .......+.+|+.+++.++|+|++++++.+...     .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence            58889999999999999999998999999999865332   223445677899999999999999999998776     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++++||++ ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            8899999998 599999988888999999999999999999999999999999999999999999999999988765332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      . ......++..|++||.+.....++.++|+||||+++|+|++|..||...........+...                 
T Consensus       156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------------  217 (258)
T cd06632         156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-----------------  217 (258)
T ss_pred             c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-----------------
Confidence            2 2344567888999999876334899999999999999999999999766532222221110                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  ......+..+++.+.+++.+||+.+|.+||++.++|.|||+
T Consensus       218 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         218 ------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                        01122335678899999999999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-40  Score=301.41  Aligned_cols=259  Identities=28%  Similarity=0.391  Sum_probs=211.4

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+...     ..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CE
Confidence            4799999999999999999999999999999998754322 22345667899999999999999999998776     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ ++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            899999998 5999999888889999999999999999999999999999999999999999999999999875321100


Q ss_pred             ---------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          188 ---------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       188 ---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                                     .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+..... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~-  233 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-  233 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence                           00112345778999999877 5789999999999999999999999987654443433322100 


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPYISGL  322 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~elL~hp~f~~~  322 (364)
                                                 ........+++.+.++|++||+.||.+||+   +.++|+||||.+.
T Consensus       234 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         234 ---------------------------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             ---------------------------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence                                       001111357888999999999999999997   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-40  Score=299.19  Aligned_cols=267  Identities=24%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      .+.+....++|++.+.||+|++|+||++.+..+++.+++|++....   .....+..|+.+++.+ +|||++++++++..
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            3555668899999999999999999999999999999999886421   1223456788999998 69999999998864


Q ss_pred             ccccccceEEEEecccc-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      .........++||||++ ++|.+++.    ....+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence            33222267899999997 58888764    23568999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          176 DFGLARTSRGNEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       176 Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      |||.+..............++..|+|||.+..    ...++.++|+|||||++|+|++|..||...........+..   
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---  243 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---  243 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---
Confidence            99998765433333334567889999999853    23478899999999999999999999976543222211100   


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...                         ........++..+.+||.+||+.||.+|||+.+||+|+||
T Consensus       244 ~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         244 NPP-------------------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCC-------------------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            000                         0001122356789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-40  Score=293.86  Aligned_cols=253  Identities=29%  Similarity=0.483  Sum_probs=215.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||++.+..++..+++|++............+.+|+++++.++|+|++++.+.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            58999999999999999999999999999999986655555666778899999999999999999998877     7889


Q ss_pred             EEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          111 LVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      +|+|+++ ++|.+.+...    ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999998 5999988763    6799999999999999999999999999999999999999999999999999876644


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .........++..|+|||.+.. ..++.++|+||+|+++++|++|..||..............                 
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------  217 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-----------------  217 (258)
T ss_pred             CcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-----------------
Confidence            4433444567888999999877 5688999999999999999999999977653333332211                 


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                   .........++..+.+++++||..+|.+|||+.++|+||||
T Consensus       218 -------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         218 -------------GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             -------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                         01122334678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=335.95  Aligned_cols=263  Identities=24%  Similarity=0.378  Sum_probs=228.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .++|+|+++||+|+||.|.+++++.+++.||+|++++-.- ...+...|..|-.+|...+.+=|++++-+|+++     .
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-----~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-----R  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-----c
Confidence            5789999999999999999999999999999999976322 244555667788888888899999999999999     9


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC-
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG-  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~-  185 (364)
                      ++|+||+|++ |+|..++....++++..++.++..|..||..+|+.|+|||||||+|||++..|+++|+|||.|..... 
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            9999999997 69999999988999999999999999999999999999999999999999999999999999987764 


Q ss_pred             CCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      +.-......|||.|++||++..    .+.|++..|+||+|+++|||+.|..||....-.+.+.+|++.-..     .   
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-----l---  300 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-----L---  300 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-----c---
Confidence            4444667899999999999963    145899999999999999999999999999999999998874100     0   


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPYISGLYD  324 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~elL~hp~f~~~~~  324 (364)
                                        .++ ....+|..+++||++.+. +|..|..   ++++-+||||.+.-+
T Consensus       301 ------------------~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  301 ------------------SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             ------------------CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence                              001 113589999999999887 8889988   999999999999865

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-40  Score=299.12  Aligned_cols=260  Identities=24%  Similarity=0.480  Sum_probs=212.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .+|...+.||.|++|.||++.+..++..+++|.+...  .......+.+|+.+++.++|||++++++.+...     ...
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~   91 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DEL   91 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeE
Confidence            3566778999999999999999999999999988642  223344567899999999999999999998876     778


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|+||+. ++|.+.+.. .++++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            99999997 599888877 6799999999999999999999999999999999999999999999999998765433322


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...   .+.             
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~-------------  233 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPP-------------  233 (285)
T ss_pred             ccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCC-------------
Confidence            2334467889999999877 56889999999999999999999999776544333332211   000             


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                  .......++..+.++|++||+.+|++||++.++++||||.+..++.
T Consensus       234 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         234 ------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             ------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence                        0011123678899999999999999999999999999999966544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=292.18  Aligned_cols=253  Identities=30%  Similarity=0.496  Sum_probs=216.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|++|.||++++..+++.+++|.+............+.+|+++++.++|+|++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence            58999999999999999999999999999999987655445666788999999999999999999998776     7889


Q ss_pred             EEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      +++|+++ ++|.+.+.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999998 599999988888999999999999999999999999999999999999999999999999998876554443


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .....++..|+|||.+.. ..++.++|+|+||+++|+|++|..||...........+..                     
T Consensus       156 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------  213 (254)
T cd06627         156 DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---------------------  213 (254)
T ss_pred             ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------------
Confidence            344567888999999877 4588999999999999999999999976653322222210                     


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                               .........++..+.++|.+||..+|++|||+.++++||||
T Consensus       214 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 ---------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                     01122335678899999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-40  Score=294.78  Aligned_cols=257  Identities=26%  Similarity=0.448  Sum_probs=207.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh---chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE---NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..|++.+.||+|++|.||++.+..++..|++|.+.....   .......+.+|+.+++.+.|||++++++++.+...   
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---
Confidence            579999999999999999999999999999998864322   12334566789999999999999999998866422   


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++++|||++ ++|.+++.+.+.+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            46789999997 59999998878899999999999999999999999999999999999999999999999998865422


Q ss_pred             CC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 NE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..   .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+..   ..         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~---------  225 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QP---------  225 (265)
T ss_pred             ccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CC---------
Confidence            11   11223456788999999877 5789999999999999999999999976543333222211   00         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                                       .....+...+..+.++|++|+. +|.+||++++|++|||+.
T Consensus       226 -----------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         226 -----------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             -----------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                             0112234567789999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.7e-41  Score=299.68  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=213.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +...|+..+.||.|++|.||+|.+..++..+++|++..... ......+.+|+.+++.+.|+|++++++.+...     .
T Consensus         2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   75 (277)
T cd06640           2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----T   75 (277)
T ss_pred             hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence            35678999999999999999999999999999999875422 33456677899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ ++|.+.+.. +++++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            8999999997 589888765 56899999999999999999999999999999999999999999999999998665443


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..                  
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------------------  215 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK------------------  215 (277)
T ss_pred             ccccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc------------------
Confidence            333334456788999999876 5689999999999999999999999976543332221100                  


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                  .........++..+.++|.+||+.+|.+||++.++++||||.....
T Consensus       216 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         216 ------------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ------------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                        0011223346778999999999999999999999999999977543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.2e-41  Score=303.30  Aligned_cols=262  Identities=24%  Similarity=0.468  Sum_probs=213.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ..-|+....||+|+||.||++.+..++..|++|.+.....  .....+.+|+.+++.+.|||++++++.+...     ..
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~   92 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EE   92 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeC-----Ce
Confidence            3456667789999999999999999999999999864322  2344567899999999999999999998877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++|+||++ ++|.+.+.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        93 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            899999998 577776544 679999999999999999999999999999999999999999999999999986554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..   ..              
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~--------------  233 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SP--------------  233 (297)
T ss_pred             ccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cC--------------
Confidence            33344567889999999977 5689999999999999999999999987654444332211   00              


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                                 .........+++.+.++|++||+.+|.+||+++++++||||.+...+.|
T Consensus       234 -----------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         234 -----------PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             -----------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence                       0001122456788999999999999999999999999999998766666

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-40  Score=298.77  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=207.3

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||+|+||+||+|.++.+|+.+++|.+...... ......+..|+.+++.++|||++++++.+...     ...++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence            68999999999999999999999998754322 22334556899999999999999999998776     7889999999


Q ss_pred             c-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccc
Q 017909          117 D-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY  193 (364)
Q Consensus       117 ~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~  193 (364)
                      + ++|.+.+...+  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..... .......
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~  154 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR  154 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence            8 59999887655  799999999999999999999999999999999999999999999999998865432 2222334


Q ss_pred             cccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhC
Q 017909          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL  273 (364)
Q Consensus       194 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
                      .++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....                       
T Consensus       155 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------  210 (277)
T cd05577         155 AGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-----------------------  210 (277)
T ss_pred             cCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-----------------------
Confidence            56778999999877 458999999999999999999999997765422222221110                       


Q ss_pred             CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCCC
Q 017909          274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~~  327 (364)
                          .......+..+++.+.++|.+||+.||.+||     ++.++++||||..+.....
T Consensus       211 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         211 ----LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             ----ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence                0011223456789999999999999999999     8899999999988755443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-40  Score=298.46  Aligned_cols=253  Identities=32%  Similarity=0.518  Sum_probs=212.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ++|++.+.||+|++|.||++++..+|+.+++|++..... .......+.+|+.+++.+. |+|++++++.+...     .
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence            479999999999999999999999999999999976433 2334456678999999998 99999999998777     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|||++. ++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            8899999995 799999998888999999999999999999999999999999999999999999999999988755332


Q ss_pred             Cc--------------------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017909          187 EQ--------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI  246 (364)
Q Consensus       187 ~~--------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i  246 (364)
                      ..                    ......++..|+|||++.. ..++.++|+||||++++++++|..||...........+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            21                    1223345788999999877 56899999999999999999999999877644333332


Q ss_pred             HHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q 017909          247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV----TEALQHPYI  319 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~elL~hp~f  319 (364)
                      ..                               .....+..+++.+.++|++||+.||.+||++    +++|+||||
T Consensus       235 ~~-------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 LK-------------------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             Hh-------------------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            21                               0112234568889999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-41  Score=303.56  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=211.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +.+.|++.+.||+|++|.||+|.+..++..+++|.+...... .....+.+|+.+++.++|||++++++.+...     .
T Consensus         2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   75 (277)
T cd06642           2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----T   75 (277)
T ss_pred             hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccC-----C
Confidence            356788999999999999999999999999999998754322 2445677899999999999999999999876     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|+||++ ++|.+.+.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            7899999998 588887754 57899999999999999999999999999999999999999999999999998765433


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..                  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------------------  215 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK------------------  215 (277)
T ss_pred             chhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc------------------
Confidence            322333456788999999877 5788999999999999999999999875543222211100                  


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                  .........++..+.++|.+||+.+|.+||++.++++||||..+.
T Consensus       216 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         216 ------------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ------------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                        001112235677899999999999999999999999999997743

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.4e-40  Score=298.63  Aligned_cols=260  Identities=23%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc-c
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI-S  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~  105 (364)
                      -.+.|++.+.||.|+||.||+|.+..+++.+++|++...   ......+..|+.+++.+ +|+|++++++.+...... .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            467999999999999999999999999999999998643   22334566788888888 699999999998643211 1


Q ss_pred             cceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ....+++|||++ |+|.+++...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            267899999998 5899888653  4588999999999999999999999999999999999999999999999998865


Q ss_pred             CCCCCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ............++..|+|||++..    ...++.++|+||||+++|+|++|..||...........+..   .      
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~------  241 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---N------  241 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---C------
Confidence            5332222334567888999999853    23578899999999999999999999976543222211100   0      


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                          .........++..+.+||++||+.||.+||++.|||+||||
T Consensus       242 --------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         242 --------------------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                00011123578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-40  Score=295.79  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=207.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc--------hHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN--------RIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      +|.+.+.||.|++|.||+|.+..+|+.+++|.++.....        ......+.+|+.+++.++|+|++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            688999999999999999999989999999988532111        11223556799999999999999999998776 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                          ...++|+||+. ++|.+.+...+.++...+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          81 ----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence                77899999997 6999999888889999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCC--cccccccccccccCCccccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNE--QFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ......  .......++..|+|||.+.... .++.++|+||||++++++++|..||...........+..   ...    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~----  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRS----  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---ccc----
Confidence            543221  1123345678899999987633 478999999999999999999999976543332222111   000    


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                        ...........++..+.++|.+||+.||.+|||++++|+||||
T Consensus       230 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 ------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                              0001112234578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-40  Score=294.76  Aligned_cols=251  Identities=24%  Similarity=0.421  Sum_probs=207.8

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||.|++|.||++++..+++.+++|++...... ......+.+|+.+++.++|||++++++.+...     ...++|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence            68999999999999999999999999754332 23445677899999999999999999998777     7789999999


Q ss_pred             c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccc
Q 017909          117 D-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV  195 (364)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  195 (364)
                      + ++|.+.+.....+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~  154 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG  154 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence            7 6999999888889999999999999999999999999999999999999999999999999987654332 2233466


Q ss_pred             cccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhC
Q 017909          196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE--CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL  273 (364)
Q Consensus       196 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
                      +..|++||.+.+ ..++.++|+||||+++|+|++|..||....  .......+..                         
T Consensus       155 ~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------------  208 (262)
T cd05572         155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-------------------------  208 (262)
T ss_pred             CcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-------------------------
Confidence            888999999876 568999999999999999999999997765  2222222211                         


Q ss_pred             CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCC
Q 017909          274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYD  324 (364)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~  324 (364)
                          .......+...++.+.++|.+||+.||.+||+     ++|+++||||+++..
T Consensus       209 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         209 ----GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ----cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence                00111223345788999999999999999999     999999999998643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=296.76  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=209.8

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC---CCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK---HDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .|++.+.||+|++|.||+|.+..+++.+++|.++... .......+.+|+.+++.+.   |||++++++++...     .
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----P   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----C
Confidence            5888999999999999999999999999999986532 2234455667888888886   99999999998776     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||+. ++|.+++.. +.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            8899999997 588888765 47999999999999999999999999999999999999999999999999998766444


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+..   .              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~--------------  217 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---S--------------  217 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---C--------------
Confidence            33334446788899999987655678999999999999999999999976543222111100   0              


Q ss_pred             HHHHhhCCCCCCCcccccC-CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLY-PQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                   ...... ..++..+.+++.+||+.||.+||++.++++|+||+....+
T Consensus       218 -------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         218 -------------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             -------------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence                         000111 1267789999999999999999999999999999775533

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=315.65  Aligned_cols=261  Identities=24%  Similarity=0.453  Sum_probs=219.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.+-|+|+..||.|+||+||+|..+.++-.-|.|++..  ........++-|+.+|..+.||+|+++++.|..+     +
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----n  102 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----N  102 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----C
Confidence            45678999999999999999999998888888888853  3455666778899999999999999999999888     8


Q ss_pred             eEEEEeccccc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMDT-DLHQIIK-SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++|+.|||+| -...++. -...+.+..+..++.|++.||.|||+++|+|+|||..|||++.+|.++|+|||.+.....
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence            89999999986 4555444 456799999999999999999999999999999999999999999999999998876555


Q ss_pred             CCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .........||++|||||+...    ..+|.+++||||||+.|.+|..+.+|-...+.   +..+.++....++..    
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTL----  255 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTL----  255 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCcc----
Confidence            5555667889999999999864    25699999999999999999999999866554   444444433333321    


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                           ..+..++..+.||+++||..||..||++.+||+||||+...
T Consensus       256 ---------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  256 ---------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             ---------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                                 22356788899999999999999999999999999999743

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4e-40  Score=299.46  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=211.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ....+|++.+.||+|++|+||+|.+..+++.|++|.+..... .......+.+|+.+++.++|||++++++++...    
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~----   87 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE----   87 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC----
Confidence            346789999999999999999999999999999999864332 233445677899999999999999999999877    


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++|+||+.|++.+.+.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        88 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          88 -HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             -CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence             77899999999998888764 4579999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..    ....++..|+|||++.+  ...++.++||||||+++|+|++|..||.+.+.......+..   ...        
T Consensus       167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~--------  231 (307)
T cd06607         167 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDS--------  231 (307)
T ss_pred             CC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCC--------
Confidence            22    23456778999998853  24588899999999999999999999977654433222211   000        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                        .......++..+.++|.+||+.||.+||++.+|+.||||..-
T Consensus       232 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         232 ------------------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ------------------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                              000012367789999999999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-40  Score=298.68  Aligned_cols=261  Identities=30%  Similarity=0.490  Sum_probs=217.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...+.|++.+.||+|++|.||++.+..++..+++|++.....   ....+.+|+..++.++|+|++++++.+...     
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   87 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----   87 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----
Confidence            457789999999999999999999998899999999975433   455677899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++|+||++ ++|.+++...+ .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            78999999998 69999998876 89999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..........++..|++||.+.+ ..++.++|+||||+++|+|++|..||...........+....  .           
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----------  233 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG--I-----------  233 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--C-----------
Confidence            33333334456788999999877 568999999999999999999999998765544333322100  0           


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                     ........++..+.++|.+||+.+|.+||++.++|+|+||++...
T Consensus       234 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         234 ---------------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             ---------------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence                           001111336788999999999999999999999999999999443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-40  Score=299.07  Aligned_cols=263  Identities=24%  Similarity=0.480  Sum_probs=213.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ...|.....||+|++|.||++..+.+++.+++|.+...  .......+.+|+.+++.++|+|++++++.+...     ..
T Consensus        19 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~   91 (292)
T cd06657          19 RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE   91 (292)
T ss_pred             HHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CE
Confidence            34455567899999999999999999999999988532  233455677899999999999999999999877     78


Q ss_pred             EEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+++ +|.+++. .+.+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        92 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          92 LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             EEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            9999999985 7777654 4568999999999999999999999999999999999999999999999999876554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.. ..++.++|+||+|+++|+|++|..||.+.........+......               
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------  234 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---------------  234 (292)
T ss_pred             ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc---------------
Confidence            23334567888999998866 56789999999999999999999999876544443332211000               


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                   .......+++.+.++|.+||+.||.+||++.++|+||||.....+.|.
T Consensus       235 -------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~  282 (292)
T cd06657         235 -------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCI  282 (292)
T ss_pred             -------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCccc
Confidence                         001123467889999999999999999999999999999998876653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.4e-40  Score=291.83  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||++.+..++..+++|.++... .......+.+|+.+++.++|+|++++++.+...     ...+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence            5899999999999999999999999999999986432 233445667899999999999999999999877     7899


Q ss_pred             EEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          111 LVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|+||++ ++|.+.+..  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999997 689888764  3458999999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..                   
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-------------------  214 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-------------------  214 (255)
T ss_pred             cccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-------------------
Confidence            33344567888999999877 5689999999999999999999999987654433332211                   


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                                 ......+..++..+.+||++||+.||.+|||+.+|++--
T Consensus       215 -----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         215 -----------GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             -----------CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                       011122345778899999999999999999999998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-41  Score=309.51  Aligned_cols=260  Identities=26%  Similarity=0.396  Sum_probs=232.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+.|.+.+.||.|.|++|.+|++..++..||||.+.+...+.....++.+|+++++.++|||||+++++....     ..
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~~  129 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----AT  129 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----ce
Confidence            5689999999999999999999999999999999999888888878889999999999999999999999888     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|+||||+. |.+.+++.++++..+.++..++.|+..|+.|||+++|+|+|||++|||++.+.+++|+|||++..+. ..
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~  208 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YG  208 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-cc
Confidence            999999997 7999999999999999999999999999999999999999999999999999999999999998874 45


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ......+|++.|.|||++.+.+..++..|+||||+++|.|+.|..||++..-.+......                    
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--------------------  268 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--------------------  268 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--------------------
Confidence            556778999999999999998889999999999999999999999998865333222211                    


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                 ..-..++--++.++.++|+++|-.+|.+|++.++++.|.|.......
T Consensus       269 -----------~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  269 -----------RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -----------eeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                       11122334577889999999999999999999999999999888766

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-40  Score=299.59  Aligned_cols=266  Identities=26%  Similarity=0.448  Sum_probs=215.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|.||++.+..++..+++|.+...  .......+.+|+.+++.++|||++++++.+...     .
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~   89 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----D   89 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----C
Confidence            457999999999999999999999888999999998643  222345677899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|+||++ ++|.+++.+ ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            7899999997 588888765 45889999999999999999999999999999999999999999999999988655443


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........++..|++||.+.. ..++.++|+||||+++|++++|..||...........+..  ..              
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~--------------  231 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG--------------  231 (293)
T ss_pred             ccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CC--------------
Confidence            333344567888999999877 5788999999999999999999999976543322111100  00              


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP  330 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~  330 (364)
                                  .........++..+.++|++||+.+|.+||++++++.|+||+....-..-+|
T Consensus       232 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         232 ------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             ------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence                        0001112346778999999999999999999999999999988665444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-40  Score=298.70  Aligned_cols=262  Identities=25%  Similarity=0.417  Sum_probs=206.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|+..+.||+|+||.||++.+..++..+++|.+...... .....+.+|+.++.++. |+|++++++++...     ..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~   77 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD   77 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence            4677888999999999999999999999999998754333 34556778999999995 99999999998776     67


Q ss_pred             EEEEeccccccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          109 VYLVYELMDTDLHQIIK-----SSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      .+++||++++++.++..     ....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            89999999876655432     236799999999999999999999975 999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..... ......++..|+|||++.+.  ..++.++|+||||+++|+|++|..||....  .....+.........     
T Consensus       158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~-----  229 (288)
T cd06616         158 LVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP-----  229 (288)
T ss_pred             hccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC-----
Confidence            43222 12233567889999999774  368899999999999999999999997653  111222111111100     


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                        .........++..+.+||.+||+.||.+|||+++|++||||+...
T Consensus       230 ------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         230 ------------------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ------------------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                              000112235788999999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.1e-40  Score=289.60  Aligned_cols=251  Identities=26%  Similarity=0.428  Sum_probs=212.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||.|++|.||++.++.+++.+++|.+............+.+|+.+++.++|+|++++++.+...     ...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            58999999999999999999999999999999986555555666778899999999999999999999877     7899


Q ss_pred             EEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          111 LVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      +|+||++ ++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            9999997 589888865    35689999999999999999999999999999999999999999999999999876544


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..                 
T Consensus       156 ~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------  215 (256)
T cd08530         156 N--MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-----------------  215 (256)
T ss_pred             C--CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Confidence            3  2334567888999999877 5788999999999999999999999987654333222211                 


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                   .........++.++.++|.+||+.+|.+||++.++++||++
T Consensus       216 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         216 -------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                         11122234577889999999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-40  Score=295.41  Aligned_cols=253  Identities=24%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchhhchH-HHHHHHHHHHHHH---hcCCCCcceeeeeeccccccccceEEEE
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-DALRTLRELVLLR---HIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      .||+|+||.||++.+..+++.+|+|.+........ ......++..+++   ...||+++.+++.+...     ...++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence            48999999999999999999999999865433222 1222234443333   34799999999999877     778999


Q ss_pred             ecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccc
Q 017909          113 YELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT  191 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~  191 (364)
                      |||+. ++|.+.+...+.+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  153 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--cc
Confidence            99998 6999888888889999999999999999999999999999999999999999999999999886543222  22


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                      ...++..|+|||.+.....++.++|+||+|+++|+|++|..||......... .+.....                    
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~--------------------  212 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL--------------------  212 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh--------------------
Confidence            3467889999999875456889999999999999999999999765322111 1111000                    


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCC
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYD  324 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~  324 (364)
                             ......+..+++.+.++|++||+.||.+||     |+.++++||||+++..
T Consensus       213 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         213 -------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             -------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence                   001123456788999999999999999999     6999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.9e-40  Score=297.48  Aligned_cols=257  Identities=24%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc----------------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE----------------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+.... .......+.+|+.++..++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence            5789999999999999999998532                34479999987532 233455678999999999999999


Q ss_pred             eeeeeeccccccccceEEEEecccc-ccHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS-------------------QSLSNDHCKYFVFQLLRGLKYLHSA  152 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~  152 (364)
                      ++++++...     ...++||||+. ++|.+++...                   ..+++..++.++.||+.||.|||++
T Consensus        83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  157 (304)
T cd05096          83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL  157 (304)
T ss_pred             EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            999999877     67899999997 6999888543                   1367788999999999999999999


Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-  229 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-  229 (364)
                      |++|+||||+||+++.++.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ 
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999875432221  1122334678999999877 578999999999999999986 


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC
Q 017909          230 -RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI  308 (364)
Q Consensus       230 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  308 (364)
                       +..||...........+........                       .......++.++..+.+||.+||+.||.+||
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP  293 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQG-----------------------RQVYLFRPPPCPQGLYELMLQCWSRDCRERP  293 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhcc-----------------------ccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence             5678877665544443322111000                       0001122346788999999999999999999


Q ss_pred             CHHHHhc
Q 017909          309 TVTEALQ  315 (364)
Q Consensus       309 s~~elL~  315 (364)
                      |+.+|.+
T Consensus       294 s~~~i~~  300 (304)
T cd05096         294 SFSDIHA  300 (304)
T ss_pred             CHHHHHH
Confidence            9999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-40  Score=318.67  Aligned_cols=287  Identities=23%  Similarity=0.314  Sum_probs=201.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCc-EEEEE--------------ecc-chhhchHHHHHHHHHHHHHHhcCCCCc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNE-KVAIK--------------KIN-NVFENRIDALRTLRELVLLRHIKHDNV   91 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~-~~aiK--------------~~~-~~~~~~~~~~~~~~e~~~l~~l~h~~i   91 (364)
                      +.++|++++.||+|+||+||++..+.... ..+.|              .+. ...........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            56799999999999999999987653322 12222              111 111122234456789999999999999


Q ss_pred             ceeeeeeccccccccceEEEEeccccccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE
Q 017909           92 IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS-----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV  166 (364)
Q Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll  166 (364)
                      +++++++...     ...++|++++.+++.+.+...     .......++.++.||+.||.|||++||+|+||||+|||+
T Consensus       226 v~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        226 LKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9999999877     778999999998888877542     234467788899999999999999999999999999999


Q ss_pred             ccCCcEEEeecCccccCCCCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCC-CCCCC--ChHHH
Q 017909          167 NANCDLKICDFGLARTSRGNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP-IFPGT--ECLNQ  242 (364)
Q Consensus       167 ~~~~~~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~-pf~~~--~~~~~  242 (364)
                      +.++.++|+|||++........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|.. ||...  .....
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999976543322 2234568999999999987 578999999999999999998875 44332  22233


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCC-CCCcccc--cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYS-RGTHISS--LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      ...+...+......... . ....-.++...... .......  ....++.++.++|.+||+.||.+|||+.|+|+||||
T Consensus       380 ~~~~~~~~~~~~~~~p~-~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPD-P-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHhcccChhhcCC-c-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            33333333222111000 0 00111111110000 0000000  112367788899999999999999999999999999


Q ss_pred             cCC
Q 017909          320 SGL  322 (364)
Q Consensus       320 ~~~  322 (364)
                      ...
T Consensus       458 ~~~  460 (501)
T PHA03210        458 SAE  460 (501)
T ss_pred             hcC
Confidence            764

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.2e-40  Score=295.69  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=204.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCC-----cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETN-----EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ++|++.+.||+|++|.||+|.+...+     ..+++|.++... .......+.+|+.+++.++|||++++++++...   
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence            58999999999999999999876555     679999987432 233445677899999999999999999998776   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                        ...+++|||++ ++|.+++...                ..+++..+..++.|++.||.+||++|++|+||+|+||+++
T Consensus        81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG  158 (283)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence              67899999997 6999988754                4578899999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017909          168 ANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLK  244 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~  244 (364)
                      .++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+...
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999986543221  12233445778999999877 578999999999999999997 999998876555444


Q ss_pred             HHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+.+.                              ........+++.+.+|+.+||+.||.+||++.+|+++
T Consensus       238 ~i~~~------------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSR------------------------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcC------------------------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33221                              0112235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-39  Score=290.65  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=202.9

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      .......||+|+||.||+|++..++..+++|.+....  ......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   81 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFK   81 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEE
Confidence            3344568999999999999999899999999886532  23445677899999999999999999999877     7889


Q ss_pred             EEecccc-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCccccCCC
Q 017909          111 LVYELMD-TDLHQIIKSS-QSL--SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRG  185 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~~~  185 (364)
                      +|+||+. ++|.+.+... ..+  ++..+..++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999997 5999988764 445  88899999999999999999999999999999999976 67899999998875543


Q ss_pred             CCcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .........++..|+|||.+... ..++.++|+||||+++|+|++|..||..............                
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----------------  225 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----------------  225 (268)
T ss_pred             CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh----------------
Confidence            33333344568889999998653 2478899999999999999999999965432111100000                


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                  ........+..+++.+.+++++||+.+|.+|||+.+++.||||
T Consensus       226 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         226 ------------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                        0001122345678889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=296.14  Aligned_cols=260  Identities=24%  Similarity=0.412  Sum_probs=220.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+-|.++++||+|+||.||+|.++.+|..+|||.+.-    ..+..++.+|+.++.+.+.|++|++++.|.-.     ..
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sD  102 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SD  102 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----Cc
Confidence            4568899999999999999999999999999998853    34666788999999999999999999998877     78


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||||+ |++.+++.. ++++++.++..+++..+.||.|||...-+|||||..|||++.+|..||+|||.+....+.
T Consensus       103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            999999998 899999974 578999999999999999999999999999999999999999999999999999776665


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      -...+...||+.|+|||++.. -.|..++||||||+...||..|++||.+-..   ++.|.- ++..++..         
T Consensus       183 MAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFM-IPT~PPPT---------  248 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFM-IPTKPPPT---------  248 (502)
T ss_pred             HHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEe-ccCCCCCC---------
Confidence            555677899999999999987 4689999999999999999999999966432   122211 11111110         


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                     ..-+..++.++.+|+++||-.+|++|-|+.++++|||++....++
T Consensus       249 ---------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  249 ---------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             ---------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence                           011234678899999999999999999999999999998865543

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=317.21  Aligned_cols=263  Identities=23%  Similarity=0.350  Sum_probs=209.8

Q ss_pred             EEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeee
Q 017909           19 YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDV   97 (364)
Q Consensus        19 ~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~   97 (364)
                      ...+..+..-..+++|.+.|.+|||+.||+|++...|..||+|.+-..  +........+|+.+++.|+ |+|||.+++.
T Consensus        26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            334566666678999999999999999999999988899999988654  4445556678999999996 9999999994


Q ss_pred             ecccc-ccc-cceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCC
Q 017909           98 MMPTH-RIS-FKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANC  170 (364)
Q Consensus        98 ~~~~~-~~~-~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~  170 (364)
                      ..... ... ...+.|+||||. |+|.|++..+  ..|++.+++.|+.++++|+.+||.++  |+|||||-+||||+.++
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence            33322 222 356889999999 6999999743  56999999999999999999999998  99999999999999999


Q ss_pred             cEEEeecCccccCCCCCcc---------cccccccccccCCcccc--cccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 017909          171 DLKICDFGLARTSRGNEQF---------MTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC  239 (364)
Q Consensus       171 ~~~L~Dfg~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  239 (364)
                      ++||||||.+.........         ......|+.|.|||++.  .....+.|+|||+|||+||-|+....||+....
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            9999999998654322211         11234489999999975  335689999999999999999999999977532


Q ss_pred             HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ...+.                                 ...-.+-.+.++..+.+||+.||+.||.+||++-||+.+
T Consensus       264 laIln---------------------------------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  264 LAILN---------------------------------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             eeEEe---------------------------------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            21111                                 111122235788999999999999999999999998853

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.9e-40  Score=305.85  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=198.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC-----CcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET-----NEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||+|+||.||+|++...     +..||+|+++.... ......+.+|+.+++.+ +|+||+++++++... 
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHG-  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence            34699999999999999999986443     35799999975432 22345677899999999 899999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC------------------------------------------------------
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (364)
                          ...++||||+. |+|.+++...                                                      
T Consensus       115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence                78899999998 6999887532                                                      


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc--c
Q 017909          128 ----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--F  189 (364)
Q Consensus       128 ----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~  189 (364)
                                      .++++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  .
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                            2478889999999999999999999999999999999999999999999999875433221  1


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....                  
T Consensus       271 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~------------------  331 (374)
T cd05106         271 KGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG------------------  331 (374)
T ss_pred             ccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc------------------
Confidence            112233567999999877 578999999999999999997 999997754333222221100                  


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                 .....+...++.+.++|.+||+.||.+|||+.+|++
T Consensus       332 -----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         332 -----------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -----------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       001112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=310.25  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=209.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..+++.++..||+|+||+||+|.+..+   ||||+++.+.........|.+|+.++++-+|.||+-+.|+|..+     .
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----~  461 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----P  461 (678)
T ss_pred             CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----c
Confidence            478899999999999999999999855   99999998888888888899999999999999999999999877     4


Q ss_pred             eEEEEeccccc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC-
Q 017909          108 DVYLVYELMDT-DLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR-  184 (364)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~-  184 (364)
                      . .||+.||+| +|+..+.- ...|.+.....|++|+++|+.|||.++|+|+|||..|||+.++++|+|+|||++.... 
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            4 999999997 88888853 3579999999999999999999999999999999999999999999999999986421 


Q ss_pred             -CCCcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          185 -GNEQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       185 -~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                       ..........|...|||||++...  .+++..+||||||+++|||++|..||.... .+.+   .-+.|..        
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqI---ifmVGrG--------  608 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQI---IFMVGRG--------  608 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhhe---EEEeccc--------
Confidence             333344556778899999998742  358999999999999999999999998432 2221   1111111        


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                    ............++.++++|+..||..++++||.+.+||.
T Consensus       609 --------------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  609 --------------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             --------------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                          0001122333567889999999999999999999999987

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-39  Score=286.82  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=214.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +|++.+.||+|++|.||+|.+..+++.+++|++............+.+|+..+++++|+|++++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            588999999999999999999999999999999766544456667789999999999999999999987653   15689


Q ss_pred             EEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc-
Q 017909          111 LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ-  188 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~-  188 (364)
                      +++|+++ ++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999996 69999998877999999999999999999999999999999999999999999999999999876644432 


Q ss_pred             -ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          189 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       189 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                       ......++..|+|||.+.. ...+.++|+||||+++++|++|..||......  ...+....                 
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-----------------  217 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIG-----------------  217 (260)
T ss_pred             ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhcc-----------------
Confidence             1334567888999999877 45899999999999999999999999876511  11111110                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                               ........+...++.+.++|.+||+.||.+||++.+++.||||
T Consensus       218 ---------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         218 ---------SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ---------ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                     0111123344568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.4e-40  Score=291.25  Aligned_cols=250  Identities=18%  Similarity=0.273  Sum_probs=202.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++.+.||+|+||.||+|.++   ..+..+++|.++... .......+.+|+..++.++|||++++++++...    
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG----   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC----
Confidence            467999999999999999999865   345689999987642 233445678899999999999999999998876    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||++ |+|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++++|||.+...
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          79 -NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             -CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence             77899999998 5888888764 57899999999999999999999999999999999999999999999999976543


Q ss_pred             CCCCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...... .....++..|+|||.+.+ ..++.++|||||||++|+++ +|..||.+....+....+...            
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~------------  224 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG------------  224 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC------------
Confidence            222111 112233567999999877 67899999999999999977 599999877655544433211            


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        .....+..++..+.+++.+||+.+|.+||++++|++
T Consensus       225 ------------------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         225 ------------------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                              001223567888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-40  Score=290.19  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=201.7

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHH-HHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVL-LRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||.|++|.||+|.+..+|+.+|+|++...... .........|..+ ....+|+|++++++.+...     ...++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence            5789999999999999999999999998654322 2222233344444 3445899999999999876     7899999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccc
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE  192 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~  192 (364)
                      ||++ ++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.....    ...
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~  152 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK  152 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence            9997 59999998888899999999999999999999999999999999999999999999999998765432    223


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS  272 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......                    
T Consensus       153 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  211 (260)
T cd05611         153 FVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--------------------  211 (260)
T ss_pred             CCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--------------------
Confidence            356778999999887 45899999999999999999999999876654443333211000                    


Q ss_pred             CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCC
Q 017909          273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPYISGLYD  324 (364)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~elL~hp~f~~~~~  324 (364)
                             ........+++.+.++|.+||+.||.+||+   ++|+|+||||+...+
T Consensus       212 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 -------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             -------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                   001122357889999999999999999994   579999999988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-39  Score=293.19  Aligned_cols=266  Identities=25%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|+..+.||.|++|.||++.+..+++.+++|.+..... .....++.+|+++++.++||||+++++++.....   ..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeE
Confidence            479999999999999999999999999999999875422 2345667889999999999999999999865532   568


Q ss_pred             EEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          110 YLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999997 588877643    3468999999999999999999999999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC--LNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ...  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....  ....... ..+......      
T Consensus       157 ~~~--~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~------  226 (287)
T cd06621         157 NSL--AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNP------  226 (287)
T ss_pred             ccc--cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCch------
Confidence            221  123345778999999876 5789999999999999999999999976532  0111111 110000000      


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                    ............++.+.++|.+||..||.+|||+.|++.||||+...
T Consensus       227 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         227 --------------ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             --------------hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                          00000011123467899999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-39  Score=293.24  Aligned_cols=251  Identities=19%  Similarity=0.186  Sum_probs=202.5

Q ss_pred             cceeee--eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHH-HHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPI--KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRID-ALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~--~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++++..  ..+|+|+++.||+|..  +|+.||+|+++........ ...+.+|+.++++++||||+++++++.+... ..
T Consensus        18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~-~~   94 (283)
T PHA02988         18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD-DL   94 (283)
T ss_pred             HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc-CC
Confidence            344444  6789999999999976  6889999999765433322 3566799999999999999999999876111 11


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||++ |+|.+++...+.+++.....++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            56899999998 69999998888899999999999999999999985 89999999999999999999999999987543


Q ss_pred             CCCcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...   ....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.+....+....+.....            
T Consensus       175 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------------  239 (283)
T PHA02988        175 SPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN------------  239 (283)
T ss_pred             ccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            221   234567889999998652 4689999999999999999999999988765555444432100            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       ....+..+++.+.++|.+||+.||.+|||+.+|++
T Consensus       240 -----------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        240 -----------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -----------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                             01122357889999999999999999999999985

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.5e-40  Score=294.35  Aligned_cols=263  Identities=22%  Similarity=0.332  Sum_probs=211.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|+||++.+..+|+.+++|++.... .......+.+|+.+++.++|||++++++.+...     ..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~   77 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NN   77 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CE
Confidence            368999999999999999999999999999999886532 233455678899999999999999999999887     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++|+||++ ++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998 5898888887889999999999999999999997 58999999999999999999999999987644221


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHhCCCchhhhhccC
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL----KLIISVFGTQQEADLEFID  262 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~  262 (364)
                      .  .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||.........    ..+..              
T Consensus       158 ~--~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------------  220 (284)
T cd06620         158 I--ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD--------------  220 (284)
T ss_pred             c--cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH--------------
Confidence            1  223467889999999876 57889999999999999999999999865432110    00000              


Q ss_pred             chhHHHHHhhCCCCCCCcccccC-CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLY-PQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                        ........       ...... ..++..+.+||.+||+.||.+|||+.|+++|+||.+..
T Consensus       221 --~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         221 --LLQQIVQE-------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             --HHHHHhhc-------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence              00000000       000111 12677899999999999999999999999999997743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.9e-40  Score=290.74  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=203.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchh-hchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF-ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|++|.||+|+++.+++.+++|.++... ........+.+|+.+++.++|||++++++.+...     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            58999999999999999999999999999999876432 2334455677899999999999999999998876     78


Q ss_pred             EEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          109 VYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .++|+||++ ++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            899999998 588887753    345899999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhhhccC
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ............+         
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  226 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP---------  226 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC---------
Confidence            443333334567888999999877 56889999999999999999999998654321 1111111100000         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                         ......++..+.++|.+||+.+|.+||++.+|++
T Consensus       227 -------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         227 -------------------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             -------------------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                               0111246778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-40  Score=305.83  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=198.6

Q ss_pred             cceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (364)
                      ++|++++.||+|+||+||+|++     ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++...  
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            4799999999999999999974     3456789999987532 223445677899999999 899999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC------------------------------------------------------
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ------------------------------------------------------  128 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~------------------------------------------------------  128 (364)
                         ...++||||++ |+|.+++...+                                                      
T Consensus       112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence               77899999998 69988886421                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          129 ---------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       129 ---------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                                           .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 46788899999999999999999999999999999999999999999999987553322


Q ss_pred             cc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          188 QF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       188 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||................              
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--------------  333 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG--------------  333 (375)
T ss_pred             cccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC--------------
Confidence            21  112233567999999977 578999999999999999997 899997764433222221100              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                     .....+...+..+.+||.+||+.||++|||+.+|++.
T Consensus       334 ---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 ---------------YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ---------------ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                           0011123457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.7e-40  Score=293.19  Aligned_cols=256  Identities=24%  Similarity=0.402  Sum_probs=211.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+-|++.+.||.|+||.||+|.+..++..+|+|.+..... ......+.+|+.+++.++|||++++++.+...     ..
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~   76 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TK   76 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----Ce
Confidence            4568889999999999999999999999999999864322 23445677899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||++ ++|.+++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            899999998 588877764 568999999999999999999999999999999999999999999999999886554333


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..                   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------  215 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-------------------  215 (277)
T ss_pred             hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-------------------
Confidence            23334456788999999876 5788999999999999999999999976543332222211                   


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                 .........++..+.++|.+||+.+|.+||++.++++||||...
T Consensus       216 -----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         216 -----------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -----------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                       00112234578889999999999999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-42  Score=307.89  Aligned_cols=266  Identities=30%  Similarity=0.478  Sum_probs=228.6

Q ss_pred             eeceeeecccceeee--eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeee
Q 017909           21 MWQTLFEIDTKYVPI--KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVM   98 (364)
Q Consensus        21 ~~~~~~~~~~~y~i~--~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (364)
                      .+++-.+|..-|+|.  +.||+|.||+||-|+++.+|+.||+|++.+..-.......+.+|+.+|..+.||.||.+...|
T Consensus       553 qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~  632 (888)
T KOG4236|consen  553 QIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF  632 (888)
T ss_pred             hhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee
Confidence            344444566677776  799999999999999999999999999998877777778889999999999999999999999


Q ss_pred             ccccccccceEEEEeccccccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cEE
Q 017909           99 MPTHRISFKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLK  173 (364)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~~  173 (364)
                      +..     ..+++|||.+.|+.++.+..  .+++++...+.++.||+.||+|||-+||+|+|+||+|||+....   ++|
T Consensus       633 ET~-----ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvK  707 (888)
T KOG4236|consen  633 ETP-----ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVK  707 (888)
T ss_pred             cCC-----ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCcee
Confidence            988     88999999999999988854  46899999999999999999999999999999999999997653   699


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||+++..+. ..+.....||+.|+|||++.+ +.|+..-|+||.|+|+|--+.|..||....+  .-..|       
T Consensus       708 lCDFGfARiIgE-ksFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQI-------  776 (888)
T KOG4236|consen  708 LCDFGFARIIGE-KSFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQI-------  776 (888)
T ss_pred             eccccceeecch-hhhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHh-------
Confidence            999999998854 455677899999999999998 7899999999999999999999999965432  22222       


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                          +.........-|..+++..++||..+|+..-.+|-|.++.|+|||+++.
T Consensus       777 --------------------QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  777 --------------------QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             --------------------hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                                1222333344456789999999999999999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=292.97  Aligned_cols=292  Identities=30%  Similarity=0.550  Sum_probs=222.1

Q ss_pred             CCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC--CC--
Q 017909           14 RGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK--HD--   89 (364)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~--   89 (364)
                      +|..-+..++.+   .++|+++..+|+|.||+|..+.++.++..+|+|+++....   -....+-|+++|.++.  .|  
T Consensus        76 dGH~v~~~gD~l---~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k---YreAa~iEi~vLqki~~~DP~g  149 (415)
T KOG0671|consen   76 DGHYVYQVGDIL---TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK---YREAALIEIEVLQKINESDPNG  149 (415)
T ss_pred             CceEEEEecccc---ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH---HhhHHHHHHHHHHHHHhcCCCC
Confidence            444444445544   8999999999999999999999999999999999975321   2223346889998883  22  


Q ss_pred             --CcceeeeeeccccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909           90 --NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus        90 --~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                        -++++.++|.-.     ++.|||+|.++-++.+++.++  .+++...++.++.|+++++++||+.+++|-|+||+|||
T Consensus       150 ~~rcv~m~~wFdyr-----ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENIL  224 (415)
T KOG0671|consen  150 KFRCVQMRDWFDYR-----GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENIL  224 (415)
T ss_pred             ceEEEeeehhhhcc-----CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEE
Confidence              255555556555     889999999999999999876  47999999999999999999999999999999999999


Q ss_pred             Ecc--------------------CCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHH
Q 017909          166 VNA--------------------NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA  225 (364)
Q Consensus       166 l~~--------------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  225 (364)
                      +..                    +..|+|+|||.+.......   +....|..|.|||++.+ -.++..+||||+||||+
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILV  300 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheec-cCcCCccCceeeeeEEE
Confidence            831                    2359999999998764444   44556889999999999 58999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh--hCCC----CCC---------CcccccC---CC
Q 017909          226 EILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK--SLPY----SRG---------THISSLY---PQ  287 (364)
Q Consensus       226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~---------~~~~~~~---~~  287 (364)
                      |+.+|...|+..++.+++..+...+|..|..-.....   ...++.  .+.+    +.+         .....+.   ..
T Consensus       301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~  377 (415)
T KOG0671|consen  301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL  377 (415)
T ss_pred             EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence            9999999999999999998887777755443221110   111110  0000    000         0000011   11


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       288 ~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      .-..+.|||++||..||.+|+|+.|+|.||||+.+.
T Consensus       378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  378 EHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            223478999999999999999999999999998754

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-40  Score=299.01  Aligned_cols=265  Identities=28%  Similarity=0.405  Sum_probs=211.2

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT  101 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (364)
                      ..+..-+..|++.+.||+||.+.||++... +...|++|.+.....+.....-+.+|+..|.+| .|.+|+++++|-..+
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            344556778999999999999999999754 335688888877777788888899999999999 499999999998887


Q ss_pred             cccccceEEEEeccccccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          102 HRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                           +.+|+|||+=+.+|..+++.... .+.-.++.+..||+.|+.++|..||+|.||||.|+|+-. |.+||+|||.+
T Consensus       433 -----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA  506 (677)
T KOG0596|consen  433 -----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIA  506 (677)
T ss_pred             -----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechh
Confidence                 99999999999999999987654 444588899999999999999999999999999998864 58999999999


Q ss_pred             ccCCCCCc--ccccccccccccCCccccccc----------CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017909          181 RTSRGNEQ--FMTEYVVTRWYRAPELLLCCD----------NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       181 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~----------~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~  248 (364)
                      .....+..  ....-.||..||+||.+....          ..++++||||||||||+|+.|++||..-.  ..+.++..
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a  584 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA  584 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh
Confidence            87755433  234568899999999986421          15789999999999999999999996532  22333322


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChH-HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPL-ALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      .......                          .+++..-+.. ++++++.||+.||++|||+.+||+|||++..
T Consensus       585 I~~P~~~--------------------------Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  585 ITDPNHE--------------------------IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hcCCCcc--------------------------ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            2111111                          1111111222 8999999999999999999999999999984

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-39  Score=288.79  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=204.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ...|++.+.||+|++|.||+|.++.+++.+++|.+...   ......+.+|+.+++.++|+|++++++++...     ..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP   76 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CC
Confidence            45699999999999999999999999999999998743   23345677899999999999999999998877     77


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .+++|||++ ++|.+.+...  ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            899999997 6999988654  3589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCccc-ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFM-TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ..... .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||++....+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            22111 11223457999998876 578999999999999999997 999998766544443332110             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       .......++..+.++|.+||+.||++|||+.++++
T Consensus       223 -----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 -----------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             01223457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.6e-40  Score=290.02  Aligned_cols=250  Identities=32%  Similarity=0.497  Sum_probs=205.9

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||.|++|.||++.+..+|+.+++|++...... ......+.+|+.+++.++|||++++++.+...     ...++++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence            68999999999999999999999998754332 23445667899999999999999999988766     7889999999


Q ss_pred             c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc-------
Q 017909          117 D-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ-------  188 (364)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~-------  188 (364)
                      . ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++........       
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            7 59999998877899999999999999999999999999999999999999999999999998865433211       


Q ss_pred             -ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          189 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       189 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                       ......++..|++||.+.. ...+.++|+||||+++|++++|..||...........+...  ...             
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------------  219 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE-------------  219 (265)
T ss_pred             ccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC-------------
Confidence             2233456778999999877 45889999999999999999999999877654444333210  000             


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH---HHHhcCCCccCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV---TEALQHPYISGL  322 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~elL~hp~f~~~  322 (364)
                                    .......+..+.+++++||+.+|.+|||+   .++|+||||+.+
T Consensus       220 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         220 --------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             --------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                          00001247889999999999999999999   999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-42  Score=282.69  Aligned_cols=296  Identities=34%  Similarity=0.566  Sum_probs=239.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+..+.|+-..++|+|.||.||+|+.+.+|+.|++|+.-.+.....--...++|+.+|..++|+|++.++++|.......
T Consensus        13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            34567888899999999999999999999999999876543333223345578999999999999999999987653322


Q ss_pred             ---cceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          106 ---FKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       106 ---~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ....|+||.+|+.+|.-++... .+++..+++.++.+++.||.|+|...|+|||+|+.|+|++.+|.++|+|||+++
T Consensus        93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence               2458999999999998888765 579999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCC-cc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNE-QF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~-~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .+.... ..   .+...-|.+|.+||.+.+...++++.|||+.||++.+|+++.+.|.+......+..|-...|....+-
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            442211 11   22234488999999999988999999999999999999999999999999999999999888888877


Q ss_pred             hhccCchhHHHHH--hhCCCCCCCcccccCC--CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          258 LEFIDNPKARRFI--KSLPYSRGTHISSLYP--QADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       258 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      |....+-.+-+-+  +.++......+.....  .-++...+|+.+||..||.+|+++.++|+|.||.+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            7766554443333  2133322222222222  23667889999999999999999999999999987

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.7e-39  Score=290.43  Aligned_cols=257  Identities=24%  Similarity=0.388  Sum_probs=204.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|++.+.||+|+||.||+|.++.     .+..|++|.++... .......+.+|+.+++.++|||++++++++...  
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence            5799999999999999999997652     34579999886442 223344567899999999999999999998776  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcE
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS----------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~  172 (364)
                         ...++||||+. |+|.+++...          ..++...+..++.|++.||.|||+++++|+||+|+||+++.++.+
T Consensus        82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence               67899999997 6999998642          234667889999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017909          173 KICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~  249 (364)
                      +|+|||.+.........  .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+...
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999988654322211  112234567999999877 578999999999999999997 78899876654443332210


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCccCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ------HPYISGL  322 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~------hp~f~~~  322 (364)
                                                    .........++.+.+++.+||+.||.+|||+.++++      ||||.++
T Consensus       238 ------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         238 ------------------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             ------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence                                          001122345788999999999999999999999987      9999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-39  Score=294.32  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=210.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..+.|...+.||+|++|+||+|++..++..+++|.+...... ......+.+|+.+++.++|||++++++++...     
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   93 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----   93 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----
Confidence            456688889999999999999999999999999998654332 23345677899999999999999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||+.+++.+.+.. ..++++..+..++.||+.++.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        94 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633          94 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            77899999999998888865 45799999999999999999999999999999999999999999999999998754322


Q ss_pred             CCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                          .....++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+...  ..          
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~----------  237 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS----------  237 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CC----------
Confidence                223467888999999853  245788999999999999999999999776544444333210  00          


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                       .......++..+.+||.+||+.+|.+||++.++++||||..
T Consensus       238 -----------------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         238 -----------------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             -----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence                             00112346678999999999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-40  Score=291.90  Aligned_cols=246  Identities=28%  Similarity=0.423  Sum_probs=197.2

Q ss_pred             eeeeeeccCCceeEEEEEec----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           33 VPIKPIGRGAYGVVCSSINR----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++.+.||.|.||.||+|..+    ..+..|++|.++. .........+.+|++.+++++||||+++++++...     ..
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~   75 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP   75 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence            57889999999999999988    4567899999965 23444577888999999999999999999999855     66


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++|+||+. |+|.+++...  ..+++..++.++.|++.||.|||+++++|++|+++||+++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            899999998 7999999886  6799999999999999999999999999999999999999999999999999876522


Q ss_pred             CC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 NE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..  ...........|+|||.+.. ..++.++||||||+++||+++ |..||...........+.+..            
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~------------  222 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ------------  222 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE------------
T ss_pred             cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc------------
Confidence            21  12233445678999999877 458999999999999999999 789998876655555442211            


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        .......++..+.++|.+||+.||.+|||+.+|++
T Consensus       223 ------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 ------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                              11223467889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.7e-39  Score=283.85  Aligned_cols=251  Identities=28%  Similarity=0.476  Sum_probs=208.7

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      .|++.+.||+|++|.||++.+..+++.+++|++.....  .....+.+|+.+++.++|++++++++.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            48899999999999999999998999999999976433  3455677899999999999999999998877     7789


Q ss_pred             EEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          111 LVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      +++||++ ++|.+++... +.+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999998 6999988776 6799999999999999999999999999999999999999999999999999876644332


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                       .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..   ....             
T Consensus       154 -~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-------------  215 (253)
T cd05122         154 -RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPP-------------  215 (253)
T ss_pred             -ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCC-------------
Confidence             334567888999999877 4588999999999999999999999977643333322211   0000             


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                                  .......++..+.++|.+||+.||++|||+.++|+|||
T Consensus       216 ------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         216 ------------GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ------------CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                        00011124788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=283.68  Aligned_cols=312  Identities=41%  Similarity=0.713  Sum_probs=254.6

Q ss_pred             eEEeec-eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeee
Q 017909           18 YYTMWQ-TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKD   96 (364)
Q Consensus        18 ~~~~~~-~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (364)
                      .++..+ +.+....||.-++.+|.|.- .|..|-+.-.+.++++|+...+........+..+|..++..++|+|+++.+.
T Consensus         4 ~~~i~~~s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n   82 (369)
T KOG0665|consen    4 SVEIPDSSTFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLN   82 (369)
T ss_pred             eEEcCCCcceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeee
Confidence            334444 66778889999999999998 8888989999999999999887777777788889999999999999999999


Q ss_pred             eecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909           97 VMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus        97 ~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      +|...... .+...|+|||++..+|...+..  .++-..+..++.|++.|+++||+.||+||||||+||++..+..+||.
T Consensus        83 ~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   83 VFTPQKTLEEFQEVYLVMELMDANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             ccCccccHHHHHhHHHHHHhhhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeec
Confidence            98765322 2466899999999999988873  67889999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          176 DFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       176 Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      |||++...... ...+....+..|.|||++.+. .+....||||+||++.||++|+..|++.+.-+++.++.+++|.+.+
T Consensus       161 dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  161 DFGLARTEDTD-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             cchhhcccCcc-cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            99999776444 456677788999999999985 5999999999999999999999999999999999999999999887


Q ss_pred             hhhhccCc---------hhHH--HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          256 ADLEFIDN---------PKAR--RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       256 ~~~~~~~~---------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ........         ++..  .+-..++.+......+..+.-+..+.+++.+||-.||++|.|++++|+||||+.|+.
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~  318 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYD  318 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecc
Confidence            65443321         1111  111223333333333333344566889999999999999999999999999997766


Q ss_pred             CCCCCCCCCC
Q 017909          325 PQCNPPAQVP  334 (364)
Q Consensus       325 ~~~~~~~~~~  334 (364)
                      ++.....+++
T Consensus       319 ~~ev~ap~pe  328 (369)
T KOG0665|consen  319 PDEVEAPPPE  328 (369)
T ss_pred             cccccCCCCc
Confidence            6555444444

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-39  Score=289.32  Aligned_cols=249  Identities=26%  Similarity=0.346  Sum_probs=199.7

Q ss_pred             cccceeeeeee--ccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           28 IDTKYVPIKPI--GRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        28 ~~~~y~i~~~l--g~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+.|++.+.+  |+|+||.||+++++.++..+++|.+........       |+.....+ +|||++++++.+...   
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~---   81 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTL---   81 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecC---
Confidence            34677787776  999999999999999999999999875422211       22222222 799999999999887   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~  182 (364)
                        ...++||||++ ++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        82 --~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~  159 (267)
T PHA03390         82 --KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI  159 (267)
T ss_pred             --CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence              78999999997 69999998888999999999999999999999999999999999999999998 999999998865


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchhhhhcc
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL-KLIISVFGTQQEADLEFI  261 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~  261 (364)
                      .....    ...++..|+|||++.+ ..++.++|+||||+++|+|++|..||......... ..+....           
T Consensus       160 ~~~~~----~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  223 (267)
T PHA03390        160 IGTPS----CYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-----------  223 (267)
T ss_pred             cCCCc----cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-----------
Confidence            53222    2356788999999977 56889999999999999999999999755432211 1111100           


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCccC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-VTEALQHPYISG  321 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~elL~hp~f~~  321 (364)
                                       .......+..++.+.++|.+||+.||.+||+ ++++|+||||..
T Consensus       224 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        224 -----------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -----------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                             0111223468899999999999999999996 699999999973

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-39  Score=289.86  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=200.7

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHH---HHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRE---LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      .||+|+||.||+|.+..+++.||+|.+....... ........|   ...++...||+++++++.+...     ...++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence            4799999999999999999999999986543221 111122233   3444556799999999999877     788999


Q ss_pred             ecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccc
Q 017909          113 YELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT  191 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~  191 (364)
                      |||+. ++|.+.+...+.+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~  153 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--Cc
Confidence            99997 5898888887889999999999999999999999999999999999999999999999999886543222  22


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                      ...++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.......... ....                    
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~--------------------  212 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL--------------------  212 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh--------------------
Confidence            3467889999999976456889999999999999999999999775322111100 0000                    


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCC
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~  326 (364)
                             ......+..+++.+.++|++||..||.+||     ++.++++||||.......
T Consensus       213 -------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         213 -------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             -------ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence                   001123345688999999999999999999     999999999998875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=306.33  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=217.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ...|+-.+.||.|+||.||-|++..+.+.||||++...... ...+.++++|+..|+++.|||.+.+.++|..+     .
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~   99 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----H   99 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----c
Confidence            44677889999999999999999999999999999865443 45667889999999999999999999999988     7


Q ss_pred             eEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..|+|||||=|+..|++.-. +++.+.++..|+.+.+.||+|||+.+.+|+|||..|||+++.|.|||+|||.+....  
T Consensus       100 TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--  177 (948)
T KOG0577|consen  100 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--  177 (948)
T ss_pred             hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--
Confidence            78999999999888888653 689999999999999999999999999999999999999999999999999986553  


Q ss_pred             CcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                        ..+...||++|||||++..  .+.|+-+.||||||+...+|.-.++|+-+.+.-..+-.|..   +..+         
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ---NesP---------  243 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESP---------  243 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh---cCCC---------
Confidence              2456789999999999863  35699999999999999999999999766655444443322   1111         


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                       ......++..++.|+..||+.-|.+|||.+++|.|+|+.-
T Consensus       244 -----------------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  244 -----------------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             -----------------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                             0012457888999999999999999999999999999864

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-39  Score=284.74  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=208.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchh---hchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF---ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+|++.+.||+|++|.||+|++..+++.+++|.+....   ........+.+|+.+++.++|+|++++++.+.....   
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---
Confidence            47999999999999999999999999999999875322   123344567789999999999999999998865422   


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++++|+++ ++|.+.+...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            46789999997 59999998878899999999999999999999999999999999999999999999999999875422


Q ss_pred             C---CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 N---EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .   ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+   ...+         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~---------  225 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP---------  225 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC---------
Confidence            1   111223457888999999877 56889999999999999999999999765433322221   1111         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                       .....+..+++.+.++|.+||. +|.+||++.++++|||.
T Consensus       226 -----------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 -----------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             -----------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                             1122345688899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.8e-39  Score=293.65  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=210.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ....|+..+.||+|+||.||++++..++..+++|.+..... .......+.+|+.+++.++|||++++++++...     
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   97 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----   97 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----
Confidence            45568999999999999999999999999999999865422 233445677899999999999999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||+.|++.+.+.. ..++++..+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        98 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635          98 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            77899999999988887754 45699999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                          .....++..|+|||.+..  ...++.++|+||||+++|+|++|..||...........+.....            
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------------  241 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------  241 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC------------
Confidence                223456788999999742  24588999999999999999999999977654444433322100            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                       .......+++.+.++|.+||+.+|.+||++.++++|+|+..
T Consensus       242 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 -----------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -----------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                             01112346778999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-39  Score=287.82  Aligned_cols=252  Identities=22%  Similarity=0.381  Sum_probs=200.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..++|++.+.||+|++|+||+|.++.     ++..+++|++.... ......++.+|+.+++.++|||++++++++... 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence            46899999999999999999998652     35679999986432 223445677899999999999999999998777 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ----------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                          ...++||||++ ++|.+++...+          .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus        82 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          82 ----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             ----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence                77899999998 69999886532          3577888999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCCccc--ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017909          172 LKICDFGLARTSRGNEQFM--TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  248 (364)
                      ++|+|||++..........  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.........+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999886543322111  12234667999999877 578999999999999999998 7899987655443333221


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .                              .........+..+.+++.+||+.||.+|||+.+++++
T Consensus       237 ~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 G------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             C------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                              0011224567789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=283.81  Aligned_cols=245  Identities=29%  Similarity=0.496  Sum_probs=206.6

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      ||.|++|.||++.+..+++.+++|.+...... ......+..|+.+++.++|+|++++++.+...     ...++|||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence            68999999999999988999999998765333 22455677899999999999999999998776     7899999999


Q ss_pred             c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccc
Q 017909          117 D-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV  195 (364)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  195 (364)
                      + ++|.+.+.....+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..............+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            5 799999988888999999999999999999999999999999999999999999999999998765443333445567


Q ss_pred             cccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCC
Q 017909          196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPY  275 (364)
Q Consensus       196 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (364)
                      +..|++||...+ ...+.++|+||||+++|++++|..||...+.......+..                           
T Consensus       156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------------------------  207 (250)
T cd05123         156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---------------------------  207 (250)
T ss_pred             CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---------------------------
Confidence            888999999877 4688999999999999999999999977654333332221                           


Q ss_pred             CCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH---HHHhcCCCc
Q 017909          276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV---TEALQHPYI  319 (364)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~elL~hp~f  319 (364)
                          .....+...+..+.++|++||..||.+||++   +++++||||
T Consensus       208 ----~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         208 ----DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                0112334458889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-39  Score=298.43  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||.|+||.||+|.+..     +++.|++|+++... .......+.+|+.++.++ +|+||+++++++....
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            5699999999999999999997533     45789999987532 223345667899999999 7999999999887552


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC------------------------------------------------------
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (364)
                          ...++++||++ ++|.+++...                                                      
T Consensus        85 ----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          85 ----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence                56889999998 5898887532                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc--cccccccccc
Q 017909          128 -------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRW  198 (364)
Q Consensus       128 -------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~  198 (364)
                             .++++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  ......++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2678999999999999999999999999999999999999999999999999876532221  1222344567


Q ss_pred             ccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCC
Q 017909          199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSR  277 (364)
Q Consensus       199 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (364)
                      |+|||++.+ ..++.++|||||||++|+|++ |..||.+....+........   .                        
T Consensus       241 y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~---~------------------------  292 (337)
T cd05054         241 WMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE---G------------------------  292 (337)
T ss_pred             ccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc---c------------------------
Confidence            999999987 578999999999999999997 99999765433322221110   0                        


Q ss_pred             CCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          278 GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                        .....+...++.+.+++.+||+.+|.+||++.+|++|
T Consensus       293 --~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         293 --TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              0011223567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=296.12  Aligned_cols=267  Identities=24%  Similarity=0.372  Sum_probs=225.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..+.|+.-+.||+|+||.|+-++.+.+|+-||+|.+.+.... .....-.++|-.+|..++.+.||.+.-+|...     
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----  257 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-----  257 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----
Confidence            467899999999999999999999999999999998654433 22334457899999999999999998888888     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ..+++|+..|+ |+|.-.+.+.+  .+++..+..++.+|+.||.+||..+|++||+||+|||+|+.|+++|+|+|++...
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence            88999999998 58876665544  7999999999999999999999999999999999999999999999999999888


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ..... .....||.+|||||++.+ ..|+...|+|||||++|+|+.|+.||..........++.......+         
T Consensus       338 ~~g~~-~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~---------  406 (591)
T KOG0986|consen  338 PEGKP-IRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP---------  406 (591)
T ss_pred             CCCCc-cccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch---------
Confidence            55444 344489999999999998 5699999999999999999999999987655544444433222221         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~~~  328 (364)
                                        -.++..+|++++++.+.+|+.||.+|.     .+++|-+||||+.+.+++-.
T Consensus       407 ------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle  458 (591)
T KOG0986|consen  407 ------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE  458 (591)
T ss_pred             ------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence                              233467899999999999999999998     67899999999998776654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-39  Score=285.42  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++.+.||+|+||+||+|.++.+   ...+++|.++... .......+..|+.+++.++|||++++++.+...    
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS----   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC----
Confidence            36899999999999999999998654   4579999887542 333455677899999999999999999998776    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++|||+++ ++|.+++... +.+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          78 -RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             -CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence             67899999997 5999988664 46899999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          184 RGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       184 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ......  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....          
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------  225 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY----------  225 (266)
T ss_pred             cccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----------
Confidence            422211  112233567999999876 578999999999999999997 999997765544443332110          


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                          .......++..+.+++.+||+.+|.+||++.+|+++
T Consensus       226 --------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         226 --------------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                011123567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.6e-39  Score=283.78  Aligned_cols=246  Identities=25%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|+||.||++.++ ++..+++|.+....   .....+.+|+.+++.++|||++++++++...     ...
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPL   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCE
Confidence            57999999999999999999875 45679999886432   2234677899999999999999999998776     778


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++||||++ |+|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999997 6999988753 468999999999999999999999999999999999999999999999999887553322


Q ss_pred             cc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 QF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...........+.....              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--------------  219 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR--------------  219 (256)
T ss_pred             eeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--------------
Confidence            21 122234567999999876 578999999999999999998 8999987765555444422100              


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      ...+...+..+.+++.+||+.||.+||++.++++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ----------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            0112235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.8e-39  Score=283.88  Aligned_cols=242  Identities=22%  Similarity=0.355  Sum_probs=197.3

Q ss_pred             eeccCCceeEEEEEe--ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEec
Q 017909           37 PIGRGAYGVVCSSIN--RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      .||+|+||.||+|.+  ..++..+++|+++...........+..|+.+++.++|||++++++++..      ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            689999999999965  4567889999987654445556677889999999999999999998743      34689999


Q ss_pred             ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc---
Q 017909          115 LMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM---  190 (364)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~---  190 (364)
                      |++ ++|.+++...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            998 6899999887889999999999999999999999999999999999999999999999999987654332211   


Q ss_pred             ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       191 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.........+.+.                    
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~--------------------  214 (257)
T cd05116         156 THGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG--------------------  214 (257)
T ss_pred             CCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC--------------------
Confidence            12233468999998866 578899999999999999997 99999876554443333210                    


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                .....+..+++.+.++|.+||+.||.+||++.+|..
T Consensus       215 ----------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         215 ----------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                      011233468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.4e-39  Score=289.34  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|.+.+.||+|++|.||+|.+..     ++..+++|.++.... ......+.+|+++++.++|+|++++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG--   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence            4579999999999999999998753     357899999875422 22446778899999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS--------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA  168 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~  168 (364)
                         ...++||||++ ++|.+++...              ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.
T Consensus        81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~  157 (280)
T cd05049          81 ---DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             ---CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence               77899999997 6999998654              24788999999999999999999999999999999999999


Q ss_pred             CCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017909          169 NCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKL  245 (364)
Q Consensus       169 ~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~  245 (364)
                      ++.++|+|||.+.......  .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999999999886542221  11223334678999999987 578999999999999999998 9999987765554443


Q ss_pred             HHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      +...                              ........++..+.+++++||+.||.+||++.|+++
T Consensus       237 ~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQG------------------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3210                              011122457888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=284.67  Aligned_cols=244  Identities=27%  Similarity=0.407  Sum_probs=204.8

Q ss_pred             eeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           36 KPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.||+|+||.||+|.+...   +..+++|.++...... ....+.+|+..++.++|+|++++++++...     ...++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEE
Confidence            4689999999999998866   8899999998654433 466778899999999999999999999875     789999


Q ss_pred             ecccc-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          113 YELMD-TDLHQIIKSS---------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      |||++ ++|.+.+...         ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            99995 7999999875         7799999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .....  .......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...........+...          
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------  223 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG----------  223 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence            64432  22334456778999999877 478999999999999999998 69999887655444443220          


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                          ........++..+.+++.+||+.||.+|||+.+++++
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 --------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                1122234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7e-39  Score=282.87  Aligned_cols=243  Identities=25%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecc
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYEL  115 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (364)
                      +.||+|+||+||+|+++.+++.+++|.+.... .......+.+|+.+++.++||||+++++++...     ...++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence            46899999999999999999999999886432 233445678899999999999999999999877     778999999


Q ss_pred             cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc--c
Q 017909          116 MD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM--T  191 (364)
Q Consensus       116 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~--~  191 (364)
                      +. ++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........  .
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            97 5999988764 468999999999999999999999999999999999999999999999999986543211111  1


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+...                     
T Consensus       155 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---------------------  212 (252)
T cd05084         155 MKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---------------------  212 (252)
T ss_pred             CCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------------------
Confidence            1122346999999877 568999999999999999997 88999765543332222110                     


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                               ........++..+.+++.+||+.||++|||+.+|++
T Consensus       213 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         213 ---------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ---------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     001123456788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=287.87  Aligned_cols=309  Identities=28%  Similarity=0.430  Sum_probs=233.6

Q ss_pred             ccCCCCcccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHH
Q 017909            5 VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR   84 (364)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~   84 (364)
                      -|++.+|..+|+|++.+++.+.  ++||.+.++||-|.|++||+|.+..+...||+|+.+....-   ....+.|+.+|+
T Consensus        55 qE~~~dY~kGGYHpV~IGD~F~--~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY---tEaAlDEIklL~  129 (590)
T KOG1290|consen   55 QEDPEDYRKGGYHPVRIGDVFN--GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY---TEAALDEIKLLQ  129 (590)
T ss_pred             ccChhhhhcCCCceeecccccc--CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH---HHHHHHHHHHHH
Confidence            3678889999999999999983  59999999999999999999999999999999999853222   233457888888


Q ss_pred             hcC--------CCCcceeeeeeccccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 017909           85 HIK--------HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSA-N  153 (364)
Q Consensus        85 ~l~--------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~  153 (364)
                      .+.        ..+||++++.|......+ .++|+|+|+++.+|+.++...  +.++...++.|++||+.||.|||.. |
T Consensus       130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg  208 (590)
T KOG1290|consen  130 QVREGDPNDPGKKCVVQLLDHFKHSGPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG  208 (590)
T ss_pred             HHHhcCCCCCCCceeeeeeccceecCCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence            772        237999999998876655 799999999999999999754  6799999999999999999999975 9


Q ss_pred             ccccCCCCCCeEEccC----------------------------------------------------------------
Q 017909          154 ILHRDLKPGNLLVNAN----------------------------------------------------------------  169 (364)
Q Consensus       154 i~H~di~~~NIll~~~----------------------------------------------------------------  169 (364)
                      |+|-||||+|||+..+                                                                
T Consensus       209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l  288 (590)
T KOG1290|consen  209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL  288 (590)
T ss_pred             ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence            9999999999999311                                                                


Q ss_pred             --------------------------------------------------------------------------------
Q 017909          170 --------------------------------------------------------------------------------  169 (364)
Q Consensus       170 --------------------------------------------------------------------------------  169 (364)
                                                                                                      
T Consensus       289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~  368 (590)
T KOG1290|consen  289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP  368 (590)
T ss_pred             cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence                                                                                            


Q ss_pred             ----------------------CcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHH
Q 017909          170 ----------------------CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI  227 (364)
Q Consensus       170 ----------------------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l  227 (364)
                                            .++||+|||-++....   ..+....|.-|.|||++.+ ..|+..+||||++|+++||
T Consensus       369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FEL  444 (590)
T KOG1290|consen  369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFEL  444 (590)
T ss_pred             CCccccccccccCCCCCCCccceeEEEeeccchhhhhh---hhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHh
Confidence                                  0022222222222110   0111223666999999999 6899999999999999999


Q ss_pred             HhCCCCCCC------CChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCC---CCcc----------cccCCCC
Q 017909          228 LGRKPIFPG------TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSR---GTHI----------SSLYPQA  288 (364)
Q Consensus       228 ~~g~~pf~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----------~~~~~~~  288 (364)
                      +||...|+.      ..+.++++.|++.++..|......  ..--+.|+.....-+   ....          .......
T Consensus       445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~--Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~  522 (590)
T KOG1290|consen  445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALG--GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEED  522 (590)
T ss_pred             hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhc--CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHH
Confidence            999999953      357889999999999988743221  111122222111111   1110          0111223


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          289 DPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       289 ~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ..++.+||.-||+.+|.+||||.++|+|||+.....+
T Consensus       523 A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  523 AQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            4557799999999999999999999999999987766

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.6e-39  Score=288.82  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=201.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .+.|.+.+.||+|+||+||++.+.     .++..+++|.+...  .......+.+|+.++++++|||++++++++...  
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence            457999999999999999999853     34567999988643  233445677899999999999999999999876  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ-------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                         ...++||||++ ++|.+++...+             .+++..++.++.|++.||.+||++|++|+||+|+||+++.+
T Consensus        80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             ---CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence               77899999998 69999886543             48999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLI  246 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i  246 (364)
                      +.++|+|||.+........  ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...........+
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999875533221  1222334667999999877 578999999999999999998 99999877655544443


Q ss_pred             HHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ....                              .......++..+.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGR------------------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCC------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2210                              01112356788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-39  Score=295.66  Aligned_cols=282  Identities=20%  Similarity=0.253  Sum_probs=203.4

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |.+++.+|.|  +.||.+++..+++.+|+|+++...........+.+|+.+++.++|+||+++++++...     ...++
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYV   76 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEE
Confidence            3344444444  5566666677899999999986544555667788999999999999999999999877     77899


Q ss_pred             Eecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          112 VYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       112 v~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      +|||++ ++|.+++...  ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+||+.+........
T Consensus        77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            999998 6898888753  4689999999999999999999999999999999999999999999999998764422111


Q ss_pred             -------ccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          189 -------FMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       189 -------~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                             ......++..|+|||.+... ..++.++|+||||+++|+|++|..||............  ..+..+. ....
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~-~~~~  233 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPC-LLDK  233 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCcc-cccc
Confidence                   11223456789999998653 35788999999999999999999999876544332221  1111100 0000


Q ss_pred             cCchhHHHHHh------hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          261 IDNPKARRFIK------SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       261 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ...+.......      ................++..+.+||++||+.||.+|||++++|+||||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            00000000000      0000000011112234567889999999999999999999999999999776

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.8e-39  Score=286.84  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ..+|++++.||.|++|.||+|.++. +..+++|++....  ......+..|+.+++.++|+|++++++++...     ..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CC
Confidence            4679999999999999999999887 8899999987542  22344567899999999999999999998777     67


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||++ ++|.+++...  ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            899999998 5999998753  4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .........++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+....              
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  221 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--------------  221 (261)
T ss_pred             ccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC--------------
Confidence            3322233344667999999876 578899999999999999998 899998776554444433210              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       222 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         222 ----------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                            01223567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.8e-39  Score=288.25  Aligned_cols=264  Identities=21%  Similarity=0.344  Sum_probs=210.7

Q ss_pred             ceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      .|++.+.||.|++|.||+|.+.   .+|..|++|+++....  .......+.+|+.+++.+ +|++|+++++.+..+   
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD---   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence            4889999999999999999875   4788999999875322  222334566799999999 599999999998877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++|+||++ ++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          78 --TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             --CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence              78899999998 599999988888999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCC-cccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNE-QFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .... .......++..|+|||.+... ..++.++|+||||+++|+|++|..||...........+......         
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK---------  226 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc---------
Confidence            3322 112234578889999998653 24678999999999999999999999754332222222211100         


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~  326 (364)
                                        .....+..+++.+.+++++||+.||.+||     +++++++||||+.+.+..
T Consensus       227 ------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         227 ------------------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             ------------------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence                              00122345788899999999999999997     899999999999986443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.3e-39  Score=286.66  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=203.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||+|++|.||+++++.++..+++|.+..... .......+.+|+.+++.++|+|++++++.+...     ..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence            479999999999999999999999999999998865322 333445677899999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          109 VYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .+++||+++ ++|.+++..    ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            899999998 589888763    356899999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL--NQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....  .....+..             
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  222 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------  222 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-------------
Confidence            443333344567889999999877 57889999999999999999999999654321  11111100             


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      ..........+++.+.++|.+||+.||.+|||+.+|++
T Consensus       223 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         223 ----------------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ----------------CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                            00001112347788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.9e-39  Score=289.58  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=198.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCc--EEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNE--KVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++|++.+.||.|+||+||+|.++.++.  .+++|.++.. ........+.+|+.++.++ +|||++++++++...     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----
Confidence            579999999999999999999877765  4688887632 2333445677899999999 799999999998776     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                      ...++++||++ ++|.+++...+                .+++..++.++.|++.||.+||++|++|+||+|+||+++.+
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence            67899999997 69999986532                48889999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  248 (364)
                      +.++|+|||++....... .......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+..
T Consensus       156 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 LASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             CeEEECCcCCCcccccee-ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            999999999875432111 1111222456999999876 568999999999999999997 9999987765444433211


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .                              .....+..++..+.+||.+||+.||.+||+++++++.
T Consensus       234 ~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 G------------------------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             C------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                              0011224578899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1e-38  Score=288.78  Aligned_cols=261  Identities=23%  Similarity=0.354  Sum_probs=205.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -.++|++.+.||+|++|.||+|.+..++..+++|.++...... ....+..|+.++... .|+|++++++++...     
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----   86 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----   86 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC-----
Confidence            4578999999999999999999999889999999997543222 333445566656555 599999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...+++|||+++++.+++.. ...+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus        87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            78999999999888877765 4579999999999999999999997 599999999999999999999999999986553


Q ss_pred             CCCcccccccccccccCCcccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhhhc
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .... .....++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||...... +....+..   ....     
T Consensus       167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~-----  237 (296)
T cd06618         167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPP-----  237 (296)
T ss_pred             CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCCC-----
Confidence            3222 2233567789999998653   24788999999999999999999999754221 11111111   1000     


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                          .......++..+.+||.+||+.||.+||+++++++||||+...
T Consensus       238 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         238 --------------------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                                0011124678899999999999999999999999999998644

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.5e-40  Score=269.09  Aligned_cols=292  Identities=29%  Similarity=0.558  Sum_probs=230.3

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  104 (364)
                      +.-.++|++++++|+|.++.||.|....+.+.++||+++.     ....++.+|+.+|..+. +|||++++++..+..+ 
T Consensus        34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S-  107 (338)
T KOG0668|consen   34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES-  107 (338)
T ss_pred             ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc-
Confidence            3457899999999999999999999989999999999964     35566778999999995 9999999999988765 


Q ss_pred             ccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg~~~~  182 (364)
                        ..+.+|||+++. +...+.   ..++..+++.++.+++.||.|||+.||.|+|+||.|++++.. ..++|+|||++.+
T Consensus       108 --ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  108 --KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             --cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence              667999999985 444433   468999999999999999999999999999999999999864 5799999999987


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchhh----
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI-FPGTECLNQLKLIISVFGTQQEAD----  257 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~----  257 (364)
                      ....... +-...+..|--||.+...+.+..+-|+|||||++..|++.+.| |.+.++.+++-+|.+.+|...-..    
T Consensus       183 YHp~~eY-nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  183 YHPGKEY-NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             cCCCcee-eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            7544432 2223356678899999888899999999999999999988766 578899999999999988755432    


Q ss_pred             hhccCchhHHHHHhhCCCC--CCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYS--RGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNP  329 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~  329 (364)
                      .....++.+........+.  ..........-.++++.+|+.++|..|..+|+|+.|++.||||.........+
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~  335 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSR  335 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcc
Confidence            1112233333332221111  01111112223578999999999999999999999999999998876655443

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.6e-39  Score=292.23  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=200.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcE----EEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEK----VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+|++.+.||+|+||+||+|.+..++..    |++|+++.. ........+.+|+.+++.++||||+++++++...   
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence            56799999999999999999998766654    899998643 2333455677899999999999999999998654   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ..++|++++. |+|.+.+... ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence               3578999987 7999998764 4689999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .......  ......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+... +....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~---------  227 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKG---------  227 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCC---------
Confidence            5433221  122233567999999877 578999999999999999997 999998765433222 21100         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                          ......+.++..+.+++.+||..||.+||++.+++.+
T Consensus       228 --------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 --------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                0011224567789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.3e-39  Score=291.70  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=209.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchh-hchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF-ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ....|...+.||.|++|.||+|+++.++..+++|.+.... .......++.+|+.+++.++|+|++++++++...     
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   87 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----   87 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence            4567889999999999999999999999999999886432 2333445677899999999999999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++|+||+.|++.+.+.. ..++++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            77899999999988887754 45689999999999999999999999999999999999999999999999998865432


Q ss_pred             CCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .    ....++..|+|||.+.+  ...++.++||||||+++|+|++|..||...+.......+....             
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------  230 (308)
T cd06634         168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------  230 (308)
T ss_pred             c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-------------
Confidence            2    23456788999999753  2457889999999999999999999987654333332221100             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                      ........++..+.+||++||+.+|.+||+++++++|||+...
T Consensus       231 ----------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         231 ----------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ----------------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                            0011123577789999999999999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9e-39  Score=286.28  Aligned_cols=251  Identities=22%  Similarity=0.371  Sum_probs=202.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|++.+.||+|++|.||+|.+..     ++..+++|.+.... .......+.+|+.+++.++|+|++++++++...  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence            4689999999999999999999887     67889999886432 233445678899999999999999999998777  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cE
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ-------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DL  172 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~  172 (364)
                         ...++||||+. ++|.+++...+       .+++..+..++.||+.||.|||+++++|+||+|+||+++.++   .+
T Consensus        82 ---~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 ---LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             ---CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence               66799999997 69999887643       489999999999999999999999999999999999998764   59


Q ss_pred             EEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017909          173 KICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~  249 (364)
                      +|+|||++.........  ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998765322111  112223457999999977 578999999999999999996 99999876655443332210


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                                    .....+..++..+.+++.+||+.||.+|||+.+||+|
T Consensus       238 ------------------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 ------------------------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                          0011234577889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=278.91  Aligned_cols=279  Identities=24%  Similarity=0.387  Sum_probs=216.6

Q ss_pred             cccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      +.+-|++. +.||+|+|+.|-.+....+|..||+|++.+.  ..-...+.++|++++... .|+||++++++|+++    
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd----  148 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD----  148 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc----
Confidence            56677776 5899999999999999999999999999765  333566778999999999 499999999999998    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cEEEeecCccc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~~L~Dfg~~~  181 (364)
                       ...|+|||.+. |.|+..++..+.+++.++..+..+|+.||.+||.+||.|+|+||+|||.....   -+||+||.+..
T Consensus       149 -~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  149 -TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             -ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence             78899999997 69999999999999999999999999999999999999999999999986544   48999998765


Q ss_pred             cCCC-------CCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017909          182 TSRG-------NEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF  250 (364)
Q Consensus       182 ~~~~-------~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (364)
                      ....       .......++|+.-|||||+..-    ...|..+.|.||||+|+|-|+.|.+||.+....+--       
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG-------  300 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG-------  300 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC-------
Confidence            3221       1222345677888999999742    245888999999999999999999999765421000       


Q ss_pred             CCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                        ......+....   ..++...+.-........|..+|...+++|..+|..|+..|.++.++++|||++.....
T Consensus       301 --WdrGe~Cr~CQ---~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  301 --WDRGEVCRVCQ---NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             --ccCCCccHHHH---HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence              00000000000   00111111112222334557789999999999999999999999999999999886544

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-38  Score=286.42  Aligned_cols=250  Identities=20%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             cceeeeeeeccCCceeEEEEEe----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSIN----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ++|++.+.||+|+||+||+|..    ..++..+++|.+.... .......+.+|+.+++.++|||++++++++...    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE----   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence            5789999999999999999985    3456789999987532 233445677899999999999999999998777    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                       ...++||||++ ++|.+++...                 ..+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~  158 (283)
T cd05090          80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG  158 (283)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence             67899999998 6999988532                 2478889999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017909          168 ANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLK  244 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~  244 (364)
                      .++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999987543322  11223334567999999876 568999999999999999998 999998765444333


Q ss_pred             HHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+...                              .....+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus       238 ~~~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKR------------------------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33210                              0112234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-38  Score=282.97  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=203.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++.+.||.|++|.||+|.+..+|+.+++|.++.... .......+.+|+.++++++|++++++++.+...     ..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence            589999999999999999999999999999998864322 233456677899999999999999999999877     77


Q ss_pred             EEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          109 VYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .++||||++ ++|.+++..    ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            899999998 599988854    345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  .....+....           
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~-----------  222 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEK-----------  222 (267)
T ss_pred             cCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhc-----------
Confidence            443333344567888999999876 57899999999999999999999999654311  1111110000           


Q ss_pred             hhHHHHHhhCCCCCCCcccccC-CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLY-PQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                     ......+ ..++..+.++|.+||..+|.+|||+.+|++
T Consensus       223 ---------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         223 ---------------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                           0001111 256778999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-40  Score=303.38  Aligned_cols=253  Identities=28%  Similarity=0.404  Sum_probs=214.5

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc--hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN--RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +....||+|.|.+||+|.|..+|..||.-.++.....  .....++..|+.+|+.|+||||++++.++.+...   ....
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            4557899999999999999999999998877655443  3344788899999999999999999999988754   5688


Q ss_pred             EEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccC-CcEEEeecCccccCCCC
Q 017909          111 LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGN  186 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~-~~~~L~Dfg~~~~~~~~  186 (364)
                      +|+|.+. |+|..+..+.+.++...++.|++||+.||.|||++.  |+|||||.+||||+++ |.|||+|+|++......
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999997 899999999999999999999999999999999996  9999999999999875 79999999999876443


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT-ECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .  .....||+-|||||++..  .|+...||||||++++||+|+..||.-. +....++++.+.+.  |.          
T Consensus       200 ~--aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK--P~----------  263 (632)
T KOG0584|consen  200 H--AKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK--PA----------  263 (632)
T ss_pred             c--cceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC--HH----------
Confidence            3  334799999999999864  7999999999999999999999999655 44555565654221  11          


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       .+..--++.+++||.+||.. ..+|||+.|||.||||..-
T Consensus       264 -----------------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  264 -----------------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                             11233477899999999999 9999999999999999874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.1e-39  Score=296.30  Aligned_cols=282  Identities=19%  Similarity=0.255  Sum_probs=205.0

Q ss_pred             eeeccC--CceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRG--AYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      ..||.|  ++|+||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++...     ...++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence            456666  889999999999999999999876544444556777899999999999999999999877     7789999


Q ss_pred             cccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc
Q 017909          114 ELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM  190 (364)
Q Consensus       114 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~  190 (364)
                      ||+. +++.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++||+.+..........
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9998 5999888764  358999999999999999999999999999999999999999999999997543221111000


Q ss_pred             -------ccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          191 -------TEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       191 -------~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                             ....++..|+|||++.+. ..++.++|||||||++|+|++|..||..............   ......+....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDITT  235 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc---CCCCCCccccc
Confidence                   011234569999998753 3478999999999999999999999987765443332222   11100000000


Q ss_pred             ch-hHHHHHhh-----------C-------CCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          263 NP-KARRFIKS-----------L-------PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       263 ~~-~~~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      .+ ....+...           .       ..............+++.+.+||++||+.||.+|||+.++|+||||....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            00 00000000           0       00000001112334678899999999999999999999999999998776


Q ss_pred             CC
Q 017909          324 DP  325 (364)
Q Consensus       324 ~~  325 (364)
                      ..
T Consensus       316 ~~  317 (328)
T cd08226         316 EQ  317 (328)
T ss_pred             Hh
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-38  Score=285.00  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCc--EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc-cccce
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNE--KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR-ISFKD  108 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  108 (364)
                      |.+++.||+|+||.||+|++..++.  .+++|.++...........+..|+.+++.++|+|++++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999877765  69999987655555566778889999999999999999998754321 12245


Q ss_pred             EEEEecccc-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          109 VYLVYELMD-TDLHQIIKS------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      .++++||+. |+|.+++..      ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            789999998 688887742      2348999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ........  .....++..|++||.+.+ ..++.++|+||||+++|+|++ |..||.+.........+...         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---------  230 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG---------  230 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---------
Confidence            65332211  122234567999999877 578999999999999999998 89999876554433322110         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                           ......+.++..+.++|.+||+.||.+|||+.+|+++
T Consensus       231 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         231 ---------------------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                 0011234577889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=302.06  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=204.9

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      ...-++.||+|+.|.||+|+.+  ++.||||+++..         -..+++-|+.|+||||+.+.++|...     ..+|
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyC  188 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYC  188 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeE
Confidence            4455689999999999999655  889999988531         12478999999999999999999877     7899


Q ss_pred             EEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      ||||||. |-|.++++..+.+.......|..+|+.|+.|||.+.|+|||||.-||||+.+..|||+|||.++-..+. ..
T Consensus       189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST  267 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST  267 (904)
T ss_pred             EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hh
Confidence            9999998 899999999999999999999999999999999999999999999999999999999999998766443 44


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      ....+||..|||||++.+ .+.+.+.||||||++||||+||..||.+.+....+-    ..|.+                
T Consensus       268 kMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGsN----------------  326 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGSN----------------  326 (904)
T ss_pred             hhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE----eccCC----------------
Confidence            456789999999999999 789999999999999999999999997754322211    01110                


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                               ......+..++.-++=||++||+..|..||++.++|.|-=+
T Consensus       327 ---------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  327 ---------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ---------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence                     01234556788889999999999999999999999998544

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.2e-39  Score=284.14  Aligned_cols=252  Identities=27%  Similarity=0.486  Sum_probs=203.1

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchh---hchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF---ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +|.+.+.||+|++|+||++.+...+..+++|+.+...   ........+..|+.+++.++|||++++++.+...     .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence            6899999999999999999988777777777665322   2223344556788999999999999999998877     6


Q ss_pred             eEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          108 DVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ..++|+||++ ++|.+.+..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence            7899999998 588887753    356999999999999999999999999999999999999975 5699999998876


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..   .          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~----------  220 (260)
T cd08222         155 LMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---G----------  220 (260)
T ss_pred             cCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---C----------
Confidence            5443333344556788999999866 5678899999999999999999999976554333322211   0          


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                       ........++..+.++|.+||+.||.+||++.++++||||
T Consensus       221 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         221 -----------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -----------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                             0111234577889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-38  Score=282.05  Aligned_cols=247  Identities=21%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|+||++.+.. +..+++|.+.....   ....+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPI   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCc
Confidence            579999999999999999997653 45699998864322   234577899999999999999999998776     668


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++||||+. ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            99999997 6899988764 468999999999999999999999999999999999999999999999999887553322


Q ss_pred             cc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 QF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....              
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  219 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR--------------  219 (256)
T ss_pred             eeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC--------------
Confidence            11 112234567999999976 568999999999999999998 9999987665444443322100              


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                      .......+..+.+++.+||+.||.+||++.+|+++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         220 ----------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                            11112357789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=284.87  Aligned_cols=254  Identities=22%  Similarity=0.291  Sum_probs=202.3

Q ss_pred             eeeeeeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc-cccc
Q 017909           32 YVPIKPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR-ISFK  107 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (364)
                      |++++.||+|+||.||+|.+..+   +..+|+|.++...........+.+|+..++.++|||++++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987654   3789999998655555556678899999999999999999998876532 2224


Q ss_pred             eEEEEecccc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          108 DVYLVYELMD-TDLHQIIKSS------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      ..++++||+. ++|...+...      ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            5899999998 6888887432      36899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          181 RTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       181 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .........  ......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+....+...        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--------  231 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--------  231 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence            755332211  111233567999999866 578999999999999999998 89999876654443333210        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                            .....+..++..+.+++++||+.||++|||+.+++++
T Consensus       232 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         232 ----------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  0112234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9e-39  Score=290.01  Aligned_cols=249  Identities=26%  Similarity=0.336  Sum_probs=197.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcE--EEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++|++.+.||+|+||+||+|.++.++..  +++|.++.. ........+.+|+.++.++ +|+|++++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----   80 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----   80 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence            4899999999999999999998877764  577766532 2233445677899999999 899999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                      ...++||||++ ++|.+++...+                .+++..++.++.||+.|+.+||++|++|+||+|+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            77899999997 69999886432                47899999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  248 (364)
                      +.++|+|||++..... .........+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+....+..
T Consensus       161 ~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CcEEeCccccCcccch-hhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            9999999998853211 111111223557999998866 568899999999999999998 9999976654433322210


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                          .                          .....+..+++.+.+||.+||+.+|.+||+++++|.+
T Consensus       239 ----~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 ----G--------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ----C--------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                0                          0011123467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=301.23  Aligned_cols=284  Identities=25%  Similarity=0.414  Sum_probs=222.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +.+.|++...+|.|+|+.|-.+.+..+++..++|++.+.....      .+|..++... +|||+++..+.+.+.     
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~------~~e~~~~~~~~~h~niv~~~~v~~~~-----  388 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN------QDEIPISLLVRDHPNIVKSHDVYEDG-----  388 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccccc------ccccchhhhhcCCCcceeecceecCC-----
Confidence            5789999999999999999999999999999999997652222      2355455444 799999999999888     


Q ss_pred             ceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE-ccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV-NANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll-~~~~~~~L~Dfg~~~~~~  184 (364)
                      .+.++|||.+.| -+.+.+...+.+. .++..|+.+|+.|+.|||++|++|||++|+|||+ +..++++|+|||.++...
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            899999999985 6666666655455 8888999999999999999999999999999999 688999999999997764


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..   ....+-|..|.|||++.. ..++.++||||||++||+|++|+.||........+   ...++.+           
T Consensus       468 ~~---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i~~~-----------  529 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRIQMP-----------  529 (612)
T ss_pred             hh---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH---HHhhcCC-----------
Confidence            43   333455788999999985 78999999999999999999999999887655222   2111111           


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccchhhh
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIG  344 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  344 (364)
                                        .....+|+.+++||++||+.||.+||++.+++.||||   ...+..|+.|++.+.-+.+...
T Consensus       530 ------------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~---~~~~t~p~~q~~~s~~v~~~~~  588 (612)
T KOG0603|consen  530 ------------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF---LSHPTFPPDQLPWSDLVREALV  588 (612)
T ss_pred             ------------------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch---hcCCCCCcccCCcccchhhHHH
Confidence                              1114689999999999999999999999999999999   2223333355555555555555


Q ss_pred             HHHHHHHHHHHHHhhCCC
Q 017909          345 EQMIRQMMWNETLHYHPE  362 (364)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~  362 (364)
                      +--++...|.++..+.|-
T Consensus       589 ~t~~a~~~~~~~~~l~pv  606 (612)
T KOG0603|consen  589 ATFRALNHEESTPRLSPV  606 (612)
T ss_pred             HHHHHHhcccCCCccCCC
Confidence            555555555555555553

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-38  Score=282.10  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=200.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|++|.||+|... ++..+++|.+...   ......+.+|+.+++.++|+|++++++.+...     ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   75 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EP   75 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CC
Confidence            578999999999999999999865 4567999987643   22345677899999999999999999998776     77


Q ss_pred             EEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .+++||++. ++|.+++..  ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            899999997 699998865  35689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------  221 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-------------  221 (261)
T ss_pred             CceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211 122334567999999876 568899999999999999998 999998765444333332110             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       .......++..+.+++.+||+.+|++||+++++++
T Consensus       222 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 -----------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             01122357788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=283.52  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=202.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCC-----cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETN-----EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..++|++.+.||+|++|.||++.++..+     ..+++|.+.... .......+.+|+.+++.++|+|++++++++... 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-
Confidence            3679999999999999999999876433     789999986432 233445677899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS----------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                          ...++||||++ ++|.+++...          ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.
T Consensus        82 ----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          82 ----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             ----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence                77899999997 6999988643          23678899999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017909          172 LKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  248 (364)
                      ++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+.........+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999998865433221  1223345678999999876 568999999999999999997 9999987655444333321


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                                    ......+..++..+.++|.+||+.+|++|||+.++++
T Consensus       237 ------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 ------------------------------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ------------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                          0011223456888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=280.68  Aligned_cols=247  Identities=25%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|.||+|.+. +++.|++|.++....   ....+.+|+.++++++|||++++++++...     ..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EP   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC-----CC
Confidence            478999999999999999999865 456899999875322   344567899999999999999999998776     77


Q ss_pred             EEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++|||++. ++|.+++....  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            899999995 79999987643  699999999999999999999999999999999999999999999999999876542


Q ss_pred             CCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .... ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.........+....             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  221 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-------------  221 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2111 111222457999998877 578999999999999999998 999998776544444332110             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       ........+..+.+++.+||+.||.+||++.+|++
T Consensus       222 -----------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         222 -----------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                             01122456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=282.08  Aligned_cols=247  Identities=21%  Similarity=0.296  Sum_probs=199.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .+|++.+.||+|++|.||++.++ ++..+++|.+.....   ....+.+|+.+++.++|||++++++++...     ...
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   74 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPI   74 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----Cce
Confidence            46899999999999999999876 456899999864322   234567899999999999999999998776     678


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++|||+++ ++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            99999997 5899988754 468999999999999999999999999999999999999999999999999887553322


Q ss_pred             cc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 QF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+....               
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------  218 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---------------  218 (256)
T ss_pred             ccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            11 112223457999999887 578999999999999999998 899998765544443332110               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                     ....+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       219 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 ---------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ---------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                           011224578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-38  Score=287.73  Aligned_cols=251  Identities=27%  Similarity=0.413  Sum_probs=202.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC-----CcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET-----NEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++.+.||+|++|.||++.+...     ...+++|.+.... .......+.+|+.+++.+ +|+|++++++++... 
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence            57899999999999999999987643     3679999987542 233445677899999999 799999999999776 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKS----------------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                          ...+++|||+. |+|.+++..                .+.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        89 ----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          89 ----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             ----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence                77899999997 699998854                246889999999999999999999999999999999999


Q ss_pred             EccCCcEEEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017909          166 VNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQ  242 (364)
Q Consensus       166 l~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~  242 (364)
                      ++.++.++|+|||.+.........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999998755332211  111223467999999877 578999999999999999996 9999987655444


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ...+...                              .....+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEG------------------------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4333211                              0011224567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-38  Score=286.23  Aligned_cols=265  Identities=21%  Similarity=0.322  Sum_probs=208.9

Q ss_pred             ceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      +|++.+.||.|++|.||++++.   .+++.+++|+++....  .......+.+|+.++.++ +||+++++++.+...   
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~---   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD---   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence            4889999999999999999864   4578899999875322  122334567899999999 599999999998776   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||+. ++|.+.+...+.+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        78 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          78 --TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             --CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence              77899999997 599999887788999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCc-ccccccccccccCCccccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNEQ-FMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ..... ......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.....          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~----------  225 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL----------  225 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----------
Confidence            33221 122345688899999986632 378899999999999999999999965432221122111100          


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPYISGLYDPQC  327 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~elL~hp~f~~~~~~~~  327 (364)
                                       ......+..+++.+.++|.+||+.||++|||   +.++|+||||+.+..+..
T Consensus       226 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         226 -----------------KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             -----------------ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence                             0011233457788999999999999999998   567899999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=280.47  Aligned_cols=242  Identities=21%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             eeeccCCceeEEEEEeccCC---cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           36 KPIGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.||+|+||.||+|.....+   ..+++|.+...... .....+.+|+.+++.+.|+|++++++++..      ...++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence            47999999999999876544   78999998755333 345567789999999999999999998753      356999


Q ss_pred             ecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccc
Q 017909          113 YELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT  191 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~  191 (364)
                      |||+. ++|.+++...+.+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+...........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99997 69999998888899999999999999999999999999999999999999999999999999876543332211


Q ss_pred             c---ccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          192 E---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       192 ~---~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .   ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+...                  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~------------------  214 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG------------------  214 (257)
T ss_pred             cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC------------------
Confidence            1   122357999999876 578999999999999999997 99999776554433332210                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                  ........++..+.++|.+||..||.+||++.+|++
T Consensus       215 ------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         215 ------------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        001223457788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.4e-38  Score=287.75  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-------TNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      .++|.+++.||+|+||.||++.+..       ++..+++|.++... ......++..|+.+++.+ +|+|++++++.+..
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            5789999999999999999998643       23469999997542 334455677899999999 79999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      .     ...++||||++ ++|.+++...+                .++...+..++.|++.||.|||++|++|+||+|+|
T Consensus        96 ~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          96 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence            7     67899999998 69999997542                47889999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~  240 (364)
                      |+++.++.++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999998655322111  111223467999999877 578999999999999999997 88999766543


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      +....+...                              .....+...+..+.+||.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEG------------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcC------------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            333322110                              0112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-38  Score=285.60  Aligned_cols=257  Identities=23%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCC----------------cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETN----------------EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      .++|++++.||+|+||.||+|.+...+                ..+++|.+..... ......+.+|+.+++.++|||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence            468999999999999999999876543                4589999875422 23456677899999999999999


Q ss_pred             eeeeeeccccccccceEEEEecccc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-----------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLK  160 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~  160 (364)
                      ++++++...     ...+++||++. ++|.+++....           .+++..++.++.|++.||.+||++|++|+||+
T Consensus        83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            999999877     67899999997 69999887655           68999999999999999999999999999999


Q ss_pred             CCCeEEccCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 017909          161 PGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG--RKPIFPG  236 (364)
Q Consensus       161 ~~NIll~~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~  236 (364)
                      |+||+++.++.++|+|||.+.......  .......++..|+|||.+.+ ..++.++||||||+++|+|++  +..||..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999986543222  11223344668999999877 578999999999999999987  7788876


Q ss_pred             CChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .................                       ...........++..+.+++.+||+.||.+|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDD-----------------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccc-----------------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            65544444332211000                       000111123456789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.2e-38  Score=282.97  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=200.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++|++.+.||+|+||+||+|++..++.    .||+|+++... .......+.+|+.++..++|||++++++++...  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence            35789999999999999999999877766    48999986532 233445677899999999999999999998643  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                          ..++++++++ |+|.+.+... +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ----~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          82 ----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             ----CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence                3578999997 7999998764 569999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ........  .....++..|+|||...+ ..++.++|||||||++|+|++ |..||...........+...         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---------  227 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG---------  227 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---------
Confidence            65332221  122234567999999877 578999999999999999997 89999766543333222110         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           .....+..++..+.+++.+||+.||.+||++.+++.
T Consensus       228 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         228 ---------------------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ---------------------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 011123457788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=278.68  Aligned_cols=243  Identities=24%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||.|++|.||+|...  |..+++|.++....   ...++.+|+.+++.++|+|++++++++...     ..
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NP   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CC
Confidence            568999999999999999999765  78999999975432   456678899999999999999999998875     77


Q ss_pred             EEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++|||+++ ++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            899999998 69999997665  799999999999999999999999999999999999999999999999999876532


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ...   ....+..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+...               
T Consensus       155 ~~~---~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------  215 (256)
T cd05039         155 GQD---SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------  215 (256)
T ss_pred             ccc---cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence            221   2234567999999876 578899999999999999996 99999776544333222110               


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                     ........+++.+.++|++||..+|.+|||+.++++
T Consensus       216 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 ---------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ---------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                           001122457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-38  Score=281.15  Aligned_cols=248  Identities=23%  Similarity=0.346  Sum_probs=200.6

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...++|+++++||+|+||.||+|..+ +++.+++|.+.....   ....+.+|+.+++.++|+|++++++.+. .     
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-----   72 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-Q-----   72 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-c-----
Confidence            35789999999999999999999865 567899999874332   3346778999999999999999998863 2     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ...+++||++. ++|.+.+...  ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            45799999997 6999988653  46899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .... .......++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.........+....           
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  220 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-----------  220 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-----------
Confidence            4222 11223344567999999876 568899999999999999998 999998776555444332110           


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                         ........+..+.++|.+||+.+|++||+++++++
T Consensus       221 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         221 -------------------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                               01122456778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=302.48  Aligned_cols=251  Identities=25%  Similarity=0.439  Sum_probs=211.3

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccc
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM  116 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (364)
                      +||.|.||+||-|++..+...+|||.+.....  ....-+.+|+...++++|.|||++++.+.++     ++.-|.||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecC
Confidence            78999999999999999999999999864322  2333455799999999999999999999888     7888999999


Q ss_pred             c-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCccccCCCCCcccc
Q 017909          117 D-TDLHQIIKSS-QSL--SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQFMT  191 (364)
Q Consensus       117 ~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~~~~~~~~~  191 (364)
                      + |+|.+++... +++  ++.++..+..||++||.|||++.|+|||||-+|||++. .|.+||+|||.++....-.....
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            8 6999988764 677  88999999999999999999999999999999999964 78999999999987765566666


Q ss_pred             cccccccccCCccccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          192 EYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ...||..|||||++.. ...|+.++|||||||.+.||.||++||.........  +.+.                     
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV---------------------  791 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV---------------------  791 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh---------------------
Confidence            7789999999999975 345999999999999999999999999655332211  1110                     


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                           ......++++..++..++.||.+|+.+||.+||++.++|.+||++.-
T Consensus       792 -----GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  792 -----GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             -----cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                 11223455667788899999999999999999999999999999876

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.7e-38  Score=280.04  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|+||+|++..+ ..+++|.++....   ....+.+|+.+++.++|+|++++++.+..      ..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~   74 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP   74 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence            57899999999999999999988755 4699999875322   22456789999999999999999988643      34


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||++ ++|.+++...  ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            689999998 6999998753  4589999999999999999999999999999999999999999999999999875533


Q ss_pred             CCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .... .....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.+.........+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  220 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------  220 (262)
T ss_pred             cccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence            2221 122344567999998876 578999999999999999998 889998766544443332100             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       .......++..+.++|.+||+.||.+||++.++++
T Consensus       221 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 -----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             01112457788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.1e-38  Score=312.82  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=199.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|+++++||+|+||.||+|++..+|+.||+|++...... .....++.+|+.+++.++|||++++++++...     ..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence            6899999999999999999999999999999998754332 33455678999999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          109 VYLVYELMD-TDLHQIIKSS-----------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      .++||||++ ++|.+++...           ...+...+..++.||+.||.|||++|++||||||+||+++.++.++|+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            899999998 5999888531           2356677889999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCC------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 017909          177 FGLARTSRGNE------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE  238 (364)
Q Consensus       177 fg~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  238 (364)
                      ||++.......                  .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            99987541110                  01122468999999999877 578999999999999999999999997643


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .......  ..... +.                        . ......+++.+.+++.+||+.||++||+..+.|.
T Consensus       236 ~~ki~~~--~~i~~-P~------------------------~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        236 GRKISYR--DVILS-PI------------------------E-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhh--hhccC-hh------------------------h-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3221111  00000 00                        0 0012357888999999999999999987665554

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.2e-38  Score=294.84  Aligned_cols=251  Identities=26%  Similarity=0.358  Sum_probs=197.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC-----CcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET-----NEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||+|+||+||+|++...     +..||+|+++.. ........+.+|+.+++.+. ||||+++++++... 
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence            56788999999999999999986432     346999999653 22334456789999999996 99999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC------------------------------------------------------
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (364)
                          ...++||||+. |+|.+++...                                                      
T Consensus       114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         114 ----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             ----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence                77899999997 6998877532                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909          128 ------------------------------------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus       128 ------------------------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                                                                ..+++..+..++.||+.||.|||+.+++|+||+|+||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil  269 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence                                                      24778888999999999999999999999999999999


Q ss_pred             EccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017909          166 VNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQ  242 (364)
Q Consensus       166 l~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~  242 (364)
                      ++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            99999999999999875432221  1222345677999999877 578999999999999999996 9999976543222


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .......                             .........++..+.+++.+||+.||++||++.+|.+
T Consensus       349 ~~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         349 FYNKIKS-----------------------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHhc-----------------------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            2111110                             0001123457888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-38  Score=283.69  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..+|.+.+.||+|++|.||++.+.     .++..+++|.+....  ......+.+|+.++++++|+|++++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   79 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--   79 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--
Confidence            357999999999999999999854     344568899886432  23334567899999999999999999999876  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV  166 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll  166 (364)
                         ...++||||++ ++|.+++....                .+++..++.++.||+.||.+||++|++|+||+|+||++
T Consensus        80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 ---DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV  156 (291)
T ss_pred             ---CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence               77899999997 69999986532                38899999999999999999999999999999999999


Q ss_pred             ccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017909          167 NANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQL  243 (364)
Q Consensus       167 ~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~  243 (364)
                      +.++.++|+|||.+........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+..
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999865433221  1223445678999999877 578999999999999999998 99999776655443


Q ss_pred             HHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..+...                              ........++..+.+++.+||+.||++|||+.+|++
T Consensus       236 ~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         236 ECITQG------------------------------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHhCC------------------------------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            332110                              011122346788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-38  Score=285.13  Aligned_cols=250  Identities=19%  Similarity=0.330  Sum_probs=201.1

Q ss_pred             cceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+|++.+.||.|+||+||+|.+..     .+..+++|+++.... ......+.+|+.++..++||||+++++++...   
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE---   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence            468999999999999999998754     357899999975432 23345667899999999999999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                        ...+++++|+. ++|.+++...                ..+++..+..++.|++.||.+||++|++|+||||+||+++
T Consensus        81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF  158 (283)
T ss_pred             --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence              67899999997 6888887421                3478899999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017909          168 ANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLK  244 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~  244 (364)
                      .++.++|+|||++........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+...
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE  237 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999998765432221  1222344678999999876 568999999999999999997 888998766554444


Q ss_pred             HHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+...                              ........++..+.+|+.+||+.+|.+||++++|++.
T Consensus       238 ~i~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNR------------------------------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcC------------------------------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            43321                              0112235688889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.8e-38  Score=280.67  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++++.||+|+||.||+|+++.++.   .+++|.++.... ......+.+|+.+++.++|||++++++++...    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence            3689999999999999999999865543   699999875432 33455678899999999999999999998766    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||++ ++|.+++... +.++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          78 -KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             -CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence             77899999997 5899988764 46899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccc---ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQFM---TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .......   ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+.+..         
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---------  226 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---------  226 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC---------
Confidence            4332211   11222457999999977 578999999999999999886 999997765544433332110         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           ..+....+++.+.+++.+||+.+|.+||++.++++
T Consensus       227 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         227 ---------------------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------------------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                 01122456788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=284.16  Aligned_cols=257  Identities=23%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC--------------CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCccee
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET--------------NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~--------------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      .++|++.+.||+|+||.||++++...              ...|++|.++... .......+.+|++++++++|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            46899999999999999999987543              2358999987532 23344567889999999999999999


Q ss_pred             eeeeccccccccceEEEEecccc-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 017909           95 KDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKP  161 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~  161 (364)
                      ++++...     ...++||||+. ++|.+++....            .+++..++.++.|++.||.|||++|++|+||+|
T Consensus        83 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  157 (295)
T cd05097          83 LGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT  157 (295)
T ss_pred             EEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence            9999876     77899999998 59998885431            368889999999999999999999999999999


Q ss_pred             CCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh--CCCCCCCC
Q 017909          162 GNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG--RKPIFPGT  237 (364)
Q Consensus       162 ~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~  237 (364)
                      +||+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++  +..||...
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999999865432221  1122233567999999877 578999999999999999987  67788776


Q ss_pred             ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ........+........                       ........+.+++.+.+|+.+||+.||.+|||+++|++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQG-----------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhcc-----------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            65554443322111000                       00011123457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=269.24  Aligned_cols=259  Identities=22%  Similarity=0.370  Sum_probs=209.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++.+++..||+|..|+||+++.+.+|...|+|.+... .+.++..+++..+.++... .+|+||+++++|..+     ..
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~d  165 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TD  165 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----ch
Confidence            4567888999999999999999999999999999764 3444556777777777665 499999999999988     77


Q ss_pred             EEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++|.||.|.--+..++.+ .+++++..+-.+...+..||.||.++ |++|||+||+|||+++.|++||+|||.+....++
T Consensus       166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            899999998555555544 35799999999999999999999765 7999999999999999999999999998766443


Q ss_pred             CcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhhhccCc
Q 017909          187 EQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-LNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      . ..+...|-+.|||||.+...  ..|..++|+||||+.++||+||+.||.+.+. .+.+.++.+   ..++        
T Consensus       246 k-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP--------  313 (391)
T KOG0983|consen  246 K-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPP--------  313 (391)
T ss_pred             c-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCC--------
Confidence            2 23445667789999999753  4588999999999999999999999998643 344444433   1111        


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                       ......++++++++|+..||..|+.+||.-.++|+|||+.-..
T Consensus       314 -----------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  314 -----------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             -----------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                             0111235899999999999999999999999999999987653

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=278.96  Aligned_cols=248  Identities=26%  Similarity=0.358  Sum_probs=201.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|+||+|.+. ++..+++|.+.....   ....+.+|+.+++.++|+|++++++++...     .
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   74 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----E   74 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----C
Confidence            4689999999999999999999876 457799999875332   234577899999999999999999998776     6


Q ss_pred             eEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..++|||++. ++|.+.+...  ..++...+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            7899999997 5999998764  368999999999999999999999999999999999999999999999999886553


Q ss_pred             CCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... .......+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.........+.....           
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-----------  222 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            2211 1112223457999999876 578999999999999999998 9999987765555544422110           


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                         ...+...+..+.+++.+||+.+|.+||+++++++
T Consensus       223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         223 -------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                               1112345778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.8e-38  Score=282.06  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..+|++.++||+|+||.||++...     .++..+++|.+...  .......+.+|+++++.++|+||+++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--
Confidence            468899999999999999999743     35668999988643  334455678899999999999999999998776  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ---------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                         ...+++|||+. ++|.+++...+               .+++..+..++.|++.|+.|||++|++|+||+|+||+++
T Consensus        80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG  156 (280)
T ss_pred             ---CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence               67899999997 69999886543               488999999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017909          168 ANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLK  244 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~  244 (364)
                      .++.++|+|||++........  ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||..........
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            999999999998865432211  1122233567999999877 578999999999999999997 999997765544443


Q ss_pred             HHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .+....                              .......+++.+.++|.+||+.||.+||++++|++
T Consensus       236 ~~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         236 CITQGR------------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHcCc------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            332110                              01122457888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8e-38  Score=283.62  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (364)
                      ..++|++.+.||+|+||.||++.+     ..++..+++|+++... .......+.+|+.+++++ +|+||+++++.+...
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            467999999999999999999975     3345689999987542 233445677899999999 799999999998777


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                           ...++||||+. |+|.+++....  .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||
T Consensus       112 -----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 -----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             -----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence                 67899999997 69999987543  38999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          179 LARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       179 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      .+.........  .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||................     
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-----  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-----  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-----
Confidence            98755332211  112234677999999877 568999999999999999997 999997765433332221100     


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                              .........++.+.+++.+||+.+|++|||+.+|++
T Consensus       261 ------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ------------------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                    001112346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.1e-38  Score=279.31  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|.||+|.+. ++..+++|.+......   ...+.+|+.++++++|++++++++++..      .
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~   73 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE------E   73 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC------C
Confidence            4678999999999999999999866 4567999998753332   2456789999999999999999998743      4


Q ss_pred             eEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..+++|||++ ++|.+.+...  ..+++..++.++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            4689999997 5999988753  458999999999999999999999999999999999999999999999999987553


Q ss_pred             CCCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+....+....            
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------  220 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------  220 (260)
T ss_pred             CcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence            32211 112234567999999876 578999999999999999998 899998766554444332110            


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                                        ....+...+..+.+|+.+||+.||.+|||+.+++
T Consensus       221 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         221 ------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                              0112345678899999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6e-38  Score=281.81  Aligned_cols=266  Identities=22%  Similarity=0.308  Sum_probs=199.4

Q ss_pred             ccce-eeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKY-VPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y-~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .+|| ++.+.||+|+||+||++.    ...++..+++|.++... .......+.+|+.+++.++|||++++++++.....
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4667 999999999999998764    34577889999987542 22344566789999999999999999998765421


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...++||||+. ++|.+++.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ---~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          81 ---KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ---ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence               56899999998 589888866 4599999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .......   .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......  ..+...   ...    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~---~~~----  226 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGP---KQG----  226 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcc---ccc----
Confidence            5332211   112234556999999876 578999999999999999999999986543211  111100   000    


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .............      .........++..+.+++.+||+.||++|||+++|++
T Consensus       227 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         227 QMTVVRLIELLER------GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ccchhhhhhhhhc------CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000011111100      0111234567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-37  Score=284.20  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=199.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-------cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-------ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      .++|.+++.||+|++|.||+|++.       .....+++|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            579999999999999999999753       234569999987532 233455677899999999 69999999999977


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      .     ...+++|||+. |+|.+++...                ..+++..+..++.||+.||.|||++|++|+||+|+|
T Consensus        90 ~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          90 E-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             C-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            6     67899999997 6999998653                348889999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~  240 (364)
                      |+++.++.++|+|||.+.........  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998755322111  112223457999999877 578999999999999999998 89999776544


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      +....+...                              ........++..+.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 ELFKLLREG------------------------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            444333210                              001123456788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-37  Score=279.07  Aligned_cols=249  Identities=21%  Similarity=0.312  Sum_probs=196.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .++|++.+.||.|+||+||+|.+..++.    .+++|.+... .......++..|+..++.+.||||+++++++..    
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC----
Confidence            4689999999999999999999877766    4777777532 122233456678888999999999999998743    


Q ss_pred             ccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++++|++. |+|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 --~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          81 --ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             --CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence              34678999987 799999975 45799999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .....  .......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+.........+..    .      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~------  227 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK----G------  227 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----C------
Confidence            43222  12223445678999999877 578999999999999999997 9999987654433222211    0      


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                          ........++.++.+++.+||..||.+|||+.++++
T Consensus       228 --------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         228 --------------------ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                001112235678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-37  Score=276.05  Aligned_cols=247  Identities=27%  Similarity=0.424  Sum_probs=202.8

Q ss_pred             eeeeeeeccCCceeEEEEEeccCC----cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETN----EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +++.+.||.|+||.||++.+...+    ..+++|+++.... ......+.+|+.+++.++|+|++++++.+...     .
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence            467899999999999999988766    8899999965422 22556777899999999999999999999887     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..+++||++. ++|.+.+.....  +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            8899999997 599999876544  9999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccc-cccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQFMT-EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ....... ...++..|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+....            
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~------------  221 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY------------  221 (258)
T ss_pred             cccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence            3322111 2235678999999865 678999999999999999997 889998765544444432210            


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        ........+..+.+++.+||+.||.+|||+.++++
T Consensus       222 ------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                              01122347888999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.8e-38  Score=281.74  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=197.3

Q ss_pred             ceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +|++.+.||+|+||+||+|++..     ....+++|.+.... .......+.+|+.+++.++||||+++++.+...    
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD----   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC----
Confidence            47899999999999999998653     23568888886432 233446677899999999999999999998877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS------------------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLK  160 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~  160 (364)
                       ...++++||+. ++|.+++...                        ..+++..++.++.|++.||.+||+++++|+||+
T Consensus        76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          76 -GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             -CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence             67899999998 6998887542                        247889999999999999999999999999999


Q ss_pred             CCCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 017909          161 PGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGT  237 (364)
Q Consensus       161 ~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~  237 (364)
                      |+||+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999865432221  1122334567999999876 578999999999999999998 99999776


Q ss_pred             ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ........+...                              ........++..+.+++.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKTG------------------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhCC------------------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            544333222110                              001123457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-37  Score=277.67  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=200.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..|++.+.||+|++|.||+|.++.+++   .|++|+++... .......+..|+.+++.++|||++++++++...     
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----
Confidence            469999999999999999999887665   59999987542 333456778899999999999999999998776     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||++ ++|.+++... +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            77899999998 5898888753 568999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCcc--ccccc---ccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          185 GNEQF--MTEYV---VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       185 ~~~~~--~~~~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .....  .....   .+..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+.......+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--------  228 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--------  228 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            22211  11111   1346999999876 578999999999999999885 999998766544443332100        


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                            .......++..+.+++.+||+.+|.+||++++|++
T Consensus       229 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 ----------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ----------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  01112456788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-37  Score=276.15  Aligned_cols=243  Identities=24%  Similarity=0.386  Sum_probs=196.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ..+|++.+.||+|++|.||++...  |..+++|.++...    ....+.+|+.+++.++|++++++++++....    ..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   74 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG   74 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----Cc
Confidence            358999999999999999999665  7889999986432    2345678999999999999999999765432    56


Q ss_pred             EEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++++||++ ++|.+++...+  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            899999998 69999987643  488999999999999999999999999999999999999999999999998865432


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..   .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.+.               
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---------------  215 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------------  215 (256)
T ss_pred             cC---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---------------
Confidence            22   12233567999999876 578999999999999999996 99999765543333322110               


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                     ........+++.+.++|.+||+.||.+|||+.++++
T Consensus       216 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         216 ---------------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ---------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                           001223467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-37  Score=276.54  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|+..+.||+|++|.||+|.+..++.   .+++|.++... .......+.+|+.+++.++|+|++++.+++...    
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC----
Confidence            4588999999999999999999876654   69999886532 233455677899999999999999999999777    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||++ ++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          79 -KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             -CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence             77899999998 5898888754 56899999999999999999999999999999999999999999999999988655


Q ss_pred             CCCCccc---ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQFM---TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .......   .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---------  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---------  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---------
Confidence            3322111   11122456999999877 578999999999999999997 999997765544444332110         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           .......++..+.+++.+||+.||.+||++.+|++
T Consensus       228 ---------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         228 ---------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                 01112346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-38  Score=288.43  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=196.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||.|+||+||+|.+     ..+++.||+|.++... .......+.+|+.++..+ +|||++++++++....
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            46899999999999999999984     3457789999987532 223445677899999999 6899999999886542


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC------------------------------------------------------
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (364)
                          ...++||||++ |+|.+++...                                                      
T Consensus        85 ----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          85 ----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence                46789999998 6999888642                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc--cccc
Q 017909          128 -------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTE  192 (364)
Q Consensus       128 -------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~  192 (364)
                                   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........  ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         2367788888999999999999999999999999999999999999999999875432221  1112


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...............   .                  
T Consensus       241 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~------------------  298 (343)
T cd05103         241 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---G------------------  298 (343)
T ss_pred             CCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc---c------------------
Confidence            234567999999877 578999999999999999996 99999765432222111110   0                  


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                              .....+...++.+.+++..||+.||.+|||+.+|++|
T Consensus       299 --------~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         299 --------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    0011122356789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-38  Score=311.89  Aligned_cols=264  Identities=28%  Similarity=0.435  Sum_probs=199.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc---
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI---  104 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---  104 (364)
                      --.+|+....||+||||.||+++++-+|..||||++.... ......++++|+..|.+++|||+|+++..+.+....   
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3567899999999999999999999999999999998766 677778889999999999999999998754221000   


Q ss_pred             ------------------------------------------------c-------------------------------
Q 017909          105 ------------------------------------------------S-------------------------------  105 (364)
Q Consensus       105 ------------------------------------------------~-------------------------------  105 (364)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ------------------------c--------ceEEEEecccccc-HHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHH
Q 017909          106 ------------------------F--------KDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLHS  151 (364)
Q Consensus       106 ------------------------~--------~~~~lv~e~~~g~-L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~lH~  151 (364)
                                              .        ..+||=||||+.+ +.+++..+... .....|.++++|++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1278999999964 55555554433 478999999999999999999


Q ss_pred             CCccccCCCCCCeEEccCCcEEEeecCccccCC------------------CCCcccccccccccccCCccccccc--CC
Q 017909          152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSR------------------GNEQFMTEYVVTRWYRAPELLLCCD--NY  211 (364)
Q Consensus       152 ~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~------------------~~~~~~~~~~~~~~~~aPE~~~~~~--~~  211 (364)
                      +|++||||||.|||++.+..|||+|||++....                  ......+...||.-|.|||++.+..  .|
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999987511                  1111344567899999999998765  69


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChH
Q 017909          212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPL  291 (364)
Q Consensus       212 ~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (364)
                      +.|+|+||||++++||+.-   |.-.  -+-...+........+..                        ..++..--+.
T Consensus       796 n~KiDmYSLGIVlFEM~yP---F~Ts--MERa~iL~~LR~g~iP~~------------------------~~f~~~~~~~  846 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLYP---FGTS--MERASILTNLRKGSIPEP------------------------ADFFDPEHPE  846 (1351)
T ss_pred             cchhhhHHHHHHHHHHhcc---CCch--HHHHHHHHhcccCCCCCC------------------------cccccccchH
Confidence            9999999999999999933   4322  111111211111111100                        0111122234


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          292 ALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       292 l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      -.++|++||+.||.+||||.|||++.||..
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            558999999999999999999999999863

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-37  Score=280.39  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=199.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|++.+.||+|+||.||+|.+..     ++..+++|.+.... .......+.+|+.+++.+.|||++++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence            4689999999999999999998753     56789999987532 233445677899999999999999999998876  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ----------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLK  160 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~  160 (364)
                         ...++|+||++ ++|.+++....                      .+++..++.++.|++.||.+||+++++|+||+
T Consensus        81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~  157 (288)
T cd05050          81 ---KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA  157 (288)
T ss_pred             ---CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence               67899999998 69999886432                      37788899999999999999999999999999


Q ss_pred             CCCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 017909          161 PGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGT  237 (364)
Q Consensus       161 ~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~  237 (364)
                      |+||+++.++.++|+|||.+........  .......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999998865422211  1112233556999999876 578999999999999999996 88888766


Q ss_pred             ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ...+....+...                              ........++..+.+||.+||+.||.+|||+.||++
T Consensus       237 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDG------------------------------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcC------------------------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            544433322110                              011122456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-37  Score=275.76  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|.||+|.+..+ ..+++|.+.....   ....+.+|+.+++.++|+|++++++++..      ..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~   74 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP   74 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence            57899999999999999999987655 4689998764322   23456789999999999999999988743      44


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .+++|||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            689999998 5999998754  3489999999999999999999999999999999999999999999999999875533


Q ss_pred             CCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ... ......++..|+|||...+ ..++.++|+||||+++|+|++ |..||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------------  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            221 1122334567999998876 568999999999999999998 899998766544443332110             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       ....+...+..+.+++.+||+.||.+||++++|++
T Consensus       221 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 -----------------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             01122456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-37  Score=282.16  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=202.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEec-------cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeee
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINR-------ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVM   98 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~   98 (364)
                      ...++|++.+.||+|+||.||+|++.       .++..+++|.+... ........+.+|+.+++.+ +||||+++++.+
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            34789999999999999999999752       23457999998753 2334456678899999999 899999999999


Q ss_pred             ccccccccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 017909           99 MPTHRISFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKP  161 (364)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~  161 (364)
                      ...     ...++||||++ ++|.+++...                ..++...+..++.||+.||.|||++|++|+||+|
T Consensus        91 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          91 TQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             ecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            877     77899999997 6999998753                2477888999999999999999999999999999


Q ss_pred             CCeEEccCCcEEEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 017909          162 GNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTE  238 (364)
Q Consensus       162 ~NIll~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~  238 (364)
                      +||+++.++.++|+|||.+.........  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+..
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999998765432221  122234567999999977 578999999999999999997 788997765


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ..+....+...                              ........++..+.+||.+||+.+|.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEG------------------------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            54444333210                              0011224578889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-37  Score=286.78  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=201.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccC-------CcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeec
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRET-------NEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMM   99 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   99 (364)
                      ...+|++++.||+|+||.||+|++...       +..+++|.++.. ........+.+|+.+++++ +||||+++++.+.
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            356899999999999999999986432       236899988743 2333456778899999999 7999999999998


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPG  162 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~  162 (364)
                      ..     ...++++||++ |+|.+++....                .++...+..++.|++.||.|||++|++|+||+|+
T Consensus        89 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          89 QD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             cC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            76     67899999997 69999987532                3778889999999999999999999999999999


Q ss_pred             CeEEccCCcEEEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017909          163 NLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTEC  239 (364)
Q Consensus       163 NIll~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~  239 (364)
                      ||+++.++.++|+|||.+.........  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999998755332211  112223457999999977 578999999999999999997 8899987665


Q ss_pred             HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                      .+....+...                              ........++..+.++|.+||+.+|.+|||+.+++++-
T Consensus       243 ~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         243 EELFKLLKEG------------------------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHHHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            4444333210                              00112345678899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-37  Score=281.31  Aligned_cols=257  Identities=23%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc----------------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE----------------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      .++|++.+.||+|+||+||++.+..                ++..+++|++.... .......+.+|+.+++.++|+|++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4689999999999999999986432                34569999987532 233445677899999999999999


Q ss_pred             eeeeeeccccccccceEEEEecccc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-----------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLK  160 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~  160 (364)
                      ++++++...     ...++||||+. ++|.+++....           .+++..+..++.|++.||.+||++|++|+||+
T Consensus        83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk  157 (296)
T cd05095          83 RLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA  157 (296)
T ss_pred             eEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            999999777     67899999997 69999886532           36778899999999999999999999999999


Q ss_pred             CCCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 017909          161 PGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG--RKPIFPG  236 (364)
Q Consensus       161 ~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~  236 (364)
                      |+||+++.++.++|+|||++........  .......+..|++||.... ..++.++|+|||||++|+|++  |..||..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999999999875432221  1112233567999998876 578999999999999999997  7788876


Q ss_pred             CChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .................                       ...........+++.+.+|+.+||+.||.+||++.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFRDQ-----------------------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHhhc-----------------------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            65444433222111000                       000011223456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=291.71  Aligned_cols=271  Identities=22%  Similarity=0.347  Sum_probs=203.7

Q ss_pred             eeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           21 MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        21 ~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ..+.+....+.|.-...||+|+||.||+|..... ..||||.+.......  ..+|.+|+.++.+++|||+|+++|+|.+
T Consensus        66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             eHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            4445555668999999999999999999987644 899999886543332  4458999999999999999999999998


Q ss_pred             ccccccc-eEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCeEEccCCcEE
Q 017909          101 THRISFK-DVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSAN---ILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus       101 ~~~~~~~-~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di~~~NIll~~~~~~~  173 (364)
                      .     . ..+||+||+. |+|.+.+....  +++|.....|+.++|.||.|||...   |+|||||++|||+|++++.|
T Consensus       143 ~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  143 G-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             C-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            8     5 5899999998 89999997654  8999999999999999999999854   99999999999999999999


Q ss_pred             EeecCccccCCCCCcccccc-cccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HH
Q 017909          174 ICDFGLARTSRGNEQFMTEY-VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ--LKLII-SV  249 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~i~-~~  249 (364)
                      |+|||++............. .||.+|++||.+.. ...+.++||||||+++.||++|+.+.+.......  ..... ..
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            99999996654311112222 78999999999877 6899999999999999999999988875431111  11110 01


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCC-CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYP-QADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ....           .+..+++..-   . . ..... ..-..+..+...|++.+|.+||++.||++.
T Consensus       297 ~~~~-----------~~~eiiD~~l---~-~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  297 LEEG-----------KLREIVDPRL---K-E-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             HHCc-----------chhheeCCCc---c-C-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            1010           1111111000   0 0 00000 112236688999999999999999998643

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=282.50  Aligned_cols=276  Identities=24%  Similarity=0.366  Sum_probs=233.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      +-..+|.++.+||.|+||+|.+|..+.+.+.||||+++++.. ++.+..--+.|-.+|... +-|.+++++..|+.-   
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm---  422 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM---  422 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh---
Confidence            345689999999999999999999999999999999987633 222333334577777766 568899999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ..+|+||||++ |+|--.++.-+++.+..+..++.+|+.||-+||++||++||||.+||+++.+|.+||+|||+++..
T Consensus       423 --DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  423 --DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             --hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence              77999999998 699999999999999999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      --........+||+.|+|||.+.. ++|+.+.|+||+|++||||+.|++||++.+..+..+.|++..-            
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv------------  567 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV------------  567 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC------------
Confidence            556666778899999999999987 7899999999999999999999999999999999999877432            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCCCCC-CCCCCCCCc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDPQCN-PPAQVPLSL  337 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~~~~-~~~~~~~~~  337 (364)
                                         .++..+|.+..++.+..|...|.+|..     -.+|-.||||.-+-+...+ ..-|+|.++
T Consensus       568 -------------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP  628 (683)
T KOG0696|consen  568 -------------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP  628 (683)
T ss_pred             -------------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence                               234568889999999999999999984     4689999999877443332 334445544


Q ss_pred             cc
Q 017909          338 DI  339 (364)
Q Consensus       338 ~~  339 (364)
                      -+
T Consensus       629 k~  630 (683)
T KOG0696|consen  629 KI  630 (683)
T ss_pred             cc
Confidence            44

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.6e-37  Score=273.84  Aligned_cols=241  Identities=20%  Similarity=0.335  Sum_probs=192.5

Q ss_pred             eeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEec
Q 017909           37 PIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      .||+|+||.||+|.++  ..+..+++|++.... .......+.+|+.++++++|||++++++.+..      ...++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e   74 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME   74 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence            4899999999999765  445579999987542 23344567899999999999999999998743      45799999


Q ss_pred             ccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc--
Q 017909          115 LMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM--  190 (364)
Q Consensus       115 ~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~--  190 (364)
                      |++ ++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........  
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            997 699988875 4579999999999999999999999999999999999999999999999999987543322211  


Q ss_pred             -ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          191 -TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       191 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                       ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+....+...                   
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------------------  214 (257)
T cd05115         155 RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-------------------  214 (257)
T ss_pred             cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-------------------
Confidence             11222467999999876 568999999999999999995 99999877655444333211                   


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                 .....+..+++.+.++|.+||..||++||++.+|++
T Consensus       215 -----------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         215 -----------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       011233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-37  Score=278.04  Aligned_cols=251  Identities=18%  Similarity=0.316  Sum_probs=200.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .++|++.+.||+|+||.||+|.+..    ++..+++|.+... ........+.+|+.+++.++|+|++++++++....  
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG--   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence            5789999999999999999999876    3578999988643 33445566788999999999999999999876642  


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS--------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                        ...++++++++ ++|.+++...        ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+
T Consensus        82 --~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          82 --EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             --CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence              56789999997 6999988653        458999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017909          176 DFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       176 Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      |||++........  ......++..|+|||.+.+ ..++.++||||||+++|++++ |..||...+..+....+...   
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---  235 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---  235 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---
Confidence            9999875432211  1122334567999999877 578999999999999999998 99999876543332222110   


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                                 ........+++.+.+++.+||..||++|||+.++++
T Consensus       236 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ---------------------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ---------------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                       001112346788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-37  Score=277.45  Aligned_cols=267  Identities=22%  Similarity=0.375  Sum_probs=199.2

Q ss_pred             ccceeeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+|++.+.||+|+||+||++.    +..++..|++|.+...  .......+.+|+.+++.++|||++++++++..... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR-   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC-
Confidence            4689999999999999999997    4457889999998653  23344567789999999999999999998754422 


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++|+||++ ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          80 --RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             --CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence              46899999997 6999998764 4689999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .......   .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..++...... .    ....+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~----~~~~~~~~~~~--  229 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-F----MRMMGNDKQGQ--  229 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-h----hhhcccccccc--
Confidence            5332221   111223445999999877 57899999999999999999988776443211 1    11111110000  


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                       .....+......      .........++..+.+||.+||+.+|++|||+.+|++
T Consensus       230 -~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         230 -MIVYHLIELLKN------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             -cchHHHHHHHhc------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             000000111110      0111233567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=273.13  Aligned_cols=242  Identities=26%  Similarity=0.408  Sum_probs=195.6

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecc
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYEL  115 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (364)
                      ++||.|++|.||++.+.. ++.+++|.+...... .....+.+|+++++.++|+||+++++++...     ...++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence            478999999999999877 899999998764333 3556778899999999999999999998877     778999999


Q ss_pred             cc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccc--
Q 017909          116 MD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT--  191 (364)
Q Consensus       116 ~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~--  191 (364)
                      +. ++|.+++.. ...++...+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+...........  
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            97 589888865 35689999999999999999999999999999999999999999999999999875532211111  


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....                    
T Consensus       154 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------------------  212 (251)
T cd05041         154 LKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------------------  212 (251)
T ss_pred             cCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------------------
Confidence            1222456999999876 578999999999999999998 889997765443333321100                    


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                ....+...+..+.+++.+||..+|.+|||+.+|++
T Consensus       213 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 ----------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                      01122356788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=291.25  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=215.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCc---E-EEEEeccc-hhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNE---K-VAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~---~-~aiK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      .+++..+.++||+|+||.||+|..+..+.   . ||+|..+. .........++++|+++++.++|||||+++|+.... 
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-  233 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-  233 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-
Confidence            37888889999999999999999876533   3 89999886 336677888899999999999999999999999888 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                          ..++||||+|. |+|.++++..+ .++..+...++.+.+.||.|||+++++||||-..|+|++.++.+||+|||++
T Consensus       234 ----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  234 ----EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ----CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence                77899999998 69999999876 5999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcccc-cccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          181 RTSRGNEQFMT-EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       181 ~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .... ...... ...-...|+|||.+.. ..++.++||||||+++||+.+ |..||++....+....+....        
T Consensus       310 ~~~~-~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~--------  379 (474)
T KOG0194|consen  310 RAGS-QYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG--------  379 (474)
T ss_pred             cCCc-ceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC--------
Confidence            6553 111111 1223567999999988 489999999999999999996 888999999888877774311        


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                           .....+...+..+..++.+|+..||++||++.++.+  ++..+.
T Consensus       380 ---------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~  421 (474)
T KOG0194|consen  380 ---------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEALE  421 (474)
T ss_pred             ---------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHHH
Confidence                                 112223456778889999999999999999999873  444443

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-37  Score=275.45  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=191.0

Q ss_pred             eeeccCCceeEEEEEeccCCc--EEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceEEEE
Q 017909           36 KPIGRGAYGVVCSSINRETNE--KVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.||+|+||.||+|+++.++.  .+++|.++.. ........+.+|+.++.++ +|||++++++++...     ...++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence            368999999999999887775  4688887642 2233445677899999999 799999999999876     678999


Q ss_pred             ecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909          113 YELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      |||+. ++|.+++...+                .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99997 69999986532                47899999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          176 DFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       176 Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      |||++...... ........+..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.........+...     
T Consensus       155 dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----  227 (270)
T cd05047         155 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----  227 (270)
T ss_pred             CCCCccccchh-hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence            99987532211 11111223456999999876 578999999999999999996 99999776544433332110     


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                               .........+..+.+++.+||+.||.+|||+.+++.
T Consensus       228 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 -------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                     001122346778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.3e-37  Score=305.22  Aligned_cols=147  Identities=27%  Similarity=0.458  Sum_probs=132.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||.|+||+||+|.+..+++.||+|+++.... .......+..|+.++..++||||++++..+...     ..
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CE
Confidence            689999999999999999999999999999999975432 233345667899999999999999999988776     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      .++||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999996 6999999888889999999999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.5e-37  Score=288.56  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=199.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  102 (364)
                      .++|.+++.||+|+||.||+|+++     .+++.||+|+++.... ......+.+|+.++..+. ||||+++++++... 
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence            467889999999999999999864     3456899999975422 223446778999999997 99999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC-----------------------------------------------------
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ-----------------------------------------------------  128 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------------------------------------  128 (364)
                          ...++|+||+. |+|.+++...+                                                     
T Consensus       114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence                77899999998 69999886431                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          129 ---------------------------------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       129 ---------------------------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                                                                   .+++..+..++.||+.||.|||+.+++|+||+|+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         35667788899999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~  240 (364)
                      |+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999875432211  1122345678999999977 568999999999999999997 88999775544


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      +........  .                           .....+..++..+.+|+.+||+.+|.+||++.+|++.
T Consensus       349 ~~~~~~~~~--~---------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIKR--G---------------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHc--C---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            333222110  0                           0011234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.3e-37  Score=271.61  Aligned_cols=243  Identities=23%  Similarity=0.321  Sum_probs=196.4

Q ss_pred             eeeccCCceeEEEEEecc-CCc--EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           36 KPIGRGAYGVVCSSINRE-TNE--KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~-~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.||+|++|+||+|.+.. +++  .+++|.+...... .....+.+|+.++++++|||++++++.+..      ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence            468999999999999865 333  6899999765443 455677899999999999999999998865      457999


Q ss_pred             ecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc-
Q 017909          113 YELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ-  188 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~-  188 (364)
                      +|+++ ++|.+.+....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99997 69999987654  689999999999999999999999999999999999999999999999999876533221 


Q ss_pred             --ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          189 --FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       189 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+....               
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------------  217 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG---------------  217 (257)
T ss_pred             eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---------------
Confidence              1112345678999998876 578999999999999999998 999998776555444432200               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                    .........+..+.+++.+||+.+|++|||+.++++
T Consensus       218 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         218 --------------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             --------------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                          001112346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.5e-37  Score=273.61  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=199.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++.+.||.|++|.||+|.+...   ...+++|....... ......+.+|+.+++.++|||++++++++...    
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN----   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC----
Confidence            56799999999999999999987543   34689998865432 33445678899999999999999999988643    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ..++||||++ ++|.+++.... .+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          80 --PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             --CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence              3589999997 69999997644 5899999999999999999999999999999999999999999999999998755


Q ss_pred             CCCCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...... .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+...            
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------  224 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG------------  224 (270)
T ss_pred             ccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC------------
Confidence            333211 112233457999998866 578999999999999999985 99999877655444333210            


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        .....+..++..+.++|.+|+..+|.+|||+.++++
T Consensus       225 ------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         225 ------------------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             ------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              011223567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.3e-38  Score=301.75  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=214.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      -..+.+..+.||+|.||+||+|+..     .....||||.++.. .+.....+|.+|++.+..++|||||+++|+|.+. 
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-  561 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREG-  561 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-
Confidence            4567888999999999999999743     23356999999864 4444778899999999999999999999999998 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ----------S----LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                          ...++|||||. |+|.+++....          .    ++..+...|+.|||.|+.||-++.++|+||-..|.||.
T Consensus       562 ----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  562 ----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             ----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence                78899999998 99999996432          2    88899999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q 017909          168 ANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLK  244 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~  244 (364)
                      ++..|||+|||+++...+..  .......-..+|||||.+.. ..++.+|||||+|++|||++ .|..||.+..+.+.++
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            99999999999998653322  22223344678999999988 68999999999999999998 7899999999998888


Q ss_pred             HHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      .+.+                              +.....+.+++..+.+|+..||+.+|++||++.||=
T Consensus       717 ~i~~------------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  717 CIRA------------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHc------------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            7743                              334666788999999999999999999999999973

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.9e-37  Score=274.61  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=201.2

Q ss_pred             cceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ++|++.+.||.|+||+||+|+.+.     +.+.+++|.+.... .......+.+|+.++++++|+|++++++++...   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC---
Confidence            689999999999999999999754     34679999886432 222445677899999999999999999998776   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ---------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                        ...++||||++ ++|.+++....         .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+++
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          81 --EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             --CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence              67899999998 69999987655         6899999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017909          175 CDFGLARTSRGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       175 ~Dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      +|||++....... .......++..|+|||.+.+ ...+.++||||||+++|+|++ |..||...........+...   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~---  234 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG---  234 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC---
Confidence            9999876442221 11223344667999999876 468899999999999999997 88899765544333322110   


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                                .........++..+.+++.+||+.||.+|||+.++++.
T Consensus       235 --------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 --------------------------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------------------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                      00011224578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.8e-37  Score=269.43  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=194.0

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecc
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYEL  115 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (364)
                      +.||+|++|.||++... ++..+++|.++.... ......+.+|+.+++.++|||++++++.+...     ...++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence            46899999999999864 678999999875432 23344677899999999999999999999777     678999999


Q ss_pred             cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccc-cc
Q 017909          116 MD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM-TE  192 (364)
Q Consensus       116 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~-~~  192 (364)
                      ++ ++|.+++... ..+++..+..++.+++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            97 6998888654 458999999999999999999999999999999999999999999999999886543221111 11


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                      ..++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+...                      
T Consensus       154 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~----------------------  210 (250)
T cd05085         154 KQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG----------------------  210 (250)
T ss_pred             CCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC----------------------
Confidence            223457999999876 578999999999999999998 99999876544433332110                      


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                              ........++..+.+++.+||+.+|++||++.++++
T Consensus       211 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         211 --------YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                    001223457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5e-37  Score=271.63  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=198.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .+|++.+.||.|++|.||++.+. ++..+++|.+.....   ....+.+|+++++.++||+++++++.+...     ...
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   74 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPI   74 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----Cce
Confidence            47899999999999999999875 467899998864322   234567899999999999999999998776     678


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++|+||+. ++|.+.+... ..+++..++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99999998 5888888754 468999999999999999999999999999999999999999999999999886543221


Q ss_pred             c-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 Q-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      . ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....               
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  218 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---------------  218 (256)
T ss_pred             ccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---------------
Confidence            1 1112233567999999876 578899999999999999997 999997765444443331100               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                     ........+..+.+|+.+||+.+|++|||+.++++.
T Consensus       219 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 ---------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           001123357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-37  Score=274.96  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=200.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .++|++.+.||+|+||+||+|.++.+|.    .+++|....... ......+.+|+.++..++|||++++++.+..    
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            5789999999999999999999876664    589998865422 3345667789999999999999999998864    


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++|+||+. |+|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence              45789999997 6999988764 4699999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCccc--ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNEQFM--TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ........  ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+....+...          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------  227 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG----------  227 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC----------
Confidence            54322211  11222457999998866 578999999999999999998 99999877654443333211          


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                          .....+...+..+.+++.+||..||.+||++.++++
T Consensus       228 --------------------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         228 --------------------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                001222346778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=270.16  Aligned_cols=293  Identities=46%  Similarity=0.792  Sum_probs=246.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .+.+-.+.||.|+||+||.+++..+|+.|++|++..-..+-....++++|+++|..++|.|++..+++.+..+..-+..+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            35667789999999999999999999999999998877777788889999999999999999999999988877667789


Q ss_pred             EEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC-CCCc
Q 017909          110 YLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR-GNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~-~~~~  188 (364)
                      |+++|.+..+|..++-+...++...++.++.||+.||+|||+.||.||||||.|.|++.|-.+||+|||+++... +...
T Consensus       133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            999999999999999998999999999999999999999999999999999999999999999999999997652 3344


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .++...-|.+|.|||.+.+...|+.+.||||.|||+.||+..+..|......+.++.|.+.+|.+..+........-...
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            45555668899999999998899999999999999999999999999999999999999999999887765544332222


Q ss_pred             HHhhCC-CCCCCcccccC--CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          269 FIKSLP-YSRGTHISSLY--PQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       269 ~~~~~~-~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      .+.... .........+.  ..-.-....++.+||..||.+|.+.++.+.|+++...
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            211111 11111111111  1334457789999999999999999999999998654

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5e-37  Score=275.97  Aligned_cols=266  Identities=23%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             ceeeeeeeccCCceeEEEEEe----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSIN----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -|++++.||+|+||.||++..    ..++..|++|.++... .......+.+|+.+++.++|||++++.+++.....   
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---
Confidence            468999999999999999974    4568899999987542 23344567889999999999999999998876522   


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||++ ++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            56799999997 6999988665 468999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          185 GNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       185 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .....   .....++..|+|||.+.+ ..++.++||||||+++|+|+++..|+.....     ...+..+.....    .
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~----~  230 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQ----M  230 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccc----c
Confidence            32211   122345667999999877 5788999999999999999998776533211     001111100000    0


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                         ..........   .......+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       231 ---~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 ---TVTRLVRVLE---EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ---cHHHHHHHHH---cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               0000000000   001122345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-37  Score=272.38  Aligned_cols=228  Identities=22%  Similarity=0.332  Sum_probs=185.4

Q ss_pred             CCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecccc-cc
Q 017909           41 GAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TD  119 (364)
Q Consensus        41 g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~  119 (364)
                      |.+|.||++.++.+++.+|+|.+.....       ..++...+....|||++++++.+...     ...++||||++ |+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCC
Confidence            8899999999999999999999975421       12344444555799999999999877     78999999998 59


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccccccc
Q 017909          120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY  199 (364)
Q Consensus       120 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~  199 (364)
                      |.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......   .....++..|
T Consensus        72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y  148 (237)
T cd05576          72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY  148 (237)
T ss_pred             HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence            9999988778999999999999999999999999999999999999999999999999987554322   1223446679


Q ss_pred             cCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCC
Q 017909          200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGT  279 (364)
Q Consensus       200 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (364)
                      +|||.+.. ..++.++|+||+|+++|+|++|..|+......     +            .                  ..
T Consensus       149 ~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~------------------~~  192 (237)
T cd05576         149 CAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------N------------------TH  192 (237)
T ss_pred             cCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------c------------------cc
Confidence            99998866 56889999999999999999999887432110     0            0                  00


Q ss_pred             cccccCCCCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCc
Q 017909          280 HISSLYPQADPLALDLLQKMLVFEPSKRITV-----TEALQHPYI  319 (364)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~elL~hp~f  319 (364)
                      .....+..+++.+.++|.+||+.||.+||++     +++++||||
T Consensus       193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            0012334578889999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.8e-38  Score=285.90  Aligned_cols=290  Identities=32%  Similarity=0.513  Sum_probs=232.6

Q ss_pred             cCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-----
Q 017909           13 SRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-----   87 (364)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----   87 (364)
                      .+|++.+.+++-+   .++|++....|.|=|++|..|.+..-|..||||++.....   -...-+.|+++|+.|+     
T Consensus       418 aEGYYrv~igE~L---D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~E  491 (752)
T KOG0670|consen  418 AEGYYRVRIGELL---DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPE  491 (752)
T ss_pred             ccceEEEehhhhh---cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCch
Confidence            3577777776665   9999999999999999999999999999999999975322   2233467999999995     


Q ss_pred             -CCCcceeeeeeccccccccceEEEEeccccccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909           88 -HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus        88 -h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                       --|++.++..|...     +++|+|||.+.-+|.+++...+   .+....+..++.||..||..|-..|++|.||||+|
T Consensus       492 dk~Hclrl~r~F~hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDN  566 (752)
T KOG0670|consen  492 DKFHCLRLFRHFKHK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDN  566 (752)
T ss_pred             hhhHHHHHHHHhhhc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccc
Confidence             23789999998877     8999999999999999998754   58999999999999999999999999999999999


Q ss_pred             eEEccCC-cEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017909          164 LLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ  242 (364)
Q Consensus       164 Ill~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  242 (364)
                      ||+++.. .+||||||.+.......  .+.+.-+..|.|||.+.+ -.|....|+||.||+||||.||+..|++..+...
T Consensus       567 iLVNE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M  643 (752)
T KOG0670|consen  567 ILVNESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM  643 (752)
T ss_pred             eEeccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence            9998754 68999999997764433  344555777999999999 5899999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCchhhhhccC---ch-------------------------------hHHHHHhhCCCCCCCcccccCCCC
Q 017909          243 LKLIISVFGTQQEADLEFID---NP-------------------------------KARRFIKSLPYSRGTHISSLYPQA  288 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~---~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~  288 (364)
                      +...+..-|.++..-+....   .-                               .+...+...     .....-.+..
T Consensus       644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~-----q~~~deq~~~  718 (752)
T KOG0670|consen  644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV-----QRLPDEQPKI  718 (752)
T ss_pred             HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc-----CCCCchhHHH
Confidence            99999998887763221100   00                               000000000     0011111223


Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          289 DPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       289 ~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      -..+.+||.+||..||.+|.|..|+|.||||++
T Consensus       719 ~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  719 VQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            456889999999999999999999999999986

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.3e-37  Score=276.29  Aligned_cols=264  Identities=18%  Similarity=0.168  Sum_probs=194.2

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHH---------HHHHHHHHHHHHhcCCCCccee
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRID---------ALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      .+.++|++.+.||+|+||+||+|.+..+   +..+++|+..........         ......+...+..+.|++++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3568999999999999999999998877   667788765432211100         0112234445566789999999


Q ss_pred             eeeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909           95 KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      ++.+...... ....+++++++..++.+.+......++..++.++.|++.||.|||+++++||||||+||+++.++.++|
T Consensus        89 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCR-MYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCC-ceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            9876554321 135688999988888888777666789999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCC-------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017909          175 CDFGLARTSRGNE-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII  247 (364)
Q Consensus       175 ~Dfg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~  247 (364)
                      +|||++.......       .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...........
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999987543211       11223468899999999887 578999999999999999999999998774322221111


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..                  ++.......     ....+..+..+.++++.|+..+|.+||+.+++++
T Consensus       247 ~~------------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KC------------------DFIKRLHEG-----KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HH------------------HHHHHhhhh-----hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            00                  000000000     0012345788999999999999999999999874

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-36  Score=270.16  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|.||++.+. .+..+++|.+...   ......+.+|+.+++.++|+|++++++.+..      .
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~   73 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E   73 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence            4789999999999999999999855 4567999988643   2234567789999999999999999998764      3


Q ss_pred             eEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..+++|||++ ++|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            4689999997 6999998763  457889999999999999999999999999999999999999999999999886543


Q ss_pred             CCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.+.......+....            
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------  220 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------------  220 (260)
T ss_pred             CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC------------
Confidence            3221 1222334567999999876 578999999999999999998 999998776544443332110            


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        ........+..+.+++.+||+.+|.+||++.++++
T Consensus       221 ------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                              01122456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.2e-37  Score=272.19  Aligned_cols=238  Identities=20%  Similarity=0.280  Sum_probs=185.0

Q ss_pred             eeeccCCceeEEEEEeccC------------CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           36 KPIGRGAYGVVCSSINRET------------NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~------------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      +.||.|++|+||+|+....            ...+++|++....  ......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD--   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            4689999999999985422            2358889876532  22344567889999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc-------EEE
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-------LKI  174 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~-------~~L  174 (364)
                         ...++||||++ ++|..++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.       +++
T Consensus        77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence               66799999998 577777654 356999999999999999999999999999999999999987654       899


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      +|||.+......    ....++..|+|||.+.....++.++||||||+++|+|+ +|..||......+... ...   ..
T Consensus       154 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~---~~  225 (262)
T cd05077         154 SDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE---GQ  225 (262)
T ss_pred             CCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh---cC
Confidence            999987654222    23456778999998875567899999999999999997 6888887643222111 100   00


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                                  .......++.+.+||.+||+.||.+||++.+|+++
T Consensus       226 ----------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 ----------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                        01112345678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.9e-37  Score=270.93  Aligned_cols=240  Identities=25%  Similarity=0.390  Sum_probs=195.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++.+.||+|++|.||++.  .+++.+++|.++...    ....+.+|+.+++.++|||++++++.+..+      ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence            679999999999999999985  568889999986432    234667899999999999999999998543      36


Q ss_pred             EEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ++||||+. ++|.+++....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            89999998 69999987543  5899999999999999999999999999999999999999999999999988654322


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                         ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+....               
T Consensus       154 ---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  214 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------  214 (254)
T ss_pred             ---CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence               112233567999998876 578899999999999999997 999998766544333221100               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                     .......++..+.+++.+||+.+|.+||++.+|+.
T Consensus       215 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ---------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           01112457788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-37  Score=274.49  Aligned_cols=238  Identities=17%  Similarity=0.265  Sum_probs=187.2

Q ss_pred             eeeccCCceeEEEEEeccCCc-------EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           36 KPIGRGAYGVVCSSINRETNE-------KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~-------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      +.||+|+||+||+|.++..+.       .+++|.+...  .......+.+|+.+++.++|||++++++.+...     ..
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence            468999999999999865443       3888887542  223345667899999999999999999999876     66


Q ss_pred             EEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc--------EEEeecC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--------LKICDFG  178 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~--------~~L~Dfg  178 (364)
                      .++||||++ |+|.+++...+ .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.        ++++|||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            899999998 68999987654 5899999999999999999999999999999999999987764        6999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .+......    ....++..|+|||++.+...++.++|+||||+++|+|++| ..||..............         
T Consensus       154 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd05078         154 ISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---------  220 (258)
T ss_pred             cccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---------
Confidence            87544321    2235677899999998755689999999999999999998 466655433222111100         


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                             ....+...+..+.++|.+||+.||.+|||++++++.
T Consensus       221 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 -----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                   011223455779999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.5e-37  Score=277.09  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .++|++.+.||+|++|.||+|.+..+|.    .+++|.+.... .......+.+|+.+++.++|||++++++.+...   
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence            5688999999999999999999877775    47888886432 233344677899999999999999999998643   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ..++++++++ |+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence               3468999998 79999887654 689999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ......  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+ ...         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~---------  227 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKG---------  227 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCC---------
Confidence            533221  1222334567999999876 578999999999999999996 89999776433332222 100         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                          .....++.++..+.+++.+||..||.+||++.++++.
T Consensus       228 --------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         228 --------------------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                0011224467789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-37  Score=273.15  Aligned_cols=237  Identities=19%  Similarity=0.243  Sum_probs=185.0

Q ss_pred             eeccCCceeEEEEEeccC------------------------CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           37 PIGRGAYGVVCSSINRET------------------------NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~------------------------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      .||+|+||.||+|....+                        ...+++|++....  ......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            689999999999985322                        2358889886432  22344667889999999999999


Q ss_pred             eeeeeeccccccccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC  170 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~  170 (364)
                      ++++++...     ...++||||++ |+|..++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++..+
T Consensus        80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            999999877     77899999998 588877765 46789999999999999999999999999999999999997654


Q ss_pred             -------cEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHH
Q 017909          171 -------DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQ  242 (364)
Q Consensus       171 -------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~  242 (364)
                             .++++|||.+......    ....++..|+|||.+.+...++.++|+||||+++|+|+ +|..||.+......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                   3899999987543221    12345677999999876566899999999999999985 79999976543322


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .... ..                               ....+...++.+.++|.+||+.+|.+|||+.+||++
T Consensus       231 ~~~~-~~-------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         231 ERFY-EK-------------------------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHH-Hh-------------------------------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1111 00                               001112345678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-36  Score=270.07  Aligned_cols=244  Identities=23%  Similarity=0.387  Sum_probs=188.4

Q ss_pred             eeeccCCceeEEEEEecc---CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEE
Q 017909           36 KPIGRGAYGVVCSSINRE---TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      +.||+|+||+||+|.+..   .+..+++|.+... ........+.+|+.+++.++|||++++++++....    ...++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence            468999999999998643   3457999988532 22334556778999999999999999999876432    457899


Q ss_pred             ecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc--
Q 017909          113 YELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--  188 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--  188 (364)
                      +||+. ++|.+++... ...++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........  
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99997 6999998764 4567888889999999999999999999999999999999999999999999865432211  


Q ss_pred             --ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          189 --FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       189 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                        ......++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+.......+...                
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~----------------  218 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG----------------  218 (262)
T ss_pred             ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC----------------
Confidence              1122344667999999877 578999999999999999998 56777665443332222110                


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                    ........+++.+.+++.+||+.+|++||++.+|++
T Consensus       219 --------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         219 --------------RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             --------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                          001112345778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.3e-37  Score=271.94  Aligned_cols=250  Identities=24%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             ceeeeeeeccCCceeEEEEEecc-CCcEEEEEeccchh--------hchHHHHHHHHHHHHHHh-cCCCCcceeeeeecc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRE-TNEKVAIKKINNVF--------ENRIDALRTLRELVLLRH-IKHDNVIALKDVMMP  100 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~-~~~~~aiK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~  100 (364)
                      .|++.+.||+|++|.||++.++. +++.+++|.+....        .......++.+|+.++.. ++|||++++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999887 67889999875332        223344556778888875 699999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEE
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      .     ...++||||++ ++|.+.+..    ...+++..++.++.|++.+|.+||+ .+++|+||+|+||+++.++.++|
T Consensus        81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          81 N-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             C-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence            7     78999999997 588887642    3569999999999999999999996 68999999999999999999999


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      +|||.+....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||...........+......  
T Consensus       156 ~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  231 (269)
T cd08528         156 TDFGLAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--  231 (269)
T ss_pred             ecccceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--
Confidence            9999987654333 3345567888999999987 56899999999999999999999999776544444333221000  


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                                 ......+++.+.++|.+||+.||.+||++.|+..+
T Consensus       232 ---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 ---------------------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                       00112467889999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-36  Score=271.77  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=198.8

Q ss_pred             eeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc-cc
Q 017909           32 YVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FK  107 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~-~~  107 (364)
                      |++.+.||+|++|.||+|.++   .++..+++|.+...........++.+|+.+++.++|||++++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999865   35788999999766555556667889999999999999999999886543221 12


Q ss_pred             eEEEEecccc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          108 DVYLVYELMD-TDLHQIIKSS------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      ..+++++|+. |+|.+.+...      ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            4578899997 6888776432      24788999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          181 RTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       181 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      ........  ......++..|++||.+.+ ..++.++||||||+++|+|++ |..||.+....+....+...        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--------  231 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--------  231 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--------
Confidence            75533221  1122234567999999877 568899999999999999998 89999776544333322210        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                            ......+..+..+.+++.+||+.+|++|||+.+++..
T Consensus       232 ----------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         232 ----------------------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ----------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  0011124567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-36  Score=270.28  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=188.7

Q ss_pred             eeeccCCceeEEEEEecc--CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRE--TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|....  ....+++|.+... ........+.+|+..++.++|+||+++++.+...     ...++||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~   74 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL   74 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence            368999999999996432  3456888877643 2333445677899999999999999999999877     7789999


Q ss_pred             cccc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          114 ELMD-TDLHQIIKSSQ-----SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ||++ |+|.+++....     ..++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9998 69999987643     24678889999999999999999999999999999999999999999999876432221


Q ss_pred             c--ccccccccccccCCccccc------ccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          188 Q--FMTEYVVTRWYRAPELLLC------CDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       188 ~--~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .  ......++..|+|||++..      ...++.++|||||||++|+|++ |..||......+.............    
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----  230 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL----  230 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC----
Confidence            1  1122334567999998753      2356889999999999999998 7889987665544433322110000    


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           ........+++.+.+++..|+ .||.+|||+++|++
T Consensus       231 ---------------------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 ---------------------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---------------------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                 001123457788889999998 59999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-36  Score=273.38  Aligned_cols=267  Identities=24%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEec----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ...|++.+.||+|++|.||++...    .+++.+|+|+++..... .....+.+|+++++.++|+|++++++++..... 
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~-   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG-   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC-
Confidence            357889999999999999999864    34789999999765333 345677889999999999999999998866321 


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++||||++ ++|.+++.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          81 --RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             --CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence              57899999997 69999987654 699999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCccc---ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          183 SRGNEQFM---TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       183 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ........   ....++..|++||.+.+ ..++.++|+||||+++++|++|..||.........     ..+....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~----  228 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-----MIGIAQG----  228 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc-----ccccccc----
Confidence            64322211   12233456999999877 57889999999999999999999998654321100     0000000    


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..........+....      .......++..+.+++.+||+.+|.+|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         229 QMIVTRLLELLKEGE------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cccHHHHHHHHHcCC------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000001111111100      01122456788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-36  Score=268.75  Aligned_cols=248  Identities=21%  Similarity=0.266  Sum_probs=188.5

Q ss_pred             eeeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||.||+|...  .++..+++|.++.... ......+.+|+.+++.++|||++++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~   74 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM   74 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence            46899999999999864  3456799998875432 23345677899999999999999999998776     6789999


Q ss_pred             cccc-ccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          114 ELMD-TDLHQIIKSS-----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       114 e~~~-g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ||++ |+|.+++...     ...++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9998 6999988643     245677888999999999999999999999999999999999999999999886543222


Q ss_pred             c--ccccccccccccCCccccccc------CCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          188 Q--FMTEYVVTRWYRAPELLLCCD------NYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       188 ~--~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .  ......++..|+|||++.+..      .++.++|+||||+++|+|++ |..||......+........  ...    
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~----  228 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE--QQL----  228 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc--ccC----
Confidence            1  112334567899999986421      35789999999999999995 99999776544332221110  000    


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                         ...........++.+.+++..|+ .+|.+|||+++|+.
T Consensus       229 -------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -------------------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -------------------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                               00001122346778899999998 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=315.89  Aligned_cols=265  Identities=26%  Similarity=0.409  Sum_probs=221.8

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      +..+.-++.-+.++|.|.||.||.|.+..+|+..|+|-++...........+.+|+.+|..++|||+|+++++=...   
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--- 1306 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--- 1306 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH---
Confidence            34466788899999999999999999999999999998876545555555667899999999999999999997766   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...+|.||||. |+|.+.++..+-.++.....+..|++.|+.|||++||||+||||.||+++.+|.+|++|||.+...
T Consensus      1307 --ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1307 --EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             --HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence              77899999998 799999988888888888899999999999999999999999999999999999999999999876


Q ss_pred             CCCCc----ccccccccccccCCccccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCchh
Q 017909          184 RGNEQ----FMTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTE-CLNQLKLIISVFGTQQEA  256 (364)
Q Consensus       184 ~~~~~----~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~  256 (364)
                      .....    ......||+.|||||++.+..  ....++|||||||++.||+||+-||...+ ....+-.+..        
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-------- 1456 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-------- 1456 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--------
Confidence            55432    234568899999999998743  46789999999999999999999996653 2333332221        


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                            ...+.++..+++...+||..||..||++|.++.|||+|-|=+.-.+
T Consensus      1457 ----------------------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1457 ----------------------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             ----------------------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence                                  1223344558889999999999999999999999999998665433

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-36  Score=270.37  Aligned_cols=243  Identities=26%  Similarity=0.371  Sum_probs=192.5

Q ss_pred             eeeccCCceeEEEEEeccCC------cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           36 KPIGRGAYGVVCSSINRETN------EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +.||+|++|.||+|+++...      ..+++|.+.... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   74 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ   74 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence            36899999999999876433      679999886432 223455677899999999999999999998776     678


Q ss_pred             EEEecccc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-----cEEEee
Q 017909          110 YLVYELMD-TDLHQIIKSS-------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-----DLKICD  176 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-----~~~L~D  176 (364)
                      ++||||++ ++|.+.+...       ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999997 6999988642       3478899999999999999999999999999999999999877     899999


Q ss_pred             cCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017909          177 FGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       177 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      ||++........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----  229 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG----  229 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----
Confidence            999865432211  1112234567999999977 578999999999999999997 99999876554433322110    


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                                ........++..+.++|.+||..+|.+||+++++++
T Consensus       230 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 --------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                      011223456788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-37  Score=300.98  Aligned_cols=250  Identities=22%  Similarity=0.379  Sum_probs=212.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc-----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ....++.+.||+|.||.||.|.-.....     .|++|.+++. .+..+..+|++|..+++.++||||+++++++.+.  
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--
Confidence            5678889999999999999998654322     4999998753 5566888999999999999999999999999987  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                         ...+|++|||. |+|+.++++.       ..+++.+...++.+||.|+.||++++++||||...|.|++....+||+
T Consensus       768 ---~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 ---GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             ---CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence               77899999998 7999999865       358999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCCccccc--ccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCC
Q 017909          176 DFGLARTSRGNEQFMTE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       176 Dfg~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      |||+++...........  ..-...|||||.+.. ..++.++||||||+++||++ .|..||++.++.+.+.-....-  
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            99999854332221111  122457999999988 68999999999999999999 7899999998888776554321  


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                                  ....++.++..+.++|..||+.+|.+||++..|++
T Consensus       922 ----------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 ----------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ----------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                        23445789999999999999999999999999887

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-36  Score=266.68  Aligned_cols=235  Identities=19%  Similarity=0.273  Sum_probs=185.6

Q ss_pred             eeeccCCceeEEEEEeccCC----------cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           36 KPIGRGAYGVVCSSINRETN----------EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +.||+|+||.||+|.+..++          ..+++|.+......   ...+.+|+.+++.++|||++++++++...    
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVRD----   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEecC----
Confidence            46899999999999998766          35788877643222   56677899999999999999999988652    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-------cEEEee
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-------DLKICD  176 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-------~~~L~D  176 (364)
                        ..++||||++ |+|.+++.... .++...+..++.||+.||.|||++|++|+||+|+||+++.++       .++|+|
T Consensus        74 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          74 --ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             --CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence              3489999998 68999887765 799999999999999999999999999999999999999887       799999


Q ss_pred             cCccccCCCCCcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      ||.+.....    .....++..|+|||.+.+. ..++.++|+||||+++|+|++ |..||..............    . 
T Consensus       152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~-  222 (259)
T cd05037         152 PGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q-  222 (259)
T ss_pred             CCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C-
Confidence            999876533    1223446679999998774 368999999999999999998 5788866542222111110    0 


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                                 ..........+.++|.+||..+|.+|||+.+|++
T Consensus       223 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ---------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                       0001112267889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=263.92  Aligned_cols=260  Identities=21%  Similarity=0.381  Sum_probs=216.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH-HHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-DALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -++|.+.++||+|+|++|.+++++.+.+.||+|+++++..+.. +..=...|-.+.... +||.+|-++.+|+.+     
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-----  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-----  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----
Confidence            3589999999999999999999999999999999987644432 222223466666666 799999999999998     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..+++|.||++ |+|--.+++.++++++.++.+..+|+.||.|||++||+++|+|.+|||++..|.+||+|+|+++....
T Consensus       324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            88999999998 58877788888999999999999999999999999999999999999999999999999999998777


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCchhhh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE-------CLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .....+..+||+.|+|||.+.+ ..|+.+.|+|+||++++||+.|+.||+-..       ..+.+-.+            
T Consensus       404 ~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------------  470 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------------  470 (593)
T ss_pred             CCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------------
Confidence            7778888999999999999999 789999999999999999999999995321       11111110            


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC------CHHHHhcCCCccCCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI------TVTEALQHPYISGLYD  324 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~elL~hp~f~~~~~  324 (364)
                                .+        .....++...+-....+++.-|+.||++|.      .+.++-.|+||..+-+
T Consensus       471 ----------il--------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  471 ----------IL--------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             ----------Hh--------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence                      00        011234456677788999999999999997      5789999999987643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-35  Score=288.62  Aligned_cols=278  Identities=22%  Similarity=0.271  Sum_probs=180.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccC----CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRET----NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      -.++|++.+.||+|+||+||+|++..+    +..||+|.+.......    ....  ..++...+.++..+...+.....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~--e~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMN--ERVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHH--HHHHhhchhhHHHHHHhhhcccc
Confidence            356899999999999999999999988    8999999876421111    1111  11222223333333332221111


Q ss_pred             -cccceEEEEecccc-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 017909          104 -ISFKDVYLVYELMD-TDLHQIIKSSQS--------------------LSNDHCKYFVFQLLRGLKYLHSANILHRDLKP  161 (364)
Q Consensus       104 -~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~  161 (364)
                       ......++|++|++ ++|.+++.....                    .....+..++.||+.||.|||+++|+|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence             12267899999998 689888864321                    12345678999999999999999999999999


Q ss_pred             CCeEEcc-CCcEEEeecCccccCCCC-CcccccccccccccCCccccccc---------------------CCCChhhHH
Q 017909          162 GNLLVNA-NCDLKICDFGLARTSRGN-EQFMTEYVVTRWYRAPELLLCCD---------------------NYGTSIDVW  218 (364)
Q Consensus       162 ~NIll~~-~~~~~L~Dfg~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~  218 (364)
                      +|||++. ++.++|+|||++...... ........+++.|+|||.+....                     .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999986 578999999999754322 22234456788999999764321                     133456999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCC---CcccccCCCCChHHHHH
Q 017909          219 SVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRG---THISSLYPQADPLALDL  295 (364)
Q Consensus       219 slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l  295 (364)
                      ||||++|+|+++..++.  ........+....+..            ...|.........   ..........+....+|
T Consensus       364 SlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD------------LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             HHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc------------HHHHHHhhccccchhhhhhhhhccccchHHHHH
Confidence            99999999998765543  2222222222211111            0111110000000   00011122234557799


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          296 LQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       296 i~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      |.+||+.||.+|||+.++|+||||++....
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999999999999885443

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.9e-35  Score=263.51  Aligned_cols=248  Identities=19%  Similarity=0.252  Sum_probs=187.8

Q ss_pred             eeeccCCceeEEEEEeccC--CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRET--NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||++....+  ...+++|.++... .......+.+|+.+++.++|||++++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~   74 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVF   74 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEE
Confidence            3689999999999975433  2346677665432 233456778999999999999999999999876     6789999


Q ss_pred             cccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC-
Q 017909          114 ELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-  187 (364)
Q Consensus       114 e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~-  187 (364)
                      ||++ |+|.+++...    ...+...++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9998 6999988753    346777888999999999999999999999999999999999999999999875422211 


Q ss_pred             -cccccccccccccCCcccccc------cCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          188 -QFMTEYVVTRWYRAPELLLCC------DNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       188 -~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                       .......++..|+|||++...      ..++.++||||||+++|+|++ |..||......+....+.......      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence             112344567889999987531      235789999999999999996 577887766555444432210000      


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                         .........+++.+.++++.|| .+|.+||++++|++
T Consensus       229 -------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                               0011222457788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=279.87  Aligned_cols=274  Identities=23%  Similarity=0.401  Sum_probs=233.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+++++..||-|+||.|=++..+.....+|+|++++... ..........|-+++.....|.||+++..|.++     .+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hh
Confidence            467788899999999999997776655689999976433 455666778899999999999999999999988     89


Q ss_pred             EEEEeccc-cccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|++||-| +|.++..+..++.+++..++.++..+++|+.|||++||++||+||+|.+++.+|-+||.|||+++......
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999998 57999999999999999999999999999999999999999999999999999999999999999885554


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      . ....+||+-|.|||++.+ +....+.|.|+||+++|||++|.+||.+.+.-..+..|.+.+..               
T Consensus       575 K-TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------------  637 (732)
T KOG0614|consen  575 K-TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------------  637 (732)
T ss_pred             c-eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------------
Confidence            4 455799999999999998 68899999999999999999999999999988888887764322               


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCCCCC-CCCCCCCCccc
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDPQCN-PPAQVPLSLDI  339 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~~~~-~~~~~~~~~~~  339 (364)
                                    .+.+..++....+||+++...+|.+|..     +.+|-+|.||.++.+.-.. ...++|....+
T Consensus       638 --------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v  701 (732)
T KOG0614|consen  638 --------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV  701 (732)
T ss_pred             --------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence                          2333567778899999999999999995     8999999999988554433 33344444333

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=280.14  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=206.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc--CC--cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE--TN--EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~--~~--~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+..++.+.||.|.||.||+|.-..  .|  -.||||.-+.+.... +...|++|+.+++++.||||++++|+|.+.   
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e~---  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeecc---
Confidence            3455667899999999999998432  23  348888887654444 578899999999999999999999999765   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ..+||||.++ |.|..+++.++ .++......++.||+.||.|||+.+++||||-..|||+....-+||+|||+++.
T Consensus       464 ---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence               4699999999 99999998764 699999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCcc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGNEQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..++... .+...-..-|||||-+.- ..++.++|+|.||+++||++ .|..||.+..+.+.+..+.             
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-------------  606 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-------------  606 (974)
T ss_pred             ccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-------------
Confidence            7544322 222222456999999866 68999999999999999987 8999999887666554442             


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                                       .....+.++.+++.+..|+.+||++||.+||.+.++.
T Consensus       607 -----------------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  607 -----------------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             -----------------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                             3345677889999999999999999999999887754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.6e-35  Score=255.99  Aligned_cols=243  Identities=40%  Similarity=0.658  Sum_probs=199.0

Q ss_pred             CceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccccc-cH
Q 017909           42 AYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DL  120 (364)
Q Consensus        42 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L  120 (364)
                      ++|.||+|.+..+|+.+++|++........ ...+.+|+..++.++|++++++++.+...     ...++++|++++ +|
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence            578999999998899999999976433332 56777899999999999999999999877     788999999986 99


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccccccccccc
Q 017909          121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR  200 (364)
Q Consensus       121 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~  200 (364)
                      .+++.....++...++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  153 (244)
T smart00220       75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM  153 (244)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence            9998877669999999999999999999999999999999999999999999999999987664332 334456678899


Q ss_pred             CCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCc
Q 017909          201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTH  280 (364)
Q Consensus       201 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (364)
                      +||.+.. ...+.++|+|+||++++++++|..||..............   ....                        .
T Consensus       154 ~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~~~------------------------~  205 (244)
T smart00220      154 APEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KPKP------------------------P  205 (244)
T ss_pred             CHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---ccCC------------------------C
Confidence            9999876 5678899999999999999999999977433322222211   1000                        0


Q ss_pred             ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          281 ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                      .......++..+.+++.+||..+|.+||++.++++||||
T Consensus       206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            011111267789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=256.95  Aligned_cols=263  Identities=22%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .+..+-...||.|+||+|++..++.+|+..|+|.+..... ..+..+++.|.....+- ++||||++++++..+     +
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----G  136 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----G  136 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----C
Confidence            4456667889999999999999999999999999976544 34555666677665555 799999999999888     8


Q ss_pred             eEEEEeccccccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          108 DVYLVYELMDTDLHQIIK-----SSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      ..||.||.|.-++..+..     ....++++.+-.+.-....||.||-. ..|+|||+||+|||++..|.+||+|||.+.
T Consensus       137 dcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  137 DCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             ceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence            889999999987776653     23579999999999999999999975 479999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCCcccccccC-CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...++ ...+...|-..|+|||.+..... +..+||+||||+.|||++||..||..-++  ....+.......++.... 
T Consensus       217 qLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~-  292 (361)
T KOG1006|consen  217 QLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF-  292 (361)
T ss_pred             hHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC-
Confidence            65332 22333445566999999987555 89999999999999999999999977543  444443333222221110 


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                           ..---.++..+..+|..||..|-..||...+++++||+.-.
T Consensus       293 ---------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  293 ---------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             ---------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence                                 11112478889999999999999999999999999999654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=270.91  Aligned_cols=246  Identities=24%  Similarity=0.399  Sum_probs=209.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .+....++||.|.||.||.|.|+.-.-.||+|.++.   +.-...+|++|+.+++.++|||+|+++++|..+     ...
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPF  338 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPF  338 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCe
Confidence            456677899999999999999999888999999975   455677899999999999999999999999888     678


Q ss_pred             EEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      |||+|||. |+|++++.+..  .++.-...+++.||..|+.||..++++||||-..|.|+.++..+|++|||+++....+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999997 89999998653  4888888999999999999999999999999999999999999999999999876433


Q ss_pred             Ccc-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ... --...-..-|+|||-+.. ..++.++|+|+||++|||+. .|-.||++-+-...+.++.+...             
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR-------------  484 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR-------------  484 (1157)
T ss_pred             ceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc-------------
Confidence            321 111222456999999876 57899999999999999998 57899999988877777755321             


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                                       ...+.++++.+.+|++.||++.|.+||++.|+-
T Consensus       485 -----------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  485 -----------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             -----------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                             223468999999999999999999999998863

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=281.22  Aligned_cols=210  Identities=28%  Similarity=0.400  Sum_probs=179.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc-cccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR-ISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (364)
                      +.-|...+.||+|+||.||+++++.+|..||+|.++... ........-+|+++|++++|+|||++.++-.+... ....
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            356778899999999999999999999999999998643 44566667789999999999999999998665541 1125


Q ss_pred             eEEEEecccc-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc--CC--cEEEeecCc
Q 017909          108 DVYLVYELMD-TDLHQIIKS---SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA--NC--DLKICDFGL  179 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~--~~--~~~L~Dfg~  179 (364)
                      ...+|||||. |+|+..+.+   ...+++.++..++.++..||.|||++||+||||||.||++-.  +|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            6789999998 699999964   357999999999999999999999999999999999999843  23  589999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL  240 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  240 (364)
                      ++...++. ......||..|.+||++...+.++...|.|||||++|+++||..||......
T Consensus       171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            98885544 6778899999999999985578999999999999999999999999665444

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=279.88  Aligned_cols=269  Identities=23%  Similarity=0.386  Sum_probs=224.5

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      .+.+-.-.+-|+|.+.+|.|-+|+||+++++.+++..|+|+.......+..   +.-|.++|+.. .|||++.++++|.-
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deE---iE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEE---IELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHH---HHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344455678899999999999999999999999999999998765444433   33588888888 59999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeec
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Df  177 (364)
                      ......+.+|||||||+ |+.-|+++.  ..++.+..+..+++.++.|+.+||.+.++|+|||-.|||++.++.|||+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence            66666688999999998 699999875  457999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccCCccccccc----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCD----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |.+..........+...||+.|||||++...+    .++..+|+||||++..||.-|.+|+-+.....   .+......+
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRNP  244 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNP  244 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCCC
Confidence            99988877777788889999999999997532    36779999999999999999999997664332   222222222


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ++.                         ..-+..++..+.++|..||..|-.+||+..++|+|||++.
T Consensus       245 PPk-------------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  245 PPK-------------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             Ccc-------------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            221                         1113457788999999999999999999999999999983

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=267.15  Aligned_cols=270  Identities=23%  Similarity=0.393  Sum_probs=213.9

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-----chHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-----NRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      .+++||-++++||+|||+.||+|-+......||+|+-.....     ...-.....+|..+.+.+.||.||+++++|..+
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            379999999999999999999999999999999998653211     112223445899999999999999999999876


Q ss_pred             cccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEcc---CCcEEEe
Q 017909          102 HRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNA---NCDLKIC  175 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~---~~~~~L~  175 (364)
                      .    ...|.|+|||+| +|.-++..++.+++.+++.|+.||..||.||....  |+|-||||.|||+-.   -|.+||+
T Consensus       540 t----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 T----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             c----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence            4    557999999997 67777788899999999999999999999999875  999999999999943   4689999


Q ss_pred             ecCccccCCCCCc-------ccccccccccccCCccccc---ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017909          176 DFGLARTSRGNEQ-------FMTEYVVTRWYRAPELLLC---CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL  245 (364)
Q Consensus       176 Dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  245 (364)
                      |||+++...+...       ..+...||.+|++||.+.-   .+..+.+.||||.|+|+|+++.|+.||........+-.
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            9999987654332       2345678999999999864   24578899999999999999999999977643222111


Q ss_pred             HHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      -.-++..                         .....+.-+.++.+..+||++||++.-.+|....++..||+|-.....
T Consensus       696 eNTIlkA-------------------------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rr  750 (775)
T KOG1151|consen  696 ENTILKA-------------------------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRR  750 (775)
T ss_pred             hhchhcc-------------------------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhh
Confidence            0000000                         000112235789999999999999999999999999999999874433

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-35  Score=271.10  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=211.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccch-hhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ...|..++.||=|+||.|.++....+...||+|.+.+. ...........-|-.||.....+-||+++-.|++.     .
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----d  702 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----D  702 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----C
Confidence            45688899999999999999998888889999998654 23344555556788999999999999999999999     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC--
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR--  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~--  184 (364)
                      .+|+||+|++ |++-.+|-+-+-|.+..++.++.++..|+.+.|..|++||||||+|||||.+|.+||+|||+|..+.  
T Consensus       703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence            8999999998 6999999998999999999999999999999999999999999999999999999999999985211  


Q ss_pred             -------CC--Cc-------------------------------ccccccccccccCCcccccccCCCChhhHHHHHHHH
Q 017909          185 -------GN--EQ-------------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF  224 (364)
Q Consensus       185 -------~~--~~-------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll  224 (364)
                             ..  ..                               ..-...||+.|+|||++.. ..++...|+||.|+||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHH
Confidence                   00  00                               0012356899999999987 6899999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCC
Q 017909          225 AEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEP  304 (364)
Q Consensus       225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  304 (364)
                      |+|+.|++||-.....+...++.+.                           +..........++.++.++|+++.+ ++
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~nw---------------------------~~~l~~~~~~~ls~e~~~li~kLc~-sa  913 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVINW---------------------------RNFLHIPYQGNLSKEALDLIQKLCC-SA  913 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeeeeh---------------------------hhccccccccccCHHHHHHHHHHhc-Ch
Confidence            9999999999776544433333221                           1111122334688999999998654 78


Q ss_pred             CCCC---CHHHHhcCCCccCCC
Q 017909          305 SKRI---TVTEALQHPYISGLY  323 (364)
Q Consensus       305 ~~Rp---s~~elL~hp~f~~~~  323 (364)
                      +.|.   -++||..||||+++-
T Consensus       914 d~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  914 DSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hhhhcccchhhhhcCccccccc
Confidence            8887   577899999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-36  Score=279.71  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=215.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ....|.++||.|.||.|++|+.+..|+   .||||.++.-. ......+|+.|+.++-+++||||+.+.++....     
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----  702 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----  702 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----
Confidence            355778899999999999999987775   59999998643 445677899999999999999999999998666     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..+.||.|||+ |+|..+|..+ +.++.-+...+++.|+.|++||-+.|++||||-..|||++.+...|++|||+++...
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            78999999997 8999999765 569999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccccccc---cccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 GNEQFMTEYVV---TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~~~~~~~~~~---~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ++........|   ..+|+|||.+.. .+++.+||+||+|+++||.+ .|.-||=+..+.+.+..|.+...-+++     
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-----  856 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-----  856 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-----
Confidence            44433332222   467999999987 68999999999999999976 889999999999999988775444433     


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                               .+++..|-.|+..||++|-.+||.+.||++
T Consensus       857 -------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 -------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             -------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                     679999999999999999999999999876

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=265.57  Aligned_cols=256  Identities=23%  Similarity=0.319  Sum_probs=211.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+...++++||+|.||.|.++.... +.+||+|+++... .......+.+|+++|.+++||||+.++++|..+     ..
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----eP  609 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DP  609 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cc
Confidence            5678899999999999999997553 5899999998653 333457889999999999999999999999998     77


Q ss_pred             EEEEecccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      +++|+||++ |+|.+++.++..  +.-.....++.||+.|++||.+.+++||||.+.|+|+++++++||+|||+++...+
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence            899999998 899999988732  34555667999999999999999999999999999999999999999999985433


Q ss_pred             CC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ..  .......-...|||+|.+.. .+++.++|+|++|+.+||++  ....||....+....++....+..+.       
T Consensus       690 g~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~-------  761 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG-------  761 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC-------
Confidence            22  22223334678999999988 68999999999999999986  66789988777766666554433332       


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      .......++-++..+.++|-.||..|-.+|||+++|-.
T Consensus       762 ----------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  762 ----------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ----------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                            23345566789999999999999999999999999853

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=269.10  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=217.3

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCC---cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeec
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMM   99 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (364)
                      ....+-.++..+.++||+|+||+|++|.|...+   ..||+|+++...... ...+|++|+.++.+++|+|++++|++..
T Consensus       103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            344556778899999999999999999987543   359999998655444 6778999999999999999999999987


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      +.      ...+|||++. |+|++.+...  ..|.......++.||+.|+.||.+++++|||+-..|+++-....|||+|
T Consensus       182 ~q------p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D  255 (1039)
T KOG0199|consen  182 DQ------PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD  255 (1039)
T ss_pred             cc------hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence            53      3579999998 8999999763  4588899999999999999999999999999999999999888999999


Q ss_pred             cCccccCCCCCcccc--cc-cccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCC
Q 017909          177 FGLARTSRGNEQFMT--EY-VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       177 fg~~~~~~~~~~~~~--~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      ||+.+..........  .. .-...|+|||.+.. ..++.++|+|++|+.||||+ .|..||.+.....++++|.+    
T Consensus       256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~----  330 (1039)
T KOG0199|consen  256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA----  330 (1039)
T ss_pred             ccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc----
Confidence            999987654433321  11 22456999999988 68999999999999999999 67999999988887777632    


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                                .+....++.+++++.++++.||..+|.+|||+..|.+.-++..
T Consensus       331 --------------------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  331 --------------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             --------------------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                                      2234455789999999999999999999999999865544433

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=276.85  Aligned_cols=248  Identities=30%  Similarity=0.416  Sum_probs=191.4

Q ss_pred             eeeeeeeccCCce-eEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccceE
Q 017909           32 YVPIKPIGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        32 y~i~~~lg~g~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      |.-.+.+|.|+.| .||+|.  ..|+.||+|.+-.+     ....+.+|+..|+.- .||||+++++.-.+.     ...
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----qF~  578 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----QFL  578 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCC-----ceE
Confidence            4445678899887 679994  55889999988543     333455799999888 699999999987666     889


Q ss_pred             EEEeccccccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---C--CcEEEeecCcc
Q 017909          110 YLVYELMDTDLHQIIKSS-QS---LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---N--CDLKICDFGLA  180 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~--~~~~L~Dfg~~  180 (364)
                      ||..|.|.++|.+++... ..   ......+.++.|++.||++||+.+|+||||||.||||+.   +  ..++|+|||+|
T Consensus       579 YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  579 YIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             EEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            999999999999999874 11   222456788999999999999999999999999999976   3  47999999999


Q ss_pred             ccCCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCchh
Q 017909          181 RTSRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQEA  256 (364)
Q Consensus       181 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (364)
                      +........   .....|+.+|+|||++.. ..-+.+.|||||||++|+.++| .+||.+...++  .+|..   ...  
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~---~~~--  730 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT---GNY--  730 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc---Ccc--
Confidence            877554333   445788999999999988 4667799999999999998855 99997753221  11111   000  


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                             ....+.+.......+||.+|++.||..||+|.+||.||+|...
T Consensus       731 -----------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  731 -----------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             -----------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                                   0011111111278899999999999999999999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.4e-33  Score=263.56  Aligned_cols=275  Identities=20%  Similarity=0.268  Sum_probs=185.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEec----------------cCCcEEEEEeccchhhchH------------HHHHHHHHH
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR----------------ETNEKVAIKKINNVFENRI------------DALRTLREL   80 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~~~------------~~~~~~~e~   80 (364)
                      .++|++.++||+|+||+||+|.+.                ..+..||+|.++.......            .......|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            679999999999999999999742                3456799999864321110            011123466


Q ss_pred             HHHHhcCCCCc-----ceeeeeecccccc---ccceEEEEecccc-ccHHHHHHhC------------------------
Q 017909           81 VLLRHIKHDNV-----IALKDVMMPTHRI---SFKDVYLVYELMD-TDLHQIIKSS------------------------  127 (364)
Q Consensus        81 ~~l~~l~h~~i-----v~~~~~~~~~~~~---~~~~~~lv~e~~~-g~L~~~l~~~------------------------  127 (364)
                      .++.+++|.++     ++++++|......   .....++|+||++ ++|.+++...                        
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766543     6667776543211   1246899999998 6998887532                        


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc-cccccccccccCCcccc
Q 017909          128 QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF-MTEYVVTRWYRAPELLL  206 (364)
Q Consensus       128 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~  206 (364)
                      ..+++..++.++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++......... .....+++.|+|||.+.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            12456788899999999999999999999999999999999999999999998654322111 11223378899999986


Q ss_pred             cccC---------------------CCChhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          207 CCDN---------------------YGTSIDVWSVGCIFAEILGRKP-IFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       207 ~~~~---------------------~~~~~Di~slG~ll~~l~~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ....                     ...+.|+||+||++|+|+++.. ||.+..........               ...
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---------------~~~  448 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---------------YDN  448 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---------------ccc
Confidence            4211                     1134799999999999999875 66543211110000               000


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCC---CCCCCHHHHhcCCCccC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEP---SKRITVTEALQHPYISG  321 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~elL~hp~f~~  321 (364)
                      ....|...   .........+...++...+|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       449 ~~~~~r~~---~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        449 DLNRWRMY---KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hHHHHHhh---cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            00111100   00111122345678999999999999876   68999999999999964

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-32  Score=242.60  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=186.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +..+.++.+.||+|.||.||+|.++  |+.||+|+|...+...+.   -..|+.....++|+||+.+++.=..+. ..-.
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWf---rEtEIYqTvmLRHENILgFIaaD~~~~-gs~T  282 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWF---RETEIYQTVMLRHENILGFIAADNKDN-GSWT  282 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhh---hHHHHHHHHHhccchhhhhhhccccCC-CceE
Confidence            6889999999999999999999888  889999999754222221   123555556669999999998754443 2235


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----C---ccccCCCCCCeEEccCCcEEEeecC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-----N---ILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----~---i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      .++||.+|.+ |+|.|++.+ ..++.+....++..++.||++||..     |   |+|||||+.|||+++++..-|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            7999999998 999999988 6799999999999999999999953     3   9999999999999999999999999


Q ss_pred             ccccCCCC----CcccccccccccccCCcccccccC-----CCChhhHHHHHHHHHHHHh----------CCCCCCCC--
Q 017909          179 LARTSRGN----EQFMTEYVVTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAEILG----------RKPIFPGT--  237 (364)
Q Consensus       179 ~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~----------g~~pf~~~--  237 (364)
                      ++......    ....+...||.+|||||++...-+     .-..+||||||.++||++.          .+.||.+.  
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            98755433    223456789999999999976322     2346999999999999972          24566433  


Q ss_pred             --ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCC--ChHHHHHHHHhcccCCCCCCCHHHH
Q 017909          238 --ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA--DPLALDLLQKMLVFEPSKRITVTEA  313 (364)
Q Consensus       238 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dP~~Rps~~el  313 (364)
                        ...+.+.+++-.....+.                         ++..|...  -..+.++++.||..+|.-|.|+--+
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~-------------------------ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPN-------------------------IPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCCCHHHHhcceeecccCCC-------------------------CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence              122222222211111111                         11111111  1235589999999999999988554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=6.8e-33  Score=244.96  Aligned_cols=286  Identities=30%  Similarity=0.483  Sum_probs=215.8

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEecc---CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRE---TNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      +..+.+.|.++++||.|.|++||++.+..   ....||+|.+..    .....++..|+++|..+ .+.||+++.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            44578899999999999999999999887   778899998853    22344577899999999 58999999999988


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFG  178 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg  178 (364)
                      +     +.+.+|+||++ ..-.++..   .++..++..+++.++.||.++|.+||+|+||||+|++.+.. +.-.|.|||
T Consensus       107 n-----d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 N-----DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             C-----CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEech
Confidence            7     88999999998 47766664   47799999999999999999999999999999999999764 578999999


Q ss_pred             ccccCCC-C------------Ccc-------------------------------cccccccccccCCcccccccCCCCh
Q 017909          179 LARTSRG-N------------EQF-------------------------------MTEYVVTRWYRAPELLLCCDNYGTS  214 (364)
Q Consensus       179 ~~~~~~~-~------------~~~-------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~  214 (364)
                      ++..... .            ...                               .-...||++|.|||++...+.-+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9851100 0            000                               0012568999999999988888999


Q ss_pred             hhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchhhhhccCc-------------hhHHHHHhhC-----CC
Q 017909          215 IDVWSVGCIFAEILGRKPIF-PGTECLNQLKLIISVFGTQQEADLEFIDN-------------PKARRFIKSL-----PY  275 (364)
Q Consensus       215 ~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~-----~~  275 (364)
                      .||||.|+|+..++++..|| ...++.+.+.+++..+|...-.......+             +....-...+     ..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999998886 45566666777766666544322111111             1111111111     11


Q ss_pred             CCC-CcccccCC-CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          276 SRG-THISSLYP-QADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       276 ~~~-~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ... +.....+. ..+..+.+|+.+||..||.+|.|++++|.||||...
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            111 12222333 355589999999999999999999999999999854

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-32  Score=283.64  Aligned_cols=254  Identities=17%  Similarity=0.248  Sum_probs=184.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ...|...+.||+|+||.||+|+++.++..||+|.+.......      ..|+..+++++||||+++++++...     ..
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~l~~l~HpnIv~~~~~~~~~-----~~  757 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSE-----KG  757 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------HHHHHHHhhCCCCCcceEEEEEEcC-----CC
Confidence            456777889999999999999999999999999986432211      2357889999999999999999877     67


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH---SANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .++||||++ |+|.+++.   .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++..++. ++......
T Consensus       758 ~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            899999997 69999885   4899999999999999999999   6689999999999999998877765 55432221


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhhhccCc
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .    .....++..|+|||++.+ ..++.++|||||||++|||++|+.||+..... .............          
T Consensus       834 ~----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  898 (968)
T PLN00113        834 T----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----------  898 (968)
T ss_pred             c----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc----------
Confidence            1    112356789999999877 57899999999999999999999998543211 1111111100000          


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .....+.+..    ..............+.+++.+||+.||++|||+.||++.
T Consensus       899 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        899 CHLDMWIDPS----IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cchhheeCcc----ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000000000    000000111122357789999999999999999999865

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=9.7e-33  Score=251.83  Aligned_cols=201  Identities=29%  Similarity=0.440  Sum_probs=176.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHH------HHHHHHHHHHHHhcC---CCCcceeeeeec
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRID------ALRTLRELVLLRHIK---HDNVIALKDVMM   99 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~---h~~iv~~~~~~~   99 (364)
                      -..|+..+.+|.|+||+|++|+++.+...|++|.+.++..-.-.      .-..-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            34699999999999999999999999999999999765322111      112236999999996   999999999999


Q ss_pred             cccccccceEEEEecccc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeec
Q 017909          100 PTHRISFKDVYLVYELMD-T-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Df  177 (364)
                      ++     .++||+||--+ | +|.+++.....+++.+++.++.|++.|+++||++||+|||||-+||+++.+|-+||+||
T Consensus       640 dd-----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  640 DD-----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             cC-----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            99     89999999987 6 89999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG  236 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  236 (364)
                      |.+....+..  .....||..|.|||++.+.++.+...|||+||+++|.++....||.+
T Consensus       715 gsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  715 GSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9987764433  34567899999999999988889999999999999999999888864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.4e-31  Score=258.72  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=203.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-------TNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      .++..+.+.||+|.||+|++|....       ....||+|.++..... .+...+..|+++++.+ .|+|++.+++++..
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            4455778899999999999998431       1456999999876555 6777888999999999 69999999999988


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      .     +.+++|.||+. |+|.+++...+                .++..+...++.||+.|+.||++.+++|||+-..|
T Consensus       374 ~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  374 D-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             C-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            5     78999999998 89999998655                38899999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCccc-cccc--ccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCC-
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQFM-TEYV--VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTE-  238 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~~~-~~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~-  238 (364)
                      ||++.+..+|++|||+++......... ....  -...|+|||.+.. ..++.++||||+|+++||++ .|..||++.. 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999998654333222 2122  2345999999988 78999999999999999998 6789998854 


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      ..+....+.                              .......+..+++++.++++.||+.+|++||++.++.
T Consensus       528 ~~~l~~~l~------------------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  528 TEELLEFLK------------------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HHHHHHHHh------------------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            333332221                              1122334467899999999999999999999999987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-33  Score=258.03  Aligned_cols=262  Identities=24%  Similarity=0.372  Sum_probs=220.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|+++..+|+|.||.||+++++.+++..|+|+++.+....  ..-..+|+-+++..+||||+.+++.+...     .
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~-----d   85 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----D   85 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhh-----c
Confidence            4689999999999999999999999999999999998754443  33445799999999999999999999888     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++|.||||+ |+|.+...-.+++++..+..++++.+.+++|||+.|-+|||||-.||+++..|.++|+|||.+......
T Consensus        86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            8899999998 699999888899999999999999999999999999999999999999999999999999998766555


Q ss_pred             CcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      -.......|++.|+|||+..-  ...|...+|+|++|+...|+.--++|.-.......+..+.+-...++.         
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~---------  236 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT---------  236 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc---------
Confidence            555567789999999999642  246899999999999999999888886555544444444332111111         


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       .......++.+-+|++.+|..+|++||+++.+|.|||.+.-
T Consensus       237 -----------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  237 -----------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             -----------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                             11224578889999999999999999999999999999765

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=213.81  Aligned_cols=205  Identities=27%  Similarity=0.432  Sum_probs=172.5

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      .-.+....+..||+|++|.|=+.++..+|...|+|.+..... .....+.+.|+++..+. .+|++|.+++.+...    
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re----  117 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE----  117 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc----
Confidence            345566777899999999999999999999999999976433 44556677888887776 799999999998888    


Q ss_pred             cceEEEEeccccccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          106 FKDVYLVYELMDTDLHQII----KSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                       +.++|.||.+.-+|..+.    ..++.+++..+-.++..+..||.|||++ .++|||+||+|||++.+|++|++|||.+
T Consensus       118 -gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  118 -GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             -ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence             889999999998887654    4567899999999999999999999987 6999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccCCccccc---ccCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLC---CDNYGTSIDVWSVGCIFAEILGRKPIFPGTE  238 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  238 (364)
                      ....++- .-+...|-..|+|||.+..   ...|+.++||||||+.+.||.+++.||+...
T Consensus       197 G~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  197 GYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            7664332 2222445567999999864   2368999999999999999999999997653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.9e-30  Score=220.35  Aligned_cols=212  Identities=37%  Similarity=0.622  Sum_probs=183.9

Q ss_pred             eccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecccc
Q 017909           38 IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD  117 (364)
Q Consensus        38 lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~  117 (364)
                      ||+|++|.||++....+++.+++|++....... ....+.+|+..++.++|++++++++++...     ...++++|+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence            689999999999998889999999997643332 345677899999999999999999999877     78899999999


Q ss_pred             -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCccccCCCCCccccccc
Q 017909          118 -TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQFMTEYV  194 (364)
Q Consensus       118 -g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~~~~~~~~~~~~  194 (364)
                       ++|.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+..............
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence             6999998775 57999999999999999999999999999999999999999 89999999999876644332233445


Q ss_pred             ccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCC
Q 017909          195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLP  274 (364)
Q Consensus       195 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (364)
                      +...|++||.+......+.++|+|+||++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            677899999987743788999999999999999                                               


Q ss_pred             CCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          275 YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                                     ..+.+++.+|++.||.+||++.++++|+
T Consensus       188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                           1366999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=251.10  Aligned_cols=247  Identities=25%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..+-.++||+|+||+||+|.+-..|+    +|++|++... .......+++.|+-++.++.|||++++++++....    
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch----
Confidence            44556899999999999999876665    5888887643 44555677889999999999999999999998662    


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                        +.||++|++ |+|.|+++.+ ..+-......|+.||++|+.|||.++++||||-..|||++.-..+|+.|||++....
T Consensus       772 --~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  772 --LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             --HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence              689999998 8999999875 469999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCcccccccc--cccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          185 GNEQFMTEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       185 ~~~~~~~~~~~--~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ..........|  .+-|+|-|.+.. ..++.++||||+|+.+||++ .|..|+.+....+.-..+..             
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------------  915 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------------  915 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------------
Confidence            55444443333  455888888877 68999999999999999998 78999998876665554432             


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       ......++.++.++.-++-+||..|++.||+++++..
T Consensus       916 -----------------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  916 -----------------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -----------------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                             1224456789999999999999999999999988653

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=234.82  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=185.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHh--cCCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH--IKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ....++.+++|+|+||.||+|..  +++.||||+|...     +...+.+|-++.+.  ++|+||++++++-...... .
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-R  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-c
Confidence            45677889999999999999954  5799999999643     44455555555554  4899999999986554322 3


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCeEEccCCcEEEee
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA---------NILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      ..++||++|.+ |+|.+++.. ..+++.+...++..|+.||+|||+-         .|+|||||+.|||+..|+...|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            57899999997 899999987 4599999999999999999999973         399999999999999999999999


Q ss_pred             cCccccCCCCC--cccccccccccccCCcccccccCCC-----ChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017909          177 FGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYG-----TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       177 fg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  249 (364)
                      ||++.......  ...-.-.||.+|||||++.+.-++.     .+.||||+|.++|||++....+...... .++.-.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp-~Yqlpf--  436 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP-EYQLPF--  436 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC-cccCch--
Confidence            99997654321  1222367899999999998754444     4689999999999999776544211000 000000  


Q ss_pred             hCCCchhhhhccCchhHHHHHh-hCCCCCCCcccccCC--CCChHHHHHHHHhcccCCCCCCCHH
Q 017909          250 FGTQQEADLEFIDNPKARRFIK-SLPYSRGTHISSLYP--QADPLALDLLQKMLVFEPSKRITVT  311 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~  311 (364)
                             ..+-...+.+++... .+.......+...|.  ..-..+.+.+..||+.||+-|.|+.
T Consensus       437 -------e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  437 -------EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             -------hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                   000001111111110 111111111122121  2334578999999999999999984

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=215.83  Aligned_cols=260  Identities=22%  Similarity=0.343  Sum_probs=194.0

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (364)
                      ...+.+.|.|.+.||+|.||.+.++.++.+.+.+++|.+..+..   ...+|.+|..----| .|.||+.-++.-.+.. 
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-   94 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-   94 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcC-
Confidence            36689999999999999999999999999999999999976433   445666777665555 5889998877644432 


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc--CCcEEEeecCcc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLA  180 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~--~~~~~L~Dfg~~  180 (364)
                         +.+++++||++ |+|.+-+.. ..+-+...+.++.|+++|+.|||+++++|||||.+|||+-.  .-++||+|||..
T Consensus        95 ---d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   95 ---DAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             ---ceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence               67889999999 899887766 45889999999999999999999999999999999999943  337999999998


Q ss_pred             ccCCCCCcccccccccccccCCcccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCch
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQE  255 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~  255 (364)
                      ...+..-...   -....|.+||+...-    -...+.+|+|.||+++|.+++|++||+..... ..+.+.+...+.   
T Consensus       171 ~k~g~tV~~~---~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r---  244 (378)
T KOG1345|consen  171 RKVGTTVKYL---EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR---  244 (378)
T ss_pred             cccCceehhh---hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc---
Confidence            6553322211   124558899887532    23678899999999999999999999744211 111112111111   


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCc
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR---ITVTEALQHPYI  319 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~elL~hp~f  319 (364)
                                          .. ...+.....+++.+..+.++-|..++++|   .++......-|.
T Consensus       245 --------------------k~-~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  245 --------------------KN-PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             --------------------cC-ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence                                11 12334445688899999999999999999   555555444554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.5e-28  Score=212.55  Aligned_cols=199  Identities=35%  Similarity=0.603  Sum_probs=172.2

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      |++++.||.|++|+||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+...     ...++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence            67889999999999999999988999999999764333 2455677899999999999999999998776     67899


Q ss_pred             Eeccccc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC-c
Q 017909          112 VYELMDT-DLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-Q  188 (364)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~-~  188 (364)
                      ++|++++ +|.+++..... +++..++.++.+++.++.+||+++++|+||+++||+++.++.++|+|||.+....... .
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999986 99999988766 8999999999999999999999999999999999999999999999999887664432 1


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG  236 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  236 (364)
                      ......++..|++||.+.....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            223445677899999984435678899999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=214.43  Aligned_cols=254  Identities=16%  Similarity=0.240  Sum_probs=203.6

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCC-----cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETN-----EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ..-.+|++..-++-+|.||.||.|+++...     +.+.+|.++. ..+......+++|--.+..+.|||+.++.+++.+
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            334678899999999999999999876433     3466666653 3566677788899999999999999999999887


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKS--------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                      +.    ...+.++++.+ |+|..++.-        .+.++..+...++.|++.|+.|||++|++|.||-..|-++++..+
T Consensus       359 ~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  359 DY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             cc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence            64    66789999999 899999872        135778888889999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHH
Q 017909          172 LKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~  248 (364)
                      +||+|=.+++......  ...........||+||.+.+ ..++.++|+||||+++|||+ .|+.||..-+..+...-+.+
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            9999998887653322  11222233557999999988 68999999999999999998 67899877665555443332


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .                              .....+-++++++..++..||..+|++||+++|+..
T Consensus       514 G------------------------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  514 G------------------------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             c------------------------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            1                              112233578999999999999999999999999863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4.2e-29  Score=253.75  Aligned_cols=202  Identities=17%  Similarity=0.171  Sum_probs=142.6

Q ss_pred             CCcceeeeeeccccccc--cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909           89 DNVIALKDVMMPTHRIS--FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus        89 ~~iv~~~~~~~~~~~~~--~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                      +||..+++.|.......  ....++++|+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL  112 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV  112 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence            46666666663322111  145788899999999999975 356999999999999999999999999999999999999


Q ss_pred             EccCCcEEEe-------------------ecCccccCCCCC----------------cccccccccccccCCcccccccC
Q 017909          166 VNANCDLKIC-------------------DFGLARTSRGNE----------------QFMTEYVVTRWYRAPELLLCCDN  210 (364)
Q Consensus       166 l~~~~~~~L~-------------------Dfg~~~~~~~~~----------------~~~~~~~~~~~~~aPE~~~~~~~  210 (364)
                      ++..+.++++                   |||++.......                .......|++.|+|||++.+ ..
T Consensus       113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~  191 (793)
T PLN00181        113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-SS  191 (793)
T ss_pred             EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-CC
Confidence            9765555554                   555443210000                00011346788999999887 57


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCCh
Q 017909          211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP  290 (364)
Q Consensus       211 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (364)
                      ++.++|||||||++|||++|.+|+....  .....+....  .+                            .......+
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~----------------------------~~~~~~~~  239 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LP----------------------------PQILLNWP  239 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cC----------------------------hhhhhcCH
Confidence            8999999999999999999988865321  1111111100  00                            00011234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          291 LALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       291 ~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ...+++.+||+.||.+||++.|||+||||.+..
T Consensus       240 ~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        240 KEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             HHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            566899999999999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.6e-27  Score=198.80  Aligned_cols=165  Identities=21%  Similarity=0.290  Sum_probs=126.8

Q ss_pred             ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccccccc
Q 017909          118 TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT  196 (364)
Q Consensus       118 g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~  196 (364)
                      |+|.+++.. .+++++..++.++.|++.||.|||+++      ||+||+++.++.+++  ||.+.......     ..|+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            688999986 456999999999999999999999999      999999999999999  99887653322     2578


Q ss_pred             ccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCC
Q 017909          197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPY  275 (364)
Q Consensus       197 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (364)
                      ..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...........                  
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------  128 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------------  128 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------------
Confidence            99999999987 57899999999999999999999999765432 22222221111100000                  


Q ss_pred             CCCCcccccCCCCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          276 SRGTHISSLYPQAD--PLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       276 ~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                            ......++  ..+.++|.+||+.||.+||++.++++|+|+.
T Consensus       129 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 ------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                  00001122  2689999999999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.8e-28  Score=234.62  Aligned_cols=282  Identities=27%  Similarity=0.317  Sum_probs=212.1

Q ss_pred             Eeeceeeecccce-eeeeeeccCCceeEEEEEeccCCcEEEEEecc----chhhchHHHHHHHHHHHHHHhcCCCCccee
Q 017909           20 TMWQTLFEIDTKY-VPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        20 ~~~~~~~~~~~~y-~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      ++......+.+.| .....+|.|++|.|+.+......+.+..|.+.    ...........+..|+-+-..+.|+|++..
T Consensus       307 ~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~  386 (601)
T KOG0590|consen  307 TIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIET  386 (601)
T ss_pred             ccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhh
Confidence            3333333344555 56778999999988888877777666666554    211222222225678888888999999888


Q ss_pred             eeeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909           95 KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      +..+...     ....-+||||+++|..++.+.+.+...++..++.|++.|++|+|+.|+.|+|+|++|+++..+|.+++
T Consensus       387 l~~~~~~-----~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki  461 (601)
T KOG0590|consen  387 LDIVQEI-----DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKI  461 (601)
T ss_pred             HHHHhhc-----ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEE
Confidence            8887766     33333499999999999988888999999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCC----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017909          175 CDFGLARTSRGNE----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF  250 (364)
Q Consensus       175 ~Dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (364)
                      +|||.+.......    .......|+..|+|||++.+........||||.|+++..|.+|+.||......+....     
T Consensus       462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----  536 (601)
T KOG0590|consen  462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----  536 (601)
T ss_pred             eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----
Confidence            9999887554332    3456678899999999999866667789999999999999999999976543322210     


Q ss_pred             CCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                         ....              ............+...++...+.+|.+||++||.+|.|+++|++.+||+...++.-.
T Consensus       537 ---~~~~--------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~  597 (601)
T KOG0590|consen  537 ---TNNY--------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD  597 (601)
T ss_pred             ---hhcc--------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence               0000              000011111223334567788899999999999999999999999999998777654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=230.06  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=187.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +...|..++.||++.|=+|.+|++.  ...|++|+|-+...  .-....+.+.+++ ....++||.+++......+    
T Consensus        21 ~~~e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~----   93 (1431)
T KOG1240|consen   21 LSVECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD----   93 (1431)
T ss_pred             CccceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh----
Confidence            3447889999999999999999765  34599999965432  2233344445555 5566999999998886666    


Q ss_pred             cceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC--
Q 017909          106 FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS--  183 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~--  183 (364)
                       ...|+|-+|...+|.|.+..+.-+..-+.+.++.||+.||..+|..||||||||.+|||++.-..+.|+||..-+..  
T Consensus        94 -kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen   94 -KAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             -HHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence             67799999999999999999888999999999999999999999999999999999999999989999999876422  


Q ss_pred             CCCC-----cccccccccccccCCccccccc----------CCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHH
Q 017909          184 RGNE-----QFMTEYVVTRWYRAPELLLCCD----------NYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLII  247 (364)
Q Consensus       184 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~----------~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~  247 (364)
                      +.+.     .+........+|+|||.+....          ..++++||||+||+++||+ -|.++|.-.    ++-.. 
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aY-  247 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAY-  247 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhH-
Confidence            1111     1122233356899999986521          1678999999999999997 669998422    11111 


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                       ..+. ..         ..+..+              ..-.+..++.+|..|++.||.+|.++++.|+.
T Consensus       248 -r~~~-~~---------~~e~~L--------------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  248 -RSGN-AD---------DPEQLL--------------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -hccC-cc---------CHHHHH--------------HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             0010 00         000000              01123468899999999999999999999987

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.4e-25  Score=188.28  Aligned_cols=236  Identities=20%  Similarity=0.263  Sum_probs=187.4

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      ....-.|+++++||.|+||++++|....+++.||||.-...    .+.-++..|....+.| ..++|+.++-+.++.   
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG---   96 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG---   96 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeecccc---
Confidence            45677899999999999999999999999999999975432    2233444566777766 578999888776666   


Q ss_pred             ccceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-----cEEEeecC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-----DLKICDFG  178 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-----~~~L~Dfg  178 (364)
                        -+-.+|+|.++.+|.|++.- .++|+..++..++.||+.-+.++|++.+++|||||+|+||..-+     .+.++|||
T Consensus        97 --~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen   97 --KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             --chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence              67789999999999999974 56799999999999999999999999999999999999996533     59999999


Q ss_pred             ccccCCCCC-------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          179 LARTSRGNE-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       179 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      +++...+..       ..-....||..||+-..+.+ ..-+.+.|+-|||-++++.+.|..||.+......-.+..++-.
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence            998654432       22345678999999999998 5789999999999999999999999999877766666655544


Q ss_pred             CCchhhhhccCchhHHHHHh
Q 017909          252 TQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~  271 (364)
                      .....+..........+|..
T Consensus       254 ~Kr~T~i~~Lc~g~P~efa~  273 (449)
T KOG1165|consen  254 TKRSTPIEVLCEGFPEEFAT  273 (449)
T ss_pred             ccccCCHHHHHhcCHHHHHH
Confidence            44444444433333334433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1e-24  Score=179.93  Aligned_cols=233  Identities=21%  Similarity=0.286  Sum_probs=184.6

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  105 (364)
                      ...+.|+++++||+|+||.+|+|..-.+|+.||||+-.......    ++.-|..+.+.++ ...|+.+..+..+.    
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~----   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEK----   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccc----
Confidence            36789999999999999999999999999999999875433332    3445777777775 46777777777666    


Q ss_pred             cceEEEEeccccccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC---CcEEEeecCccc
Q 017909          106 FKDVYLVYELMDTDLHQIIK-SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~---~~~~L~Dfg~~~  181 (364)
                       .+-.+||+.++.+|.+++. .++.++..++..++-|++.-+.|+|.++++|+||||+|+|..-+   .++.|+|||+++
T Consensus        84 -~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   84 -DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             -ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence             6779999999999999987 45789999999999999999999999999999999999998543   369999999998


Q ss_pred             cCCCCC-------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          182 TSRGNE-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       182 ~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      ...+..       .......||..|.+-..+.+ ..-+.+.|+-|+|.++..+..|..||++.......++...+.....
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            654322       22345677888988877766 4568899999999999999999999999987777777666655554


Q ss_pred             hhhhhccCchhHHHH
Q 017909          255 EADLEFIDNPKARRF  269 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~  269 (364)
                      ....+........+|
T Consensus       242 s~~ie~LC~G~P~EF  256 (341)
T KOG1163|consen  242 STPIEVLCKGFPAEF  256 (341)
T ss_pred             CCCHHHHhCCCcHHH
Confidence            444443333333333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-23  Score=190.34  Aligned_cols=252  Identities=19%  Similarity=0.191  Sum_probs=187.6

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCC-cEEEEEeccchhhchHHHHHHHHHHHHHHhcC----CCCcceeeeeec-ccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETN-EKVAIKKINNVFENRIDALRTLRELVLLRHIK----HDNVIALKDVMM-PTHRI  104 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~~-~~~~~  104 (364)
                      +|++.+.||+|+||.||.+.+..++ ..+|+|+-.........  .+..|..++..+.    .+++..++.... ..   
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~---   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE---   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC---
Confidence            8999999999999999999988764 67888887653222211  3345777777775    368889888884 44   


Q ss_pred             ccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-----CcEEEeec
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-----CDLKICDF  177 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-----~~~~L~Df  177 (364)
                        ...++||+.++.+|.++....  +.++..++..++.|++.+|.+||+.|++||||||.|+++...     ..+.|.||
T Consensus        94 --~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   94 --DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             --ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence              678999999999999988544  579999999999999999999999999999999999999765     36999999


Q ss_pred             Cccc--cCC-CCCc------c-cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017909          178 GLAR--TSR-GNEQ------F-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII  247 (364)
Q Consensus       178 g~~~--~~~-~~~~------~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~  247 (364)
                      |+++  ... ....      . .....||..|.++..+.+ ...+++.|+||++.++.++..|..||.+........++.
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9997  321 1110      1 123458999999999988 689999999999999999999999997766443333332


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ..........                          .....+..+.++...+-..+...+|.-..+...
T Consensus       251 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLLTDR--------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhcccc--------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2111100000                          122344556666666666788888876665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=4.5e-22  Score=181.30  Aligned_cols=263  Identities=32%  Similarity=0.504  Sum_probs=206.5

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH-HHHHHHHHHHHHHhcCCC-CcceeeeeeccccccccceE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-DALRTLRELVLLRHIKHD-NVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  109 (364)
                      |++...||.|+|+.||++.+.   ..+++|.+........ ....+.+|+..+..+.|+ +++++...+...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            789999999999999999887   7899999987655553 566778899999999988 799999999554     557


Q ss_pred             EEEecccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCC
Q 017909          110 YLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSR  184 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~  184 (364)
                      +++++++. +++.+.+....   .++...+..++.|++.++.++|+.+++|+|++|+||+++..+ .++++|||.+....
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999998 57776766654   799999999999999999999999999999999999999988 79999999987543


Q ss_pred             CCCc------ccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC
Q 017909          185 GNEQ------FMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTEC---LNQLKLIISVFGTQ  253 (364)
Q Consensus       185 ~~~~------~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~  253 (364)
                      ....      ......++..|++||.+.+.  .......|+|++|+++++++.|..||.....   ..............
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            3321      34667889999999999874  4789999999999999999999999877764   22222222211111


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccC----CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLY----PQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                                               .......    ......+.+++..++..+|..|.+..+...+++.........
T Consensus       234 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~  286 (384)
T COG0515         234 -------------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES  286 (384)
T ss_pred             -------------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence                                     0000000    122356889999999999999999999999977766544333

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=180.94  Aligned_cols=241  Identities=15%  Similarity=0.183  Sum_probs=192.1

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      +..+..+|.....|..|+|+++  |..++.|+++-..........|.+|.-.|+-+.||||+++++.|...     .++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCce
Confidence            4556678889999999999887  55788899887666666667788899999999999999999999887     7889


Q ss_pred             EEecccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCCcEEEe--ecCccccC
Q 017909          111 LVYELMD-TDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKIC--DFGLARTS  183 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~~~~L~--Dfg~~~~~  183 (364)
                      ++..|++ |+|.+.+.....  ++..++..++.+++.++.|||+..  |.--.+++..|+++++...+|+  |--++.. 
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-  342 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-  342 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence            9999999 899999987654  678899999999999999999986  4455789999999998765553  3322211 


Q ss_pred             CCCCcccccccccccccCCcccccccC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                            .....-.+.|++||.+...+.  .-.++|+|||++++|||.|...||.+...-+.-.++.              
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------------  402 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------------  402 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------------
Confidence                  111222667999999976332  3468999999999999999999998776554443331              


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                                     ......++++++++.+..|+.-|++.||.+||.++.++
T Consensus       403 ---------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  403 ---------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ---------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                           12233567799999999999999999999999998876

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.4e-23  Score=189.89  Aligned_cols=169  Identities=20%  Similarity=0.245  Sum_probs=128.2

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEecc-CCcEEEEEeccchhh---chHHHHHHHHHHHHHHhcCCCCcceeeeeec
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRE-TNEKVAIKKINNVFE---NRIDALRTLRELVLLRHIKHDNVIALKDVMM   99 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~-~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (364)
                      ....+.++|++.+.||+|+||+||+|+++. ++..+|+|+......   .......+.+|+.+|+.++|+|+++.+..+ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            344578999999999999999999999876 677789998653211   223345678999999999999998533321 


Q ss_pred             cccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCeEEccCCcEEEeec
Q 017909          100 PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDL-KPGNLLVNANCDLKICDF  177 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di-~~~NIll~~~~~~~L~Df  177 (364)
                             +..++||||++| +|. .+..   ..   ...++.+++++|.+||++||+|||| ||+|||++.++.++|+||
T Consensus        91 -------~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 -------GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             -------CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence                   346999999986 664 2211   11   1467889999999999999999999 999999999999999999


Q ss_pred             CccccCCCCCccc--------ccccccccccCCccccc
Q 017909          178 GLARTSRGNEQFM--------TEYVVTRWYRAPELLLC  207 (364)
Q Consensus       178 g~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~  207 (364)
                      |++..........        ....++..|.|||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9998654332111        23355677899998864

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=2.1e-23  Score=182.62  Aligned_cols=240  Identities=19%  Similarity=0.247  Sum_probs=152.4

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcC----------CCCcceeeeee
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIK----------HDNVIALKDVM   98 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~   98 (364)
                      -.+..+..||.|+++.||.+++..+|+.+++|++..... ......++.+|.-....+.          |-.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            356778899999999999999999999999999864432 2334444444443333322          11233333333


Q ss_pred             cccc---------ccccc---eEEEEeccccccHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017909           99 MPTH---------RISFK---DVYLVYELMDTDLHQIIKS---SQS----LSNDHCKYFVFQLLRGLKYLHSANILHRDL  159 (364)
Q Consensus        99 ~~~~---------~~~~~---~~~lv~e~~~g~L~~~l~~---~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~di  159 (364)
                      ....         .....   +.+++|+-+.++|.+++..   ...    +.......+..|++..+++||+.|++|+||
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            2111         00001   4578999999888887642   221    233334455689999999999999999999


Q ss_pred             CCCCeEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccc-------cCCCChhhHHHHHHHHHHHHhCCC
Q 017909          160 KPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC-------DNYGTSIDVWSVGCIFAEILGRKP  232 (364)
Q Consensus       160 ~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l~~g~~  232 (364)
                      +|+|++++.+|.+.|+||+.....+.....   ...+..|.+||.....       -.++.+.|.|+||+++|.|+++..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999999987655332221   2334678899876542       237889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCC
Q 017909          233 IFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR  307 (364)
Q Consensus       233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  307 (364)
                      ||.........                                  ...+..+. ++++.++.||+.+|+.||.+|
T Consensus       249 Pf~~~~~~~~~----------------------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP----------------------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS----------------------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc----------------------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99765311100                                  00234444 788999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-24  Score=200.51  Aligned_cols=242  Identities=23%  Similarity=0.346  Sum_probs=198.0

Q ss_pred             eeccCCceeEEEEE---eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceEEEE
Q 017909           37 PIGRGAYGVVCSSI---NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        37 ~lg~g~~g~V~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      .+|.|.+|.|++++   ....|..|++|+.++.............|..++...+ ||.++++.-.++.+     ...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence            37899999998875   2345678999988754333322224446778888886 99999999999988     889999


Q ss_pred             ecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccc
Q 017909          113 YELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT  191 (364)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~  191 (364)
                      .++.. |.+...+.....+.+.....+...++-++.++|+.+++|+|+|++||+++.+|.+++.|||.++........  
T Consensus        76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99997 588888888888999999999999999999999999999999999999999999999999998766443332  


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                        +|+.-|+|||++.   ....++|+||+|+++++|++|..||..    +.+..|...-                     
T Consensus       154 --cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~---------------------  203 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE---------------------  203 (612)
T ss_pred             --ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc---------------------
Confidence              8899999999986   468899999999999999999999987    4444443310                     


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCCC
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYDP  325 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~~  325 (364)
                                ...+...+..+.++++.++..+|..|.-     +.++++|+||+++...
T Consensus       204 ----------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  204 ----------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ----------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                      1222346677889999999999999984     4899999999998666

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.5e-22  Score=172.08  Aligned_cols=177  Identities=15%  Similarity=0.178  Sum_probs=132.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHH-HH------HHHHHHHHHhcCCCCcceeeeeecc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-LR------TLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~------~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      +.++|++.+.+|.|+||.||++..  ++..+|+|++.......... ..      +.+|+..+.++.|+++..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            799999999999999999999755  46689999997654443322 22      4578889999999999999988664


Q ss_pred             ccccc---cceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          101 THRIS---FKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       101 ~~~~~---~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      .....   ....++||||++| +|.+..    .+++    ....+++.++..+|+.|++|+|++|+||+++.++ ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            42111   1458999999997 777663    2333    2456999999999999999999999999999998 99999


Q ss_pred             cCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHH
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL  228 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~  228 (364)
                      ||.............            .... ..+..++|+|+||+.+..+.
T Consensus       178 fg~~~~~~e~~a~d~------------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAKDR------------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhHHH------------HHHH-hHhcccccccceeEeehHHH
Confidence            998754422111000            1222 34568999999999876554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.1e-22  Score=174.55  Aligned_cols=196  Identities=23%  Similarity=0.337  Sum_probs=146.1

Q ss_pred             CCCCcceeeeeeccccc----------------------cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHH
Q 017909           87 KHDNVIALKDVMMPTHR----------------------ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR  144 (364)
Q Consensus        87 ~h~~iv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~  144 (364)
                      +|||||.+.+.|-+.-.                      .....+|+||.....+|..++..+ ..+......++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence            69999999988754311                      112458999999999999998764 4677778889999999


Q ss_pred             HHHHHHHCCccccCCCCCCeEEcc--CC--cEEEeecCccccCCCCC------cccccccccccccCCcccccccC----
Q 017909          145 GLKYLHSANILHRDLKPGNLLVNA--NC--DLKICDFGLARTSRGNE------QFMTEYVVTRWYRAPELLLCCDN----  210 (364)
Q Consensus       145 ~l~~lH~~~i~H~di~~~NIll~~--~~--~~~L~Dfg~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~----  210 (364)
                      |+.|||.+|+.|+|+|++|||+.-  ++  .+.|+|||.|--.....      ......-|+...+|||+....+.    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            999999999999999999999943  33  58999999874332211      11223345667899999865322    


Q ss_pred             -CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCC
Q 017909          211 -YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD  289 (364)
Q Consensus       211 -~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (364)
                       .-.++|.|+.|.+.||+++...||.+......                             ..........+.++..++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------------------------~~r~Yqe~qLPalp~~vp  483 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------------------------DTRTYQESQLPALPSRVP  483 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchhee-----------------------------chhhhhhhhCCCCcccCC
Confidence             23589999999999999999999977211000                             000122334566778899


Q ss_pred             hHHHHHHHHhcccCCCCCCCHHH
Q 017909          290 PLALDLLQKMLVFEPSKRITVTE  312 (364)
Q Consensus       290 ~~l~~li~~~l~~dP~~Rps~~e  312 (364)
                      +.+++|+..+|+.||++|+++.-
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccH
Confidence            99999999999999999998754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=4.4e-22  Score=167.21  Aligned_cols=140  Identities=19%  Similarity=0.221  Sum_probs=108.5

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHH------------------------HHHHHHHHHHHHhcCCCC
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRID------------------------ALRTLRELVLLRHIKHDN   90 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~   90 (364)
                      ...||+|++|+||+|.+. +|+.||+|+++........                        ......|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999987 8999999999754321111                        112235889999998777


Q ss_pred             cceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCeEEcc
Q 017909           91 VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL-HSANILHRDLKPGNLLVNA  168 (364)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~di~~~NIll~~  168 (364)
                      +.....+..       ...++||||++| ++........+++...+..++.|++.+|.++ |+.|++|+||||+||+++ 
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            644333221       223899999996 4444434457899999999999999999999 799999999999999998 


Q ss_pred             CCcEEEeecCccccC
Q 017909          169 NCDLKICDFGLARTS  183 (364)
Q Consensus       169 ~~~~~L~Dfg~~~~~  183 (364)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.1e-20  Score=159.33  Aligned_cols=141  Identities=18%  Similarity=0.144  Sum_probs=110.0

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH------------------------HHHHHHHHHHHHHhcCCC
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI------------------------DALRTLRELVLLRHIKHD   89 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~   89 (364)
                      +.+.||+|++|+||+|.+. +|+.||+|+++.......                        .......|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999875422100                        011224688999999888


Q ss_pred             CcceeeeeeccccccccceEEEEecccccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEc
Q 017909           90 NVIALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVN  167 (364)
Q Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~  167 (364)
                      ++.....+...       ..++||||++|. +.........++...+..++.|++.++.++|+ .|++|+||||+||+++
T Consensus        80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            87544443321       238999999863 44333344678889999999999999999999 9999999999999999


Q ss_pred             cCCcEEEeecCccccC
Q 017909          168 ANCDLKICDFGLARTS  183 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~  183 (364)
                       ++.++|+|||++...
T Consensus       153 -~~~~~liDFG~a~~~  167 (190)
T cd05145         153 -DGKPYIIDVSQAVEL  167 (190)
T ss_pred             -CCCEEEEEcccceec
Confidence             789999999998765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=3.3e-21  Score=188.09  Aligned_cols=249  Identities=28%  Similarity=0.353  Sum_probs=183.1

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ........|..++.+..|+||.||.++|+.+.+++|+|+-+..              .+++.     |..+    .    
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------------lilRn-----ilt~----a----  129 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------------LILRN-----ILTF----A----  129 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccc--------------hhhhc-----cccc----c----
Confidence            4455788999999999999999999999999999999543210              12221     1111    1    


Q ss_pred             cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          104 ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                         +..+.|     |+-.+.+..-++++...        +.++.|||+.||+|+|+||+|.+++.-|.+|++|||+.+..
T Consensus       130 ---~npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  130 ---GNPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ---CCccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence               112222     44444555555555544        77899999999999999999999999999999999987543


Q ss_pred             CCCC---------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017909          184 RGNE---------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       184 ~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~  248 (364)
                      ....               ......+|++.|+|||++.- +.|+...|+|++|+|+|+.+.|+.||.+....+....++.
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            2111               11234588999999999987 6899999999999999999999999999887777776655


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCCCC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI---TVTEALQHPYISGLYDP  325 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~elL~hp~f~~~~~~  325 (364)
                      .-...                            .+-....+++++++|.++|+.+|..|.   .+-+|.+|+||+.+-+.
T Consensus       273 d~i~w----------------------------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  273 DDIEW----------------------------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhccc----------------------------cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            32222                            222356788999999999999999997   77889999999998655


Q ss_pred             ---C-CCCCCCCCCCcccchhhh
Q 017909          326 ---Q-CNPPAQVPLSLDIDENIG  344 (364)
Q Consensus       326 ---~-~~~~~~~~~~~~~~~~~~  344 (364)
                         + -+.=.++--..|..+++|
T Consensus       325 ~llRqkaefvpql~~eddtsyfd  347 (1205)
T KOG0606|consen  325 SLLRQKAEFVPQLESEDDTSYFD  347 (1205)
T ss_pred             hhhhhhccccccccccccchhhc
Confidence               2 223334444445555554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6.2e-20  Score=152.92  Aligned_cols=186  Identities=15%  Similarity=0.098  Sum_probs=136.3

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc--hHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceE
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN--RIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      -++..|++|+||+|+.+..  .+.+++.+.+......  ......+.+|+++|+++. ++++++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            4678999999999998854  6788888888754332  112234678999999995 5889999885         345


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDL-KPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di-~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +++|+|+.| +|......      . ...++.|++.+|.++|++|++|+|| +|+||+++.++.++|+|||++.......
T Consensus        74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999999987 56433211      1 2357789999999999999999999 7999999999999999999997554332


Q ss_pred             cc----cc---------cccccccccCCcccccccCCC-ChhhHHHHHHHHHHHHhCCCCCCC
Q 017909          188 QF----MT---------EYVVTRWYRAPELLLCCDNYG-TSIDVWSVGCIFAEILGRKPIFPG  236 (364)
Q Consensus       188 ~~----~~---------~~~~~~~~~aPE~~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~  236 (364)
                      ..    ..         ....++.+++|+...--...+ .+.++++.|.-+|.++|+..++-+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            21    00         011245566676544322334 678999999999999999987643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.1e-20  Score=187.28  Aligned_cols=192  Identities=21%  Similarity=0.277  Sum_probs=157.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcC---CCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIK---HDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~  103 (364)
                      -++.|.|-+.+|.|+||+||+|.+.. |+.+|+|+-+...... +-..      +++.+|+   -+.|+.+..++...  
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~--  766 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQ--  766 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccC--
Confidence            46789999999999999999999877 9999999987543332 2222      2233333   34566666666555  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-------CCcEEEe
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-------NCDLKIC  175 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-------~~~~~L~  175 (364)
                         +..++|++|.+ |+|++++..++-+++..+..++.||+..+.+||..+|+||||||+|+||..       +.-++|+
T Consensus       767 ---~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  767 ---NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ---CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence               66799999999 899999998899999999999999999999999999999999999999943       3359999


Q ss_pred             ecCccccC--CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCC
Q 017909          176 DFGLARTS--RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP  232 (364)
Q Consensus       176 Dfg~~~~~--~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~  232 (364)
                      |||.+...  ..........+++..+-.+|+..+ ..+++..|.|+|+.+++.|++|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            99988643  233445677788999999999988 799999999999999999998874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=2.6e-19  Score=166.59  Aligned_cols=207  Identities=25%  Similarity=0.307  Sum_probs=155.1

Q ss_pred             HHhcCCCCcceeeeeeccccccccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCC
Q 017909           83 LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANI-LHRDL  159 (364)
Q Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i-~H~di  159 (364)
                      |+.+.|.|+.++++.+...     ...++|.+||. |+|.|.+.. ...++......++++|+.||.|+|+..+ +||.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            3567899999999999988     78899999998 899999987 4568888899999999999999999876 89999


Q ss_pred             CCCCeEEccCCcEEEeecCccccCCC--CCcccccccccccccCCccccccc------CCCChhhHHHHHHHHHHHHhCC
Q 017909          160 KPGNLLVNANCDLKICDFGLARTSRG--NEQFMTEYVVTRWYRAPELLLCCD------NYGTSIDVWSVGCIFAEILGRK  231 (364)
Q Consensus       160 ~~~NIll~~~~~~~L~Dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~g~  231 (364)
                      ++.|-+++..+.+||+|||+......  .............|.|||.+....      ..+.+.|+||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999998765532  111122223456799999987631      1467899999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH
Q 017909          232 PIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT  311 (364)
Q Consensus       232 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  311 (364)
                      .||+.........+++..+......                   ......... ....+.+..+++.||..+|.+||+++
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~-------------------~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSN-------------------PFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCC-------------------CcCcchhhh-hhcchHHHHHHHHhcccChhhCccHH
Confidence            9998753332222322221110000                   000000000 13455789999999999999999999


Q ss_pred             HHh
Q 017909          312 EAL  314 (364)
Q Consensus       312 elL  314 (364)
                      ++-
T Consensus       216 ~i~  218 (484)
T KOG1023|consen  216 QIR  218 (484)
T ss_pred             HHH
Confidence            875

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=6.6e-19  Score=152.93  Aligned_cols=143  Identities=16%  Similarity=0.090  Sum_probs=111.0

Q ss_pred             ceeeeeeeccCCceeEEEEE-eccCCcEEEEEeccchhhch----------------------HHHHHHHHHHHHHHhcC
Q 017909           31 KYVPIKPIGRGAYGVVCSSI-NRETNEKVAIKKINNVFENR----------------------IDALRTLRELVLLRHIK   87 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~-~~~~~~~~aiK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~   87 (364)
                      -|++.+.||.|++|.||+|. +..+|..||+|+++......                      .....+..|+..+..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 66789999999987532110                      01123457999999986


Q ss_pred             CC--CcceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCC
Q 017909           88 HD--NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN-ILHRDLKPGN  163 (364)
Q Consensus        88 h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~di~~~N  163 (364)
                      +.  .+++++..         ...++||||++| ++.........+....+..++.|++.++.+||+.| ++|+||+|+|
T Consensus       109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe---------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            53  33444432         224899999997 56554444456677778899999999999999999 9999999999


Q ss_pred             eEEccCCcEEEeecCccccC
Q 017909          164 LLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~  183 (364)
                      |+++ ++.++|+|||.+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 789999999987644

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.9e-18  Score=145.43  Aligned_cols=138  Identities=20%  Similarity=0.265  Sum_probs=105.6

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-----CCCCcceeeeeeccccccccc
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-----KHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .-.+.||+|++|.||.  +..++.. +||++.....  .....+.+|+.+++.+     .||||+++++++.++...  +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~--g   77 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT--G   77 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC--e
Confidence            3457899999999995  6666665 6898865322  2335678899999999     579999999999876321  3


Q ss_pred             eEE-EEecccc---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCCeEEcc----CCcEEEeecC
Q 017909          108 DVY-LVYELMD---TDLHQIIKSSQSLSNDHCKYFVFQLLRGL-KYLHSANILHRDLKPGNLLVNA----NCDLKICDFG  178 (364)
Q Consensus       108 ~~~-lv~e~~~---g~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~i~H~di~~~NIll~~----~~~~~L~Dfg  178 (364)
                      .++ +|+||.+   ++|.+++... .+++.  ..++.+++.++ .|||+++|+|+||||+||+++.    ++.++|+|++
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            434 7899954   6999999764 46655  35677888777 8999999999999999999974    3479999955


Q ss_pred             cc
Q 017909          179 LA  180 (364)
Q Consensus       179 ~~  180 (364)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            43

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.9e-19  Score=163.54  Aligned_cols=177  Identities=27%  Similarity=0.430  Sum_probs=133.9

Q ss_pred             ceEEEEecccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      .+++|.|++|. .+|.+++..+.   ..+......++.|++.++.|   ++.+|+|++|.||++..+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            46899999998 79999997543   47888999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCC------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          183 SRGNE------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       183 ~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      .....      ...+...|+..||+||++.+ ..|+.++|||+||++++|++. -...|.-      ......+      
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~------  472 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDI------  472 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhh------
Confidence            53333      13445678999999999998 689999999999999999996 2222211      1111110      


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                                           +...+++....-.+.-..|+.+|+...|.+||++.+.--|+|.+
T Consensus       473 ---------------------r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  473 ---------------------RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             ---------------------hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                                 01111111112233445899999999999999888877777753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2.6e-17  Score=141.22  Aligned_cols=136  Identities=26%  Similarity=0.275  Sum_probs=110.3

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc------hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN------RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +.||+|++|.||+|.+  .|..+++|+.......      ......+.+|+.++..+.+++++....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5789999999999976  5778999986533221      11234566899999999999887777776555     557


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ++||||++| +|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+...
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            899999985 88888765332    7888999999999999999999999999999999 788999999987653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=4.5e-17  Score=138.29  Aligned_cols=137  Identities=19%  Similarity=0.176  Sum_probs=104.2

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch--------------------HHHHHHHHHHHHHHhcCCCC
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR--------------------IDALRTLRELVLLRHIKHDN   90 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~~   90 (364)
                      -|.+.+.||+|++|.||++.+. +|+.+++|++.......                    ........|..++..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888999999999999999875 78999999875432110                    01122456888888887663


Q ss_pred             --cceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909           91 --VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus        91 --iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                        ++.+++.         ...++||||++| +|.+...      ......++.+++.++.++|+.|++|+||+|+||+++
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence              3333331         345899999986 6654432      134567889999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccC
Q 017909          168 ANCDLKICDFGLARTS  183 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~  183 (364)
                      .++.++|+|||.+...
T Consensus       160 ~~~~~~liDfg~~~~~  175 (198)
T cd05144         160 DDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcEEEEECCccccC
Confidence            9999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=9.1e-17  Score=136.56  Aligned_cols=132  Identities=26%  Similarity=0.299  Sum_probs=102.5

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchhh------chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVFE------NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      .||+|++|+||++..  +|..+++|+......      ......++.+|+.+++.+.++++.....++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            479999999999974  578899998653211      112235566899999999887655554444443     4568


Q ss_pred             EEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          111 LVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       111 lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      +||||++| +|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999985 88887655321       7889999999999999999999999999999 789999999987653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=5.3e-16  Score=151.09  Aligned_cols=147  Identities=24%  Similarity=0.323  Sum_probs=112.8

Q ss_pred             eeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccch-h-----hchHHHHHHHHHHHHHHhcCCCCccee
Q 017909           21 MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV-F-----ENRIDALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        21 ~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~-~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      .|.........|...+.||+|+||+||++.+..  ..+++|+.... .     .......++.+|+.+++.++|++++..
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            344444455667788999999999999997653  34444432211 1     111233556789999999999999887


Q ss_pred             eeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEE
Q 017909           95 KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~  173 (364)
                      ..++...     ...++||||++| +|.+.+.        ....++.+++.+|.+||+.|++||||+|+||++ .++.++
T Consensus       402 ~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        402 VIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             EEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEE
Confidence            7766554     456899999985 8888775        356789999999999999999999999999999 577999


Q ss_pred             EeecCccccC
Q 017909          174 ICDFGLARTS  183 (364)
Q Consensus       174 L~Dfg~~~~~  183 (364)
                      |+|||++...
T Consensus       468 liDFGla~~~  477 (535)
T PRK09605        468 LIDFGLGKYS  477 (535)
T ss_pred             EEeCcccccC
Confidence            9999998654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=5.2e-18  Score=164.94  Aligned_cols=262  Identities=25%  Similarity=0.368  Sum_probs=202.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCC-cEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETN-EKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...|.+.+.||+|+++.|-.+....+. ..++.|.+..............+|..+-+.+. |+|++..++.....     
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence            568899999999999999888764333 34666655543322333334445777777776 99999999998877     


Q ss_pred             ceEEEEecccc-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCeEEccCC-cEEEeecCccc
Q 017909          107 KDVYLVYELMD-TDLHQII-KSSQ-SLSNDHCKYFVFQLLRGLKYLH-SANILHRDLKPGNLLVNANC-DLKICDFGLAR  181 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~  181 (364)
                      ...++++++.. +++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+||+|+|.+++..+ .++++|||++.
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            77899999976 4777766 4444 6888889999999999999999 99999999999999999999 99999999997


Q ss_pred             cCCC---CCcccccccc-cccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRG---NEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~---~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      ....   ........+| ++.|.|||.+.+.....+..|+||.|+++..+++|..|+.........              
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------  239 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------  239 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------
Confidence            6544   2223345567 899999999988667889999999999999999999998665422210              


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                              ...|..    .........+...+....+++.+++..+|..|.+.+++-.+||+..
T Consensus       240 --------~~~~~~----~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 --------YSSWKS----NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             --------ceeecc----cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                    000000    0111124456678888999999999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.9e-16  Score=132.08  Aligned_cols=137  Identities=23%  Similarity=0.227  Sum_probs=96.6

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHH----------------------HHHHHHHHhcCCC--
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT----------------------LRELVLLRHIKHD--   89 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~--   89 (364)
                      +.+.||+|++|+||+|.+. +|..||+|++.............                      ..|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999876 78999999987543221111111                      2455555555332  


Q ss_pred             CcceeeeeeccccccccceEEEEeccccc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEE
Q 017909           90 NVIALKDVMMPTHRISFKDVYLVYELMDT-DLH-QIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLV  166 (364)
Q Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~-~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll  166 (364)
                      .+++++..         ...++||||++| ++. ..+.... .. ..+..++.+++.++.++|. .|++|+||+|+||++
T Consensus        80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCCceEec---------CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence            23444332         235899999986 221 1111111 11 6788899999999999999 999999999999999


Q ss_pred             ccCCcEEEeecCccccC
Q 017909          167 NANCDLKICDFGLARTS  183 (364)
Q Consensus       167 ~~~~~~~L~Dfg~~~~~  183 (364)
                      + ++.++|+|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 889999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=6.3e-17  Score=150.89  Aligned_cols=256  Identities=23%  Similarity=0.245  Sum_probs=200.5

Q ss_pred             cccceeeeeeecc--CCceeEEEEEe--ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGR--GAYGVVCSSIN--RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~--g~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      ....+.+.+.+|.  |.+|.||.+..  ..++..+++|.-+..........+-.+++...+.+ .|++.++.+..+... 
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~-  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS-  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC-
Confidence            5678888999999  99999999998  88899999998665444444444445677777777 489999977777766 


Q ss_pred             ccccceEEEEeccccccHHHHHHhCC-CCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCCeEEccC-CcEEEee
Q 017909          103 RISFKDVYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLLR----GLKYLHSANILHRDLKPGNLLVNAN-CDLKICD  176 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~----~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~D  176 (364)
                          +..++-+|+|+.+|.+...... .++...++..+.+...    ||.++|+.+++|.|++|.||+...+ ...+++|
T Consensus       191 ----~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  191 ----GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ----CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence                8899999999998888876654 4899999999999999    9999999999999999999999999 7899999


Q ss_pred             cCccccCCCCCcccc-----cccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHH
Q 017909          177 FGLARTSRGNEQFMT-----EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT--ECLNQLKLIISV  249 (364)
Q Consensus       177 fg~~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--~~~~~~~~i~~~  249 (364)
                      ||......+......     ...+...|++||...+  -++.+.|+|+||.++.+...+..+....  ..+...+.+.  
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--  342 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--  342 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence            999887655543322     2266778999999866  6899999999999999988776655333  2111111110  


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                                    ...++-.+.+..+...+..|++.+|..|+++..+++|+++..-
T Consensus       343 ------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 ------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                          1112223456667789999999999999999999999999753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=7.2e-17  Score=139.55  Aligned_cols=244  Identities=19%  Similarity=0.180  Sum_probs=159.8

Q ss_pred             eEEEEEeccCCcEEEEEeccchhhchHHH--HHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecccc-ccHH
Q 017909           45 VVCSSINRETNEKVAIKKINNVFENRIDA--LRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLH  121 (364)
Q Consensus        45 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~  121 (364)
                      .||++.++..|.+++...+..........  .+...-+..|-.+-|.|+++++.++-+..........++.||+. |++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            34555555555555544332211111110  11112334445557999999999987654323356889999998 8999


Q ss_pred             HHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCCcEEEeecCccccCCCC----Ccccc
Q 017909          122 QIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTSRGN----EQFMT  191 (364)
Q Consensus       122 ~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~----~~~~~  191 (364)
                      .++++.    +.+.....++|+.||+.||.|||+..  ++|+++..+.|++..+|-++++--........-    .....
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            988753    46899999999999999999999986  999999999999999988887643322111100    01112


Q ss_pred             cccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHH
Q 017909          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI-FPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI  270 (364)
Q Consensus       192 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
                      ...+.++|.+||.=.. .+.+-++|||++|++..+|..+..- -.+.........+.+.+..                  
T Consensus       241 ~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~------------------  301 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG------------------  301 (458)
T ss_pred             ccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee------------------
Confidence            2345678899985333 4567799999999999999877643 3333322222222221110                  


Q ss_pred             hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                      -..+.-.+++.+|++..|..||++.++|.||.+-+++
T Consensus       302 ----------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  302 ----------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             ----------------ccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence                            0111233789999999999999999999999987654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=8.7e-15  Score=127.42  Aligned_cols=140  Identities=16%  Similarity=0.229  Sum_probs=104.1

Q ss_pred             eeec-cCCceeEEEEEeccCCcEEEEEeccchh-----------hchHHHHHHHHHHHHHHhcCCCCc--ceeeeeeccc
Q 017909           36 KPIG-RGAYGVVCSSINRETNEKVAIKKINNVF-----------ENRIDALRTLRELVLLRHIKHDNV--IALKDVMMPT  101 (364)
Q Consensus        36 ~~lg-~g~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~  101 (364)
                      ..|| .|+.|+||.+...  +..+++|.+....           .......++.+|+.++..+.|+++  +.++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888899988654  7789999885311           012334566789999999988775  6666664433


Q ss_pred             cccccceEEEEeccccc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          102 HRISFKDVYLVYELMDT--DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                      .. .....++|+|+++|  +|.+.+.. .++++..    +.+|+.+|.+||++||+|+||+|.|||++.++.++|+|||.
T Consensus       115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            21 11335699999985  78777754 4455543    56899999999999999999999999999988999999998


Q ss_pred             cccC
Q 017909          180 ARTS  183 (364)
Q Consensus       180 ~~~~  183 (364)
                      +...
T Consensus       189 ~~~~  192 (239)
T PRK01723        189 GELR  192 (239)
T ss_pred             cccC
Confidence            7553

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.3e-14  Score=117.12  Aligned_cols=132  Identities=24%  Similarity=0.242  Sum_probs=107.6

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCC--CCcceeeeeeccccccccceEEE
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH--DNVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      +++.+|+|.++.||++...  +..+++|.......    ...+.+|+..++.+.+  .++++++......     +..++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL   70 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence            5688999999999999875  47899999865432    3456678889988865  5888888877655     67899


Q ss_pred             Eeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          112 VYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA---NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ++||++| .+...       +......++.+++.++..+|..   +++|+|++|+||++++.+.++++|||.+...
T Consensus        71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9999986 34322       5667778899999999999985   6999999999999999889999999987543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.52  E-value=1.3e-13  Score=130.28  Aligned_cols=184  Identities=19%  Similarity=0.323  Sum_probs=135.2

Q ss_pred             ceeeeeeeccCCceeEE-EEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           31 KYVPIKPIGRGAYGVVC-SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~-~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      -|.+ ...+-++.+ +| .|..+.++.++.+.+++....  .......+.++.|+.++||||+++++.+...     .+.
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~   84 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTL   84 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc-----Cce
Confidence            3455 333344444 44 577788899999998876433  3444566788999999999999999999988     789


Q ss_pred             EEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH-SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      |||+|.+.. |...+.+   +....+..-++||+.||.+|| +.+++|++|+.+.|+++..|..+|++|..+........
T Consensus        85 ylvTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   85 YLVTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA  160 (690)
T ss_pred             EEEeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc
Confidence            999999864 2222222   236777788899999999997 56799999999999999999999999998865432222


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR  230 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  230 (364)
                      ......-...|..|+.+...   ....|.|.|||++++++.|
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            11222223446677655332   2568999999999999988

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=6.9e-13  Score=110.63  Aligned_cols=139  Identities=19%  Similarity=0.192  Sum_probs=99.1

Q ss_pred             eeeeccCCceeEEEEEecc------CCcEEEEEeccchhhc--------------------hHHHHHH----HHHHHHHH
Q 017909           35 IKPIGRGAYGVVCSSINRE------TNEKVAIKKINNVFEN--------------------RIDALRT----LRELVLLR   84 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~------~~~~~aiK~~~~~~~~--------------------~~~~~~~----~~e~~~l~   84 (364)
                      ...||.|.-+.||.|....      .+..+|+|+++.....                    ......+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999997653      3578999988521000                    0011111    37999999


Q ss_pred             hcCC--CCcceeeeeeccccccccceEEEEecccccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCC
Q 017909           85 HIKH--DNVIALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYL-HSANILHRDLK  160 (364)
Q Consensus        85 ~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~di~  160 (364)
                      ++..  -++++++.+         ...+||||+++++ +.........++...+..+..+++.++..| |..|++|||++
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            8843  456666654         3348999999863 222112223456667778889999999988 89999999999


Q ss_pred             CCCeEEccCCcEEEeecCccccC
Q 017909          161 PGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       161 ~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      +.||+++ ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999988655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.41  E-value=1.1e-11  Score=113.99  Aligned_cols=216  Identities=12%  Similarity=0.190  Sum_probs=157.9

Q ss_pred             CceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecccc--cc
Q 017909           42 AYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD--TD  119 (364)
Q Consensus        42 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--g~  119 (364)
                      ...+.|++....+|..|++|.++........  +.-.-+++++++.|+|+|++.++|.... .+...+++|++|.+  ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence            4568999999999999999999544333221  2234678899999999999999998432 23367899999998  48


Q ss_pred             HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          120 LHQIIKS---------------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       120 L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      |.+..-.               +...++..+|.++.||..||.++|+.|+.-.-+.+.+|+++++.+++|+..|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            8887632               2357889999999999999999999999999999999999999999999988876553


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ...            .+|  +..    -.+-|.-.||.+++.|.+|..--...+......                    
T Consensus       445 ~d~------------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------------------  486 (655)
T KOG3741|consen  445 EDP------------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------------------  486 (655)
T ss_pred             CCC------------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHH--------------------
Confidence            333            111  111    235688999999999999975321111111110                    


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      ...+.+.++.++.++|.-....++.+ -++.+++.
T Consensus       487 ----------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  487 ----------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             ----------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                            01122467788888888888888876 67777774

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.40  E-value=2e-13  Score=134.43  Aligned_cols=265  Identities=22%  Similarity=0.230  Sum_probs=192.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -.+.+.+.+-+.+|.++.++.+.-..+|....+|+...... ...+......+-+++-.-.+|.++...-.+...     
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r-----  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR-----  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC-----
Confidence            46788889999999999999998777787777776643211 111122222222222212234444332222222     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++++++++ +++...+...+..+.+-++..+..+..++.+||+..+.|+|++|.|.+...++...++||+.......
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            67899999997 58888888888888888999999999999999999999999999999999999999999973321100


Q ss_pred             ------C---------------C----------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCC
Q 017909          186 ------N---------------E----------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF  234 (364)
Q Consensus       186 ------~---------------~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  234 (364)
                            .               .          ...-...+++.|.+||...+ ......+|+|+.|+++++.++|.+||
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                  0               0          00112356888999999988 57889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH---
Q 017909          235 PGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT---  311 (364)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~---  311 (364)
                      .........+.+...                            ...|.......+....+++...+..+|.+|..+.   
T Consensus      1036 na~tpq~~f~ni~~~----------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR----------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred             CCcchhhhhhccccC----------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence            887665555444321                            1223334455778899999999999999999998   


Q ss_pred             HHhcCCCccCCCCCC
Q 017909          312 EALQHPYISGLYDPQ  326 (364)
Q Consensus       312 elL~hp~f~~~~~~~  326 (364)
                      ++-.|+||+...+..
T Consensus      1088 e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             ccccCCccCCCCccc
Confidence            999999998875543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.40  E-value=3.1e-12  Score=120.93  Aligned_cols=140  Identities=24%  Similarity=0.310  Sum_probs=95.0

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHH--------------------------------------HHHHH
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRID--------------------------------------ALRTL   77 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--------------------------------------~~~~~   77 (364)
                      +.||+|+.|+||+|+.+ +|+.||||+.+........                                      ...+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999865 7899999998642111000                                      01223


Q ss_pred             HHHHHHHhc----CCCCcceeeeeeccccccccceEEEEeccccc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 017909           78 RELVLLRHI----KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS-QSLSNDHCKYFVFQLLR-GLKYLH  150 (364)
Q Consensus        78 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~lH  150 (364)
                      +|+..+.++    ++.+-+.+..++.+..    ...++||||++| +|.+..... ...+   ...++..++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            455555554    2333344444443321    446999999986 777665432 1222   2345556655 467889


Q ss_pred             HCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          151 SANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       151 ~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ..|++|+|++|.||+++.++.++|+|||++...
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            999999999999999999999999999998665

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=9.3e-13  Score=123.26  Aligned_cols=253  Identities=19%  Similarity=0.162  Sum_probs=185.6

Q ss_pred             ecccceeeeeeeccCCceeEEEEEec-cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINR-ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      ....+|..+..||.|.++.|+...-+ .++..|++|...............+.|+.+...+ .|.+++.+...+...   
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---  338 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---  338 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence            35678999999999999999887644 5678899998877666665555556788877777 588888887777766   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg~~~~  182 (364)
                        ...++--|||. +++.........+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++||+....
T Consensus       339 --r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  339 --RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             --ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence              56679999997 4555444444568889999999999999999999999999999999999886 7788999988753


Q ss_pred             CCCCCccccccccccccc-CCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          183 SRGNEQFMTEYVVTRWYR-APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ..-   ...-..+..++. ..|.+.....+..+.|+++||.-+.+.+++...-......   ..                
T Consensus       417 ~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~----------------  474 (524)
T KOG0601|consen  417 LAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LT----------------  474 (524)
T ss_pred             cce---ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---ee----------------
Confidence            211   111112223334 2555555567899999999999999999887653322110   00                


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                     .........++....+..+.+.|+..|+..||++.++..|.=|-.
T Consensus       475 ---------------i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  475 ---------------IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ---------------eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                           011112222344467889999999999999999999988876643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.4e-11  Score=99.56  Aligned_cols=133  Identities=20%  Similarity=0.250  Sum_probs=98.8

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccc------hhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINN------VFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ..+++|+-+.++.+...  |..+++|.-..      .........+..+|+.++..+.--.+....-+..+.     ..-
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-----~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-----DNG   74 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCC
Confidence            45788999999999553  55677775432      222333445556899999998755655555555555     556


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .|+|||++| .|.+.+...       ...++..+-.-+.-||..||+|||++++||++..++ +.++|||++...
T Consensus        75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            899999998 666677664       245667777778899999999999999999998874 999999998654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=4.3e-12  Score=104.77  Aligned_cols=127  Identities=21%  Similarity=0.193  Sum_probs=91.6

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeccccccccceEEEEe
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV-IALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      ++.++.|.++.||+++..  +..+++|........   ......|+.+++.+...++ ++++....       ...++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEE
Confidence            467899999999999754  788999998654221   1233568888888754443 44444322       2247999


Q ss_pred             ccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          114 ELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI-----LHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       114 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-----~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      |+++| ++.+.        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99997 44322        11123456789999999999985     9999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=4.1e-12  Score=121.65  Aligned_cols=144  Identities=17%  Similarity=0.272  Sum_probs=94.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch--------------------------------HHH---
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR--------------------------------IDA---   73 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------~~~---   73 (364)
                      -..|+. +.||+|++|+||+|+.+.+|+.||+|+.+......                                .-.   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345676 79999999999999998889999999996431110                                000   


Q ss_pred             ---HHHHHHHHHHHhc----CCCCcceeeeeeccccccccceEEEEeccccc-cHHHH--HHhCC----CCCHHHHHHHH
Q 017909           74 ---LRTLRELVLLRHI----KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQI--IKSSQ----SLSNDHCKYFV  139 (364)
Q Consensus        74 ---~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~--l~~~~----~~~~~~~~~i~  139 (364)
                         .++.+|+..+.++    .+...+.+-.++.+-.    ...++||||+.| .+.+.  +...+    .+....+..++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence               1122344444444    2333444444443321    456899999986 77653  22222    23333333344


Q ss_pred             HHHHHHHHHHHHCCccccCCCCCCeEEccCC----cEEEeecCccccCC
Q 017909          140 FQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDFGLARTSR  184 (364)
Q Consensus       140 ~qi~~~l~~lH~~~i~H~di~~~NIll~~~~----~~~L~Dfg~~~~~~  184 (364)
                      .|+       ...|++|+|++|.||+++.++    .+++.|||++....
T Consensus       274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            444       468999999999999999988    99999999986653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=2.7e-11  Score=97.39  Aligned_cols=143  Identities=22%  Similarity=0.282  Sum_probs=107.2

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEecc-----ch-hhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKIN-----NV-FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~-----~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ....+.+|+-+.|+++.  ..|+.++||.--     ++ ........+..+|+..|.++.--.|.-..-++.+.     .
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y   83 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence            56788999999999995  458888888542     22 22333455667899999888655555555555555     5


Q ss_pred             eEEEEeccccc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cEEEeecCcc
Q 017909          108 DVYLVYELMDT--DLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLA  180 (364)
Q Consensus       108 ~~~lv~e~~~g--~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~~L~Dfg~~  180 (364)
                      .-.|+|||++|  ++.+++...  ..........++..|-+.+.-||..+++|||++.+||++..++   .+.|+|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            56899999997  888888653  2233333378899999999999999999999999999997765   4689999998


Q ss_pred             ccC
Q 017909          181 RTS  183 (364)
Q Consensus       181 ~~~  183 (364)
                      ...
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.24  E-value=4e-10  Score=101.55  Aligned_cols=263  Identities=13%  Similarity=0.037  Sum_probs=160.1

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc--cccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT--HRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~~~  107 (364)
                      -...++.||+|+.+.+|-.-.-   ...+-|++.........     +.+..|... .||-+..-+.+=+..  ......
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             ccCCCccccCCccceeeecchh---hchhheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            3456789999999999976322   23566888654222211     122333333 455433211110000  000112


Q ss_pred             eEEEEeccccc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          108 DVYLVYELMDT--DLHQIIKS------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       108 ~~~lv~e~~~g--~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                      -..++|+.+.|  .+..++..      ....++......++.|+.+...||..|.+-||++++|+|+++++.+.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            27889999875  55555532      23478899999999999999999999999999999999999999999998765


Q ss_pred             cccCCCCCcccccccccccccCCcccc-c---ccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCc
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLL-C---CDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~---~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      .... ..........|...|++||.-. +   ...-+..+|.|.||+++++++.| .+||.+-..          .+.-+
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~----------~~~ap  232 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL----------ISDAP  232 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc----------cCCCC
Confidence            5444 3344455667788999999864 1   12357789999999999999865 999976421          00111


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhccc--CCCCCCCHHH
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVF--EPSKRITVTE  312 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rps~~e  312 (364)
                      ....-.+....+-.--.........-...-+.-+++++..|..+|+..  ++.-|||++-
T Consensus       233 ~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         233 NPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             CcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            100101111100000000000111111122345788899999999985  3568998753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.21  E-value=4.5e-10  Score=99.01  Aligned_cols=144  Identities=13%  Similarity=0.072  Sum_probs=97.6

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchhhchH---------HHHHHHHHHHHHHhcCCCCc--ceeeeeeccccccc
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI---------DALRTLRELVLLRHIKHDNV--IALKDVMMPTHRIS  105 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~  105 (364)
                      .+.......|+++..  .|+.|.+|..........         ....+.+|...+..+..-+|  ++++.+........
T Consensus        29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            333333344556643  577899997743221110         11135678888877743333  33444543322211


Q ss_pred             cceEEEEeccccc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-------CCcEEE
Q 017909          106 FKDVYLVYELMDT--DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-------NCDLKI  174 (364)
Q Consensus       106 ~~~~~lv~e~~~g--~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-------~~~~~L  174 (364)
                      ....++|+|++++  +|.+++..  ..+.+......++.+++..+..||..|++|+|++++|||++.       +..+.|
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            2457899999986  78888754  345677788899999999999999999999999999999975       468999


Q ss_pred             eecCcccc
Q 017909          175 CDFGLART  182 (364)
Q Consensus       175 ~Dfg~~~~  182 (364)
                      +||+.+..
T Consensus       187 IDl~r~~~  194 (268)
T PRK15123        187 IDLHRAQI  194 (268)
T ss_pred             EECCcccc
Confidence            99998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=2.4e-11  Score=115.51  Aligned_cols=154  Identities=23%  Similarity=0.337  Sum_probs=115.5

Q ss_pred             HHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc---------cccccccccccCCcccccccCC
Q 017909          142 LLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---------MTEYVVTRWYRAPELLLCCDNY  211 (364)
Q Consensus       142 i~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~  211 (364)
                      ++.|+.++|.. +++|++|.|++|.++.++..||+.|+++.........         .........|.|||.+.+ ...
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~  186 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTN  186 (700)
T ss_pred             ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccc
Confidence            34899999976 7999999999999999999999999988654332111         112233567999999988 678


Q ss_pred             CChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCCh
Q 017909          212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP  290 (364)
Q Consensus       212 ~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (364)
                      +.++|+||||+++|.+. .|+..+...........-...                           ...........+++
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---------------------------~~~~~~~~s~~~p~  239 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---------------------------LNAGAFGYSNNLPS  239 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---------------------------cccccccccccCcH
Confidence            99999999999999998 777766554333222211110                           01111223367899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          291 LALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       291 ~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ++++=|.+++..++..||++.+++..|||+...
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            999999999999999999999999999998743

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.11  E-value=7.5e-10  Score=94.85  Aligned_cols=139  Identities=20%  Similarity=0.145  Sum_probs=105.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccc------------------h--hhchHHHHHHHHHHHHHHhcCCC-
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN------------------V--FENRIDALRTLRELVLLRHIKHD-   89 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~------------------~--~~~~~~~~~~~~e~~~l~~l~h~-   89 (364)
                      -+.++..||-|.-+.||.|.+. +|.++++|.-+.                  .  .+-......+.+|..+|..+... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3567889999999999999876 688999996421                  0  11122344556899999998644 


Q ss_pred             -CcceeeeeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc
Q 017909           90 -NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA  168 (364)
Q Consensus        90 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~  168 (364)
                       .+++.+++         +..++|||+++|..+..+    +++...+..++..|++-+..+-..|++|||++.-||++++
T Consensus       171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         171 VKVPKPIAW---------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCCcccc---------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence             67777665         566899999998332211    2346666677778888888777999999999999999999


Q ss_pred             CCcEEEeecCccccC
Q 017909          169 NCDLKICDFGLARTS  183 (364)
Q Consensus       169 ~~~~~L~Dfg~~~~~  183 (364)
                      +|.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999877544

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=7.3e-10  Score=92.18  Aligned_cols=126  Identities=26%  Similarity=0.264  Sum_probs=80.7

Q ss_pred             EEEEEeccCCcEEEEEeccch------------------------hhchHHHHHHHHHHHHHHhcCCC--Ccceeeeeec
Q 017909           46 VCSSINRETNEKVAIKKINNV------------------------FENRIDALRTLRELVLLRHIKHD--NVIALKDVMM   99 (364)
Q Consensus        46 V~~~~~~~~~~~~aiK~~~~~------------------------~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~   99 (364)
                      ||.|.. .+|..+|+|+++..                        ...........+|+..|..+..-  ++++++.+  
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            788865 45678999987421                        01111223345899999999755  56666644  


Q ss_pred             cccccccceEEEEecccc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          100 PTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY-LHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                             ...+|||||++  |.....+... .++......++.+++..+.. +|..|++|||+++.||+++++ .+.++|
T Consensus        79 -------~~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   79 -------NRNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             -------ETTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred             -------eCCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence                   23379999998  7433333331 12255667778888885555 689999999999999999988 999999


Q ss_pred             cCccccC
Q 017909          177 FGLARTS  183 (364)
Q Consensus       177 fg~~~~~  183 (364)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988655

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=8e-10  Score=95.29  Aligned_cols=143  Identities=18%  Similarity=0.204  Sum_probs=98.7

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCC--CCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.|+.|..+.||++.... |+.+++|........ .....+..|+.+++.+.+  ..+++++.+.....  ..+..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence            678999999999997643 578999998654321 123355678899998865  34566777665432  113568999


Q ss_pred             ccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 017909          114 ELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-----------------------------------------  151 (364)
Q Consensus       114 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-----------------------------------------  151 (364)
                      |+++| ++.+.+.. ..++......++.+++.+|..||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99986 55443221 245555566666666666666663                                         


Q ss_pred             ---------------CCccccCCCCCCeEEcc--CCcEEEeecCccccC
Q 017909          152 ---------------ANILHRDLKPGNLLVNA--NCDLKICDFGLARTS  183 (364)
Q Consensus       152 ---------------~~i~H~di~~~NIll~~--~~~~~L~Dfg~~~~~  183 (364)
                                     ..++|+|+.+.||+++.  ++.+.|+||+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                           23689999999999998  566899999987543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=3e-09  Score=90.60  Aligned_cols=111  Identities=23%  Similarity=0.271  Sum_probs=85.9

Q ss_pred             HHHHHHHHHHHHHhcCC--CCcceeeeeeccccccccceEEEEeccccc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 017909           72 DALRTLRELVLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMDT--DLHQIIKSSQSLSNDHCKYFVFQLLRGLK  147 (364)
Q Consensus        72 ~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  147 (364)
                      ...+..+|...+..+..  -..++++.+........ ...++|+|.+++  +|.+++......+......++.+++..+.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence            34456677777777742  33555556554432222 457899999985  78888887555788888999999999999


Q ss_pred             HHHHCCccccCCCCCCeEEccCC---cEEEeecCccccC
Q 017909          148 YLHSANILHRDLKPGNLLVNANC---DLKICDFGLARTS  183 (364)
Q Consensus       148 ~lH~~~i~H~di~~~NIll~~~~---~~~L~Dfg~~~~~  183 (364)
                      -||..|++|+|+++.|||++.++   .+.|+||+.+...
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999999887   8999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.02  E-value=8.8e-09  Score=86.27  Aligned_cols=141  Identities=14%  Similarity=0.123  Sum_probs=101.6

Q ss_pred             ccCCceeEEEEEeccCCcEEEEEeccchhhc----hHHHHHHHHHHHHHHhcCCC--CcceeeeeeccccccccceEEEE
Q 017909           39 GRGAYGVVCSSINRETNEKVAIKKINNVFEN----RIDALRTLRELVLLRHIKHD--NVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        39 g~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      |+||-+.|+.....  |+.+-+|........    ......+.+|+..+..+..-  .+++++ ++...........+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            55888888887543  557888876411111    22455667888888887422  255554 3332222233568899


Q ss_pred             eccccc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc--EEEeecCcccc
Q 017909          113 YELMDT--DLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--LKICDFGLART  182 (364)
Q Consensus       113 ~e~~~g--~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~--~~L~Dfg~~~~  182 (364)
                      +|-++|  +|.+++...  .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.++.  +.++||.-+..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  898888653  35677888899999999999999999999999999999987677  99999997653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.00  E-value=8.9e-09  Score=86.53  Aligned_cols=143  Identities=19%  Similarity=0.192  Sum_probs=94.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHH-H------HHHHHHHHhc---CCCCcceeeee
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-T------LRELVLLRHI---KHDNVIALKDV   97 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~-~------~~e~~~l~~l---~h~~iv~~~~~   97 (364)
                      ++++|.+.+.+.......|.+.  ..+|+.+++|..+......+.... +      .+.+..+..+   .....+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            6889999999999888888777  566899999998754333222111 1      1333433333   34444443333


Q ss_pred             eccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909           98 MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      ..-....-....+++|||++| .|.+..    .+++    .+...+.+++.-+|+.|++|||+.|.|++++.+ .++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence            332222112456789999998 554432    1232    244567788999999999999999999999966 499999


Q ss_pred             cCccc
Q 017909          177 FGLAR  181 (364)
Q Consensus       177 fg~~~  181 (364)
                      ++.-.
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.73  E-value=1.8e-07  Score=79.57  Aligned_cols=144  Identities=19%  Similarity=0.146  Sum_probs=96.0

Q ss_pred             cccceeeee---eeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHH-----------------HH-----HHHHHH
Q 017909           28 IDTKYVPIK---PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-----------------RT-----LRELVL   82 (364)
Q Consensus        28 ~~~~y~i~~---~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----------------~~-----~~e~~~   82 (364)
                      +..+..+..   .|++|.-+.||+|.. .++..+|+|+++..........                 ++     .+|+..
T Consensus        43 L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~N  121 (268)
T COG1718          43 LLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRN  121 (268)
T ss_pred             HhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHH
Confidence            444555544   555677779999864 4678999999863222111110                 11     257777


Q ss_pred             HHhcC--CCCcceeeeeeccccccccceEEEEeccccccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Q 017909           83 LRHIK--HDNVIALKDVMMPTHRISFKDVYLVYELMDTDL--HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHR  157 (364)
Q Consensus        83 l~~l~--h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L--~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~  157 (364)
                      |+++.  +-.+++.+..         ....||||+++...  .=.|.. -++...++..+..++++.+.-|-. .+++|+
T Consensus       122 L~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHg  191 (268)
T COG1718         122 LKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHG  191 (268)
T ss_pred             HHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccc
Confidence            77774  3344444444         34589999997421  001111 123344788888999999998876 899999


Q ss_pred             CCCCCCeEEccCCcEEEeecCccccC
Q 017909          158 DLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       158 di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ||+.-|||+. ++.+.++|++.+...
T Consensus       192 DLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         192 DLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             cchhhheEEE-CCeEEEEECcccccc
Confidence            9999999999 779999999988655

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.57  E-value=4.6e-07  Score=91.57  Aligned_cols=214  Identities=22%  Similarity=0.262  Sum_probs=145.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 017909           72 DALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH  150 (364)
Q Consensus        72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH  150 (364)
                      .......|...+..+.|+|++.++.+.......+ .-..+..++|.+ ++...++.-..++....+.+..++.++|.++|
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3344456888888889999999999987763322 122234466764 88888888889999999999999999999999


Q ss_pred             HCCccccCCCCC---CeEEccCCcEEEe--ecCccccCCCCCcccccccccccccCCcccccc-cCCCChhhHHHHHHHH
Q 017909          151 SANILHRDLKPG---NLLVNANCDLKIC--DFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIF  224 (364)
Q Consensus       151 ~~~i~H~di~~~---NIll~~~~~~~L~--Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll  224 (364)
                      +....|.-+..+   +...+..+.+..+  ||+.+........... ......+.++|..... .......|+|++|.+.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            997666555555   4444556666666  8887766544332222 2224456677766542 1233457999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCCh-HHHHHHHHhcccC
Q 017909          225 AEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP-LALDLLQKMLVFE  303 (364)
Q Consensus       225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~d  303 (364)
                      ..+..|..+-....      ..                                   ..+.+..+. .+.+.+.+|+.-+
T Consensus       383 ~~~~~~~~i~~~~~------~~-----------------------------------~~~l~~~~~~~~~d~~~~~~~~~  421 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA------VP-----------------------------------VSLLDVLSTSELLDALPKCLDED  421 (1351)
T ss_pred             hhhhhcCccccccc------ch-----------------------------------hhhhccccchhhhhhhhhhcchh
Confidence            99987764321110      00                                   000111111 4668899999999


Q ss_pred             CCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          304 PSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       304 P~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      +++|+++.+++.|+|.+........
T Consensus       422 ~~~Rl~~~~ll~~~f~~~~~~~~~~  446 (1351)
T KOG1035|consen  422 SEERLSALELLTHPFLRFPTDNESS  446 (1351)
T ss_pred             hhhccchhhhhhchhcccccccccc
Confidence            9999999999999999875544443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=8.1e-07  Score=85.00  Aligned_cols=139  Identities=24%  Similarity=0.346  Sum_probs=90.7

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc--------------------------------------hHHHHHHH
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN--------------------------------------RIDALRTL   77 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------------~~~~~~~~   77 (364)
                      +.++.++-|+||+|+.+. |+.||||+.......                                      -....++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            688999999999999775 999999997421000                                      00111223


Q ss_pred             HHHHHHHhc----CCCCcceeeeeeccccccccceEEEEeccccc-cHHHH--HHhCCCCCHHHHHHHHHHHHHH-HHHH
Q 017909           78 RELVLLRHI----KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQI--IKSSQSLSNDHCKYFVFQLLRG-LKYL  149 (364)
Q Consensus        78 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~--l~~~~~~~~~~~~~i~~qi~~~-l~~l  149 (364)
                      +|+..+.++    +..--+.+-.++.+-.    +...++|||++| .+.+.  +.. ..++...+..   .++.+ +..+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~---~~~~~f~~q~  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAE---LLVRAFLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHH---HHHHHHHHHH
Confidence            455555554    3333444445554422    456899999998 56655  333 4455433333   22222 2333


Q ss_pred             HHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       150 H~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      =..|++|+|..|.||+++.+|.+.+.|||+....
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            4489999999999999999999999999988654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.44  E-value=3.5e-06  Score=72.80  Aligned_cols=133  Identities=21%  Similarity=0.225  Sum_probs=79.1

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC--cceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN--VIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      ..||+|..+.||+.    .+..+++|......    ......+|.++++.+..-.  +++++.+....     ...++||
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-----Ceeeeee
Confidence            57899999999984    25568899886422    2223467888888885332  46666666544     4567899


Q ss_pred             cccccc--HHHHH---------------------HhC--CCCCHHHHH-HHHH----------HHHHH-HHHHHH----C
Q 017909          114 ELMDTD--LHQII---------------------KSS--QSLSNDHCK-YFVF----------QLLRG-LKYLHS----A  152 (364)
Q Consensus       114 e~~~g~--L~~~l---------------------~~~--~~~~~~~~~-~i~~----------qi~~~-l~~lH~----~  152 (364)
                      ++++|.  +...+                     ..-  ...+..... .+..          .+... ..+|..    .
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            999873  11111                     000  011111100 0100          11111 112221    1


Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      .++|||+.|.||++++++ +.++||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            378999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=8.7e-06  Score=70.50  Aligned_cols=139  Identities=22%  Similarity=0.279  Sum_probs=77.9

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC--CcceeeeeeccccccccceEEEE
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD--NVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      ++.++.|..+.||++....  ..+++|.....    .......+|..+++.+...  .+++++........  ....+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~--~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF--NGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE--TSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc--cccceEE
Confidence            5788999999999997664  58999997643    3444555777777777422  35566654322221  1457999


Q ss_pred             eccccc-cHHH----------------HH---HhC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 017909          113 YELMDT-DLHQ----------------II---KSS----QSLSNDH------CKYF---------------VFQLLR-GL  146 (364)
Q Consensus       113 ~e~~~g-~L~~----------------~l---~~~----~~~~~~~------~~~i---------------~~qi~~-~l  146 (364)
                      |++++| .+..                .+   ...    .++....      ....               ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            999986 4444                11   011    1111000      0000               111222 23


Q ss_pred             HHHHH-------CCccccCCCCCCeEEc-cCCcEEEeecCccc
Q 017909          147 KYLHS-------ANILHRDLKPGNLLVN-ANCDLKICDFGLAR  181 (364)
Q Consensus       147 ~~lH~-------~~i~H~di~~~NIll~-~~~~~~L~Dfg~~~  181 (364)
                      ..++.       ..++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            33332       2499999999999999 66677899999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=9.5e-06  Score=71.07  Aligned_cols=133  Identities=14%  Similarity=0.036  Sum_probs=77.3

Q ss_pred             eccCCc-eeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceEEEEecc
Q 017909           38 IGRGAY-GVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYEL  115 (364)
Q Consensus        38 lg~g~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (364)
                      |..|.+ +.||++...  +..+++|......     .....+|+.+++.+. +--+++++.+....     +..++||++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~   73 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTSA   73 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEEe
Confidence            344444 789999543  4688889886432     223456778877773 44466677666544     456899999


Q ss_pred             ccc-cHHHHH----------------H---hCC----CCCHH--HHHHHHH--------------------HHHHHHHHH
Q 017909          116 MDT-DLHQII----------------K---SSQ----SLSND--HCKYFVF--------------------QLLRGLKYL  149 (364)
Q Consensus       116 ~~g-~L~~~l----------------~---~~~----~~~~~--~~~~i~~--------------------qi~~~l~~l  149 (364)
                      ++| ++....                .   .-.    ++...  .......                    .+...+..|
T Consensus        74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  153 (244)
T cd05150          74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL  153 (244)
T ss_pred             eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence            987 444221                0   000    11100  0000000                    011112222


Q ss_pred             HH-------CCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          150 HS-------ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       150 H~-------~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      -.       ..++|+|+.|.||++++++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11       2389999999999999987788999998743

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=8.9e-06  Score=65.72  Aligned_cols=132  Identities=19%  Similarity=0.185  Sum_probs=92.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV-IALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~  107 (364)
                      ....++.+.|+.|.+|.||++.+.  |..+++|+-..+.    ....+..|+++|..++-.++ ++++.+         +
T Consensus        21 ~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~y---------g   85 (201)
T COG2112          21 KYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFY---------G   85 (201)
T ss_pred             chhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEe---------c
Confidence            344566789999999999999776  6799999886543    33345678888888864443 344444         3


Q ss_pred             eEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCCeEEccCCcEEEeecCcccc
Q 017909          108 DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLK-PGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~-~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ..++.|||+.| .|.+.....   +    +.-+..+++...-|-..||-|+.|+ |...++-.++.+.|+||..++.
T Consensus        86 ~~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          86 EDFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            34577999998 666544321   1    3344567777777888999999986 4545555555999999998863

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=2.9e-05  Score=74.37  Aligned_cols=139  Identities=20%  Similarity=0.269  Sum_probs=87.2

Q ss_pred             eeeccCCceeEEEEEeccCCcEEEEEeccchhhc-----------------------------------hHHHHHHHHHH
Q 017909           36 KPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-----------------------------------RIDALRTLREL   80 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------------------------------~~~~~~~~~e~   80 (364)
                      +.||..+.|+|++|+.+. |+.||+|+-+.....                                   -....++.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            578999999999999876 999999997431111                                   00111222344


Q ss_pred             HHHHh----cCCCC---cceeeeeeccccccccceEEEEeccccc-cHH--HHHHhCCCCCHHHHHHHHHHHHHHHHH-H
Q 017909           81 VLLRH----IKHDN---VIALKDVMMPTHRISFKDVYLVYELMDT-DLH--QIIKSSQSLSNDHCKYFVFQLLRGLKY-L  149 (364)
Q Consensus        81 ~~l~~----l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~--~~l~~~~~~~~~~~~~i~~qi~~~l~~-l  149 (364)
                      +...+    +.|-+   -|.+-.++++-.    ....++|||++| .+.  +.+.+. .++...+.   ..+.++... +
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~---~~l~~~~~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL---NKLVEAYLEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHc-CCCHHHHH---HHHHHHHHHHH
Confidence            33333    34444   223334443332    457999999986 333  444443 46665443   333333332 3


Q ss_pred             HHCCccccCCCCCCeEEcc----CCcEEEeecCccccC
Q 017909          150 HSANILHRDLKPGNLLVNA----NCDLKICDFGLARTS  183 (364)
Q Consensus       150 H~~~i~H~di~~~NIll~~----~~~~~L~Dfg~~~~~  183 (364)
                      =..|++|+|-.|.||+++.    ++.+.+.|||+....
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            4578999999999999984    568999999998655

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.08  E-value=8.3e-05  Score=62.49  Aligned_cols=133  Identities=20%  Similarity=0.243  Sum_probs=89.1

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchh--------------hchHHHHHHHHHHHHHHhcC------CCCccee
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVF--------------ENRIDALRTLRELVLLRHIK------HDNVIAL   94 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~   94 (364)
                      ...||+|+...||.-  . .....+||+.....              .......+..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457999999999964  3 33557889987654              00111223334444444443      8899999


Q ss_pred             eeeeccccccccceEEEEecccc---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909           95 KDVMMPTHRISFKDVYLVYELMD---T----DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~---g----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                      +|..+++     ....+|+|.+.   |    ||.+++.. +.++. ..   ...+-+-..+|-+.+|+.+|++|.||++.
T Consensus        83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            9999888     77899998762   2    67787754 44666 33   33444555678889999999999999996


Q ss_pred             cCC----cEEEee-cCcc
Q 017909          168 ANC----DLKICD-FGLA  180 (364)
Q Consensus       168 ~~~----~~~L~D-fg~~  180 (364)
                      .+.    .+.|+| ||..
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            532    466666 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.97  E-value=1.4e-06  Score=83.08  Aligned_cols=261  Identities=16%  Similarity=0.119  Sum_probs=169.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC-cceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN-VIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~  108 (364)
                      .-|...+-+++++++++++.+...+.... .+.+...       ....-++++|.+.+||| .+..++-+..+     ..
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E-----~~  308 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGE-----DY  308 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcc-----cc
Confidence            45667788899999999999765443333 4444321       22334788999999999 55555554444     78


Q ss_pred             EEEEecccccc--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMDTD--LHQIIK-SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~g~--L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .+++++++++.  ...... ..-.+.......+.+.-+.+++++|+.--+|+|    ||+.++ +..++.+|+.......
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence            89999999742  222211 112355556666777788899999998768888    776665 5789999998765533


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .. ..+...+++.++|||+... ..+....|.|++|.--.++.-|.+|-......      ...++..+       +.+.
T Consensus       384 ~~-~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~------~~~~g~~p-------~s~~  448 (829)
T KOG0576|consen  384 TM-KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV------LPMIGNGP-------NSPM  448 (829)
T ss_pred             cc-ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCccc------cCCCCCCC-------Cccc
Confidence            32 3455677889999998877 57888999999998777888777775431100      00000000       0000


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHH-HHHHHhcccCCCCCCCHHHHhcCCCccCC-CCCCCCCCCCCCCCccc
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGL-YDPQCNPPAQVPLSLDI  339 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~li~~~l~~dP~~Rps~~elL~hp~f~~~-~~~~~~~~~~~~~~~~~  339 (364)
                      +.+             ..   ..++... ++.+.|+..-|..|+.....+.|.+|.+= -...|+++-=+|++.+.
T Consensus       449 L~~-------------~~---aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aaswIhp~t~dq  508 (829)
T KOG0576|consen  449 LTD-------------KS---AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAASWIHPSTRDQ  508 (829)
T ss_pred             cch-------------hh---hcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcccceecccccCcchhhh
Confidence            000             00   0111111 47788999999999999999999999874 34456666666766553

>PLN02876 acyl-CoA dehydrogenase

Probab=97.96  E-value=0.00012  Score=75.36  Aligned_cols=83  Identities=13%  Similarity=0.130  Sum_probs=55.2

Q ss_pred             eeeeeccCCceeEEEEEeccCC--cEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCc--ceeeeeeccccccccce
Q 017909           34 PIKPIGRGAYGVVCSSINRETN--EKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNV--IALKDVMMPTHRISFKD  108 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~  108 (364)
                      -++.++.|.++.+|+......+  ..+++|+...... ......+.+|+.+++.+. |+++  ++++.++.+...  .+.
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v--~G~  118 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV--IGT  118 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc--CCC
Confidence            3677899999999998765432  4688887643211 112335668999999885 6654  666666654321  245


Q ss_pred             EEEEecccccc
Q 017909          109 VYLVYELMDTD  119 (364)
Q Consensus       109 ~~lv~e~~~g~  119 (364)
                      .|+|||+++|.
T Consensus       119 ~flVME~v~G~  129 (822)
T PLN02876        119 AFYIMEYLEGR  129 (822)
T ss_pred             ceEEEEecCCc
Confidence            78999999873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.96  E-value=7.1e-05  Score=65.17  Aligned_cols=31  Identities=39%  Similarity=0.536  Sum_probs=25.8

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      +++|||+.+.||+++.++..-|+||+.+...
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            4899999999999987655679999987543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.94  E-value=4.3e-05  Score=68.83  Aligned_cols=142  Identities=22%  Similarity=0.224  Sum_probs=98.1

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHH------------------------HHHHHHHHHhcCC
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR------------------------TLRELVLLRHIKH   88 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~------------------------~~~e~~~l~~l~h   88 (364)
                      +|-..|+.|.-+-||.|+ ..+|..+|||+++.+-....+..+                        +.+|+.-|.++..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            345678889999999987 457788999998632111111110                        1268888888876


Q ss_pred             CCcceeeeeeccccccccceEEEEecccccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCeEE
Q 017909           89 DNVIALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYL-HSANILHRDLKPGNLLV  166 (364)
Q Consensus        89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~di~~~NIll  166 (364)
                      ..|+-.--+..       ....|||+++++. ...-....-.++...+..+-.+++.-+.-| +..++||.||+=-|+|+
T Consensus       226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY  298 (520)
T ss_pred             cCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence            66554433333       3458999999842 211112234678888888888888888876 67799999999999998


Q ss_pred             ccCCcEEEeecCccccC
Q 017909          167 NANCDLKICDFGLARTS  183 (364)
Q Consensus       167 ~~~~~~~L~Dfg~~~~~  183 (364)
                      -. |.+.++|.+.+...
T Consensus       299 hd-G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVEH  314 (520)
T ss_pred             EC-CEEEEEEccccccC
Confidence            75 58999999977543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.92  E-value=0.00015  Score=63.01  Aligned_cols=72  Identities=21%  Similarity=0.243  Sum_probs=44.5

Q ss_pred             eeeeccCCceeEEEEEecc-CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC-CcceeeeeeccccccccceEEEE
Q 017909           35 IKPIGRGAYGVVCSSINRE-TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-NVIALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~~lv  112 (364)
                      ++.|..|-...+|++.... +++.|++|+.........   ...+|+.+++.+... ..++++..+. .        .+|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~---d~~~E~~~~~~l~~~gl~P~v~~~~~-~--------~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELII---DRERELRIHKLLSKHGLAPKLYATFQ-N--------GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcccee---cHHHHHHHHHHHHhCCCCCeEEEEeC-C--------cEE
Confidence            4667888888999986443 357899998764321111   223577788777433 3444443321 1        489


Q ss_pred             eccccc
Q 017909          113 YELMDT  118 (364)
Q Consensus       113 ~e~~~g  118 (364)
                      |||++|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.84  E-value=9.9e-05  Score=61.65  Aligned_cols=132  Identities=21%  Similarity=0.218  Sum_probs=90.2

Q ss_pred             cceeeeeeeccCCc-eeEEEEEeccCCcEEEEEeccc---hhh--------ch--------HHHHHHHHHHHHHHhc---
Q 017909           30 TKYVPIKPIGRGAY-GVVCSSINRETNEKVAIKKINN---VFE--------NR--------IDALRTLRELVLLRHI---   86 (364)
Q Consensus        30 ~~y~i~~~lg~g~~-g~V~~~~~~~~~~~~aiK~~~~---~~~--------~~--------~~~~~~~~e~~~l~~l---   86 (364)
                      ..++.++.||.|.. |.||++..  .|..||+|++..   ...        ..        ....-+..|.....++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            79999999999999 99999954  588999999421   000        00        1122344566666666   


Q ss_pred             CCCCc--ceeeeeecccc-------------ccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017909           87 KHDNV--IALKDVMMPTH-------------RISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS  151 (364)
Q Consensus        87 ~h~~i--v~~~~~~~~~~-------------~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~  151 (364)
                      .+.++  ++++++..-..             ........||.||....-        .+....    +.+|+.-+..+|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k  182 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHK  182 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHH
Confidence            34455  99999875431             011223578888876422        233333    4567777889999


Q ss_pred             CCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          152 ANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       152 ~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      .||+-+|+++.|..     .=+|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999986     3488999864

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.80  E-value=0.0001  Score=69.14  Aligned_cols=174  Identities=25%  Similarity=0.354  Sum_probs=112.7

Q ss_pred             HHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 017909           74 LRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN  153 (364)
Q Consensus        74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  153 (364)
                      .+++--..+++.+.|++..+++.+-....    ....+|+|+++-++.+.+..+. +......              .+|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~~   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AHG   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------ccc
Confidence            34556778999999999999998865543    4488999999999999887654 2222211              122


Q ss_pred             ccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC
Q 017909          154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI  233 (364)
Q Consensus       154 i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p  233 (364)
                      +.|-     |+       ++.+| .+...                |  |      ....+++|||++|.++.++.-|...
T Consensus        88 ~~~~-----~~-------~~~td-~~~t~----------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   88 VLHL-----NI-------IYITD-HFLTK----------------Y--P------SPIGPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             ccee-----hh-------hhccc-ccccc----------------C--C------CCCCcchhhhhHHHHHHHHHHhhHH
Confidence            2221     11       22222 00000                0  1      1122599999999999999999888


Q ss_pred             CCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHH
Q 017909          234 FPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA  313 (364)
Q Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  313 (364)
                      +......+....+.+....+.. ........   .               +...++.....+..+|+-..|..||...++
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~-~~~~a~e~---~---------------~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQE-LLSTAMEH---L---------------IQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchh-HHHHHHHH---H---------------HHHhhhHhHHHHhccCCccccccccchhHH
Confidence            8776666666555543322221 11111000   1               112356678899999999999999999999


Q ss_pred             hcCCCccCC
Q 017909          314 LQHPYISGL  322 (364)
Q Consensus       314 L~hp~f~~~  322 (364)
                      .+++-|+++
T Consensus       192 ~k~~i~~ev  200 (725)
T KOG1093|consen  192 SKRCSFTEV  200 (725)
T ss_pred             hcCccHHHH
Confidence            999999887

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.69  E-value=8.8e-05  Score=65.85  Aligned_cols=139  Identities=16%  Similarity=0.147  Sum_probs=96.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccch--------------------hhchHHHHHHHHHHHHHHhcC
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV--------------------FENRIDALRTLRELVLLRHIK   87 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~--------------------~~~~~~~~~~~~e~~~l~~l~   87 (364)
                      -..-+.++..||=|.-+-||.+.+. .|...++|.-..-                    .+-........+|+..++.+.
T Consensus        90 R~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~  168 (465)
T KOG2268|consen   90 RGSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY  168 (465)
T ss_pred             cchhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence            3345788999999999999999754 5778888854210                    011112233457888888884


Q ss_pred             C-C-CcceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 017909           88 H-D-NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNL  164 (364)
Q Consensus        88 h-~-~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NI  164 (364)
                      . - -+++.+++         +..++||+++.| .|...-      ....+..+...+...+--|..+|++|||+.=-||
T Consensus       169 e~gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  169 ERGFPVPKPIDH---------NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNI  233 (465)
T ss_pred             HcCCCCCCcccc---------cceeeHHHhhcccceeeee------ecCChHHHHHHHHHHHHHHHHcCceecccchhee
Confidence            3 2 23344433         556899999987 554321      1223344556667777788899999999999999


Q ss_pred             EEccCCcEEEeecCcccc
Q 017909          165 LVNANCDLKICDFGLART  182 (364)
Q Consensus       165 ll~~~~~~~L~Dfg~~~~  182 (364)
                      +++.++.++++||-.+..
T Consensus       234 mv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  234 MVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             EEecCCCEEEeechHhhc
Confidence            999999999999986643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.68  E-value=0.0002  Score=63.15  Aligned_cols=133  Identities=20%  Similarity=0.210  Sum_probs=74.4

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeccccccccceEEEEecc
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV-IALKDVMMPTHRISFKDVYLVYEL  115 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~  115 (364)
                      .+..|-.+.+|+..  .++..+++|......... . ....+|..+++.+....+ ++++...  .       -++|++|
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEe
Confidence            45677788999885  457789999865421111 0 123457788877753323 3444332  1       2689999


Q ss_pred             ccc-cHHH--------------HHH---hC----CCCCHH-HHHHHHHHH---------HHHHHHHHHC--------Ccc
Q 017909          116 MDT-DLHQ--------------IIK---SS----QSLSND-HCKYFVFQL---------LRGLKYLHSA--------NIL  155 (364)
Q Consensus       116 ~~g-~L~~--------------~l~---~~----~~~~~~-~~~~i~~qi---------~~~l~~lH~~--------~i~  155 (364)
                      ++| .+..              .+.   ..    .+++.. .+..+..++         ...+..+-..        .+|
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            886 3211              111   10    112211 111221111         1122222221        489


Q ss_pred             ccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          156 HRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       156 H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      |+|+.|.||++++++ +.|+||+.+...
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            999999999999876 789999987544

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.60  E-value=0.002  Score=60.19  Aligned_cols=77  Identities=19%  Similarity=0.113  Sum_probs=50.9

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchh----h-chHHHHHHHHHHHHHHhcC---CCCcceeeeeecccccccc
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVF----E-NRIDALRTLRELVLLRHIK---HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~----~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.||.|....||++.....++.+++|.-....    . ......+...|...|+.+.   -.++++++.+-.       
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-------  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-------  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence            467899999999999886444589999753110    1 1123345556778887762   245677776632       


Q ss_pred             ceEEEEeccccc
Q 017909          107 KDVYLVYELMDT  118 (364)
Q Consensus       107 ~~~~lv~e~~~g  118 (364)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            446899999874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.56  E-value=0.00086  Score=60.49  Aligned_cols=142  Identities=16%  Similarity=0.039  Sum_probs=78.3

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC--Ccceeeeeecccc-ccccceEEE
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD--NVIALKDVMMPTH-RISFKDVYL  111 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~-~~~~~~~~l  111 (364)
                      ++.+..|....+|++..  ++..+++|++..  .   .......|+.++..+...  .+++++....... ....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            56777888889998853  345799998864  1   122344566666666322  2444444211100 001145689


Q ss_pred             Eeccccc-cHH----HHH----------Hh-CCCC----------CHHHH----------HHHHHHHHHHHHHHHH----
Q 017909          112 VYELMDT-DLH----QII----------KS-SQSL----------SNDHC----------KYFVFQLLRGLKYLHS----  151 (364)
Q Consensus       112 v~e~~~g-~L~----~~l----------~~-~~~~----------~~~~~----------~~i~~qi~~~l~~lH~----  151 (364)
                      |+++++| .+.    ..+          .. ...+          .+...          ......+..++..+..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999976 211    000          00 0000          00000          0011122333444443    


Q ss_pred             ---CCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          152 ---ANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       152 ---~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                         .++||+|+.|.||+++.++.+.|+||+.+...
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g  206 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD  206 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence               36999999999999999877789999987543

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.51  E-value=0.00033  Score=58.55  Aligned_cols=97  Identities=22%  Similarity=0.213  Sum_probs=76.8

Q ss_pred             HHHHHHHhcCC-CCcceeeeeeccccccccceEEEEecccc-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 017909           78 RELVLLRHIKH-DNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQI---IKSSQSLSNDHCKYFVFQLLRGLKYLHSA  152 (364)
Q Consensus        78 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~---l~~~~~~~~~~~~~i~~qi~~~l~~lH~~  152 (364)
                      +|.-++..+++ +++++++|+|        + .++|.|+.+ +++...   +......++.....++.++++.+.+++..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            57888888865 6999999997        2 257889988 455421   12223578999999999999999999873


Q ss_pred             ---CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          153 ---NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       153 ---~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                         .+.-.|++++|+-++.+++++++|...+...
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence               3677899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.48  E-value=0.0032  Score=57.48  Aligned_cols=30  Identities=27%  Similarity=0.340  Sum_probs=26.0

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ++||+|+.+.||+++.+...-|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            799999999999999765568999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.43  E-value=0.0027  Score=57.61  Aligned_cols=143  Identities=16%  Similarity=0.125  Sum_probs=76.7

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC--cceeeeeecccc-ccccceEE
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN--VIALKDVMMPTH-RISFKDVY  110 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~-~~~~~~~~  110 (364)
                      ..+.++.|....+|++..  ++..+++|.+.... .   ......+..++..+....  +++++....... ....+..+
T Consensus        26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             eccccCCccccceEEEEe--CCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            356677787789998853  34468899875421 1   112234556666553222  444444221110 00114578


Q ss_pred             EEecccccc-H----HHH-------H---H-hCCCCCH-------HHHHH----------------HHHHHHHHHHHHHH
Q 017909          111 LVYELMDTD-L----HQI-------I---K-SSQSLSN-------DHCKY----------------FVFQLLRGLKYLHS  151 (364)
Q Consensus       111 lv~e~~~g~-L----~~~-------l---~-~~~~~~~-------~~~~~----------------i~~qi~~~l~~lH~  151 (364)
                      ++++|++|. +    .+.       +   . ....++.       ...+.                ....+...+.++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999998762 1    111       1   1 0011100       00000                01112234444432


Q ss_pred             -------CCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          152 -------ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       152 -------~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                             .++||+|+.+.||+++.++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                   5799999999999999987778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.28  E-value=0.0042  Score=56.16  Aligned_cols=30  Identities=33%  Similarity=0.456  Sum_probs=26.4

Q ss_pred             CccccCCCCCCeEEccC----CcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNAN----CDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~----~~~~L~Dfg~~~~  182 (364)
                      .+||+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            48999999999999985    7899999998743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.20  E-value=0.0061  Score=55.01  Aligned_cols=147  Identities=14%  Similarity=0.157  Sum_probs=82.3

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC--CCCcceeeeeeccccccccceE
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK--HDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ..+++.+..|-...+|.....  ++.++++ ............+..+|+.+++.+.  ..-+...+++|.+..   .+..
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~p  100 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTP  100 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCc
Confidence            345555555555566666444  7889999 3311122223334446777777763  233445556665553   2577


Q ss_pred             EEEeccccc-cHH------------------HHHHh-------C-------CCCCHHHHHHHHHH--------------H
Q 017909          110 YLVYELMDT-DLH------------------QIIKS-------S-------QSLSNDHCKYFVFQ--------------L  142 (364)
Q Consensus       110 ~lv~e~~~g-~L~------------------~~l~~-------~-------~~~~~~~~~~i~~q--------------i  142 (364)
                      +.||+|+.| .+.                  +.+..       .       .......+..+..+              +
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            999999877 211                  11110       0       00011111111111              1


Q ss_pred             HHHHHHHHHC--------CccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          143 LRGLKYLHSA--------NILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       143 ~~~l~~lH~~--------~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .....+++.+        .++|||+.+.|++++.++-+-|.||+.+...+
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            1223344432        38999999999999999889999999986653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.16  E-value=0.0031  Score=57.80  Aligned_cols=30  Identities=37%  Similarity=0.541  Sum_probs=25.9

Q ss_pred             ccccCCCCCCeEEcc-CCcEEEeecCccccC
Q 017909          154 ILHRDLKPGNLLVNA-NCDLKICDFGLARTS  183 (364)
Q Consensus       154 i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~  183 (364)
                      +||+|+.+.||++++ ++.++++||+.+...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            799999999999975 568999999987543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.04  E-value=0.0097  Score=54.55  Aligned_cols=82  Identities=15%  Similarity=0.034  Sum_probs=50.4

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccch-----hhchHHHHHHHHHHHHHHhcC--CC-Ccceeeeeeccccccccce
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNV-----FENRIDALRTLRELVLLRHIK--HD-NVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+|.|....||++.+...++.++||.-..-     ........+..-|...|+...  .| .+++++.+  +.     ..
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~-----e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DT-----EM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cc-----cc
Confidence            578999999999987543467999854311     112334445556778887763  34 45555554  22     44


Q ss_pred             EEEEeccccc--cHHHHHH
Q 017909          109 VYLVYELMDT--DLHQIIK  125 (364)
Q Consensus       109 ~~lv~e~~~g--~L~~~l~  125 (364)
                      ..+|||+++.  .+++.+.
T Consensus        75 ~~~vMEdL~~~~ilR~~Li   93 (370)
T TIGR01767        75 AVTVMEDLSHHKIARKGLI   93 (370)
T ss_pred             ceehHhhCccchHHHHHHH
Confidence            5799999863  4555543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.00  E-value=0.00018  Score=75.42  Aligned_cols=154  Identities=15%  Similarity=0.077  Sum_probs=109.3

Q ss_pred             HHHHHHHHhcCCCCcceeeeeeccccccccceEEEEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH
Q 017909           77 LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHS  151 (364)
Q Consensus        77 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~  151 (364)
                      +.|.+-++...|+++.....-......   ...++.++++. |.+.+.+-.+    ..+...-+.....+......-+|+
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            345555566688887766554443322   45688999987 7888888643    223333333333333666666665


Q ss_pred             CC-----ccccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHH
Q 017909          152 AN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE  226 (364)
Q Consensus       152 ~~-----i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~  226 (364)
                      +.     .+|.++++-|.++..+-+++++++|+.+.............+++.|++|+.... -.++.++|+|.+|+.+|.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHH
Confidence            52     689999999999999999999999999854444444555566778888887765 467778999999999999


Q ss_pred             HHhCCCCC
Q 017909          227 ILGRKPIF  234 (364)
Q Consensus       227 l~~g~~pf  234 (364)
                      ...|..+|
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            99888877

>PLN02236 choline kinase

Probab=97.00  E-value=0.0095  Score=54.96  Aligned_cols=140  Identities=17%  Similarity=0.192  Sum_probs=77.3

Q ss_pred             eeeeeeeccCCceeEEEEEecc----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC-Ccceeeeeecccccccc
Q 017909           32 YVPIKPIGRGAYGVVCSSINRE----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-NVIALKDVMMPTHRISF  106 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~  106 (364)
                      ..-+..+..|-...+|++....    .++.+++|+.........+   ..+|..+++.+... --+++++.+. .     
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id---R~~E~~~~~~l~~~gl~P~~~~~~~-~-----  108 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD---RDDEIRTFECMSRHGQGPRLLGRFP-N-----  108 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec---hHHHHHHHHHHHHcCCCCceEEEEC-C-----
Confidence            3344566668888999986432    3468999988653222222   24577777777433 3345555542 2     


Q ss_pred             ceEEEEeccccc-cHHH----------HH----H---hCC------CCCHHHHHHHHHHH-----------------HHH
Q 017909          107 KDVYLVYELMDT-DLHQ----------II----K---SSQ------SLSNDHCKYFVFQL-----------------LRG  145 (364)
Q Consensus       107 ~~~~lv~e~~~g-~L~~----------~l----~---~~~------~~~~~~~~~i~~qi-----------------~~~  145 (364)
                         ..|.+|++| ++..          .+    .   ...      ......+..+..++                 ...
T Consensus       109 ---g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~  185 (344)
T PLN02236        109 ---GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE  185 (344)
T ss_pred             ---ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence               246777764 3211          01    0   100      01122333332221                 111


Q ss_pred             HHHH----H----HCCccccCCCCCCeEEcc-CCcEEEeecCccccC
Q 017909          146 LKYL----H----SANILHRDLKPGNLLVNA-NCDLKICDFGLARTS  183 (364)
Q Consensus       146 l~~l----H----~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~  183 (364)
                      +..|    .    ...+||+|+++.||++++ ++.+.|+||+.+...
T Consensus       186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            1112    1    124899999999999976 468999999987543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.94  E-value=0.015  Score=54.21  Aligned_cols=76  Identities=17%  Similarity=0.149  Sum_probs=49.8

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccc-----hhhchHHHHHHHHHHHHHHhcC---CCCcceeeeeeccccccc
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINN-----VFENRIDALRTLRELVLLRHIK---HDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~  105 (364)
                      ..+.+|.|....||++.+.  +..++||.-..     .....-...+...|+..|+.+.   -..+++++.++.+.    
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence            4678899999999999763  45688987641     1101112334445677776663   24788888887633    


Q ss_pred             cceEEEEeccccc
Q 017909          106 FKDVYLVYELMDT  118 (364)
Q Consensus       106 ~~~~~lv~e~~~g  118 (364)
                         .+++||++++
T Consensus       110 ---~vlvME~L~~  119 (418)
T PLN02756        110 ---ALIGMRYLEP  119 (418)
T ss_pred             ---CEEEEeecCC
Confidence               4788999865

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.92  E-value=0.01  Score=55.03  Aligned_cols=83  Identities=19%  Similarity=0.095  Sum_probs=52.4

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEecc----chhhchHHHHHHHHHHHHHHhcC--CC-Ccceeeeeeccccccccc
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLLRHIK--HD-NVIALKDVMMPTHRISFK  107 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~----~~~~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  107 (364)
                      .+.||.|.-..||++.+...++.++||.-.    ..........+..-|...|+...  .| ++++++.+  +.     .
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~-----e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS-----V  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc-----H
Confidence            678899999999999874445678888532    11122334455566888888763  34 45555554  22     4


Q ss_pred             eEEEEeccccc--cHHHHH
Q 017909          108 DVYLVYELMDT--DLHQII  124 (364)
Q Consensus       108 ~~~lv~e~~~g--~L~~~l  124 (364)
                      ...+|||+++.  .|++.+
T Consensus       107 ~~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        107 MNCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             HhhHHHHhCcccHHHHHHH
Confidence            45788888853  455444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.68  E-value=0.032  Score=50.64  Aligned_cols=31  Identities=16%  Similarity=0.191  Sum_probs=28.0

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ++||+|+.++||++++++.+.++||..+...
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            6999999999999999999999999987544

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.66  E-value=0.031  Score=52.22  Aligned_cols=30  Identities=27%  Similarity=0.247  Sum_probs=25.0

Q ss_pred             CCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          152 ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       152 ~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ..+||.|+.+.||+.+.+ .+.++||..+..
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEeccccC
Confidence            358999999999997654 699999998754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.50  E-value=0.11  Score=47.03  Aligned_cols=30  Identities=20%  Similarity=0.375  Sum_probs=25.9

Q ss_pred             CCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          152 ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       152 ~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      .++||||+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            46899999999999988 5789999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.36  E-value=0.043  Score=48.95  Aligned_cols=30  Identities=27%  Similarity=0.645  Sum_probs=25.3

Q ss_pred             ccccCCCCCCeEEccCCc-EEEeecCccccC
Q 017909          154 ILHRDLKPGNLLVNANCD-LKICDFGLARTS  183 (364)
Q Consensus       154 i~H~di~~~NIll~~~~~-~~L~Dfg~~~~~  183 (364)
                      ++|+|+++.||+++.++. .-|+||+.+...
T Consensus       187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         187 LVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            899999999999997555 569999987544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK10593 hypothetical protein; Provisional

Probab=96.28  E-value=0.033  Score=50.30  Aligned_cols=109  Identities=12%  Similarity=0.065  Sum_probs=72.5

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCC---CCcceeeeeeccccccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH---DNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~  107 (364)
                      ...-.+.||.|..+.||.....  +..+++|..+.    ......+..|+..|+.+..   -.++++++.+......  +
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~--g   86 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP--G   86 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC--CCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC--C
Confidence            4555678999999999998543  33577787543    1122345678888888843   4678888776543211  5


Q ss_pred             eEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 017909          108 DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA  152 (364)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~  152 (364)
                      ..++|||+++| ++.+ .    ..+......+..+++.+|..||+.
T Consensus        87 ~~~LVmE~i~G~~~~~-~----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         87 PDVLLLERLRGVSVEA-P----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CeEEEEeccCCEecCC-C----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            57999999986 5543 1    123444556677888888888874

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.10  E-value=0.052  Score=49.50  Aligned_cols=106  Identities=17%  Similarity=0.243  Sum_probs=72.7

Q ss_pred             ceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .+.|++|++-++++.-    .+.....++..++.+.+..+.-+..+ .+-|+|+...||+++ +|+|.|+||-+++...+
T Consensus       299 ~y~yl~~kdhgt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            6788999988876532    23456778888888888777777655 588999999999999 99999999999874433


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHH
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF  224 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll  224 (364)
                      +......     ..--|-.+.+  .-+..-+||.+--.+
T Consensus       374 q~~isy~-----rldhp~lF~G--~dd~QFeIYrlMr~l  405 (488)
T COG5072         374 QGIISYN-----RLDHPDLFNG--VDDYQFEIYRLMRRL  405 (488)
T ss_pred             Cceeecc-----ccCchhhhcC--ccceeeeHHHHHHHH
Confidence            3322211     1223444443  336777888754443

>PTZ00296 choline kinase; Provisional

Probab=95.91  E-value=0.067  Score=51.00  Aligned_cols=29  Identities=24%  Similarity=0.417  Sum_probs=24.4

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      .+||+|+.+.||+.+.+ .++|+||..+..
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence            38999999999987755 499999998743

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.64  E-value=0.018  Score=51.56  Aligned_cols=136  Identities=19%  Similarity=0.182  Sum_probs=87.8

Q ss_pred             eeeeeccCCceeEEEEEe-------cc---CCcEEEEEeccchhhchHHHH----------------------HH--HHH
Q 017909           34 PIKPIGRGAYGVVCSSIN-------RE---TNEKVAIKKINNVFENRIDAL----------------------RT--LRE   79 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~-------~~---~~~~~aiK~~~~~~~~~~~~~----------------------~~--~~e   79 (364)
                      |...|+.|.-++|+-|.-       ..   ....+|||+++..........                      ++  .+|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            445778888888888842       11   235689998863211111111                      11  135


Q ss_pred             HHHHHhc-----CCCCcceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHC
Q 017909           80 LVLLRHI-----KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL-HSA  152 (364)
Q Consensus        80 ~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~  152 (364)
                      +--|.++     .+|-+|.+            ....+||.+++. .+..--...-.++..+....-.|+..++.-| |..
T Consensus       336 mhNL~RMq~~GlpcP~vV~l------------kkhvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec  403 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKL------------KKHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKEC  403 (531)
T ss_pred             HHHHHHHHhcCCCCCceeee------------ecceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhh
Confidence            5445444     34555544            345799999973 2211111223588888888888999988876 677


Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      -++|.|++-.|+|...+ .+-++|...+..
T Consensus       404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQsve  432 (531)
T KOG2269|consen  404 LLVHADLSEYNLLWTPG-KVWVIDVSQSVE  432 (531)
T ss_pred             heeecchhhhhheecCC-ceEEEechhccC
Confidence            89999999999999987 889999886643

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.55  E-value=0.54  Score=43.03  Aligned_cols=28  Identities=36%  Similarity=0.487  Sum_probs=23.9

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      +++|+|+.+.||+++ + .+.|+||+.+..
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            589999999999995 4 578999998753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.48  E-value=0.081  Score=47.36  Aligned_cols=74  Identities=14%  Similarity=0.056  Sum_probs=43.9

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccccccce
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+-.+.++.|....+|+..  .+++.+.+|+-.....     ..+..|+.-|+.+   .--.+++++.+....     ..
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~   86 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DD   86 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SC
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CC
Confidence            4556788999999999985  6788999998763222     2233466666666   345677888877655     44


Q ss_pred             EEEEecccc
Q 017909          109 VYLVYELMD  117 (364)
Q Consensus       109 ~~lv~e~~~  117 (364)
                      .++|+||++
T Consensus        87 ~fLlle~l~   95 (288)
T PF03881_consen   87 AFLLLEFLE   95 (288)
T ss_dssp             CEEEEE---
T ss_pred             ceEEEEeec
Confidence            599999986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.20  E-value=0.26  Score=45.05  Aligned_cols=28  Identities=39%  Similarity=0.628  Sum_probs=25.6

Q ss_pred             ccccCCCCCCeEEccCCc-EEEeecCccc
Q 017909          154 ILHRDLKPGNLLVNANCD-LKICDFGLAR  181 (364)
Q Consensus       154 i~H~di~~~NIll~~~~~-~~L~Dfg~~~  181 (364)
                      ++|+|+.|.||+++.+.. ..++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999999875 8999999874

>PRK06148 hypothetical protein; Provisional

Probab=94.55  E-value=0.89  Score=48.30  Aligned_cols=31  Identities=35%  Similarity=0.551  Sum_probs=25.9

Q ss_pred             CCccccCCCCCCeEEccCC--cEE-EeecCcccc
Q 017909          152 ANILHRDLKPGNLLVNANC--DLK-ICDFGLART  182 (364)
Q Consensus       152 ~~i~H~di~~~NIll~~~~--~~~-L~Dfg~~~~  182 (364)
                      .+++|+|+.++||+++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3699999999999999875  454 999998754

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.48  E-value=0.44  Score=40.86  Aligned_cols=74  Identities=14%  Similarity=0.034  Sum_probs=46.7

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccccccce
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+..+.+..|.--..|...+  ...++.+|+-..+     ....+.-|+.-|+.+   +--.+++++.+-...     .+
T Consensus        18 i~er~~v~gG~inea~~v~d--g~~~~FvK~n~~~-----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~-----~~   85 (286)
T COG3001          18 IKEREEVSGGDINEAWRLRD--GTDPFFVKCNQRE-----QLSMFTAEADGLELLARSNTITVPKVIAVGASR-----DH   85 (286)
T ss_pred             hhcccccCCccccceeEeec--CCcceEEEecchh-----hHHHHHHHHHHHHHHHhcCCccccceEEecCCC-----Ce
Confidence            33445566666666676643  3567888876433     223334466666555   345677777776655     78


Q ss_pred             EEEEecccc
Q 017909          109 VYLVYELMD  117 (364)
Q Consensus       109 ~~lv~e~~~  117 (364)
                      .|+|++|++
T Consensus        86 sylVle~L~   94 (286)
T COG3001          86 SYLVLEYLP   94 (286)
T ss_pred             eEEEEeecc
Confidence            999999986

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.41  E-value=0.19  Score=42.70  Aligned_cols=116  Identities=16%  Similarity=0.123  Sum_probs=67.9

Q ss_pred             CCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEeccccccH
Q 017909           41 GAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL  120 (364)
Q Consensus        41 g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L  120 (364)
                      ++.++.-.+..+.  .+..+|++......- ...-+.++..++.++  ..|+++.   .++    ...+.++.|+|...-
T Consensus        73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~-~~~~y~nky~v~Arm--hGilrL~---NDn----~~~yGvIlE~Cy~~~  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCI-NDALYFNKYRVFARM--HGILRLK---NDN----NYKYGVILERCYKIK  140 (308)
T ss_pred             CCceEEEEecccc--chhhhhhccCCCccc-chhhhhhhhhHHHHh--hheeEee---cCC----CceeEEEEeeccCcc
Confidence            4445555553332  345556555432321 222335677777654  2455554   121    156789999986311


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA--NILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       121 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      .        ...    .++..=+.+|.-.|+.  +..|||-.|+||+-++.|.+||.|-+..
T Consensus       141 i--------~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 I--------NFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             c--------chh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            0        011    1111124567778844  5999999999999999999999998754

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	364
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-93
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-93
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-91
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-91
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-91
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-91
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-91
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-91
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-91
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-91
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-91
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-91
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-91
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-91
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-91
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-90
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-90
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-90
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-90
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-90
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-90
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-89
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-89
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-89
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-89
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-89
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-89
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-88
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-88
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-83
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-83
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-83
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-82
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-82
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-82
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-82
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-82
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-82
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-82
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-82
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-82
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-82
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-82
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-82
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-82
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-82
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-82
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-82
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-82
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-82
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-82
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-82
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-82
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-82
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-82
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-82
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-82
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-82
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-82
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-82
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-82
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-82
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-82
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-82
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-82
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-82
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-82
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-82
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-82
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-82
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-82
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-82
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-81
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-81
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-81
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-81
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-81
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-81
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-81
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-81
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-81
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-81
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-81
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-81
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-81
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-81
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-81
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-81
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-81
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-81
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-81
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-79
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-79
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-76
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-72
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-69
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-69
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-68
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-68
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-68
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-68
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-68
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-68
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-68
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-68
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-68
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-68
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-68
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-67
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-67
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-67
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-67
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-67
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-67
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-67
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-67
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-67
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-67
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-67
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-67
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-66
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-66
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-66
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-66
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-66
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-66
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-66
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-66
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-65
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-64
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-62
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-61
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-55
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-54
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-53
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-51
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-51
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-51
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-51
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-51
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-51
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-51
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-51
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-51
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-51
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-51
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-50
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-50
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-50
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-50
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-50
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-50
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-50
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-50
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-50
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-50
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-50
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-50
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-50
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-50
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-50
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-50
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-50
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-50
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-50
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-50
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-50
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-50
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-50
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-50
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-50
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-50
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-49
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-49
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-48
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-48
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-48
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-47
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-47
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-47
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-46
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-44
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-44
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-44
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-44
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-43
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-43
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-42
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-41
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-41
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-41
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-41
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-41
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-41
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-41
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-41
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-41
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-41
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-40
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-40
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-40
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-40
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-40
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-40
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-40
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-40
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-40
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-40
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-40
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-40
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-38
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-38
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-38
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-38
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-38
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-37
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-35
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-35
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-31
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-31
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-31
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-30
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-30
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-29
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-29
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		7e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-29
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-28
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-28
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-27
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-27
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-27
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-27
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-26
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-26
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-26
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-26
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-26
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-26
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-25
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-25
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-24
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-24
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-24
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-24
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-24
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-23
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-23
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-23
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-23
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-23
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-23
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-23
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-23
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-23
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-23
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-22
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-22
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-22
3soa_A	444	Full-Length Human Camkii Length = 444		3e-22
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-22
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-22
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-22
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-22
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-21
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-21
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-21
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-21
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-21
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-21
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-21
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-21
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-21
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-21
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-21
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-21
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-21
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-21
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-21
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-21
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-20
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-20
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-20
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-20
2jam_B	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-20
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-20
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		9e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-19
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-19
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-19
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-19
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-18
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-17
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-16
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-16
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-16
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-16
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-16
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-16
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-16
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-16
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-16
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-16
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-16
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-16
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-15
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-15
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-15
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-15
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-14
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-13
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-13
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-09
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-08

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  338 bits (866), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 175/375 (46%), Positives = 239/375 (63%), Gaps = 19/375 (5%)
Query: 5   VEPPNGMKSRGKHYYTM-------------WQTLFEIDTKYVPIKPIGRGAYGVVCSSIN 51
            EPP  +K+   H                 +   F++  +Y  I+ IG GAYGVV S+  
Sbjct: 16  AEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARR 75
Query: 52  RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVY 110
           R T ++VAIKKI N F+   +A RTLREL +L+H KHDN+IA+KD++ PT     FK VY
Sbjct: 76  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135
Query: 111 LVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC 170
           +V +LM++DLHQII SSQ L+ +H +YF++QLLRGLKY+HSA ++HRDLKP NLLVN NC
Sbjct: 136 VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC 195
Query: 171 DLKICDFGLAR---TSRGNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE 226
           +LKI DFG+AR   TS    Q FMTEYV TRWYRAPEL+L    Y  +ID+WSVGCIF E
Sbjct: 196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 255
Query: 227 ILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYP 286
           +L R+ +FPG   ++QL+LI+ V GT   A ++ +   + R +I+SLP  +     ++YP
Sbjct: 256 MLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYP 315
Query: 287 QADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID-ENIGE 345
            AD  AL LL +ML FEPS RI+   AL+HP+++  +DP   P    P     D E +  
Sbjct: 316 GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTR 375
Query: 346 QMIRQMMWNETLHYH 360
           + I++ +  E   +H
Sbjct: 376 ERIKEAIVAEIEDFH 390

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  337 bits (864), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 175/375 (46%), Positives = 239/375 (63%), Gaps = 19/375 (5%)
Query: 5   VEPPNGMKSRGKHYYTM-------------WQTLFEIDTKYVPIKPIGRGAYGVVCSSIN 51
            EPP  +K+   H                 +   F++  +Y  I+ IG GAYGVV S+  
Sbjct: 17  AEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARR 76
Query: 52  RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVY 110
           R T ++VAIKKI N F+   +A RTLREL +L+H KHDN+IA+KD++ PT     FK VY
Sbjct: 77  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 136
Query: 111 LVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC 170
           +V +LM++DLHQII SSQ L+ +H +YF++QLLRGLKY+HSA ++HRDLKP NLLVN NC
Sbjct: 137 VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC 196
Query: 171 DLKICDFGLAR---TSRGNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE 226
           +LKI DFG+AR   TS    Q FMTEYV TRWYRAPEL+L    Y  +ID+WSVGCIF E
Sbjct: 197 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 256
Query: 227 ILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYP 286
           +L R+ +FPG   ++QL+LI+ V GT   A ++ +   + R +I+SLP  +     ++YP
Sbjct: 257 MLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYP 316
Query: 287 QADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID-ENIGE 345
            AD  AL LL +ML FEPS RI+   AL+HP+++  +DP   P    P     D E +  
Sbjct: 317 GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTR 376
Query: 346 QMIRQMMWNETLHYH 360
           + I++ +  E   +H
Sbjct: 377 ERIKEAIVAEIEDFH 391

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  331 bits (849), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 233/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 74
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 133
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+ ++ DL  I
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 314 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  331 bits (849), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 233/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILL 78
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 137
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY++ 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 318 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  331 bits (848), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 26  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 84
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 143
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 264 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 324 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 367

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  331 bits (848), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  330 bits (847), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 78
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 137
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 318 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  330 bits (847), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  330 bits (847), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILL 96
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 155
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 336 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 379

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 74
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 133
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 314 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 81
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 140
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 321 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 24  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 82
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 141
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 262 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 322 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 365

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 15  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 73
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 132
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 253 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 313 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 356

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 160/340 (47%), Positives = 235/340 (69%), Gaps = 6/340 (1%)
Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F++  +Y  ++ IG GAYG+V S+ +     +VAIKKI+  FE++    RTLRE+ +L  
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISP-FEHQTYCQRTLREIQILLR 97
Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            +H+NVI ++D++  +   + +DVY+V +LM+TDL++++KS Q LSNDH  YF++Q+LRG
Sbjct: 98  FRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRG 156
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAP 202
           LKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +     +  F+TE V TRWYRAP
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I 
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
           N KAR +++SLP       + L+P++D  ALDLL +ML F P+KRITV EAL HPY+   
Sbjct: 277 NMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336
Query: 323 YDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHP 361
           YDP   P A+ P +  ++ +++ ++ ++++++ ET  + P
Sbjct: 337 YDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  329 bits (843), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 162/344 (47%), Positives = 232/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAI+KI+  FE++    RTLRE+ +L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  329 bits (843), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 163/344 (47%), Positives = 231/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K  Q LSNDH  YF++Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  327 bits (839), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 162/344 (47%), Positives = 231/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  327 bits (837), Expect = 8e-90,   Method: Compositional matrix adjust.
 Identities = 162/344 (47%), Positives = 231/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLREIKILL 80
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  327 bits (837), Expect = 9e-90,   Method: Compositional matrix adjust.
 Identities = 162/344 (47%), Positives = 231/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  327 bits (837), Expect = 9e-90,   Method: Compositional matrix adjust.
 Identities = 162/344 (47%), Positives = 231/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  325 bits (832), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 161/344 (46%), Positives = 230/344 (66%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+ E V TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  325 bits (832), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 161/344 (46%), Positives = 230/344 (66%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 81
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 140
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+ E V TRWYRA
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 321 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  325 bits (832), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 161/344 (46%), Positives = 231/344 (67%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 78
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 137
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY++ 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 318 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  324 bits (831), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 162/344 (47%), Positives = 228/344 (66%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILL 96
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVYLV  LM  DL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILR 155
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR +  +     F+TEYV TRWYRA
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 336 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 379

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  324 bits (830), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 161/344 (46%), Positives = 230/344 (66%), Gaps = 6/344 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             +H+N+I + D++        KDVY+V +LM+TDL++++K+ Q LSNDH  YF++Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKI DFGLAR +  +     F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
            YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  324 bits (830), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 158/336 (47%), Positives = 226/336 (67%), Gaps = 18/336 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GAYGVVCS+ ++ T E VAIKKI   F+  + ALRTLRE+ +L+H KH+N+I + ++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
             P    +F +VY++ ELM TDLH++I S+Q LS+DH +YF++Q LR +K LH +N++HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 158 DLKPGNLLVNANCDLKICDFGLART----------SRGNEQFMTEYVVTRWYRAPELLLC 207
           DLKP NLL+N+NCDLK+CDFGLAR             G +  MTEYV TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT-QQEADLEFIDNPKA 266
              Y  ++DVWS GCI AE+  R+PIFPG +  +QL LI  + GT   + DL  I++P+A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
           R +IKSLP      +  ++P+ +P  +DLLQ+MLVF+P+KRIT  EAL+HPY+   +DP 
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 327 CNPPAQ--VPLSLDID---ENIGEQMIRQMMWNETL 357
             P  +   P   + D   E +  + +++++WNE  
Sbjct: 317 DEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  321 bits (822), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 156/336 (46%), Positives = 225/336 (66%), Gaps = 18/336 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GAYGVVCS+ ++ T E VAIKKI   F+  + ALRTLRE+ +L+H KH+N+I + ++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
             P    +F +VY++ ELM TDLH++I S+Q LS+DH +YF++Q LR +K LH +N++HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 158 DLKPGNLLVNANCDLKICDFGLART----------SRGNEQFMTEYVVTRWYRAPELLLC 207
           DLKP NLL+N+NCDLK+CDFGLAR             G +  M E+V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT-QQEADLEFIDNPKA 266
              Y  ++DVWS GCI AE+  R+PIFPG +  +QL LI  + GT   + DL  I++P+A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
           R +IKSLP      +  ++P+ +P  +DLLQ+MLVF+P+KRIT  EAL+HPY+   +DP 
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 327 CNPPAQ--VPLSLDID---ENIGEQMIRQMMWNETL 357
             P  +   P   + D   E +  + +++++WNE  
Sbjct: 317 DEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  321 bits (822), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 157/334 (47%), Positives = 225/334 (67%), Gaps = 18/334 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GAYGVVCS+ ++ T E VAIKKI   F+  + ALRTLRE+ +L+H KH+N+I + ++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
             P    +F +VY++ ELM TDLH++I S+Q LS+DH +YF++Q LR +K LH +N++HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 158 DLKPGNLLVNANCDLKICDFGLART----------SRGNEQFMTEYVVTRWYRAPELLLC 207
           DLKP NLL+N+NCDLK+CDFGLAR             G +  MTE V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT-QQEADLEFIDNPKA 266
              Y  ++DVWS GCI AE+  R+PIFPG +  +QL LI  + GT   + DL  I++P+A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
           R +IKSLP      +  ++P+ +P  +DLLQ+MLVF+P+KRIT  EAL+HPY+   +DP 
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 327 CNPPAQ--VPLSLDID---ENIGEQMIRQMMWNE 355
             P  +   P   + D   E +  + +++++WNE
Sbjct: 317 DEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  305 bits (782), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 155/341 (45%), Positives = 229/341 (67%), Gaps = 7/341 (2%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +   ++P+G GAYG VCS+ +    +KVA+KK++  F++ I A RT REL L
Sbjct: 13  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 72
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   I  F +VYLV  LM  DL+ I+K  Q+LS++H ++ V+Q
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQ 131
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN +C+L+I DFGLAR +   ++ MT YV TRWYRA
Sbjct: 132 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA---DEEMTGYVATRWYRA 188
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +FPG++ ++QLK I+ V GT     L  I
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKI 248
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SLP      +SS++  A+PLA+DLL +MLV +  +R++  EAL H Y S 
Sbjct: 249 SSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 308
Query: 322 LYDPQCNPPAQ-VPLSLDIDENIGEQMIRQMMWNETLHYHP 361
            +DP+  P A+    S++  E   E+  +++ + E L + P
Sbjct: 309 YHDPEDEPEAEPYDESVEAKERTLEEW-KELTYQEVLSFKP 348

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  304 bits (779), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 149/311 (47%), Positives = 217/311 (69%), Gaps = 5/311 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VCSS + ++  K+A+KK++  F++ I A RT REL L
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 162
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 219
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ +NQL+ I+ + GT   + +  +
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRM 279
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            + +AR +I SLP     + + ++  A+PLA+DLL+KMLV +  KRIT +EAL HPY S 
Sbjct: 280 PSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339
Query: 322 LYDPQCNPPAQ 332
            +DP   P ++
Sbjct: 340 YHDPDDEPESE 350

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  303 bits (776), Expect = 9e-83,   Method: Compositional matrix adjust.
 Identities = 154/335 (45%), Positives = 221/335 (65%), Gaps = 17/335 (5%)
Query: 10  GMKSRGKHYYTMWQ------------TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEK 57
           G+  RG H   M Q            T++E+  +Y  + P+G GAYG VC++ + +T  +
Sbjct: 13  GLVPRGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLR 72
Query: 58  VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELM 116
           VA+KK++  F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM
Sbjct: 73  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 132
Query: 117 DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD 176
             DL+ I+K  Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D
Sbjct: 133 GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 191
Query: 177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           FGLAR +   +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPG
Sbjct: 192 FGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLL 296
           T+ ++QLKLI+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL
Sbjct: 249 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 308
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA 331
           +KMLV +  KRIT  +AL H Y +  +DP   P A
Sbjct: 309 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 343

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  303 bits (775), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 153/332 (46%), Positives = 223/332 (67%), Gaps = 14/332 (4%)
Query: 10  GMKSRGKH-------YY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           G+  RG H       +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAV 72
Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTD 119
           KK++  F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  D
Sbjct: 73  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 132
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L+ I+K  Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGL
Sbjct: 133 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 191
Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC 239
           AR +   +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ 
Sbjct: 192 ARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
           ++QLKLI+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KM
Sbjct: 249 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKM 308
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPA 331
           LV +  KRIT  +AL H Y +  +DP   P A
Sbjct: 309 LVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 340

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  303 bits (775), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 149/311 (47%), Positives = 215/311 (69%), Gaps = 5/311 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +   ++P+G GAYG VCS+ +    +KVA+KK++  F++ I A RT REL L
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   I  F +VYLV  LM  DL+ I+KS Q+LS++H ++ V+Q
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN + +L+I DFGLAR +   ++ MT YV TRWYRA
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA---DEEMTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +FPG++ ++QLK I+ V GT     L  I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKI 256
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SLP      +SS++  A+PLA+DLL +MLV +  +R++  EAL H Y S 
Sbjct: 257 SSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 316
Query: 322 LYDPQCNPPAQ 332
            +DP+  P A+
Sbjct: 317 YHDPEDEPEAE 327

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  303 bits (775), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 153/332 (46%), Positives = 223/332 (67%), Gaps = 14/332 (4%)
Query: 10  GMKSRGKH-------YY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           G+  RG H       +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+
Sbjct: 12  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAV 71
Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTD 119
           KK++  F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  D
Sbjct: 72  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 131
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L+ I+K  Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGL
Sbjct: 132 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 190
Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC 239
           AR +   +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ 
Sbjct: 191 ARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 247
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
           ++QLKLI+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KM
Sbjct: 248 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKM 307
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPA 331
           LV +  KRIT  +AL H Y +  +DP   P A
Sbjct: 308 LVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 339

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  302 bits (774), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  302 bits (774), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 257 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  302 bits (773), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 143
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 200
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 320
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 321 YHDPDDEPVA 330

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  302 bits (773), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  301 bits (772), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  301 bits (772), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  301 bits (772), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +      MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  301 bits (771), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 153/332 (46%), Positives = 223/332 (67%), Gaps = 14/332 (4%)
Query: 10  GMKSRGKH-------YY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           G+  RG H       +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 72
Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTD 119
           KK++  F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  D
Sbjct: 73  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 132
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L+ I+K  Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGL
Sbjct: 133 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 191
Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC 239
           AR +   +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ 
Sbjct: 192 ARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
           ++QLKLI+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KM
Sbjct: 249 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 308
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPA 331
           LV +  KRIT  +AL H Y +  +DP   P A
Sbjct: 309 LVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 340

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 153/332 (46%), Positives = 223/332 (67%), Gaps = 14/332 (4%)
Query: 10  GMKSRGKH-------YY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           G+  RG H       +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+
Sbjct: 12  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 71
Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTD 119
           KK++  F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  D
Sbjct: 72  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 131
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L+ I+K  Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGL
Sbjct: 132 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 190
Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC 239
           AR +   +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ 
Sbjct: 191 ARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 247
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
           ++QLKLI+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KM
Sbjct: 248 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 307
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPA 331
           LV +  KRIT  +AL H Y +  +DP   P A
Sbjct: 308 LVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 339

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +      MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +      MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 202
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 323 YHDPDDEPVA 332

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  301 bits (771), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  301 bits (770), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 202
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 323 YHDPDDEPVA 332

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  301 bits (770), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  301 bits (770), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 202
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 323 YHDPDDEPVA 332

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  301 bits (770), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 151/325 (46%), Positives = 220/325 (67%), Gaps = 7/325 (2%)
Query: 10  GMKSRGKHYY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF 67
           GM      +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 68  ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKS 126
           ++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
            Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   
Sbjct: 131 -QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 186
Query: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
           +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246
Query: 247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
           + + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  K
Sbjct: 247 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 306
Query: 307 RITVTEALQHPYISGLYDPQCNPPA 331
           RIT  +AL H Y +  +DP   P A
Sbjct: 307 RITAAQALAHAYFAQYHDPDDEPVA 331

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 132
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 189
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 309
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 310 YHDPDDEPVA 319

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 216/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K ++ L++DH ++ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  300 bits (769), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  300 bits (769), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 131
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 188
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 308
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 309 YHDPDDEPVA 318

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  300 bits (769), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 187
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 308 YHDPDDEPVA 317

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  300 bits (769), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  300 bits (769), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  300 bits (769), Expect = 7e-82,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 187
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 308 YHDPDDEPVA 317

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  300 bits (768), Expect = 8e-82,   Method: Compositional matrix adjust.
 Identities = 148/311 (47%), Positives = 214/311 (68%), Gaps = 5/311 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +   ++P+G GAYG VCS+ +    +KVA+KK++  F++ I A RT REL L
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   I  F +VYLV  LM  DL+ I+K  Q+LS++H ++ V+Q
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN + +L+I DFGLAR +   ++ MT YV TRWYRA
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA---DEEMTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +FPG++ ++QLK I+ V GT     L  I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKI 256
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SLP      +SS++  A+PLA+DLL +MLV +  +R++  EAL H Y S 
Sbjct: 257 SSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 316
Query: 322 LYDPQCNPPAQ 332
            +DP+  P A+
Sbjct: 317 YHDPEDEPEAE 327

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  300 bits (767), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 215/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D+GLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  299 bits (766), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 146/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  M  +V TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMAGFVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  299 bits (765), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 156
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  M  YV TRWYRA
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMXGYVATRWYRA 213
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 334 YHDPDDEPVA 343

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  299 bits (765), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 146/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  M  +V TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMAGFVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  299 bits (765), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 146/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  M  +V TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMAGFVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  298 bits (764), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT---DDEMTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  298 bits (763), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DF LAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  298 bits (763), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI  FGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  298 bits (763), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  298 bits (762), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+KS Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGL R +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  298 bits (762), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT---DDEMTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  298 bits (762), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D GLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  298 bits (762), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 148/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + PIG GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  297 bits (761), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 151/332 (45%), Positives = 221/332 (66%), Gaps = 14/332 (4%)
Query: 10  GMKSRGKH-------YY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAI 60
           G+  RG H       +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAV 72
Query: 61  KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTD 119
           KK++  F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  D
Sbjct: 73  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 132
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L+ I+K  Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGL
Sbjct: 133 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 191
Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC 239
           AR +   +  M   V TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ 
Sbjct: 192 ARHT---DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
           ++QLKLI+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KM
Sbjct: 249 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKM 308
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPA 331
           LV +  KRIT  +AL H Y +  +DP   P A
Sbjct: 309 LVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 340

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  297 bits (761), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D GLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  297 bits (761), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 150/325 (46%), Positives = 219/325 (67%), Gaps = 7/325 (2%)
Query: 10  GMKSRGKHYY--TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF 67
           GM      +Y   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 68  ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKS 126
           ++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
            Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR +   
Sbjct: 131 -QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--- 186
Query: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
           +  MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246
Query: 247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
           + + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  K
Sbjct: 247 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 306
Query: 307 RITVTEALQHPYISGLYDPQCNPPA 331
           RIT  +AL H Y +  +DP   P A
Sbjct: 307 RITAAQALAHAYFAQYHDPDDEPVA 331

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  297 bits (761), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT  V TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGXVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  297 bits (761), Expect = 6e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D GLAR +   +  MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHT---DDEMTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  297 bits (760), Expect = 6e-81,   Method: Compositional matrix adjust.
 Identities = 147/310 (47%), Positives = 214/310 (69%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT REL L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K  Q L++DH ++ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR +   +  MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT     L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPQCNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 148/353 (41%), Positives = 223/353 (63%), Gaps = 7/353 (1%)
Query: 11  MKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR 70
           ++ +G +   + +T +E+   YV    +G GAYG VCS+I++ + EKVAIKK++  F++ 
Sbjct: 23  IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 82
Query: 71  IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQS 129
           I A R  REL+LL+H++H+NVI L DV  P   + +F D YLV   M TDL +I+     
Sbjct: 83  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GME 140
Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
            S +  +Y V+Q+L+GLKY+HSA ++HRDLKPGNL VN +C+LKI DFGLAR +      
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 197
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           MT YVVTRWYRAPE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ V
Sbjct: 198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257
Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
            G      ++ +++  A+ +I+SLP +     + L+P+A P A DLL+KML  +  KR+T
Sbjct: 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 310 VTEALQHPYISGLYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHP 361
             +AL HP+     DP+    AQ P    ++ E +     +Q ++ E +++ P
Sbjct: 318 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  291 bits (746), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 148/353 (41%), Positives = 223/353 (63%), Gaps = 7/353 (1%)
Query: 11  MKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR 70
           ++ +G +   + +T +E+   YV    +G GAYG VCS+I++ + EKVAIKK++  F++ 
Sbjct: 5   IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 64
Query: 71  IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQS 129
           I A R  REL+LL+H++H+NVI L DV  P   + +F D YLV   M TDL +I+     
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLK 122
Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
            S +  +Y V+Q+L+GLKY+HSA ++HRDLKPGNL VN +C+LKI DFGLAR +      
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 179
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           MT YVVTRWYRAPE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ V
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
            G      ++ +++  A+ +I+SLP +     + L+P+A P A DLL+KML  +  KR+T
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 310 VTEALQHPYISGLYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHP 361
             +AL HP+     DP+    AQ P    ++ E +     +Q ++ E +++ P
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  282 bits (722), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 144/342 (42%), Positives = 215/342 (62%), Gaps = 9/342 (2%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +T +E+   Y  ++P+G GAYG VCS+++  T  KVAIKK+   F++ + A R  REL L
Sbjct: 18  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 77
Query: 83  LRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L+H++H+NVI L DV  P   +  F D YLV   M TDL +++K  + L  D  ++ V+Q
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQ 136
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +L+GL+Y+H+A I+HRDLKPGNL VN +C+LKI DFGLAR +      M   VVTRWYRA
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MXGXVVTRWYRA 193
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE++L    Y  ++D+WSVGCI AE++  K +F G++ L+QLK I+ V GT     ++ +
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
            + +A+ ++K LP       +S+   A PLA++LL+KMLV +  +R+T  EAL HPY   
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
Query: 322 LYDPQCNPPAQVPLSL--DIDENIGEQMIRQMMWNETLHYHP 361
           L+D +  P  Q       D+D  + E   +++ + E L + P
Sbjct: 314 LHDTEDEPQVQKYDDSFDDVDRTLDEW--KRVTYKEVLSFKP 353

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  267 bits (683), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 149/404 (36%), Positives = 219/404 (54%), Gaps = 64/404 (15%)
Query: 19  YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR 78
           ++ WQ    I  +Y     IG G+YG VC + ++     VAIKKI  VFE+ ID  R LR
Sbjct: 46  HSDWQ----IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR 101
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYF 138
           E+ +L  + HD+V+ + D+++P     F ++Y+V E+ D+D  ++ ++   L+  H K  
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTL 161
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----SRGNEQF----- 189
           ++ LL G+KY+HSA ILHRDLKP N LVN +C +K+CDFGLART      GN Q      
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 190 ------------------MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-- 229
                             +T +VVTRWYRAPEL+L  +NY  +IDVWS+GCIFAE+L   
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 230 ---------RKPIFPGTECL--------------------NQLKLIISVFGTQQEADLEF 260
                    R P+FPG+ C                     +QL +I ++ GT  E D+E 
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           ++   A+R+I+  P   GT ++  +P +   A+ LL++MLVF P+KRIT+ E L HP+  
Sbjct: 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401
Query: 321 G--LYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHPE 362
              + + + N   +V L  +   N+ E  +R     E   YHPE
Sbjct: 402 EVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 144/365 (39%), Positives = 221/365 (60%), Gaps = 44/365 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HD 89
           KY  +K +G+GAYG+V  SI+R T E VA+KKI + F+N  DA RT RE+++L  +  H+
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           N++ L +V+   +    +DVYLV++ M+TDLH +I+++  L   H +Y V+QL++ +KYL
Sbjct: 70  NIVNLLNVLRADND---RDVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYL 125
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLART---------------SRGNEQF----- 189
           HS  +LHRD+KP N+L+NA C +K+ DFGL+R+               +   E F     
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 190 -MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            +T+YV TRWYRAPE+LL    Y   ID+WS+GCI  EIL  KPIFPG+  +NQL+ II 
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 249 VFGTQQEADLEFIDNPKARRFIKSLPYS---RGTHISSLY-----------PQAD--PLA 292
           V       D+E I +P A+  I+SL      R ++   ++           P+AD    A
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 293 LDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQM--IRQ 350
           LDLL K+L F P+KRI+  +AL+HP++S  ++P   P     +++ I++N+   +   R 
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRN 365
Query: 351 MMWNE 355
           ++++E
Sbjct: 366 LVYSE 370

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  256 bits (655), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 135/377 (35%), Positives = 212/377 (56%), Gaps = 52/377 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG+YG V  + ++ T + VAIKK+N +FE+ ID  R LRE+ +L  +K D +I L D+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
           ++P   + F ++Y+V E+ D+DL ++ K+   L+ +H K  ++ LL G  ++H + I+HR
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 158 DLKPGNLLVNANCDLKICDFGLART----------------------SRGNEQFMTEYVV 195
           DLKP N L+N +C +K+CDFGLART                      ++  ++ +T +VV
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-----------GRKPIFPGTECL---- 240
           TRWYRAPEL+L  +NY  SID+WS GCIFAE+L            R P+FPG+ C     
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 241 -------------NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ 287
                        +QL +I ++ GT  E DL+ I+ P+  ++IK  P+ +  ++   YP 
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333
Query: 288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDE--NIGE 345
                ++LL+ ML F P+KRIT+ +AL HPY+  +   +    +   + L  D+   + E
Sbjct: 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSE 393
Query: 346 QMIRQMMWNETLHYHPE 362
             +R +   E   +HPE
Sbjct: 394 TQLRYIFLKEVQSFHPE 410

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  255 bits (652), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 148/364 (40%), Positives = 220/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  254 bits (648), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 147/364 (40%), Positives = 219/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  254 bits (648), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 148/364 (40%), Positives = 220/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  254 bits (648), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 136
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 195
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 251
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 252 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 311
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 312 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 363

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  254 bits (648), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 136
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 195
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 251
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 252 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 311
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 312 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 363

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  254 bits (648), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 142/353 (40%), Positives = 214/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 250
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 362

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  254 bits (648), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 250
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 362

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  254 bits (648), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 173
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 232
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 288
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 349 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 400

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  253 bits (647), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 250
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 362

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  253 bits (647), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 17  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 76
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 77  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 134
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 193
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 194 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 249
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 250 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 309
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 310 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 361

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  253 bits (647), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 173
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 232
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 288
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 349 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 400

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 128
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 243
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 304 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 355

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  253 bits (646), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 71
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 189 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 244
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 245 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 304
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 305 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 356

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  253 bits (646), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 143/353 (40%), Positives = 215/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 71
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 189 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 244
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 245 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 304
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 305 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 356

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  253 bits (645), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 147/364 (40%), Positives = 219/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  253 bits (645), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 152/373 (40%), Positives = 224/373 (60%), Gaps = 31/373 (8%)
Query: 8   PNGMKSRGK---HYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKK 62
           P G  SR K   ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK
Sbjct: 2   PLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK 61
Query: 63  INNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLH 121
           ++  F+N+  A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L 
Sbjct: 62  LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 121
Query: 122 QIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR 181
           Q+I+    L ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLAR
Sbjct: 122 QVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179
Query: 182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN 241
           T+ G    MT YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++
Sbjct: 180 TA-GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYID 237
Query: 242 QLKLIISVFGTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD------ 289
           Q   +I   GT      EF+    P  R ++++ P   G     L+P     AD      
Sbjct: 238 QWNKVIEQLGTPCP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 294
Query: 290 --PLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIG 344
               A DLL KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  
Sbjct: 295 KASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTI 354
Query: 345 EQMIRQMMWNETL 357
           E+  +++++ E +
Sbjct: 355 EEW-KELIYKEVM 366

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 147/364 (40%), Positives = 219/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 148/364 (40%), Positives = 220/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPCP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 151/370 (40%), Positives = 223/370 (60%), Gaps = 31/370 (8%)
Query: 11  MKSRGK---HYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN 65
           M SR K   ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++ 
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 66  VFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQII 124
            F+N+  A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I
Sbjct: 61  PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI 120
Query: 125 KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR 184
           +    L ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ 
Sbjct: 121 Q--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 177
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
           G    MT YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q  
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 245 LIISVFGTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------P 290
            +I   GT      EF+    P  R ++++ P   G     L+P     AD         
Sbjct: 237 KVIEQLGTPCP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 291 LALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQM 347
            A DLL KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+ 
Sbjct: 294 QARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW 353
Query: 348 IRQMMWNETL 357
            +++++ E +
Sbjct: 354 -KELIYKEVM 362

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 142/353 (40%), Positives = 214/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 250
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 362

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  251 bits (642), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 142/353 (40%), Positives = 214/353 (60%), Gaps = 26/353 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 128
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 243
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 309 TVTEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
           +V +ALQHPYI+  YDP   +  PP      LD  E+  E+  +++++ E ++
Sbjct: 304 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW-KELIYKEVMN 355

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  251 bits (640), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 146/364 (40%), Positives = 218/364 (59%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVG I  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  251 bits (640), Expect = 7e-67,   Method: Compositional matrix adjust.
 Identities = 146/352 (41%), Positives = 214/352 (60%), Gaps = 26/352 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+  A R  RELVL+
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 71
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 72  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 189 EVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 244
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P     AD          A DLL KMLV + SKRI
Sbjct: 245 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 304
Query: 309 TVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMWNETL 357
           +V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++ E +
Sbjct: 305 SVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIYKEVM 355

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 139/325 (42%), Positives = 199/325 (61%), Gaps = 20/325 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +      VA+KK++  F+N+  A R  RELVLL
Sbjct: 16  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL 75
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I     L ++   Y ++Q+
Sbjct: 76  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQM 133
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+  N   MT YVVTR+YRAP
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN-FMMTPYVVTRYYRAP 192
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++    IF GT+ ++Q   +I   GT   A+     
Sbjct: 193 EVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS-AEFMAAL 250
Query: 263 NPKARRFIKSLPYSRGTHISSLYP--------QADPL----ALDLLQKMLVFEPSKRITV 310
            P  R ++++ P   G     L+P        + D +    A DLL KMLV +P KRI+V
Sbjct: 251 QPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 310
Query: 311 TEALQHPYISGLYDP--QCNPPAQV 333
            EAL+HPYI+  YDP     PP Q+
Sbjct: 311 DEALRHPYITVWYDPAEAEAPPPQI 335

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  249 bits (636), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 146/364 (40%), Positives = 219/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 8   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 67
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 68  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 125
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 126 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 184
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
             +VVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 185 VPFVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 243
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 244 GTPCP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 300
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 301 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 359
Query: 354 NETL 357
            E +
Sbjct: 360 KEVM 363

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  249 bits (636), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 147/364 (40%), Positives = 219/364 (60%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T  VVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPEVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPCP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  249 bits (636), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 135/317 (42%), Positives = 197/317 (62%), Gaps = 22/317 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 250
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 309 TVTEALQHPYISGLYDP 325
           +V +ALQHPYI+  YDP
Sbjct: 311 SVDDALQHPYINVWYDP 327

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  249 bits (635), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 142/352 (40%), Positives = 212/352 (60%), Gaps = 22/352 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +      VA+KK++  F+N+  A R  RELVLL
Sbjct: 18  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL 77
Query: 84  RHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I     L ++   Y ++Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+  N   MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++    IF GT+ ++Q   +I   GT   A+     
Sbjct: 195 EVILGM-GYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPS-AEFMAAL 252
Query: 263 NPKARRFIKSLPYSRGTHISSLYP--------QADPL----ALDLLQKMLVFEPSKRITV 310
            P  R ++++ P   G     L+P        + D +    A DLL KMLV +P KRI+V
Sbjct: 253 QPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 312
Query: 311 TEALQHPYISGLYDP---QCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHY 359
            EAL+HPYI+  YDP   +  PP      L+  E+  E+  +++++ E + +
Sbjct: 313 DEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEW-KELIYKEVMDW 363

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  248 bits (634), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 145/362 (40%), Positives = 219/362 (60%), Gaps = 24/362 (6%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
              VVTR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   
Sbjct: 183 EPEVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 241
Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLLQK 298
           GT   A ++ +  P  R ++++ P   G     L+P     AD          A DLL K
Sbjct: 242 GTPCPAFMKKL-QPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 300
Query: 299 MLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMWNE 355
           MLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++ E
Sbjct: 301 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIYKE 359
Query: 356 TL 357
            +
Sbjct: 360 VM 361

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  248 bits (633), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 145/364 (39%), Positives = 217/364 (59%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+V ++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           T YVVTR+YRAPE++L    Y  ++D+WSVG I  E++    +FPGT+ ++Q   +I   
Sbjct: 183 TPYVVTRYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPSP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  247 bits (631), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 136/380 (35%), Positives = 202/380 (53%), Gaps = 55/380 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG+YG V  + ++  N+ VAIKK+N +FE+ ID  R LRE+ +L  +K D +I L D+
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
           ++P   + F ++Y+V E+ D+DL ++ K+   L+  H K  ++ LL G K++H + I+HR
Sbjct: 96  IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHR 155
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQF-------------------------MTE 192
           DLKP N L+N +C +KICDFGLART   ++                           +T 
Sbjct: 156 DLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-----------GRKPIFPGTECL- 240
           +VVTRWYRAPEL+L  +NY  SID+WS GCIFAE+L            R P+FPG+ C  
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFP 275
Query: 241 ----------------NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSL 284
                           +QL +I +V GT  E DL+ I   +  ++IK  P   G  +S  
Sbjct: 276 LSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKK 335
Query: 285 YPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDE--N 342
           Y       +DLL+ ML F   KRIT+ +AL HPY+  +        +   + L  D+   
Sbjct: 336 YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMV 395
Query: 343 IGEQMIRQMMWNETLHYHPE 362
           + E  +R +   E   +H +
Sbjct: 396 LSETQLRYIFLKEIQSFHAD 415

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 146/364 (40%), Positives = 218/364 (59%), Gaps = 28/364 (7%)
Query: 14  RGKHYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R  ++Y+  +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  F+N+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSL 130
            A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+    L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 123
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
            ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 182
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
              VVTR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   
Sbjct: 183 EPEVVTRYYRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQL 241
Query: 251 GTQQEADLEFID--NPKARRFIKSLPYSRGTHISSLYPQ----AD--------PLALDLL 296
           GT      EF+    P  R ++++ P   G     L+P     AD          A DLL
Sbjct: 242 GTPCP---EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ--CNPPAQVP-LSLDIDENIGEQMIRQMMW 353
            KMLV + SKRI+V EALQHPYI+  YDP     PP ++P   LD  E+  E+  +++++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW-KELIY 357
Query: 354 NETL 357
            E +
Sbjct: 358 KEVM 361

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  243 bits (619), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 133/315 (42%), Positives = 195/315 (61%), Gaps = 22/315 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R  RELVL+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++   Y ++Q+
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G    MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT      EF+ 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP---EFMK 250
Query: 263 --NPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRI 308
              P  R ++++ P   G     L+P +               A DLL KMLV +P+KRI
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 309 TVTEALQHPYISGLY 323
           +V +ALQHPYI+  Y
Sbjct: 311 SVDDALQHPYINVWY 325

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  234 bits (597), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 131/350 (37%), Positives = 197/350 (56%), Gaps = 25/350 (7%)
Query: 10  GMKSRGKHYY-TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVF 67
           GM+++G+     +   L  + + Y   + I  G+YG VC+ ++ E    VAIK++ N V 
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVS 59
Query: 68  ENRI-----DAL---RTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD 119
           + R      D+    R LRE+ LL H  H N++ L+D+ +     +   +YLV ELM TD
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119
Query: 120 LHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG 178
           L Q+I   +  +S  H +YF++ +L GL  LH A ++HRDL PGN+L+  N D+ ICDF 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
           LAR    +    T YV  RWYRAPEL++    +   +D+WS GC+ AE+  RK +F G+ 
Sbjct: 180 LAREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238
Query: 239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIK-SLPYSRGTHISSLYPQADPLALDLLQ 297
             NQL  I+ V GT +  D+    +P AR +++ SL        +++ P ADP+ALDL+ 
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298
Query: 298 KMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQM 347
           KML F P +RI+  +AL+HPY   L+DP           LD+ E + E+ 
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDP-----------LDLTEGLSERF 337

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  232 bits (592), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 128/334 (38%), Positives = 189/334 (56%), Gaps = 24/334 (7%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRI-----DAL---R 75
           L  + + Y   + I  G+YG VC+ ++ E    VAIK++ N V + R      D+    R
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 76  TLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ-SLSNDH 134
            LRE+ LL H  H N++ L+D+ +     +   +YLV ELM TDL Q+I   +  +S  H
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +YF++ +L GL  LH A ++HRDL PGN+L+  N D+ ICDF LAR    +    T YV
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYV 194
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
             RWYRAPEL++    +   +D+WS GC+ AE+  RK +F G+   NQL  I+ V GT +
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 255 EADLEFIDNPKARRFIK-SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
             D+    +P AR +++ SL        +++ P ADP+ALDL+ KML F P +RI+  +A
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 314 LQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQM 347
           L+HPY   L+DP           LD+ E + E+ 
Sbjct: 315 LRHPYFESLFDP-----------LDLTEGLSERF 337

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  212 bits (539), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 119/319 (37%), Positives = 188/319 (58%), Gaps = 21/319 (6%)
Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F++ ++Y+ +KP+G G  G+V S+++ + +++VAIKKI  V  +       LRE+ ++R 
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRR 64
Query: 86  IKHDNVIALKDVMMPTHR---------ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCK 136
           + HDN++ + +++ P+                VY+V E M+TDL  +++    L  +H +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-PLLEEHAR 123
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLART---SRGNEQFMTE 192
            F++QLLRGLKY+HSAN+LHRDLKP NL +N  +  LKI DFGLAR       ++  ++E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
            +VT+WYR+P LLL  +NY  +ID+W+ GCIFAE+L  K +F G   L Q++LI+     
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 253 QQEADLEFIDN--PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
             E D + + +  P   R   + P+     ++ L P     A+D L+++L F P  R+T 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKP---LTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 311 TEALQHPYISGLYDPQCNP 329
            EAL HPY+S    P   P
Sbjct: 301 EEALSHPYMSIYSFPMDEP 319

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 122/300 (40%), Positives = 168/300 (56%), Gaps = 15/300 (5%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ +KH N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           ++ L DV+      S K + LV+E  D DL +   S    L  +  K F+FQLL+GL + 
Sbjct: 63  IVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS N+LHRDLKP NLL+N N +LK+ DFGLAR      +  +  VVT WYR P++L    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 210 NYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
            Y TSID+WS GCIFAE+    +P+FPG +  +QLK I  + GT  E        P   +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW-----PSMTK 232
Query: 269 FIKSLP---YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
                P   Y   T + ++ P+ +    DLLQ +L   P +RI+  EALQHPY S    P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  204 bits (520), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 168/300 (56%), Gaps = 15/300 (5%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ +KH N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           ++ L DV+      S K + LV+E  D DL +   S    L  +  K F+FQLL+GL + 
Sbjct: 63  IVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS N+LHRDLKP NLL+N N +LK+ +FGLAR      +  +  VVT WYR P++L    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 210 NYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
            Y TSID+WS GCIFAE+    +P+FPG +  +QLK I  + GT  E        P   +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW-----PSMTK 232
Query: 269 FIKSLP---YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
                P   Y   T + ++ P+ +    DLLQ +L   P +RI+  EALQHPY S    P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 75  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 247
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 72  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 244
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 67  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 67  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 69  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  197 bits (502), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 118/314 (37%), Positives = 179/314 (57%), Gaps = 28/314 (8%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
           +Q L E   KY  ++ +G G YGVV  + + +    VA+K+I    E+       +RE+ 
Sbjct: 16  FQGLME---KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREIS 71
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVF 140
           LL+ + H N+++L DV+      S + + LV+E M+ DL +++  +++ L +   K +++
Sbjct: 72  LLKELHHPNIVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           QLLRG+ + H   ILHRDLKP NLL+N++  LK+ DFGLAR      +  T  VVT WYR
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           AP++L+    Y TS+D+WS+GCIFAE++  KP+FPG    +QL  I S+ GT        
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP------- 239
Query: 261 IDNPKARRFIKSLPYSRGTHI--------SSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
             NP+    ++ LP  +            SS+ P      +DLL  ML F+P+KRI+  +
Sbjct: 240 --NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 313 ALQHPYISGLYDPQ 326
           A+ HPY   L DPQ
Sbjct: 298 AMNHPYFKDL-DPQ 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  197 bits (502), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 118/314 (37%), Positives = 179/314 (57%), Gaps = 28/314 (8%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
           +Q L E   KY  ++ +G G YGVV  + + +    VA+K+I    E+       +RE+ 
Sbjct: 16  FQGLME---KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREIS 71
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVF 140
           LL+ + H N+++L DV+      S + + LV+E M+ DL +++  +++ L +   K +++
Sbjct: 72  LLKELHHPNIVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           QLLRG+ + H   ILHRDLKP NLL+N++  LK+ DFGLAR      +  T  VVT WYR
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           AP++L+    Y TS+D+WS+GCIFAE++  KP+FPG    +QL  I S+ GT        
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP------- 239
Query: 261 IDNPKARRFIKSLPYSRGTHI--------SSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
             NP+    ++ LP  +            SS+ P      +DLL  ML F+P+KRI+  +
Sbjct: 240 --NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 313 ALQHPYISGLYDPQ 326
           A+ HPY   L DPQ
Sbjct: 298 AMNHPYFKDL-DPQ 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  197 bits (500), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 163/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +D DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 71  LDVIHTENKL-----YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 71  LDVIHTENKL-----YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 69  LDVIHTENKL-----YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 71  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 70  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 70  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 69  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 70  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 67  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 69  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 161/293 (54%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL   + +S    +     K ++FQLL+GL + HS 
Sbjct: 70  LDVIHTENKL-----YLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 242
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 71  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 72  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 244
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 69  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 241
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+ KI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+ KI    E        +RE+ LL+ + H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 67  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 67  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 161/293 (54%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL   + +S    +     K ++FQLL+GL + HS 
Sbjct: 71  LDVIHTENKL-----YLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL   + +S    +     K ++FQLL+GL + HS 
Sbjct: 67  LDVIHTENKL-----YLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 239
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 161/293 (54%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL   + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  195 bits (495), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 161/293 (54%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL   + +S    +     K ++FQLL+GL + HS 
Sbjct: 71  LDVIHTENKL-----YLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 243
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 75  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL    Y 
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 247
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  194 bits (493), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 162/293 (55%), Gaps = 9/293 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL    Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  194 bits (493), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 160/287 (55%), Gaps = 9/287 (3%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSA 152
            DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL + HS 
Sbjct: 68  LDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E     + +     +  S
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPS 240
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            P       S + P  D     LL +ML ++P+KRI+   AL HP+ 
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 122/308 (39%), Positives = 167/308 (54%), Gaps = 14/308 (4%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRT-LRELVLLRHIK 87
           +Y  +  +G G +  V  + ++ TN+ VAIKKI   +  E +    RT LRE+ LL+ + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIK-SSQSLSNDHCKYFVFQLLRGL 146
           H N+I L D       IS     LV++ M+TDL  IIK +S  L+  H K ++   L+GL
Sbjct: 71  HPNIIGLLDAFGHKSNIS-----LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +YLH   ILHRDLKP NLL++ N  LK+ DFGLA++     +     VVTRWYRAPELL 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
               YG  +D+W+VGCI AE+L R P  PG   L+QL  I    GT  E     + +   
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
               KS P   G  +  ++  A    LDL+Q + +F P  RIT T+AL+  Y S    P 
Sbjct: 246 YVTFKSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN--RPG 300
Query: 327 CNPPAQVP 334
             P  Q+P
Sbjct: 301 PTPGCQLP 308

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 160/293 (54%), Gaps = 10/293 (3%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y+ +  +G G Y  V    ++ T+  VA+K+I    E        +RE+ LL+ +KH N+
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC-TAIREVSLLKDLKHANI 62
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFVFQLLRGLKYLH 150
           + L D++      + K + LV+E +D DL Q +    ++ N H  K F+FQLLRGL Y H
Sbjct: 63  VTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
              +LHRDLKP NLL+N   +LK+ DFGLAR      +     VVT WYR P++LL   +
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI-DNPKARRF 269
           Y T ID+W VGCIF E+   +P+FPG+    QL  I  + GT  E     I  N + + +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
             + P  R   + S  P+ D    DLL K+L FE   RI+  +A++HP+   L
Sbjct: 238 --NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 161/294 (54%), Gaps = 17/294 (5%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YGVV  + N    E  A+KKI    E+      T+RE+ +L+ +KH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           ++ L DV+    R+      LV+E +D DL +++   +  L +   K F+ QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKRL-----VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  VVT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN-PKAR- 267
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  + GT    +   +   PK   
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 268 --RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                + LP+       S     D   +DLL KML  +P++RIT  +AL+H Y 
Sbjct: 237 NFTVYEPLPW------ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 161/294 (54%), Gaps = 17/294 (5%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YGVV  + N    E  A+KKI    E+      T+RE+ +L+ +KH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           ++ L DV+    R+      LV+E +D DL +++   +  L +   K F+ QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKRL-----VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  VVT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN-PKAR- 267
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  + GT    +   +   PK   
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 268 --RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                + LP+       S     D   +DLL KML  +P++RIT  +AL+H Y 
Sbjct: 237 NFTVYEPLPW------ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  189 bits (479), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 113/294 (38%), Positives = 161/294 (54%), Gaps = 17/294 (5%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YGVV  + N    E  A+KKI    E+      T+RE+ +L+ +KH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYL 149
           ++ L DV+    R+      LV+E +D DL +++   +  L +   K F+ QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKRL-----VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  +VT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN-PKAR- 267
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  + GT    +   +   PK   
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 268 --RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                + LP+       S     D   +DLL KML  +P++RIT  +AL+H Y 
Sbjct: 237 NFTVYEPLPW------ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 120/324 (37%), Positives = 173/324 (53%), Gaps = 14/324 (4%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLL 83
           L   D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 84  RHIK---HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYF 138
           RH++   H NV+ L DV   +       + LV+E +D DL   +       +  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW 198
           +FQLLRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR     +  +T  VVT W
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLW 184
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPE+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I+ V G   E D 
Sbjct: 185 YRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 259 EFIDNPKARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                P+     +   +S+    I       D L  DLL K L F P+KRI+   AL HP
Sbjct: 244 -----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 318 YISGLYDPQCNPPAQVPLSLDIDE 341
           Y   L   + N  + +P S +  E
Sbjct: 299 YFQDLERCKENLDSHLPPSQNTSE 322

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 110/305 (36%), Positives = 166/305 (54%), Gaps = 19/305 (6%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           +++  ++ +G G Y  V   +N+ T   VA+K++    E    +   +RE+ L++ +KH+
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS-TAIREISLMKELKHE 63
Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS------QSLSNDHCKYFVFQLL 143
           N++ L DV+   ++++     LV+E MD DL + + S       + L  +  KYF +QLL
Sbjct: 64  NIVRLYDVIHTENKLT-----LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           +GL + H   ILHRDLKP NLL+N    LK+ DFGLAR         +  VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +L+    Y TSID+WS GCI AE++  KP+FPGT    QLKLI  + GT  E+    +  
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 264 -PKARRFIKSLPYSRGTHISSLYPQA-DPL---ALDLLQKMLVFEPSKRITVTEALQHPY 318
            PK    I+  P      +  L P   +PL    +D L  +L   P  R++  +AL HP+
Sbjct: 239 LPKYNPNIQQRPPRDLRQV--LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 319 ISGLY 323
            +  Y
Sbjct: 297 FAEYY 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 116/305 (38%), Positives = 165/305 (54%), Gaps = 14/305 (4%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLL 83
           L   D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 84  RHIK---HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYF 138
           RH++   H NV+ L DV   +       + LV+E +D DL   +       +  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW 198
           +FQLLRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR     +  +T  VVT W
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLW 184
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPE+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I+ V G   E D 
Sbjct: 185 YRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 259 EFIDNPKARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                P+     +   +S+    I       D L  DLL K L F P+KRI+   AL HP
Sbjct: 244 -----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 318 YISGL 322
           Y   L
Sbjct: 299 YFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 114/298 (38%), Positives = 163/298 (54%), Gaps = 14/298 (4%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHIK 87
           D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRH++
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 88  ---HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQL 142
              H NV+ L DV   +       + LV+E +D DL   +       +  +  K  +FQL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           LRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR     +  +T  VVT WYRAP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I+ V G   E D     
Sbjct: 189 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 243
Query: 263 NPKARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            P+     +   +S+    I       D L  DLL K L F P+KRI+   AL HPY 
Sbjct: 244 -PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 114/302 (37%), Positives = 165/302 (54%), Gaps = 14/302 (4%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  I  +G G YG V  +I+  TNE VAIK+I    E        +RE+ LL+ ++H N
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +I LK V+   HR+     +L++E  + DL + +  +  +S    K F++QL+ G+ + H
Sbjct: 95  IIELKSVIHHNHRL-----HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 151 SANILHRDLKPGNLLVNANCD-----LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           S   LHRDLKP NLL++ +       LKI DFGLAR      +  T  ++T WYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L   +Y TS+D+WS+ CI+AE+L + P+FPG   ++QL  I  V G     D  +     
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD--DTTWPGVTA 267
Query: 266 ARRFIKSLPYSRGTHISS-LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLY 323
              + +S P  RG  +   L    D   LDLL  ML  +P KRI+   AL+HPY S   +
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327
Query: 324 DP 325
           DP
Sbjct: 328 DP 329

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 103/302 (34%), Positives = 160/302 (52%), Gaps = 24/302 (7%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  I  IG G+YGVV    NR+T + VAIKK     ++ +     LRE+ +L+ +KH N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L +V     R+     +LV+E  D T LH++ +  + +     K   +Q L+ + + 
Sbjct: 64  LVNLLEVFRRKRRL-----HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H  N +HRD+KP N+L+  +  +K+CDFG AR   G   +  + V TRWYR+PELL+   
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            YG  +DVW++GC+FAE+L   P++PG   ++QL LI    G     DL     P+ ++ 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG-----DL----IPRHQQV 229
Query: 270 IKSLPYSRGTHISS---------LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
             +  Y  G  I            +P     AL LL+  L  +P++R+T  + L HPY  
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
Query: 321 GL 322
            +
Sbjct: 290 NI 291

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/299 (37%), Positives = 158/299 (52%), Gaps = 16/299 (5%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI---NNVFENRIDALRTLRELVLLRHI 86
           ++Y P+  IG GAYG V  + +  +   VA+K +   N         + T+RE+ LLR +
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 87  K---HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQ 141
           +   H NV+ L DV   +       V LV+E +D DL   +  +    L  +  K  + Q
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
            LRGL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR     +  +T  VVT WYRA
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVVTLWYRA 187
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE+LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I  + G   E D    
Sbjct: 188 PEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW--- 243
Query: 262 DNPKARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             P+     +     RG   + S+ P+ +     LL +ML F P KRI+   ALQH Y+
Sbjct: 244 --PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 113/306 (36%), Positives = 160/306 (52%), Gaps = 16/306 (5%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-- 87
           ++Y P+  IG GAYG V  + +  +   VA+K +          + T+RE+ LLR ++  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 88  -HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLR 144
            H NV+ L DV   +       V LV+E +D DL   +  +    L  +  K  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           GL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR     +  +   VVT WYRAPE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALAPVVVTLWYRAPEV 182
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I  + G   E D      P
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW-----P 236
Query: 265 KARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
           +     +     RG   + S+ P+ +     LL +ML F P KRI+   ALQH Y   L+
Sbjct: 237 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY---LH 293
Query: 324 DPQCNP 329
             + NP
Sbjct: 294 KDEGNP 299

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 113/306 (36%), Positives = 160/306 (52%), Gaps = 16/306 (5%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-- 87
           ++Y P+  IG GAYG V  + +  +   VA+K +          + T+RE+ LLR ++  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 88  -HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLR 144
            H NV+ L DV   +       V LV+E +D DL   +  +    L  +  K  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           GL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR     +  +   VVT WYRAPE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEV 182
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I  + G   E D      P
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW-----P 236
Query: 265 KARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
           +     +     RG   + S+ P+ +     LL +ML F P KRI+   ALQH Y   L+
Sbjct: 237 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY---LH 293
Query: 324 DPQCNP 329
             + NP
Sbjct: 294 KDEGNP 299

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 113/306 (36%), Positives = 160/306 (52%), Gaps = 16/306 (5%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-- 87
           ++Y P+  IG GAYG V  + +  +   VA+K +          + T+RE+ LLR ++  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 88  -HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLR 144
            H NV+ L DV   +       V LV+E +D DL   +  +    L  +  K  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           GL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR     +  +   VVT WYRAPE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALFPVVVTLWYRAPEV 182
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I  + G   E D      P
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW-----P 236
Query: 265 KARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
           +     +     RG   + S+ P+ +     LL +ML F P KRI+   ALQH Y   L+
Sbjct: 237 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY---LH 293
Query: 324 DPQCNP 329
             + NP
Sbjct: 294 KDEGNP 299

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 95/296 (32%), Positives = 156/296 (52%), Gaps = 6/296 (2%)
Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F+   KY  +  +G G+YG+V    N++T   VAIKK     ++++     +RE+ LL+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           ++H+N++ L +V     R      YLV+E +D T L  +      L     + ++FQ++ 
Sbjct: 81  LRHENLVNLLEVCKKKKRW-----YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           G+ + HS NI+HRD+KP N+LV+ +  +K+CDFG ART     +   + V TRWYRAPEL
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           L+    YG ++DVW++GC+  E+   +P+FPG   ++QL  I+   G       E  +  
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                ++         +   YP+   + +DL +K L  +P KR    E L H +  
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 169/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+     F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 248 REM-NPNYTEFAFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 302 AHSFFDELRDPNVKLP 317

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 169/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+     F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 248 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 302 AHSFFDELRDPNVKLP 317

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 75
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 76  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 135 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 192
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 252
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 253 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 307 AHSFFDELRDPNVKLP 322

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 106
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 107 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 166 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 223
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 283
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 284 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 338 AHSFFDELRDPNVKLP 353

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 98
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 99  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 215
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 275
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 276 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 330 AHSFFDELRDPNVKLP 345

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 149
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 150 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 266
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 326
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 327 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 381 AHSFFDELRDPNVKLP 396

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 83
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 84  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 143 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 200
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 260
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 261 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 315 AHSFFDELRDPNVKLP 330

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 104
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 105 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 221
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 282 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 336 AHSFFDELRDPNVKLP 351

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 248 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 302 AHSFFDELRDPNVKLP 317

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/316 (34%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 108
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 109 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLART-SRGNEQFMTEYVVTRW 198
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+   RG       Y+ +R+
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 225
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 285
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 286 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 340 AHSFFDELRDPNVKLP 355

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 169/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+     F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 249 EM-NPNYTEFAFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 303 HSFFDELRDPNVKLP 317

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 104
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 105 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 222
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 283 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 337 HSFFDELRDPNVKLP 351

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 74
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 75  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 134 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 192
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 252
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 253 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 306
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 307 HSFFDELRDPNVKLP 321

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/316 (33%), Positives = 170/316 (53%), Gaps = 31/316 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVY---LVYELMDTDLHQIIK----SSQSLSNDHCKYFV 139
            H N++ L+     +     KDV    LV + +   ++++ +    + Q+L   + K ++
Sbjct: 71  DHCNIVRLRYFFYSSGEK--KDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRW 198
           +QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY 187
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 259 EFIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 248 REM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 315 QHPYISGLYDPQCNPP 330
            H +   L DP    P
Sbjct: 302 AHSFFDELRDPNVKLP 317

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 82
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 83  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 200
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 260
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 261 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 314
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 315 HSFFDELRDPNVKLP 329

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 249 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 303 HSFFDELRDPNVKLP 317

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 82
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 83  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 200
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 260
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 261 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 314
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 315 HSFFDELRDPNVKLP 329

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 249 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 303 HSFFDELRDPNVKLP 317

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 71
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 72  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 131 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 189
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 249
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 250 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 303
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 304 HSFFDELRDPNVKLP 318

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 89
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 90  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 149 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 207
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 267
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 268 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 321
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 322 HSFFDELRDPNVKLP 336

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 29/315 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   ++ E VAIKK+  +  F+NR        EL ++R +
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 78
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIK----SSQSLSNDHCKYFVF 140
            H N++ L+     +      +VYL  V + +   ++++ +    + Q+L   + K +++
Sbjct: 79  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++  + +R+Y
Sbjct: 138 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYY 196
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     + 
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 256
Query: 260 FIDNPKARRF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            + NP    F    IK+ P+++        P+  P A+ L  ++L + P+ R+T  EA  
Sbjct: 257 EM-NPNYTEFKFPQIKAHPWTK-----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 310
Query: 316 HPYISGLYDPQCNPP 330
           H +   L DP    P
Sbjct: 311 HSFFDELRDPNVKLP 325

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 108/306 (35%), Positives = 171/306 (55%), Gaps = 28/306 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHI 86
           +  Y   K IG G++GVV  +   E++E VAIKK+  +  F+NR        EL ++R +
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR--------ELQIMRIV 89
Query: 87  KHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQI----IKSSQSLSNDHCKYFVF 140
           KH NV+ LK     ++     +V+L  V E +   +++      K  Q++     K +++
Sbjct: 90  KHPNVVDLKAFFY-SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           QLLR L Y+HS  I HRD+KP NLL++     LK+ DFG A+     E  ++  + +R+Y
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX-ICSRYY 207
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           RAPEL+    NY T+ID+WS GC+ AE++  +P+FPG   ++QL  II V GT     ++
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 260 FID-NPKARRF--IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
            ++ N    +F  I+  P+S+        P+  P A+DL+ ++L + PS R+T  EAL H
Sbjct: 268 TMNPNYMEHKFPQIRPHPFSK-----VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 317 PYISGL 322
           P+   L
Sbjct: 323 PFFDEL 328

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 161/302 (53%), Gaps = 15/302 (4%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA--LRTLRELVLLRHIK 87
           +KY  +  IG+G +G V  + +R+T +KVA+KK+  + EN  +   +  LRE+ +L+ +K
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLK 75
Query: 88  HDNVIALKDV----MMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQL 142
           H+NV+ L ++      P +R     +YLV++  + DL  ++ +     +    K  +  L
Sbjct: 76  HENVVNLIEICRTKASPYNRCK-GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRW 198
           L GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S         Y   VVT W
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YR PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+      
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQHP 317
             +DN +    ++ +   +      L     DP ALDL+ K+LV +P++RI   +AL H 
Sbjct: 255 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 318 YI 319
           + 
Sbjct: 315 FF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 158/300 (52%), Gaps = 11/300 (3%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           +KY  +  IG+G +G V  + +R+T +KVA+KK+    E     +  LRE+ +L+ +KH+
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 90  NVIALKDV----MMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLR 144
           NV+ L ++      P +R     +YLV++  + DL  ++ +     +    K  +  LL 
Sbjct: 78  NVVNLIEICRTKASPYNRCK-ASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRWYR 200
           GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S         Y   VVT WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
            PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+        
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +DN +    ++ +   +      L     DP ALDL+ K+LV +P++RI   +AL H + 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 158/300 (52%), Gaps = 11/300 (3%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           +KY  +  IG+G +G V  + +R+T +KVA+KK+    E     +  LRE+ +L+ +KH+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 90  NVIALKDV----MMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLR 144
           NV+ L ++      P +R     +YLV++  + DL  ++ +     +    K  +  LL 
Sbjct: 77  NVVNLIEICRTKASPYNRCK-GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRWYR 200
           GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S         Y   VVT WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
            PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+        
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +DN +    ++ +   +      L     DP ALDL+ K+LV +P++RI   +AL H + 
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 158/300 (52%), Gaps = 11/300 (3%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           +KY  +  IG+G +G V  + +R+T +KVA+KK+    E     +  LRE+ +L+ +KH+
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 90  NVIALKDV----MMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLR 144
           NV+ L ++      P +R     +YLV++  + DL  ++ +     +    K  +  LL 
Sbjct: 78  NVVNLIEICRTKASPYNRCK-GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRWYR 200
           GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S         Y   VVT WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
            PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+        
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +DN +    ++ +   +      L     DP ALDL+ K+LV +P++RI   +AL H + 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 103/331 (31%), Positives = 167/331 (50%), Gaps = 49/331 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   K +G G++G+VC   + E+ ++ A+KK+        D     REL +++ + H N
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVN 61
Query: 91  VIALKDVMMPT--------------------------HRISF-------KDVYLVYELMD 117
           +I L D    T                          H  S        K + ++ E + 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 118 TDLHQI----IKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-L 172
             LH++    I+S +S+  +    +++QL R + ++HS  I HRD+KP NLLVN+  + L
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 173 KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKP 232
           K+CDFG A+    +E  +   + +R+YRAPEL+L    Y  SID+WS+GC+F E++  KP
Sbjct: 182 KLCDFGSAKKLIPSEPSVAX-ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 233 IFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP-L 291
           +F G   ++QL  II + GT  +  +  + NP         P  +      + P+  P L
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRM-NPHYTEV--RFPTLKAKDWRKILPEGTPSL 297
Query: 292 ALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
           A+DLL+++L +EP  RI   EA+ HP+   L
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 110/316 (34%), Positives = 163/316 (51%), Gaps = 24/316 (7%)
Query: 39  GRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRTLRELVLLRHIKHDNVIALKD 96
           G+G +G V     + T   VAIKK+  +  F NR   L+ +++L +L H    N++ L+ 
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--ELQIMQDLAVLHH---PNIVQLQS 86
Query: 97  VMMPTHRISFKDVYL--VYELMDTDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLH 150
                     +D+YL  V E +   LH+  ++      +      K F+FQL+R +  LH
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 151 --SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
             S N+ HRD+KP N+LVN A+  LK+CDFG A+    +E  +  Y+ +R+YRAPEL+  
Sbjct: 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-YICSRYYRAPELIFG 205
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
             +Y T++D+WSVGCIFAE++  +PIF G     QL  I+ V G      L  + NP   
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL-NPSHT 264
Query: 268 RF----IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                  K +P+S      SL    +  A DLL  +L + P +R+   EAL HPY   L+
Sbjct: 265 DVDLYNSKGIPWSNVFSDHSLKDAKE--AYDLLSALLQYLPEERMKPYEALCHPYFDELH 322
Query: 324 DPQCNPPAQVPLSLDI 339
           DP    P    L  D+
Sbjct: 323 DPATKLPNNKDLPEDL 338

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 111/322 (34%), Positives = 167/322 (51%), Gaps = 43/322 (13%)
Query: 38  IGRGAYGVV--CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +GRG YG V      + + ++  A+K+I    E    ++   RE+ LLR +KH NVI+L+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS---------LSNDHCKYFVFQLLRGL 146
            V + +H  + + V+L+++  + DL  IIK  ++         L     K  ++Q+L G+
Sbjct: 85  KVFL-SH--ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR      + + +    VVT WY
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE---------CLNQLKLIISVF 250
           RAPELLL   +Y  +ID+W++GCIFAE+L  +PIF   +           +QL  I +V 
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261
Query: 251 GTQQEADLEFIDN-PKARRFIKSLPYSRGTHISSL------YPQADPLALDLLQKMLVFE 303
           G   + D E I   P+    +K    +  T+ S +        + D  A  LLQK+L  +
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321
Query: 304 PSKRITVTEALQHPYISGLYDP 325
           P KRIT  +A+Q PY   L DP
Sbjct: 322 PIKRITSEQAMQDPYF--LEDP 341

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 97/305 (31%), Positives = 166/305 (54%), Gaps = 36/305 (11%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V +N+I      RE+ +L +++   N
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPN 93
Query: 91  VIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ L Y
Sbjct: 94  IITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 149 LHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
            HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PELL+ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVD 205
Query: 208 CDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ----------EA 256
              Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+           E 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 257 DLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  EA+
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAREAM 319
Query: 315 QHPYI 319
           +HPY 
Sbjct: 320 EHPYF 324

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 99/316 (31%), Positives = 163/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKVA+K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N+L++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 93/324 (28%), Positives = 165/324 (50%), Gaps = 44/324 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG+G++G V  + + + ++ VA+K + N       A   +R L  LR    DN
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 91  VIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLK 147
            +   +V+      +F++ + + +EL+  +L+++IK +  Q  S    + F   +L+ L 
Sbjct: 158 TM---NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 148 YLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            LH   I+H DLKP N+L+       +K+ DFG   +S    Q +   + +R+YRAPE++
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L    YG  ID+WS+GCI AE+L   P+ PG +  +QL  +I + G   +  L+   + +
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD--ASKR 328
Query: 266 ARRFIKSLPYSRGTHISSLY-------------------PQA-----------DPLALDL 295
           A+ F+    Y R   +++L                    P++           DPL LD 
Sbjct: 329 AKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388
Query: 296 LQKMLVFEPSKRITVTEALQHPYI 319
           L++ L ++P+ R+T  +AL+HP++
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 93/324 (28%), Positives = 165/324 (50%), Gaps = 44/324 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG+G++G V  + + + ++ VA+K + N       A   +R L  LR    DN
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 91  VIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLK 147
            +   +V+      +F++ + + +EL+  +L+++IK +  Q  S    + F   +L+ L 
Sbjct: 158 TM---NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 148 YLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            LH   I+H DLKP N+L+       +K+ DFG   +S    Q +   + +R+YRAPE++
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L    YG  ID+WS+GCI AE+L   P+ PG +  +QL  +I + G   +  L+   + +
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD--ASKR 328
Query: 266 ARRFIKSLPYSRGTHISSLY-------------------PQA-----------DPLALDL 295
           A+ F+    Y R   +++L                    P++           DPL LD 
Sbjct: 329 AKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388
Query: 296 LQKMLVFEPSKRITVTEALQHPYI 319
           L++ L ++P+ R+T  +AL+HP++
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/324 (28%), Positives = 164/324 (50%), Gaps = 44/324 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG+G +G V  + + + ++ VA+K + N       A   +R L  LR    DN
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 91  VIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLK 147
            +   +V+      +F++ + + +EL+  +L+++IK +  Q  S    + F   +L+ L 
Sbjct: 158 TM---NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 148 YLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            LH   I+H DLKP N+L+       +K+ DFG   +S    Q +   + +R+YRAPE++
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYXXIQSRFYRAPEVI 271
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L    YG  ID+WS+GCI AE+L   P+ PG +  +QL  +I + G   +  L+   + +
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLD--ASKR 328
Query: 266 ARRFIKSLPYSRGTHISSLY-------------------PQA-----------DPLALDL 295
           A+ F+    Y R   +++L                    P++           DPL LD 
Sbjct: 329 AKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388
Query: 296 LQKMLVFEPSKRITVTEALQHPYI 319
           L++ L ++P+ R+T  +AL+HP++
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 99/319 (31%), Positives = 165/319 (51%), Gaps = 40/319 (12%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NE+V +K +  V + +I      L  LR         
Sbjct: 40  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGT------ 93
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
             N+I L D +     +S K   LV+E ++ TD  Q+    Q L++   ++++++LL+ L
Sbjct: 94  --NIIKLIDTVKDP--VS-KTPALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKAL 145
Query: 147 KYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            Y HS  I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL
Sbjct: 146 DYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELL 204
Query: 206 LCCDNYGTSIDVWSVGCIFAE-ILGRKPIFPGTECLNQLKLIISVFGTQQ---------- 254
           +    Y  S+D+WS+GC+ A  I  R+P F G +  +QL  I  V GT++          
Sbjct: 205 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 264
Query: 255 EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           + D  F D     +R+  ++  +S   H+ S      P ALDLL K+L ++  +R+T  E
Sbjct: 265 DLDPHFNDILGQHSRKRWENFIHSENRHLVS------PEALDLLDKLLRYDHQQRLTAKE 318
Query: 313 ALQHPYISGLYDPQCNPPA 331
           A++HPY   +   Q  P A
Sbjct: 319 AMEHPYFYPVVKEQSQPSA 337

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 144/293 (49%), Gaps = 39/293 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +  +G+G++G V    +R T ++ A+K IN       D    LRE+ LL+ + H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 91  VIALKDVMMPTHRISF-KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L +++  +       ++Y   EL D    +IIK  +   +D  +  + Q+  G+ Y+
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFD----EIIKRKRFSEHDAAR-IIKQVFSGITYM 137
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H  NI+HRDLKP N+L+ +   +CD+KI DFGL+   + N + M + + T +Y APE+L 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLR 196
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
               Y    DVWS G I   +L   P F G    + LK +                  + 
Sbjct: 197 GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------------------ET 236
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            ++   LP  R              A DL++KML F PS RIT T+ L+HP+I
Sbjct: 237 GKYAFDLPQWRTISDD---------AKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/286 (31%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G++G V    +R T ++ A+K IN       D    LRE+ LL+ + H N++ L ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 98  MMPTHRISF-KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +  +       ++Y   EL D    +IIK  +   +D  +  + Q+  G+ Y+H  NI+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFD----EIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVH 144
Query: 157 RDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           RDLKP N+L+ +   +CD+KI DFGL+   + N + M + + T +Y APE+L     Y  
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLR--GTYDE 201
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
             DVWS G I   +L   P F G    + LK +        E      D P+ R      
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ETGKYAFDLPQWRTISDD- 252
Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                             A DL++KML F PS RIT T+ L+HP+I
Sbjct: 253 ------------------AKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 99/320 (30%), Positives = 164/320 (51%), Gaps = 42/320 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQCNPPA 331
           EA++HPY   +   Q  P A
Sbjct: 317 EAMEHPYFYPVVKEQSQPCA 336

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/286 (31%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G++G V    +R T ++ A+K IN       D    LRE+ LL+ + H N++ L ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 98  MMPTHRISF-KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +  +       ++Y   EL D    +IIK  +   +D  +  + Q+  G+ Y+H  NI+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFD----EIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVH 144
Query: 157 RDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           RDLKP N+L+ +   +CD+KI DFGL+   + N + M + + T +Y APE+L     Y  
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLR--GTYDE 201
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
             DVWS G I   +L   P F G    + LK +        E      D P+ R      
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ETGKYAFDLPQWRTISDD- 252
Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                             A DL++KML F PS RIT T+ L+HP+I
Sbjct: 253 ------------------AKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 44  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 95
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 96  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 148
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 149 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 207
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 208 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 267
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 268 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 321
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 322 EAMEHPYFYTVVKDQA 337

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 89
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 90  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 142
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 201
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 315
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 316 EAMEHPYFYTVVKDQA 331

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 42/316 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYISGLYDPQC 327
           EA++HPY   +   Q 
Sbjct: 317 EAMEHPYFYTVVKDQA 332

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 160/308 (51%), Gaps = 42/308 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 89
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 90  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 142
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 201
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 315
Query: 312 EALQHPYI 319
           EA++HPY 
Sbjct: 316 EAMEHPYF 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 160/308 (51%), Gaps = 42/308 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 90
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 91  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 143
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 202
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 316
Query: 312 EALQHPYI 319
           EA++HPY 
Sbjct: 317 EAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 160/308 (51%), Gaps = 42/308 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I      L  LR         
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--------G 88
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
             N+I L D++  P  R       LV+E + +TD  Q+    Q+L++   +++++++L+ 
Sbjct: 89  GPNIITLADIVKDPVSRTPA----LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 141
Query: 146 LKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L Y HS  I+HRD+KP N++++  +  L++ D+GLA      +++    V +R+++ PEL
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPEL 200
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGTQQ--------- 254
           L+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  V GT+          
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 255 -EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            E D  F D     +R+  +   +S   H+ S      P ALD L K+L ++   R+T  
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVS------PEALDFLDKLLRYDHQSRLTAR 314
Query: 312 EALQHPYI 319
           EA++HPY 
Sbjct: 315 EAMEHPYF 322

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 161/307 (52%), Gaps = 40/307 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA----LRTLRELVLLRHIK 87
           Y  ++ +GRG Y  V  +IN   NE+V +K +  V + +I      L  LR         
Sbjct: 45  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGT------ 98
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
             N+I L D +     +S K   LV+E ++ TD  Q+    Q L++   ++++++LL+ L
Sbjct: 99  --NIIKLIDTVKDP--VS-KTPALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKAL 150
Query: 147 KYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            Y HS  I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL
Sbjct: 151 DYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELL 209
Query: 206 LCCDNYGTSIDVWSVGCIFAE-ILGRKPIFPGTECLNQLKLIISVFGTQQ---------- 254
           +    Y  S+D+WS+GC+ A  I  R+P F G +  +QL  I  V GT++          
Sbjct: 210 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 269
Query: 255 EADLEFID--NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           + D  F D     +R+  ++  +S   H+ S      P ALDLL K+L ++  +R+T  E
Sbjct: 270 DLDPHFNDILGQHSRKRWENFIHSENRHLVS------PEALDLLDKLLRYDHQQRLTAKE 323
Query: 313 ALQHPYI 319
           A++HPY 
Sbjct: 324 AMEHPYF 330

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 153/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L   +   N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLMGGPNI 88
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 318 YIS 320
           Y  
Sbjct: 317 YFQ 319

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 54  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLXGGPNI 109
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 110 VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 164
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 165 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 223
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 224 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQ 283
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 284 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 337
Query: 318 YIS 320
           Y  
Sbjct: 338 YFQ 340

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLXGGPNI 88
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 318 YIS 320
           Y  
Sbjct: 317 YFQ 319

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLXGGPNI 88
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 318 YIS 320
           Y  
Sbjct: 317 YFQ 319

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLXGGPNI 89
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 90  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 144
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 203
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 318 YIS 320
           Y  
Sbjct: 318 YFQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLXGGPNI 88
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 318 YIS 320
           Y  
Sbjct: 317 YFQ 319

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 88
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 318 YIS 320
           Y  
Sbjct: 317 YFQ 319

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 89
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 90  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 144
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 203
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 318 YIS 320
           Y  
Sbjct: 318 YFQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 88
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 318 YIS 320
           Y  
Sbjct: 317 YFQ 319

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 30/303 (9%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +GRG Y  V   IN   NEK  IK +  V +            +L       N+
Sbjct: 35  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 90
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  L++   +Y++++LL+ L Y HS
Sbjct: 91  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 145
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA      +++    V +R+++ PELL+   +
Sbjct: 146 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 204
Query: 211 YGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKLIISVFGT------------QQEAD 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  V GT            + +  
Sbjct: 205 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 264
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           LE +    +R+       +   H+ S      P A+D L K+L ++  +R+T  EA+ HP
Sbjct: 265 LEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRYDHQERLTALEAMTHP 318
Query: 318 YIS 320
           Y  
Sbjct: 319 YFQ 321

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+              AL    E+ +L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 71  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 183
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 228
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 229 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 319 I 319
           +
Sbjct: 278 L 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+              AL    E+ +L+
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 70  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 123
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 124 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 182
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 227
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 228 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 276
Query: 319 I 319
           +
Sbjct: 277 L 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+              AL    E+ +L+
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 77  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 130
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 131 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 189
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 234
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 235 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 283
Query: 319 I 319
           +
Sbjct: 284 L 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+              AL    E+ +L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 71  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 183
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 228
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 229 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 319 I 319
           +
Sbjct: 278 L 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+              AL    E+ +L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 71  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 183
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 228
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 229 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 319 I 319
           +
Sbjct: 278 L 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAI+ I+              AL    E+ +L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 308
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 353
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 354 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402
Query: 319 I 319
           +
Sbjct: 403 L 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 145/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLRELVLLR 84
           +Y+  K +G GA G V  +  R+T +KVAI+ I+              AL    E+ +L+
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + +Q+L
Sbjct: 210 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 263
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T  Y 
Sbjct: 264 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPTYL 322
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE+L+      Y  ++D WS+G I    L   P  P +E   Q+ L             
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSL------------- 367
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                   +  I S  Y+    I  ++ +    ALDL++K+LV +P  R T  EAL+HP+
Sbjct: 368 --------KDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 416
Query: 319 I 319
           +
Sbjct: 417 L 417

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 88/311 (28%), Positives = 143/311 (45%), Gaps = 46/311 (14%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE----NRIDALR-- 75
           W    E   KY P   IGRG   VV   ++R T  + A+K +    E     +++ +R  
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 76  TLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSND 133
           T RE  +LR +  H ++I L D    +   SF  ++LV++LM   +L   +    +LS  
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESS---SF--MFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 134 HCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
             +  +  LL  + +LH+ NI+HRDLKP N+L++ N  +++ DFG +      E+ + E 
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LREL 259
Query: 194 VVTRWYRAPELLLCC-----DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
             T  Y APE+L C        YG  +D+W+ G I   +L   P F     +  L++I+ 
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI 308
             G  Q +  E+ D     +                         DL+ ++L  +P  R+
Sbjct: 320 --GQYQFSSPEWDDRSSTVK-------------------------DLISRLLQVDPEARL 352
Query: 309 TVTEALQHPYI 319
           T  +ALQHP+ 
Sbjct: 353 TAEQALQHPFF 363

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 141/306 (46%), Gaps = 37/306 (12%)
Query: 18  YYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL 77
           Y+    T       Y   + +G+GA+ VV   + +   ++ A K IN    +  D  +  
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCK 136
           RE  + R +KH N++ L D +       F   YLV++L+   +L + I + +  S     
Sbjct: 79  REARICRLLKHPNIVRLHDSISEE---GFH--YLVFDLVTGGELFEDIVAREYYSEADAS 133
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEY 193
           + + Q+L  + ++H  +I+HRDLKP NLL+ + C    +K+ DFGLA   +G +Q    +
Sbjct: 134 HCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF 193
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ 253
             T  Y +PE+L   D YG  +D+W+ G I   +L   P F                   
Sbjct: 194 AGTPGYLSPEVLR-KDPYGKPVDIWACGVILYILLVGYPPFWDE---------------- 236
Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
                   D  K  + IK+  Y      S  +    P A +L+ +ML   P+KRIT  +A
Sbjct: 237 --------DQHKLYQQIKAGAYD---FPSPEWDTVTPEAKNLINQMLTINPAKRITADQA 285
Query: 314 LQHPYI 319
           L+HP++
Sbjct: 286 LKHPWV 291

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 138/297 (46%), Gaps = 49/297 (16%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K +G GAYG V    ++ T+ + AIK I     +     + L E+ +L+ + H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 92  IALKDVMMPTHRISFKDVYLVYE------LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           + L D          ++ YLV E      L D  +H++       +       + Q+L G
Sbjct: 99  MKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSG 148
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + YLH  NI+HRDLKP NLL+ +   +  +KI DFGL+     N++ M E + T +Y AP
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAP 207
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L     Y    DVWS+G I   +L   P F G               T QE       
Sbjct: 208 EVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQ--------------TDQE------- 244
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                  ++ +   + T  S  +      A DL+++ML F+  +RI+  +AL+HP+I
Sbjct: 245 ------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 101/350 (28%), Positives = 164/350 (46%), Gaps = 59/350 (16%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN--VFENRIDALRTLRE 79
           W   +EID+       IG+G++G V  + +R   E VAIK I N   F N+      L E
Sbjct: 33  WMDRYEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKY 137
           L+     KHD  +    V +  H +    + LV+E++  +L+ +++++  + +S +  + 
Sbjct: 87  LM----NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 142
Query: 138 FVFQLLRGLKYLHSA--NILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEY 193
           F  Q+   L +L +   +I+H DLKP N+L+       +KI DFG   +S    Q + + 
Sbjct: 143 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQX 199
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ 253
           + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ V G  
Sbjct: 200 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 258
Query: 254 QEADLEFIDNPKARRFIKSL-------------------PYSRGTH-------------- 280
               L+    PKAR+F + L                   P +R  H              
Sbjct: 259 PAHILD--QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 316
Query: 281 -ISSLYPQADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN 328
              S +  AD L   DL+ +ML ++P  RI    ALQH +     D   N
Sbjct: 317 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTN 366

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 145/293 (49%), Gaps = 44/293 (15%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-LRTLRELVLLRHIKHDN 90
           Y+  + +G G++G V  + + +T +KVA+K I+     + D  +R  RE+  L+ ++H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           +I L DV+  PT      D+ +V E    +L   I   + ++ D  + F  Q++  ++Y 
Sbjct: 71  IIKLYDVITTPT------DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCC 208
           H   I+HRDLKP NLL++ N ++KI DFGL+   + GN  F+     +  Y APE++   
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGK 182
Query: 209 DNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              G  +DVWS G + +  ++GR P                        D EFI  P   
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF-----------------------DDEFI--PNLF 217
Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           + + S  Y     +S       P A  L+++M+V +P +RIT+ E  + P+ +
Sbjct: 218 KKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 100/346 (28%), Positives = 163/346 (47%), Gaps = 59/346 (17%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN--VFENRIDALRTLRE 79
           W   +EID+       IG+G++G V  + +R   E VAIK I N   F N+      L E
Sbjct: 52  WMDRYEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKY 137
           L+     KHD  +    V +  H +    + LV+E++  +L+ +++++  + +S +  + 
Sbjct: 106 LM----NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161
Query: 138 FVFQLLRGLKYLHSA--NILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEY 193
           F  Q+   L +L +   +I+H DLKP N+L+       +KI DFG   +S    Q + + 
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQX 218
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ 253
           + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ V G  
Sbjct: 219 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277
Query: 254 QEADLEFIDNPKARRFIKSL-------------------PYSRGTH-------------- 280
               L+    PKAR+F + L                   P +R  H              
Sbjct: 278 PAHILD--QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335
Query: 281 -ISSLYPQADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGLYD 324
              S +  AD L   DL+ +ML ++P  RI    ALQH +     D
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 142/302 (47%), Gaps = 47/302 (15%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-----NVFENRIDALR--TLRELVLLR 84
           Y P + +GRG   VV   I++ T ++ A+K I+     +     +  LR  TL+E+ +LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 85  HIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
            +  H N+I LKD    T+   F    LV++LM   +L   +    +LS    +  +  L
Sbjct: 79  KVSGHPNIIQLKDTY-ETNTFFF----LVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +      E+ + E   T  Y AP
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLAP 192
Query: 203 ELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E++ C  N     YG  +D+WS G I   +L   P F   + +  L++I+S  G  Q   
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGS 250
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            E+ D     +                         DL+ + LV +P KR T  EAL HP
Sbjct: 251 PEWDDYSDTVK-------------------------DLVSRFLVVQPQKRYTAEEALAHP 285
Query: 318 YI 319
           + 
Sbjct: 286 FF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 142/302 (47%), Gaps = 47/302 (15%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-----NVFENRIDALR--TLRELVLLR 84
           Y P + +GRG   VV   I++ T ++ A+K I+     +     +  LR  TL+E+ +LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 85  HIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
            +  H N+I LKD    T+   F    LV++LM   +L   +    +LS    +  +  L
Sbjct: 66  KVSGHPNIIQLKDTY-ETNTFFF----LVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +      E+ + E   T  Y AP
Sbjct: 121 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLAP 179
Query: 203 ELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E++ C  N     YG  +D+WS G I   +L   P F   + +  L++I+S  G  Q   
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGS 237
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            E+ D     +                         DL+ + LV +P KR T  EAL HP
Sbjct: 238 PEWDDYSDTVK-------------------------DLVSRFLVVQPQKRYTAEEALAHP 272
Query: 318 YI 319
           + 
Sbjct: 273 FF 274

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 101/349 (28%), Positives = 165/349 (47%), Gaps = 65/349 (18%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN--VFENRIDALRTLRE 79
           W   +EID+       IG+G++G V  + +R   E VAIK I N   F N+      L E
Sbjct: 52  WMDRYEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKY 137
           L+     KHD  +    V +  H +    + LV+E++  +L+ +++++  + +S +  + 
Sbjct: 106 LM----NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161
Query: 138 FVFQLLRGLKYLHSA--NILHRDLKPGNLLVNANCD-----LKICDFGLARTSRGNEQFM 190
           F  Q+   L +L +   +I+H DLKP N+L+   C+     +KI DFG   +S    Q +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILL---CNPKRXAIKIVDFG---SSCQLGQRI 215
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
            + + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ V 
Sbjct: 216 YQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274
Query: 251 GTQQEADLEFIDNPKARRFIKSL-------------------PYSRGTH----------- 280
           G      L+    PKAR+F + L                   P +R  H           
Sbjct: 275 GIPPAHILD--QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPG 332
Query: 281 ----ISSLYPQADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGLYD 324
                 S +  AD L   DL+ +ML ++P  RI    ALQH +     D
Sbjct: 333 GRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 135/293 (46%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  + T ++VA+KK++   + R + L    E+V++R   HDNV+     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHDNVVD---- 106
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M +  +   ++++V E ++      I +   ++ +        +LR L YLH+  ++HR
Sbjct: 107 -MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+ ++  +K+ DFG               V T ++ APE++     YGT +D+
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP-YGTEVDI 224
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSR 277
           WS+G +  E++  +P +     L  +                       RR   SLP   
Sbjct: 225 WSLGIMVIEMIDGEPPYFNEPPLQAM-----------------------RRIRDSLP--- 258
Query: 278 GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
              +  L+  +  L    L  MLV EPS+R T  E L HP++     P C  P
Sbjct: 259 -PRVKDLHKVSSVLR-GFLDLMLVREPSQRATAQELLGHPFLKLAGPPSCIVP 309

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 138/293 (47%), Gaps = 37/293 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y   + +G+GA+ VV   +   T ++ A K IN    +  D  +  RE  + R +KH N
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 91  VIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L D +       F   YLV++L+   +L + I + +  S     + + Q+L  + + 
Sbjct: 65  IVRLHDSISEE---GFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 150 HSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H   I+HRDLKP NLL+   +    +K+ DFGLA   +G++Q    +  T  Y +PE+L 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             D YG  +D+W+ G I   +L   P F                           D  + 
Sbjct: 180 -KDPYGKPVDMWACGVILYILLVGYPPFWDE------------------------DQHRL 214
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            + IK+  Y      S  +    P A DL+ KML   P+KRIT +EAL+HP+I
Sbjct: 215 YQQIKAGAYD---FPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 41/295 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y   + +G+GA+ VV   +   T ++ A K IN    +  D  +  RE  + R +KH N
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 91  VIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L D +       F   YLV++L+   +L + I + +  S     + + Q+L  + + 
Sbjct: 65  IVRLHDSISEE---GFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 150 HSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H   I+HRDLKP NLL+   +    +K+ DFGLA   +G++Q    +  T  Y +PE+L 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             D YG  +D+W+ G I   +L   P                           F D  + 
Sbjct: 180 -KDPYGKPVDMWACGVILYILLVGYP--------------------------PFWDEDQH 212
Query: 267 RRF--IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           R +  IK+  Y      S  +    P A DL+ KML   P+KRIT +EAL+HP+I
Sbjct: 213 RLYQQIKAGAYD---FPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 37/293 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y   + IG+GA+ VV   +   T  + A K IN    +  D  +  RE  + R +KH N
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSN 64
Query: 91  VIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L D +       F   YLV++L+   +L + I + +  S     + + Q+L  + + 
Sbjct: 65  IVRLHDSISEE---GFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 150 HSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H   ++HRDLKP NLL+ + C    +K+ DFGLA   +G++Q    +  T  Y +PE+L 
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             + YG  +D+W+ G I   +L   P F                           D  K 
Sbjct: 180 -KEAYGKPVDIWACGVILYILLVGYPPFWDE------------------------DQHKL 214
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            + IK+  Y      S  +    P A +L+ +ML   P+KRIT  EAL+HP++
Sbjct: 215 YQQIKAGAYD---FPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/302 (30%), Positives = 141/302 (46%), Gaps = 49/302 (16%)
Query: 25  LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
            FE++++      +GRGA  +V     + T +  A+K +    + +I  +RT  E+ +L 
Sbjct: 54  FFEVESE------LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRT--EIGVLL 103
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLL 143
            + H N+I LK++      IS     LV EL+   +L   I      S       V Q+L
Sbjct: 104 RLSHPNIIKLKEIFETPTEIS-----LVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             + YLH   I+HRDLKP NLL      +  LKI DFGL++    ++  M     T  Y 
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYC 217
Query: 201 APELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           APE+L  C  YG  +D+WSVG I +  + G +P +                        E
Sbjct: 218 APEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYD-----------------------E 253
Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             D    RR +    Y     IS  + +    A DL++K++V +P KR+T  +ALQHP++
Sbjct: 254 RGDQFMFRRILNCEYY----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309
Query: 320 SG 321
           +G
Sbjct: 310 TG 311

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 149/334 (44%), Gaps = 49/334 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G GA+G V   I+ +   + VA+K + NV +   +A R+  E+ +L H+
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL 68
Query: 87  KH-DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN--DHCKYFVFQLL 143
              D     + V M         + +V+EL+    +  IK +  L    DH +   +Q+ 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA-------------------NCDLKICDFGLARTSR 184
           + + +LHS  + H DLKP N+L                      N D+K+ DFG A    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
            +++  +  V TR YRAPE++L    +    DVWS+GCI  E      +FP  +    L 
Sbjct: 187 -DDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISS---LYPQADPLA--------- 292
           ++  + G   +     I   + R++          H S+   +     PL          
Sbjct: 245 MMERILGPLPK---HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 293 ----LDLLQKMLVFEPSKRITVTEALQHPYISGL 322
                DL+QKML ++P+KRIT+ EAL+HP+   L
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 134/294 (45%), Gaps = 39/294 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y   + +G+GA+ VV   +     ++ A K IN    +  D  +  RE  + R +KH N+
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 92  IALKD-VMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           + L D +    H       YL+++L+   +L + I + +  S     + + Q+L  + + 
Sbjct: 84  VRLHDSISEEGHH------YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H   ++HRDLKP NLL+ +      +K+ DFGLA    G +Q    +  T  Y +PE+L 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             D YG  +D+W+ G I   +L   P F                           D  + 
Sbjct: 198 -KDPYGKPVDLWACGVILYILLVGYPPFWDE------------------------DQHRL 232
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            + IK+  Y      S  +    P A DL+ KML   PSKRIT  EAL+HP+IS
Sbjct: 233 YQQIKAGAYD---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 283

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 47/302 (15%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-----NVFENRIDALR--TLRELVLLR 84
           Y P + +GRG   VV   I++ T ++ A+K I+     +     +  LR  TL+E+ +LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 85  HIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
            +  H N+I LKD    T+   F    LV++LM   +L   +    +LS    +  +  L
Sbjct: 79  KVSGHPNIIQLKDTY-ETNTFFF----LVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +      E+  +    T  Y AP
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-VCGTPSYLAP 192
Query: 203 ELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E++ C  N     YG  +D+WS G I   +L   P F   + +  L++I+S  G  Q   
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGS 250
Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            E+ D     +                         DL+ + LV +P KR T  EAL HP
Sbjct: 251 PEWDDYSDTVK-------------------------DLVSRFLVVQPQKRYTAEEALAHP 285
Query: 318 YI 319
           + 
Sbjct: 286 FF 287

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 140/310 (45%), Gaps = 60/310 (19%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN------------------------NVFENRIDA 73
           IG+G+YGVV  + N   N   A+K ++                           + R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 74  LRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSND 133
            +  +E+ +L+ + H NV+ L +V+   +      +Y+V+EL++      + + + LS D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 134 HCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
             +++   L++G++YLH   I+HRD+KP NLLV  +  +KI DFG++   +G++  ++  
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 194 VVTRWYRAPELLLCCDNY--GTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVF 250
           V T  + APE L        G ++DVW++G  ++  + G+ P           + I+ + 
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD--------ERIMCLH 249
Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
              +   LEF D P     +K                      DL+ +ML   P  RI V
Sbjct: 250 SKIKSQALEFPDQPDIAEDLK----------------------DLITRMLDKNPESRIVV 287
Query: 311 TEALQHPYIS 320
            E   HP+++
Sbjct: 288 PEIKLHPWVT 297

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/334 (26%), Positives = 148/334 (44%), Gaps = 49/334 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G GA+G V   I+ +   + VA+K + NV +   +A R+  E+ +L H+
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL 68
Query: 87  KH-DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN--DHCKYFVFQLL 143
              D     + V M         + +V+EL+    +  IK +  L    DH +   +Q+ 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA-------------------NCDLKICDFGLARTSR 184
           + + +LHS  + H DLKP N+L                      N D+K+ DFG A    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
            +++  +  V  R YRAPE++L    +    DVWS+GCI  E      +FP  +    L 
Sbjct: 187 -DDEHHSTLVXXRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISS---LYPQADPLA--------- 292
           ++  + G   +     I   + R++          H S+   +     PL          
Sbjct: 245 MMERILGPLPK---HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 293 ----LDLLQKMLVFEPSKRITVTEALQHPYISGL 322
                DL+QKML ++P+KRIT+ EAL+HP+   L
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHI 86
           +  +Y  +K +G GAYG V    ++ T  + AIK I  +      ++   L E+ +L+ +
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H N++ L +          ++ YLV E+    +L   I   Q  S       + Q+L G
Sbjct: 79  DHPNIMKLYEFFEDK-----RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 133
Query: 146 LKYLHSANILHRDLKPGNLLVNANCD---LKICDFGL-ARTSRGNEQFMTEYVVTRWYRA 201
             YLH  NI+HRDLKP NLL+ +      +KI DFGL A    G +  M E + T +Y A
Sbjct: 134 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIA 191
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE+L     Y    DVWS G I   +L   P F G                  + D E +
Sbjct: 192 PEVLR--KKYDEKCDVWSCGVILYILLCGYPPFGG------------------QTDQEIL 231
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              +  +F    P          + Q    A  L++ ML +EPSKRI+  EAL HP+I
Sbjct: 232 KRVEKGKFSFDPPD---------WTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 135/298 (45%), Gaps = 42/298 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHI 86
           +  +Y  +K +G GAYG V    ++ T  + AIK I  +      ++   L E+ +L+ +
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H N++ L +          ++ YLV E+    +L   I   Q  S       + Q+L G
Sbjct: 62  DHPNIMKLYEFFEDK-----RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 116
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL-ARTSRGNEQFMTEYVVTRWYRA 201
             YLH  NI+HRDLKP NLL+ +   +  +KI DFGL A    G +  M E + T +Y A
Sbjct: 117 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIA 174
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE+L     Y    DVWS G I   +L   P F G                  + D E +
Sbjct: 175 PEVLR--KKYDEKCDVWSCGVILYILLCGYPPFGG------------------QTDQEIL 214
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              +  +F    P          + Q    A  L++ ML +EPSKRI+  EAL HP+I
Sbjct: 215 KRVEKGKFSFDPPD---------WTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/318 (27%), Positives = 139/318 (43%), Gaps = 50/318 (15%)
Query: 10  GMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN 69
           G+  RG H   ++         YV  + IG G+Y      +++ TN + A+K I+    +
Sbjct: 13  GLVPRGSHMNLVF------SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRD 66
Query: 70  RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQ 128
             + +      +LLR+ +H N+I LKDV         K VYLV ELM   +L   I   +
Sbjct: 67  PSEEIE-----ILLRYGQHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQK 116
Query: 129 SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV-----NANCDLKICDFGLARTS 183
             S     + +  + + ++YLHS  ++HRDLKP N+L      N  C L+ICDFG A+  
Sbjct: 117 FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQL 175
Query: 184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQ 242
           R     +     T  + APE+L     Y    D+WS+G +   +L G  P   G      
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLAGYTPFANGPS---- 230
Query: 243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVF 302
                              D P+    +  +   + T     +      A DL+ KML  
Sbjct: 231 -------------------DTPE--EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHV 269
Query: 303 EPSKRITVTEALQHPYIS 320
           +P +R+T  + LQHP+++
Sbjct: 270 DPHQRLTAKQVLQHPWVT 287

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 153/330 (46%), Gaps = 48/330 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHD 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE+ LL+ + H 
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           N++ L +         F+D    YLV E+    +L   I S +  S       + Q+L G
Sbjct: 111 NIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 162
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y+H   I+HRDLKP NLL+ +   + +++I DFGL+     +++ M + + T +Y AP
Sbjct: 163 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAP 221
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L     Y    DVWS G I   +L   P F G    + LK +                
Sbjct: 222 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 263
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
             +  ++   LP          + +    A DL++KML + PS RI+  +AL H +I   
Sbjct: 264 --EKGKYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 312
Query: 323 YDPQ--CNPPAQVPLSLDIDENIGEQMIRQ 350
              Q   + P+     L+I +  G Q + Q
Sbjct: 313 TKEQISVDVPSLDNAILNIRQFQGTQKLAQ 342

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 153/330 (46%), Gaps = 48/330 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHD 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE+ LL+ + H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           N++ L +         F+D    YLV E+    +L   I S +  S       + Q+L G
Sbjct: 87  NIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y+H   I+HRDLKP NLL+ +   + +++I DFGL+     +++ M + + T +Y AP
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAP 197
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L     Y    DVWS G I   +L   P F G    + LK +                
Sbjct: 198 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 239
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
             +  ++   LP          + +    A DL++KML + PS RI+  +AL H +I   
Sbjct: 240 --EKGKYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288
Query: 323 YDPQ--CNPPAQVPLSLDIDENIGEQMIRQ 350
              Q   + P+     L+I +  G Q + Q
Sbjct: 289 TKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 153/330 (46%), Gaps = 48/330 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHD 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE+ LL+ + H 
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           N++ L +         F+D    YLV E+    +L   I S +  S       + Q+L G
Sbjct: 110 NIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 161
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y+H   I+HRDLKP NLL+ +   + +++I DFGL+     +++ M + + T +Y AP
Sbjct: 162 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAP 220
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L     Y    DVWS G I   +L   P F G    + LK +                
Sbjct: 221 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 262
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
             +  ++   LP          + +    A DL++KML + PS RI+  +AL H +I   
Sbjct: 263 --EKGKYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 311
Query: 323 YDPQ--CNPPAQVPLSLDIDENIGEQMIRQ 350
              Q   + P+     L+I +  G Q + Q
Sbjct: 312 TKEQISVDVPSLDNAILNIRQFQGTQKLAQ 341

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           YV  + IG G+Y      +++ TN + A+K I+    +  + +      +LLR+ +H N+
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE-----ILLRYGQHPNI 83
Query: 92  IALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I LKDV         K VYLV ELM   +L   I   +  S     + +  + + ++YLH
Sbjct: 84  ITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 151 SANILHRDLKPGNLLV-----NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           S  ++HRDLKP N+L      N  C L+ICDFG A+  R     +     T  + APE+L
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 206 LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
                Y    D+WS+G +   +L G  P   G                         D P
Sbjct: 198 K-RQGYDEGCDIWSLGILLYTMLAGYTPFANGPS-----------------------DTP 233
Query: 265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           +    +  +   + T     +      A DL+ KML  +P +R+T  + LQHP+++
Sbjct: 234 E--EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 46/297 (15%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHD 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE+ LL+ + H 
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           N++ L +         F+D    YLV E+    +L   I S +  S       + Q+L G
Sbjct: 93  NIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 144
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y+H   I+HRDLKP NLL+ +   + +++I DFGL+     +++ M + + T +Y AP
Sbjct: 145 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAP 203
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L     Y    DVWS G I   +L   P F G    + LK +                
Sbjct: 204 EVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 245
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             +  ++   LP          + +    A DL++KML + PS RI+  +AL H +I
Sbjct: 246 --EKGKYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/327 (29%), Positives = 150/327 (45%), Gaps = 52/327 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVA---IKKINNVFENR-IDALRTLRELVLLRHIKHDNV 91
           + +G G + +V     + T  + A   IKK  +    R +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +  I H DLKP N +L++ N     +K+ DFGLA       +F   +  T  + APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIV- 190
Query: 207 CCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              NY   G   D+WS+G I   +L     F G      L  I +V     + D EF   
Sbjct: 191 ---NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---SYDFDEEF--- 241
Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                                + Q   LA D ++K+LV E  KR+T+ EAL+HP+I+ + 
Sbjct: 242 ---------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           + Q     +  ++L   EN  +Q +R+
Sbjct: 281 NQQAMVRRESVVNL---ENFRKQYVRR 304

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 133/294 (45%), Gaps = 37/294 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y   + +G+GA+ VV   +     ++ A   IN    +  D  +  RE  + R +KH N
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 91  VIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L D +           YL+++L+   +L + I + +  S     + + Q+L  + + 
Sbjct: 72  IVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H   ++HR+LKP NLL+ +      +K+ DFGLA    G +Q    +  T  Y +PE+L 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             D YG  +D+W+ G I   +L   P F                           D  + 
Sbjct: 187 -KDPYGKPVDLWACGVILYILLVGYPPFWDE------------------------DQHRL 221
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            + IK+  Y      S  +    P A DL+ KML   PSKRIT  EAL+HP+IS
Sbjct: 222 YQQIKAGAYD---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/327 (29%), Positives = 150/327 (45%), Gaps = 52/327 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVA---IKKINNVFENR-IDALRTLRELVLLRHIKHDNV 91
           + +G G + +V     + T  + A   IKK  +    R +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +  I H DLKP N +L++ N     +K+ DFGLA       +F   +  T  + APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIV- 190
Query: 207 CCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              NY   G   D+WS+G I   +L     F G      L  I +V     + D EF   
Sbjct: 191 ---NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---SYDFDEEF--- 241
Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                                + Q   LA D ++K+LV E  KR+T+ EAL+HP+I+ + 
Sbjct: 242 ---------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           + Q     +  ++L   EN  +Q +R+
Sbjct: 281 NQQAMVRRESVVNL---ENFRKQYVRR 304

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 96/327 (29%), Positives = 149/327 (45%), Gaps = 52/327 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVA---IKKINNVFENR-IDALRTLRELVLLRHIKHDNV 91
           + +G G + +V     + T  + A   IKK  +    R +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +  I H DLKP N +L++ N     +K+ DFGLA       +F   +  T  + APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIV- 190
Query: 207 CCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              NY   G   D+WS+G I   +L     F G      L  I SV     + D EF   
Sbjct: 191 ---NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---SYDFDEEF--- 241
Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                                +     LA D ++K+LV E  KR+T+ EAL+HP+I+ + 
Sbjct: 242 ---------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           + Q     +  ++L   EN  +Q +R+
Sbjct: 281 NQQAMVRRESVVNL---ENFRKQYVRR 304

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 142/293 (48%), Gaps = 41/293 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG G +GV     ++++NE VA+K I      +ID     RE++  R ++H N
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDE-NVKREIINHRSLRHPN 75
Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K+V++ PTH      + +V E     +L + I ++   S D  ++F  QL+ G+ Y
Sbjct: 76  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKICDFG +++S  + Q  +  V T  Y APE+LL
Sbjct: 130 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 188
Query: 207 CCDNYGTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             +  G   DVWS G  ++  ++G  P     E  N  K I  +   Q            
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 237
Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 ++P     HIS       P    L+ ++ V +P+KRI++ E   H +
Sbjct: 238 ------AIP--DYVHIS-------PECRHLISRIFVADPAKRISIPEIRNHEW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 96/327 (29%), Positives = 149/327 (45%), Gaps = 52/327 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVA---IKKINNVFENR-IDALRTLRELVLLRHIKHDNV 91
           + +G G + +V     + T  + A   IKK  +    R +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +  I H DLKP N +L++ N     +K+ DFGLA       +F   +  T  + APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIV- 190
Query: 207 CCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              NY   G   D+WS+G I   +L     F G      L  I SV     + D EF   
Sbjct: 191 ---NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---SYDFDEEF--- 241
Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                                +     LA D ++K+LV E  KR+T+ EAL+HP+I+ + 
Sbjct: 242 ---------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           + Q     +  ++L   EN  +Q +R+
Sbjct: 281 NQQAMVRRESVVNL---ENFRKQYVRR 304

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG G +GV     ++++NE VA+K I         A    RE++  R ++H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K+V++ PTH      + +V E     +L + I ++   S D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKICDFG +++S  + Q  +  V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             +  G   DVWS G  ++  ++G  P     E  N  K I  +   Q            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 ++P     HIS       P    L+ ++ V +P+KRI++ E   H +
Sbjct: 239 ------AIP--DYVHIS-------PECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR ++H +
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +I L DV+      S  ++ +V E    +L   I     +S    + F  Q++  ++Y H
Sbjct: 70  IIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLKP NLL++ + ++KI DFGL+   + GN  F+     +  Y APE++    
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKL 182
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS G I   +L R+  F                           D+      
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPF---------------------------DDESIPVL 215
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            K++  S G +  +L     P A  L+++ML+  P  RI++ E +Q
Sbjct: 216 FKNI--SNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 257

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR ++H +
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +I L DV+      S  ++ +V E    +L   I     +S    + F  Q++  ++Y H
Sbjct: 66  IIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLKP NLL++ + ++KI DFGL+   + GN  F+     +  Y APE++    
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKL 178
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS G I   +L R+  F                           D+      
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPF---------------------------DDESIPVL 211
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            K++  S G +  +L     P A  L+++ML+  P  RI++ E +Q
Sbjct: 212 FKNI--SNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 253

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR ++H +
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +I L DV+      S  ++ +V E    +L   I     +S    + F  Q++  ++Y H
Sbjct: 76  IIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLKP NLL++ + ++KI DFGL+   + GN  F+     +  Y APE++    
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKL 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS G I   +L R+  F                           D+      
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPF---------------------------DDESIPVL 221
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            K++  S G +  +L     P A  L+++ML+  P  RI++ E +Q
Sbjct: 222 FKNI--SNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 263

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR ++H +
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +I L DV+      S  ++ +V E    +L   I     +S    + F  Q++  ++Y H
Sbjct: 75  IIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLKP NLL++ + ++KI DFGL+   + GN  F+     +  Y APE++    
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKL 187
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS G I   +L R+  F                           D+      
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPF---------------------------DDESIPVL 220
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            K++  S G +  +L     P A  L+++ML+  P  RI++ E +Q
Sbjct: 221 FKNI--SNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 144/293 (49%), Gaps = 45/293 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT---LRELVLLRHIKHDNVIAL 94
           IG+GA+ VV   INRET ++ A+K ++         L T    RE  +   +KH +++ L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 95  KDVMMPTHRISFKDVYLVYELMD-TDL-HQIIKSSQS---LSNDHCKYFVFQLLRGLKYL 149
            +       +     Y+V+E MD  DL  +I+K + +    S     +++ Q+L  L+Y 
Sbjct: 92  LETYSSDGML-----YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H  NI+HRD+KP N+L+ +   +  +K+ DFG+A     +       V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             + YG  +DVW  G I   +L     F GT    + +L   +   + +       NP+ 
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGKYKM------NPR- 254
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     + +HIS         A DL+++ML+ +P++RITV EAL HP++
Sbjct: 255 ----------QWSHISE-------SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 41/283 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +   +DVWS G +   +L G  P                 +    ++  E+ D  + + +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-----------------WDQPSDSXQEYSDWKEKKTY 226
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           +              + + D   L LL K+LV  PS RIT+ +
Sbjct: 227 LNP------------WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 141/301 (46%), Gaps = 46/301 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  R + + VA+KK++   + R + L    E+V++R  +H+NV+ + + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 216
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 217 YL-----VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 330
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  P+ +   K  P 
Sbjct: 331 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHKVSPS 376
Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ-VP 334
            +G                 L ++LV +P++R T  E L+HP+++     +  PPA  VP
Sbjct: 377 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASIVP 415
Query: 335 L 335
           L
Sbjct: 416 L 416

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 140/301 (46%), Gaps = 46/301 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  R + + VA+KK++   + R + L    E+V++R  +H+NV+     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVE---- 90
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +   ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 91  -MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 208
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  P+ +   K  P 
Sbjct: 209 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHKVSPS 254
Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ-VP 334
            +G                 L ++LV +P++R T  E L+HP+++     +  PPA  VP
Sbjct: 255 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASIVP 293
Query: 335 L 335
           L
Sbjct: 294 L 294

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 141/301 (46%), Gaps = 46/301 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  R + + VA+KK++   + R + L    E+V++R  +H+NV+ + + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 139
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 140 YL-----VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 253
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  P+ +   K  P 
Sbjct: 254 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHKVSPS 299
Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ-VP 334
            +G                 L ++LV +P++R T  E L+HP+++     +  PPA  VP
Sbjct: 300 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASIVP 338
Query: 335 L 335
           L
Sbjct: 339 L 339

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 222
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 223 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 140/301 (46%), Gaps = 46/301 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  R + + VA+KK++   + R + L    E+V++R  +H+NV+     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVE---- 85
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +   ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 86  -MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 203
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  P+ +   K  P 
Sbjct: 204 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHKVSPS 249
Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ-VP 334
            +G                 L ++LV +P++R T  E L+HP+++     +  PPA  VP
Sbjct: 250 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASIVP 288
Query: 335 L 335
           L
Sbjct: 289 L 289

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 140/301 (46%), Gaps = 46/301 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  R + + VA+KK++   + R + L    E+V++R  +H+NV+     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVE---- 92
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +   ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 93  -MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 210
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  P+ +   K  P 
Sbjct: 211 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHKVSPS 256
Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ-VP 334
            +G                 L ++LV +P++R T  E L+HP+++     +  PPA  VP
Sbjct: 257 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASIVP 295
Query: 335 L 335
           L
Sbjct: 296 L 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 140/301 (46%), Gaps = 46/301 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  R + + VA+KK++   + R + L    E+V++R  +H+NV+     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVE---- 81
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +   ++++V E ++      I +   ++ +        +L+ L  LH+  ++HR
Sbjct: 82  -MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG               V T ++ APEL+     YG  +D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 199
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PKARRFIKSLPY 275
           WS+G +  E++  +P +     L  +K+I               DN  P+ +   K  P 
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHKVSPS 245
Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ-VP 334
            +G                 L ++LV +P++R T  E L+HP+++     +  PPA  VP
Sbjct: 246 LKG----------------FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASIVP 284
Query: 335 L 335
           L
Sbjct: 285 L 285

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 138/304 (45%), Gaps = 49/304 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVA---IKKINNVFENR-IDALRTLRELVLLRHIKHDNV 91
           + +G G + +V     + T  + A   IKK  +    R +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +  I H DLKP N +L++ N     +K+ DFGLA       +F   +  T  + APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIV- 190
Query: 207 CCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              NY   G   D+WS+G I   +L     F G      L  I SV     + D EF   
Sbjct: 191 ---NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---SYDFDEEF--- 241
Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                                +     LA D ++K+LV E  KR+T+ EAL+HP+I+ + 
Sbjct: 242 ---------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 324 DPQC 327
           + Q 
Sbjct: 281 NQQA 284

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 93/335 (27%), Positives = 149/335 (44%), Gaps = 45/335 (13%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I     E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EI 67
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYF 138
            +L  IKH N++AL D+       S   +YL+ +L+       +I++       D  +  
Sbjct: 68  AVLHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR-L 121
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           +FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++         T    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           T  Y APE +L    Y  ++D WS+G I   +L   P F      N  KL   +   + E
Sbjct: 181 TPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYE 236
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            D  + D+                 IS         A D ++ ++  +P KR T  +ALQ
Sbjct: 237 FDSPYWDD-----------------ISD-------SAKDFIRHLMEKDPEKRFTCEQALQ 272
Query: 316 HPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           HP+I+G  D   +      +S  I +N  +   +Q
Sbjct: 273 HPWIAG--DTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 93/335 (27%), Positives = 149/335 (44%), Gaps = 45/335 (13%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I     E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN--EI 67
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYF 138
            +L  IKH N++AL D+       S   +YL+ +L+       +I++       D  +  
Sbjct: 68  AVLHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR-L 121
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           +FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++         T    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           T  Y APE +L    Y  ++D WS+G I   +L   P F      N  KL   +   + E
Sbjct: 181 TPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYE 236
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            D  + D+                 IS         A D ++ ++  +P KR T  +ALQ
Sbjct: 237 FDSPYWDD-----------------ISD-------SAKDFIRHLMEKDPEKRFTCEQALQ 272
Query: 316 HPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           HP+I+G  D   +      +S  I +N  +   +Q
Sbjct: 273 HPWIAG--DTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 93/335 (27%), Positives = 149/335 (44%), Gaps = 45/335 (13%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I     E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EI 67
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYF 138
            +L  IKH N++AL D+       S   +YL+ +L+       +I++       D  +  
Sbjct: 68  AVLHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR-L 121
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           +FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++         T    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           T  Y APE +L    Y  ++D WS+G I   +L   P F      N  KL   +   + E
Sbjct: 181 TPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYE 236
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            D  + D+                 IS         A D ++ ++  +P KR T  +ALQ
Sbjct: 237 FDSPYWDD-----------------ISD-------SAKDFIRHLMEKDPEKRFTCEQALQ 272
Query: 316 HPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           HP+I+G  D   +      +S  I +N  +   +Q
Sbjct: 273 HPWIAG--DTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 132/281 (46%), Gaps = 48/281 (17%)
Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCK 136
           RE+ +LR + H N+I L DV       +  DV L+ EL+   +L   +   +SLS +   
Sbjct: 64  REVSILRQVLHPNIITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTE 192
            F+ Q+L G+ YLH+  I H DLKP N +L++ N     +K+ DFGLA       +F   
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 193 YVVTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           +  T  + APE++    NY   G   D+WS+G I   +L     F G      L  I +V
Sbjct: 179 F-GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
                + D EF                        + Q   LA D ++K+LV E  KR+T
Sbjct: 234 ---SYDFDEEF------------------------FSQTSELAKDFIRKLLVKETRKRLT 266
Query: 310 VTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           + EAL+HP+I+ +   Q     +  ++L   EN  +Q +R+
Sbjct: 267 IQEALRHPWITPVDTQQAMVRRESVVNL---ENFKKQYVRR 304

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 222
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 223 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 139/306 (45%), Gaps = 43/306 (14%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I     E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EI 67
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYF 138
            +L  IKH N++AL D+       S   +YL+ +L+       +I++       D  +  
Sbjct: 68  AVLHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR-L 121
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           +FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++         T    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           T  Y APE +L    Y  ++D WS+G I   +L   P F      N  KL   +   + E
Sbjct: 181 TPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYE 236
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            D  + D+                 IS         A D ++ ++  +P KR T  +ALQ
Sbjct: 237 FDSPYWDD-----------------ISD-------SAKDFIRHLMEKDPEKRFTCEQALQ 272
Query: 316 HPYISG 321
           HP+I+G
Sbjct: 273 HPWIAG 278

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           ++              + + D   L LL K+LV  PS RIT+ +
Sbjct: 226 YLNP------------WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           ++              + + D   L LL K+LV  PS RIT+ +
Sbjct: 227 YLNP------------WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 68  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 220
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 221 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 256

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 222
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 223 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 41/283 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +   +DVWS G +   +L G  P                 +    ++  E+ D  + + +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-----------------WDQPSDSCQEYSDWKEKKTY 227
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           +              + + D   L LL K+LV  PS RIT+ +
Sbjct: 228 LNP------------WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 41/283 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +   +DVWS G +   +L G  P                 +    ++  E+ D  + + +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-----------------WDQPSDSCQEYSDWKEKKTY 227
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           +              + + D   L LL K+LV  PS RIT+ +
Sbjct: 228 LNP------------WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 41/283 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +   +DVWS G +   +L G  P                 +    ++  E+ D  + + +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-----------------WDQPSDSCQEYSDWKEKKTY 227
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           +              + + D   L LL K+LV  PS RIT+ +
Sbjct: 228 LNP------------WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 41/293 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG G +GV     ++++NE VA+K I      +ID     RE++  R ++H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDE-NVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K+V++ PTH      + +V E     +L + I ++   S D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKIC FG +++S  + Q   + V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ-PKDTVGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             +  G   DVWS G  ++  ++G  P     E  N  K I  +   Q            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 ++P     HIS       P    L+ ++ V +P+KRI++ E   H +
Sbjct: 239 ------AIP--DYVHIS-------PECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+Y V    I++ TN + A+K I+    +  + +      +LLR+ +H N+I LKDV
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE-----ILLRYGQHPNIITLKDV 84
Query: 98  MMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
                    K VY+V ELM   +L   I   +  S       +F + + ++YLH+  ++H
Sbjct: 85  YD-----DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 157 RDLKPGNLL-VNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           RDLKP N+L V+ + +   ++ICDFG A+  R     +     T  + APE+L     Y 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE-RQGYD 198
Query: 213 TSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
            + D+WS+G +   +L G  P   G +                       D P+    + 
Sbjct: 199 AACDIWSLGVLLYTMLTGYTPFANGPD-----------------------DTPE--EILA 233
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            +   + +     +      A DL+ KML  +P +R+T    L+HP+I
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 41/293 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG G +GV     ++++NE VA+K I      +ID     RE++  R ++H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDE-NVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K+V++ PTH      + +V E     +L + I ++   S D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKIC FG +++S  + Q  +  V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             +  G   DVWS G  ++  ++G  P     E  N  K I  +   Q            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 ++P     HIS       P    L+ ++ V +P+KRI++ E   H +
Sbjct: 239 ------AIP--DYVHIS-------PECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 64
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 65  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 177
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 178 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 230
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 231 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 266
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 267 DSLQHPWI 274

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GAYG V  ++NR T E VA+K ++   +  +D    ++ E+ +   + H+NV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINAMLNHENVVK 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 222
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 223 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 258

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 93/338 (27%), Positives = 148/338 (43%), Gaps = 46/338 (13%)
Query: 20  TMWQTLFEIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTL 77
           + W+   E   K    K  +G GA+  V  +  + T +  A+K I     + +  ++   
Sbjct: 11  SSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN- 69
Query: 78  RELVLLRHIKHDNVIALKDVM-MPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHC 135
            E+ +LR IKH+N++AL+D+   P H      +YLV +L+   +L   I      +    
Sbjct: 70  -EIAVLRKIKHENIVALEDIYESPNH------LYLVMQLVSGGELFDRIVEKGFYTEKDA 122
Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTE 192
              + Q+L  + YLH   I+HRDLKP NLL    +    + I DFGL++   G    M+ 
Sbjct: 123 STLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMST 181
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
              T  Y APE +L    Y  ++D WS+G I   +L   P F      N  KL   +   
Sbjct: 182 ACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDSKLFEQILKA 237
Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           + E D  + D+                 IS         A D ++ ++  +P+KR T  +
Sbjct: 238 EYEFDSPYWDD-----------------ISD-------SAKDFIRNLMEKDPNKRYTCEQ 273
Query: 313 ALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQ 350
           A +HP+I+G  D   N      +S  I +N  +   RQ
Sbjct: 274 AARHPWIAG--DTALNKNIHESVSAQIRKNFAKSKWRQ 309

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG G +GV     +++ NE VA+K I      +ID     RE++  R ++H N
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDE-NVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K+V++ PTH      + +V E     +L + I ++   S D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKI DFG ++ S  + Q  +  V T  Y APE+LL
Sbjct: 131 AHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-VGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             +  G   DVWS G  ++  ++G  P     E  N  K I  +   Q            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                 ++P     HIS       P    L+ ++ V +P+KRI++ E   H +
Sbjct: 239 ------AIP--DYVHIS-------PECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 64
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 65  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 177
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 178 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 230
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 231 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 266
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 267 DSLQHPWI 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 135/293 (46%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+ G+VC +  + +  +VA+K ++   + R + L    E+V++R  +H NV+     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFNVVE---- 106
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
            M    +  ++++++ E +       I S   L+ +        +L+ L YLH+  ++HR
Sbjct: 107 -MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG       +       V T ++ APE ++    Y T +D+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDI 224
Query: 218 WSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSR 277
           WS+G +  E++  +P +     +  +K                 D+P         P  +
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMK--------------RLRDSPP--------PKLK 262
Query: 278 GTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
            +H      +  P+  D L++MLV +P +R T  E L HP++     P+C  P
Sbjct: 263 NSH------KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPAFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 33/218 (15%)
Query: 109 VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           VY+V E+     L ++ K  ++++    +YF+ Q ++G++YLH+  ++HRDLK GNL +N
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 168 ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI 227
            + D+KI DFGLA     + +   +   T  Y APE +LC   +   +D+WS+GCI   +
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYTL 235
Query: 228 LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ 287
           L  KP F  T CL +  +                        IK   YS   HI      
Sbjct: 236 LVGKPPFE-TSCLKETYI-----------------------RIKKNEYSVPRHI------ 265
Query: 288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            +P+A  L+++ML  +P+ R +V E L   + +  Y P
Sbjct: 266 -NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 49/262 (18%)
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDH 134
           E+ + R + H +V+             F+D   V++V EL     L ++ K  ++L+   
Sbjct: 71  EISIHRSLAHQHVVGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 122
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +Y++ Q++ G +YLH   ++HRDLK GNL +N + ++KI DFGLA     + +      
Sbjct: 123 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC 182
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y APE +L    +   +DVWS+GCI   +L  KP F  T CL +  L         
Sbjct: 183 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL--------- 231
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                          IK   YS   HI       +P+A  L+QKML  +P+ R T+ E L
Sbjct: 232 --------------RIKKNEYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELL 270
Query: 315 QHPYISGLYDPQCNPPAQVPLS 336
              + +  Y      PA++P++
Sbjct: 271 NDEFFTSGYI-----PARLPIT 287

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILIGELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 33/218 (15%)
Query: 109 VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           VY+V E+     L ++ K  ++++    +YF+ Q ++G++YLH+  ++HRDLK GNL +N
Sbjct: 101 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 160
Query: 168 ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI 227
            + D+KI DFGLA     + +   +   T  Y APE +LC   +   +D+WS+GCI   +
Sbjct: 161 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYTL 219
Query: 228 LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ 287
           L  KP F  T CL +  +                        IK   YS   HI      
Sbjct: 220 LVGKPPFE-TSCLKETYIR-----------------------IKKNEYSVPRHI------ 249
Query: 288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            +P+A  L+++ML  +P+ R +V E L   + +  Y P
Sbjct: 250 -NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 49/262 (18%)
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDH 134
           E+ + R + H +V+             F+D   V++V EL     L ++ K  ++L+   
Sbjct: 67  EISIHRSLAHQHVVGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +Y++ Q++ G +YLH   ++HRDLK GNL +N + ++KI DFGLA     + +      
Sbjct: 119 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC 178
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y APE +L    +   +DVWS+GCI   +L  KP F  T CL +  L         
Sbjct: 179 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL--------- 227
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                          IK   YS   HI       +P+A  L+QKML  +P+ R T+ E L
Sbjct: 228 --------------RIKKNEYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELL 266
Query: 315 QHPYISGLYDPQCNPPAQVPLS 336
              + +  Y      PA++P++
Sbjct: 267 NDEFFTSGYI-----PARLPIT 283

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 49/262 (18%)
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDH 134
           E+ + R + H +V+             F+D   V++V EL     L ++ K  ++L+   
Sbjct: 67  EISIHRSLAHQHVVGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +Y++ Q++ G +YLH   ++HRDLK GNL +N + ++KI DFGLA     + +      
Sbjct: 119 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC 178
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y APE +L    +   +DVWS+GCI   +L  KP F  T CL +  L         
Sbjct: 179 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL--------- 227
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                          IK   YS   HI       +P+A  L+QKML  +P+ R T+ E L
Sbjct: 228 --------------RIKKNEYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELL 266
Query: 315 QHPYISGLYDPQCNPPAQVPLS 336
              + +  Y      PA++P++
Sbjct: 267 NDEFFTSGYI-----PARLPIT 283

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           +D  Y   + +G G + VV     + T  + A K I    + R  + R         RE+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREV 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFV 139
            +L+ I+H NVI L +V          DV L+ EL+   +L   +   +SL+ +    F+
Sbjct: 66  SILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSRGNEQFMTEYV 194
            Q+L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA +   GNE       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G     + + + +V  
Sbjct: 179 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 231
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              E + E+  N  A                        LA D ++++LV +P KR+T+ 
Sbjct: 232 VNYEFEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQ 267
Query: 312 EALQHPYI 319
           ++LQHP+I
Sbjct: 268 DSLQHPWI 275

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 109 VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           VY+V E+     L ++ K  ++++    +YF+ Q ++G++YLH+  ++HRDLK GNL +N
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 168 ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI 227
            + D+KI DFGLA     + +       T  Y APE +LC   +   +D+WS+GCI   +
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYTL 235
Query: 228 LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ 287
           L  KP F  T CL +  +                        IK   YS   HI      
Sbjct: 236 LVGKPPFE-TSCLKETYI-----------------------RIKKNEYSVPRHI------ 265
Query: 288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            +P+A  L+++ML  +P+ R +V E L   + +  Y P
Sbjct: 266 -NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 49/262 (18%)
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSSQSLSNDH 134
           E+ + R + H +V+             F+D   V++V EL     L ++ K  ++L+   
Sbjct: 89  EISIHRSLAHQHVVGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 140
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +Y++ Q++ G +YLH   ++HRDLK GNL +N + ++KI DFGLA     + +      
Sbjct: 141 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 200
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y APE +L    +   +DVWS+GCI   +L  KP F  T CL +  L         
Sbjct: 201 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL--------- 249
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                          IK   YS   HI       +P+A  L+QKML  +P+ R T+ E L
Sbjct: 250 --------------RIKKNEYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELL 288
Query: 315 QHPYISGLYDPQCNPPAQVPLS 336
              + +  Y      PA++P++
Sbjct: 289 NDEFFTSGYI-----PARLPIT 305

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 49/262 (18%)
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDH 134
           E+ + R + H +V+             F+D   V++V EL     L ++ K  ++L+   
Sbjct: 91  EISIHRSLAHQHVVGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 142
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +Y++ Q++ G +YLH   ++HRDLK GNL +N + ++KI DFGLA     + +      
Sbjct: 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 202
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y APE +L    +   +DVWS+GCI   +L  KP F  T CL +  L         
Sbjct: 203 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL--------- 251
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                          IK   YS   HI       +P+A  L+QKML  +P+ R T+ E L
Sbjct: 252 --------------RIKKNEYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELL 290
Query: 315 QHPYISGLYDPQCNPPAQVPLS 336
              + +  Y      PA++P++
Sbjct: 291 NDEFFTSGYI-----PARLPIT 307

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 49/262 (18%)
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDH 134
           E+ + R + H +V+             F+D   V++V EL     L ++ K  ++L+   
Sbjct: 65  EISIHRSLAHQHVVGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 116
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +Y++ Q++ G +YLH   ++HRDLK GNL +N + ++KI DFGLA     + +      
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 176
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y APE +L    +   +DVWS+GCI   +L  KP F  T CL +  L         
Sbjct: 177 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL--------- 225
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                          IK   YS   HI       +P+A  L+QKML  +P+ R T+ E L
Sbjct: 226 --------------RIKKNEYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELL 264
Query: 315 QHPYISGLYDPQCNPPAQVPLS 336
              + +  Y      PA++P++
Sbjct: 265 NDEFFTSGYI-----PARLPIT 281

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 109 VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           VY+V E+     L ++ K  ++++    +YF+ Q ++G++YLH+  ++HRDLK GNL +N
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 168 ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI 227
            + D+KI DFGLA     + +       T  Y APE +LC   +   +D+WS+GCI   +
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYTL 235
Query: 228 LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ 287
           L  KP F  T CL +  +                        IK   YS   HI      
Sbjct: 236 LVGKPPF-ETSCLKETYI-----------------------RIKKNEYSVPRHI------ 265
Query: 288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
            +P+A  L+++ML  +P+ R +V E L   + +  Y P
Sbjct: 266 -NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 89/330 (26%), Positives = 149/330 (45%), Gaps = 48/330 (14%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHD 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE+ LL+ + H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           N+  L +         F+D    YLV E+    +L   I S +  S       + Q+L G
Sbjct: 87  NIXKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y H   I+HRDLKP NLL+ +   + +++I DFGL+     +++   + + T +Y AP
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-XKDKIGTAYYIAP 197
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L     Y    DVWS G I   +L   P F G    + LK +                
Sbjct: 198 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 239
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
             +  ++   LP          + +    A DL++K L + PS RI+  +AL H +I   
Sbjct: 240 --EKGKYTFELPQ---------WKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTY 288
Query: 323 YDPQ--CNPPAQVPLSLDIDENIGEQMIRQ 350
              Q   + P+     L+I +  G Q + Q
Sbjct: 289 TKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 43/284 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIA 93
           ++ +G GA G V  ++NR T E VA+K ++   +  +D    ++ E+ + + + H+NV+ 
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                   HR      YL  E     +L   I+    +     + F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA   R N  E+ + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF--PGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           +   +DVWS G +   +L  +  +  P   C             Q+ +D +         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------------QEYSDWK--------- 221
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   + T+++  + + D   L LL K+LV  PS RIT+ +
Sbjct: 222 -------EKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPD 257

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/336 (26%), Positives = 151/336 (44%), Gaps = 53/336 (15%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G G +G V   ++    + +VA+K I NV + R +A R   E+ +L+ I
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARL--EINVLKKI 73
Query: 87  KH-DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLL 143
           K  D       V+M         + + +EL+  +  + +K +  Q     H ++  +QL 
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 144 RGLKYLHSANILHRDLKPGNLL-VNA------------------NCDLKICDFGLARTSR 184
             L++LH   + H DLKP N+L VN+                  N  +++ DFG A    
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF-- 191
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
            + +  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E    L 
Sbjct: 192 -DHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 245 LIISVFG---------TQQE-----ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP 290
           ++  + G         T+++       L + +N    R++K             Y   D 
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE-----NCKPLKSYMLQDS 304
Query: 291 LA----LDLLQKMLVFEPSKRITVTEALQHPYISGL 322
           L      DL+++ML F+P++RIT+ EAL HP+ +GL
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 155/333 (46%), Gaps = 47/333 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G G +G V   ++    + +VA+K I NV + R +A R   E+ +L+ I
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARL--EINVLKKI 105
Query: 87  KH-DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLL 143
           K  D       V+M         + + +EL+  +  + +K +  Q     H ++  +QL 
Sbjct: 106 KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 165
Query: 144 RGLKYLHSANILHRDLKPGNLL-VNA------------------NCDLKICDFGLARTSR 184
             L++LH   + H DLKP N+L VN+                  N  +++ DFG A    
Sbjct: 166 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF-- 223
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
            + +  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E    L 
Sbjct: 224 -DHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 281
Query: 245 LIISVFG---------TQQE-----ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP 290
           ++  + G         T+++       L + +N    R++K       +++  L    + 
Sbjct: 282 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM--LQDSLEH 339
Query: 291 LAL-DLLQKMLVFEPSKRITVTEALQHPYISGL 322
           + L DL+++ML F+P++RIT+ EAL HP+ +GL
Sbjct: 340 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 139/310 (44%), Gaps = 55/310 (17%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLREL 80
           ++  Y   + +G G + +V     + T ++ A K I    + R+ + R         RE+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK---KRRLSSSRRGVSREEIEREV 59
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFV 139
            +LR I+H N+I L D+          DV L+ EL+   +L   +   +SL+ D    F+
Sbjct: 60  NILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSRGNEQFMTEYVV 195
            Q+L G+ YLHS  I H DLKP N+++      N  +K+ DFG+A       +F   +  
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-G 173
Query: 196 TRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
           T  + APE++    NY   G   D+WS+G I   +L     F G      L  I +V   
Sbjct: 174 TPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--- 226
Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
             + D E+  N                           LA D ++++LV +P +R+T+ +
Sbjct: 227 NYDFDEEYFSN------------------------TSELAKDFIRRLLVKDPKRRMTIAQ 262
Query: 313 ALQHPYISGL 322
           +L+H +I  +
Sbjct: 263 SLEHSWIKAI 272

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 155/333 (46%), Gaps = 47/333 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G G +G V   ++    + +VA+K I NV + R +A R   E+ +L+ I
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARL--EINVLKKI 82
Query: 87  KH-DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLL 143
           K  D       V+M         + + +EL+  +  + +K +  Q     H ++  +QL 
Sbjct: 83  KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 142
Query: 144 RGLKYLHSANILHRDLKPGNLL-VNA------------------NCDLKICDFGLARTSR 184
             L++LH   + H DLKP N+L VN+                  N  +++ DFG A    
Sbjct: 143 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF-- 200
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
            + +  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E    L 
Sbjct: 201 -DHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 258
Query: 245 LIISVFG---------TQQE-----ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP 290
           ++  + G         T+++       L + +N    R++K       +++  L    + 
Sbjct: 259 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM--LQDSLEH 316
Query: 291 LAL-DLLQKMLVFEPSKRITVTEALQHPYISGL 322
           + L DL+++ML F+P++RIT+ EAL HP+ +GL
Sbjct: 317 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 140/296 (47%), Gaps = 47/296 (15%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLLRHIK 87
           +Y  +K IG G +GV     ++ T E VA+K I     + EN        RE++  R ++
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN------VQREIINHRSLR 74
Query: 88  HDNVIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           H N++  K+V++ PTH      + ++ E     +L++ I ++   S D  ++F  QLL G
Sbjct: 75  HPNIVRFKEVILTPTH------LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 146 LKYLHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           + Y HS  I HRDLK  N L++ +    LKICDFG +++S  + Q  +  V T  Y APE
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 187
Query: 204 LLLCCDNYGTSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           +LL  +  G   DVWS G  ++  ++G  P                      E   E  D
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---------------------EDPEEPRD 226
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
             K  + I S+ YS    I     +  P    L+ ++ V +P+ RI++ E   H +
Sbjct: 227 YRKTIQRILSVKYSIPDDI-----RISPECCHLISRIFVADPATRISIPEIKTHSW 277

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIAL 94
           KP+G G++ +    +++++N+  A+K    +   R++A  T +E+  L+  + H N++ L
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVK----IISKRMEA-NTQKEITALKLCEGHPNIVKL 71
Query: 95  KDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
            +V        F D    +LV EL++  +L + IK  +  S     Y + +L+  + ++H
Sbjct: 72  HEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 151 SANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
              ++HRDLKP NLL    N N ++KI DFG AR    + Q +     T  Y APE LL 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLN 182
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
            + Y  S D+WS+G I   +L  +  F   +        + +    ++ D  F       
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------- 235
Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
                            +      A DL+Q +L  +P+KR+ ++
Sbjct: 236 -------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G+Y V    I++ TN + A+K I+    +  + +      +LLR+ +H N+I LKDV
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE-----ILLRYGQHPNIITLKDV 84
Query: 98  MMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
                    K VY+V EL    +L   I   +  S       +F + + ++YLH+  ++H
Sbjct: 85  YD-----DGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 157 RDLKPGNLL-VNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           RDLKP N+L V+ + +   ++ICDFG A+  R     +     T  + APE+L     Y 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLE-RQGYD 198
Query: 213 TSIDVWSVGC-IFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
            + D+WS+G  ++  + G  P   G +                +   E +    + +F  
Sbjct: 199 AACDIWSLGVLLYTXLTGYTPFANGPD----------------DTPEEILARIGSGKFSL 242
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           S  Y         +      A DL+ K L  +P +R+T    L+HP+I
Sbjct: 243 SGGY---------WNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 154/342 (45%), Gaps = 46/342 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSIN-RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G G +G V   ++ R    +VA+K I NV + +  A   +  L  +   
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEK 90
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN--DHCKYFVFQLLR 144
             DN      V M         + + +EL+       +K +  L       ++  FQL +
Sbjct: 91  DPDNKNLC--VQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 145 GLKYLHSANILHRDLKPGNLL-VNANCDL------------------KICDFGLARTSRG 185
            +K+LH   + H DLKP N+L VN++ +L                  ++ DFG A     
Sbjct: 149 AVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--- 205
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
           + +  +  V TR YRAPE++L    +    DVWS+GCI  E      +F   +    L +
Sbjct: 206 DHEHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 246 IISVFG---------TQQE-----ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPL 291
           +  + G         T+++       L++ +N  A R+++        +++S   +   L
Sbjct: 265 MERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQL 324
Query: 292 ALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQV 333
             DL++ ML +EP+KR+T+ EALQHP+ + L   +  PP ++
Sbjct: 325 -FDLIESMLEYEPAKRLTLGEALQHPFFARL---RAEPPNKL 362

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 138/310 (44%), Gaps = 55/310 (17%)
Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-------TLRE 79
           +++  Y   + +G G + +V     + T ++ A K I    + R+ + R         RE
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK---KRRLSSSRRGVSREEIERE 65
Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYF 138
           + +LR I+H N+I L D+          DV L+ EL+   +L   +   +SL+ D    F
Sbjct: 66  VNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQF 120
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSRGNEQFMTEYV 194
           + Q+L G+ YLHS  I H DLKP N+++      N  +K+ DFG+A       +F   + 
Sbjct: 121 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF- 179
Query: 195 VTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
            T  + APE++    NY   G   D+WS+G I   +L     F G      L  I +V  
Sbjct: 180 GTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-- 233
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              + D E+  N                           LA D ++++LV +P +R+ + 
Sbjct: 234 -NYDFDEEYFSN------------------------TSELAKDFIRRLLVKDPKRRMXIA 268
Query: 312 EALQHPYISG 321
           ++L+H +I  
Sbjct: 269 QSLEHSWIKA 278

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 49/307 (15%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTL--RELVLL 83
           ++  Y   + +G G + +V     + T ++ A K  K   +  +R    R    RE+ +L
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
           R I+H N+I L D+          DV L+ EL+   +L   +   +SL+ D    F+ Q+
Sbjct: 84  REIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSRGNEQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +K+ DFG+A       +F   +  T  
Sbjct: 139 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPE 197
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           + APE++    NY   G   D+WS+G I   +L     F G      L  I +V     +
Sbjct: 198 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV---NYD 250
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            D E+  N                           LA D ++++LV +P +R+ + ++L+
Sbjct: 251 FDEEYFSN------------------------TSELAKDFIRRLLVKDPKRRMXIAQSLE 286
Query: 316 HPYISGL 322
           H +I  +
Sbjct: 287 HSWIKAI 293

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 140/316 (44%), Gaps = 42/316 (13%)
Query: 10  GMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN 69
           G +  G+    M     +    Y   + +G+GA+ VV   +++ T  + A K IN    +
Sbjct: 9   GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 70  RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQ 128
             D  +  RE  + R ++H N++ L D +      SF   YLV++L+   +L + I + +
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEE---SFH--YLVFDLVTGGELFEDIVARE 123
Query: 129 SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRG 185
             S     + + Q+L  + Y HS  I+HR+LKP NLL+ +      +K+ DFGLA     
Sbjct: 124 FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
           +E +   +  T  Y +PE+L   D Y   +D+W+ G I   +L   P             
Sbjct: 184 SEAWHG-FAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYP------------- 228
Query: 246 IISVFGTQQEADLEFIDNPKARRF--IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFE 303
                         F D  + R +  IK+  Y    + S  +    P A  L+  ML   
Sbjct: 229 -------------PFWDEDQHRLYAQIKAGAYD---YPSPEWDTVTPEAKSLIDSMLTVN 272
Query: 304 PSKRITVTEALQHPYI 319
           P KRIT  +AL+ P+I
Sbjct: 273 PKKRITADQALKVPWI 288

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 142/293 (48%), Gaps = 45/293 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT---LRELVLLRHIKHDNVIAL 94
           IG+G + VV   INRET ++ A+K ++         L T    RE  +   +KH +++ L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 95  KDVMMPTHRISFKDVYLVYELMD-TDL-HQIIKSSQS---LSNDHCKYFVFQLLRGLKYL 149
            +        S   +Y+V+E MD  DL  +I+K + +    S     +++ Q+L  L+Y 
Sbjct: 94  LETYS-----SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H  NI+HRD+KP  +L+ +   +  +K+  FG+A     +       V T  + APE++ 
Sbjct: 149 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 208
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             + YG  +DVW  G I   +L     F GT    + +L   +   + +       NP+ 
Sbjct: 209 -REPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGKYKM------NPR- 256
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     + +HIS         A DL+++ML+ +P++RITV EAL HP++
Sbjct: 257 ----------QWSHISE-------SAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 142/293 (48%), Gaps = 45/293 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT---LRELVLLRHIKHDNVIAL 94
           IG+G + VV   INRET ++ A+K ++         L T    RE  +   +KH +++ L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 95  KDVMMPTHRISFKDVYLVYELMD-TDL-HQIIKSSQS---LSNDHCKYFVFQLLRGLKYL 149
            +        S   +Y+V+E MD  DL  +I+K + +    S     +++ Q+L  L+Y 
Sbjct: 92  LETYS-----SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H  NI+HRD+KP  +L+ +   +  +K+  FG+A     +       V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             + YG  +DVW  G I   +L     F GT    + +L   +   + +       NP+ 
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGKYKM------NPR- 254
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     + +HIS         A DL+++ML+ +P++RITV EAL HP++
Sbjct: 255 ----------QWSHISE-------SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+GA+ VV   +++ T  + A K IN    +  D  +  RE  + R ++H N++ L D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 98  MMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +      SF   YLV++L+   +L + I + +  S     + + Q+L  + Y HS  I+H
Sbjct: 74  IQEE---SFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA     +E +   +  T  Y +PE+L   D Y  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 186
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF--IK 271
            +D+W+ G I   +L   P                           F D  + R +  IK
Sbjct: 187 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 220
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +  Y    + S  +    P A  L+  ML   P KRIT  +AL+ P+I
Sbjct: 221 AGAYD---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+GA+ VV   +++ T  + A K IN    +  D  +  RE  + R ++H N++ L D 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 98  MMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +      SF   YLV++L+   +L + I + +  S     + + Q+L  + Y HS  I+H
Sbjct: 73  IQEE---SFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 127
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA     +E +   +  T  Y +PE+L   D Y  
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 185
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF--IK 271
            +D+W+ G I   +L   P                           F D  + R +  IK
Sbjct: 186 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 219
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +  Y    + S  +    P A  L+  ML   P KRIT  +AL+ P+I
Sbjct: 220 AGAYD---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 144/325 (44%), Gaps = 68/325 (20%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI--DALRTLRELVLLRHIKH 88
           KY+    +G G+YG V   ++ ET  + A+K +      RI        +E+ LLR ++H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCK---YFVFQLLRG 145
            NVI L DV+    +   + +Y+V E     + +++ S        C+   YF  QL+ G
Sbjct: 66  KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC-QLIDG 121
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA------------RTSRGNEQFMTEY 193
           L+YLHS  I+H+D+KPGNLL+     LKI   G+A            RTS+G+  F    
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF---- 177
Query: 194 VVTRWYRAPELLLCCDNY-GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
                 + PE+    D + G  +D+WS G     I      F G    N  KL  ++   
Sbjct: 178 ------QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENI--- 225
Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   +G++  ++     P   DLL+ ML +EP+KR ++ +
Sbjct: 226 -----------------------GKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQ 260
Query: 313 ALQHPYISGLYDPQCNPPAQVPLSL 337
             QH +       + +PPA+ P+ +
Sbjct: 261 IRQHSWFR-----KKHPPAEAPVPI 280

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+GA+ VV   +++ T  + A K IN    +  D  +  RE  + R ++H N++ L D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 98  MMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +      SF   YLV++L+   +L + I + +  S     + + Q+L  + Y HS  I+H
Sbjct: 74  IQEE---SFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA     +E +   +  T  Y +PE+L   D Y  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 186
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF--IK 271
            +D+W+ G I   +L   P                           F D  + R +  IK
Sbjct: 187 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 220
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +  Y    + S  +    P A  L+  ML   P KRIT  +AL+ P+I
Sbjct: 221 AGAYD---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 19/231 (8%)
Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F+   KYV ++ IG G++G      + E   +  IK+IN    +  +   + RE+ +L +
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSL--SNDHCKYFV 139
           +KH N++         +R SF++   +Y +MD     DL + I + + +    D    + 
Sbjct: 80  MKHPNIV--------QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
            Q+   LK++H   ILHRD+K  N+ +  +  +++ DFG+AR      +     + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 200 RAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            +PE+   C+N  Y    D+W++GC+  E+   K  F      N +  IIS
Sbjct: 192 LSPEI---CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAI-KKINNVFENRIDALRTLRELVLLRHIKHDN 90
           Y  +  IG G+YG  C  I R+++ K+ + K+++       +    + E+ LLR +KH N
Sbjct: 8   YEVLYTIGTGSYGR-CQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII----KSSQSLSNDHCKYFVFQLLRG 145
           ++   D ++     +   +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 67  IVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR    +E F  E+V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           +PE +    +Y    D+WS+GC+  E+    P F
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 46/297 (15%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  ++ +G GA+GVV   + + T      K IN  +   +D      E+ ++  + H  +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKL 110
Query: 92  IALKDVMMPTHRISFKDVY---LVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           I L D        +F+D Y   L+ E +       +I      +S      ++ Q   GL
Sbjct: 111 INLHD--------AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 147 KYLHSANILHRDLKPGNLLVNAN--CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           K++H  +I+H D+KP N++        +KI DFGLA T    ++ +     T  + APE+
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA-TKLNPDEIVKVTTATAEFAAPEI 221
Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           +   +  G   D+W++G +   +L     F G + L  L+ +       +  D EF ++ 
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDWEFDEDA 273
Query: 265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                            SS+ P+A     +LLQK    EP KR+TV +AL+HP++ G
Sbjct: 274 ----------------FSSVSPEAKDFIKNLLQK----EPRKRLTVHDALEHPWLKG 310

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 140/289 (48%), Gaps = 46/289 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDNVIALKD 96
           +G+G++  V  + +  T  +VAIK I+     +   + R   E+ +   +KH +++ L +
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 97  VMMPTHRISFKD---VYLVYEL-MDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHS 151
                    F+D   VYLV E+  + ++++ +K+  +  S +  ++F+ Q++ G+ YLHS
Sbjct: 79  Y--------FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ILHRDL   NLL+  N ++KI DFGLA   +   +       T  Y +PE +     +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAH 189
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
           G   DVWS+GC+F  +L  +P F      N L  ++        AD E            
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-------ADYE------------ 230
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            +P       S L  +A     DL+ ++L   P+ R++++  L HP++S
Sbjct: 231 -MP-------SFLSIEAK----DLIHQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 133/305 (43%), Gaps = 41/305 (13%)
Query: 19  YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR 78
           Y    T  +I+  Y     IGRG++G V  ++ + T  + A KKI   F   +D  +  +
Sbjct: 15  YFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--Q 72
Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYEL-MDTDLHQIIKSSQSLSNDHCKY 137
           E+ +++ + H N+I L +           D+YLV EL    +L + +   +         
Sbjct: 73  EIEIMKSLDHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRVFRESDAAR 127
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYV 194
            +  +L  + Y H  N+ HRDLKP N L    + +  LK+ DFGLA   +  +   T+ V
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-V 186
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T +Y +P++L     YG   D WS G +   +L   P F                 T  
Sbjct: 187 GTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAP--------------TDX 230
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  L      K R    + P     ++S   PQA+     L++++L   P +RIT  +AL
Sbjct: 231 EVML------KIREGTFTFPEKDWLNVS---PQAE----SLIRRLLTKSPKQRITSLQAL 277
Query: 315 QHPYI 319
           +H + 
Sbjct: 278 EHEWF 282

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 131/297 (44%), Gaps = 41/297 (13%)
Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +I+  Y     IGRG++G V  ++ + T  + A KKI   F   +D  +  +E+ +++ +
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSL 63
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYEL-MDTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H N+I L +           D+YLV EL    +L + +   +          +  +L  
Sbjct: 64  DHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 146 LKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y H  N+ HRDLKP N L    + +  LK+ DFGLA   +  +   T+ V T +Y +P
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYVSP 177
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           ++L     YG   D WS G +   +L   P F                 T  E  L    
Sbjct: 178 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAP--------------TDXEVML---- 217
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             K R    + P     ++S   PQA+     L++++L   P +RIT  +AL+H + 
Sbjct: 218 --KIREGTFTFPEKDWLNVS---PQAE----SLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G YG+V +  +     ++AIK+I          L    E+ L +H+KH N++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 73
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH---CKYFVFQLLRGLKYLHSANI 154
                 I       + ++    L  +++S      D+     ++  Q+L GLKYLH   I
Sbjct: 74  FSENGFIKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 155 LHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL-LCCDNYG 212
           +HRD+K  N+L+N     LKI DFG ++   G       +  T  Y APE++      YG
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 213 TSIDVWSVGCIFAEILGRKPIF 234
            + D+WS+GC   E+   KP F
Sbjct: 190 KAADIWSLGCTIIEMATGKPPF 211

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G YG+V +  +     ++AIK+I          L    E+ L +H+KH N++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 87
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH---CKYFVFQLLRGLKYLHSANI 154
                 I       + ++    L  +++S      D+     ++  Q+L GLKYLH   I
Sbjct: 88  FSENGFIKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 155 LHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL-LCCDNYG 212
           +HRD+K  N+L+N     LKI DFG ++   G       +  T  Y APE++      YG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 213 TSIDVWSVGCIFAEILGRKPIF 234
            + D+WS+GC   E+   KP F
Sbjct: 204 KAADIWSLGCTIIEMATGKPPF 225

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 99
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
            D     + +     +     +D  + ++    + L+    +    Q L  L YLH   I
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    DVWS+G    E+   +P  P  E LN +++++                    +  
Sbjct: 217 YDYKADVWSLGITLIEMAEIEP--PHHE-LNPMRVLL--------------------KIA 253
Query: 271 KSLP--YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           KS P   ++ +  SS +        D L+K L      R T ++ LQHP+++
Sbjct: 254 KSEPPTLAQPSRWSSNFK-------DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 99
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
            D     + +     +     +D  + ++    + L+    +    Q L  L YLH   I
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    DVWS+G    E+   +P  P  E LN +++++                    +  
Sbjct: 217 YDYKADVWSLGITLIEMAEIEP--PHHE-LNPMRVLL--------------------KIA 253
Query: 271 KSLP--YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           KS P   ++ +  SS +        D L+K L      R T ++ LQHP+++
Sbjct: 254 KSEPPTLAQPSRWSSNFK-------DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D       +   ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +E V T ++ APE ++    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE-VVTRKA 192
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 240
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  KR +  E LQH ++
Sbjct: 241 ---------KLSAIF-------RDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 99
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
            D     + +     +     +D  + ++    + L+    +    Q L  L YLH   I
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    DVWS+G    E+   +P  P  E LN +++++                    +  
Sbjct: 217 YDYKADVWSLGITLIEMAEIEP--PHHE-LNPMRVLL--------------------KIA 253
Query: 271 KSLP--YSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           KS P   ++ +  SS +        D L+K L      R T ++ LQHP+++
Sbjct: 254 KSEPPTLAQPSRWSSNFK-------DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 150/333 (45%), Gaps = 57/333 (17%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + A
Sbjct: 14  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS- 151
           LK       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS 
Sbjct: 74  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D Y
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-Y 187
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D W +G +  E++ GR P +      NQ            E   E I        +
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LM 224
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL--- 322
           + + + R     +L P+A  L   LL+K    +P +R+        E +QH + +G+   
Sbjct: 225 EEIRFPR-----TLGPEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVWQ 275
Query: 323 --YDPQCNPP--AQVPLSLD---IDENIGEQMI 348
             Y+ + +PP   QV    D    DE    QMI
Sbjct: 276 HVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMI 308

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 150/333 (45%), Gaps = 57/333 (17%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + A
Sbjct: 15  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS- 151
           LK       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS 
Sbjct: 75  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D Y
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-Y 188
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D W +G +  E++ GR P +      NQ            E   E I        +
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LM 225
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGL--- 322
           + + + R     +L P+A  L   LL+K    +P +R+        E +QH + +G+   
Sbjct: 226 EEIRFPR-----TLGPEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVWQ 276
Query: 323 --YDPQCNPP--AQVPLSLD---IDENIGEQMI 348
             Y+ + +PP   QV    D    DE    QMI
Sbjct: 277 HVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMI 309

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 150/333 (45%), Gaps = 57/333 (17%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + A
Sbjct: 13  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS- 151
           LK       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS 
Sbjct: 73  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D Y
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-Y 186
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D W +G +  E++ GR P +      NQ            E   E I        +
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LM 223
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGL--- 322
           + + + R     +L P+A  L   LL+K    +P +R+        E +QH + +G+   
Sbjct: 224 EEIRFPR-----TLGPEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVWQ 274
Query: 323 --YDPQCNPP--AQVPLSLD---IDENIGEQMI 348
             Y+ + +PP   QV    D    DE    QMI
Sbjct: 275 HVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMI 307

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 120/244 (49%), Gaps = 29/244 (11%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           + +  I  +G+GA+G V  + N   +   AIKKI +  E ++  +  L E++LL  + H 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTI--LSEVMLLASLNHQ 62
Query: 90  NVIAL-------KDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF- 140
            V+         ++ + P   +  K  +++  E  +      +  S++L+    +Y+   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR--------------G 185
            Q+L  L Y+HS  I+HRDLKP N+ ++ + ++KI DFGLA+                 G
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
           +   +T  + T  Y A E+L    +Y   ID++S+G IF E++   P   G E +N LK 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK 240
Query: 246 IISV 249
           + SV
Sbjct: 241 LRSV 244

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK IG G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E M   D+   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +K+ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 96/355 (27%), Positives = 142/355 (40%), Gaps = 79/355 (22%)
Query: 19  YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI------D 72
           Y    +L E+  KY     IG+G+YGVV  +I  +T    AIK +N   +N+I      D
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN---KNKIRQINPKD 71
Query: 73  ALRTLRELVLLRHIKHDNVIALKDV----------MMPTHRISFKDVYLVY--------- 113
             R   E+ L++ + H N+  L +V          M   H     D   V+         
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 114 ----------------ELMDTDLHQIIKSSQSLSNDH-CKYFVFQLLRGLKYLHSANILH 156
                           E ++  +H   +S   +  +      + Q+   L YLH+  I H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191
Query: 157 RDLKPGNLL--VNANCDLKICDFGLART----SRGNEQFMTEYVVTRWYRAPELL-LCCD 209
           RD+KP N L   N + ++K+ DFGL++     + G    MT    T ++ APE+L    +
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           +YG   D WS G +   +L     FPG   +N    I  V   +    L F +NP     
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPG---VNDADTISQVLNKK----LCF-ENPN---- 299
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD 324
                          Y    PLA DLL  +L     +R     ALQHP+IS   D
Sbjct: 300 ---------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK IG G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E M   D+   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +K+ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAI-KKINNVFENRIDALRTLRELVLLRHIKHDN 90
           Y  +  IG G+YG  C  I R+++ K+ + K+++       +    + E+ LLR +KH N
Sbjct: 8   YEVLYTIGTGSYGR-CQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII----KSSQSLSNDHCKYFVFQLLRG 145
           ++   D ++     +   +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 67  IVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR    +  F   +V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           +PE +    +Y    D+WS+GC+  E+    P F
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAI-KKINNVFENRIDALRTLRELVLLRHIKHDN 90
           Y  +  IG G+YG  C  I R+++ K+ + K+++       +    + E+ LLR +KH N
Sbjct: 8   YEVLYTIGTGSYGR-CQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII----KSSQSLSNDHCKYFVFQLLRG 145
           ++   D ++     +   +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 67  IVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR    +  F   +V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           +PE +    +Y    D+WS+GC+  E+    P F
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           +  ++ IG G++G V  + +   +E VAIKK++   +   +  +  ++E+  L+ ++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 91  VIALKDVMMPTHRISFKDVYLVYEL---MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            I  +   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 116 TIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 168
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L++    +K+ DFG A        F    V T ++ APE++L 
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILA 224
Query: 208 CD--NYGTSIDVWSVGCIFAEILGRKP 232
            D   Y   +DVWS+G    E+  RKP
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 120/244 (49%), Gaps = 29/244 (11%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           + +  I  +G+GA+G V  + N   +   AIKKI +  E ++  +  L E++LL  + H 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTI--LSEVMLLASLNHQ 62
Query: 90  NVIAL-------KDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF- 140
            V+         ++ + P   +  K  +++  E  +      +  S++L+    +Y+   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR--------------G 185
            Q+L  L Y+HS  I+HRDLKP N+ ++ + ++KI DFGLA+                 G
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
           +   +T  + T  Y A E+L    +Y   ID++S+G IF E++   P   G E +N LK 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK 240
Query: 246 IISV 249
           + SV
Sbjct: 241 LRSV 244

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 35/280 (12%)
Query: 3   TLVEPPNGMKSRGKHYYTMWQTLFEIDTKYV-PIKPIGRGAYGVVCSSINRETNEKVAIK 61
           T   PP  + S  K   ++    FE+    + PI  +GRGAYGVV    +  + + +A+K
Sbjct: 25  TSSTPPRDLDS--KACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK 82
Query: 62  KINNVFENRIDALRTLREL-VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL 120
           +I     N  +  R L +L + +R +     +     +         DV++  ELMDT L
Sbjct: 83  RIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----DVWICMELMDTSL 136
Query: 121 ----HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKIC 175
                Q+I   Q++  D        +++ L++LHS  +++HRD+KP N+L+NA   +K+C
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 196
Query: 176 DFGLARTSRGNEQFMTEYVVT------RWYRAPELL---LCCDNYGTSIDVWSVGCIFAE 226
           DFG++        ++ + V        + Y APE +   L    Y    D+WS+G    E
Sbjct: 197 DFGIS-------GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249
Query: 227 I-LGRKPIFPGTECLNQLKLIISVFGTQQEAD---LEFID 262
           + + R P         QLK ++     Q  AD    EF+D
Sbjct: 250 LAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 289

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 151/332 (45%), Gaps = 53/332 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + A
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS- 151
           LK       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS 
Sbjct: 213 LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D Y
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-Y 326
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D W +G +  E++ GR P +      NQ            E   E I        +
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LM 363
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL--- 322
           + + + R     +L P+A  L   LL+K    +P +R+        E +QH + +G+   
Sbjct: 364 EEIRFPR-----TLGPEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414
Query: 323 --YDPQCNPPAQVPLSLDIDEN-IGEQMIRQM 351
             Y+ + +PP +  ++ + D     E+   QM
Sbjct: 415 HVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM 446

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           +  ++ IG G++G V  + +   +E VAIKK++   +   +  +  ++E+  L+ ++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 91  VIALKDVMMPTHRISFKDVYLVYEL---MDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            I  +   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 77  TIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L++    +K+ DFG A        F    V T ++ APE++L 
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILA 185
Query: 208 CD--NYGTSIDVWSVGCIFAEILGRKP 232
            D   Y   +DVWS+G    E+  RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 139/301 (46%), Gaps = 41/301 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA++ I+    N     +  RE+ +++ + H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  + E+  +  Y APEL     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPELFQGKK 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCN 328
           +      RG +    Y   D    +LL+K L+  PSKR T+ + ++  +++ G  D +  
Sbjct: 226 L------RGKYRIPFYMSTD--CENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELK 277
Query: 329 P 329
           P
Sbjct: 278 P 278

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 147/320 (45%), Gaps = 52/320 (16%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN-VFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + A
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS- 151
           LK       R+ F     V E  +  +L   +   +  S D  +++  +++  L YLHS 
Sbjct: 216 LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D Y
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-Y 329
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           G ++D W +G +  E++ GR P +      NQ            E   E I        +
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFY------NQ----------DHEKLFELI-------LM 366
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL--- 322
           + + + R     +L P+A  L   LL+K    +P +R+        E +QH + +G+   
Sbjct: 367 EEIRFPR-----TLGPEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVWQ 417
Query: 323 --YDPQCNPPAQVPLSLDID 340
             Y+ + +PP +  ++ + D
Sbjct: 418 HVYEKKLSPPFKPQVTSETD 437

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D       +   ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-VVTRKA 192
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 240
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  KR +  E LQH ++
Sbjct: 241 ---------KLSAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  TE   T  Y  PE++     +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TELCGTLDYLPPEMIE-GRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 137/303 (45%), Gaps = 51/303 (16%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           ID  ++  + +G GA+G V     R +  +  IK IN    +++   +   E+ +L+ + 
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLD 78
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQS----LSNDHCKYFV 139
           H N+I + +V        F+D + +Y +M+T    +L + I S+Q+    LS  +    +
Sbjct: 79  HPNIIKIFEV--------FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSRGNEQFMTEYVVT 196
            Q++  L Y HS +++H+DLKP N+L    + +  +KI DFGLA   + +E   T    T
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGT 189
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
             Y APE+     +     D+WS G +   +L     F GT          S+   QQ+A
Sbjct: 190 ALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGT----------SLEEVQQKA 237
Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                             Y    +     P   P A+DLL++ML  +P +R +  + L H
Sbjct: 238 -----------------TYKEPNYAVECRPLT-PQAVDLLKQMLTKDPERRPSAAQVLHH 279
Query: 317 PYI 319
            + 
Sbjct: 280 EWF 282

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D       +   ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKA 192
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 240
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  KR +  E LQH ++
Sbjct: 241 ---------KLSAIF-------RDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 88/324 (27%), Positives = 140/324 (43%), Gaps = 51/324 (15%)
Query: 27  EIDTKYVPIKPIGRGAYGVV--CSSINRETNEKVAIKKINNVFENRI-DALRTLR----- 78
           +I   Y  ++ +G GAYG V  C   N  + + + + K +   + R  D  + +      
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 79  ---ELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDH 134
              E+ LL+ + H N+I L DV         K  YLV E  +  +L + I +        
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMT 191
               + Q+L G+ YLH  NI+HRD+KP N+L+   N+  ++KI DFGL+     + + + 
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LR 206
Query: 192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
           + + T +Y APE+L     Y    DVWS G I   +L   P  P              FG
Sbjct: 207 DRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYP--P--------------FG 248
Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            Q + D+           IK +   +     + +      A +L++ ML ++ +KR T  
Sbjct: 249 GQNDQDI-----------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297
Query: 312 EALQHPYISGLYDPQCNPPAQVPL 335
           EAL   +I   Y    N   Q  L
Sbjct: 298 EALNSRWIKK-YANNINKSDQKTL 320

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 117/248 (47%), Gaps = 32/248 (12%)
Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRHIKHDNVI 92
           PI  +GRGAYGVV    +  + + +A+K+I     N  +  R L +L + +R +     +
Sbjct: 11  PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDL----HQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                +         DV++  ELMDT L     Q+I   Q++  D        +++ L++
Sbjct: 70  TFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 149 LHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRA 201
           LHS  +++HRD+KP N+L+NA   +K+CDFG++        ++ + V        + Y A
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDDVAKDIDAGCKPYMA 177
Query: 202 PELL---LCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           PE +   L    Y    D+WS+G    E+ + R P         QLK ++     Q  AD
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 258 ---LEFID 262
               EF+D
Sbjct: 238 KFSAEFVD 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 79
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D       +   ++++V E +       + +   +          + L+ L++LH
Sbjct: 80  IVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 135 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-VVTRKA 193
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 241
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  KR +  E +QH ++
Sbjct: 242 ---------KLSAIF-------RDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 138/301 (45%), Gaps = 41/301 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+ +++ + H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  +  +  +  Y APEL     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKK 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCN 328
           +      RG +    Y   D    +LL+K L+  PSKR T+ + ++  +++ G  D +  
Sbjct: 226 L------RGKYRIPFYMSTD--CENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELK 277
Query: 329 P 329
           P
Sbjct: 278 P 278

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  R++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLS---NDHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 78  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +N +LKI DFG +  +  + +  T    T  Y  PE ++    +
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIEGRMH 187
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L   P F                 T QE                
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAH--------------TYQET--------------- 218
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L    S+R+T+ E L+HP+I  
Sbjct: 219 ---YRRISRVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T+   T  Y  PE++     +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPEMIE-GRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 138/301 (45%), Gaps = 41/301 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+ +++ + H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  +  +  +  Y APEL     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKK 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCN 328
           +      RG +    Y   D    +LL+K L+  PSKR T+ + ++  +++ G  D +  
Sbjct: 226 L------RGKYRIPFYMSTD--CENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELK 277
Query: 329 P 329
           P
Sbjct: 278 P 278

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T+   T  Y  PE++     +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPEMIE-GRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 75  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T+   T  Y  PE++     +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPEMIE-GRMH 184
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 215
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 216 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 79  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T+   T  Y  PE++     +
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPEMIE-GRMH 188
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 219
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 220 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 131/289 (45%), Gaps = 44/289 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ +G G+YG V  +I++ET + VAIK++        D    ++E+ +++     +V+  
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 95  KDVMMPTHRISFK--DVYLVYELMDT-DLHQIIK-SSQSLSNDHCKYFVFQLLRGLKYLH 150
                  +   FK  D+++V E      +  II+  +++L+ D     +   L+GL+YLH
Sbjct: 90  -------YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
               +HRD+K GN+L+N     K+ DFG+A             + T ++ APE++     
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI-G 201
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    D+WS+G    E+   KP +     +  + +I +              NP      
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT--------------NPP----- 242
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              P  R   + S     D    D +++ LV  P +R T T+ LQHP++
Sbjct: 243 ---PTFRKPELWS-----DNFT-DFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 137/301 (45%), Gaps = 41/301 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+ +++ + H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  +  +     Y APEL     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGKK 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCN 328
           +      RG +    Y   D    +LL+K L+  PSKR T+ + ++  +++ G  D +  
Sbjct: 226 L------RGKYRIPFYMSTD--CENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELK 277
Query: 329 P 329
           P
Sbjct: 278 P 278

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 3   TLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK- 61
            L EPP  ++  G     +     E   KY  + P+G GA+G V +++++E N++V +K 
Sbjct: 2   ALEEPPKAVELEG-----LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF 56
Query: 62  -KINNVFEN----RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM 116
            K   V E+         +   E+ +L  ++H N+I + D+        F  + +     
Sbjct: 57  IKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---ENQGFFQLVMEKHGS 113
Query: 117 DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD 176
             DL   I     L      Y   QL+  + YL   +I+HRD+K  N+++  +  +K+ D
Sbjct: 114 GLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173
Query: 177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVG 221
           FG A      + F T +  T  Y APE+L+     G  +++WS+G
Sbjct: 174 FGSAAYLERGKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLG 217

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 24  TLFEIDTKYVPIKPI-GRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +L  ID K + ++ + GRGA+GVVC +  R  +  VAIK+I +  E +      + EL  
Sbjct: 2   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA----FIVELRQ 55
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSL---SNDHCKYF 138
           L  + H N++ L       +      V LV E  +   L+ ++  ++ L   +  H   +
Sbjct: 56  LSRVNHPNIVKL-------YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 108
Query: 139 VFQLLRGLKYLHSAN---ILHRDLKPGN-LLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
             Q  +G+ YLHS     ++HRDLKP N LLV     LKICDFG   T+   +  MT   
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQTHMTNNK 165
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
            +  + APE+     NY    DV+S G I  E++ R+  F
Sbjct: 166 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E       ++ K  Q LS         ++ +L   L Y HS
Sbjct: 79  YGYFHDATR-----VYLILEYAPRG--EVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE++     +
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 188
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 219
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 220 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 73  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE ++    +
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIEGRMH 182
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 213
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 214 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 40/287 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V       T  K+A K I        D      E+ ++  + H N+I L D 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 98  MMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
                  S  D+ LV E +D      +II  S +L+      F+ Q+  G++++H   IL
Sbjct: 155 FE-----SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 156 HRDLKPGNLL-VNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           H DLKP N+L VN +   +KI DFGLAR  +  E+    +  T  + APE ++  D    
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPE-VVNYDFVSF 267
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
             D+WSVG I   +L     F G      L  I++     ++ + + I + +A+ FI   
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI-SEEAKEFI--- 323
Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                                   K+L+ E S RI+ +EAL+HP++S
Sbjct: 324 -----------------------SKLLIKEKSWRISASEALKHPWLS 347

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 138/301 (45%), Gaps = 41/301 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+ +++ + H N+
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 69  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH 123
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  +  +  +  Y APEL     
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKK 181
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 218
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCN 328
           +      RG +    Y   D    +LL+K L+  PSKR T+ + ++  +++ G  D +  
Sbjct: 219 L------RGKYRIPFYMSTD--CENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELK 270
Query: 329 P 329
           P
Sbjct: 271 P 271

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE ++    +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TXLCGTLDYLPPE-MIEGRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 41/301 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA++ I+    N     +  RE+ +++ + H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  +  +  +  Y APEL     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKK 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS-GLYDPQCN 328
           +      RG +    Y   D    +LL+K L+  PSKR T+ + ++  +++ G  D +  
Sbjct: 226 L------RGKYRIPFYMSTD--CENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELK 277
Query: 329 P 329
           P
Sbjct: 278 P 278

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    +R +   +A K    +I     N+I     +REL +L 
Sbjct: 15  DDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLH 69
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K ++ +  +        +L
Sbjct: 70  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 124
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           RGL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y AP
Sbjct: 125 RGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMAP 182
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 183 ERLQGT-HYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 77  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE ++    +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIEGRMH 186
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 217
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 218 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 98
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 213
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPAAFFPKAR-- 265
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 266 ------------------------DLVEKLLVLDATKRLGCEE 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 24  TLFEIDTKYVPIKPI-GRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +L  ID K + ++ + GRGA+GVVC +  R  +  VAIK+I +  E +      + EL  
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA----FIVELRQ 54
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSL---SNDHCKYF 138
           L  + H N++ L       +      V LV E  +   L+ ++  ++ L   +  H   +
Sbjct: 55  LSRVNHPNIVKL-------YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 139 VFQLLRGLKYLHSAN---ILHRDLKPGN-LLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
             Q  +G+ YLHS     ++HRDLKP N LLV     LKICDFG   T+   +  MT   
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQTHMTNNK 164
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
            +  + APE+     NY    DV+S G I  E++ R+  F
Sbjct: 165 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 77  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE++     +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 186
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 217
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 218 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK IG G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +K+ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------KLEYDFPEKFFPKAR-- 262
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 263 ------------------------DLVEKLLVLDATKRLGCEE 281

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 78  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE ++    +
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIEGRMH 187
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 218
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 219 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 100 YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE++     +
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 209
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 240
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 241 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE++     +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 39/290 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDN 90
           Y+    +G G +G V    +  T  KVA+K +N      +D + +  RE+  L+  +H +
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           +I L  V+      +  D+++V E +   +L   I  +  L     +    Q+L G+ Y 
Sbjct: 78  IIKLYQVIS-----TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   ++HRDLKP N+L++A+ + KI DFGL+      E F+     +  Y APE++    
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRXSCGSPNYAAPEVISGRL 191
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +D+WS G I   +L          C           GT     L F D+     F
Sbjct: 192 YAGPEVDIWSSGVILYALL----------C-----------GT-----LPFDDDHVPTLF 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            K      G   +  Y   +P  + LL+ ML  +P KR T+ +  +H + 
Sbjct: 226 KK---ICDGIFYTPQY--LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 91  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE++     +
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 200
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 231
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 232 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 79  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE++     +
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 188
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 219
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 220 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 79
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D       +   ++++V E +       + +   +          + L+ L++LH
Sbjct: 80  IVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HR++K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 135 SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKA 193
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L L I+  GT +      + NP+     
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE------LQNPE----- 241
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     +S+++        D L + L  +  KR +  E +QH ++
Sbjct: 242 ---------KLSAIF-------RDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 53/294 (18%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 75  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGL---ARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
             ++HRD+KP NLL+ +  +LKI DFG    A +SR      T    T  Y  PE ++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR-----RTTLSGTLDYLPPE-MIEG 181
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             +   +D+WS+G +  E L  KP F                 T QE             
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET------------ 215
Query: 269 FIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                 Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 216 ------YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y +M+     ++   ++     S  H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NL+++    +K+ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 117/245 (47%), Gaps = 31/245 (12%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           + +  I  +G+GA+G V  + N   +   AIKKI +  E ++  +  L E+ LL  + H 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTI--LSEVXLLASLNHQ 62
Query: 90  NVIAL-------KDVMMPTHRISFKDVYLVYELM--DTDLHQIIKSSQSLSNDHCKYFVF 140
            V+         ++ + P   +  K    +      +  L+ +I  S++L+    +Y+  
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI-HSENLNQQRDEYWRL 121
Query: 141 --QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR-------------- 184
             Q+L  L Y+HS  I+HR+LKP N+ ++ + ++KI DFGLA+                 
Sbjct: 122 FRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
           G+   +T  + T  Y A E+L    +Y   ID +S+G IF E +   P   G E +N LK
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXERVNILK 239
Query: 245 LIISV 249
            + SV
Sbjct: 240 KLRSV 244

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E       ++ K  Q LS         ++ +L   L Y HS
Sbjct: 79  YGYFHDATR-----VYLILEYAPRG--EVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +      +   Y  PE ++    +
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLD--YLPPE-MIEGRMH 188
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 219
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 220 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------KLEYDFPEKFFPKAR-- 262
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 263 ------------------------DLVEKLLVLDATKRLGCEE 281

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 141/321 (43%), Gaps = 64/321 (19%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G+G++G V  +  ++TN+  AIK +  +V     D   T+ E  +L        +A 
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS-------LAW 76
Query: 95  KDVMMPTHRISFK---DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +   +     +F+   +++ V E ++  DL   I+S          ++  +++ GL++LH
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLK  N+L++ +  +KI DFG+ + +   +    E+  T  Y APE+LL    
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QK 195
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEF---IDNPKA 266
           Y  S+D WS G +  E+L G+ P                 F  Q E +L     +DNP  
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSP-----------------FHGQDEEELFHSIRMDNP-- 236
Query: 267 RRFIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEAL-QHPYISGL-- 322
                             YP+  +  A DLL K+ V EP KR+ V   + QHP    +  
Sbjct: 237 -----------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 279
Query: 323 -------YDPQCNPPAQVPLS 336
                   DP   P  + P  
Sbjct: 280 EELERKEIDPPFRPKVKSPFD 300

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 119/254 (46%), Gaps = 26/254 (10%)
Query: 12  KSRGKHYYTMWQTLFEI-DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNV 66
           + R + + T  Q + E+ D  +  I  +G G  GVV    ++ +   +A K    +I   
Sbjct: 49  RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 108
Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK 125
             N+I     +REL +L       ++           IS     +  E MD   L Q++K
Sbjct: 109 IRNQI-----IRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLK 158
Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSR 184
            +  +           +++GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +
Sbjct: 159 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQ 216
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQL 243
             +     +V TR Y +PE L    +Y    D+WS+G    E+ +GR PI P      +L
Sbjct: 217 LIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KEL 273
Query: 244 KLIISVFGTQQEAD 257
           +L+   FG Q E D
Sbjct: 274 ELM---FGCQVEGD 284

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 53/294 (18%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 100 YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGL---ARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
             ++HRD+KP NLL+ +  +LKI DFG    A +SR +     +   T  Y  PE++   
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-----DLCGTLDYLPPEMIE-G 206
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             +   +D+WS+G +  E L  KP F                 T QE             
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET------------ 240
Query: 269 FIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                 Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 241 ------YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 77  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +   +   T  Y  PE ++    +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DDLCGTLDYLPPE-MIEGRMH 186
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 217
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 218 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  ++    +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 71  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE ++    +
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIEGRMH 180
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 211
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 212 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y +M+     ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NL+++    +K+ DFGLA+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 67  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 126
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 127 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 234
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 92
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 207
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 259
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 260 ------------------------DLVEKLLVLDATKRLGCEE 278

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 96
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 211
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 263
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 264 ------------------------DLVEKLLVLDATKRLGCEE 282

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 79  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +  T    T  Y  PE +     +
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEXIE-GRXH 188
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 219
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 220 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  R++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLS---NDHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 78  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +N +LKI DFG +  +  + +       T  Y  PE ++    +
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPE-MIEGRMH 187
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L   P F                 T QE                
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAH--------------TYQET--------------- 218
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L    S+R+T+ E L+HP+I  
Sbjct: 219 ---YRRISRVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 73
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 74  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 188
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 240
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 241 ------------------------DLVEKLLVLDATKRLGCEE 259

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 262
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 263 ------------------------DLVEKLLVLDATKRLGCEE 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   E +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVS 252

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 72
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 73  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 187
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 239
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 240 ------------------------DLVEKLLVLDATKRLGCEE 258

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 139/298 (46%), Gaps = 43/298 (14%)
Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           E+  KY+  + +GRG +G+V   +   +++K  + K   V     D +   +E+ +L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVE-TSSKKTYMAKFVKV--KGTDQVLVKKEISILNIA 58
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLLR 144
           +H N++ L +        S +++ +++E +   D+ + I +S   L+      +V Q+  
Sbjct: 59  RHRNILHLHESFE-----SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 145 GLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
            L++LHS NI H D++P N++     +  +KI +FG AR  +  + F   +    +Y AP
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-AP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           E +   D   T+ D+WS+G +   +L G  P    T   NQ                   
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQ------------------- 209
Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                 + I+++  +  T     + +    A+D + ++LV E   R+T +EALQHP++
Sbjct: 210 ------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 260
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 261 ------------------------DLVEKLLVLDATKRLGCEE 279

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 96
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 211
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 263
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 264 ------------------------DLVEKLLVLDATKRLGCEE 282

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 13/219 (5%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHI 86
           I+ +Y  +  +G G    V  + +   N KVAIK I      + + L+   RE+     +
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 87  KHDNVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            H N++++ DV         +D   YLV E ++   L + I+S   LS D    F  Q+L
Sbjct: 69  SHQNIVSMIDV-------DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAP 202
            G+K+ H   I+HRD+KP N+L+++N  LKI DFG+A+         T +V+ T  Y +P
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN 241
           E     +      D++S+G +  E+L  +P F G   ++
Sbjct: 182 E-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 98
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 99  LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 206
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 245

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 92
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 207
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 259
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 260 ------------------------DLVEKLLVLDATKRLGCEE 278

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 38  IGRGAYGVVCSS--INRETNE-KVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIA 93
           IG+G +GVV     I++  N  + AIK ++ + E  +++A   LRE +L+R + H NV+A
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--LREGLLMRGLNHPNVLA 86
Query: 94  LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCK---YFVFQLLRGLKYLH 150
           L  +M+P        V L Y +   DL Q I+S Q   N   K    F  Q+ RG++YL 
Sbjct: 87  LIGIMLPPE--GLPHVLLPY-MCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLA 141
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
               +HRDL   N +++ +  +K+ DFGLAR     E +  +    R  R P      ++
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHARLPVKWTALES 199
Query: 211 -----YGTSIDVWSVGCIFAEILGR 230
                + T  DVWS G +  E+L R
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 260
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 261 ------------------------DLVEKLLVLDATKRLGCEE 279

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 119/254 (46%), Gaps = 26/254 (10%)
Query: 12  KSRGKHYYTMWQTLFEI-DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNV 66
           + R + + T  Q + E+ D  +  I  +G G  GVV    ++ +   +A K    +I   
Sbjct: 14  RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 73
Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK 125
             N+I     +REL +L       ++           IS     +  E MD   L Q++K
Sbjct: 74  IRNQI-----IRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLK 123
Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSR 184
            +  +           +++GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +
Sbjct: 124 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQ 181
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQL 243
             +     +V TR Y +PE L    +Y    D+WS+G    E+ +GR PI P      +L
Sbjct: 182 LIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KEL 238
Query: 244 KLIISVFGTQQEAD 257
           +L+   FG Q E D
Sbjct: 239 ELM---FGCQVEGD 249

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE ++    +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--AALCGTLDYLPPE-MIEGRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 260
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 261 ------------------------DLVEKLLVLDATKRLGCEE 279

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 262
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 263 ------------------------DLVEKLLVLDATKRLGCEE 281

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 AG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 262
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 263 ------------------------DLVEKLLVLDATKRLGCEE 281

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 70
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 71  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 185
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 237
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 238 ------------------------DLVEKLLVLDATKRLGCEE 256

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 71
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 72  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 186
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 238
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 239 ------------------------DLVEKLLVLDATKRLGCEE 257

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 53/294 (18%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL----RTLRELVLLRHIKHDNV 91
           +P+G+G +G V   + RE N K  I  +  +F+ +++      +  RE+ +  H++H N+
Sbjct: 14  RPLGKGKFGNVY--LAREKNSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKY 148
           + L      + R     VYL+ E     L  + +  Q LS         ++ +L   L Y
Sbjct: 71  LRLYGYFHDSTR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
            HS  ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE ++  
Sbjct: 124 CHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--AALCGTLDYLPPE-MIEG 180
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             +   +D+WS+G +  E L  KP F                 T Q+             
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQDT------------ 214
Query: 269 FIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                 Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ------YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 77
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 78  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 192
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 244
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 245 ------------------------DLVEKLLVLDATKRLGCEE 263

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 139/319 (43%), Gaps = 53/319 (16%)
Query: 12  KSRGKHYYTMWQTLFEI-DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNV 66
           + R + + T  Q + E+ D  +  I  +G G  GVV    ++ +   +A K    +I   
Sbjct: 6   RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 65
Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK 125
             N+I     +REL +L       ++           IS     +  E MD   L Q++K
Sbjct: 66  IRNQI-----IRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLK 115
Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSR 184
            +  +           +++GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +
Sbjct: 116 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQ 173
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQL 243
             +     +V TR Y +PE L    +Y    D+WS+G    E+ +GR PI  G+  +   
Sbjct: 174 LIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF 232
Query: 244 KLIISVFGTQQEADLEFIDN---PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKML 300
           +L            L++I N   PK    + SL +                  D + K L
Sbjct: 233 EL------------LDYIVNEPPPKLPSGVFSLEFQ-----------------DFVNKCL 263
Query: 301 VFEPSKRITVTEALQHPYI 319
           +  P++R  + + + H +I
Sbjct: 264 IKNPAERADLKQLMVHAFI 282

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 100
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 101 KLYFCFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 215
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 267
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 268 ------------------------DLVEKLLVLDATKRLGCEE 286

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 137/312 (43%), Gaps = 39/312 (12%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T  +VAIK I+    N     +  RE+ +++ + H N+
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YL+ E     ++   + +   +     +    Q++  ++Y H
Sbjct: 74  VKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +       +  T +  +  Y APEL      
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-FCGSPPYAAPELFQGKKY 187
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
            G  +DVWS+G I   ++     F G + L +L+                       R +
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERVL 224
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
                 RG +    Y   D    +LL++ LV  P KR T+ + ++  +I+  ++     P
Sbjct: 225 ------RGKYRIPFYMSTD--CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 276
Query: 331 AQVPLSLDIDEN 342
              P  LDI + 
Sbjct: 277 FVEP-ELDISDQ 287

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 77  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI +FG +  +  + +  T    T  Y  PE ++    +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR--TTLCGTLDYLPPE-MIEGRMH 186
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 217
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 218 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 77  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE++     +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--AALCGTLDYLPPEMIE-GRMH 186
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 217
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 218 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 XG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 74  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE ++    +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLCGTLDYLPPE-MIEGRMH 183
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 214
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 215 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 77  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE ++    +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLCGTLDYLPPE-MIEGRMH 186
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 217
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 218 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 132/299 (44%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 66
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 67  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +   +TE   T +Y 
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYYV 184
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 185 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 239
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 240 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++  V  +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      +  L + I+   S      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 262
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 263 ------------------------DLVEKLLVLDATKRLGCEE 281

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 74
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 75  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 130 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 188
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 72
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 73  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YG 186
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFY 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 76  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI +FG +  +  + +  T    T  Y  PE++     +
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR--TTLCGTLDYLPPEMIE-GRMH 185
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 216
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 217 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 76  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE++     +
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLCGTLDYLPPEMIE-GRMH 185
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 216
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 217 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++E+    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 92
Query: 94  LKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 93  LE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 145 HSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 200
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 201 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           I+ +G G++G V    ++ET    A+K ++   + ++  L+ +   +  + I+     A+
Sbjct: 47  IRTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRIQQ----AV 99
Query: 95  KDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
               +     SFKD   +Y+V E     ++   ++     S  H +++  Q++   +YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S ++++RDLKP NLL++    +K+ DFG A+  +G    +     T  Y APE++L    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKG 215
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
           Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y +M+     ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NL+++    +++ DFGLA+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y +M+     ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NL+++    +K+ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           LK       R+ F     V E  +  +L   +   +  + +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAEIL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 29  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 87
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 139
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 199
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 200 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-ELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  +++   +A+K +      +      LR E+ +  H++H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHS 151
                   R     VYL+ E     L  + +  Q LS         ++ +L   L Y HS
Sbjct: 75  YGYFHDATR-----VYLILEY--APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             ++HRD+KP NLL+ +  +LKI DFG +  +  + +       T  Y  PE++     +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMIE-GRMH 184
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
              +D+WS+G +  E L  KP F                 T QE                
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQET--------------- 215
Query: 272 SLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
              Y R + +   +P      A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 216 ---YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH--DNVI 92
           IK +G G++G V    + ET    A+K ++             +++V L+ I+H  +   
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK------------QKVVKLKQIEHTLNEKR 94
Query: 93  ALKDVMMP---THRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            L+ V  P       SFKD   +Y +M+     ++   ++     S  H +++  Q++  
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            +YLHS ++++RDLKP NL+++    +K+ DFG A+  +G    +     T  Y APE++
Sbjct: 155 FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEII 211
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
           L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 212 L-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH--DNVI 92
           IK +G G++G V    + ET    A+K ++             +++V L+ I+H  +   
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK------------QKVVKLKQIEHTLNEKR 94
Query: 93  ALKDVMMP---THRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            L+ V  P       SFKD   +Y +M+     ++   ++     S  H +++  Q++  
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            +YLHS ++++RDLKP NL+++    +K+ DFG A+  +G    +     T  Y APE++
Sbjct: 155 FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEII 211
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
           L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 212 L-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 36/215 (16%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDNVIALKD 96
           +G+G +G      +RET E + +K++    E   +  RT L+E+ ++R ++H NV+    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 97  VMMPTHRISFKDVYLVYELMDTDLHQIIKS-------SQSLSNDHCKYFVFQLLRGLKYL 149
           V+    R++F   Y+        L  IIKS       SQ +S      F   +  G+ YL
Sbjct: 75  VLYKDKRLNFITEYI----KGGTLRGIIKSMDSQYPWSQRVS------FAKDIASGMAYL 124
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLAR--------------TSRGNEQFMTEYVV 195
           HS NI+HRDL   N LV  N ++ + DFGLAR                + + +     V 
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR 230
             ++ APE ++   +Y   +DV+S G +  EI+GR
Sbjct: 185 NPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 32  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 91
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 92  LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 144 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SK 199
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 49  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 107
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 108 HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 159
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 160 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTL 219
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 220 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 273

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           K +G G++     +    T+ + AIK   K + + EN++  +   RE  ++  + H   +
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            L        ++ F   Y      + +L + I+   S      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
              S D+W++GCI  +++ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEKFFPKAR-- 260
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                                   DL++K+LV + +KR+   E
Sbjct: 261 ------------------------DLVEKLLVLDATKRLGCEE 279

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 111/247 (44%), Gaps = 30/247 (12%)
Query: 34  PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           PI  +GRGAYGVV    +  + +  A+K+I     N  +  R L +L     I    V  
Sbjct: 38  PIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATV-NSQEQKRLLXDL----DISXRTVDC 92
Query: 94  LKDVMMPTHRISFKDVYLVYELMDTDL----HQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
              V          DV++  EL DT L     Q+I   Q++  D        +++ L++L
Sbjct: 93  PFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 152
Query: 150 HSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAP 202
           HS  +++HRD+KP N+L+NA   +K CDFG++        ++ + V        + Y AP
Sbjct: 153 HSKLSVIHRDVKPSNVLINALGQVKXCDFGIS-------GYLVDDVAKDIDAGCKPYXAP 205
Query: 203 ELL---LCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD- 257
           E +   L    Y    D+WS+G    E+ + R P         QLK ++     Q  AD 
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 265
Query: 258 --LEFID 262
              EF+D
Sbjct: 266 FSAEFVD 272

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 98
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++        H +++  Q++   +YL
Sbjct: 99  LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 150
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 206
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKHDNVIA 93
           K IGRG +  V  +        VA+KK+  +F+      R   ++E+ LL+ + H NVI 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK---SSQSLSNDHC--KYFVFQLLRGLK 147
                +  + ++     +V EL D  DL ++IK     + L  +    KYFV QL   L+
Sbjct: 97  YYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV-QLCSALE 150
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           ++HS  ++HRD+KP N+ + A   +K+ D GL R            V T +Y +PE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 209
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
            + Y    D+WS+GC+  E+   +  F G
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++     S  H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 137/314 (43%), Gaps = 43/314 (13%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T  +VAIK I+    N     +  RE+ +++ + H N+
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YL+ E     ++   + +   +     +    Q++  ++Y H
Sbjct: 77  VKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCC 208
              I+HRDLK  NLL++A+ ++KI DFG +   T  G    +  +     Y APEL    
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGK 188
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
              G  +DVWS+G I   ++     F G + L +L+                       R
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ER 225
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN 328
            +      RG +    Y   D    +LL++ LV  P KR T+ + ++  +I+  ++    
Sbjct: 226 VL------RGKYRIPFYMSTD--CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
Query: 329 PPAQVPLSLDIDEN 342
            P   P  LDI + 
Sbjct: 278 KPFVEP-ELDISDQ 290

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 142/325 (43%), Gaps = 64/325 (19%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDN 90
           ++  K +G+G++G V  +  ++TN+  AIK +  +V     D   T+ E  +L       
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS------ 72
Query: 91  VIALKDVMMPTHRISFK---DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
            +A +   +     +F+   +++ V E ++  DL   I+S          ++  +++ GL
Sbjct: 73  -LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           ++LHS  I++RDLK  N+L++ +  +KI DFG+ + +   +     +  T  Y APE+LL
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 207 CCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEF---ID 262
               Y  S+D WS G +  E+L G+ P                 F  Q E +L     +D
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSP-----------------FHGQDEEELFHSIRMD 233
Query: 263 NPKARRFIKSLPYSRGTHISSLYPQ-ADPLALDLLQKMLVFEPSKRITVTEAL-QHPYIS 320
           NP                    YP+  +  A DLL K+ V EP KR+ V   + QHP   
Sbjct: 234 NP-------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
Query: 321 GL---------YDPQCNPPAQVPLS 336
            +          DP   P  + P  
Sbjct: 275 EINWEELERKEIDPPFRPKVKSPFD 299

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           +  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 AEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E L    +Y    D+WS+G    E+ +GR PI P      +L+L+   FG Q E D
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELM---FGCQVEGD 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 73
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 74  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 191
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 192 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 246
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 247 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  ++    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVS 252

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
           ++ IG+G++G VC     +T +  A+K +N      R +     +EL +++ ++H  ++ 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L          SF+D   +++V +L+   DL   ++ +     +  K F+ +L+  L YL
Sbjct: 80  L--------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
            +  I+HRD+KP N+L++ +  + I DF +A       Q +T    T+ Y APE+     
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSRK 190
Query: 210 NYGTS--IDVWSVGCIFAEIL-GRKP 232
             G S  +D WS+G    E+L GR+P
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 72
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 73  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 190
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 191 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 245
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 246 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y +M+     ++   ++     S  H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NL+++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E L    +Y    D+WS+G    E+ +GR PI P      +L+L+   FG Q E D
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELM---FGCQVEGD 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 74
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 75  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 192
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 193 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 247
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 248 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 119/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 49  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 107
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 108 HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 159
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
              H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 160 XEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 219
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 220 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 273

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 10/219 (4%)
Query: 35  IKPIGRGAYGVV--CSSINR-ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +K +G+G++G V     + R ++    A+K +        D +RT  E  +L  + H  V
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFV 92
Query: 92  IALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L        ++     YL+ + +   DL   +      + +  K+++ +L  GL +LH
Sbjct: 93  VKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLKP N+L++    +K+ DFGL++ +  +E+    +  T  Y APE ++    
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQG 206
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           +  S D WS G +  E+L     F G +    + LI+  
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKA 245

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 66
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 67  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 184
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 185 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 239
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 240 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 69  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 186
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 187 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 241
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 242 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+ + + + H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +         +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCD 209
              I+HRDLK  NLL++A+ ++KI DFG +   + GN+  +  +     Y APEL     
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGKK 188
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
             G  +DVWS+G I   ++     F G + L +L+                       R 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR----------------------ERV 225
Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
           +      RG +    Y   D    +LL+K L+  PSKR T+ +
Sbjct: 226 L------RGKYRIPFYXSTD--CENLLKKFLILNPSKRGTLEQ 260

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 82
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 83  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 200
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 201 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 255
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 256 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 67
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 68  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 185
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 186 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 240
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 241 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E L    +Y    D+WS+G    E+ +GR PI P      +L+L+   FG Q E D
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELM---FGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           E L    +Y    D+WS+G    E+ +GR PI P      +L+L+   FG Q E D
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELM---FGCQVEGD 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y +M+     ++   ++        H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NL+++    +K+ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 112
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 113 QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 230
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 231 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 285
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 286 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 69  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 186
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 187 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 241
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 242 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 119/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
              H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 XEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 119/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
              H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 XEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    ++E+    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 100
Query: 94  LKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++        H +++  Q++   +YL
Sbjct: 101 LE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 152
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 153 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 208
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 209 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 247

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH--DNVI 92
           IK +G G++G V    + ET    A+K ++             +++V L+ I+H  +   
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK------------QKVVKLKQIEHTLNEKR 94
Query: 93  ALKDVMMP---THRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            L+ V  P       SFKD   +Y +M+     ++   ++        H +++  Q++  
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT 154
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            +YLHS ++++RDLKP NL+++    +K+ DFG A+  +G    +     T  Y APE++
Sbjct: 155 FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEII 211
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
           L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 212 L-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 118
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 119 QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 236
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 237 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 291
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 292 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           ++ +G G++G V    +R      A+K +      R+  +  T  E ++L  + H  +I 
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           +          +F+D   ++ +MD     +L  +++ SQ   N   K++  ++   L+YL
Sbjct: 71  MWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS +I++RDLKP N+L++ N  +KI DFG A+              T  Y APE ++   
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLCGTPDYIAPE-VVSTK 178
Query: 210 NYGTSIDVWSVGCIFAEIL-GRKPIF 234
            Y  SID WS G +  E+L G  P +
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 119/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
              H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 XEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++        H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++        H +++  Q++   +YL
Sbjct: 107 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 214
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 253

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NL+++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y APE+++    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDNVIA 93
           IK +G G++G V    + ET    A+K ++     ++  +  TL E  +L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94  LKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L+         SFKD   +Y+V E +   ++   ++        H +++  Q++   +YL
Sbjct: 106 LE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G    +     T  Y APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SK 213
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GA+GVV     R T    A K +    E+  + +R  +E+  +  ++H  ++ L D 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPTLVNLHDA 116
Query: 98  MMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
               +     ++ ++YE M       ++      +S D    ++ Q+ +GL ++H  N +
Sbjct: 117 FEDDN-----EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 156 HRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           H DLKP N++     + +LK+ DFGL       +Q +     T  + APE+       G 
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTAEFAAPEVAE-GKPVGY 229
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
             D+WSVG +   +L                  +S FG   E D E + N      +KS 
Sbjct: 230 YTDMWSVGVLSYILLSG----------------LSPFGG--ENDDETLRN------VKSC 265
Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQV 333
            ++      S +        D ++K+L+ +P+ R+T+ +AL+HP+++    P  +  +Q+
Sbjct: 266 DWNMD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD--SQI 320
Query: 334 PLS 336
           P S
Sbjct: 321 PSS 323

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G GA+GVV     R T    A K +    E+  + +R  +E+  +  ++H  ++ L D 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPTLVNLHDA 222
Query: 98  MMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
               +     ++ ++YE M       ++      +S D    ++ Q+ +GL ++H  N +
Sbjct: 223 FEDDN-----EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 156 HRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           H DLKP N++     + +LK+ DFGL       +Q +     T  + APE+       G 
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTAEFAAPEVAE-GKPVGY 335
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
             D+WSVG +   +L                  +S FG   E D E + N      +KS 
Sbjct: 336 YTDMWSVGVLSYILLSG----------------LSPFGG--ENDDETLRN------VKSC 371
Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQV 333
            ++      S +        D ++K+L+ +P+ R+T+ +AL+HP+++    P  +  +Q+
Sbjct: 372 DWNMD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD--SQI 426
Query: 334 PLS 336
           P S
Sbjct: 427 PSS 429

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 119/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T  Y AP ++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V   I+++T E+VAIK+       + +  R   E+ +++ + H NV++ ++V
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 98  MMPTHRISFKDV-YLVYELMDT-DLHQIIKSSQS---LSNDHCKYFVFQLLRGLKYLHSA 152
                +++  D+  L  E  +  DL + +   ++   L     +  +  +   L+YLH  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 153 NILHRDLKPGNLLVNANCDL---KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
            I+HRDLKP N+++         KI D G A+     E   TE+V T  Y APELL    
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLE-QK 199
Query: 210 NYGTSIDVWSVGCI-FAEILGRKPIFP 235
            Y  ++D WS G + F  I G +P  P
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V   I+++T E+VAIK+       + +  R   E+ +++ + H NV++ ++V
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 98  MMPTHRISFKDV-YLVYELMDT-DLHQIIKSSQS---LSNDHCKYFVFQLLRGLKYLHSA 152
                +++  D+  L  E  +  DL + +   ++   L     +  +  +   L+YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 153 NILHRDLKPGNLLVNANCDL---KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
            I+HRDLKP N+++         KI D G A+     E   TE+V T  Y APELL    
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLE-QK 198
Query: 210 NYGTSIDVWSVGCI-FAEILGRKPIFP 235
            Y  ++D WS G + F  I G +P  P
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKHDN 90
           YV    +G G +G V    ++ T  KVA+K +N      +D +  + RE+  L+  +H +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 91  VIALKDVM-MPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +I L  V+  PT      D ++V E +   +L   I     +     +    Q+L  + Y
Sbjct: 73  IIKLYQVISTPT------DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
            H   ++HRDLKP N+L++A+ + KI DFGL+      E F+ +   +  Y APE++   
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRDSCGSPNYAAPEVISGR 185
Query: 209 DNYGTSIDVWSVGCIFAEIL 228
              G  +D+WS G I   +L
Sbjct: 186 LYAGPEVDIWSCGVILYALL 205

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           K IG+G +  V  + +  T  +VA+K I+    N     +  RE+ +++ + H N++ L 
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 96  DVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
           +V+      + K +YLV E     ++   + +   +     +    Q++  ++Y H   I
Sbjct: 81  EVIE-----TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYI 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           +HRDLK  NLL++ + ++KI DFG +   + GN+  +  +  +  Y APEL       G 
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK--LDTFCGSPPYAAPELFQGKKYDGP 193
Query: 214 SIDVWSVGCIFAEILGRKPIFPG 236
            +DVWS+G I   ++     F G
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDG 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 43/292 (14%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH-DNVIAL 94
           K +GRG + VV   I++ T ++ A K +      +      L E+ +L   K    VI L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 95  KDVMMPTHRISFKDVYL----VYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
            +V   T  I     Y     ++ L   +L +++       ND  +  + Q+L G+ YLH
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----NDVIR-LIKQILEGVYYLH 148
Query: 151 SANILHRDLKPGNLLVNAN---CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
             NI+H DLKP N+L+++     D+KI DFG++R   G+   + E + T  Y APE +L 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPE-ILN 206
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
            D   T+ D+W++G I   +L     F G +               QE  L         
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGED--------------NQETYLNISQ----- 247
Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
               ++ YS  T     +     LA D +Q +LV  P KR T    L H ++
Sbjct: 248 ---VNVDYSEET-----FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 89/335 (26%), Positives = 133/335 (39%), Gaps = 84/335 (25%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK-HDNVIAL 94
           +G GA+  V + IN  T+++ A+K    + E +   +R+   RE+ +L   + H NV+ L
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVK----IIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            +      R      YLV+E M    +   I   +  +       V  +   L +LH+  
Sbjct: 77  IEFFEEEDRF-----YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 154 ILHRDLKPGNLLV---NANCDLKICDFGLAR-----------------TSRGNEQFMTEY 193
           I HRDLKP N+L    N    +KICDFGL                   T  G+ ++M   
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT--------------EC 239
           VV  +     +      Y    D+WS+G I   +L   P F G                C
Sbjct: 192 VVEAFSEEASI------YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
            N L      F + QE   EF D   A             HIS         A DL+ K+
Sbjct: 246 QNML------FESIQEGKYEFPDKDWA-------------HISCA-------AKDLISKL 279
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVP 334
           LV +  +R++  + LQHP++ G     C P   +P
Sbjct: 280 LVRDAKQRLSAAQVLQHPWVQG-----CAPENTLP 309

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 39/293 (13%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +  +G GA+G V  + N+ET    A K I    E  ++    + E+ +L    H  ++ L
Sbjct: 16  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHPYIVKL 73
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                   ++     +     +D  + ++    + L+    +    Q+L  L +LHS  I
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC----CDN 210
           +HRDLK GN+L+    D+++ DFG++  +    Q    ++ T ++ APE+++C       
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    D+WS+G    E+   +P  P  E LN +++++ +  +         D P      
Sbjct: 191 YDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKIAKS---------DPP------ 232
Query: 271 KSLPYSRGTHISSLYPQADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGL 322
                      + L P    +   D L+  L   P  R +  + L+HP++S +
Sbjct: 233 -----------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 274

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 39/293 (13%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +  +G GA+G V  + N+ET    A K I    E  ++    + E+ +L    H  ++ L
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHPYIVKL 81
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                   ++     +     +D  + ++    + L+    +    Q+L  L +LHS  I
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC----CDN 210
           +HRDLK GN+L+    D+++ DFG++  +    Q    ++ T ++ APE+++C       
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           Y    D+WS+G    E+   +P  P  E LN +++++ +  +         D P      
Sbjct: 199 YDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKIAKS---------DPP------ 240
Query: 271 KSLPYSRGTHISSLYPQADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGL 322
                      + L P    +   D L+  L   P  R +  + L+HP++S +
Sbjct: 241 -----------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 65/318 (20%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R   EL+    +    ++ L   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 134
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +     ++     +  EL++   L Q++K    L  D   Y++ Q L GL+YLHS  ILH
Sbjct: 135 VREGPWVN-----IFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSRGNEQFMTEYV-VTRWYRAPELLL--CC 208
            D+K  N+L++++     +CDFG    L     G +    +Y+  T  + APE++L   C
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           D     +DVWS  C+   +L      P T                     +F   P   +
Sbjct: 250 D---AKVDVWSSCCMMLHML--NGCHPWT---------------------QFFRGPLCLK 283
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE-------------ALQ 315
                P  R      + P   PL    +Q+ L  EP  R++  E              L+
Sbjct: 284 IASEPPPVR-----EIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLK 338
Query: 316 HPYISGLYDPQCNPPAQV 333
            P+     +P+  PP Q 
Sbjct: 339 SPWRGEYKEPRHPPPNQA 356

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 128/308 (41%), Gaps = 51/308 (16%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-NVIALKD 96
           +G GAY  V  +++ +  ++ A+K I    +      R  RE+  L   + + N++ L +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEK--QAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 97  VMMPTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
                 R      YLV+E L    +   I+  +  +       V  +   L +LH+  I 
Sbjct: 79  FFEDDTRF-----YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 156 HRDLKPGNLLVNAN---CDLKICDFGLARTSRGNEQF-------MTEYVVTRWYRAPELL 205
           HRDLKP N+L  +      +KICDF L    + N          +T    +  Y APE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 206 LCCDN----YGTSIDVWSVGCIFAEILGRKPIFPG---TECLNQLKLIISV-----FGTQ 253
               +    Y    D+WS+G +   +L   P F G    +C      +  V     F + 
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 253
Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
           QE   EF D   A             HISS        A DL+ K+LV +  +R++  + 
Sbjct: 254 QEGKYEFPDKDWA-------------HISSE-------AKDLISKLLVRDAKQRLSAAQV 293
Query: 314 LQHPYISG 321
           LQHP++ G
Sbjct: 294 LQHPWVQG 301

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 119/238 (50%), Gaps = 18/238 (7%)
Query: 16  KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR 75
           K + T  Q   ++D ++  IK +G G++G V    ++E+    A+K ++     ++  + 
Sbjct: 28  KKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 76  -TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYE-LMDTDLHQIIKSSQSL 130
            TL E  +L+ +    ++ L+         SFKD   +Y+V E +   ++   ++     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           S  H +++  Q++   +YLHS ++++RDLKP NLL++    +++ DFG A+  +G    +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL 198
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
                T    APE++L    Y  ++D W++G +  E+    P F   + +   + I+S
Sbjct: 199 CG---TPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKHDN 90
           YV    +G G +G V    ++ T  KVA+K +N      +D +  + RE+  L+  +H +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 91  VIALKDVM-MPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +I L  V+  PT      D ++V E +   +L   I     +     +    Q+L  + Y
Sbjct: 73  IIKLYQVISTPT------DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
            H   ++HRDLKP N+L++A+ + KI DFGL+      E F+     +  Y APE++   
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGR 185
Query: 209 DNYGTSIDVWSVGCIFAEIL 228
              G  +D+WS G I   +L
Sbjct: 186 LYAGPEVDIWSCGVILYALL 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 36  KPIGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       +     L E  +++ ++HD ++ L
Sbjct: 21  KKLGAGQFGEVWMATYNKHT--KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKL 75
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKY--FVFQLLRGLKYLHS 151
             V      ++ + +Y++ E M    L   +KS +       K   F  Q+  G+ ++  
Sbjct: 76  HAV------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+A+   KI DFGLAR    NE    E      +W  APE +    
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 184
Query: 210 NYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           N+G+     DVWS G +  EI+  GR P +PG
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 215

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 46/301 (15%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           E L    +Y    D+WS+G    E+ +GR PI P  +     +  +++F       L++I
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPI-PPPDAKEDSRPPMAIFEL-----LDYI 225
Query: 262 DN---PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            N   PK    + SL +                  D + K L+  P++R  + + + H +
Sbjct: 226 VNEPPPKLPSGVFSLEFQ-----------------DFVNKCLIKNPAERADLKQLMVHAF 268
Query: 319 I 319
           I
Sbjct: 269 I 269

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 36  KPIGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       +     L E  +++ ++HD ++ L
Sbjct: 194 KKLGAGQFGEVWMATYNKHT--KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKY--FVFQLLRGLKYLHS 151
             V      ++ + +Y++ E M    L   +KS +       K   F  Q+  G+ ++  
Sbjct: 249 HAV------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+A+   KI DFGLAR    NE    E      +W  APE +    
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 357
Query: 210 NYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           N+G+     DVWS G +  EI+  GR P +PG
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIK----KINNVFENRIDALRTLRELVLLR 84
           D  +  I  +G G  GVV    ++ +   +A K    +I     N+I     +REL +L 
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 62
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
                 ++           IS     +  E MD   L Q++K +  +           ++
Sbjct: 63  ECNSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 117
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  + +  ++   E+V TR Y +P
Sbjct: 118 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDEMANEFVGTRSYMSP 175
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR P  P
Sbjct: 176 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 133/315 (42%), Gaps = 45/315 (14%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ-------DCPKARREVELHWRAS 112
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +          + 
Sbjct: 113 QCPHIVRIVDVYENLY-AGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 230
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D WS+G I   +L   P F      +   L IS            
Sbjct: 231 APE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPF-----YSNHGLAIS------------ 272
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
              P  +  I+   Y      +  + +       L++ +L  EP++R T+TE   HP+I 
Sbjct: 273 ---PGXKTRIRXGQYE---FPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIX 326
Query: 321 GLYDPQCNPPAQVPL 335
                Q     Q PL
Sbjct: 327 -----QSTKVPQTPL 336

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 126/304 (41%), Gaps = 61/304 (20%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R   EL+    +    ++ L   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 153
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +          V +  EL++   L Q++K    L  D   Y++ Q L GL+YLHS  ILH
Sbjct: 154 VR-----EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSRGNEQFMTEYV-VTRWYRAPELLL--CC 208
            D+K  N+L++++     +CDFG    L     G      +Y+  T  + APE++L   C
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           D     +DVWS  C+   +L      P T                     +F   P   +
Sbjct: 269 D---AKVDVWSSCCMMLHML--NGCHPWT---------------------QFFRGPLCLK 302
Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE-------ALQHPYISG 321
                P  R      + P   PL    +Q+ L  EP  R++  E       ALQ   + G
Sbjct: 303 IASEPPPVR-----EIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQ--VGG 355
Query: 322 LYDP 325
           L  P
Sbjct: 356 LKSP 359

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 112/242 (46%), Gaps = 61/242 (25%)
Query: 109 VYLVYELMDTDLHQIIKSSQSLSNDHCK----YFVFQLLR----GLKYLHSANILHRDLK 160
           +Y+  EL + +L  +++S +++S+++ K    Y    LLR    G+ +LHS  I+HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 161 PGNLLVNA-------------NCDLKICDFGLART-SRGNEQFMTEY---VVTRWYRAPE 203
           P N+LV+              N  + I DFGL +    G   F T       T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 204 LLLCCDNYGT------SIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQE 255
           LL   +N  T      SID++S+GC+F  IL  G+ P                 FG +  
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP-----------------FGDKYS 245
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            +   I      R I SL   +  H  SL  +    A DL+ +M+  +P KR T  + L+
Sbjct: 246 RESNII------RGIFSLDEMKCLHDRSLIAE----ATDLISQMIDHDPLKRPTAMKVLR 295
Query: 316 HP 317
           HP
Sbjct: 296 HP 297

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 10/224 (4%)
Query: 30  TKYVPIKPIGRGAYG---VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +++  +K +G+G++G   +V      +  +  A+K +        D +RT  E  +L  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H  ++ L        ++     YL+ + +   DL   +      + +  K+++ +L   
Sbjct: 84  NHPFIVKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L +LHS  I++RDLKP N+L++    +K+ DFGL++ S  +E+    +  T  Y APE +
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-V 197
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           +    +  S D WS G +  E+L     F G +    + +I+  
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 10/224 (4%)
Query: 30  TKYVPIKPIGRGAYG---VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +++  +K +G+G++G   +V      +  +  A+K +        D +RT  E  +L  +
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H  ++ L        ++     YL+ + +   DL   +      + +  K+++ +L   
Sbjct: 85  NHPFIVKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 139
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L +LHS  I++RDLKP N+L++    +K+ DFGL++ S  +E+    +  T  Y APE +
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-V 198
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           +    +  S D WS G +  E+L     F G +    + +I+  
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 242

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 10/224 (4%)
Query: 30  TKYVPIKPIGRGAYG---VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +++  +K +G+G++G   +V      +  +  A+K +        D +RT  E  +L  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H  ++ L        ++     YL+ + +   DL   +      + +  K+++ +L   
Sbjct: 84  NHPFIVKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L +LHS  I++RDLKP N+L++    +K+ DFGL++ S  +E+    +  T  Y APE +
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-V 197
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           +    +  S D WS G +  E+L     F G +    + +I+  
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 88/335 (26%), Positives = 132/335 (39%), Gaps = 84/335 (25%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK-HDNVIAL 94
           +G GA+  V + IN  T+++ A+K    + E +   +R+   RE+ +L   + H NV+ L
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVK----IIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            +      R      YLV+E M    +   I   +  +       V  +   L +LH+  
Sbjct: 77  IEFFEEEDRF-----YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 154 ILHRDLKPGNLLV---NANCDLKICDFGLAR-----------------TSRGNEQFMTEY 193
           I HRDLKP N+L    N    +KICDF L                   T  G+ ++M   
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT--------------EC 239
           VV  +     +      Y    D+WS+G I   +L   P F G                C
Sbjct: 192 VVEAFSEEASI------YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
            N L      F + QE   EF D   A             HIS         A DL+ K+
Sbjct: 246 QNML------FESIQEGKYEFPDKDWA-------------HISCA-------AKDLISKL 279
Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVP 334
           LV +  +R++  + LQHP++ G     C P   +P
Sbjct: 280 LVRDAKQRLSAAQVLQHPWVQG-----CAPENTLP 309

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            DNV+ +K        +     YL +E         +    SLS    + ++  L + LK
Sbjct: 79  QDNVMGVKYCFRKNDHVVIAMPYLEHE-------SFLDILNSLSFQEVREYMLNLFKALK 131
Query: 148 YLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVV----------- 195
            +H   I+HRD+KP N L N       + DFGLA+ +   +  + ++V            
Sbjct: 132 RIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQN 191
Query: 196 -----------------TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
                            T  +RAPE+L  C N  T+ID+WS G IF  +L GR P +  +
Sbjct: 192 KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251
Query: 238 ECLNQLKLIISVFGTQQ 254
           + L  L  I+++ G+++
Sbjct: 252 DDLTALAQIMTIRGSRE 268

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR---IDALRTLRELVLLRHIKHDNV 91
           ++ IGRG+Y  V     ++T+   A+K +     N    ID ++T +  V  +   H  +
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH-VFEQASNHPFL 72
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L        R+ F    ++  +   DL   ++  + L  +H +++  ++   L YLH 
Sbjct: 73  VGLHSCFQTESRLFF----VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   D Y
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-Y 187
Query: 212 GTSIDVWSVGCIFAEIL-GRKPI 233
           G S+D W++G +  E++ GR P 
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR---IDALRTLRELVLLRHIKHDNV 91
           ++ IGRG+Y  V     ++T+   A+K +     N    ID ++T +  V  +   H  +
Sbjct: 10  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH-VFEQASNHPFL 68
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L        R+ F    ++  +   DL   ++  + L  +H +++  ++   L YLH 
Sbjct: 69  VGLHSCFQTESRLFF----VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   D Y
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-Y 183
Query: 212 GTSIDVWSVGCIFAEIL-GRKPI 233
           G S+D W++G +  E++ GR P 
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 135/293 (46%), Gaps = 64/293 (21%)
Query: 52  RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYL 111
           +  N+K++IK   + F+N         EL ++  IK++  +  + ++      ++ +VY+
Sbjct: 75  KSNNDKISIKSKYDDFKN---------ELQIITDIKNEYCLTCEGIIT-----NYDEVYI 120
Query: 112 VYELMDTDLHQIIKSSQSL----SNDHC-------KYFVFQLLRGLKYLHS-ANILHRDL 159
           +YE M+ D   I+K  +       N  C       K  +  +L    Y+H+  NI HRD+
Sbjct: 121 IYEYMEND--SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 160 KPGNLLVNANCDLKICDFGLA--------RTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
           KP N+L++ N  +K+ DFG +        + SRG  +FM           PE      +Y
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM----------PPEFFSNESSY 228
Query: 212 -GTSIDVWSVG-CIFAEILGRKPIFPGTECLNQLKL-IISVFGTQQEADLEFIDNPKARR 268
            G  +D+WS+G C++       P          LK+ ++ +F   +  ++E+   P  R 
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPF--------SLKISLVELFNNIRTKNIEY---PLDRN 277
Query: 269 -FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            F+  L   + T  ++     D   +D L+  L   P++RIT  +AL+H +++
Sbjct: 278 HFLYPLTNKKSTCSNNFLSNED---IDFLKLFLRKNPAERITSEDALKHEWLA 327

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IK +G G +G V        N KVAIK +       +     L E  +++ +KHD ++ L
Sbjct: 14  IKRLGNGQFGEVWMG-TWNGNTKVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQL 69
Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHS 151
             V      +S + +Y+V E M+   L   +K  +  +L   +      Q+  G+ Y+  
Sbjct: 70  YAV------VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV      KI DFGLAR    NE    +      +W  APE  L   
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YG 181
Query: 210 NYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
            +    DVWS G +  E++  GR P +PG    E L Q++
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVP-YPGMNNREVLEQVE 220

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIALKD 96
           IG GA  VV ++      EKVAIK+IN    +  +D L  L+E+  +    H N+++   
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHHPNIVSYY- 79
Query: 97  VMMPTHRISFKDVYLVYELM------DTDLHQIIKS---SQSLSNDHCKYFVFQLLRGLK 147
               T  +   +++LV +L+      D   H + K    S  L        + ++L GL+
Sbjct: 80  ----TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGL-ARTSRGNE----QFMTEYVVTRWYRAP 202
           YLH    +HRD+K GN+L+  +  ++I DFG+ A  + G +    +    +V T  + AP
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI 227
           E++     Y    D+WS G    E+
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIEL 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 18/236 (7%)
Query: 35  IKPIGRGAYGVVC---SSINRETNEKVAIKKINN--VFENRIDALRTLRELVLLRHIKHD 89
           ++ +G+G YG V          T +  A+K +    +  N  D   T  E  +L  +KH 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 90  NVIALKDVMMPTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            ++ L        ++     YL+ E L   +L   ++       D   +++ ++   L +
Sbjct: 82  FIVDLIYAFQTGGKL-----YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLKP N+++N    +K+ DFGL + S  +      +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGT------ECLNQLKLIISVFGTQQEADL 258
             +  ++D WS+G +  ++L   P F G       + + + KL +  + TQ+  DL
Sbjct: 197 -GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL 251

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 18/236 (7%)
Query: 35  IKPIGRGAYGVVC---SSINRETNEKVAIKKINN--VFENRIDALRTLRELVLLRHIKHD 89
           ++ +G+G YG V          T +  A+K +    +  N  D   T  E  +L  +KH 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 90  NVIALKDVMMPTHRISFKDVYLVYE-LMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            ++ L        ++     YL+ E L   +L   ++       D   +++ ++   L +
Sbjct: 82  FIVDLIYAFQTGGKL-----YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLKP N+++N    +K+ DFGL + S  +      +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGT------ECLNQLKLIISVFGTQQEADL 258
             +  ++D WS+G +  ++L   P F G       + + + KL +  + TQ+  DL
Sbjct: 197 -GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL 251

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIALKD 96
           IG GA  VV ++      EKVAIK+IN    +  +D L  L+E+  +    H N+++   
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHHPNIVSYY- 74
Query: 97  VMMPTHRISFKDVYLVYELM------DTDLHQIIKS---SQSLSNDHCKYFVFQLLRGLK 147
               T  +   +++LV +L+      D   H + K    S  L        + ++L GL+
Sbjct: 75  ----TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGL-ARTSRGNE----QFMTEYVVTRWYRAP 202
           YLH    +HRD+K GN+L+  +  ++I DFG+ A  + G +    +    +V T  + AP
Sbjct: 131 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEI 227
           E++     Y    D+WS G    E+
Sbjct: 191 EVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR---IDALRTLRELVLLRHIKHDNV 91
           ++ IGRG+Y  V     ++T+   A+K +     N    ID ++T +  V  +   H  +
Sbjct: 25  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH-VFEQASNHPFL 83
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L        R+ F    ++  +   DL   ++  + L  +H +++  ++   L YLH 
Sbjct: 84  VGLHSCFQTESRLFF----VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   D Y
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-Y 198
Query: 212 GTSIDVWSVGCIFAEIL-GRKPI 233
           G S+D W++G +  E++ GR P 
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPF 221

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINN--VFENRIDALRTLRELVLLRHIKHDNVI 92
           +K IG+G++G V  + ++      A+K +    + + + +        VLL+++KH  ++
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 93  ALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            L          SF+    +Y ++D     +L   ++  +       +++  ++   L Y
Sbjct: 103 GL--------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LHS NI++RDLKP N+L+++   + + DFGL + +  +    + +  T  Y APE +L  
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHK 213
Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIF 234
             Y  ++D W +G +  E+L   P F
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 62
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E M+   DL   I    +L  +  +
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERMEPVQDLFDFITERGALQEELAR 117
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 175
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 214
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 215 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 257
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 258 NHPWMQDVLLPQ 269

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 27  EIDTKYVPIKP-IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID  YV I+  IG G +G VC    +   +K   VAIK +   +  R      L E  +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 70
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +   +H N+I L+ V+  +  +     ++    +D+ L           ND  ++ V QL
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL---------NDG-QFTVIQL 120
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY-- 193
           +        G++YL   + +HRDL   N+LVN+N   K+ DFGL+R    N    TE   
Sbjct: 121 VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180
Query: 194 ----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
               +  RW  APE  +    + ++ D WS G +  E++  G +P +
Sbjct: 181 LGGKIPIRWT-APE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYW 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 72
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 127
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++F            WY AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-AP 186
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 187 E-SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 112/242 (46%), Gaps = 61/242 (25%)
Query: 109 VYLVYELMDTDLHQIIKSSQSLSNDHCK----YFVFQLLR----GLKYLHSANILHRDLK 160
           +Y+  EL + +L  +++S +++S+++ K    Y    LLR    G+ +LHS  I+HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 161 PGNLLVNA-------------NCDLKICDFGLART-SRGNEQF---MTEYVVTRWYRAPE 203
           P N+LV+              N  + I DFGL +    G   F   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 204 LLLCCDNYGT------SIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQE 255
           LL   +N  T      SID++S+GC+F  IL  G+ P                 FG +  
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP-----------------FGDKYS 245
Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            +   I      R I SL   +  H  SL  +    A DL+ +M+  +P KR T  + L+
Sbjct: 246 RESNII------RGIFSLDEMKCLHDRSLIAE----ATDLISQMIDHDPLKRPTAMKVLR 295
Query: 316 HP 317
           HP
Sbjct: 296 HP 297

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + ELV    +    ++ L   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 134
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +     ++     +  EL++   L Q+IK    L  D   Y++ Q L GL+YLH+  ILH
Sbjct: 135 VREGPWVN-----IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSRGNEQFMTEYV-VTRWYRAPELLLC--C 208
            D+K  N+L++++     +CDFG    L     G      +Y+  T  + APE+++   C
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 209 DNYGTSIDVWSVGCIFAEIL 228
           D     +D+WS  C+   +L
Sbjct: 250 D---AKVDIWSSCCMMLHML 266

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V    + +T +  AIK ++   +   +  + +  L    H  H N+      
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 89
Query: 98  MMPTHRISFKD-VYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
            +  +     D ++LV E       TDL +  K + +L  +   Y   ++LRGL +LH  
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQH 148
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN-- 210
            ++HRD+K  N+L+  N ++K+ DFG++            ++ T ++ APE++ C +N  
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 211 --YGTSIDVWSVGCIFAEILGRKP 232
             Y    D+WS+G    E+    P
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + ELV    +    ++ L   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +     ++     +  EL++   L Q+IK    L  D   Y++ Q L GL+YLH+  ILH
Sbjct: 119 VREGPWVN-----IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSRGNEQFMTEYV-VTRWYRAPELLLC--C 208
            D+K  N+L++++     +CDFG    L     G      +Y+  T  + APE+++   C
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 209 DNYGTSIDVWSVGCIFAEIL 228
           D     +D+WS  C+   +L
Sbjct: 234 D---AKVDIWSSCCMMLHML 250

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 76  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPE-SLAYNKF 187
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP-YPG 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           ++P+G+G +G V  +  ++    +A+K +  +  E      +  RE+ +  H++H N++ 
Sbjct: 19  VRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           + +      RI     YL+ E     +L++ ++            F+ +L   L Y H  
Sbjct: 79  MYNYFHDRKRI-----YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+    +LKI DFG +  +    +       T  Y  PE ++    + 
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RXMCGTLDYLPPE-MIEGKTHD 190
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
             +D+W  G +  E L   P F         + I++V       DL+F            
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------DLKFP----------- 232
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                        P     + DL+ K+L + P +R+ +   ++HP++  
Sbjct: 233 -------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR---IDALRTLRELVLLRHIKHDNV 91
           ++ IGRG+Y  V     ++T+   A++ +     N    ID ++T +  V  +   H  +
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH-VFEQASNHPFL 115
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           + L        R+ F    ++  +   DL   ++  + L  +H +++  ++   L YLH 
Sbjct: 116 VGLHSCFQTESRLFF----VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   D Y
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-Y 230
Query: 212 GTSIDVWSVGCIFAEIL-GRKPI 233
           G S+D W++G +  E++ GR P 
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPF 253

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + ELV    +    ++ L   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 132
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +     ++     +  EL++   L Q+IK    L  D   Y++ Q L GL+YLH+  ILH
Sbjct: 133 VREGPWVN-----IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSRGNEQFMTEYV-VTRWYRAPELLLC--C 208
            D+K  N+L++++     +CDFG    L     G      +Y+  T  + APE+++   C
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 209 DNYGTSIDVWSVGCIFAEIL 228
           D     +D+WS  C+   +L
Sbjct: 248 D---AKVDIWSSCCMMLHML 264

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/331 (24%), Positives = 136/331 (41%), Gaps = 51/331 (15%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
           D +Y+ ++ +G G +  V  + +   N  VA+K +     +++       E+ LL+ + +
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRV-N 73
Query: 89  DNVIALKDVMMPTHRISFKD-----------VYLVYELMDTDLHQIIKSSQ--SLSNDHC 135
           D     +D M   H +   D           V +V+E++  +L  +IK  +   +   + 
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 136 KYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN------CDLKICDFGLARTSRGNEQ 188
           K    QLL GL Y+H    I+H D+KP N+L+           +KI D G A      ++
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DE 190
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL------NQ 242
             T  + TR YR+PE+LL    +G   D+WS  C+  E++    +F   E        + 
Sbjct: 191 HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 243 LKLIISVFGTQQEADLEFIDNPK-ARRFIKSLPYSRGTHISSLYPQADPLA--------- 292
           +  II + G   E     + N K  R F  S    R       +P  D L          
Sbjct: 250 IAQIIELLG---ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 293 ----LDLLQKMLVFEPSKRITVTEALQHPYI 319
                D L  ML  +P KR      + HP++
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/331 (24%), Positives = 136/331 (41%), Gaps = 51/331 (15%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
           D +Y+ ++ +G G +  V  + +   N  VA+K +     +++       E+ LL+ + +
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRV-N 73
Query: 89  DNVIALKDVMMPTHRISFKD-----------VYLVYELMDTDLHQIIK--SSQSLSNDHC 135
           D     +D M   H +   D           V +V+E++  +L  +IK    + +   + 
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 136 KYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN------CDLKICDFGLARTSRGNEQ 188
           K    QLL GL Y+H    I+H D+KP N+L+           +KI D G A      ++
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DE 190
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL------NQ 242
             T  + TR YR+PE+LL    +G   D+WS  C+  E++    +F   E        + 
Sbjct: 191 HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 243 LKLIISVFGTQQEADLEFIDNPK-ARRFIKSLPYSRGTHISSLYPQADPLA--------- 292
           +  II + G   E     + N K  R F  S    R       +P  D L          
Sbjct: 250 IAQIIELLG---ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 293 ----LDLLQKMLVFEPSKRITVTEALQHPYI 319
                D L  ML  +P KR      + HP++
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 10  GMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVV--C--SSINRETNEKVAIKKINN 65
           G+  RG H  T ++   E   K+  ++ +G+G +G V  C    +   T E VA+KK+ +
Sbjct: 13  GLVPRGSHNMTQFE---ERHLKF--LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH 67
Query: 66  VFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV--YLVYELMDTDLHQI 123
             E  +      RE+ +L+ ++HDN++  K V     R + K +  YL Y  +   L   
Sbjct: 68  STEEHLRDFE--REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-- 123
Query: 124 IKSSQSLSNDHCKYFVF--QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR 181
            K  + +  DH K   +  Q+ +G++YL +   +HRDL   N+LV     +KI DFGL +
Sbjct: 124 -KHKERI--DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 180
Query: 182 TSRGNEQFMTEYVVTR----WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
               +++             WY APE  L    +  + DVWS G +  E+ 
Sbjct: 181 VLPQDKEXXKVKEPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELF 229

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   ++       +    + L + H   I+HRD+KP N+L++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 169 NCDLKICDFGLAR--TSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR     GN    T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 210
Query: 226 EILGRKPIFPG 236
           E+L  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 10  GMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVV--C--SSINRETNEKVAIKKINN 65
           G+  RG H  T ++   E   K+  ++ +G+G +G V  C    +   T E VA+KK+ +
Sbjct: 13  GLVPRGSHNMTQFE---ERHLKF--LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH 67
Query: 66  VFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV--YLVYELMDTDLHQI 123
             E  +      RE+ +L+ ++HDN++  K V     R + K +  YL Y  +   L   
Sbjct: 68  STEEHLRDFE--REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-- 123
Query: 124 IKSSQSLSNDHCKYFVF--QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR 181
            K  + +  DH K   +  Q+ +G++YL +   +HRDL   N+LV     +KI DFGL +
Sbjct: 124 -KHKERI--DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 180
Query: 182 TSRGNEQFMTEYVVTR----WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
               +++             WY APE  L    +  + DVWS G +  E+ 
Sbjct: 181 VLPQDKEXXKVKEPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELF 229

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 76  C--TREPPF---YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 187
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               DVW+ G +  EI   G  P +PG +
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 59/302 (19%)
Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKH 88
           T + PI+ +GRG +GVV  + N+  +   AIK+I     NR +   + +RE+  L  ++H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLEH 62
Query: 89  DNVIALKDVMMPTHRI-----SFKDVYLVYELM---DTDLHQIIKSSQSLSNDH---CKY 137
             ++   +  +  +       S   VYL  ++      +L   +    ++       C +
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM------- 190
              Q+   +++LHS  ++HRDLKP N+    +  +K+ DFGL      +E+         
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 191 -----TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
                T  V T+ Y +PE  +  ++Y   +D++S+G I  E+L     +P          
Sbjct: 183 AYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL-----YP---------- 226
Query: 246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPS 305
               F TQ E              +++L   R      L+ Q  P    ++Q ML   P 
Sbjct: 227 ----FSTQMER-------------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 306 KR 307
           +R
Sbjct: 270 ER 271

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 83  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  EI   G  P +PG +     +L+
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 78  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPG 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 78  C--TREPPF---YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPG 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 78  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  EI   G  P +PG +     +L+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 34/210 (16%)
Query: 36  KPIGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       +     L E  +++ ++HD ++ L
Sbjct: 188 KKLGAGQFGEVWMATYNKHT--KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKL 242
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKY--FVFQLLRGLKYLHS 151
             V      ++ + +Y++ E M    L   +KS +       K   F  Q+  G+ ++  
Sbjct: 243 HAV------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 296
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL+  N+LV+A+   KI DFGLAR      +F  ++       APE +    N+
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARV---GAKFPIKWT------APEAI----NF 343
Query: 212 GT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           G+     DVWS G +  EI+  GR P +PG
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIP-YPG 372

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 78  C--TREPPF---YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  EI   G  P +PG +     +L+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 13  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 68
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 69  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 122
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 183 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 66  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 180 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 12  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 67
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 68  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 182 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 221

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 59
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 60  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 174 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +P+G+G +G V  +  ++    +A+K +  +  E      +  RE+ +  H++H N++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            +      RI     YL+ E     +L++ ++            F+ +L   L Y H   
Sbjct: 81  YNYFHDRKRI-----YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           ++HRD+KP NLL+    +LKI DFG +  +    +       T  Y  PE ++    +  
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RXMCGTLDYLPPE-MIEGKTHDE 192
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSL 273
            +D+W  G +  E L   P F         + I++V       DL+F             
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------DLKFP------------ 233
Query: 274 PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                       P     + DL+ K+L + P +R+ +   ++HP++  
Sbjct: 234 ------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   ++       +    + L + H   I+HRD+KP N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 169 NCDLKICDFGLAR--TSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR     GN    T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 210
Query: 226 EILGRKPIFPG 236
           E+L  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 42/292 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRGAYG V   +++ + + +A+K+I +  + +      +   V++R      ++     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHC-----KYFVFQLLRGLKYL-HS 151
           +         D ++  ELM T   +  K   S+ +D              ++ L +L  +
Sbjct: 90  LFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL---LCC 208
             I+HRD+KP N+L++ + ++K+CDFG++     +    T     R Y APE +      
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 209 DNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
             Y    DVWS+G    E+  GR P        +QL  ++       + D   + N + R
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-------KGDPPQLSNSEER 256
Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            F                    P  ++ +   L  + SKR    E L+HP+I
Sbjct: 257 EF-------------------SPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 14  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 69
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 70  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 123
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 184 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 41/194 (21%)
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLV---NANCDLK--ICDFGLART-SRGNEQFMTEYV 194
           Q   GL +LHS NI+HRDLKP N+L+   NA+  +K  I DFGL +  + G   F     
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 195 V--TRWYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF 250
           V  T  + APE+L   C +N   ++D++S GC+F  ++       G     Q  +++   
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG-- 243
Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA--DPLALDLLQKMLVFEPSKRI 308
                                         +  L+P+   D +A +L++KM+  +P KR 
Sbjct: 244 ---------------------------ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276
Query: 309 TVTEALQHPYISGL 322
           +    L+HP+   L
Sbjct: 277 SAKHVLKHPFFWSL 290

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   ++       +    + L + H   I+HRD+KP N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 169 NCDLKICDFGLAR--TSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR     GN    T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 210
Query: 226 EILGRKPIFPG 236
           E+L  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   ++       +    + L + H   I+HRD+KP N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 169 NCDLKICDFGLAR--TSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR     GN    T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 210
Query: 226 EILGRKPIFPG 236
           E+L  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 115 SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 285
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 286 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 319
Query: 315 QHPYI 319
            HPY+
Sbjct: 320 AHPYV 324

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 6   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 61
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 62  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 115
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 176 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   ++       +    + L + H   I+HRD+KP N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 169 NCDLKICDFGLAR--TSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR     GN    T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 210
Query: 226 EILGRKPIFPG 236
           E+L  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGLAR          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 87  SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 142 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 257
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 258 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 291
Query: 315 QHPYI 319
            HPY+
Sbjct: 292 AHPYV 296

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 83  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               DVW+ G +  EI   G  P +PG +
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 59
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 60  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 174 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 5   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 60
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 61  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 114
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 175 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 214

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 115 SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 285
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 286 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 319
Query: 315 QHPYI 319
            HPY+
Sbjct: 320 AHPYV 324

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 27  EIDTKYVPIKP-IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID  YV I+  IG G +G VC    +   +K   VAIK +   +  R      L E  +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 68
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +   +H N+I L+ V+  +  +     ++    +D+ L           ND  ++ V QL
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL---------NDG-QFTVIQL 118
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE------QF 189
           +        G++YL   + +HRDL   N+LVN+N   K+ DFGL+R    N         
Sbjct: 119 VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +   +  RW  APE  +    + ++ D WS G +  E++  G +P +
Sbjct: 179 LGGKIPIRW-TAPE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYW 223

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 83  C--TREPPF---YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               DVW+ G +  EI   G  P +PG +
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 79  C--TREPPF---YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 190
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               DVW+ G +  EI   G  P +PG +
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSP-YPGID 218

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 132/305 (43%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 87  SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTRWYRAPELL 205
            +H   I+H DLKP N L+  +  LK+ DFG+A   + +   + +   V T  Y  PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 206 LCCDN----------YGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
               +               DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 257
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 258 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 291
Query: 315 QHPYI 319
            HPY+
Sbjct: 292 AHPYV 296

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 65
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 66  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 180 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 82  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 193
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  EI   G  P +PG +     +L+
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 229

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 83  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPG 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 70
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 71  SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 126 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 241
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 242 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 275
Query: 315 QHPYI 319
            HPY+
Sbjct: 276 AHPYV 280

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 94/201 (46%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  ++ IG+G++G V   I+  T + VAIK I+ + E   +     +E+ +L       V
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                  +   ++     +++ E +       +  +           + ++L+GL YLHS
Sbjct: 84  TKYYGSYLKGSKL-----WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS 138
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++   D+K+ DFG+A      +     +V T ++ APE++     Y
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AY 197
Query: 212 GTSIDVWSVGCIFAEILGRKP 232
            +  D+WS+G    E+   +P
Sbjct: 198 DSKADIWSLGITAIELAKGEP 218

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 9   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 64
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 65  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 179 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   ++       +    + L + H   I+HRD+KP N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 169 NCDLKICDFGLAR--TSRGNEQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR     GN    T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 227
Query: 226 EILGRKPIFPG 236
           E+L  +P F G
Sbjct: 228 EVLTGEPPFTG 238

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 83  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPG 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 67
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 68  SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 123 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 238
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 239 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 272
Query: 315 QHPYI 319
            HPY+
Sbjct: 273 AHPYV 277

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 76  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 187
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP-YPG 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 73
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 128
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------WY 199
           +YL +   +HR+L   N+LV     +KI DFGL +    ++++   Y V         WY
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY---YKVKEPGESPIFWY 185
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
            APE  L    +  + DVWS G +  E+ 
Sbjct: 186 -APE-SLTESKFSVASDVWSFGVVLYELF 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G+G++G V  +  + T E  AIK  K + V ++       + + VL    K   +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 96  DVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                  R+     Y V E ++  DL   I+           ++  ++  GL +LH   I
Sbjct: 87  SCFQTVDRL-----YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RDLK  N+++++   +KI DFG+ +    +     E+  T  Y APE ++    YG S
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPE-IIAYQPYGKS 200
Query: 215 IDVWSVGCIFAEILGRKPIFPGTE 238
           +D W+ G +  E+L  +P F G +
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGED 224

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 78  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               DVW+ G +  EI   G  P +PG +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 66
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 67  SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 122 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 237
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 238 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 271
Query: 315 QHPYI 319
            HPY+
Sbjct: 272 AHPYV 276

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 97
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 98  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 210
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 249
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 250 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 292
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 293 NHPWMQDVLLPQ 304

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 91  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 202
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMSP-YPG 228

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 63
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 118
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 176
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 215
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 216 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 258
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 259 NHPWMQDVLLPQ 270

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 78  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               DVW+ G +  EI   G  P +PG +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +    +  +     L E 
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 59
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 60  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E     
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 174 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH- 88
           Y  +K IG G    V   +N E  +  AIK +N        +D+ R   E+  L  ++  
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 89  -DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            D +I L D     + I+ + +Y+V E  + DL+  +K  +S+     K +   +L  + 
Sbjct: 115 SDKIIRLYD-----YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGNEQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
                + E            DVWS+GCI +    G+ P     + +NQ+  + ++     
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNH 285
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E  +EF D P+     K L                    D+L+  L  +P +RI++ E L
Sbjct: 286 E--IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELL 319
Query: 315 QHPYI 319
            HPY+
Sbjct: 320 AHPYV 324

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 105
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 160
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 218
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 257
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 258 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 300
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 301 NHPWMQDVLLPQ 312

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 80  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 191
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP-YPG 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IK IGRGA+G            +VA+ K+ N    RI A++ L +  +L+  +       
Sbjct: 95  IKVIGRGAFG------------EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREE 140
Query: 95  KDVM-------MPTHRISFKDVYLVYELMD----TDLHQII-KSSQSLSNDHCKYFVFQL 142
           +DV+       +     +F+D   +Y +MD     DL  ++ K    L  D  ++++ ++
Sbjct: 141 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 200
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSRGNEQFMTEYVVTRWYR 200
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG  L     G  Q  +  V T  Y 
Sbjct: 201 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ-SSVAVGTPDYI 259
Query: 201 APELLLCCDN----YGTSIDVWSVG-CIFAEILGRKPIF 234
           +PE+L   ++    YG   D WS+G C++  + G  P +
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 80  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 191
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPG 236
               DVW+ G +  EI   G  P +PG
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP-YPG 217

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 63
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 118
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 176
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 215
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 216 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 258
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 259 NHPWMQDVLLPQ 270

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IK IGRGA+G            +VA+ K+ N    RI A++ L +  +L+  +       
Sbjct: 79  IKVIGRGAFG------------EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREE 124
Query: 95  KDVM-------MPTHRISFKDVYLVYELMD----TDLHQII-KSSQSLSNDHCKYFVFQL 142
           +DV+       +     +F+D   +Y +MD     DL  ++ K    L  D  ++++ ++
Sbjct: 125 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 184
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSRGNEQFMTEYVVTRWYR 200
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG  L     G  Q  +  V T  Y 
Sbjct: 185 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ-SSVAVGTPDYI 243
Query: 201 APELLLCCDN----YGTSIDVWSVG-CIFAEILGRKPIF 234
           +PE+L   ++    YG   D WS+G C++  + G  P +
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEXMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 78
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 133
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 191
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 230
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 231 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 273
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 274 NHPWMQDVLLPQ 285

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 58
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 113
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 171
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 210
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 211 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 253
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 254 NHPWMQDVLLPQ 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 77
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 78  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 132
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 190
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 229
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 230 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 272
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 273 NHPWMQDVLLPQ 284

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 62
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 117
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 175
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 214
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 215 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 257
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 258 NHPWMQDVLLPQ 269

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 61
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 116
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 117 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 174
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 213
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 214 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 256
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 257 NHPWMQDVLLPQ 268

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 63
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 118
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 176
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 215
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 216 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 258
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 259 NHPWMQDVLLPQ 270

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 90
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 203
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 242
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I   + + F +    S   H              L++  L   PS R T  E  
Sbjct: 243 EHDEEII---RGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 285
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 286 NHPWMQDVLLPQ 297

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 11/239 (4%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG++  V   ++ ET  +VA  ++ +    + +  R   E   L+ ++H N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 98  MMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--I 154
              T +   K + LV EL  +  L   +K  +       + +  Q+L+GL++LH+    I
Sbjct: 94  WESTVK-GKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 155 LHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT 213
           +HRDLK  N+ +      +KI D GLA   R +  F    + T  + APE     + Y  
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFXAPEXYE--EKYDE 208
Query: 214 SIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
           S+DV++ G    E    +  +P +EC N  ++   V    + A  + +  P+ +  I+ 
Sbjct: 209 SVDVYAFGXCXLEXATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 75
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKY 148
           ++  K V     R + K   L+ E +     +    + +   DH K   +  Q+ +G++Y
Sbjct: 76  IVKYKGVCYSAGRRNLK---LIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAPEL 204
           L +   +HRDL   N+LV     +KI DFGL +    +++             WY APE 
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE- 190
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
            L    +  + DVWS G +  E+ 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  +  IG+G++G V   I+  T E VAIK I ++ E   +     +E+ +L       +
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                  + + ++     +++ E +       +     L   +    + ++L+GL YLHS
Sbjct: 80  TRYFGSYLKSTKL-----WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHS 134
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++   D+K+ DFG+A      +     +V T ++ APE++     Y
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS-AY 193
Query: 212 GTSIDVWSVGCIFAEILGRKP 232
               D+WS+G    E+   +P
Sbjct: 194 DFKADIWSLGITAIELAKGEP 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 68
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEXMENG------SLDSFLRKHDAQFTV 117
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 118 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 178 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 6/192 (3%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G++G V  +    ++  V I    +    R++    LRE+ +++ ++H N++     
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF--LREVAIMKRLRHPNIVLFMGA 102
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--IL 155
           +     +S    YL    +   LH+   + + L         + + +G+ YLH+ N  I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           HRDLK  NLLV+    +K+CDFGL+R              T  + APE+L    +   S 
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 216 DVWSVGCIFAEI 227
           DV+S G I  E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEXMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 103
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 158
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 217
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 218 E-SLTESKFSVASDVWSFGVVLYELF 242

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D    L E 
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD---FLGEA 85
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 134
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 135 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 195 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 240

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 68
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 117
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 118 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 178 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 130/293 (44%), Gaps = 47/293 (16%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  ++ IG+G++G V   I+  T + VAIK I ++ E   +     +E+ +L       V
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 92  IA-----LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
                  LKD  +          +++ E +       +     L        + ++L+GL
Sbjct: 83  TKYYGSYLKDTKL----------WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGL 132
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            YLHS   +HRD+K  N+L++ + ++K+ DFG+A      +     +V T ++ APE++ 
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK 192
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
               Y +  D+WS+G    E+   +P  P +E L+ +K++  +            +NP  
Sbjct: 193 QS-AYDSKADIWSLGITAIELARGEP--PHSE-LHPMKVLFLIPK----------NNP-- 236
Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                  P   G +       + PL  + ++  L  EPS R T  E L+H +I
Sbjct: 237 -------PTLEGNY-------SKPLK-EFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 70
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K V     R + K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 127
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAPEL 204
           L +   +HRDL   N+LV     +KI DFGL +    +++             WY APE 
Sbjct: 128 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE- 185
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
            L    +  + DVWS G +  E+ 
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELF 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ +G G +G V        + KVA+K +    +  +     L E  L++ ++H  ++ L
Sbjct: 13  VERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRL 68
Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHS 151
             V      ++ + +Y++ E M+   L   +K  S   L+ +       Q+  G+ ++  
Sbjct: 69  YAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+     KI DFGLAR    NE    E      +W  APE +    
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEAI---- 177
Query: 210 NYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 72
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 127
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 186
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 187 E-SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 95
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 144
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T
Sbjct: 145 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 205 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 250

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 18  LRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 75
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKY 148
           ++  K V     R + K   L+ E +     +          DH K   +  Q+ +G++Y
Sbjct: 76  IVKYKGVCYSAGRRNLK---LIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAPEL 204
           L +   +HRDL   N+LV     +KI DFGL +    +++             WY APE 
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE- 190
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
            L    +  + DVWS G +  E+ 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 75
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 130
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 189
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 190 E-SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 129/288 (44%), Gaps = 37/288 (12%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  ++ IG+G++G V   I+  T + VAIK I ++ E   +     +E+ +L       V
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                  +   ++     +++ E +       +     L        + ++L+GL YLHS
Sbjct: 68  TKYYGSYLKDTKL-----WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A      +     +V T ++ APE++     Y
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS-AY 181
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
            +  D+WS+G    E+   +P  P +E L+ +K++  +            +NP       
Sbjct: 182 DSKADIWSLGITAIELARGEP--PHSE-LHPMKVLFLIPK----------NNP------- 221
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             P   G +       + PL  + ++  L  EPS R T  E L+H +I
Sbjct: 222 --PTLEGNY-------SKPLK-EFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 21  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 78
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 133
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 192
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 193 E-SLTESKFSVASDVWSFGVVLYELF 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 19  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 76
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K V     R + K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 133
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAPEL 204
           L +   +HRDL   N+LV     +KI DFGL +    +++             WY APE 
Sbjct: 134 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE- 191
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
            L    +  + DVWS G +  E+ 
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELF 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 42/231 (18%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID   + I K IG G +G VCS   +   ++   VAIK +   + ++      L E  +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 83
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H N+I L+ V+        K V ++ E M+            L  +  ++ V QL
Sbjct: 84  MGQFDHPNIIHLEGVVTKC-----KPVMIITEYMENGSLDAF-----LRKNDGRFTVIQL 133
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSRG 185
           +        G+KYL   + +HRDL   N+LVN+N   K+ DFG++R          T+RG
Sbjct: 134 VGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
            +      +  RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 194 GK------IPIRWT-APE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 236

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 71
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K V     R + K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 128
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAPEL 204
           L +   +HRDL   N+LV     +KI DFGL +    +++             WY APE 
Sbjct: 129 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE- 186
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
            L    +  + DVWS G +  E+ 
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELF 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 48/234 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDH-CKYFV 139
            ++    H N+I L+ V+  +     K V +V E M+        S  S    H  ++ V
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENG------SLDSFLRKHDAQFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------T 182
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL R          T
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           +RG +      +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGK------IPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 129/288 (44%), Gaps = 37/288 (12%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  ++ IG+G++G V   I+  T + VAIK I ++ E   +     +E+ +L       V
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                  +   ++     +++ E +       +     L        + ++L+GL YLHS
Sbjct: 68  TKYYGSYLKDTKL-----WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A      +     +V T ++ APE++     Y
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AY 181
Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
            +  D+WS+G    E+   +P  P +E L+ +K++  +            +NP       
Sbjct: 182 DSKADIWSLGITAIELARGEP--PHSE-LHPMKVLFLIPK----------NNP------- 221
Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             P   G +       + PL  + ++  L  EPS R T  E L+H +I
Sbjct: 222 --PTLEGNY-------SKPLK-EFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 20  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 77
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 132
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 191
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 192 E-SLTESKFSVASDVWSFGVVLYELF 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 22  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 79
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 134
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 193
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 194 E-SLTESKFSVASDVWSFGVVLYELF 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q +S     Y   Q+   ++YL   N 
Sbjct: 285 C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HR+L   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 396
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  EI   G  P +PG +     +L+
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 432

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 109/238 (45%), Gaps = 57/238 (23%)
Query: 109 VYLVYELMDTDLHQIIKSSQSLSNDHCK----YFVFQLLR----GLKYLHSANILHRDLK 160
           +Y+  EL + +L  +++S +++S+++ K    Y    LLR    G+ +LHS  I+HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 161 PGNLLVNA-------------NCDLKICDFGLART-SRGNEQF---MTEYVVTRWYRAPE 203
           P N+LV+              N  + I DFGL +    G   F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 204 LL--LCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           LL          SID++S+GC+F  IL  G+ P                 FG +   +  
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP-----------------FGDKYSRESN 263
Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            I      R I SL   +  H  SL  +    A DL+ +M+  +P KR T  + L+HP
Sbjct: 264 II------RGIFSLDEMKCLHDRSLIAE----ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 109/238 (45%), Gaps = 57/238 (23%)
Query: 109 VYLVYELMDTDLHQIIKSSQSLSNDHCK----YFVFQLLR----GLKYLHSANILHRDLK 160
           +Y+  EL + +L  +++S +++S+++ K    Y    LLR    G+ +LHS  I+HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 161 PGNLLVNA-------------NCDLKICDFGLART-SRGNEQF---MTEYVVTRWYRAPE 203
           P N+LV+              N  + I DFGL +    G   F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 204 LL--LCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           LL          SID++S+GC+F  IL  G+ P                 FG +   +  
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP-----------------FGDKYSRESN 263
Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            I      R I SL   +  H  SL  +    A DL+ +M+  +P KR T  + L+HP
Sbjct: 264 II------RGIFSLDEMKCLHDRSLIAE----ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++ +G+G +G V  C    +   T E VA+KK+ +  E  +      RE+ +L+ ++HDN
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 72
Query: 91  VIALKDVMMPTHRISFKDV--YLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGL 146
           ++  K V     R + K +  YL Y  +   L    K  + +  DH K   +  Q+ +G+
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERI--DHIKLLQYTSQICKGM 127
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR----WYRAP 202
           +YL +   +HRDL   N+LV     +KI DFGL +    +++             WY AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-AP 186
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E  L    +  + DVWS G +  E+ 
Sbjct: 187 E-SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  ++ IG+G++G V   I+  T + VAIK I+ + E   +     +E+ +L       V
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
                  +   ++     +++ E +       +     L        + ++L+GL YLHS
Sbjct: 88  TKYYGSYLKDTKL-----WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A      +     +V T ++ APE++     Y
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AY 201
Query: 212 GTSIDVWSVGCIFAEILGRKP 232
            +  D+WS+G    E+   +P
Sbjct: 202 DSKADIWSLGITAIELARGEP 222

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 85
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 86  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 140
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 141 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 198
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 38/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFLTL 147
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  ++ +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 208 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 58
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 113
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 171
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 210
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I     + F +    S   H              L++  L   PS R T  E  
Sbjct: 211 EHDEEII---GGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 253
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 254 NHPWMQDVLLPQ 265

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 91
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 204
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 243
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I     + F +    S   H              L++  L   PS R T  E  
Sbjct: 244 EHDEEII---GGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 286
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 287 NHPWMQDVLLPQ 298

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 38/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFLTL 184
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  ++ +
Sbjct: 185 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 245 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 292

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 133/291 (45%), Gaps = 57/291 (19%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G GAYG V             ++KI+     ++ A++ L++  +++  K       
Sbjct: 59  LKVLGTGAYGKV-----------FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 107
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQII------------KSSQSLSNDHCKYFVFQ 141
           +  ++   R S   V L Y    +T LH I+               +  +    + +V +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-QFMTEYVVTRWYR 200
           ++  L++LH   I++RD+K  N+L+++N  + + DFGL++    +E +   ++  T  Y 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           AP+++   D+ +  ++D WS+G +  E+L G  P     E  +Q ++             
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------- 274
Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRI 308
                  +RR +KS P          YPQ    LA DL+Q++L+ +P KR+
Sbjct: 275 -------SRRILKSEPP---------YPQEMSALAKDLIQRLLMKDPKKRL 309

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 79  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL   N LV  N  +K+ DFGL+R   G+            +W  APE  L  + + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPE-SLAYNKFS 191
Query: 213 TSIDVWSVGCIFAEI--LGRKPIFPG 236
              DVW+ G +  EI   G  P +PG
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSP-YPG 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 42/231 (18%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID   + I K IG G +G VCS   +   ++   VAIK +   + ++      L E  +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 68
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H N+I L+ V+        K V ++ E M+            L  +  ++ V QL
Sbjct: 69  MGQFDHPNIIHLEGVVTKC-----KPVMIITEYMENGSLDAF-----LRKNDGRFTVIQL 118
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSRG 185
           +        G+KYL   + +HRDL   N+LVN+N   K+ DFG++R          T+RG
Sbjct: 119 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
            +      +  RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 179 GK------IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 221

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 9/204 (4%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G+G++G V  S  + T+E  A+K  K + V ++       + + VL    K   +  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 96  DVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                  R+     Y V E ++  DL   I+        H  ++  ++  GL +L S  I
Sbjct: 88  SCFQTMDRL-----YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RDLK  N+++++   +KI DFG+ + +  +      +  T  Y APE ++    YG S
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE-IIAYQPYGKS 201
Query: 215 IDVWSVGCIFAEILGRKPIFPGTE 238
           +D W+ G +  E+L  +  F G +
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGED 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 90
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 203
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 242
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I     + F +    S   H              L++  L   PS R T  E  
Sbjct: 243 EHDEEII---GGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 285
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 286 NHPWMQDVLLPQ 297

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 38/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTL 138
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  ++ +
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 199 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 90
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 203
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 242
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I     + F +    S   H              L++  L   PS R T  E  
Sbjct: 243 EHDEEII---GGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 285
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 286 NHPWMQDVLLPQ 297

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 78
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 133
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 191
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 91
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 204
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQ 254
           TR Y  PE +     +G S  VWS+G +  +++ G  P                      
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--------------------- 243
Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E D E I     + F +    S   H              L++  L   PS R T  E  
Sbjct: 244 EHDEEII---GGQVFFRQRVSSECQH--------------LIRWCLALRPSDRPTFEEIQ 286
Query: 315 QHPYISGLYDPQ 326
            HP++  +  PQ
Sbjct: 287 NHPWMQDVLLPQ 298

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 38/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFLTL 138
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  ++ +
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 199 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 42/231 (18%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID   + I K IG G +G VCS   +   ++   VAIK +   + ++      L E  +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 62
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H N+I L+ V+        K V ++ E M+            L  +  ++ V QL
Sbjct: 63  MGQFDHPNIIHLEGVVTKC-----KPVMIITEYMENGSLDAF-----LRKNDGRFTVIQL 112
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSRG 185
           +        G+KYL   + +HRDL   N+LVN+N   K+ DFG++R          T+RG
Sbjct: 113 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
            +      +  RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 173 GK------IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 215

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 78
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 133
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 191
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 49/241 (20%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRIDALRTLREL 80
           EI+   + I + IG G +G VCS   +   ++   VAIK  K+    + R D    L E 
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD---FLGEA 74
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF 140
            ++    H N+I L+ V+  +  +     Y+    +DT L +         ND  ++ V 
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK---------NDG-QFTVI 124
Query: 141 QLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TS 183
           QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R          T+
Sbjct: 125 QLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
Query: 184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLN 241
           RG +      +  RW  APE  +    + ++ DVWS G +  E++  G +P +   E  N
Sbjct: 185 RGGK------IPIRW-TAPE-AIAFRKFTSASDVWSYGIVMWEVVSYGERPYW---EMTN 233
Query: 242 Q 242
           Q
Sbjct: 234 Q 234

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 105
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 160
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 218
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 80  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL   N LV  N  +K+ DFGL+R   G+            +W  APE  L  + + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPE-SLAYNKFS 192
Query: 213 TSIDVWSVGCIFAEI--LGRKPIFPG 236
              DVW+ G +  EI   G  P +PG
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSP-YPG 217

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 77
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 78  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 132
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 190
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 58
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 113
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 114 SFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 171
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 91
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 204
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 91
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 204
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 14/206 (6%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHR 157
                       Y+ Y  +   L +   + + ++     Y   Q+   ++YL   N +HR
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLREC--NREEVTAVVLLYMATQISSAMEYLEKKNFIHR 154
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNYGTS 214
           DL   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +   
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNTFSIK 211
Query: 215 IDVWSVGCIFAEI--LGRKPIFPGTE 238
            DVW+ G +  EI   G  P +PG +
Sbjct: 212 SDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 110
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 111 VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 165
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 166 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 223
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           W+  +E+  + +  ++ +G G  G V        + KVA+K +    +  +     L E 
Sbjct: 4   WEDAWEVPRETLKLVERLGAGQAGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEA 59
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
            L++ ++H  ++ L  V      ++ + +Y++ E M+   L   +K  S   L+ +    
Sbjct: 60  NLMKQLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFM 190
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR       T+R   +F 
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 191 TEYVVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
            ++       APE +    NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 174 IKWT------APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLREL 80
           ++++Y     +G G +G V S I    N  VAIK +    ++RI       +  R   E+
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEV 90
Query: 81  VLLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCK 136
           VLL+ +      VI L D              L+ E  +   DL   I    +L  +  +
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVV 195
            F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +  +   T++  
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 203
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 6/192 (3%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IG G++G V  +    ++  V I    +    R++    LRE+ +++ ++H N++     
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF--LREVAIMKRLRHPNIVLFMGA 102
Query: 98  MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--IL 155
           +     +S    YL    +   LH+   + + L         + + +G+ YLH+ N  I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           HR+LK  NLLV+    +K+CDFGL+R              T  + APE+L    +   S 
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 216 DVWSVGCIFAEI 227
           DV+S G I  E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDN---VIA 93
           IGRG +G V      +T +  A+K ++    + +      L E ++L  +   +   ++ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           +        ++SF     + +LM+  DLH  +      S    +++  +++ GL+++H+ 
Sbjct: 257 MSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +++RDLKP N+L++ +  ++I D GLA      +   +  V T  Y APE+L     Y 
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYD 369
Query: 213 TSIDVWSVGCIFAEIL-GRKPI 233
           +S D +S+GC+  ++L G  P 
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDN---VIA 93
           IGRG +G V      +T +  A+K ++    + +      L E ++L  +   +   ++ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           +        ++SF     + +LM+  DLH  +      S    +++  +++ GL+++H+ 
Sbjct: 257 MSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +++RDLKP N+L++ +  ++I D GLA      +   +  V T  Y APE+L     Y 
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYD 369
Query: 213 TSIDVWSVGCIFAEIL-GRKPI 233
           +S D +S+GC+  ++L G  P 
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 32/225 (14%)
Query: 27  EIDTKYVPIKP-IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID   V I+  IG G +G VCS   +   ++   VAIK + + +  +      L E  +
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 87
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H NVI L+ V+  +  +     ++    +D+ L Q         ND  ++ V QL
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---------NDG-QFTVIQL 137
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN------EQF 189
           +        G+KYL   N +HRDL   N+LVN+N   K+ DFGL+R    +         
Sbjct: 138 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           +   +  RW  APE +     + ++ DVWS G +  E++  G +P
Sbjct: 198 LGGKIPIRW-TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ I+H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 188
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +G V       +  KVA+K +       +     L E  L++ ++HD ++ L
Sbjct: 18  VKRLGAGQFGEVWMGYYNNST-KVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRL 73
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKYLHS 151
             V+     I     Y++ E M    L   +KS +       K   F  Q+  G+ Y+  
Sbjct: 74  YAVVTREEPI-----YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+ +   KI DFGLAR    NE    E      +W  APE +    
Sbjct: 129 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 183
Query: 210 NYG---TSIDVWSVGCIFAEIL--GRKPIFPG 236
           N+G      DVWS G +  EI+  G+ P +PG
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIP-YPG 214

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +G V       +  KVA+K +       +     L E  L++ ++HD ++ L
Sbjct: 17  VKKLGAGQFGEVWMGYYNNST-KVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRL 72
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKYLHS 151
             V+     I     Y++ E M    L   +KS +       K   F  Q+  G+ Y+  
Sbjct: 73  YAVVTKEEPI-----YIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+ +   KI DFGLAR    NE    E      +W  APE +    
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 182
Query: 210 NYG---TSIDVWSVGCIFAEIL--GRKPIFPG 236
           N+G      +VWS G +  EI+  G+ P +PG
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIP-YPG 213

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ +G G +G V        + KVA+K +    +  +     L E  L++ ++H  ++ L
Sbjct: 14  VERLGAGQFGEVWMGY-YNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRL 69
Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHS 151
             V      ++ + +Y++ E M+   L   +K  S   L+ +       Q+  G+ ++  
Sbjct: 70  YAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCD 209
            N +HR+L+  N+LV+     KI DFGLAR    NE    E      +W  APE +    
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEAI---- 178
Query: 210 NYGT---SIDVWSVGCIFAEIL--GRKPIFPG 236
           NYGT     DVWS G +  EI+  GR P +PG
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 209

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDN---VIA 93
           IGRG +G V      +T +  A+K ++    + +      L E ++L  +   +   ++ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           +        ++SF     + +LM+  DLH  +      S    +++  +++ GL+++H+ 
Sbjct: 257 MSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +++RDLKP N+L++ +  ++I D GLA      +   +  V T  Y APE+L     Y 
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYD 369
Query: 213 TSIDVWSVGCIFAEIL-GRKPI 233
           +S D +S+GC+  ++L G  P 
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDN---VIA 93
           IGRG +G V      +T +  A+K ++    + +      L E ++L  +   +   ++ 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
           +        ++SF     + +LM+  DLH  +      S    +++  +++ GL+++H+ 
Sbjct: 256 MSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 310
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            +++RDLKP N+L++ +  ++I D GLA      +   +  V T  Y APE+L     Y 
Sbjct: 311 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYD 368
Query: 213 TSIDVWSVGCIFAEIL-GRKPI 233
           +S D +S+GC+  ++L G  P 
Sbjct: 369 SSADWFSLGCMLFKLLRGHSPF 390

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ IKH N++ L  V
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 98  MMPTHRISFKDVYLVYELMD-TDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
              T    F   Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 324 C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HR+L   N LV  N  +K+ DFGL+R   G+    T +   ++   + APE  L  + +
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 435
Query: 212 GTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  EI   G  P +PG +     +L+
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 471

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 36  KPIGRGAYGVVCSSINRETNEK----VAIKKINNVF--ENRIDALRTLRELVLLRHIKHD 89
           K IG G +G V   + + ++ K    VAIK +   +  + R+D    L E  ++    H 
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD---FLGEAGIMGQFSHH 106
Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLL------ 143
           N+I L+ V+       +K + ++ E M+          + L     ++ V QL+      
Sbjct: 107 NIIRLEGVIS-----KYKPMMIITEYMENGALD-----KFLREKDGEFSVLQLVGMLRGI 156
Query: 144 -RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTE--YVVTRW 198
             G+KYL + N +HRDL   N+LVN+N   K+ DFGL+R    + +  + T    +  RW
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
             APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 217 -TAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 9/204 (4%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G+G++G V  S  + T+E  A+K  K + V ++       + + VL    K   +  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 96  DVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                  R+     Y V E ++  DL   I+        H  ++  ++  GL +L S  I
Sbjct: 409 SCFQTMDRL-----YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RDLK  N+++++   +KI DFG+ + +  +      +  T  Y APE ++    YG S
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE-IIAYQPYGKS 522
Query: 215 IDVWSVGCIFAEILGRKPIFPGTE 238
           +D W+ G +  E+L  +  F G +
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGED 546

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 38/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFLTL 147
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +   + +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 208 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 48/237 (20%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFLTL 138
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSR 184
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR          +
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           G+ +   +++      APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 199 GDARLPLKWM------APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 48/237 (20%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTL 138
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSR 184
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR          +
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           G+ +   +++      APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 199 GDARLPLKWM------APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 38/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y+    DL++       L+ 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-----LTL 149
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  ++ +
Sbjct: 150 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 210 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 257

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 19  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 75  ------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 128
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 181
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 222

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 48/237 (20%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y++   DL++       L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFLTL 147
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSR 184
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR          +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 185 GNEQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           G+ +   +++      APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 208 GDARLPLKWM------APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 61/299 (20%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL-LRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I  +  Q+ +       +  + 
Sbjct: 69  QCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ + G               
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--------------- 172
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
                   + Y  S D+WS+G I   +L   P F     L     I     T+       
Sbjct: 173 --------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQYE 220
Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             NP+                   + +       L++ +L  EP++R+T+TE + HP+I
Sbjct: 221 FPNPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 23  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M+   L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 79  ------VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT------APEAAL- 185
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 226

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 188
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 23  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M+   L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 79  ------VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 185
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 226

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 17  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 73  ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 126
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 179
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 220

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 15  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 71  ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 124
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 177
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 218

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/353 (21%), Positives = 147/353 (41%), Gaps = 75/353 (21%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLR-EL 80
           W+    ++  ++ I+ +G G +G V    + +  +  A+K + N+ +      R+ + E 
Sbjct: 27  WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEA 82
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYF 138
            +L+ I++D++     V      + +  + L++E +   L++II  +       +  K +
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLY 142
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVN-------------------------ANCDLK 173
             ++L+ L YL   ++ H DLKP N+L++                          +  +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 174 ICDFGLARTSRGNEQFMTEY----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG 229
           + DFG A        F ++Y    + TR YRAPE++L    +  S D+WS GC+ AE+  
Sbjct: 203 LIDFGCA-------TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254
Query: 230 RKPIFPGTECLNQLKLIISV-------------------FGTQQEADLEFIDNPKARRFI 270
              +F   E +  L ++ S+                   +  + E  L + +N  +   I
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 271 KSLPYSRGTHISSLYPQ----ADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           K        H+    P        L  D L  +L  +P+ R +  E L+H ++
Sbjct: 315 K--------HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 28/206 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVI---A 93
           +G+GA   V    +++T +  AIK  NN+ F   +D    +RE  +L+ + H N++   A
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFA 74
Query: 94  LKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVF--QLLRGLKYL 149
           +++     H++      L+ E      L+ +++  S +      ++ +    ++ G+ +L
Sbjct: 75  IEEETTTRHKV------LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 150 HSANILHRDLKPGNLL----VNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL- 204
               I+HR++KPGN++     +     K+ DFG AR    +EQF++ Y  T  Y  P++ 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMY 187
Query: 205 ---LLCCDN---YGTSIDVWSVGCIF 224
              +L  D+   YG ++D+WS+G  F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDTD-LHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDTD-LHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 25  LFEIDTKYVPIKPI-GRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELV 81
           L EID   + ++ I G G +G V  +  I  E   K A    +      I+ +R  +E  
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVR--QEAK 58
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L   +KH N+IAL+ V +        ++ LV E         + S + +  D    +  Q
Sbjct: 59  LFAMLKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ 113
Query: 142 LLRGLKYLHSANI---LHRDLKPGNLLV--------NANCDLKICDFGLARTSRGNEQFM 190
           + RG+ YLH   I   +HRDLK  N+L+         +N  LKI DFGLAR      + M
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-M 172
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
           +      W  APE++     +    DVWS G +  E+L  +  F G + L
Sbjct: 173 SAAGAYAWM-APEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 192 LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 248 ------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 354
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 395

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 82  ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL   N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 275 LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 331 ------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 437
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 478

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 192 LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 248 ------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 354
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 395

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  ++H N++ L
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 80  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + +   +   T  +  +W  APE L     +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 191
Query: 212 GTSIDVWSVGCIFAEI--LGRKP 232
            T  DVWS G +  EI   GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG +G V S   R  N  VA+K         + A + L+E  +L+   H N++ L  V
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 180
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLHSANIL 155
                    + +Y+V EL+   D    +++  + L        V     G++YL S   +
Sbjct: 181 CTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT---EYVVTRWYRAPELLLCCDNYG 212
           HRDL   N LV     LKI DFG++R         +     V  +W  APE L    NYG
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPEAL----NYG 290
Query: 213 ---TSIDVWSVGCIFAEI--LGRKP 232
              +  DVWS G +  E   LG  P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP 315

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  ++H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 252 LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + +   +   T  +  +W  APE L     +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 363
Query: 212 GTSIDVWSVGCIFAEI--LGRKP 232
            T  DVWS G +  EI   GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  ++H N++ L
Sbjct: 17  LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 71  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + +   +   T  +  +W  APE L     +
Sbjct: 127 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALREA-AF 182
Query: 212 GTSIDVWSVGCIFAEI--LGRKP 232
            T  DVWS G +  EI   GR P
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVP 205

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 129/290 (44%), Gaps = 41/290 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G  G V    +R T +K A+K + +  + R +     +           +++ + DV
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA------SGGPHIVCILDV 90
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
               H    + + ++ E M+  +L   I  +  Q+ +       +  +   +++LHS NI
Sbjct: 91  YENMHH-GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 155 LHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            HRD+KP NLL  +   +  LK+ DFG A+ +  N   +     T +Y APE +L  + Y
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKY 206
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
             S D+WS+G I   +L G  P +  T         IS               P  +R I
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNT------GQAIS---------------PGMKRRI 245
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           +   Y      +  + +    A  L++ +L  +P++R+T+T+ + HP+I+
Sbjct: 246 RLGQYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E  +L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTD-----LHQIIKSSQSLSNDHCKYFVFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA   +  +     Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           L  + Y  S+D +++G    E++  +  F
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E  +L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTD-----LHQIIKSSQSLSNDHCKYFVFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA   +  +     Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           L  + Y  S+D +++G    E++  +  F
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
           I+ +G G +G V  C        T E+VA+K +      N I  L+  +E+ +LR++ H+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHE 83
Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSN--DHCKYFVFQLLRGL 146
           N++  K +         K   L+ E + +  L + +  +++  N     KY V Q+ +G+
Sbjct: 84  NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGM 139
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT----EYVVTRWYRAP 202
            YL S   +HRDL   N+LV +   +KI DFGL +    +++  T          WY AP
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 198
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E L+    Y  S DVWS G    E+L
Sbjct: 199 ECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 129/290 (44%), Gaps = 41/290 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G  G V    +R T +K A+K + +  + R +     +           +++ + DV
Sbjct: 18  LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA------SGGPHIVCILDV 71
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
               H    + + ++ E M+  +L   I  +  Q+ +       +  +   +++LHS NI
Sbjct: 72  YENMHH-GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 130
Query: 155 LHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            HRD+KP NLL  +   +  LK+ DFG A+ +  N   +     T +Y APE +L  + Y
Sbjct: 131 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKY 187
Query: 212 GTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
             S D+WS+G I   +L G  P +  T         IS               P  +R I
Sbjct: 188 DKSCDMWSLGVIMYILLCGFPPFYSNT------GQAIS---------------PGMKRRI 226
Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           +   Y      +  + +    A  L++ +L  +P++R+T+T+ + HP+I+
Sbjct: 227 RLGQYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 273

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 192 LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 248 ------VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+R   +F  ++       APE  L 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 354
Query: 208 CDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 395

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E  +L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTD-----LHQIIKSSQSLSNDHCKYFVFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA   +  +     Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           L  + Y  S+D +++G    E++  +  F
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-TLRELVLLRHIKHDN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E  +L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTD-----LHQIIKSSQSLSNDHCKYFVFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA   +  +     Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
           L  + Y  S+D +++G    E++  +  F
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y+ +  D          L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF---------LTL 143
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  ++ +
Sbjct: 144 EHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 204 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 251

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTLRELVLLRHIKHDNVI---A 93
           +G+GA   V    +++T +  AIK  NN+ F   +D    +RE  +L+ + H N++   A
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFA 74
Query: 94  LKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVF--QLLRGLKYL 149
           +++     H++      L+ E      L+ +++  S +      ++ +    ++ G+ +L
Sbjct: 75  IEEETTTRHKV------LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 150 HSANILHRDLKPGNLL----VNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL- 204
               I+HR++KPGN++     +     K+ DFG AR    +EQF+  Y  T  Y  P++ 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY-GTEEYLHPDMY 187
Query: 205 ---LLCCDN---YGTSIDVWSVGCIF 224
              +L  D+   YG ++D+WS+G  F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  ++H N++ L
Sbjct: 11  LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 95  KDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + +   +   T  +  +W  APE L     +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 176
Query: 212 GTSIDVWSVGCIFAEI--LGRKP 232
            T  DVWS G +  EI   GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG +G V S   R  N  VA+K         + A + L+E  +L+   H N++ L  V
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 180
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLHSANIL 155
                    + +Y+V EL+   D    +++  + L        V     G++YL S   +
Sbjct: 181 CTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT---EYVVTRWYRAPELLLCCDNYG 212
           HRDL   N LV     LKI DFG++R         +     V  +W  APE L    NYG
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPEAL----NYG 290
Query: 213 ---TSIDVWSVGCIFAEI--LGRKP 232
              +  DVWS G +  E   LG  P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP 315

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 32/230 (13%)
Query: 27  EIDTKYVPIKP-IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID   V I+  IG G +G VCS   +   ++   VAIK + + +  +      L E  +
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 61
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H NVI L+ V+  +  +     ++    +D+ L Q         ND  ++ V QL
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---------NDG-QFTVIQL 111
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN------EQF 189
           +        G+KYL   N +HR L   N+LVN+N   K+ DFGL+R    +         
Sbjct: 112 VGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT 237
           +   +  RW  APE +     + ++ DVWS G +  E++  G +P +  T
Sbjct: 172 LGGKIPIRW-TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 219

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
           I+ +G G +G V  C        T E+VA+K +      N I  L+  +E+ +LR++ H+
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHE 71
Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSN--DHCKYFVFQLLRGL 146
           N++  K +         K   L+ E + +  L + +  +++  N     KY V Q+ +G+
Sbjct: 72  NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGM 127
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT----EYVVTRWYRAP 202
            YL S   +HRDL   N+LV +   +KI DFGL +    +++  T          WY AP
Sbjct: 128 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 186
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL 228
           E L+    Y  S DVWS G    E+L
Sbjct: 187 ECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 53/88 (60%), Gaps = 2/88 (2%)
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           Q+ +G+ Y+HS  ++HRDLKP N+ +     +KI DFGL  TS  N+   T    T  Y 
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRTRSKGTLRYM 202
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEIL 228
           +PE +   D YG  +D++++G I AE+L
Sbjct: 203 SPEQISSQD-YGKEVDLYALGLILAELL 229

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 61/107 (57%), Gaps = 10/107 (9%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           + FQ+ RG+++L S   +HRDL   N+L++ N  +KICDFGLAR    N  ++ +    +
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
             +W  APE +   D  Y T  DVWS G +  EI  LG  P +PG +
Sbjct: 264 PLKWM-APESIF--DKIYSTKSDVWSYGVLLWEIFSLGGSP-YPGVQ 306

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 107/219 (48%), Gaps = 34/219 (15%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K IGRGA+G            +VA+ K+ N   +++ A++ L +  +L+  +       
Sbjct: 79  LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 124
Query: 95  KDVM-------MPTHRISFKDVYLVYELMD----TDLHQII-KSSQSLSNDHCKYFVFQL 142
           +DV+       + T   +F+D   +Y +MD     DL  ++ K    L  +  ++++ ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSRGNEQFMTEYVVTRWYR 200
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG  L     G  Q  +  V T  Y 
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 243
Query: 201 APELLLCCDN----YGTSIDVWSVG-CIFAEILGRKPIF 234
           +PE+L   +     YG   D WS+G C++  + G  P +
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 16  LGQGCFGEVWMGTWNGTT-RVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + + +V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 72  ------VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 125
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  APE  L    + 
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YGRFT 183
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 184 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 219

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSS---INRETNEKVAIK--KINNVFENRIDALRTLREL 80
           E+D   + I + IG G +G VCS    +  + +  VAIK  K+    + R D    L E 
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD---FLCEA 95
Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF 140
            ++    H NV+ L+ V+        K V +V E M+            L     ++ V 
Sbjct: 96  SIMGQFDHPNVVHLEGVV-----TRGKPVMIVIEFMENGALDAF-----LRKHDGQFTVI 145
Query: 141 QLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
           QL+        G++YL     +HRDL   N+LVN+N   K+ DFGL+R    + + +  Y
Sbjct: 146 QLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV--Y 203
Query: 194 VVT------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
             T      RW  APE +     + ++ DVWS G +  E++  G +P +
Sbjct: 204 TTTGGKIPVRW-TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYW 250

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIK-HDNVI 92
           I+ +G+G++G V  +  +ET +  A+K +  +V     D   T+ E  +L   + H  + 
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
            L        R+     + V E ++  DL   I+ S+       +++  +++  L +LH 
Sbjct: 88  QLFCCFQTPDRL-----FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+L++     K+ DFG+ +    N      +  T  Y APE+L     Y
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LY 201
Query: 212 GTSIDVWSVGCIFAEIL-GRKPI 233
           G ++D W++G +  E+L G  P 
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E  +++ ++H+ ++ L  V
Sbjct: 193 LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 +S + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 249 ------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 302
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV--TRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGL R    NE    +      +W  APE  L    + 
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 360
Query: 213 TSIDVWSVGCIFAEIL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  E+   GR P +PG    E L+Q++
Sbjct: 361 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 396

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHD 89
           Y  +K IGRGA+G V   +  + ++KV   K+ + FE   R D+     E  ++      
Sbjct: 77  YDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            V+ L          +F+D   +Y+V E M   DL  ++ S+  +     K++  +++  
Sbjct: 136 WVVQL--------FCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLA 186
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAP 202
           L  +HS  ++HRD+KP N+L++ +  LK+ DFG     + +E  M      V T  Y +P
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM--KMDETGMVHCDTAVGTPDYISP 244
Query: 203 ELLLCCDN---YGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
           E+L        YG   D WSVG    E+L G  P +  +
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 283

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 36  KPIGRGAYGVVCSSI-----NRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K + +    +  +AL  + EL ++ H+ +H
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  DNVIAL-------KDVMMPTHRISFKDVYLVYE----LMDTDLHQIIKSSQSLSNDHCKY 137
           +N++ L         V++ T    + D+         +++TD    I +S +LS     +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS-TLSTRDLLH 168
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +  ++ +    +
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 229 PVKW-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 269

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 40/232 (17%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y+    DL++       L+ 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--PEDLYKDF-----LTL 147
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +   + +
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 208 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL----RTLRELVLLRHIKHDNV 91
           +P+G+G +G V  +  ++++  VA+K +   F+++I+      +  RE+ +  H+ H N+
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVL---FKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 92  IALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           + L +      RI     YL+ E     +L++ ++ S +         + +L   L Y H
Sbjct: 86  LRLYNYFYDRRRI-----YLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
              ++HRD+KP NLL+    +LKI DFG +  +    +       T  Y  PE++     
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR--KTMCGTLDYLPPEMIE-GRM 197
Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           +   +D+W +G +  E+L   P F         + I+ V       DL+F          
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-------DLKF---------- 240
Query: 271 KSLPYSRGTHISSLYPQADPL-ALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                          P + P  A DL+ K+L   PS+R+ + +   HP++  
Sbjct: 241 ---------------PASVPTGAQDLISKLLRHNPSERLPLAQVSAHPWVRA 277

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 36  KPIGRGAYGVVCSSI-----NRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K + +    +  +AL  + EL ++ H+ +H
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  DNVIAL-------KDVMMPTHRISFKDVYLVYE----LMDTDLHQIIKSSQSLSNDHCKY 137
           +N++ L         V++ T    + D+         +++TD    I +S + + D   +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD-LLH 168
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +  ++ +    +
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 229 PVKW-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 269

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKI---NNVFENRIDALRTLRELVLLRH--- 85
           +  I+ IG G +G V  + +R   +   IK++   N   E  + AL  L  + ++ +   
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 86  ---IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVF- 140
                +D   + K+    + R   K +++  E  D   L Q I+  +    D        
Sbjct: 73  WDGFDYDPETSSKN----SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
            Q+ +G+ Y+HS  +++RDLKP N+ +     +KI DFGL  TS  N+        T  Y
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRXRSKGTLRY 187
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
            +PE +   D YG  +D++++G I AE+L
Sbjct: 188 MSPEQISSQD-YGKEVDLYALGLILAELL 215

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHD 89
           Y  +K IGRGA+G V   +  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 76  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            V+ L          +F+D   +Y+V E M   DL  ++ S+  +     +++  +++  
Sbjct: 135 WVVQL--------FYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLA 185
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAP 202
           L  +HS   +HRD+KP N+L++ +  LK+ DFG     + N++ M      V T  Y +P
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISP 243
Query: 203 ELLLCCDN---YGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
           E+L        YG   D WSVG    E+L G  P +  +
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHD 89
           Y  +K IGRGA+G V   +  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 76  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            V+ L          +F+D   +Y+V E M   DL  ++ S+  +     +++  +++  
Sbjct: 135 WVVQL--------FYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLA 185
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAP 202
           L  +HS   +HRD+KP N+L++ +  LK+ DFG     + N++ M      V T  Y +P
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISP 243
Query: 203 ELLLCCDN---YGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
           E+L        YG   D WSVG    E+L G  P +  +
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHD 89
           Y  +K IGRGA+G V   +  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 71  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELM-DTDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            V+ L          +F+D   +Y+V E M   DL  ++ S+  +     +++  +++  
Sbjct: 130 WVVQL--------FYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLA 180
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTRWYRAP 202
           L  +HS   +HRD+KP N+L++ +  LK+ DFG     + N++ M      V T  Y +P
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISP 238
Query: 203 ELLLCCDN---YGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
           E+L        YG   D WSVG    E+L G  P +  +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/311 (23%), Positives = 142/311 (45%), Gaps = 36/311 (11%)
Query: 5   VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKI 63
            +  N ++ RG+   + +   +EI+   V +   IG G++G V        +  V I K+
Sbjct: 13  TQEKNKIRPRGQRDSSYY---WEIEASEVMLSTRIGSGSFGTVYKG-KWHGDVAVKILKV 68
Query: 64  NNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQ 122
            +    +  A R   E+ +LR  +H N++     M         ++ +V +  + + L++
Sbjct: 69  VDPTPEQFQAFRN--EVAVLRKTRHVNILLFMGYMTK------DNLAIVTQWCEGSSLYK 120
Query: 123 IIKSSQSLSNDHCKYFVFQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKIC 175
                  L     K+ +FQL+       +G+ YLH+ NI+HRD+K  N+ ++    +KI 
Sbjct: 121 ------HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIG 174
Query: 176 DFGLA--RTSRGNEQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAEILGRK 231
           DFGLA  ++     Q + +   +  + APE++   DN  +    DV+S G +  E++  +
Sbjct: 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234
Query: 232 PIFPGTECLNQLKLIISVFGTQQEADLE--FIDNPKARRFIKSLPYSRGTHISSLYPQAD 289
              P +   N+ ++I  V       DL   + + PKA + + +    +      L+PQ  
Sbjct: 235 --LPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292
Query: 290 PLALDLLQKML 300
             +++LLQ  L
Sbjct: 293 S-SIELLQHSL 302

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 127/321 (39%), Gaps = 54/321 (16%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-LRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G VC+   R T +  A KK+      +       L E  +L  +    V++L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 249
Query: 97  VMMPTHRISFKDVY-LVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                +    KD   LV  LM   D   H               ++  ++  GL+ LH  
Sbjct: 250 ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ +  ++I D GLA       Q +   V T  Y APE++   + Y 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVK-NERYT 363
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
            S D W++GC+  E++  +  F                  QQ    + I   +  R +K 
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPF------------------QQRK--KKIKREEVERLVKE 403
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYI-------- 319
           +P       S       P A  L  ++L  +P++R+     +  E  +HP          
Sbjct: 404 VPEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456
Query: 320 -SGLYDPQCNPPAQVPLSLDI 339
            +G+ +P   P  Q     D+
Sbjct: 457 GAGMLEPPFKPDPQAIYCKDV 477

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 93
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y+  + DL++       L+ 
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE-DLYK-----DFLTL 147
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +   + +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 208 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 127/321 (39%), Gaps = 54/321 (16%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-LRTLRELVLLRHIKHDNVIALKD 96
           +G+G +G VC+   R T +  A KK+      +       L E  +L  +    V++L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 249
Query: 97  VMMPTHRISFKDVY-LVYELM---DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA 152
                +    KD   LV  LM   D   H               ++  ++  GL+ LH  
Sbjct: 250 ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ +  ++I D GLA       Q +   V T  Y APE++   + Y 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVK-NERYT 363
Query: 213 TSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKS 272
            S D W++GC+  E++  +  F                  QQ    + I   +  R +K 
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPF------------------QQRK--KKIKREEVERLVKE 403
Query: 273 LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYI-------- 319
           +P       S       P A  L  ++L  +P++R+     +  E  +HP          
Sbjct: 404 VPEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456
Query: 320 -SGLYDPQCNPPAQVPLSLDI 339
            +G+ +P   P  Q     D+
Sbjct: 457 GAGMLEPPFKPDPQAIYCKDV 477

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKD 96
           +G G+YG V    ++E     A+K+  + F    D  R L E+     + +H   + L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 97  VMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
                       +YL  EL    L Q  ++   SL       ++   L  L +LHS  ++
Sbjct: 125 AWE-----EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 156 HRDLKPGNLLVNANCDLKICDFGL---------ARTSRGNEQFMTEYVVTRWYRAPELLL 206
           H D+KP N+ +      K+ DFGL              G+ ++M          APELL 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM----------APELLQ 229
Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK 244
              +YGT+ DV+S+G    E+     +  G E   QL+
Sbjct: 230 --GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 114
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 115 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 229
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N +  +  +  + L E ++++   H NV++L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 89  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 203
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 47/294 (15%)
Query: 36  KPIGRGAYGVV----CSSINRETNE-KVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           + +G GA+G V    C ++  E ++  VA+K + +  +N        RE  LL +++H++
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQHEH 76
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS-------------QSLSNDHCK 136
           ++    V      +    + +V+E M   DL++ +++                L+     
Sbjct: 77  IVKFYGVC-----VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT---EY 193
           +   Q+  G+ YL S + +HRDL   N LV  N  +KI DFG++R     + +       
Sbjct: 132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT-----ECLNQLKLI 246
           +  RW   PE ++    + T  DVWS+G +  EI   G++P +  +     EC+ Q +++
Sbjct: 192 LPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249
Query: 247 ISVFGTQQEADLEFID----NPKARRFIKSLPYSRGTHISSLYPQADPLALDLL 296
                  QE     +      P  R+ IK +     T + +L  +A P+ LD+L
Sbjct: 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH----TLLQNL-AKASPVYLDIL 298

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 115
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 116 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 230
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N +  +  +  + L E ++++   H NV++L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 95  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 209
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 40/231 (17%)
Query: 36  KPIGRGAYGVVCSS----INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD-N 90
           KP+GRGA+G V  +    I++    +    K+        +    + EL +L HI H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN 132
           V+ L                  K   + T+  S ++ ++ Y+ +  D          L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF---------LTL 143
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KI DFGLAR    +  ++ +
Sbjct: 144 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 193 ---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
               +  +W  APE +     Y    DVWS G +  EI  LG  P +PG +
Sbjct: 204 GDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 251

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 211
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 95
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 210
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 91
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 92  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 206
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 93
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 94  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 208
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E +         +  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 211
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 92
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 93  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR---GNE 187
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 188 QFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
           +     +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 208 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 263
Query: 245 LI 246
           L+
Sbjct: 264 LL 265

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKH 88
           I+ +G G +G V        N  T E VA+K +    E     LR+   RE+ +LR + H
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---EGCGPQLRSGWQREIEILRTLYH 70
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++++  K           K V LV E +     +       +       F  Q+  G+ Y
Sbjct: 71  EHIVKYKGCCEDQGE---KSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAY 127
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRWYRAPEL 204
           LH+ + +HR L   N+L++ +  +KI DFGLA+    G+E +           WY APE 
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 186
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
           L  C  Y  S DVWS G    E+L
Sbjct: 187 LKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           I  +G+G +G V  C    +   T   VA+K++ +   ++    +  RE+ +L+ +  D 
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 72
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKY 148
           ++  + V     R S +   LV E + +   +          D  +  ++  Q+ +G++Y
Sbjct: 73  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 129
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------WYRA 201
           L S   +HRDL   N+LV +   +KI DFGLA+    ++ +   YVV         WY A
Sbjct: 130 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIFWY-A 185
Query: 202 PELLLCCDN-YGTSIDVWSVGCIFAEIL 228
           PE L   DN +    DVWS G +  E+ 
Sbjct: 186 PESL--SDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           I  +G+G +G V  C    +   T   VA+K++ +   ++    +  RE+ +L+ +  D 
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 85
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKY 148
           ++  + V     R S +   LV E + +   +          D  +  ++  Q+ +G++Y
Sbjct: 86  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------WYRA 201
           L S   +HRDL   N+LV +   +KI DFGLA+    ++ +   YVV         WY A
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIFWY-A 198
Query: 202 PELLLCCDN-YGTSIDVWSVGCIFAEIL 228
           PE L   DN +    DVWS G +  E+ 
Sbjct: 199 PESL--SDNIFSRQSDVWSFGVVLYELF 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKH 88
           I+ +G G +G V        N  T E VA+K +    E     LR+   RE+ +LR + H
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---EGCGPQLRSGWQREIEILRTLYH 69
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++++  K           K V LV E +     +       +       F  Q+  G+ Y
Sbjct: 70  EHIVKYKGCCEDQGE---KSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAY 126
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRWYRAPEL 204
           LH+ + +HR L   N+L++ +  +KI DFGLA+    G+E +           WY APE 
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 185
Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL 228
           L  C  Y  S DVWS G    E+L
Sbjct: 186 LKECKFYYAS-DVWSFGVTLYELL 208

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 92
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 93  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 190 -MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKL 245
             T   +   + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL
Sbjct: 208 KTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKL 264
Query: 246 I 246
           +
Sbjct: 265 L 265

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 92
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 93  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 190 -MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKL 245
             T   +   + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL
Sbjct: 208 KTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKL 264
Query: 246 I 246
           +
Sbjct: 265 L 265

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           I  +G+G +G V  C    +   T   VA+K++ +   ++    +  RE+ +L+ +  D 
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 73
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKY 148
           ++  + V     R S +   LV E + +   +          D  +  ++  Q+ +G++Y
Sbjct: 74  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 130
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR-------WYRA 201
           L S   +HRDL   N+LV +   +KI DFGLA+    ++ +   YVV         WY A
Sbjct: 131 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIFWY-A 186
Query: 202 PELLLCCDN-YGTSIDVWSVGCIFAEIL 228
           PE L   DN +    DVWS G +  E+ 
Sbjct: 187 PESL--SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVI---A 93
           +  G +  V  + +  +  + A+K++ +  E +  A+  ++E+  ++ +  H N++   +
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPNIVQFCS 93
Query: 94  LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS---LSNDHCKYFVFQLLRGLKYLH 150
              +          +  L+ EL    L + +K  +S   LS D      +Q  R ++++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 151 SAN--ILHRDLKPGNLLVNANCDLKICDFGLARTS--------RGNEQFMTEYVVTR--- 197
                I+HRDLK  NLL++    +K+CDFG A T             + + E  +TR   
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 198 -WYRAPELLLCCDNY--GTSIDVWSVGCIF 224
             YR PE++    N+  G   D+W++GCI 
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 92
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 93  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 208 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 263
Query: 245 LI 246
           L+
Sbjct: 264 LL 265

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 133
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 134 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 190 -MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKL 245
             T   +   + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL
Sbjct: 249 KTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKL 305
Query: 246 I 246
           +
Sbjct: 306 L 306

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 85
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 86  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 201 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 256
Query: 245 LI 246
           L+
Sbjct: 257 LL 258

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 81
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 82  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 197 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 252
Query: 245 LI 246
           L+
Sbjct: 253 LL 254

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR  + +  ++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G    E+  LG  P +PG
Sbjct: 233 PVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 84
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 85  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 200 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 255
Query: 245 LI 246
           L+
Sbjct: 256 LL 257

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR  + +  ++ +    +
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G    E+  LG  P +PG
Sbjct: 228 PVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 268

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EI+   + I K IG G  G VC    R   ++   VAIK +   +  R      L E  +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASI 103
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H N+I L+ V+           Y+    +DT           L     ++ + QL
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT----------FLRTHDGQFTIMQL 153
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           +        G++YL     +HRDL   N+LV++N   K+ DFGL+R    +      Y  
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTT 211
Query: 196 T------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
           T      RW  APE  +    + ++ DVWS G +  E+L  G +P +
Sbjct: 212 TGGKIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR  + +  ++ +    +
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G    E+  LG  P +PG
Sbjct: 226 PVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 266

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--VVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G  V+  +I  + ++     KVA+K + +    + D    + E+ +++ I K
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 77
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + L
Sbjct: 78  HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           S+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     + + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 193 KTTNGRLPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 248
Query: 245 LI 246
           L+
Sbjct: 249 LL 250

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR  + +  ++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G    E+  LG  P +PG
Sbjct: 233 PVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 447 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 506
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 507 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 562
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 563 MWEAFSYGQKP 573

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 12/121 (9%)
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 180 ARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCIFAEIL--GRK 231
           ++  R +E +       +W   + APE    C NY    +  DVWS G +  E    G+K
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQK 229
Query: 232 P 232
           P
Sbjct: 230 P 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 12/121 (9%)
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 180 ARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCIFAEIL--GRK 231
           ++  R +E +       +W   + APE    C NY    +  DVWS G +  E    G+K
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQK 229
Query: 232 P 232
           P
Sbjct: 230 P 230

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 505
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 506 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 561
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 562 MWEAFSYGQKP 572

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 102 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 161
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 162 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 217
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 218 MWEAFSYGQKP 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YV 194
           F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR  + +  ++ +    +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G    E+  LG  P +PG
Sbjct: 210 PVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 250

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 153
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 209
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 210 MWEAFSYGQKP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 147
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 148 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 203
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 204 MWEAFSYGQKP 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID K +  +K +G G +GVV     R   + VAIK I    E  +     + E  ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 74
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQ 141
           ++ H+ ++ L  V      I     Y+    +   L ++    ++ Q L  + CK     
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----D 128
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT--EYVVTRWY 199
           +   ++YL S   LHRDL   N LVN    +K+ DFGL+R    +E+  +       RW 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW- 187
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
            +P  +L    + +  D+W+ G +  EI  LG+ P
Sbjct: 188 -SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 12/121 (9%)
Query: 120 LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 180 ARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCIFAEIL--GRK 231
           ++  R +E +       +W   + APE    C NY    +  DVWS G +  E    G+K
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQK 209
Query: 232 P 232
           P
Sbjct: 210 P 210

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 42/210 (20%)
Query: 119 DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDF 177
           DL   I    +L  +  + F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPG 236
           G     +  +   T++  TR Y  PE +     +G S  VWS+G +  +++ G  P    
Sbjct: 203 GSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 257
Query: 237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLL 296
                             E D E I   + + F +    S   H              L+
Sbjct: 258 ------------------EHDEEII---RGQVFFRQRVSSECQH--------------LI 282
Query: 297 QKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
           +  L   PS R T  E   HP++  +  PQ
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 312

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 95
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+KYL S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR     E           +  +W     L    
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ--T 210
Query: 209 DNYGTSIDVWSVGCIFAEILGR-KPIFP 235
             + T  DVWS G +  E++ R  P +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID K +  +K +G G +GVV     R   + VAIK I    E  +     + E  ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQ 141
           ++ H+ ++ L  V      I     Y+    +   L ++    ++ Q L  + CK     
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----D 113
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSRGNEQFMTEY 193
           +   ++YL S   LHRDL   N LVN    +K+ DFGL+R        +SRG++      
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK------ 167
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
              RW  +P  +L    + +  D+W+ G +  EI  LG+ P
Sbjct: 168 FPVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 82  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 141
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E +       +W   + APE    C NY    +  DVWS G +
Sbjct: 142 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 197
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 198 MWEAFSYGQKP 208

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 36  KPIGRGAYGVVCSSI-----NRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K + +    +  +AL  + EL ++ H+ +H
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  DNVIAL-------KDVMMPTHRISFKDVY-LVYELMDTDLHQIIKSSQSLSNDHCKYFVF 140
           +N++ L         V++ T    + D+   +    + DL +  +  + L      +F  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK--EDGRPLELRDLLHFSS 167
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTR 197
           Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +  ++ +    +  +
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           W  APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 228 WM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 265

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 36  KPIGRGAYGVVCSSI-----NRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K + +    +  +AL  + EL ++ H+ +H
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 101
Query: 89  DNVIAL-------KDVMMPTHRISFKDVY-LVYELMDTDLHQIIKSSQSLSNDHCKYFVF 140
           +N++ L         V++ T    + D+   +    + DL +  +  + L      +F  
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK--EDGRPLELRDLLHFSS 159
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---YVVTR 197
           Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +  ++ +    +  +
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           W  APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 220 WM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 257

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 42/231 (18%)
Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EI+   + I K IG G  G VC    R   ++   VAIK +   +  R      L E  +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASI 103
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           +    H N+I L+ V+           Y+    +DT           L     ++ + QL
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT----------FLRTHDGQFTIMQL 153
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSRG 185
           +        G++YL     +HRDL   N+LV++N   K+ DFGL+R          T+ G
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTG 213
Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIF 234
            +      +  RW  APE  +    + ++ DVWS G +  E+L  G +P +
Sbjct: 214 GK------IPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKIN--------NVFENRIDALRTLRELVL 82
           I+ +G G +G V        N  T E VA+K +         + ++  ID LRTL     
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY---- 91
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
                H+++I  K         S +   LV E +     +      S+       F  Q+
Sbjct: 92  -----HEHIIKYKGCCEDAGAASLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI 143
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRW 198
             G+ YLH+ + +HRDL   N+L++ +  +KI DFGLA+    G+E +           W
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           Y APE L     Y  S DVWS G    E+L
Sbjct: 204 Y-APECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRTLRELVLLR 84
           +T+   +K +G GA+G V   I     E V    AIK +N     + + +  + E +++ 
Sbjct: 37  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMA 95
Query: 85  HIKHDNVIALKDV-MMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQ 141
            + H +++ L  V + PT       + LV +LM     L  + +   ++ +     +  Q
Sbjct: 96  SMDHPHLVRLLGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ 148
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------VV 195
           + +G+ YL    ++HRDL   N+LV +   +KI DFGLAR   G+E+   EY      + 
Sbjct: 149 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK---EYNADGGKMP 205
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKP 232
            +W     + L C +Y       DVWS G    E++  G KP
Sbjct: 206 IKW-----MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G V  +    I+++  ++   VA+K + +    + D    + E+ +++ I K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + +
Sbjct: 100 HKNIITLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           +        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 215 KTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y          H +  S              Q  RG+ Y
Sbjct: 89  STAPQLAIV---TQWCEGSSLY----------HHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSR--GNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA   SR  G+ QF        W  APE++
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 194
Query: 206 LCCDN--YGTSIDVWSVGCIFAEIL 228
              D+  Y    DV++ G +  E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELM 219

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ IG G +G+V     +N++   KVAIK I    E  +     + E  ++  + H  ++
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLH 150
            L  V +    I      LV+E M+   L   +++ + L + +        +  G+ YL 
Sbjct: 66  QLYGVCLEQAPIC-----LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPE 203
            A+++HRDL   N LV  N  +K+ DFG+ R       TS    +F  ++       +PE
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 174
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 175 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRTLRELVLLR 84
           +T+   +K +G GA+G V   I     E V    AIK +N     + + +  + E +++ 
Sbjct: 14  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMA 72
Query: 85  HIKHDNVIALKDV-MMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQ 141
            + H +++ L  V + PT       + LV +LM     L  + +   ++ +     +  Q
Sbjct: 73  SMDHPHLVRLLGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ 125
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------VV 195
           + +G+ YL    ++HRDL   N+LV +   +KI DFGLAR   G+E+   EY      + 
Sbjct: 126 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK---EYNADGGKMP 182
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAEIL--GRKP 232
            +W     + L C +Y       DVWS G    E++  G KP
Sbjct: 183 IKW-----MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID K +  +K +G G +GVV     R   + VAIK I    E  +     + E  ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 74
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQ 141
           ++ H+ ++ L  V      I     Y+    +   L ++    ++ Q L  + CK     
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----D 128
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWY 199
           +   ++YL S   LHRDL   N LVN    +K+ DFGL+R    +E    +      RW 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 187
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
            +P  +L    + +  D+W+ G +  EI  LG+ P
Sbjct: 188 -SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G V  +    I+++  ++   VA+K + +    + D    + E+ +++ I K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + +
Sbjct: 100 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG---NE 187
           +        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR        +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 188 QFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
           +     +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 215 KTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G V  +    I+++  ++   VA+K + +    + D    + E+ +++ I K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + +
Sbjct: 100 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG---NE 187
           +        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR        +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 188 QFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
           +     +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 215 KTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID K +  +K +G G +GVV     R   + VAIK I    E  +     + E  ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQ 141
           ++ H+ ++ L  V      I     Y+    +   L ++    ++ Q L  + CK     
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----D 113
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWY 199
           +   ++YL S   LHRDL   N LVN    +K+ DFGL+R    +E    +      RW 
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 172
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
            +P  +L    + +  D+W+ G +  EI  LG+ P
Sbjct: 173 -SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/114 (38%), Positives = 57/114 (50%), Gaps = 10/114 (8%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---MTEYVV 195
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +       + 
Sbjct: 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 196 TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
            +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 269 VKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 318

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G V  +    I+++  ++   VA+K + +    + D    + E+ +++ I K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + +
Sbjct: 100 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
           +        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 191 TEY---VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 215 NTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 38  IGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G G +G V   + R   ++  VAIK +    E + D    +RE  ++  + +  ++ L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 96  DVMMPTHRISFKDVYLVYELMDTD-LHQ-IIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            V         + + LV E+     LH+ ++   + +   +    + Q+  G+KYL   N
Sbjct: 77  GV------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDN 210
            +HRDL   N+L+      KI DFGL++    ++ + T     +W   + APE    C N
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE----CIN 186
Query: 211 ---YGTSIDVWSVGCIFAEIL--GRKP 232
              + +  DVWS G    E L  G+KP
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID K +  +K +G G +GVV     R   + VAIK I    E  +     + E  ++ 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 65
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQ 141
           ++ H+ ++ L  V      I     Y+    +   L ++    ++ Q L  + CK     
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----D 119
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWY 199
           +   ++YL S   LHRDL   N LVN    +K+ DFGL+R    +E    +      RW 
Sbjct: 120 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 178
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
            +P  +L    + +  D+W+ G +  EI  LG+ P
Sbjct: 179 -SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 73  STAPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 119
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 178
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQ 262

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 26  FEIDTKYVP-IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EID K +  +K +G G +GVV     R   + VAIK I    E  +     + E  ++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 58
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQ 141
           ++ H+ ++ L  V      I     Y+    +   L ++    ++ Q L  + CK     
Sbjct: 59  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----D 112
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWY 199
           +   ++YL S   LHRDL   N LVN    +K+ DFGL+R    +E    +      RW 
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 171
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP 232
            +P  +L    + +  D+W+ G +  EI  LG+ P
Sbjct: 172 -SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 37/240 (15%)
Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G V  +    I+++  ++   VA+K + +    + D    + E+ +++ I K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 88  HDNVIALKDVMM---PTHRI-SFKDVYLVYELMDT----------DLHQIIKSSQSLSN- 132
           H N+I L        P + I ++     + E +            D++++ +   +  + 
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--- 189
             C Y   QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +   
Sbjct: 160 VSCTY---QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
               +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 217 TNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 272

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/114 (38%), Positives = 57/114 (50%), Gaps = 10/114 (8%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---MTEYVV 195
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +       + 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 196 TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
            +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 223 VKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 272

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/114 (38%), Positives = 57/114 (50%), Gaps = 10/114 (8%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---MTEYVV 195
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +       + 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 196 TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
            +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 223 VKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 272

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
           ++ +LS+    +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL   SRG
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL---SRG 191
Query: 186 NEQFMTEYVV---TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTEC 239
            E ++ + +     RW     L      Y T+ DVWS G +  EI  LG  P + G  C
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 247

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 95/389 (24%), Positives = 154/389 (39%), Gaps = 82/389 (21%)
Query: 6   EPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN 65
           E PN     G H   +   LF  + +Y  I+ +G G +  V  S + +  + VA+K + +
Sbjct: 16  EDPNDYCKGGYHLVKI-GDLF--NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS 72
Query: 66  VFENRIDALRTLRELVLLRHIKHDN-----VIALKDVMMPTHRISFKDVYLVYELMDTDL 120
                  AL  +R L  +R+   ++     V+ L D    +  ++   + +V+E++   L
Sbjct: 73  AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-GVNGTHICMVFEVLGHHL 131
Query: 121 HQ-IIKSS-QSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN-------- 169
            + IIKS+ Q L     K  + Q+L+GL YLH+   I+H D+KP N+L++ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 170 -----------------------------------------CDLKICDFGLARTSRGNEQ 188
                                                      +KI D G A       +
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---K 248
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF---PGTECL---NQ 242
             TE + TR YR+ E+L+    Y T  D+WS  C+  E+     +F    G E     + 
Sbjct: 249 HFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 243 LKLIISVFG-------TQQEADLEFIDNPKARRFIKSL-PYSRGTHISSLYPQADPLA-- 292
           + LII + G          +   EF       + I  L P+     +   Y  +   A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 293 -LDLLQKMLVFEPSKRITVTEALQHPYIS 320
             D L  ML   P KR T  E L+HP+++
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 155
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 156 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQ-- 269
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
           ++ +LS+    +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL   SRG
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL---SRG 181
Query: 186 NEQFMTEYVV---TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTEC 239
            E ++ + +     RW     L      Y T+ DVWS G +  EI  LG  P + G  C
Sbjct: 182 QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 237

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVT 196
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +   T   + 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
             + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 223 VKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 272

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y          H +  S              Q  RG+ Y
Sbjct: 89  STKPQLAIV---TQWCEGSSLY----------HHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSR--GNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA   SR  G+ QF        W  APE++
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 194
Query: 206 LCCDN--YGTSIDVWSVGCIFAEIL 228
              D+  Y    DV++ G +  E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELM 219

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVT 196
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +   T   + 
Sbjct: 150 TYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
             + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 210 VKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 259

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    V Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 147
Query: 170 CDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++  R +E         +W   + APE    C NY    +  DVWS G +
Sbjct: 148 HYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 203
Query: 224 FAEIL--GRKP 232
             E    G+KP
Sbjct: 204 MWEAFSYGQKP 214

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVT 196
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +   T   + 
Sbjct: 152 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
             + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 212 VKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 261

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVT 196
            +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR     + +   T   + 
Sbjct: 155 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLKLI 246
             + APE L   D  Y    DVWS G +  EI  LG  P +PG       KL+
Sbjct: 215 VKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 264

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 113/259 (43%), Gaps = 53/259 (20%)
Query: 36  KPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRT---LRELVLLRHI-KHDN 90
           K +G GA+G V ++     ++  V+I+    + + + D+      + EL ++  +  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 91  VIALKDVMMPTHRISFKDVYLVYELM-DTDLHQIIKSS-QSLSNDHCKY----------- 137
           ++ L      +  I     YL++E     DL   ++S  +  S D  +Y           
Sbjct: 111 IVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 138 -----------FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----- 181
                      F +Q+ +G+++L   + +HRDL   N+LV     +KICDFGLAR     
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 182 ---TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
                RGN +   +++      APE L     Y    DVWS G +  EI  LG  P +PG
Sbjct: 226 SNYVVRGNARLPVKWM------APESLF-EGIYTIKSDVWSYGILLWEIFSLGVNP-YPG 277
Query: 237 TEC-LNQLKLIISVFGTQQ 254
                N  KLI + F   Q
Sbjct: 278 IPVDANFYKLIQNGFKMDQ 296

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y          H +  S              Q  RG+ Y
Sbjct: 77  STKPQLAIV---TQWCEGSSLY----------HHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 124 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 182
Query: 206 LCCDN--YGTSIDVWSVGCIFAEIL 228
              D+  Y    DV++ G +  E++
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELM 207

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 38  IGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G G +G V   + R   ++  VAIK +    E + D    +RE  ++  + +  ++ L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 96  DVMMPTHRISFKDVYLVYELMDTD-LHQ-IIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            V         + + LV E+     LH+ ++   + +   +    + Q+  G+KYL   N
Sbjct: 403 GV------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW---YRAPELLLCCDN 210
            +HR+L   N+L+      KI DFGL++    ++ + T     +W   + APE    C N
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE----CIN 512
Query: 211 ---YGTSIDVWSVGCIFAEIL--GRKP 232
              + +  DVWS G    E L  G+KP
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 36  KPIGRGAYGVVCSSI-----NRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K + +    +  +AL  + EL ++ H+ +H
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  DNVIAL-------KDVMMPTHRISFKDVYLVYEL-----MDTDLHQIIKSSQSLSNDHCK 136
           +N++ L         V++ T    + D+           ++   +      + LS+    
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE---Y 193
           +F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +  ++ +    
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           +  +W  APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 230 LPVKW-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 271

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQ-- 210
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 101
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 102 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQ-- 215
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQ-- 210
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 88/367 (23%), Positives = 146/367 (39%), Gaps = 79/367 (21%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
            + +Y  I+ +G G +  V  S + +  + VA+K + +       AL  +R L  +R+  
Sbjct: 19  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSD 78
Query: 88  HDN-----VIALKDVMMPTHRISFKDVYLVYELMDTDLHQ-IIKSS-QSLSNDHCKYFVF 140
            ++     V+ L D    +  ++   + +V+E++   L + IIKS+ Q L     K  + 
Sbjct: 79  PNDPNREMVVQLLDDFKIS-GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 137
Query: 141 QLLRGLKYLHS-ANILHRDLKPGNLLVNAN------------------------------ 169
           Q+L+GL YLH+   I+H D+KP N+L++ N                              
Sbjct: 138 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 197
Query: 170 -------------------CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
                                +KI D G A       +  TE + TR YR+ E+L+    
Sbjct: 198 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLI-GSG 253
Query: 211 YGTSIDVWSVGCIFAEILGRKPIF---PGTECL---NQLKLIISVFG-------TQQEAD 257
           Y T  D+WS  C+  E+     +F    G E     + + LII + G          +  
Sbjct: 254 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 313
Query: 258 LEFIDNPKARRFIKSL-PYSRGTHISSLYPQADPLAL---DLLQKMLVFEPSKRITVTEA 313
            EF       + I  L P+     +   Y  +   A    D L  ML   P KR T  E 
Sbjct: 314 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 373
Query: 314 LQHPYIS 320
           L+HP+++
Sbjct: 374 LRHPWLN 380

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 73  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 119
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSR--GNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA   SR  G+ QF        W  APE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 178
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQ 262

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 78  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 124
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 183
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 242 NCPKAMKRLMAECLKKKRDERPLFPQ 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 73  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 119
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 178
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQ 262

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 75  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 121
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 180
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 238
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 239 NCPKAMKRLMAECLKKKRDERPLFPQ 264

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYGVVCSS----INRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHI-K 87
           KP+G GA+G V  +    I+++  ++   VA+K + +    + D    + E+ +++ I K
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99
Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS----------------SQSL 130
           H N+I L         +     Y++ E     +L + +++                 + +
Sbjct: 100 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF- 189
           +        +QL RG++YL S   +HRDL   N+LV  N  ++I DFGLAR     + + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTECLNQLK 244
                 +  +W  APE L   D  Y    DVWS G +  EI  LG  P +PG       K
Sbjct: 215 KTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 97
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 98  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQ-- 211
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 78  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 124
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 183
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 242 NCPKAMKRLMAECLKKKRDERPLFPQ 267

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 10  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 68
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 122
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 123 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 179
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 180 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 97
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 98  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDML-DKEFDSVHNKTGAKLPVKWMALESLQ-- 211
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 94
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
             + +   R     + ++  +   DL   I++ + + +      F  Q+ +G+K+L S  
Sbjct: 95  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    +++F + +  T      +W     L   
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQ-- 208
Query: 208 CDNYGTSIDVWSVGCIFAEILGR-KPIFP 235
              + T  DVWS G +  E++ R  P +P
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 93  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 139
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSR--GNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA   SR  G+ QF        W  APE++
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 198
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 256
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 257 NCPKAMKRLMAECLKKKRDERPLFPQ 282

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 101 STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 147
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSR--GNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA   SR  G+ QF        W  APE++
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 206
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 264
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 265 NCPKAMKRLMAECLKKKRDERPLFPQ 290

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 21/231 (9%)
Query: 19  YTMWQTL-FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDA 73
           YTM  T  +EI  + + + + IG G +G V   I          VAIK   N   + +  
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 74  LRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLS 131
            + L+E + +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL 
Sbjct: 437 -KFLQEALTMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKFSLD 489
Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT 191
                 + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +  
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 192 E--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
               +  +W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 550 SKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 597

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGXLLDYVREHKDNIGSQY 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 7   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 65
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGXLLDYVREHKDNIGSQY 119
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 120 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 176
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 177 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ IG G +G+V     +N++   KVAIK I    E  +     + E  ++  + H  ++
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLH 150
            L  V +    I      LV+E M+   L   +++ + L + +        +  G+ YL 
Sbjct: 66  QLYGVCLEQAPIC-----LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS    +F  ++       +PE
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 174
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 175 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 16  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 74
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 75  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 128
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 129 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 185
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 186 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ IG G +G+V     +N++   KVAIK I    E  +     + E  ++  + H  ++
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLH 150
            L  V +    I      LV+E M+   L   +++ + L + +        +  G+ YL 
Sbjct: 69  QLYGVCLEQAPIC-----LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 123
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS    +F  ++       +PE
Sbjct: 124 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 177
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 178 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 12  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 70
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 71  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 124
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 125 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 181
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 182 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 31  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 89
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 90  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 143
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 144 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 200
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 201 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 101 STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 147
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 206
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 264
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 265 NCPKAMKRLMAECLKKKRDERPLFPQ 290

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 7   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 65
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 119
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 120 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 176
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 177 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 35/266 (13%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKIN---------NVFENRIDALRTLRELVLLRHIKH 88
           IG G++G V      + +  VA+K +N           F+N +  LR  R + +L  + +
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
                L  V   T       +Y    +++T    I                 Q  +G+ Y
Sbjct: 100 STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMI----------KLIDIARQTAQGMDY 146
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---RGNEQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA       G+ QF        W  APE++
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 205
Query: 206 LCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
              D   Y    DV++ G +  E++  +   P +   N+ ++I  V       DL  + +
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRS 263
Query: 264 --PKARRFIKSLPYSRGTHISSLYPQ 287
             PKA + + +    +      L+PQ
Sbjct: 264 NCPKAMKRLMAECLKKKRDERPLFPQ 289

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ IG G +G+V     +N++   KVAIK I    E  +     + E  ++  + H  ++
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLH 150
            L  V +    I      LV+E M+   L   +++ + L + +        +  G+ YL 
Sbjct: 64  QLYGVCLEQAPIC-----LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS    +F  ++       +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 172
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 173 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 13  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 71
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 125
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 126 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 182
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 183 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 43/244 (17%)
Query: 36  KPIGRGAYGVV----CSSINRETNEK-VAIKKINN-VFENRIDALRTLRELVLLRHIKHD 89
           + +G GA+G V    C +++   ++  VA+K + +     R D     RE  LL +++H+
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQREAELLTNLQHE 77
Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS----------------SQSLSN 132
           +++    V           + +V+E M   DL++ +++                   L  
Sbjct: 78  HIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT- 191
               +   Q+  G+ YL S + +HRDL   N LV AN  +KI DFG++R     + +   
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 192 --EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT-----ECLNQ 242
               +  RW   PE ++    + T  DVWS G I  EI   G++P F  +     EC+ Q
Sbjct: 193 GHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 243 LKLI 246
            +++
Sbjct: 251 GRVL 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ IG G +G+V     +N++   KVAIK I    E  +     + E  ++  + H  ++
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLV 85
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLH 150
            L  V +    I      LV+E M+   L   +++ + L + +        +  G+ YL 
Sbjct: 86  QLYGVCLEQAPIC-----LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS    +F  ++       +PE
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 194
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 195 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 223

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 7   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 65
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 66  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 119
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 180 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 219

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 33  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 91
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 92  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPI 233
           W  APE  +    + ++ DVW  G    EIL  G KP 
Sbjct: 206 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 13/106 (12%)
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT--- 191
           C +   Q+   +++LHS  ++HRDLKP N+    +  +K+ DFGL      +E+  T   
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 192 ---------EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
                      V T+ Y +PE  +  +NY   +D++S+G I  E+L
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 10/115 (8%)
Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
           L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 250 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 300

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K +G G +GVV     R   + VAIK I    E  +     + E  ++ ++ H+ ++ L
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 95  KDVMMPTHRISFKDVYLVYELMDTDLHQI---IKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
             V      I     Y+    +   L ++    ++ Q L  + CK     +   ++YL S
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCK----DVCEAMEYLES 118
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCD 209
              LHRDL   N LVN    +K+ DFGL+R    +E    +      RW  +P  +L   
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SPPEVLMYS 176
Query: 210 NYGTSIDVWSVGCIFAEI--LGRKP 232
            + +  D+W+ G +  EI  LG+ P
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 8   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 66
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 67  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 121 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 181 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 64  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 217

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 10/115 (8%)
Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
           L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  +
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 255 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 305

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 21/223 (9%)
Query: 28  IDTK-YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           ID K Y+ I+ +G G +  V            A+K+I  +   + D     RE  + R  
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLF 83
Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMD-----TDLHQIIKSSQSLSNDHCKYFVFQ 141
            H N++ L    +   R +  + +L+           ++ ++      L+ D   + +  
Sbjct: 84  NHPNILRLVAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS----RGNEQFMT--EYVV 195
           + RGL+ +H+    HRDLKP N+L+       + D G    +     G+ Q +T  ++  
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 196 TRW---YRAPELLLCCDN--YGTSIDVWSVGCI-FAEILGRKP 232
            R    YRAPEL     +       DVWS+GC+ +A + G  P
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 10/115 (8%)
Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
           L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  +
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 257 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 307

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 64  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 68
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 69  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 183 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 222

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 61  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +      +  +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 175 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKIN--------NVFENRIDALRTLRELVL 82
           I+ +G G +G V        N  T E VA+K +         + ++  ID LRTL     
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY---- 74
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
                H+++I  K         S +   LV E +     +      S+       F  Q+
Sbjct: 75  -----HEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI 126
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRW 198
             G+ YLHS + +HR+L   N+L++ +  +KI DFGLA+    G+E +           W
Sbjct: 127 CEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           Y APE L     Y  S DVWS G    E+L
Sbjct: 187 Y-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 10/115 (8%)
Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
           L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    +  +
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  EI  LG  P +PG +
Sbjct: 248 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 298

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRTLRELVLLR 84
           +T++  IK +G GA+G V   +     EKV    AIK++      + +    L E  ++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQL 142
            + + +V  L  + + +       V L+ +LM     L  + +   ++ + +   +  Q+
Sbjct: 67  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------VVT 196
            +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY      V  
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPI 177
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           +W     +L     Y    DVWS G    E++  G KP
Sbjct: 178 KWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
           ++ +LS+    +F   + RG+ YL     +HR+L   N+LV  N   KI DFGL   SRG
Sbjct: 132 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGL---SRG 188
Query: 186 NEQFMTEYVV---TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPGTEC 239
            E ++ + +     RW     L      Y T+ DVWS G +  EI  LG  P + G  C
Sbjct: 189 QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 244

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 21/231 (9%)
Query: 19  YTMWQTL-FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDA 73
           YTM  T  +EI  + + + + IG G +G V   I          VAIK   N   + +  
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 74  LRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLS 131
            + L+E + +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL 
Sbjct: 437 -KFLQEALTMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKFSLD 489
Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT 191
                 + +QL   L YL S   +HRD+   N+LV+A   +K+ DFGL+R    +  +  
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA 549
Query: 192 E--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
               +  +W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 550 SKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 597

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 35  IKPIGRGAYGVV--C--SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           I  +G+G +G V  C    +   T   VA+K++ +   ++    +  RE+ +L+ +  D 
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 69
Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVF--QLLRGLKY 148
           ++  + V     R   +   LV E + +   +          D  +  ++  Q+ +G++Y
Sbjct: 70  IVKYRGVSYGPGRPELR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 126
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR--------WYR 200
           L S   +HRDL   N+LV +   +KI DFGLA+    ++    +  V R        WY 
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DXXVVREPGQSPIFWY- 181
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAEIL 228
           APE L   DN +    DVWS G +  E+ 
Sbjct: 182 APESL--SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 64  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV+A   +K+ DFGL+R    +  +      +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRTLRELVLLR 84
           +T++  IK +G GA+G V   +     EKV    AIK++      + +    L E  ++ 
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 69
Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQL 142
            + + +V  L  + + +       V L+ +LM     L  + +   ++ + +   +  Q+
Sbjct: 70  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY------VVT 196
             G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY      V  
Sbjct: 124 AEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPI 180
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           +W     +L     Y    DVWS G    E++  G KP
Sbjct: 181 KWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKIN--------NVFENRIDALRTLRELVL 82
           I+ +G G +G V        N  T E VA+K +         + ++  ID LRTL     
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY---- 74
Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
                H+++I  K         S +   LV E +     +      S+       F  Q+
Sbjct: 75  -----HEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI 126
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEY---VVTRW 198
             G+ YLH+ + +HR+L   N+L++ +  +KI DFGLA+    G+E +           W
Sbjct: 127 CEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           Y APE L     Y  S DVWS G    E+L
Sbjct: 187 Y-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 38  IGRGAYGVVCSS-INRETNEKVAIKKINNVFENRIDALRTL--RELVLLRHIKHDNVIAL 94
           +G G +GVV    +N   N  VA+KK+  + +   + L+    +E+ ++   +H+N++ L
Sbjct: 39  MGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 95  KDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLS-NDHCKYFVFQLLRGLKYL 149
                        D+ LVY  M      D    +  +  LS +  CK        G+ +L
Sbjct: 96  LGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK-IAQGAANGINFL 149
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLC 207
           H  + +HRD+K  N+L++     KI DFGLAR S    Q    +  V T  Y APE L  
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR- 208
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKP 232
                   D++S G +  EI+   P
Sbjct: 209 -GEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 94/368 (25%), Positives = 145/368 (39%), Gaps = 83/368 (22%)
Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI- 86
            + +Y  I+ +G G +  V    + +    VA+K + +       AL  ++ L  +R   
Sbjct: 29  FNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESD 88
Query: 87  ----KHDNVIALKDVMMPTHRISFKD---VYLVYELMDTDLHQ-IIKSS-QSLSNDHCKY 137
                 D V+ L D      +IS  +   V +V+E++   L + IIKS+ Q L     K 
Sbjct: 89  PSDPNKDMVVQLID----DFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKS 144
Query: 138 FVFQLLRGLKYLHS-ANILHRDLKPGN--------------------------------- 163
            + Q+L+GL YLHS   I+H D+KP N                                 
Sbjct: 145 IIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAV 204
Query: 164 -------LLVNA----NCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
                  LLVN     N D   +KI D G A       +  TE + TR YR+ E+L+   
Sbjct: 205 STAPAADLLVNPLDPRNADKIRVKIADLGNACWVH---KHFTEDIQTRQYRSIEVLIGA- 260
Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPG------TECLNQLKLIISVFGT-------QQEA 256
            Y T  D+WS  C+  E+     +F        +   + +  II + G+         + 
Sbjct: 261 GYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKY 320
Query: 257 DLEFIDNPKARRFIKSL-PYSRGTHISSLY--PQADPLAL-DLLQKMLVFEPSKRITVTE 312
             EF +     R I  L P+S    +   Y  P  D     D L  ML   P KR +  E
Sbjct: 321 SREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGE 380
Query: 313 ALQHPYIS 320
            L+HP+++
Sbjct: 381 CLRHPWLN 388

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI  + + + + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFV 139
            +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       + 
Sbjct: 64  TMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVVTR 197
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +         +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTE 238
           W  APE  +    + ++ DVW  G    EIL  G KP F G +
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVK 217

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGVVCSS--INRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ IG G +G+V     +N++   KVAIK I    E  +     + E  ++  + H  ++
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 93  ALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSL-SNDHCKYFVFQLLRGLKYLH 150
            L  V +    I      LV E M+   L   +++ + L + +        +  G+ YL 
Sbjct: 67  QLYGVCLEQAPIC-----LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS    +F  ++       +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 175
Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 176 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 10  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 68
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 122
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+     E+   EY 
Sbjct: 123 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 179
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 180 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+     E+   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AI ++      + +    
Sbjct: 40  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK-EI 98
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 99  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 152
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 153 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 209
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 210 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+     E+   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 38  IGRGAYGVVCSS-INRETNEKVAIKKINNVFENRIDALRTL--RELVLLRHIKHDNVIAL 94
           +G G +GVV    +N   N  VA+KK+  + +   + L+    +E+ ++   +H+N++ L
Sbjct: 33  MGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 95  KDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLS-NDHCKYFVFQLLRGLKYL 149
                        D+ LVY  M      D    +  +  LS +  CK        G+ +L
Sbjct: 90  LGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK-IAQGAANGINFL 143
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLC 207
           H  + +HRD+K  N+L++     KI DFGLAR S    Q       V T  Y APE L  
Sbjct: 144 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR- 202
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKP 232
                   D++S G +  EI+   P
Sbjct: 203 -GEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+     E+   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +  GA+G V   +     EKV    AIK++      + +    
Sbjct: 13  QALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 71
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 125
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 126 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 182
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 183 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 38  IGRGAYGVVCSS-INRETNEKVAIKKINNVFENRIDALRTL--RELVLLRHIKHDNVIAL 94
           +G G +GVV    +N   N  VA+KK+  + +   + L+    +E+ ++   +H+N++ L
Sbjct: 39  MGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 95  KDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLS-NDHCKYFVFQLLRGLKYL 149
                        D+ LVY  M      D    +  +  LS +  CK        G+ +L
Sbjct: 96  LGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK-IAQGAANGINFL 149
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLC 207
           H  + +HRD+K  N+L++     KI DFGLAR S    Q       V T  Y APE L  
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR- 208
Query: 208 CDNYGTSIDVWSVGCIFAEILGRKP 232
                   D++S G +  EI+   P
Sbjct: 209 -GEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+     E+   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 38/238 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G  G V     R+T   +A+K++     N+ +  R L +L               DV
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDL---------------DV 76
Query: 98  MMPTHR-----------ISFKDVYLVYELMDTDLHQIIKSSQS-LSNDHCKYFVFQLLRG 145
           ++ +H            I+  DV++  ELM T   ++ K  Q  +           +++ 
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 146 LKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           L YL     ++HRD+KP N+L++    +K+CDFG++     +++          Y APE 
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS-GRLVDDKAKDRSAGCAAYMAPER 195
Query: 205 LLCCD----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           +   D    +Y    DVWS+G    E+   +  FP   C    +++  V   Q+E  L
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYKNCKTDFEVLTKVL--QEEPPL 249

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++      + +    
Sbjct: 13  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 71
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 125
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+     E+   EY 
Sbjct: 126 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 182
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 183 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +  GA+G V   +     EKV    AIK++      + +    
Sbjct: 6   QALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 53/106 (50%), Gaps = 12/106 (11%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           F +Q+ +G++YL    ++HRDL   N+LV     +KI DFGL+R     +     YV   
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRS 210
Query: 198 WYRAPELLLCCDN-----YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             R P   +  ++     Y T  DVWS G +  EI  LG  P +PG
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRT 76
           Q L  I  +T++  IK +  GA+G V   +     EKV    AIK++      + +    
Sbjct: 13  QALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 71
Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDH 134
           L E  ++  + + +V  L  + + +       V L+ +LM     L  + +   ++ + +
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 125
Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY 
Sbjct: 126 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 182
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
                V  +W     +L     Y    DVWS G    E++  G KP
Sbjct: 183 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI--KHDNVIALK 95
           +G+G YG V         E VA+K    +F +R D     RE  L   +  +H+N++   
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVK----IFSSR-DEKSWFRETELYNTVMLRHENILGFI 68
Query: 96  DVMMPTHRISFKDVYLV--YELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH--- 150
              M T R S   ++L+  Y  M + L+  ++ + +L    C   V  +  GL +LH   
Sbjct: 69  ASDM-TSRHSSTQLWLITHYHEMGS-LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 151 -----SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQF---MTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA   S+   Q        V T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 202 PELL------LCCDNYGTSIDVWSVGCIFAEILGR 230
           PE+L       C D+Y   +D+W+ G +  E+  R
Sbjct: 186 PEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARR 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI--KHDNVIALK 95
           +G+G YG V         E VA+K    +F +R D     RE  L   +  +H+N++   
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVK----IFSSR-DEKSWFRETELYNTVMLRHENILGFI 68
Query: 96  DVMMPTHRISFKDVYLV--YELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH--- 150
              M T R S   ++L+  Y  M + L+  ++ + +L    C   V  +  GL +LH   
Sbjct: 69  ASDM-TSRHSSTQLWLITHYHEMGS-LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 151 -----SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQF---MTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA   S+   Q        V T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 202 PELL------LCCDNYGTSIDVWSVGCIFAEILGR 230
           PE+L       C D+Y   +D+W+ G +  E+  R
Sbjct: 186 PEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARR 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI--KHDNVIALK 95
           +G+G YG V         E VA+K    +F +R D     RE  L   +  +H+N++   
Sbjct: 45  VGKGRYGEVWR--GSWQGENVAVK----IFSSR-DEKSWFRETELYNTVMLRHENILGFI 97
Query: 96  DVMMPTHRISFKDVYLV--YELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH--- 150
              M T R S   ++L+  Y  M + L+  ++ + +L    C   V  +  GL +LH   
Sbjct: 98  ASDM-TSRHSSTQLWLITHYHEMGS-LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 151 -----SANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQF---MTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA   S+   Q        V T+ Y A
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 202 PELL------LCCDNYGTSIDVWSVGCIFAEILGR 230
           PE+L       C D+Y   +D+W+ G +  E+  R
Sbjct: 215 PEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARR 248

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +G+G +G V  +  ++ +    KVA+K +        D    LRE   ++   H +V  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 95  KDVMMPTH---RISFKDVYLVYELMDTDLHQIIKSSQSLSN------DHCKYFVFQLLRG 145
             V + +    R+    V L + +   DLH  + +S+   N           F+  +  G
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPF-MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---QFMTEYVVTRWYRAP 202
           ++YL S N +HRDL   N ++  +  + + DFGL+R     +   Q     +  +W    
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209
Query: 203 ELLLCCDN-YGTSIDVWSVGCIFAEILGR 230
            L    DN Y    DVW+ G    EI+ R
Sbjct: 210 SL---ADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 36  KPIGRGAYGVVCSSI-----NRETNEKVAIKKI-NNVFENRIDALRTLRELVLLRHI-KH 88
           K +G GA+G V  +        +   KVA+K + +    +  +AL  + EL ++ H+ +H
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 94
Query: 89  DNVIAL-------KDVMMPTHRISFKDVY-LVYELMDTDLHQIIKSSQ---SLSNDHCK- 136
           +N++ L         V++ T    + D+   +    +  L   +   Q    L  +  + 
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 137 -------YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
                  +F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +  +
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 214
Query: 190 MTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           + +    +  +W  APE +  C  Y    DVWS G +  EI  LG  P +PG
Sbjct: 215 IVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 263

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI-------DALRTLR 78
           FE + +  P+  +G+G +G V +        +VAIK I     NR+       D++    
Sbjct: 29  FEAEYRLGPL--LGKGGFGTVFAGHRLTDRLQVAIKVIPR---NRVLGWSPLSDSVTCPL 83
Query: 79  ELVLLRHIK----HDNVIALKDVMMPTHRISFKDVYLVYE--LMDTDLHQIIKSSQSLSN 132
           E+ LL  +     H  VI L D        + +   LV E  L   DL   I     L  
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFE-----TQEGFMLVLERPLPAQDLFDYITEKGPLGE 138
Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN--ANCDLKICDFGLARTSRGNEQFM 190
              + F  Q++  +++ HS  ++HRD+K  N+L++    C  K+ DFG       +++  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGALL--HDEPY 195
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL 228
           T++  TR Y  PE +     +     VWS+G +  +++
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL 80
           Q L  I  +T+   +K +G GA+G V   I     E V I            A++ LRE 
Sbjct: 8   QALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPV----------AIKVLREN 57
Query: 81  VLLRHIKH--DNVIALKDVMMP-THRIS----FKDVYLVYELMDTD--LHQIIKSSQSLS 131
              +  K   D    +  V  P   R+        V LV +LM     L  + ++   L 
Sbjct: 58  TSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLG 117
Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT 191
           +     +  Q+ +G+ YL    ++HRDL   N+LV +   +KI DFGLAR    +E   T
Sbjct: 118 SQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---T 174
Query: 192 EY------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKP 232
           EY      V  +W     +L     +    DVWS G    E++  G KP
Sbjct: 175 EYHADGGKVPIKWMALESILR--RRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY---V 194
           F +Q+ +G++YL   +++HRDL   N+LV     +KI DFGL+R     +  +      +
Sbjct: 155 FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W     L    D+ Y T  DVWS G +  EI  LG  P +PG
Sbjct: 215 PVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 36  KPIGRGAYG-VVCSSINRE--TNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDN 90
           K +G G +G V+  ++ +E  T+ KVA+K  K++N  +  I+    L E   ++   H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF--LSEAACMKDFSHPN 97
Query: 91  VIALKDV--------------MMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCK 136
           VI L  V              ++P  +      YL+Y  ++T    I    Q+L      
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI--PLQTLLK---- 151
Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV- 195
            F+  +  G++YL + N LHRDL   N ++  +  + + DFGL++     + +    +  
Sbjct: 152 -FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 196 --TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEILGRKPI-FPGTE 238
              +W     L    D  Y +  DVW+ G    EI  R    +PG +
Sbjct: 211 MPVKWIAIESL---ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 39  GRGAYGVVCSS-INRETNEKVAIKKINNVFENRIDALRTL--RELVLLRHIKHDNVIALK 95
           G G +GVV    +N   N  VA+KK+  + +   + L+    +E+ +    +H+N++ L 
Sbjct: 31  GEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLS-NDHCKYFVFQLLRGLKYLHSANI 154
                   +    VY     +  D    +  +  LS +  CK        G+ +LH  + 
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSL-LDRLSCLDGTPPLSWHXRCK-IAQGAANGINFLHENHH 145
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM--TEYVVTRWYRAPELLLCCDNYG 212
           +HRD+K  N+L++     KI DFGLAR S    Q +  +  V T  Y APE L       
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR--GEIT 203
Query: 213 TSIDVWSVGCIFAEILGRKP 232
              D++S G +  EI+   P
Sbjct: 204 PKSDIYSFGVVLLEIITGLP 223

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY---V 194
           F +Q+ +G++YL    ++HRDL   N+LV     +KI DFGL+R     +  +      +
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             +W     L    D+ Y T  DVWS G +  EI  LG  P +PG
Sbjct: 215 PVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	364
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	0.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	0.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	0.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	0.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	0.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	0.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	0.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	0.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-163
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-163
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-162
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-154
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-154
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-138
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-129
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-109
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-109
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-108
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-107
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-107
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-106
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-106
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-106
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-105
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-104
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-102
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-64
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-61
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-60
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-60
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-60
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-59
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-59
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-58
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-57
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-57
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-57
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-56
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-56
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-56
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-56
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-55
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-55
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-55
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-55
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-54
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-54
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-54
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-54
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-54
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-54
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-54
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-54
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-54
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-53
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-53
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-53
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-53
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-52
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-52
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-52
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-52
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-52
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-52
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-52
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-52
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-52
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-52
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-52
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-50
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-50
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-50
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-49
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-49
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-49
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-49
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-49
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-49
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-49
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-48
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-48
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-48
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-47
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-46
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-46
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-46
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-45
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-44
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-44
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-43
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-43
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-42
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-42
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-41
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-41
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-39
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-34
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-30
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-30
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-27
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-25
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-06

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  567 bits (1463), Expect = 0.0
 Identities = 164/362 (45%), Positives = 236/362 (65%), Gaps = 7/362 (1%)

Query: 8   PNGMKSRGKHY-YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
            + M +        +   +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  
Sbjct: 4   HHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP- 62

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS 126
           FE++    RTLRE+ +L   +H+N+I + D++        KDVY+V +LM+TDL++++K+
Sbjct: 63  FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT 122

Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS--- 183
            Q LSNDH  YF++Q+LRGLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +   
Sbjct: 123 -QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL 243
             +  F+TEYV TRWYRAPE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

Query: 244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFE 303
             I+ + G+  + DL  I N KAR ++ SLP+      + L+P AD  ALDLL KML F 
Sbjct: 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 301

Query: 304 PSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPE 362
           P KRI V +AL HPY+   YDP   P A+ P   D++ +++ ++ ++++++ ET  + P 
Sbjct: 302 PHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 361

Query: 363 AR 364
            R
Sbjct: 362 YR 363

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  568 bits (1467), Expect = 0.0
 Identities = 138/412 (33%), Positives = 221/412 (53%), Gaps = 52/412 (12%)

Query: 5   VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN 64
           +   +   S  ++ Y        +   Y+    IGRG+YG V  + ++ T + VAIKK+N
Sbjct: 1   MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60

Query: 65  NVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQII 124
            +FE+ ID  R LRE+ +L  +K D +I L D+++P   + F ++Y+V E+ D+DL ++ 
Sbjct: 61  RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120

Query: 125 KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-- 182
           K+   L+ +H K  ++ LL G  ++H + I+HRDLKP N L+N +C +K+CDFGLART  
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 183 --------------------SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGC 222
                               ++  ++ +T +VVTRWYRAPEL+L  +NY  SID+WS GC
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 223 IFAEIL-----------GRKPIFPGTEC-----------------LNQLKLIISVFGTQQ 254
           IFAE+L            R P+FPG+ C                  +QL +I ++ GT  
Sbjct: 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300

Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
           E DL+ I+ P+  ++IK  P+ +  ++   YP      ++LL+ ML F P+KRIT+ +AL
Sbjct: 301 EDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL 360

Query: 315 QHPYISGLYDPQCNPPAQVPLSLDIDEN--IGEQMIRQMMWNETLHYHPEAR 364
            HPY+  +   +    +   + L  D+   + E  +R +   E   +HPE  
Sbjct: 361 DHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV 412

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  557 bits (1438), Expect = 0.0
 Identities = 148/353 (41%), Positives = 224/353 (63%), Gaps = 7/353 (1%)

Query: 11  MKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR 70
           ++ +G +   + +T +E+   YV    +G GAYG VCS+I++ + EKVAIKK++  F++ 
Sbjct: 5   IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 64

Query: 71  IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQS 129
           I A R  REL+LL+H++H+NVI L DV  P   + +F D YLV   M TDL +I+     
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LK 122

Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
            S +  +Y V+Q+L+GLKY+HSA ++HRDLKPGNL VN +C+LKI DFGLAR +   +  
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAE 179

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           MT YVVTRWYRAPE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ V
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
            G      ++ +++  A+ +I+SLP +     + L+P+A P A DLL+KML  +  KR+T
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299

Query: 310 VTEALQHPYISGLYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHP 361
             +AL HP+     DP+    AQ P    ++ E +     +Q ++ E +++ P
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  557 bits (1438), Expect = 0.0
 Identities = 126/364 (34%), Positives = 196/364 (53%), Gaps = 16/364 (4%)

Query: 10  GMKSRGKHY-YTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN---- 64
           GM+++G+     +   L  + + Y   + I  G+YG VC+ ++      VAIK++     
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVS 59

Query: 65  -----NVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD 119
                N+  +     R LRE+ LL H  H N++ L+D+ +     +   +YLV ELM TD
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119

Query: 120 LHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG 178
           L Q+I   +  +S  H +YF++ +L GL  LH A ++HRDL PGN+L+  N D+ ICDF 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
           LAR     +   T YV  RWYRAPEL++    +   +D+WS GC+ AE+  RK +F G+ 
Sbjct: 180 LARED-TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

Query: 239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIK-SLPYSRGTHISSLYPQADPLALDLLQ 297
             NQL  I+ V GT +  D+    +P AR +++ SL        +++ P ADP+ALDL+ 
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298

Query: 298 KMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENI-GEQMIRQMMWNET 356
           KML F P +RI+  +AL+HPY   L+DP              DE++     + ++   E 
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFTAEV 357

Query: 357 LHYH 360
             ++
Sbjct: 358 ERFN 361

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  557 bits (1437), Expect = 0.0
 Identities = 145/353 (41%), Positives = 220/353 (62%), Gaps = 7/353 (1%)

Query: 14  RGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA 73
            G +   + +T +E+   Y  ++P+G GAYG VCS+++  T  KVAIKK+   F++ + A
Sbjct: 9   SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 68

Query: 74  LRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSN 132
            R  REL LL+H++H+NVI L DV  P   +  F D YLV   M TDL +++K  + L  
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGE 127

Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           D  ++ V+Q+L+GL+Y+H+A I+HRDLKPGNL VN +C+LKI DFGLAR +   +  MT 
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 184

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
           YVVTRWYRAPE++L    Y  ++D+WSVGCI AE++  K +F G++ L+QLK I+ V GT
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                ++ + + +A+ ++K LP       +S+   A PLA++LL+KMLV +  +R+T  E
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304

Query: 313 ALQHPYISGLYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHPEAR 364
           AL HPY   L+D +  P  Q       D+ +      +++ + E L + P  +
Sbjct: 305 ALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQ 356

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  559 bits (1441), Expect = 0.0
 Identities = 143/413 (34%), Positives = 220/413 (53%), Gaps = 60/413 (14%)

Query: 12  KSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
            S+         + ++I  +Y     IG G+YG VC + ++     VAIKKI  VFE+ I
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI 94

Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLS 131
           D  R LRE+ +L  + HD+V+ + D+++P     F ++Y+V E+ D+D  ++ ++   L+
Sbjct: 95  DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT 154

Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--------- 182
             H K  ++ LL G+KY+HSA ILHRDLKP N LVN +C +K+CDFGLART         
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 183 ------------------SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF 224
                             ++  ++ +T +VVTRWYRAPEL+L  +NY  +IDVWS+GCIF
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274

Query: 225 AEILG-----------RKPIFPGTECL--------------------NQLKLIISVFGTQ 253
           AE+L            R P+FPG+ C                     +QL +I ++ GT 
Sbjct: 275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP 334

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
            E D+E ++   A+R+I+  P   GT ++  +P +   A+ LL++MLVF P+KRIT+ E 
Sbjct: 335 SEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINEC 394

Query: 314 LQHPYISGLYDPQCNPPAQVPLSLDIDEN--IGEQMIRQMMWNETLHYHPEAR 364
           L HP+   +   +    A   + L  ++   + E  +R     E   YHPE +
Sbjct: 395 LAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQ 447

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  552 bits (1425), Expect = 0.0
 Identities = 154/351 (43%), Positives = 227/351 (64%), Gaps = 18/351 (5%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           + ++ I + +     +G GAYGVVCS+ ++ T E VAIKKI   F+  + ALRTLRE+ +
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKI 62

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           L+H KH+N+I + ++  P    +F +VY++ ELM TDLH++I + Q LS+DH +YF++Q 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQT 121

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----------SRGNEQFMTE 192
           LR +K LH +N++HRDLKP NLL+N+NCDLK+CDFGLAR             G +  M E
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
           +V TRWYRAPE++L    Y  ++DVWS GCI AE+  R+PIFPG +  +QL LI  + GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 253 -QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
              + DL  I++P+AR +IKSLP      +  ++P+ +P  +DLLQ+MLVF+P+KRIT  
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 312 EALQHPYISGLYDPQ----CNPPAQVPLSLDIDE-NIGEQMIRQMMWNETL 357
           EAL+HPY+   +DP       P        D  +  +  + +++++WNE  
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  553 bits (1427), Expect = 0.0
 Identities = 151/358 (42%), Positives = 230/358 (64%), Gaps = 7/358 (1%)

Query: 7   PPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
             +  +    +   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  
Sbjct: 6   HHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIK 125
           F++ I A RT REL LL+H+KH+NVI L DV  P   +  F DVYLV  LM  DL+ I+K
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
             Q L++DH ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR    
Sbjct: 126 C-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--- 181

Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
               MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKL
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

Query: 246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPS 305
           I+ + GT     L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  
Sbjct: 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 301

Query: 306 KRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHPE 362
           KRIT  +AL H Y +  +DP   P A  P    ++  ++     + + ++E + + P 
Sbjct: 302 KRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPP 358

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  540 bits (1393), Expect = 0.0
 Identities = 140/382 (36%), Positives = 214/382 (56%), Gaps = 44/382 (11%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +    +  KY  +K +G+GAYG+V  SI+R T E VA+KKI + F+N  DA RT RE+++
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI 61

Query: 83  LRHIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQ 141
           L  +  H+N++ L +V+      + +DVYLV++ M+TDLH +I++   L   H +Y V+Q
Sbjct: 62  LTELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQ 117

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART------------------- 182
           L++ +KYLHS  +LHRD+KP N+L+NA C +K+ DFGL+R+                   
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 183 --SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
                ++  +T+YV TRWYRAPE+LL    Y   ID+WS+GCI  EIL  KPIFPG+  +
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237

Query: 241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLY--------------- 285
           NQL+ II V       D+E I +P A+  I+SL        S+                 
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297

Query: 286 -PQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDEN-- 342
               +  ALDLL K+L F P+KRI+  +AL+HP++S  ++P   P     +++ I++N  
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVK 357

Query: 343 IGEQMIRQMMWNETLHYHPEAR 364
                 R ++++E      E  
Sbjct: 358 HSIDDYRNLVYSEISRRKRELI 379

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  518 bits (1336), Expect = 0.0
 Identities = 118/323 (36%), Positives = 189/323 (58%), Gaps = 17/323 (5%)

Query: 20  TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRE 79
           +M    F++ ++Y+ +KP+G G  G+V S+++ + +++VAIKKI  V  +       LRE
Sbjct: 1   SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALRE 58

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRI---------SFKDVYLVYELMDTDLHQIIKSSQSL 130
           + ++R + HDN++ + +++ P+                VY+V E M+TDL  +++    L
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPL 117

Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTS---RGN 186
             +H + F++QLLRGLKY+HSAN+LHRDLKP NL +N  +  LKI DFGLAR       +
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
           +  ++E +VT+WYR+P LLL  +NY  +ID+W+ GCIFAE+L  K +F G   L Q++LI
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
           +       E D + + +     +I++        ++ L P     A+D L+++L F P  
Sbjct: 238 LESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 307 RITVTEALQHPYISGLYDPQCNP 329
           R+T  EAL HPY+S    P   P
Sbjct: 297 RLTAEEALSHPYMSIYSFPMDEP 319

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  517 bits (1333), Expect = 0.0
 Identities = 135/373 (36%), Positives = 207/373 (55%), Gaps = 20/373 (5%)

Query: 7   PPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
                +    +   +  + F +  +Y  +KPIG GA G+VC++ +      VAIKK++  
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIK 125
           F+N+  A R  RELVL++ + H N+I L +V  P   +  F+DVY+V ELMD +L Q+I+
Sbjct: 62  FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 121

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
               L ++   Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G
Sbjct: 122 --MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-G 178

Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
               MT YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237

Query: 246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA------------DPLAL 293
           +I   GT     ++ +  P  R ++++ P   G     L+P                 A 
Sbjct: 238 VIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296

Query: 294 DLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDEN--IGEQMIRQM 351
           DLL KMLV + SKRI+V EALQHPYI+  YDP         +     +      +  +++
Sbjct: 297 DLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356

Query: 352 MWNETLHYHPEAR 364
           ++ E +       
Sbjct: 357 IYKEVMDLEHHHH 369

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  519 bits (1337), Expect = 0.0
 Identities = 138/363 (38%), Positives = 215/363 (59%), Gaps = 20/363 (5%)

Query: 17  HYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT 76
           +   +  + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A R 
Sbjct: 49  YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 108

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSNDHC 135
            RELVL++ + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+    L ++  
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERM 166

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV 195
            Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G    MT YVV
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV 225

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           TR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT   
Sbjct: 226 TRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFE 303
             ++ +  P  R ++++ P   G     L+P +               A DLL KMLV +
Sbjct: 285 EFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343

Query: 304 PSKRITVTEALQHPYISGLYDPQ-CNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHP 361
           P+KRI+V +ALQHPYI+  YDP     P        +DE     +  +++++ E ++   
Sbjct: 344 PAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403

Query: 362 EAR 364
           + +
Sbjct: 404 KTK 406

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  461 bits (1187), Expect = e-163
 Identities = 119/379 (31%), Positives = 184/379 (48%), Gaps = 26/379 (6%)

Query: 1   MATLVEPPNGMKSRG--------KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINR 52
                 P NG+K           K   +  +T  + +  Y   K IG G++GVV  +   
Sbjct: 3   FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62

Query: 53  ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPT-HRISFKDVYL 111
           E++E VAIKK+        D     REL ++R +KH NV+ LK        +     + L
Sbjct: 63  ESDE-VAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115

Query: 112 VYELMDTDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           V E +   +++  +      Q++     K +++QLLR L Y+HS  I HRD+KP NLL++
Sbjct: 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD 175

Query: 168 ANCD-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE 226
                LK+ DFG A+     E     Y+ +R+YRAPEL+    NY T+ID+WS GC+ AE
Sbjct: 176 PPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234

Query: 227 ILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLY- 285
           ++  +P+FPG   ++QL  II V GT     ++ + NP         P  R    S ++ 
Sbjct: 235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM-NPNYMEH--KFPQIRPHPFSKVFR 291

Query: 286 PQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGE 345
           P+  P A+DL+ ++L + PS R+T  EAL HP+   L   +   P    L    +    E
Sbjct: 292 PRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEE 351

Query: 346 QMIRQMMWNETLHYHPEAR 364
             +R  + +  +  H EA 
Sbjct: 352 LSVRPDLISRLVPQHAEAE 370

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  459 bits (1183), Expect = e-163
 Identities = 102/346 (29%), Positives = 162/346 (46%), Gaps = 20/346 (5%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
            +   ++   +  G+G +G V     + T   VAIKK+    ++     R L+ +  L  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAV 75

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYL--VYELMDTDLHQIIKS----SQSLSNDHCKYFV 139
           + H N++ L+           +D+YL  V E +   LH+  ++      +      K F+
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 140 FQLLRGLKYLH--SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVT 196
           FQL+R +  LH  S N+ HRD+KP N+LVN A+  LK+CDFG A+    +E     Y+ +
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICS 194

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
           R+YRAPEL+    +Y T++D+WSVGCIFAE++  +PIF G     QL  I+ V G     
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

Query: 257 DLEFIDNPKARR-FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            L  ++          S         S    +    A DLL  +L + P +R+   EAL 
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314

Query: 316 HPYISGLYDPQCNPPAQVPLSLDI------DENIGEQMIRQMMWNE 355
           HPY   L+DP    P    L  D+      +  +  +  +  +  +
Sbjct: 315 HPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  458 bits (1181), Expect = e-162
 Identities = 105/352 (29%), Positives = 168/352 (47%), Gaps = 19/352 (5%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
                  +  Y   K IG G++GVV  +   ++ E VAIKK+        D     REL 
Sbjct: 46  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQ 99

Query: 82  LLRHIKHDNVIALKDVMMPT-HRISFKDVYLVYELMDTDLHQIIK----SSQSLSNDHCK 136
           ++R + H N++ L+     +  +     + LV + +   ++++ +    + Q+L   + K
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYVV 195
            +++QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E     Y+ 
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYIC 218

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           +R+YRAPEL+    +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT   
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISS-LYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
             +  + NP    F    P  +    +    P+  P A+ L  ++L + P+ R+T  EA 
Sbjct: 279 EQIREM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335

Query: 315 QHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETL--HYHPEAR 364
            H +   L DP    P         +    E      +    +  H   +A 
Sbjct: 336 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAA 387

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  439 bits (1130), Expect = e-154
 Identities = 98/344 (28%), Positives = 167/344 (48%), Gaps = 49/344 (14%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
              KY   K +G G++G+VC   + E+ ++ A+KK+        D     REL +++ + 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLD 58

Query: 88  HDNVIALKDVM---------------------------------MPTHRISFKDVYLVYE 114
           H N+I L D                                   +  +    K + ++ E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 115 LMDTDLHQII----KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC 170
            +   LH+++    +S +S+  +    +++QL R + ++HS  I HRD+KP NLLVN+  
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178

Query: 171 D-LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG 229
           + LK+CDFG A+    +E     Y+ +R+YRAPEL+L    Y  SID+WS+GC+F E++ 
Sbjct: 179 NTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD 289
            KP+F G   ++QL  II + GT  +  +  ++           P  +      + P+  
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGT 294

Query: 290 P-LALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ 332
           P LA+DLL+++L +EP  RI   EA+ HP+   L +   +    
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKN 338

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  434 bits (1119), Expect = e-154
 Identities = 92/327 (28%), Positives = 158/327 (48%), Gaps = 20/327 (6%)

Query: 9   NGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE 68
           N  + R    Y      +     Y  ++ +GRG Y  V  +IN   NEKV +K +  V  
Sbjct: 15  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-- 72

Query: 69  NRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS 127
                 +  RE+ +L +++   N+I L D++      S     +   + +TD  Q+    
Sbjct: 73  ---KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY--- 124

Query: 128 QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGN 186
           Q+L++   +++++++L+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA      
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HP 183

Query: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRK-PIFPGTECLNQLKL 245
            Q     V +R+++ PELL+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243

Query: 246 IISVFGTQQEAD-LEFIDNPKARRFIKSLPYSRGTHISSLYPQ-----ADPLALDLLQKM 299
           I  V GT+   D ++  +     RF   L                     P ALD L K+
Sbjct: 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303

Query: 300 LVFEPSKRITVTEALQHPYISGLYDPQ 326
           L ++   R+T  EA++HPY   +   Q
Sbjct: 304 LRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  394 bits (1015), Expect = e-138
 Identities = 94/297 (31%), Positives = 153/297 (51%), Gaps = 6/297 (2%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  I  IG G+YGVV    NR+T + VAIKK     ++ +     LRE+ +L+ +KH N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYL 149
           ++ L +V         + ++LV+E  D  +   +    + +     K   +Q L+ + + 
Sbjct: 64  LVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H  N +HRD+KP N+L+  +  +K+CDFG AR   G   +  + V TRWYR+PELL+   
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            YG  +DVW++GC+FAE+L   P++PG   ++QL LI    G       +     +    
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
           +K         +   +P     AL LL+  L  +P++R+T  + L HPY   + + +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  373 bits (959), Expect = e-129
 Identities = 93/294 (31%), Positives = 156/294 (53%), Gaps = 6/294 (2%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           F+   KY  +  +G G+YG+V    N++T   VAIKK     ++++     +RE+ LL+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLR 144
           ++H+N++ L +V         K  YLV+E +D  +   ++     L     + ++FQ++ 
Sbjct: 81  LRHENLVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           G+ + HS NI+HRD+KP N+LV+ +  +K+CDFG ART     +   + V TRWYRAPEL
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
           L+    YG ++DVW++GC+  E+   +P+FPG   ++QL  I+   G       E  +  
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                ++         +   YP+   + +DL +K L  +P KR    E L H +
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  321 bits (825), Expect = e-109
 Identities = 119/309 (38%), Positives = 165/309 (53%), Gaps = 16/309 (5%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI--NNVFENRIDALRT-LRELVLLRHIK 87
           +Y  +  +G G +  V  + ++ TN+ VAIKKI   +  E +    RT LRE+ LL+ + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGL 146
           H N+I L D           ++ LV++ M+TDL  IIK  S  L+  H K ++   L+GL
Sbjct: 71  HPNIIGLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +YLH   ILHRDLKP NLL++ N  LK+ DFGLA++     +  T  VVTRWYRAPELL 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDNPK 265
               YG  +D+W+VGCI AE+L R P  PG   L+QL  I    GT  E    +    P 
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
                 +     G  +  ++  A    LDL+Q + +F P  RIT T+AL+  Y S    P
Sbjct: 246 Y----VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 326 QCNPPAQVP 334
              P  Q+P
Sbjct: 300 GPTPGCQLP 308

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  318 bits (816), Expect = e-108
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 10/302 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y+ +  +G G Y  V    ++ T+  VA+K+I    E        +RE+ LL+ +KH N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHAN 61

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L D++      + K + LV+E +D DL Q +      ++  + K F+FQLLRGL Y 
Sbjct: 62  IVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LK+ DFGLAR      +     VVT WYR P++LL   
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDNPKARR 268
           +Y T ID+W VGCIF E+   +P+FPG+    QL  I  + GT  E      + N + + 
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN 328
           +  + P  R   + S  P+ D    DLL K+L FE   RI+  +A++HP+   L +    
Sbjct: 237 Y--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294

Query: 329 PP 330
            P
Sbjct: 295 LP 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  315 bits (810), Expect = e-107
 Identities = 111/296 (37%), Positives = 160/296 (54%), Gaps = 23/296 (7%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR------TLRELVLLR 84
           KY  ++ IG G YGVV  + N    E  A+KKI      R++         T+RE+ +L+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI------RLEKEDEGIPSTTIREISILK 55

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLL 143
            +KH N++ L DV+      + K + LV+E +D DL +++      L +   K F+ QLL
Sbjct: 56  ELKHSNIVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
            G+ Y H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  +VT WYRAP+
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFID 262
           +L+    Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  + GT    +     +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            PK   +  +          S     D   +DLL KML  +P++RIT  +AL+H Y
Sbjct: 231 LPK---YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  315 bits (810), Expect = e-107
 Identities = 118/297 (39%), Positives = 167/297 (56%), Gaps = 23/297 (7%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR------TLRELVLLR 84
           KY  ++ IG G YG V  + NRET+E VA+K++      R+D          LRE+ LL+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLK 56

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLL 143
            +KH N++ L DV+    ++      LV+E  D DL +   S +  L  +  K F+FQLL
Sbjct: 57  ELKHKNIVRLHDVLHSDKKL-----TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           +GL + HS N+LHRDLKP NLL+N N +LK+ +FGLAR      +  +  VVT WYR P+
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADL-EFI 261
           +L     Y TSID+WS GCIFAE+    +P+FPG +  +QLK I  + GT  E       
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
             P  + +     Y   T + ++ P+ +    DLLQ +L   P +RI+  EALQHPY
Sbjct: 232 KLPDYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  314 bits (806), Expect = e-106
 Identities = 113/304 (37%), Positives = 170/304 (55%), Gaps = 23/304 (7%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR------TLRELVLLR 84
           KY  ++ +G G YGVV  + +      VA+K+I      R+DA         +RE+ LL+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI------RLDAEDEGIPSTAIREISLLK 74

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLL 143
            + H N+++L DV+     +      LV+E M+ DL +++      L +   K +++QLL
Sbjct: 75  ELHHPNIVSLIDVIHSERCL-----TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
           RG+ + H   ILHRDLKP NLL+N++  LK+ DFGLAR      +  T  VVT WYRAP+
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EFID 262
           +L+    Y TS+D+WS+GCIFAE++  KP+FPG    +QL  I S+ GT    +  +  +
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
            P  ++   +         SS+ P      +DLL  ML F+P+KRI+  +A+ HPY   L
Sbjct: 250 LPLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

Query: 323 YDPQ 326
            DPQ
Sbjct: 308 -DPQ 310

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  314 bits (807), Expect = e-106
 Identities = 107/300 (35%), Positives = 159/300 (53%), Gaps = 25/300 (8%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR------TLRELVLLR 84
           +Y  I  +G G YG V  +I+  TNE VAIK+I      R++          +RE+ LL+
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLK 88

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
            ++H N+I LK V+   HR+     +L++E  + DL + +  +  +S    K F++QL+ 
Sbjct: 89  ELQHRNIIELKSVIHHNHRL-----HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCD-----LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           G+ + HS   LHRDLKP NLL++ +       LKI DFGLAR      +  T  ++T WY
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL- 258
           R PE+LL   +Y TS+D+WS+ CI+AE+L + P+FPG   ++QL  I  V G   +    
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                P  ++            +  L    D   LDLL  ML  +P KRI+   AL+HPY
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRV--LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  313 bits (805), Expect = e-106
 Identities = 111/299 (37%), Positives = 155/299 (51%), Gaps = 20/299 (6%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR-----TLRELVLLRH 85
           +Y P+  IG GAYG V  + +  +   VA+K +     N           T+RE+ LLR 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRR 67

Query: 86  IK---HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS--LSNDHCKYFVF 140
           ++   H NV+ L DV   +       V LV+E +D DL   +  +    L  +  K  + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           Q LRGL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR     +  +T  VVT WYR
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVVTLWYR 186

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-E 259
           APE+LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I  + G   E D   
Sbjct: 187 APEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            +  P+      + P      + S+ P+ +     LL +ML F P KRI+   ALQH Y
Sbjct: 246 DVSLPRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  310 bits (797), Expect = e-105
 Identities = 117/324 (36%), Positives = 169/324 (52%), Gaps = 26/324 (8%)

Query: 31  KYVPIKPIGRGAYGVVCSSIN-RETNEKVAIKKINNVFENRIDALR------TLRELVLL 83
           +Y  +  IG GAYG V  + + +     VA+K++      R+          T+RE+ +L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVL 65

Query: 84  RHIK---HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQS--LSNDHCKYF 138
           RH++   H NV+ L DV   +       + LV+E +D DL   +       +  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW 198
           +FQLLRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR     +  +T  VVT W
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLW 184

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           YRAPE+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I+ V G   E D 
Sbjct: 185 YRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 259 -EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
              +  P+      +        I       D L  DLL K L F P+KRI+   AL HP
Sbjct: 244 PRDVALPRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 318 YISGLYDPQCNPPAQVPLSLDIDE 341
           Y   L   + N  + +P S +  E
Sbjct: 299 YFQDLERCKENLDSHLPPSQNTSE 322

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  308 bits (792), Expect = e-104
 Identities = 106/314 (33%), Positives = 160/314 (50%), Gaps = 26/314 (8%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-----LRTLRELVLLRH 85
           ++  ++ +G G Y  V   +N+ T   VA+K++      ++D+        +RE+ L++ 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKE 59

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS------QSLSNDHCKYFV 139
           +KH+N++ L DV+      +   + LV+E MD DL + + S       + L  +  KYF 
Sbjct: 60  LKHENIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           +QLL+GL + H   ILHRDLKP NLL+N    LK+ DFGLAR         +  VVT WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL- 258
           RAP++L+    Y TSID+WS GCI AE++  KP+FPGT    QLKLI  + GT  E+   
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 259 EFIDNPKARRFIKSLPYSRGTHI--SSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                PK    I+  P      +         D   +D L  +L   P  R++  +AL H
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294

Query: 317 PYISGLYDPQCNPP 330
           P+ +       +  
Sbjct: 295 PWFAEY-YHHASMG 307

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  303 bits (779), Expect = e-102
 Identities = 102/324 (31%), Positives = 156/324 (48%), Gaps = 19/324 (5%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALR--TLRELVLLRHIKH 88
           KY  +  IG+G +G V  + +R+T +KVA+KK+    EN  +      LRE+ +L+ +KH
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKH 75

Query: 89  DNVIALKDVMMPTHRISFKD---VYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLR 144
           +NV+ L ++         +    +YLV++  + DL  ++ +     +    K  +  LL 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----SRGNEQFMTEYVVTRWYR 200
           GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR             T  VVT WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-E 259
            PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+        
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQ--ADPLALDLLQKMLVFEPSKRITVTEALQHP 317
             +     +    L   +   +         DP ALDL+ K+LV +P++RI   +AL H 
Sbjct: 256 VDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 318 YISGLYDPQCNPPAQVPLSLDIDE 341
           +     DP  +    +  +     
Sbjct: 314 FFWS--DPMPSDLKGMLSTHLTSM 335

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  291 bits (747), Expect = 2e-96
 Identities = 107/334 (32%), Positives = 161/334 (48%), Gaps = 43/334 (12%)

Query: 38  IGRGAYGVVCSSINRE--TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +GRG YG V  +  ++   ++  A+K+I         ++   RE+ LLR +KH NVI+L+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGI--SMSACREIALLRELKHPNVISLQ 84

Query: 96  DVMMPTHRISFKDVYLVYELMDTDLHQIIKS---------SQSLSNDHCKYFVFQLLRGL 146
            V +     + + V+L+++  + DL  IIK             L     K  ++Q+L G+
Sbjct: 85  KVFLSH---ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR      + + +    VVT WY
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE---------CLNQLKLIISVF 250
           RAPELLL   +Y  +ID+W++GCIFAE+L  +PIF   +           +QL  I +V 
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 251 GTQQEADLEFIDN-PKARRFIKSLP------YSRGTHISSLYPQADPLALDLLQKMLVFE 303
           G   + D E I   P+    +K          S   ++     + D  A  LLQK+L  +
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 304 PSKRITVTEALQHPYISGLYDPQCNPPAQVPLSL 337
           P KRIT  +A+Q PY     DP           +
Sbjct: 322 PIKRITSEQAMQDPYFLE--DPLPTSDVFAGCQI 353

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  210 bits (536), Expect = 1e-64
 Identities = 91/332 (27%), Positives = 159/332 (47%), Gaps = 50/332 (15%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI- 86
           +  +Y  +K IG+G++G V  + + + ++ VA+K + N    +    +   E+ +L H+ 
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLR 151

Query: 87  KHD-----NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFV 139
           K D     NVI + +      R     + + +EL+  +L+++IK +  Q  S    + F 
Sbjct: 152 KQDKDNTMNVIHMLENFT--FR---NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVN--ANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
             +L+ L  LH   I+H DLKP N+L+       +K+ DFG +       Q +  Y+ +R
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTYIQSR 263

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG------ 251
           +YRAPE++L    YG  ID+WS+GCI AE+L   P+ PG +  +QL  +I + G      
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322

Query: 252 ----------------------TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD 289
                                 T        ++  ++RR     P       ++L    D
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382

Query: 290 PLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
           PL LD L++ L ++P+ R+T  +AL+HP++  
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  199 bits (507), Expect = 6e-61
 Identities = 75/344 (21%), Positives = 134/344 (38%), Gaps = 41/344 (11%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR------IDALRTLRELV 81
            D +Y+ ++ +G G +  V  + +   N  VA+K +             I  L+ + +  
Sbjct: 17  KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76

Query: 82  LLR--HIKHDNVIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCK 136
             +   +  ++++ L D     H+      V +V+E++  +L  +IK    + +   + K
Sbjct: 77  NTKEDSMGANHILKLLDHFN--HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134

Query: 137 YFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCD------LKICDFGLARTSRGNEQF 189
               QLL GL Y+H    I+H D+KP N+L+           +KI D G A      ++ 
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEH 191

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC------LNQL 243
            T  + TR YR+PE+LL    +G   D+WS  C+  E++    +F   E        + +
Sbjct: 192 YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250

Query: 244 KLIISVFG--------TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLA--- 292
             II + G          +     F      R   K   +     ++  Y  +   A   
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310

Query: 293 LDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS 336
            D L  ML  +P KR      + HP++      +        L 
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  196 bits (501), Expect = 1e-60
 Identities = 74/319 (23%), Positives = 120/319 (37%), Gaps = 51/319 (15%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
           +Q++      Y  +K IG G    V   +N E  +  AIK +N    +         E+ 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 82  LLRHIKH--DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFV 139
            L  ++   D +I L D  +    I     Y+V E  + DL+  +K  +S+     K + 
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYI-----YMVMECGNIDLNSWLKKKKSIDPWERKSYW 133

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTR 197
             +L  +  +H   I+H DLKP N L+  +  LK+ DFG+A   + +         V T 
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 198 WYRAPELLLCCDN----------YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLI 246
            Y  PE +    +               DVWS+GCI   +  G+ P       +++L  I
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252

Query: 247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
           I                                H        +    D+L+  L  +P +
Sbjct: 253 I-----------------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 283

Query: 307 RITVTEALQHPYISGLYDP 325
           RI++ E L HPY+     P
Sbjct: 284 RISIPELLAHPYVQIQTHP 302

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  198 bits (506), Expect = 3e-60
 Identities = 90/307 (29%), Positives = 140/307 (45%), Gaps = 45/307 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLREL 80
            +  +Y+  K +G GA G V  +  R+T +KVAI+ I+              AL    E+
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191

Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFV 139
            +L+ + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + 
Sbjct: 192 EILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVT 196
           +Q+L  ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGT 304

Query: 197 RWYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
             Y APE+L+      Y  ++D WS+G I    L   P F        LK  I       
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------T 358

Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                FI    A              +S         ALDL++K+LV +P  R T  EAL
Sbjct: 359 SGKYNFIPEVWA-------------EVS-------EKALDLVKKLLVVDPKARFTTEEAL 398

Query: 315 QHPYISG 321
           +HP++  
Sbjct: 399 RHPWLQD 405

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  195 bits (498), Expect = 4e-60
 Identities = 97/338 (28%), Positives = 150/338 (44%), Gaps = 48/338 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------NVFENRIDALRTLREL 80
            +  +Y+  K +G GA G V  +  R+T +KVAIK I+              AL    E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFV 139
            +L+ + H  +I +K+          +D Y+V ELM+  +L   +  ++ L    CK + 
Sbjct: 67  EILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVT 196
           +Q+L  ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G    M     T
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGT 179

Query: 197 RWYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
             Y APE+L+      Y  ++D WS+G I    L   P F        LK  I       
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------T 233

Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                FI    A              +S         ALDL++K+LV +P  R T  EAL
Sbjct: 234 SGKYNFIPEVWA-------------EVS-------EKALDLVKKLLVVDPKARFTTEEAL 273

Query: 315 QHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMM 352
           +HP++    D       Q  LS + +     Q++ Q  
Sbjct: 274 RHPWLQ---DEDMKRKFQDLLSEENESTALPQVLAQPS 308

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  194 bits (495), Expect = 3e-59
 Identities = 47/330 (14%), Positives = 86/330 (26%), Gaps = 55/330 (16%)

Query: 20  TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-R 78
           T+   L + + K   ++P+  G   VV    + E  E  A+K      EN    L  L  
Sbjct: 52  TVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHE 111

Query: 79  ELVLLRHIKHDNVIALKD---------------------VMMPTHRISFKDVYLVYELMD 117
                  +  ++    +D                     +       +  +  L+     
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171

Query: 118 TDLHQIIK-------SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC 170
            DL  +                        QL+R    L S  ++H    P NL +  + 
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG 231

Query: 171 DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAEILG 229
            L + D                  V   Y   E L      +  +++ W +G     +  
Sbjct: 232 RLMLGDVSALWK---VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD 289
               F                         +           SL +   T +        
Sbjct: 289 LFLPFGLVT---------------PGIKGSWKRPSLRVPGTDSLAFGSCTPLP------- 326

Query: 290 PLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                L+ + L F+  +R+   EA++ P  
Sbjct: 327 DFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  194 bits (496), Expect = 4e-59
 Identities = 90/343 (26%), Positives = 153/343 (44%), Gaps = 59/343 (17%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI- 86
              +Y     IG+G++G V  + +R   E VAIK I N       A     E+ LL  + 
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMN 108

Query: 87  KHD-----NVIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKYF 138
           KHD      ++ LK   M      F++ + LV+E++  +L+ +++++  + +S +  + F
Sbjct: 109 KHDTEMKYYIVHLKRHFM------FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF 162

Query: 139 VFQLLRGLKYLHS--ANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYV 194
             Q+   L +L +   +I+H DLKP N+L+       +KI DFG +       Q + +Y+
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYI 219

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG--- 251
            +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ V G   
Sbjct: 220 QSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278

Query: 252 ---------------TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYP---------- 286
                             +           +R  K     +  +I  +            
Sbjct: 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGE 338

Query: 287 ----QADPLAL-DLLQKMLVFEPSKRITVTEALQHPYISGLYD 324
                AD L   DL+ +ML ++P  RI    ALQH +     D
Sbjct: 339 SGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 7e-59
 Identities = 59/306 (19%), Positives = 117/306 (38%), Gaps = 24/306 (7%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
            +  ++    +G+GA   V    +++T +  AIK  NN+   R      +RE  +L+ + 
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLN 65

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS---LSNDHCKYFVFQLL 143
           H N++ L  +       + +   L+ E      L+ +++   +   L        +  ++
Sbjct: 66  HKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEYVVTRWY 199
            G+ +L    I+HR++KPGN++     D     K+ DFG AR    +EQF++    T  Y
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGTEEY 181

Query: 200 RAPELL-------LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFG 251
             P++             YG ++D+WS+G  F     G  P  P        +++  +  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
            +    +  +   +      S        +S        L   +L  +L  +  K     
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298

Query: 312 EALQHP 317
           +     
Sbjct: 299 QFFAET 304

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  191 bits (487), Expect = 3e-58
 Identities = 72/317 (22%), Positives = 117/317 (36%), Gaps = 51/317 (16%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
              Y  +K IG G    V   +N E  +  AIK +N    +         E+  L  ++ 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 89  --DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
             D +I L D  +     + + +Y+V E  + DL+  +K  +S+     K +   +L  +
Sbjct: 67  HSDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPEL 204
             +H   I+H DLKP N L+  +  LK+ DFG+A   + +         V T  Y  PE 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 205 LL----------CCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQ 253
           +                    DVWS+GCI   +  G+ P       +++L  II      
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 234

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
                                     H        +    D+L+  L  +P +RI++ E 
Sbjct: 235 -----------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 314 LQHPYISGLYDPQCNPP 330
           L HPY+     P     
Sbjct: 272 LAHPYVQIQTHPVNQMA 288

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  193 bits (491), Expect = 8e-58
 Identities = 71/305 (23%), Positives = 114/305 (37%), Gaps = 58/305 (19%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHD 89
            + P   +G GA G +        N  VA+K+I     +  D     RE+ LLR   +H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78

Query: 90  NVIALKDVMMPTHRISFKD---VYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLLRG 145
           NVI              KD    Y+  EL    L + ++    +         + Q   G
Sbjct: 79  NVIRYFCT--------EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 146 LKYLHSANILHRDLKPGNLLV-----NANCDLKICDFGLARTSRGNEQ---FMTEYVVTR 197
           L +LHS NI+HRDLKP N+L+     +      I DFGL +            +    T 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 198 WYRAPELLLCCDN--YGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQ 254
            + APE+L          ++D++S GC+F  ++      F  +       L+        
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-------G 243

Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
              L+ +                           D +A +L++KM+  +P KR +    L
Sbjct: 244 ACSLDCLHPE---------------------KHEDVIARELIEKMIAMDPQKRPSAKHVL 282

Query: 315 QHPYI 319
           +HP+ 
Sbjct: 283 KHPFF 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  190 bits (484), Expect = 2e-57
 Identities = 72/323 (22%), Positives = 114/323 (35%), Gaps = 51/323 (15%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH-- 88
            Y  +K IG G    V   +N E  +  AIK +N    +         E+  L  ++   
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           D +I L D  +    I     Y+V E  + DL+  +K  +S+     K +   +L  +  
Sbjct: 116 DKIIRLYDYEITDQYI-----YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLL 206
           +H   I+H DLKP N L+  +  LK+ DFG+A   + +         V    Y  PE + 
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 207 ----------CCDNYGTSIDVWSVGCIFAEILGRKPIFPG-TECLNQLKLIISVFGTQQE 255
                              DVWS+GCI   +   K  F      +++L  II        
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-------- 281

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
                                   H        +    D+L+  L  +P +RI++ E L 
Sbjct: 282 ---------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

Query: 316 HPYISGLYDPQCNPPAQVPLSLD 338
           HPY+     P           + 
Sbjct: 321 HPYVQIQTHPVNQMAKGTTEEMK 343

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  187 bits (477), Expect = 3e-57
 Identities = 72/313 (23%), Positives = 122/313 (38%), Gaps = 56/313 (17%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            +  I  +G+GA+G V  + N   +   AIKKI +           L E++LL  + H  
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQY 63

Query: 91  VIALKDV--------MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSN-DHCKYFVF 140
           V+                T       +++  E  +   L+ +I S       D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------------TSRGN 186
           Q+L  L Y+HS  I+HRDLKP N+ ++ + ++KI DFGLA+                 G+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
              +T  + T  Y A E+L    +Y   ID++S+G IF E++   P   G E +N LK +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

Query: 247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
                               R      P     +          +   +++ ++  +P+K
Sbjct: 242 --------------------RSVSIEFPPDFDDNKM-------KVEKKIIRLLIDHDPNK 274

Query: 307 RITVTEALQHPYI 319
           R      L   ++
Sbjct: 275 RPGARTLLNSGWL 287

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  189 bits (481), Expect = 4e-57
 Identities = 71/344 (20%), Positives = 139/344 (40%), Gaps = 69/344 (20%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           ++  ++ I+ +G G +G V    + +  +  A+K + N+ +    A     E  +L+ I+
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQ 89

Query: 88  HD-----NVIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKYFV 139
           +D     N++      M      + D + L++E +   L++II  +       +  K + 
Sbjct: 90  NDDINNNNIVKYHGKFM------YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYC 143

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVN-------------------------ANCDLKI 174
            ++L+ L YL   ++ H DLKP N+L++                          +  +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF 234
            DFG    +     +    + TR YRAPE++L    +  S D+WS GC+ AE+     +F
Sbjct: 204 IDFG---CATFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF 259

Query: 235 PGTECLNQLKLIISVFG-------------------TQQEADLEFIDNPKARRFIKSLPY 275
              E +  L ++ S+                      + E  L + +N  +   IK +  
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319

Query: 276 SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
               +          L  D L  +L  +P+ R +  E L+H ++
Sbjct: 320 CLPLY----KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  185 bits (472), Expect = 2e-56
 Identities = 83/312 (26%), Positives = 134/312 (42%), Gaps = 53/312 (16%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-------NVFENRIDALRTLRE 79
                Y P + +GRG   VV   I++ T ++ A+K I+       +  E +     TL+E
Sbjct: 14  GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 80  LVLLRHIK-HDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDH 134
           + +LR +  H N+I LKD         ++     +LV++LM   +L   +    +LS   
Sbjct: 74  VDILRKVSGHPNIIQLKDT--------YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
            +  +  LL  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +      E  + E  
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVC 184

Query: 195 VTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
            T  Y APE++ C        YG  +D+WS G I   +L   P F       Q+ ++  +
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMI 241

Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
                  + +F                     S           DL+ + LV +P KR T
Sbjct: 242 ----MSGNYQFGSPE-------------WDDYS-------DTVKDLVSRFLVVQPQKRYT 277

Query: 310 VTEALQHPYISG 321
             EAL HP+   
Sbjct: 278 AEEALAHPFFQQ 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  190 bits (485), Expect = 2e-56
 Identities = 87/336 (25%), Positives = 146/336 (43%), Gaps = 48/336 (14%)

Query: 8   PNGMKSRGKHYYTMWQTLF--EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN- 64
           P  M         M+          +Y   + +G+G++G V    ++ T ++ A+K I+ 
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 65  NVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDL 120
              + + D    LRE+ LL+ + H N++ L +         F+D    YLV E+    +L
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF--------FEDKGYFYLVGEVYTGGEL 113

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDF 177
              I S +  S       + Q+L G+ Y+H   I+HRDLKP NLL+   + + +++I DF
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173

Query: 178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT 237
           GL+     +++ M + + T +Y APE+L     Y    DVWS G I   +L   P F G 
Sbjct: 174 GLSTHFEASKK-MKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGCPPFNGA 230

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
              N+  ++  V    ++    F                        + +    A DL++
Sbjct: 231 ---NEYDILKKV----EKGKYTFELPQ--------------------WKKVSESAKDLIR 263

Query: 298 KMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQV 333
           KML + PS RI+  +AL H +I      Q +     
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS 299

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  185 bits (471), Expect = 7e-56
 Identities = 86/343 (25%), Positives = 140/343 (40%), Gaps = 61/343 (17%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETN-EKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G GA+G V   I+ +     VA+K + NV      A     E+ +L H+
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHL 68

Query: 87  -KHD-----NVIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKY 137
              D       + + +             + +V+EL+    +  IK +       DH + 
Sbjct: 69  NTTDPNSTFRCVQMLEWFE------HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVN-------------------ANCDLKICDFG 178
             +Q+ + + +LHS  + H DLKP N+L                      N D+K+ DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

Query: 179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
            A       +  +  V TR YRAPE++L    +    DVWS+GCI  E      +FP  +
Sbjct: 183 SATYDD---EHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISS---LYPQADPLA--- 292
               L ++  + G         I   + R++          H S+   +     PL    
Sbjct: 239 SKEHLAMMERILGP---LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295

Query: 293 ----------LDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
                      DL+QKML ++P+KRIT+ EAL+HP+   L   
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  185 bits (472), Expect = 7e-56
 Identities = 84/344 (24%), Positives = 138/344 (40%), Gaps = 61/344 (17%)

Query: 28  IDTKYVPIKPIGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y  +  +G G +G VV    +     +VA+K I NV + R  A     E+ +L+ I
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKI 73

Query: 87  -KHD-----NVIALKDVMMPTHRISFKD-VYLVYELMDTDLHQIIKSS--QSLSNDHCKY 137
            + D       + + D         F   + + +EL+  +  + +K +  Q     H ++
Sbjct: 74  KEKDKENKFLCVLMSDWFN------FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH 127

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVN-------------------ANCDLKICDFG 178
             +QL   L++LH   + H DLKP N+L                      N  +++ DFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
            A       +  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E
Sbjct: 188 SATFDH---EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHE 243

Query: 239 CLNQLKLIISVFGTQQEADLEFIDN-PKARRFIKSLPYSRGTHISSLYPQA--------- 288
               L ++  + G         I    K + F K             Y +          
Sbjct: 244 NREHLVMMEKILGP---IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300

Query: 289 ------DPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
                      DL+++ML F+P++RIT+ EAL HP+ +GL   +
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  184 bits (470), Expect = 2e-55
 Identities = 85/310 (27%), Positives = 132/310 (42%), Gaps = 54/310 (17%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--------NVFENRIDALRTLR 78
           E   KY P   IGRG   VV   ++R T  + A+K +            E   +A R  R
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR--R 148

Query: 79  ELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCK 136
           E  +LR +  H ++I L D        S   ++LV++LM   +L   +    +LS    +
Sbjct: 149 ETHILRQVAGHPHIITLIDSYE-----SSSFMFLVFDLMRKGELFDYLTEKVALSEKETR 203

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT 196
             +  LL  + +LH+ NI+HRDLKP N+L++ N  +++ DFG +      E  + E   T
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGT 262

Query: 197 RWYRAPELLLCC-----DNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISV 249
             Y APE+L C        YG  +D+W+ G I    L  G  P F       Q+ ++  +
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVI-LFTLLAGSPP-FWHR---RQILMLRMI 317

Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
                E   +F                     S           DL+ ++L  +P  R+T
Sbjct: 318 ----MEGQYQFSSPE-------------WDDRS-------STVKDLISRLLQVDPEARLT 353

Query: 310 VTEALQHPYI 319
             +ALQHP+ 
Sbjct: 354 AEQALQHPFF 363

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  187 bits (478), Expect = 2e-55
 Identities = 89/327 (27%), Positives = 139/327 (42%), Gaps = 50/327 (15%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           +   Y  +K +G GAYG V    ++ T+ + AIK I     +     + L E+ +L+ + 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 88  HDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLL 143
           H N++ L D         F+D    YLV E     +L   I      +       + Q+L
Sbjct: 95  HPNIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
            G+ YLH  NI+HRDLKP NLL+     +  +KI DFGL+       + M E + T +Y 
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYI 205

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE+L     Y    DVWS+G I   +L   P F G       +++  V    ++    F
Sbjct: 206 APEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEILRKV----EKGKYTF 256

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                                   +      A DL+++ML F+  +RI+  +AL+HP+I 
Sbjct: 257 DSPE--------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296

Query: 321 GLYDPQCNPPAQVPLSLDIDENIGEQM 347
            +         +  + L    N  E M
Sbjct: 297 EM-----CSKKESGIELPSLANAIENM 318

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  181 bits (462), Expect = 4e-55
 Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 44/302 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +    Y   + +G+GA+ VV   +++ T  + A K IN    +  D  +  RE  + R +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
           +H N++ L D          ++    YLV++L+   +L + I + +  S     + + Q+
Sbjct: 63  QHPNIVRLHDS--------IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWY 199
           L  + Y HS  I+HR+LKP NLL+ +      +K+ DFGLA     + +    +  T  Y
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGY 173

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
            +PE+L   D Y   +D+W+ G I   +L   P F      +Q +L   +    +    +
Sbjct: 174 LSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQI----KAGAYD 225

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           +                    ++       P A  L+  ML   P KRIT  +AL+ P+I
Sbjct: 226 YPSPE-------------WDTVT-------PEAKSLIDSMLTVNPKKRITADQALKVPWI 265

Query: 320 SG 321
             
Sbjct: 266 CN 267

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  186 bits (474), Expect = 8e-55
 Identities = 93/323 (28%), Positives = 144/323 (44%), Gaps = 46/323 (14%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
              +Y  +  +G+G++G V    +R T ++ A+K IN       D    LRE+ LL+ + 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 88  HDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLL 143
           H N++ L ++         +D    Y+V EL    +L   I   +  S       + Q+ 
Sbjct: 80  HPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF 131

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
            G+ Y+H  NI+HRDLKP N+L+     +CD+KI DFGL+   + N + M + + T +Y 
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYI 190

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE+L     Y    DVWS G I   +L   P F G    N+  ++  V    +     F
Sbjct: 191 APEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRV----ETGKYAF 241

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                                   +      A DL++KML F PS RIT T+ L+HP+I 
Sbjct: 242 DLPQ--------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

Query: 321 GLYDPQCNPPAQVPLSLDIDENI 343
             Y  +    + +P       NI
Sbjct: 282 K-YSSETPTISDLPSLESAMTNI 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  181 bits (461), Expect = 9e-55
 Identities = 84/302 (27%), Positives = 131/302 (43%), Gaps = 47/302 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
            I   ++ ++ +G GA+  V     R T +  A+K I      R  +L    E+ +L+ I
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKI 63

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
           KH+N++ L+D+        ++     YLV +L+   +L   I      +       + Q+
Sbjct: 64  KHENIVTLEDI--------YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115

Query: 143 LRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           L  +KYLH   I+HRDLKP NLL      N  + I DFGL++        M+    T  Y
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGY 173

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
            APE+L     Y  ++D WS+G I   +L   P F       + KL   +    +E   E
Sbjct: 174 VAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFEKI----KEGYYE 225

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           F             P+     IS         A D +  +L  +P++R T  +AL HP+I
Sbjct: 226 FES-----------PFWD--DIS-------ESAKDFICHLLEKDPNERYTCEKALSHPWI 265

Query: 320 SG 321
            G
Sbjct: 266 DG 267

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  183 bits (466), Expect = 1e-54
 Identities = 60/306 (19%), Positives = 117/306 (38%), Gaps = 26/306 (8%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
            +  ++    +G+GA   V    +++T +  AIK  NN+   R      +RE  +L+ + 
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLN 65

Query: 88  HDNVIALKDVM-MPTHRISFKDVYLVYELMDT-DLHQII---KSSQSLSNDHCKYFVFQL 142
           H N++ L  +    T     +   L+ E      L+ ++    ++  L        +  +
Sbjct: 66  HKNIVKLFAIEEETTT----RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEYVVTRW 198
           + G+ +L    I+HR++KPGN++     D     K+ DFG AR    +EQF++    T  
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGTEE 180

Query: 199 YRAPELL-------LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVF 250
           Y  P++             YG ++D+WS+G  F     G  P  P        +++  + 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV 310
             +    +  +   +      S        +S        L   +L  +L  +  K    
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGF 297

Query: 311 TEALQH 316
            +    
Sbjct: 298 DQFFAE 303

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  182 bits (464), Expect = 1e-54
 Identities = 82/339 (24%), Positives = 140/339 (41%), Gaps = 48/339 (14%)

Query: 7   PPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
              G +  G+    M     +    Y   + +G+GA+ VV   +++ T  + A K IN  
Sbjct: 6   SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQ 122
             +  D  +  RE  + R ++H N++ L D          ++    YLV++L+   +L +
Sbjct: 66  KLSARDFQKLEREARICRKLQHPNIVRLHDS--------IQEESFHYLVFDLVTGGELFE 117

Query: 123 IIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGL 179
            I + +  S     + + Q+L  + Y HS  I+HR+LKP NLL+ +      +K+ DFGL
Sbjct: 118 DIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT 237
           A     + +    +  T  Y +PE+L   D Y   +D+W+ G I   IL  G  P F   
Sbjct: 178 AIEVN-DSEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVI-LYILLVGYPP-FWDE 233

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
              +Q +L   +    +    ++                    ++       P A  L+ 
Sbjct: 234 ---DQHRLYAQI----KAGAYDYPSPEWD-------------TVT-------PEAKSLID 266

Query: 298 KMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS 336
            ML   P KRIT  +AL+ P+I            Q  + 
Sbjct: 267 SMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 305

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  180 bits (460), Expect = 3e-54
 Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 48/304 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRH 85
           +    Y   + IG G+Y V    I++ TN + A+K I+              E+ +LLR+
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRY 72

Query: 86  IKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQ 141
            +H N+I LKDV        + D   VY+V ELM   +L   I   +  S       +F 
Sbjct: 73  GQHPNIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSRGNEQFMTEYVVTR 197
           + + ++YLH+  ++HRDLKP N+L          ++ICDFG A+  R     +     T 
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            + APE+L     Y  + D+WS+G +   +L     F         +++  +        
Sbjct: 185 NFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGK 239

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                                  +S         A DL+ KML  +P +R+T    L+HP
Sbjct: 240 FSLSGGY-------------WNSVS-------DTAKDLVSKMLHVDPHQRLTAALVLRHP 279

Query: 318 YISG 321
           +I  
Sbjct: 280 WIVH 283

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  183 bits (466), Expect = 3e-54
 Identities = 76/329 (23%), Positives = 122/329 (37%), Gaps = 77/329 (23%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
            +    V  K +G G+ G V           VA+K++   F +         E+ LL   
Sbjct: 12  SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTES 65

Query: 87  K-HDNVIALKDVMMPTHRISFKD---VYLVYELMDTDLHQIIKS-------SQSLSNDHC 135
             H NVI                   +Y+  EL + +L  +++S        +     + 
Sbjct: 66  DDHPNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLV-------------NANCDLKICDFGLART 182
              + Q+  G+ +LHS  I+HRDLKP N+LV               N  + I DFGL + 
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 183 SRGNEQ----FMTEYVVTRWYRAPELLLCCDN------YGTSIDVWSVGCIFAEIL--GR 230
               +      +     T  +RAPELL   +N         SID++S+GC+F  IL  G+
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 231 KPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP 290
            P                 FG +   +   I   +    +  +       +         
Sbjct: 238 HP-----------------FGDKYSRESNII---RGIFSLDEMKCLHDRSLI-------A 270

Query: 291 LALDLLQKMLVFEPSKRITVTEALQHPYI 319
            A DL+ +M+  +P KR T  + L+HP  
Sbjct: 271 EATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  178 bits (455), Expect = 4e-54
 Identities = 78/308 (25%), Positives = 139/308 (45%), Gaps = 53/308 (17%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLL 83
           ++  Y   + +G G + +V     + T ++ A K I     +     +      RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 84  RHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFV 139
           R I+H N+I L D+        F++   V L+ EL+   +L   +   +SL+ D    F+
Sbjct: 63  REIRHPNIITLHDI--------FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSRGNEQFMTEYVV 195
            Q+L G+ YLHS  I H DLKP N+++      N  +K+ DFG+A               
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFG 173

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQ 253
           T  + APE++   +  G   D+WS+G I   IL  G  P F G     + + + ++    
Sbjct: 174 TPEFVAPEIVN-YEPLGLEADMWSIGVI-TYILLSGASP-FLGE---TKQETLTNI---- 223

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
              + +F +      F         ++ S        LA D ++++LV +P +R+T+ ++
Sbjct: 224 SAVNYDFDEEY----F---------SNTS-------ELAKDFIRRLLVKDPKRRMTIAQS 263

Query: 314 LQHPYISG 321
           L+H +I  
Sbjct: 264 LEHSWIKA 271

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  183 bits (466), Expect = 4e-54
 Identities = 84/319 (26%), Positives = 136/319 (42%), Gaps = 47/319 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
               +Y   + +G+GA+ VV   +     ++ A   IN    +  D  +  RE  + R +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQL 142
           KH N++ L D           +    YL+++L+   +L + I + +  S     + + Q+
Sbjct: 68  KHPNIVRLHDS--------ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119

Query: 143 LRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           L  + + H   ++HR+LKP NLL+        +K+ DFGLA    G +Q    +  T  Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            +PE+L   D YG  +D+W+ G I   IL  G  P F      +Q +L   +    +   
Sbjct: 180 LSPEVLR-KDPYGKPVDLWACGVI-LYILLVGYPP-FWDE---DQHRLYQQI----KAGA 229

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            +F                    ++       P A DL+ KML   PSKRIT  EAL+HP
Sbjct: 230 YDFPSPE-------------WDTVT-------PEAKDLINKMLTINPSKRITAAEALKHP 269

Query: 318 YISGLYDPQCNPPAQVPLS 336
           +IS           Q  + 
Sbjct: 270 WISHRSTVASCMHRQETVD 288

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  178 bits (454), Expect = 5e-54
 Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 57/302 (18%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  I+ IG G +G V  + +R   +   IK++      + +  +  RE+  L  + H N+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHVNI 66

Query: 92  IALKD-----------VMMPTHRISFKDVYLVYELMDT-DLHQIIK--SSQSLSNDHCKY 137
           +                   + R   K +++  E  D   L Q I+    + L       
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
              Q+ +G+ Y+HS  +++RDLKP N+ +     +KI DFGL  + + + +       T 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SKGTL 185

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            Y +PE +    +YG  +D++++G I AE+L         E       +           
Sbjct: 186 RYMSPEQIS-SQDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDL----------- 231

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                              R   IS ++ +       LLQK+L  +P  R   +E L+  
Sbjct: 232 -------------------RDGIISDIFDKK---EKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 318 YI 319
            +
Sbjct: 270 TV 271

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  178 bits (454), Expect = 6e-54
 Identities = 90/302 (29%), Positives = 135/302 (44%), Gaps = 45/302 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
               +Y  +  +G+G++G V    +R T ++ A+K IN       D    LRE+ LL+ +
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQL 142
            H N++ L ++         +D    Y+V EL    +L   I   +  S       + Q+
Sbjct: 79  DHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 143 LRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
             G+ Y+H  NI+HRDLKP N+L+     +CD+KI DFGL+         M + + T +Y
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYY 189

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
            APE+L     Y    DVWS G I   +L   P F G    N+  ++  V    +     
Sbjct: 190 IAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRV----ETGKYA 240

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           F                    IS         A DL++KML F PS RIT T+ L+HP+I
Sbjct: 241 FDLPQ-------------WRTIS-------DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

Query: 320 SG 321
             
Sbjct: 281 QK 282

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  187 bits (475), Expect = 8e-54
 Identities = 76/342 (22%), Positives = 134/342 (39%), Gaps = 27/342 (7%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            +   + +G G +G V   I+++T E+VAIK+       + +  R   E+ +++ + H N
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPN 73

Query: 91  VIALKDVM-MPTHRISFKDVYLVYELMDT-DLHQIIKSSQS---LSNDHCKYFVFQLLRG 145
           V++ ++V              L  E  +  DL + +   ++   L     +  +  +   
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 146 LKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L+YLH   I+HRDLKP N+++         KI D G A+     E     +V T  Y AP
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAP 192

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           ELL     Y  ++D WS G +  E + G +P  P  + +     +        E  + + 
Sbjct: 193 ELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIVVYD 248

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
           D   A +F   LP       + L           LQ ML++   +R T  +         
Sbjct: 249 DLTGAVKFSSVLPTP-----NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

Query: 322 LYDPQC-------NPPAQVPLSLDIDENIGEQMIRQMMWNET 356
           L            N  +    +  + EN   Q ++  +  +T
Sbjct: 304 LDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDT 345

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  178 bits (454), Expect = 9e-54
 Identities = 67/296 (22%), Positives = 108/296 (36%), Gaps = 48/296 (16%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-K 87
              +  +  +G G+YG V    ++E     A+K+  + F    D  R L E+     + +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 88  HDNVIALKDVMMPTHRISFKD---VYLVYELMDTDLHQII-KSSQSLSNDHCKYFVFQLL 143
           H   + L+         ++++   +YL  EL    L Q       SL       ++   L
Sbjct: 116 HPCCVRLEQ--------AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTL 167

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
             L +LHS  ++H D+KP N+ +      K+ DFGL     G             Y APE
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPE 226

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           LL    +YGT+ DV+S+G    E+     +  G E   QL                    
Sbjct: 227 LLQ--GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              R+      ++    +S            +L  ML  +P  R T    L  P +
Sbjct: 265 ---RQGYLPPEFTA--GLS-------SELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  178 bits (454), Expect = 1e-53
 Identities = 86/323 (26%), Positives = 144/323 (44%), Gaps = 47/323 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVL 82
           +++  Y   + +G G + +V     + T  + A K I           +      RE+ +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQ 141
           LR + H NVI L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q
Sbjct: 69  LRQVLHHNVITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           +L G+ YLH+  I H DLKP N+++         +K+ DFGLA     +         T 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIFGTP 182

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQE 255
            + APE++   +  G   D+WS+G I   IL  G  P F G     + + + ++      
Sbjct: 183 EFVAPEIVN-YEPLGLEADMWSIGVI-TYILLSGASP-FLGD---TKQETLANI----TS 232

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
              +F +      F         +H S        LA D ++K+LV E  KR+T+ EAL+
Sbjct: 233 VSYDFDEEF----F---------SHTS-------ELAKDFIRKLLVKETRKRLTIQEALR 272

Query: 316 HPYISGLYDPQCNPPAQVPLSLD 338
           HP+I+ + + Q     +  ++L+
Sbjct: 273 HPWITPVDNQQAMVRRESVVNLE 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  179 bits (456), Expect = 1e-53
 Identities = 84/323 (26%), Positives = 140/323 (43%), Gaps = 49/323 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINN---VFENRIDALRTLRELVLL 83
             +  Y   + IG+G + VV   INRET ++ A+K ++         +      RE  + 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDL-HQIIK---SSQSLSNDHCKYF 138
             +KH +++ L +        S   +Y+V+E MD  DL  +I+K   +    S     ++
Sbjct: 81  HMLKHPHIVELLETYS-----SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVV 195
           + Q+L  L+Y H  NI+HRD+KP  +L+     +  +K+  FG+A     +       V 
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQ 253
           T  + APE++   + YG  +DVW  G I   IL  G  P F GT    +      +F   
Sbjct: 196 TPHFMAPEVVK-REPYGKPVDVWGCGVI-LFILLSGCLP-FYGT---KE-----RLFEGI 244

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
            +   +      +             HIS         A DL+++ML+ +P++RITV EA
Sbjct: 245 IKGKYKMNPRQWS-------------HIS-------ESAKDLVRRMLMLDPAERITVYEA 284

Query: 314 LQHPYISGLYDPQCNPPAQVPLS 336
           L HP++               + 
Sbjct: 285 LNHPWLKERDRYAYKIHLPETVE 307

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  182 bits (465), Expect = 2e-53
 Identities = 84/329 (25%), Positives = 133/329 (40%), Gaps = 56/329 (17%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-----------NVFENRIDALR 75
           +I   Y  ++ +G GAYG V     +  + + AIK I            +          
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92

Query: 76  TLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLHQIIKSSQSLS 131
              E+ LL+ + H N+I L DV        F+D    YLV E  +  +L + I +     
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFD 144

Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQ 188
                  + Q+L G+ YLH  NI+HRD+KP N+L+   N+  ++KI DFGL+     + +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS 248
            + + + T +Y APE+L     Y    DVWS G I   +L   P F G    N   +I  
Sbjct: 205 -LRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKK 258

Query: 249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI 308
           V    ++    F  N                     +      A +L++ ML ++ +KR 
Sbjct: 259 V----EKGKYYFDFND--------------------WKNISDEAKELIKLMLTYDYNKRC 294

Query: 309 TVTEALQHPYISGLYDPQCNPPAQVPLSL 337
           T  EAL   +I    +       +     
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGA 323

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  178 bits (453), Expect = 4e-53
 Identities = 68/298 (22%), Positives = 131/298 (43%), Gaps = 51/298 (17%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KYV ++ IG G++G      + E   +  IK+IN    +  +   + RE+ +L ++KH N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 91  VIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLS---NDHCKYFVFQLL 143
           ++  ++        SF++   +Y+V +  +  DL + I + + +    +    +FV Q+ 
Sbjct: 85  IVQYRE--------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV-QIC 135

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
             LK++H   ILHRD+K  N+ +  +  +++ DFG+AR      +     + T +Y +PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 204 LLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           +   C+N  Y    D+W++GC+  E+   K  F      +   L++              
Sbjct: 196 I---CENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLK------------- 236

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                   I S  +     +S  Y         L+ ++    P  R +V   L+  +I
Sbjct: 237 --------IISGSFPP---VSLHYSYD---LRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  175 bits (445), Expect = 9e-53
 Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 41/299 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           +I+  Y     IGRG++G V  ++ + T  + A KKI   F   +D  +  +E+ +++ +
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSL 63

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H N+I L +           D+YLV EL    +L + +   +          +  +L  
Sbjct: 64  DHPNIIRLYETFE-----DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 146 LKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           + Y H  N+ HRDLKP N L    + +  LK+ DFGLA   +   + M   V T +Y +P
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSP 177

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           ++L     YG   D WS G +   +L   P F         ++++ +    +E    F +
Sbjct: 178 QVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAP---TDSEVMLKI----REGTFTFPE 228

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                            ++S       P A  L++++L   P +RIT  +AL+H +   
Sbjct: 229 KDWL-------------NVS-------PQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  177 bits (451), Expect = 1e-52
 Identities = 84/323 (26%), Positives = 142/323 (43%), Gaps = 47/323 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVL 82
           +++  Y   + +G G + +V     + T  + A K I           +      RE+ +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQ 141
           LR + H N+I L DV       +  DV L+ EL+   +L   +   +SLS +    F+ Q
Sbjct: 69  LRQVLHPNIITLHDVYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           +L G+ YLH+  I H DLKP N+++         +K+ DFGLA     +         T 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQE 255
            + APE++   +  G   D+WS+G I   IL  G  P F G     + + + ++      
Sbjct: 183 EFVAPEIVN-YEPLGLEADMWSIGVI-TYILLSGASP-FLGD---TKQETLANI----TA 232

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
              +F +      F         +  S        LA D ++K+LV E  KR+T+ EAL+
Sbjct: 233 VSYDFDEEF----F---------SQTS-------ELAKDFIRKLLVKETRKRLTIQEALR 272

Query: 316 HPYISGLYDPQCNPPAQVPLSLD 338
           HP+I+ +   Q     +  ++L+
Sbjct: 273 HPWITPVDTQQAMVRRESVVNLE 295

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  174 bits (444), Expect = 1e-52
 Identities = 67/302 (22%), Positives = 131/302 (43%), Gaps = 47/302 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRH 85
            ID  ++  + +G GA+G V     R +  +  IK IN +  +  ++ +    E+ +L+ 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKS 76

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-----TDLHQIIKSSQSLSNDHCKYFVF 140
           + H N+I + +V        + ++Y+V E  +       +       ++LS  +    + 
Sbjct: 77  LDHPNIIKIFEVFE-----DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           Q++  L Y HS +++H+DLKP N+L    + +  +KI DFGLA   + +++  T    T 
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTA 190

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            Y APE+     +     D+WS G +   +L     F GT   +  ++           +
Sbjct: 191 LYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGT---SLEEVQQKA----TYKE 241

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
             +    +               ++       P A+DLL++ML  +P +R +  + L H 
Sbjct: 242 PNYAVECR--------------PLT-------PQAVDLLKQMLTKDPERRPSAAQVLHHE 280

Query: 318 YI 319
           + 
Sbjct: 281 WF 282

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  176 bits (447), Expect = 2e-52
 Identities = 91/363 (25%), Positives = 132/363 (36%), Gaps = 89/363 (24%)

Query: 12  KSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN---NVFE 68
            S  ++ Y    +L E+  KY     IG+G+YGVV  +I  +T    AIK +N       
Sbjct: 8   SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67

Query: 69  NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELM--------- 116
           N  D  R   E+ L++ + H N+  L +V        ++D   + LV EL          
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEV--------YEDEQYICLVMELCHGGHLLDKL 119

Query: 117 --------------------------------DTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
                                            +                    + Q+  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 145 GLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLAR----TSRGNEQFMTEYVVTRW 198
            L YLH+  I HRD+KP N L   N + ++K+ DFGL++     + G    MT    T +
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 199 YRAPELLLCCD-NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           + APE+L   + +YG   D WS G +   +L     FPG    N    I  V        
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV---NDADTISQV----LNKK 292

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           L F +                      Y    PLA DLL  +L     +R     ALQHP
Sbjct: 293 LCFENPN--------------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332

Query: 318 YIS 320
           +IS
Sbjct: 333 WIS 335

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  177 bits (450), Expect = 2e-52
 Identities = 77/312 (24%), Positives = 139/312 (44%), Gaps = 50/312 (16%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
            +   Y  ++ +G GA+GVV   + + T      K IN  +      ++   E+ ++  +
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK--NEISIMNQL 105

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLH-QIIKSSQSLSNDHCKYFVFQ 141
            H  +I L D         F+D   + L+ E +   +L  +I      +S      ++ Q
Sbjct: 106 HHPKLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
              GLK++H  +I+H D+KP N++        +KI DFGLA     +E  +     T  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEF 216

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            APE++   +  G   D+W++G +   +L  G  P F G    + L+ + +V    +  D
Sbjct: 217 AAPEIVD-REPVGFYTDMWAIGVL-GYVLLSGLSP-FAGE---DDLETLQNV----KRCD 266

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            EF ++     F         + +S       P A D ++ +L  EP KR+TV +AL+HP
Sbjct: 267 WEFDEDA----F---------SSVS-------PEAKDFIKNLLQKEPRKRLTVHDALEHP 306

Query: 318 YISGLYDPQCNP 329
           ++ G +    + 
Sbjct: 307 WLKGDHSNLTSR 318

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  174 bits (443), Expect = 3e-52
 Identities = 66/319 (20%), Positives = 121/319 (37%), Gaps = 57/319 (17%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
           T + PI+ +GRG +GVV  + N+  +   AIK+I  +    +   + +RE+  L  ++H 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHP 63

Query: 90  NVIALKDV-------MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSN---DHCKYF 138
            ++   +                   +Y+  +L    +L   +    ++       C + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSRGN 186
             Q+   +++LHS  ++HRDLKP N+    +  +K+ DFGL              T    
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
               T  V T+ Y +PE +   ++Y   +D++S+G I  E+L   P     E +  L  +
Sbjct: 184 YARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV 240

Query: 247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK 306
                                         R      L+ Q  P    ++Q ML   P +
Sbjct: 241 ------------------------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPME 270

Query: 307 RITVTEALQHPYISGLYDP 325
           R      +++     L  P
Sbjct: 271 RPEAINIIENAVFEDLDFP 289

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  175 bits (445), Expect = 3e-52
 Identities = 73/313 (23%), Positives = 137/313 (43%), Gaps = 61/313 (19%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           E+  KY+  + +GRG +G+V   +   + +    K +     +++   +   E+ +L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIA 58

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLH-QIIKSSQSLSNDHCKYFVFQ 141
           +H N++ L +         F+    + +++E +   D+  +I  S+  L+      +V Q
Sbjct: 59  RHRNILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMT-----EYV 194
           +   L++LHS NI H D++P N++     +  +KI +FG AR  +  + F       EY 
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGT 252
                 APE+    D   T+ D+WS+G +   +L  G  P F         ++I ++   
Sbjct: 171 ------APEVHQ-HDVVSTATDMWSLGTL-VYVLLSGINP-FLAE---TNQQIIENI--- 215

Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
              A+  F +      F           IS         A+D + ++LV E   R+T +E
Sbjct: 216 -MNAEYTFDEEA----F---------KEIS-------IEAMDFVDRLLVKERKSRMTASE 254

Query: 313 ALQHPYISGLYDP 325
           ALQHP++    + 
Sbjct: 255 ALQHPWLKQKIER 267

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  175 bits (445), Expect = 4e-52
 Identities = 86/356 (24%), Positives = 147/356 (41%), Gaps = 62/356 (17%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLL 83
           +D  Y   + +G G + VV     + T  + A K I           +      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 84  RHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFV 139
           + I+H NVI L +V        +++   V L+ EL+   +L   +   +SL+ +    F+
Sbjct: 69  KEIQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSRGNEQFMTEYVV 195
            Q+L G+ YLHS  I H DLKP N+++         +KI DFGLA       +       
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFG 179

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQ 253
           T  + APE++   +  G   D+WS+G I   IL  G  P F G     + + + +V    
Sbjct: 180 TPEFVAPEIVN-YEPLGLEADMWSIGVI-TYILLSGASP-FLGD---TKQETLANV---- 229

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
              + EF D                      +     LA D ++++LV +P KR+T+ ++
Sbjct: 230 SAVNYEFEDEY--------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269

Query: 314 LQHPYISGLYDPQCNPPAQVPLSLD---------IDENIGEQMIRQMMWNETLHYH 360
           LQHP+I      Q        ++++            N     +  +   + + +H
Sbjct: 270 LQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQKIEWH 325

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  172 bits (439), Expect = 6e-52
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 50/302 (16%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y  +  IG G+YG       +   + +  K+++       +    + E+ LLR +KH N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLS-----NDHCKYFVFQLLR 144
           ++   D ++         +Y+V E  +  DL  +I                +    QL  
Sbjct: 67  IVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTL 122

Query: 145 GLKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
            LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR    +  F   +V T +Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 200 RAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            +PE     +   Y    D+WS+GC+  E+    P F      +Q +L            
Sbjct: 183 MSPEQ---MNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGK--------- 227

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                       I+   + R   I   Y        +++ +ML  +   R +V E L++P
Sbjct: 228 ------------IREGKFRR---IPYRYSDE---LNEIITRMLNLKDYHRPSVEEILENP 269

Query: 318 YI 319
            I
Sbjct: 270 LI 271

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  174 bits (444), Expect = 7e-52
 Identities = 88/324 (27%), Positives = 135/324 (41%), Gaps = 51/324 (15%)

Query: 7   PPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNV 66
              G  S    Y+        +   +     +GRGA  +V     + T +  A+K +   
Sbjct: 30  AAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK- 88

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQ 122
               +D      E+ +L  + H N+I LK++        F+    + LV EL+   +L  
Sbjct: 89  ---TVDKKIVRTEIGVLLRLSHPNIIKLKEI--------FETPTEISLVLELVTGGELFD 137

Query: 123 IIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGL 179
            I      S       V Q+L  + YLH   I+HRDLKP NLL      +  LKI DFGL
Sbjct: 138 RIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGL 197

Query: 180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGT 237
           ++    ++  M     T  Y APE+L  C  YG  +D+WSVG I   IL  G +P F   
Sbjct: 198 SKIV-EHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITY-ILLCGFEP-FYDE 253

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
                  +   +       +  FI                       + +    A DL++
Sbjct: 254 R--GDQFMFRRI----LNCEYYFISPW--------------------WDEVSLNAKDLVR 287

Query: 298 KMLVFEPSKRITVTEALQHPYISG 321
           K++V +P KR+T  +ALQHP+++G
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTG 311

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  174 bits (442), Expect = 8e-52
 Identities = 75/329 (22%), Positives = 140/329 (42%), Gaps = 42/329 (12%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDN 90
            +  KP+G G++ +    +++++N+  A+K I+   +      +  +E+  L+  + H N
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQ--KEITALKLCEGHPN 67

Query: 91  VIALKDVMMPTHRISFKD---VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           ++ L +V        F D    +LV EL++  +L + IK  +  S     Y + +L+  +
Sbjct: 68  IVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119

Query: 147 KYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
            ++H   ++HRDLKP NLL    N N ++KI DFG AR    + Q +     T  Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           LL   + Y  S D+WS+G I   +L  +  F   +        + +    ++ D  F   
Sbjct: 180 LLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
                           ++S         A DL+Q +L  +P+KR+ ++    + ++    
Sbjct: 239 AWK-------------NVS-------QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQMM 352
               NP     +       +   +     
Sbjct: 279 QLSSNPLMTPDILGSSGAAVHTCVKATFH 307

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  180 bits (457), Expect = 9e-52
 Identities = 73/313 (23%), Positives = 135/313 (43%), Gaps = 50/313 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
            +   Y   + +G GA+GVV     R T    A K +    E+  + +R  +E+  +  +
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVL 211

Query: 87  KHDNVIALKDVMMPTHRISFKD---VYLVYELMD-TDL-HQIIKSSQSLSNDHCKYFVFQ 141
           +H  ++ L D         F+D   + ++YE M   +L  ++      +S D    ++ Q
Sbjct: 212 RHPTLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           + +GL ++H  N +H DLKP N++     + +LK+ DFGL       +  +     T  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEF 322

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            APE+       G   D+WSVG + + IL  G  P F G    N  + + +V    +  D
Sbjct: 323 AAPEVAE-GKPVGYYTDMWSVGVL-SYILLSGLSP-FGGE---NDDETLRNV----KSCD 372

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
               D+                     +        D ++K+L+ +P+ R+T+ +AL+HP
Sbjct: 373 WNMDDSA--------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412

Query: 318 YISGLYDPQCNPP 330
           +++    P  +  
Sbjct: 413 WLTPGNAPGRDSQ 425

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  171 bits (435), Expect = 1e-50
 Identities = 78/317 (24%), Positives = 139/317 (43%), Gaps = 52/317 (16%)

Query: 27  EIDTKY-VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
             +  Y +  K +GRG + VV   I++ T ++ A K +      +      L E+ +L  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 86  IKHD-NVIALKDVMMPTHRISFKD---VYLVYELMDT-DL-HQII-KSSQSLSNDHCKYF 138
            K    VI L +V        +++   + L+ E     ++    + + ++ +S +     
Sbjct: 85  AKSCPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL 136

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVV 195
           + Q+L G+ YLH  NI+H DLKP N+L+       D+KI DFG++R   G+   + E + 
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMG 195

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQ 253
           T  Y APE+L   D   T+ D+W++G I A +L     P F G    +  +  +++    
Sbjct: 196 TPEYLAPEILN-YDPITTATDMWNIGII-AYMLLTHTSP-FVGE---DNQETYLNI---- 245

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
            + ++++ +      F         + +S        LA D +Q +LV  P KR T    
Sbjct: 246 SQVNVDYSEET----F---------SSVS-------QLATDFIQSLLVKNPEKRPTAEIC 285

Query: 314 LQHPYISGLYDPQCNPP 330
           L H ++          P
Sbjct: 286 LSHSWLQQWDFENLFHP 302

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  170 bits (434), Expect = 2e-50
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 41/293 (13%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIAL 94
           + +G G  G V    +R T +K A+K +        D+ +  +E+          +++ +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCI 87

Query: 95  KDVMMPTHRISFKDVYLVYELMDTD--LHQII-KSSQSLSNDHCKYFVFQLLRGLKYLHS 151
            DV    H    + + ++ E M+      +I  +  Q+ +       +  +   +++LHS
Sbjct: 88  LDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146

Query: 152 ANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
            NI HRD+KP NLL      +  LK+ DFG A+ +  N   +     T +Y APE+L   
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLG-P 203

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           + Y  S D+WS+G I   +L   P F          +   +    +     F +   +  
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSN---TGQAISPGMKRRIRLGQYGFPNPEWS-- 258

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                       +S         A  L++ +L  +P++R+T+T+ + HP+I+ 
Sbjct: 259 -----------EVS-------EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  171 bits (436), Expect = 4e-50
 Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 46/304 (15%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI- 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L     
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 112

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQII-KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV         K + +V E +D      +I  +  Q+ +       +  + 
Sbjct: 113 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL      N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYV 230

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF---PGTECLNQLKLIISVFGTQQEAD 257
           APE+L   + Y  S D+WS+G I   +L   P F    G      +K  I      +   
Sbjct: 231 APEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------RMGQ 283

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
            EF +   +              +S            L++ +L  EP++R+T+TE + HP
Sbjct: 284 YEFPNPEWS-------------EVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHP 323

Query: 318 YISG 321
           +I  
Sbjct: 324 WIMQ 327

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  169 bits (431), Expect = 9e-50
 Identities = 88/328 (26%), Positives = 140/328 (42%), Gaps = 45/328 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           +Y  +K IG G +GV     ++ T E VA+K I              RE++  R ++H N
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77

Query: 91  VIALKDVMM-PTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++  K+V++ PTH      + ++ E     +L++ I ++   S D  ++F  QLL G+ Y
Sbjct: 78  IVRFKEVILTPTH------LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131

Query: 149 LHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
            HS  I HRDLK  N L+  +    LKICDFG +++S  + Q  +  V T  Y APE+LL
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL 190

Query: 207 CCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
             +  G   DVWS G   +  ++G  P F   E     +                    K
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPRDYR--------------------K 229

Query: 266 ARRFIKSLPYS--RGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
             + I S+ YS      IS       P    L+ ++ V +P+ RI++ E   H +     
Sbjct: 230 TIQRILSVKYSIPDDIRIS-------PECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282

Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQM 351
                  +         E   + +   M
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQSLDTIM 310

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  169 bits (431), Expect = 1e-49
 Identities = 83/295 (28%), Positives = 130/295 (44%), Gaps = 54/295 (18%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G G +G V       T  K+A K I        + ++   E+ ++  + H N+I L D 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK--NEISVMNQLDHANLIQLYDA 154

Query: 98  MMPTHRISFKDVYLVYELMDT-DLH-QIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANIL 155
                  S  D+ LV E +D  +L  +II  S +L+      F+ Q+  G++++H   IL
Sbjct: 155 FE-----SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209

Query: 156 HRDLKPGNLLV--NANCDLKICDFGLARTSRGNEQFMT-----EYVVTRWYRAPELLLCC 208
           H DLKP N+L        +KI DFGLAR  +  E+        E++      APE++   
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFL------APEVVN-Y 262

Query: 209 DNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
           D      D+WSVG I A +L  G  P F G    N  + + ++         +  D    
Sbjct: 263 DFVSFPTDMWSVGVI-AYMLLSGLSP-FLGD---NDAETLNNI----LACRWDLEDEE-- 311

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
             F           IS         A + + K+L+ E S RI+ +EAL+HP++S 
Sbjct: 312 --F---------QDIS-------EEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  167 bits (425), Expect = 1e-49
 Identities = 82/302 (27%), Positives = 133/302 (44%), Gaps = 39/302 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
           +YV  + +G+G +       + +T E  A K +  ++        +   E+ + R + H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           +V+                V++V EL     L ++ K  ++L+    +Y++ Q++ G +Y
Sbjct: 76  HVVGFHGFFE-----DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LH   ++HRDLK GNL +N + ++KI DFGLA     + +       T  Y APE +L  
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSK 189

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             +   +DVWS+GCI   +L  KP F  T CL +                          
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKET-----------------------YL 225

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN 328
            IK   YS   HI+       P+A  L+QKML  +P+ R T+ E L   + +  Y P   
Sbjct: 226 RIKKNEYSIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

Query: 329 PP 330
           P 
Sbjct: 279 PI 280

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  167 bits (426), Expect = 2e-49
 Identities = 81/314 (25%), Positives = 123/314 (39%), Gaps = 59/314 (18%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIAL 94
             +G GA+  V + IN  T+++ A+K I     +    +   RE+ +L   + H NV+ L
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGHRNVLEL 76

Query: 95  KDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
            +         F++    YLV+E M    +   I   +  +       V  +   L +LH
Sbjct: 77  IEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 151 SANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQF-------MTEYVVTRWYR 200
           +  I HRDLKP N+L    N    +KICDF L    + N          +     +  Y 
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 201 APELLLCCD----NYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQ- 253
           APE++         Y    D+WS+G I   IL  G  P               +    Q 
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVI-LYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247

Query: 254 ------QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
                 QE   EF D   A             HIS         A DL+ K+LV +  +R
Sbjct: 248 MLFESIQEGKYEFPDKDWA-------------HISC-------AAKDLISKLLVRDAKQR 287

Query: 308 ITVTEALQHPYISG 321
           ++  + LQHP++ G
Sbjct: 288 LSAAQVLQHPWVQG 301

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  167 bits (424), Expect = 2e-49
 Identities = 85/329 (25%), Positives = 132/329 (40%), Gaps = 63/329 (19%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
           KY+    +G G+YG V   ++ ET  + A+K +    +           +E+ LLR ++H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 89  DNVIALKDVMMPTHRISFKDVYLV--------YELMDTDLHQIIKSSQSLSNDHCKYFVF 140
            NVI L DV+    +   + +Y+V         E++D+   +     Q+       YF  
Sbjct: 66  KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA-----HGYFC- 116

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW-- 198
           QL+ GL+YLHS  I+H+D+KPGNLL+     LKI   G+A        F  +        
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQG 173

Query: 199 ---YRAPELLLCCDNY-GTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQ 253
              ++ PE+    D + G  +D+WS G   +    G  P F G                 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEG----------------- 215

Query: 254 QEADLEFIDN-PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                   DN  K    I    Y+             P   DLL+ ML +EP+KR ++ +
Sbjct: 216 --------DNIYKLFENIGKGSYAIPGDCG-------PPLSDLLKGMLEYEPAKRFSIRQ 260

Query: 313 ALQHPYISGLYDPQCNPPAQVPLSLDIDE 341
             QH +    + P   P    P     D 
Sbjct: 261 IRQHSWFRKKHPPAEAPVPIPPSPDTKDR 289

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  166 bits (423), Expect = 6e-49
 Identities = 73/321 (22%), Positives = 135/321 (42%), Gaps = 40/321 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y  +K IG+G +  V  + +  T  +VAIK I+    N     +  RE+ +++ + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L +V+      + K +YL+ E     ++   + +   +     +    Q++  ++Y 
Sbjct: 76  IVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   I+HRDLK  NLL++A+ ++KI DFG +       +    +     Y APEL     
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKK 189

Query: 210 NYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             G  +DVWS+G I +  + G  P F G                         +  + R 
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLP-FDGQ------------------------NLKELRE 224

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN 328
            +    Y    ++S           +LL++ LV  P KR T+ + ++  +I+  ++    
Sbjct: 225 RVLRGKYRIPFYMS-------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277

Query: 329 PPAQVPLSLDIDENIGEQMIR 349
            P   P     D+   + M+ 
Sbjct: 278 KPFVEPELDISDQKRIDIMVG 298

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  166 bits (423), Expect = 7e-49
 Identities = 83/328 (25%), Positives = 138/328 (42%), Gaps = 44/328 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
           +YV  + +G+G +       + +T E  A K +    + +      +   E+ + R + H
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAH 100

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            +V+                V++V EL     L ++ K  ++L+    +Y++ Q++ G +
Sbjct: 101 QHVVGFHGFFE-----DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
           YLH   ++HRDLK GNL +N + ++KI DFGLA     + +       T  Y APE +L 
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLS 214

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
              +   +DVWS+GCI   +L  KP F  T CL +                         
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKET-----------------------Y 250

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC 327
             IK   YS   HI+       P+A  L+QKML  +P+ R T+ E L   + +  Y P  
Sbjct: 251 LRIKKNEYSIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303

Query: 328 NPP---AQVPLSLDIDENIGEQMIRQMM 352
            P       P       ++     + + 
Sbjct: 304 LPITCLTIPPRFSIAPSSLDPSNRKPLT 331

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  165 bits (421), Expect = 8e-49
 Identities = 75/303 (24%), Positives = 117/303 (38%), Gaps = 55/303 (18%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA---LRTLRELVLLRHIK 87
            +   K IGRG +  V  +        VA+KK+     + +DA      ++E+ LL+ + 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLN 90

Query: 88  HDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLS-----NDHCKYF 138
           H NVI            SF +   + +V EL D  DL ++IK  +            KYF
Sbjct: 91  HPNVIKYYA--------SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW 198
           V QL   L+++HS  ++HRD+KP N+ + A   +K+ D GL R            V T +
Sbjct: 143 V-QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201

Query: 199 YRAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
           Y +PE         Y    D+WS+GC+  E+   +  F G + +N   L   +       
Sbjct: 202 YMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP 257

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                        + S  YS                  L+   +  +P KR  VT     
Sbjct: 258 -------------LPSDHYSEELR-------------QLVNMCINPDPEKRPDVTYVYDV 291

Query: 317 PYI 319
              
Sbjct: 292 AKR 294

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  165 bits (420), Expect = 2e-48
 Identities = 85/355 (23%), Positives = 135/355 (38%), Gaps = 66/355 (18%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKHD 89
            +  ++ +G GAYG V  ++NR T E VA+K ++   +  +D    + +E+ + + + H+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHE 65

Query: 90  NVIALKDVMMPTHRISFKDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
           NV+                 YL   Y    EL D      I+    +     + F  QL+
Sbjct: 66  NVVKFYGHRR-----EGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR--GNEQFMTEYVVTRWYRA 201
            G+ YLH   I HRD+KP NLL++   +LKI DFGLA   R    E+ + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 202 PELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           PELL   + +   +DVWS G +  A + G  P    ++   +                  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 222

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                  +     P+     I           L LL K+LV  PS RIT+ +  +  + +
Sbjct: 223 ------EKKTYLNPWK---KID-------SAPLALLHKILVENPSARITIPDIKKDRWYN 266

Query: 321 GLYDPQCNPPAQVPLS---------------LDIDENIGEQMIRQMMWNETLHYH 360
                    P                     LD              W++  H+H
Sbjct: 267 KPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHH 321

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  165 bits (419), Expect = 3e-48
 Identities = 73/359 (20%), Positives = 137/359 (38%), Gaps = 58/359 (16%)

Query: 3   TLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKK 62
            L EPP  ++  G           E   KY  + P+G GA+G V +++++E N++V +K 
Sbjct: 2   ALEEPPKAVELEGLAACEG-----EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF 56

Query: 63  IN------NVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM 116
           I       + +       +   E+ +L  ++H N+I + D+       +     LV E  
Sbjct: 57  IKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-----NQGFFQLVMEKH 111

Query: 117 DT--DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
            +  DL   I     L      Y   QL+  + YL   +I+HRD+K  N+++  +  +K+
Sbjct: 112 GSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKL 171

Query: 175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPI 233
            DFG A      + F T +  T  Y APE+L+     G  +++WS+G   +  +    P 
Sbjct: 172 IDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP- 229

Query: 234 FPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLAL 293
                                     F +  +        PY     +S          +
Sbjct: 230 --------------------------FCELEETVEAAIHPPY----LVS-------KELM 252

Query: 294 DLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMM 352
            L+  +L   P +R T+ + +  P+++   +       +V      +  +      +M 
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMG 311

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  163 bits (416), Expect = 3e-48
 Identities = 79/320 (24%), Positives = 136/320 (42%), Gaps = 72/320 (22%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN------------------------NV 66
           +Y     IG+G+YGVV  + N   N   A+K ++                          
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYE------LMDTDL 120
            + R    +  +E+ +L+ + H NV+ L +V+   +      +Y+V+E      +M+   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVME--- 127

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
              + + + LS D  +++   L++G++YLH   I+HRD+KP NLLV  +  +KI DFG++
Sbjct: 128 ---VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLL-CCDNY-GTSIDVWSVGCI-FAEILGRKPIFPGT 237
              +G++  ++  V T  + APE L      + G ++DVW++G   +  + G+ P F   
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP-FMDE 243

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
             +     I       +   LEF   P                     P       DL+ 
Sbjct: 244 RIMCLHSKI-------KSQALEF---PD-------------------QPDIAEDLKDLIT 274

Query: 298 KMLVFEPSKRITVTEALQHP 317
           +ML   P  RI V E   HP
Sbjct: 275 RMLDKNPESRIVVPEIKLHP 294

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  163 bits (414), Expect = 4e-48
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 62/310 (20%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
            +     +G+G++  V  + +  T  +VAIK I+   +++  +   R   E+ +   +KH
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLKH 70

Query: 89  DNVIALKDVMMPTHRISFKDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
            +++ L +            VYLV       E+       +    +  S +  ++F+ Q+
Sbjct: 71  PSILELYNYFE-----DSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQI 121

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSRGNEQFMT-----EYVVT 196
           + G+ YLHS  ILHRDL   NLL+  N ++KI DFGLA +    +E+  T      Y+  
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI-- 179

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
               +PE +     +G   DVWS+GC+F  +L  +P F                    + 
Sbjct: 180 ----SPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPF--------------------DT 214

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
           D            +    Y   + +S         A DL+ ++L   P+ R++++  L H
Sbjct: 215 D----TVKNTLNKVVLADYEMPSFLS-------IEAKDLIHQLLRRNPADRLSLSSVLDH 263

Query: 317 PYISGLYDPQ 326
           P++S     +
Sbjct: 264 PFMSRNSSTK 273

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  162 bits (412), Expect = 7e-48
 Identities = 64/302 (21%), Positives = 126/302 (41%), Gaps = 51/302 (16%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
            +   +P+G+G +G V  +  +++   +A+K +    + +  ++  +  RE+ +  H++H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH 68

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            N++ L              VYL+ E      +++ ++            ++ +L   L 
Sbjct: 69  PNILRLYGYFH-----DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT----EYVVTRWYRAPE 203
           Y HS  ++HRD+KP NLL+ +  +LKI DFG +  +  + +       +Y+       PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++     +   +D+WS+G +  E L  KP F         K I          +  F   
Sbjct: 178 MIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VEFTF--- 226

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
           P                ++         A DL+ ++L   PS+R  + E L+HP+I+   
Sbjct: 227 PD--------------FVT-------EGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265

Query: 324 DP 325
             
Sbjct: 266 SK 267

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  160 bits (407), Expect = 4e-47
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 51/310 (16%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKHD 89
            +  ++ +G GAYG V  ++NR T E VA+K ++   +  +D    + +E+ + + + H+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHE 65

Query: 90  NVIALKDVMMPTHRISFKDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
           NV+                 YL   Y    EL D      I+    +     + F  QL+
Sbjct: 66  NVVKFYGHRR-----EGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR--GNEQFMTEYVVTRWYRA 201
            G+ YLH   I HRD+KP NLL++   +LKI DFGLA   R    E+ + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 202 PELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           PELL   + +   +DVWS G +  A + G  P    ++   +                  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 222

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                  +     P+     I           L LL K+LV  PS RIT+ +  +  + +
Sbjct: 223 ------EKKTYLNPWK---KID-------SAPLALLHKILVENPSARITIPDIKKDRWYN 266

Query: 321 GLYDPQCNPP 330
                    P
Sbjct: 267 KPLKKGAKRP 276

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  160 bits (406), Expect = 2e-46
 Identities = 62/338 (18%), Positives = 126/338 (37%), Gaps = 66/338 (19%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN---------------NVFENRIDALR 75
            Y  I+ + +G +  +   +  + N+  A+KK                 +    +     
Sbjct: 32  DYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 76  TLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLV--Y----ELMDTDLHQ---IIKS 126
              EL ++  IK++  +  + ++      ++ +VY++  Y     ++  D +        
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLA----- 180
           +  +     K  +  +L    Y+H+  NI HRD+KP N+L++ N  +K+ DFG +     
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 181 ---RTSRGNEQFMTEYVVTRWYRAPELLLCCDNY-GTSIDVWSVGCIFAEILGRKPIFPG 236
              + SRG          T  +  PE      +Y G  +D+WS+G     +      F  
Sbjct: 205 KKIKGSRG----------TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 237 TECLNQLKLIISVFGTQQEADLEF--IDNPKARRFIKSLPYSRGTHISSLYPQADPLALD 294
              L +L   I      +  ++E+    N                 +S          +D
Sbjct: 255 KISLVELFNNI------RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS-------NEDID 301

Query: 295 LLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ 332
            L+  L   P++RIT  +AL+H +++          ++
Sbjct: 302 FLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSK 339

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  160 bits (406), Expect = 3e-46
 Identities = 83/328 (25%), Positives = 147/328 (44%), Gaps = 51/328 (15%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
            Y+  + +G G++G V  + + +T +KVA+K I+  + +     +R  RE+  L+ ++H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++I L DV+      +  D+ +V E    +L   I   + ++ D  + F  Q++  ++Y 
Sbjct: 70  HIIKLYDVIT-----TPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW-----YRAPEL 204
           H   I+HRDLKP NLL++ N ++KI DFGL+          T            Y APE+
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT------SCGSPNYAAPEV 178

Query: 205 LLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +      G  +DVWS G + +  ++GR P F                    +  +     
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLP-F-------------------DDEFI----- 213

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
           P   + + S  Y     +S       P A  L+++M+V +P +RIT+ E  + P+ +   
Sbjct: 214 PNLFKKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266

Query: 324 DPQCNPPAQVPLSLDIDENIGEQMIRQM 351
                P  +V  S   D  I  ++   M
Sbjct: 267 PDYLRPMEEVQGS-YADSRIVSKLGEAM 293

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  157 bits (400), Expect = 4e-46
 Identities = 63/307 (20%), Positives = 129/307 (42%), Gaps = 52/307 (16%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKH 88
            +   +P+G+G +G V  +  ++    +A+K +    + +  ++  +  RE+ +  H++H
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH 73

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
            N++ + +          K +YL+ E     +L++ ++            F+ +L   L 
Sbjct: 74  PNILRMYNYFH-----DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT----EYVVTRWYRAPE 203
           Y H   ++HRD+KP NLL+    +LKI DFG +  +    +       +Y+       PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++     +   +D+W  G +  E L   P F         + I++V       DL+F   
Sbjct: 183 MIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------DLKF--- 231

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY 323
           P                +S         + DL+ K+L + P +R+ +   ++HP++    
Sbjct: 232 PP--------------FLS-------DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270

Query: 324 DPQCNPP 330
             +  PP
Sbjct: 271 -RRVLPP 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  160 bits (405), Expect = 7e-46
 Identities = 54/346 (15%), Positives = 105/346 (30%), Gaps = 84/346 (24%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRE----LVLLRHI 86
             V    +G+        + ++ET E   +           +A++ ++E    L LLR I
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 87  KHDNVIALK-------------------DVMMPTHRISFKDVYLVYELMDTD-------L 120
           K+     +                     V +    +     + +Y  M ++       L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 121 HQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
                + +SL +        Q++R L  LH   ++H  L+P +++++    + +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDN----------YGTSIDVWSVGCIFAEIL-G 229
                 +       V+R +  PEL                   S D W++G +   I   
Sbjct: 254 V----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQAD 289
             P       L   + I                     R  K++P               
Sbjct: 310 DLP-ITKDAALGGSEWIF--------------------RSCKNIP--------------- 333

Query: 290 PLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPL 335
                LL+  L +    R+   +A++ P    L   +    A +PL
Sbjct: 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL-RTE--LSAALPL 376

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  157 bits (400), Expect = 1e-45
 Identities = 56/304 (18%), Positives = 106/304 (34%), Gaps = 49/304 (16%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y+ I+ +G G +  V            A+K+I    +   +  +  RE  + R   H N
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ--READMHRLFNHPN 87

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQS----LSNDHCKYFVFQLLRG 145
           ++ L    +   R +  + +L+        L   I+  +     L+ D   + +  + RG
Sbjct: 88  ILRLVAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV---------T 196
           L+ +H+    HRDLKP N+L+       + D G    +  + +   + +          T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 197 RWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGT-ECLNQLKLIISVFGTQ 253
             YRAPEL             DVWS+GC+   ++  +  +    +  + + L +      
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----- 261

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
                            +S  +S                  LL  M+  +P +R  +   
Sbjct: 262 -----------NQLSIPQSPRHSSALW-------------QLLNSMMTVDPHQRPHIPLL 297

Query: 314 LQHP 317
           L   
Sbjct: 298 LSQL 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  154 bits (392), Expect = 2e-44
 Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 56/322 (17%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLLRHI 86
           +Y     +G G +G V S I    N  VAIK +     + +    +  R   E+VLL+ +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 87  KHD--NVIALKDVMMPTHRISFKDVYLVYELMDT--DLHQIIKSSQSLSNDHCKYFVFQL 142
                 VI L D              L+ E  +   DL   I    +L  +  + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDSF-----VLILERPEPVQDLFDFITERGALQEELARSFFWQV 158

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG     +      T++  TR Y  
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSP 216

Query: 202 PELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           PE +     +G S  VWS+G + +  + G  P                           F
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------------------F 249

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
             + +  R            +S            L++  L   PS R T  E   HP++ 
Sbjct: 250 EHDEEIIRGQVFFRQ----RVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

Query: 321 GLYDPQCNPPAQVPLSLDIDEN 342
            +  PQ      +  SL    +
Sbjct: 299 DVLLPQETAEIHLH-SLSPGPS 319

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  153 bits (388), Expect = 4e-44
 Identities = 72/301 (23%), Positives = 115/301 (38%), Gaps = 61/301 (20%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI- 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ L     
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDTD--LHQII-KSSQSLSNDHCKYFVFQLL 143
           +  +++ + DV         K + +V E +D      +I  +  Q+ +       +  + 
Sbjct: 69  QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL      N  LK+ DFG                      
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------- 166

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           A E     + Y  S D+WS+G I   +L   P F     L     +       +    EF
Sbjct: 167 AKETTG--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYEF 221

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            +   +              +S            L++ +L  EP++R+T+TE + HP+I 
Sbjct: 222 PNPEWS-------------EVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

Query: 321 G 321
            
Sbjct: 262 Q 262

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  157 bits (398), Expect = 5e-44
 Identities = 78/335 (23%), Positives = 135/335 (40%), Gaps = 55/335 (16%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
            Y+    +G G +G V    +  T  KVA+K +N     +     +  RE+  L+  +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++I L  V+      +  D+++V E +   +L   I  +  L     +    Q+L G+ Y
Sbjct: 77  HIIKLYQVIS-----TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW-----YRAPE 203
            H   ++HRDLKP N+L++A+ + KI DFGL+      E   T            Y APE
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPE 185

Query: 204 LLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           ++      G  +D+WS G I +A + G  P                           F D
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP---------------------------FDD 218

Query: 263 N--PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           +  P   + I    +    +++       P  + LL+ ML  +P KR T+ +  +H +  
Sbjct: 219 DHVPTLFKKICDGIFYTPQYLN-------PSVISLLKHMLQVDPMKRATIKDIREHEWFK 271

Query: 321 GLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNE 355
                   P      S  ID+   +++  +   +E
Sbjct: 272 QDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSE 306

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  152 bits (385), Expect = 8e-44
 Identities = 63/294 (21%), Positives = 121/294 (41%), Gaps = 53/294 (18%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           IGRG++  V   ++ ET  +VA  ++ +    + +  R   E  +L+ ++H N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--I 154
              T +   K + LV ELM +  L   +K  + +     + +  Q+L+GL++LH+    I
Sbjct: 94  WESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 155 LHRDLKPGNLLVNA-NCDLKICDFGLA--------RTSRGNEQFMTEYVVTRWYRAPELL 205
           +HRDLK  N+ +      +KI D GLA        +   G  +FM          APE  
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM----------APE-- 200

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           +  + Y  S+DV++ G    E+   +  +   +   Q+   +                  
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------------ 242

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                     + G   +S    A P   ++++  +     +R ++ + L H + 
Sbjct: 243 ----------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  150 bits (382), Expect = 4e-43
 Identities = 70/321 (21%), Positives = 113/321 (35%), Gaps = 58/321 (18%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLLR-- 84
           +Y     +G+G +G V +        +VAIK I       +    D++    E+ LL   
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 85  --HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT--DLHQIIKSSQSLSNDHCKYFVF 140
                H  VI L D              LV E      DL   I     L     + F  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGF-----MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           Q++  +++ HS  ++HRD+K  N+L++      K+ DFG            T++  TR Y
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRVY 204

Query: 200 RAPELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
             PE +     +     VWS+G + +  + G  P                          
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-------------------------- 238

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
            F  + +        P     H+S       P    L+++ L  +PS R ++ E L  P+
Sbjct: 239 -FERDQEILEAELHFPA----HVS-------PDCCALIRRCLAPKPSSRPSLEEILLDPW 286

Query: 319 I-SGLYDPQCNPPAQVPLSLD 338
           + +   D   NP    P  L 
Sbjct: 287 MQTPAEDVPLNPSKGGPAPLA 307

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  149 bits (378), Expect = 8e-43
 Identities = 72/298 (24%), Positives = 119/298 (39%), Gaps = 57/298 (19%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
            YV    +G G +G V    ++ T  KVA+K +N     +     +  RE+  L+  +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDH-CKYFVFQLLRGLK 147
           ++I L  V+      +  D ++V E +   +L   I     +      + F  Q+L  + 
Sbjct: 72  HIIKLYQVIS-----TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILSAVD 125

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW-----YRAP 202
           Y H   ++HRDLKP N+L++A+ + KI DFGL+      E   T            Y AP
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAP 179

Query: 203 ELLLCCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           E++      G  +D+WS G I +A + G  P                           F 
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP---------------------------FD 212

Query: 262 DN--PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
           D   P   + I+   +    +++            LL  ML  +P KR T+ +  +H 
Sbjct: 213 DEHVPTLFKKIRGGVFYIPEYLN-------RSVATLLMHMLQVDPLKRATIKDIREHE 263

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  149 bits (377), Expect = 1e-42
 Identities = 61/340 (17%), Positives = 112/340 (32%), Gaps = 86/340 (25%)

Query: 8   PNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF 67
             GMKSR               T++  ++ IG G +G V   + R      AIK+     
Sbjct: 2   AMGMKSR-------------YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL 48

Query: 68  ENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQ 122
              +D    LRE+     + +H +V+            ++ +   + +  E  +   L  
Sbjct: 49  AGSVDEQNALREVYAHAVLGQHSHVVRYFS--------AWAEDDHMLIQNEYCNGGSLAD 100

Query: 123 IIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN--------- 169
            I               K  + Q+ RGL+Y+HS +++H D+KP N+ ++           
Sbjct: 101 AISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160

Query: 170 ----------CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWS 219
                        KI D G   T   + Q          + A E+L     +    D+++
Sbjct: 161 GDEDDWASNKVMFKIGDLGHV-TRISSPQVE---EGDSRFLANEVLQENYTHLPKADIFA 216

Query: 220 VGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGT 279
           +        G +P+       +Q   I                          LP     
Sbjct: 217 LALTVVCAAGAEPLP---RNGDQWHEIRQ----------------------GRLP----- 246

Query: 280 HISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
            I  +  Q      +LL+ M+  +P +R +    ++H  +
Sbjct: 247 RIPQVLSQE---FTELLKVMIHPDPERRPSAMALVKHSVL 283

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  150 bits (379), Expect = 1e-42
 Identities = 71/360 (19%), Positives = 123/360 (34%), Gaps = 100/360 (27%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRH-- 85
           T + PI+ +GRG +GVV  + N+  +   AIK+I   N    R   +R ++ L  L H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 86  -----------------------------------------------IKHDNVIALKDVM 98
                                                           + D       V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 99  MPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSN---DHCKYFVFQLLRGLKYLHSANI 154
                     +Y+  +L    +L   +    SL +     C +   Q+   +++LHS  +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF------------MTEYVVTRWYRAP 202
           +HRDLKP N+    +  +K+ DFGL      +E+              T  V T+ Y +P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E  +  +NY   +D++S+G I  E+L         E +  +  +                
Sbjct: 246 E-QIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDV---------------- 286

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
                         R      L+ Q  P    ++Q ML   P++R   T+ +++     L
Sbjct: 287 --------------RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  146 bits (371), Expect = 2e-41
 Identities = 62/337 (18%), Positives = 124/337 (36%), Gaps = 61/337 (18%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HD 89
           +    + +  G +  V  + +  +  + A+K++ +  E +  A+   +E+  ++ +  H 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII--QEVCFMKKLSGHP 86

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQ--SLSNDHCKYFVFQLL 143
           N++            S         L +      +  + K      LS D      +Q  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 144 RGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTSRGN--------EQFMTEY 193
           R ++++H     I+HRDLK  NLL++    +K+CDFG A T             + + E 
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 194 VVTR----WYRAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII 247
            +TR     YR PE++    N   G   D+W++GCI   +  R+  F       +L+++ 
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---AKLRIVN 263

Query: 248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
             +                             H              L++ ML   P +R
Sbjct: 264 GKY-----------------SIPPHDTQYTVFH-------------SLIRAMLQVNPEER 293

Query: 308 ITVTEALQHPYISGLYDPQCNPPAQVPLSLDIDENIG 344
           +++ E +             N   + P++  +++N G
Sbjct: 294 LSIAEVVHQLQ---EIAAARNVNPKSPITELLEQNGG 327

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  146 bits (370), Expect = 4e-41
 Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 48/290 (16%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + ELV    +    ++ L   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118

Query: 98  MMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILH 156
           +          V +  EL++   L Q+IK    L  D   Y++ Q L GL+YLH+  ILH
Sbjct: 119 VREGPW-----VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 157 RDLKPGNLLVNAN-CDLKICDFG----LARTSRGNEQFMTEYVV-TRWYRAPELLLCCDN 210
            D+K  N+L++++     +CDFG    L     G      +Y+  T  + APE+++    
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-GKP 232

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
               +D+WS  C+   +L     +       +  L + +  ++     E           
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKI-ASEPPPIREIPP-------- 280

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                      +       PL    +Q+ L  EP  R +  E  +    +
Sbjct: 281 ---------SCA-------PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  147 bits (372), Expect = 8e-41
 Identities = 41/320 (12%), Positives = 91/320 (28%), Gaps = 76/320 (23%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRE---------------- 79
             +G+        + ++ET E   +           +A++ ++E                
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 80  -------LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKS------ 126
                  +     +K      +  V +    +     + +Y  M ++L    +       
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 127 -SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
             +SL +        Q++R L  LH   ++H  L+P +++++    + +  F      R 
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RD 261

Query: 186 NEQFMTE---YVVTRWYRAPELLLCCD----NYGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
               ++            A  +L            + D W++G     I     P     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-NTDD 320

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
             L   + I                     R  K++P                    LL+
Sbjct: 321 AALGGSEWIF--------------------RSCKNIP---------------QPVRALLE 345

Query: 298 KMLVFEPSKRITVTEALQHP 317
             L +    R+   +A++ P
Sbjct: 346 GFLRYPKEDRLLPLQAMETP 365

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (356), Expect = 2e-39
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 41/289 (14%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDV 97
           +G+G YG+V +  +     ++AIK+I          L    E+ L +H+KH N++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 87

Query: 98  MMPTHRISFKDVYLVYELMDTD-LHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSAN 153
                      + +  E +    L  +++S       +     ++  Q+L GLKYLH   
Sbjct: 88  FSENGF-----IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 154 ILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE-LLLCCDNY 211
           I+HRD+K  N+L+N  +  LKI DFG ++   G       +  T  Y APE +      Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 212 GTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK 271
           G + D+WS+GC   E+   KP  P  E       +  V G  +         P+      
Sbjct: 203 GKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMFKV-GMFKVH-------PE------ 246

Query: 272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
            +P      +S         A   + K    +P KR    + L   ++ 
Sbjct: 247 -IP----ESMS-------AEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  137 bits (346), Expect = 4e-37
 Identities = 87/392 (22%), Positives = 142/392 (36%), Gaps = 86/392 (21%)

Query: 5   VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN 64
            E PN     G H   +       + +Y  I+ +G G +  V  S + +  + VA+K + 
Sbjct: 15  QEDPNDYCKGGYHLVKIGDLF---NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71

Query: 65  NVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD-------VYLVYELMD 117
           +       AL    E+ LL+ +++ +       M+      FK        + +V+E++ 
Sbjct: 72  SAEHYTETALD---EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG 128

Query: 118 TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN----- 169
             L + I  S  Q L     K  + Q+L+GL YLH+   I+H D+KP N+L++ N     
Sbjct: 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188

Query: 170 --------------------------------------------CDLKICDFGLARTSRG 185
                                                         +KI D G A     
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WV 246

Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK- 244
           ++ F TE + TR YR+ E+L+    Y T  D+WS  C+  E+     +F         + 
Sbjct: 247 HKHF-TEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304

Query: 245 -----LIISVFG-------TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADP-- 290
                LII + G          +   EF       + I  L       +     +     
Sbjct: 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364

Query: 291 --LALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                D L  ML   P KR T  E L+HP+++
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  132 bits (335), Expect = 3e-36
 Identities = 61/324 (18%), Positives = 110/324 (33%), Gaps = 54/324 (16%)

Query: 9   NGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVF 67
           +  K  G       +   EI+     +  +G G  G V     R+T   +A+K++  +  
Sbjct: 5   SSGKQTGYLTIGGQRYQAEIN-DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63

Query: 68  ENRIDALRTLREL-VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIK- 125
           +     +  L +L V+L+      ++      +        DV++  ELM T   ++ K 
Sbjct: 64  KEENKRI--LMDLDVVLKSHDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKR 116

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFG----LA 180
               +           +++ L YL     ++HRD+KP N+L++    +K+CDFG    L 
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

Query: 181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDN----YGTSIDVWSVGCIFAEI-LGRKPIFP 235
                             Y APE +   D     Y    DVWS+G    E+  G+ P   
Sbjct: 177 DDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

Query: 236 GTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDL 295
                  L  ++                         + +S                   
Sbjct: 232 CKTDFEVLTKVL--------------QEE-PPLLPGHMGFS-------------GDFQSF 263

Query: 296 LQKMLVFEPSKRITVTEALQHPYI 319
           ++  L  +  KR    + L+H +I
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFI 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  131 bits (332), Expect = 6e-36
 Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 26/228 (11%)

Query: 24  TLFEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           +L  ID K + + + +GRGA+GVVC +  R   + VAIK+I +  E+   A     EL  
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFI--VELRQ 54

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII---KSSQSLSNDHCKYF 138
           L  + H N++ L              V LV E  +   L+ ++   +     +  H   +
Sbjct: 55  LSRVNHPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107

Query: 139 VFQLLRGLKYLHSAN---ILHRDLKPGNLLVNANCD-LKICDFGLARTSRGNEQFMTEYV 194
             Q  +G+ YLHS     ++HRDLKP NLL+ A    LKICDFG A   + +   MT   
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNK 164

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ 242
            +  + APE+     NY    DV+S G I  E++ R+  F        
Sbjct: 165 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  132 bits (334), Expect = 9e-36
 Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 40/311 (12%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  I  +G G  GVV    ++ +   +A K I+ +        + +REL +L       +
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           +               ++ +  E MD   L Q++K +  +           +++GL YL 
Sbjct: 94  VGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 151 SA-NILHRDLKPGNLLVNANCDLKICDFG--------LARTSRGNEQFMTEYVVTRWYRA 201
               I+HRD+KP N+LVN+  ++K+CDFG        +A +  G          TR Y +
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG----------TRSYMS 198

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQE----- 255
           PE L    +Y    D+WS+G    E+ +GR PI P      +L     V G   E     
Sbjct: 199 PERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 256 ------ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRI 308
                  +   +D+       + L Y        L          D + K L+  P++R 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

Query: 309 TVTEALQHPYI 319
            + + + H +I
Sbjct: 318 DLKQLMVHAFI 328

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  131 bits (331), Expect = 2e-35
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 52/303 (17%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRHIKHDN 90
              +  IGRGAYG V   +++ + + +A+K+I     +  +  + L +L V++R      
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSN-----DHCKYFVFQLLRG 145
           ++     +         D ++  ELM T   +  K   S+ +     +         ++ 
Sbjct: 83  IVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 146 LKYLHSA-NILHRDLKPGNLLVNANCDLKICDFG----LARTSRGNEQFMTEYVVTRWYR 200
           L +L     I+HRD+KP N+L++ + ++K+CDFG    L  +        T     R Y 
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA-----KTRDAGCRPYM 192

Query: 201 APELLLC---CDNYGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEA 256
           APE +        Y    DVWS+G    E+  GR P        +QL  ++         
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK-------- 244

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                D P+       L  S     S       P  ++ +   L  + SKR    E L+H
Sbjct: 245 ----GDPPQ-------LSNSEEREFS-------PSFINFVNLCLTKDESKRPKYKELLKH 286

Query: 317 PYI 319
           P+I
Sbjct: 287 PFI 289

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (325), Expect = 7e-35
 Identities = 55/231 (23%), Positives = 103/231 (44%), Gaps = 18/231 (7%)

Query: 26  FEIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
            +I    + IK  IG G++G V  +        VA+K +     +       LRE+ +++
Sbjct: 32  MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMK 89

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQII---KSSQSLSNDHCKYFVF 140
            ++H N++     +     +      +V E +    L++++    + + L         +
Sbjct: 90  RLRHPNIVLFMGAVTQPPNL-----SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144

Query: 141 QLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW 198
            + +G+ YLH+ N  I+HR+LK  NLLV+    +K+CDFGL+R              T  
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE 204

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
           + APE +L  +      DV+S G I  E+   +  +     LN  +++ +V
Sbjct: 205 WMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAV 251

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  128 bits (324), Expect = 8e-35
 Identities = 74/302 (24%), Positives = 122/302 (40%), Gaps = 54/302 (17%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRHIKHDN 90
             PI  +GRGAYGVV    +  + + +A+K+I     N  +  R L +L + +R +    
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
            +     +         DV++  ELMDT       Q+I   Q++  D        +++ L
Sbjct: 68  TVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 147 KYLHSA-NILHRDLKPGNLLVNANCDLKICDFG----LARTSRGNEQFMTEYVVTRWYRA 201
           ++LHS  +++HRD+KP N+L+NA   +K+CDFG    L                 + Y A
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-----KDIDAGCKPYMA 177

Query: 202 PELLLCCDN---YGTSIDVWSVGCIFAEI-LGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           PE +    N   Y    D+WS+G    E+ + R P         QLK ++          
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--------- 228

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                +P+      +  +S                 D   + L     +R T  E +QHP
Sbjct: 229 ---EPSPQL----PADKFSAEFV-------------DFTSQCLKKNSKERPTYPELMQHP 268

Query: 318 YI 319
           + 
Sbjct: 269 FF 270

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  128 bits (324), Expect = 8e-35
 Identities = 67/298 (22%), Positives = 132/298 (44%), Gaps = 50/298 (16%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
            KY   + IG+GA G V ++++  T ++VAI+++N   + + + +  + E++++R  K+ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77

Query: 90  NVIALKDVMMPTHRISF---KDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQL 142
           N++   D        S+    ++++V E +     TD    + +   +          + 
Sbjct: 78  NIVNYLD--------SYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCREC 125

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L+ L++LHS  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++     YG  +D+WS+G +  E++  +P +     L  L LI                
Sbjct: 186 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--------------AT 230

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           N          P  +     S       +  D L + L  +  KR +  E LQH ++ 
Sbjct: 231 NGT--------PELQNPEKLS------AIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  127 bits (322), Expect = 1e-34
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 26/228 (11%)

Query: 25  LFEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNV-FENRIDALRTL----R 78
           L  +    +   K IG+G +G+V      +    VAIK +     E   + +       R
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72

Query: 79  ELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII-KSSQSLSNDHCK 136
           E+ ++ ++ H N++ L  +M            +V E +   DL+  +   +  +      
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125

Query: 137 YFVFQLLRGLKYLHSAN--ILHRDLKPGNLLV-----NANCDLKICDFGLARTSRGNEQF 189
             +  +  G++Y+ + N  I+HRDL+  N+ +     NA    K+ DFGL++ S  +   
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--- 182

Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEILGRKPIFPG 236
           ++  +    + APE +   +  Y    D +S   I   IL  +  F  
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  128 bits (323), Expect = 1e-34
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 25/233 (10%)

Query: 27  EIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
                 +     +G+G +G      +RET E + +K++    E        L+E+ ++R 
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRC 63

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS-SQSLSNDHCKYFVFQLL 143
           ++H NV+    V+        K +  + E +    L  IIKS            F   + 
Sbjct: 64  LEHPNVLKFIGVL--YKD---KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------------TSRGNEQF 189
            G+ YLHS NI+HRDL   N LV  N ++ + DFGLAR                + + + 
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ 242
               V   ++ APE++    +Y   +DV+S G +  EI+GR    P       
Sbjct: 179 RYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  129 bits (326), Expect = 1e-34
 Identities = 42/312 (13%), Positives = 84/312 (26%), Gaps = 69/312 (22%)

Query: 31  KYVPIKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
                  +G GA+  V         + +  +K  +K       N  +     + +  L+ 
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKP 123

Query: 86  IKHDNVIALKDVMMPTHRISFKD-VYLVYELMD-TDLHQIIK-----SSQSLSNDHCKYF 138
                 +      +      F++   LV EL     L   I        + +       F
Sbjct: 124 SMQHMFMKFYSAHL------FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVN-----------ANCDLKICDFGLARTSR--G 185
             ++L  ++ +H   I+H D+KP N ++             +  L + D G +   +   
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL 245
                T    T  ++  E+L     +   ID + V      +L    +            
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMK----------- 285

Query: 246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPS 305
                  + E      +    R                  P  D    +    ML     
Sbjct: 286 ------VKNEGGECKPEGLFRR-----------------LPHLDMWN-EFFHVMLNIPDC 321

Query: 306 KRITVTEALQHP 317
             +   + L+  
Sbjct: 322 HHLPSLDLLRQK 333

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (321), Expect = 2e-34
 Identities = 65/314 (20%), Positives = 122/314 (38%), Gaps = 73/314 (23%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
           +  +  +  +G GA+G V  + N+ET    A K I    E  ++    + E+ +L    H
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDH 75

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
             ++ L              ++++ E         +  +++  + L+    +    Q+L 
Sbjct: 76  PYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLE 128

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
            L +LHS  I+HRDLK GN+L+    D+++ DFG++  +    Q    ++ T ++ APE+
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188

Query: 205 LLCCDN----YGTSIDVWSVGCIFA-EILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           ++C       Y    D+WS+G I   E+   +P                           
Sbjct: 189 VMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--------------------------- 220

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLY--PQADPLAL-----------DLLQKMLVFEPSK 306
                         P+     +  L    ++DP  L           D L+  L   P  
Sbjct: 221 --------------PHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPET 266

Query: 307 RITVTEALQHPYIS 320
           R +  + L+HP++S
Sbjct: 267 RPSAAQLLEHPFVS 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  127 bits (321), Expect = 3e-34
 Identities = 66/307 (21%), Positives = 113/307 (36%), Gaps = 51/307 (16%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDN 90
           Y   + IG GA  VV ++      EKVAIK+IN    +  +D L   +E+  +    H N
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHHPN 74

Query: 91  VIA-----LKD----VMMPTHRISFKDVYL----VYELMDTDLHQIIKSSQSLSNDHCKY 137
           +++     +      ++M           L    V +++   + +    S  L       
Sbjct: 75  IVSYYTSFVVKDELWLVMK---------LLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSRGNEQFMTEY 193
            + ++L GL+YLH    +HRD+K GN+L+  +  ++I DFG    LA         + + 
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 194 VV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
            V T  + APE++     Y    D+WS G    E+      +     +  L L +     
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---- 241

Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                     N                     +         ++   L  +P KR T  E
Sbjct: 242 ----------NDPPSLETGVQDKEMLKKYGKSF-------RKMISLCLQKDPEKRPTAAE 284

Query: 313 ALQHPYI 319
            L+H + 
Sbjct: 285 LLRHKFF 291

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  128 bits (323), Expect = 3e-34
 Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 52/301 (17%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIK 87
           +  +  ++ IG G++G V  + +   +E VAIKK++   +   +  + + +E+  L+ ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 88  HDNVIALKDVMMPTHRISF---KDVYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLL 143
           H N I  +          +      +LV E        +++  +  L            L
Sbjct: 113 HPNTIQYRG--------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL 164

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SRGNEQFMTEYVVTRWYRAP 202
           +GL YLHS N++HRD+K GN+L++    +K+ DFG A   +  N      +V T ++ AP
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SFVGTPYWMAP 219

Query: 203 ELLLCCDN--YGTSIDVWSVGCIFA-EILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           E++L  D   Y   +DVWS+G I   E+  RKP       ++ L  I             
Sbjct: 220 EVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ----------- 267

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              N      ++S  +S                 + +   L   P  R T    L+H ++
Sbjct: 268 ---NESPA--LQSGHWSEYFR-------------NFVDSCLQKIPQDRPTSEVLLKHRFV 309

Query: 320 S 320
            
Sbjct: 310 L 310

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  126 bits (319), Expect = 4e-34
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 21/235 (8%)

Query: 27  EIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           EI    + +   IG G++G V        +  VA+K +N              E+ +LR 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLL 143
            +H N++                + +V +  +   L+  + +S+             Q  
Sbjct: 77  TRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRA 201
           RG+ YLH+ +I+HRDLK  N+ ++ +  +KI DFGLA   +         +   +  + A
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 202 PELLLCCDN--YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQ 253
           PE++   D+  Y    DV++ G +  E++ G+ P +     +N    II + G  
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN---INNRDQIIEMVGRG 241

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (321), Expect = 4e-34
 Identities = 69/298 (23%), Positives = 136/298 (45%), Gaps = 50/298 (16%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
                   IG G+ G+VC +  + +  +VA+K ++   + R + L    E+V++R  +H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHF 102

Query: 90  NVIALKDVMMPTHRISF---KDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQL 142
           NV+ +          S+   ++++++ E +     TD   I+   + L+ +        +
Sbjct: 103 NVVEMYK--------SYLVGEELWVLMEFLQGGALTD---IVSQVR-LNEEQIATVCEAV 150

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L+ L YLH+  ++HRD+K  ++L+  +  +K+ DFG       +       V T ++ AP
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E++     Y T +D+WS+G +  E++  +P +     +  +K +               D
Sbjct: 211 EVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------------RD 255

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           +P         P  + +H  S      P+  D L++MLV +P +R T  E L HP++ 
Sbjct: 256 SPP--------PKLKNSHKVS------PVLRDFLERMLVRDPQERATAQELLDHPFLL 299

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  125 bits (316), Expect = 2e-33
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 43/301 (14%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
             +  ++ +G G YG V    + +T +  AIK ++   +   +  + +   +L ++  H 
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN--MLKKYSHHR 81

Query: 90  NVIALKDVMMPTHRISFKD-VYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           N+       +  +     D ++LV E       TDL +  K   +L  +   Y   ++LR
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILR 140

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
           GL +LH   ++HRD+K  N+L+  N ++K+ DFG++            ++ T ++ APE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200

Query: 205 LLCCDN----YGTSIDVWSVGCIFA-EILGRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           + C +N    Y    D+WS+G I A E+    P       +  L LI             
Sbjct: 201 IACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLIPR----------- 248

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
              NP  R  +KS  +S+                  ++  LV   S+R    + ++HP+I
Sbjct: 249 ---NPAPR--LKSKKWSKKFQ-------------SFIESCLVKNHSQRPATEQLMKHPFI 290

Query: 320 S 320
            
Sbjct: 291 R 291

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (315), Expect = 7e-33
 Identities = 56/323 (17%), Positives = 109/323 (33%), Gaps = 43/323 (13%)

Query: 30  TKYVPIKPIGRGA--YGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRH 85
             Y  +  IG+G      V  +  + T E V +++IN        +  L+   EL + + 
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ--GELHVSKL 82

Query: 86  IKHDNVIALKDVMMPTHRISFK---DVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFV 139
             H N++  +         +F    ++++V   M       +I +     ++     Y +
Sbjct: 83  FNHPNIVPYRA--------TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------RTSRGNEQFMTE 192
             +L+ L Y+H    +HR +K  ++L++ +  + +             +  R    F   
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 193 YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEIL-GRKPIF-------------PGT 237
            V    + +PE+L      Y    D++SVG    E+  G  P                  
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLL 296
            CL     I +   T   +               +   S G   S  Y +   P     +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 297 QKMLVFEPSKRITVTEALQHPYI 319
           ++ L   P  R + +  L H + 
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFF 337

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  121 bits (306), Expect = 2e-32
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 29/240 (12%)

Query: 25  LFEIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELV 81
           L EID   + ++  IG G +G V  +      ++VA+K   +  +  I        +E  
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAK 58

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVF 140
           L   +KH N+IAL+ V +    +      LV E      L++++   + +  D    +  
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNL-----CLVMEFARGGPLNRVLSG-KRIPPDILVNWAV 112

Query: 141 QLLRGLKYLHSAN---ILHRDLKPGNLLVN--------ANCDLKICDFGLARTSRGNEQF 189
           Q+ RG+ YLH      I+HRDLK  N+L+         +N  LKI DFGLAR        
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-- 170

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
                    + APE++     +    DVWS G +  E+L  +  F G   ++ L +   V
Sbjct: 171 KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGV 226

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (307), Expect = 3e-32
 Identities = 72/298 (24%), Positives = 133/298 (44%), Gaps = 52/298 (17%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
             +  ++ +G G+YG V  +I++ET + VAIK++    E+ +  +  ++E+ +++     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEI--IKEISIMQQCDSP 84

Query: 90  NVIALKDVMMPTHRISF---KDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQL 142
           +V+            S+    D+++V E       +D+  I   +++L+ D     +   
Sbjct: 85  HVVKYYG--------SYFKNTDLWIVMEYCGAGSVSDI--IRLRNKTLTEDEIATILQST 134

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L+GL+YLH    +HRD+K GN+L+N     K+ DFG+A             + T ++ AP
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194

Query: 203 ELLLCCDNYGTSIDVWSVGCIFA-EILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           E++     Y    D+WS+G I A E+   KP +     +  + +I               
Sbjct: 195 EVIQ-EIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI--------------- 237

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             P         P  R   + S          D +++ LV  P +R T T+ LQHP++
Sbjct: 238 --PT-----NPPPTFRKPELWS------DNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  121 bits (305), Expect = 6e-32
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 25/227 (11%)

Query: 26  FEIDTKYVPIKP-IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           ++I  + + I   IG+G +G V           VAI+ I+   +N        RE++  R
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYR 84

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKS-SQSLSNDHCKYFVFQL 142
             +H+NV+      M    +      ++  L     L+ +++     L  +  +    ++
Sbjct: 85  QTRHENVVLFMGACMSPPHL-----AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTR---WY 199
           ++G+ YLH+  ILH+DLK  N+  + N  + I DFGL   S   +    E  +     W 
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 200 R--APELL--------LCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
              APE++             +    DV+++G I+ E+  R+  F  
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (294), Expect = 2e-30
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 23/200 (11%)

Query: 30  TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKH 88
             +  ++ IG+G++G V   I+  T + VAIK I+    E+ I+ ++  +E+ +L     
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDS 79

Query: 89  DNVIALKDVMMPTHRISF---KDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQ 141
             V             S+     ++++ E +      DL +       L        + +
Sbjct: 80  PYVTKYYG--------SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILRE 127

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +L+GL YLHS   +HRD+K  N+L++ + ++K+ DFG+A      +     +V T ++ A
Sbjct: 128 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 202 PELLLCCDNYGTSIDVWSVG 221
           PE++     Y +  D+WS+G
Sbjct: 188 PEVIK-QSAYDSKADIWSLG 206

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  117 bits (295), Expect = 5e-30
 Identities = 71/319 (22%), Positives = 138/319 (43%), Gaps = 58/319 (18%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLR 84
           FEI      ++ IG+G++G VC     +T +  A+K +N      R +     +EL +++
Sbjct: 17  FEI------LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70

Query: 85  HIKHDNVIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVF 140
            ++H  ++ L          SF+D   +++V +L+   DL   ++ +     +  K F+ 
Sbjct: 71  GLEHPFLVNL--------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           +L+  L YL +  I+HRD+KP N+L++ +  + I DF +A       Q  T    T+ Y 
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181

Query: 201 APELLLCCDN--YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEAD 257
           APE+        Y  ++D WS+G    E+L GR+P +      +  +++ +     +   
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSKEIVHTF----ETTV 236

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ-H 316
           + +   P                            + LL+K+L   P +R +    +Q  
Sbjct: 237 VTY---P---------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272

Query: 317 PYISG-----LYDPQCNPP 330
           PY++      ++  +  P 
Sbjct: 273 PYMNDINWDAVFQKRLIPG 291

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (291), Expect = 6e-30
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 59/304 (19%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNV 91
            K +G G++  V  +    T+ + AIK   K + + EN++      RE  ++  + H   
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP--YVTRERDVMSRLDHPFF 92

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
           + L          +F+D   +Y  +      +L + I+   S      +++  +++  L+
Sbjct: 93  VKLY--------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY--VVTRWYRAPELL 205
           YLH   I+HRDLKP N+L+N +  ++I DFG A+      +       V T  Y +PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 206 LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP 264
                   S D+W++GCI  +++ G  P   G E           +   Q+         
Sbjct: 205 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------YLIFQK--------- 243

Query: 265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT------VTEALQHPY 318
                I  L Y              P A DL++K+LV + +KR+             HP+
Sbjct: 244 -----IIKLEYDFPEKFF-------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

Query: 319 ISGL 322
              +
Sbjct: 292 FESV 295

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  112 bits (283), Expect = 3e-29
 Identities = 36/232 (15%), Positives = 78/232 (33%), Gaps = 21/232 (9%)

Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
             ID K +     +     G +     +     + +K +     +   +     E   LR
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQII--KSSQSLSNDHCKYFVFQ 141
              H NV+ +                L+   M    L+ ++   ++  +       F   
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119

Query: 142 LLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           + RG+ +LH+    I    L   +++++ +   +I    +              +    +
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAW 174

Query: 200 RAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
            APE L     D    S D+WS   +  E++ R+  F     L+ +++ + V
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD---LSNMEIGMKV 223

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  113 bits (285), Expect = 6e-29
 Identities = 57/222 (25%), Positives = 86/222 (38%), Gaps = 25/222 (11%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           +K IG+G YG V     R   EKVA+K             R   E+     ++H+N++  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFT--TEEASWFRE-TEIYQTVLMRHENILGF 96

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN 153
               +     S+  +YL+ +  +   L+  +KS  +L         +  + GL +LH+  
Sbjct: 97  IAADI-KGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 154 --------ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF----MTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA     +           V T+ Y  
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 202 PELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTE 238
           PE+L    N          D++S G I  E+  R       E
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  112 bits (282), Expect = 9e-29
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 25/222 (11%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           ++ +G+G YG V     +   E VA+K  ++   +     R   EL     ++H+N++  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSS--RDEKSWFRE-TELYNTVMLRHENILGF 67

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA- 152
               M +   S   ++L+    +   L+  ++   +L    C   V  +  GL +LH   
Sbjct: 68  IASDMTSRHSS-TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 153 -------NILHRDLKPGNLLVNANCDLKICDFGLAR----TSRGNEQFMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA     ++   +      V T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 202 PELL-----LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE 238
           PE+L     + C +    +D+W+ G +  E+  R       E
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  112 bits (281), Expect = 2e-28
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 32/236 (13%)

Query: 27  EIDTKYVP-IKPIGRGAYGVVC----SSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
             + +++  I  +G+G +G V       +   T   VA+K++ +   ++       RE+ 
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--QREIQ 76

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQ-IIKSSQSLSNDHCKYFV 139
           +L+ +  D ++  + V     R S   + LV E + +  L   + +    L       + 
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT--- 196
            Q+ +G++YL S   +HRDL   N+LV +   +KI DFGLA+    ++     YVV    
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPG 190

Query: 197 ----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPGTECLNQL 243
                WY APE L    +    S   DVWS G +  E+     K   P  E L  +
Sbjct: 191 QSPIFWY-APESL----SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (281), Expect = 2e-28
 Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 25/222 (11%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
            + IG+G +G V     R   E+VA+K  ++         R   E+     ++H+N++  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSS--REERSWFRE-AEIYQTVMLRHENILGF 101

Query: 95  KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA- 152
                     ++  ++LV +  +   L   +    +++ +           GL +LH   
Sbjct: 102 IAADN-KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 153 -------NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ----FMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA                 V T+ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 202 PELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTE 238
           PE+L    N          D++++G +F EI  R  I    E
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (273), Expect = 1e-27
 Identities = 58/236 (24%), Positives = 107/236 (45%), Gaps = 32/236 (13%)

Query: 27  EIDTKYVP-IKPIGRGAYGVVC----SSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
           + + +++  ++ +G+G +G V       +   T E VA+KK+ +  E  +      RE+ 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIE 63

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQ-IIKSSQSLSNDHCKYFV 139
           +L+ ++HDN++  K V     R +   + L+ E +    L   + K  + + +     + 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT--- 196
            Q+ +G++YL +   +HRDL   N+LV     +KI DFGL +    +++    + V    
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---FFKVKEPG 177

Query: 197 ----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEIL--GRKPIFPGTECLNQL 243
                WY APE L         S+  DVWS G +  E+     K   P  E +  +
Sbjct: 178 ESPIFWY-APESL----TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 2e-27
 Identities = 60/261 (22%), Positives = 110/261 (42%), Gaps = 32/261 (12%)

Query: 2   ATLVEPPNGMKSRGKHYYTMWQTLFEIDTKYVP-IKPIGRGAYGVVC----SSINRETNE 56
             +    N             +   + + +++  ++ +G+G +G V       +   T E
Sbjct: 12  YDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE 71

Query: 57  KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM 116
            VA+KK+ +  E  +      RE+ +L+ ++HDN++  K V     R +   + L+ E +
Sbjct: 72  VVAVKKLQHSTEEHLRDF--EREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYL 126

Query: 117 DT-DLHQ-IIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
               L   + K  + + +     +  Q+ +G++YL +   +HRDL   N+LV     +KI
Sbjct: 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186

Query: 175 CDFGLARTSRGNEQFMTEYVVT-------RWYRAPELLLCCDNYGT-SI--DVWSVGCIF 224
            DFGL +    +++    Y V         WY APE L         S+  DVWS G + 
Sbjct: 187 GDFGLTKVLPQDKE---YYKVKEPGESPIFWY-APESL----TESKFSVASDVWSFGVVL 238

Query: 225 AEIL--GRKPIFPGTECLNQL 243
            E+     K   P  E +  +
Sbjct: 239 YELFTYIEKSKSPPAEFMRMI 259

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  108 bits (271), Expect = 3e-27
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 34/229 (14%)

Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKH 88
           I+ +G G +G V           T E+VA+K  K  +   +  D     +E+ +LR++ H
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYH 82

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQ-IIKSSQSLSNDHCKYFVFQLLRGL 146
           +N++  K +           + L+ E + +  L + + K+   ++      +  Q+ +G+
Sbjct: 83  ENIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWY 199
            YL S   +HRDL   N+LV +   +KI DFGL +    +++    Y V         WY
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---YYTVKDDRDSPVFWY 196

Query: 200 RAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPGTECLNQL 243
            APE    C       I  DVWS G    E+         P    L  +
Sbjct: 197 -APE----CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  108 bits (272), Expect = 3e-27
 Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 35/236 (14%)

Query: 25  LFEIDT-KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
                +     ++   RG +G V  +     NE VA+K           + +   E+  L
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF---PIQDKQSWQNEYEVYSL 72

Query: 84  RHIKHDNVIAL-----KDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKY 137
             +KH+N++       +   +          +L+    +   L   +K+   +S +   +
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDL------WLITAFHEKGSLSDFLKA-NVVSWNELCH 125

Query: 138 FVFQLLRGLKYLHSA----------NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE 187
               + RGL YLH             I HRD+K  N+L+  N    I DFGLA      +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 188 QF--MTEYVVTRWYRAPELL----LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT 237
                   V TR Y APE+L        +    ID++++G +  E+  R     G 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  106 bits (267), Expect = 9e-27
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 36/230 (15%)

Query: 26  FEIDTKYVPI--KPIGRGAYGVVCSSI--NRETNEKVAIK--KINNVFENRIDALRTLRE 79
             +D K + +  K +G G +G V       ++  + VA+K  K         D L  L E
Sbjct: 11  VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL--LAE 68

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYF 138
             +++ + +  ++ +  +         +   LV E+ +   L++ ++ ++ + + +    
Sbjct: 69  ANVMQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 122

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-- 196
           V Q+  G+KYL  +N +HRDL   N+L+      KI DFGL++  R +E     Y     
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE---NYYKAQTH 179

Query: 197 -----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEIL--GRKPIFPG 236
                +WY APE    C NY   S   DVWS G +  E    G+KP + G
Sbjct: 180 GKWPVKWY-APE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRG 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  108 bits (271), Expect = 1e-26
 Identities = 76/325 (23%), Positives = 122/325 (37%), Gaps = 58/325 (17%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K IGRGA+G V    ++ T +  A+K ++      R D+     E  ++       V+ 
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           L          +F+D   +Y +M+     DL  ++ S+  +     +++  +++  L  +
Sbjct: 134 LF--------YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAI 184

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPELLLCC 208
           HS   +HRD+KP N+L++ +  LK+ DFG             +  V T  Y +PE+L   
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 209 D---NYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADL-EFIDN 263
                YG   D WSVG    E+L G  P                 F           I N
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTP-----------------FYADSLVGTYSKIMN 287

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPYIS 320
            K      SL +     IS         A +L+   L  +   R+    V E  +H +  
Sbjct: 288 HK-----NSLTFPDDNDIS-------KEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334

Query: 321 G-----LYDPQCNPPAQVPLSLDID 340
                         P    LS DID
Sbjct: 335 NDQWAWETLRDTVAPVVPDLSSDID 359

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  106 bits (266), Expect = 1e-26
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 37/227 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           E++   + +   +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKE 65

Query: 86  IKHDNVIALKDVMMPTHRISFKD-VYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQ 141
           IKH N++ L  V       + +   Y++ E M   +L   ++    Q +S     Y   Q
Sbjct: 66  IKHPNLVQLLGV------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT----- 196
           +   ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G+      Y        
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKF 174

Query: 197 --RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE L     Y   SI  DVW+ G +  EI   G  P +PG
Sbjct: 175 PIKWT-APESL----AYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  107 bits (269), Expect = 3e-26
 Identities = 48/212 (22%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K IGRGA+  V     ++T +  A+K +N      R +      E  +L +     +  
Sbjct: 66  LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDL-HQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           L          +F+D   +Y +M+     DL   + K  + +  +  ++++ +++  +  
Sbjct: 126 LH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPELLL- 206
           +H    +HRD+KP N+L++    +++ DFG     R +    +   V T  Y +PE+L  
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 207 -----CCDNYGTSIDVWSVGCIFAEIL-GRKP 232
                   +YG   D W++G    E+  G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  106 bits (266), Expect = 3e-26
 Identities = 71/327 (21%), Positives = 133/327 (40%), Gaps = 70/327 (21%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           IK +G G++G V    ++E+    A+K      V + +     TL E  +L+ +    ++
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAVNFPFLV 104

Query: 93  ALKDVMMPTHRISFKDVYLVYELMDT----DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            L+         SFKD   +Y +M+     ++   ++     S  H +++  Q++   +Y
Sbjct: 105 KLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT-----EYVVTRWYRAPE 203
           LHS ++++RDLKP NLL++    +++ DFG A+  R   +  T     E +      APE
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEAL------APE 208

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++L    Y  ++D W++G +  E+    P F   + +   + I+S         + F   
Sbjct: 209 IILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------GKVRF--- 257

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPY 318
           P               H S           DLL+ +L  + +KR       V +   H +
Sbjct: 258 PS--------------HFS-------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

Query: 319 ISG-----LYDPQCNPPAQVPLSLDID 340
            +      +Y  +   P         D
Sbjct: 297 FATTDWIAIYQRKVEAPFIPKFKGPGD 323

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  107 bits (269), Expect = 5e-26
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 19/218 (8%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           E++   + +   +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++ 
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKE 272

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQL 142
           IKH N++ L  V   T        Y++ E M   +L   ++    Q +S     Y   Q+
Sbjct: 273 IKHPNLVQLLGVC--TRE---PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY--VVTRWYR 200
              ++YL   N +HR+L   N LV  N  +K+ DFGL+R   G+            +W  
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 386

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           APE L   + +    DVW+ G +  EI   G  P +PG
Sbjct: 387 APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 422

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  106 bits (267), Expect = 7e-26
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLR 84
           FEI      +K IGRGA+G V     +  ++  A+K +N      R +      E  +L 
Sbjct: 76  FEI------LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD----TDL-HQIIKSSQSLSNDHCKYFV 139
           +     +  L          +F+D   +Y +MD     DL   + K    L  +  ++++
Sbjct: 130 NGDSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRW 198
            +++  +  +H  + +HRD+KP N+L++ N  +++ DFG       +    +   V T  
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 199 YRAPELLLCCDN----YGTSIDVWSVGCIFAEIL-GRKP 232
           Y +PE+L   +     YG   D WS+G    E+L G  P
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (270), Expect = 7e-26
 Identities = 62/283 (21%), Positives = 119/283 (42%), Gaps = 50/283 (17%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRE---LVLLRHIKHDN 90
            + IGRG +G V      +T +  A+K ++    + +      L E   L L+       
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 91  VIALKDVMMPTHRISFKD---VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           ++ +          +F     +  + +LM+  DLH  +      S    +++  +++ GL
Sbjct: 254 IVCMS--------YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +++H+  +++RDLKP N+L++ +  ++I D GLA     +++     V T  Y APE+L 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQ 363

Query: 207 CCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
               Y +S D +S+GC+  ++L G  P                 F   +  D   ID   
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSP-----------------FRQHKTKDKHEID--- 403

Query: 266 ARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKR 307
             R   ++            P +  P    LL+ +L  + ++R
Sbjct: 404 --RMTLTMAVE--------LPDSFSPELRSLLEGLLQRDVNRR 436

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  107 bits (268), Expect = 9e-26
 Identities = 68/330 (20%), Positives = 137/330 (41%), Gaps = 61/330 (18%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
            + +GRG +G V +   + T +  A KK+N    + R      + E  +L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 94  LKDVMMPTHRISFK---DVYLVYELMD-----TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           L          +F+   D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 250 LA--------YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA   +  +     Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           L  + Y  S+D +++G    E++  +  F                        E ++N +
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPFRA--------------------RGEKVENKE 400

Query: 266 ARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRI-----TVTEALQHPY- 318
            ++ +     +        YP    P + D  + +L  +P KR+     +      HP  
Sbjct: 401 LKQRVLEQAVT--------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

Query: 319 --------ISGLYDPQCNPPAQVPLSLDID 340
                    +G+  P   P ++   + +I 
Sbjct: 453 RDISWRQLEAGMLTPPFVPDSRTVYAKNIQ 482

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (263), Expect = 1e-25
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 29/224 (12%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLL 83
            ++ + + + + IGRG +G V S   R  N  VA+K      E     L+   L+E  +L
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARIL 166

Query: 84  RHIKHDNVIALKDVMMPTHRISFKD-VYLVYELMDT-DLHQIIKS-SQSLSNDHCKYFVF 140
           +   H N++ L  V       + K  +Y+V EL+   D    +++    L        V 
Sbjct: 167 KQYSHPNIVRLIGV------CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT---R 197
               G++YL S   +HRDL   N LV     LKI DFG++R         +  +     +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280

Query: 198 WYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
           W  APE L    NYG  S   DVWS G +  E   LG  P +P 
Sbjct: 281 WT-APEAL----NYGRYSSESDVWSFGILLWETFSLGASP-YPN 318

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  103 bits (260), Expect = 2e-25
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 34/228 (14%)

Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKH 88
           I+ +G G +G V        N  T E VA+K  K +   ++R       +E+ +LR + H
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYH 92

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
           +++I  K         S   + LV E +    L   +    S+       F  Q+  G+ 
Sbjct: 93  EHIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMA 148

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYR 200
           YLH+ + +HRDL   N+L++ +  +KI DFGLA+      +    Y V         WY 
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWY- 204

Query: 201 APELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPGTECLNQL 243
           APE    C          DVWS G    E+         P T+ L  +
Sbjct: 205 APE----CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (259), Expect = 3e-25
 Identities = 53/245 (21%), Positives = 86/245 (35%), Gaps = 31/245 (12%)

Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
             +D   + + + IGRG YG V           VA+K                + +  + 
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVF---SFANRQNFINEKNIYRVP 62

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
            ++HDN+                +  LV E      L + +    +            + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVT 121

Query: 144 RGLKYLHSA---------NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF----- 189
           RGL YLH+           I HRDL   N+LV  +    I DFGL+    GN        
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 190 ---MTEYVVTRWYRAPELL------LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240
                  V T  Y APE+L         ++    +D++++G I+ EI  R       E +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

Query: 241 NQLKL 245
            + ++
Sbjct: 242 PEYQM 246

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  105 bits (264), Expect = 3e-25
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           EI  + + +   +G+G +G V          +VAIK +       +     L+E  +++ 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLK---PGTMSPEAFLQEAQVMKK 318

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQL 142
           ++H+ ++ L  V      +S + +Y+V E M    L   +K    + L          Q+
Sbjct: 319 LRHEKLVQLYAV------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY--VVTRWYR 200
             G+ Y+   N +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 431

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           APE       +    DVWS G +  E+   GR P +PG
Sbjct: 432 APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  102 bits (257), Expect = 5e-25
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 37/221 (16%)

Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKH 88
           IK +G GA+G V          +    VAIK++    E          L E  ++  + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDN 76

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLLRGL 146
            +V  L  +           V L+ +LM    L   ++  + ++ + +   +  Q+ +G+
Sbjct: 77  PHVCRLLGI------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYR 200
            YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY         +W  
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWM- 186

Query: 201 APELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
           A E +     +   +   DVWS G    E+   G KP + G
Sbjct: 187 ALESI----LHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (260), Expect = 7e-25
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 21/218 (9%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           EI  + + +   +G+G +G V          +VAIK +       +     L+E  +++ 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLK---PGTMSPEAFLQEAQVMKK 235

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQL 142
           ++H+ ++ L  V      +S + +Y+V E M    L   +K    + L          Q+
Sbjct: 236 LRHEKLVQLYAV------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY--VVTRWYR 200
             G+ Y+   N +HRDL+  N+LV  N   K+ DFGLAR    NE    +      +W  
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           APE  L    +    DVWS G +  E+   GR P +PG
Sbjct: 349 APEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (253), Expect = 8e-25
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 37/226 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           E+  + + + + +G G +G V          KVA+K +    +  +     L E  L++ 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQ 64

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQL 142
           ++H  ++ L  V      ++ + +Y++ E M+   L   +K+     L+ +       Q+
Sbjct: 65  LQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSRGNEQFMTEYVV 195
             G+ ++   N +HRDL+  N+LV+     KI DFGLAR       T+R   +F      
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP----- 173

Query: 196 TRWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
            +W  APE +    NYGT +I  DVWS G +  EI   GR P +PG
Sbjct: 174 IKWT-APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (251), Expect = 1e-24
 Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 43/241 (17%)

Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIK--KINNVFENRIDALRTLRE 79
           +EI  + + + + IG G +G V   I          VAIK  K       R   L+   E
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---E 66

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKY 137
            + +R   H +++ L  V      I+   V+++ EL    +L   ++  + SL       
Sbjct: 67  ALTMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 120

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT- 196
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +      Y    
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKAS 175

Query: 197 ------RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG---TECLNQ 242
                 +W  APE +    N+   +   DVW  G    EI   G KP F G    + + +
Sbjct: 176 KGKLPIKWM-APESI----NFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGR 229

Query: 243 L 243
           +
Sbjct: 230 I 230

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  101 bits (253), Expect = 2e-24
 Identities = 73/317 (23%), Positives = 129/317 (40%), Gaps = 70/317 (22%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVI 92
           ++ +G G++G V    +R      A+K  K   V   +     T  E ++L  + H  +I
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVTHPFII 69

Query: 93  ALKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            +          +F+D   ++ +MD     +L  +++ SQ   N   K++  ++   L+Y
Sbjct: 70  RMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT-----EYVVTRWYRAPE 203
           LHS +I++RDLKP N+L++ N  +KI DFG A+     +   T     +Y+      APE
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLCGTPDYI------APE 173

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++     Y  SID WS G +  E+L     F  +  +   + I+        A+L F   
Sbjct: 174 VVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------NAELRF--- 222

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPY 318
           P                     P  +    DLL +++  + S+R+        +   HP+
Sbjct: 223 P---------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

Query: 319 ISG-----LYDPQCNPP 330
                   L       P
Sbjct: 262 FKEVVWEKLLSRNIETP 278

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 99.6 bits (249), Expect = 2e-24
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
            ID   +   + IG G +G+V        + KVAIK I    E  +     + E  ++  
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMK 59

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLL 143
           + H  ++ L  V +         + LV E M+   L   +++ +   + +        + 
Sbjct: 60  LSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------- 196
            G+ YL  A ++HRDL   N LV  N  +K+ DFG+ R    +     +Y  +       
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPV 169

Query: 197 RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
           +W  +PE+     ++   S   DVWS G +  E+   G+ P +  
Sbjct: 170 KWA-SPEVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIP-YEN 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (255), Expect = 4e-24
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 37/226 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           EI  + + + K +G G +G V  +   +   KVA+K +     +       L E  +++ 
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKT 239

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVFQL 142
           ++HD ++ L  V      ++ + +Y++ E M    L   +KS             F  Q+
Sbjct: 240 LQHDKLVKLHAV------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------ 196
             G+ ++   N +HRDL+  N+LV+A+   KI DFGLAR    N     EY         
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-----EYTAREGAKFP 348

Query: 197 -RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
            +W  APE +    N+G+ +I  DVWS G +  EI   GR P +PG
Sbjct: 349 IKWT-APEAI----NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 36/230 (15%)

Query: 35  IKPIGRGAYGVVCS---SINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDN 90
           ++ +G G++GVV              VA+K +     ++ +A+   +RE+  +  + H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKY 148
           +I L  V      +    + +V EL     L   ++  Q          +  Q+  G+ Y
Sbjct: 83  LIRLYGV------VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRA 201
           L S   +HRDL   NLL+     +KI DFGL R    N+     YV+         W  A
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD---HYVMQEHRKVPFAWC-A 192

Query: 202 PELLLCCDNYGT-SI--DVWSVGCIFAEIL--GRKPIFPG---TECLNQL 243
           PE         T S   D W  G    E+   G++P + G   ++ L+++
Sbjct: 193 PE----SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 98.4 bits (246), Expect = 6e-24
 Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 42/237 (17%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSI-NRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           E+  + + + K +G G +GVV       +    VA+K I    E  +      +E   + 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIK---EGSMSEDEFFQEAQTMM 58

Query: 85  HIKHDNVIALKDVMMPTHRISFKD-VYLVYELMDT-DLHQIIKSS-QSLSNDHCKYFVFQ 141
            + H  ++    V       S +  +Y+V E +    L   ++S  + L         + 
Sbjct: 59  KLSHPKLVKFYGV------CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT----- 196
           +  G+ +L S   +HRDL   N LV+ +  +K+ DFG+ R    +     +YV +     
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-----QYVSSVGTKF 167

Query: 197 --RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG---TECLNQL 243
             +W  APE+     +Y   S   DVW+ G +  E+  LG+ P +     +E + ++
Sbjct: 168 PVKWS-APEVF----HYFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 29/232 (12%)

Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
             ID   + + K +G G +G V     ++ +    KVA+K +     ++ +    L E  
Sbjct: 29  VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA 88

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS------QSLSNDH 134
            ++   H NVI L  V +           ++   M   DLH  +  S      + +    
Sbjct: 89  CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
              F+  +  G++YL + N LHRDL   N ++  +  + + DFGL++     +     Y 
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD----YYR 204

Query: 195 VT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
                    +W  A E L   D  Y +  DVW+ G    EI   G  P +PG
Sbjct: 205 QGRIAKMPVKWI-AIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTP-YPG 252

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 40/240 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCS---SINRETNEKVAIKKINNVFENRIDALRT--LREL 80
           EI+   + I K IG G  G VC     +  + +  VAIK +        +  R   L E 
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEA 101

Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYF 138
            ++    H N+I L+ V+            +V E M+   L   +++     +       
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLA-----MIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-- 196
           +  +  G++YL     +HRDL   N+LV++N   K+ DFGL+R    +         T  
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD---AAYTTTG 213

Query: 197 -----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG---TECLNQL 243
                RW  APE +     + T S   DVWS G +  E+   G +P +      + ++ +
Sbjct: 214 GKIPIRWT-APEAI----AFRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 98.0 bits (245), Expect = 8e-24
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 43/227 (18%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLL 83
            ++ K + + + IG+G +G V     R    KVA+K I N      DA     L E  ++
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKN------DATAQAFLAEASVM 68

Query: 84  RHIKHDNVIALKDV---MMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKY 137
             ++H N++ L  V              +Y+V E M    L   ++S     L  D    
Sbjct: 69  TQLRHSNLVQLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSRGNEQFMTEYV 194
           F   +   ++YL   N +HRDL   N+LV+ +   K+ DFGL +   +++   +      
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----- 176

Query: 195 VTRWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
             +W  APE L         S   DVWS G +  EI   GR P +P 
Sbjct: 177 PVKWT-APEAL----REKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  101 bits (254), Expect = 8e-24
 Identities = 45/217 (20%), Positives = 90/217 (41%), Gaps = 22/217 (10%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHI 86
           +  +Y     I  G  G +  +++R  N + V +K + +   +       + E   L  +
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEV 136

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
            H +++ + + +  T R      Y+V E +    L +     Q L       ++ ++L  
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPA 194

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY---VVTRWYRAP 202
           L YLHS  +++ DLKP N+++     LK+ D G           +  +     T  ++AP
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-------INSFGYLYGTPGFQAP 246

Query: 203 ELLLCCDNYGTSI--DVWSVGCIFAEILGRKPIFPGT 237
           E++      G ++  D+++VG   A +    P   G 
Sbjct: 247 EIVR----TGPTVATDIYTVGRTLAALTLDLPTRNGR 279

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 99.3 bits (248), Expect = 9e-24
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 39/240 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCS----SINRETNEKVAIKKINNVFENRIDALRT--LRE 79
           EI    V   K IG G +G V      + + +    VAIK +        +  R   L E
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGE 96

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKY 137
             ++    H N+I L+ V+     +      ++ E M+   L + ++      S      
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKDGEFSVLQLVG 151

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT- 196
            +  +  G+KYL + N +HRDL   N+LVN+N   K+ DFGL+R    + +    Y  + 
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTTSG 209

Query: 197 -----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG---TECLNQL 243
                RW  APE +    +Y   +   DVWS G +  E+   G +P +      E +  +
Sbjct: 210 GKIPIRWT-APEAI----SYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 42/230 (18%), Positives = 89/230 (38%), Gaps = 38/230 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVC----SSINRETNEKVAIKKINNVF-ENRIDALRTLREL 80
                 +   K +G G +G V               V IK I +        A+     +
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV--TDHM 66

Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYF 138
           + +  + H +++ L  +           + LV + +    L   ++  + +L       +
Sbjct: 67  LAIGSLDHAHIVRLLGL------CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-- 196
             Q+ +G+ YL    ++HR+L   N+L+ +   +++ DFG+A     ++    + ++   
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD----KQLLYSE 176

Query: 197 -----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
                +W  A E +    ++G  +   DVWS G    E+   G +P + G
Sbjct: 177 AKTPIKWM-ALESI----HFGKYTHQSDVWSYGVTVWELMTFGAEP-YAG 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)

Query: 38  IGRGAYGVVCSSI--NRETNEKVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +G G +G V   +   R+    VAIK  K      +  + +R   E  ++  + +  ++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVR 74

Query: 94  LKDVMMPTHRISFKDVYLVYELMDT-DLHQ-IIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
           L  V         + + LV E+     LH+ ++   + +   +    + Q+  G+KYL  
Sbjct: 75  LIGV------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRAPEL 204
            N +HRDL   N+L+      KI DFGL++    ++   + Y          +WY APE 
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWY-APE- 183

Query: 205 LLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
              C N+   S   DVWS G    E    G+KP +  
Sbjct: 184 ---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKK 216

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 35/225 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
           EID K +   K +G G +GVV     R     VAIK I     +  +    + E  ++ +
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDE---FIEEAKVMMN 75

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLL 143
           + H+ ++ L  V      I     +++ E M    L   ++  +              + 
Sbjct: 76  LSHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------- 196
             ++YL S   LHRDL   N LVN    +K+ DFGL+R    +     EY  +       
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPV 185

Query: 197 RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
           RW   PE+L     Y   S   D+W+ G +  EI  LG+ P +  
Sbjct: 186 RWS-PPEVL----MYSKFSSKSDIWAFGVLMWEIYSLGKMP-YER 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.9 bits (249), Expect = 4e-23
 Identities = 62/248 (25%), Positives = 107/248 (43%), Gaps = 22/248 (8%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
            + +G+G +G VC+   R T +  A KK+     + R      L E  +L  +    V++
Sbjct: 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 94  LKDVMMPTHRISF---KDVYLVYELMDT-DL-HQIIKSSQS-LSNDHCKYFVFQLLRGLK 147
           L          ++     + LV  LM+  DL   I    Q+        ++  ++  GL+
Sbjct: 249 LA--------YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC 207
            LH   I++RDLKP N+L++ +  ++I D GLA      +      V T  Y APE++  
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVK- 358

Query: 208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN--PK 265
            + Y  S D W++GC+  E++  +  F       +      V    +E   E+ +   P+
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQR---KKKIKREEVERLVKEVPEEYSERFSPQ 415

Query: 266 ARRFIKSL 273
           AR     L
Sbjct: 416 ARSLCSQL 423

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 37/221 (16%)

Query: 35  IKPIGRGAYGVVC----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIKH 88
           IK +G GA+G V          +    VAIK++    E          L E  ++  + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDN 76

Query: 89  DNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLLRGL 146
            +V  L  +           V L+ +LM    L   ++  + ++ + +   +  Q+ +G+
Sbjct: 77  PHVCRLLGI------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------RWYR 200
            YL    ++HRDL   N+LV     +KI DFGLA+     E+   EY         +W  
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWM- 186

Query: 201 APELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
           A E +     +   +   DVWS G    E+   G KP + G
Sbjct: 187 ALESI----LHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.9 bits (246), Expect = 9e-23
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 39/229 (17%)

Query: 36  KPIGRGAYGVVCSSINRETNE--KVAIK--KINNVFENRIDALRTLRELVLLRHIKHDNV 91
             +G G +G V   + R   +   VAIK  K      +  + +R   E  ++  + +  +
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYI 398

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYL 149
           + L  V         + + LV E+     LH+ +   +  +   +    + Q+  G+KYL
Sbjct: 399 VRLIGV------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRAP 202
              N +HR+L   N+L+      KI DFGL++    ++   + Y          +WY AP
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWY-AP 508

Query: 203 ELLLCCDNYGT-SI--DVWSVGCIFAEIL--GRKPIFPG---TECLNQL 243
           E    C N+   S   DVWS G    E L  G+KP +      E +  +
Sbjct: 509 E----CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 552

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 95.8 bits (239), Expect = 9e-23
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 22/215 (10%)

Query: 35  IKPIGRGAYGVVCS---SINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
            + IG+G +GVV         +   + AIK ++ + E +      LRE +L+R + H NV
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-QVEAFLREGLLMRGLNHPNV 84

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYL 149
           +AL  +M+P   +     +++   M   DL Q I+S  ++ +      F  Q+ RG++YL
Sbjct: 85  LALIGIMLPPEGL----PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-----RWYRAPEL 204
                +HRDL   N +++ +  +K+ DFGLAR     E +  +         +W  A E 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALES 199

Query: 205 LLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           L      + T  DVWS G +  E+   G  P +  
Sbjct: 200 LQ--TYRFTTKSDVWSFGVLLWELLTRGAPP-YRH 231

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.3 bits (238), Expect = 1e-22
 Identities = 52/241 (21%), Positives = 105/241 (43%), Gaps = 43/241 (17%)

Query: 26  FEIDTKYVPI-KPIGRGAYGVVCSSI---NRETNEKVAIK--KINNVFENRIDALRTLRE 79
           + I  + V + + +G G +G V   +   ++     VA+K  K +   +N+      + E
Sbjct: 7   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 63

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKY 137
            V+++++ H +++ L  +      I  +  +++ EL    +L   ++ ++ SL       
Sbjct: 64  AVIMKNLDHPHIVKLIGI------IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT- 196
           +  Q+ + + YL S N +HRD+   N+LV +   +K+ DFGL+R          +Y    
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKAS 172

Query: 197 ------RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG---TECLNQ 242
                 +W  +PE +    N+   +   DVW       EI   G++P F      + +  
Sbjct: 173 VTRLPIKWM-SPESI----NFRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGV 226

Query: 243 L 243
           L
Sbjct: 227 L 227

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)

Query: 35  IKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
            + +G+G +G V  +  ++ +    KVA+K +        D    LRE   ++   H +V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 92  IALKDVMMPTH-RISFKDVYLVYELMDT-DLHQIIKSS------QSLSNDHCKYFVFQLL 143
             L  V + +  +       ++   M   DLH  + +S       +L       F+  + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT------- 196
            G++YL S N +HRDL   N ++  +  + + DFGL+R     +     Y          
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD----YYRQGCASKLPV 203

Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           +W  A E L   DN Y    DVW+ G    EI   G+ P + G
Sbjct: 204 KWL-ALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTP-YAG 242

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 27/242 (11%)

Query: 18  YYTMWQTLFEIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIK--KINNVFENRI 71
           Y       +EI  + + + + IG G +G V   I          VAIK  K       R 
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436

Query: 72  DALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-S 129
                L+E + +R   H +++ L  V      I+   V+++ EL    +L   ++  + S
Sbjct: 437 K---FLQEALTMRQFDHPHIVKLIGV------ITENPVWIIMELCTLGELRSFLQVRKFS 487

Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
           L       + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547

Query: 190 MTEY--VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLNQ 242
                 +  +W  APE +     + ++ DVW  G    EI   G KP F G    + + +
Sbjct: 548 KASKGKLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGR 604

Query: 243 LK 244
           ++
Sbjct: 605 IE 606

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 37/224 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLL 83
            ++ K + + + IG+G +G V     R    KVA+K I N      DA     L E  ++
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKN------DATAQAFLAEASVM 240

Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSS--QSLSNDHCKYFVF 140
             ++H N++ L  V+          +Y+V E M    L   ++S     L  D    F  
Sbjct: 241 TQLRHSNLVQLLGVI--VE--EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 296

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSRGNEQFMTEYVVTR 197
            +   ++YL   N +HRDL   N+LV+ +   K+ DFGL +   +++   +        +
Sbjct: 297 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVK 351

Query: 198 WYRAPELLLCCDNYGT-SI--DVWSVGCIFAEI--LGRKPIFPG 236
           W  APE L         S   DVWS G +  EI   GR P +P 
Sbjct: 352 WT-APEAL----REKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 389

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 40/240 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCS---SINRETNEKVAIK--KINNVFENRIDALRTLREL 80
           E+D   + I K +G G +G VCS    +  +    VAIK  K+    + R D    L E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD---FLGEA 97

Query: 81  VLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYF 138
            ++    H N+I L+ V+  +     K V +V E M+   L   ++      +       
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152

Query: 139 VFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-- 196
           +  +  G+KYL     +HRDL   N+L+N+N   K+ DFGL R    + +       T  
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE---AAYTTRG 209

Query: 197 -----RWYRAPELLLCCDNYG---TSIDVWSVGCIFAEI--LGRKPIFPG---TECLNQL 243
                RW  +PE +     Y    ++ DVWS G +  E+   G +P +      + +  +
Sbjct: 210 GKIPIRWT-SPEAI----AYRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 23/224 (10%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
              +  V   + IGRG +G V      + + K    A+K +N + +   +  + L E ++
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGII 79

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQ-IIKSSQSLSNDHCKYFVF 140
           ++   H NV++L  + + +         +V   M   DL   I   + + +      F  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 135

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT---- 196
           Q+ +G+KYL S   +HRDL   N +++    +K+ DFGLAR     E +           
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195

Query: 197 -RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
            +W  A E L      + T  DVWS G +  E+   G  P +P 
Sbjct: 196 VKWM-ALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPP-YPD 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 76/308 (24%), Positives = 133/308 (43%), Gaps = 52/308 (16%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRE-LVLLRHIKHDNVI 92
            K +G+G++G V  +  ++TN+  AIK +  +V     D   T+ E  VL    +H  + 
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 93  ALKDVMMPTHRISF---KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            +          +F   ++++ V E ++  DL   I+S          ++  +++ GL++
Sbjct: 82  HMF--------CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LHS  I++RDLK  N+L++ +  +KI DFG+ + +   +     +  T  Y APE+LL  
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             Y  S+D WS G +  E+L  +  F G +       I          +  +   P+   
Sbjct: 194 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------MDNPFY---PR--- 239

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ-HPYISG-----L 322
                       +          A DLL K+ V EP KR+ V   ++ HP         L
Sbjct: 240 -----------WLE-------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281

Query: 323 YDPQCNPP 330
              + +PP
Sbjct: 282 ERKEIDPP 289

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 27/221 (12%)

Query: 28  IDTKYVPIKPIGRGAYGVV----CSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVL 82
           I+ +Y  +  +G G    V     + +N +    VAIK I      + + L R  RE+  
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIK----VAIKAIFIPPREKEETLKRFEREVHN 64

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQ 141
              + H N++++ DV            YLV E ++   L + I+S   LS D    F  Q
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDC-----YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ 119

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYR 200
           +L G+K+ H   I+HRD+KP N+L+++N  LKI DFG+A+         T +V+ T  Y 
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179

Query: 201 APELLLCCDNYGTSI----DVWSVGCIFAEIL-GRKPIFPG 236
           +PE        G +     D++S+G +  E+L G  P F G
Sbjct: 180 SPEQAK-----GEATDECTDIYSIGIVLYEMLVGEPP-FNG 214

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 94  LKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           LK         +F     +  V  Y    EL     H  +   +  + +  +++  +++ 
Sbjct: 70  LK--------YAFQTHDRLCFVMEYANGGELF---FH--LSRERVFTEERARFYGAEIVS 116

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
            L+YLHS ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 205 LLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           L   D YG ++D W +G +  E++  +  F  
Sbjct: 177 LEDND-YGRAVDWWGLGVVMYEMMCGRLPFYN 207

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 33/229 (14%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
              +  V   + IGRG +G V      + + K    A+K +N + +   +  + L E ++
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGII 143

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDHCKYFVF 140
           ++   H NV++L  + + +         +V   M   DL   I++   + +      F  
Sbjct: 144 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT---- 196
           Q+ +G+K+L S   +HRDL   N +++    +K+ DFGLAR     + +  E+       
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKT 254

Query: 197 ------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
                 +W  A E L      + T  DVWS G +  E+   G  P +P 
Sbjct: 255 GAKLPVKWM-ALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPP-YPD 299

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 39/233 (16%), Positives = 82/233 (35%), Gaps = 34/233 (14%)

Query: 25  LFEIDTKYVPI-KPIGRGAYGVVCSSINRETNE-------KVAIKKINNVFENRIDALRT 76
             +I  + +   + +G+G +  +   + RE  +       +V +K ++    N  ++   
Sbjct: 2   FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-- 59

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQ-SLSNDH 134
                ++  + H +++    V +           LV E +    L   +K ++  ++   
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDEN-----ILVQEFVKFGSLDTYLKKNKNCINILW 114

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL--------KICDFGLARTSRGN 186
                 QL   + +L    ++H ++   N+L+    D         K+ D G++ T    
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

Query: 187 EQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           +           W   PE +    N   + D WS G    EI   G KP    
Sbjct: 175 D----ILQERIPWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSA 221

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.4 bits (225), Expect = 8e-21
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 25/223 (11%)

Query: 28  IDTKYVPIKPIGRGAYGVV----CSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVL 82
           +  +Y   + +G G    V        +R+    VA+K +            R  RE   
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQN 65

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQ 141
              + H  ++A+ D        +    Y+V E +D   L  I+ +   ++       +  
Sbjct: 66  AAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE--YVV-TRW 198
             + L + H   I+HRD+KP N++++A   +K+ DFG+AR    +   +T+   V+ T  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 199 YRAPELLLCCDNYGTSI----DVWSVGCIFAEIL-GRKPIFPG 236
           Y +PE        G S+    DV+S+GC+  E+L G  P F G
Sbjct: 185 YLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEPP-FTG 221

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 31/219 (14%)

Query: 32  YVPIKPIGRGAYGVV----CSSINRETNEKVAIKKINNVFENRIDA---LRTLRELVLLR 84
           Y   + +GRG  G V     +   R     VA+K ++    +  D     R  RE     
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERI----VALKLMSETLSS--DPVFRTRMQREARTAG 89

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLL 143
            ++  +V+ + D      +     +Y+   L++  DL  +++    L+       V Q+ 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQ-----LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAP 202
             L   H+A   HRD+KP N+LV+A+    + DFG+A  +   +       V T +Y AP
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204

Query: 203 ELLLCCDNYGTSI----DVWSVGCIFAEIL-GRKPIFPG 236
           E         +      D++++ C+  E L G  P + G
Sbjct: 205 ERFS-----ESHATYRADIYALTCVLYECLTGSPP-YQG 237

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)

Query: 35  IKPIGRGAYG---VVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKHD 89
           ++ +G+G YG    V       T +  A+K +    +  N  D   T  E  +L  +KH 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81

Query: 90  NVIALKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVF 140
            ++ L          +F     +YL+  Y    EL    +   ++       D   +++ 
Sbjct: 82  FIVDLI--------YAFQTGGKLYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLA 128

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           ++   L +LH   I++RDLKP N+++N    +K+ DFGL + S  +      +  T  Y 
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           APE+L+    +  ++D WS+G +  ++L   P F G
Sbjct: 189 APEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTG 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 37/279 (13%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRE-LVLLRHIKHDNVI 92
           ++ IGRG+Y  V     ++T+   A+K +   +  +  D      E  V  +   H  ++
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 93  ALKDVMMPTHRISF---KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            L           F     ++ V E ++  DL   ++  + L  +H +++  ++   L Y
Sbjct: 74  GLH--------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           D YG S+D W++G +  E++  +  F      +            ++   + I       
Sbjct: 186 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILE----- 233

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
             K +   R   +S         A  +L+  L  +P +R
Sbjct: 234 --KQIRIPR--SLS-------VKAASVLKSFLNKDPKER 261

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHDNVIA 93
           +K +G+G +G V     + T    A+K +   V   + +   TL E  +L++ +H  + A
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 94  LKDVMMPTHRISFKDVYLVYELMD----TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           LK         SF+    +  +M+     +L   +   +  S D  +++  +++  L YL
Sbjct: 213 LK--------YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264

Query: 150 HSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           HS  N+++RDLK  NL+++ +  +KI DFGL +    +   M  +  T  Y APE+L   
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           D YG ++D W +G +  E++  +  F  
Sbjct: 325 D-YGRAVDWWGLGVVMYEMMCGRLPFYN 351

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 64/297 (21%), Positives = 130/297 (43%), Gaps = 71/297 (23%)

Query: 35  IKPIGRGAYG---VVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIKHD 89
           +K +G GAYG   +V      +T +  A+K +    + +       T  E  +L HI+  
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 90  N-VIALKDVMMPTHRISFKD---VYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFV 139
             ++ L          +F+    ++L+  Y    EL     H  +   +  +    + +V
Sbjct: 119 PFLVTLH--------YAFQTETKLHLILDYINGGELF---TH--LSQRERFTEHEVQIYV 165

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT-------E 192
            +++  L++LH   I++RD+K  N+L+++N  + + DFGL++    +E           E
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225

Query: 193 YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVF 250
           Y+      AP+++   D+ +  ++D WS+G +  E+L G  P     E  +Q ++   + 
Sbjct: 226 YM------APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI- 278

Query: 251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
               +++  +   P+               +S        LA DL+Q++L+ +P KR
Sbjct: 279 ---LKSEPPY---PQ--------------EMS-------ALAKDLIQRLLMKDPKKR 308

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRE-LVLLRHIKHDNVI 92
           +K IG+G++G V  + ++      A+K +       + +    + E  VLL+++KH  ++
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 93  ALKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
            L          SF     +Y V  Y    EL     H  ++  +       +++  ++ 
Sbjct: 103 GLH--------FSFQTADKLYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIA 149

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
             L YLHS NI++RDLKP N+L+++   + + DFGL + +  +    + +  T  Y APE
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           +L     Y  ++D W +G +  E+L   P F  
Sbjct: 210 VLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYS 241

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 51/243 (20%)

Query: 35  IKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK 87
            + +G+G++G+V        +  E   +VAIK +N   E      R   L E  +++   
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFN 86

Query: 88  HDNVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQIIKSS----------QSLSNDH 134
             +V+ L  V         +     ++ ELM   DL   ++S              S   
Sbjct: 87  CHHVVRLLGV-------VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
                 ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     +     Y 
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYR 195

Query: 195 VT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLN 241
                    RW  +PE L   D  + T  DVWS G +  EI  L  +P + G    + L 
Sbjct: 196 KGGKGLLPVRWM-SPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLR 251

Query: 242 QLK 244
            + 
Sbjct: 252 FVM 254

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 58/285 (20%), Positives = 116/285 (40%), Gaps = 49/285 (17%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRE-LVLLRHIKHDNVI 92
           ++ IGRG+Y  V     ++T+   A++ +   +  +  D      E  V  +   H  ++
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 93  ALKDVMMPTHRISF---KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            L           F     ++ V E ++  DL   ++  + L  +H +++  ++   L Y
Sbjct: 117 GLH--------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRW------YRAP 202
           LH   I++RDLK  N+L+++   +K+ D+G+ +      + +     T        Y AP
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTTSTFCGTPNYIAP 222

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+L   D YG S+D W++G +  E++  +  F      +            ++   + I 
Sbjct: 223 EILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVIL 275

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
                   K +   R   +S         A  +L+  L  +P +R
Sbjct: 276 E-------KQIRIPR--SLS-------VKAASVLKSFLNKDPKER 304

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 51/236 (21%)

Query: 35  IKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
            + +G GA+G V      +    +    VA+K + +            RE  LL +++H+
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF--QREAELLTNLQHE 77

Query: 90  NVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQ----------------IIKSSQSL 130
           +++    V             + +V+E M   DL++                  ++   L
Sbjct: 78  HIVKFYGV-------CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM 190
                 +   Q+  G+ YL S + +HRDL   N LV AN  +KI DFG++R     +   
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD--- 187

Query: 191 TEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
             Y V        RW   PE ++     + T  DVWS G I  EI   G++P +  
Sbjct: 188 -YYRVGGHTMLPIRWM-PPESIM--YRKFTTESDVWSFGVILWEIFTYGKQP-WFQ 238

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 55/249 (22%)

Query: 25  LFEIDTKYVPI-KPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRT-- 76
           L EI    V   + +G   +G V           E  + VAIK +    +     LR   
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEF 59

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQIIKSSQSLSND 133
             E +L   ++H NV+ L  V         KD  + +++      DLH+ +      S+ 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGV-------VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 112

Query: 134 HCK----------------YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF 177
                              + V Q+  G++YL S +++H+DL   N+LV    ++KI D 
Sbjct: 113 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL 172

Query: 178 GLARTSRGNEQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI-- 227
           GL R     +     Y +        RW  APE ++     +    D+WS G +  E+  
Sbjct: 173 GLFREVYAAD----YYKLLGNSLLPIRWM-APEAIM--YGKFSIDSDIWSYGVVLWEVFS 225

Query: 228 LGRKPIFPG 236
            G +P + G
Sbjct: 226 YGLQP-YCG 233

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 56/284 (19%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRE-LVLLRHIKHDNVI 92
           I+ +G+G++G V  +  +ET +  A+K +  +V     D   T+ E  +L     H  + 
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 93  ALKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
            L           F     ++ V  +    +LM    H  I+ S+       +++  +++
Sbjct: 88  QLF--------CCFQTPDRLFFVMEFVNGGDLM---FH--IQKSRRFDEARARFYAAEII 134

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
             L +LH   I++RDLK  N+L++     K+ DFG+ +    N      +  T  Y APE
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           +L     YG ++D W++G +  E+L     F      +  + I+         ++ +   
Sbjct: 195 ILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEVVY--- 243

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR 307
           P                +          A  +L+  +   P+ R
Sbjct: 244 PT--------------WLH-------EDATGILKSFMTKNPTMR 266

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 68/254 (26%), Positives = 93/254 (36%), Gaps = 55/254 (21%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSI--NRETNEKVAIKKINNVFENRIDALRT--LRELV 81
            +D   +     IG G +G V  +           AIK++    E            EL 
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELE 77

Query: 82  LLRHI-KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCK--- 136
           +L  +  H N+I L       HR     +YL  E     +L   ++ S+ L  D      
Sbjct: 78  VLCKLGHHPNIINLLGAC--EHR---GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132

Query: 137 -------------YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS 183
                        +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL+R  
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 192

Query: 184 RGNEQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPI 233
                    YV         RW  A E L    + Y T+ DVWS G +  EI  LG  P 
Sbjct: 193 E-------VYVKKTMGRLPVRWM-AIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTP- 241

Query: 234 FPG---TECLNQLK 244
           + G    E   +L 
Sbjct: 242 YCGMTCAELYEKLP 255

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  +G+G++G V  S  + T+E  A+K   K   + ++ ++     +  VL    K   +
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-VLALPGKPPFL 404

Query: 92  IALKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
             L           F     +Y V  Y    +LM    H  I+        H  ++  ++
Sbjct: 405 TQLH--------SCFQTMDRLYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEI 451

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
             GL +L S  I++RDLK  N+++++   +KI DFG+ + +  +      +  T  Y AP
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 511

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           E++     YG S+D W+ G +  E+L  +  F G
Sbjct: 512 EIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEG 544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 60/248 (24%), Positives = 98/248 (39%), Gaps = 55/248 (22%)

Query: 35  IKPIGRGAYGVV----CSSINRETNE-KVAIKKINNVFENRIDALRT--LRELVLLRHI- 86
            K +G GA+G V       + +E    KVA+K +           +   + EL ++ H+ 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLG 107

Query: 87  KHDNVIALKDVMMPTHRISFKD--VYLVYELM---------------DTDLHQIIKSSQS 129
           +H+N++ L                V ++ E                          ++ +
Sbjct: 108 QHENIVNLLGA-------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF 189
            S     +F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR    +   
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-- 218

Query: 190 MTEYVVT-------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKPIFPG---- 236
              Y+V        +W  APE +  C  Y    DVWS G +  EI  LG  P +PG    
Sbjct: 219 --NYIVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGILVN 273

Query: 237 TECLNQLK 244
           ++    +K
Sbjct: 274 SKFYKLVK 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIK---KINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  +G+G++G V  S  + T+E  A+K   K   + ++ ++     +  VL    K   +
Sbjct: 25  LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-VLALPGKPPFL 83

Query: 92  IALKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
             L           F     +Y V  Y    +LM    H  I+        H  ++  ++
Sbjct: 84  TQLH--------SCFQTMDRLYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEI 130

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
             GL +L S  I++RDLK  N+++++   +KI DFG+ + +  +      +  T  Y AP
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           E++     YG S+D W+ G +  E+L  +  F G
Sbjct: 191 EIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEG 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 85.3 bits (212), Expect = 8e-19
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 35  IKPIGRGAYG---VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +K +G+G++G   +V      +  +  A+K +        D +RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 92  IALKDVMMPTHRISF---KDVYLV--Y----ELMDTDLHQIIKSSQSLSNDHCKYFVFQL 142
           + L          +F     +YL+  +    +L        +      + +  K+++ +L
Sbjct: 89  VKLH--------YAFQTEGKLYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAEL 135

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
              L +LHS  I++RDLKP N+L++    +K+ DFGL++ S  +E+    +  T  Y AP
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG 236
           E++     +  S D WS G +  E+L     F G
Sbjct: 196 EVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQG 228

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 67/282 (23%), Positives = 109/282 (38%), Gaps = 59/282 (20%)

Query: 11  MKSRGKHYYTMWQTLFEIDTKY-VP------IKPIGRGAYGVV-----CSSINRETNEKV 58
             S    Y+ +    +E D K+  P       K +G GA+G V             + +V
Sbjct: 19  TGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 78

Query: 59  AIKKINNVFENRIDALRT--LRELVLLRHI-KHDNVIAL-----KD-----VM--MP--- 100
           A+K +    E    + R   + EL ++  +  H+N++ L            +        
Sbjct: 79  AVKMLK---EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135

Query: 101 ------THRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANI 154
                 + R  F +  + YE  +    +  +    L+ +    F +Q+ +G+++L   + 
Sbjct: 136 LLNYLRSKREKFSEDEIEYE--NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRAPELLLC 207
           +HRDL   N+LV     +KICDFGLAR    +      YVV        +W  APE L  
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWM-APESLFE 248

Query: 208 CDNYGTSIDVWSVGCIFAEI--LGRKP---IFPGTECLNQLK 244
              Y    DVWS G +  EI  LG  P   I         ++
Sbjct: 249 G-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 84.6 bits (210), Expect = 9e-19
 Identities = 66/248 (26%), Positives = 98/248 (39%), Gaps = 58/248 (23%)

Query: 35  IKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHI- 86
            KP+GRGA+G V            T   VA+K +    E    +     + EL +L HI 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIG 88

Query: 87  KHDNVIAL----KDVMMPTHRISFKDVYLVYELM-----------------DTDLHQIIK 125
            H NV+ L         P          ++ E                      +     
Sbjct: 89  HHLNVVNLLGACTKPGGPL--------MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
               L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR    
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 186 NEQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFP 235
           +     +YV         +W  APE +   D  Y    DVWS G +  EI  LG  P +P
Sbjct: 201 DP----DYVRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YP 252

Query: 236 GTECLNQL 243
           G +   + 
Sbjct: 253 GVKIDEEF 260

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 65/251 (25%), Positives = 92/251 (36%), Gaps = 53/251 (21%)

Query: 35  IKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK 87
            K +G G +G V          R     VA+K +    EN   +     L E  +L+ + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVN 84

Query: 88  HDNVIALKDV------------MMP---------THRISFKDVYLVYELMDTDLHQIIKS 126
           H +VI L                             R      YL               
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG-YLGSGGSRNSSSLDHPD 143

Query: 127 SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN 186
            ++L+      F +Q+ +G++YL    ++HRDL   N+LV     +KI DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 187 EQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           +     YV         +W  A E L   D+ Y T  DVWS G +  EI  LG  P +PG
Sbjct: 204 D----SYVKRSQGRIPVKWM-AIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

Query: 237 ---TECLNQLK 244
                  N LK
Sbjct: 256 IPPERLFNLLK 266

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 55/235 (23%), Positives = 89/235 (37%), Gaps = 50/235 (21%)

Query: 35  IKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD 89
              +G GA+G V      + +  +    VA+K +    E+        RE  LL  ++H 
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF--QREAELLTMLQHQ 103

Query: 90  NVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQ---------------IIKSSQSLS 131
           +++    V         +   + +V+E M   DL++                  +   L 
Sbjct: 104 HIVRFFGV-------CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMT 191
                    Q+  G+ YL   + +HRDL   N LV     +KI DFG++R     +    
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---- 212

Query: 192 EYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
            Y V        RW   PE +L     + T  DVWS G +  EI   G++P +  
Sbjct: 213 YYRVGGRTMLPIRWM-PPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQP-WYQ 263

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 71/289 (24%), Positives = 109/289 (37%), Gaps = 74/289 (25%)

Query: 12  KSRGKHYYTMWQTLFEIDTKYVP--------------IKPIGRGAYGVV-------CSSI 50
            S   H+++    L  +    +P               KP+G GA+G V           
Sbjct: 3   SSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKD 62

Query: 51  NRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHI-KHDNVIALKDVMMPTHRISFK 107
             +    VA+K +    ++  +   +  + E+ +++ I KH N+I L            +
Sbjct: 63  KPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA-------CTQ 112

Query: 108 D--VYLVYELM-----------------DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           D  +Y++ E                   +          + ++        +QL RG++Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRA 201
           L S   +HRDL   N+LV  N  +KI DFGLAR     +     Y  T       +W  A
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWM-A 227

Query: 202 PELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLNQLK 244
           PE L   D  Y    DVWS G +  EI  LG  P +PG    E    LK
Sbjct: 228 PEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLK 273

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 63/241 (26%), Positives = 96/241 (39%), Gaps = 57/241 (23%)

Query: 35  IKPIGRGAYGVV-------CSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRH 85
            KP+G G +G V             +    VA+K +    ++  +   +  + E+ +++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKM 142

Query: 86  I-KHDNVIALKDVMMPTHRISFKD--VYLVYELM-----------------DTDLHQIIK 125
           I KH N+I L            +D  +Y++ E                   +        
Sbjct: 143 IGKHKNIINLLGA-------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
             + ++        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR    
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 186 NEQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFP 235
            +     Y  T       +W  APE L   D  Y    DVWS G +  EI  LG  P +P
Sbjct: 256 ID----YYKKTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YP 307

Query: 236 G 236
           G
Sbjct: 308 G 308

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 83.4 bits (205), Expect = 3e-18
 Identities = 41/261 (15%), Positives = 74/261 (28%), Gaps = 58/261 (22%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKI---------------NNV 66
           +      + K    + IG G +G V  +I    +  VAIK I                  
Sbjct: 13  FSHCLPTE-KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEE 69

Query: 67  FENRIDALRTLRELVLLRHIKHDNVIALKDVMM-----PTHRISFKD------------- 108
               I   + L  L      + +  I L  V       P   +   D             
Sbjct: 70  ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129

Query: 109 -------VYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLK 160
                  +++V E     +      ++  S    K  + QL   L    ++    HRDL 
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189

Query: 161 PGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV 220
            GN+L+      K+      ++S          + +   +         +Y  S      
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST---------IPSCGLQV-----SIIDYTLSRLERDG 235

Query: 221 GCIFAEILGRKPIFPGTECLN 241
             +F ++   + +F G     
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQ 256

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 60/251 (23%), Positives = 94/251 (37%), Gaps = 57/251 (22%)

Query: 35  IKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHI- 86
            K +G GA+G V        I  +    VA+K +     +     R   + EL +L ++ 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLG 84

Query: 87  KHDNVIALKDVMMPTHRISFKD--VYLVYELM-------------------DTDLHQIIK 125
            H N++ L                  ++ E                      T    +  
Sbjct: 85  NHMNIVNLLGA-------CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 126 SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG 185
              +L  +    F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR  + 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 186 NEQFMTEYVVT-------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEI--LGRKP---I 233
           +      YVV        +W  APE +  C  Y    DVWS G    E+  LG  P   +
Sbjct: 198 DS----NYVVKGNARLPVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 234 FPGTECLNQLK 244
              ++    +K
Sbjct: 252 PVDSKFYKMIK 262

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 65/275 (23%), Positives = 93/275 (33%), Gaps = 63/275 (22%)

Query: 7   PPNGMKSRGKHYYTMWQTLFEIDTKYVPI-KPIGRGAYGVVC-----SSINRETNEKVAI 60
            PN M  R            E     +   + IG GA+G V        +  E    VA+
Sbjct: 23  HPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAV 82

Query: 61  KKINNVFENRIDALRT--LRELVLLRHIKHDNVIALKDVMMPTHRISFKD--VYLVYELM 116
           K +    E     ++    RE  L+    + N++ L  V             + L++E M
Sbjct: 83  KMLK---EEASADMQADFQREAALMAEFDNPNIVKLLGV-------CAVGKPMCLLFEYM 132

Query: 117 DT-DLHQ------------------------IIKSSQSLSNDHCKYFVFQLLRGLKYLHS 151
              DL++                               LS         Q+  G+ YL  
Sbjct: 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRAPEL 204
              +HRDL   N LV  N  +KI DFGL+R     +     Y          RW   PE 
Sbjct: 193 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWM-PPES 247

Query: 205 LLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG 236
           +    N Y T  DVW+ G +  EI   G +P + G
Sbjct: 248 IF--YNRYTTESDVWAYGVVLWEIFSYGLQP-YYG 279

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 51/243 (20%)

Query: 35  IKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK 87
           I+ +G GA+G V         N  +  +VA+K +    E   +      L E +++    
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFN 91

Query: 88  HDNVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQIIKSS-------QSLSNDHCKY 137
           H N++    V       S +    +++ ELM   DL   ++ +        SL+     +
Sbjct: 92  HQNIVRCIGV-------SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYV 194
               +  G +YL   + +HRD+   N L+         KI DFG+AR           Y 
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY----YR 200

Query: 195 VT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLN 241
                    +W   PE  +  +  + +  D WS G +  EI  LG  P +P     E L 
Sbjct: 201 KGGCAMLPVKWM-PPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLE 256

Query: 242 QLK 244
            + 
Sbjct: 257 FVT 259

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 74/287 (25%), Positives = 111/287 (38%), Gaps = 61/287 (21%)

Query: 1   MATLVEPPNGMKSRGKHYYTMWQTLFEID-TKYVPIKPIGRGAYGVV-------CSSINR 52
             T      GM +    Y       +E+   + V  KP+G GA+G V             
Sbjct: 39  PTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKP 98

Query: 53  ETNEKVAIKKINNVFENRIDALRT--LRELVLLRHI-KHDNVIALKDVMMPTHRISFKD- 108
               KVA+K +     +  +   +  + E+ +++ I KH N+I L            +D 
Sbjct: 99  NRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGKHKNIINLLGA-------CTQDG 148

Query: 109 -VYLVYELM-----------------DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
            +Y++ E                   +   +      + LS+       +Q+ RG++YL 
Sbjct: 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 208

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT-------RWYRAPE 203
           S   +HRDL   N+LV  +  +KI DFGLAR     +     Y  T       +W  APE
Sbjct: 209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYKKTTNGRLPVKWM-APE 263

Query: 204 LLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLNQLK 244
            L   D  Y    DVWS G +  EI  LG  P +PG    E    LK
Sbjct: 264 ALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLK 307

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 51/243 (20%)

Query: 35  IKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRT--LRELVLLRHIK 87
           I+ +G GA+G V         N  +  +VA+K +    E   +      L E +++    
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFN 132

Query: 88  HDNVIALKDVMMPTHRISFKD--VYLVYELMDT-DLHQIIKSS-------QSLSNDHCKY 137
           H N++    V       S +    +++ ELM   DL   ++ +        SL+     +
Sbjct: 133 HQNIVRCIGV-------SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 138 FVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSRGNEQFMTEYV 194
               +  G +YL   + +HRD+   N L+         KI DFG+AR           Y 
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY----YR 241

Query: 195 VT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEI--LGRKPIFPG---TECLN 241
                    +W   PE  +  +  + +  D WS G +  EI  LG  P +P     E L 
Sbjct: 242 KGGCAMLPVKWM-PPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLE 297

Query: 242 QLK 244
            + 
Sbjct: 298 FVT 300

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 18/134 (13%)

Query: 113 YELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL 172
              ++ +          L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 173 KICDFGLARTSRGNEQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIF 224
           KICDFGLAR    +     +YV         +W  APE +   D  Y    DVWS G + 
Sbjct: 233 KICDFGLARDIYKDP----DYVRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLL 285

Query: 225 AEI--LGRKPIFPG 236
            EI  LG  P +PG
Sbjct: 286 WEIFSLGASP-YPG 298

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 17/99 (17%)

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS-RGNEQFMTEYVV-TRWYRA 201
            G+ +LH  + +HRD+K  N+L++     KI DFGLAR S +  +  MT  +V T  Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 202 PELLLCCDNYGT------SIDVWSVGCIFAEIL-GRKPI 233
           PE                S D++S G +  EI+ G   +
Sbjct: 204 PE-------ALRGEITPKS-DIYSFGVVLLEIITGLPAV 234

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.2 bits (172), Expect = 6e-14
 Identities = 29/219 (13%), Positives = 59/219 (26%), Gaps = 39/219 (17%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHI 86
            + +Y  +   G         +++   + +VA+  ++            TL   + L  I
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
               V  + DV+            +V E +    L ++  +S   S       +  L   
Sbjct: 89  DKPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAA 141

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
               H A +      P  + V+ + D+ +                               
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA-- 179

Query: 206 LCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQL 243
                     D+  +G     +L  R P  P     + L
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP-LPEAGVRSGL 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 19/167 (11%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           ++V  K IG G +G++  +      EK A   +    E + +      EL   + +   +
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQ-ENGPLFSELKFYQRVAKKD 94

Query: 91  VIALKDVMMPTHRISFKDVY--------------LVYELMDTDLHQIIKSSQSLSNDHCK 136
            I           +     Y              +V E +  DL +I   + +       
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCD-LKICDFGLAR 181
               ++L  L+Y+H    +H D+K  NLL+   N D + + D+GL+ 
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 75/233 (32%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNV-------FENRIDALRTLRELVLLRHIKHDN 90
           IG G +G V   + R+   KVA+K+           FE          E+  L   +H +
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFET---------EIETLSFCRHPH 96

Query: 91  VIAL------KDVMMPTHRISFKDVYLVYELMDTD-----LHQIIKSSQSLSNDHCKYFV 139
           +++L      ++ M+           L+Y+ M+       L+     + S+S +      
Sbjct: 97  LVSLIGFCDERNEMI-----------LIYKYMENGNLKRHLYGSDLPTMSMSWE------ 139

Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
            Q L       RGL YLH+  I+HRD+K  N+L++ N   KI DFG+++   G E   T 
Sbjct: 140 -QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK--GTELDQT- 195

Query: 193 YVVTRW-----YRAPELLLCCDNYGTSI------DVWSVGCIFAEIL-GRKPI 233
           ++ T       Y  PE       Y          DV+S G +  E+L  R  I
Sbjct: 196 HLSTVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 22/164 (13%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHI 86
           +   +   K IG G +G +    N  TNE VAIK      E        L  E    + +
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQL 61

Query: 87  KHDNVIALKDVMMPTHRISFKDV---YLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQL 142
              + I       P             +V EL+   L  +     ++ S         QL
Sbjct: 62  GSGDGI-------PQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 143 LRGLKYLHSANILHRDLKPGNLLV--NANCDLKIC---DFGLAR 181
           +  ++Y+HS N+++RD+KP N L+    N   ++    DF LA+
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 34/214 (15%)

Query: 38  IGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT-LRELVLLRHIKHDNVIALKD 96
           +GRG +G V           VA+K++    E           E+ ++    H N++ L+ 
Sbjct: 38  LGRGGFGKVYKGR-LADGTLVAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 97  V-MMPTHRISFKDVYLVYELM-----DTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
             M PT R+      LVY  M      + L +  +S   L     +       RGL YLH
Sbjct: 95  FCMTPTERL------LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148

Query: 151 ---SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPELLL 206
                 I+HRD+K  N+L++   +  + DFGLA+     +  +T  V  T  + APE   
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE--- 205

Query: 207 CCDNYGTS------IDVWSVGCIFAEIL-GRKPI 233
               Y ++       DV+  G +  E++ G++  
Sbjct: 206 ----YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 20/162 (12%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHI 86
           +  +Y   + IG G++G +    +    E+VAIK      E        L  E  + + +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMM 61

Query: 87  KHDNVIALKDVMMPTHRISFKDV---YLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQL 142
           +    I       PT R    +     +V EL+   L  +    S+  S         Q+
Sbjct: 62  QGGVGI-------PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 114

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR 181
           +  ++Y+HS N +HRD+KP N L+        + I DFGLA+
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 27/173 (15%), Positives = 55/173 (31%), Gaps = 28/173 (16%)

Query: 31  KYVPIKPIGRGAYGVV--------CSSINRETNEKVAIKKINNVFENRIDALRTLRELVL 82
           ++       R   G++         +  +    +K ++K      + +   L    +   
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDGRLFN-EQNFF 96

Query: 83  LRHIKHDNVIALKDVM------MPTHRISFKDV----YLVYELMDTDLHQIIKSS--QSL 130
            R  K   V   K +       +PT            +LV   +   L   +  S    L
Sbjct: 97  QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156

Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI--CDFGLAR 181
           S         +LL  L++LH    +H ++   N+ V+     ++    +G A 
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 20/162 (12%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHI 86
           +  K+   + IG G++G +    N +TNE+VAIK      EN       L  E  + R +
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRIL 59

Query: 87  KHDNVIALKDVMMPTHRISFKDV---YLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQL 142
           +    I       P  R    +     LV +L+   L  +    S+ LS         Q+
Sbjct: 60  QGGTGI-------PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR 181
           +  ++++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 36/164 (21%), Positives = 65/164 (39%), Gaps = 22/164 (13%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHI 86
           +   Y   + IG G++GV+    N   N++VAIK     FE R      L  E    + +
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLL 62

Query: 87  KHDNVIALKDVMMPTHRISFKDV---YLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQL 142
                I       P      ++     LV +L+   L  ++    +  S         Q+
Sbjct: 63  AGCTGI-------PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 115

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLK-----ICDFGLAR 181
           L  ++ +H  ++++RD+KP N L+            + DFG+ +
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 33/173 (19%), Positives = 63/173 (36%), Gaps = 28/173 (16%)

Query: 31  KYVPIKPIGRGAYGVV-----CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
            +    PIG+G +G +      SS +  ++    +K          D      EL   + 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK------VEPSDNGPLFTELKFYQR 89

Query: 86  IKHDNVIALKDVMMPTHRISFKDVY--------------LVYELMDTDLHQIIKS-SQSL 130
                 I           +     +              ++ +   +DL +I ++ ++  
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 131 SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCD-LKICDFGLAR 181
           S         ++L  L+Y+H    +H D+K  NLL+N  N D + + D+GLA 
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 1e-07
 Identities = 51/440 (11%), Positives = 126/440 (28%), Gaps = 131/440 (29%)

Query: 17  HYYTMWQTLFEIDTKYVPIKPIGRGAY--GVVCSSINRETNEKVAIKKINNVFENRIDAL 74
           H++ M     E   +Y  I  +   A+     C  +       ++ ++I+++  ++    
Sbjct: 3   HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62

Query: 75  RTLRELVLLRHIKHDNVIA--LKDVMMPTH-------RISFKDVYLVYELMDTDLHQIIK 125
            TLR    L   K + ++   +++V+   +       +   +   ++  +      ++  
Sbjct: 63  GTLRLFWTLLS-KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121

Query: 126 SSQSLSNDHCKYFV------FQLLRGLKYLHSAN--ILH---------------RDLK-- 160
            +Q  +    KY V       +L + L  L  A   ++                   K  
Sbjct: 122 DNQVFA----KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177

Query: 161 ---PGNLL-VN-ANCD---------LKIC-DFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
                 +  +N  NC+          K+        TSR +     +  +         L
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 206 LCCDNYGTSI----DVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           L    Y   +    +V +     A        F    C    K++++   T+ +   +F+
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNA--------F-NLSC----KILLT---TRFKQVTDFL 281

Query: 262 DNPKARR------------------FIKSLPYSRGTHISSLYPQA---DPLALDLLQKML 300
                                     +K L          L  +    +P  L ++ + +
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYL----DCRPQDLPREVLTTNPRRLSIIAESI 337

Query: 301 VFEPS----------KRITVT-----EALQHPYISGLYDPQCNPPAQVPLSLDI---DEN 342
               +           ++T         L+      ++D            L +     +
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-----------RLSVFPPSAH 386

Query: 343 IGEQMIRQMMWNETLHYHPE 362
           I   ++  ++W + +     
Sbjct: 387 IPTILL-SLIWFDVIKSDVM 405

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 35/172 (20%), Positives = 67/172 (38%), Gaps = 22/172 (12%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVV--CSSINRETNEKVAIKKI--NNVFENRIDALRTL 77
           W    +   + +P   IG+GA   +   S ++ +   K  +KK   +   +  I   RT 
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTA 387

Query: 78  RELVLLRHIKHDNVIA--LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHC 135
           RE   L  +K   + A  + DV +   RI    +             +I+ +  ++    
Sbjct: 388 REARYLALVKDFGIPAPYIFDVDLDNKRIMMSYIN------GKLAKDVIEDNLDIAYK-- 439

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE 187
                 +   +  LH  +++H DL   N + + +  +   DFGL + S  +E
Sbjct: 440 ------IGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI--IDFGLGKISNLDE 483

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	364
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.07
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.54
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.29
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.14
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.11
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.94
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.5
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.15
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.03
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.0
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.89
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.83
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.82
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.65
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.11
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.0
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.7

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-63  Score=459.79  Aligned_cols=336  Identities=49%  Similarity=0.870  Sum_probs=286.7

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc-
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-  104 (364)
                      +.+.++|++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++|||||++++++...... 
T Consensus        50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            3467899999999999999999999999999999999987666666677888999999999999999999998754321 


Q ss_pred             ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ....+|||||||+|+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       130 ~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          130 EFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             TCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             cCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            23679999999999999999998999999999999999999999999999999999999999999999999999997653


Q ss_pred             CC----CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 GN----EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..    .......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..|....+.+....+..
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            32    22345678999999999998866789999999999999999999999999999999999999999998888777


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID  340 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~  340 (364)
                      ........+....+......+....+.+++.+++||++||..||.+|||++|+|+||||++..++...+...+|...+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~  369 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFD  369 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHH
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCCCCccc
Confidence            77777777777777777777777888999999999999999999999999999999999999998888877777665543


Q ss_pred             h-hhhHHHHHHHHHHHHHhhCC
Q 017909          341 E-NIGEQMIRQMMWNETLHYHP  361 (364)
Q Consensus       341 ~-~~~~~~~~~~~~~~~~~~~~  361 (364)
                      . ....+++++..|.+...+|+
T Consensus       370 ~~~~~~~~~k~~i~~ei~~~~~  391 (398)
T 4b99_A          370 REALTRERIKEAIVAEIEDFHA  391 (398)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhcCHHHHHHHHHHHHHHHHH
Confidence            2 33456677777766655553

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-61  Score=430.99  Aligned_cols=268  Identities=24%  Similarity=0.383  Sum_probs=232.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.++     .
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence            4689999999999999999999999999999999976433 233445678999999999999999999999988     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .+|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            8999999998 699999999899999999999999999999999999999999999999999999999999999876432


Q ss_pred             --CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 --EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                        .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++.+..              
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--------------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------------
T ss_pred             CCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------
Confidence              233456789999999999988 678999999999999999999999999988777777665421              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHH------HhcCCCccCCCCCCCCCCCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE------ALQHPYISGLYDPQCNPPAQV  333 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e------lL~hp~f~~~~~~~~~~~~~~  333 (364)
                                       ..++..+++.+++||++||+.||.+|||++|      |++||||+++.+..-....|+
T Consensus       251 -----------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP  308 (311)
T 4aw0_A          251 -----------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP  308 (311)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCC
T ss_pred             -----------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCC
Confidence                             1223568899999999999999999999988      589999999876654433333

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.9e-61  Score=423.96  Aligned_cols=255  Identities=30%  Similarity=0.473  Sum_probs=210.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++++..... .....+.+|+.+++.++||||+++++++.+.     ..
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence            58999999999999999999999999999999997654332 2345678999999999999999999999887     88


Q ss_pred             EEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          109 VYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      +++|||||+|+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus        88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~  166 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-GN  166 (275)
T ss_dssp             EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-CC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999976533 33


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....                  
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------------  228 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------------  228 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------------
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            34557899999999999885556789999999999999999999999877666655554311                  


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                   ...+..+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus       229 -------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                         1223568899999999999999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.6e-61  Score=437.26  Aligned_cols=257  Identities=24%  Similarity=0.419  Sum_probs=222.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+++.++|||||++++++.++     ..+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEE
Confidence            699999999999999999999999999999999987666666777889999999999999999999999887     889


Q ss_pred             EEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      |||||||+ |+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999998 6999999754  35799999999999999999999999999999999999999999999999999876444


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----------------  240 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-----------------  240 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----------------
T ss_pred             cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----------------
Confidence            344456789999999999988 67999999999999999999999999998877776666542                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                   .....+..+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus       241 -------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          241 -------------SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             -------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             -------------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                         1122345789999999999999999999999999999999764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6e-60  Score=429.29  Aligned_cols=260  Identities=24%  Similarity=0.477  Sum_probs=226.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||+++.....  ....+.+|+.+|+.++|||||+++++|.+.     ..
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~  145 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE  145 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence            46799999999999999999999999999999999754333  234567899999999999999999999988     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|||||||+ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999998 599998876 569999999999999999999999999999999999999999999999999998776555


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......              
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------------  289 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------------  289 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC--------------
T ss_pred             CcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence            55667889999999999977 678999999999999999999999999888777766664421111              


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                    ...+..+++.+.+||.+||+.||.+|||++|+|+||||++...+
T Consensus       290 --------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          290 --------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             --------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             --------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence                          11224578999999999999999999999999999999975543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-58  Score=412.43  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=219.0

Q ss_pred             cccce-eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKY-VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y-~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++| ++.+.||+|+||+||+|.++.++..||+|++............+.+|+.+++.++|||||+++++|...... .
T Consensus        23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~-~  101 (290)
T 3fpq_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG-K  101 (290)
T ss_dssp             TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT-E
T ss_pred             CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC-C
Confidence            45566 788899999999999999999999999999987666666777889999999999999999999998653211 1


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEcc-CCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNA-NCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~-~~~~~L~Dfg~~~~  182 (364)
                      ..++||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++. ++.+||+|||++..
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            56899999998 699999999899999999999999999999999998  999999999999974 78999999999975


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ...  ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+............   ...        
T Consensus       182 ~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~---~~~--------  246 (290)
T 3fpq_A          182 KRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---SGV--------  246 (290)
T ss_dssp             CCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---TTC--------
T ss_pred             CCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH---cCC--------
Confidence            432  23456689999999999865  589999999999999999999999987655443322211   100        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                       .....+...++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus       247 -----------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          247 -----------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                             001122457889999999999999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-60  Score=423.83  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=218.8

Q ss_pred             cceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++|++++.||+|+||+||+|++.   .+++.||+|+++..........++.+|+.+++.++||||+++++++.++     
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----
Confidence            68999999999999999999874   4678999999976544433344567899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            88999999998 69999999989999999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+..               
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------------  242 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---------------  242 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------------
Confidence            5555566789999999999987 689999999999999999999999999988777777665421               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~  323 (364)
                                      ...+..+|+.+.+||++||+.||.+|||     ++|+++||||+++.
T Consensus       243 ----------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          243 ----------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                            1223568999999999999999999998     58999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.1e-59  Score=431.93  Aligned_cols=260  Identities=24%  Similarity=0.472  Sum_probs=227.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++......  ....+.+|+.+|+.++|||||+++++|...     ..
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CE
Confidence            46799999999999999999999999999999999754332  234567899999999999999999999887     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +|||||||+ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999998 699998865 569999999999999999999999999999999999999999999999999998775555


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+......+..+......               
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------------  365 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---------------  365 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------------
T ss_pred             ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence            55667789999999999977 67999999999999999999999999988877777666442111               


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                   ....+..+++.+.+||.+||+.||.+|||++|+|+||||++...+
T Consensus       366 -------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          366 -------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             -------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             -------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence                         112335689999999999999999999999999999999985443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-58  Score=414.11  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=219.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++.+...       .+|+.+++.++|||||++++++.+.     ..+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~-----~~~  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREG-----PWV  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            5789999999999999999999999999999999754322       3699999999999999999999887     889


Q ss_pred             EEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~~~~  187 (364)
                      |||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||++.......
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999998 69999999888999999999999999999999999999999999999999988 69999999998654322


Q ss_pred             c-----ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          188 Q-----FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       188 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .     .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...   .         
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---~---------  272 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---P---------  272 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---C---------
T ss_pred             cccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---C---------
Confidence            1     1233579999999999988 68999999999999999999999999887665555555431   0         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCccCCCCCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA-------------LQHPYISGLYDPQC  327 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el-------------L~hp~f~~~~~~~~  327 (364)
                                      ......++.+++.+.+||.+||+.||.+|||+.||             |+|||+.+...|..
T Consensus       273 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          273 ----------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             ----------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             ----------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence                            01123456899999999999999999999999997             68999999877654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-55  Score=417.40  Aligned_cols=338  Identities=42%  Similarity=0.777  Sum_probs=279.4

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..+.++|++++.||+|+||+||+|+++.+++.||+|++...........++.+|+.+++.++||||+++++++.......
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            45679999999999999999999999999999999999876666667778889999999999999999999997664444


Q ss_pred             cceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...+++|||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus       129 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          129 FDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             CceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            47799999999999999999888999999999999999999999999999999999999999999999999999976532


Q ss_pred             CC---------------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh---------
Q 017909          186 NE---------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG---------  229 (364)
Q Consensus       186 ~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~---------  229 (364)
                      ..                           .......||+.|+|||++.....++.++|||||||++|+|++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            21                           123445779999999987665679999999999999999998         


Q ss_pred             --CCCCCCCCC--------------------hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCC
Q 017909          230 --RKPIFPGTE--------------------CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQ  287 (364)
Q Consensus       230 --g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (364)
                        |.++|++..                    ....+..+.+.++.+....+..........+....+......+...++.
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              788887765                    3577888999999999998888888888888888888888888888899


Q ss_pred             CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcc--cchhhhHHHHHHHHHHHHHhhCCCC
Q 017909          288 ADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLD--IDENIGEQMIRQMMWNETLHYHPEA  363 (364)
Q Consensus       288 ~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  363 (364)
                      .++.+.+||++||..||.+|||++|+|+||||+++..+..++....+....  ...+.+..+.+...|.+...|||+.
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  446 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEI  446 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCTTC
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCccc
Confidence            999999999999999999999999999999999998877665444333333  3346778889999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.2e-55  Score=412.36  Aligned_cols=340  Identities=39%  Similarity=0.750  Sum_probs=289.6

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+.+.++|++++.||+|+||+||+|+++.+++.||+|++...........++.+|+.+++.++||||+++++++......
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence            35578999999999999999999999999999999999987666667777889999999999999999999999876544


Q ss_pred             ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .....++|||+++++|.+.+.....+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus       101 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          101 KFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             TCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             cCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            44679999999999999999988889999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC----------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-----------CC
Q 017909          185 GNE----------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-----------RK  231 (364)
Q Consensus       185 ~~~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-----------g~  231 (364)
                      ...                      .......||+.|+|||++.....++.++|||||||++|+|++           |.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            322                      123566789999999997665779999999999999999997           56


Q ss_pred             CCCCCCC-----------------hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHH
Q 017909          232 PIFPGTE-----------------CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALD  294 (364)
Q Consensus       232 ~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  294 (364)
                      ++|++.+                 ....+..+.+.++.+....+..........+....+...........+.+++.+.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            6666654                 36788889999999999999888888888888887777777777777889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCccc--chhhhHHHHHHHHHHHHHhhCCCCC
Q 017909          295 LLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDI--DENIGEQMIRQMMWNETLHYHPEAR  364 (364)
Q Consensus       295 li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  364 (364)
                      ||++||+.||.+|||++|+|+||||+++.++...+....+.....  .......+.+.+-|.+..++||+.+
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  412 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV  412 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCcccc
Confidence            999999999999999999999999999988877754443333333  3456788899999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-54  Score=399.81  Aligned_cols=346  Identities=42%  Similarity=0.768  Sum_probs=287.1

Q ss_pred             cCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           13 SRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      ..+++........+.+.++|++++.||+|+||+||+|.+..+|+.||+|++...........++.+|+.+++.++||||+
T Consensus         8 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv   87 (367)
T 1cm8_A            8 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI   87 (367)
T ss_dssp             CCSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred             cCCceEEEecCceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCC
Confidence            45666777788888999999999999999999999999999999999999976655666667788999999999999999


Q ss_pred             eeeeeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909           93 ALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus        93 ~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                      ++++++...... .....++|||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.
T Consensus        88 ~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~  166 (367)
T 1cm8_A           88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE  166 (367)
T ss_dssp             CCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred             CceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC
Confidence            999999765321 2245799999998899998876 67999999999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          172 LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      ++|+|||++......   .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.+..+
T Consensus       167 ~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  243 (367)
T 1cm8_A          167 LKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  243 (367)
T ss_dssp             EEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999999765332   34457799999999998766799999999999999999999999999999999999999999


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA  331 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~  331 (364)
                      .++..............+....+......+....+..++.+.+||.+||+.||.+|||++|+|+||||+.+.++...+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  323 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV  323 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC
Confidence            99998888888888888888888777777888888999999999999999999999999999999999999888776555


Q ss_pred             CCCCCcccch-hhhHHHHHHHHHHHHHhhCCCC
Q 017909          332 QVPLSLDIDE-NIGEQMIRQMMWNETLHYHPEA  363 (364)
Q Consensus       332 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  363 (364)
                      + +...+..+ .....+.++..|.+.+.++|..
T Consensus       324 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (367)
T 1cm8_A          324 Q-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR  355 (367)
T ss_dssp             C-CCCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred             C-CCCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence            4 33333222 3346677888899999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.5e-54  Score=398.35  Aligned_cols=352  Identities=43%  Similarity=0.785  Sum_probs=278.9

Q ss_pred             ccCCCCcccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHH
Q 017909            5 VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR   84 (364)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~   84 (364)
                      .++..-.+++ .+...+....+.+.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++
T Consensus         5 ~~~~~~~~~~-~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~   83 (367)
T 2fst_X            5 HHHHSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK   83 (367)
T ss_dssp             -------CCC-EEEEEETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHH
T ss_pred             cccccccCCC-cceEeecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH
Confidence            3344433333 344567778888999999999999999999999999999999999999876556666777889999999


Q ss_pred             hcCCCCcceeeeeeccccc-cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909           85 HIKHDNVIALKDVMMPTHR-ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus        85 ~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      .++||||+++++++..... ......++|+++++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+|
T Consensus        84 ~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N  162 (367)
T 2fst_X           84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN  162 (367)
T ss_dssp             HCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             hCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhh
Confidence            9999999999999876422 12256899999999999888866 679999999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL  243 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  243 (364)
                      |+++.++.++|+|||++......   .....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+.....
T Consensus       163 Ill~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l  239 (367)
T 2fst_X          163 LAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL  239 (367)
T ss_dssp             EEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998765322   344577999999999987667899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ..+.+..+.+...............+...........+....+..++.+.+||++||+.||.+|||+.|+|+||||+.+.
T Consensus       240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            99999999998888888888888888777776666667777788999999999999999999999999999999999998


Q ss_pred             CCCCCCCCCCCCCcccc-hhhhHHHHHHHHHHHHHhhCCC
Q 017909          324 DPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPE  362 (364)
Q Consensus       324 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  362 (364)
                      .+...+... |...+.. ......+.++..|.+...++|+
T Consensus       320 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~  358 (367)
T 2fst_X          320 DPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPP  358 (367)
T ss_dssp             CGGGCCCCC-CCCGGGSSCCCCHHHHHHHHHHHHHHCCCC
T ss_pred             CCCCCCCCC-CCCcchhhccCCHHHHHHHHHHHHHHhccC
Confidence            877665544 4444433 2445677889999999998886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-54  Score=399.32  Aligned_cols=286  Identities=28%  Similarity=0.449  Sum_probs=221.3

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      +..+.++|++.+.||+|+||+||+|+++   .+++.||+|.+....    ...++.+|+++|+.+ +||||++++++|..
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            3457899999999999999999999875   457889999886432    233567899999998 69999999999988


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFG  178 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg  178 (364)
                      .     .++++||||++ |+|.+++   +.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus        92 ~-----~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 N-----DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             T-----TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             C-----CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            7     88999999997 6999988   469999999999999999999999999999999999999877 799999999


Q ss_pred             ccccCCCCC----------------------------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC
Q 017909          179 LARTSRGNE----------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR  230 (364)
Q Consensus       179 ~~~~~~~~~----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  230 (364)
                      +++......                            ......+||+.|+|||++.+...++.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997543221                            1123357999999999998866799999999999999999999


Q ss_pred             CCCCC-CCChHHHHHHHHHHhCCCchhhhhcc-----------CchhHHHHHhhC---CC---------CCCCcccccCC
Q 017909          231 KPIFP-GTECLNQLKLIISVFGTQQEADLEFI-----------DNPKARRFIKSL---PY---------SRGTHISSLYP  286 (364)
Q Consensus       231 ~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~---~~---------~~~~~~~~~~~  286 (364)
                      +.||. +.+..+.+..|....+.+........           ............   ..         .........+.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            99984 45667778888877765332211100           000011110000   00         01111223456


Q ss_pred             CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          287 QADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       287 ~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      .+++++++||++||+.||.+|||++|+|+||||+++
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            789999999999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5e-55  Score=392.43  Aligned_cols=262  Identities=24%  Similarity=0.432  Sum_probs=199.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc-----
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-----  104 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-----  104 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+++.++|||||++++++.+....     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            46999999999999999999999999999999997543 333456778999999999999999999998765321     


Q ss_pred             --ccceEEEEecccc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          105 --SFKDVYLVYELMD-TDLHQIIKSSQS---LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       105 --~~~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                        ...++|+|||||. |+|.+++.....   .+...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence              1135799999997 699999987654   4456788999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCc------------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017909          179 LARTSRGNEQ------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI  246 (364)
Q Consensus       179 ~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i  246 (364)
                      +++.......            .....+||+.|+|||++.+ ..++.++|||||||++|+|++   ||.+.  .+....+
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~  237 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL  237 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence            9976533221            1234579999999999987 689999999999999999996   67542  2222223


Q ss_pred             HHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ........+                           ..+...++.+.+||++||+.||.+|||+.|+|+||||+++..+
T Consensus       238 ~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          238 TDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            222111111                           1112345677899999999999999999999999999987543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.7e-53  Score=392.50  Aligned_cols=352  Identities=42%  Similarity=0.767  Sum_probs=299.2

Q ss_pred             ccCCCCcccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHH
Q 017909            5 VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR   84 (364)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~   84 (364)
                      .+++.-....|............+.++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++
T Consensus        17 ~~~m~~~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~   96 (371)
T 4exu_A           17 RGSMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK   96 (371)
T ss_dssp             ----CCSSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHH
T ss_pred             cCceeeeccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHH
Confidence            45566677888889999999999999999999999999999999999999999999999876666666777889999999


Q ss_pred             hcCCCCcceeeeeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909           85 HIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus        85 ~l~h~~iv~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      .++||||+++++++...... .....++|||+++++|.+.+.  ..+++..++.++.||+.||.|||++|++|+||+|+|
T Consensus        97 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  174 (371)
T 4exu_A           97 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN  174 (371)
T ss_dssp             HCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             hcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHH
Confidence            99999999999999876432 122359999999999988774  459999999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL  243 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  243 (364)
                      |+++.++.++|+|||.+......   .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+..
T Consensus       175 Ill~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  251 (371)
T 4exu_A          175 LAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL  251 (371)
T ss_dssp             EEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999998755322   334567899999999987667999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ..+....+.+...............+...........+....+.+++.+.+||++||+.||.+|||+.|+|+||||+.+.
T Consensus       252 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          252 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            99999999988888887777777778777777777777777888999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCCcccch-hhhHHHHHHHHHHHHHhhCC
Q 017909          324 DPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHP  361 (364)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  361 (364)
                      .+......+.|....+.. .+...+.++..|.+.+.++|
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          332 DPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             CGGGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             CcccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            877777777666655543 34466778888888888887

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-52  Score=388.46  Aligned_cols=338  Identities=48%  Similarity=0.903  Sum_probs=286.0

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ...+.++|++++.||+|+||+||+|.+..++..||+|++... ........+.+|+.+++.++||||+++++++......
T Consensus        22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            456789999999999999999999999999999999999753 2334456778999999999999999999999776444


Q ss_pred             ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .....++|||+++|+|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       101 ~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          101 QMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             TCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            4467899999999999998876 569999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          185 GNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       185 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ....   ......|++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+.+........
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3221   1344578999999999877567899999999999999999999999999999999999999999988888777


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccc-
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID-  340 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~-  340 (364)
                      .......+....+......+....+.+++.+.+||++||+.||.+|||+.|+|+||||+....+...+....|...+.. 
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~  339 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMEL  339 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC---
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCccccc
Confidence            7777777777777666666777778899999999999999999999999999999999999888888877777776653 


Q ss_pred             hhhhHHHHHHHHHHHHHhhCCCCC
Q 017909          341 ENIGEQMIRQMMWNETLHYHPEAR  364 (364)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~  364 (364)
                      +.++...+++..+.++-.++|+-|
T Consensus       340 ~~~~~~~~~~~~~~e~~~~~~~~~  363 (364)
T 3qyz_A          340 DDLPKEKLKELIFEETARFQPGYR  363 (364)
T ss_dssp             --CCHHHHHHHHHHHTGGGCC---
T ss_pred             ccCCHHHHHHHHHHHHHHhhhhcC
Confidence            334455666777777777888754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-53  Score=397.71  Aligned_cols=331  Identities=42%  Similarity=0.767  Sum_probs=256.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (364)
                      +.++|++++.||+|+||+||+|.++.+|+.||+|++...........+..+|+.+++.+. ||||+++++++.....   
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---
Confidence            568999999999999999999999999999999999766666667778889999999997 9999999999976532   


Q ss_pred             ceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ...++||||++++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        84 ~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           84 RDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             SCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             CEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            57899999999999998876 57999999999999999999999999999999999999999999999999998754221


Q ss_pred             ---------------------CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017909          187 ---------------------EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL  245 (364)
Q Consensus       187 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  245 (364)
                                           ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                 12234457899999999998766799999999999999999999999999999999999


Q ss_pred             HHHHhCCCchhhhhccCchhHHHHHhhCCCC---CCCcccc-------------cCCCCChHHHHHHHHhcccCCCCCCC
Q 017909          246 IISVFGTQQEADLEFIDNPKARRFIKSLPYS---RGTHISS-------------LYPQADPLALDLLQKMLVFEPSKRIT  309 (364)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-------------~~~~~~~~l~~li~~~l~~dP~~Rps  309 (364)
                      +....+.+..........+....+.......   .......             ....+++.+.+||++||+.||.+|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            9999998888776655544433332211110   0111111             12367899999999999999999999


Q ss_pred             HHHHhcCCCccCCCCCCCCCCCCCCCCcccchh--hhHHHHHHHHHHHHHhhCCC
Q 017909          310 VTEALQHPYISGLYDPQCNPPAQVPLSLDIDEN--IGEQMIRQMMWNETLHYHPE  362 (364)
Q Consensus       310 ~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  362 (364)
                      ++|+|+||||+.+..+...+....+....+.+.  ....+.+...|.+...++|+
T Consensus       323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (388)
T 3oz6_A          323 ANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRE  377 (388)
T ss_dssp             HHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhhh
Confidence            999999999999988777766665555555433  23556677777666555543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.6e-53  Score=402.02  Aligned_cols=312  Identities=43%  Similarity=0.766  Sum_probs=253.1

Q ss_pred             ccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCc
Q 017909           12 KSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV   91 (364)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i   91 (364)
                      ...+++.....+..+.+.++|++++.||+|+||+||+|.+..+|+.||+|++...........++.+|+.+++.++||||
T Consensus        44 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  123 (464)
T 3ttj_A           44 VDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI  123 (464)
T ss_dssp             --CCEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccccceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC
Confidence            34566777788888889999999999999999999999999999999999998766666677788899999999999999


Q ss_pred             ceeeeeeccccc-cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC
Q 017909           92 IALKDVMMPTHR-ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC  170 (364)
Q Consensus        92 v~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~  170 (364)
                      +++++++..... ......++||||+++++.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       124 v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred             CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC
Confidence            999999976532 22357899999999988887754  599999999999999999999999999999999999999999


Q ss_pred             cEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017909          171 DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF  250 (364)
Q Consensus       171 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (364)
                      .++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+
T Consensus       202 ~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l  279 (464)
T 3ttj_A          202 TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  279 (464)
T ss_dssp             CEEECCCCCC------CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             CEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999999976533 333455678999999999988 579999999999999999999999999999999999999999


Q ss_pred             CCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCC------------ChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                      +.+.+..+.... .....+....+......+....+..            ++.+.+||++||+.||.+|||++|+|+|||
T Consensus       280 g~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          280 GTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             CSCCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CCCCHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence            988877665543 3444444433333222222222221            567999999999999999999999999999


Q ss_pred             ccCCCCCCCC
Q 017909          319 ISGLYDPQCN  328 (364)
Q Consensus       319 f~~~~~~~~~  328 (364)
                      |+.+.++...
T Consensus       359 ~~~~~~~~~~  368 (464)
T 3ttj_A          359 INVWYDPAEV  368 (464)
T ss_dssp             TGGGCCHHHH
T ss_pred             hhhccCcccc
Confidence            9988776543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-53  Score=381.20  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=207.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+++++.+.||+|+||+||+|+++.   .||||+++...........+.+|+.++++++|||||++++++..      ..
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            5789999999999999999998653   59999998666666677788999999999999999999998753      34


Q ss_pred             EEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC-
Q 017909          109 VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG-  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~-  185 (364)
                      ++||||||+ |+|.+++... .++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..... 
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            799999998 6999999764 5799999999999999999999999999999999999999999999999999976532 


Q ss_pred             -CCcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 -NEQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 -~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                       .........||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+.......+.......         
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  256 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS---------  256 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC---------
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC---------
Confidence             22234456899999999999642  358999999999999999999999998877655554443311111         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      ......+..+++.+.+||.+||+.||.+|||+.||++
T Consensus       257 ----------------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          257 ----------------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             ----------------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ----------------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                            1123345678999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-53  Score=381.97  Aligned_cols=254  Identities=22%  Similarity=0.345  Sum_probs=213.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|.+.+.||+|+||+||+|++.     .++..||+|+++..  ......++.+|+.++++++|||||++++++.+.  
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence            468999999999999999999865     35788999999753  344556788999999999999999999999887  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                         ...+||||||+ |+|.+++...             ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        88 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence               78899999998 7999999753             369999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLI  246 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i  246 (364)
                      +.+||+|||+++.......  ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+....+....+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999975533222  2233468999999999988 689999999999999999998 89999998877766665


Q ss_pred             HHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ...                              .....+..+++.+.+||.+||+.||.+|||+.+|+  +||+.+
T Consensus       244 ~~~------------------------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          244 TQG------------------------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             HHT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             HcC------------------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence            431                              11223457899999999999999999999999995  677654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-53  Score=413.24  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=217.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc----hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN----RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++++....    .........++.+++.++|||||+++++|.+.   
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~---  264 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---  264 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC---
Confidence            46899999999999999999999999999999999754322    11222223456677778999999999999988   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ..+|+|||||+ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus       265 --~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          265 --DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             --CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence              88999999998 699999999899999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ....  ....+||+.|+|||++.....++.++|||||||++|+|++|.+||.+...............            
T Consensus       343 ~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~------------  408 (689)
T 3v5w_A          343 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------------  408 (689)
T ss_dssp             SSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH------------
T ss_pred             CCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC------------
Confidence            4332  34568999999999997646799999999999999999999999976533222211111000            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLYD  324 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~~  324 (364)
                                      .....+..+++.+++||.+||+.||.+|++     ++||++||||+++.+
T Consensus       409 ----------------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          409 ----------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             ----------------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             ----------------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence                            012334578999999999999999999998     799999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8e-53  Score=382.61  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|.+.++||+|+||+||+|+++     .++..||||+++..  ......++.+|+.++++++|||||+++++|.+.  
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence            468999999999999999999865     36788999999753  344556788999999999999999999999887  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS---------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~  167 (364)
                         ...+||||||+ |+|.+++...               .++++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus       116 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence               78999999998 7999998653               3589999999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017909          168 ANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLK  244 (364)
Q Consensus       168 ~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~  244 (364)
                      .++.+||+|||+++......  .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+....+...
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999997653322  22345678999999999987 689999999999999999998 899999888777666


Q ss_pred             HHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          245 LIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+....                              ....+..+++.+.+||.+||+.||.+|||+.||+++
T Consensus       272 ~i~~g~------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGR------------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTC------------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCC------------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            654311                              122345789999999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.4e-53  Score=412.78  Aligned_cols=265  Identities=25%  Similarity=0.413  Sum_probs=229.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +-++|++++.||+|+||+||+|+++.+|+.||+|++...  .......+.+|+.+|+.++||||++++++|.+.     .
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~  227 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----N  227 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----S
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----C
Confidence            347899999999999999999999999999999998753  233455677899999999999999999999887     8


Q ss_pred             eEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC--CcEEEeecCccccC
Q 017909          108 DVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN--CDLKICDFGLARTS  183 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~--~~~~L~Dfg~~~~~  183 (364)
                      .+++|||||. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++...
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            8999999997 699998864 4679999999999999999999999999999999999999854  79999999999876


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+         
T Consensus       308 ~~-~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------  376 (573)
T 3uto_A          308 DP-KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------  376 (573)
T ss_dssp             CT-TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------
T ss_pred             cC-CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence            43 333455689999999999988 6789999999999999999999999999888777776654221111         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                        ...+..+++.+++||++||+.||.+|||+.|+|+||||+....+...
T Consensus       377 ------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~  423 (573)
T 3uto_A          377 ------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD  423 (573)
T ss_dssp             ------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred             ------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCch
Confidence                              22335789999999999999999999999999999999987766543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.6e-52  Score=376.72  Aligned_cols=292  Identities=37%  Similarity=0.648  Sum_probs=241.0

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ...+.++|++++.||+|+||+||+|++. +|+.||+|++............+.+|+.+++.++||||+++++++...   
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   91 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE---   91 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS---
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC---
Confidence            3456899999999999999999999985 589999999976554444556778999999999999999999999877   


Q ss_pred             ccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||++++|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        92 --~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           92 --RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             --SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             --CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence              789999999999999988765 45999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...........++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+.+....+.....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            54444455667899999999998766789999999999999999999999999999999999998888877665543322


Q ss_pred             hhHHHHHh-hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          264 PKARRFIK-SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       264 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      .  ..+.. .........+....+.+++.+.+||++||+.||.+|||++|+|+||||+++..
T Consensus       250 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          250 L--PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             S--HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             c--chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            1  11111 11112233344456778999999999999999999999999999999998643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.1e-53  Score=378.79  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=211.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++++.+.||+|+||+||+|...     .+++.||||+++... .......+.+|+.++++++|||||+++++|...  
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--
Confidence            467899999999999999999864     356889999997543 333456788999999999999999999999887  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV  166 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll  166 (364)
                         ...++|||||+ |+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus       102 ---~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 ---QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             ---SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ---CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence               77899999998 7999999643                358999999999999999999999999999999999999


Q ss_pred             ccCCcEEEeecCccccCCCC--CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017909          167 NANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQL  243 (364)
Q Consensus       167 ~~~~~~~L~Dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~  243 (364)
                      +.++.+||+|||+++.....  ........||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+....+..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999998754322  223445678999999999987 689999999999999999998 89999998776666


Q ss_pred             HHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ..+.+.                              ...+.+..+++.+.+||.+||+.||.+|||+.||+++
T Consensus       258 ~~i~~~------------------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNR------------------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcC------------------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555321                              1123346789999999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-51  Score=374.87  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=231.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .-++|++++.||+|+||+||+|.+..+|+.||+|++...........++.+|+.+++.++||||+++++++...     .
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----K   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence            45789999999999999999999999999999999987666666777788999999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            8999999997 699999988889999999999999999999999999999999999999999999999999998765333


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                       .......|++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....                
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  230 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----------------  230 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------------
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence             334566789999999999885445689999999999999999999999887666665554311                


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                     ...+..+++.+.+||++||+.||.+|||++|+|+||||+........
T Consensus       231 ---------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~  277 (328)
T 3fe3_A          231 ---------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL  277 (328)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCCC
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccccc
Confidence                           11234578899999999999999999999999999999987665443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.1e-52  Score=374.21  Aligned_cols=289  Identities=40%  Similarity=0.674  Sum_probs=240.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence            589999999999999999999999999999999987665665667778999999999999999999999877     789


Q ss_pred             EEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++||||+++++.+.+.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99999999988877765 57899999999999999999999999999999999999999999999999999987655555


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI-FPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ......++..|+|||++.+...++.++||||||+++|+|++|..| |.+.........+....+.+....+.....  ..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~  234 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK--LP  234 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG--ST
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc--cc
Confidence            556667899999999998755689999999999999999977655 777777888888888877766654432211  11


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      .+................+.+++.+.+||++||+.||.+|||++|+|+||||+++..|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~pP  292 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC---
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCCC
Confidence            1111111222333445556789999999999999999999999999999999987543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=379.73  Aligned_cols=344  Identities=43%  Similarity=0.788  Sum_probs=287.3

Q ss_pred             cCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           13 SRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      ..|+...........+.++|++.+.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||+
T Consensus         7 ~~~~~~~~~~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   86 (353)
T 3coi_A            7 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI   86 (353)
T ss_dssp             HHHEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cCCcEEEeecCcccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcc
Confidence            34555666667778889999999999999999999999999999999999987655565667788999999999999999


Q ss_pred             eeeeeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909           93 ALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus        93 ~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                      ++++++...... .....++|||+++++|.+.+.  ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~  164 (353)
T 3coi_A           87 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE  164 (353)
T ss_dssp             CCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC
T ss_pred             cHhheEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc
Confidence            999999876321 123469999999998887764  35999999999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          172 LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      ++|+|||.+......   .....++..|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+....+
T Consensus       165 ~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  241 (353)
T 3coi_A          165 LKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  241 (353)
T ss_dssp             EEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred             EEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999998755322   33456789999999998756789999999999999999999999999999999999999888


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA  331 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~  331 (364)
                      .++..............+....+......+....+.+++.+.+||++||+.||.+|||+.++|+||||+....+...+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~  321 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEA  321 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCC
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccC
Confidence            88887777777777777776666666666667778899999999999999999999999999999999998887777666


Q ss_pred             CCCCCcccch-hhhHHHHHHHHHHHHHhhCC
Q 017909          332 QVPLSLDIDE-NIGEQMIRQMMWNETLHYHP  361 (364)
Q Consensus       332 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  361 (364)
                      +.|....+.. .+...+..+.-+.+.+.+.|
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          322 QQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             SSCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             CCCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            6666555443 45566777777888777766

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.1e-51  Score=380.78  Aligned_cols=345  Identities=40%  Similarity=0.716  Sum_probs=257.3

Q ss_pred             cccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC
Q 017909           11 MKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN   90 (364)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~   90 (364)
                      ....+++....++....+.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++|||
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn   85 (371)
T 2xrw_A            6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN   85 (371)
T ss_dssp             GGGGGEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccCcceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCC
Confidence            34456677788888888899999999999999999999999999999999999866555566677889999999999999


Q ss_pred             cceeeeeeccccc-cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909           91 VIALKDVMMPTHR-ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus        91 iv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                      |+++++++..... ......++||||++++|.+.+.  ..+++..++.++.||+.||.|||++|++|+||||+||+++.+
T Consensus        86 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~  163 (371)
T 2xrw_A           86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD  163 (371)
T ss_dssp             BCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             ccceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC
Confidence            9999999976532 1224789999999999998886  469999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  249 (364)
                      +.++|+|||++...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+.
T Consensus       164 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  241 (371)
T 2xrw_A          164 CTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  241 (371)
T ss_dssp             SCEEECCCCC-----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred             CCEEEEEeecccccccc-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999998765332 22345678999999999987 57899999999999999999999999999988888888887


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCC------------CCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYP------------QADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                      .+.+.+...... .+....+....+...........+            ..++.+.+||++||+.||.+|||++|+|+||
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          242 LGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CCCCCHHHHTTS-CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hCCCCHHHHHHh-hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            777665544332 222223322222111111111111            1256789999999999999999999999999


Q ss_pred             CccCCCCCCCC--CCCCCCCCcccchhhhHHHHHHHHHHHHHhhC
Q 017909          318 YISGLYDPQCN--PPAQVPLSLDIDENIGEQMIRQMMWNETLHYH  360 (364)
Q Consensus       318 ~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (364)
                      ||+.+.++...  ++...|...........++..+.-|.+..+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 2xrw_A          321 YINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE  365 (371)
T ss_dssp             HHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred             chhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence            99988765432  22222222222333345656677776665543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-51  Score=370.54  Aligned_cols=293  Identities=33%  Similarity=0.596  Sum_probs=230.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|++|+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...     ..
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----Ce
Confidence            5789999999999999999999999999999999876655555566778999999999999999999999877     78


Q ss_pred             EEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+++ +|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            8999999995 677777777889999999999999999999999999999999999999999999999999998765544


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......++..|+|||++.+...++.++||||||+++|+|++|..||.+....+....+....+...+............
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            44556678999999999987667899999999999999999999999999988888888877766554332221111100


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                      ..................+.+++.+.+||++||+.||.+|||++|+|+||||++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            00000000011111223357899999999999999999999999999999999875544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.9e-51  Score=368.01  Aligned_cols=285  Identities=38%  Similarity=0.649  Sum_probs=231.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence            5899999999999999999998 6789999999875544333345667899999999999999999999877     789


Q ss_pred             EEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|||+++++|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            999999999999998764 6799999999999999999999999999999999999999999999999999876544443


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+......+.....  ...
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE--LPK  233 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STT
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc--ccc
Confidence            444557799999999998756789999999999999999999999999988888888888777665544332111  111


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      +...........+......+++.+.+||++||+.||.+|||+.|+|+||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            111111122233444556789999999999999999999999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-51  Score=376.61  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=209.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccC-----CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCC-CCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRET-----NEKVAIKKINNVFENRIDALRTLRELVLLRHIKH-DNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||+|+||+||+|.+...     ++.||+|+++... .......+.+|+.++..+.| ||||+++++|..+.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            57899999999999999999987654     3679999987542 33445678899999999975 89999999987652


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                          ..++||||||+ |+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus       142 ----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          142 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             ----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence                56899999998 7999999753                34899999999999999999999999999999999999


Q ss_pred             EccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017909          166 VNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQ  242 (364)
Q Consensus       166 l~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~  242 (364)
                      ++.++.+||+|||+++.......  ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+......
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999986543322  2345678999999999988 689999999999999999997 8999988764444


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ........                             .....+..+++.+.+||.+||+.||.+|||+.||++|
T Consensus       297 ~~~~i~~g-----------------------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEG-----------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcC-----------------------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            33332210                             1122345688999999999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-51  Score=373.31  Aligned_cols=292  Identities=37%  Similarity=0.648  Sum_probs=234.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEE
Confidence            5899999999999999999999999999999998653221 1111334699999999999999999999877     788


Q ss_pred             EEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++||||++|+|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            999999999999988765 4599999999999999999999999999999999999999999999999999876654444


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......++..|+|||++.+...++.++||||||+++|+|++|..||.+....+....+....+.+....+........-.
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            45556779999999999876678999999999999999999999999999999999999988887776654332221111


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      . ...+...........+.+++.+.+||++||+.||.+|||++|+|+||||.+.......
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  294 (324)
T 3mtl_A          236 T-YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK  294 (324)
T ss_dssp             H-TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred             c-cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence            1 1112222233344556789999999999999999999999999999999998655433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.1e-51  Score=372.02  Aligned_cols=295  Identities=35%  Similarity=0.615  Sum_probs=222.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|.++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~   76 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTE-----N   76 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----T
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----C
Confidence            35799999999999999999999999999999999875432 22234567899999999999999999999877     7


Q ss_pred             eEEEEeccccccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          108 DVYLVYELMDTDLHQIIKSS------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      ..++||||++|+|.+++...      ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            89999999999999988653      359999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .............+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.+..+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            76544444455678999999999987567899999999999999999999999999999999888888777655443322


Q ss_pred             CchhHHHHHhhCCCCCCC-----cccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 017909          262 DNPKARRFIKSLPYSRGT-----HISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP  330 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~  330 (364)
                      ..  ...+..........     ........+++.+.+||++||+.||.+|||+.|+|+||||+.....+...+
T Consensus       237 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~  308 (317)
T 2pmi_A          237 TK--LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGG  308 (317)
T ss_dssp             GG--CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC------
T ss_pred             hh--hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccc
Confidence            11  00000000000000     011233468899999999999999999999999999999999876654433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-50  Score=369.74  Aligned_cols=258  Identities=23%  Similarity=0.418  Sum_probs=225.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence            4689999999999999999999999999999999976432 223445667899999999999999999999887     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            8999999997 599999988889999999999999999999999999999999999999999999999999999765444


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......+|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                 
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------  220 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------  220 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred             CCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            444556788999999999987 57899999999999999999999999887766655555331                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                    ....+..+++.+.+||++||+.||.+||     +++||++||||.+..
T Consensus       221 --------------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          221 --------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence                          0122346889999999999999999999     999999999998764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-49  Score=366.99  Aligned_cols=304  Identities=49%  Similarity=0.915  Sum_probs=251.3

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ....+.++|++.+.||+|+||+||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            3456789999999999999999999999999999999999643 233445567789999999999999999999876543


Q ss_pred             cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          104 ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ......++|||+++++|.+.+.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           84 ENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            33467899999999999998876 57999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc----------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          184 RGNEQ----------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       184 ~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      .....          ......|+..|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            33211          12234678999999998765678999999999999999999999999999888888888877776


Q ss_pred             chh-hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 017909          254 QEA-DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNP  329 (364)
Q Consensus       254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~  329 (364)
                      ... ............+....+...........+.+++.+.+||++||+.||.+|||+.|+|+||||+....+...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  319 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP  319 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc
Confidence            533 2333444555555555554444455556678999999999999999999999999999999999987665543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-50  Score=369.41  Aligned_cols=290  Identities=38%  Similarity=0.607  Sum_probs=227.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++...........+.+|+.+++.++||||+++++++...     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  106 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----H  106 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----T
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----C
Confidence            56799999999999999999999999999999999986555554555667899999999999999999999877     7


Q ss_pred             eEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc-----cCCcEEEeecCcccc
Q 017909          108 DVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-----ANCDLKICDFGLART  182 (364)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~-----~~~~~~L~Dfg~~~~  182 (364)
                      ..++||||++|+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++     .++.++|+|||++..
T Consensus       107 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          107 RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            899999999999999999988999999999999999999999999999999999999994     455699999999976


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ............++..|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+.+....+....
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            65444445556779999999999876668999999999999999999999999999988888888887776654432211


Q ss_pred             chhHHHHHhhCCCCCCCc-ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          263 NPKARRFIKSLPYSRGTH-ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      .  ...+....+...... .......+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus       267 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          267 A--LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             G--STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             h--hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            0  000100000000000 01112237889999999999999999999999999999998643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.4e-50  Score=361.51  Aligned_cols=290  Identities=38%  Similarity=0.595  Sum_probs=230.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc---hHHHHHHHHHHHHHHhc---CCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN---RIDALRTLRELVLLRHI---KHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~  101 (364)
                      +.++|++++.||+|+||+||+|++..+++.||+|++......   ........+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            578999999999999999999999999999999998743211   11112233455555554   599999999999876


Q ss_pred             cccccceEEEEeccccccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          102 HRISFKDVYLVYELMDTDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                      ........++|||+++++|.+++.....  +++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            4433346899999999999999987654  99999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +..... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+..+.++...+.
T Consensus       167 a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          167 ARIYSY-QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             TTTSTT-CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccCC-CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            976533 333455678999999999987 578999999999999999999999999999999999999888877765544


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ........    ..............+.+++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       245 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          245 RDVSLPRG----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SSCSSCGG----GSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             chhhcccc----ccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            32211111    1111222233345567899999999999999999999999999999998743

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-49  Score=367.68  Aligned_cols=333  Identities=37%  Similarity=0.698  Sum_probs=258.6

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh---------chHHHHHHHHHHHHHHhcCCCCccee
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE---------NRIDALRTLRELVLLRHIKHDNVIAL   94 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (364)
                      .+..+.++|++++.||+|+||.||+|.+.. |..||+|++.....         .......+.+|+.+++.++||||+++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            345578999999999999999999999865 89999998864322         22334677899999999999999999


Q ss_pred             eeeeccccccccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEE
Q 017909           95 KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~  173 (364)
                      ++++...........++||||++|+|.+.+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence            999865543333678999999999999988765 4799999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||.+..... ........++..|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+.+
T Consensus       175 l~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          175 ICDFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEecCccccccc-ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999999875432 2233455778899999999876679999999999999999999999999999999999999998888


Q ss_pred             chhhhhccCchhHHHHHhh-CCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKS-LPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ  332 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~  332 (364)
                      ..........+....+... ........+....+..++.+.+||.+||+.||.+|||+.|+|+||||+.+..+.......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  333 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL  333 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc
Confidence            8777666666665555432 222334445556678899999999999999999999999999999999987766554332


Q ss_pred             CCCCcccch-hhhHHHHHHHHHHHHHhh
Q 017909          333 VPLSLDIDE-NIGEQMIRQMMWNETLHY  359 (364)
Q Consensus       333 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~  359 (364)
                      . ...+... ..+....++..+.++..+
T Consensus       334 ~-~~~~~~~~~~~~~~~~~~~~~e~~~~  360 (362)
T 3pg1_A          334 S-ERFHFDESVTDVYDMHKIFTAEVERF  360 (362)
T ss_dssp             C-CCCCCCTTCCCHHHHHHHHHHHHHHH
T ss_pred             c-cccChhhhhhhHHHHHHHHHHHHHHh
Confidence            2 2233332 223334455555555443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.9e-50  Score=370.57  Aligned_cols=263  Identities=31%  Similarity=0.478  Sum_probs=226.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      .+.++|++++.||+|+||+||+|+++.+|..||+|+++......    .....+.+|+.+++.++||||+++++++... 
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-   87 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-   87 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-
Confidence            47899999999999999999999999999999999997643321    1345677899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC----cEEEeec
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~----~~~L~Df  177 (364)
                          ...++||||+. |+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++    .++|+||
T Consensus        88 ----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           88 ----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence                78999999996 69999998888999999999999999999999999999999999999998877    7999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |++...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.......+.  
T Consensus       164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  239 (361)
T 2yab_A          164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE--  239 (361)
T ss_dssp             SSCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH--
T ss_pred             CCceEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc--
Confidence            999766433 23445678999999999977 57899999999999999999999999988777766665442211111  


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                               ..+..+++.+.+||++||..||.+|||+.|+|+||||+...
T Consensus       240 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 -------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             -------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                                     12356788999999999999999999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=373.15  Aligned_cols=258  Identities=22%  Similarity=0.367  Sum_probs=220.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -++|++++.||+|+||+||+|+++.+|+.||+|+++.... .........+|..+++.+ +||||+++++++...     
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-----   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----
Confidence            5789999999999999999999999999999999976432 223445567899999988 799999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            78999999998 59999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....               
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------  240 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------------  240 (353)
T ss_dssp             ---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             CCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            4455566789999999999987 578999999999999999999999999988777776665421               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV------TEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~elL~hp~f~~~~  323 (364)
                                      ...+..+++.+.+||++||+.||.+||++      +++++||||+++.
T Consensus       241 ----------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          241 ----------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence                            12234578899999999999999999999      8999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=378.74  Aligned_cols=264  Identities=30%  Similarity=0.451  Sum_probs=229.7

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..+.++|++++.||+|+||+||+|.++.+|+.+|+|++............+.+|+.+++.++||||+++++++...    
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----   82 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE----   82 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS----
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC----
Confidence            3468899999999999999999999999999999999987655555667788999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc---cCCcEEEeecCccc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN---ANCDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~---~~~~~~L~Dfg~~~  181 (364)
                       ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++.
T Consensus        83 -~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           83 -GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             -SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             -CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence             88999999997 59999999989999999999999999999999999999999999999998   45789999999997


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .............|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+       
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------  233 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP-------  233 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------
T ss_pred             EecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-------
Confidence            76555555556789999999999977 5789999999999999999999999998877777666654322111       


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                          ...+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       234 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          234 --------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             --------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             --------------------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                22335688999999999999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.7e-50  Score=366.10  Aligned_cols=260  Identities=28%  Similarity=0.444  Sum_probs=220.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .-++|++.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++...     
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----   81 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----   81 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----
Confidence            3579999999999999999999999999999999997543221 1234567899999999999999999999887     


Q ss_pred             ceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ...++||||++|+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..... 
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-  160 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-  160 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred             CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence            7899999999999999998888999999999999999999999999999999999999999999999999999876533 


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .......+|++.|+|||++.+....+.++||||||+++|+|++|..||.+.......                       
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------------  217 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------------  217 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------------
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------------
Confidence            333455678999999999987544588999999999999999999999764321110                       


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                              ..........+..+++.+.+||++||+.||.+|||++|+++||||+....
T Consensus       218 --------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          218 --------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             --------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             --------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence                    00111122344568999999999999999999999999999999987543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.2e-49  Score=357.35  Aligned_cols=260  Identities=24%  Similarity=0.435  Sum_probs=223.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++.......  ...+.+|+.+++.++||||+++++++...    
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG----   89 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEEC----
Confidence            346789999999999999999999999999999999987543333  34567899999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||+. |+|.+++... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        90 -~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           90 -DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             -TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             -CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence             78999999996 6999988764 69999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......           
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  235 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-----------  235 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-----------
T ss_pred             CcccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence            55555566788999999999987 578999999999999999999999998877665555443321110           


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       ...+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          236 -----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             -----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                             11123578889999999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-49  Score=365.42  Aligned_cols=294  Identities=38%  Similarity=0.629  Sum_probs=233.0

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH---HHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI---DALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ...++|++++.||+|+||+||+|.+..+|+.||+|++........   ....+.+|+.+++.++||||+++++++...  
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--   84 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence            456899999999999999999999999999999999975332221   123567899999999999999999999876  


Q ss_pred             cccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...++||||++++|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        85 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           85 ---SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             ---TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ---CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence               778999999999999888765 4699999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ............+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+....+.+....+....
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            65555445566789999999999775668999999999999999999999999999988888888877776655443221


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      ...  .+. ................+++.+.+||++||+.||.+|||+.|+|+||||+....+...
T Consensus       242 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~  304 (346)
T 1ua2_A          242 SLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG  304 (346)
T ss_dssp             SST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred             cCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence            100  000 000001111223446788999999999999999999999999999999987555443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-49  Score=368.45  Aligned_cols=265  Identities=29%  Similarity=0.432  Sum_probs=227.6

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ....+.++|++.+.||+|+||+||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++...  
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--  100 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--  100 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--
Confidence            334568899999999999999999999999999999999987655566667788999999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cEEEeecCc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGL  179 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~~L~Dfg~  179 (364)
                         ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++   .++|+|||+
T Consensus       101 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          101 ---SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             ---CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence               78899999998 59999998888899999999999999999999999999999999999998654   599999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+     
T Consensus       178 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----  250 (362)
T 2bdw_A          178 AIEVNDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-----  250 (362)
T ss_dssp             CBCCTTC-CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             ceEecCC-cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            9766433 23345678999999999977 5789999999999999999999999998877666665544221111     


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                            ...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       251 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          251 ----------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ----------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ----------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                  11224578899999999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9e-50  Score=365.35  Aligned_cols=292  Identities=33%  Similarity=0.607  Sum_probs=232.2

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..+..-++|++++.||+|+||+||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++...  
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   96 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--   96 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--
Confidence            344567899999999999999999999999999999999976655555666678999999999999999999999877  


Q ss_pred             cccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...++||||+++ +|.++....+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        97 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           97 ---KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             ---TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             ---CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence               788999999996 5666666677899999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ............++..|+|||++.+...++.++||||||+++|+|++|..||.+.........+....+...+.......
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            65544445566789999999999875578999999999999999999999999999888888888777665543322111


Q ss_pred             c-hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          263 N-PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       263 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      . +..... ...............+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       254 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          254 KNPVFAGV-RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HCGGGTTC-CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hccccccc-cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            0 000000 000001111122334578999999999999999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.6e-49  Score=361.71  Aligned_cols=267  Identities=21%  Similarity=0.371  Sum_probs=219.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -++|++++.||+|+||+||+|+++.+++.||+|+++..... ......+.+|..+++.+ +||||+++++++...     
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----
Confidence            46899999999999999999999999999999999865433 33455667899999988 899999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            78999999997 69999998888999999999999999999999999999999999999999999999999999976544


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........+|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........               .....
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------~~~~~  226 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDY  226 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------CHHH
T ss_pred             CCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc---------------ccHHH
Confidence            4444556788999999999987 5789999999999999999999999975321110000               00000


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV------TEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~elL~hp~f~~~~  323 (364)
                      ....+..       .....+..+++.+.+||++||+.||.+||++      +++++||||++..
T Consensus       227 ~~~~i~~-------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          227 LFQVILE-------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             HHHHHHH-------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             HHHHHHc-------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            0000000       0112345688999999999999999999995      8999999998864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-49  Score=365.94  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=223.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|+++.... ..........|..++..+ +||||+++++++...    
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~----   90 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK----   90 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS----
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC----
Confidence            45799999999999999999999999999999999976432 122334556788888877 899999999999887    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        91 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           91 -ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence             78999999997 6999999888899999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .........+|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....              
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------------  234 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------------  234 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred             cCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence            44444556788999999999987 578999999999999999999999999887666665553310              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT-EALQHPYISGLY  323 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-elL~hp~f~~~~  323 (364)
                                       ...+..+++.+.+||++||+.||.+||++. +|++||||+++.
T Consensus       235 -----------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          235 -----------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -----------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence                             112345789999999999999999999998 999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.4e-49  Score=351.34  Aligned_cols=272  Identities=28%  Similarity=0.418  Sum_probs=233.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++.+.||+|+||+||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++...     
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   77 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----   77 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----
Confidence            468999999999999999999999999999999999987666666667788999999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc---EEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~---~~L~Dfg~~~~  182 (364)
                      ...++||||+. ++|.+.+...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            78899999997 599999988888999999999999999999999999999999999999987665   99999999876


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......+        
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  227 (284)
T 3kk8_A          158 VNDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP--------  227 (284)
T ss_dssp             CCSS-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             cccC-ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC--------
Confidence            5432 23345678999999999987 5789999999999999999999999988876666655543221111        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ  332 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~  332 (364)
                                         ...+..+++.+.+||.+||+.||.+|||+.|+|+||||+.......+...+
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~  278 (284)
T 3kk8_A          228 -------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ  278 (284)
T ss_dssp             -------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCC
T ss_pred             -------------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcC
Confidence                               122346789999999999999999999999999999999876666655444

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.2e-49  Score=368.61  Aligned_cols=267  Identities=21%  Similarity=0.371  Sum_probs=218.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -++|++++.||+|+||+||+|+++.+++.||+|++++..... .....+..|..++..+ +||||+++++++...     
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----
Confidence            468999999999999999999999999999999998654332 2334566788998877 899999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            78999999997 59999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........               .....
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---------------~~~~~  269 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDY  269 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------------CCHHH
T ss_pred             CCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------------hhHHH
Confidence            4555666789999999999987 6789999999999999999999999975422111000               00000


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV------TEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~elL~hp~f~~~~  323 (364)
                      ....+..       .....+..+++.+.+||++||+.||.+||++      +||++||||+++.
T Consensus       270 ~~~~i~~-------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          270 LFQVILE-------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             HHHHHHH-------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             HHHHHhc-------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            0000000       1123345689999999999999999999985      8999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=359.69  Aligned_cols=262  Identities=30%  Similarity=0.476  Sum_probs=224.5

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      .+.++|++.+.||+|+||+||+|.++.+|..||+|+++......    .....+.+|+.+++.++||||+++++++... 
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   86 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-   86 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence            46889999999999999999999999999999999987543221    1345677899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC----cEEEeec
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~----~~~L~Df  177 (364)
                          ...++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++    .++|+||
T Consensus        87 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           87 ----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence                78999999997 69999998888899999999999999999999999999999999999998887    7999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.......+.  
T Consensus       163 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--  238 (326)
T 2y0a_A          163 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--  238 (326)
T ss_dssp             TTCEECCTTS-CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH--
T ss_pred             CCCeECCCCC-ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc--
Confidence            9997664332 2345578999999999976 57899999999999999999999999988776666655442211111  


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                               ..+..+++.+.+||++||+.||.+|||+.|+|+||||+..
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          239 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                                     1224678899999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-49  Score=360.10  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=223.9

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++++.||+|+||+||+|.+..+++.+|+|.+...   ......+.+|+.+++.++||||+++++++...     
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----   73 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----   73 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----
Confidence            4678999999999999999999999999999999998743   33445677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc--CCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~--~~~~~L~Dfg~~~~  182 (364)
                      ...++||||++ ++|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.++|+|||++..
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            78999999998 5999999765 47999999999999999999999999999999999999987  78999999999977


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......+..      
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  225 (321)
T 1tki_A          154 LKPG-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE------  225 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred             CCCC-CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh------
Confidence            6433 33445678999999999977 568999999999999999999999999988777776665532222211      


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                           .++.+++.+.+||++||+.||.+|||+.|+|+||||+..
T Consensus       226 ---------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          226 ---------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ---------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ---------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                 124678899999999999999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.7e-49  Score=359.95  Aligned_cols=282  Identities=23%  Similarity=0.385  Sum_probs=218.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..++|++++.||+|+||+||+|++.   .+|+.||+|+++....  .......+.+|+.+++.++||||+++++++... 
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-
Confidence            4689999999999999999999875   6889999999976432  223344567899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                          ...++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        94 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           94 ----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             ----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence                78999999997 6999999888889999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .............|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+....           
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----------  237 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-----------  237 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred             ccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            65444444455678999999999977 578999999999999999999999999887766665554311           


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCCC-CCCCCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQC-NPPAQVPL  335 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~~-~~~~~~~~  335 (364)
                                          ...++.+++.+.+||++||+.||.+||     +++++++||||+++..... ....++|.
T Consensus       238 --------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~  297 (327)
T 3a62_A          238 --------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPF  297 (327)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSC
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCC
Confidence                                122346788999999999999999999     8999999999998743221 22233444


Q ss_pred             CcccchhhhHH
Q 017909          336 SLDIDENIGEQ  346 (364)
Q Consensus       336 ~~~~~~~~~~~  346 (364)
                      .+.+....+.+
T Consensus       298 ~p~~~~~~~~~  308 (327)
T 3a62_A          298 KPLLQSEEDVS  308 (327)
T ss_dssp             CCC--------
T ss_pred             CCCcCChhhhh
Confidence            44444444433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-49  Score=364.35  Aligned_cols=277  Identities=29%  Similarity=0.430  Sum_probs=219.3

Q ss_pred             ccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc---hHHHHHHHHHHHHHHhcCC
Q 017909           12 KSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN---RIDALRTLRELVLLRHIKH   88 (364)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h   88 (364)
                      .+++.....+.+.-..+.++|++.+.||+|+||+||+|.++.+|+.||+|++......   ......+.+|+.+++.++|
T Consensus         6 ~~~~g~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   85 (351)
T 3c0i_A            6 SGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH   85 (351)
T ss_dssp             --------------CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC
T ss_pred             CCCCcccccccCCCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC
Confidence            3444455556666666899999999999999999999999999999999998653221   1134567789999999999


Q ss_pred             CCcceeeeeeccccccccceEEEEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909           89 DNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus        89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      |||+++++++...     ...++||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus        86 pnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N  160 (351)
T 3c0i_A           86 PHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC  160 (351)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence            9999999999877     78999999998 6998877542    358999999999999999999999999999999999


Q ss_pred             eEEccCCc---EEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 017909          164 LLVNANCD---LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~---~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  240 (364)
                      |+++.++.   ++|+|||++..............|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .
T Consensus       161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~  238 (351)
T 3c0i_A          161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-E  238 (351)
T ss_dssp             EEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-H
T ss_pred             eEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-H
Confidence            99987654   999999999877555544556678999999999987 578999999999999999999999998753 2


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      .....+........                           ...+..+++.+.+||++||+.||.+|||+.++|+||||+
T Consensus       239 ~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          239 RLFEGIIKGKYKMN---------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             HHHHHHHHTCCCCC---------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHcCCCCCC---------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence            33333322111111                           111246788999999999999999999999999999998


Q ss_pred             CC
Q 017909          321 GL  322 (364)
Q Consensus       321 ~~  322 (364)
                      ..
T Consensus       292 ~~  293 (351)
T 3c0i_A          292 ER  293 (351)
T ss_dssp             TH
T ss_pred             CC
Confidence            74

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.7e-50  Score=368.03  Aligned_cols=300  Identities=34%  Similarity=0.530  Sum_probs=235.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc---c
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI---S  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~  105 (364)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+.+++.++||||+++++++......   .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            5799999999999999999999999999999999876554444445667899999999999999999998765311   1


Q ss_pred             cceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ....++||||++++|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            2568999999999988888764 579999999999999999999999999999999999999999999999999987553


Q ss_pred             CC----CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 GN----EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..    ........+++.|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+..+...+..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            21    22234456799999999998756789999999999999999999999999999999888888877776654433


Q ss_pred             cCchhHHHHHhhCCCCCCCcccc-cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISS-LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      ....................... .....++.+.+||++||+.||.+|||++|+|+||||+....+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  324 (351)
T 3mi9_A          256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL  324 (351)
T ss_dssp             GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCS
T ss_pred             cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccc
Confidence            22211110000000000000000 000136789999999999999999999999999999886555443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=355.39  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=222.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -++|++++.||+|+||+||+|+++.+|+.||+|+++..... ......+.+|..+++.++||||+++++++.+.     .
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----S
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----C
Confidence            46899999999999999999999999999999999764322 22345567899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||+. |+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            8999999998 599999998889999999999999999999999999999999999999999999999999999765332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                         .....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                
T Consensus       160 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  219 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------------  219 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC----------------
T ss_pred             ---cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence               334578999999999987 578999999999999999999999999887766666554310                


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                     ...++.+++.+.+||++||+.||.+||     ++++|++||||++..
T Consensus       220 ---------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          220 ---------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence                           122346788999999999999999999     999999999998864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.6e-49  Score=362.43  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=224.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      .-++|++++.||+|+||+||+|+++.+|+.||+|+++.... .......+..|..++..+ +||+|+++++++...    
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----   93 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----   93 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS----
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC----
Confidence            35799999999999999999999999999999999976432 222344567899999887 799999999999887    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        94 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           94 -DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence             78999999997 5999999888889999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .........+|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....              
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------  237 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------  237 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred             cCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence            44444556788999999999987 578999999999999999999999999887776666664411              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLY  323 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~  323 (364)
                                       ...+..+++.+.+||++||+.||.+||+     +++|++||||+++.
T Consensus       238 -----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          238 -----------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence                             1223468899999999999999999994     69999999998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-48  Score=365.36  Aligned_cols=300  Identities=35%  Similarity=0.569  Sum_probs=236.5

Q ss_pred             EeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeec
Q 017909           20 TMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMM   99 (364)
Q Consensus        20 ~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (364)
                      +...+......+|++++.||+|+||+||+|++..++. +|+|++.......      .+|+.+++.++||||+++++++.
T Consensus        30 ~~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~------~~E~~il~~l~h~niv~l~~~~~  102 (394)
T 4e7w_A           30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK------NRELQIMRIVKHPNVVDLKAFFY  102 (394)
T ss_dssp             EESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cCCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH------HHHHHHHHhCCCCCcceEEEEEE
Confidence            3334445567899999999999999999999887766 7777765432211      25899999999999999999986


Q ss_pred             cccc-cccceEEEEeccccccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc-cCCcEE
Q 017909          100 PTHR-ISFKDVYLVYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDLK  173 (364)
Q Consensus       100 ~~~~-~~~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~-~~~~~~  173 (364)
                      .... ......++||||+++++...+.    ..+.+++..++.++.||+.||.|||++|++||||||+||+++ .++.++
T Consensus       103 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             EESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             ecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence            6532 2224588999999987766554    356799999999999999999999999999999999999999 789999


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||++....... ......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.+..+.+
T Consensus       183 L~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          183 LIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             ECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999997653322 23455679999999999876679999999999999999999999999999999999999988888


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcc-cccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHI-SSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP  330 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~  330 (364)
                      ....+..........   ..+......+ ....+.+++.+.+||.+||+.||.+|||+.|+|+||||+++..+....+
T Consensus       262 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~  336 (394)
T 4e7w_A          262 SREQIKTMNPNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMP  336 (394)
T ss_dssp             CHHHHHHHCGGGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCT
T ss_pred             CHHHHHhhChhhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCC
Confidence            776554332211110   0111111111 1234468999999999999999999999999999999999877665543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.7e-48  Score=353.61  Aligned_cols=298  Identities=39%  Similarity=0.612  Sum_probs=235.8

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEec-cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeecc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINR-ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMP  100 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~  100 (364)
                      +....++|++++.||+|+||+||+|.+. .+|+.||+|+++...........+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            3456799999999999999999999985 6788999999875433222222334566665555   89999999999874


Q ss_pred             ccccccceEEEEeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          101 THRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      .........++|||+++|+|.+++....  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            3222227789999999999999998653  49999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .+..... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+....+.+....+
T Consensus       166 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          166 LARIYSF-QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             SCCCCCG-GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             ccccccC-CCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            9876532 223345577899999999987 57899999999999999999999999999988888888887776665544


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      .........    ................+++.+.+||.+||+.||.+|||+.++|+||||+....+...
T Consensus       244 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~  309 (326)
T 1blx_A          244 PRDVALPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN  309 (326)
T ss_dssp             CTTCSSCGG----GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCCC
T ss_pred             ccccccchh----hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhhh
Confidence            322111100    111112223345567889999999999999999999999999999999988655443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-48  Score=360.08  Aligned_cols=256  Identities=23%  Similarity=0.401  Sum_probs=223.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .-++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----
Confidence            35799999999999999999999999999999999975432 223345677899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            78999999997 69999999888999999999999999999999999999999999999999999999999999976533


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .   .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....               
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------  254 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------------  254 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             C---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            2   234578999999999987 578999999999999999999999999887666666554310               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~  323 (364)
                                      ...+..+++.+.+||++||+.||.+||+     +++|++||||++..
T Consensus       255 ----------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          255 ----------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence                            1223468899999999999999999998     99999999998753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-49  Score=374.74  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=215.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++...     
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----
Confidence            35789999999999999999999999999999999976533 233445667899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||+ +||+|+||||+|||++.++.++|+|||++....
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            78999999998 5999999888899999999999999999999998 999999999999999999999999999997654


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....              
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------------  365 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------------  365 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred             CCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------------
Confidence            44445566788999999999977 678999999999999999999999998887766665554310              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                       ...+..+++.+.+||.+||+.||.+||     +++|+|+||||+++.
T Consensus       366 -----------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          366 -----------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence                             122346789999999999999999999     999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.9e-49  Score=357.13  Aligned_cols=268  Identities=28%  Similarity=0.390  Sum_probs=218.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++++.||+|+||+||+|.++.+++.||+|++...... .....+.+|+.+++.++||||+++++++...     
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----   77 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG-----   77 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----
Confidence            3678999999999999999999999999999999998643222 2234567899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ ++|.+.+.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            78899999997 59999998888899999999999999999999999999999999999999999999999999875432


Q ss_pred             C--CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 N--EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .  ........|++.|+|||++.+....+.++||||||+++|+|++|..||................             
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------  224 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------------  224 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-------------
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-------------
Confidence            2  2223456789999999999875445889999999999999999999998765432221111100             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                     ......+..+++.+.+||++||+.||.+|||++|+|+||||+........
T Consensus       225 ---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~  274 (323)
T 3tki_A          225 ---------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK  274 (323)
T ss_dssp             ---------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCCCC
T ss_pred             ---------------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccccccc
Confidence                           00011124578899999999999999999999999999999876544433

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-48  Score=363.42  Aligned_cols=301  Identities=16%  Similarity=0.231  Sum_probs=224.3

Q ss_pred             ceeeecccceeeeeeeccC--CceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           23 QTLFEIDTKYVPIKPIGRG--AYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      .++..-.++|++++.||+|  +||+||+|+++.+|+.||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3455568899999999999  99999999999999999999998766666666777889999999999999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeec
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Df  177 (364)
                      .     ...++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus        98 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           98 D-----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             T-----TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             C-----CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence            7     78999999998 6999999875  67999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCC-------CcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017909          178 GLARTSRGN-------EQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       178 g~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  249 (364)
                      |.+......       ........|+..|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            987543211       1112234678889999999763 46899999999999999999999999887665555443221


Q ss_pred             hCCCchh-----hhhcc-------CchhHHH-HH--hhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          250 FGTQQEA-----DLEFI-------DNPKARR-FI--KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       250 ~~~~~~~-----~~~~~-------~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      .......     .....       ....... ..  ...+..........+..+++.+.+||++||+.||.+|||+.|+|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            1000000     00000       0000000 00  00000011112234567899999999999999999999999999


Q ss_pred             cCCCccCCCCCCCC
Q 017909          315 QHPYISGLYDPQCN  328 (364)
Q Consensus       315 ~hp~f~~~~~~~~~  328 (364)
                      +||||+.+......
T Consensus       333 ~hp~f~~~~~~~~~  346 (389)
T 3gni_B          333 NHSFFKQIKRRASE  346 (389)
T ss_dssp             TSGGGGGC---CCS
T ss_pred             cCHHHHHHhhcchh
Confidence            99999998665443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-48  Score=358.73  Aligned_cols=287  Identities=23%  Similarity=0.441  Sum_probs=229.7

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-----CCCcceeee
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-----HDNVIALKD   96 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~   96 (364)
                      ++....+.++|++++.||+|+||+||+|++..+++.||+|+++..   .........|+.+++.+.     ||||+++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344455789999999999999999999999999999999999742   233445567899999886     999999999


Q ss_pred             eeccccccccceEEEEeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc------
Q 017909           97 VMMPTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA------  168 (364)
Q Consensus        97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~------  168 (364)
                      ++...     ...++|||+++++|.+++....  .+++..++.++.||+.||.|||++|++|+||||+|||++.      
T Consensus       104 ~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          104 KFMYY-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred             eeeEC-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence            99877     7899999999889999998754  5999999999999999999999999999999999999975      


Q ss_pred             -------------------CCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh
Q 017909          169 -------------------NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG  229 (364)
Q Consensus       169 -------------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  229 (364)
                                         ++.++|+|||++......   .....|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHH
Confidence                               788999999999765332   234567999999999987 579999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCC------C---------CCcccccCCCCChHHHH
Q 017909          230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYS------R---------GTHISSLYPQADPLALD  294 (364)
Q Consensus       230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---------~~~~~~~~~~~~~~l~~  294 (364)
                      |..||.+....+....+....+..+..............+.......      .         ...........++.+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            99999999998888888888777665443322211111111000000      0         00001111234578889


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          295 LLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       295 li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      ||++||+.||.+|||+.|+|+||||+
T Consensus       335 li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-48  Score=366.69  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=221.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|+++.+++.||+|+++.... .......+.+|+.+++.++||||+++++++.+.     
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----
Confidence            46799999999999999999999999999999999975322 111223456899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            88999999996 699998876 5699999999999999999999999999999999999999999999999999976644


Q ss_pred             CCc-ccccccccccccCCcccccccC---CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          186 NEQ-FMTEYVVTRWYRAPELLLCCDN---YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       186 ~~~-~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ... .....+|++.|+|||++.+...   ++.++|||||||++|+|++|..||.+.+.......+.......        
T Consensus       221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------  292 (410)
T 3v8s_A          221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--------  292 (410)
T ss_dssp             TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------
T ss_pred             CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--------
Confidence            332 2345678999999999976322   7899999999999999999999999888777777665421000        


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGLY  323 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~~  323 (364)
                                         .......+++.+.+||++||+.+|.+  ||+++||++||||++..
T Consensus       293 -------------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          293 -------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             -------------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             -------------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence                               01112468899999999999999998  99999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-48  Score=370.86  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=224.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            357999999999999999999999999999999999754322 22345677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ |+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            78999999996 69999998888999999999999999999999999999999999999999999999999999976643


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      . ......+|++.|+|||++.+....+.++|||||||++|+|++|..||.+.........+....               
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------  232 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------------  232 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---------------
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence            2 334456789999999999875445789999999999999999999999877666555553211               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                      ...+..+++.+.+||++||+.||.+|||+.|+++||||+......
T Consensus       233 ----------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  277 (476)
T 2y94_A          233 ----------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKY  277 (476)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTT
T ss_pred             ----------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccc
Confidence                            112345788999999999999999999999999999998754433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=353.75  Aligned_cols=254  Identities=24%  Similarity=0.303  Sum_probs=209.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +.++|++.+.||+|+||+||+|.+..+|+.||+|++...............|+..+..+ +||||+++++++...     
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----  129 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----  129 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----
Confidence            46899999999999999999999999999999999876555555555666666666666 899999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++|||+++++|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            789999999999999988764 4699999999999999999999999999999999999999999999999999876533


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      . .......|++.|+|||++.+  .++.++||||||+++|+|++|..++.+...   ...+..   ..            
T Consensus       210 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~---~~------------  268 (311)
T 3p1a_A          210 A-GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ---GY------------  268 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT---TC------------
T ss_pred             C-CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc---cC------------
Confidence            2 23344568999999999876  689999999999999999999776654321   111110   00            


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                    ........+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus       269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                          001122467899999999999999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=359.05  Aligned_cols=262  Identities=23%  Similarity=0.428  Sum_probs=220.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   87 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----   87 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence            35799999999999999999999999999999999975432 233445677899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            78999999997 69999999888999999999999999999999999999999999999999999999999999976633


Q ss_pred             CCcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                       ........|++.|+|||++...  ..++.++|||||||++|+|++|..||...........+.....            
T Consensus       168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------  234 (384)
T 4fr4_A          168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------------  234 (384)
T ss_dssp             -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------------
T ss_pred             -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------------
Confidence             3334566789999999999742  3589999999999999999999999976543222221111100            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCccCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-VTEALQHPYISGLY  323 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~elL~hp~f~~~~  323 (364)
                                      .....+..+++.+.+||++||+.||.+||+ +++|++||||+++.
T Consensus       235 ----------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          235 ----------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             ----------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             ----------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence                            112234568899999999999999999998 99999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-48  Score=361.06  Aligned_cols=267  Identities=28%  Similarity=0.400  Sum_probs=207.8

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...++|++++.||+|+||+||+++++.+++.||+|++.......   ..+.+|+.+++.++||||+++++++...     
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~-----   88 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTP-----   88 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeC-----
Confidence            35789999999999999999999999999999999997543322   3456899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc--EEEeecCccccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--LKICDFGLARTS  183 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~--~~L~Dfg~~~~~  183 (364)
                      ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.  ++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            78999999997 699999988889999999999999999999999999999999999999987765  999999998643


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. ........|++.|+|||++.+....+.++|||||||++|+|++|..||.+.........+...+....         
T Consensus       169 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------  238 (361)
T 3uc3_A          169 VL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------  238 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC---------
T ss_pred             cc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC---------
Confidence            22 22234457899999999998744445559999999999999999999987654333332222110000         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                                      ........+++.+.+||++||+.||.+|||+.|+|+||||........
T Consensus       239 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  286 (361)
T 3uc3_A          239 ----------------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADL  286 (361)
T ss_dssp             ----------------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC-
T ss_pred             ----------------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhh
Confidence                            001112357899999999999999999999999999999977654443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-48  Score=362.18  Aligned_cols=259  Identities=23%  Similarity=0.401  Sum_probs=217.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHH-HHhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVL-LRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..++|++++.||+|+||+||+|+++.+++.||+|+++..... ......+..|..+ ++.++||||+++++++...    
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~----  111 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA----  111 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS----
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC----
Confidence            457999999999999999999999999999999999765432 2233445566666 4667999999999999887    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus       112 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          112 -DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence             78999999997 5999999988899999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .........+|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...               
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------------  254 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---------------  254 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS---------------
T ss_pred             cCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------
Confidence            44444566788999999999987 67899999999999999999999999988777666665431               


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV----TEALQHPYISGLY  323 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~elL~hp~f~~~~  323 (364)
                                      .....+.+++.+.+||++||+.||.+||++    .++++||||+++.
T Consensus       255 ----------------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          255 ----------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             ----------------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             ----------------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence                            012235688999999999999999999987    6999999998864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=352.59  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=211.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch------------------------HHHHHHHHHHHHHH
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR------------------------IDALRTLRELVLLR   84 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------------------~~~~~~~~e~~~l~   84 (364)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.......                        .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            579999999999999999999999999999999986543211                        12345678999999


Q ss_pred             hcCCCCcceeeeeeccccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909           85 HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus        85 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      .++||||+++++++.....   ...++||||++ ++|.+++ ..+.+++..++.++.||+.||.|||++|++|+||||+|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             hCCCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            9999999999999876422   67899999998 5776643 44679999999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLN  241 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  241 (364)
                      |+++.++.++|+|||++..............|++.|+|||++.+...  ++.++||||||+++|+|++|..||.+.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999876554444556678999999999976332  4788999999999999999999998876554


Q ss_pred             HHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          242 QLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ....+......                             ....+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       248 ~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          248 LHSKIKSQALE-----------------------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHCCCC-----------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHhcccCC-----------------------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            44433221000                             1112468899999999999999999999999999999963

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-48  Score=368.17  Aligned_cols=268  Identities=21%  Similarity=0.341  Sum_probs=224.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|+++.+++.||+|+++..... ......+.+|..++..++||||+++++++.+.     
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----  146 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-----  146 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-----
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----
Confidence            467999999999999999999999999999999999753221 11222366899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            88999999996 699999987 5789999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc-ccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          185 GNEQ-FMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       185 ~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      .... ......||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+..+....+......       
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  299 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-------  299 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-------
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-------
Confidence            3332 2344678999999999872    346899999999999999999999999998877777766532100       


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCCCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSK--RITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~elL~hp~f~~~~~~~  326 (364)
                                         ...+.....+++.+.+||++||+.+|++  ||+++|+++||||+++.+..
T Consensus       300 -------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          300 -------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             -------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             -------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence                               0112223468999999999999998888  99999999999999875443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.1e-48  Score=351.68  Aligned_cols=263  Identities=31%  Similarity=0.484  Sum_probs=224.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      .+.++|++++.||+|+||.||+|+++.+|+.||+|+++......    .....+.+|+.+++.++||||+++++++... 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   87 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-   87 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-
Confidence            46889999999999999999999999999999999997543322    1345677899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC----cEEEeec
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~----~~~L~Df  177 (364)
                          ...++||||+. ++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++    .++|+||
T Consensus        88 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           88 ----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence                78999999997 69999999888899999999999999999999999999999999999999887    7999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |.+....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.......+.  
T Consensus       164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--  239 (321)
T 2a2a_A          164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE--  239 (321)
T ss_dssp             TTCEECCTTC-CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH--
T ss_pred             ccceecCccc-cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh--
Confidence            9997664332 2345568999999999977 57899999999999999999999999888766666555432111111  


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                               ..+..+++.+.+||++||+.||.+|||+.|+|+||||+...
T Consensus       240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                                     11246788999999999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.9e-48  Score=343.85  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=224.3

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      +...+.++|++.+.||+|+||+||+|.++.++..+++|++......  ....+.+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   78 (277)
T 3f3z_A            3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDN--   78 (277)
T ss_dssp             ---CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred             chhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            3456789999999999999999999999999999999999764433  345677899999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEEeecCc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGL  179 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L~Dfg~  179 (364)
                         ...++||||++ ++|.+.+...+.+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.
T Consensus        79 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           79 ---TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             ---SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             ---CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence               78999999997 5999999888889999999999999999999999999999999999999   7788999999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +...... .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.........+.......+..   
T Consensus       156 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  229 (277)
T 3f3z_A          156 AARFKPG-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK---  229 (277)
T ss_dssp             CEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---
T ss_pred             ceeccCc-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---
Confidence            8765333 33445578999999999866  48999999999999999999999999888777666665432222221   


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                              .+..+++.+.+||++||+.||.+|||+.++|+||||+...
T Consensus       230 ------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          230 ------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                    1135788999999999999999999999999999998743

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=352.15  Aligned_cols=300  Identities=38%  Similarity=0.702  Sum_probs=229.3

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc-
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR-  103 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  103 (364)
                      ...+.++|++++.||+|++|+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++..... 
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            456799999999999999999999999999999999998643  33455677899999999999999999998854321 


Q ss_pred             --------cccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc-cCCcEEE
Q 017909          104 --------ISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDLKI  174 (364)
Q Consensus       104 --------~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~-~~~~~~L  174 (364)
                              ......++||||++|+|.+++.. +++++..++.++.||+.||.+||++|++|+||+|+||+++ .++.++|
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence                    12267899999999999998865 6799999999999999999999999999999999999997 5679999


Q ss_pred             eecCccccCCCC---CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          175 CDFGLARTSRGN---EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       175 ~Dfg~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      +|||.+......   ........++..|+|||.+.+...++.++||||||+++|+|++|..||.+.........+....+
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999998765322   11223445688899999987656789999999999999999999999999988888888877666


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      .............. ..+................+.+++.+.+||++||+.||.+|||+.|+|+||||+....+..+
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~  318 (320)
T 2i6l_A          243 VVHEEDRQELLSVI-PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE  318 (320)
T ss_dssp             CCCHHHHHHHHTTS-CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred             CCchhhhhhhhhcC-cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence            55444322211100 00000001111122233456789999999999999999999999999999999987666544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-48  Score=372.88  Aligned_cols=264  Identities=33%  Similarity=0.538  Sum_probs=226.2

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..+.++|++++.||+|+||+||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++...    
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----   93 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS----   93 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC----
Confidence            4578999999999999999999999999999999999976655555566778999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc---cCCcEEEeecCccc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN---ANCDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~---~~~~~~L~Dfg~~~  181 (364)
                       ...++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++.
T Consensus        94 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           94 -SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence             78999999997 69999998888999999999999999999999999999999999999995   45679999999987


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ..... .......|++.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+........       
T Consensus       173 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------  242 (486)
T 3mwu_A          173 CFQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------  242 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-------
T ss_pred             ECCCC-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            65332 33445678999999999876  589999999999999999999999999887777766654221111       


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                          ...+..+++.+.+||++||+.||.+|||+.++|+||||+....
T Consensus       243 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          243 --------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             --------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             --------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                                1122457889999999999999999999999999999998643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-47  Score=343.84  Aligned_cols=262  Identities=27%  Similarity=0.405  Sum_probs=213.9

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      .....+.++|++.+.||+|+||+||+|.++.++..+|+|++..... ......+.+|+.+++.++||||+++++++... 
T Consensus        15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   92 (285)
T 3is5_A           15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-   92 (285)
T ss_dssp             EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred             CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecC-
Confidence            3444578999999999999999999999999999999999976532 22345677899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEE
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKI  174 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L  174 (364)
                          ...++||||++ ++|.+.+..    ...+++..++.++.||+.||.+||++|++|+||+|+||++   +.++.++|
T Consensus        93 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           93 ----HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             ----SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             ----CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence                78999999998 599988853    3679999999999999999999999999999999999999   45678999


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      +|||++..... ........++..|+|||++.+  .++.++||||||+++|+|++|..||.+.........+......  
T Consensus       169 ~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--  243 (285)
T 3is5_A          169 IDFGLAELFKS-DEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN--  243 (285)
T ss_dssp             CCCCCCCC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--
T ss_pred             EeeecceecCC-cccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc--
Confidence            99999876533 223445578999999999854  6899999999999999999999999887655544433221100  


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                                .......+++.+.+||++||+.||.+|||+.|||+||||++
T Consensus       244 --------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 --------------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --------------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --------------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                                      01112347889999999999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.4e-48  Score=356.93  Aligned_cols=312  Identities=32%  Similarity=0.491  Sum_probs=232.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc--cc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR--IS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~  105 (364)
                      .-++|++.+.||+|+||+||+|+++.+|..||+|++.......   ....+++..++.++||||+++++++.....  ..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            4579999999999999999999999999999999886533222   234567788888899999999999876432  11


Q ss_pred             cceEEEEeccccccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCeEEcc-CCcEEEeecC
Q 017909          106 FKDVYLVYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLH--SANILHRDLKPGNLLVNA-NCDLKICDFG  178 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~di~~~NIll~~-~~~~~L~Dfg  178 (364)
                      ....++||||++++|.+.+.    ....+++..++.++.|++.||.+||  ++|++|+||||+||+++. ++.++|+|||
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A           98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            23488999999988776554    4567999999999999999999999  999999999999999997 8999999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ++....... ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+.+....+
T Consensus       178 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3e3p_A          178 SAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL  256 (360)
T ss_dssp             TCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence            997664332 3345567999999999977566899999999999999999999999999999999999888887776554


Q ss_pred             hccCchhHH-HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCc
Q 017909          259 EFIDNPKAR-RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSL  337 (364)
Q Consensus       259 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~  337 (364)
                      ......... .+...................++.+.+||.+||+.||.+|||+.|+|+||||++...+....+.......
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~  336 (360)
T 3e3p_A          257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPE  336 (360)
T ss_dssp             HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCG
T ss_pred             HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCc
Confidence            332211100 0000000000011122233467889999999999999999999999999999999887776665555554


Q ss_pred             ccchhh
Q 017909          338 DIDENI  343 (364)
Q Consensus       338 ~~~~~~  343 (364)
                      ++.+..
T Consensus       337 ~~~~~~  342 (360)
T 3e3p_A          337 DLFRFL  342 (360)
T ss_dssp             GGGCCC
T ss_pred             HHHHcC
Confidence            544443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.9e-47  Score=360.37  Aligned_cols=283  Identities=31%  Similarity=0.578  Sum_probs=228.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc------CCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI------KHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~  101 (364)
                      +.++|++++.||+|+||+||+|.+..+++.||+|+++..   ......+.+|+.+++.+      +|+||+++++.+...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            578999999999999999999999999999999999753   22334455677777766      577999999999877


Q ss_pred             cccccceEEEEeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc--EEEeec
Q 017909          102 HRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--LKICDF  177 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~--~~L~Df  177 (364)
                           ...++|||+++++|.+++....  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.  ++|+||
T Consensus       172 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          172 -----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             -----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             -----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence                 7899999999999999998654  5999999999999999999999999999999999999999887  999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |++......   .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+....+.++...
T Consensus       247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          247 GSSCYEHQR---VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccceecCCc---ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            998755322   234577899999999988 5789999999999999999999999999999999999999888877765


Q ss_pred             hhccCchhHHHHHhhCCCCC------------------------------CCcccccCCCCChHHHHHHHHhcccCCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSR------------------------------GTHISSLYPQADPLALDLLQKMLVFEPSKR  307 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  307 (364)
                      ......  ...++.......                              ......+....++.+.+||++||+.||.+|
T Consensus       323 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          323 LDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence            433211  111111100000                              000011223458889999999999999999


Q ss_pred             CCHHHHhcCCCccCCCC
Q 017909          308 ITVTEALQHPYISGLYD  324 (364)
Q Consensus       308 ps~~elL~hp~f~~~~~  324 (364)
                      ||++|+|+||||+....
T Consensus       401 pta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          401 MTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             CCHHHHHTSTTTC----
T ss_pred             CCHHHHhCChhhccCCC
Confidence            99999999999998543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.7e-48  Score=344.83  Aligned_cols=261  Identities=25%  Similarity=0.404  Sum_probs=220.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -++|++++.||+|++|+||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----C
Confidence            479999999999999999999999999999999986543222 2234567899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ ++|.+.+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            8999999998 699999988888999999999999999999999999999999999999999999999999988554332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .  .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....                
T Consensus       163 ~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------  223 (279)
T 3fdn_A          163 R--RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----------------  223 (279)
T ss_dssp             -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------------
T ss_pred             c--ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC----------------
Confidence            2  334567899999999977 578999999999999999999999999877666655553311                


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                     ...+..+++.+.+||.+||+.||.+|||+.|||+||||+........
T Consensus       224 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~  270 (279)
T 3fdn_A          224 ---------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN  270 (279)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCC
T ss_pred             ---------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCccc
Confidence                           11234578899999999999999999999999999999886554433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=363.46  Aligned_cols=279  Identities=21%  Similarity=0.306  Sum_probs=226.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|..++..++||||+++++++.+.     
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-----  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-----
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----
Confidence            46799999999999999999999999999999999975322 122233456899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            78999999996 6999999775 479999999999999999999999999999999999999999999999999997664


Q ss_pred             CCCc-ccccccccccccCCccccc------ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          185 GNEQ-FMTEYVVTRWYRAPELLLC------CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       185 ~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .... .....+||+.|+|||++..      ...++.++|||||||++|+|++|..||.+.+..+...++......     
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----  288 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-----  288 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-----
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----
Confidence            4332 2334578999999999973      246899999999999999999999999998877777666532100     


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCCCCCCCCCCCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKR---ITVTEALQHPYISGLYDPQCNPPAQVP  334 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~elL~hp~f~~~~~~~~~~~~~~~  334 (364)
                                           .........+++.+.+||++||+ +|.+|   |+++|+++||||+++.+.... ..++|
T Consensus       289 ---------------------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~-~~~~p  345 (412)
T 2vd5_A          289 ---------------------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR-DSVPP  345 (412)
T ss_dssp             ---------------------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST-TSCCS
T ss_pred             ---------------------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh-hcCCC
Confidence                                 00111224689999999999999 99998   599999999999988555443 23334


Q ss_pred             CCccc
Q 017909          335 LSLDI  339 (364)
Q Consensus       335 ~~~~~  339 (364)
                      ..+++
T Consensus       346 ~~p~~  350 (412)
T 2vd5_A          346 FTPDF  350 (412)
T ss_dssp             CCCC-
T ss_pred             CCCcC
Confidence            44433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-48  Score=360.37  Aligned_cols=286  Identities=34%  Similarity=0.623  Sum_probs=228.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc----
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR----  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  103 (364)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++.......      .+|+.+++.++||||+++++++.....    
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~------~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC------CHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH------HHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4789999999999999999999999999999999986542222      259999999999999999999865422    


Q ss_pred             -----------------------------cccceEEEEeccccccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 017909          104 -----------------------------ISFKDVYLVYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLH  150 (364)
Q Consensus       104 -----------------------------~~~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH  150 (364)
                                                   ......++||||++|+|.+.+.    ..+.+++..++.++.||+.||.|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                         1224589999999998777664    3578999999999999999999999


Q ss_pred             HCCccccCCCCCCeEEc-cCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh
Q 017909          151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG  229 (364)
Q Consensus       151 ~~~i~H~di~~~NIll~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  229 (364)
                      ++|++|+||||+||+++ .++.++|+|||++...... .......++..|+|||++.+...++.++|||||||++|+|++
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            99999999999999997 6889999999999765333 234455678999999999876669999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcc-cccCCCCChHHHHHHHHhcccCCCCCC
Q 017909          230 RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHI-SSLYPQADPLALDLLQKMLVFEPSKRI  308 (364)
Q Consensus       230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rp  308 (364)
                      |..||.+....+....+....+.+........+.....   ...+......+ ......+++.+.+||.+||+.||.+||
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999999999999998888776544332211000   00011111111 123456899999999999999999999


Q ss_pred             CHHHHhcCCCccCCC
Q 017909          309 TVTEALQHPYISGLY  323 (364)
Q Consensus       309 s~~elL~hp~f~~~~  323 (364)
                      |+.|+|+||||+.+.
T Consensus       315 t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          315 NPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CHHHHHTSGGGHHHH
T ss_pred             CHHHHhcCHHHHHHH
Confidence            999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.4e-48  Score=354.73  Aligned_cols=260  Identities=30%  Similarity=0.473  Sum_probs=215.6

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (364)
                      ...+.++|++.+.||+|+||+||+|.++.+|+.||+|++......      ..+|+.++.++ +||||+++++++.+.  
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~--   88 (342)
T 2qr7_A           17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG--   88 (342)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS--
T ss_pred             ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC--
Confidence            345789999999999999999999999999999999999764332      23577788777 799999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC----CcEEEeecC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN----CDLKICDFG  178 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~----~~~~L~Dfg  178 (364)
                         ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||++..+    +.++|+|||
T Consensus        89 ---~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           89 ---KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence               78999999997 6999999988899999999999999999999999999999999999998543    359999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCch
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC---LNQLKLIISVFGTQQE  255 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~  255 (364)
                      ++..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...   .+....+...      
T Consensus       166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~------  238 (342)
T 2qr7_A          166 FAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG------  238 (342)
T ss_dssp             TCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC------
T ss_pred             CcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC------
Confidence            99876554444556678999999999977 4688999999999999999999999986422   2222222210      


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                           ........+..+++.+.+||++||+.||.+|||+.++|+||||..+.
T Consensus       239 ---------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          239 ---------------------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             ---------------------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             ---------------------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                                 00011223467899999999999999999999999999999998753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-47  Score=356.44  Aligned_cols=261  Identities=26%  Similarity=0.459  Sum_probs=221.9

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++++.||+|+||+||+|.++.+|+.+|+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----  120 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----  120 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----
Confidence            35789999999999999999999999999999999997542  23445677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc--CCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~--~~~~~L~Dfg~~~~  182 (364)
                      ...++||||+. |+|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.++|+|||++..
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            78999999997 6999988765 47999999999999999999999999999999999999974  46799999999987


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......          
T Consensus       201 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------  268 (387)
T 1kob_A          201 LNPDE-IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----------  268 (387)
T ss_dssp             CCTTS-CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC----------
T ss_pred             cCCCc-ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            64332 3344578999999999987 57899999999999999999999999988766666555432111          


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                       .....+..+++.+.+||++||+.||.+|||+.|+|+||||++..
T Consensus       269 -----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          269 -----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                             01223356889999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.3e-48  Score=354.34  Aligned_cols=272  Identities=28%  Similarity=0.410  Sum_probs=226.2

Q ss_pred             eceeeecccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeec
Q 017909           22 WQTLFEIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMM   99 (364)
Q Consensus        22 ~~~~~~~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   99 (364)
                      .+....+.++|.+. +.||+|+||+||+|.+..+++.||+|+++...........+.+|+.+++.+ .||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            34445578999998 899999999999999999999999999986655554556778999999999 4699999999998


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEE
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLK  173 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~  173 (364)
                      ..     ...++||||+. |+|.+++...  +.+++..++.++.||+.||.+||++|++|+||+|+||+++.   ++.++
T Consensus       100 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          100 NT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             CS-----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred             eC-----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence            77     78999999998 5998888543  67999999999999999999999999999999999999988   78999


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||++...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus       175 L~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  252 (327)
T 3lm5_A          175 IVDFGMSRKIGHA-CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY  252 (327)
T ss_dssp             ECCGGGCEEC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             EeeCccccccCCc-cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc
Confidence            9999999766332 22344578999999999977 578999999999999999999999999887776666554432211


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                      .                           ......+++.+.+||++||+.||.+|||++++|+||||+++.....
T Consensus       253 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          253 S---------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             C---------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             C---------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            1                           2223568889999999999999999999999999999999855444

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=353.48  Aligned_cols=262  Identities=31%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ....+.++|++.+.||+|+||+||+|.++.+++.||+|+++...    ....+.+|+.+++.++||||+++++++...  
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  120 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--  120 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS--
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC--
Confidence            34457889999999999999999999999999999999997532    234566899999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEEEeecCc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL  179 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~L~Dfg~  179 (364)
                         ...++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.   ++.++|+|||+
T Consensus       121 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          121 ---TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             ---CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence               78999999997 699999988888999999999999999999999999999999999999975   88999999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN-QLKLIISVFGTQQEADL  258 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  258 (364)
                      +..... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+....        
T Consensus       198 a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~--------  267 (349)
T 2w4o_A          198 SKIVEH-QVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE--------  267 (349)
T ss_dssp             ----------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC--------
T ss_pred             ccccCc-ccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC--------
Confidence            876533 222345678999999999987 578999999999999999999999997765443 222222110        


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                         .......+..++..+.+||++||+.||.+|||+.|+|+||||++..
T Consensus       268 -------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          268 -------------------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -------------------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -------------------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                               0011223456889999999999999999999999999999998743

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-48  Score=351.83  Aligned_cols=270  Identities=22%  Similarity=0.257  Sum_probs=191.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      |..+|.+.+.||+|+||+||+|++  +|+.||||+++....   .......|+..+..++||||+++++++...... ..
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~-~~   74 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGT-WT   74 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC-ce
Confidence            356899999999999999999977  488999999975322   222223466666788999999999999865321 13


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCeEEccCCcEEEeecC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA--------NILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      .++||||||+ |+|.+++.. .++++..+..++.|++.||.|||++        +|+||||||+|||++.++.+||+|||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            6899999998 799999976 5699999999999999999999987        89999999999999999999999999


Q ss_pred             ccccCCCCCc----ccccccccccccCCccccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017909          179 LARTSRGNEQ----FMTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       179 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  249 (364)
                      ++........    ......||+.|+|||++.+..     .++.++|||||||++|||++|.+||.........      
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p------  227 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP------  227 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT------
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc------
Confidence            9876543322    123457899999999997531     3567999999999999999998877543211000      


Q ss_pred             hCCCchhhhhccCchhHHHHHhhC-CCCCCCccccc--CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSL-PYSRGTHISSL--YPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                          . ... ....+......... ........+..  ....+..+.+|+.+||+.||.+|||+.||++.
T Consensus       228 ----~-~~~-~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          228 ----Y-YDL-VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             ----T-TTT-SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ----c-hhc-ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                0 000 00000000000000 00000000000  11233468899999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.5e-48  Score=352.01  Aligned_cols=264  Identities=26%  Similarity=0.444  Sum_probs=195.7

Q ss_pred             cccceeee---eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 017909           28 IDTKYVPI---KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~---~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  103 (364)
                      +.++|++.   +.||+|+||+||+|.++.+++.||+|++...     ......+|+.+++.+. ||||+++++++...  
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--   78 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--   78 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--
Confidence            45678886   7899999999999999999999999999653     2234567999999996 99999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cEEEeecCc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGL  179 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~~L~Dfg~  179 (364)
                         ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++   .++|+|||+
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           79 ---LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             ---CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence               78999999997 59999999988999999999999999999999999999999999999997765   799999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ---LKLIISVFGTQQEA  256 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  256 (364)
                      +..............++..|+|||++.+ ..++.++||||||+++|+|++|..||.+......   ...+...+..    
T Consensus       156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~----  230 (325)
T 3kn6_A          156 ARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK----  230 (325)
T ss_dssp             CEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT----
T ss_pred             ceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc----
Confidence            9866555555556678999999999977 5789999999999999999999999976543110   0111111000    


Q ss_pred             hhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                         .........+..+++.+.+||++||+.||.+|||+.|+++||||+.....
T Consensus       231 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          231 -------------------GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             -------------------TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             -------------------CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence                               00001111224578999999999999999999999999999999975433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-48  Score=372.93  Aligned_cols=266  Identities=31%  Similarity=0.492  Sum_probs=227.6

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+.++|++.+.||+|+||+||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++...   
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---   98 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK---   98 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence            45789999999999999999999999999999999998654332 33456678999999999999999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEEeecCcc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLA  180 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L~Dfg~~  180 (364)
                        ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++
T Consensus        99 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A           99 --GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence              78999999997 6999999988899999999999999999999999999999999999999   56789999999998


Q ss_pred             ccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...... .......|++.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+........      
T Consensus       177 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------  247 (484)
T 3nyv_A          177 THFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE------  247 (484)
T ss_dssp             HHBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             EEcccc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            766433 23445678999999999866  589999999999999999999999999887777766654221111      


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                           ...+..+++.+.+||++||+.||.+|||+.|+|+||||+......
T Consensus       248 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~  292 (484)
T 3nyv_A          248 ---------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ  292 (484)
T ss_dssp             ---------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred             ---------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence                                 112245788999999999999999999999999999999875543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.4e-47  Score=342.40  Aligned_cols=264  Identities=28%  Similarity=0.436  Sum_probs=227.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|.+..+++.+++|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----
Confidence            57899999999999999999999999999999999876543 334556677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ ++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            78999999998 69999998888999999999999999999999999999999999999999999999999999876644


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+...                
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------  230 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------------  230 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------------
T ss_pred             CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------------
Confidence            4444455678999999999977 57899999999999999999999999887655544333210                


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                     ....+..+++.+.++|++||+.||.+|||++++|+||||+....+...
T Consensus       231 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~  278 (294)
T 2rku_A          231 ---------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  278 (294)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             ---------------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCC
Confidence                           012234678899999999999999999999999999999987655544

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7e-48  Score=371.30  Aligned_cols=262  Identities=32%  Similarity=0.504  Sum_probs=220.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++++.||+|+||+||+|+++.++..+|+|++............+.+|+.+++.++||||+++++++...     
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----  108 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----  108 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----
Confidence            467799999999999999999999999999999999976544444456778999999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC---CcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~---~~~~L~Dfg~~~~  182 (364)
                      ...++||||+. |+|.+.+.....+++..++.++.||+.||.|||++|++|+||||+||+++.+   +.++|+|||++..
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            78999999997 5999999888899999999999999999999999999999999999999764   4599999999876


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... .......|++.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+........        
T Consensus       189 ~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------  257 (494)
T 3lij_A          189 FENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD--------  257 (494)
T ss_dssp             CBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             CCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            6433 23445678999999999864  689999999999999999999999999887777766654322211        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                         ...+..+++.+.+||++||+.||.+|||+.|+|+||||+...
T Consensus       258 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          258 -------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             -------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             -------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                               122356889999999999999999999999999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.7e-47  Score=348.61  Aligned_cols=264  Identities=28%  Similarity=0.436  Sum_probs=227.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||.||++.+..+++.+++|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----
Confidence            56899999999999999999999999999999999876533 334556677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            78999999998 69999998888999999999999999999999999999999999999999999999999999976644


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .........++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...                
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------------  256 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------------  256 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------------
T ss_pred             CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----------------
Confidence            4444455678999999999987 57899999999999999999999999887655554443321                


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                     .......+++.+.+||++||+.||.+|||+.|+|+||||+....+...
T Consensus       257 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~  304 (335)
T 2owb_A          257 ---------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  304 (335)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccC
Confidence                           011234678899999999999999999999999999999987665544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-47  Score=369.56  Aligned_cols=263  Identities=30%  Similarity=0.443  Sum_probs=222.6

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch-----------HHHHHHHHHHHHHHhcCCCCcceee
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR-----------IDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      .+.++|++++.||+|+||+||+|.++.++..||+|++.......           .....+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            46899999999999999999999999999999999997543221           2345677899999999999999999


Q ss_pred             eeeccccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---c
Q 017909           96 DVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---D  171 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~  171 (364)
                      +++...     ...++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++   .
T Consensus       113 ~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          113 DVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            999877     78999999997 59999998888999999999999999999999999999999999999998876   6


Q ss_pred             EEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          172 LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      ++|+|||++...... .......|++.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.....
T Consensus       188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  264 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY  264 (504)
T ss_dssp             EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999999766433 33445678999999999864  589999999999999999999999999887777776654322


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ..+.                           ..+..+++.+.+||++||+.||.+|||++|+|+||||++...
T Consensus       265 ~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          265 YFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            1111                           112468899999999999999999999999999999988643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-48  Score=356.76  Aligned_cols=279  Identities=30%  Similarity=0.443  Sum_probs=225.5

Q ss_pred             ceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh---chHHHHHHHHHHHHHHhcCCCCcc
Q 017909           16 KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE---NRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      ....+++.++..+.++|++++.||+|+||+||+|.+..++..||+|++.....   .......+.+|+.+++.++||||+
T Consensus        12 ~~~~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   91 (345)
T 3hko_A           12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA   91 (345)
T ss_dssp             --CCCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            34456677778899999999999999999999999999999999999975432   234556778999999999999999


Q ss_pred             eeeeeeccccccccceEEEEecccc-ccHHHHHHh----------------------------------------CCCCC
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS----------------------------------------SQSLS  131 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----------------------------------------~~~~~  131 (364)
                      ++++++...     ...++||||++ |+|.+.+..                                        ...++
T Consensus        92 ~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (345)
T 3hko_A           92 RLYEVYEDE-----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR  166 (345)
T ss_dssp             CEEEEEECS-----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHH
T ss_pred             eeehhhccC-----CeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999877     78999999997 699988742                                        11246


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC--cEEEeecCccccCCCC----CcccccccccccccCCccc
Q 017909          132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC--DLKICDFGLARTSRGN----EQFMTEYVVTRWYRAPELL  205 (364)
Q Consensus       132 ~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~--~~~L~Dfg~~~~~~~~----~~~~~~~~~~~~~~aPE~~  205 (364)
                      +..++.++.||+.||.|||++|++|+||+|+||+++.++  .++|+|||.+......    ........|++.|+|||++
T Consensus       167 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            788999999999999999999999999999999998776  8999999998754221    1123456789999999998


Q ss_pred             ccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCccccc
Q 017909          206 LCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSL  284 (364)
Q Consensus       206 ~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
                      .+. ..++.++||||||+++|+|++|..||.+....+....+.........                           ..
T Consensus       247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~  299 (345)
T 3hko_A          247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------PN  299 (345)
T ss_dssp             TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------GG
T ss_pred             ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------cc
Confidence            652 56899999999999999999999999988877776666542211111                           11


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          285 YPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       285 ~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                      ...+++.+.+||.+||+.||.+|||+.++|+||||+.+.+.-
T Consensus       300 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~  341 (345)
T 3hko_A          300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI  341 (345)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence            234788999999999999999999999999999999876543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.6e-47  Score=359.79  Aligned_cols=291  Identities=34%  Similarity=0.596  Sum_probs=231.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc-ccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR-ISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~  106 (364)
                      ...+|++++.||+|+||+||+|++..+|+.||+|++......      ..+|+.+++.++||||+++++++..... ...
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            345899999999999999999999999999999998653221      2359999999999999999999865322 112


Q ss_pred             ceEEEEeccccccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecCccc
Q 017909          107 KDVYLVYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLAR  181 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg~~~  181 (364)
                      .+.++||||+++++.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus       126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            4578999999988877664    35679999999999999999999999999999999999999965 568999999997


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+.++.+.++.+....+...
T Consensus       206 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          206 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             ECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            653322 2344577999999999987567999999999999999999999999999999999999988887766544322


Q ss_pred             CchhHHHHHhhCCCCCCCccc-ccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHIS-SLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                      ... ...+  ..+......+. .+.+..++.+.+||.+||+.||.+|||+.|+|+||||+++..+...
T Consensus       285 ~~~-~~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  349 (420)
T 1j1b_A          285 NPN-YTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK  349 (420)
T ss_dssp             CSC-CCCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred             Chh-hhhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccccc
Confidence            110 0000  00000011111 1335678999999999999999999999999999999988766554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-47  Score=341.37  Aligned_cols=257  Identities=23%  Similarity=0.399  Sum_probs=220.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .++|++++.||+|++|+||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++...     .
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----K   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----C
Confidence            57999999999999999999999999999999999754322 22234667899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ ++|.+.+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            8899999997 599999988888999999999999999999999999999999999999999999999999998655332


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      .  .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+...                 
T Consensus       168 ~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------  227 (284)
T 2vgo_A          168 R--RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------  227 (284)
T ss_dssp             C--BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------
T ss_pred             c--cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------------
Confidence            2  334567899999999987 57899999999999999999999999887665554444321                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                    ....+..+++.+.++|.+||+.||.+|||++++++||||+....
T Consensus       228 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          228 --------------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             --------------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                          01223567889999999999999999999999999999987544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-47  Score=342.69  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...++|++++.||+|+||+||+|.+..+|+.||+|+++...........+.++...++.++||||+++++++...     
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----   78 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----   78 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----
Confidence            357899999999999999999999999999999999976544444444445566668888999999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          107 KDVYLVYELMDTDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      ...++||||++|+|.+.+..    ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++.++|+|||.+.
T Consensus        79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            77899999999998777653    56899999999999999999999998 99999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCCcccc---cccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLL---CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-LNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  257 (364)
                      ..... .......+++.|+|||++.   ....++.++||||||+++|+|++|..||..... ...........       
T Consensus       159 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  230 (290)
T 3fme_A          159 YLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-------  230 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-------
T ss_pred             ccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-------
Confidence            65332 2233446889999999973   335689999999999999999999999986432 22222222110       


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                            ........+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       231 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          231 ----------------------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----------------------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------------------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                                  0011123578899999999999999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-47  Score=358.66  Aligned_cols=304  Identities=27%  Similarity=0.406  Sum_probs=228.4

Q ss_pred             ccCCCCcccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHH
Q 017909            5 VEPPNGMKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR   84 (364)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~   84 (364)
                      +|.+..+..+|++....++.+   .++|++++.||+|+||+||+|++..+++.||+|+++..   ......+.+|+.+++
T Consensus        15 ~e~~~~~~~~~~~~~~~g~~~---~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~   88 (397)
T 1wak_A           15 QEDPNDYCKGGYHLVKIGDLF---NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLK   88 (397)
T ss_dssp             -------CC--CCSSCTTCEE---TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHH
T ss_pred             ccccccCCCCCceEEehhhhc---CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHH
Confidence            567777888888887777665   89999999999999999999999999999999999743   334456678999998


Q ss_pred             hcC--------CCCcceeeeeeccccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 017909           85 HIK--------HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSA-N  153 (364)
Q Consensus        85 ~l~--------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~  153 (364)
                      .++        |+||+++++++...... ....++|||++++++.+.+...  +.+++..++.++.||+.||.|||++ |
T Consensus        89 ~l~~~~~~~~~~~~iv~~~~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g  167 (397)
T 1wak_A           89 SVRNSDPNDPNREMVVQLLDDFKISGVN-GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR  167 (397)
T ss_dssp             HHHHSCTTCGGGGGBCCEEEEEEEEETT-EEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHhhcCCCCCCcceeeeeecceeecCCC-CceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            885        78899999998743211 1678999999998888888654  5699999999999999999999998 9


Q ss_pred             ccccCCCCCCeEEccCC-------------------------------------------------cEEEeecCccccCC
Q 017909          154 ILHRDLKPGNLLVNANC-------------------------------------------------DLKICDFGLARTSR  184 (364)
Q Consensus       154 i~H~di~~~NIll~~~~-------------------------------------------------~~~L~Dfg~~~~~~  184 (364)
                      ++|+||||+|||++.++                                                 .++|+|||.+....
T Consensus       168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~  247 (397)
T 1wak_A          168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH  247 (397)
T ss_dssp             EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred             EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence            99999999999998775                                                 79999999987653


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCchhhh
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE------CLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ..   .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+..      .......+....+..+....
T Consensus       248 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  323 (397)
T 1wak_A          248 KH---FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI  323 (397)
T ss_dssp             BC---SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred             cc---CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence            32   334578999999999988 578999999999999999999999998665      45566667777776655432


Q ss_pred             hccCchhHHHHHhhCCCCCCC-------------cccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          259 EFIDNPKARRFIKSLPYSRGT-------------HISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ......  ..+..........             .........++.+.+||.+||+.||.+|||+.|||+||||+.
T Consensus       324 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          324 VAGKYS--KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHCTTG--GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hccccc--ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            111100  0000000000000             000112234567889999999999999999999999999974

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-47  Score=346.60  Aligned_cols=265  Identities=27%  Similarity=0.390  Sum_probs=208.2

Q ss_pred             ecccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      .+.++|++. +.||+|+||+||+|.+..+++.||+|++.....  .....+.+|+.++.++ +||||+++++++...   
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~---   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE---   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC---
Confidence            468899996 789999999999999999999999999975432  2345677899999885 799999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc---EEEeecCcc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLA  180 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~---~~L~Dfg~~  180 (364)
                        ...++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++
T Consensus        84 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           84 --DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             --CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence              78999999997 699999988889999999999999999999999999999999999999998776   999999998


Q ss_pred             ccCCCCC-------cccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH--------
Q 017909          181 RTSRGNE-------QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN--------  241 (364)
Q Consensus       181 ~~~~~~~-------~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--------  241 (364)
                      .......       .......|+..|+|||++.+    ...++.++|||||||++|+|++|..||.+.....        
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            6543211       11223458999999999864    1347899999999999999999999998764211        


Q ss_pred             -------HHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          242 -------QLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       242 -------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                             ....+......                           .....+..+++.+.+||++||+.||.+|||+.|+|
T Consensus       242 ~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYE---------------------------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCC---------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             chhHHHHHHHHHhccCcc---------------------------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                   11111110000                           00111245788999999999999999999999999


Q ss_pred             cCCCccCCCCC
Q 017909          315 QHPYISGLYDP  325 (364)
Q Consensus       315 ~hp~f~~~~~~  325 (364)
                      +||||++....
T Consensus       295 ~hp~~~~~~~~  305 (316)
T 2ac3_A          295 QHPWVQGCAPE  305 (316)
T ss_dssp             HSTTCC-----
T ss_pred             cChhhcCCCCc
Confidence            99999986443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-46  Score=337.95  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=218.7

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .-...|++.+.||+|+||+||+|.+..++..|++|++............+.+|+.+++.++||||+++++++..... ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC-CC
Confidence            34567999999999999999999999999999999998766666677788899999999999999999998865322 12


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEc-cCCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVN-ANCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~-~~~~~~L~Dfg~~~~  182 (364)
                      ...++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            66899999997 599999998889999999999999999999999999  99999999999997 788999999999865


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ....  ......+++.|+|||++.+  .++.++||||||+++|+|++|..||...............  ..         
T Consensus       182 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~---------  246 (290)
T 1t4h_A          182 KRAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GV---------  246 (290)
T ss_dssp             CCTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TC---------
T ss_pred             cccc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--cC---------
Confidence            4332  2344568999999998865  5899999999999999999999999876544433322111  00         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                       .........++.+.+||.+||+.||.+|||+.+||+||||++
T Consensus       247 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          247 -----------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                             011122456788999999999999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-47  Score=347.78  Aligned_cols=266  Identities=26%  Similarity=0.357  Sum_probs=214.0

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCC--CCcceeeeeecccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH--DNVIALKDVMMPTH  102 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~  102 (364)
                      +....++|++++.||+|+||+||++.+. ++..||+|++............+.+|+.+++.++|  |||+++++++... 
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-   81 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-   81 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-
Confidence            3446788999999999999999999874 58899999998766666666778899999999976  9999999999877 


Q ss_pred             ccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          103 RISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                          ...++|||+.+++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+|||++ ++.++|+|||++..
T Consensus        82 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           82 ----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             ----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             ----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence                7899999987899999999989999999999999999999999999999999999999997 57899999999976


Q ss_pred             CCCCCc--ccccccccccccCCccccc----------ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017909          183 SRGNEQ--FMTEYVVTRWYRAPELLLC----------CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF  250 (364)
Q Consensus       183 ~~~~~~--~~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (364)
                      ......  ......|++.|+|||++.+          ...++.++|||||||++|+|++|..||........  .+....
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~  234 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHAII  234 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--HHHHHh
Confidence            543322  2335578999999999864          24688899999999999999999999976533211  111111


Q ss_pred             CCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ..                          ......+...+..+.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       235 ~~--------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          235 DP--------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CT--------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             cC--------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            10                          01122334567789999999999999999999999999999865443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8e-47  Score=341.57  Aligned_cols=270  Identities=27%  Similarity=0.433  Sum_probs=220.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc--hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN--RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +.++|++++.||+|+||.||+|.+..++..+++|+++.....  ......+.+|+.+++.++||||+++++++.....  
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--   80 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK--   80 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC--
Confidence            568999999999999999999999999999999999764322  2345677899999999999999999999854322  


Q ss_pred             cceEEEEeccccccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||+++++.+.+..  .+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           81 -QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             --CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence             57899999999888888865  457999999999999999999999999999999999999999999999999998765


Q ss_pred             CC--CCcccccccccccccCCccccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          184 RG--NEQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       184 ~~--~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..  .........++..|+|||++.+.. ..+.++||||||+++|+|++|..||.+.........+...           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----------  228 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-----------  228 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence            32  222234556789999999987632 2477999999999999999999999887665555444321           


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA  331 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~  331 (364)
                                          .......+++.+.+||++||+.||.+|||+.++++||||+....+...+..
T Consensus       229 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~  279 (305)
T 2wtk_C          229 --------------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP  279 (305)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCCCC
T ss_pred             --------------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCCCC
Confidence                                012234678899999999999999999999999999999987666544333

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.7e-47  Score=344.78  Aligned_cols=259  Identities=24%  Similarity=0.445  Sum_probs=218.4

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVY  110 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (364)
                      .|+..+.||+|+||+||+|+++.+|+.||+|++......  ....+.+|+.+++.++||||+++++++...     ...+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  118 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW  118 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence            488889999999999999999999999999998754322  344567899999999999999999999877     7899


Q ss_pred             EEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc
Q 017909          111 LVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF  189 (364)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~  189 (364)
                      +||||++ ++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus       119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            9999997 588887754 57999999999999999999999999999999999999999999999999998766544444


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF  269 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (364)
                      .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......                
T Consensus       198 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  260 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK----------------  260 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC----------------
T ss_pred             cccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----------------
Confidence            456678999999999977 578999999999999999999999998877655554443211000                


Q ss_pred             HhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                  ......+++.+.+||.+||+.||.+|||+.++|+||||.....+.
T Consensus       261 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          261 ------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             ------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             ------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence                        011134688899999999999999999999999999998754433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-46  Score=339.41  Aligned_cols=269  Identities=30%  Similarity=0.474  Sum_probs=222.3

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-------chHHHHHHHHHHHHHHhcC-CCCccee
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-------NRIDALRTLRELVLLRHIK-HDNVIAL   94 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~~iv~~   94 (364)
                      .....+.++|++.+.||+|++|+||+|.++.+|+.||+|++.....       .......+.+|+.+++.+. ||||+++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3345578999999999999999999999999999999999864321       1223456678999999995 9999999


Q ss_pred             eeeeccccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEE
Q 017909           95 KDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~  173 (364)
                      ++++...     ...++|||+++ ++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++
T Consensus        90 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           90 KDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             EEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             eeeeccC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence            9999876     78999999998 69999998888899999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCCcccccccccccccCCccccc-----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~  248 (364)
                      |+|||.+...... .......++..|+|||++.+     ...++.++||||||+++|+|++|..||.+.........+..
T Consensus       165 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          165 LTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            9999998765332 23345578899999999862     34678999999999999999999999988776665555543


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ......                           ...+..+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus       244 ~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          244 GNYQFG---------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             TCCCCC---------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             CCcccC---------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            211111                           1112357889999999999999999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.1e-47  Score=377.35  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=225.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .++|++++.||+|+||+||+|+++.+++.||+|+++.... ..........|..++..+ +||+|++++.++...     
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-----  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-----
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-----
Confidence            4689999999999999999999999999999999976422 233345566788999887 799999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..+++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            78999999997 69999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....               
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------------  558 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------------  558 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------------
T ss_pred             CCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------------
Confidence            4445566789999999999977 678999999999999999999999999988777766664311               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV-----TEALQHPYISGLYD  324 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~elL~hp~f~~~~~  324 (364)
                                      ..++..+++.+.+||++||+.||.+||++     +||++||||+++.+
T Consensus       559 ----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          559 ----------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence                            12335689999999999999999999997     99999999998743

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.6e-47  Score=347.03  Aligned_cols=288  Identities=30%  Similarity=0.530  Sum_probs=220.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  104 (364)
                      ....++|++++.||+|+||+||+|++..+++.||+|+++...     ...+.+|+.+++.++ ||||+++++++..... 
T Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-  105 (330)
T 3nsz_A           32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVS-  105 (330)
T ss_dssp             CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT-
T ss_pred             ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC-
Confidence            345789999999999999999999999999999999987432     345678999999997 9999999999986422 


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~  182 (364)
                        ...++|||+++ ++|.+.+.   .+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus       106 --~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          106 --RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             --CCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             --CceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence              67899999998 58877764   499999999999999999999999999999999999999777 899999999976


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCchhhhh-c
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG-TECLNQLKLIISVFGTQQEADLE-F  260 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~-~  260 (364)
                      ..... ......++..|+|||++.+...++.++|||||||++|+|++|..||.. .........+....+........ .
T Consensus       181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            54332 234557788999999998766799999999999999999999999854 45555555555544432211100 0


Q ss_pred             ---cCchhHHHHHhhCCCCCC--CcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          261 ---IDNPKARRFIKSLPYSRG--THISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       261 ---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                         ...+..............  .........+++.+.+||++||+.||.+|||++|+|+||||+.+..+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence               011111111111111000  00111223378999999999999999999999999999999987654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.3e-47  Score=337.78  Aligned_cols=265  Identities=28%  Similarity=0.401  Sum_probs=217.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +.++|++++.||+|++|+||+|.++.+++.||+|++...... .....+.+|+.+++.++||||+++++++...     .
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG-----N   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----C
Confidence            467999999999999999999999999999999998754332 3445677899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|||+++ ++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            8899999998 599998887778999999999999999999999999999999999999999999999999998754322


Q ss_pred             C--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchhhhhccCc
Q 017909          187 E--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL-KLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       187 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .  .......++..|+|||++.+....+.++||||||+++|+|++|..||......... ..+..   ..          
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~----------  225 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KK----------  225 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---TC----------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---cc----------
Confidence            1  22344567899999999987444578999999999999999999999876543221 11111   00          


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                                      .....+..+++.+.+||.+||+.||.+|||+.|+++||||+.......
T Consensus       226 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  273 (276)
T 2yex_A          226 ----------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA  273 (276)
T ss_dssp             ----------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC---
T ss_pred             ----------------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhccC
Confidence                            001112357889999999999999999999999999999998755443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9e-47  Score=347.49  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=218.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----  126 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----  126 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence            45679999999999999999999999999999999875433 233445678999999999999999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||+.|++.+.+.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       127 ~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            78999999999999988864 56799999999999999999999999999999999999999999999999999876532


Q ss_pred             CCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                          .....|++.|+|||++.+  ...++.++||||||+++|+|++|..||.+.........+.....            
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------------  270 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------  270 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------------
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------
Confidence                234568999999999853  35689999999999999999999999988766555444432100            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                       .......+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus       271 -----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 -----------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                             011124578899999999999999999999999999999763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.7e-48  Score=352.27  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=215.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch------HHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR------IDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      .+.++|++++.||+|+||+||+|+++.+++.||+|+++......      .....+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            46789999999999999999999999999999999997543211      122344579999999999999999999987


Q ss_pred             ccccccceEEEEecccc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          101 THRISFKDVYLVYELMD-T-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      .     ...++|||++. | +|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus       101 ~-----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 Q-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             S-----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             C-----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            7     78999999986 5 999999998899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ++....... ......|++.|+|||++.+....+.++||||||+++|+|++|..||......                  
T Consensus       176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------  236 (335)
T 3dls_A          176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------  236 (335)
T ss_dssp             TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred             cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence            997664332 3345678999999999987544588999999999999999999999652110                  


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                         .......+..+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus       237 -------------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          237 -------------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             -------------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             -------------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                               0001122345789999999999999999999999999999998743

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-47  Score=339.08  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=194.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .-++|++++.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----
Confidence            346899999999999999999999999999999999754322 12235677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||++ ++|.+++... +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            78999999997 6999998865 679999999999999999999999999999999999999999999999999987664


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.                 
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----------------  225 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------  225 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-----------------
T ss_pred             CCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-----------------
Confidence            44333445678899999999877 578999999999999999999999997754332221110                 


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                    ......+..++..+.+||.+||+.||.+|||++++|+||||+..
T Consensus       226 --------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          226 --------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             --------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             --------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                          00112334678899999999999999999999999999999863

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=359.05  Aligned_cols=294  Identities=36%  Similarity=0.603  Sum_probs=217.5

Q ss_pred             eecccceee-eeeeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           26 FEIDTKYVP-IKPIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        26 ~~~~~~y~i-~~~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..+.+.|++ +++||+|+||+||+|+++  .++..||+|++......    ..+.+|+.+++.++||||+++++++....
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            346788988 558999999999999965  56889999999754322    24568999999999999999999996432


Q ss_pred             ccccceEEEEeccccccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE----ccC
Q 017909          103 RISFKDVYLVYELMDTDLHQIIKSS---------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV----NAN  169 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll----~~~  169 (364)
                      .   ...++||||++++|.+.+...         ..+++..++.++.||+.||.|||++||+|+||||+|||+    +.+
T Consensus        92 ~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           92 D---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             T---TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             C---CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence            2   678999999999999888532         249999999999999999999999999999999999999    677


Q ss_pred             CcEEEeecCccccCCCCC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-------
Q 017909          170 CDLKICDFGLARTSRGNE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-------  239 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-------  239 (364)
                      +.++|+|||++.......   .......|++.|+|||++.+...++.++|||||||++|+|++|..||.+...       
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            899999999997654321   2234567899999999998766699999999999999999999999977654       


Q ss_pred             --HHHHHHHHHHhCCCchhhhhccCc-hhHHHHHhhCCCCCCC------cccccCCCCChHHHHHHHHhcccCCCCCCCH
Q 017909          240 --LNQLKLIISVFGTQQEADLEFIDN-PKARRFIKSLPYSRGT------HISSLYPQADPLALDLLQKMLVFEPSKRITV  310 (364)
Q Consensus       240 --~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  310 (364)
                        .+.+..+...++.+....+..... +...............      .........++.+.+||++||+.||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              477888888888877765544321 1111111111110000      0011223347889999999999999999999


Q ss_pred             HHHhcCCCccCCCCCC
Q 017909          311 TEALQHPYISGLYDPQ  326 (364)
Q Consensus       311 ~elL~hp~f~~~~~~~  326 (364)
                      +|+|+||||++...+.
T Consensus       329 ~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          329 EQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHHTSGGGTSSSCCC
T ss_pred             HHHhcChhhccCCCCc
Confidence            9999999999865543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-46  Score=348.05  Aligned_cols=263  Identities=30%  Similarity=0.513  Sum_probs=220.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc------hHHHHHHHHHHHHHHhc-CCCCcceeeeee
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN------RIDALRTLRELVLLRHI-KHDNVIALKDVM   98 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~   98 (364)
                      ..+.++|++.+.||+|++|+||+|.++.+|+.||+|++......      ......+.+|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            34568999999999999999999999999999999998654211      12234567899999999 799999999999


Q ss_pred             ccccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeec
Q 017909           99 MPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (364)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Df  177 (364)
                      ...     ...++||||+. ++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus       170 ~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESS-----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBS-----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEec
Confidence            876     78999999998 599999988888999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccc-----cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCC-----DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      |++...... .......|++.|+|||++.+.     ..++.++||||||+++|+|++|..||.+.........+......
T Consensus       245 G~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          245 GFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             TTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            998766433 234456789999999998642     35788999999999999999999999887766655555432111


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ...                           ..+..+++.+.+||++||+.||.+|||+.++|+||||+.
T Consensus       324 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          324 FSS---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCH---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCC---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            111                           112457888999999999999999999999999999973

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.9e-47  Score=341.03  Aligned_cols=259  Identities=30%  Similarity=0.471  Sum_probs=219.8

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|+++....  .....+.+|+.+++.++||||+++++++...     
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYEST-----   78 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccC-----
Confidence            468899999999999999999999999999999999975422  2334567899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L~Dfg~~~~  182 (364)
                      ...++|||+++ ++|.+.+...+.+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.+..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            78999999997 6999999888889999999999999999999999999999999999999   7788999999999865


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ....  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......         
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------  226 (304)
T 2jam_A          159 EQNG--IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF---------  226 (304)
T ss_dssp             CCCB--TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC---------
T ss_pred             cCCC--ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            4322  2344568999999999977 578999999999999999999999998877666555554321111         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                        ....+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          227 ------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                              122335688999999999999999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.8e-47  Score=339.36  Aligned_cols=262  Identities=28%  Similarity=0.487  Sum_probs=219.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      +.++|++++.||+|+||+||+|.+..+|+.||+|+++......    .....+.+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   80 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--   80 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--
Confidence            5789999999999999999999999999999999987543221    1345677899999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC----cEEEeecC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDFG  178 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~----~~~L~Dfg  178 (364)
                         ...++|||+++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++    .++|+|||
T Consensus        81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           81 ---TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             ---SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             ---CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence               78999999997 69999998888899999999999999999999999999999999999998877    89999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .+....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+........    
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  231 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD----  231 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----
T ss_pred             cceeccCCC-cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc----
Confidence            987653322 2344567899999999977 5789999999999999999999999988776655554432211111    


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                             ......+++.+.+||++||+.||.+|||+.++|+||||+...
T Consensus       232 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          232 -----------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             -----------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             -----------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                                   112246788999999999999999999999999999998763

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-47  Score=346.97  Aligned_cols=274  Identities=20%  Similarity=0.281  Sum_probs=221.0

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+.++|++++.||+|+||+||+|++..+++.||+|+++..... ......+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            45789999999999999999999999999999999999765433 33445677899999999999999999998766332


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      . ...++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        88 ~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           88 G-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             E-EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             C-cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            1 34699999997 699999998889999999999999999999999999999999999999999999999999998755


Q ss_pred             CCCC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          184 RGNE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       184 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ....   .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.................+      
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------  239 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP------  239 (311)
T ss_dssp             ---------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH------
T ss_pred             cccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc------
Confidence            3322   12234567999999999987 5789999999999999999999999988876655544433211111      


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                           ......+++.+.+||.+||+.||.+||++.++|.|+|++........
T Consensus       240 ---------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~  286 (311)
T 3ork_A          240 ---------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE  286 (311)
T ss_dssp             ---------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCS
T ss_pred             ---------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCC
Confidence                                 11224688999999999999999999999999999999876544433

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.6e-47  Score=338.51  Aligned_cols=253  Identities=19%  Similarity=0.300  Sum_probs=212.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|+++...........+.+|+..+..+ +||||+++++++...     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence            57899999999999999999999999999999999987656666677888999999999 899999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC------------
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN------------  169 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~------------  169 (364)
                      ...++||||++ ++|.+++...    +.+++..++.++.||+.||.|||++|++|+||||+||+++.+            
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            78999999997 5999999764    679999999999999999999999999999999999999844            


Q ss_pred             -------CcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017909          170 -------CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ  242 (364)
Q Consensus       170 -------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  242 (364)
                             ..++|+|||.+.......    ...++..|+|||++.+...++.++||||||+++|+|++|.+++.....   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                   479999999987664332    235789999999998755677899999999999999999987754321   


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ...+..                              ......+..+++.+.+||++||+.||.+|||+.++|+||||+..
T Consensus       237 ~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQ------------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHT------------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHc------------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            111111                              11123345789999999999999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-46  Score=350.58  Aligned_cols=264  Identities=26%  Similarity=0.363  Sum_probs=213.7

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC--CCCcceeeeeecccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK--HDNVIALKDVMMPTH  102 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~  102 (364)
                      ......+|++++.||+|+||+||+|.+.. +..||+|++............+.+|+.+++.++  ||||+++++++... 
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-  128 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-  128 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-
Confidence            34456679999999999999999999875 889999999876556666778889999999996  59999999999877 


Q ss_pred             ccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          103 RISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                          ...++|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++ ++.++|+|||++..
T Consensus       129 ----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          129 ----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             ----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             ----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence                7799999977789999999988999999999999999999999999999999999999996 57999999999976


Q ss_pred             CCCCCc--ccccccccccccCCccccc----------ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Q 017909          183 SRGNEQ--FMTEYVVTRWYRAPELLLC----------CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISV  249 (364)
Q Consensus       183 ~~~~~~--~~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~  249 (364)
                      ......  ......|++.|+|||++.+          ...++.++|||||||++|+|++|..||...... .....+.  
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~--  281 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--  281 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh--
Confidence            543221  2345578999999999865          135889999999999999999999999765332 2222111  


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                       ...                          .....+...+..+.+||++||+.||.+|||+.|||+||||+....
T Consensus       282 -~~~--------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 -DPN--------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             -CTT--------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             -Ccc--------------------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence             110                          011223345778999999999999999999999999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-46  Score=335.75  Aligned_cols=259  Identities=26%  Similarity=0.368  Sum_probs=212.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|++|.||+|.+..+|+.|++|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----
Confidence            467999999999999999999999999999999999754322 22344667899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++|||++. ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            78999999997 59999998888899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                      . .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+....               
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  227 (276)
T 2h6d_A          164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------------  227 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------------
Confidence            2 223445678999999999874445789999999999999999999998876555444442210               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                      ...+..++..+.++|.+||+.||.+|||+.++++||||+...
T Consensus       228 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          228 ----------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             ----------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence                            112345788999999999999999999999999999998743

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.5e-47  Score=336.75  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=220.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|.++.+++.|++|++............+.+|+.+++.++||||+++++++.....   .
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---T   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---T
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---c
Confidence            4679999999999999999999999999999999998765556666778899999999999999999998854322   6


Q ss_pred             eEEEEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCeEEccCCcEEEeec
Q 017909          108 DVYLVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDF  177 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~di~~~NIll~~~~~~~L~Df  177 (364)
                      ..++||||++ ++|.+++...    ..+++..++.++.|++.||.+||++|     ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            7899999997 5999998653    35999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |.+..............++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+...        
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------  231 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--------  231 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred             chheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc--------
Confidence            998766444433445577899999999987 57899999999999999999999999887665554444321        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                            ........+++.+.++|.+||+.||.+|||+.|||+|+|+.+..
T Consensus       232 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          232 ----------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ----------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ----------------------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                                  01123346789999999999999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.5e-47  Score=338.64  Aligned_cols=263  Identities=33%  Similarity=0.540  Sum_probs=223.0

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.++|++++.||+|++|+||+|.+..+++.|++|++............+.+|+.+++.++||||+++++++...     
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----
Confidence            367899999999999999999999999999999999976655555566788999999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC---CcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~---~~~~L~Dfg~~~~  182 (364)
                      ...++|+|++. ++|.+.+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.+   +.++|+|||.+..
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            78899999997 6999999888889999999999999999999999999999999999999764   4699999999876


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ..... ......++..|+|||.+.+  .++.++||||||+++|+|++|..||.+.........+.......         
T Consensus       174 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------  241 (287)
T 2wei_A          174 FQQNT-KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF---------  241 (287)
T ss_dssp             BCCCS-SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred             ecCCC-ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            53332 2334467889999999866  48999999999999999999999999887666555543311110         


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                        ....+..+++.+.++|++||+.||.+|||+.++|+||||+++..
T Consensus       242 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          242 ------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             ------------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             ------------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                              01122467889999999999999999999999999999987643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-46  Score=364.53  Aligned_cols=262  Identities=25%  Similarity=0.407  Sum_probs=218.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----
Confidence            46789999999999999999999999999999999976432 222345567899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ...++||||++ |+|.+.+...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            78999999997 69999987654  4999999999999999999999999999999999999999999999999999776


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...+             
T Consensus       337 ~~~~-~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i-------------  401 (576)
T 2acx_A          337 PEGQ-TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-------------  401 (576)
T ss_dssp             CTTC-CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH-------------
T ss_pred             ccCc-cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh-------------
Confidence            4332 2344588999999999987 578999999999999999999999998764321111111110             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                             ...       ....+..+++.+.+||++||+.||.+||     +++||++||||+++.
T Consensus       402 -------~~~-------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          402 -------KEV-------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             -------HHC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             -------hcc-------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence                   000       0122356889999999999999999999     899999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.2e-46  Score=359.41  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=219.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----
Confidence            357999999999999999999999999999999999764332 22345667899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS----QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      ..+++||||++ |+|.+.+...    ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence            78999999998 6999988753    469999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC----LNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~  257 (364)
                      .............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...    ......+...        
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--------  408 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--------  408 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--------
T ss_pred             eccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--------
Confidence            76554444455689999999999987 6789999999999999999999999987632    1222222110        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGLY  323 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~~  323 (364)
                                             ....+..+++.+.+||++||+.||.+||+     +++|++||||+++.
T Consensus       409 -----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          409 -----------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             -----------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence                                   01233568999999999999999999995     58999999999853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=350.02  Aligned_cols=259  Identities=29%  Similarity=0.415  Sum_probs=214.2

Q ss_pred             cccceee--eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVP--IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i--~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +.+.|++  .+.||+|+||+||+|.+..+|..||+|+++...  ......+.+|+.+++.++||||+++++++...    
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  158 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESK----  158 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC----
Confidence            4566666  678999999999999999999999999997542  23456778999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE--ccCCcEEEeecCccc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll--~~~~~~~L~Dfg~~~  181 (364)
                       ...++||||++ ++|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+|||+  +.++.++|+|||++.
T Consensus       159 -~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          159 -NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             -SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence             78999999997 5998888654 469999999999999999999999999999999999999  567789999999997


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......+       
T Consensus       238 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-------  308 (373)
T 2x4f_A          238 RYKPRE-KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE-------  308 (373)
T ss_dssp             ECCTTC-BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-------
T ss_pred             ecCCcc-ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------
Confidence            664332 2344568999999999876 5789999999999999999999999998887776666654211111       


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                          ...+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       309 --------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          309 --------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             --------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             --------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                                12234678999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-46  Score=339.11  Aligned_cols=266  Identities=23%  Similarity=0.362  Sum_probs=215.3

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ......++|++++.||+|+||+||+|.+..++..+++|++.....  .....+.+|+.+++.++||||+++++++...  
T Consensus        13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   88 (302)
T 2j7t_A           13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHD--   88 (302)
T ss_dssp             SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--
T ss_pred             cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--
Confidence            345678999999999999999999999999999999999875432  2345677899999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++||||++ ++|.+++.. .+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           89 ---GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             ---CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence               78899999997 588888765 5679999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCCcccccccccccccCCcccc----cccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLL----CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .............++..|+|||++.    ....++.++||||||+++|+|++|..||...........+......     
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  240 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-----  240 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-----
Confidence            3222112223446788999999985    2356889999999999999999999999887765554444321100     


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                             .......++..+.++|.+||+.||.+|||+.++++||||+....
T Consensus       241 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          241 -----------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             -----------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             -----------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                                   01112356888999999999999999999999999999988653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.6e-46  Score=341.84  Aligned_cols=284  Identities=28%  Similarity=0.501  Sum_probs=225.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEe-ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC------Ccceeeeeec
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSIN-RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD------NVIALKDVMM   99 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~   99 (364)
                      .+.++|++++.||+|+||+||+|.+ +.++..||+|+++..   ......+.+|+.+++.++|+      +++++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3588999999999999999999998 567899999999743   23345566788888888655      4899999988


Q ss_pred             cccccccceEEEEeccccccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---------
Q 017909          100 PTHRISFKDVYLVYELMDTDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---------  168 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---------  168 (364)
                      ..     ...++|||+++++|.+++...+  ++++..++.++.||+.||.|||++|++|+||||+||+++.         
T Consensus        88 ~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           88 HH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             ET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            77     7899999999989999998765  6899999999999999999999999999999999999987         


Q ss_pred             ----------CCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 017909          169 ----------NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE  238 (364)
Q Consensus       169 ----------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  238 (364)
                                ++.++|+|||.+......   .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...+
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                      668999999998765332   234567999999999987 578999999999999999999999999998


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCch--------------hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCC
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNP--------------KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEP  304 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  304 (364)
                      ..+....+....+..+..........              ........... ............++.+.+||++||+.||
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            88888888887776665433221111              00111100000 0001111223346779999999999999


Q ss_pred             CCCCCHHHHhcCCCccCCC
Q 017909          305 SKRITVTEALQHPYISGLY  323 (364)
Q Consensus       305 ~~Rps~~elL~hp~f~~~~  323 (364)
                      .+|||+.|+|+||||+...
T Consensus       318 ~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          318 AKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             TTSCCHHHHTTSGGGGGGG
T ss_pred             ccccCHHHHhcCHHHHHHh
Confidence            9999999999999998753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.2e-46  Score=338.47  Aligned_cols=263  Identities=22%  Similarity=0.312  Sum_probs=211.1

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      +.......++|++.+.||+|+||+||+|.+  +|..||+|++............+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            344445678999999999999999999976  588999999987665666667888999999999999999999999877


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCCcEEEe
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQS---LSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~~~~L~  175 (364)
                           ...++||||+. |+|.+++...+.   +++..++.++.||+.||.|||++|  ++|+||||+||+++.++.++|+
T Consensus       107 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          107 -----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             -----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             -----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence                 67899999997 599999987553   999999999999999999999999  9999999999999999999999


Q ss_pred             ecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          176 DFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       176 Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      |||++..............|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+....     
T Consensus       182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----  255 (309)
T 3p86_A          182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-----  255 (309)
T ss_dssp             CCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-----
T ss_pred             CCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----
Confidence            99998765444444455678999999999987 578999999999999999999999998877655554442210     


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ--HPYISG  321 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~--hp~f~~  321 (364)
                                              .....+..+++.+.+||++||+.||.+|||+.+|++  .++++.
T Consensus       256 ------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          256 ------------------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ------------------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                    112334578899999999999999999999999997  566655

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-46  Score=354.98  Aligned_cols=261  Identities=33%  Similarity=0.546  Sum_probs=205.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc------hHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN------RIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      +.++|++.+.||+|+||+||+|.++.+++.||+|++......      ......+.+|+.+++.++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            578999999999999999999999999999999998754321      1122245689999999999999999999743 


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---cEEEeec
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDF  177 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~~~L~Df  177 (364)
                           ...++||||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+|||++.++   .++|+||
T Consensus       212 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence                 44789999997 69999888888999999999999999999999999999999999999997654   5999999


Q ss_pred             CccccCCCCCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      |++..... ........|++.|+|||++.+  ...++.++||||||+++|+|++|..||..................   
T Consensus       287 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~---  362 (419)
T 3i6u_A          287 GHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY---  362 (419)
T ss_dssp             STTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC---
T ss_pred             ccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC---
Confidence            99976643 333445678999999999863  346788999999999999999999999875433222222111000   


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                             ......+..+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus       363 -----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          363 -----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             -----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -----------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence                                   0111223568899999999999999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.4e-46  Score=342.21  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=206.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc----
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR----  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  103 (364)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+++.++||||+++++++.+...    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            4579999999999999999999999999999999997543 33355677899999999999999999999865421    


Q ss_pred             ------------------------------------------------cccceEEEEecccc-ccHHHHHHhCCC---CC
Q 017909          104 ------------------------------------------------ISFKDVYLVYELMD-TDLHQIIKSSQS---LS  131 (364)
Q Consensus       104 ------------------------------------------------~~~~~~~lv~e~~~-g~L~~~l~~~~~---~~  131 (364)
                                                                      ......++||||+. ++|.+++.....   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                            01124899999998 599999987643   55


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC------------cccccccccccc
Q 017909          132 NDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE------------QFMTEYVVTRWY  199 (364)
Q Consensus       132 ~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~------------~~~~~~~~~~~~  199 (364)
                      +..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......            .......|++.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            66789999999999999999999999999999999999999999999987664432            122345689999


Q ss_pred             cCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCC
Q 017909          200 RAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGT  279 (364)
Q Consensus       200 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (364)
                      +|||++.+ ..++.++||||||+++|+|++|..|+..     ....+........+                        
T Consensus       243 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~------------------------  292 (332)
T 3qd2_B          243 MSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP------------------------  292 (332)
T ss_dssp             SCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC------------------------
T ss_pred             cChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC------------------------
Confidence            99999987 5789999999999999999998776421     11111111111110                        


Q ss_pred             cccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          280 HISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                         ......++.+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       293 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          293 ---LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               1112345678899999999999999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.9e-46  Score=345.42  Aligned_cols=285  Identities=31%  Similarity=0.513  Sum_probs=224.2

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CC-----Ccceeeeeec
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HD-----NVIALKDVMM   99 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~   99 (364)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||+|+++..   ......+..|+.+++.++ |+     +++++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            34578999999999999999999999999999999999743   223344556778887774 44     4899999988


Q ss_pred             cccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCeEEc--cCCcEE
Q 017909          100 PTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLH--SANILHRDLKPGNLLVN--ANCDLK  173 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~di~~~NIll~--~~~~~~  173 (364)
                      ..     ...++|||+++++|.+++...  +.+++..++.++.|++.||.|||  +.||+|+||||+|||++  .++.++
T Consensus       127 ~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          127 FR-----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             ET-----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             cC-----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            77     789999999999999999865  46999999999999999999999  57899999999999995  477899


Q ss_pred             EeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          174 ICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      |+|||++......   .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.+
T Consensus       202 L~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  277 (382)
T 2vx3_A          202 IVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP  277 (382)
T ss_dssp             ECCCTTCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEeccCceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999766332   334577899999999988 578999999999999999999999999999999999999888877


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCC-------c--c-cc------------------cCCC-------CChHHHHHHHH
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGT-------H--I-SS------------------LYPQ-------ADPLALDLLQK  298 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~--~-~~------------------~~~~-------~~~~l~~li~~  298 (364)
                      +.......  +....++...+...-.       .  . ..                  ...+       .++.+.+||++
T Consensus       278 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          278 PAHILDQA--PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             CHHHHTTC--TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CHHHHHhh--HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            66544322  2222222221110000       0  0 00                  0000       11478999999


Q ss_pred             hcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          299 MLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       299 ~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ||+.||.+|||+.|+|+||||++..+
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred             hcCCChhhCCCHHHHhcCcccccCCC
Confidence            99999999999999999999987643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.6e-46  Score=346.03  Aligned_cols=304  Identities=25%  Similarity=0.388  Sum_probs=226.6

Q ss_pred             cccCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC---
Q 017909           11 MKSRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK---   87 (364)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---   87 (364)
                      |.++|+++....+.+  ..++|++++.||+|+||+||+|.+..+++.||+|++...   ......+.+|+.+++.++   
T Consensus         2 y~~~~~~p~~~~~~~--~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~   76 (373)
T 1q8y_A            2 YRPGGYHPAFKGEPY--KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDAD   76 (373)
T ss_dssp             -----CCCCCTTCEE--TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTC
T ss_pred             CCCCCceeeecCCcc--cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhccc
Confidence            456666666666555  578999999999999999999999999999999999743   233445667888888775   


Q ss_pred             --------CCCcceeeeeeccccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Q 017909           88 --------HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSA-NILH  156 (364)
Q Consensus        88 --------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H  156 (364)
                              ||||+++++++...... ....++|||+++++|.+++...  ..+++..++.++.||+.||.|||++ |++|
T Consensus        77 ~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH  155 (373)
T 1q8y_A           77 NTKEDSMGANHILKLLDHFNHKGPN-GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH  155 (373)
T ss_dssp             CSHHHHHHHTTBCCCCEEEEEEETT-EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred             ccchhccccchHHHHHHHhhccCCC-CceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence                    89999999998765321 1478999999988999999763  4599999999999999999999998 9999


Q ss_pred             cCCCCCCeEEcc------CCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC
Q 017909          157 RDLKPGNLLVNA------NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR  230 (364)
Q Consensus       157 ~di~~~NIll~~------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  230 (364)
                      +||||+||+++.      .+.++|+|||++......   .....++..|+|||++.+ ..++.++||||||+++|+|++|
T Consensus       156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g  231 (373)
T 1q8y_A          156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITG  231 (373)
T ss_dssp             SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhC
Confidence            999999999953      347999999998765332   334567999999999987 5789999999999999999999


Q ss_pred             CCCCCCCC------hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCC-------------CcccccCCCCChH
Q 017909          231 KPIFPGTE------CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRG-------------THISSLYPQADPL  291 (364)
Q Consensus       231 ~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~  291 (364)
                      ..||.+..      .......+....+..+.........  ...++........             .........+++.
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (373)
T 1q8y_A          232 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE  309 (373)
T ss_dssp             SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred             CCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccch--hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence            99998654      4556666777777665543221110  0111000000000             0001122345678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          292 ALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       292 l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                      +.+||.+||+.||.+|||+.|||+||||++.....
T Consensus       310 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred             HHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence            89999999999999999999999999999864443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-46  Score=344.68  Aligned_cols=295  Identities=27%  Similarity=0.466  Sum_probs=228.7

Q ss_pred             CceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCC-cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC---
Q 017909           15 GKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETN-EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN---   90 (364)
Q Consensus        15 ~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~---   90 (364)
                      |...+..++.   +.++|++++.||+|+||+||+|.+..++ ..||+|+++..   ......+.+|+.+++.++|++   
T Consensus         7 ~~~~~~~g~~---~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~   80 (355)
T 2eu9_A            7 GHLVCRIGDW---LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKEN   80 (355)
T ss_dssp             SCBCCCTTCE---ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTS
T ss_pred             CCcccccCce---ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCC
Confidence            3444444443   4899999999999999999999998776 68999999743   233455667888888886655   


Q ss_pred             ---cceeeeeeccccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909           91 ---VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus        91 ---iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                         ++.+.+++...     ...++|||++++++.+.+...  ..+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus        81 ~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIl  155 (355)
T 2eu9_A           81 KFLCVLMSDWFNFH-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL  155 (355)
T ss_dssp             CSCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             ceeEEEeeeeeeeC-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence               88888888776     789999999998998888765  36999999999999999999999999999999999999


Q ss_pred             E-------------------ccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHH
Q 017909          166 V-------------------NANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE  226 (364)
Q Consensus       166 l-------------------~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~  226 (364)
                      +                   +.++.++|+|||++......   .....|+..|+|||++.+ ..++.++||||||+++|+
T Consensus       156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFE  231 (355)
T ss_dssp             ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHH
T ss_pred             EecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHH
Confidence            9                   56789999999998764332   234578999999999987 578999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh--------------HHHHHhhCCCCCCCcccccCCCCChHH
Q 017909          227 ILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK--------------ARRFIKSLPYSRGTHISSLYPQADPLA  292 (364)
Q Consensus       227 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (364)
                      |++|..||.+.........+....+..+...........              ...+....... ...........++.+
T Consensus       232 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  310 (355)
T 2eu9_A          232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQL  310 (355)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHH
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHH
Confidence            999999999998888888888877776654332211110              00010000000 000011112235678


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          293 LDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       293 ~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      .+||++||+.||.+|||+.|+|+||||++....
T Consensus       311 ~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          311 FDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence            999999999999999999999999999987543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.7e-48  Score=358.38  Aligned_cols=258  Identities=17%  Similarity=0.174  Sum_probs=202.7

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHH---HHHHhcCCCCcceeeeee---
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLREL---VLLRHIKHDNVIALKDVM---   98 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~---   98 (364)
                      ....++|++.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|+   ..++.++||||+++++.+   
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            3446899999999999999999999999999999999975422 333556677898   455555899999998443   


Q ss_pred             ----ccccc---------cc---cceEEEEeccccccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcc
Q 017909           99 ----MPTHR---------IS---FKDVYLVYELMDTDLHQIIKSSQSLSN-------DHCKYFVFQLLRGLKYLHSANIL  155 (364)
Q Consensus        99 ----~~~~~---------~~---~~~~~lv~e~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~lH~~~i~  155 (364)
                          .....         ..   ....++||||++|+|.+++...+.+++       ..++.++.||+.||.|||++||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence                32210         00   013789999999999999987655555       88888999999999999999999


Q ss_pred             ccCCCCCCeEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccc----------cCCCChhhHHHHHHHHH
Q 017909          156 HRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC----------DNYGTSIDVWSVGCIFA  225 (364)
Q Consensus       156 H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~  225 (364)
                      |+||||+|||++.++.++|+|||++.....   ......| ..|+|||++.+.          ..++.++|||||||++|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999999999999999999875422   3344566 899999999873          26899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCC
Q 017909          226 EILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPS  305 (364)
Q Consensus       226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  305 (364)
                      +|++|..||.+.......                                   .........+++.+.+||.+||+.||.
T Consensus       305 elltg~~Pf~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~  349 (377)
T 3byv_A          305 WIWCADLPITKDAALGGS-----------------------------------EWIFRSCKNIPQPVRALLEGFLRYPKE  349 (377)
T ss_dssp             HHHHSSCCC------CCS-----------------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHCCCCCcccccccch-----------------------------------hhhhhhccCCCHHHHHHHHHHcCCCch
Confidence            999999999654321110                                   011112357889999999999999999


Q ss_pred             CCCCHHHHhcCCCccCC
Q 017909          306 KRITVTEALQHPYISGL  322 (364)
Q Consensus       306 ~Rps~~elL~hp~f~~~  322 (364)
                      +|||+.|+|+||||+++
T Consensus       350 ~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          350 DRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             GCCCHHHHHTSHHHHHH
T ss_pred             hCCCHHHHhhChHHHHH
Confidence            99999999999999764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-46  Score=340.16  Aligned_cols=263  Identities=33%  Similarity=0.545  Sum_probs=211.0

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh------chHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE------NRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....      .......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            367899999999999999999999999999999999875422      11223346789999999999999999999854


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc---EEEee
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICD  176 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~---~~L~D  176 (364)
                      .      ..++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.   ++|+|
T Consensus        87 ~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           87 E------DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S------SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             C------ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4      3799999997 599999988889999999999999999999999999999999999999987664   99999


Q ss_pred             cCccccCCCCCcccccccccccccCCcccc--cccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      ||++...... .......|+..|+|||++.  +...++.++||||||+++|+|++|..||..................  
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--  237 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--  237 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC--
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc--
Confidence            9998766332 2234456799999999985  2356889999999999999999999999765433222221111000  


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                              ......+..+++.+.+||++||+.||.+|||+.++|+||||+..
T Consensus       238 ------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 ------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             ------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ------------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                                    00111234678899999999999999999999999999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=336.38  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=212.6

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|.+....    ....+.+|+.+++.++||||+++++++...    
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   96 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN----   96 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC----
Confidence            446889999999999999999999999999999999997532    234567899999999999999999999876    


Q ss_pred             cceEEEEecccc-ccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIK-SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||++ ++|.+++. ....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        97 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           97 -TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             -TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence             78899999998 59999986 4568999999999999999999999999999999999999999999999999999766


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+......           
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  243 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-----------  243 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------
T ss_pred             hhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-----------
Confidence            554444455678999999999977 57899999999999999999999999877654443332211000           


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                       .......+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       244 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 -----------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             -----------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             -----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                             0011234688899999999999999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.8e-46  Score=347.88  Aligned_cols=260  Identities=28%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             ecccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHH-hcCCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR-HIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+.++|.+. +.||+|+||+||+|.++.+|+.||+|+++..       ....+|+.++. ..+||||+++++++..... 
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc-
Confidence            355677777 7999999999999999999999999998632       23456777764 4489999999999865211 


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEEEeecC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFG  178 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~L~Dfg  178 (364)
                      ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+|+||||+|||++.   ++.++|+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            1167899999997 59999998753  5999999999999999999999999999999999999988   7889999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCc
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN----QLKLIISVFGTQQ  254 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~  254 (364)
                      ++...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....    ....+...     
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-----  282 (400)
T 1nxk_A          210 FAKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----  282 (400)
T ss_dssp             TCEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----
T ss_pred             cccccCCC-CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-----
Confidence            99765332 23445678999999999876 678999999999999999999999997754321    11111110     


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                         .   .......+..+++.+.+||++||+.||.+|||+.|+|+||||....
T Consensus       283 -------------------~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          283 -------------------Q---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             -------------------C---CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             -------------------c---ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                               0   0001122356899999999999999999999999999999998743

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-47  Score=348.75  Aligned_cols=283  Identities=21%  Similarity=0.340  Sum_probs=219.9

Q ss_pred             cceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (364)
                      ++|++.+.||+|+||+||+|++.   .+++.||+|+++....  .......+.+|+.+++.+ +||||+++++++...  
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  131 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--  131 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence            79999999999999999999984   5789999999875322  112223345688999999 699999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++..
T Consensus       132 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ---ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence               78999999997 59999998888999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCC-CcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGN-EQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .... ........|+..|+|||++.+. ..++.++|||||||++|+|++|..||...........+....          
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----------  278 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----------  278 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----------
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH----------
Confidence            4322 2223345789999999999752 347899999999999999999999997653322222221110          


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCC-CCCCCCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDP-QCNPPAQVP  334 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~-~~~~~~~~~  334 (364)
                               ..        .....+..+++.+.+||++||+.||.+||     +++++++||||++.... -.....+.|
T Consensus       279 ---------~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p  341 (355)
T 1vzo_A          279 ---------LK--------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP  341 (355)
T ss_dssp             ---------HH--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             ---------hc--------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCC
Confidence                     00        01223456888999999999999999999     99999999999986422 222334445


Q ss_pred             CCcccchhhh
Q 017909          335 LSLDIDENIG  344 (364)
Q Consensus       335 ~~~~~~~~~~  344 (364)
                      ....+.+..+
T Consensus       342 ~~p~~~~~~d  351 (355)
T 1vzo_A          342 FKPVIRDELD  351 (355)
T ss_dssp             CCCCCCC-CC
T ss_pred             CCCccccccc
Confidence            5554544433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-45  Score=332.16  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=222.2

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .....++|++++.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++...   
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   92 (303)
T 3a7i_A           17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD---   92 (303)
T ss_dssp             EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            455788999999999999999999999999999999999754332 2345677899999999999999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||++ ++|.+++.. +++++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        93 --~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           93 --TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             --TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             --CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceec
Confidence              78999999998 588888765 67999999999999999999999999999999999999999999999999999776


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...........++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+...              
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------  234 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--------------  234 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--------------
T ss_pred             CccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--------------
Confidence            554444455678999999999977 57899999999999999999999999877655444333221              


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                      ........++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus       235 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          235 ----------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ----------------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ----------------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                            0122335678899999999999999999999999999999763

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=336.31  Aligned_cols=269  Identities=22%  Similarity=0.376  Sum_probs=213.2

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      ...+....++|++++.||+|+||.||+|.+..+|+.||+|++.....   ....+.+|+.+++.+ +||||+++++++..
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            44556678999999999999999999999999999999999865322   234567899999998 79999999999976


Q ss_pred             ccccc-cceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          101 THRIS-FKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       101 ~~~~~-~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      ..... ....++||||++ ++|.+++...  ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence            43211 267899999998 5999999764  5799999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          177 FGLARTSRGNEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      ||++..............++..|+|||++..    ...++.++||||||+++|+|++|..||.+.........+....  
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--  250 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--  250 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--
Confidence            9998765443333445578999999999863    2468899999999999999999999998776554443332210  


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                                 ........+++.+.+||++||+.||.+|||+.++|+||||+..
T Consensus       251 ---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 ---------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ---------------------------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ---------------------------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                       0011234678899999999999999999999999999999863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-45  Score=332.32  Aligned_cols=267  Identities=25%  Similarity=0.338  Sum_probs=216.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +.++|++++.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----
Confidence            58899999999999999999999999999999999865433 334456778999999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++||||++ ++|.+++...+++++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            78999999997 59999999888999999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .. .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.............  ..+          
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~----------  230 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVP----------  230 (294)
T ss_dssp             -----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCC----------
T ss_pred             ccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCC----------
Confidence            32 22334568999999999987 57899999999999999999999999887655443332211  000          


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                    .......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-.....
T Consensus       231 --------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          231 --------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             --------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             --------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence                          011223457889999999999999999999666667777766554443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-46  Score=337.45  Aligned_cols=271  Identities=24%  Similarity=0.369  Sum_probs=196.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...     .
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   86 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D   86 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence            47899999999999999999999998999999999875432 22345667899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          108 DVYLVYELMD-TDLHQIIKS--------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      ..++||||+. ++|.+++..        .+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            7899999997 699998863        4569999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC-----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          179 LARTSRGNE-----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       179 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      .+.......     .......+++.|+|||++.+...++.++||||||+++|+|++|..||..............   ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~  243 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---ND  243 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT---SS
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc---cC
Confidence            886553321     1123456788999999987655789999999999999999999999988765544332221   11


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ....                  ............+++.+.+||.+||+.||.+|||+.++++||||+.....
T Consensus       244 ~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          244 PPSL------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCCT------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CCcc------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            0000                  00011123345788999999999999999999999999999999886543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6e-46  Score=343.85  Aligned_cols=282  Identities=22%  Similarity=0.344  Sum_probs=219.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++...     .
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  104 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----G  104 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----T
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----C
Confidence            5789999999999999999999999999999999997642 344556778999999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||++ ++|.+++...+.+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            8999999997 59999999888999999999999999999999996 999999999999999999999999998864322


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh-hc----
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL-EF----  260 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~----  260 (364)
                      .  ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||...........+............ ..    
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c--cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1  1234567899999999987 57899999999999999999999999987655543332211111110000 00    


Q ss_pred             -------------cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          261 -------------IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       261 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                   ..............     ........++..+.+||++||+.||.+|||++|+|+||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEP-----PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSC-----CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccC-----CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                         00000000110000     01111234788999999999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.8e-46  Score=337.29  Aligned_cols=272  Identities=21%  Similarity=0.326  Sum_probs=199.3

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ......++|++++.||+|+||+||+|.+..++.   .||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            344567899999999999999999999887765   89999998766566677788899999999999999999999877


Q ss_pred             ccccc-cceEEEEecccc-ccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcE
Q 017909          101 THRIS-FKDVYLVYELMD-TDLHQIIKSSQ------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus       101 ~~~~~-~~~~~lv~e~~~-g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~  172 (364)
                      ....+ ....++||||+. |+|.+++....      .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            63221 123499999998 59999886432      69999999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017909          173 KICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~  249 (364)
                      +|+|||.+.......  .......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999987653322  12223445678999999987 578999999999999999999 99999988766655544321


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-------HHHHhcCCCccCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-------VTEALQHPYISGL  322 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~elL~hp~f~~~  322 (364)
                                                    ......+.+++.+.+||.+||+.||.+|||       ++++++|||+...
T Consensus       256 ------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          256 ------------------------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             ------------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             ------------------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                                          112233568889999999999999999999       8899999999886


Q ss_pred             CCCC
Q 017909          323 YDPQ  326 (364)
Q Consensus       323 ~~~~  326 (364)
                      ....
T Consensus       306 ~~~p  309 (323)
T 3qup_A          306 SQDP  309 (323)
T ss_dssp             ----
T ss_pred             CCCC
Confidence            4443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=339.72  Aligned_cols=283  Identities=20%  Similarity=0.313  Sum_probs=213.9

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..++++|++++.||+|+||+||+|.+..+++.||+|+++...... ....+.+|+.+++.++||||+++++++.....  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   81 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--   81 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCC--
Confidence            346899999999999999999999999999999999997543322 24456789999999999999999999876632  


Q ss_pred             cceEEEEecccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE----ccCCcEEEeec
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDF  177 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll----~~~~~~~L~Df  177 (364)
                       ...++||||++ ++|.+++....   .+++..++.++.||+.||.|||++|++|+||||+||++    +.++.++|+||
T Consensus        82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           82 -RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             -ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence             47899999997 69999997643   39999999999999999999999999999999999999    77788999999


Q ss_pred             CccccCCCCCcccccccccccccCCccccc-------ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLC-------CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQ-LKLIISV  249 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~i~~~  249 (364)
                      |++....... ......|+..|+|||++..       ...++.++|||||||++|+|++|..||........ ...+...
T Consensus       161 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          161 GAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            9997664433 2344578999999999863       25789999999999999999999999975443221 2222222


Q ss_pred             hCCCchhhhhccCchhHH--HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          250 FGTQQEADLEFIDNPKAR--RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                      ....+...+.........  .|....     .........+++.+.+||++||+.||.+|||++|+|+||-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDM-----PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSC-----CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccC-----CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            222221111111000000  000000     0011223345667889999999999999999999999973

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.7e-45  Score=330.82  Aligned_cols=269  Identities=26%  Similarity=0.360  Sum_probs=213.7

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC--CCCcceeeeeec
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK--HDNVIALKDVMM   99 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~   99 (364)
                      .+.+....++|++++.||+|+||.||++.+. +++.||+|++............+.+|+.+++.++  |+||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            4555667889999999999999999999886 4889999999766556666677889999999997  599999999998


Q ss_pred             cccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          100 PTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                      ..     ...++|||+.+++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++. +.++|+|||+
T Consensus        99 ~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccc
Confidence            77     78999999777899999999889999999999999999999999999999999999999964 7999999999


Q ss_pred             cccCCCCCc--ccccccccccccCCcccccc----------cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017909          180 ARTSRGNEQ--FMTEYVVTRWYRAPELLLCC----------DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII  247 (364)
Q Consensus       180 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~  247 (364)
                      +........  ......|+..|+|||.+.+.          ..++.++||||||+++|+|++|..||.........  +.
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~  250 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--LH  250 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--HH
Confidence            876533221  22345679999999998651          36788999999999999999999999765432211  11


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      .....                          ......+...+..+.+||++||+.||.+|||+.|+|+||||+....+
T Consensus       251 ~~~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          251 AIIDP--------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             HHHCT--------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             HHHhc--------------------------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            11100                          00112234567889999999999999999999999999999875433

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8e-45  Score=327.69  Aligned_cols=263  Identities=26%  Similarity=0.379  Sum_probs=204.8

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc---
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR---  103 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---  103 (364)
                      .+.++|++++.||+|+||+||+|++..+++.||+|++..   .......+.+|+.+++.++||||+++++++.....   
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            357899999999999999999999999999999999964   23345667889999999999999999998865321   


Q ss_pred             -----cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          104 -----ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       104 -----~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                           ......++||||++ ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                 11267899999997 5999999854 4688999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCC--------------CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-H
Q 017909          177 FGLARTSRGN--------------EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-N  241 (364)
Q Consensus       177 fg~~~~~~~~--------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~  241 (364)
                      ||.+......              ........++..|+|||++.+...++.++||||||+++|+|++   ||...... .
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998755321              1123345678899999999875578999999999999999998   44332111 1


Q ss_pred             HHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          242 QLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ....+...                           ............++.+.++|++||+.||.+|||+.++|+||||+.
T Consensus       237 ~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          237 ILKKLRSV---------------------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHST---------------------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHhcccc---------------------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            11111100                           000112233566778999999999999999999999999999976


Q ss_pred             C
Q 017909          322 L  322 (364)
Q Consensus       322 ~  322 (364)
                      .
T Consensus       290 ~  290 (303)
T 1zy4_A          290 K  290 (303)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=336.36  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhc----CCCCcce
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHI----KHDNVIA   93 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~iv~   93 (364)
                      ......+.++|++++.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.+    +||||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            3444567899999999999999999999999999999999997543322    1222334688999888    8999999


Q ss_pred             eeeeeccccccccceEEEEecc-cc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc-cCC
Q 017909           94 LKDVMMPTHRISFKDVYLVYEL-MD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANC  170 (364)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~-~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~-~~~  170 (364)
                      +++++...     ...++|+|+ +. ++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++ .++
T Consensus       103 ~~~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          103 LLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT
T ss_pred             EEEEEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC
Confidence            99999877     678999998 55 69999999888899999999999999999999999999999999999999 789


Q ss_pred             cEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017909          171 DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVF  250 (364)
Q Consensus       171 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (364)
                      .++|+|||.+.......  .....++..|+|||++.+....+.++||||||+++|+|++|..||....      .+..  
T Consensus       178 ~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~--  247 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE--  247 (312)
T ss_dssp             EEEECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--
T ss_pred             eEEEEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh--
Confidence            99999999987654332  3445678999999998774445669999999999999999999996531      1111  


Q ss_pred             CCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                                                   ........+++.+.+||.+||+.||.+|||++|+|+||||+.......
T Consensus       248 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~  295 (312)
T 2iwi_A          248 -----------------------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP  295 (312)
T ss_dssp             -----------------------------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred             -----------------------------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence                                         001233568899999999999999999999999999999998655433

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=328.44  Aligned_cols=263  Identities=19%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..--++|++++.||+|+||+||+|.++.+|+.||+|++............+.++..+++.++||||+++++++...    
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----   96 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN----   96 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC----
Confidence            3345799999999999999999999999999999999976544333334444555677888999999999999877    


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||+++.+..+... ...+++..++.++.||+.||.|||++ |++|+||+|+||+++.++.++|+|||.+...
T Consensus        97 -~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 -TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             -SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             -CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence             78999999997666666654 56799999999999999999999996 9999999999999999999999999998655


Q ss_pred             CCCCcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhh
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-LNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  258 (364)
                      ... .......++..|+|||++..    ...++.++||||||+++|+|++|..||..... ......+...   ..    
T Consensus       176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~----  247 (318)
T 2dyl_A          176 VDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE---EP----  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS---CC----
T ss_pred             cCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc---CC----
Confidence            332 22334567899999999852    34688999999999999999999999987433 3333333221   00    


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                           ........+++.+.+||.+||+.||.+|||+++||+||||+..
T Consensus       248 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          248 ---------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             ---------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             ---------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence                                 0011123578999999999999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.3e-45  Score=333.04  Aligned_cols=265  Identities=23%  Similarity=0.387  Sum_probs=192.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHH-HHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELV-LLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|.++.+|+.||+|+++..... .....+..|+. +++.++||||+++++++...     
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----   93 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----   93 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----
Confidence            468999999999999999999999999999999999754332 23344445555 67777999999999999877     


Q ss_pred             ceEEEEeccccccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          107 KDVYLVYELMDTDLHQIIKS-----SQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                      ...++||||++++|.+++..     ...+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            78899999999998888763     56799999999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccCCcccc---cccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLL---CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      ....... ......|+..|+|||++.   ....++.++||||||+++|+|++|..||.+......  .+...        
T Consensus       174 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~--------  242 (327)
T 3aln_A          174 GQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV--------  242 (327)
T ss_dssp             CC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC--------
T ss_pred             eeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH--------
Confidence            7653322 233346889999999984   224689999999999999999999999976432100  00000        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                     ...............+++.+.+||++||+.||.+|||+.+|++||||.....
T Consensus       243 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          243 ---------------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             ---------------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ---------------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                           0000001111223468899999999999999999999999999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-45  Score=338.46  Aligned_cols=274  Identities=20%  Similarity=0.317  Sum_probs=215.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH---------------HHHHHHHHHHHHHhcCCCCcc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI---------------DALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      ..++|++++.||+|+||+||+|.+  +|+.||+|++........               ....+.+|+.+++.++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            468999999999999999999988  899999999975433321               115677899999999999999


Q ss_pred             eeeeeeccccccccceEEEEeccccc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCC
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMDT-DLHQI------IKS--SQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPG  162 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~  162 (364)
                      ++++++...     ...++||||+++ +|.++      +..  ...+++..++.++.||+.||.+||+ +|++|+||+|+
T Consensus       107 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          107 TCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             eEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            999999887     789999999985 99887      655  5679999999999999999999999 99999999999


Q ss_pred             CeEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCh-H
Q 017909          163 NLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGT-SIDVWSVGCIFAEILGRKPIFPGTEC-L  240 (364)
Q Consensus       163 NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~-~  240 (364)
                      ||+++.++.++|+|||.+......  ......++..|+|||++.+...++. ++||||||+++|+|++|..||..... .
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999998765333  3445678999999999987435555 99999999999999999999988765 4


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      .....+.......+......         .   ..............+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHF---------L---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSS---------T---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHhccCcCCccchhhh---------h---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            44333322111111000000         0   00000011122356899999999999999999999999999999998


Q ss_pred             CC
Q 017909          321 GL  322 (364)
Q Consensus       321 ~~  322 (364)
                      +.
T Consensus       328 ~~  329 (348)
T 2pml_X          328 DT  329 (348)
T ss_dssp             TC
T ss_pred             CC
Confidence            74

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-45  Score=337.00  Aligned_cols=266  Identities=24%  Similarity=0.362  Sum_probs=186.7

Q ss_pred             eecccceeeee-eeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIK-PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~-~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+.++|++.+ .||+|+||+||+|.++.+|+.||+|++....   ...   .+....++.++|||++++++++......
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KAR---QEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHH---HHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            45789999965 6999999999999999999999999986421   111   1233345667999999999998763221


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEEEeecC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFG  178 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~L~Dfg  178 (364)
                       ....++||||+. |+|.+++...+  .+++..++.++.||+.||.|||++|++|+||+|+||+++.   ++.++|+|||
T Consensus        98 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           98 -KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             -EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             -CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             156899999997 59999998753  6999999999999999999999999999999999999976   4459999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ++......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+......      
T Consensus       177 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  247 (336)
T 3fhr_A          177 FAKETTQN--ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------  247 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             cceecccc--ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------
Confidence            98765332  2334567899999999866 56889999999999999999999999766433222111110000      


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                       .........+..+++.+.+||++||+.||.+|||+.|+|+||||+....
T Consensus       248 -----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          248 -----------------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             --------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             -----------------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence                             0001112233568999999999999999999999999999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=323.63  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|.....||+|+||+||+|.+..++..|++|.+...  .......+.+|+.+++.++||||+++++++...     ...
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   94 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFI   94 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcE
Confidence            3455556999999999999999999999999998754  233445677899999999999999999999877     788


Q ss_pred             EEEecccc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-CCcEEEeecCccccCC
Q 017909          110 YLVYELMD-TDLHQIIKSS---QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSR  184 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-~~~~~L~Dfg~~~~~~  184 (364)
                      ++|||+++ ++|.+++...   ..+++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||.+....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999997 6999998765   24679999999999999999999999999999999999987 8899999999987664


Q ss_pred             CCCcccccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ..........++..|+|||++.+. ..++.++||||||+++|+|++|..||................             
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------  241 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-------------  241 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-------------
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-------------
Confidence            443334456788999999998763 237899999999999999999999997643322211111000             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                     ......+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       242 ---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          242 ---------------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             ---------------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             ---------------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                           011223456889999999999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-45  Score=336.17  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=214.2

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcC--CCCcceee
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIK--HDNVIALK   95 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~   95 (364)
                      ......+.++|++++.||+|+||+||+|.+..+++.||+|++.......    .....+.+|+.+++.++  |+|+++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            3444557999999999999999999999999999999999997543322    11233456889999996  59999999


Q ss_pred             eeeccccccccceEEEEecccc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc-cCCcE
Q 017909           96 DVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDL  172 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~-~~~~~  172 (364)
                      +++...     ...++|+|++.  ++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.+
T Consensus       115 ~~~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          115 DWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence            999877     78899999996  69999999888999999999999999999999999999999999999999 77899


Q ss_pred             EEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          173 KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      +|+|||++......  ......|+..|+|||++.+....+.++||||||+++|+|++|..||....      .+..    
T Consensus       190 kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~----  257 (320)
T 3a99_A          190 KLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR----  257 (320)
T ss_dssp             EECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----
T ss_pred             EEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc----
Confidence            99999998765432  23345689999999999875445789999999999999999999996531      0100    


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                                                 ........+++.+.+||++||+.||.+|||+++|++||||+....+
T Consensus       258 ---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          258 ---------------------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             ---------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ---------------------------ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence                                       0011234688999999999999999999999999999999986543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.2e-45  Score=340.36  Aligned_cols=270  Identities=15%  Similarity=0.133  Sum_probs=194.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhc--CCCCcceeeeeec-----
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHI--KHDNVIALKDVMM-----   99 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~-----   99 (364)
                      ....|++.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+++.+  +|||+++++..+.     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            34569999999999999999999999999999999987544 333444556675444444  6999888654332     


Q ss_pred             --ccccc------------ccceEEEEeccccccHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHCCccccC
Q 017909          100 --PTHRI------------SFKDVYLVYELMDTDLHQIIKSS-QSLSNDHC------KYFVFQLLRGLKYLHSANILHRD  158 (364)
Q Consensus       100 --~~~~~------------~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~lH~~~i~H~d  158 (364)
                        .....            .....++||||++|+|.+++... ..+.....      ..++.||+.||.|||++||+|+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence              22110            01448999999999999999763 34555555      67779999999999999999999


Q ss_pred             CCCCCeEEccCCcEEEeecCccccCCCCCcccccccccccccCCccccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 017909          159 LKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAEILGRKPIFPGT  237 (364)
Q Consensus       159 i~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  237 (364)
                      |||+|||++.++.++|+|||++......   .....+++.|+|||++.+ ...++.++|||||||++|+|++|..||.+.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999999999865322   224455699999999965 236899999999999999999999999775


Q ss_pred             ChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                      ......             .+...   .      ..............+.+++.+.+||.+||+.||.+|||+.++|+||
T Consensus       297 ~~~~~~-------------~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          297 TPGIKG-------------SWKRP---S------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             CTTCTT-------------CCCBC---C------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             Cccccc-------------chhhh---h------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            321000             00000   0      0000011111222357899999999999999999999999999999


Q ss_pred             CccCC
Q 017909          318 YISGL  322 (364)
Q Consensus       318 ~f~~~  322 (364)
                      ||++.
T Consensus       355 ~f~~~  359 (371)
T 3q60_A          355 EFLQL  359 (371)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-44  Score=333.66  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=210.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEec-------cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeec
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR-------ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMM   99 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   99 (364)
                      ..++|++++.||+|+||+||+|.+.       .++..||+|+++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            3579999999999999999999864       34567999999764 3344566788999999999 8999999999998


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPG  162 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~  162 (364)
                      ..     ...++||||+. |+|.+++...+                .+++..++.++.||+.||.|||++|++|+||||+
T Consensus       158 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          158 QD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             SS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             cC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            77     77899999997 59999997643                4799999999999999999999999999999999


Q ss_pred             CeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017909          163 NLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTEC  239 (364)
Q Consensus       163 NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~  239 (364)
                      |||++.++.++|+|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999976543222  2233455778999999987 579999999999999999998 9999988765


Q ss_pred             HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+....+...                              .....+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus       312 ~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEG------------------------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTT------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5554433221                              1122335688899999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=339.58  Aligned_cols=260  Identities=21%  Similarity=0.287  Sum_probs=213.0

Q ss_pred             cccceeeeeeeccCCceeEEEEE-----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSI-----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..++|++++.||+|+||+||+|+     +..++..||+|+++.. ........+.+|+.+++.++||||+++++++... 
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  146 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-  146 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence            46899999999999999999999     4456788999999743 2344555678899999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC---c
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS-------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC---D  171 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~---~  171 (364)
                          ...++||||+. |+|.+++...       ..+++..++.++.||+.||.|||++|++||||||+|||++.++   .
T Consensus       147 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          147 ----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             ----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence                67799999996 6999999764       3589999999999999999999999999999999999999555   5


Q ss_pred             EEEeecCccccCCC--CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017909          172 LKICDFGLARTSRG--NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  248 (364)
                      ++|+|||++.....  .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999864321  1122334456889999999987 579999999999999999997 9999998876665555432


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ..                              .......+++.+.+||++||+.||.+|||+.+|+++.++..-..
T Consensus       302 ~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          302 GG------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             TC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CC------------------------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11                              11223467889999999999999999999999999988755433

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=324.45  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=210.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----Ce
Confidence            67999999999999999999999999999999988542  444566778999999999999999999999877     78


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++||||+. ++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999997 599999987 567999999999999999999999999999999999999999999999999998765332


Q ss_pred             Cccc--------------ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          187 EQFM--------------TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       187 ~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      ....              ....|++.|+|||++.+ ..++.++||||||+++|+|++|..||.........         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---------  231 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---------  231 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---------
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---------
Confidence            2211              14568999999999987 67899999999999999999999998654211000         


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                               ..........          ...++.+++.+.++|.+||+.||.+|||+.+|++  |+..+
T Consensus       232 ---------~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          232 ---------FGLNVRGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             ---------SSBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ---------Hhhhhhcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence                     0000011111          1123568889999999999999999999999996  66654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=327.84  Aligned_cols=251  Identities=21%  Similarity=0.303  Sum_probs=209.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..++|++.+.||+|+||+||+|.+..++.   .||+|+++... .......+.+|+.+++.++||||+++++++...   
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG---  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG---
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence            57899999999999999999999986555   49999997542 344556778999999999999999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++||||++ ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus       123 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          123 --RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             --GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             --CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence              77899999997 5999999754 5799999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          183 SRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       183 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ......   ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+....        
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------  271 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--------  271 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------
Confidence            543322   1223344668999999977 578999999999999999998 999998887766655543211        


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                            .......+++.+.+||.+||+.||.+|||+.+|++
T Consensus       272 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          272 ----------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                  11233568899999999999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.7e-44  Score=326.71  Aligned_cols=252  Identities=20%  Similarity=0.185  Sum_probs=206.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++......    ..+.+|+.+++.+ +||||+++++++...    
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----   77 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG----   77 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEET----
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecC----
Confidence            4689999999999999999999999999999999998654222    2456799999999 899999999999877    


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc-----EEEeecCc
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-----LKICDFGL  179 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~-----~~L~Dfg~  179 (364)
                       ...++|||+++++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.     ++|+|||+
T Consensus        78 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           78 -KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             -CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence             78899999998899999986 468999999999999999999999999999999999999998887     99999999


Q ss_pred             cccCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHH
Q 017909          180 ARTSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLK---LIISV  249 (364)
Q Consensus       180 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~---~i~~~  249 (364)
                      +........       ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+........   .+...
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            976533222       1245678999999999988 678999999999999999999999998864433332   22211


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ....+..                          .....++ .+.++|..||+.||.+||++++|++
T Consensus       236 ~~~~~~~--------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          236 KRATPIE--------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHSCHH--------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCCHH--------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1000000                          0012234 8999999999999999999998876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-44  Score=332.34  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             cccceeeeeeeccCCceeEEEEE-----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSI-----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (364)
                      ..++|++++.||+|+||+||+|.     +..+++.||+|+++.. ........+.+|+.++..+ +||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            47899999999999999999998     5567789999999754 2333456778999999999 789999999998775


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCCC---------------------------------------------------
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQS---------------------------------------------------  129 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---------------------------------------------------  129 (364)
                      .    ...++||||+. |+|.+++.....                                                   
T Consensus        99 ~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           99 G----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             T----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             C----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            3    45799999998 599999976532                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC--ccccc
Q 017909          130 ---------------LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTE  192 (364)
Q Consensus       130 ---------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~--~~~~~  192 (364)
                                     +++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......  .....
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           8999999999999999999999999999999999999999999999999997553322  22344


Q ss_pred             ccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHh
Q 017909          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIK  271 (364)
Q Consensus       193 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (364)
                      ..++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+..............                     
T Consensus       255 ~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---------------------  312 (359)
T 3vhe_A          255 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---------------------  312 (359)
T ss_dssp             CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT---------------------
T ss_pred             cCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC---------------------
Confidence            567888999999987 678999999999999999998 999998876544443332211                     


Q ss_pred             hCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          272 SLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                              .....+..+++.+.++|.+||+.||.+|||+.||++|
T Consensus       313 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          313 --------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                    0122234578899999999999999999999999976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-44  Score=316.65  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=208.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|++++.||+|+||+||+|.+. ++..||+|++.......   ..+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~   78 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A   78 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecC-----C
Confidence            3579999999999999999999986 46789999997543332   4577899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||++ ++|.+++... +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            7899999997 5999998654 5699999999999999999999999999999999999999999999999999875533


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. .......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+....             
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-------------  224 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------------  224 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------------
T ss_pred             cccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-------------
Confidence            21 12233445678999999977 578999999999999999999 999998877666555543211             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                       ....+...++.+.++|.+||+.||.+|||+.++++|
T Consensus       225 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          225 -----------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                             111234578899999999999999999999999975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-43  Score=318.76  Aligned_cols=254  Identities=16%  Similarity=0.170  Sum_probs=208.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (364)
                      ..+.++|++++.||+|++|+||+|.+..+|+.||+|++......    ..+.+|+.+++.+ +|++++++++++...   
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~---   78 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG---   78 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET---
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCC---
Confidence            34689999999999999999999999999999999998643322    2355788999999 799999999998766   


Q ss_pred             ccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc-----EEEeecC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-----LKICDFG  178 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~-----~~L~Dfg  178 (364)
                        ...++|||+++++|.+++... +++++..++.++.||+.||.|||++|++|+||+|+||+++.++.     ++|+|||
T Consensus        79 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           79 --LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             --ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence              788999999988999999865 46999999999999999999999999999999999999987776     9999999


Q ss_pred             ccccCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHH
Q 017909          179 LARTSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN---QLKLIIS  248 (364)
Q Consensus       179 ~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~i~~  248 (364)
                      ++........       ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.....   ....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            9976543322       2345568999999999977 578999999999999999999999998854332   2222222


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .....+                          .....+.+++.+.++|.+||+.||.+|||+++|++
T Consensus       236 ~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          236 KKQSTP--------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHSC--------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCcc--------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            111010                          11123468899999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.3e-44  Score=316.26  Aligned_cols=249  Identities=20%  Similarity=0.268  Sum_probs=208.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|.++ ++..||+|+++.....   ...+.+|+.+++.++||||+++++++...     .
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~   76 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----Y   76 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence            4689999999999999999999776 4667999999764333   24567899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||++ ++|.+++... +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            7899999997 6899998765 4599999999999999999999999999999999999999999999999999876544


Q ss_pred             CCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------  222 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-------------  222 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------------
T ss_pred             hhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-------------
Confidence            322 2233445667999999977 568999999999999999998 999998877665554443211             


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                       ....+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       223 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          223 -----------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             111224568889999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=329.78  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=211.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEecc-------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeec
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRE-------TNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMM   99 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   99 (364)
                      ..++|++++.||+|+||+||+|.+..       .+..||+|+++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            46899999999999999999998653       3357999999754 3344556778999999999 8999999999998


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPG  162 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~  162 (364)
                      ..     ...++||||+. |+|.+++....                .+++..++.++.||+.||.|||++|++|+||||+
T Consensus       146 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          146 QD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             SS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             cC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            77     77899999997 59999998653                4999999999999999999999999999999999


Q ss_pred             CeEEccCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017909          163 NLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTEC  239 (364)
Q Consensus       163 NIll~~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~  239 (364)
                      ||+++.++.++|+|||++.......  .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999997654322  22334456788999999987 678999999999999999998 9999988776


Q ss_pred             HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+....+....                              .......+++.+.+||++||+.||.+|||+.+|+++
T Consensus       300 ~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 EELFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTTC------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            65554443210                              112235688999999999999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-43  Score=322.50  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=210.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..++|++++.||+|+||.||+|.+.     .++..||+|+++.. ........+.+|+.+++.++||||+++++++... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-
Confidence            4689999999999999999999873     45588999999754 2344556778999999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQS------------------------LSNDHCKYFVFQLLRGLKYLHSANILHR  157 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~  157 (364)
                          ...++||||+. ++|.+++...+.                        +++..++.++.||+.||.|||++|++|+
T Consensus        99 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           99 ----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence                77899999998 699999976543                        8999999999999999999999999999


Q ss_pred             CCCCCCeEEccCCcEEEeecCccccCCCCCcc--cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCC
Q 017909          158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIF  234 (364)
Q Consensus       158 di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf  234 (364)
                      ||||+||+++.++.++|+|||++.........  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999998765433222  233455778999999987 578999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          235 PGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      .+.........+...                              .....+..+++.+.++|.+||+.||.+|||+.+|+
T Consensus       254 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~  303 (314)
T 2ivs_A          254 PGIPPERLFNLLKTG------------------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS  303 (314)
T ss_dssp             TTCCGGGHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHhhcC------------------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            887665544433221                              01223356889999999999999999999999998


Q ss_pred             cC
Q 017909          315 QH  316 (364)
Q Consensus       315 ~h  316 (364)
                      ++
T Consensus       304 ~~  305 (314)
T 2ivs_A          304 KD  305 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-43  Score=317.13  Aligned_cols=249  Identities=21%  Similarity=0.290  Sum_probs=206.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|++++.||+|+||+||++.+. ++..||+|+++.....   ...+.+|+.+++.++||||+++++++...     .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~   92 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----R   92 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecC-----C
Confidence            4689999999999999999999876 5678999999754333   24567899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||+. ++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            7899999997 699999976 46799999999999999999999999999999999999999999999999999875533


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....            
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------  239 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------  239 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             cccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------------
Confidence            21 11223345678999999987 578999999999999999998 9999988876666555533211            


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                        ...+...++.+.++|.+||+.||.+|||+.++++|
T Consensus       240 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 ------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                              11224568899999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=326.28  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=209.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ..++|++++.||+|+||+||+|++.     .+++.||+|+++... .......+.+|+.+++.++||||+++++++... 
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-
Confidence            5689999999999999999999987     345889999997543 333456778999999999999999999999876 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS------------------------QSLSNDHCKYFVFQLLRGLKYLHSANILHR  157 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  157 (364)
                          ...++||||+. |+|.+++...                        ..+++..++.++.||+.||.|||++|++|+
T Consensus       123 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          123 ----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                77899999998 5999999763                        569999999999999999999999999999


Q ss_pred             CCCCCCeEEccCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCC
Q 017909          158 DLKPGNLLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIF  234 (364)
Q Consensus       158 di~~~NIll~~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf  234 (364)
                      ||||+||+++.++.++|+|||++.......  .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            999999999999999999999987543221  22234456888999999987 578999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          235 PGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      .+....+....+...                              .....+..+++.+.+||++||+.||.+|||+.+++
T Consensus       278 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~  327 (343)
T 1luf_A          278 YGMAHEEVIYYVRDG------------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH  327 (343)
T ss_dssp             TTSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChHHHHHHHhCC------------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            887765555444221                              11223356889999999999999999999999998


Q ss_pred             c
Q 017909          315 Q  315 (364)
Q Consensus       315 ~  315 (364)
                      +
T Consensus       328 ~  328 (343)
T 1luf_A          328 R  328 (343)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-43  Score=322.17  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=203.9

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEecc---CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRE---TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      +....++|++++.||+|+||+||+|.+..   ++..||+|+++...........+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34456899999999999999999998765   456899999987655666667788999999999999999999999876


Q ss_pred             cccccceEEEEecccc-ccHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIK------SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      ........++||||+. ++|.+++.      ..+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            5433346799999998 59999984      2356999999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017909          175 CDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       175 ~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      +|||++.......  .......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence            9999987553322  12233455778999999977 678999999999999999999 999998877665554443211 


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                                   .......+++.+.++|.+||+.||.+|||+.+|+++
T Consensus       267 -----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 -----------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -----------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                         112235688899999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-43  Score=318.70  Aligned_cols=254  Identities=22%  Similarity=0.294  Sum_probs=202.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .-++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence            467999999999999999999999999999999999765443 33446678999999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ...++|||+++ ++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            78999999998 59999999888899999999999999999999999999999999999999999999999999876533


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+ ..  .            
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~--~------------  250 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQ--A------------  250 (309)
T ss_dssp             ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HS--C------------
T ss_pred             cccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-cc--C------------
Confidence            22 22334567899999999977 57899999999999999999999999876543222111 10  0            


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-CHHHHhc
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-TVTEALQ  315 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~elL~  315 (364)
                                   ........+.+++.+.++|.+||+.||.+|| +++++++
T Consensus       251 -------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          251 -------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                         0011233467889999999999999999999 8888775

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-43  Score=316.44  Aligned_cols=251  Identities=20%  Similarity=0.301  Sum_probs=207.3

Q ss_pred             cccceeeee-eeccCCceeEEEEE--eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           28 IDTKYVPIK-PIGRGAYGVVCSSI--NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        28 ~~~~y~i~~-~lg~g~~g~V~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      -.++|++.+ .||+|+||+||+|.  ...+++.||+|+++...........+.+|+.+++.++||||+++++++ ..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC---
Confidence            467999998 99999999999995  456778999999987655555567788999999999999999999998 33   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++|||++. ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        90 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           90 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             --CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence              56799999998 699999998888999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ......   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+...          
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------  236 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----------  236 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred             ccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence            433322   122344678999999976 568899999999999999998 99999887765544443221          


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                          .....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       237 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          237 --------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                112234578899999999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.2e-43  Score=315.49  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=199.6

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ....++|++++.||+|+||+||+|.+..+   +..+++|+++.. ........+.+|+.+++.++||||+++++++..  
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--
Confidence            34578999999999999999999998654   456999998753 234455677899999999999999999999742  


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                          ...++||||++ ++|.+++...+ .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++
T Consensus        88 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           88 ----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             ----CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence                45789999998 59999997654 6999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          181 RTSRGNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       181 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ........ ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---------  233 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------  233 (281)
T ss_dssp             ---------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred             cccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---------
Confidence            76533221 2233445678999999977 578999999999999999996 99999887766555444321         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                           .....++.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       234 ---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          234 ---------------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ---------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                 1122345788999999999999999999999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.8e-44  Score=333.04  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|++++.||+|+||+||+|.++.+++.||+|+++.. ........+.+|+.+++.++||||+++++++...     .
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~  185 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----Q  185 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----C
Confidence            467999999999999999999999999999999998753 2333445677899999999999999999999877     6


Q ss_pred             eEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||++ |+|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            7899999997 6999998764 4699999999999999999999999999999999999999999999999999875433


Q ss_pred             CCccc--ccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          186 NEQFM--TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       186 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .....  ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+...             
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------------  331 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-------------  331 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-------------
T ss_pred             CceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------
Confidence            22111  11234667999999977 568999999999999999998 99999887765554433211             


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       .....+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus       332 -----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          332 -----------------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             011233567889999999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-43  Score=316.26  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=212.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|+||+|.++.++..||+|++...   ......+.+|+.+++.++||||+++++++...     .
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~   82 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----P   82 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence            478999999999999999999999999999999999753   33455678899999999999999999999877     7


Q ss_pred             eEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..++|||++. ++|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            7899999998 6999999864  459999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ... .......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+...             
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-------------  228 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------  228 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------------
T ss_pred             CCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-------------
Confidence            332 22333455778999999987 578999999999999999999 99999887665554444221             


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       .....+..+++.+.+||++||+.||.+|||+.++++
T Consensus       229 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          229 -----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                             011223568899999999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-44  Score=327.16  Aligned_cols=261  Identities=21%  Similarity=0.292  Sum_probs=209.8

Q ss_pred             eecccceeeeeeeccCCceeEEEEE-----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSI-----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ....++|++++.||+|+||+||+|+     +..++..||+|++... .......++.+|+.+++.++||||+++++++..
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4467899999999999999999998     4567889999999643 234455677899999999999999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---C
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQ-------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---N  169 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~  169 (364)
                      .     ...++||||++ ++|.+++....       .+++..++.++.||+.||.|||++|++|+||+|+||+++.   +
T Consensus       105 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          105 S-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             S-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             C-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence            7     67799999996 69999998653       4899999999999999999999999999999999999984   4


Q ss_pred             CcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLI  246 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i  246 (364)
                      ..++|+|||++.......  .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            469999999986432222  22234456888999999977 578999999999999999998 99999887665554443


Q ss_pred             HHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                      ...                              ........+++.+.++|.+||+.||.+|||+.+|+++.|+....
T Consensus       259 ~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          259 TSG------------------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcC------------------------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            221                              01122356788999999999999999999999999999875543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-43  Score=318.85  Aligned_cols=268  Identities=19%  Similarity=0.326  Sum_probs=204.7

Q ss_pred             cccceeeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++|++++.||+|+||+||+|+    +..+++.||+|++...  .......+.+|+.+++.++||||+++++++.....
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            57899999999999999999998    5678899999998753  33445667899999999999999999999865432


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++||||++ ++|.+++...+ .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        86 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 ---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             ---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             ---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence               45799999997 69999997754 59999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .......   ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......     .....+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~  236 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQM  236 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccch
Confidence            6543321   2223445677999999987 57899999999999999999999998653211     1111111111000


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..   .........      ......+..+++.+.+||++||+.||.+|||+.||++
T Consensus       237 ~~---~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IV---FHLIELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HH---HHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hH---HHHHHHHhc------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00   000001110      1112334678999999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-43  Score=321.38  Aligned_cols=261  Identities=21%  Similarity=0.356  Sum_probs=215.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ....++|++.+.||+|+||+||+|.++     .++..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            446789999999999999999999876     45788999999753 233445567899999999999999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSS----------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                      .     ...++|||++. |+|.+++...          ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+
T Consensus       100 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A          100 G-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             S-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             C-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence            7     67899999997 5999988642          457999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLI  246 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i  246 (364)
                      +.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            9999999999875433221  1223455788999999987 578999999999999999998 89999887665554444


Q ss_pred             HHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC------CCcc
Q 017909          247 ISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH------PYIS  320 (364)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h------p~f~  320 (364)
                      ...                              ........+++.+.+||.+||+.||.+|||+.+++++      ++|+
T Consensus       254 ~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~  303 (322)
T 1p4o_A          254 MEG------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  303 (322)
T ss_dssp             HTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence            221                              1122335688999999999999999999999999986      7776


Q ss_pred             CCC
Q 017909          321 GLY  323 (364)
Q Consensus       321 ~~~  323 (364)
                      ...
T Consensus       304 ~~~  306 (322)
T 1p4o_A          304 EVS  306 (322)
T ss_dssp             HHC
T ss_pred             ccc
Confidence            543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-43  Score=318.31  Aligned_cols=253  Identities=24%  Similarity=0.333  Sum_probs=210.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (364)
                      ..++|++++.||+|+||+||+|.+     ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            468999999999999999999984     4567899999997542 233456778999999999 899999999999877


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQ------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPG  162 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~  162 (364)
                           ...++||||++ |+|.+++....                  .+++..++.++.||+.||.+||++|++|+||+|+
T Consensus       100 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  174 (313)
T 1t46_A          100 -----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (313)
T ss_dssp             -----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             -----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence                 67899999997 59999997653                  4899999999999999999999999999999999


Q ss_pred             CeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017909          163 NLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTEC  239 (364)
Q Consensus       163 NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~  239 (364)
                      ||+++.++.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            99999999999999999876544322  1233456778999999987 578999999999999999998 9999988765


Q ss_pred             HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ............                             .......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGF-----------------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCC-----------------------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            444433332110                             011234678899999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.5e-43  Score=314.98  Aligned_cols=255  Identities=19%  Similarity=0.189  Sum_probs=206.1

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..+.++|++++.||+|+||+||+|++..+|+.||+|++......    ..+.+|+.+++.++|++++..+..+....   
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (296)
T 3uzp_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG---   77 (296)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEET---
T ss_pred             ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCC---
Confidence            45789999999999999999999999999999999998654332    24668999999999888777776664432   


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEEeecCccc
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L~Dfg~~~  181 (364)
                       ...++||||++++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+.
T Consensus        78 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           78 -DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             -CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence             67899999998899999974 4679999999999999999999999999999999999999   478899999999987


Q ss_pred             cCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 017909          182 TSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL---NQLKLIISVFG  251 (364)
Q Consensus       182 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~i~~~~~  251 (364)
                      .......       ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+....   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            6544322       1245578999999999987 57899999999999999999999999874322   22222222100


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..+                          .......+++.+.++|++||+.||.+|||+.+|++
T Consensus       236 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          236 STP--------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSC--------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CCc--------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            000                          01122467899999999999999999999999885

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=324.21  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=206.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (364)
                      -.++|++++.||+|+||+||+|.+     ..++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            468999999999999999999997     3456789999997532 233445678999999999 899999999999877


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQ-----------------------SLSNDHCKYFVFQLLRGLKYLHSANILHR  157 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  157 (364)
                           ...++||||++ |+|.+++....                       .+++..++.++.||+.||.|||++|++|+
T Consensus       122 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          122 -----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             -----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                 77899999997 69999997643                       37999999999999999999999999999


Q ss_pred             CCCCCCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCC
Q 017909          158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIF  234 (364)
Q Consensus       158 di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf  234 (364)
                      ||+|+||+++.++.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999999875533221  2334456778999999987 578999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          235 PGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      .+.........+....                             .....+..+++.+.+||.+||+.||.+|||+.+|+
T Consensus       276 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  326 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNG-----------------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  326 (344)
T ss_dssp             TTCCCSHHHHHHHHTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccCCcHHHHHHHHhcC-----------------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            8876544443332210                             01122346788999999999999999999999999


Q ss_pred             cCC
Q 017909          315 QHP  317 (364)
Q Consensus       315 ~hp  317 (364)
                      ++.
T Consensus       327 ~~l  329 (344)
T 1rjb_A          327 SFL  329 (344)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.2e-43  Score=311.83  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=195.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch--HHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR--IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .++|++.+.||+|+||+||+|.+.  +..+|+|+++......  .....+.+|+.+++.++||||+++++++...     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence            579999999999999999999875  8899999987543322  2235677899999999999999999999877     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCeEEcc--------CCcEEE
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN---ILHRDLKPGNLLVNA--------NCDLKI  174 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di~~~NIll~~--------~~~~~L  174 (364)
                      ...++||||++ ++|.+++. .+.+++..++.++.|++.||.+||++|   ++|+||+|+||+++.        ++.++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            77899999997 58877774 467999999999999999999999999   889999999999986        678999


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      +|||.+.......  .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+...     
T Consensus       158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----  229 (271)
T 3dtc_A          158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-----  229 (271)
T ss_dssp             CCCCC---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-----
T ss_pred             ccCCccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-----
Confidence            9999987553322  224567899999999987 57899999999999999999999999887655444333211     


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                              .........+++.+.++|.+||+.||.+|||+.|++++
T Consensus       230 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 ------------------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                    01122345678999999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.4e-43  Score=316.83  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=196.5

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchh-hchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF-ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...    
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----  104 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----  104 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence            34578999999999999999999999999999999987533 2344556778999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                       ...++|||++. ++|.+++..    ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus       105 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          105 -NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             -TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             -CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence             78999999998 499988864    467999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhh
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL--NQLKLIISVFGTQQEADL  258 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  258 (364)
                      ..............++..|+|||++.+ ..++.++||||||+++|+|++|..||.+....  .....+.. .        
T Consensus       184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--------  253 (310)
T 2wqm_A          184 RFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-C--------  253 (310)
T ss_dssp             ---------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-T--------
T ss_pred             eeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-c--------
Confidence            766444444445578899999999977 57899999999999999999999999764321  11111110 0        


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                          .........+++.+.+||.+||+.||.+|||+.+|++
T Consensus       254 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          254 --------------------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             --------------------CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                0001112467889999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-43  Score=316.70  Aligned_cols=256  Identities=16%  Similarity=0.265  Sum_probs=205.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCC-------cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETN-------EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      ..++|++.+.||+|+||+||+|.+..++       ..|++|++....  ......+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4789999999999999999999998777       469999986543  2344567889999999999999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc-------
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQS-LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-------  171 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~-------  171 (364)
                      .     ...++||||+. ++|.+++...+. +++..++.++.||+.||.|||++|++|+||||+||+++.++.       
T Consensus        84 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 G-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             T-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             C-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence            7     67799999998 699999987654 999999999999999999999999999999999999998887       


Q ss_pred             -EEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q 017909          172 -LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       172 -~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~  249 (364)
                       ++|+|||.+.....    .....++..|+|||++.+...++.++||||||+++|+|++| .+||............ ..
T Consensus       159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~  233 (289)
T 4fvq_A          159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-ED  233 (289)
T ss_dssp             EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HT
T ss_pred             eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hc
Confidence             99999999865422    22345688899999998756789999999999999999995 5555554433322221 10


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                                     ....+...++.+.+||++||+.||.+|||+.++++|  |+.+..+.+.
T Consensus       234 -------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~~~  279 (289)
T 4fvq_A          234 -------------------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLV  279 (289)
T ss_dssp             -------------------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-----
T ss_pred             -------------------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCCCC
Confidence                                           012234567789999999999999999999999964  4555444443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.2e-43  Score=314.34  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=200.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...++|++.+.||+|+||+||+|.+..   .+++|+++...........+.+|+.+++.++||||++++++.. .     
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~-----   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A-----   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C-----
Confidence            358899999999999999999997653   5999999876666667778889999999999999999999653 3     


Q ss_pred             ceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||+. ++|.+.+.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            45799999998 699998864 4569999999999999999999999999999999999999999999999999986543


Q ss_pred             C--CCcccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 G--NEQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~--~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .  .........|+..|+|||++..  ...++.++||||||+++|+|++|..||.+.................       
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------  244 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS-------  244 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC-------
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC-------
Confidence            2  1222344567999999999862  2467889999999999999999999998876665554443321111       


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        .........+++.+.+||.+||+.||.+|||+.++++
T Consensus       245 ------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          245 ------------------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ------------------CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              1112334578899999999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.6e-43  Score=320.17  Aligned_cols=252  Identities=26%  Similarity=0.380  Sum_probs=209.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEec-------cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeec
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINR-------ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMM   99 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   99 (364)
                      ..++|++++.||+|+||+||+|.+.       .++..||+|+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            4689999999999999999999875       456789999997542 344556778999999999 8999999999998


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPG  162 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~  162 (364)
                      ..     ...++||||+. |+|.+++....                .+++..++.++.||+.||.|||++|++|+||+|+
T Consensus       112 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          112 QD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             SS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             cC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            77     77899999997 59999997654                3899999999999999999999999999999999


Q ss_pred             CeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017909          163 NLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTEC  239 (364)
Q Consensus       163 NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~  239 (364)
                      ||+++.++.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            99999999999999999876543322  1223445778999999977 568999999999999999998 9999988766


Q ss_pred             HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .+....+....                              .......+++.+.++|++||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCC------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55554443211                              112235688899999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.7e-43  Score=310.64  Aligned_cols=249  Identities=14%  Similarity=0.183  Sum_probs=209.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|++.+.||+|+||+||+|++.  +..+|+|+++...........+.+|+.+++.++||||+++++++.....   .
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA---P   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS---S
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC---C
Confidence            4579999999999999999999875  8899999998766666667788899999999999999999999876532   5


Q ss_pred             eEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ..++||||++ |+|.+++...+  .+++..++.++.||+.||.|||++|  ++|+||+|+||+++.++.++|+|||+...
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            6799999998 59999998765  4899999999999999999999999  99999999999999999999999887654


Q ss_pred             CCCCCcccccccccccccCCccccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...     ....+++.|+|||.+.+..  .++.++||||||+++|+|++|..||.+.........+...           
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------  226 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE-----------  226 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS-----------
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc-----------
Confidence            322     2346688999999997632  2334899999999999999999999887766554444321           


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        ......+..+++.+.++|.+||+.||.+|||++++++
T Consensus       227 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          227 ------------------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              1112334578999999999999999999999999985

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-42  Score=310.64  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=205.0

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHH-----HHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA-----LRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++..........     ..+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            35789999999999999999999999999999999986543332221     5677899999999999999999998655


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCCc-----E
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCD-----L  172 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~~-----~  172 (364)
                           .  ++||||+. ++|.+.+... ..+++..++.++.|++.||.|||++|  ++|+||+|+||+++.++.     +
T Consensus        96 -----~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           96 -----P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             -----T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             -----C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence                 2  69999998 6998888654 57999999999999999999999999  999999999999988776     9


Q ss_pred             EEeecCccccCCCCCcccccccccccccCCccccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          173 KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      +|+|||++.....   ......++..|+|||++.. ...++.++||||||+++|+|++|..||................ 
T Consensus       169 kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-  244 (287)
T 4f0f_A          169 KVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-  244 (287)
T ss_dssp             EECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-
T ss_pred             EeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-
Confidence            9999999875432   2345678999999999843 2457889999999999999999999998765433211111000 


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                                ..........+++.+.++|.+||+.||.+|||+.++++
T Consensus       245 --------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          245 --------------------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             --------------------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                      01112334578899999999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-43  Score=327.32  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=197.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEec---cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR---ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++.+.||+|+||+||+|+++   .++..||+|+++... .......+.+|+.+++.++||||+++++++...    
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS----  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC----
Confidence            568999999999999999999876   457789999997542 344556788999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||++ |+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus       119 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          119 -KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             -CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence             77899999996 6999999765 46999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ......   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....         
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---------  267 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---------  267 (373)
T ss_dssp             ----------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE---------
T ss_pred             ccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            432221   122234667999999987 578999999999999999997 999998877655554442210         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           .......++..+.++|.+||+.||.+||++.+|++
T Consensus       268 ---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 ---------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                 01123457889999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=322.59  Aligned_cols=264  Identities=13%  Similarity=0.135  Sum_probs=200.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEecc---CCcEEEEEeccchhhchHH---------HHHHHHHHHHHHhcCCCCcceee
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRE---TNEKVAIKKINNVFENRID---------ALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      ..++|++++.||+|+||+||+|.+..   ++..+|+|++.........         ...+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            46799999999999999999999987   7889999998754221111         12345788889999999999999


Q ss_pred             eeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC--cEE
Q 017909           96 DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC--DLK  173 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~--~~~  173 (364)
                      +++..... .....++||||++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++  .++
T Consensus       115 ~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFK-GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESS-SCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccC-CCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            99877321 117899999999779999998877899999999999999999999999999999999999999887  999


Q ss_pred             EeecCccccCCCC-------CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHH
Q 017909          174 ICDFGLARTSRGN-------EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGT-ECLNQLKL  245 (364)
Q Consensus       174 L~Dfg~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~  245 (364)
                      |+|||++......       ........|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+. ........
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            9999999754321       111244578999999999987 57899999999999999999999999653 22222222


Q ss_pred             HH-HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          246 II-SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       246 i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .. ......+...         ...             .....+++.+.++|.+||+.||.+|||+++|++
T Consensus       273 ~~~~~~~~~~~~~---------~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          273 AKTNLLDELPQSV---------LKW-------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHTTTHHH---------HHH-------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhcccccHHH---------Hhh-------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            11 1111111100         000             001268889999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-43  Score=322.82  Aligned_cols=251  Identities=19%  Similarity=0.277  Sum_probs=203.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcE----EEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEK----VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      -.++|++++.||+|+||+||+|.+..++..    +++|.+.... .......+.+|+.+++.++||||+++++++. .  
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~--   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G--   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B--
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C--
Confidence            367999999999999999999999888876    7777764332 1122234457999999999999999999885 2  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++||||+. |+|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        87 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           87 ---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             ---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             ---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence               45789999997 6999998764 579999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ......  .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+...         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---------  233 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---------  233 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---------
T ss_pred             ccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------
Confidence            654332  22344566778999999987 578999999999999999999 99999887665554444321         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                           ........+++.+.++|.+||+.||.+|||+.+++++
T Consensus       234 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          234 ---------------------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---------------------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 0112234467788999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-43  Score=317.16  Aligned_cols=255  Identities=19%  Similarity=0.189  Sum_probs=200.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..+.++|++++.||+|+||+||+|++..+++.||+|++......    ..+.+|+.+++.++|++++..+..+....   
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG---   77 (296)
T ss_dssp             ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEET---
T ss_pred             cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCC---
Confidence            45689999999999999999999999999999999987543222    23567999999999888887777765432   


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEEeecCccc
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L~Dfg~~~  181 (364)
                       ...++|||+++++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+.
T Consensus        78 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           78 -DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             -CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence             67899999998899999975 4679999999999999999999999999999999999999   788999999999997


Q ss_pred             cCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Q 017909          182 TSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLN---QLKLIISVFG  251 (364)
Q Consensus       182 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~i~~~~~  251 (364)
                      .......       ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.....   ....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            6543322       2235578999999999987 578999999999999999999999998754322   2222111100


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..+                          .......+++.+.+||.+||+.||.+|||+.+|++
T Consensus       236 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 STP--------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSC--------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cch--------------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            000                          01122467889999999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.3e-43  Score=309.12  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=207.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|++|+||+|.+. ++..|++|++......   ...+.+|+.+++.++||||+++++++...     ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SS
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CC
Confidence            579999999999999999999986 5678999999764333   24577899999999999999999999877     67


Q ss_pred             EEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++|||+++ ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            899999997 6999999765 56999999999999999999999999999999999999999999999999998765332


Q ss_pred             C-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 E-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      . .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+....              
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~--------------  222 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------------  222 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------------
T ss_pred             cccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            1 11223445678999999977 578999999999999999999 899998877655554443210              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                      ....+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       223 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          223 ----------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            011234578899999999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.5e-43  Score=321.06  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=199.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcE----EEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEK----VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++|++.+.||+|+||+||+|++..+++.    |++|.+.... .......+.+|+.+++.++||||+++++++...  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence            468999999999999999999998877765    4777775432 223445678899999999999999999999754  


Q ss_pred             cccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                          ..++|++++. |+|.+.+.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        90 ----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             ----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence                3578888887 799999876 4579999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .......  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+...         
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------  235 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---------  235 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred             EccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC---------
Confidence            6533222  2233455778999999987 678999999999999999999 99999887665544433221         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                           ........++..+.+++.+||+.||.+|||+.+|+++
T Consensus       236 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          236 ---------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                 0112235678899999999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8e-43  Score=316.82  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=209.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEe-----ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSIN-----RETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      ...++|++++.||+|+||+||+|.+     ..+++.||+|+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            3578999999999999999999984     4567899999997542 333455678999999999 69999999999876


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSSQS----------------LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      ..    ...++||||++ ++|.+++.....                +++..++.++.||+.||.|||++|++|+||+|+|
T Consensus       103 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A          103 PG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             TT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            52    45899999998 599999987543                8999999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~  240 (364)
                      |+++.++.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            9999999999999999876533322  2334456788999999987 578999999999999999998 99999877544


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ...........                             .......+++.+.++|.+||+.||.+|||+.+|++|
T Consensus       258 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCc-----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33332222100                             012234578899999999999999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=320.05  Aligned_cols=262  Identities=21%  Similarity=0.337  Sum_probs=193.6

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMP  100 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  100 (364)
                      .+.+.....+|++.+.||+|+||+||+|++..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            344445567999999999999999999999999999999998543  3344556788999999995 9999999999843


Q ss_pred             ccc---cccceEEEEeccccccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEccCCcE
Q 017909          101 THR---ISFKDVYLVYELMDTDLHQIIKS---SQSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus       101 ~~~---~~~~~~~lv~e~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~~~~~~  172 (364)
                      ...   ......++||||++|+|.+++..   .+.+++..++.++.||+.||.|||++|  ++|+||||+||+++.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence            211   12256899999999999998864   467999999999999999999999999  9999999999999999999


Q ss_pred             EEeecCccccCCCCCcc------------cccccccccccCCcccc--cccCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 017909          173 KICDFGLARTSRGNEQF------------MTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE  238 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  238 (364)
                      +|+|||++.........            .....+++.|+|||++.  ....++.++||||||+++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999998765432211            11345788999999984  22568899999999999999999999997543


Q ss_pred             hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 017909          239 CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY  318 (364)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~  318 (364)
                      .......                                 ..........++.+.+||++||+.||.+|||+.|++++.+
T Consensus       258 ~~~~~~~---------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          258 KLRIVNG---------------------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhhcC---------------------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2211110                                 0001122456778999999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.5e-43  Score=321.99  Aligned_cols=250  Identities=26%  Similarity=0.327  Sum_probs=204.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEE--EEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKV--AIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++.+.||+|+||+||+|+++.++..+  ++|.++.. ........+.+|+.+++.+ +||||+++++++...    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC----
Confidence            479999999999999999999999888865  99988643 2233445677899999999 899999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQ----------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA  168 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~  168 (364)
                       ...++||||++ ++|.+++...+                .+++..++.++.||+.||.+||++|++|+||+|+||+++.
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             -CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence             78999999997 59999997654                7999999999999999999999999999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017909          169 NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLII  247 (364)
Q Consensus       169 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~  247 (364)
                      ++.++|+|||++..... ........++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+.
T Consensus       178 ~~~~kL~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GGCEEECCTTCEESSCE-ECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CCeEEEcccCcCccccc-cccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            99999999999864322 112233455778999999976 568999999999999999998 999998876554443331


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ..                              ........+++.+.+||.+||+.||.+|||+.+++++
T Consensus       256 ~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QG------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GT------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            10                              0112234678899999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.7e-43  Score=314.33  Aligned_cols=268  Identities=22%  Similarity=0.365  Sum_probs=205.5

Q ss_pred             cccceeeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ...+|++++.||+|+||+||+|+    +..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            36789999999999999999998    577899999999975432 2234567789999999999999999999986532


Q ss_pred             cccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++||||++ ++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        98 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 ---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence               55799999997 599999954 4679999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .......   ......++..|+|||++.+ ..++.++||||||+++|+|++|..|+...     ................
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQMT  248 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGGH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccccC
Confidence            6644332   2334556778999999977 56889999999999999999999986432     1112222111111100


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                          .........      .......+..+++.+.+||++||+.||.+|||+.++++
T Consensus       249 ----~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          249 ----VTRLVNTLK------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             ----HHHHHHHHH------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHHHh------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                000111111      11123345678999999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-43  Score=315.49  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=207.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc---
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR---  103 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---  103 (364)
                      .+.++|++++.||+|+||.||+|.+..+++.||+|.++...      ..+.+|+.+++.++||||+++++++.....   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            35789999999999999999999999999999999997542      234579999999999999999998854210   


Q ss_pred             --------cccceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcE
Q 017909          104 --------ISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus       104 --------~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~  172 (364)
                              ......++||||++ ++|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                    11256899999998 5999999754  579999999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          173 KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      +|+|||.+....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||....  .....+.     
T Consensus       162 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~-----  232 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR-----  232 (284)
T ss_dssp             EECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH-----
T ss_pred             EECcchhheeccccc-cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh-----
Confidence            999999987664432 2344568999999999987 578999999999999999999998874210  0000000     


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                        .          ......+++.+.++|.+||+.||.+|||+.|+++|.+.-.
T Consensus       233 ------------------~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 ------------------D----------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ------------------T----------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ------------------c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                              0          1122457889999999999999999999999999988754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=316.55  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=202.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCC----cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETN----EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++|++.+.||+|+||+||+|.++.++    ..||+|+++... .......+.+|+.+++.++||||+++++++...  
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--
Confidence            4678999999999999999999877553    359999997543 334555678999999999999999999999876  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++|||+++ ++|.+++... +.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus       119 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          119 ---KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             ---SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ---CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence               78899999998 5999999764 679999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .......   ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+....       
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-------  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-------  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------
T ss_pred             hhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-------
Confidence            6543221   1222344678999999977 578999999999999999998 999998877655554442210       


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                             .......+++.+.++|.+||+.||.+||++.+++++
T Consensus       268 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 -----------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   112234678899999999999999999999998864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.3e-43  Score=331.74  Aligned_cols=261  Identities=29%  Similarity=0.350  Sum_probs=196.6

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      ....+.+.|.+.+.||+|+||+||.+ ...+|+.||+|++....     ...+.+|+.+++.+ +||||+++++++... 
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-   81 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD-   81 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC-
Confidence            33457888999999999999999865 45678999999986532     23456799999876 899999999998877 


Q ss_pred             ccccceEEEEeccccccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC------
Q 017909          103 RISFKDVYLVYELMDTDLHQIIKSSQSL-------SNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN------  169 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~-------~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~------  169 (364)
                          ...++|||+++|+|.+++......       ++..++.++.||+.||.|||++|++|+||||+||+++.+      
T Consensus        82 ----~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           82 ----RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             ----SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred             ----CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence                789999999999999999865433       233457799999999999999999999999999999754      


Q ss_pred             -------CcEEEeecCccccCCCCCc----ccccccccccccCCccccc------ccCCCChhhHHHHHHHHHHHHh-CC
Q 017909          170 -------CDLKICDFGLARTSRGNEQ----FMTEYVVTRWYRAPELLLC------CDNYGTSIDVWSVGCIFAEILG-RK  231 (364)
Q Consensus       170 -------~~~~L~Dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~  231 (364)
                             +.++|+|||++........    ......|++.|+|||++.+      ...++.++|||||||++|+|++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   4899999999986644322    1234578999999999865      2468999999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH
Q 017909          232 PIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT  311 (364)
Q Consensus       232 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  311 (364)
                      .||.+.....  ..+.........                        ........+++.+.+||.+||+.||.+|||+.
T Consensus       238 ~Pf~~~~~~~--~~i~~~~~~~~~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  291 (434)
T 2rio_A          238 HPFGDKYSRE--SNIIRGIFSLDE------------------------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAM  291 (434)
T ss_dssp             CTTCSTTTHH--HHHHHTCCCCCC------------------------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCchhhH--HHHhcCCCCccc------------------------ccccccccchHHHHHHHHHHhhCChhhCCCHH
Confidence            9997654332  122211100000                        00000123457799999999999999999999


Q ss_pred             HHhcCCCccC
Q 017909          312 EALQHPYISG  321 (364)
Q Consensus       312 elL~hp~f~~  321 (364)
                      +||+||||+.
T Consensus       292 eil~hp~f~~  301 (434)
T 2rio_A          292 KVLRHPLFWP  301 (434)
T ss_dssp             HHHTSGGGSC
T ss_pred             HHHhCCccCC
Confidence            9999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-43  Score=330.74  Aligned_cols=256  Identities=27%  Similarity=0.358  Sum_probs=195.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -..+|++.+.||+|+||+|+. ....+|+.||+|++.......     +.+|+.+++.+ +||||+++++++...     
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~-----~~~E~~~l~~l~~HpnIv~l~~~~~~~-----   90 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF-----ADREVQLLRESDEHPNVIRYFCTEKDR-----   90 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEE-----CHHHHHHHHHSCCCTTBCCEEEEEEET-----
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHH-----HHHHHHHHHhccCCCCcCeEEEEEecC-----
Confidence            355899999999999998653 345678999999986543322     34689999999 799999999998877     


Q ss_pred             ceEEEEeccccccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-----CCcEEEeecCcc
Q 017909          107 KDVYLVYELMDTDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-----NCDLKICDFGLA  180 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-----~~~~~L~Dfg~~  180 (364)
                      ...++|||+++|+|.+++.... ...+..++.++.||+.||.|||++||+||||||+||+++.     ...++|+|||++
T Consensus        91 ~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           91 QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            7889999999999999997654 4666677899999999999999999999999999999953     336889999999


Q ss_pred             ccCCCCC---cccccccccccccCCccccc--ccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          181 RTSRGNE---QFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       181 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      .......   .......|++.|+|||++.+  ...++.++|||||||++|+|++ |..||.......... +   .....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~  246 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACS  246 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCC
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCC
Confidence            7654322   22345678999999999974  2467889999999999999999 999996654322211 1   11100


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      .                        .........+..+.+||.+||+.||.+|||+.+||+||||+..
T Consensus       247 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          247 L------------------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             C------------------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             c------------------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            0                        0000112234568899999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=333.26  Aligned_cols=280  Identities=20%  Similarity=0.318  Sum_probs=209.5

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ..++++|++.+.||+|+||+||+|++..+|+.||+|++....... ....+.+|+.+++.++||||+++++++.....  
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--   81 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--   81 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC--
Confidence            346899999999999999999999999999999999997543222 24456789999999999999999999876632  


Q ss_pred             cceEEEEecccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE----ccCCcEEEeec
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDF  177 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll----~~~~~~~L~Df  177 (364)
                       ...++||||+. |+|.+++....   .+++..++.++.||+.||.|||++|++|+||||+||++    +.++.++|+||
T Consensus        82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           82 -RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             -CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             -CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence             47899999997 69999987543   39999999999999999999999999999999999999    77778999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccc-------cCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCC-------DNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISV  249 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~  249 (364)
                      |++...... .......|+..|+|||++.+.       ..++.++|||||||++|+|++|..||...... .....+...
T Consensus       161 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          161 GAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            999766433 233456789999999998642       35678999999999999999999999754321 112222222


Q ss_pred             hCCCchhhhhccCchhHH--HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          250 FGTQQEADLEFIDNPKAR--RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ....+...+.........  .|....     .....+...++..+.++|++||+.||.+|||+.++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDM-----PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSC-----CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccC-----CcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            222222111111000000  000000     0111222345667889999999999999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9e-43  Score=323.04  Aligned_cols=265  Identities=13%  Similarity=0.114  Sum_probs=202.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccC-----CcEEEEEeccchhhchHHHH---------HHHHHHHHHHhcCCCCcce
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRET-----NEKVAIKKINNVFENRIDAL---------RTLRELVLLRHIKHDNVIA   93 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~---------~~~~e~~~l~~l~h~~iv~   93 (364)
                      ..++|++++.||+|+||+||+|.++.+     ++.||+|++...........         ....++..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456999999999999999999998765     57899999875432211111         2234666777889999999


Q ss_pred             eeeeeccccccccceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc--cCC
Q 017909           94 LKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN--ANC  170 (364)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~--~~~  170 (364)
                      +++++...... ....++||||++++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~-~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNG-KSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETT-EEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCC-cceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998765221 1568999999988999999875 6799999999999999999999999999999999999999  889


Q ss_pred             cEEEeecCccccCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017909          171 DLKICDFGLARTSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQL  243 (364)
Q Consensus       171 ~~~L~Dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  243 (364)
                      .++|+|||++........       ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.......
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999965432211       1133458999999999987 56899999999999999999999999864333222


Q ss_pred             HHHHH-HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          244 KLIIS-VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       244 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..... ....            ....+....         .....+++.+.++|..||+.||.+||++.+|++
T Consensus       271 ~~~~~~~~~~------------~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRE------------NIASLMDKC---------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHH------------CHHHHHHHH---------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhh------------hHHHHHHHh---------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22111 1100            011111100         011467889999999999999999999999885

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.2e-42  Score=308.89  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=205.4

Q ss_pred             eecccceeeeeeeccCCceeEEEEEecc---CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRE---TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      ....++|++.+.||+|+||+||+|.+..   ++..||+|.+.... .......+.+|+.+++.++||||+++++++... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            3357899999999999999999998653   34469999997642 333556778999999999999999999998643 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                           ..++|||++. ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        86 -----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           86 -----PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             -----CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCC
Confidence                 3589999998 6999999765 46999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          181 RTSRGNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       181 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ........ ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~--------  231 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD--------  231 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC--------
T ss_pred             cccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC--------
Confidence            76543221 2233455778999999976 578999999999999999998 999998776655554443210        


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                            .......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       232 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          232 ----------------------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                  012234578899999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-42  Score=310.65  Aligned_cols=253  Identities=21%  Similarity=0.335  Sum_probs=208.7

Q ss_pred             ecccceeeee-eeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           27 EIDTKYVPIK-PIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        27 ~~~~~y~i~~-~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .-.++|.+.+ .||+|+||+||+|.+.  .++..||+|+++.. ........+.+|+.+++.++||||+++++++. .  
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~--   81 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A--   81 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S--
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C--
Confidence            3467888887 9999999999999854  46778999999764 23445667789999999999999999999983 3  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++|||+++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           82 ---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             ---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence               45899999998 5999988654 569999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      ........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+...        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--------  229 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------  229 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--------
T ss_pred             eeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--------
Confidence            65433221   223345788999999976 568999999999999999998 99999887765555443221        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                                            .....++.+++.+.++|.+||+.||.+||++.+++++.
T Consensus       230 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          230 ----------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ----------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ----------------------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                                  11233457899999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=317.49  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=200.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEE----EEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKV----AIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++|++++.||+|+||+||+|.+..+++.+    ++|.+... ........+.+|+.+++.++||||+++++++...  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   89 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--   89 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence            4689999999999999999999998888765    66665432 2233455677899999999999999999998755  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                          ..++|++++. |+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        90 ----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence                3678888887 6999998764 579999999999999999999999999999999999999999999999999997


Q ss_pred             cCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ......  .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+...         
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---------  235 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---------  235 (327)
T ss_dssp             --------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred             EccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence            653322  22233445778999999987 678999999999999999999 99999887665554443221         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           ........+++.+.++|++||+.||.+|||+.|+++
T Consensus       236 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          236 ---------------------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ---------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 112233567889999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-42  Score=334.73  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=210.9

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|++.+.||+|+||+||+|.++.++..||+|+++....   ....+.+|+.+++.++||||+++++++...     .
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~  289 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----P  289 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC-----C
Confidence            46789999999999999999999999999999999975432   345678999999999999999999999877     6


Q ss_pred             eEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            7899999998 6999999764  459999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ... .......++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.........+...             
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------------  435 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------  435 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------------
T ss_pred             CCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------
Confidence            322 12223345678999999977 578999999999999999998 99999887765554443221             


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                       .....+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus       436 -----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 -----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                             011234568899999999999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-43  Score=320.03  Aligned_cols=273  Identities=21%  Similarity=0.244  Sum_probs=201.5

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      +..-.++|++++.||+|+||+||+|++.  ++.||+|++...   .........|+.+++.++||||+++++++......
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            3335679999999999999999999776  789999999653   22334445688999999999999999999765321


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCCeEEccCCcEE
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA----------NILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------~i~H~di~~~NIll~~~~~~~  173 (364)
                       ....++||||+. |+|.+++.. +.+++..++.++.|++.||.|||+.          |++|+||||+||+++.++.++
T Consensus        94 -~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           94 -DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             -SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             -CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence             145899999997 599999876 4599999999999999999999999          999999999999999999999


Q ss_pred             EeecCccccCCCCCc--ccccccccccccCCcccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017909          174 ICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII  247 (364)
Q Consensus       174 L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~  247 (364)
                      |+|||++........  ......|+..|+|||++.+.    ..++.++|||||||++|+|++|..||.+...........
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976533222  23345789999999998763    235668899999999999999999998754321111110


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhC-CCCCCCccccc--CCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSL-PYSRGTHISSL--YPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .....+           ......... ...........  ....++.+.+||.+||+.||.+|||+.+|++
T Consensus       252 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHP-----------SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCC-----------chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            000000           011110000 00000000010  1123445999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.5e-44  Score=324.62  Aligned_cols=272  Identities=23%  Similarity=0.287  Sum_probs=209.1

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      ...+....++|++.+.||+|+||+||+|.++ ++..||+|++....  ......+.+|+.+++.++||||+++++++...
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            3344557789999999999999999999864 68899999987542  33455678999999999999999999999877


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEee
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQ----SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                           ...++||||+. |+|.+++....    .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus       108 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          108 -----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             -----TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             -----CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEee
Confidence                 77899999997 69988886543    589999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCC--CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          177 FGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       177 fg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      ||++......  ........|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+..............    
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~----  257 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV----  257 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH----
T ss_pred             cccccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh----
Confidence            9998754322  222334567899999999977 578999999999999999999999997653221111100000    


Q ss_pred             hhhhhccCchhHHHHHhhCCCC-CCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYS-RGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP  317 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp  317 (364)
                          .....       ...... .........+..+..+.+++.+||+.||.+|||+.|++++.
T Consensus       258 ----~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          258 ----ESHNN-------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             ----HHHTT-------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ----hcccc-------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                00000       000000 00111122334566789999999999999999999999764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-42  Score=317.29  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=208.1

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCc-----EEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      ...++|++++.||+|+||+||+|.+..++.     .|++|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            346899999999999999999999876654     79999997542 333456678999999999 89999999999987


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKS--------------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                      .     ...++||||++ |+|.+++..              ...+++..++.++.||+.||.|||++|++|+||+|+||+
T Consensus       122 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          122 G-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             S-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             C-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            7     67899999997 599999864              245899999999999999999999999999999999999


Q ss_pred             EccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017909          166 VNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQ  242 (364)
Q Consensus       166 l~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~  242 (364)
                      ++.++.++|+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+......
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            99999999999999875433221  2233455778999999987 578999999999999999998 9999988765544


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ...+......                             ...+...++.+.++|.+||+.||.+|||+.+|++
T Consensus       276 ~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQ-----------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            4433321100                             1123456889999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-42  Score=316.59  Aligned_cols=273  Identities=21%  Similarity=0.313  Sum_probs=208.6

Q ss_pred             cccceeeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      -.++|++++.||+|+||+||+|+    +..++..||+|++...  .......+.+|+.+++.++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            35799999999999999999998    5678899999999754  33345567899999999999999999998875422


Q ss_pred             cccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++||||++ ++|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 ---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             ---CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ---ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence               67899999996 699999976 4569999999999999999999999999999999999999999999999999997


Q ss_pred             cCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .......   ......++..|+|||++.+ ..++.++||||||+++|+|++|..||..........     .....    
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~~~----  245 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-----MGCER----  245 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----CC-------
T ss_pred             ecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-----ccccc----
Confidence            6543332   2233456778999999977 568999999999999999999999997543211110     00000    


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc---CCCccC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ---HPYISG  321 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~---hp~f~~  321 (364)
                         ............   ...........+++.+.+||++||+.||.+|||+.+|++   ..|...
T Consensus       246 ---~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          246 ---DVPALSRLLELL---EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             ----CCHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             ---ccccHHHHHHHh---hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence               000000100000   011122334678999999999999999999999999954   444443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=315.83  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=205.9

Q ss_pred             eeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecc
Q 017909           21 MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMP  100 (364)
Q Consensus        21 ~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (364)
                      .++.+....++|++++.||+|+||.||++.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            3455555678999999999999999999999999999999998653  33455677899999999999999999999874


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      ... .....++||||+. |+|.+++..    ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+
T Consensus        98 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A           98 ERG-AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EET-TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             ccC-CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence            321 1157899999998 599998875    4679999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCCcc---------cccccccccccCCccccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HH
Q 017909          176 DFGLARTSRGNEQF---------MTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAEILGRKPIFPGTECL--NQ  242 (364)
Q Consensus       176 Dfg~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~  242 (364)
                      |||.+.........         .....|+..|+|||++.+..  .++.++||||||+++|+|++|..||......  ..
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  256 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV  256 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence            99987654221110         12334588999999987532  3689999999999999999999999531100  00


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ...+.                       .       .........+++.+.++|.+||+.||.+|||+.+|+++
T Consensus       257 ~~~~~-----------------------~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          257 ALAVQ-----------------------N-------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHH-----------------------C-------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHhh-----------------------c-------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            00000                       0       00011235678899999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-42  Score=307.87  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=201.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      -+|++.+.||+|+||+||+|.+..++.   .+|+|.+... ........+.+|+.+++.++||||+++++++....    
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            367788999999999999998755544   7999998753 33345567789999999999999999999997662    


Q ss_pred             ceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++|||++. ++|.+++.. ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            34489999996 799999976 4579999999999999999999999999999999999999999999999999987543


Q ss_pred             CC----CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          185 GN----EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       185 ~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ..    ........++..|+|||.+.+ ..++.++||||||+++|+|++ +.+||...........+....         
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC---------
T ss_pred             CCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC---------
Confidence            32    122334456788999999977 578999999999999999999 555566555444443332210         


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       246 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          246 ---------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                 11223467889999999999999999999999885

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-42  Score=307.83  Aligned_cols=244  Identities=24%  Similarity=0.371  Sum_probs=197.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|++|+||++.+.  |+.||+|+++...    ....+.+|+.+++.++|||++++++++....    .
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~   88 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G   88 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----C
Confidence            3679999999999999999999764  8899999997532    3456778999999999999999999976542    4


Q ss_pred             eEEEEecccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..++||||++ ++|.+++...+.  +++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            6899999998 599999976543  8999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...   ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+...              
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------------  230 (278)
T 1byg_A          169 STQ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------  230 (278)
T ss_dssp             ----------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------------
T ss_pred             ccc---cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------------
Confidence            322   23355778999999977 578999999999999999998 99999877655444333210              


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      ........+++.+.++|++||+.||.+|||+.++++
T Consensus       231 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 ----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                            112234568899999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.4e-42  Score=328.77  Aligned_cols=244  Identities=25%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      -.++|++.+.||+|+||+||+|.+.  |+.||+|+++...    ....+.+|+.+++.++||||+++++++....    .
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  260 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G  260 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----S
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----C
Confidence            4679999999999999999999775  7799999997543    3346788999999999999999999986652    4


Q ss_pred             eEEEEecccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQS--LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..++||||+. |+|.+++...+.  +++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            6899999997 699999986543  7999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ...   ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...              
T Consensus       341 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------------  402 (450)
T 1k9a_A          341 STQ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------  402 (450)
T ss_dssp             ---------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT--------------
T ss_pred             ccc---cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------
Confidence            221   22355778999999987 579999999999999999998 99999887665555444221              


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                      .....+..+++.+.+||++||+.||.+|||+.+|++
T Consensus       403 ----------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          403 ----------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            112234578999999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.3e-42  Score=309.01  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCC---cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ...+|++.+.||+|+||+||+|.+..++   ..+++|.+... ........+.+|+.+++.++||||+++++++....  
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   99 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--   99 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC--
Confidence            4568999999999999999999865433   35899988753 33345567789999999999999999999865542  


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++||||++ |+|.+++... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+..
T Consensus       100 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          100 --GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             --SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             --CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence              56799999998 5999999763 5689999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCC----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          183 SRGNE----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       183 ~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      .....    .......++..|+|||.+.+ ..++.++||||||+++|+|++ +.+||.+.........+....       
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-------  249 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------  249 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-------
T ss_pred             ccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-------
Confidence            53322    12233455778999999977 578999999999999999999 677887766555444432211       


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                             ....+..+++.+.++|++||+.||.+|||+.++++
T Consensus       250 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 -----------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   11223457889999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-43  Score=344.93  Aligned_cols=283  Identities=24%  Similarity=0.313  Sum_probs=210.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc-ccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  107 (364)
                      .++|++.+.||+|+||+||+|.+..+|..||+|+++.. ........+.+|+.+++.++||||+++++++...... ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            47999999999999999999999999999999998754 3344566778999999999999999999998662211 126


Q ss_pred             eEEEEecccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc---EEEeecCcc
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLA  180 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~---~~L~Dfg~~  180 (364)
                      ..++||||++ |+|.+++....   .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.   ++|+|||.+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            7899999996 69999998654   6999999999999999999999999999999999999997765   999999999


Q ss_pred             ccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.+......+...   ...........
T Consensus       172 ~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~  246 (676)
T 3qa8_A          172 KELDQG-ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVV  246 (676)
T ss_dssp             CBTTSC-CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCS
T ss_pred             cccccc-cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhh
Confidence            766433 23345678999999999977 67899999999999999999999999775433211000   00000000000


Q ss_pred             cCchhHHHHHhhCCC-CCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          261 IDNPKARRFIKSLPY-SRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ...     ....... ............+++.+.+||++||+.||.+|||+.++|+||||+.+
T Consensus       247 ~~~-----l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          247 YDD-----LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CCC-----CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhh-----hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            000     0000000 00111122344567889999999999999999999999999999765

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.1e-42  Score=327.61  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=207.6

Q ss_pred             eecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ....++|++.+.||+|+||+||+|.++ ++..||+|+++....   ....+.+|+.+++.++||||+++++++. .    
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~----  254 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-K----  254 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S----
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C----
Confidence            345789999999999999999999876 467899999975432   3456789999999999999999999985 3    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                       ...++||||+. |+|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..
T Consensus       255 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          255 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             -SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             -CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence             45799999997 6999999754  3689999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ..... .......++..|+|||++.. ..++.++||||||+++|+|++ |..||.+....+....+.....         
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---------  403 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---------  403 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---------
T ss_pred             cCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            53321 11223345678999999977 578999999999999999998 9999998877666655543111         


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           ...+..+++.+.+||.+||+.||.+|||+++|++
T Consensus       404 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          404 ---------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                 1123467899999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=320.42  Aligned_cols=254  Identities=12%  Similarity=0.088  Sum_probs=199.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc--------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCccee------
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE--------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL------   94 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~------   94 (364)
                      .++|++.+.||+|+||+||+|++..        +++.||+|++...       ..+.+|+.+++.++|||++++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            6899999999999999999999987        4889999998753       245689999999999999984      


Q ss_pred             ---------eeeeccccccccceEEEEeccccccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909           95 ---------KDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus        95 ---------~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                               ++++...    ....++||||++++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus       114 ~~~~~i~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQ----DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             CTTCSCCCCCEEEEET----TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             CCccCccchhhccccC----CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                     4444332    1678999999988999999876  789999999999999999999999999999999999


Q ss_pred             eEEccCC--cEEEeecCccccCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCC
Q 017909          164 LLVNANC--DLKICDFGLARTSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF  234 (364)
Q Consensus       164 Ill~~~~--~~~L~Dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  234 (364)
                      |+++.++  .++|+|||++........       ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9999998  899999999975432211       1234478999999999987 57899999999999999999999999


Q ss_pred             CCCC-hHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHH
Q 017909          235 PGTE-CLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA  313 (364)
Q Consensus       235 ~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  313 (364)
                      .+.. ..................                     .......+..+++.+.+||.+||+.||.+|||+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGP---------------------FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCC---------------------EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhh---------------------hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            8764 222222221111000000                     000011123578999999999999999999999999


Q ss_pred             hc
Q 017909          314 LQ  315 (364)
Q Consensus       314 L~  315 (364)
                      ++
T Consensus       328 ~~  329 (352)
T 2jii_A          328 RN  329 (352)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.9e-42  Score=306.28  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=204.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|.+. ++..||+|++.....   ....+.+|+.+++.++||||+++++++..      .
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   80 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------E   80 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------C
Confidence            4689999999999999999999875 467899999875432   23467789999999999999999998753      3


Q ss_pred             eEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ..++|||++. ++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            4789999997 69999986543  79999999999999999999999999999999999999999999999999987664


Q ss_pred             CCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      .... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+....            
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------  227 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------  227 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------
Confidence            3322 2223445678999999976 568999999999999999998 999998877665554442210            


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                        .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       228 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              01223467889999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-42  Score=313.57  Aligned_cols=267  Identities=22%  Similarity=0.308  Sum_probs=205.0

Q ss_pred             cccce-eeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           28 IDTKY-VPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        28 ~~~~y-~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      +.++| ++++.||+|+||+||++.    +..+++.||+|+++.. ........+.+|+.+++.++||||+++++++....
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            56677 999999999999997775    4457889999999764 33445667789999999999999999999998753


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      .   ...++||||++ ++|.+++... .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus       107 ~---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          107 A---ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             T---TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             C---ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence            2   67899999997 5999988764 59999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .......   ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......     ........... 
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~-  255 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQM-  255 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHH-
T ss_pred             cccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccch-
Confidence            6644332   2233456778999999987 568899999999999999999999996542111     00011100000 


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                         ...........      .........+++.+.+||++||+.||.+|||+.+|++
T Consensus       256 ---~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          256 ---TVLRLTELLER------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ---HHHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---hHHHHHHHHhc------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               00001111111      1123334678999999999999999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=304.95  Aligned_cols=250  Identities=30%  Similarity=0.435  Sum_probs=196.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|+||+||+|.+.  ++.||+|.+...    .....+.+|+.+++.++||||+++++++..       .
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~   73 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN-------P   73 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence            479999999999999999999775  788999998642    244567889999999999999999998863       2


Q ss_pred             EEEEecccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCCeEEccCCc-EEEeecCcc
Q 017909          109 VYLVYELMD-TDLHQIIKSSQ---SLSNDHCKYFVFQLLRGLKYLHS---ANILHRDLKPGNLLVNANCD-LKICDFGLA  180 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~di~~~NIll~~~~~-~~L~Dfg~~  180 (364)
                      .++||||++ ++|.+++....   .++...++.++.|++.||.|||+   +|++|+||||+||+++.++. ++|+|||.+
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            589999997 69999998664   37899999999999999999999   89999999999999998886 799999998


Q ss_pred             ccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          181 RTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ......   .....|+..|+|||++.+ ..++.++||||||+++|+|++|..||............ ....         
T Consensus       154 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~---------  219 (307)
T 2eva_A          154 CDIQTH---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-AVHN---------  219 (307)
T ss_dssp             --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH-HHHT---------
T ss_pred             cccccc---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH-HHhc---------
Confidence            654322   223457899999999987 57899999999999999999999999765332211110 0000         


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc-----CCCccCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ-----HPYISGLY  323 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~-----hp~f~~~~  323 (364)
                                        .........+++.+.++|.+||+.||.+|||++++++     ..++.+..
T Consensus       220 ------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          220 ------------------GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             ------------------TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             ------------------CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence                              0112233568889999999999999999999999987     45555443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-42  Score=310.14  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHh--cCCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH--IKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+.++|++++.||+|+||+||+|.+  +++.||+|++....     ...+..|.+++..  ++||||+++++++......
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            3689999999999999999999976  58899999986532     2233456666665  7999999999987654221


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCeEEccCCcEEEe
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH--------SANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                       ....++||||++ |+|.+++.. ..+++..++.++.||+.||.|||        ++|++|+||||+||+++.++.++|+
T Consensus        78 -~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           78 -STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             -EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             -CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             156899999998 599999854 57999999999999999999999        9999999999999999999999999


Q ss_pred             ecCccccCCCCCcc----cccccccccccCCccccccc-----CCCChhhHHHHHHHHHHHHhC----------CCCCCC
Q 017909          176 DFGLARTSRGNEQF----MTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAEILGR----------KPIFPG  236 (364)
Q Consensus       176 Dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g----------~~pf~~  236 (364)
                      |||++.........    .....|++.|+|||++.+..     .++.++||||||+++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99998654332222    22347899999999997732     234689999999999999999          778754


Q ss_pred             CCh----HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHH
Q 017909          237 TEC----LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE  312 (364)
Q Consensus       237 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  312 (364)
                      ...    ..............+                       ...........++.+.+||.+||+.||.+|||+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  292 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRP-----------------------NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR  292 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCC-----------------------CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCC-----------------------CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence            321    111111111000000                       00000011234567999999999999999999999


Q ss_pred             Hhc
Q 017909          313 ALQ  315 (364)
Q Consensus       313 lL~  315 (364)
                      |++
T Consensus       293 i~~  295 (301)
T 3q4u_A          293 IKK  295 (301)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.2e-43  Score=319.69  Aligned_cols=274  Identities=20%  Similarity=0.274  Sum_probs=207.1

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      ...+....++|++.+.||+|+||+||+|.+. +|+.||+|++....... ....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             THHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             HHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            3455567899999999999999999999754 68899999997543221 122567899999999999999999999877


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCeEEccCCcEE
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQ----SLSNDHCKYFVFQLLRGLKYLHSA---NILHRDLKPGNLLVNANCDLK  173 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~di~~~NIll~~~~~~~  173 (364)
                           ...++||||+. |+|.+++....    .+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++
T Consensus       100 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A          100 -----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             -----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             -----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence                 67899999997 59999997643    499999999999999999999999   999999999999999999999


Q ss_pred             EeecCccccCCCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHH
Q 017909          174 ICDFGLARTSRGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE-----CLNQLKLII  247 (364)
Q Consensus       174 L~Dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-----~~~~~~~i~  247 (364)
                      |+|||++....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||....     .......+.
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999997654332 22344558999999999977 568999999999999999999999995211     000000000


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                      ......           .....      .............+..+.+++.+||+.||.+|||+.+|++|-.-.
T Consensus       254 ~~~~~~-----------~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEK-----------KLEAL------VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSC-----------CSTTS------SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhch-----------hhhhh------cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            000000           00000      000001112223446799999999999999999999999886543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.6e-42  Score=310.45  Aligned_cols=243  Identities=28%  Similarity=0.434  Sum_probs=189.3

Q ss_pred             cccceeee-eeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHH-HhcCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL-RHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~-~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +.++|.+. +.||+|+||+||+|.+..+++.||+|+++..       ....+|+.++ +..+||||+++++++..... .
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-G   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-T
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC-C
Confidence            56778887 7899999999999999999999999998642       2345677777 55589999999999876211 1


Q ss_pred             cceEEEEecccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEEEeecCc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQ--SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL  179 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~L~Dfg~  179 (364)
                      ....++||||+. ++|.+++....  .+++..++.++.||+.||.|||++|++|+||+|+||+++.   ++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            167899999997 59999998754  6999999999999999999999999999999999999998   78899999998


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +.....                       ..++.++|||||||++|+|++|..||.+.........+..           
T Consensus       167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-----------  212 (299)
T 3m2w_A          167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-----------  212 (299)
T ss_dssp             CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-----------
T ss_pred             cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-----------
Confidence            754311                       3467899999999999999999999976543221100000           


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                  .............+..+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       213 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          213 ------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             ------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             ------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence                        00000000011112568899999999999999999999999999999987543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7e-42  Score=307.00  Aligned_cols=254  Identities=21%  Similarity=0.274  Sum_probs=198.6

Q ss_pred             eecccceeeeeeeccCCceeEEEEEecc-CCc--EEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           26 FEIDTKYVPIKPIGRGAYGVVCSSINRE-TNE--KVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        26 ~~~~~~y~i~~~lg~g~~g~V~~~~~~~-~~~--~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      ....++|++++.||+|+||+||+|++.. ++.  .|++|+++.... .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3457899999999999999999998643 333  689999875433 334556778999999999999999999998765


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCc
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~  179 (364)
                            ..++|+|++. ++|.+.+... +.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus        94 ------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           94 ------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             ------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence                  2689999998 6999988764 5799999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          180 ARTSRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       180 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      +.........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+....     
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----  241 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----  241 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC-----
Confidence            8765433221   223455678999999977 568899999999999999999 999998887655554442210     


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                              ........+++.+.++|.+||+.||.+|||+.++++
T Consensus       242 ------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          242 ------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                    011223568899999999999999999999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-42  Score=318.49  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=195.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCC---cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+|++.+.||+|+||+||+|.+..++   ..+++|.++.. ........+.+|+.+++.++||||+++++++....    
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----  163 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----  163 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----
Confidence            46889999999999999999875432   46899988753 33445677889999999999999999999875542    


Q ss_pred             ceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ...++||||+. |+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            56789999998 5999999765 458999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCc----ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          185 GNEQ----FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       185 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ....    ......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+....+....+...          
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~----------  312 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----------  312 (373)
T ss_dssp             --------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT----------
T ss_pred             ccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC----------
Confidence            2221    1233455678999999987 578999999999999999998 78888876554444333211          


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                          .....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       313 --------------------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          313 --------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             --------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                0112234678899999999999999999999999863

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-41  Score=335.06  Aligned_cols=243  Identities=21%  Similarity=0.318  Sum_probs=202.7

Q ss_pred             eeeccCCceeEEEEEe--ccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSIN--RETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.+  +.+++.||+|+++...........+.+|+.+++.++||||+++++++..      ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4899999999999954  4567889999998765555566778899999999999999999999853      3478999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc---c
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ---F  189 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~---~  189 (364)
                      ||+. |+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........   .
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9997 69999999888999999999999999999999999999999999999999999999999999876543321   2


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...                   
T Consensus       529 ~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------------------  588 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------------------  588 (635)
T ss_dssp             ------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------------
T ss_pred             ccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------------
Confidence            223345678999999977 679999999999999999998 99999988776655554321                   


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                 .....+..+++.+.+||++||+.||.+|||+.+|++
T Consensus       589 -----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          589 -----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                       112234568899999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-41  Score=324.79  Aligned_cols=256  Identities=21%  Similarity=0.240  Sum_probs=202.8

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc-eeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI-ALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~  105 (364)
                      .+.++|++++.||+|+||+||+|.+..+++.||||++.......    .+..|+.+++.++|++.+ .+..++...    
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~----   75 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEG----   75 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEET----
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeC----
Confidence            36899999999999999999999999999999999876543322    356799999999875544 444444433    


Q ss_pred             cceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEE---ccCCcEEEeecCccc
Q 017909          106 FKDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll---~~~~~~~L~Dfg~~~  181 (364)
                       ...++||||++++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||++.
T Consensus        76 -~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           76 -DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             -CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence             67899999998899999975 5679999999999999999999999999999999999999   688899999999997


Q ss_pred             cCCCCCc-------ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          182 TSRGNEQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       182 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      .......       ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            6543322       1225678999999999987 5789999999999999999999999988654333333222110000


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ..                       ....+...+++.+.+||..||+.||.+||++.+|++
T Consensus       234 ~~-----------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 AT-----------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HS-----------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cc-----------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            00                       001112467889999999999999999999988764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.6e-42  Score=308.59  Aligned_cols=261  Identities=24%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchh--hchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF--ENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .|..++.||+|+||+||+|.+  +++.+|+|++....  ........+.+|+.+++.++||||+++++++...     ..
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----Cc
Confidence            344559999999999999976  58899999986532  2233456778999999999999999999999877     67


Q ss_pred             EEEEecccc-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          109 VYLVYELMD-TDLHQIIKS---SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .++||||++ ++|.+++..   ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  184 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE  184 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence            899999996 699998864   3569999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          185 GNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       185 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ....  ......|+..|+|||.+.+  .++.++||||||+++|+|++|..||...........+.........       
T Consensus       185 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  255 (307)
T 2nru_A          185 KFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-------  255 (307)
T ss_dssp             SCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-------
T ss_pred             cccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-------
Confidence            3221  2334567999999999865  4789999999999999999999999876543322222221111110       


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                        ....+..       ..........+..+.++|.+||+.||.+|||+.+|+++
T Consensus       256 --~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          256 --TIEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             --CHHHHSC-------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --hhhhhcc-------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              1111110       01111223345678899999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-41  Score=322.22  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=204.8

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...++|++.+.||+|+||+||+|.++. +..||+|+++....   ....+.+|+.+++.++||||+++++++..      
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------  250 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------  250 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------
Confidence            346889999999999999999999875 46799999975432   23467899999999999999999999854      


Q ss_pred             ceEEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ...++||||+. |+|.+++..  ...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++...
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            34689999997 699999964  356999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .... .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...            
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------------  397 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------  397 (452)
T ss_dssp             ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred             CCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence            3322 12223445678999999987 578999999999999999999 99999988766655544321            


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ--HPYISG  321 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~--hp~f~~  321 (364)
                                        .....+..+++.+.+||.+||+.||.+|||+++|++  ..++..
T Consensus       398 ------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 ------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                              011233568899999999999999999999999987  355544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=307.09  Aligned_cols=268  Identities=19%  Similarity=0.329  Sum_probs=205.9

Q ss_pred             cccceeeeeeeccCCceeEEEEE----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSI----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      ..++|++++.||+|+||+||+|.    +..+++.||+|++...  .......+.+|+.+++.++||||+++++++.....
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            46789999999999999999998    4678899999998753  34455677899999999999999999999876532


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                         ...++|||+++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus       117 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 ---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence               46799999997 5999999875 469999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          182 TSRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       182 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ........   .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....     .......+.......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQM  267 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHH
T ss_pred             hccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhh
Confidence            66433221   223345677999999977 568899999999999999999999986431     111111111111000


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .   ..........      .........+++.+.+||++||+.||.+|||+.+|++
T Consensus       268 ~---~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 I---VFHLIELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             H---HHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             h---HHHHHHHhhc------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0   0001111111      0112234678999999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-42  Score=326.30  Aligned_cols=256  Identities=16%  Similarity=0.170  Sum_probs=194.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCC-CCcceeee---------
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKH-DNVIALKD---------   96 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~---------   96 (364)
                      -...|+.++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+++.++| ++...+..         
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34568899999999999999999999999999999873322 22234567789999998876 32211111         


Q ss_pred             ------------eeccccccccceEEEEeccccccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017909           97 ------------VMMPTHRISFKDVYLVYELMDTDLHQIIKS-------SQSLSNDHCKYFVFQLLRGLKYLHSANILHR  157 (364)
Q Consensus        97 ------------~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  157 (364)
                                  ++...........+++|+.+.++|.+++..       .+.+++..+..++.||+.||.|||++||+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                        111111111245789999999999988841       2357888999999999999999999999999


Q ss_pred             CCCCCCeEEccCCcEEEeecCccccCCCCCcccccccccccccCCcccc---------cccCCCChhhHHHHHHHHHHHH
Q 017909          158 DLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL---------CCDNYGTSIDVWSVGCIFAEIL  228 (364)
Q Consensus       158 di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~Di~slG~ll~~l~  228 (364)
                      ||||+|||++.++.+||+|||++......   .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999999998765332   344566 8999999994         2245788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC
Q 017909          229 GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI  308 (364)
Q Consensus       229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  308 (364)
                      +|+.||.+........                                   ........+++.+.+||.+||+.||.+||
T Consensus       312 tg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          312 CADLPNTDDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             HSSCCCCTTGGGSCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HCCCCCCCcchhhhHH-----------------------------------HHHhhcccCCHHHHHHHHHHccCChhhCc
Confidence            9999997653211100                                   00112246789999999999999999999


Q ss_pred             CHHHHhcCCCccCC
Q 017909          309 TVTEALQHPYISGL  322 (364)
Q Consensus       309 s~~elL~hp~f~~~  322 (364)
                      |+.++|+||||+.+
T Consensus       357 t~~~~l~~~~~~~~  370 (413)
T 3dzo_A          357 LPLQAMETPEYEQL  370 (413)
T ss_dssp             CHHHHTTSHHHHHH
T ss_pred             CHHHHHhCHHHHHH
Confidence            99999999999764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.7e-42  Score=312.49  Aligned_cols=285  Identities=20%  Similarity=0.216  Sum_probs=193.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|++  +++.||+|++......   ......++..+..++||||+++++.+..........
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh---hHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            57999999999999999999965  5889999999643221   111223444455579999999998655433333357


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCeEEccCCcEEEeecC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA---------NILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      .++||||++ |+|.+++... ..++..++.++.||+.||.|||++         |++|+||||+|||++.++.++|+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            899999996 6999999764 459999999999999999999999         99999999999999999999999999


Q ss_pred             ccccCCCCC--------cccccccccccccCCcccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 017909          179 LARTSRGNE--------QFMTEYVVTRWYRAPELLLCC------DNYGTSIDVWSVGCIFAEILGRKPIFPGTEC-LNQL  243 (364)
Q Consensus       179 ~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~  243 (364)
                      ++.......        .......|+..|+|||++.+.      ..++.++|||||||++|+|++|..||..... ....
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            997653321        122344689999999998762      2456789999999999999999766533221 1110


Q ss_pred             HHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCccccc---CCCCChHHHHHHHHhcccCCCCCCCHHHH------h
Q 017909          244 KLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSL---YPQADPLALDLLQKMLVFEPSKRITVTEA------L  314 (364)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~el------L  314 (364)
                      ..+....+..+..       .........  ..........   ...+++.+.+||.+||+.||.+|||+.||      +
T Consensus       246 ~~~~~~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          246 MAFQTEVGNHPTF-------EDMQVLVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CTTHHHHCSSCCH-------HHHHHHHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhcccCCCchH-------HHHHhhhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            0000001110000       000111100  0000111111   11244579999999999999999999999      5


Q ss_pred             cCCCccCCCCCCCC
Q 017909          315 QHPYISGLYDPQCN  328 (364)
Q Consensus       315 ~hp~f~~~~~~~~~  328 (364)
                      -++|-++....+.+
T Consensus       317 l~~~~~~~~~~~~~  330 (336)
T 3g2f_A          317 MMIWERNKSVSPTA  330 (336)
T ss_dssp             HHCCCC--------
T ss_pred             HHHHHhcccCCCcc
Confidence            57777665544443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-41  Score=328.71  Aligned_cols=249  Identities=21%  Similarity=0.343  Sum_probs=201.4

Q ss_pred             ccceeeee-eeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIK-PIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~-~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+++.+.+ .||+|+||+||+|.++  .++..||+|+++... .......+.+|+.+++.++||||+++++++..     
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----  407 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----  407 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence            45566666 8999999999999875  355679999997642 23345678899999999999999999999864     


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             34799999998 6999988654 56999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          184 RGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       184 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      ......   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...          
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~----------  555 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----------  555 (613)
T ss_dssp             C--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT----------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------
Confidence            332211   122334578999999977 579999999999999999997 99999988776665554321          


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                          .....+..+++.+.+||.+||+.||.+||++.+|++
T Consensus       556 --------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          556 --------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             --------------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             --------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                112234568899999999999999999999999853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=309.61  Aligned_cols=262  Identities=22%  Similarity=0.261  Sum_probs=204.9

Q ss_pred             ceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           23 QTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        23 ~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      +......++|++++.||+|+||+||+|.+..   .+++|+++...........+.+|+.+++.++||||+++++++... 
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-
Confidence            3333456899999999999999999998753   499999875543333334456799999999999999999999877 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcc
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~  180 (364)
                          ...++||||+. ++|.+++...+ .+++..++.++.||+.||.+||++|++|+||+|+||+++ ++.++|+|||++
T Consensus       102 ----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          102 ----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             ----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             ----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence                77899999997 69999987654 699999999999999999999999999999999999998 679999999987


Q ss_pred             ccCCC-----CCcccccccccccccCCccccc--------ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017909          181 RTSRG-----NEQFMTEYVVTRWYRAPELLLC--------CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII  247 (364)
Q Consensus       181 ~~~~~-----~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~  247 (364)
                      .....     .........|+..|+|||++..        ...++.++||||||+++|+|++|..||...........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            64321     1122334457889999999875        2347889999999999999999999998876655544432


Q ss_pred             HHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          248 SVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ...                             ........++..+.++|.+||+.||.+|||+.++++  .|+.+..
T Consensus       257 ~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          257 TGM-----------------------------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             TTC-----------------------------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             cCC-----------------------------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence            210                             001112357888999999999999999999999995  4555433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.7e-41  Score=324.38  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ...++|++.+.||+|+||+||+|.+.. +..||+|+++....   ....+.+|+.+++.++||||+++++++..      
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------  333 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------  333 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------
Confidence            346789999999999999999999875 46799999975432   23467899999999999999999999854      


Q ss_pred             ceEEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ...++||||+. |+|.+++..  ...+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++...
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            34689999997 699999964  356999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGNE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .... .......++..|+|||++.. ..++.++||||||+++|+|++ |..||.+....+....+...            
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~------------  480 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------  480 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred             CCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence            3221 11223345678999999987 578999999999999999999 99999988766655544321            


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC--CCccC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH--PYISG  321 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h--p~f~~  321 (364)
                                        ........+++.+.+||.+||+.||.+|||+++|++.  .+|..
T Consensus       481 ------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          481 ------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                              0112335688999999999999999999999999863  44443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=303.67  Aligned_cols=257  Identities=24%  Similarity=0.306  Sum_probs=189.9

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc--CCCCcceeeeeecccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI--KHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~~~  104 (364)
                      .+.++|++++.||+|+||+||+|.++  ++.||+|++.....     .....|.+++...  +||||+++++++......
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            35789999999999999999999875  88999999864321     2233455555444  899999999998765321


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCeEEccCCcEEEe
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA--------NILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~di~~~NIll~~~~~~~L~  175 (364)
                       ....++||||+. |+|.+++.. ..+++..++.++.|++.||.|||++        |++|+||||+||+++.++.++|+
T Consensus       107 -~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          107 -WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             -GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             -CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence             156899999997 599999966 4699999999999999999999999        99999999999999999999999


Q ss_pred             ecCccccCCCCCcc----cccccccccccCCcccccccCCCC------hhhHHHHHHHHHHHHhC----------CCCCC
Q 017909          176 DFGLARTSRGNEQF----MTEYVVTRWYRAPELLLCCDNYGT------SIDVWSVGCIFAEILGR----------KPIFP  235 (364)
Q Consensus       176 Dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~------~~Di~slG~ll~~l~~g----------~~pf~  235 (364)
                      |||++.........    .....|+..|+|||++.+. ....      ++|||||||++|+|++|          ..||.
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99998655332221    2245789999999999773 3333      49999999999999999          55554


Q ss_pred             CCCh----HHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH
Q 017909          236 GTEC----LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT  311 (364)
Q Consensus       236 ~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  311 (364)
                      ....    ..............                       ...........+++.+.+||.+||+.||.+|||+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  320 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLR-----------------------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL  320 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCC-----------------------CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhcCCCCchhhhHHHHhhhccC-----------------------ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence            3211    11111111000000                       00000001124566799999999999999999999


Q ss_pred             HHhcC
Q 017909          312 EALQH  316 (364)
Q Consensus       312 elL~h  316 (364)
                      +|++|
T Consensus       321 ell~~  325 (337)
T 3mdy_A          321 RVKKT  325 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6e-40  Score=324.96  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=205.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccC---CcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRET---NEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ..++|++++.||+|+||+||+|.+..+   +..+++|.++.. ........+.+|+.+++.++||||+++++++..    
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            467899999999999999999998643   457999998753 233455677899999999999999999999843    


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++||||++ |+|.+++...+ .+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus       463 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          463 --NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             --CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence              45799999998 69999998654 699999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCc-ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGNEQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+....          
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~----------  609 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------  609 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC----------
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------
Confidence            543221 2233455678999999977 578999999999999999996 999999887766655553311          


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                          ....++.+++.+.+||.+||+.||.+|||+.+|++
T Consensus       610 --------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          610 --------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                11234568899999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=307.54  Aligned_cols=247  Identities=15%  Similarity=0.187  Sum_probs=194.9

Q ss_pred             eeeecccceeeeeeeccCCceeEEEEE-----eccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC---CCCcceee
Q 017909           24 TLFEIDTKYVPIKPIGRGAYGVVCSSI-----NRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK---HDNVIALK   95 (364)
Q Consensus        24 ~~~~~~~~y~i~~~lg~g~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~   95 (364)
                      .+....++|++.+.||+|+||+||+|.     +..+++.||+|+++...     ...+..|+.+++.+.   |+|+++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            344457889999999999999999994     67788999999997532     224456777777775   99999999


Q ss_pred             eeeccccccccceEEEEecccc-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-
Q 017909           96 DVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-----SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-  168 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-  168 (364)
                      +++...     ...++||||++ |+|.+++..     .+.+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus       134 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          134 SAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             EEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred             eeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence            999887     77899999997 699999973     467999999999999999999999999999999999999998 


Q ss_pred             ----------CCcEEEeecCccccCC--CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 017909          169 ----------NCDLKICDFGLARTSR--GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG  236 (364)
Q Consensus       169 ----------~~~~~L~Dfg~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  236 (364)
                                ++.++|+|||++....  ..........||..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                      8999999999996432  23334456678999999999988 5689999999999999999999999854


Q ss_pred             CChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .....                +. .                ......  ...++.+.+++..||+.+|.+|++..+.|.+
T Consensus       288 ~~~~~----------------~~-~----------------~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          288 NEGGE----------------CK-P----------------EGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             EETTE----------------EE-E----------------CSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             CCCCc----------------ee-e----------------chhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            32100                00 0                000000  1235678899999999999999765554443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-39  Score=299.49  Aligned_cols=258  Identities=22%  Similarity=0.292  Sum_probs=196.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHh--cCCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH--IKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~  105 (364)
                      +.++|++.+.||+|+||+||+|.+  +|+.||+|++...     ....+.+|++++..  ++||||+++++++...... 
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~-  111 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-  111 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS-
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc-
Confidence            578999999999999999999987  4889999999643     22345678888887  6899999999998776321 


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCeEEccCCcEEEee
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH--------SANILHRDLKPGNLLVNANCDLKICD  176 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~i~H~di~~~NIll~~~~~~~L~D  176 (364)
                      ....++||||++ |+|.+++.. ..+++..++.++.|++.||.|||        +.|++|+||||+||+++.++.++|+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence            137899999998 599999976 46999999999999999999999        89999999999999999999999999


Q ss_pred             cCccccCCCCCc----ccccccccccccCCcccccccC-----CCChhhHHHHHHHHHHHHhC----------CCCCCCC
Q 017909          177 FGLARTSRGNEQ----FMTEYVVTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAEILGR----------KPIFPGT  237 (364)
Q Consensus       177 fg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g----------~~pf~~~  237 (364)
                      ||++........    ......++..|+|||++.+...     ++.++||||||+++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999876543322    1234568999999999876322     23689999999999999999          6777654


Q ss_pred             ChHH-HHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccc--cCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q 017909          238 ECLN-QLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISS--LYPQADPLALDLLQKMLVFEPSKRITVTEAL  314 (364)
Q Consensus       238 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~elL  314 (364)
                      .... ....+........                      .......  .....++.+.+||.+||+.||.+|||+.+|+
T Consensus       271 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~  328 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQK----------------------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  328 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSC----------------------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CcCcccHHHHHHHHHHHH----------------------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence            2110 0111111100000                      0000000  0123445788999999999999999999998


Q ss_pred             cC
Q 017909          315 QH  316 (364)
Q Consensus       315 ~h  316 (364)
                      +|
T Consensus       329 ~~  330 (342)
T 1b6c_B          329 KT  330 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.5e-40  Score=293.64  Aligned_cols=230  Identities=12%  Similarity=0.048  Sum_probs=186.3

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.++..++||||+++++++...    
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----  103 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR----  103 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC----
Confidence            4689999999999999999999999999999999999865443 34456778999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||++ ++|.+++.. + ....++..++.||+.||.|||++|++|+||||+||+++.++.++|++++.     
T Consensus       104 -~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-----  175 (286)
T 3uqc_A          104 -AGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-----  175 (286)
T ss_dssp             -TEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred             -CcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence             78999999997 599999854 2 46667889999999999999999999999999999999999999984432     


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                                     ++        .++.++|||||||++|+|++|..||.+.............               
T Consensus       176 ---------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~---------------  217 (286)
T 3uqc_A          176 ---------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD---------------  217 (286)
T ss_dssp             ---------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC---------------
T ss_pred             ---------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH---------------
Confidence                           22        3688999999999999999999999875432110000000               


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                               ............+.+++.+.+||.+||+.||.+| |+.|+++.
T Consensus       218 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          218 ---------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             ---------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             ---------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence                     0000011122346789999999999999999999 99999963

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.6e-41  Score=311.14  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=186.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh------chHHHHHHHHHHHHHHhcC---------CCCcce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE------NRIDALRTLRELVLLRHIK---------HDNVIA   93 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~~iv~   93 (364)
                      .++|++++.||+|+||+||+|++  +|+.||+|++.....      .......+.+|+.+++.++         |||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            57999999999999999999987  689999999976432      1223355667888888775         555555


Q ss_pred             ee-----------------eeeccccc--------cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 017909           94 LK-----------------DVMMPTHR--------ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLK  147 (364)
Q Consensus        94 ~~-----------------~~~~~~~~--------~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  147 (364)
                      +.                 +++.....        ......++||||+. |++.+.+.. +.+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            54                 44443100        01278999999997 566666544 67899999999999999999


Q ss_pred             HHH-HCCccccCCCCCCeEEccCC--------------------cEEEeecCccccCCCCCcccccccccccccCCcccc
Q 017909          148 YLH-SANILHRDLKPGNLLVNANC--------------------DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL  206 (364)
Q Consensus       148 ~lH-~~~i~H~di~~~NIll~~~~--------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  206 (364)
                      ||| ++||+||||||+|||++.++                    .+||+|||++......     ...|++.|+|||++.
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence            999 99999999999999999887                    8999999999765332     347899999999998


Q ss_pred             cccCCCChhhHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCccccc
Q 017909          207 CCDNYGTSIDVWSVGCI-FAEILGRKPIFPGTECLN-QLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSL  284 (364)
Q Consensus       207 ~~~~~~~~~Di~slG~l-l~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
                      +. . +.++||||||+. .++++.|..||.+..... ....+.......                        .......
T Consensus       251 g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~  304 (336)
T 2vuw_A          251 GD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------------TKCNTPA  304 (336)
T ss_dssp             CC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------------SCCCSHH
T ss_pred             CC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------------cccchhh
Confidence            73 3 889999998766 677889999985421111 111111110000                        0001112


Q ss_pred             CCCCChHHHHHHHHhcccCCCCCCCHHHHh-cCCCcc
Q 017909          285 YPQADPLALDLLQKMLVFEPSKRITVTEAL-QHPYIS  320 (364)
Q Consensus       285 ~~~~~~~l~~li~~~l~~dP~~Rps~~elL-~hp~f~  320 (364)
                      ++.+++.+.+||++||+.|     |++|+| +||||+
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            2346788999999999977     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-40  Score=328.20  Aligned_cols=248  Identities=20%  Similarity=0.288  Sum_probs=199.7

Q ss_pred             ecccceeeeeeeccCCceeEEEEEecc-CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRE-TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+.++|++.+.||+|+||+||+|.+.. +|+.||+|++... ........+.+|+.+++.++||||+++++++.......
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            357999999999999999999999976 7899999998653 23334556778999999999999999999998764322


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ....++||||++ ++|.+.+..  .+++..++.++.||+.||.|||++||+|+||||+||+++.+ .++|+|||++....
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            233799999998 588877654  79999999999999999999999999999999999999986 89999999997664


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ..    ....|++.|+|||++.+  .++.++||||||+++|+|++|..||.+.....           .+.      .. 
T Consensus       233 ~~----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~~------~~-  288 (681)
T 2pzi_A          233 SF----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LPE------DD-  288 (681)
T ss_dssp             CC----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CCT------TC-
T ss_pred             cC----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccccc-----------ccc------cc-
Confidence            33    34568999999999876  34899999999999999999999886531100           000      00 


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                         .....++.+.+||.+||+.||.+||+..+.+.|+|+..
T Consensus       289 -------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          289 -------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                               00113567889999999999999999999999998853

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.1e-32  Score=268.41  Aligned_cols=187  Identities=18%  Similarity=0.099  Sum_probs=136.2

Q ss_pred             eeccCCceeEEEEEeccCCcEEEEEeccchh--------hchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccccc
Q 017909           37 PIGRGAYGVVCSSINRETNEKVAIKKINNVF--------ENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        37 ~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ....|+.|.+..++....|+.+++|++....        .......++.+|+++|+++ .|+||+++++++.++     .
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----Q  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----S
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----C
Confidence            3456777788888888889999999996532        1233455678999999999 699999999999988     8


Q ss_pred             eEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..||||||++| +|.+.+...++++..   .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            89999999985 999999998888875   47899999999999999999999999999999999999999999877665


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI  233 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p  233 (364)
                      .......+||+.|+|||++.+  .+..++|+|++|++++.+.++..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence            555667789999999999976  467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1e-25  Score=218.07  Aligned_cols=187  Identities=20%  Similarity=0.255  Sum_probs=139.0

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh------chHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE------NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+...+.||+|+||+||++  ...+..+++|.......      ......++.+|+.+++.++||||+++..++...   
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---  411 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL---  411 (540)
T ss_dssp             -----------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET---
T ss_pred             cCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC---
Confidence            3345679999999999999  44578889987643221      122344578999999999999999555555444   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                        ...++||||++ ++|.+++..        +..++.|++.+|.|||++||+|+||||+|||++.  .++|+|||++...
T Consensus       412 --~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          412 --DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             --TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             --CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence              45699999997 699998865        6689999999999999999999999999999998  9999999999876


Q ss_pred             CCCCcc-------cccccccccccCCcccccc-cCCCChhhHHHHHHHHHHHHhCCCCC
Q 017909          184 RGNEQF-------MTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAEILGRKPIF  234 (364)
Q Consensus       184 ~~~~~~-------~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf  234 (364)
                      ......       .....||+.|+|||++... ..|+...|+|+..+-..+.+.++.+|
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            443221       2356789999999999751 24677889999988888777666655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.9e-22  Score=179.48  Aligned_cols=147  Identities=18%  Similarity=0.164  Sum_probs=114.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----------------HHHHHHHHHHHHHHhcCCCCcc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----------------IDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      ...|++++.||+|++|.||+|.+ .+|+.||+|+++......                .....+.+|+.+++.++  | +
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            34455669999999999999999 789999999996432211                23456779999999998  4 6


Q ss_pred             eeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909           93 ALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                      ++.+++. .     ...++||||++| +|.+ +      .......++.|++.||.+||++|++|+||||+|||++ ++.
T Consensus       165 ~v~~~~~-~-----~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          165 AVPKVYA-W-----EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SSCCEEE-E-----ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred             CcCeEEe-c-----cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence            6666542 2     445999999974 8876 3      2234567999999999999999999999999999999 999


Q ss_pred             EEEeecCccccCCCCCcccccccccccccCCcccc
Q 017909          172 LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL  206 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  206 (364)
                      ++|+|||++...             ..+.|||.+.
T Consensus       231 vkl~DFG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          231 IWIIDFPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             EEECCCTTCEET-------------TSTTHHHHHH
T ss_pred             EEEEECCCCeEC-------------CCCCHHHHHH
Confidence            999999998533             2356787764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2.2e-20  Score=164.15  Aligned_cols=139  Identities=18%  Similarity=0.109  Sum_probs=108.1

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcE--EEEEeccchhhc----------------------hHHHHHHHHHHHHHHhc
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEK--VAIKKINNVFEN----------------------RIDALRTLRELVLLRHI   86 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~--~aiK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l   86 (364)
                      -|++.+.||+|++|.||+|.+..+|+.  ||+|+++.....                      ......+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778888  999987543111                      11123567899999999


Q ss_pred             CCCCc--ceeeeeeccccccccceEEEEeccccc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccc
Q 017909           87 KHDNV--IALKDVMMPTHRISFKDVYLVYELMDT------DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH-SANILHR  157 (364)
Q Consensus        87 ~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~g------~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~  157 (364)
                      .|+++  +.++..         ...++||||+++      +|.+....   .++..+..++.|++.+|.+|| +.|++|+
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            87754  333322         345899999953      66665432   345678889999999999999 9999999


Q ss_pred             CCCCCCeEEccCCcEEEeecCccccC
Q 017909          158 DLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       158 di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=2.1e-17  Score=151.28  Aligned_cols=140  Identities=14%  Similarity=0.149  Sum_probs=97.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc---------------hHH-----HHHHHHHHHHHHhcCCC
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN---------------RID-----ALRTLRELVLLRHIKHD   89 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------~~~-----~~~~~~e~~~l~~l~h~   89 (364)
                      .-|++++.||.|++|.||+|.+. +|+.||||+++.....               ...     .....+|...|.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34999999999999999999875 6899999987532110               000     01113466666666433


Q ss_pred             CcceeeeeeccccccccceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc
Q 017909           90 NVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA  168 (364)
Q Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~  168 (364)
                      ++....-+. .      ...+|||||++| +|..+      .....+..++.||+.+|.+||++|++||||||.|||++.
T Consensus       174 gv~vp~p~~-~------~~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          174 GFPVPEPIA-Q------SRHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             TCSCCCEEE-E------ETTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred             CCCCCeeee-c------cCceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence            332111111 1      223799999986 55432      222345678899999999999999999999999999988


Q ss_pred             CC----------cEEEeecCccccC
Q 017909          169 NC----------DLKICDFGLARTS  183 (364)
Q Consensus       169 ~~----------~~~L~Dfg~~~~~  183 (364)
                      ++          .+.|+||+.+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999987554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=7.8e-12  Score=109.60  Aligned_cols=138  Identities=15%  Similarity=0.111  Sum_probs=106.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      +.|++...++.|+.+.||++...  +..+++|+........  ...+.+|+.+++.+. +..++++++++...     +.
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~   84 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GW   84 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----Cc
Confidence            56999999999999999999643  6899999987532111  124567888888884 66788888887655     67


Q ss_pred             EEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 017909          109 VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS------------------------------------  151 (364)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------  151 (364)
                      .++|||+++| ++.+.+     .+......++.+++.+|..||+                                    
T Consensus        85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            8999999997 776542     1223345788899999999998                                    


Q ss_pred             -----------------------CCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          152 -----------------------ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       152 -----------------------~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                                             ..++|||+++.||+++.++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   348999999999999876556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.10  E-value=9.5e-11  Score=102.27  Aligned_cols=136  Identities=15%  Similarity=0.039  Sum_probs=94.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC--cceeeeeeccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN--VIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~  105 (364)
                      ....|.+....+.|..+.||++.. .+|..+++|......     ...+..|+.+++.+.+.+  +++++.+....    
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~----   87 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA----   87 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS----
T ss_pred             hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC----
Confidence            344566655555667799999964 456789999976431     123456888888874333  55677776554    


Q ss_pred             cceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q 017909          106 FKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN-------------------------------  153 (364)
Q Consensus       106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------------------------------  153 (364)
                       +..++|||+++| ++ + .   ...+   ...++.+++..|..||+..                               
T Consensus        88 -~~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           88 -GRDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             -SCEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             -CCCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence             568999999987 55 3 1   1122   2245667777777777643                               


Q ss_pred             ---------------------------ccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          154 ---------------------------ILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       154 ---------------------------i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                                                 ++|+|++|.||+++.++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                       89999999999998776667999998743

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.07  E-value=6.8e-10  Score=101.84  Aligned_cols=144  Identities=13%  Similarity=0.164  Sum_probs=103.3

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEecc--chhhchHHHHHHHHHHHHHHhcC--CCCcceeeeeeccccccccce
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRHIK--HDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ..++.|+.|.++.||++...  +..+++|+..  .... ......+.+|+.+++.+.  +..+++++..+.....  .+.
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~  115 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGR  115 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSS
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCC
Confidence            34678899999999999654  5689999876  3211 112335567899998886  4557888887765422  245


Q ss_pred             EEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 017909          109 VYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS------------------------------------  151 (364)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------  151 (364)
                      .++|||+++| .+.+.  ....++......++.+++.+|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            7999999997 44221  12347788888999999999999997                                    


Q ss_pred             ----------------------CCccccCCCCCCeEEccCCc--EEEeecCccccC
Q 017909          152 ----------------------ANILHRDLKPGNLLVNANCD--LKICDFGLARTS  183 (364)
Q Consensus       152 ----------------------~~i~H~di~~~NIll~~~~~--~~L~Dfg~~~~~  183 (364)
                                            ..++|||+++.||+++.++.  +.|+||+.+...
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                  35899999999999997753  689999987643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=3.7e-10  Score=101.13  Aligned_cols=186  Identities=18%  Similarity=0.187  Sum_probs=118.1

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCC--cceeeeeeccccccccceEEE
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDN--VIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      ++.++.|....||++.     ..+++|+....    .....+.+|+.+++.+ .+..  +++++......  ......|+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceE
Confidence            4568999999999873     56999986532    2345567899999887 3333  33444333222  11234689


Q ss_pred             Eeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 017909          112 VYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS---------------------------------------  151 (364)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------  151 (364)
                      ||++++| ++.+...  ..++..+...++.+++..+..||+                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999997 5544322  346777788888888888888886                                       


Q ss_pred             -------------------CCccccCCCCCCeEEcc--CCcEEEeecCccccCCCCCcccccccccccccCCcccc----
Q 017909          152 -------------------ANILHRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL----  206 (364)
Q Consensus       152 -------------------~~i~H~di~~~NIll~~--~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~----  206 (364)
                                         ..++|+|+++.||+++.  ...+.|+||+.+................ .-..|+...    
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~  250 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHH
Confidence                               13699999999999998  4568899999876542211111100000 001222111    


Q ss_pred             cccC---------CCChhhHHHHHHHHHHHHhCCCCC
Q 017909          207 CCDN---------YGTSIDVWSVGCIFAEILGRKPIF  234 (364)
Q Consensus       207 ~~~~---------~~~~~Di~slG~ll~~l~~g~~pf  234 (364)
                      ....         .....+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0000         112368999999999999999876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=1.5e-06  Score=77.58  Aligned_cols=134  Identities=20%  Similarity=0.200  Sum_probs=89.0

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC---CcceeeeeeccccccccceEEE
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD---NVIALKDVMMPTHRISFKDVYL  111 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~l  111 (364)
                      ++.++.|....||++     |..+++|+...    ......+..|+.+++.+.+.   .+++++.+....    .+..++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEE
Confidence            456788888899988     56789998532    22345667899999998642   245555555321    156789


Q ss_pred             Eeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 017909          112 VYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA--------------------------------------  152 (364)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------------------------------------  152 (364)
                      ||++++| ++.+...  ..++......++.++...|..||+.                                      
T Consensus        91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9999997 5544211  1234444444555555555554432                                      


Q ss_pred             ----------------------CccccCCCCCCeEEcc---CCc-EEEeecCccccC
Q 017909          153 ----------------------NILHRDLKPGNLLVNA---NCD-LKICDFGLARTS  183 (364)
Q Consensus       153 ----------------------~i~H~di~~~NIll~~---~~~-~~L~Dfg~~~~~  183 (364)
                                            .++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                  2589999999999987   455 489999987654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.54  E-value=2e-06  Score=75.22  Aligned_cols=131  Identities=18%  Similarity=0.200  Sum_probs=90.2

Q ss_pred             eccCCce-eEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceEEEEecc
Q 017909           38 IGRGAYG-VVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYEL  115 (364)
Q Consensus        38 lg~g~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (364)
                      +..|..+ .||+......+..+++|+....     ....+..|+..|+.+. +--+++++.++.+.     +..++||++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~  101 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTA  101 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEEC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEe
Confidence            3445444 6999888777888999987532     2334567888888774 33467777777666     678999999


Q ss_pred             ccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 017909          116 MDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA------------------------------------------  152 (364)
Q Consensus       116 ~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~------------------------------------------  152 (364)
                      ++| ++.+.....    ......+..++...|..||+.                                          
T Consensus       102 l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          102 IPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             eCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            987 665544321    122233455555555555531                                          


Q ss_pred             ----------------CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 ----------------NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ----------------~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                                      .++|||+.+.||+++.++.+-|+||+.+..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                            168999999999999877778999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.27  E-value=1.5e-05  Score=66.20  Aligned_cols=97  Identities=14%  Similarity=0.096  Sum_probs=66.5

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCCcEEEeecCccccCCCCCccccccccc
Q 017909          119 DLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT  196 (364)
Q Consensus       119 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~  196 (364)
                      +|.++++. +.+++++++|.++.|.+.+|..+-. +.-...=+.|..|++..+|+|.+.+ ..+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            79999975 5789999999999999999887632 2222344667899999999988764 1110            112


Q ss_pred             ccccCCcccccccCCCChhhHHHHHHHHHHHHhC
Q 017909          197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR  230 (364)
Q Consensus       197 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  230 (364)
                      ..+.|||...  ...+.+.-|||||+++|.-+--
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhc
Confidence            3466888753  3567899999999999999833

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.14  E-value=1.5e-05  Score=73.83  Aligned_cols=78  Identities=18%  Similarity=0.080  Sum_probs=46.6

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhh--c---hHHHHHHHHHHHHHHhcCC--C-Ccceeeeeeccccccc
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE--N---RIDALRTLRELVLLRHIKH--D-NVIALKDVMMPTHRIS  105 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~  105 (364)
                      ..+.+|.|..+.||++....++..+++|.......  .   .....+...|..+++.+..  + .+++++.+.  .    
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~----  107 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----  107 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence            35688999999999997766678899997642111  0   0112334568888877632  3 344555432  2    


Q ss_pred             cceEEEEeccccc
Q 017909          106 FKDVYLVYELMDT  118 (364)
Q Consensus       106 ~~~~~lv~e~~~g  118 (364)
                       ...++|||+++|
T Consensus       108 -~~~~lvmE~l~g  119 (397)
T 2olc_A          108 -EMAVTVMEDLSH  119 (397)
T ss_dssp             -TTTEEEECCCTT
T ss_pred             -CccEEEEEeCCC
Confidence             234799999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.11  E-value=4.5e-05  Score=68.74  Aligned_cols=31  Identities=26%  Similarity=0.411  Sum_probs=27.5

Q ss_pred             CCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          152 ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       152 ~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      ..+||||+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4699999999999998888999999998743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.94  E-value=2.4e-05  Score=71.22  Aligned_cols=85  Identities=7%  Similarity=0.072  Sum_probs=51.5

Q ss_pred             eeeeeee-ccCCceeEEEEEec--c----CCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcC-C--CCcceeeeeecc
Q 017909           32 YVPIKPI-GRGAYGVVCSSINR--E----TNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIK-H--DNVIALKDVMMP  100 (364)
Q Consensus        32 y~i~~~l-g~g~~g~V~~~~~~--~----~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~  100 (364)
                      ....+.| +.|....+|++...  .    ++..+++|....... .......+..|+.+++.+. +  -.+++++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445778 88889999988643  1    256899998754320 0000123345777777663 2  356677776644


Q ss_pred             ccccccceEEEEeccccc
Q 017909          101 THRISFKDVYLVYELMDT  118 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~g  118 (364)
                      ...  .+..++|||+++|
T Consensus       102 ~~~--~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 GDV--LGTPFFLMDYVEG  117 (357)
T ss_dssp             STT--TSSCEEEEECCCC
T ss_pred             CCc--cCCceEEEEecCC
Confidence            321  1356899999976

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.83  E-value=0.00011  Score=65.23  Aligned_cols=68  Identities=13%  Similarity=0.028  Sum_probs=41.1

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccccceEEEEe
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      ++.|+.|....+|++      ..+++|+.........+   ...|+.+++.+. +.-.++++....+       .-++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~---r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYIN---RANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCC---HHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeC---HHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEE
Confidence            788999999999998      46899988643111111   124666666653 2222556554322       236899


Q ss_pred             ccc-cc
Q 017909          114 ELM-DT  118 (364)
Q Consensus       114 e~~-~g  118 (364)
                      +|+ +|
T Consensus        87 e~i~~g   92 (301)
T 3dxq_A           87 RYIAGA   92 (301)
T ss_dssp             ECCTTC
T ss_pred             eecCCC
Confidence            999 65

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=0.00021  Score=66.64  Aligned_cols=32  Identities=19%  Similarity=0.412  Sum_probs=27.7

Q ss_pred             HCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          151 SANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       151 ~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      ...++|||+++.||+++.++ +.|+||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            34699999999999999876 999999988654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.50  E-value=0.0017  Score=57.74  Aligned_cols=74  Identities=12%  Similarity=0.013  Sum_probs=54.3

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC---CCCcceeeeeeccccccccceE
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK---HDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .-.+.|+.|....+|++..  ++..+++|+....     ....+..|+..|+.+.   ...+++++......     +..
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~  106 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHS  106 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----Cce
Confidence            3457789999999999964  4678999987542     1334567888887773   35677777776554     678


Q ss_pred             EEEeccccc
Q 017909          110 YLVYELMDT  118 (364)
Q Consensus       110 ~lv~e~~~g  118 (364)
                      ++|||+++|
T Consensus       107 ~lvme~l~G  115 (312)
T 3jr1_A          107 FLLLEALNK  115 (312)
T ss_dssp             EEEEECCCC
T ss_pred             EEEEEeccC
Confidence            999999975

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.0019  Score=59.02  Aligned_cols=136  Identities=14%  Similarity=0.201  Sum_probs=77.8

Q ss_pred             eeeeccCCceeEEEEEecc-------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccccc
Q 017909           35 IKPIGRGAYGVVCSSINRE-------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++.|..|-...+|++....       ++..+++|+......   ......+|..+++.+. +.-.++++..+.       
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-------  124 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFP-------  124 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcC-------
Confidence            4567788888999997642       357899999743211   1223346888887773 333456665542       


Q ss_pred             ceEEEEeccccc-cHH--------------HHH---HhC-----CCCC--HHHHHHHHHHHHH-----------------
Q 017909          107 KDVYLVYELMDT-DLH--------------QII---KSS-----QSLS--NDHCKYFVFQLLR-----------------  144 (364)
Q Consensus       107 ~~~~lv~e~~~g-~L~--------------~~l---~~~-----~~~~--~~~~~~i~~qi~~-----------------  144 (364)
                      +  .+|+||++| ++.              +.+   ...     +...  ...+..+..++..                 
T Consensus       125 ~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          125 E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence            1  389999875 221              111   111     1122  3455555544422                 


Q ss_pred             --HHHHH----HHC----CccccCCCCCCeEEccC----CcEEEeecCcccc
Q 017909          145 --GLKYL----HSA----NILHRDLKPGNLLVNAN----CDLKICDFGLART  182 (364)
Q Consensus       145 --~l~~l----H~~----~i~H~di~~~NIll~~~----~~~~L~Dfg~~~~  182 (364)
                        .+..|    ...    .+||+|+.+.||+++.+    +.+.|+||..+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              12222    222    38999999999999876    6899999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.15  E-value=0.0017  Score=60.60  Aligned_cols=72  Identities=15%  Similarity=0.094  Sum_probs=46.3

Q ss_pred             eeeeeccCCceeEEEEEecc-------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccc
Q 017909           34 PIKPIGRGAYGVVCSSINRE-------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  105 (364)
                      -++.|+.|....+|++....       .+..+++|+....  ..  ...+..|+.+++.+. +.-.+++++.+. +    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~-~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFS-G----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEET-T----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC-C----
Confidence            35678888889999997542       2578999998432  11  123346778887774 323356665542 1    


Q ss_pred             cceEEEEeccccc
Q 017909          106 FKDVYLVYELMDT  118 (364)
Q Consensus       106 ~~~~~lv~e~~~g  118 (364)
                          .+|++|++|
T Consensus       148 ----g~v~e~l~G  156 (429)
T 1nw1_A          148 ----GRLEEYIPS  156 (429)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----CEEEEEeCC
Confidence                388999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.03  E-value=0.0034  Score=55.90  Aligned_cols=143  Identities=15%  Similarity=0.101  Sum_probs=72.8

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC--cceeeeeecccc-ccccceEE
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN--VIALKDVMMPTH-RISFKDVY  110 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~-~~~~~~~~  110 (364)
                      -++.|+.|....+|++...  +..+++|.......    ...+..|+.+++.+....  +++++....... ....+..+
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            3466778888899998653  34789998865211    112234556655553112  333332210000 00014568


Q ss_pred             EEecccccc-H-----HH---------HHH-hCCCC--------CHHHHHH---------------HHHHHHHHHHHHHH
Q 017909          111 LVYELMDTD-L-----HQ---------IIK-SSQSL--------SNDHCKY---------------FVFQLLRGLKYLHS  151 (364)
Q Consensus       111 lv~e~~~g~-L-----~~---------~l~-~~~~~--------~~~~~~~---------------i~~qi~~~l~~lH~  151 (364)
                      +++++++|. +     ..         .+. ....+        ....-..               +...+...+..+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999762 1     00         011 11111        1110000               00113344555542


Q ss_pred             -------CCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          152 -------ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       152 -------~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                             .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                   2589999999999999876568999997753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.0024  Score=57.25  Aligned_cols=32  Identities=28%  Similarity=0.415  Sum_probs=27.4

Q ss_pred             CccccCCCCCCeEEccC----CcEEEeecCccccCC
Q 017909          153 NILHRDLKPGNLLVNAN----CDLKICDFGLARTSR  184 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~----~~~~L~Dfg~~~~~~  184 (364)
                      .++|||+.+.||+++.+    +.+.|+||+.+....
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            59999999999999874    689999999886543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.00  E-value=0.0035  Score=57.05  Aligned_cols=72  Identities=13%  Similarity=0.109  Sum_probs=40.5

Q ss_pred             eeeeccCCceeEEEEEecc--------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCC-cceeeeeeccccccc
Q 017909           35 IKPIGRGAYGVVCSSINRE--------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN-VIALKDVMMPTHRIS  105 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~  105 (364)
                      ++.++.|....+|++....        .+..+++|+.........   ....|..+++.+...+ .++++...  .    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~---~~~~E~~~l~~L~~~g~~P~~~~~~--~----  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELY---NTISEFEVYKTMSKYKIAPQLLNTF--N----  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTS---CHHHHHHHHHHHHHTTSSCCEEEEE--T----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcccee---cHHHHHHHHHHHHhcCCCCceEEec--C----
Confidence            4567788888999997653        136899998864321111   1235666776663222 44565443  1    


Q ss_pred             cceEEEEeccccc
Q 017909          106 FKDVYLVYELMDT  118 (364)
Q Consensus       106 ~~~~~lv~e~~~g  118 (364)
                         -++|++|++|
T Consensus       109 ---~~~v~e~i~G  118 (369)
T 3c5i_A          109 ---GGRIEEWLYG  118 (369)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CcEEEEEecC
Confidence               1689999876

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.89  E-value=0.011  Score=52.65  Aligned_cols=29  Identities=31%  Similarity=0.381  Sum_probs=25.1

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .++|||+++.||+++ + .+.|+||+.+...
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            489999999999999 4 8999999887543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.85  E-value=0.0069  Score=56.83  Aligned_cols=73  Identities=15%  Similarity=0.134  Sum_probs=45.3

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeccccccccceEEEE
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV-IALKDVMMPTHRISFKDVYLV  112 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv  112 (364)
                      -++.|+.|-...+|++.....+..+++|+.........+   ...|..+++.+...++ +++++.+. +        .+|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~-~--------G~v  179 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT-N--------GRI  179 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET-T--------EEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC-C--------eEE
Confidence            356788888899999976544578999988542211111   1368888888854333 56666652 2        359


Q ss_pred             eccccc
Q 017909          113 YELMDT  118 (364)
Q Consensus       113 ~e~~~g  118 (364)
                      ++|++|
T Consensus       180 ~e~I~G  185 (458)
T 2qg7_A          180 EEFMDG  185 (458)
T ss_dssp             EECCCS
T ss_pred             EEeeCC
Confidence            999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.83  E-value=0.013  Score=51.22  Aligned_cols=77  Identities=12%  Similarity=0.008  Sum_probs=51.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCC---Ccceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHD---NVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~  105 (364)
                      .....-++.+|.|..+.||+++. .+|+.+++|+........  ...+..|+..|+.+...   .+++++..        
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--------   82 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW--------   82 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE--------
T ss_pred             CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec--------
Confidence            34567788999999999999975 468899999875432221  12345688888887422   23444443        


Q ss_pred             cceEEEEecccc
Q 017909          106 FKDVYLVYELMD  117 (364)
Q Consensus       106 ~~~~~lv~e~~~  117 (364)
                       +..++|||++.
T Consensus        83 -~~~~lv~e~l~   93 (288)
T 3f7w_A           83 -DDRTLAMEWVD   93 (288)
T ss_dssp             -ETTEEEEECCC
T ss_pred             -cCceEEEEeec
Confidence             22378999885

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.65  E-value=0.017  Score=51.84  Aligned_cols=31  Identities=26%  Similarity=0.420  Sum_probs=27.4

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                      .++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            4899999999999998888999999877543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.11  E-value=0.027  Score=51.88  Aligned_cols=29  Identities=28%  Similarity=0.495  Sum_probs=24.8

Q ss_pred             ccccCCCCCCeEE------ccCCcEEEeecCcccc
Q 017909          154 ILHRDLKPGNLLV------NANCDLKICDFGLART  182 (364)
Q Consensus       154 i~H~di~~~NIll------~~~~~~~L~Dfg~~~~  182 (364)
                      +||+|+.+.||++      +.+..+.++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      4466799999998753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.00  E-value=0.013  Score=54.32  Aligned_cols=73  Identities=12%  Similarity=0.059  Sum_probs=44.6

Q ss_pred             eeeeeccCCceeEEEEEeccC-------CcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeeccccccc
Q 017909           34 PIKPIGRGAYGVVCSSINRET-------NEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  105 (364)
                      -++.+..|-...+|++.....       +..+++|+.........+   ..+|..+++.+. +.-.+++++.+.      
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~id---R~~E~~~l~~L~~~gi~P~l~~~~~------  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYD---SKVELDVFRYLSNINIAPNIIADFP------  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCC---HHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcC---HHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence            345677788889999976521       578999997542211112   235667776663 333455554321      


Q ss_pred             cceEEEEeccccc
Q 017909          106 FKDVYLVYELMDT  118 (364)
Q Consensus       106 ~~~~~lv~e~~~g  118 (364)
                         -+.|++|++|
T Consensus       145 ---~~~I~efI~G  154 (424)
T 3mes_A          145 ---EGRIEEFIDG  154 (424)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CCEEEEEeCC
Confidence               2789999976

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.70  E-value=0.098  Score=49.05  Aligned_cols=63  Identities=8%  Similarity=0.014  Sum_probs=16.8

Q ss_pred             eeeeeccCCceeEEEEEeccCCcEEEE------EeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeec
Q 017909           34 PIKPIGRGAYGVVCSSINRETNEKVAI------KKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMM   99 (364)
Q Consensus        34 i~~~lg~g~~g~V~~~~~~~~~~~~ai------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (364)
                      +.+.+|   ||.||++.......+||+      |..+...........+.++..+.+.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345555   999999988765567888      665543333444455677888888889999999987654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	364
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-95
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-89
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-86
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-77
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-74
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-74
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-74
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-71
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-71
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-71
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-68
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-67
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-67
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-66
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-66
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-65
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-65
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-64
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-64
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-63
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-63
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-62
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-61
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-58
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-58
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-57
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-56
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-55
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-53
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-49
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-48
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-47
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-35
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-23

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  284 bits (728), Expect = 6e-95
 Identities = 163/345 (47%), Positives = 229/345 (66%), Gaps = 6/345 (1%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
            +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+ +L
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKIL 60

Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLL 143
              +H+N+I + D++        KDVYLV  LM  DL++++K+ Q LSNDH  YF++Q+L
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQIL 119

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE---QFMTEYVVTRWYR 200
           RGLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +  +     F+TEYV TRWYR
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ + G+  + DL  
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
           I N KAR ++ SLP+      + L+P AD  ALDLL KML F P KRI V +AL HPY+ 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299

Query: 321 GLYDPQCNPPAQVPLSLDID-ENIGEQMIRQMMWNETLHYHPEAR 364
             YDP   P A+ P   D++ +++ ++ ++++++ ET  + P  R
Sbjct: 300 QYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 344

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  271 bits (693), Expect = 1e-89
 Identities = 145/349 (41%), Positives = 218/349 (62%), Gaps = 5/349 (1%)

Query: 14  RGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDA 73
            G +   + +T +E+   Y  ++P+G GAYG VCS+++  T  KVAIKK+   F++ + A
Sbjct: 2   SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61

Query: 74  LRTLRELVLLRHIKHDNVIALKDVMMPTHRIS-FKDVYLVYELMDTDLHQIIKSSQSLSN 132
            R  REL LL+H++H+NVI L DV  P   +  F D YLV   M TDL +++K  + L  
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGE 120

Query: 133 DHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTE 192
           D  ++ V+Q+L+GL+Y+H+A I+HRDLKPGNL VN +C+LKI DFGLAR +   +  MT 
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT 252
           YVVTRWYRAPE++L    Y  ++D+WSVGCI AE++  K +F G++ L+QLK I+ V GT
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE 312
                ++ + + +A+ ++K LP       +S+   A PLA++LL+KMLV +  +R+T  E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 313 ALQHPYISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMMWNETLHYHP 361
           AL HPY   L+D +  P  Q       D +      +++ + E L + P
Sbjct: 298 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  262 bits (670), Expect = 4e-86
 Identities = 149/347 (42%), Positives = 227/347 (65%), Gaps = 7/347 (2%)

Query: 17  HYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRT 76
           +   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ I A RT
Sbjct: 5   YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 64

Query: 77  LRELVLLRHIKHDNVIALKDVM-MPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHC 135
            REL LL+H+KH+NVI L DV         F DVYLV  LM  DL+ I+K  Q L++DH 
Sbjct: 65  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHV 123

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV 195
           ++ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +   +  MT YV 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVA 180

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE 255
           TRWYRAPE++L   +Y  ++D+WSVGCI AE+L  + +FPGT+ ++QLKLI+ + GT   
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
             L+ I +  AR +I+SL      + ++++  A+PLA+DLL+KMLV +  KRIT  +AL 
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

Query: 316 HPYISGLYDPQCNPPAQVPLSLDIDE-NIGEQMIRQMMWNETLHYHP 361
           H Y +  +DP  + P   P     +  ++     + + ++E + + P
Sbjct: 301 HAYFAQYHDP-DDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 8e-77
 Identities = 115/304 (37%), Positives = 158/304 (51%), Gaps = 14/304 (4%)

Query: 35  IKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL---RTLRELVLLRHIKHDNV 91
           +  +G G +  V  + ++ TN+ VAIKKI     +          LRE+ LL+ + H N+
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           I L D       I      LV++ M+TD    I  +S  L+  H K ++   L+GL+YLH
Sbjct: 63  IGLLDAFGHKSNI-----SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
              ILHRDLKP NLL++ N  LK+ DFGLA++     +  T  VVTRWYRAPELL     
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+W+VGCI AE+L R P  PG   L+QL  I    GT  E     + +       
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
           KS P   G  +  ++  A    LDL+Q + +F P  RIT T+AL+  Y S    P   P 
Sbjct: 238 KSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT--PG 292

Query: 331 AQVP 334
            Q+P
Sbjct: 293 CQLP 296

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 1e-74
 Identities = 102/304 (33%), Positives = 153/304 (50%), Gaps = 9/304 (2%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  +  IG+G +G V  + +R+T +KVA+KK+    E     +  LRE+ +L+ +KH+N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 91  VIALKDVM---MPTHRISFKDVYLVYELMDTDLHQI-IKSSQSLSNDHCKYFVFQLLRGL 146
           V+ L ++       +      +YLV++  + DL  +        +    K  +  LL GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSRGNEQFMTEYVVTRWYRAP 202
            Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR             T  VVT WYR P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           ELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + G+        +D
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 263 NPKARRFIKSLPYSRGTHISSLYP-QADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
           N +    ++ +   +      L     DP ALDL+ K+LV +P++RI   +AL H +   
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

Query: 322 LYDP 325
              P
Sbjct: 311 DPMP 314

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 2e-74
 Identities = 111/297 (37%), Positives = 162/297 (54%), Gaps = 9/297 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            +  ++ IG G YGVV  + N+ T E VA+KKI    E        +RE+ LL+ + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKY 148
           ++ L DV+   +++     YLV+E +  DL + + +S    +     K ++FQLL+GL +
Sbjct: 63  IVKLLDVIHTENKL-----YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
            HS  +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             Y T++D+WS+GCIFAE++ R+ +FPG   ++QL  I    GT  E             
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVTSMPD 235

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
           +  S P       S + P  D     LL +ML ++P+KRI+   AL HP+   +  P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 2e-74
 Identities = 137/359 (38%), Positives = 213/359 (59%), Gaps = 22/359 (6%)

Query: 17  HYYT--MWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL 74
            +Y+  +  + F +  +Y  +KPIG GA G+VC++ +   +  VAIKK++  F+N+  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 75  RTLRELVLLRHIKHDNVIALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSND 133
           R  RELVL++ + H N+I+L +V  P   +  F+DVYLV ELMD +L Q+I+       +
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH--E 119

Query: 134 HCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEY 193
              Y ++Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLAR + G    MT Y
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPY 178

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ 253
           VVTR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I   GT 
Sbjct: 179 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQA------------DPLALDLLQKMLV 301
               ++ +  P  R ++++ P   G     L+P +               A DLL KMLV
Sbjct: 238 CPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 302 FEPSKRITVTEALQHPYISGLYDPQC--NPPAQVPLSLDIDENIGEQMIRQMMWNETLH 358
            +P+KRI+V +ALQHPYI+  YDP     PP Q+      +     +  +++++ E ++
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 3e-74
 Identities = 99/311 (31%), Positives = 159/311 (51%), Gaps = 15/311 (4%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           Y   K IG G++GVV  +   ++ E VAIKK+        D     REL ++R + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNI 75

Query: 92  IALKDVMM-PTHRISFKDVYLVYELMDTDLHQII----KSSQSLSNDHCKYFVFQLLRGL 146
           + L+        +     + LV + +   ++++     ++ Q+L   + K +++QL R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 147 KYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELL 205
            Y+HS  I HRD+KP NLL++ +   LK+CDFG A+     E  ++ Y+ +R+YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPELI 194

Query: 206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
               +Y +SIDVWS GC+ AE+L  +PIFPG   ++QL  II V GT     +  ++   
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
                  +     T +    P+  P A+ L  ++L + P+ R+T  EA  H +   L DP
Sbjct: 255 TEFKFPQIKAHPWTKV--FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 326 QCNPPAQVPLS 336
               P      
Sbjct: 313 NVKLPNGRDTP 323

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 2e-71
 Identities = 73/325 (22%), Positives = 132/325 (40%), Gaps = 24/325 (7%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            +  I  +G G  GVV    ++ +   +A K I+   +  I   + +REL +L       
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPY 65

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++            S  ++ +  E MD   L Q++K +  +           +++GL YL
Sbjct: 66  IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 150 HSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
              + I+HRD+KP N+LVN+  ++K+CDFG++      +     +V TR Y +PE L   
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGT 178

Query: 209 DNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLE-------- 259
            +Y    D+WS+G    E+  GR PI P      +L     V G   E            
Sbjct: 179 -HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 260 ---FIDNPKARRFIKSLPYSRGTHISSLYPQA-DPLALDLLQKMLVFEPSKRITVTEALQ 315
               +D+       + L Y        L          D + K L+  P++R  + + + 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 316 HPYISGLYDPQCNPPAQVPLSLDID 340
           H +I      + +    +  ++ ++
Sbjct: 298 HAFIKRSDAEEVDFAGWLCSTIGLN 322

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 3e-71
 Identities = 111/296 (37%), Positives = 161/296 (54%), Gaps = 7/296 (2%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ +KH N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++ L DV+    +++     +               +  L  +  K F+FQLL+GL + H
Sbjct: 63  IVRLHDVLHSDKKLTL----VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S N+LHRDLKP NLL+N N +LK+ +FGLAR      +  +  VVT WYR P++L     
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           Y TSID+WS GCIFAE+    +P+FPG +  +QLK I  + GT  E     +   K   +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--KLPDY 236

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP 325
                Y   T + ++ P+ +    DLLQ +L   P +RI+  EALQHPY S    P
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  222 bits (565), Expect = 3e-71
 Identities = 107/290 (36%), Positives = 154/290 (53%), Gaps = 9/290 (3%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY  ++ IG G YGVV  + N    E  A+KKI    E+      T+RE+ +L+ +KH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           ++ L DV+    R+      LV+E +D      +      L +   K F+ QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKRL-----VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  +VT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  + GT    +   +   +  ++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--TELPKY 234

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
             +          S     D   +DLL KML  +P++RIT  +AL+H Y 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 2e-68
 Identities = 111/300 (37%), Positives = 156/300 (52%), Gaps = 12/300 (4%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEK-VAIKKINNVFENRIDALRTLRELVLLRHIK 87
           D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRH++
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 88  ---HDNVIALKDVMMPTHRISFKDVYLVYELM--DTDLHQIIKSSQSLSNDHCKYFVFQL 142
              H NV+ L DV   +       + LV+E +  D   +        +  +  K  +FQL
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           LRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR         +  VVT WYRAP
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLWYRAP 184

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I+ V G   E D     
Sbjct: 185 EVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
               + F           I       D L  DLL K L F P+KRI+   AL HPY   L
Sbjct: 244 ALPRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-67
 Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 39/294 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLRHIKHD 89
            +  ++ +G GAYG V  ++NR T E VA+K ++   +  +D    + +E+ + + + H+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 63

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLH-QIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           NV+         +       YL  E          I+    +     + F  QL+ G+ Y
Sbjct: 64  NVVKFYGHRREGNIQ-----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLL 206
           LH   I HRD+KP NLL++   +LKI DFGLA   R N +   + +   T  Y APELL 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             + +   +DVWS G +   +L  +  +       Q                        
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------------- 219

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
                           + + + D   L LL K+LV  PS RIT+ +  +  + +
Sbjct: 220 ---------KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-67
 Identities = 68/296 (22%), Positives = 124/296 (41%), Gaps = 41/296 (13%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
           +  I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N+
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNI 71

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTDL--HQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           + L D     + +     +++ E          +++  + L+    +    Q L  L YL
Sbjct: 72  VKLLDAFYYENNL-----WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           H   I+HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186

Query: 210 N----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK 265
           +    Y    DVWS+G    E+   +P       +  L  I        +++   +  P 
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------KSEPPTLAQP- 238

Query: 266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                                +      D L+K L      R T ++ LQHP+++ 
Sbjct: 239 --------------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-66
 Identities = 64/300 (21%), Positives = 128/300 (42%), Gaps = 36/300 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E++++R  K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLH 150
           ++   D       +   ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG        +   +  V T ++ APE ++    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKA 192

Query: 211 YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------------- 229

Query: 271 KSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPP 330
                + GT       +   +  D L + L  +  KR +  E LQH ++          P
Sbjct: 230 -----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  211 bits (537), Expect = 4e-66
 Identities = 68/321 (21%), Positives = 128/321 (39%), Gaps = 40/321 (12%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y   + +G GA+GVV     R T    A K +    E+  + +R  +E+  +  ++H  
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPT 84

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
           ++ L D           ++ ++YE M       ++      +S D    ++ Q+ +GL +
Sbjct: 85  LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139

Query: 149 LHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +H  N +H DLKP N++     + +LK+ DFGL       +        T  + APE+  
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAE 198

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
                G   D+WSVG +   +L     F G      L+ + S      +           
Sbjct: 199 -GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
                           S +        D ++K+L+ +P+ R+T+ +AL+HP+++    P 
Sbjct: 247 ----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290

Query: 327 CNPPAQVPLSLDIDENIGEQM 347
            +          I ++I  + 
Sbjct: 291 RDSQIPSSRYTKIRDSIKTKY 311

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (530), Expect = 1e-65
 Identities = 71/343 (20%), Positives = 137/343 (39%), Gaps = 46/343 (13%)

Query: 21  MWQTLFEID--TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTL 77
           + +  F+ D    +  ++ IG G++G V  + +   +E VAIKK++ +  ++       +
Sbjct: 4   VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCK 136
           +E+  L+ ++H N I  +   +  H       +LV E    +    +    + L      
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIA 118

Query: 137 YFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVT 196
                 L+GL YLHS N++HRD+K GN+L++    +K+ DFG A            +V T
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGT 174

Query: 197 RWYRAPELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            ++ APE++L  D   Y   +DVWS+G    E+  RKP       ++ L  I        
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------- 227

Query: 255 EADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEAL 314
                                 +    +           + +   L   P  R T    L
Sbjct: 228 ----------------------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

Query: 315 QHPYISGLYDPQCNPP--AQVPLSLDIDENIGEQMIRQMMWNE 355
           +H ++     P        +   ++   +N+  + ++++++ E
Sbjct: 266 KHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 1e-65
 Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 42/298 (14%)

Query: 26  FEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTL-RELVLLR 84
           + ++  +   +P+G+G +G V  +  +++   +A+K +      +      L RE+ +  
Sbjct: 3   WALE-DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLL 143
           H++H N++ L        R     VYL+ E      +++ ++            ++ +L 
Sbjct: 62  HLRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPE 203
             L Y HS  ++HRD+KP NLL+ +  +LKI DFG +  +  +    T    T  Y  PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTTLCGTLDYLPPE 174

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
           ++     +   +D+WS+G +  E L  KP F         K I          +  F D 
Sbjct: 175 MIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEFTFPDF 226

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG 321
                                       A DL+ ++L   PS+R  + E L+HP+I+ 
Sbjct: 227 ------------------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  206 bits (524), Expect = 1e-64
 Identities = 90/321 (28%), Positives = 163/321 (50%), Gaps = 24/321 (7%)

Query: 14  RGKHYYTM--WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI 71
           R + Y+        +     Y  ++ +GRG Y  V  +IN   NEKV +K +  V + +I
Sbjct: 17  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 76

Query: 72  DALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQS 129
                 RE+ +L +++   N+I L D++        +   LV+E ++ TD  Q+    Q+
Sbjct: 77  -----KREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLY---QT 125

Query: 130 LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQ 188
           L++   +++++++L+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA      ++
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185

Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLII 247
                V +R+++ PELL+    Y  S+D+WS+GC+ A ++  ++P F G +  +QL  I 
Sbjct: 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 248 SVFGTQQEAD-LEFIDNPKARRFIKSLPYSRGTHISSLYPQ-----ADPLALDLLQKMLV 301
            V GT+   D ++  +     RF   L                     P ALD L K+L 
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304

Query: 302 FEPSKRITVTEALQHPYISGL 322
           ++   R+T  EA++HPY   +
Sbjct: 305 YDHQSRLTAREAMEHPYFYTV 325

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-64
 Identities = 70/299 (23%), Positives = 119/299 (39%), Gaps = 44/299 (14%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y  +  IG G+YG       +   + +  K+++       +    + E+ LLR +KH N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQII----KSSQSLSNDHCKYFVFQLLRG 145
           ++   D ++         +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 65  IVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 146 LKYLH-----SANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
           LK  H        +LHRDLKP N+ ++   ++K+ DFGLAR    +  F   +V T +Y 
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           +PE +    +Y    D+WS+GC+  E+    P F           I       +E     
Sbjct: 182 SPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGKFRR 233

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
           I                         +      +++ +ML  +   R +V E L++P I
Sbjct: 234 IP-----------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  204 bits (519), Expect = 2e-63
 Identities = 72/310 (23%), Positives = 128/310 (41%), Gaps = 43/310 (13%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDN 90
            Y  ++ +G GA+GVV   + + T      K IN      +D      E+ ++  + H  
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKY 148
           +I L D     + +      L+ E +   +L   I +    +S      ++ Q   GLK+
Sbjct: 88  LINLHDAFEDKYEM-----VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 149 LHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +H  +I+H D+KP N++        +KI DFGLA     +E  +     T  + APE++ 
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVD 201

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
             +  G   D+W++G +   +L     F G + L  L+ +                    
Sbjct: 202 -REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------------- 243

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ 326
                             +    P A D ++ +L  EP KR+TV +AL+HP++ G +   
Sbjct: 244 ----------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS-- 291

Query: 327 CNPPAQVPLS 336
            N  +++P S
Sbjct: 292 -NLTSRIPSS 300

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (513), Expect = 4e-63
 Identities = 84/335 (25%), Positives = 137/335 (40%), Gaps = 41/335 (12%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELV 81
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I        +      E+ 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG-SMENEIA 59

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVF 140
           +L  IKH N++AL D+      +     YL+ +L+   +L   I      +       +F
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHL-----YLIMQLVSGGELFDRIVEKGFYTERDASRLIF 114

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSRGNEQFMTEYVVTR 197
           Q+L  +KYLH   I+HRDLKP NLL    + +  + I DFGL++        ++    T 
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-LSTACGTP 173

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD 257
            Y APE+L     Y  ++D WS+G I   +L   P F         + I+          
Sbjct: 174 GYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--------- 223

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                             +     S  +      A D ++ ++  +P KR T  +ALQHP
Sbjct: 224 ------------------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265

Query: 318 YISGLYDPQCNPPAQVPLSLDIDENIGEQMIRQMM 352
           +I+G  D   +      +S  I +N  +   +Q  
Sbjct: 266 WIAG--DTALDKNIHQSVSEQIKKNFAKSKWKQAF 298

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  199 bits (507), Expect = 1e-62
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 47/303 (15%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-------RTLRELVLL 83
            Y P + +GRG   VV   I++ T ++ A+K I+        A         TL+E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 84  RHIK-HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQ 141
           R +  H N+I LKD             +LV++LM   +L   +    +LS    +  +  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFF-----FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           LL  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +      E+ + E   T  Y A
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLA 177

Query: 202 PELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
           PE++ C  N     YG  +D+WS G I   +L   P F   + +  L++I+S        
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS-------- 229

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                                    S  +        DL+ + LV +P KR T  EAL H
Sbjct: 230 -------------------GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270

Query: 317 PYI 319
           P+ 
Sbjct: 271 PFF 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 2e-61
 Identities = 64/310 (20%), Positives = 130/310 (41%), Gaps = 41/310 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           E+  KY+  + +GRG +G+V   +   + +    K +        D +   +E+ +L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIA 58

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLR 144
           +H N++ L +        S +++ +++E +   D+ + I +S   L+      +V Q+  
Sbjct: 59  RHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113

Query: 145 GLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
            L++LHS NI H D++P N++     +  +KI +FG AR  +  + F   +    +Y   
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
                 D   T+ D+WS+G +   +L     F        ++ I++              
Sbjct: 174 VHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-------------- 217

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL 322
                        +  T     + +    A+D + ++LV E   R+T +EALQHP++   
Sbjct: 218 -------------AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

Query: 323 YDPQCNPPAQ 332
            +       +
Sbjct: 265 IERVSTKVIR 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-61
 Identities = 64/297 (21%), Positives = 126/297 (42%), Gaps = 38/297 (12%)

Query: 28  IDTKYVPI-KPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
            D +++     IGRG++  V   ++ ET  +VA  ++ +    + +  R   E  +L+ +
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           +H N++   D    T +   K + LV ELM +  L   +K  + +     + +  Q+L+G
Sbjct: 66  QHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 146 LKYLHSAN--ILHRDLKPGNLLVNA-NCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
           L++LH+    I+HRDLK  N+ +      +KI D GLA   R +  F    + T  + AP
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAP 182

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
           E+    + Y  S+DV++ G    E+   +  +   +   Q+   +               
Sbjct: 183 EMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--------------- 225

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI 319
                        + G   +S    A P   ++++  +     +R ++ + L H + 
Sbjct: 226 -------------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 4e-58
 Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 47/302 (15%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
            +   K +G G++  V  +    T+ + AIK +               RE  ++  + H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
             + L        ++     Y         +L + I+   S      +++  +++  L+Y
Sbjct: 69  FFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLL 206
           LH   I+HRDLKP N+L+N +  ++I DFG A+  +    +     +V T  Y +PELL 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
              +   S D+W++GCI  +++   P F         + II                   
Sbjct: 184 -EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------------------- 223

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA------LQHPYIS 320
                 L Y              P A DL++K+LV + +KR+   E         HP+  
Sbjct: 224 -----KLEYDFPEKFF-------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

Query: 321 GL 322
            +
Sbjct: 272 SV 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 7e-58
 Identities = 83/335 (24%), Positives = 139/335 (41%), Gaps = 43/335 (12%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLREL-VLLRHI 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE+ +  R  
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 62

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLL 143
           +  +++ + DV    +    K + +V E +D  +L   I+    Q+ +       +  + 
Sbjct: 63  QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +  +    T    T +Y 
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYV 180

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
           APE +L  + Y  S D+WS+G I   +L   P F     L     + +            
Sbjct: 181 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------ 227

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS 320
               + R      P    + +S            L++ +L  EP++R+T+TE + HP+I 
Sbjct: 228 ----RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276

Query: 321 GLYDPQCNPPAQVPLSLDIDEN---IGEQMIRQMM 352
                   P     +  +  E    + E+M   + 
Sbjct: 277 QSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALA 311

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-57
 Identities = 71/317 (22%), Positives = 124/317 (39%), Gaps = 55/317 (17%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLL 83
           ++++Y     +G G +G V S I    N  VAIK +     + +    +  R   E+VLL
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 84  RHIK--HDNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCKYFV 139
           + +      VI L D              L+ E  +   DL   I    +L  +  + F 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSF-----VLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSRGNEQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG        +   T++  TR 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 174

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           Y  PE +     +G S  VWS+G +  +++     F   E + + ++             
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------- 224

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPY 318
                                       +       L++  L   PS R T  E   HP+
Sbjct: 225 ---------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257

Query: 319 ISGLYDPQCNPPAQVPL 335
           +  +  PQ    A++ L
Sbjct: 258 MQDVLLPQ--ETAEIHL 272

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-56
 Identities = 81/330 (24%), Positives = 141/330 (42%), Gaps = 47/330 (14%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLREL-VLLRHIKHD 89
           ++  K +G+G++G V  +  ++TN+  AIK +  +V     D   T+ E  VL    +H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            +  +         +     + V E ++  DL   I+S          ++  +++ GL++
Sbjct: 64  FLTHMFCTFQTKENL-----FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LHS  I++RDLK  N+L++ +  +KI DFG+ + +   +     +  T  Y APE+LL  
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-G 177

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
             Y  S+D WS G +  E+L  +  F G +       I               DNP   R
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------DNPFYPR 224

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT-EALQHPYISG-----L 322
           ++                  +  A DLL K+ V EP KR+ V  +  QHP         L
Sbjct: 225 WL------------------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266

Query: 323 YDPQCNPPAQVPLSLDID-ENIGEQMIRQM 351
              + +PP +  +    D  N  ++ + + 
Sbjct: 267 ERKEIDPPFRPKVKSPFDCSNFDKEFLNEK 296

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-55
 Identities = 83/323 (25%), Positives = 131/323 (40%), Gaps = 46/323 (14%)

Query: 24  TLF---EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVF----ENRIDALRT 76
           T+F    +D  Y   + +G G + VV     + T  + A K I           +     
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60

Query: 77  LRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHC 135
            RE+ +L+ I+H NVI L +V       +  DV L+ EL+    L   +   +SL+ +  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYE-----NKTDVILILELVAGGELFDFLAEKESLTEEEA 115

Query: 136 KYFVFQLLRGLKYLHSANILHRDLKPGNLLVN----ANCDLKICDFGLARTSRGNEQFMT 191
             F+ Q+L G+ YLHS  I H DLKP N+++         +KI DFGLA       +   
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FK 174

Query: 192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG 251
               T  + APE++   +  G   D+WS+G I   +L     F G      L  + +V  
Sbjct: 175 NIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-- 231

Query: 252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT 311
                                            +     LA D ++++LV +P KR+T+ 
Sbjct: 232 -------------------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266

Query: 312 EALQHPYISGLYDPQCNPPAQVP 334
           ++LQHP+I      Q    A   
Sbjct: 267 DSLQHPWIKPKDTQQALSSAWSH 289

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  178 bits (453), Expect = 1e-53
 Identities = 59/314 (18%), Positives = 125/314 (39%), Gaps = 50/314 (15%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN----NVFENRIDALRTLRELVLLRHIK 87
           +   + IGRG +G V      +T +  A+K ++     + +    AL     L L+    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
              ++ +        ++       + +LM+  DLH  +      S    +++  +++ GL
Sbjct: 66  CPFIVCMSYAFHTPDKL-----SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLL 206
           +++H+  +++RDLKP N+L++ +  ++I D GLA      +   +    T  Y APE+L 
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQ 178

Query: 207 CCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA 266
               Y +S D +S+GC+  ++L     F   +  ++ ++                     
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------------- 218

Query: 267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITV-----TEALQHPYISG 321
            R   ++        S       P    LL+ +L  + ++R+        E  + P+   
Sbjct: 219 -RMTLTMAVELPDSFS-------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

Query: 322 -----LYDPQCNPP 330
                ++  +  PP
Sbjct: 271 LDWQMVFLQKYPPP 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 6e-53
 Identities = 53/298 (17%), Positives = 111/298 (37%), Gaps = 41/298 (13%)

Query: 26  FEIDT-KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EI   +    + IG G++G V      + +  VA+K +N              E+ +LR
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQS-LSNDHCKYFVFQL 142
             +H N++                + +V +  + + L+  +   ++            Q 
Sbjct: 60  KTRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYR 200
            +G+ YLH+ +I+HRDLK  N+ ++ +  +KI DFGLA   +         +   +  + 
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 201 APELLLCCDN--YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL 258
           APE++   D   Y    DV++ G +  E++  +  +      +Q+  ++           
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------- 223

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
               +P   +   + P                    L+ + L  +  +R    + L  
Sbjct: 224 RGYLSPDLSKVRSNCP---------------KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-51
 Identities = 65/322 (20%), Positives = 136/322 (42%), Gaps = 49/322 (15%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRHIKHD 89
            +  +K +G+G +G V     + T    A+K +   V   + +   T+ E  +L++ +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTD-LHQIIKSSQSLSNDHCKYFVFQLLRGLKY 148
            + ALK       R+       V E  +   L   +   +  + +  +++  +++  L+Y
Sbjct: 66  FLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCC 208
           LHS ++++RD+K  NL+++ +  +KI DFGL +    +   M  +  T  Y APE +L  
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLED 179

Query: 209 DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR 268
           ++YG ++D W +G +  E++  +  F   +     +LI+         ++ F        
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EEIRFPRT----- 227

Query: 269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISG-- 321
                                P A  LL  +L  +P +R+        E ++H +     
Sbjct: 228 -------------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

Query: 322 ---LYDPQCNPPAQVPLSLDID 340
              +   +  PP +  ++ ++D
Sbjct: 269 WQDVVQKKLLPPFKPQVTSEVD 290

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (429), Expect = 5e-51
 Identities = 57/296 (19%), Positives = 110/296 (37%), Gaps = 34/296 (11%)

Query: 27  EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKIN-NVFENRIDALRTLRELVLLRH 85
            +  +Y   + +G G    V  + +   +  VA+K +  ++  +    LR  RE      
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           + H  ++A+ D        +    Y+V E +D   L  I+ +   ++       +    +
Sbjct: 64  LNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSRGNEQFMTEYVVTRWYRA 201
            L + H   I+HRD+KP N++++A   +K+ DFG+AR    S  +       + T  Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           PE     D+     DV+S+GC+  E+L  +P F G   ++     +              
Sbjct: 183 PEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------------- 228

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHP 317
                               S+ +         ++ K L   P  R      ++  
Sbjct: 229 --------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  165 bits (419), Expect = 5e-49
 Identities = 69/317 (21%), Positives = 129/317 (40%), Gaps = 52/317 (16%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHDN 90
           +  ++ +G G++G V    +R      A+K +      R+  +  T  E ++L  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 91  VIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           +I +        +I     +++ + ++  +L  +++ SQ   N   K++  ++   L+YL
Sbjct: 66  IIRMWGTFQDAQQI-----FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS +I++RDLKP N+L++ N  +KI DFG A+              T  Y APE ++   
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPE-VVSTK 176

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            Y  SID WS G +  E+L     F  +  +   + I+        A+L F         
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------NAELRF--------- 220

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISG--- 321
                           P  +    DLL +++  + S+R+        +   HP+      
Sbjct: 221 ---------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265

Query: 322 --LYDPQCNPPAQVPLS 336
             L       P + P+ 
Sbjct: 266 EKLLSRNIETPYEPPIQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 2e-48
 Identities = 61/322 (18%), Positives = 126/322 (39%), Gaps = 50/322 (15%)

Query: 31  KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDAL-RTLRELVLLRHIKHD 89
           ++  IK +G G++G V    ++E+    A+K ++     ++  +  TL E  +L+ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 90  NVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
            ++ L+        +      ++  +   ++   ++     S  H +++  Q++   +YL
Sbjct: 102 FLVKLEFSFKDNSNL----YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+  +G          T    APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIIL-SK 213

Query: 210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
            Y  ++D W++G +  E+    P F   + +                             
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------------------------EK 249

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISG--- 321
           I S      +H S           DLL+ +L  + +KR       V +   H + +    
Sbjct: 250 IVSGKVRFPSHFS-------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

Query: 322 --LYDPQCNPPAQVPLSLDIDE 341
             +Y  +   P         D 
Sbjct: 303 IAIYQRKVEAPFIPKFKGPGDT 324

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (412), Expect = 1e-47
 Identities = 71/344 (20%), Positives = 128/344 (37%), Gaps = 43/344 (12%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH 88
           D +Y+ ++ +G G +  V  + +   N  VA+K +     +++       E+ LL+ +  
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVND 68

Query: 89  DNVIALKDVMMP----------THRISFKDVYLVYELMDTDLHQIIKSSQSLSN--DHCK 136
            +      +                 +   V +V+E++  +L  +IK  +       + K
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 137 YFVFQLLRGLKYLH-SANILHRDLKPGNLLVNAN------CDLKICDFGLARTSRGNEQF 189
               QLL GL Y+H    I+H D+KP N+L+           +KI D G A     +   
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPG------TECLNQL 243
             +    R YR+PE+LL    +G   D+WS  C+  E++    +F        T+  + +
Sbjct: 189 SIQT---REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

Query: 244 KLIISVFGTQQEADLE-------FIDNPKARRFIKSLPYSRGTHISS----LYPQADPLA 292
             II + G      L        F ++    R I  L +     + +             
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

Query: 293 LDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLS 336
            D L  ML  +P KR      + HP++      +        L 
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-47
 Identities = 62/328 (18%), Positives = 130/328 (39%), Gaps = 49/328 (14%)

Query: 31  KYVPIKPIGRGAYGVVC---SSINRETNEKVAIKKIN--NVFENRIDALRTLRELVLLRH 85
            +  +K +G GAYG V         +T +  A+K +    + +       T  E  +L H
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLR 144
           I+    +    V +     +   ++L+ + ++  +L   +   +  +    + +V +++ 
Sbjct: 85  IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYRAP 202
            L++LH   I++RD+K  N+L+++N  + + DFGL++   +   E+         +    
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
            +      +  ++D WS+G +  E+L     F      N    I                
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------------- 244

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHP 317
              +RR +KS P            +   LA DL+Q++L+ +P KR+        E  +H 
Sbjct: 245 ---SRRILKSEP--------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293

Query: 318 YISG-----LYDPQCNPPAQVPLSLDID 340
           +        L   +   P +  +  ++D
Sbjct: 294 FFQKINWDDLAAKKVPAPFKPVIRDELD 321

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 6e-47
 Identities = 58/295 (19%), Positives = 111/295 (37%), Gaps = 49/295 (16%)

Query: 27  EID-TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
            ++  +   ++ IG+G +G V     R    KVA+K I N    +      L E  ++  
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ----AFLAEASVMTQ 56

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQL 142
           ++H N++ L  V++         +Y+V E M    L   ++S     L  D    F   +
Sbjct: 57  LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAP 202
              ++YL   N +HRDL   N+LV+ +   K+ DFGL + +           +   + AP
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP 169

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFI 261
           E L     + T  DVWS G +  EI    +  +P     + +  +      ++   ++  
Sbjct: 170 EALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------EKGYKMDAP 222

Query: 262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
           D                           P   ++++     + + R +  +  + 
Sbjct: 223 DG------------------------CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-46
 Identities = 55/303 (18%), Positives = 115/303 (37%), Gaps = 49/303 (16%)

Query: 28  IDTKYVPI--KPIGRGAYGVV--CSSINRETNEKVAIKKINNVFENRIDALRTLRELVLL 83
           +D K + +  K +G G +G V       ++  + VA+K + N   +       L E  ++
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 84  RHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQL 142
           + + +  ++ +  +         +   LV E+ +   L++ ++ ++ + + +    V Q+
Sbjct: 63  QQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---MTEYVVTRWY 199
             G+KYL  +N +HRDL   N+L+      KI DFGL++  R +E +    T       +
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADL 258
            APE  +    + +  DVWS G +  E     +  + G +      ++      ++   +
Sbjct: 177 YAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML------EKGERM 229

Query: 259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQ 315
                                              DL+     ++   R     V   L+
Sbjct: 230 GCPAG------------------------CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

Query: 316 HPY 318
           + Y
Sbjct: 266 NYY 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-45
 Identities = 56/303 (18%), Positives = 107/303 (35%), Gaps = 48/303 (15%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +E+       ++ +G G +G V        + KVA+K +    +  +     L E  L++
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMK 63

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDL---HQIIKSSQSLSNDHCKYFVFQ 141
            ++H  ++ L  V      ++ + +Y++ E M+           S   L+ +       Q
Sbjct: 64  QLQHQRLVRLYAV------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRA 201
           +  G+ ++   N +HRDL+  N+LV+     KI DFGLAR    NE    E         
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEF 260
               +    +    DVWS G +  EI+   +  +PG      ++ +              
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-------------- 223

Query: 261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHP 317
                     +     R  +              L++      P  R T   +   L+  
Sbjct: 224 ---------ERGYRMVRPDNCP-------EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

Query: 318 YIS 320
           + +
Sbjct: 268 FTA 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 67/312 (21%), Positives = 111/312 (35%), Gaps = 50/312 (16%)

Query: 26  FEIDTK-YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +EI  +       +G+G +G V       T   VAIK +       +     L+E  +++
Sbjct: 12  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMK 67

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD---TDLHQIIKSSQSLSNDHCKYFVFQ 141
            ++H+ ++ L  V      +S + +Y+V E M           ++ + L          Q
Sbjct: 68  KLRHEKLVQLYAV------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE-QFMTEYVVTRWYR 200
           +  G+ Y+   N +HRDL+  N+LV  N   K+ DFGLAR    NE            + 
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           APE  L    +    DVWS G +  E+    +  +PG      L  +   +         
Sbjct: 182 APEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---- 236

Query: 260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ--HP 317
                                     P+      DL+ +    EP +R T          
Sbjct: 237 --------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270

Query: 318 YISGLYDPQCNP 329
           Y +   +PQ  P
Sbjct: 271 YFTST-EPQYQP 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 34/306 (11%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           I    V  + IG+G +G V     +   E+VA+K  ++       +     E+     ++
Sbjct: 1   IARTIVLQESIGKGRFGEVWR--GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLR 55

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGL 146
           H+N++            ++  ++LV +  +   L   +    +++ +           GL
Sbjct: 56  HENILGFIAADN-KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGL 113

Query: 147 KYLHSA--------NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFM----TEYV 194
            +LH           I HRDLK  N+LV  N    I D GLA         +       V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 195 VTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV 249
            T+ Y APE+L    N          D++++G +F EI  R  I    E        +  
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT 309
                E   + +   K R  I +   S          +A  +   ++++      + R+T
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQS---------CEALRVMAKIMRECWYANGAARLT 284

Query: 310 VTEALQ 315
                +
Sbjct: 285 ALRIKK 290

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (383), Expect = 4e-44
 Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 37/292 (12%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLR 84
           +E++ T       +G G YG V   + ++ +  VA+K +    E+ ++    L+E  +++
Sbjct: 12  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMK 68

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
            IKH N++ L  V            ++ Y  +   L +   + Q +S     Y   Q+  
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISS 126

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPEL 204
            ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G+                  
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 205 LLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN 263
            L  + +    DVW+ G +  EI       +PG +     +L+      +++  +E  + 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------EKDYRMERPEG 240

Query: 264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
                                         +L++    + PS R +  E  Q
Sbjct: 241 ------------------------CPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 65/325 (20%), Positives = 114/325 (35%), Gaps = 70/325 (21%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRE 79
           +E         K +G GA+G V ++     ++     +VA+K +    ++  +    + E
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSE 90

Query: 80  LVLLRHI-KHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQS-------- 129
           L ++  +  H+N++ L              +YL++E     DL   ++S +         
Sbjct: 91  LKMMTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 130 ---------------LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
                          L+ +    F +Q+ +G+++L   + +HRDL   N+LV     +KI
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205

Query: 175 CDFGLAR--TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-K 231
           CDFGLAR   S  N        +   + APE L     Y    DVWS G +  EI     
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGV 264

Query: 232 PIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPL 291
             +PG         +I     Q    ++                            A   
Sbjct: 265 NPYPGIPVDANFYKLI-----QNGFKMDQPFY------------------------ATEE 295

Query: 292 ALDLLQKMLVFEPSKRITVTEALQH 316
              ++Q    F+  KR +       
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-42
 Identities = 55/294 (18%), Positives = 98/294 (33%), Gaps = 44/294 (14%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDAL-RTLRELVLLRHIK 87
              ++ +G G++GVV        + K   VA+K +     ++ +A+   +RE+  +  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCKYFVFQLLRG 145
           H N+I L  V      +    + +V EL    + L ++ K            +  Q+  G
Sbjct: 70  HRNLIRLYGV------VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPE 203
           + YL S   +HRDL   NLL+     +KI DFGL R    N+    M E+    +     
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
             L    +  + D W  G    E+    +  + G      L  I                
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID--------------- 228

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                         +                +++ +    +P  R T       
Sbjct: 229 --------------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-42
 Identities = 58/294 (19%), Positives = 106/294 (36%), Gaps = 49/294 (16%)

Query: 38  IGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK 95
           +G G +G V   + R   ++  VAIK +    E   D    +RE  ++  + +  ++ L 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 75

Query: 96  DVMMPTHRISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSAN 153
            V           + LV E+     LH+ +    + +   +    + Q+  G+KYL   N
Sbjct: 76  GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV---TRWYRAPELLLCCDN 210
            +HRDL   N+L+      KI DFGL++    ++ + T          + APE +     
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRK 188

Query: 211 YGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARRF 269
           + +  DVWS G    E L   +  +   +    +  I      +Q   +E          
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------EQGKRMECPPE------ 236

Query: 270 IKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEALQHPYIS 320
                               P    L+    +++   R     V + ++  Y S
Sbjct: 237 ------------------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-42
 Identities = 65/299 (21%), Positives = 108/299 (36%), Gaps = 46/299 (15%)

Query: 26  FEIDT-KYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELV 81
           +EI   +    + IG G +G V   I          VAIK   N   + +   + L+E +
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM--DTDLHQIIKSSQSLSNDHCKYFV 139
            +R   H +++ L  V+          V+++ EL         +     SL       + 
Sbjct: 61  TMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWY 199
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R    +  +          
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEIL--GRKPIFPGTECLNQLKLIISVFGTQQEAD 257
                 +    + ++ DVW  G    EIL  G KP                  G +    
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF----------------QGVKNNDV 218

Query: 258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
           +  I+N +      + P               P    L+ K   ++PS+R   TE    
Sbjct: 219 IGRIENGERLPMPPNCP---------------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 8e-41
 Identities = 48/312 (15%), Positives = 95/312 (30%), Gaps = 46/312 (14%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           +  +Y   + IG G++G +    +    E+VAIK      ++     +   E  + + ++
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQ 60

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQI-IKSSQSLSNDHCKYFVFQLLRGL 146
               I                  +V EL+   L  +    S+  S         Q++  +
Sbjct: 61  GGVGIPTIRWCGAEGDY----NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 147 KYLHSANILHRDLKPGNLLVN---ANCDLKICDFGLARTSRGNE-------QFMTEYVVT 196
           +Y+HS N +HRD+KP N L+        + I DFGLA+  R          +       T
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
             Y +    L  +      D+ S+G +          + G +   + +            
Sbjct: 177 ARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---------- 225

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT---VTEA 313
                         +       T I  L           L          +     + + 
Sbjct: 226 -------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272

Query: 314 LQHPYISGLYDP 325
            ++ +    +  
Sbjct: 273 FRNLFHRQGFSY 284

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-40
 Identities = 58/294 (19%), Positives = 100/294 (34%), Gaps = 45/294 (15%)

Query: 28  IDTK-YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI 86
           ID K    +K +G G +GVV     R     VAIK I    E  +     + E  ++ ++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK---EGSMSEDEFIEEAKVMMNL 56

Query: 87  KHDNVIALKDVMMPTHRISFKDVYLVYELM--DTDLHQIIKSSQSLSNDHCKYFVFQLLR 144
            H+ ++ L  V         + ++++ E M     L+ + +                +  
Sbjct: 57  SHEKLVQLYGVC-----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 111

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF-MTEYVVTRWYRAPE 203
            ++YL S   LHRDL   N LVN    +K+ DFGL+R    +E            +  PE
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFID 262
            +L    + +  D+W+ G +  EI    K  +         + I                
Sbjct: 172 -VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------------- 214

Query: 263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                   + L   R    S            ++      +  +R T    L +
Sbjct: 215 -------AQGLRLYRPHLAS-------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 27/311 (8%)

Query: 29  DTKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLR 84
           +T++  IK +G GA+G V   +     E     VAIK++      + +    L E  ++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66

Query: 85  HIKHDNVIALKDVMMPTHRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCKYFVFQL 142
            + + +V  L  + +         V L+ +LM     L  + +   ++ + +   +  Q+
Sbjct: 67  SVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSRGNEQFMTEYVVTRWYR 200
            +G+ YL    ++HRDL   N+LV     +KI DFGLA+   +   E       V   + 
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLE 259
           A E +L    Y    DVWS G    E++      + G        ++       Q     
Sbjct: 181 ALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC- 238

Query: 260 FIDNPKARRFIKSL----PYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
                     +         SR      L  +   +A D  Q+ LV +  +R+ +     
Sbjct: 239 ---TIDVYMIMVKCWMIDADSRPK-FRELIIEFSKMARD-PQRYLVIQGDERMHLPSPTD 293

Query: 316 HPYISGLYDPQ 326
             +   L D +
Sbjct: 294 SNFYRALMDEE 304

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 9e-40
 Identities = 52/289 (17%), Positives = 96/289 (33%), Gaps = 44/289 (15%)

Query: 32  YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV 91
              ++ IG G +G+V         +KVAIK I    E  +     + E  ++  + H  +
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 92  IALKDVMMPTHRISFKDVYLVYELMDTD--LHQIIKSSQSLSNDHCKYFVFQLLRGLKYL 149
           + L  V      +    + LV+E M+       +       + +        +  G+ YL
Sbjct: 63  VQLYGVC-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVV-TRWYRAPELLLCC 208
             A ++HRDL   N LV  N  +K+ DFG+ R    ++   +        + +PE+    
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 209 DNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
             Y +  DVWS G +  E+    K  +        ++ I + F   +             
Sbjct: 178 -RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA--------- 227

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
                                      ++       P  R   +  L+ 
Sbjct: 228 ---------------------STHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (352), Expect = 2e-39
 Identities = 60/318 (18%), Positives = 100/318 (31%), Gaps = 70/318 (22%)

Query: 31  KYVPIKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRH 85
               ++ IG GA+G V        +  E    VA+K +       + A    RE  L+  
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMAE 72

Query: 86  IKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKS------------------ 126
             + N++ L  V      +      L++E M   DL++ ++S                  
Sbjct: 73  FDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 127 ------SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
                    LS         Q+  G+ YL     +HRDL   N LV  N  +KI DFGL+
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 181 R--TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
           R   S    +      +   +  PE +     Y T  DVW+ G +  EI       + G 
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
                +  +                                 +I +          +L++
Sbjct: 247 AHEEVIYYVRD------------------------------GNILACPENCPLELYNLMR 276

Query: 298 KMLVFEPSKRITVTEALQ 315
                 P+ R +     +
Sbjct: 277 LCWSKLPADRPSFCSIHR 294

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (350), Expect = 3e-39
 Identities = 57/301 (18%), Positives = 104/301 (34%), Gaps = 47/301 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVL 82
           EID   V I + IG G +G VCS   +   ++   VAIK + + +  +      L E  +
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 80

Query: 83  LRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQII--KSSQSLSNDHCKYFVF 140
           +    H NVI L+ V+  +  +      ++ E M+         ++    +       + 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYVVTRWYR 200
            +  G+KYL   N +HRDL   N+LVN+N   K+ DFGL+R    +    T         
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195

Query: 201 APELL----LCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQE 255
                    +    + ++ DVWS G +  E++   +  +      + +  I   +     
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255

Query: 256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            D                                     L+      + + R    + + 
Sbjct: 256 MDC------------------------------PSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 316 H 316
            
Sbjct: 286 T 286

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-39
 Identities = 63/319 (19%), Positives = 111/319 (34%), Gaps = 65/319 (20%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRTLRE 79
           +E    +    K +G GA+G V        I  +    VA+K +     +  +    + E
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSE 76

Query: 80  LVLLRHIK-HDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQS-------- 129
           L +L ++  H N++ L                ++ E     DL   ++  +         
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 130 ----------LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
                     L  +    F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 180 ARTSRGNEQFM--TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPG 236
           AR  + +  ++      +   + APE +  C  Y    DVWS G    E+       +PG
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLL 296
               ++   +I                       +        H             D++
Sbjct: 251 MPVDSKFYKMIK----------------------EGFRMLSPEHAP-------AEMYDIM 281

Query: 297 QKMLVFEPSKRITVTEALQ 315
           +     +P KR T  + +Q
Sbjct: 282 KTCWDADPLKRPTFKQIVQ 300

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-38
 Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 59/303 (19%)

Query: 35  IKPIGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHI-KHDNV 91
              IG G +G V  +  ++   +   AIK++   + ++ D      EL +L  +  H N+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 92  IALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIK----------------SSQSLSNDH 134
           I L         +     YL  E     +L   ++                ++ +LS+  
Sbjct: 74  INLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 135 CKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQFMTEYV 194
             +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL+R  +      T   
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGR 187

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQ 253
           +   + A E  L    Y T+ DVWS G +  EI+      + G  C    + +   +   
Sbjct: 188 LPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--- 243

Query: 254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA 313
               LE   N                         D    DL+++    +P +R +  + 
Sbjct: 244 ---RLEKPLN------------------------CDDEVYDLMRQCWREKPYERPSFAQI 276

Query: 314 LQH 316
           L  
Sbjct: 277 LVS 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (343), Expect = 3e-38
 Identities = 42/245 (17%), Positives = 83/245 (33%), Gaps = 22/245 (8%)

Query: 28  IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK 87
           +   Y   + IG G++GV+    N   N++VAIK       +        R   LL    
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAG-- 59

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGL 146
              +  +                LV +L+   L  ++    +  S         Q+L  +
Sbjct: 60  CTGIPNVYYFGQEGLHN-----VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 147 KYLHSANILHRDLKPGNLLVNANC-----DLKICDFGLAR-------TSRGNEQFMTEYV 194
           + +H  ++++RD+KP N L+          + + DFG+ +             +      
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ 254
            T  Y +    L  +      D+ ++G +F   L     + G +     +    +   +Q
Sbjct: 175 GTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

Query: 255 EADLE 259
              L 
Sbjct: 234 STPLR 238

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 9e-38
 Identities = 65/317 (20%), Positives = 115/317 (36%), Gaps = 60/317 (18%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVC-----SSINRETNEKVAIKKINNVFENRIDALRTLRE 79
           +E    +    KP+GRGA+G V            T   VA+K +     +          
Sbjct: 8   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIKSSQS--------- 129
            +L+    H NV+ L              + ++ E     +L   ++S ++         
Sbjct: 68  KILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123

Query: 130 -------LSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART 182
                  L+ +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR 
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 183 SRGNEQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTEC 239
              +  +    +  +   + APE +     Y    DVWS G +  EI       +PG + 
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 240 LNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKM 299
             +    +     ++   +   D                           P     +   
Sbjct: 243 DEEFCRRL-----KEGTRMRAPDY------------------------TTPEMYQTMLDC 273

Query: 300 LVFEPSKRITVTEALQH 316
              EPS+R T +E ++H
Sbjct: 274 WHGEPSQRPTFSELVEH 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-37
 Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 46/299 (15%)

Query: 27  EIDT-KYVPIKPIGRGAYGVVCSSINRETNEK----VAIKKINNVFENRIDALRTLRELV 81
           EI        K IG G +G V   + + ++ K    VAIK +   +  +   +  L E  
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAG 61

Query: 82  LLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELM--DTDLHQIIKSSQSLSNDHCKYFV 139
           ++    H N+I L+ V+       +K + ++ E M        + +     S       +
Sbjct: 62  IMGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---MTEYVVT 196
             +  G+KYL + N +HRDL   N+LVN+N   K+ DFGL+R    + +     +   + 
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEA 256
             + APE +        S DVWS G +  E++            +++             
Sbjct: 177 IRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEV------------- 222

Query: 257 DLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ 315
            ++ I++          P                    L+ +    E ++R    + + 
Sbjct: 223 -MKAINDGFRLPTPMDCP---------------SAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-36
 Identities = 56/311 (18%), Positives = 112/311 (36%), Gaps = 57/311 (18%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRE 79
           +E+   K    + +G+G++G+V   + +     E   +VAIK +N     R + +  L E
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 73

Query: 80  LVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIK----------SSQ 128
             +++     +V+ L  V+            ++ ELM   DL   ++             
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 129 SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ 188
             S         ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + 
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 189 F--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKL 245
           +    + ++   + +PE L     + T  DVWS G +  EI    +  + G      L+ 
Sbjct: 189 YRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247

Query: 246 IISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPS 305
           ++                                 +         +  +L++    + P 
Sbjct: 248 VME------------------------------GGLLDKPDNCPDMLFELMRMCWQYNPK 277

Query: 306 KRITVTEALQH 316
            R +  E +  
Sbjct: 278 MRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 7e-36
 Identities = 56/289 (19%), Positives = 109/289 (37%), Gaps = 46/289 (15%)

Query: 38  IGRGAYGVVCSSINRETNEK---VAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIAL 94
           IGRG +G V      + + K    A+K +N + +   +  + L E ++++   H NV++L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 93

Query: 95  KDVMMPTHRISFKDVYLVYELMD-TDLHQIIK-SSQSLSNDHCKYFVFQLLRGLKYLHSA 152
             + + +         +V   M   DL   I+  + + +      F  Q+ +G+K+L S 
Sbjct: 94  LGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE----QFMTEYVVTRWYRAPELLLCC 208
             +HRDL   N +++    +K+ DFGLAR     E       T   +   + A E L   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-T 208

Query: 209 DNYGTSIDVWSVGCIFAEIL-GRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR 267
             + T  DVWS G +  E++    P +P     +    +                     
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------------------- 247

Query: 268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH 316
             ++     +  +             +++ K    +   R + +E +  
Sbjct: 248 --LQGRRLLQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-35
 Identities = 62/319 (19%), Positives = 114/319 (35%), Gaps = 64/319 (20%)

Query: 26  FEID-TKYVPIKPIGRGAYGVVCSSINRETNE-------KVAIKKINNVFENRIDALRTL 77
           +E+   + V  KP+G GA+G V  +     ++       KVA+K + +    + D    +
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLI 66

Query: 78  RELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVYELMD-TDLHQIIK----------- 125
            E+ +++ I     I    + +         +Y++ E     +L + ++           
Sbjct: 67  SEMEMMKMIGKHKNI----INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122

Query: 126 -----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
                  + LS+       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLA
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 181 RTSRGNEQFMTEYV--VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEIL-GRKPIFPGT 237
           R     + +       +   + APE L     Y    DVWS G +  EI       +PG 
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 238 ECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQ 297
                            E   + +          +                      +++
Sbjct: 242 P---------------VEELFKLLKEGHRMDKPSNCT---------------NELYMMMR 271

Query: 298 KMLVFEPSKRITVTEALQH 316
                 PS+R T  + ++ 
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 93.7 bits (232), Expect = 3e-23
 Identities = 30/205 (14%), Positives = 67/205 (32%), Gaps = 32/205 (15%)

Query: 36  KPIGRGAYGVVCSSINRETNEKVAIKKI--------NNVFENRIDALRTLRELVLLRHIK 87
           K +G G    V +  + E   +  +K              +     L      +     +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 88  HDNVIALKDVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLK 147
              +  L+ + +P    +++   ++ EL+D      ++       ++    +  +L  + 
Sbjct: 65  FRALQKLQGLAVP-KVYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVA 117

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSRGNEQFMTE---YVVTRWYRAPE 203
             +   I+H DL   N+LV+    + I DF  +        + + E     +  ++    
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR-- 174

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEIL 228
                  Y T  D+ S       IL
Sbjct: 175 ------TYRTEKDINSA---IDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	364
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.1
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.72
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.2
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.08
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.54

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=424.64  Aligned_cols=343  Identities=43%  Similarity=0.773  Sum_probs=282.9

Q ss_pred             cCCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcc
Q 017909           13 SRGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVI   92 (364)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   92 (364)
                      +.|++..+..++..++.++|++++.||+|+||+||+|+++.+|+.||+|+++...........+.+|+.+|+.++|||++
T Consensus         1 ~~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv   80 (346)
T d1cm8a_           1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI   80 (346)
T ss_dssp             CCSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred             CCCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCee
Confidence            36888899999999999999999999999999999999999999999999987666666677888999999999999999


Q ss_pred             eeeeeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCc
Q 017909           93 ALKDVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (364)
Q Consensus        93 ~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~  171 (364)
                      +++++|...... .....++||||++++|...+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        81 ~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~  159 (346)
T d1cm8a_          81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE  159 (346)
T ss_dssp             CCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred             EEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc
Confidence            999999876432 2346899999998788777654 67999999999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017909          172 LKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFG  251 (364)
Q Consensus       172 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (364)
                      ++|+|||.+......   .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+
T Consensus       160 ~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         160 LKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             EEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            999999999766332   34567899999999998766789999999999999999999999999999999999999999


Q ss_pred             CCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 017909          252 TQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPA  331 (364)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~  331 (364)
                      .++...+......................+.......++.+++||++||..||.+|||++|||+||||+...++...|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~  316 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV  316 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccC
Confidence            98888877777777777777777777777778888999999999999999999999999999999999998766554433


Q ss_pred             CC--CCCcccchhhhHHHHHHHHHHHHHhhCC
Q 017909          332 QV--PLSLDIDENIGEQMIRQMMWNETLHYHP  361 (364)
Q Consensus       332 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (364)
                      +.  .+..+++.  ...+.++..+++.+..+|
T Consensus       317 ~~~~~~~~~~~~--~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         317 QKYDDSFDDVDR--TLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             CCCCCC-----C--CHHHHHHHHHHHHHTCCC
T ss_pred             CCCCCchhhhhc--CHHHHHHHHHHHhhcCCC
Confidence            31  11112222  245567888888888776

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=407.25  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=222.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|+++.+++.||+|++...... ......+.+|+.+++.++||||+++++++.++     ..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence            5799999999999999999999999999999998754322 23345677899999999999999999999887     78


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++|||||+ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999998 6999999988899999999999999999999999999999999999999999999999999997654332


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                 
T Consensus       161 --~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------------  220 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------------  220 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------------
T ss_pred             --ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence              345678999999999988 578999999999999999999999998877666655543210                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                    ...+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus       221 --------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 --------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                          1223468899999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-59  Score=409.18  Aligned_cols=261  Identities=29%  Similarity=0.399  Sum_probs=217.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|+++..... .....+.+|+.+++.++||||+++++++.+.     .
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~   76 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG-----N   76 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----c
Confidence            457899999999999999999999999999999998754322 2334677899999999999999999999887     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            8999999998 699999988889999999999999999999999999999999999999999999999999999865332


Q ss_pred             --CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 --EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                        ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.................             
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-------------  223 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------  223 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-------------
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Confidence              22344567999999999998754567889999999999999999999987654333322221100             


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                     .....+..+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus       224 ---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         224 ---------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             ---------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ---------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence                           0111224578899999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=415.41  Aligned_cols=345  Identities=43%  Similarity=0.764  Sum_probs=288.3

Q ss_pred             CCceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcce
Q 017909           14 RGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIA   93 (364)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   93 (364)
                      .+++......+.+.+.++|++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++|||+++
T Consensus         2 ~~~~~~~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~   81 (348)
T d2gfsa1           2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG   81 (348)
T ss_dssp             CCEEEEECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcEEEecCCccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeee
Confidence            35666777788888999999999999999999999999999999999999877666667778889999999999999999


Q ss_pred             eeeeecccccccc-ceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcE
Q 017909           94 LKDVMMPTHRISF-KDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus        94 ~~~~~~~~~~~~~-~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~  172 (364)
                      +++++........ ...++++++++|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~  160 (348)
T d2gfsa1          82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL  160 (348)
T ss_dssp             CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             EEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccc
Confidence            9999875533221 34555655556899998854 579999999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017909          173 KICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGT  252 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (364)
                      +++|||.+....   .......|+..|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.
T Consensus       161 kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         161 KILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             EECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999986542   23345677899999999888667899999999999999999999999999999999999999888


Q ss_pred             CchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCC
Q 017909          253 QQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQ  332 (364)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~  332 (364)
                      ................+...........+.......++.+++||++||+.||.+|||++|+|+||||+++..+..++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~  317 (348)
T d2gfsa1         238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD  317 (348)
T ss_dssp             CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC
T ss_pred             CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC
Confidence            88877777777777777776666666666667788999999999999999999999999999999999998877766554


Q ss_pred             CCCCcccchhhhHHHHHHHHHHHHHhhCCC
Q 017909          333 VPLSLDIDENIGEQMIRQMMWNETLHYHPE  362 (364)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (364)
                      +-...........++++.....+++.+.|.
T Consensus       318 ~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         318 PYDQSFESRDLLIDEWKSLTYDEVISFVPP  347 (348)
T ss_dssp             CCCCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred             CCCCcccchhcCHHHHHHHHHHHhhccCCC
Confidence            333333455666788888888999988874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=411.65  Aligned_cols=338  Identities=48%  Similarity=0.889  Sum_probs=278.6

Q ss_pred             eeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           25 LFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        25 ~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      ++++.++|++++.||+|+||+||+|+++.+|+.||||+++... ......++.+|+.+|+.++|||++++++++......
T Consensus         3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence            4567899999999999999999999999999999999997533 344556778999999999999999999999876544


Q ss_pred             ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          105 SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      .....+++++.++|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          82 QMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             TCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            4356778888777899999876 469999999999999999999999999999999999999999999999999987543


Q ss_pred             CCC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          185 GNE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       185 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...   .......|++.|+|||++.....++.++||||+||++|+|++|+.||.+................+........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            321   22345678999999999877667899999999999999999999999999988888888888888777766666


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCCCcccc-
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVPLSLDID-  340 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~-  340 (364)
                      ............+......+....+.+++.+++||.+||+.||.+|||++|+|+||||+....+...+..+.+...+.. 
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~  320 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMEL  320 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC------
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhh
Confidence            6666666666666666666677788899999999999999999999999999999999998888777666666555432 


Q ss_pred             hhhhHHHHHHHHHHHHHhhCCCCC
Q 017909          341 ENIGEQMIRQMMWNETLHYHPEAR  364 (364)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~  364 (364)
                      +....+++++....++..++|.-|
T Consensus       321 ~~~~~~~l~~l~~~e~~~~~~~~~  344 (345)
T d1pmea_         321 DDLPKEKLKELIFEETARFQPGYR  344 (345)
T ss_dssp             --CCHHHHHHHHHHHSGGGSTTTC
T ss_pred             hhCCHHHHHHHHHHHHHhcCCCCC
Confidence            334566677778889999999876

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=408.39  Aligned_cols=268  Identities=24%  Similarity=0.390  Sum_probs=226.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++.... .......+.+|+.++++++||||+++++++.++     .
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----S
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----C
Confidence            3689999999999999999999999999999999975432 233445678999999999999999999999887     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++||||++ |+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            8999999998 699999998899999999999999999999999999999999999999999999999999999866432


Q ss_pred             --CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 --EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                        ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....              
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--------------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--------------
T ss_pred             CcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--------------
Confidence              223345679999999999987 578999999999999999999999999887666665553210              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHH------HhcCCCccCCCCCCCCCCCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTE------ALQHPYISGLYDPQCNPPAQV  333 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e------lL~hp~f~~~~~~~~~~~~~~  333 (364)
                                       ...+..+++.+.+||++||+.||.+|||++|      +++||||+++....-..-.|+
T Consensus       227 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP  284 (288)
T d1uu3a_         227 -----------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP  284 (288)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCC
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCC
Confidence                             1223568899999999999999999999998      588999999865554443333

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-58  Score=407.06  Aligned_cols=257  Identities=24%  Similarity=0.439  Sum_probs=223.4

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|+++.....  ....+.+|+.+++.++||||+++++++...     .
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~   90 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-----D   90 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----C
Confidence            356899999999999999999999999999999999764333  235678999999999999999999999887     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|||||+ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            8999999998 588887765 57999999999999999999999999999999999999999999999999999877555


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......             
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-------------  235 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------------  235 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-------------
T ss_pred             cccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence            555667789999999999988 678999999999999999999999999887766665554321110             


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                     ...+..+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus       236 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                           1122457889999999999999999999999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-58  Score=411.36  Aligned_cols=265  Identities=30%  Similarity=0.473  Sum_probs=212.7

Q ss_pred             eceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 017909           22 WQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPT  101 (364)
Q Consensus        22 ~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (364)
                      |....++.++|++++.||+|+||+||+|+++.+|+.||+|++....... ....+.+|+.+++.++||||+++++++.++
T Consensus         1 ~~~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   79 (307)
T d1a06a_           1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG   79 (307)
T ss_dssp             CEECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4455678899999999999999999999999999999999997654332 234567899999999999999999999887


Q ss_pred             cccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc---cCCcEEEeec
Q 017909          102 HRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN---ANCDLKICDF  177 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~---~~~~~~L~Df  177 (364)
                           ...++|||||+ |+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||++.   .++.+||+||
T Consensus        80 -----~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          80 -----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             -----SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             -----CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecc
Confidence                 88999999998 69999999988999999999999999999999999999999999999995   4789999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......     
T Consensus       155 G~a~~~~~~-~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-----  227 (307)
T d1a06a_         155 GLSKMEDPG-SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE-----  227 (307)
T ss_dssp             -------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC-----
T ss_pred             ceeEEccCC-CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-----
Confidence            999765333 33445679999999999987 57899999999999999999999999988776666555432111     


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                            .....++.+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus       228 ----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         228 ----------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ----------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ----------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                                  112234578999999999999999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-58  Score=404.39  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=211.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++...........+.+|+.+++.++||||+++++++.+...   ..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CE
Confidence            478999999999999999999999999999999998766666667778899999999999999999999875422   56


Q ss_pred             EEEEecccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCeEEccCCcEEEeecC
Q 017909          109 VYLVYELMD-TDLHQIIKS----SQSLSNDHCKYFVFQLLRGLKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      +++|||||+ |+|.+++..    .+.+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            899999998 699998853    467999999999999999999999976     9999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ++..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...         
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~---------  229 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---------  229 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC---------
Confidence            99877555555566788999999999977 57899999999999999999999999988766665555331         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYI  319 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f  319 (364)
                                           .....+..+++.+.+||++||+.||.+|||++|||+|||+
T Consensus       230 ---------------------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         230 ---------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ---------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                 1122345689999999999999999999999999999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=408.05  Aligned_cols=294  Identities=37%  Similarity=0.599  Sum_probs=234.4

Q ss_pred             eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchH---HHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           33 VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRI---DALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      +.+++||+|+||+||+|+++.+|+.||+|+++.......   ....+.+|+.+++.++||||+++++++..+     .+.
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~   75 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNI   75 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCC
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Cce
Confidence            346899999999999999999999999999975433221   224577899999999999999999999888     788


Q ss_pred             EEEeccccccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQ-IIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++||||+.|++.. ....+..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||.+........
T Consensus        76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9999999964444 444566799999999999999999999999999999999999999999999999999987765555


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......||+.|+|||++.....++.++|||||||++|+|++|.+||.+....+.+..+.+..+.+....+..........
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            55667889999999999876678999999999999999999999999999999999999988877665443222111000


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCNPPAQVP  334 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~~~~~~~  334 (364)
                         ..............+..++.+.+||++||+.||++|||++|+|+||||+....+....+.|.|
T Consensus       236 ---~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p  298 (299)
T d1ua2a_         236 ---TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP  298 (299)
T ss_dssp             ---CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred             ---hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence               001111122233456789999999999999999999999999999999975544433333433

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-57  Score=404.00  Aligned_cols=266  Identities=30%  Similarity=0.465  Sum_probs=225.7

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc----hHHHHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN----RIDALRTLRELVLLRHIKHDNVIALKDVMMPTH  102 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (364)
                      .+.++|++++.||+|+||+||+|+++.+|+.||+|+++.....    ......+.+|+.+++.++||||+++++++.+. 
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-   85 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-   85 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-
Confidence            4688999999999999999999999999999999998654222    22356678999999999999999999999888 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC----cEEEeec
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~----~~~L~Df  177 (364)
                          ...++|||||+ |+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++    .+||+||
T Consensus        86 ----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          86 ----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence                88999999998 69999999888999999999999999999999999999999999999998776    5999999


Q ss_pred             CccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          178 GLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      |++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+   
T Consensus       162 G~a~~~~~~~-~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~---  236 (293)
T d1jksa_         162 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE---  236 (293)
T ss_dssp             TTCEECTTSC-BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---
T ss_pred             hhhhhcCCCc-cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence            9997764333 3445678999999999987 6789999999999999999999999998887777666644221111   


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQ  326 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~  326 (364)
                                              ...++.+++.+.+||++||+.||.+|||++|+|+||||+......
T Consensus       237 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         237 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             ------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             ------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence                                    112256889999999999999999999999999999998764443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-57  Score=408.62  Aligned_cols=256  Identities=23%  Similarity=0.426  Sum_probs=227.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+|+.++||||+++++++.+.     ..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----cc
Confidence            589999999999999999999999999999999976533 233455677899999999999999999999988     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      +++||||++ |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            999999998 6999999998999999999999999999999999999999999999999999999999999998765555


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...                  
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------------  220 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------  220 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------------
T ss_pred             cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------------
Confidence            55667789999999999988 67899999999999999999999999998876666655431                  


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL  322 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~  322 (364)
                                   ....+..+++.+++||++||+.||.+|++     ++|+++||||++.
T Consensus       221 -------------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         221 -------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             -------------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence                         12234568999999999999999999994     9999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-57  Score=404.98  Aligned_cols=289  Identities=38%  Similarity=0.668  Sum_probs=240.4

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|+++...........+.+|++++++++||||+++++++.+.     ...
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence            689999999999999999999999999999999976544444456778999999999999999999999887     889


Q ss_pred             EEEeccccccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMDTDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++||||+++++.+.+..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99999999877776643  4569999999999999999999999999999999999999999999999999998776666


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      .......|++.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+....  ...
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~  234 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT--SMP  234 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG--GST
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc--ccc
Confidence            666677889999999998886678999999999999999999999999999888888888877776654433211  111


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ......+...........+.+++.+.+||++||+.||++|||++|+|+||||+....|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            2222222233333344556789999999999999999999999999999999987554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=395.32  Aligned_cols=260  Identities=24%  Similarity=0.367  Sum_probs=217.4

Q ss_pred             cccce-eeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           28 IDTKY-VPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y-~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .+++| ++.+.||+|+||+||+|+++.++..||+|++............+.+|++++++++||||+++++++...... .
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-~   84 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG-K   84 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS-C
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc-C
Confidence            35566 778899999999999999999999999999987666666677788999999999999999999998653211 1


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeEEc-cCCcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSAN--ILHRDLKPGNLLVN-ANCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di~~~NIll~-~~~~~~L~Dfg~~~~  182 (364)
                      ..+++||||++ |+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++..
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            57899999998 699999998889999999999999999999999998  99999999999996 478999999999976


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ....  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.............  ...        
T Consensus       165 ~~~~--~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~--------  230 (270)
T d1t4ha_         165 KRAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVK--------  230 (270)
T ss_dssp             CCTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCC--------
T ss_pred             ccCC--ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCC--------
Confidence            4332  2345689999999999865  5899999999999999999999999876544433222110  000        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYIS  320 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~  320 (364)
                                        ........++.+.+||.+||+.||++|||++|+|+||||+
T Consensus       231 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ------------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                              0112245788999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=403.64  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=220.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .+.|++++.||+|+||+||+|+++.+|..||+|+++...  ......+.+|+++++.++||||+++++++.+.     ..
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~   83 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NN   83 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----Ce
Confidence            567999999999999999999999999999999987542  23345677899999999999999999999887     88


Q ss_pred             EEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++|||||+ |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999998 699888765 467999999999999999999999999999999999999999999999999998765433


Q ss_pred             CcccccccccccccCCccccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          187 EQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ........||+.|+|||++..    ...++.++|||||||++|+|++|..||.+....+....+......          
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~----------  233 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP----------  233 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC----------
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            333446688999999999853    245789999999999999999999999988777766665432100          


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                        ....+..+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus       234 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                              01122457899999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-56  Score=408.80  Aligned_cols=265  Identities=25%  Similarity=0.411  Sum_probs=227.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +-++|++++.||+|+||+||+|+++.+|+.||+|++....  ......+.+|+.+++.++||||+++++++.+.     .
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~   96 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----N   96 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----T
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            3468999999999999999999999999999999997543  33456678999999999999999999999887     8


Q ss_pred             eEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc--CCcEEEeecCccccC
Q 017909          108 DVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTS  183 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~--~~~~~L~Dfg~~~~~  183 (364)
                      ..++|||||+ |+|.+.+.. .+++++..++.++.||+.||.|||++|++||||||+|||++.  ++.+||+|||++...
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            8999999998 699998854 467999999999999999999999999999999999999964  578999999999876


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+         
T Consensus       177 ~~-~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------  245 (350)
T d1koaa2         177 DP-KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------  245 (350)
T ss_dssp             CT-TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---------
T ss_pred             cc-ccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            43 333455688999999999987 5789999999999999999999999998887777777654322211         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQCN  328 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~~  328 (364)
                                        ....+.+++.+.+||++||+.||.+|||++|+|+||||+....+...
T Consensus       246 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~  292 (350)
T d1koaa2         246 ------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD  292 (350)
T ss_dssp             ------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCC
T ss_pred             ------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCch
Confidence                              11224578899999999999999999999999999999987665443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.3e-56  Score=405.60  Aligned_cols=261  Identities=26%  Similarity=0.459  Sum_probs=226.1

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|+++...  ......+.+|+.+++.++||||+++++++.++     .
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~   99 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----Y   99 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----S
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            5688999999999999999999999999999999987543  33445677899999999999999999999887     8


Q ss_pred             eEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEc--cCCcEEEeecCccccC
Q 017909          108 DVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVN--ANCDLKICDFGLARTS  183 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~--~~~~~~L~Dfg~~~~~  183 (364)
                      .+++|||||+ |+|.+.+... .++++.+++.++.||+.||.|||++||+||||||+|||++  .++.++|+|||++...
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            8999999998 6998887654 4699999999999999999999999999999999999997  5789999999999876


Q ss_pred             CCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          184 RGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      ... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......+         
T Consensus       180 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  248 (352)
T d1koba_         180 NPD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------  248 (352)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             CCC-CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            443 33455678999999999987 6799999999999999999999999999888777776654221111         


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                                        ...++.+++.+.+||++||+.||.+|||++|+|+||||++...
T Consensus       249 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         249 ------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             ------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence                              2234578999999999999999999999999999999987543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.7e-56  Score=391.45  Aligned_cols=262  Identities=32%  Similarity=0.497  Sum_probs=225.0

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-------hHHHHHHHHHHHHHHhcC-CCCcceeeeeec
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-------RIDALRTLRELVLLRHIK-HDNVIALKDVMM   99 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   99 (364)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|+++.....       ......+.+|+.++++++ ||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            468999999999999999999999999999999998653221       223345678999999996 999999999998


Q ss_pred             cccccccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecC
Q 017909          100 PTHRISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      ++     ...++||||++ |+|.+++..++++++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus        81 ~~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          81 TN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             CS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cC-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccch
Confidence            87     88999999997 6999999988999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCCccccc-----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQ  253 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (364)
                      ++....... ......||..|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus       156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~  234 (277)
T d1phka_         156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  234 (277)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            998764433 3445678999999999864     2347889999999999999999999999988777766665421111


Q ss_pred             chhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          254 QEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      +                           ....+.+|+.+.+||++||+.||.+|||++|||+||||++.
T Consensus       235 ~---------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         235 G---------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             C---------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             C---------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            1                           11234688999999999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-56  Score=398.20  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=218.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.+.     .
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~   88 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H   88 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----C
Confidence            44699999999999999999999999999999998765433 34456678999999999999999999999887     7


Q ss_pred             eEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..++|||||.| ++...+...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            89999999985 6665666778899999999999999999999999999999999999999999999999999976533 


Q ss_pred             CcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          187 EQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                         .....||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.+.........+.....             
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~-------------  231 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------------  231 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------------
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence               2345789999999998642  3588999999999999999999999988877666655543110             


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                      .......+++.+.+||++||+.||.+|||++|+|+||||..
T Consensus       232 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         232 ----------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ----------------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                            01122457899999999999999999999999999999976

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-55  Score=396.13  Aligned_cols=254  Identities=24%  Similarity=0.428  Sum_probs=224.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.     ..
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Ce
Confidence            479999999999999999999999999999999976433 233455678999999999999999999999887     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++||||+. |++...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            999999998 589999999899999999999999999999999999999999999999999999999999999876433 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                 
T Consensus       158 --~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------  217 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------------  217 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------------
T ss_pred             --cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------------
Confidence              335678999999999987 578999999999999999999999999887777766664411                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                    ...++.+++.+.++|++||..||.+|+     |++++|+||||++..
T Consensus       218 --------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         218 --------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence                          123356889999999999999999996     999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=405.81  Aligned_cols=283  Identities=22%  Similarity=0.342  Sum_probs=218.2

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|+++... ......++.+|+.+|+.++||||++++++|.+.     .
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----G   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----S
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            5789999999999999999999999999999999997543 333456778999999999999999999999888     7


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      ..++||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            8999999998 59999999888999999999999999999999975 999999999999999999999999999875432


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCchhhhh-cc--
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV-FGTQQEADLE-FI--  261 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~-~~--  261 (364)
                      .  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........... .+........ ..  
T Consensus       158 ~--~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 S--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             H--TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             C--ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            2  2335688999999999988 68999999999999999999999999887654332221111 1111000000 00  


Q ss_pred             -----------CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          262 -----------DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       262 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                                 .................  .......++..+.+||++||+.||.+|||++|+|+||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                       00000000000000000  00011246889999999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-55  Score=392.94  Aligned_cols=284  Identities=38%  Similarity=0.653  Sum_probs=234.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|+++ +|+.||+|+++...........+.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            69999999999999999999986 779999999976544444456778999999999999999999999888     889


Q ss_pred             EEEeccccccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDTDLHQII-KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      +++++++.+++...+ ...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+........
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            999999997655555 4567899999999999999999999999999999999999999999999999999987655544


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+...  .....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~  233 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--TELPK  233 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG--GGSTT
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch--hhhhh
Confidence            4555678899999999987677899999999999999999999999999988888888888777665544322  11222


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      .................+.+++.+.+||++||+.||++|||++|+|+||||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            22223333344455667788999999999999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-55  Score=401.37  Aligned_cols=254  Identities=23%  Similarity=0.412  Sum_probs=223.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     ..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence            689999999999999999999999999999999975432 233445678999999999999999999999888     88


Q ss_pred             EEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      .++|||++. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            999999997 699999988889999999999999999999999999999999999999999999999999999876432 


Q ss_pred             cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       188 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....                 
T Consensus       195 --~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------  254 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----------------  254 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------
T ss_pred             --cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-----------------
Confidence              334678999999999988 678999999999999999999999999887776666664421                 


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLY  323 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~  323 (364)
                                    ...+..+++.+.+||++||+.||.+|+     |+++|++||||++..
T Consensus       255 --------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         255 --------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             --------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence                          122356899999999999999999995     999999999998763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-55  Score=392.53  Aligned_cols=291  Identities=39%  Similarity=0.635  Sum_probs=233.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccC-CcEEEEEeccchhhchHHHHHHHHHHHHHHhc---CCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRET-NEKVAIKKINNVFENRIDALRTLRELVLLRHI---KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~  103 (364)
                      .+++|++++.||+|+||+||+|++..+ ++.||+|+++...........+.+|+.+++.+   +||||++++++|.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            368999999999999999999999755 66799999875433332223344566665554   89999999999875543


Q ss_pred             cccceEEEEeccccccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMDTDLHQIIK--SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                      ......+++||++++.+.....  ....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||.+.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            3346789999999976555443  34569999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          182 TSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      .. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+...
T Consensus       165 ~~-~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IY-SFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CC-CGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hh-cccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            55 33334556788999999999987 67999999999999999999999999999999999999998888776655433


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      .......+    ..............+++.+.+||++||+.||.+|||++|+|+||||+++..
T Consensus       243 ~~~~~~~~----~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         243 VALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CSSCGGGS----CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccchhhhh----ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            22221111    112223344556788999999999999999999999999999999998744

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=394.54  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=223.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhh-chHHHHHHHHHHHHHH-hcCCCCcceeeeeeccccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFE-NRIDALRTLRELVLLR-HIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+..|..++. .++||||+++++++.+.     .
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence            579999999999999999999999999999999975432 2223344556666654 68999999999999988     8


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      ..|+||||++ |+|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||.+......
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            8999999998 699999999899999999999999999999999999999999999999999999999999999876555


Q ss_pred             CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhH
Q 017909          187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKA  266 (364)
Q Consensus       187 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (364)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...                 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----------------  218 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------------  218 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred             cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            555666789999999999988 67899999999999999999999999988877766665431                 


Q ss_pred             HHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCCC
Q 017909          267 RRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT-EALQHPYISGLY  323 (364)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-elL~hp~f~~~~  323 (364)
                                    ....+..+++.+.+||++||+.||.+|||+. +|++||||+++.
T Consensus       219 --------------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         219 --------------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             --------------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                          0123356899999999999999999999996 899999999863

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=394.98  Aligned_cols=305  Identities=43%  Similarity=0.762  Sum_probs=243.0

Q ss_pred             ceeEEeeceeeecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceee
Q 017909           16 KHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      ++.+.++++.+.+.++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+++.++||||++++
T Consensus         3 ~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~   82 (355)
T d2b1pa1           3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL   82 (355)
T ss_dssp             EEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             CEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            57888999888888999999999999999999999999999999999987766666777888999999999999999999


Q ss_pred             eeecccccc-ccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEE
Q 017909           96 DVMMPTHRI-SFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (364)
Q Consensus        96 ~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L  174 (364)
                      ++|...... ...+.|+||||+.+++.+.+.  +.+++..++.++.||+.||.|||++||+|+||||+|||++.++.+++
T Consensus        83 ~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             EEEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceee
Confidence            999765331 236899999999988877664  57999999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q 017909          175 CDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQ  254 (364)
Q Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (364)
                      +|||.+..... ........+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+......+.
T Consensus       161 ~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         161 LDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             CCCCC----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             echhhhhcccc-ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            99998876533 333455678999999999988 6899999999999999999999999999999999999998888877


Q ss_pred             hhhhhccCchhHHHHHhhCCCCCCCcccc------------cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          255 EADLEFIDNPKARRFIKSLPYSRGTHISS------------LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                      ...+..... ....+..............            .....++.+.+||++||+.||++|||++|||+||||+..
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         239 PEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHTTSCH-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHHHHhhh-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            765554432 2333333222221111111            111246778999999999999999999999999999987


Q ss_pred             CCC
Q 017909          323 YDP  325 (364)
Q Consensus       323 ~~~  325 (364)
                      .++
T Consensus       318 ~~~  320 (355)
T d2b1pa1         318 YDP  320 (355)
T ss_dssp             CCH
T ss_pred             CCc
Confidence            653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-54  Score=395.89  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=216.6

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.......    ........++.+++.++||||+++++++...    
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~----   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP----   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence            57999999999999999999999999999999986543221    1222233457777788899999999999887    


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...++||||+. |+|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus        80 -~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          80 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             -CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence             78999999998 6999999988999999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      ...  .....||+.|+|||++.....++.++|||||||++|+|++|+.||.+..............              
T Consensus       159 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------------  222 (364)
T d1omwa3         159 KKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------------  222 (364)
T ss_dssp             SSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--------------
T ss_pred             CCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Confidence            432  3455789999999999765678999999999999999999999998765433322221110              


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRIT-----VTEALQHPYISGL  322 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~elL~hp~f~~~  322 (364)
                                    ......+..+++.+.+||.+||+.||.+|||     ++|+++||||+++
T Consensus       223 --------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         223 --------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             --------------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             --------------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence                          1112334578999999999999999999999     7999999999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-55  Score=393.80  Aligned_cols=259  Identities=25%  Similarity=0.438  Sum_probs=224.4

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      +|-++|++++.||+|+||+||+|+++.+|+.||+|+++...   .+...+.+|+.+|+.++||||+++++++.+.     
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----   73 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM-----   73 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----
Confidence            46789999999999999999999999999999999997642   3344567899999999999999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC--CcEEEeecCcccc
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQ-SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN--CDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~--~~~~L~Dfg~~~~  182 (364)
                      ..+|+|||||+ |+|.+.+...+ ++++.+++.++.||+.||.|||++||+||||||+|||++.+  ..++|+|||++..
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            88999999998 59999998665 79999999999999999999999999999999999999854  4899999999977


Q ss_pred             CCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          183 SRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                      ... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+....+.+.....+..      
T Consensus       154 ~~~-~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------  225 (321)
T d1tkia_         154 LKP-GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE------  225 (321)
T ss_dssp             CCT-TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred             ccc-CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh------
Confidence            633 333445678899999999877 578999999999999999999999999988887777776532222221      


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                           .++.+++.+.+||++||..||.+|||++|+|+||||++-
T Consensus       226 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         226 ---------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ---------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ---------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                                 224688999999999999999999999999999999764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-54  Score=383.42  Aligned_cols=289  Identities=39%  Similarity=0.647  Sum_probs=240.3

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|+++.+|+.||+|+++..........++.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence            589999999999999999999999999999999977655666677888999999999999999999999888     788


Q ss_pred             EEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCc
Q 017909          110 YLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQ  188 (364)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~  188 (364)
                      ++|++++.| ++..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||.+........
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999999985 6777777788999999999999999999999999999999999999999999999999999987765555


Q ss_pred             ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchhhhhccCchhHH
Q 017909          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPI-FPGTECLNQLKLIISVFGTQQEADLEFIDNPKAR  267 (364)
Q Consensus       189 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (364)
                      ......++..|.|||.+.+...++.++|||||||++|+|++|..| |.+.+..+....+....+......+.....  ..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  234 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK--LP  234 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG--ST
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh--cc
Confidence            555566788899999988766689999999999999999999877 566666777777777766655543322211  11


Q ss_pred             HHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 017909          268 RFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDP  325 (364)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~  325 (364)
                      ..................+.+++.+.+||++||+.||++|||++|||+||||+++.+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            1111111122333445566789999999999999999999999999999999987664

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=388.76  Aligned_cols=288  Identities=33%  Similarity=0.577  Sum_probs=230.9

Q ss_pred             ceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc-cccceE
Q 017909           31 KYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR-ISFKDV  109 (364)
Q Consensus        31 ~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  109 (364)
                      +|+.+++||+|+||+||+|+++.+|+.||||+++......      .+|+.+++.++||||++++++|..... ....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC------CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH------HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            7999999999999999999999999999999997543222      369999999999999999999865422 122568


Q ss_pred             EEEeccccccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCC
Q 017909          110 YLVYELMDTDLHQIIK----SSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSR  184 (364)
Q Consensus       110 ~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~  184 (364)
                      ++||||+++++.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            9999999976655543    456799999999999999999999999999999999999999875 89999999987663


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .. .......|+..|+|||.+.+...++.++|||||||++|+|++|..||......+.+..+.+..+......+......
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            33 33445678999999999887678999999999999999999999999999999999999988888776654433221


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYDPQC  327 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~~~~  327 (364)
                      .........  ..........+..++.+.+||.+||+.||.+|||+.|+|+||||+....+..
T Consensus       254 ~~~~~~~~~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  314 (350)
T d1q5ka_         254 YTEFKFPQI--KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  314 (350)
T ss_dssp             --CCCCCCC--CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             hhhcccccc--ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCC
Confidence            111110000  0111112234568999999999999999999999999999999998866543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=384.57  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=212.8

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhch----HHHHHHHHHHHHHHhcC--CCCcceeeeeeccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENR----IDALRTLRELVLLRHIK--HDNVIALKDVMMPT  101 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~  101 (364)
                      ++++|++++.||+|+||+||+|+++.+|+.||+|+++......    ....++.+|+.+++.++  ||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            6789999999999999999999999999999999987543221    12223457999999986  89999999999887


Q ss_pred             cccccceEEEEecccc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC-CcEEEeecC
Q 017909          102 HRISFKDVYLVYELMD--TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFG  178 (364)
Q Consensus       102 ~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~-~~~~L~Dfg  178 (364)
                           ...++|||++.  +++.+.+...+.+++..++.++.||+.||.|||++|++||||||+|||++.+ +.++|+|||
T Consensus        82 -----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          82 -----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             -----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             -----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence                 78999999996  4788888888899999999999999999999999999999999999999854 799999999


Q ss_pred             ccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          179 LARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+      .+...         
T Consensus       157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~---------  219 (273)
T d1xwsa_         157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG---------  219 (273)
T ss_dssp             TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC---------
T ss_pred             cceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc---------
Confidence            99765332  24456789999999999875556788999999999999999999997531      11110         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLY  323 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~  323 (364)
                                            .......+|+++.+||++||+.||.+|||++|+|+||||++..
T Consensus       220 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                                  0123356899999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=384.72  Aligned_cols=293  Identities=34%  Similarity=0.551  Sum_probs=227.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc---c
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI---S  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~  105 (364)
                      -++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++|||++++++++......   .
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            4799999999999999999999999999999999976655555556778999999999999999999998664211   1


Q ss_pred             cceEEEEeccccccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMDTDLHQII-KSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                      ....++|||++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            2568999999997555544 445679999999999999999999999999999999999999999999999999997553


Q ss_pred             CCC----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          185 GNE----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       185 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      ...    .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+....+.........
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            322    2223356899999999998766789999999999999999999999999999999999988888877665544


Q ss_pred             cCchhHHHHHhhCCCCCCCcccc-cCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISS-LYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISG  321 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~  321 (364)
                      ....................... .....++.+++||.+||+.||++|||++|+|+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            43333222221111110000000 00124678889999999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=383.63  Aligned_cols=262  Identities=29%  Similarity=0.413  Sum_probs=208.3

Q ss_pred             cccceeeee-eeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccccc
Q 017909           28 IDTKYVPIK-PIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        28 ~~~~y~i~~-~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (364)
                      +-++|++.+ .||+|+||+||+|+++.+++.||||+++..       ....+|+.++.++ +||||++++++|.+.... 
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~-   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG-   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT-
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC-
Confidence            457899875 699999999999999999999999998642       2345788886554 899999999998652111 


Q ss_pred             cceEEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEEEeecCc
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL  179 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~L~Dfg~  179 (364)
                      ...+|+|||||+ |+|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            167899999997 6999999864  46999999999999999999999999999999999999985   45799999999


Q ss_pred             cccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhh
Q 017909          180 ARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLE  259 (364)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (364)
                      +...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...+....     
T Consensus       161 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~-----  233 (335)
T d2ozaa1         161 AKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----  233 (335)
T ss_dssp             CEECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-----
T ss_pred             eeeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-----
Confidence            9866443 33455689999999999987 5789999999999999999999999987765444443322211100     


Q ss_pred             ccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          260 FIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                        .......+..+++.+.+||++||+.||.+|||+.|+|+||||++.
T Consensus       234 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         234 ------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             ------------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             ------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                              000011123578899999999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=367.02  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=208.6

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|+.+   ..||+|+++...........+.+|+.++++++||||+++++++..      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            578999999999999999999754   359999998666666677788899999999999999999998643      34


Q ss_pred             EEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGN  186 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~  186 (364)
                      .++|||||+ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            799999998 6999999754 56999999999999999999999999999999999999999999999999998765332


Q ss_pred             --CcccccccccccccCCcccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhccC
Q 017909          187 --EQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       187 --~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                        ........||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.................+        
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--------  229 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--------  229 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC--------
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--------
Confidence              2233456789999999998652  3478999999999999999999999998776655544433211111        


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                       ........+++.+.+||.+||+.||.+|||+.||+++
T Consensus       230 -----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 -----------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -----------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                             1223446789999999999999999999999999976

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-51  Score=366.17  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=210.7

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++.+.||+|+||+||+|+++.+|..||+|+++....   ...++.+|+.+++.++||||+++++++.+.     ..
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~   87 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP   87 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC-----Ce
Confidence            5799999999999999999999999999999999975433   344678999999999999999999999877     77


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||++ |+|.+.+...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            899999998 7999998754  5689999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIF-PGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. .......|+..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+.......+..               
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~---------------  231 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------------  231 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---------------
T ss_pred             CCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc---------------
Confidence            33 22334557889999999987 57899999999999999999866554 44443333332211               


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGL  322 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~  322 (364)
                                     ......+..+++.+.+||++||+.||.+|||+.||++  +|+.+
T Consensus       232 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         232 ---------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ---------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                           0112334578999999999999999999999999975  45443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.8e-52  Score=367.57  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=213.0

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN-RIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .+.++|++.+.||+|+||+||+|++..+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.......
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            3689999999999999999999999999999999999865443 344567789999999999999999999987653221


Q ss_pred             cceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSR  184 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~  184 (364)
                       ...|+||||++ ++|.+.+...+++++.+++.++.||+.||.|||++|++||||||+||+++.++..+|+|||.+....
T Consensus        84 -~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          84 -PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             -EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             -ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence             45899999998 5999999888999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          185 GNE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       185 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ...   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.......        
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--------  233 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--------  233 (277)
T ss_dssp             ----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--------
T ss_pred             cccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC--------
Confidence            222   23445678999999999987 578999999999999999999999999887666655544321111        


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-CHHHHhcCCCcc
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-TVTEALQHPYIS  320 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~elL~hp~f~  320 (364)
                                         .....+.+|+.+.+||++||+.||.+|| |++++ .|+|++
T Consensus       234 -------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         234 -------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             -------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             -------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence                               1223457899999999999999999999 56654 466553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-51  Score=371.94  Aligned_cols=285  Identities=31%  Similarity=0.532  Sum_probs=219.7

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (364)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|+++...     ..++.+|+.+|+.++ ||||+++++++.....   
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---  104 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVS---  104 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---
Confidence            4578999999999999999999999999999999987532     345678999999995 9999999999875432   


Q ss_pred             ceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCC-cEEEeecCccccCC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSR  184 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~-~~~L~Dfg~~~~~~  184 (364)
                      ...++||||++ ++|...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus       105 ~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             CSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             CceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            57899999998 476544   35799999999999999999999999999999999999998655 69999999997664


Q ss_pred             CCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCchhhhhcc-C
Q 017909          185 GNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE-CLNQLKLIISVFGTQQEADLEFI-D  262 (364)
Q Consensus       185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~-~  262 (364)
                      .. .......+|..|+|||.+.+...++.++|||||||++|+|++|..||.... .......+....+.+........ .
T Consensus       182 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         182 PG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            33 234556789999999999886678999999999999999999999997654 44455555555543322221111 0


Q ss_pred             chhHHHHHhhCCCCCCCc-----ccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 017909          263 NPKARRFIKSLPYSRGTH-----ISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQHPYISGLYD  324 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~hp~f~~~~~  324 (364)
                      ......+...........     .......+++++.+||++||+.||.+|||++|+|+||||+.+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            101111111111111111     11223347889999999999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=365.63  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=204.3

Q ss_pred             eeeccCCceeEEEEEec--cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceEEEEe
Q 017909           36 KPIGRGAYGVVCSSINR--ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDVYLVY  113 (364)
Q Consensus        36 ~~lg~g~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (364)
                      +.||+|+||+||+|.++  .+++.||+|+++...........+.+|+.++++++||||+++++++..      ...++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            47999999999999865  345789999998665566666788999999999999999999999853      3468999


Q ss_pred             cccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCCcc---
Q 017909          114 ELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNEQF---  189 (364)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~~~---  189 (364)
                      ||++ |+|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.........   
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9998 699999999899999999999999999999999999999999999999999999999999999765433222   


Q ss_pred             cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchhHHH
Q 017909          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPKARR  268 (364)
Q Consensus       190 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (364)
                      .....|++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.+.                   
T Consensus       167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-------------------  226 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------------------  226 (277)
T ss_dssp             ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------------
T ss_pred             ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-------------------
Confidence            233567889999999987 578999999999999999997 89999988766555544321                   


Q ss_pred             HHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHH---hcCCCcc
Q 017909          269 FIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA---LQHPYIS  320 (364)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el---L~hp~f~  320 (364)
                                 .....+..+++.+.+||.+||+.||.+|||+++|   |+|+|+.
T Consensus       227 -----------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         227 -----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                       1123346789999999999999999999999998   4666653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=359.10  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=199.0

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|+++ ++..||||+++.....   ..++.+|+.+++.++||||+++++++..+     ...
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~   75 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----API   75 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC-----Cce
Confidence            68999999999999999999876 4678999999753322   34678999999999999999999999887     778


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++||||++ |+|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.......
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999998 7999988755 568999999999999999999999999999999999999999999999999997654332


Q ss_pred             -cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 -QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                       .......|+..|+|||++.+ ..++.++|||||||++|||++ |.+||......+....+.....              
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------------  220 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------------  220 (263)
T ss_dssp             ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------------
T ss_pred             ceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC--------------
Confidence             22334567899999999987 579999999999999999998 5777776666555555433110              


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                      ...+..+++.+.+||.+||+.||.+|||++|||+|
T Consensus       221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            12234578899999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-51  Score=364.16  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=200.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCc---EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNE---KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++.+.||+|+||+||+|+++.+++   .||+|.+.... .......+.+|+.+|+.++||||+++++++...    
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS----   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC----
Confidence            4789999999999999999999887665   58888876432 334556788999999999999999999999877    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++|||||+ |+|.+++... +.+++.++..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus       100 -~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         100 -TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             -CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence             77899999998 6999988764 56999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCcc-----cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          184 RGNEQF-----MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       184 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      ......     .....+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+...        
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~--------  249 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD--------  249 (299)
T ss_dssp             -----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence            432211     223456889999999987 679999999999999999997 89999988776665554321        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                            .....+..+++.+.+||.+||+.||.+|||+.||+++
T Consensus       250 ----------------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         250 ----------------------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  1122335688999999999999999999999998864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=370.13  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=207.9

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCc-----EEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeeccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNE-----KVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHR  103 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (364)
                      ++|++++.||+|+||+||+|++...++     .||+|.+.... .......+.+|+.+++++ +||||+++++++...  
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--  113 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  113 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence            789999999999999999999876543     68999886532 233445678899999998 899999999999887  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ-----------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDL  159 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di  159 (364)
                         ...++|||||+ |+|.+++...+                       .+++..++.++.||+.||.|||++||+||||
T Consensus       114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence               77899999998 69999997542                       4899999999999999999999999999999


Q ss_pred             CCCCeEEccCCcEEEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 017909          160 KPGNLLVNANCDLKICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPG  236 (364)
Q Consensus       160 ~~~NIll~~~~~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~  236 (364)
                      ||+||+++.++.+||+|||+++.......  ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            99999999999999999999976543322  2345567999999999987 679999999999999999997 8999998


Q ss_pred             CChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          237 TECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .........+....                             .....+..+++.+.+||.+||+.||++|||++||++|
T Consensus       270 ~~~~~~~~~~~~~~-----------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNG-----------------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcC-----------------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            76665555543311                             0122345688999999999999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-51  Score=356.42  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=211.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      ++|++++.||+|+||+||+|+++ ++..||+|+++.....   ...+.+|+.++++++||||+++++++.++     ..+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~   74 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPI   74 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cce
Confidence            68999999999999999999975 6778999999764333   34678999999999999999999999877     789


Q ss_pred             EEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++||||+. |+|.+.+.. ...+++..++.++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.......
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99999997 788888654 4679999999999999999999999999999999999999999999999999997654332


Q ss_pred             -cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCchh
Q 017909          188 -QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNPK  265 (364)
Q Consensus       188 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (364)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++ |+.||.+....+....+.+..               
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---------------  218 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------------  218 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC---------------
T ss_pred             ceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC---------------
Confidence             22334667899999999987 578999999999999999997 899999988777666554311               


Q ss_pred             HHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          266 ARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                     ....+...++.+.+||++||+.||.+|||+++||+|
T Consensus       219 ---------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         219 ---------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                           112234678899999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=373.94  Aligned_cols=281  Identities=21%  Similarity=0.342  Sum_probs=224.0

Q ss_pred             cceeeeeeeccCCceeEEEEEe---ccCCcEEEEEeccchhh--chHHHHHHHHHHHHHHhcCC-CCcceeeeeeccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSIN---RETNEKVAIKKINNVFE--NRIDALRTLRELVLLRHIKH-DNVIALKDVMMPTHR  103 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~---~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~  103 (364)
                      ++|++++.||+|+||+||+|.+   +.+|+.||+|+++....  .......+.+|+.++++++| |||+++++++.+.  
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~--  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence            6799999999999999999987   44689999999875432  22233456689999999976 8999999999888  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                         ...+++|||+. |+|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus       102 ---~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         102 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ---CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence               88999999998 69999999999999999999999999999999999999999999999999999999999999976


Q ss_pred             CCCC-CcccccccccccccCCccccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          183 SRGN-EQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       183 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .... ........|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.........+......        
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--------  250 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--------  250 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--------
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--------
Confidence            5332 23344567899999999997633 4788999999999999999999999887655444444332100        


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCCCCC-CCCCCCCC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRI-----TVTEALQHPYISGLYDPQ-CNPPAQVP  334 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~elL~hp~f~~~~~~~-~~~~~~~~  334 (364)
                                         .....+..+++.+.+||.+||++||.+||     |++|+|+||||++..... .....++|
T Consensus       251 -------------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p  311 (322)
T d1vzoa_         251 -------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP  311 (322)
T ss_dssp             -------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             -------------------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcC
Confidence                               01223456899999999999999999999     589999999999865222 22334444


Q ss_pred             CCcccchh
Q 017909          335 LSLDIDEN  342 (364)
Q Consensus       335 ~~~~~~~~  342 (364)
                      ..+.+.+.
T Consensus       312 ~~p~~~~~  319 (322)
T d1vzoa_         312 FKPVIRDE  319 (322)
T ss_dssp             CCCCCCC-
T ss_pred             CCCCCCCC
Confidence            44444433

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=361.00  Aligned_cols=255  Identities=21%  Similarity=0.334  Sum_probs=211.6

Q ss_pred             cccceeeeee-eccCCceeEEEEEecc--CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           28 IDTKYVPIKP-IGRGAYGVVCSSINRE--TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        28 ~~~~y~i~~~-lg~g~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      -.++|.+.+. ||+|+||+||+|.++.  ++..||||+++.. .......++.+|+.++++++||||+++++++..    
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----   80 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----   80 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence            3468899885 9999999999998764  3457999999754 234456678899999999999999999999854    


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++||||++ |+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence              34799999998 6999987654 5799999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCc---ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          183 SRGNEQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       183 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      ......   ......|++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.+.         
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---------  228 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---------  228 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---------
T ss_pred             ccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence            644322   2234467889999999977 578999999999999999997 89999988766655554321         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHH---hcCCCcc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEA---LQHPYIS  320 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el---L~hp~f~  320 (364)
                                           .....++.+++.+.+||.+||+.||.+|||+.+|   |+|+|++
T Consensus       229 ---------------------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         229 ---------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ---------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                 1123446789999999999999999999999888   6788874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=362.00  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=208.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|+++ ++..||||+++....   ....+.+|+.++++++||||+++++++..      ..
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence            579999999999999999999976 567899999975432   23467899999999999999999998753      34


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||++ |+|.+.+...  .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            689999998 6998877543  3699999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. .......|++.|+|||++.+ ..++.++|||||||++|||++| .+||......+....+...              
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~--------------  226 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------------  226 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------------
T ss_pred             CccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------------
Confidence            32 23344567889999999987 5789999999999999999985 5666666655555444221              


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ--HPYISG  321 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~--hp~f~~  321 (364)
                                      .....+..+++.+.+||++||+.||.+|||+++|++  |+||+.
T Consensus       227 ----------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         227 ----------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                            112233568899999999999999999999999998  788853

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=353.75  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=204.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||+||+|+++.+ ..||+|+++....   ....+.+|+.++++++||||+++++++.+      ..
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~   85 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP   85 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence            47899999999999999999998755 5799999975433   23567899999999999999999999854      34


Q ss_pred             EEEEecccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKS--SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||+. |+|.+.+..  .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            689999998 688888754  35799999999999999999999999999999999999999999999999999976533


Q ss_pred             CC-cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCchhhhhccCc
Q 017909          186 NE-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQEADLEFIDN  263 (364)
Q Consensus       186 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (364)
                      .. .......+++.|+|||.+.. ..++.++||||||+++|||++| .+|+.+....+....+...              
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~--------------  230 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------------  230 (285)
T ss_dssp             ----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------------
T ss_pred             CCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------------
Confidence            32 23344677899999999987 6789999999999999999985 5556665555555444321              


Q ss_pred             hhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCC
Q 017909          264 PKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ--HPYISGL  322 (364)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~--hp~f~~~  322 (364)
                                      .....+..+++.+.+||.+||+.||++|||+++|++  ++||+..
T Consensus       231 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         231 ----------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------------CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                            112344678899999999999999999999999998  8888764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=352.03  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=199.8

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCC---cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      .++|++++.||+|+||+||+|++..++   ..||+|.++.. ........+.+|+.+++.++||||+++++++.+     
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            479999999999999999999986543   46888888643 334455678899999999999999999999853     


Q ss_pred             cceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       ...++||||+. |++.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             45799999998 688887765 457999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC-CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhcc
Q 017909          184 RGN-EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFI  261 (364)
Q Consensus       184 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (364)
                      ... ........|++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+.+.            
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~------------  225 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------  225 (273)
T ss_dssp             ------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------------
T ss_pred             cCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence            332 223344567889999999987 578999999999999999997 89999988877766655331            


Q ss_pred             CchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          262 DNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                        .....++.+++.+.+||.+||+.||.+|||+.||++|
T Consensus       226 ------------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         226 ------------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                              1123456789999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=348.92  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=198.1

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCC----cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETN----EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRI  104 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (364)
                      .+.|++.++||+|+||+||+|.++.++    ..||+|+++... ......++.+|+.+++.++||||+++++++...   
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~---   81 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY---   81 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---
Confidence            357999999999999999999987654    469999986543 333455688999999999999999999999877   


Q ss_pred             ccceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          105 SFKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                        ...++||||+. +++.+.+... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 --~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          82 --KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             --CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence              77899999998 5787777654 6799999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCC---cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCchhhh
Q 017909          183 SRGNE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISVFGTQQEADL  258 (364)
Q Consensus       183 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (364)
                      .....   .......||..|+|||++.+ ..++.++|||||||++|||+++ .+|+......+....+...         
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---------  229 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---------  229 (283)
T ss_dssp             --------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc---------
Confidence            53322   12334567889999999987 6899999999999999999985 5555555554444433221         


Q ss_pred             hccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          259 EFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           .....+..+++.+.+||.+||+.||.+|||+.||++
T Consensus       230 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 ---------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                 112234568889999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=355.14  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=200.8

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCc----EEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNE----KVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRIS  105 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (364)
                      ++|++++.||+|+||+||+|.+..+|+    +||+|.++... .......+.+|+.++++++||||+++++++.+.    
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            579999999999999999999988776    58888876432 222445678999999999999999999999765    


Q ss_pred             cceEEEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccC
Q 017909          106 FKDVYLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (364)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~  183 (364)
                       . .+++++++. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        84 -~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          84 -T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             -S-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             -C-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence             3 456666665 7888877654 67999999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhc
Q 017909          184 RGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEF  260 (364)
Q Consensus       184 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (364)
                      .....  ......||..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+...           
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-----------  229 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----------  229 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-----------
T ss_pred             ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence            43322  2334467899999999988 579999999999999999997 89999887766655544331           


Q ss_pred             cCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          261 IDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                         .....++.+++.+.+||.+||+.||.+|||+.||++|
T Consensus       230 -------------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         230 -------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             -------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                               1122345688999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=344.03  Aligned_cols=244  Identities=24%  Similarity=0.376  Sum_probs=199.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccce
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKD  108 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (364)
                      .++|++++.||+|+||.||+|+++  |+.||+|+++.+.    ....+.+|+.++++++||||+++++++.+..    ..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~   75 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG   75 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----Cc
Confidence            468999999999999999999875  7899999997532    3356789999999999999999999986542    45


Q ss_pred             EEEEecccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCC
Q 017909          109 VYLVYELMD-TDLHQIIKSS--QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRG  185 (364)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~  185 (364)
                      .++||||++ |+|.+++...  ..+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence            799999997 7999998654  3599999999999999999999999999999999999999999999999999876533


Q ss_pred             CCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhhhccCch
Q 017909          186 NEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEADLEFIDNP  264 (364)
Q Consensus       186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (364)
                      .   .....++..|+|||++.+ ..++.++||||||+++|||++ |.+||......+....+.+                
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~----------------  215 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------------  215 (262)
T ss_dssp             ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----------------
T ss_pred             C---CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------------
Confidence            2   233456889999999987 579999999999999999997 7899988766665555422                


Q ss_pred             hHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          265 KARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                    ......+..+++.+.+||++||+.||.+|||+.+|+++
T Consensus       216 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         216 --------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                          11233445788999999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=349.64  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=198.3

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||+|+||+||+|++..     +++.||+|+++... .......+.+|...+.++ .|+||+.+++++....
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            4789999999999999999999754     44689999997543 333445667787877777 6899999999887653


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeE
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLL  165 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIl  165 (364)
                          ...++|||||+ |+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        91 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          91 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             ----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence                56899999998 7999998643                24899999999999999999999999999999999999


Q ss_pred             EccCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 017909          166 VNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQ  242 (364)
Q Consensus       166 l~~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~  242 (364)
                      ++.++.+||+|||+++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++| .+||.+......
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999997653322  23345678999999999988 6789999999999999999976 578887765544


Q ss_pred             HHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          243 LKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      ........                             .....+..+++.+.+||.+||+.||.+|||++||++|
T Consensus       246 ~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEG-----------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcC-----------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43332211                             1122345688999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=345.36  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=198.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccC-C--cEEEEEeccchhh-chHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRET-N--EKVAIKKINNVFE-NRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~-~--~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      -.++|++.+.||+|+||+||+|+.... +  ..||+|+++.... .......+.+|+.+++.++||||+++++++.++  
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--   83 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--   83 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--
Confidence            357899999999999999999986533 2  3689999976543 334456788999999999999999999999643  


Q ss_pred             cccceEEEEecccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccc
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~  181 (364)
                          ..++||||++ |++.+.+.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        84 ----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          84 ----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence                4589999998 688877654 4579999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCcc---cccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhh
Q 017909          182 TSRGNEQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECLNQLKLIISVFGTQQEAD  257 (364)
Q Consensus       182 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (364)
                      ........   .....++..|+|||++.+ ..++.++||||||+++|||++ |..||.+.+..+....+...        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--------  230 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--------  230 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC--------
Confidence            76443221   223456778999999988 678999999999999999997 89999988877766655431        


Q ss_pred             hhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          258 LEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                                           ......+..+++.+.+||.+||+.||++|||+.+|++
T Consensus       231 ---------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         231 ---------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ---------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 1112334678899999999999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-48  Score=347.79  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=208.5

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|++++.||+|+||+||+|+++     .+++.||||+++... ......++.+|+.+++.++|||++++++++...  
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence            468999999999999999999875     356789999997542 333456788999999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSSQ------------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRD  158 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d  158 (364)
                         ...++|||++. |+|.+++....                        .+++..+..++.|++.||.|||+++++|||
T Consensus        89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence               77899999997 79999886432                        488999999999999999999999999999


Q ss_pred             CCCCCeEEccCCcEEEeecCccccCCCC--CcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCC-CCCC
Q 017909          159 LKPGNLLVNANCDLKICDFGLARTSRGN--EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRK-PIFP  235 (364)
Q Consensus       159 i~~~NIll~~~~~~~L~Dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~  235 (364)
                      |||+|||++.++.+||+|||++......  ........+++.|+|||.+.+ ..++.++|||||||++|||++|. +||.
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999998754322  222334567889999999987 67999999999999999999885 7888


Q ss_pred             CCChHHHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          236 GTECLNQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      +....+....+.+.                              .....+..+++.+.+||.+||+.||++|||+.||++
T Consensus       245 ~~~~~e~~~~v~~~------------------------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDG------------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcC------------------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88777666555321                              112334578899999999999999999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=342.58  Aligned_cols=250  Identities=27%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCC-------cEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETN-------EKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMP  100 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  100 (364)
                      .++|++++.||+|+||.||+|++..++       ..||+|+++... ......++.+|+..+.++ +||||+++++++.+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            689999999999999999999876543       479999997643 334556778888888888 79999999999988


Q ss_pred             ccccccceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          101 THRISFKDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                      +     ...++||||+. |+|.+++...                ..+++..++.++.||+.||.|||+++++||||||+|
T Consensus        91 ~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          91 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             S-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             C-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            7     77899999998 7999999644                358999999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~  240 (364)
                      ||++.++.+||+|||.+.......  .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+....
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999999999999999987553322  22344567889999999987 689999999999999999997 79999887766


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      .....+.+.                              .....+..+++.+.+||.+||+.||.+|||+.|||+
T Consensus       245 ~~~~~i~~~------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 ELFKLLKEG------------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHTT------------------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcC------------------------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            555444221                              112234568899999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=347.58  Aligned_cols=249  Identities=26%  Similarity=0.327  Sum_probs=204.2

Q ss_pred             cceeeeeeeccCCceeEEEEEeccCCcE--EEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccccccc
Q 017909           30 TKYVPIKPIGRGAYGVVCSSINRETNEK--VAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        30 ~~y~i~~~lg~g~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++|++.+.||+|+||+||+|+++.+|..  |+||.++... .......+.+|+.++..+ +||||+++++++...     
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----   83 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----   83 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence            6999999999999999999999888775  6677765322 223455678999999998 799999999999887     


Q ss_pred             ceEEEEecccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccC
Q 017909          107 KDVYLVYELMD-TDLHQIIKSS----------------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (364)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~  169 (364)
                      ...++||||++ |+|.+++...                ..+++..+..++.||+.||.|||+++++||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            78999999998 7999998643                579999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 017909          170 CDLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIIS  248 (364)
Q Consensus       170 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~  248 (364)
                      +.+||+|||++..... ........++..|+|||.+.+ ..++.++|||||||++|+|++| .+||.+.+..+....+.+
T Consensus       164 ~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 YVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GCEEECCTTCEESSCE-ECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CceEEccccccccccc-cccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            9999999999875532 222334567889999999987 5789999999999999999986 467887766555544422


Q ss_pred             HhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          249 VFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                      .                              .....+..+++.+.+||.+||+.||++|||+.||+++
T Consensus       242 ~------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 G------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             T------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c------------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            1                              1123345688999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=344.19  Aligned_cols=256  Identities=21%  Similarity=0.365  Sum_probs=215.2

Q ss_pred             ccceeeeeeeccCCceeEEEEEecc-----CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRE-----TNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHR  103 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (364)
                      .++|++++.||+|+||+||+|.++.     ++..||||+++.. ........+.+|+.++++++||||+++++++...  
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--   95 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--   95 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence            5899999999999999999998763     3578999999754 3444556788999999999999999999999877  


Q ss_pred             cccceEEEEecccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcE
Q 017909          104 ISFKDVYLVYELMD-TDLHQIIKSS----------QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (364)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~  172 (364)
                         ...++||||+. |+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus        96 ---~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ---CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence               77899999997 7999887532          347899999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCCc--ccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q 017909          173 KICDFGLARTSRGNEQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGR-KPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       173 ~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~  249 (364)
                      ||+|||++........  ......+++.|+|||.+.+ ..++.++||||||+++|||++| .+||.+....+....+.+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999875533322  2334467899999999987 5789999999999999999988 5889888777666655431


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCccC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ------HPYISG  321 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~------hp~f~~  321 (364)
                                                    .....+..+++.+.+||.+||+.||.+|||+++|++      +|+|++
T Consensus       252 ------------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         252 ------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             ------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             ------------------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence                                          112334568899999999999999999999999998      777754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=341.59  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=210.9

Q ss_pred             ccceeeeeeeccCCceeEEEEEec-----cCCcEEEEEeccchhhchHHHHHHHHHHHHHHhc-CCCCcceeeeeecccc
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINR-----ETNEKVAIKKINNVFENRIDALRTLRELVLLRHI-KHDNVIALKDVMMPTH  102 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (364)
                      .++|++++.||+|+||+||+|+++     .+++.||+|+++... .......+.+|+.+++.+ +||||+++++++... 
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence            579999999999999999999853     466789999997543 344556788999999999 699999999999887 


Q ss_pred             ccccceEEEEecccc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 017909          103 RISFKDVYLVYELMD-TDLHQIIKSSQ------------------SLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGN  163 (364)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~N  163 (364)
                          ...++|||||+ |+|.+++....                  .+++..+..++.||+.||.|||++|++||||||+|
T Consensus       100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_         100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence                77899999998 69999986543                  58999999999999999999999999999999999


Q ss_pred             eEEccCCcEEEeecCccccCCCCC--cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017909          164 LLVNANCDLKICDFGLARTSRGNE--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILG-RKPIFPGTECL  240 (364)
Q Consensus       164 Ill~~~~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~  240 (364)
                      |+++.++.++++|||.+.......  .......|++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998664432  23345678999999999987 678999999999999999997 67778777666


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      +...++....                             .....+..+++.+.+||.+||+.||.+|||+++||+
T Consensus       255 ~~~~~~i~~~-----------------------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEG-----------------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHT-----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcC-----------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6555554321                             112223467899999999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=334.10  Aligned_cols=248  Identities=22%  Similarity=0.309  Sum_probs=197.7

Q ss_pred             eeeeeeccCCceeEEEEEeccCC---cEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccceE
Q 017909           33 VPIKPIGRGAYGVVCSSINRETN---EKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFKDV  109 (364)
Q Consensus        33 ~i~~~lg~g~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (364)
                      .+.++||+|+||+||+|++..++   ..||+|+++.. .......++.+|++++++++||||+++++++....    +..
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~  104 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP  104 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence            33678999999999999986543   35899998642 34556677899999999999999999999986542    578


Q ss_pred             EEEecccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEeecCccccCCCCC
Q 017909          110 YLVYELMD-TDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSRGNE  187 (364)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~Dfg~~~~~~~~~  187 (364)
                      ++|||||+ |+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++.......
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999998 6888888754 458888999999999999999999999999999999999999999999999997654322


Q ss_pred             ----cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhhhccC
Q 017909          188 ----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL-NQLKLIISVFGTQQEADLEFID  262 (364)
Q Consensus       188 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  262 (364)
                          .......|+..|+|||.+.. ..++.++||||||+++|||++|..||...... +....+..              
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--------------  249 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------------  249 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--------------
T ss_pred             cccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--------------
Confidence                12233567889999999987 57899999999999999999987777554322 22222111              


Q ss_pred             chhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          263 NPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                                      ......+..+++.+.+||.+||+.||++|||+.||++|
T Consensus       250 ----------------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         250 ----------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                            01122335678899999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-46  Score=337.49  Aligned_cols=264  Identities=18%  Similarity=0.186  Sum_probs=204.1

Q ss_pred             ecccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeecccccccc
Q 017909           27 EIDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        27 ~~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (364)
                      .++++|++++.||+|+||+||+|++..+|+.||+|++......    .++..|+.+++.++|++++..+..+....    
T Consensus         4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~----   75 (299)
T d1ckia_           4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG----   75 (299)
T ss_dssp             EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEET----
T ss_pred             eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecC----
Confidence            3578999999999999999999999999999999988654322    23567999999998777665555543332    


Q ss_pred             ceEEEEeccccccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc---CCcEEEeecCcccc
Q 017909          107 KDVYLVYELMDTDLHQIIKS-SQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLART  182 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~---~~~~~L~Dfg~~~~  182 (364)
                      ...++|||++++++.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.   +..++|+|||++..
T Consensus        76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            67899999999988877754 467999999999999999999999999999999999999864   45799999999986


Q ss_pred             CCCCC-------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q 017909          183 SRGNE-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISVFGTQQE  255 (364)
Q Consensus       183 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (364)
                      .....       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            54322       12334578999999999988 57999999999999999999999999887655444433221100000


Q ss_pred             hhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHH---HHhcCCCccCC
Q 017909          256 ADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVT---EALQHPYISGL  322 (364)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~---elL~hp~f~~~  322 (364)
                                             .........+++.+.+||..||+.||.+||++.   ++|+|+|.+..
T Consensus       235 -----------------------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         235 -----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             -----------------------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             -----------------------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence                                   001122356889999999999999999999987   55778876543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.4e-45  Score=326.61  Aligned_cols=252  Identities=16%  Similarity=0.174  Sum_probs=204.3

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCC-CCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKH-DNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~  106 (364)
                      ++++|++++.||+|+||+||+|++..+|+.||+|++......    ..+.+|++.++.++| +|++.+++++...     
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----   73 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----   73 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET-----
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecC-----
Confidence            578999999999999999999999999999999998653322    234568888888865 8999999998777     


Q ss_pred             ceEEEEeccccccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEcc-----CCcEEEeecCcc
Q 017909          107 KDVYLVYELMDTDLHQIIKSS-QSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNA-----NCDLKICDFGLA  180 (364)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~-----~~~~~L~Dfg~~  180 (364)
                      ...++|||+++++|.+.+... ..++...+..++.|++.||.+||++||+||||||+||+++.     ++.++|+|||++
T Consensus        74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            788999999999999998765 47999999999999999999999999999999999999964     568999999999


Q ss_pred             ccCCCCC-------cccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHh
Q 017909          181 RTSRGNE-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKL---IISVF  250 (364)
Q Consensus       181 ~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~---i~~~~  250 (364)
                      .......       .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........   +....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            7653321       12334578999999999988 6799999999999999999999999987654333222   22110


Q ss_pred             CCCchhhhhccCchhHHHHHhhCCCCCCCcccccCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 017909          251 GTQQEADLEFIDNPKARRFIKSLPYSRGTHISSLYPQADPLALDLLQKMLVFEPSKRITVTEALQ  315 (364)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~elL~  315 (364)
                      ...+                          .....+.+++.+.+++..|++.+|++||+.+.+.+
T Consensus       233 ~~~~--------------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 QSTP--------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHSC--------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCCC--------------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            0000                          11123567889999999999999999998777653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-45  Score=336.55  Aligned_cols=284  Identities=25%  Similarity=0.377  Sum_probs=206.0

Q ss_pred             ccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-----------CCCcceeeee
Q 017909           29 DTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-----------HDNVIALKDV   97 (364)
Q Consensus        29 ~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~   97 (364)
                      ++||+++++||+|+||+||+|+++.+|+.||||+++....   ......+|+.+++.+.           |+||++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            4689999999999999999999999999999999975422   2334556777777664           5789999988


Q ss_pred             eccccccccceEEEEeccc--cccHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeEEccCC--
Q 017909           98 MMPTHRISFKDVYLVYELM--DTDLHQII--KSSQSLSNDHCKYFVFQLLRGLKYLHS-ANILHRDLKPGNLLVNANC--  170 (364)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~--~g~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~di~~~NIll~~~~--  170 (364)
                      +.....   ...++++.++  .++.....  .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++  
T Consensus        89 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          89 FNHKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             eeeccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            865432   3445555554  34433333  334679999999999999999999998 8899999999999998765  


Q ss_pred             ----cEEEeecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hH
Q 017909          171 ----DLKICDFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTE------CL  240 (364)
Q Consensus       171 ----~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~------~~  240 (364)
                          .++++|||.+.....   ......|++.|+|||++.+ ..++.++|+||+||++++|++|+.||....      ..
T Consensus       166 ~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                399999999875532   2345678999999999987 578999999999999999999999997543      33


Q ss_pred             HHHHHHHHHhCCCchhhhhccCchhHHHHHhhC---CCCCCC----------cccccCCCCChHHHHHHHHhcccCCCCC
Q 017909          241 NQLKLIISVFGTQQEADLEFIDNPKARRFIKSL---PYSRGT----------HISSLYPQADPLALDLLQKMLVFEPSKR  307 (364)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R  307 (364)
                      .........++..+..........  ..+....   ......          .........++.+.+||.+||+.||.+|
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             HHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence            455556666666554433221111  0000000   000000          0111223456789999999999999999


Q ss_pred             CCHHHHhcCCCccCCCC
Q 017909          308 ITVTEALQHPYISGLYD  324 (364)
Q Consensus       308 ps~~elL~hp~f~~~~~  324 (364)
                      ||++|+|+||||+....
T Consensus       320 pta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         320 ADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             BCHHHHHTCGGGTTCTT
T ss_pred             cCHHHHhcCcccCCCCC
Confidence            99999999999996543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=324.54  Aligned_cols=271  Identities=21%  Similarity=0.218  Sum_probs=191.5

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCcceeeeeeccccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNVIALKDVMMPTHRISFK  107 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (364)
                      |..+|.+.+.||+|+||+||+|+.  +|+.||||+++....   .......|+..+..++||||+++++++..+.... .
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~-~   74 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW-T   74 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS-E
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc-e
Confidence            467899999999999999999975  588999999975422   1122224556666789999999999998764221 4


Q ss_pred             eEEEEecccc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCCeEEccCCcEEEeecC
Q 017909          108 DVYLVYELMD-TDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS--------ANILHRDLKPGNLLVNANCDLKICDFG  178 (364)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------~~i~H~di~~~NIll~~~~~~~L~Dfg  178 (364)
                      ..++||||+. |+|.+++.+ .++++.....++.|++.||.|||+        +||+||||||+|||++.++.+||+|||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            6899999997 699999976 469999999999999999999996        589999999999999999999999999


Q ss_pred             ccccCCCCCc----ccccccccccccCCccccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017909          179 LARTSRGNEQ----FMTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIISV  249 (364)
Q Consensus       179 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  249 (364)
                      ++........    ......||+.|+|||.+.+..     .++.++|||||||++|||++|..||..........     
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-----  228 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-----  228 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-----
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-----
Confidence            9876543322    233467899999999987532     25678999999999999999998874432110000     


Q ss_pred             hCCCchhhhhccCchhHHHHHhhCCCCCCCccccc--CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017909          250 FGTQQEADLEFIDNPKARRFIKSLPYSRGTHISSL--YPQADPLALDLLQKMLVFEPSKRITVTEALQH  316 (364)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~elL~h  316 (364)
                          ....................  .........  .......+.+|+.+||+.||.+|||+.||+++
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 ----YDLVPSDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             ----TTTSCSSCCHHHHHHHHTTS--CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ----hhcccccchHHHHHHHHhcc--ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                00000000000011110000  000000000  11123458899999999999999999999863

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=8.5e-24  Score=175.42  Aligned_cols=170  Identities=16%  Similarity=0.088  Sum_probs=119.5

Q ss_pred             eeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhc----------------hHHHHHHHHHHHHHHhcCCCCcceee
Q 017909           32 YVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFEN----------------RIDALRTLRELVLLRHIKHDNVIALK   95 (364)
Q Consensus        32 y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (364)
                      +.+++.||+|+||+||+|++. +|+.||+|+++.....                .........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999875 6889999987532110                11223334688899999999998877


Q ss_pred             eeeccccccccceEEEEeccccccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeEEccCCcEEEe
Q 017909           96 DVMMPTHRISFKDVYLVYELMDTDLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (364)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di~~~NIll~~~~~~~L~  175 (364)
                      +..         ..+++||++++...      ..++...+..++.|++.+|.+||++|++|+||||+|||++++ .++|+
T Consensus        81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence            652         23799999986321      235666678899999999999999999999999999999966 58999


Q ss_pred             ecCccccCCCCCcccccccccccccCCcccccccCCCChhhHHHHHH
Q 017909          176 DFGLARTSRGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGC  222 (364)
Q Consensus       176 Dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  222 (364)
                      |||.+.....+...  ...........+.+ . ..++.++|+||+.-
T Consensus       145 DFG~a~~~~~~~~~--~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWR--EILERDVRNIITYF-S-RTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHH--HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcH--HHHHHHHHHHHHHH-c-CCCCCcccHHHHHH
Confidence            99998665322211  00000000001112 2 46788999999643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=4.3e-07  Score=76.96  Aligned_cols=141  Identities=15%  Similarity=0.114  Sum_probs=88.6

Q ss_pred             cccceeeeeeeccCCceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccccc
Q 017909           28 IDTKYVPIKPIGRGAYGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        28 ~~~~y~i~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (364)
                      +-+.|++++..+.++.+.||++.  .++..+++|.........  ...+..|...++.+. +--+++++.+...+     
T Consensus        12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-----   82 (263)
T d1j7la_          12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD-----   82 (263)
T ss_dssp             HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----
T ss_pred             hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecC-----
Confidence            44678888877666678999884  456778888876432221  123345777777663 43456677666555     


Q ss_pred             ceEEEEeccccc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 017909          107 KDVYLVYELMDT-DLHQIIKSSQSLSNDHCKYFVFQLLRGLKYLHS----------------------------------  151 (364)
Q Consensus       107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------  151 (364)
                      +..++||++++| ++.+....     ......++.++...+..||+                                  
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             CceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            678999999987 55433211     11111223333333333332                                  


Q ss_pred             -------------------C------CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          152 -------------------A------NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       152 -------------------~------~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                                         .      .++|+|+.|.||++++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                               1      278999999999999876667999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.10  E-value=4e-06  Score=75.30  Aligned_cols=77  Identities=19%  Similarity=0.081  Sum_probs=45.3

Q ss_pred             eeeeccCCceeEEEEEeccCCcEEEEEeccch-----hhchHHHHHHHHHHHHHHhcC-C--CCcceeeeeecccccccc
Q 017909           35 IKPIGRGAYGVVCSSINRETNEKVAIKKINNV-----FENRIDALRTLRELVLLRHIK-H--DNVIALKDVMMPTHRISF  106 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  106 (364)
                      .+.||.|....||++.+..+++.+++|.-...     ........+...|+..|+.+. +  ..+++++.+.  .     
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~-----  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C-----
Confidence            45689999999999988877888999954311     001112223445777777662 2  2355555543  2     


Q ss_pred             ceEEEEeccccc
Q 017909          107 KDVYLVYELMDT  118 (364)
Q Consensus       107 ~~~~lv~e~~~g  118 (364)
                      ...++|||++++
T Consensus       104 ~~~~lvmE~L~~  115 (392)
T d2pula1         104 EMAVTVMEDLSH  115 (392)
T ss_dssp             TTTEEEECCCTT
T ss_pred             CCCEEEEeccCC
Confidence            334789999974

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.72  E-value=7.4e-05  Score=62.27  Aligned_cols=70  Identities=14%  Similarity=0.010  Sum_probs=43.9

Q ss_pred             eccCC-ceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC--CCCcceeeeeeccccccccceEEEEec
Q 017909           38 IGRGA-YGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIK--HDNVIALKDVMMPTHRISFKDVYLVYE  114 (364)
Q Consensus        38 lg~g~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (364)
                      +..|. .+.||++... ++..+++|........     .+..|+..++.+.  .-.+++++......     +..++||+
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~   86 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLG   86 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEE
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEE
Confidence            34444 4678988643 4666888987654322     2345666666653  23356667665554     67899999


Q ss_pred             cccc
Q 017909          115 LMDT  118 (364)
Q Consensus       115 ~~~g  118 (364)
                      +++|
T Consensus        87 ~i~G   90 (255)
T d1nd4a_          87 EVPG   90 (255)
T ss_dssp             CCSS
T ss_pred             eeec
Confidence            9976

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.20  E-value=0.0005  Score=61.24  Aligned_cols=71  Identities=17%  Similarity=0.119  Sum_probs=47.0

Q ss_pred             eeeeccCCceeEEEEEecc-------CCcEEEEEeccchhhchHHHHHHHHHHHHHHhcC-CCCcceeeeeecccccccc
Q 017909           35 IKPIGRGAYGVVCSSINRE-------TNEKVAIKKINNVFENRIDALRTLRELVLLRHIK-HDNVIALKDVMMPTHRISF  106 (364)
Q Consensus        35 ~~~lg~g~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (364)
                      ++.|+.|-.-.+|++....       .++.++++++... ....   ...+|..+++.+. +.-.+++++.+. +     
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~i---dr~~E~~i~~~ls~~gl~Pkll~~~~-~-----  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETES---HLVAESVIFTLLSERHLGPKLYGIFS-G-----  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHH---HHHHHHHHHHHHHHTTSSSCEEEEET-T-----
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhh---HHHHHHHHHHHHHhCCCCCeEEEEcC-C-----
Confidence            4678888889999997543       3467888887632 2222   2346777887774 444567777653 2     


Q ss_pred             ceEEEEeccccc
Q 017909          107 KDVYLVYELMDT  118 (364)
Q Consensus       107 ~~~~lv~e~~~g  118 (364)
                         ++|++|++|
T Consensus       117 ---g~I~efi~g  125 (395)
T d1nw1a_         117 ---GRLEEYIPS  125 (395)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---ceEEEEecc
Confidence               688898875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.08  E-value=0.0036  Score=53.84  Aligned_cols=72  Identities=15%  Similarity=-0.001  Sum_probs=39.6

Q ss_pred             ceeEEEEEeccCCcEEEEEeccchhhchHHHHHHHHHHHHHHhcCCCCc--ceeeeeeccccccccceEEEEeccccc
Q 017909           43 YGVVCSSINRETNEKVAIKKINNVFENRIDALRTLRELVLLRHIKHDNV--IALKDVMMPTHRISFKDVYLVYELMDT  118 (364)
Q Consensus        43 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~g  118 (364)
                      -..||+++. .+|..|++|+......+   ..++..|...+..+....+  +..+..............+.++++++|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            458999965 46788999998654333   2334556676666632222  222211111111112557888888865

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.54  E-value=0.0086  Score=50.97  Aligned_cols=30  Identities=23%  Similarity=0.294  Sum_probs=26.7

Q ss_pred             CccccCCCCCCeEEccCCcEEEeecCcccc
Q 017909          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (364)
Q Consensus       153 ~i~H~di~~~NIll~~~~~~~L~Dfg~~~~  182 (364)
                      |++|+|+.++||+++++...-|.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            599999999999999887778999998753